<SEC-DOCUMENT>0001493152-23-039934.txt : 20231108
<SEC-HEADER>0001493152-23-039934.hdr.sgml : 20231108
<ACCEPTANCE-DATETIME>20231108170111
ACCESSION NUMBER:		0001493152-23-039934
CONFORMED SUBMISSION TYPE:	S-1
PUBLIC DOCUMENT COUNT:		87
FILED AS OF DATE:		20231108
DATE AS OF CHANGE:		20231108

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Connexa Sports Technologies Inc.
		CENTRAL INDEX KEY:			0001674440
		STANDARD INDUSTRIAL CLASSIFICATION:	 [3949]
		IRS NUMBER:				611789640
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0430

	FILING VALUES:
		FORM TYPE:		S-1
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-275407
		FILM NUMBER:		231389060

	BUSINESS ADDRESS:	
		STREET 1:		2709 N ROLLING RD
		STREET 2:		UNIT 138 NEW WINDSOR
		CITY:			NEW WINDSOR
		STATE:			DE
		ZIP:			21244
		BUSINESS PHONE:		(443) 407-7564

	MAIL ADDRESS:	
		STREET 1:		2709 N ROLLING RD
		STREET 2:		UNIT 138 NEW WINDSOR
		CITY:			NEW WINDSOR
		STATE:			DE
		ZIP:			21244

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Slinger Bag Inc.
		DATE OF NAME CHANGE:	20220412

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Connexa Sports Technologies Inc.
		DATE OF NAME CHANGE:	20220412

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Slinger Bag Inc.
		DATE OF NAME CHANGE:	20191210
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1
<SEQUENCE>1
<FILENAME>froms-1.htm
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:CNXA="http://connexasports.com/20230731">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_03B_CNXA_connexasports.com_20230731 -->
<!-- Field: Set; Name: xdx; ID: xdx_043_20230501_20230731 -->
<!-- Field: Set; Name: xdx; ID: xdx_053_edei%2D%2DEntityCentralIndexKey_0001674440 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_076_XDX_form10%2Dk.xdx -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_064_Integer_5_Integer -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2023-05-01to2023-07-31" name="dei:EntityCentralIndexKey">0001674440</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-05-01to2023-07-31" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2023-07-31" id="xdx2ixbrl0070" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2023-07-31" id="xdx2ixbrl0154" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2023-04-30" id="xdx2ixbrl0155" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2023-05-01to2023-07-31" id="xdx2ixbrl0212" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="CNXA:LossOnConversionOfAccountsPayableToCommonStock" contextRef="From2022-05-012022-07-31" id="xdx2ixbrl0237" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2023-05-012023-07-31_us-gaap_RelatedPartyMember" id="xdx2ixbrl0248" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2023-05-012023-07-31_us-gaap_RelatedPartyMember" id="xdx2ixbrl0251" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" contextRef="From2023-05-01to2023-07-31" id="xdx2ixbrl0260" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" contextRef="From2023-05-01to2023-07-31" id="xdx2ixbrl0263" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" contextRef="From2023-05-01to2023-07-31" id="xdx2ixbrl0266" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2023-05-01to2023-07-31" id="xdx2ixbrl0272" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2022-05-012022-07-31" id="xdx2ixbrl0273" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" contextRef="From2023-05-01to2023-07-31" id="xdx2ixbrl0298" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" contextRef="From2023-05-01to2023-07-31" id="xdx2ixbrl0300" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" contextRef="From2022-05-012022-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0338" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" contextRef="From2022-05-012022-07-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0339" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2022-05-012022-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0346" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2022-05-012022-07-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0347" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-05-012022-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0354" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-05-012022-07-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0355" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-05-012022-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0362" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-05-012022-07-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0363" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2022-05-012022-07-31_us-gaap_CommonStockMember" id="xdx2ixbrl0368" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2022-05-012022-07-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0369" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2022-05-012022-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0370" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2022-05-012022-07-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0371" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2022-05-012022-07-31" id="xdx2ixbrl0372" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2022-05-012022-07-31_us-gaap_CommonStockMember" id="xdx2ixbrl0376" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2022-05-012022-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0378" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2022-05-012022-07-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0379" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2022-05-012022-07-31_us-gaap_CommonStockMember" id="xdx2ixbrl0382" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2022-05-012022-07-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0383" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2022-05-012022-07-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0385" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2022-05-012022-07-31_us-gaap_CommonStockMember" id="xdx2ixbrl0388" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2022-05-012022-07-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0389" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2022-05-012022-07-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0391" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-05-012022-07-31_us-gaap_CommonStockMember" id="xdx2ixbrl0394" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-05-012022-07-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0395" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-05-012022-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0396" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-05-012023-07-31_us-gaap_CommonStockMember" id="xdx2ixbrl0430" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-05-012023-07-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0431" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-05-012023-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0432" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-05-012023-07-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0433" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-05-01to2023-07-31" id="xdx2ixbrl0434" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="CNXA:StockIssuedDuringPeriodValueAccountsPayable" contextRef="From2023-05-012023-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0440" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="CNXA:StockIssuedDuringPeriodValueAccountsPayable" contextRef="From2023-05-012023-07-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0441" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2023-05-012023-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0448" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2023-05-012023-07-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0449" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2023-05-01to2023-07-31" id="xdx2ixbrl0450" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="CNXA:StockIssuedDuringPeriodValueCashlessExerciseOfWarrants" contextRef="From2023-05-012023-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0456" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="CNXA:StockIssuedDuringPeriodValueCashlessExerciseOfWarrants" contextRef="From2023-05-012023-07-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0457" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="CNXA:StockIssuedDuringPeriodValueCashlessExerciseOfWarrants" contextRef="From2023-05-01to2023-07-31" id="xdx2ixbrl0458" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="CNXA:StockIssuedDuringPeriodValueSatisfactionOfProfitGuaranteeOnNotePayable" contextRef="From2023-05-012023-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0464" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="CNXA:StockIssuedDuringPeriodValueSatisfactionOfProfitGuaranteeOnNotePayable" contextRef="From2023-05-012023-07-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0465" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2023-05-012023-07-31_us-gaap_CommonStockMember" id="xdx2ixbrl0470" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2023-05-012023-07-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0471" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2023-05-012023-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0472" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2023-05-012023-07-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0473" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2023-05-01to2023-07-31" id="xdx2ixbrl0474" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2023-05-012023-07-31_us-gaap_CommonStockMember" id="xdx2ixbrl0476" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2023-05-012023-07-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0477" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2023-05-012023-07-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0479" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2023-05-012023-07-31_us-gaap_CommonStockMember" id="xdx2ixbrl0482" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2023-05-012023-07-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0483" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2023-05-012023-07-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0485" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-05-012023-07-31_us-gaap_CommonStockMember" id="xdx2ixbrl0488" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-05-012023-07-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0489" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-05-012023-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0490" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2022-05-012022-07-31" id="xdx2ixbrl0520" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" contextRef="From2023-05-01to2023-07-31" id="xdx2ixbrl0525" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2023-05-01to2023-07-31" id="xdx2ixbrl0528" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="CNXA:SettlementExpense" contextRef="From2022-05-012022-07-31" id="xdx2ixbrl0550" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="CNXA:LossOnSettlementOfAccountsPayable" contextRef="From2022-05-012022-07-31" id="xdx2ixbrl0553" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="CNXA:GainLossOnIssuanceOfConvertibleNotes" contextRef="From2023-05-01to2023-07-31" id="xdx2ixbrl0555" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="CNXA:GainLossOnIssuanceOfConvertibleNotes" contextRef="From2022-05-012022-07-31" id="xdx2ixbrl0556" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2022-05-012022-07-31" id="xdx2ixbrl0562" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2022-05-012022-07-31" id="xdx2ixbrl0565" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="CNXA:IncreaseDecreaseInPrepaidInventory" contextRef="From2022-05-012022-07-31" id="xdx2ixbrl0568" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="From2022-05-012022-07-31" id="xdx2ixbrl0571" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" contextRef="From2022-05-012022-07-31" id="xdx2ixbrl0574" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" contextRef="From2022-05-012022-07-31" id="xdx2ixbrl0580" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInInterestPayableNet" contextRef="From2022-05-012022-07-31" id="xdx2ixbrl0583" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="CNXA:IncreaseDecreaseInInterestPayableRelatedParty" contextRef="From2023-05-01to2023-07-31" id="xdx2ixbrl0585" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="CNXA:IncreaseDecreaseInInterestPayableRelatedParty" contextRef="From2022-05-012022-07-31" id="xdx2ixbrl0586" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" contextRef="From2023-05-01to2023-07-31" id="xdx2ixbrl0594" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" contextRef="From2022-05-012022-07-31" id="xdx2ixbrl0595" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2023-05-01to2023-07-31" id="xdx2ixbrl0621" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromNotesPayable" contextRef="From2023-05-01to2023-07-31" id="xdx2ixbrl0627" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2023-05-01to2023-07-31" id="xdx2ixbrl0660" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2022-05-012022-07-31" id="xdx2ixbrl0661" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" contextRef="From2023-05-01to2023-07-31" id="xdx2ixbrl0663" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" contextRef="From2022-05-012022-07-31" id="xdx2ixbrl0664" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="CNXA:ConversionOfConvertibleNotesPayableAndAccruedInterestToCommonStock" contextRef="From2023-05-01to2023-07-31" id="xdx2ixbrl0672" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="CNXA:SharesIssuedForContingentConsideration" contextRef="From2023-05-01to2023-07-31" id="xdx2ixbrl0675" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="CNXA:SharesIssuedForSettlementOfAccountsPayable" contextRef="From2022-05-012022-07-31" id="xdx2ixbrl0688" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2023-05-012023-07-31_custom_ProfitGuarantyMember" id="xdx2ixbrl0787" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonNumeric contextRef="AsOf2023-07-31_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputExpectedTermMember" id="xdx2ixbrl0857" name="us-gaap:WarrantsAndRightsOutstandingTerm">P0Y</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2023-07-31_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_WarrantMember" id="xdx2ixbrl0863" unitRef="Pure" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2023-07-31_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputRiskFreeInterestRateMember" id="xdx2ixbrl0869" unitRef="Pure" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2023-07-31_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputExpectedDividendRateMember" id="xdx2ixbrl0875" unitRef="Pure" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2023-07-31_us-gaap_CustomerRelationshipsMember" id="xdx2ixbrl0905" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2023-07-31_us-gaap_ComputerSoftwareIntangibleAssetMember" id="xdx2ixbrl0911" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2023-04-30_us-gaap_CustomerRelationshipsMember" id="xdx2ixbrl0927" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2023-04-30_us-gaap_ComputerSoftwareIntangibleAssetMember" id="xdx2ixbrl0933" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2023-05-012023-07-31_us-gaap_RelatedPartyMember" id="xdx2ixbrl0980" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommodityContractAssetCurrent" contextRef="AsOf2023-04-30" id="xdx2ixbrl1286" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" contextRef="AsOf2023-04-30" id="xdx2ixbrl1292" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherReceivables" contextRef="AsOf2022-04-30" id="xdx2ixbrl1302" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2023-04-30" id="xdx2ixbrl1310" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" contextRef="AsOf2023-04-30" id="xdx2ixbrl1313" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PurchaseObligation" contextRef="AsOf2023-04-30" id="xdx2ixbrl1337" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="AsOf2023-04-30" id="xdx2ixbrl1340" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleNotesPayableCurrent" contextRef="AsOf2023-04-30" id="xdx2ixbrl1355" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" contextRef="AsOf2023-04-30" id="xdx2ixbrl1367" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent" contextRef="AsOf2023-04-30" id="xdx2ixbrl1379" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2023-04-30" id="xdx2ixbrl1388" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2022-04-30" id="xdx2ixbrl1389" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="From2022-05-012023-04-30" id="xdx2ixbrl1458" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="CNXA:GainLossOnIssuanceOfConvertibleNotes" contextRef="From2022-05-012023-04-30" id="xdx2ixbrl1461" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="CNXA:GainLossOnChangeInFairValueOfContingentConsideration" contextRef="From2022-05-012023-04-30" id="xdx2ixbrl1464" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="CNXA:DerivativeExpense" contextRef="From2021-05-012022-04-30" id="xdx2ixbrl1471" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" contextRef="From2021-05-012022-04-30" id="xdx2ixbrl1492" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2022-05-012023-04-30" id="xdx2ixbrl1500" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2021-05-012022-04-30" id="xdx2ixbrl1501" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="CNXA:StockIssuedDuringPeriodValueConversionofNotesPayableRelatedParties" contextRef="From2021-05-012022-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl1566" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="CNXA:StockIssuedDuringPeriodValueConversionofNotesPayableRelatedParties" contextRef="From2021-05-012022-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl1567" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2021-05-012022-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl1574" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2021-05-012022-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl1575" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" contextRef="From2021-05-012022-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl1582" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" contextRef="From2021-05-012022-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl1583" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2021-05-012022-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl1590" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2021-05-012022-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl1591" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2021-05-012022-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl1598" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2021-05-012022-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl1599" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2021-05-012022-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl1606" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2021-05-012022-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl1607" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" contextRef="From2021-05-012022-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl1612" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" contextRef="From2021-05-012022-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl1614" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" contextRef="From2021-05-012022-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl1615" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2021-05-012022-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember_custom_GamefaceLtdMember" id="xdx2ixbrl1618" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2021-05-012022-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember_custom_GamefaceLtdMember" id="xdx2ixbrl1620" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2021-05-012022-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember_custom_GamefaceLtdMember" id="xdx2ixbrl1621" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2021-05-012022-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember_custom_PlaySightInteractiveLtdMember" id="xdx2ixbrl1624" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2021-05-012022-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember_custom_PlaySightInteractiveLtdMember" id="xdx2ixbrl1626" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2021-05-012022-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember_custom_PlaySightInteractiveLtdMember" id="xdx2ixbrl1627" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2021-05-012022-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl1630" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2021-05-012022-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl1631" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2021-05-012022-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl1633" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-05-012022-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl1636" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-05-012022-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl1637" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-05-012022-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl1638" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2022-05-012023-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl1666" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2022-05-012023-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl1667" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2022-05-012023-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl1674" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2022-05-012023-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl1675" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-05-012023-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl1682" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-05-012023-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl1683" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-05-012023-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl1690" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-05-012023-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl1691" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="CNXA:StockIssuedDuringPeriodValueCashlessExerciseOfWarrants" contextRef="From2022-05-012023-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl1698" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="CNXA:StockIssuedDuringPeriodValueCashlessExerciseOfWarrants" contextRef="From2022-05-012023-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl1699" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="CNXA:StockIssuedDuringPeriodValueCashlessExerciseOfWarrants" contextRef="From2022-05-012023-04-30_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl1700" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2022-05-012023-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl1706" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2022-05-012023-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl1707" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2022-05-012023-04-30_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl1708" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2022-05-012023-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl1712" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2022-05-012023-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl1714" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2022-05-012023-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl1715" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2022-05-012023-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl1718" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2022-05-012023-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl1719" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2022-05-012023-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl1721" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2022-05-012023-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl1724" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2022-05-012023-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl1725" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2022-05-012023-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl1727" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-05-012023-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl1730" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-05-012023-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl1731" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-05-012023-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl1732" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:GainLossOnSaleOfOtherAssets" contextRef="From2021-05-012022-04-30" id="xdx2ixbrl1766" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="CNXA:GainLossOnChangeInFairValueOfContingentConsideration" contextRef="From2022-05-012023-04-30" id="xdx2ixbrl1768" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="From2022-05-012023-04-30" id="xdx2ixbrl1771" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="CNXA:DerivativeExpense" contextRef="From2021-05-012022-04-30" id="xdx2ixbrl1778" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="CNXA:GainLossOnIssuanceOfConvertibleNotes" contextRef="From2022-05-012023-04-30" id="xdx2ixbrl1783" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CashAcquiredFromAcquisition" contextRef="From2022-05-012023-04-30" id="xdx2ixbrl1831" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PaymentsToAcquireNotesReceivable" contextRef="From2022-05-012023-04-30" id="xdx2ixbrl1834" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" contextRef="From2022-05-012023-04-30" id="xdx2ixbrl1837" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" contextRef="From2022-05-012023-04-30" id="xdx2ixbrl1840" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2022-05-012023-04-30" id="xdx2ixbrl1843" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2021-05-012022-04-30" id="xdx2ixbrl1850" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PaymentsOfDebtIssuanceCosts" contextRef="From2022-05-012023-04-30" id="xdx2ixbrl1852" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="From2022-05-012023-04-30" id="xdx2ixbrl1858" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2022-05-012023-04-30" id="xdx2ixbrl1861" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RepaymentsOfRelatedPartyDebt" contextRef="From2021-05-012022-04-30" id="xdx2ixbrl1865" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" contextRef="From2022-05-012023-04-30" id="xdx2ixbrl1891" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssued1" contextRef="From2022-05-012023-04-30" id="xdx2ixbrl1897" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="CNXA:SharesIssuedForContingentConsideration" contextRef="From2021-05-012022-04-30" id="xdx2ixbrl1904" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="CNXA:EliminationOfRelatedPartyDerivativeLiabilities" contextRef="From2022-05-012023-04-30" id="xdx2ixbrl1906" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="CNXA:DerivativeLiabilitiesRecordedAsDebtDiscountsOfConvertibleNotes" contextRef="From2022-05-012023-04-30" id="xdx2ixbrl1909" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="CNXA:DerivativeLiabilityRecordedForSharesAndWarrantsIssuedInPrivatePlacement" contextRef="From2021-05-012022-04-30" id="xdx2ixbrl1913" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NotesIssued1" contextRef="From2021-05-012022-04-30" id="xdx2ixbrl1916" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DerivativeInstrumentsAndHedgesLiabilities" contextRef="AsOf2023-04-30_custom_OtherDerivativeLiabilitiesMember" id="xdx2ixbrl2020" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2023-04-30_us-gaap_CustomerRelationshipsMember" id="xdx2ixbrl2160" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2023-04-30_us-gaap_ComputerSoftwareIntangibleAssetMember" id="xdx2ixbrl2166" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" contextRef="From2021-05-012022-04-30_us-gaap_TradeNamesMember" id="xdx2ixbrl2175" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" contextRef="From2021-05-012022-04-30_us-gaap_CustomerRelationshipsMember" id="xdx2ixbrl2181" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" contextRef="From2021-05-012022-04-30_us-gaap_ComputerSoftwareIntangibleAssetMember" id="xdx2ixbrl2187" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" contextRef="From2021-05-012022-04-30_custom_IntangiableAssetMember" id="xdx2ixbrl2193" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonNumeric contextRef="AsOf2023-04-30_custom_MonteCarloSimulationMember" id="xdx2ixbrl2279" name="us-gaap:WarrantsAndRightsOutstandingTerm">P5Y</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-04-30" id="xdx2ixbrl2401" decimals="INF" unitRef="Shares">4194836</ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2022-05-012023-04-30" id="xdx2ixbrl2497" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="CNXA:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised" contextRef="From2022-05-012023-04-30" id="xdx2ixbrl2499" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2021-05-012022-04-30" id="xdx2ixbrl2501" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="CNXA:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised" contextRef="From2021-05-012022-04-30" id="xdx2ixbrl2503" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" contextRef="From2022-05-012023-04-30" id="xdx2ixbrl2505" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="CNXA:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceForfeited" contextRef="From2022-05-012023-04-30" id="xdx2ixbrl2507" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" contextRef="From2021-05-012022-04-30" id="xdx2ixbrl2509" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="CNXA:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceForfeited" contextRef="From2021-05-012022-04-30" id="xdx2ixbrl2511" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="CNXA:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExpired" contextRef="From2022-05-012023-04-30" id="xdx2ixbrl2515" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2021-05-012022-04-30" id="xdx2ixbrl2517" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="CNXA:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExpired" contextRef="From2021-05-012022-04-30" id="xdx2ixbrl2519" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="CNXA:DeferredTaxAssetsAccruedPayroll" contextRef="AsOf2022-04-30" id="xdx2ixbrl2570" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2023-04-30" id="xdx2ixbrl2590" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2022-04-30" id="xdx2ixbrl2591" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" contextRef="From2022-05-012023-04-30" id="xdx2ixbrl2598" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" contextRef="From2021-05-012022-04-30" id="xdx2ixbrl2599" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="CNXA:IncomeTaxRecociliationLossOnExtinguishmentOfDebt" contextRef="From2021-05-012022-04-30" id="xdx2ixbrl2629" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="CNXA:IncomeTaxRecociliationAccruedPayroll" contextRef="From2022-05-012023-04-30" id="xdx2ixbrl2631" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="CNXA:IncomeTaxRecociliationAccruedPayroll" contextRef="From2021-05-012022-04-30" id="xdx2ixbrl2632" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2022-05-012023-04-30" id="xdx2ixbrl2643" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2021-05-012022-04-30" id="xdx2ixbrl2644" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="CNXA:DeferredTaxAssetsStartupCostsForeign" contextRef="AsOf2023-04-30_country_IL" id="xdx2ixbrl2657" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="CNXA:DeferredTaxAssetsStartupCostsForeign" contextRef="AsOf2022-04-30_country_IL" id="xdx2ixbrl2658" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2023-04-30_country_IL" id="xdx2ixbrl2666" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2022-04-30_country_IL" id="xdx2ixbrl2667" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2022-05-012023-04-30_us-gaap_IsraelTaxAuthorityMember" id="xdx2ixbrl2679" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2021-05-012022-04-30_us-gaap_IsraelTaxAuthorityMember" id="xdx2ixbrl2680" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="CNXA:DisposalGroupIncludingDiscontinuedOperationOtherIncomeLoss" contextRef="From2022-05-012023-04-30" id="xdx2ixbrl2750" unitRef="USD" xs:nil="true"></ix:nonFraction>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="cnxa-20230731.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2023-05-01to2023-07-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2023-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012023-07-31_dei_BusinessContactMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2023-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-07-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-07-31_us-gaap_NonrelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_us-gaap_NonrelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-07-31_us-gaap_RelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_us-gaap_RelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-30_us-gaap_NonrelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-30_us-gaap_RelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-30_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012022-07-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2022-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012023-07-31_us-gaap_NonrelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2023-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012022-07-31_us-gaap_NonrelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2022-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012023-07-31_us-gaap_RelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2023-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012022-07-31_us-gaap_RelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2022-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012023-04-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-012022-04-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-01</xbrli:startDate>
        <xbrli:endDate>2022-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012023-04-30_us-gaap_NonrelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-012022-04-30_us-gaap_NonrelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-01</xbrli:startDate>
        <xbrli:endDate>2022-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012023-04-30_us-gaap_RelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-012022-04-30_us-gaap_RelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-01</xbrli:startDate>
        <xbrli:endDate>2022-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-04-30_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012022-07-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2022-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012022-07-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2022-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012022-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2022-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012022-07-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2022-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012023-07-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2023-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012023-07-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2023-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012023-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2023-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012023-07-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2023-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-012022-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-01</xbrli:startDate>
        <xbrli:endDate>2022-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-012022-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-01</xbrli:startDate>
        <xbrli:endDate>2022-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-012022-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-01</xbrli:startDate>
        <xbrli:endDate>2022-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-012022-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-01</xbrli:startDate>
        <xbrli:endDate>2022-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-012022-04-30_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-01</xbrli:startDate>
        <xbrli:endDate>2022-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-012022-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember_custom_GamefaceLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CNXA:GamefaceLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-01</xbrli:startDate>
        <xbrli:endDate>2022-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-012022-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember_custom_GamefaceLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CNXA:GamefaceLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-01</xbrli:startDate>
        <xbrli:endDate>2022-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-012022-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember_custom_GamefaceLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CNXA:GamefaceLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-01</xbrli:startDate>
        <xbrli:endDate>2022-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-012022-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember_custom_GamefaceLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CNXA:GamefaceLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-01</xbrli:startDate>
        <xbrli:endDate>2022-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-012022-04-30_srt_ScenarioPreviouslyReportedMember_custom_GamefaceLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CNXA:GamefaceLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-01</xbrli:startDate>
        <xbrli:endDate>2022-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-012022-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember_custom_PlaySightInteractiveLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CNXA:PlaySightInteractiveLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-01</xbrli:startDate>
        <xbrli:endDate>2022-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-012022-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember_custom_PlaySightInteractiveLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CNXA:PlaySightInteractiveLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-01</xbrli:startDate>
        <xbrli:endDate>2022-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-012022-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember_custom_PlaySightInteractiveLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CNXA:PlaySightInteractiveLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-01</xbrli:startDate>
        <xbrli:endDate>2022-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-012022-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember_custom_PlaySightInteractiveLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CNXA:PlaySightInteractiveLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-01</xbrli:startDate>
        <xbrli:endDate>2022-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-012022-04-30_srt_ScenarioPreviouslyReportedMember_custom_PlaySightInteractiveLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CNXA:PlaySightInteractiveLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-01</xbrli:startDate>
        <xbrli:endDate>2022-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012023-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012023-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012023-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012023-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012023-04-30_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-07-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-07-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-07-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-07-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-07-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-07-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-07-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-04-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-08-23_custom_SlingerBagAmericasIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">CNXA:SlingerBagAmericasIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-08-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-08-232019-08-23_custom_SlingerBagAmericasIncMember_custom_StockPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CNXA:SlingerBagAmericasIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:StockPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-08-23</xbrli:startDate>
        <xbrli:endDate>2019-08-23</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-08-23_custom_StockPurchaseAgreementMember_custom_SlingerBagAmericasIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:StockPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CNXA:SlingerBagAmericasIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-08-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-162019-09-16_custom_SlingerBagAmericasIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">CNXA:SlingerBagAmericasIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-16</xbrli:startDate>
        <xbrli:endDate>2019-09-16</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-09-16_custom_SlingerBagAmericasIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">CNXA:SlingerBagAmericasIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-09-16</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-162019-09-16_custom_SoleShareholderofSBLMember_custom_StockPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CNXA:SoleShareholderofSBLMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:StockPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-16</xbrli:startDate>
        <xbrli:endDate>2019-09-16</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-09-16_custom_SoleShareholderofSBLMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">CNXA:SoleShareholderofSBLMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-09-16</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-02-10_custom_SlingerBagAmericasIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">CNXA:SlingerBagAmericasIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-02-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-21_custom_FoundationSportsSystemsLLCMember_custom_CharlesRuddyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">CNXA:FoundationSportsSystemsLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:CharlesRuddyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-21</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-05_custom_FoundationSportsSystemsLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">CNXA:FoundationSportsSystemsLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-06-142022-06-14">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-06-14</xbrli:startDate>
        <xbrli:endDate>2022-06-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-07-26_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-07-26</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-08-232019-08-23_custom_SlingerBagAmericasIncMember_custom_StockPurchaseAgreementMember_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CNXA:SlingerBagAmericasIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:StockPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-08-23</xbrli:startDate>
        <xbrli:endDate>2019-08-23</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-162019-09-16_custom_SlingerBagAmericasIncMember_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">CNXA:SlingerBagAmericasIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-16</xbrli:startDate>
        <xbrli:endDate>2019-09-16</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-162019-09-16_custom_SoleShareholderofSBLMember_custom_StockPurchaseAgreementMember_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CNXA:SoleShareholderofSBLMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:StockPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-16</xbrli:startDate>
        <xbrli:endDate>2019-09-16</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-11-30_custom_PlaySightMember_custom_FoundationSportsSystemsLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">CNXA:PlaySightMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CNXA:FoundationSportsSystemsLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_PlaySightMember_custom_FoundationSportsSystemsLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">CNXA:PlaySightMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CNXA:FoundationSportsSystemsLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012023-07-31_custom_FoundationSportsSystemsLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CNXA:FoundationSportsSystemsLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2023-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-07-31_custom_FoundationSportsSystemsLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CNXA:FoundationSportsSystemsLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012023-04-30_custom_FoundationSportsSystemsLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CNXA:FoundationSportsSystemsLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_custom_FoundationSportsSystemsLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CNXA:FoundationSportsSystemsLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012023-07-31_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2023-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012023-04-30_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-012022-04-30_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-01</xbrli:startDate>
        <xbrli:endDate>2022-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012023-04-30_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-062023-01-06_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-06</xbrli:startDate>
        <xbrli:endDate>2023-01-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012023-07-31_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2023-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012023-04-30_us-gaap_WarrantMember30671140">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-07-31_custom_ProfitGuarantyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">CNXA:ProfitGuarantyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012023-07-31_custom_ProfitGuarantyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">CNXA:ProfitGuarantyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2023-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-07-31_custom_ConvertibleNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">CNXA:ConvertibleNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012023-07-31_custom_ConvertibleNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">CNXA:ConvertibleNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2023-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-07-31_custom_UnderwriterWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">CNXA:UnderwriterWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012023-07-31_custom_UnderwriterWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">CNXA:UnderwriterWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2023-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-07-31_custom_WarrantsIssuedWithCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">CNXA:WarrantsIssuedWithCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012023-07-31_custom_WarrantsIssuedWithCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">CNXA:WarrantsIssuedWithCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2023-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-07-31_custom_WarrantsIssuedWithNotesPayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">CNXA:WarrantsIssuedWithNotesPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012023-07-31_custom_WarrantsIssuedWithNotesPayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">CNXA:WarrantsIssuedWithNotesPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2023-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_custom_ProfitGuarantyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">CNXA:ProfitGuarantyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012023-04-30_custom_ProfitGuarantyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">CNXA:ProfitGuarantyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_custom_ConvertibleNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">CNXA:ConvertibleNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012023-04-30_custom_ConvertibleNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">CNXA:ConvertibleNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_custom_UnderwriterWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">CNXA:UnderwriterWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012023-04-30_custom_UnderwriterWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">CNXA:UnderwriterWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_custom_OtherDerivativeLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">CNXA:OtherDerivativeLiabilitiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012023-04-30_custom_OtherDerivativeLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">CNXA:OtherDerivativeLiabilitiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_custom_WarrantsIssuedWithCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">CNXA:WarrantsIssuedWithCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012023-04-30_custom_WarrantsIssuedWithCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">CNXA:WarrantsIssuedWithCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_custom_WarrantsIssuedWithNotesPayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">CNXA:WarrantsIssuedWithNotesPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012023-04-30_custom_WarrantsIssuedWithNotesPayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">CNXA:WarrantsIssuedWithNotesPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012023-07-31_srt_MinimumMember_us-gaap_MeasurementInputExpectedTermMember_us-gaap_ValuationTechniqueOptionPricingModelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2023-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012023-07-31_srt_MaximumMember_us-gaap_MeasurementInputExpectedTermMember_us-gaap_ValuationTechniqueOptionPricingModelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2023-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012022-07-31_srt_MinimumMember_us-gaap_MeasurementInputExpectedTermMember_us-gaap_ValuationTechniqueOptionPricingModelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2022-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012022-07-31_srt_MaximumMember_us-gaap_MeasurementInputExpectedTermMember_us-gaap_ValuationTechniqueOptionPricingModelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2022-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-07-31_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ValuationTechniqueOptionPricingModelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-07-31_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ValuationTechniqueOptionPricingModelMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-07-31_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ValuationTechniqueOptionPricingModelMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-07-31_srt_MinimumMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_us-gaap_ValuationTechniqueOptionPricingModelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-07-31_srt_MaximumMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_us-gaap_ValuationTechniqueOptionPricingModelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-07-31_srt_MinimumMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_us-gaap_ValuationTechniqueOptionPricingModelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-07-31_srt_MaximumMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_us-gaap_ValuationTechniqueOptionPricingModelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-07-31_us-gaap_MeasurementInputExpectedDividendRateMember_us-gaap_ValuationTechniqueOptionPricingModelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-07-31_us-gaap_MeasurementInputExpectedDividendRateMember_us-gaap_ValuationTechniqueOptionPricingModelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012023-04-30_srt_MinimumMember_us-gaap_MeasurementInputExpectedTermMember_us-gaap_ValuationTechniqueOptionPricingModelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012023-04-30_srt_MaximumMember_us-gaap_MeasurementInputExpectedTermMember_us-gaap_ValuationTechniqueOptionPricingModelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-012022-04-30_srt_MinimumMember_us-gaap_MeasurementInputExpectedTermMember_us-gaap_ValuationTechniqueOptionPricingModelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-01</xbrli:startDate>
        <xbrli:endDate>2022-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-012022-04-30_srt_MaximumMember_us-gaap_MeasurementInputExpectedTermMember_us-gaap_ValuationTechniqueOptionPricingModelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-01</xbrli:startDate>
        <xbrli:endDate>2022-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ValuationTechniqueOptionPricingModelMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ValuationTechniqueOptionPricingModelMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-30_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ValuationTechniqueOptionPricingModelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_srt_MinimumMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_us-gaap_ValuationTechniqueOptionPricingModelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_srt_MaximumMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_us-gaap_ValuationTechniqueOptionPricingModelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-30_srt_MinimumMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_us-gaap_ValuationTechniqueOptionPricingModelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-30_srt_MaximumMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_us-gaap_ValuationTechniqueOptionPricingModelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_us-gaap_MeasurementInputExpectedDividendRateMember_us-gaap_ValuationTechniqueOptionPricingModelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-30_us-gaap_MeasurementInputExpectedDividendRateMember_us-gaap_ValuationTechniqueOptionPricingModelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-07-31_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputExpectedTermMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-07-31_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputExpectedTermMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-07-31_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputExpectedTermMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-07-31_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-07-31_srt_MinimumMember_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-07-31_srt_MaximumMember_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-07-31_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputRiskFreeInterestRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-07-31_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-07-31_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-07-31_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputExpectedDividendRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-07-31_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputExpectedDividendRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputExpectedTermMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputExpectedTermMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-30_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputExpectedTermMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-30_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputExpectedTermMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_srt_MinimumMember_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_srt_MaximumMember_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-30_srt_MinimumMember_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-30_srt_MaximumMember_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-30_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-30_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputExpectedDividendRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-30_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputExpectedDividendRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012023-07-31_us-gaap_AccountsReceivableMember_us-gaap_CreditConcentrationRiskMember_custom_CustomerTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">CNXA:CustomerTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2023-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012023-04-30_us-gaap_AccountsReceivableMember_us-gaap_CreditConcentrationRiskMember_custom_CustomerTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">CNXA:CustomerTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012023-07-31_us-gaap_LenderConcentrationRiskMember_custom_CustomerFourMember_us-gaap_AccountsPayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:LenderConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">CNXA:CustomerFourMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2023-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012023-04-30_us-gaap_LenderConcentrationRiskMember_custom_CustomerFourMember_us-gaap_AccountsPayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:LenderConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">CNXA:CustomerFourMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012023-04-30_us-gaap_AccountsReceivableMember_us-gaap_CreditConcentrationRiskMember_custom_CustomerOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">CNXA:CustomerOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-012022-04-30_us-gaap_AccountsReceivableMember_us-gaap_CreditConcentrationRiskMember_custom_CustomerTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">CNXA:CustomerTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-01</xbrli:startDate>
        <xbrli:endDate>2022-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-012022-04-30_us-gaap_LenderConcentrationRiskMember_custom_CustomerFourMember_us-gaap_AccountsPayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:LenderConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">CNXA:CustomerFourMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-01</xbrli:startDate>
        <xbrli:endDate>2022-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-07-31_custom_TradeNamesAndPatentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">CNXA:TradeNamesAndPatentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012023-07-31_custom_TradeNamesAndPatentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">CNXA:TradeNamesAndPatentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2023-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-07-31_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012023-07-31_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2023-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-07-31_us-gaap_ComputerSoftwareIntangibleAssetMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012023-07-31_us-gaap_ComputerSoftwareIntangibleAssetMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2023-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-07-31_custom_IntangiableAssetMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">CNXA:IntangiableAssetMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012023-07-31_custom_IntangiableAssetMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">CNXA:IntangiableAssetMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2023-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_custom_TradeNamesAndPatentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">CNXA:TradeNamesAndPatentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012023-04-30_custom_TradeNamesAndPatentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">CNXA:TradeNamesAndPatentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012023-04-30_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_us-gaap_ComputerSoftwareIntangibleAssetMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012023-04-30_us-gaap_ComputerSoftwareIntangibleAssetMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_custom_IntangiableAssetMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">CNXA:IntangiableAssetMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012023-04-30_custom_IntangiableAssetMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">CNXA:IntangiableAssetMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_us-gaap_TradeNamesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012023-04-30_us-gaap_TradeNamesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-30_us-gaap_TradeNamesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-012022-04-30_us-gaap_TradeNamesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-01</xbrli:startDate>
        <xbrli:endDate>2022-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-30_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-012022-04-30_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-01</xbrli:startDate>
        <xbrli:endDate>2022-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-30_us-gaap_ComputerSoftwareIntangibleAssetMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-012022-04-30_us-gaap_ComputerSoftwareIntangibleAssetMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-01</xbrli:startDate>
        <xbrli:endDate>2022-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-30_custom_IntangiableAssetMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">CNXA:IntangiableAssetMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-012022-04-30_custom_IntangiableAssetMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">CNXA:IntangiableAssetMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-01</xbrli:startDate>
        <xbrli:endDate>2022-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012023-07-31_custom_FoundationSportsSystemsLLCMember30673109">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">CNXA:FoundationSportsSystemsLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2023-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-07-31_us-gaap_PatentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-14_custom_LoanAgreementsMember_us-gaap_RelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:LoanAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-132022-01-14_custom_LoanAgreementsMember_us-gaap_RelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:LoanAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-13</xbrli:startDate>
        <xbrli:endDate>2022-01-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-062023-01-06_us-gaap_RelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-06</xbrli:startDate>
        <xbrli:endDate>2023-01-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-01-06">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-01-06</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-06-172022-06-17">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-06-17</xbrli:startDate>
        <xbrli:endDate>2022-06-17</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-17">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-17</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-08-06_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-08-06</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-052021-08-06_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-05</xbrli:startDate>
        <xbrli:endDate>2021-08-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_custom_MonteCarloSimulationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">CNXA:MonteCarloSimulationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-012021-10-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-01</xbrli:startDate>
        <xbrli:endDate>2021-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-12-302021-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-12-30</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-30_custom_OmnibusAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:OmnibusAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-012022-04-30_custom_OmnibusAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:OmnibusAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-01</xbrli:startDate>
        <xbrli:endDate>2022-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-06-162022-06-17">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-06-16</xbrli:startDate>
        <xbrli:endDate>2022-06-17</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-17_custom_ConvertibleNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CNXA:ConvertibleNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-17</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-102021-04-11_custom_PromissoryNotePayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CNXA:PromissoryNotePayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-10</xbrli:startDate>
        <xbrli:endDate>2021-04-11</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-04-11_custom_PromissoryNotePayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CNXA:PromissoryNotePayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-04-11</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-102021-04-11">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-10</xbrli:startDate>
        <xbrli:endDate>2021-04-11</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-04-11_us-gaap_ValuationTechniqueOptionPricingModelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-04-11</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_custom_PromissoryNotePayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CNXA:PromissoryNotePayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-30_custom_PromissoryNotePayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CNXA:PromissoryNotePayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-02-142022-02-15">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-02-14</xbrli:startDate>
        <xbrli:endDate>2022-02-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-012022-07-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-01</xbrli:startDate>
        <xbrli:endDate>2022-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-01_custom_NotesPayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CNXA:NotesPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-04-01">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-04-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-08-012022-08-01">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-08-01</xbrli:startDate>
        <xbrli:endDate>2022-08-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-292022-07-29_custom_UFSAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:UFSAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-29</xbrli:startDate>
        <xbrli:endDate>2022-07-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-292022-07-29_custom_UFSAgreementMember_custom_EachWeekForNextThreeWeeksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:UFSAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">CNXA:EachWeekForNextThreeWeeksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-29</xbrli:startDate>
        <xbrli:endDate>2022-07-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-292022-07-29_custom_UFSAgreementMember_custom_ThereafterPerWeekMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:UFSAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">CNXA:ThereafterPerWeekMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-29</xbrli:startDate>
        <xbrli:endDate>2022-07-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-292022-07-29_custom_CedarAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:CedarAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-29</xbrli:startDate>
        <xbrli:endDate>2022-07-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-292022-07-29_custom_CedarAgreementMember_custom_EachWeekForNextThreeWeeksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:CedarAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">CNXA:EachWeekForNextThreeWeeksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-29</xbrli:startDate>
        <xbrli:endDate>2022-07-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-292022-07-29_custom_CedarAgreementMember_custom_ThereafterPerWeekMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:CedarAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">CNXA:ThereafterPerWeekMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-29</xbrli:startDate>
        <xbrli:endDate>2022-07-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-01-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">CNXA:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-01-06</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-042023-01-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember_custom_NotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">CNXA:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">CNXA:NotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-04</xbrli:startDate>
        <xbrli:endDate>2023-01-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-01-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">CNXA:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-01-06</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-042023-01-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">CNXA:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-04</xbrli:startDate>
        <xbrli:endDate>2023-01-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-062023-01-06_us-gaap_WarrantMember_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">CNXA:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-06</xbrli:startDate>
        <xbrli:endDate>2023-01-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-01-06_us-gaap_WarrantMember_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">CNXA:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-01-06</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-312023-07-31_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">CNXA:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-31</xbrli:startDate>
        <xbrli:endDate>2023-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-07-31_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">CNXA:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">CNXA:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012023-07-31_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">CNXA:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2023-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-06-082023-06-08_custom_MegedAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:MegedAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-06-08</xbrli:startDate>
        <xbrli:endDate>2023-06-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_custom_LoanAgreementMember_custom_MontsaicInvestmentsLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:LoanAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">CNXA:MontsaicInvestmentsLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-24_custom_PromissoryNotePayableMember_custom_ThirdPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CNXA:PromissoryNotePayableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:ThirdPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-24</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-102021-04-11_custom_PromissoryNotePayableMember_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CNXA:PromissoryNotePayableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-10</xbrli:startDate>
        <xbrli:endDate>2021-04-11</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-30_custom_PromissoryNotePayableMember_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CNXA:PromissoryNotePayableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-302023-04-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-30</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-01-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">CNXA:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-01-06</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-062023-01-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">CNXA:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-06</xbrli:startDate>
        <xbrli:endDate>2023-01-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-01-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember_srt_MaximumMember_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">CNXA:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-01-06</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-302023-04-30_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">CNXA:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-30</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">CNXA:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012023-04-30_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">CNXA:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-07-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">CNXA:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-07-06</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-07-31_us-gaap_RelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-06-152022-06-15">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-06-15</xbrli:startDate>
        <xbrli:endDate>2022-06-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-06-152022-06-15_us-gaap_InvestorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-06-15</xbrli:startDate>
        <xbrli:endDate>2022-06-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-06-272022-06-27_custom_GabrielGoldmanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:GabrielGoldmanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-06-27</xbrli:startDate>
        <xbrli:endDate>2022-06-27</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-06-272022-06-27_custom_GamefaceAIMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">CNXA:GamefaceAIMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-06-27</xbrli:startDate>
        <xbrli:endDate>2022-06-27</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-08-252022-08-25_custom_MidcityCapitalLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">CNXA:MidcityCapitalLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-08-25</xbrli:startDate>
        <xbrli:endDate>2022-08-25</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-09-282022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-09-28</xbrli:startDate>
        <xbrli:endDate>2022-09-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_custom_FiveYearWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">CNXA:FiveYearWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-09-282022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_custom_SevenYearWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">CNXA:SevenYearWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-09-28</xbrli:startDate>
        <xbrli:endDate>2022-09-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_custom_SevenPointFiveYearWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">CNXA:SevenPointFiveYearWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-10-122022-10-12">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-10-12</xbrli:startDate>
        <xbrli:endDate>2022-10-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-11-212022-11-21">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-11-21</xbrli:startDate>
        <xbrli:endDate>2022-11-21</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-262023-01-26">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-26</xbrli:startDate>
        <xbrli:endDate>2023-01-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-09-282022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_custom_SevenPointFiveYearWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">CNXA:SevenPointFiveYearWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-09-28</xbrli:startDate>
        <xbrli:endDate>2022-09-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-01-31_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-10-31_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012022-05-01">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2022-05-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-06-152022-06-15_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-06-15</xbrli:startDate>
        <xbrli:endDate>2022-06-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-06-152022-06-15_us-gaap_InvestorMember_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-06-15</xbrli:startDate>
        <xbrli:endDate>2022-06-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-06-272022-06-27_custom_GabrielGoldmanMember_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:GabrielGoldmanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-06-27</xbrli:startDate>
        <xbrli:endDate>2022-06-27</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-06-272022-06-27_custom_GamefaceAIMember_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">CNXA:GamefaceAIMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-06-27</xbrli:startDate>
        <xbrli:endDate>2022-06-27</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-08-252022-08-25_custom_MidcityCapitalLtdMember_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">CNXA:MidcityCapitalLtdMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-08-25</xbrli:startDate>
        <xbrli:endDate>2022-08-25</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-09-282022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-09-28</xbrli:startDate>
        <xbrli:endDate>2022-09-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_custom_FiveYearWarrantsMember_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">CNXA:FiveYearWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-09-282022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_custom_SevenYearWarrantsMember_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">CNXA:SevenYearWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-09-28</xbrli:startDate>
        <xbrli:endDate>2022-09-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_custom_SevenPointFiveYearWarrantsMember_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">CNXA:SevenPointFiveYearWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-10-31_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-10-122022-10-12_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-10-12</xbrli:startDate>
        <xbrli:endDate>2022-10-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-11-212022-11-21_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-11-21</xbrli:startDate>
        <xbrli:endDate>2022-11-21</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-262023-01-26_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-26</xbrli:startDate>
        <xbrli:endDate>2023-01-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-252021-05-26_custom_RelatedPartyLenderMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:RelatedPartyLenderMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-25</xbrli:startDate>
        <xbrli:endDate>2021-05-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-06-222021-06-23_custom_FoundationSportsSystemsLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CNXA:FoundationSportsSystemsLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-06-22</xbrli:startDate>
        <xbrli:endDate>2021-06-23</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-052021-07-06_custom_ServicesRenderedInLieuOfCashMember_custom_TwoEmployeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">CNXA:ServicesRenderedInLieuOfCashMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:TwoEmployeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-05</xbrli:startDate>
        <xbrli:endDate>2021-07-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-012022-04-30_custom_ServicesRenderedInLieuOfCashMember_custom_TwoEmployeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">CNXA:ServicesRenderedInLieuOfCashMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:TwoEmployeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-01</xbrli:startDate>
        <xbrli:endDate>2022-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-092021-07-11_custom_MarketingAndAdvisoryServicesMember_custom_VendorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">CNXA:MarketingAndAdvisoryServicesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:VendorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-09</xbrli:startDate>
        <xbrli:endDate>2021-07-11</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-012022-04-30_custom_MarketingAndAdvisoryServicesMember_custom_VendorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">CNXA:MarketingAndAdvisoryServicesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:VendorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-01</xbrli:startDate>
        <xbrli:endDate>2022-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-012021-07-31_custom_AsCompensationMember_custom_SixNewBrandAmbassadorsMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">CNXA:AsCompensationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:SixNewBrandAmbassadorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-01</xbrli:startDate>
        <xbrli:endDate>2021-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-012021-07-31_srt_MaximumMember_custom_AsCompensationMember_custom_SixNewBrandAmbassadorsMember_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">CNXA:AsCompensationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:SixNewBrandAmbassadorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-01</xbrli:startDate>
        <xbrli:endDate>2021-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-012022-04-30_custom_BrandAmbassadorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:BrandAmbassadorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-01</xbrli:startDate>
        <xbrli:endDate>2022-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-08-06_custom_NotePayableHolderMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CNXA:NotePayableHolderMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-08-06</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-052021-08-06_custom_NotePayableHolderMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CNXA:NotePayableHolderMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-05</xbrli:startDate>
        <xbrli:endDate>2021-08-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-08-06_custom_RelatedPartyLenderMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">CNXA:RelatedPartyLenderMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-08-06</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-052021-08-06_custom_RelatedPartyLenderMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">CNXA:RelatedPartyLenderMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-05</xbrli:startDate>
        <xbrli:endDate>2021-08-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-10-102021-10-11_custom_MarketingAndAdvisoryServicesMember_custom_VendorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">CNXA:MarketingAndAdvisoryServicesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:VendorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-10-10</xbrli:startDate>
        <xbrli:endDate>2021-10-11</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-102022-01-11_custom_MarketingAndAdvisoryServicesMember_custom_VendorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">CNXA:MarketingAndAdvisoryServicesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:VendorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-10</xbrli:startDate>
        <xbrli:endDate>2022-01-11</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-012022-04-30_custom_MarketingAndAdvisoryServicesMember_custom_VendorOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">CNXA:MarketingAndAdvisoryServicesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:VendorOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-01</xbrli:startDate>
        <xbrli:endDate>2022-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-04-30_us-gaap_CommonStockMember_custom_KeyEmployeesAndOfficersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:KeyEmployeesAndOfficersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-012022-04-30_us-gaap_CommonStockMember_custom_KeyEmployeesAndOfficersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:KeyEmployeesAndOfficersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-01</xbrli:startDate>
        <xbrli:endDate>2022-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-10-272020-10-28_us-gaap_WarrantMember_custom_ServiceProviderMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:ServiceProviderMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-10-27</xbrli:startDate>
        <xbrli:endDate>2020-10-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-28_custom_ServiceProviderMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:ServiceProviderMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-012022-01-31_us-gaap_WarrantMember_custom_ThreeMembersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:ThreeMembersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-29_custom_AsCompensationMember_custom_ThreeMembersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">CNXA:AsCompensationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:ThreeMembersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012023-01-31_custom_AsCompensationMember_custom_ThreeMembersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">CNXA:AsCompensationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:ThreeMembersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2023-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-012022-04-30_custom_AsCompensationMember_custom_ThreeMembersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">CNXA:AsCompensationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:ThreeMembersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-01</xbrli:startDate>
        <xbrli:endDate>2022-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-08-06_custom_SecuritiesPurchaseAgreementMember30681312">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">CNXA:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-08-06</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-08-06_us-gaap_WarrantMember_custom_LeadPlacementAgentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:LeadPlacementAgentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-08-06</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-012022-04-30_us-gaap_WarrantMember_custom_LeadPlacementAgentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:LeadPlacementAgentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-01</xbrli:startDate>
        <xbrli:endDate>2022-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-09-032021-09-03_custom_AsCompensationMember_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">CNXA:AsCompensationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-09-03</xbrli:startDate>
        <xbrli:endDate>2021-09-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-03_us-gaap_WarrantMember_custom_KeyEmployeesAndOfficersMember_custom_ExercisePriceOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:KeyEmployeesAndOfficersMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">CNXA:ExercisePriceOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-09-032021-09-03_us-gaap_WarrantMember_custom_LeadPlacementAgentMember_custom_ExercisePriceOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:LeadPlacementAgentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">CNXA:ExercisePriceOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-09-03</xbrli:startDate>
        <xbrli:endDate>2021-09-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-03_us-gaap_WarrantMember_custom_KeyEmployeesAndOfficersMember_custom_ExercisePriceTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:KeyEmployeesAndOfficersMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">CNXA:ExercisePriceTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-09-032021-09-03_us-gaap_WarrantMember_custom_KeyEmployeesAndOfficersMember_custom_ExercisePriceTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:KeyEmployeesAndOfficersMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">CNXA:ExercisePriceTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-09-03</xbrli:startDate>
        <xbrli:endDate>2021-09-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-03_us-gaap_WarrantMember_custom_KeyEmployeesAndOfficersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:KeyEmployeesAndOfficersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-012022-04-30_us-gaap_WarrantMember_custom_KeyEmployeesAndOfficersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:KeyEmployeesAndOfficersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-01</xbrli:startDate>
        <xbrli:endDate>2022-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-02-022022-02-02_custom_GamefaceMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CNXA:GamefaceMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-02-02</xbrli:startDate>
        <xbrli:endDate>2022-02-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_custom_SevenYearWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">CNXA:SevenYearWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-01-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-06-012022-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-06-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-01-31_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-06-012022-06-30_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-06-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-11-252022-11-27_custom_SharePurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:SharePurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-11-25</xbrli:startDate>
        <xbrli:endDate>2022-11-27</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-11-27_custom_EmployeeAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:EmployeeAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-11-27</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-11-27_custom_SharePurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:SharePurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-11-27</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-05_custom_FoundationSportsToCharlesRuddyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">CNXA:FoundationSportsToCharlesRuddyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-05">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-08-012023-08-01_us-gaap_CommonStockMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-08-01</xbrli:startDate>
        <xbrli:endDate>2023-08-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-08-172023-08-17_us-gaap_CommonStockMember_us-gaap_SubsequentEventMember_custom_RodneyRapsonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">CNXA:RodneyRapsonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-08-17</xbrli:startDate>
        <xbrli:endDate>2023-08-17</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-08-312023-08-31_us-gaap_CommonStockMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-08-31</xbrli:startDate>
        <xbrli:endDate>2023-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-09-182023-09-18_us-gaap_CommonStockMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-09-18</xbrli:startDate>
        <xbrli:endDate>2023-09-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-09-192023-09-19_us-gaap_CommonStockMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-09-19</xbrli:startDate>
        <xbrli:endDate>2023-09-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-08-072023-08-07_us-gaap_SubsequentEventMember_custom_UFSAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:UFSAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-08-07</xbrli:startDate>
        <xbrli:endDate>2023-08-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-08-072023-08-07_us-gaap_SubsequentEventMember_custom_UFSAgreementMember_custom_EachWeekForNextThreeWeeksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:UFSAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">CNXA:EachWeekForNextThreeWeeksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-08-07</xbrli:startDate>
        <xbrli:endDate>2023-08-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-08-212023-08-21_custom_AmendedUFSAgreementMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:AmendedUFSAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-08-21</xbrli:startDate>
        <xbrli:endDate>2023-08-21</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-09-192023-09-19_us-gaap_SubsequentEventMember_custom_SecondMegedAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:SecondMegedAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-09-19</xbrli:startDate>
        <xbrli:endDate>2023-09-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-09-192023-09-19_us-gaap_SubsequentEventMember_custom_SecondMegedAgreementMember_custom_EachWeekForNextThreeWeeksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:SecondMegedAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">CNXA:EachWeekForNextThreeWeeksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-09-19</xbrli:startDate>
        <xbrli:endDate>2023-09-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-05-01_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-05-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-012023-05-01_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2023-05-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-06-082023-06-08_us-gaap_SubsequentEventMember_custom_MegedAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:MegedAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-06-08</xbrli:startDate>
        <xbrli:endDate>2023-06-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-06-082023-06-08_us-gaap_SubsequentEventMember_custom_MegedAgreementMember_custom_EachWeekForNextThreeWeeksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:MegedAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">CNXA:EachWeekForNextThreeWeeksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-06-08</xbrli:startDate>
        <xbrli:endDate>2023-06-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-09-122023-09-13_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-09-12</xbrli:startDate>
        <xbrli:endDate>2023-09-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-13_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-13</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-10-022022-10-03_custom_PreFundedWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">CNXA:PreFundedWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-10-02</xbrli:startDate>
        <xbrli:endDate>2022-10-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-10-03_custom_PreFundedWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">CNXA:PreFundedWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-10-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-10-022022-10-03_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-10-02</xbrli:startDate>
        <xbrli:endDate>2022-10-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-10-03_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-10-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-10-022022-10-03_custom_WarrantOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">CNXA:WarrantOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-10-02</xbrli:startDate>
        <xbrli:endDate>2022-10-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-10-03_custom_WarrantOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">CNXA:WarrantOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-10-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-10-03_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-10-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-10-022022-10-03_custom_WarrantTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">CNXA:WarrantTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-10-02</xbrli:startDate>
        <xbrli:endDate>2022-10-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-10-03_custom_WarrantTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">CNXA:WarrantTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-10-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-10-03">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-10-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_FoundationSportsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CNXA:FoundationSportsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-11-30_custom_PlaySightMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CNXA:PlaySightMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012023-04-30_custom_PlaySightAndGameFaceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CNXA:PlaySightAndGameFaceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012023-04-30_country_US">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_country_US">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-30_country_US">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012023-04-30_country_IL">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_country_IL">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-30_country_IL">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-012023-04-30_us-gaap_IsraelTaxAuthorityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:IsraelTaxAuthorityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-012022-04-30_us-gaap_IsraelTaxAuthorityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:IsraelTaxAuthorityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-01</xbrli:startDate>
        <xbrli:endDate>2022-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-012022-04-30_country_IL">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-01</xbrli:startDate>
        <xbrli:endDate>2022-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_custom_PlaySightAndFoundationSportsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001674440</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">CNXA:PlaySightAndFoundationSportsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Integer">
      <xbrli:measure>CNXA:Integer</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As
Filed with Securities and Exchange Commission on November 8, 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Registration
No. 333- </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 4pt solid; font-size: 1pt; border-bottom: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>WASHINGTON,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_905_edei--DocumentType_c20230501__20230731_zMI0QFK0KxP2"><ix:nonNumeric contextRef="From2023-05-01to2023-07-31" name="dei:DocumentType">S-1</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>REGISTRATION
STATEMENT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>UNDER</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
SECURITIES ACT OF 1933</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_909_edei--EntityRegistrantName_c20230501__20230731_zQc0QUFuGJh"><ix:nonNumeric contextRef="From2023-05-01to2023-07-31" name="dei:EntityRegistrantName">CONNEXA
SPORTS TECHNOLOGIES, INC.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90D_edei--EntityIncorporationStateCountryCode_c20230501__20230731_zhVqbskhdCla"><ix:nonNumeric contextRef="From2023-05-01to2023-07-31" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3949</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_909_edei--EntityTaxIdentificationNumber_c20230501__20230731_z0EPuq8Z9BZg"><ix:nonNumeric contextRef="From2023-05-01to2023-07-31" name="dei:EntityTaxIdentificationNumber">61-1789640</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or other jurisdiction of<br />
    incorporation or organization)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Primary
    Standard Industrial<br />
    Classification Code Number)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
    Employer<br />
    Identification Number)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_903_edei--EntityAddressAddressLine1_c20230501__20230731_zewDQEF7A988"><ix:nonNumeric contextRef="From2023-05-01to2023-07-31" name="dei:EntityAddressAddressLine1">2709
N. Rolling Road</ix:nonNumeric></span>, <span id="xdx_90B_edei--EntityAddressAddressLine2_c20230501__20230731_zJ7PozHGDhKk"><ix:nonNumeric contextRef="From2023-05-01to2023-07-31" name="dei:EntityAddressAddressLine2">Suite 138</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90A_edei--EntityAddressCityOrTown_c20230501__20230731_zbsm9CeEA4v4"><ix:nonNumeric contextRef="From2023-05-01to2023-07-31" name="dei:EntityAddressCityOrTown">Windsor
Mill</ix:nonNumeric></span>, <span id="xdx_906_edei--EntityAddressStateOrProvince_c20230501__20230731_zZFEICglAsO8"><ix:nonNumeric contextRef="From2023-05-01to2023-07-31" name="dei:EntityAddressStateOrProvince">MD</ix:nonNumeric></span> <span id="xdx_90C_edei--EntityAddressPostalZipCode_c20230501__20230731_zVjxcITO2mN8"><ix:nonNumeric contextRef="From2023-05-01to2023-07-31" name="dei:EntityAddressPostalZipCode">21244</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span><span id="xdx_907_edei--CityAreaCode_c20230501__20230731_z5JXQTqjMY93"><ix:nonNumeric contextRef="From2023-05-01to2023-07-31" name="dei:CityAreaCode">(443)</ix:nonNumeric></span></span>
<span id="xdx_900_edei--LocalPhoneNumber_c20230501__20230731_z8loDVO9XTM6"><ix:nonNumeric contextRef="From2023-05-01to2023-07-31" name="dei:LocalPhoneNumber">407-7564</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
and telephone number of registrant&#8217;s principal executive offices)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90B_edei--ContactPersonnelName_c20230501__20230731__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zcw2p8e1hW7c"><ix:nonNumeric contextRef="From2023-05-012023-07-31_dei_BusinessContactMember" name="dei:ContactPersonnelName">Vcorp
Services LLC</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_907_edei--EntityAddressAddressLine1_c20230501__20230731__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zvWAeHPC1ym1"><ix:nonNumeric contextRef="From2023-05-012023-07-31_dei_BusinessContactMember" name="dei:EntityAddressAddressLine1">1013
Centre Road</ix:nonNumeric></span>, <span id="xdx_906_edei--EntityAddressAddressLine2_c20230501__20230731__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zRI2dMuwFPjj"><ix:nonNumeric contextRef="From2023-05-012023-07-31_dei_BusinessContactMember" name="dei:EntityAddressAddressLine2">Suite 403-B</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90A_edei--EntityAddressCityOrTown_c20230501__20230731__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_z2pB7YBITbb"><ix:nonNumeric contextRef="From2023-05-012023-07-31_dei_BusinessContactMember" name="dei:EntityAddressCityOrTown">Wilmington</ix:nonNumeric></span>,
<span id="xdx_907_edei--EntityAddressStateOrProvince_c20230501__20230731__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zGay1xyzgmAl"><ix:nonNumeric contextRef="From2023-05-012023-07-31_dei_BusinessContactMember" name="dei:EntityAddressStateOrProvince">DE</ix:nonNumeric></span> <span id="xdx_90D_edei--EntityAddressPostalZipCode_c20230501__20230731__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_z4n2X4CVfoG6"><ix:nonNumeric contextRef="From2023-05-012023-07-31_dei_BusinessContactMember" name="dei:EntityAddressPostalZipCode">19805</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span><span><span id="xdx_906_edei--CityAreaCode_c20230501__20230731__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zeEPJgaZ7TSe"><ix:nonNumeric contextRef="From2023-05-012023-07-31_dei_BusinessContactMember" name="dei:CityAreaCode">(888)</ix:nonNumeric></span>
<span id="xdx_901_edei--LocalPhoneNumber_c20230501__20230731__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zc5I5yg026x"><ix:nonNumeric contextRef="From2023-05-012023-07-31_dei_BusinessContactMember" name="dei:LocalPhoneNumber">528-2677</ix:nonNumeric></span></span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name,
address, including zip code, and telephone number, including area code, of agent for service)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Copies
to:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Joseph
M. Lucosky, Esq.</b><br />
<b>Seth A. Brookman, Esq.</b><br />
<b>Lucosky Brookman LLP</b><br />
<b>101 Wood Avenue South, 5th Floor</b><br />
<b>Woodbridge, New Jersey 08830</b><br />
<b>Tel: (732) 395-4402</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Approximate
date of commencement of proposed sale to the public:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As
soon as practicable after the effective date of this registration statement becomes effective.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the
Securities Act of 1933 check the following box: &#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the
following box and list the Securities Act registration statement number of the earlier effective registration statement for the same
offering. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221;
&#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 28%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large
    accelerated filer &#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated
    filer &#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 22%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_edei--EntityFilerCategory_c20230501__20230731_z8iQvexdbFPa"><ix:nonNumeric contextRef="From2023-05-01to2023-07-31" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory">Non-accelerated
    filer</ix:nonNumeric></span> &#9746;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 26%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller
    reporting company <span id="xdx_90B_edei--EntitySmallBusiness_c20230501__20230731_zPlktnpaMD9f"><ix:nonNumeric contextRef="From2023-05-01to2023-07-31" format="ixt:booleantrue" name="dei:EntitySmallBusiness">&#9746;</ix:nonNumeric></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
    growth company <span id="xdx_905_edei--EntityEmergingGrowthCompany_c20230501__20230731_zowm4EqDT6o4"><ix:nonNumeric contextRef="From2023-05-01to2023-07-31" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></td></tr>
  </table>
<p style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided to Section 7(a)(2)(B) of the Securities Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the
Registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective
in accordance with Section 8(a) of the Securities Act of 1933, or until the Registration Statement shall become effective on such date
as the Commission, acting pursuant to said Section 8(a), may determine.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt; border-bottom: Black 4pt solid">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><b>The
information in this preliminary prospectus is not complete and may be changed. The selling stockholders may not sell these securities
until the registration statement filed with the Securities and Exchange Commission relating to these securities is effective. This preliminary
prospectus is not an offer to sell these securities and it is not a solicitation of an offer to buy these securities in any jurisdiction
where such offer, solicitation or sale is not permitted.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
  <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><b>PROSPECTUS</b></span></td>
  <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><b>SUBJECT TO COMPLETION, DATED NOVEMBER
[&#9679;], 2023</b></span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Connexa
Sports Technologies, Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5,365,871
</b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares of Common Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus relates to the offer and sale from time to time by the selling stockholders identified in this prospectus of up to
an aggregate of 5,365,871 shares of our common stock, par value $0.001 per share, consisting of (x) 136,642 shares of common
stock by Sapir LLC, a consultant engaged by the Company for compensation to be owed to such consultant through November 30, 2023 and
a grant of 87,830 shares of common stock to such consultant for his extraordinary contribution to the Company, and (y) up to 5,141,399
shares of common stock consisting of (i) 1,410,151 shares of common stock issuable upon the exercise of warrants issued on September
28, 2022 each at an exercise price of $3.546 per share with a term of five years (the &#8220;5-Year Warrants&#8221;), (ii) 3,109,563
shares of common stock issuable upon the exercise of warrants issued on September 28, 2022 each at an exercise price of $3.546 per
share with a term of seven and one half years (the &#8220;7.5-Year Warrants&#8221;), (iii) 452,489 shares of our common stock issuable
upon the exercise of warrants issued on January 6, 2023 each at an exercise price of $3.546 per share with a term of five and one
half years (the &#8220;January Warrants&#8221;), and (iv) 169,196 shares of common stock issuable upon the exercise of warrants issued
on October 11, 2023 each at an exercise price of $1.90 per share with a term of five and one half years (the &#8220;Common Warrants&#8221;
and, collectively, the &#8220;Warrants&#8221;). The Warrants are exercisable immediately and may be exercised until all Warrants
are exercised in full.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are registering the resale of the shares of common stock as required by the Registration Rights Agreement that we entered into with Armistice
Capital Master Fund Ltd (the &#8220;Armistice Selling Stockholder&#8221;) on September 28, 2022 (the &#8220;Registration Rights Agreement&#8221;)
and, in respect of the shares of common stock issuable upon exercise of the Common Warrants, as required by the Loan and Security Modification
Agreement that we entered into with the Armistice Selling Stockholder (as defined therein) on October 11, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
registration of the shares of common stock covered by this prospectus does not mean that the selling stockholders will offer or
sell any of the shares. The selling stockholders may offer and sell or otherwise dispose of the shares of common stock described
in this prospectus from time to time through public or private transactions at prevailing market prices, at prices related to prevailing
market prices or at privately negotiated prices. See &#8220;Plan of Distribution&#8221; beginning on page 75 for more information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are not selling any shares of common stock and will not receive any of the proceeds from the sale by the selling stockholders
of the shares of common stock offered hereby. Upon the exercise of the Warrants, for all 5,141,399 shares of our common stock by payment
of cash, however, we will receive aggregate gross proceeds of approximately $9,768,658.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
selling stockholders will pay all underwriting discounts and selling commissions, if any, in connection with the sale of the shares
of common stock. We have agreed to pay certain expenses in connection with this registration statement and to indemnify Armistice
Capital Master Fund Ltd (one of the selling stockholders) and certain related persons against certain liabilities. As of the date
of this prospectus, no underwriter or other person has been engaged to facilitate the sale of shares of common stock in this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
shares of common stock traded on the Nasdaq Capital Market (the &#8220;Nasdaq&#8221;) under the symbol &#8220;CNXA.&#8221; On October
31, 2023, the closing sale price of our common stock was $0.85.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>You
should carefully consider the risks that we have described in &#8220;Risk Factors&#8221; beginning on page 5 before deciding whether
to invest in our common stock.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Neither
the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined
if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
date of this prospectus is&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; , 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TABLE
OF CONTENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#SJ_001"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#SJ_002"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PROSPECTUS SUMMARY</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#cst_001">THE OFFERING</a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">3</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#SJ_003"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RISK FACTORS SUMMARY</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#SJ_004"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RISK FACTORS</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ch_001">USE OF PROCEEDS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ch_003">MARKET PRICE OF AND DIVIDENDS ON COMMON STOCK AND RELATED STOCKHOLDER MATTERS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ch_004">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ak_001">DESCRIPTION OF BUSINESS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">46</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ak_002">DIRECTORS AND EXECUTIVE OFFICERS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">59</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ak_003">EXECUTIVE COMPENSATION</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">64</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ak_004">CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">67</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ak_005">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">68</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ak_006">SELLING
    STOCKHOLDERS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">70</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ak_007">DESCRIPTION OF CAPITAL STOCK</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">71</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ak_008">PLAN OF DISTRIBUTION</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">75</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ak_009">LEGAL MATTERS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">77</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ak_010">EXPERTS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">77</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ak_011">CHANGE IN CERTIFYING ACCOUNTANT</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">77</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ak_012">WHERE YOU CAN FIND MORE INFORMATION</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">77</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#SA_001"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-1</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#su_001">PART II - INFORMATION NOT REQUIRED IN PROSPECTUS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">II-1</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#su_002">SIGNATURES</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">II-6</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>


<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should read this prospectus carefully before you invest. It contains important information you should consider when making your investment
decision. You should rely only on the information provided in this prospectus. We have not authorized anyone to provide you with different
information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information in this document may only be accurate on the date of this document. You should assume that the information appearing in this
prospectus is accurate only as of the date on the front cover of this prospectus. Our business, financial condition, results of operations
and prospects may have changed since that date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>We
have not authorized anyone to provide any information or to make any representations other than those contained in or incorporated by
reference in this prospectus or in any free writing prospectuses prepared by or on behalf of us or to which we have referred you. We
take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. This
prospectus is an offer to sell only the shares offered hereby, but only under circumstances and in jurisdictions where it is lawful to
do so. The information contained in this prospectus is accurate only as of its date regardless of the time of delivery of this prospectus
or of any sale of common stock.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus contains summaries of certain provisions contained in some of the documents described herein, but reference is made to the
actual documents for complete information. All of the summaries are qualified in their entirety by the actual documents. Copies of some
of the documents referred to herein have been filed or will be filed, and you may obtain copies of those documents as described below
under &#8220;<i>Where You Can Find More Information</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
we nor the selling stockholders have done anything that would permit this offering or possession or distribution of this prospectus
in any jurisdiction where action for that purpose is required, other than in the United States. Persons who come into possession of this
prospectus and any free writing prospectus in jurisdictions outside the United States are required to inform themselves about and to
observe any restrictions as to this offering and the distribution of this prospectus and any free writing prospectus applicable to that
jurisdiction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus and the documents in this prospectus contain market data and industry statistics and forecasts that are based on independent
industry publications and other publicly available information. Although we believe that these sources are reliable, we do not guarantee
the accuracy or completeness of this information and we have not independently verified this information. Although we are not aware of
any misstatements regarding the market and industry data presented in this prospectus, these estimates involve risks and uncertainties
and are subject to change based on various factors, including those discussed under the heading &#8220;<b>Risk Factors</b>&#8221; and
any related free writing prospectus. Accordingly, investors should not place undue reliance on this information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise stated, all share figures in this prospectus have been adjusted to reflect the one-for-forty (1-for-40) reverse stock split effected by the
Company on September 25, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="SJ_001"></span>CAUTIONARY
STATEMENT REGARDING FORWARD-LOOKING STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">This prospectus
contains forward-looking statements within the meaning of Section 27A of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange
Act&#8221;). The words &#8220;believe,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;estimate,&#8221;
&#8220;may,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;will,&#8221; &#8220;plan,&#8221; &#8220;future,&#8221; &#8220;continue,&#8221;
and other expressions that are predictions of or indicate future events and trends and that do not relate to historical matters identify
forward-looking statements. These forward-looking statements are based largely on our expectations or forecasts of future events, can
be affected by inaccurate assumptions, and are subject to various business risks and known and unknown uncertainties, a number of which
are beyond our control. Therefore, actual results could differ materially from the forward-looking statements contained in this document,
and readers are cautioned not to place undue reliance on such forward-looking statements. We undertake no obligation to publicly update
or revise any forward-looking statements, whether as a result of new information, future events or otherwise. A wide variety of factors
could cause or contribute to such differences and could adversely impact revenues, profitability, cash flows and capital needs. There
can be no assurance that the forward-looking statements contained in this document will, in fact, transpire or prove to be accurate.
These statements are only predictions and involve known and unknown risks, uncertainties and other factors, including the risks in the
section entitled &#8220;Risk Factors&#8221; in our Form 10-K for the fiscal year ended April 30, 2023, filed on September 14, 2023, that
may cause our or our industry&#8217;s actual results, levels of activity, performance or achievements to be materially different from
any future results, levels of activity, performance or achievements expressed or implied by any forward-looking statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Important
factors that may cause the actual results to differ from the forward-looking statements, projections or other expectations include, but
are not limited to, the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; background-color: white; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">risk
    that we will not be able to remediate identified material weaknesses in our internal control over financial reporting and disclosure
    controls and procedures;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">risk
    that we fail to meet the requirements of the agreements under which we acquired our business interests, including any cash payments
    to the business operations, which could result in the loss of our right to continue to operate or develop the specific businesses
    described in the agreements;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">risk
    that we will be unable to secure additional financing in the near future in order to commence and sustain our planned development
    and growth plans;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">risk
    that we cannot attract, retain and motivate qualified personnel, particularly employees, consultants and contractors for our operations;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">risks
    and uncertainties relating to the various industries and operations we are currently engaged in;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">results
    of initial feasibility, pre-feasibility and feasibility studies, and the possibility that future growth, development or expansion
    will not be consistent with our expectations;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">risks
    related to the inherent uncertainty of business operations including profit, cost of goods, production costs and cost estimates and
    the potential for unexpected costs and expenses;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">risks
    related to commodity price fluctuations;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    uncertainty of profitability based upon our history of losses;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">risks
    related to failure to obtain adequate financing on a timely basis and on acceptable terms for our planned development projects;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">risks
    related to environmental regulation and liability;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">risks
    related to tax assessments; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">other
    risks and uncertainties related to our prospects, properties and business strategy.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels
of activity, performance or achievements. You should not place undue reliance on these forward-looking statements, which speak only as
of the date of this report. Except as required by law, we do not undertake to update or revise any of the forward-looking statements
to conform these statements to actual results, whether as a result of new information, future events or otherwise. The identification
in this document of factors that may affect future performance and the accuracy of forward-looking statements is meant to be illustrative
and by no means exhaustive. All forward-looking statements should be evaluated with the understanding of their inherent uncertainty.
You may rely only on the information contained in this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not authorized anyone to provide information different from that contained in this prospectus. Neither the delivery of this prospectus
nor the sale of our common stock means that the information contained in this prospectus is correct after the date of this prospectus.
This prospectus is not an offer to sell or solicitation of an offer to buy these securities in any circumstances under which the offer
or solicitation is unlawful.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
used in this prospectus, the &#8220;Connexa,&#8221; &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; or &#8220;our&#8221; refer
to Connexa Sports Technologies Inc. and its subsidiaries, unless otherwise indicated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 5 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<div style="border: Black 1.5pt solid; padding: 0.1in">

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="SJ_002"></span>PROSPECTUS
SUMMARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>This
summary highlights information contained elsewhere in the prospectus. Because it is a summary, it does not contain all of the information
that you should consider before investing in our common stock. You should read and carefully consider this entire prospectus before making
an investment decision, especially the information presented under the headings &#8220;Risk Factors,&#8221; and &#8220;Cautionary Note
Regarding Forward-Looking Statements and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operation&#8221;
and our consolidated financial statements and related notes beginning on page F-1&#8221;.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Unless
otherwise indicated by the context, references to &#8220;Connexa,&#8221; &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; or
&#8220;our&#8221; and similar terms refer to the operations of Connexa Sports Technologies Inc., Slinger Bag Inc., Slinger Bag Americas,
Slinger Bag Canada, Slinger Bag UK, SBL and Gameface. </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Our
fiscal year end is April 30 and our fiscal years ended April 30, 2023 and 2022 are sometimes referred to herein as fiscal
years 2023 and 2022, respectively. </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>On
September 20, 2023, we filed a Certificate of Amendment to our Articles of Incorporation, as amended, to effect a one-for-forty (1-for-40)
reverse stock split effective September 25, 2023. All share and per share information in this prospectus has been adjusted to reflect
this reverse stock split.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
Company</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company operates in the sports equipment and technology business. The Company is the owner of the Slinger Bag Launcher, which is comprised
of a portable tennis ball launcher, a portable padel tennis ball launcher and a portable pickleball launcher and Gameface AI, providing
AI technology and performance analytics for sports.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Brief
History</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lazex
Inc. (&#8220;Lazex&#8221;) was incorporated under the laws of the State of Nevada on July 12, 2015. On August 23, 2019, the majority
owner of Lazex entered into a Stock Purchase Agreement with Slinger Bag Americas Inc., a Delaware corporation (&#8220;Slinger Bag Americas&#8221;),
which was 100% owned by Slinger Bag Ltd. (&#8220;SBL&#8221;), an Israeli company. Effective September 13, 2019, Lazex changed its name
to Slinger Bag Inc. On October 31, 2019, Slinger Bag Americas acquired control of Slinger Bag Canada, Inc., (&#8220;Slinger Bag Canada&#8221;)
a Canadian company incorporated on November 3, 2017. On February 10, 2020, Slinger Bag Americas became the 100% owner of SBL, along with
SBL&#8217;s wholly owned subsidiary Slinger Bag International (UK) Limited (&#8220;Slinger Bag UK&#8221;), which was formed on April
3, 2019. On February 10, 2021, Zehava Tepler, the owner of SBL, contributed Slinger Bag UK to Slinger Bag Americas for no consideration.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 21, 2021, Slinger Bag Americas entered into a membership interest purchase agreement with Charles Ruddy to acquire a 100% ownership
stake in Foundation Sports Systems, LLC (&#8220;Foundation Sports&#8221;). On February 2, 2022, the Company entered into a share purchase
agreement with Flixsense Pty, Ltd. (&#8220;Gameface&#8221;). As a result of the share purchase agreement, Gameface would become a wholly
owned subsidiary of the Company. On February 22, 2022, the Company entered into a merger agreement with PlaySight Interactive Ltd. (&#8220;PlaySight&#8221;)
and Rohit Krishnan. As a result of the merger agreement, PlaySight became a wholly owned subsidiary of the Company. On December 5, 2022,
the Company assigned 75% of its membership interest in Foundation Sports to Charles Ruddy, its founder and granted him the right for
a period of three years to purchase the remaining 25% of its Foundation Sports membership interests for $500,000 in cash. As of December
5, 2022, the results of Foundation Sports were no longer consolidated in the Company&#8217;s financial statements, the Company recorded
a loss on the sale and the investment is now accounted for as an equity method investment. On December 5, 2022, the Company analyzed
this investment and established a reserve for the investment at the full amount of $500,000. On November 27, 2022, the Company entered
into a share purchase agreement (the &#8220;Agreement&#8221;) with PlaySight, Chen Shachar and Evgeni Khazanov (together, the &#8220;Buyer&#8221;)
pursuant to which the Buyer purchased 100% of the issued and outstanding shares of PlaySight from the Company in exchange for consideration.
The total loss on disposal of Foundation Sports and PlaySight amounted to $41,413,892 in the year ended April 30, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
April 2023, the Company determined that the technology utilized in Gameface would take substantially more financial resources and more
time to bring to market and achieve profitability than originally anticipated. As a result, the goodwill and intangible assets related
to Gameface were fully impaired as of April 30, 2023, resulting in an impairment loss of $11,421,817. The Company previously classified
Foundation Sports in continuing operations, until December 5, 2022 when they sold 75% of Foundation Sports back to the original owners
at which time it deconsolidated this subsidiary and recorded a loss on the sale. The Company also determined to dispose of the PlaySight
entity during the year ended April 30, 2023. The Company completed the sale in November 2022 and recorded a loss on the sale at that
time. The total loss on disposal of Foundation Sports and PlaySight amounted to $41,413,892 in the year ended April 30, 2023. The Company
impaired all goodwill as of April 30, 2023. For a more detailed description of our history, please refer to the section entitled &#8220;Description
of Business.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 6; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<div style="border: Black 1.5pt solid; padding: 0.1in">

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Recent
Developments</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 8, 2023, the Company entered into a merchant cash advance agreement with Meged Funding Group (&#8220;Meged&#8221;) pursuant to which
the Company sold $315,689 in future receivables to Meged (the &#8220;Meged Receivables Purchased Amount&#8221;) to in exchange for payment
to the Company of $210,600 in cash less fees of $10,580. The Company agreed to pay Meged $17,538 each week until the Meged Receivables
Purchased Amount is paid in full.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">On July 26, 2023, the Company received a letter from the Listing Qualifications
Department of Nasdaq indicating that the Company&#8217;s stockholders&#8217; equity as reported in its Quarterly Report on Form 10-Q for
the quarterly period ended January 31, 2023 did not satisfy the continued listing requirement under Nasdaq Listing Rule 5550(b)(1), which
requires that a listed company&#8217;s stockholders&#8217; equity be at least $2.5 million (the &#8220;Minimum Stockholders&#8217; Equity
Requirement&#8221;). The Company timely submitted a compliance plan to the Panel and on August 23, 2023 received notice from Nasdaq that
it has until January 22, 2024 to demonstrate compliance with the Minimum Stockholders&#8217; Equity Requirement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 7, 2023, the Company entered into an agreement with UFS (the &#8220;UFS Agreement&#8221;) pursuant to which the Company sold $797,500
in future receivables (the &#8220;UFS Second Receivables Purchased Amount&#8221;) to UFS in exchange for payment to the Company of $550,000
in cash less fees of $50,000. The Company agreed to pay UFS $30,000 each week until the UFS Second Receivables Purchased Amount is paid
in full.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to secure payment and performance of the Company&#8217;s obligations to UFS under the UFS Agreement, the Company granted to UFS
a security interest in the following collateral: all accounts receivable and all proceeds as such term is defined by Article 9 of the
UCC. The Company also agreed not to create, incur, assume, or permit to exist, directly or indirectly, any lien on or with respect to
any of such collateral.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 13, 2023, the Company held a special meeting of stockholders in which the following items were approved: (i) the issuance of
(i) 25,463 shares of the our common stock, par value $0.001 per share, that were issued on October 3, 2022, and, (ii) 295,051
shares of our common stock issuable upon exercise of Pre-Funded Warrants at an exercise price of $0.00001 per share, (iii) 320,513
shares of common stock issuable upon the exercise of the 5-Year Warrants at an exercise price of $15.60 per share,
(iv) 641,026 shares of common stock issuable upon the exercise of the 7.5 Year Warrants at an exercise price of $17.20
per share and (v) 452,489 shares of our common stock issuable upon the exercise of the 5.5 Year Warrants at an exercise
price per share equal to $8.84 per share to Armistice Capital Master Fund Ltd and (ii) a reverse stock split of our common stock
within a range of one (1)-for-ten (10) to one (1)-for-forty (40) (&#8220;Reverse Stock Split&#8221;), with the Board of Directors of
the Company to set the specific ratio and determine the date for the reverse split to be effective and any other action deemed necessary
to effectuate the Reverse Stock Split, without further approval or authorization of stockholders, at any time within 12 months of the
special meeting date. The Company effected a one-for-forty (1-for-40) reverse stock split of its common stock on September 25, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">On September 25,
2023, as a result of the shareholder approval obtained at the special meeting of stockholders on September 13, 2023 and the Reverse Stock
Split, the aggregate number of Pre-Funded Warrants, 5-Year Warrants, 5.5-Year Warrants and 7-Year Warrants increased from 1,709,097 to
9,426,952 due to certain adjustments that were required to be made by the terms of the relevant warrants in the event of receipt of shareholder
approval and the occurrence of the Reverse Stock Split.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 19, 2023, the Company entered into an agreement with Meged (the &#8220;Second Meged Agreement&#8221;) pursuant to which the
Company sold $423,000 in future receivables to Meged (the &#8220;Meged Second Receivable Amount&#8221;) in exchange for paying the then
outstanding balance of $70,153 of the Meged Receivables Purchased Amount in full with the balance being retained by the Company in
cash for general purposes. The Company agreed to pay Meged $15,107 each week until the Meged Second Receivable Amount is paid in full.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to secure payment and performance of the Company&#8217;s obligations to Meged under the Second Meged Agreement, the Company granted
to Meged a security interest in the following collateral: all accounts receivable and all proceeds as such term is defined by Article
9 of the UCC. The Company also agreed not to create, incur, assume, or permit to exist, directly or indirectly, any lien on or with respect
to any of such collateral.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 11, 2023, the Company entered into a loan and security modification agreement (the &#8220;Loan and Security Modification Agreement&#8221;)
with a one or more institutional investors (the &#8220;Lenders&#8221;) and a certain institutional investor, as agent for the Lenders
(the &#8220;Agent&#8221;) amending the terms of the Loan and Security Agreement dated January 6, 2023 (the &#8220;LSA&#8221;) by and
among the Company, the Lenders and the Agent to make an additional loan of $1,000,000 and modify the terms of the LSA to reflect the
New Loan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Loan and Security Modification Agreement, the Company agreed to issue to the investor warrants (the &#8220;Common
Warrants&#8221;) to purchase up to 169,196 shares of Common Stock at an exercise price of $1.90 per share. The Common Warrants are exercisable
six months after their issuance and will expire five and one-half years from their date of issuance. The Common Warrants and the shares
of our Common Stock issuable upon the exercise of the Common Warrants are not being registered under the Securities Act of 1933, as amended
(the &#8220;Securities Act&#8221;), were not offered pursuant to the Registration Statement and were offered pursuant to the exemption
provided in Section 4(a)(2) under the Securities Act, and Rule 506(b) promulgated thereunder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 12, 2023, the Board of Directors of the Company approved an amendment to the Bylaws of the Company to reduce the percentage of
shares of stock, issued and outstanding and entitled to vote, to be present in person or represented by proxy in order to constitute
a quorum for the transaction of any business from a majority to thirty three and one third percent (33 1/3%).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 18.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
Corporate Information</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company was incorporated under the laws of the State of Nevada on July 12, 2015 and redomiciled in the State of Delaware on April 7,
2022 under the name Connexa Sports Technologies Inc.
Please refer to our brief history described above. Our corporate offices are located at 2709 North Rolling Road, Suite 138, Windsor Mill,
Maryland, 21244. Our telephone number is (443) 407-7564. Our website is www.connexasports.com. None of the information on our
website or any other website identified herein is part of this prospectus or the registration statement of which it forms a part.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<div style="border: Black 1.5pt solid; padding: 0.1in">

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="cst_001"></span>The
Offering</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Issuer</b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Connexa
    Sports Technologies, Inc.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common
    Stock offered by the selling stockholders </b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Up
                                            to 5,365,871 shares of common stock, comprised of shares of common stock and the shares
                                            of common stock issuable upon exercise of Warrants.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common
    Stock issued and outstanding after this prospectus (1)</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,509,445
                                            </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use
    of proceeds</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            will not receive any of the proceeds from the sale by the selling stockholders of
                                            the securities. However, upon the exercise of the Warrants for 5,141,399 shares of common
                                            stock by payment of cash, we will receive aggregate gross proceeds of approximately $9,768,658.
                                            Any proceeds from the exercise of the warrants will be used for working capital and general
                                            corporate purposes. See section entitled &#8220;Use of Proceeds.&#8221;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common
    Stock NASDAQ Symbol</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CNXA</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risk
    factors</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
    should read the section entitled &#8220;Risk Factors&#8221; beginning on page 5  for a discussion of some of the risks and
    uncertainties you should carefully consider before deciding to invest in our securities. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    number of shares of common stock outstanding is based on 2,372,803 shares of our common stock outstanding as of October 31, 2023
    and excludes the following: </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
    of common stock underlying other outstanding warrants, which include, without limitation, (i) 57,151; </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">46,651
    </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of our common stock issuable upon exercise
    of outstanding stock options by the members of our board of directors and third parties; and</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,500
shares of our common stock reserved for future issuance under our 2020 Slinger Bag Inc. Global Share Incentive Plan (the &#8220;2020
Plan&#8221;). </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 5.25pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as otherwise indicated herein, all information in this prospectus assumes the exercise of the Warrants and sale of all shares available
for sale under this prospectus and no further acquisitions of shares by the selling stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5pt; text-align: justify"></p>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<div style="border: Black 1.5pt solid; padding: 0.1in">

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="SJ_003"></span>RISK
FACTORS SUMMARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investing
in shares of our common stock involves a high degree of risk. See section entitled &#8220;Risk Factors&#8221; beginning on page 5 of
this prospectus for a discussion of factors you should carefully consider before investing in our common stock. If any of these
risks actually occurs, our business, financial condition, results of operations, cash flows and prospects would likely be materially
and adversely affected. As a result, the trading price of our common stock would likely decline, and you could lose all or part of
your investment. Listed below is a summary of some of the principal risks related to our business:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; white-space: nowrap; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
    cost of raw materials, labor or freight could lead to an increase in our cost of sales and cause our results of operations to suffer</i>.</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Our
    international operations involve inherent risks which could result in harm to our business. </i></span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>We
    develop products in Israel and our chief marketing officer is located in Israel and, therefore, our business, financial condition
    and results of operation may be adversely affected by political, economic and military instability in Israel.</i></span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><i>&#160;</i></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; white-space: nowrap; vertical-align: top"><i>&#9679;</i></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><i>Conditions in Israel, including the recent attack by&#160;Hamas&#160;and
    other terrorist organizations from the Gaza Strip and Israel&#8217;s war against them, may adversely affect our operations and limit
    our ability to manage and market our products, which would lead to a decrease in revenues.</i></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>We
    rely heavily on supply chain reliability and predictability and continued disruption in our supply chain could have a material adverse
    impact on operations.</i></span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
    growth of our business depends on the successful execution of our growth strategy, and our efforts to expand internationally by growing
    our e-commerce business.</i></span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Our
    extended supply chain requires long lead times and relies heavily on manufacturers in Asia.</i></span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>We
    do not employ traditional advertising channels, and if we fail to adequately market our brand through product introductions and other
    means of promotion, our business could be adversely affected.</i></span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Our
    products face intense competition.</i></span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Failure
    to continue to obtain or maintain high-quality endorsers of our products could harm our business.</i></span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>There
    is substantial doubt regarding our ability to continue as a going concern absent obtaining adequate new debt or equity financing
    and achieving sufficient sales levels</i>.</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Our
    business may be affected by seasonality, which could result in fluctuations in our operating results.</i></span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Our
    products are subject to risks associated with overseas sourcing, manufacturing and financing</i>.</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Our
    internal controls may be inadequate, which could cause our financial reporting to be unreliable and lead to misinformation being
    disseminated to the public</i>.</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
    costs of being a public company could result in us being unable to continue as a going concern.</i></span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Our
    ability to sell our products and services will be dependent on the quality of our technical support and our failure to deliver high-quality
    technical support services could have a material adverse effect on our sales and results of operations</i>.</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Failure
    to adequately protect our intellectual property and curb the sale of counterfeit merchandise could injure our brand and negatively
    affect our sales</i>.</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>We
    may become subject to claims for remuneration or royalties for assigned service invention rights by our employees, which could result
    in litigation and adversely affect our business</i>.</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>We
    may be subject to product liability lawsuits or claims, which could harm our financial condition and liquidity if we are not able
    to successfully defend or insure against such claims</i>.</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Failure
    of our contractors or our licensees&#8217; contractors to comply with local laws and other standards could harm our business</i>.</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Our
    stock price may be volatile, or may decline regardless of our operating performance, and you could lose all or part of your investment
    as a result</i>.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#9679;</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Shareholders may be diluted significantly through our efforts to obtain
financing, satisfy obligations through issuance of additional shares, or reset the exercise price of the Warrants.</i></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="SJ_004"></span>RISK
FACTORS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>You
should carefully consider the risks described below and other information in this prospectus, including the financial statements and
related notes that appear at the end of this report, before deciding to invest in our securities. These risks should be considered in
conjunction with any other information included herein, including in conjunction with forward-looking statements made herein. If any
of the following risks actually occur, they could materially adversely affect our business, financial condition and operating results.
Additional risks and uncertainties that we do not presently know or that we currently deem immaterial may also impair our business, financial
condition and operating results. The following discussion of risks is not all-inclusive but is designed to highlight what we believe
are the material factors to consider when evaluating our business and expectations. These factors could cause our future results to differ
materially from our historical results and from expectations reflected in forward-looking statements.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><b>Risks Related to Our Business, Operations,
and Industry</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
depend on the strength of our brands.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect to derive substantially all of our net sales from sales of branded products and services we own, including Slinger and Gameface.
The reputation and integrity of our brands are essential to the success of our business. We believe that our consumers value the status
and reputation of brands we promote, and the superior quality, performance, functionality and durability that our brands represent. Building,
maintaining and enhancing the status and reputation of our brands&#8217; image is important to expanding our consumer base. Our continued
success and growth depend on our ability to protect and promote our brands, which, in turn, depends on factors such as the quality, performance,
functionality and durability of our products and services, our communication activities, including advertising and public relations,
and our management of the consumer experience, including direct interfaces through customer service and warranty repairs. We may decide
to make substantial investments in these areas in order to maintain and enhance our brand, and such investments may not be successful.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
in order to expand our reach, we engage with third-party distributors. To the extent those third-party distributors fail to comply with
our operating guidelines, we may not be successful in protecting our brand image. Product defects, product recalls, counterfeit products
and ineffective marketing are among the potential threats to the strength of our brands and to protect our brands&#8217; status we may
need to make substantial expenditures to mitigate the impact of such threats.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Moreover,
if we fail to continue to innovate to ensure that our products are deemed to achieve superior levels of function, quality and design,
or to otherwise be sufficiently distinguishable from our competitors&#8217; products, or if we fail to manage the growth of our on-line
sales in a way that protects the high-end nature of our brands, the value of our brands may be diluted, and we may not be able to maintain
our premium position and pricing or sales volumes, which could adversely affect our financial performance and business. We believe that
maintaining and enhancing our brands image in new markets where we have limited brand recognition is important to expanding our consumer
base. If we are unable to maintain or enhance our brands in new markets, then our growth strategy could be adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
cost of raw materials, labor or freight could lead to an increase in our cost of sales and cause our results of operations to suffer</i>.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increasing
costs for raw materials, labor or freight could make our sourcing processes more costly and negatively affect our gross margin and profitability.
Labor costs at our independent manufacturers&#8217; sites have been increasing and it is unlikely that these increases will abate. Wage
and price inflation in our source countries could cause unanticipated price increases, which may be significant. Such price increases
by our independent manufacturers could be rapid in the absence of manufacturing contracts. Energy costs have fluctuated dramatically
in the past and may fluctuate in the future. Rising energy costs may increase our costs of transporting our products for distribution
and the costs of products that we source from independent suppliers. Further, many of our products are made of materials, such as high
impact plastics, plastic-injected molded parts, and lightweight high tensile strength metals, that are either petroleum-based or require
energy to construct and transport. Costs for transportation of such materials have been increasing as the price of petroleum increases.
Our independent suppliers and manufacturers may attempt to pass these cost increases on to us, and our relationships with them may be
harmed or lost if we refuse to pay such increases, which could lead to product shortages. If we pay such increases, we may not be able
to offset them through increases in our pricing and other means, which could adversely affect our ability to maintain our targeted gross
margins. If we attempt to pass the increases on to consumers, our sales may be adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
international operations involve inherent risks which could result in harm to our business.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of our equipment is manufactured outside of the U.S. with a large volume of our products being also sold outside of the U.S. Accordingly,
we are subject to the risks generally associated with global trade and doing business abroad, which include foreign laws and regulations,
varying consumer preferences across geographic regions, political unrest, disruptions or delays in cross-border shipments and changes
in economic conditions in countries in which our products are manufactured or where we sell products. This includes, for example, the
uncertainty surrounding the effect of Brexit, including changes to the legal and regulatory framework that apply to the United Kingdom
and its relationship with the European Union, as well as new and proposed changes affecting tax laws and trade policy in the U.S. and
elsewhere as further described in other risks in this section. The U.S. presidential administration has indicated a focus on policy reforms
that discourage U.S. corporations from outsourcing manufacturing and production activities to foreign jurisdictions, including through
tariffs or penalties on goods manufactured outside the U.S., which may require us to change the way we conduct business and adversely
affect our results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
develop products in Israel, our chief marketing officer and general counsel are located in Israel, and our team developing our
baseball and softball launcher products are located in Israel, and, therefore, our business, financial condition and results of
operation may be adversely affected by political, economic and military instability in Israel.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
portion of our operations, including product development, is based in Israel. Our research and development is conducted through our Israeli
subsidiary and our chief marketing officer and chief innovation officer are both located in Israel. Accordingly, political, economic
and military conditions in Israel directly affect our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Political,
economic and military conditions in Israel may directly affect our business. Since the establishment of the State of Israel in 1948,
a number of armed conflicts have taken place between Israel and its neighboring countries, and between Israel and the Hamas and Hezbollah
extremist groups. In addition, several countries, principally in the Middle East, restrict doing business with Israel, and additional
countries may impose restrictions on doing business with Israel and Israeli companies whether as a result of hostilities in the region
or otherwise. Any hostilities involving Israel, terrorist activities, political instability or violence in the region or the interruption
or curtailment of trade or transport between Israel and its trading partners could adversely affect our operations and results of operations
and adversely affect the market price of our shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
commercial insurance does not cover losses that may occur as a result of an event associated with the security situation in the Middle
East. Although the Israeli government is currently committed to covering the reinstatement value of direct damages that are caused by
terrorist attacks or acts of war, there can be no assurance that this government coverage will be maintained, or if maintained, will
be sufficient to compensate us fully for damages incurred. Any losses or damages incurred by us could have a material adverse effect
on our business, financial condition and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
our operations could be disrupted by the obligations of our employees to perform military service. Our chief marketing officer is subject
to the obligation to perform reserve military duty. In response to increased tension and hostilities in the region, there have been,
at times, call-ups of military reservists, and it is possible that there will be additional call-ups in the future. Our operations could
be disrupted by the absence of these employees due to military service. Such disruption could harm our business and operating results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Popular
uprisings in various countries in the Middle East and North Africa are affecting the political stability of those countries. Such instability
may lead to deterioration in the political and trade relationships that exist between the State of Israel and these countries. Furthermore,
several countries, principally in the Middle East, restrict doing business with Israel and companies with an Israeli presence, and additional
countries may impose restrictions on doing business with Israel and Israeli companies if hostilities in the region continue or intensify.
Such restrictions may seriously limit our ability to sell our products to customers in those countries.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Conditions
in Israel, including the recent attack by&#160;Hamas&#160;and other terrorist organizations from the Gaza Strip and Israel&#8217;s war
against them, may adversely affect our operations and limit our ability to manage and market our products, which would lead to a decrease
in revenues.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
we develop products in Israel, our chief marketing officer and general
counsel are located in Israel, and our team developing our baseball and softball launcher are located in Israel, our business and operations
are directly affected by economic, political, geopolitical and military conditions affecting Israel. Since the establishment of the State
of Israel in 1948, a number of armed conflicts have occurred between Israel and its neighboring countries and other hostile non-state
actors. These conflicts have involved missile strikes, hostile infiltrations and terrorism against civilian targets in various parts of
Israel, which have negatively affected business conditions in Israel.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 7, 2023, Hamas&#160;militants and members of other terrorist organizations infiltrated Israel&#8217;s southern border from
the Gaza Strip and conducted a series of terror attacks on civilian and military targets. Thereafter, these terrorists launched extensive
rocket attacks on the Israeli population and industrial centers located along the Israeli border with the Gaza Strip. As of October 11,
2023, such attacks collectively resulted in over 1,200 deaths and over 2,600 injured people, in addition to the kidnapping of a currently
indefinite number of civilians, including women and children. Shortly following the attack, Israel&#8217;s security cabinet declared
war against&#160;Hamas.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
intensity and duration of Israel&#8217;s current war against Hamas&#160;is difficult to predict, and as are such war&#8217;s economic
implications on the Company&#8217;s business and operations and on Israel&#8217;s economy in general. On October 9, 2023, the Central
Bank of Israel announced its intent to sell up to $30 billion order to protect the New Israeli Shekel (&#8220;NIS&#8221;) from collapse,
however despite the foregoing announcement the NIS weakened to approximately 3.92 NIS for one US dollar as of the same day. In addition,
on October 9, 2023, the Tel Aviv-35 stock index of blue-chip companies dropped by 6.4% whereas the benchmark TA-125 index fell by 6.2%.
These events may imply wider macroeconomic indications of a deterioration of Israel&#8217;s economic standing, which may have a material
adverse effect on the Company and its ability to effectively conduct is business, operations and affairs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is possible that other terrorist organizations will join the hostilities as well, including Hezbollah in Lebanon, and Palestinian military
organizations in the West Bank. In the event that hostilities disrupt the development of our products, our ability to deliver products
to customers in a timely manner to meet our contractual obligations with customers and vendors could be materially and adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
commercial insurance does not cover losses that may occur as a result of events associated with war and terrorism. Although the Israeli
government currently covers the reinstatement value of direct damages that are caused by terrorist attacks or acts of war, we cannot
assure you that this government coverage will be maintained or that it will sufficiently cover our potential damages. Any losses or damages
incurred by us could have a material adverse effect on our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of the Israeli security cabinet&#8217;s decision to declare war against&#160;Hamas, several hundred thousand Israeli reservists
were drafted to perform immediate military service. If any of our employees and consultants in Israel are called for service in the current
war with Hamas, our operations may be disrupted by such absences, which may materially and adversely affect our business and results
of operations. Additionally, the absence of employees of our Israeli suppliers and contract manufacturers due to their military service
in the current war or future wars or other armed conflicts may disrupt their operations, in which event our ability to deliver products
to customers may be materially and adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, popular uprisings in various countries in the Middle East and North Africa have affected the political stability of those countries.
Such instability may lead to a deterioration in the political and trade relationships that exist between the State of Israel and these
countries, such as Turkey. Moreover, some countries around the world restrict doing business with Israel and Israeli companies, and additional
countries may impose restrictions on doing business with Israel and Israeli companies if hostilities in Israel or political instability
in the region continues or increases. These restrictions may limit materially our ability to obtain raw materials from these countries
or sell our products to companies and customers in these countries. In addition, there have been increased efforts by activists to cause
companies and consumers to boycott Israeli goods. Such efforts, particularly if they become more widespread, may materially and adversely
impact our ability to sell our products outside of Israel.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to the Hamas&#160;attack in October 2023, the Israeli government pursued extensive changes to Israel&#8217;s judicial system, which sparked
extensive political debate and unrest. In response to such initiative, many individuals, organizations and institutions, both within
and outside of Israel, have voiced concerns that the proposed changes may negatively impact the business environment in Israel including
due to reluctance of foreign investors to invest or transact business in Israel as well as to increased currency fluctuations, downgrades
in credit rating, increased interest rates, increased volatility in security markets, and other changes in macroeconomic conditions.
The risk of such negative developments has increased in light of the recent&#160;Hamas&#160;attacks and the war against&#160;Hamas&#160;declared
by Israel. To the extent that any of these negative developments do occur, they may have an adverse effect on our business, our results
of operations and our ability to raise additional funds, if deemed necessary by our management and board of&#160;directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
manufacturing takes place in China and is susceptible to shutdowns and delays caused by the Coronavirus and other diseases and epidemics.
Additionally, we rely on independent manufacturers and suppliers.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of October 31, 2023, one of our manufacturing facilities is located in southern China. Following the outbreak of the Coronavirus our manufacturing
facility was shut down for three months, which caused some unforeseen delays in manufacturing and delivery of our products. However,
there may be further outbreaks of the Coronavirus and other diseases and epidemics, which may cause further delays and shutdowns. This,
in turn, will negatively affect our revenue and increase our expenses and costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not control our independent manufacturers and suppliers or their labor and other business practices. Violations of labor, environmental
or other laws by an independent manufacturer or supplier, or divergence of an independent manufacturer&#8217;s or supplier&#8217;s labor
or other practices from those generally accepted as ethical or appropriate in the U.S., could disrupt the shipments of our products or
draw negative publicity for us, thereby diminishing the value of our brand, reducing demand for our products and adversely affecting
our net income. Additionally, since we do not manufacture our products, we are subject to risks associated with inventory and product
quality-control.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
we have not historically entered into manufacturing contracts with our manufacturers; instead, we have hired them on an ad hoc basis.
Identifying a suitable manufacturer is an involved process that requires us to become satisfied with the prospective manufacturer&#8217;s
quality control, responsiveness and service capabilities, financial stability and labor practices. While we have business continuity
and contingency plans for alternative sourcing, we may be unable, in the event of a significant disruption in our sourcing, to locate
alternative manufacturers or suppliers of comparable quality at an acceptable price, or at all, which could result in product shortages
or decreases in product quality, and adversely affect our net sales, gross margin, net income, customer relationships and our reputation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
rely heavily on supply chain reliability and predictability and continued disruption in our supply chain could have a material adverse
impact on operations.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
rely heavily on supply chain reliability and predictability in producing, transporting and delivering our products. The COVID-19
pandemic, Ukraine war, Israel-Hamas war, inflationary trends, shifts in consumer purchasing patterns, availability of transport,
labor shortages in the shipping, trucking, and warehousing industries, port strikes, infrastructure congestion, equipment shortages
and other factors have all contributed to delivery delays, greater costs and uncertainty in arranging and scheduling transport of
our products. If we are unable to reliably and consistently arrange shipment and storage of our products, we may be unable to ship,
deliver and store our products in which case, we will have to reverse sales and issue refunds to purchasers of our products. Changes
in U.S. and international trade policies, including to import tariffs and trade policies and agreements, to address supply chain
issues or otherwise could also have a significant impact on our activities both in the United States and internationally. Supply
chain disruptions, both domestic and international, have adversely impacted our operations. Continued disruptions in our supply
chain and adverse consequences from aggressive trade policies could have a material adverse impact on our profitability and
financial performance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
face risks associated with operating in international markets.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
operate in a global marketplace and international sales growth is a key element of our growth strategy. We are subject to risks associated
with our international operations, including, but not limited to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 10.1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign
    currency exchange rates;</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Economic
    or governmental instability in foreign markets in which we operate or in those countries from which we source our merchandise;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unexpected
    changes in laws, regulatory requirements, taxes or trade laws;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increases
    in the cost of transporting goods globally;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acts
    of war, terrorist attacks, outbreaks of contagious disease and other events over which we have no control; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes
    in foreign or domestic legal and regulatory requirements resulting in the imposition of new or more onerous trade restrictions, tariffs,
    duties, taxes, embargoes, exchange or other government controls.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
of these risks could have an adverse impact on our results of operations, financial position or growth strategy. Furthermore, some of
our international operations are conducted in parts of the world that experience corruption to some degree. Our employees and wholesalers
could take actions that violate applicable anti-corruption laws or regulations. Violations of these laws, or allegations of such violations,
could have an adverse impact on our reputation, our results of operations or our financial position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign
exchange movements may also negatively affect the relative purchasing power of consumers and their willingness to purchase discretionary
premium goods, such as our products, which would adversely affect our net sales. We do not currently use the derivative markets to hedge
foreign currency fluctuations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
growth of our business depends on the successful execution of our growth strategy, and our efforts to expand internationally by growing
our e-commerce business.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are focused on developing an integrated Play and Learn platform under our Connexa brand. The Platform will bring together our owned offerings
of Gameface and Slinger Bag under the umbrella of the Connexa brand. We believe our success will in large part depend on our ability
to develop a cohesive platform that integrates elements of performance analysis from each. We may face difficulties integrating the technology
and offerings from each brand in order create a cohesive business. For example, users of the Slinger Bag may view us a sporting goods
company and choose not to engage with our technology offerings from the Gameface brand, and users of our Gameface AI app services may
not purchase our ball launchers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
current growth strategy depends on our ability to continue to expand our reach geographically in a number of international regions in
Asia, Europe, North America, Africa and Australia. This growth strategy is contingent upon our ability to introduce our products to new
markets. The implementation of higher tariffs, quotas or other restrictive trade policies in any international regions in which we seek
to operate could adversely affect our ability to commence new international operations, which could have an adverse impact on our growth
strategy. Further, consumer demand behavior, as well as tastes and purchasing trends, may differ in various countries and, as a result,
sales of our products may not be, or may take time to become, successful, and gross margins on those net sales may not be in line with
what we currently experience. Our ability to execute our international growth strategy, especially where we are not yet established,
depends on our ability to understand regional market demographics, and we may not be able to do so.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we are unable to develop the integrated Play and Learn platform and expand our business internationally, our growth strategy and our
financial results could be materially adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we are unable to respond effectively to changes in market trends and consumer preferences, our market share, net sales and profitability
could be adversely affected.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
success of our business depends on our ability to identify the key product and market trends and bring products to market in a timely
manner that satisfy the current preferences of a broad range of consumers (either by enhancing existing products or by developing new
product offerings). Consumer preferences differ across and within different parts of the world, and shift over time in response to changing
aesthetics and economic circumstances. We believe that our success in developing products that are innovative and that meet our consumers&#8217;
functional needs is an important factor in our image as a premium brand, and in our ability to charge premium prices. We may not be able
to anticipate or respond to changes in consumer preferences, and, even if we do anticipate and respond to such changes, we may not be
able to bring to market in a timely manner enhanced or new products that meet these changing preferences. If we fail to anticipate or
respond to changes in consumer preferences or fail to bring products to market in a timely manner that satisfy new preferences, our market
share and our net sales and profitability could be adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may be unable to appeal to new consumers while maintaining the loyalty of our core consumers.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Part
of our growth strategy is to introduce new consumers, including young consumers, to our brands. If we are unable to attract new consumers,
including young consumers, our business and results of operations may be adversely affected as our core consumers&#8217; age increases
and purchasing frequency decrease. Initiatives and strategies intended to position our brand to appeal to new and young consumers may
not appeal to our core consumers and may diminish the appeal of our brand to our core consumers, resulting in reduced core consumer loyalty.
If we are unable to successfully appeal to new and young consumers while maintaining our brand&#8217;s image with our core consumers,
then our net sales and our brand image may be adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
business could suffer if we are unable to maintain our website or manage our inventory effectively.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
employ a distribution strategy that is heavily dependent upon our website and third-party distributors&#8217; e-commerce websites. The
effectiveness of our e-commerce strategy depends on our ability to manage our inventory and our distribution processes effectively so
as to ensure that our products are available in sufficient quantities and thereby prevent lost sales. If we are not able to maintain
our e-commerce channels, or if we are not able to effectively manage our inventory, we could experience a decline in net sales, as well
as excess inventories for some products and missed opportunities for other products. In addition, the failure to deliver our products
to customers in accordance with our delivery schedules could damage our relationship with these customers and lead to negative feedback
being posted on e-commerce sites. Consequently, our net sales, profitability and the implementation of our growth strategy could be adversely
affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
plan to use cash provided by operating activities to fund our expanding business and execute our growth strategy and may require additional
capital, which may not be available to us.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect our business to rely on net cash provided by our future operating activities as our primary source of liquidity. To support our
business and execute our growth strategy as planned, we will need to generate significant amounts of cash from operations in order to
purchase inventory, pay personnel, invest in research and development, and pay for the increased costs associated with operating as a
public company. Operating cash flows were weak earlier this year and, as a result, we had to significantly curtail operations and dispose
of our PlaySight and Foundation Sports operations. See section entitled &#8220;Description of Business&#8212;Recent Developments&#8221;
for more information. If our business does not generate cash flow from operating activities sufficient to fund these activities, and
if sufficient funds are not otherwise available to us, we will need to seek additional capital, through debt or equity financings, to
fund our growth. Conditions in the credit markets (such as availability of finance and fluctuations in interest rates) may make it difficult
for us to obtain such financing on attractive terms or even at all. Additional debt financing that we may undertake, may be expensive
and might impose on us covenants that restrict our operations and strategic initiatives, including limitations on our ability to incur
liens or additional debt, pay dividends, repurchase our capital stock, make investments and engage in merger, consolidation and asset
sale transactions. Equity financings may be on terms that are dilutive or potentially dilutive to our shareholders, and the prices at
which new investors would be willing to purchase our equity securities may be lower than the price per share of our common stock. The
holders of new securities may also have rights, preferences or privileges that are senior to those of existing holders of common stock.
If new sources of financing are required, but are unattractive, insufficient or unavailable, then we will be required to modify our growth
and operating plans based on available funding, if any, which would inhibit our growth and could harm our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
extended supply chain requires long lead times and relies heavily on manufacturers in Asia.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
rely heavily on manufacturers in Asia, which requires long lead times to get goods to markets. The long lead times will require us to
carry extra inventory to avoid out-of-stock scenarios. In the event of a decline in demand for our products, due to general economic
conditions or other factors, we may be forced to liquidate this extra inventory at lower margins or at a loss. In addition, consumers&#8217;
tastes can change between the time a product is designed and the time it takes to get to market. If the designs are not popular with
consumers, it could also result in the need to liquidate the inventories at lower margins or at a loss, which would adversely affect
our results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
depend on existing members of management and key employees to implement key elements in our strategy for growth, and the failure to retain
them or to attract appropriately qualified new personnel could affect our ability to implement our growth strategy successfully.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
successful implementation of our growth strategy depends in part on our ability to retain our experienced management team and key employees
and on our ability to attract appropriately qualified new personnel. For instance, our chief executive officer has extensive experience
running branded sporting goods. The loss of any key member of our management team or other key employees could hinder or delay our ability
to implement our growth strategy effectively. Further, if we are unable to attract appropriately qualified new personnel, including a
chief financial officer, we may not be successful in implementing our growth strategy. In either instance, our profitability and financial
performance could be adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
do not employ traditional advertising channels, and if we fail to adequately market our brand through product introductions and other
means of promotion, our business could be adversely affected.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
marketing strategy depends on our ability to promote our brand&#8217;s message by using online advertising and social media, and possibly
the use of newspapers and magazines to promote new product introductions in a cost-effective manner. We do not employ traditional advertising
channels such as billboards, television and radio. If our marketing efforts are not successful at attracting new consumers and increasing
purchasing frequency by our existing consumers, there may be no cost-effective marketing channels available to us for the promotion of
our brand. If we increase our spending on advertising, or initiate spending on traditional advertising, our expenses will rise, and our
advertising efforts may not be successful. In addition, if we are unable to successfully and cost-effectively employ advertising channels
to promote our brand to new consumers and new markets, our growth strategy may be adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
rely significantly on information technology to operate our business. Any significant security breach of our confidential information
of our customers, applications, technology, networks, or other systems critical to our operations, or failure to comply with privacy
and security laws and regulations could damage our reputation, brands and business.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are heavily dependent on information technology systems and networks, including the Internet and third-party services (&#8220;Information
Technology Systems&#8221;), across our supply chain, including product design, production, forecasting, ordering, manufacturing, transportation,
sales and distribution, as well as for processing financial information for external and internal reporting purposes, operations and
other business activities. Information Technology Systems are critical to many of our operating activities and our business processes
and they may be negatively impacted by any service interruption or shutdown. For example, our ability to effectively manage and maintain
our inventory and to ship products to customers on a timely basis depends significantly on the reliability of these Information Technology
Systems. We rely on a third party systems provider to manage all our company data and transactions, record our financial transactions
and manage our operations. The failure of these systems to operate effectively, including as a result of security breaches, viruses,
hackers, malware, natural disasters, vendor business interruptions or other causes, or failure to properly maintain, protect, repair
or upgrade systems, or problems with transitioning to upgraded or replacement systems could cause delays in product fulfillment and reduced
efficiency of our operations, could require additional capital to remediate the problem which may not be sufficient to cover all eventualities,
and may have an adverse effect on our reputation, results of operations and financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also use Information Technology Systems to process financial information and results of operations for internal reporting purposes and
to comply with regulatory financial reporting, legal and tax requirements. If Information Technology Systems suffer severe damage, disruption
or shutdown and our business continuity plans, or those of our vendors, do not effectively resolve the issues in a timely manner, we
could experience delays in reporting our financial results, which could result in lost revenues and profits, as well as reputational
damage. Furthermore, we depend on Information Technology Systems and personal data collection for digital marketing, digital commerce,
consumer engagement and the marketing and use of our digital products and services. We also rely on our ability to engage in electronic
communications throughout the world between and among our employees as well as with other third parties, including customers, suppliers,
vendors and consumers. Any interruption in Information Technology Systems may impede our ability to engage in the digital space and result
in lost revenues, damage to our reputation, and loss of users.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with various facets of our business, we collect and use a variety of personal data related to our customers. Our failure to
prevent security breaches could damage our reputation and brands and substantially harm our business and results of operations. On our
website, a majority of the sales are billed to our consumers&#8217; credit card accounts directly, orders are shipped to a consumer&#8217;s
address, and consumers log on using their email address. In such transactions, maintaining complete security for the transmission of
confidential information on our website, such as consumers&#8217; credit card numbers and expiration dates, personal information and
billing addresses is essential to maintaining consumer confidence. In addition, we hold certain private information about our consumers,
such as their names, addresses, phone numbers and browsing and purchasing records. We rely on encryption and authentication technology
licensed from third parties to effect the secure transmission of confidential information, including credit card numbers. Advances in
computer capabilities, new discoveries in the field of cryptography or other developments may result in a compromise or breach of the
technology used by us to protect consumer transaction data. In addition, any party who is able to illicitly obtain a user&#8217;s password
could potentially access the user&#8217;s transaction data or personal information. We may not be able to prevent third parties, such
as hackers or criminal organizations, from stealing information provided by our consumers to us through our website. In addition, our
third-party merchants and delivery service providers may violate their confidentiality obligations and disclose information about our
consumers. Any compromise of our security or material violation of a non-disclosure obligation could damage our reputation and brand
and expose us to a risk of loss or litigation and possible liability, which could substantially harm our business and results of operations.
In addition, anyone who is able to circumvent our security measures could misappropriate proprietary information or cause interruptions
in our operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Moreover,
the platform and applications that we use to operate our business are highly technical and complex and may now or in the future contain
undetected errors, bugs, or vulnerabilities. Some errors in our code may only be discovered after the code has been deployed. Any errors,
bugs or vulnerabilities discovered in our code after deployment, inability to identify the cause or causes of performance problems within
an acceptable period of time or difficultly maintaining and improving the performance of our platform, particularly during peak usage
times, could result in damage to our reputation or brand, loss of revenues, or liability for damages, any of which could adversely affect
our business and financial results. To the extent that we do not effectively address capacity constraints, upgrade our systems as needed
and continually develop our technology and network architecture to accommodate actual and anticipated changes in technology, our business
and operating results may be harmed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Global
economic, political and industry conditions constantly change and unfavorable conditions may have a material adverse effect on our business
and results of operations.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a global company with worldwide operations. Volatile economic, political and market conditions, such as political or economic
instability, civil unrest, trade sanctions, acts of terrorism in the regions or hostilities, including the recent conflict between
Russia and Ukraine, and the Israel-Hamas war, in which we operate may have a negative impact on our operating results and our
ability to achieve our business objectives. We may not have insight into economic and political trends that could emerge and
negatively affect our business. In addition, significant or volatile changes in exchange rates between the U.S. dollar and other
currencies may have a material adverse impact upon our liquidity, revenues, costs and operating results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
natural disasters and public health emergencies, such as extreme weather
events and the COVID-19 pandemic, the Ukraine War and the Israel-Hamas war, could have a significant adverse effect on our business, including
interruption of our business operations, supply chain disruption, endangerment of our personnel, and other delays or losses of materials
and results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
Russian-Ukrainian Conflict may adversely affect our business, financial condition and results.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. The specific impact on our
financial condition, results of operations and cash flows is not determinable as of October 31, 2023. However, to the extent that such
military action spreads to other countries, intensifies, or otherwise remains active, such action could have an impact on the broader
macroeconomic impact and therefore, could have a material adverse effect on our financial condition, results of operations, and cash
flows. If the Russia-Ukraine conflict continues, the U.S., the European Union, the United Kingdom, and other jurisdictions could impose
wider economic and trade sanctions as well as export restrictions, which could impact our business opportunities. In addition, our contractors
may take actions in violation of such policies and applicable law, and we could be held ultimately responsible. If we are held responsible
for a violation of U.S. or other countries&#8217; sanctions laws, we may be subject to various penalties, any of which could have a material
adverse effect on our business, financial condition or results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Geopolitical
tensions and conflicts in the Middle East, specifically the Israel-Hamas war, may lead to global economic instability and adversely affect
supply chains, which may adversely impact our operations, financial conditions and business prospects.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
we do not have any direct operations or significant sales in the Middle East, geopolitical tensions and ongoing conflicts in the region,
particularly between Israel and Hamas, may lead to global economic instability and fluctuating energy prices that could materially affect
our business. It is not possible to predict the broader consequences of the Israel-Hamas war, including related geopolitical tensions,
and the measures and actions taken by other countries in respect thereof, which could materially adversely affect global trade, currency
exchange rates, regional economies and the global economy. While it is difficult to predict the impact of any of the foregoing, the Israel-Hamas
war may increase our costs, disrupt our supply chain, reduce our sales and earnings, impair our ability to raise additional capital when
needed on acceptable terms, if at all, or otherwise adversely affect our business, financial condition and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
products face intense competition.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a sports equipment and technology company delivering products and technologies and the relative popularity of tennis, pickleball
and padel tennis and other various sports activities and changing design trends affect the demand for our products. The sports equipment
industry and sports-related technology industry are both are highly competitive both in the U.S. and worldwide. We compete internationally
with a significant number of athletic and sports equipment companies and sports-related technology companies, including sports-related
technology companies, including large companies having diversified lines of athletic and sports equipment and sports technology products.
We also compete with other companies for the production capacity of independent manufacturers that produce our products. Our online digital
e-commerce operations compete with brand wholesalers or specialist retailers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Product
offerings, technologies, marketing expenditures (including expenditures for advertising and endorsements), pricing, costs of production,
customer service, digital commerce platforms and social media presence are areas of intense competition. This, in addition to rapid changes
in technology and consumer preferences in the markets for athletic and sports equipment, constitute significant risk factors in our operations.
In addition, the competitive nature of retail including shifts in the ways in which consumers are shopping, and the rising trend of digital
commerce, constitutes a risk factor implicating our online and wholesale operations. If we do not adequately and timely anticipate and
respond to our competitors, our costs may increase or the consumer demand for our products may decline significantly.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
AI-based technology market is new and unproven, and it may decline or experience limited growth, which would adversely affect our ability
to fully realize the potential of our platforms.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
AI-based technology market is relatively new and evaluating the size and scope of the market is subject to a number of risks and uncertainties.
We believe that our future success will depend in large part on the continued growth of this market. The utilization of our app platform
by users is untested, and users may not recognize the need for, or benefits of, this app platform, which may prompt them to cease use
of our platform or decide to adopt alternative products and services to satisfy their cognitive computing search and analytics requirements.
In order to expand our business and extend our market position, we intend to focus our marketing and sales efforts on educating users
about the benefits and technological capabilities of our platforms and the applications of our platform to the specific needs of customers
in different market verticals. Our ability to access and expand the market that our platform is designed to address depends upon a number
of factors, including the cost, performance and perceived value of our platforms. Market opportunity estimates are subject to significant
uncertainty and are based on assumptions and estimates, including our internal analysis and industry experience. The market for our platform
may fail to grow significantly or be unable to meet the level of growth we expect. As a result, we may experience lower-than-expected
demand for our products and services due to lack of customer acceptance, technological challenges, competing products and services, decreases
in spending by current and prospective customers, weakening economic conditions and other causes. If our market does not experience significant
growth, or if demand for our products does not increase in line with our projections, then our business, results of operations and financial
condition will be adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
rely on technical innovation and high-quality products to compete in the market for our products.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
and development plays a key role in technical innovation. We rely upon specialists in the fields of electrical and mechanical engineering,
industrial design, sustainability and related fields, as well as other experts to develop and test cutting-edge performance products.
While we strive to produce products that help to enhance player performance, if we fail to introduce technical innovation in our products,
consumer demand for our products could decline, and if we experience problems with the quality of our products, we may incur substantial
expense to remedy the problems.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>With
the acquisition of Gameface, we are slowly transforming from a sports products only company to offering an additional sports technology
platform focused on the Play &amp; Learn Platform. If we are unable to successfully integrate this new technology with our existing products,
we may not realize the benefits of the Gameface acquisition and / or our relationships with Foundation, and our business may be materially
adversely affected.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to our acquisition of Gameface, we focused on the production and sale of the Slinger Bag. Now our focused has shifted to the Play and
Learn integrated platform which includes the analysis and AI offered by Gameface. The Play and Learn Platform requires integration of
the capabilities of our existing business with those of Gameface. we may not realize the benefits of the Gameface acquisition and our
business may be materially adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Failure
to continue to obtain or maintain high-quality endorsers of our products could harm our business.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
establish relationships with professional athletes, as well as other public figures such as teaching pros and influencers, to develop,
evaluate and promote our products, as well as establish product authenticity with consumers. However, as competition in our industry
has increased, the costs associated with establishing and retaining such sponsorships and other relationships have increased. If we are
unable to maintain our current associations with professional athletes, or other public figures, or to do so at a reasonable cost, we
could lose the high visibility or on-field authenticity associated with our products, and we may be required to modify and substantially
increase our marketing investments. Any substantial deterioration in these relationships, or substantial deterioration of our relationship
with their talent managers or other key personnel, could adversely affect our business. As a result, our brands, net revenues, expenses
and profitability could be harmed. If certain endorsers were to stop using our products contrary to their endorsement agreements, our
business could be adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Actions
taken by athletes or other endorsers, associated with our products that harm the reputations of those athletes or endorsers, could also
seriously harm our brand image with consumers and, as a result, could have an adverse effect on our sales and financial condition.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Actions
taken by athletes or other endorsers, associated with our products that harm the reputations of those athletes or endorsers, could also
seriously harm our brand image with consumers and, as a result, could have an adverse effect on our sales and financial condition. Poor
performance by our endorsers, a failure to continue to correctly identify future athletes, public figures or sports organizations, to
use and endorse our products or a failure to enter into cost-effective endorsement arrangements with prominent athletes, public figures,
and sports organizations could adversely affect our brand, sales and profitability. We are also subject to laws, regulations and industry
standards relating to endorsements and influencer marketing. Many of these laws, regulations and industry standards are changing and
may be subject to differing interpretations, are costly to comply with or inconsistent among jurisdictions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
business may be affected by seasonality, which could result in fluctuations in our operating results.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect to experience moderate fluctuations in aggregate sales volume during the year. We expect revenues in the first and fourth fiscal
quarters to exceed those in the second and third fiscal quarters. However, the mix of product sales may vary considerably from time to
time as a result of changes in seasonal and geographic demand for tennis and other sports equipment and in connection with the timing
of significant sporting events, such as any Grand Slam tennis tournament and, over time, other sports competitions. In addition, our
customers may cancel orders, change delivery schedules or change the mix of products ordered with minimal notice. As a result, we may
not be able to accurately predict our quarterly sales. Accordingly, our results of operations are likely to fluctuate significantly from
period to period. Our operating margins are also sensitive to a number of additional factors that are beyond our control, including manufacturing
and transportation costs, shifts in product sales mix and geographic sales trends, all of which we expect to continue. Results of operations
in any period should not be considered indicative of the results to be expected for any future period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may be adversely affected by the financial health of our third-party internet partners, wholesale purchasers, retailers, and distributors.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
extend credit to our distributors and to a select number of third party internet partners based on an assessment of a customer&#8217;s
financial condition, generally without requiring collateral. To assist in the scheduling of production and the shipping of our products,
we offer our distributor partners the opportunity to place orders three months ahead of delivery under our direct ship ordering program.
These advance orders may be canceled under certain conditions, and the risk of cancellation may increase when dealing with financially
unstable distribution partners struggling with economic uncertainty. In the past, some sports customers have experienced financial difficulties
up to and including bankruptcies. Such future events would have an adverse effect on our sales, our ability to collect on receivables
and our financial condition. When the retail economy weakens or as consumer behavior shifts, distributors may be more cautious with orders.
A slowing or changing economy in our key markets could adversely affect the financial health of our customers, which in turn could have
an adverse effect on our results of operations and financial condition. In addition, product sales are dependent in part on high quality
digital advertising and merchandising to attract consumers, which requires continuing investments by the company, our distributors and
our third party internet partners. Distributors or partners that experience financial difficulties may fail to make such investments
or delay them, resulting in lower sales and orders for our products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Failure
to accurately forecast consumer demand could lead to excess inventories or inventory shortages, which could result in decreased operating
margins, reduced cash flows and harm to our business.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is a risk we may be unable to sell excess products ordered from manufacturers. Inventory levels in excess of customer demand may result
in inventory write-downs, and the sale of excess inventory at discounted prices could significantly impair our brand image and have an
adverse effect on our operating results, financial condition and cash flows. Conversely, if we underestimate consumer demand for our
products or if our manufacturers fail to supply products we require at the time we need them, we may experience inventory shortages.
Inventory shortages might delay shipments to customers, negatively impact retailer, distributor and consumer relationships and diminish
brand loyalty. The difficulty in forecasting demand also makes it difficult to estimate our future results of operations, financial condition
and cash flows from period to period. A failure to accurately predict the level of demand for our products could adversely affect our
net revenues and net income, and we are unlikely to forecast such effects with any certainty in advance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Consolidation
of retailers or concentration of retail market share among a few retailers may increase and concentrate our credit risk and impair our
ability to sell products.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
sports equipment retail markets in some countries are dominated by a few large athletic equipment retailers with many stores. These retailers
have in the past increased their market share by expanding through acquisitions and construction of additional stores. These situations
concentrate our credit risk with a relatively small number of retailers, and, if any of these retailers were to experience a shortage
of liquidity or consumer behavior shifts away from traditional retail, it would increase the risk that their outstanding payables to
us may not be paid. In addition, increasing market share concentration among one or a few retailers in a particular country or region
increases the risk that if any one of them substantially reduces their purchases of our products, we may be unable to find a sufficient
number of other retail outlets for our products to sustain the same level of sales and revenues.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
the technology-based systems that give our consumers the ability to shop with us online do not function effectively, our operating results,
as well as our ability to grow our digital commerce business globally, could be materially adversely affected.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Many
of our consumers shop with us through our digital platforms. Increasingly, consumers are using mobile-based devices and applications
to shop online with us and with our competitors and to do comparison shopping. We are increasingly using social media and proprietary
mobile applications to interact with our consumers and as a means to enhance their shopping experience. Any failure on our part to provide
attractive, effective, reliable, user-friendly digital commerce platforms that offer a wide assortment of merchandise with rapid delivery
options and that continually meet the changing expectations of online shoppers could place us at a competitive disadvantage, result in
the loss of digital commerce and other sales, harm our reputation with consumers, have a material adverse impact on the growth of our
digital commerce business globally and could have a material adverse impact on our business and results of operations. Risks specific
to our digital commerce business also include liability for online content. Our failure to successfully respond to these risks might
adversely affect sales in our digital commerce business, as well as damage our reputation and brands. Many factors unique to e-commerce
operations, some of which are beyond our control, pose risks and uncertainties. Risks include, but are not limited to, credit card fraud
or data mismanagement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
products are subject to risks associated with overseas sourcing, manufacturing and financing.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
principal materials used in our products (e.g., injection molded plastics, polyester, electrical motors, remote controls, trolley bags)
are available in countries where our manufacturing takes place. Our products are dependent upon the ability of our unaffiliated contract
manufacturers to locate, train, employ and retain adequate personnel. Our contractors and suppliers buy raw materials and are subject
to wage rates that are oftentimes regulated by the governments of the countries in which our products are manufactured.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
could be a significant disruption in the supply of raw materials from current sources or, in the event of a disruption, our contract
manufacturers might not be able to locate alternative suppliers of materials of comparable quality at an acceptable price or at all.
Further, our unaffiliated contract manufacturers have experienced and may continue to experience in the future, unexpected increases
in work wages, whether government mandated or otherwise and increases in compliance costs due to governmental regulation concerning certain
metals used in the manufacturing of our products. In addition, we cannot be certain that our unaffiliated manufacturers will be able
to fill our orders in a timely manner. If we experience significant increases in demand, or reductions in the availability of materials,
or need to replace an existing manufacturer, there can be no assurance additional supplies of raw materials or additional manufacturing
capacity will be available when required on terms acceptable to us, or at all, or that any supplier or manufacturer would allocate sufficient
capacity to us in order to meet our requirements. In addition, even if we are able to expand existing or find new manufacturing or sources
of materials, we may encounter delays in production and added costs as a result of the time it takes to train suppliers and manufacturers
in our methods, products, quality control standards and labor, health and safety standards. Any delays, interruption or increased costs
in labor or wages, or the supply of materials or manufacture of our products could have an adverse effect on our ability to meet retail
customer and consumer demand for our products and result in lower revenues and net income both in the short- and long-term.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
independent manufacturers make all of our products outside of our principal sales markets, our products must be transported by third
parties over large geographic distances. Delays in the shipment or delivery of our products due to the availability of transportation,
work stoppages, port strikes, infrastructure congestion or other factors, and costs and delays associated with consolidating or transitioning
between manufacturers, could adversely impact our financial performance. In addition, manufacturing delays or unexpected demand for our
products may require us to use faster, but more expensive, transportation methods such as air freight, which could adversely affect our
profit margins. The cost of oil is a significant component in manufacturing and transportation costs, so increases in the price of petroleum
products can adversely affect our profit margins. Changes in U.S. trade policies, including new and potential changes to import tariffs
and existing trade policies and agreements, could also have a significant impact on our activities in foreign jurisdictions, and could
adversely affect our results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
financial results may be adversely affected if substantial investments in businesses and operations fail to produce the expected returns.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, we may invest in technology, business infrastructure, new businesses, product offering and manufacturing innovation and
expansion of existing businesses, such as our digital commerce operations, which require substantial cash investments and management
attention. We believe cost-effective investments are essential to business growth and profitability; however, significant investments
are subject to typical risks and uncertainties inherent in developing a new business or expanding an existing business. The failure of
any significant investment to provide expected returns or profitability could have a material adverse effect on our financial results
and divert management attention from more profitable business operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
business is sensitive to consumer spending and general economic conditions.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business may be adversely affected by the COVID-19 pandemic, the Ukraine
war, and the Israel-Hamas war, as well as macro-economic conditions such as inflation, employment levels, wage and salary levels, trends
in consumer confidence and spending, reductions in consumer net worth, interest rates, inflation, the availability of consumer credit
and taxation policies influence on public spending confidence. Recent dramatic downturns in the strength of global stock markets, currencies
and key economies have highlighted many if not all, of these risks.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 20; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consumer
purchases in general may decline during recessions, periods of prolonged declines in the equity markets or housing markets and periods
when disposable income and perceptions of consumer wealth are lower, and these risks may be exacerbated for us due to our focus on discretionary
premium sporting good items. A downturn in the global economy, or in a regional economy in which we have significant sales, could have
a material, adverse effect on consumer purchases of our products, our results of operations and our financial position, and a downturn
adversely affecting our consumer base or travelers could have a disproportionate impact on our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
continues to be a significant and growing volatility and uncertainty in the global economy due to the Coronavirus pandemic affecting
all business sectors and industries. In addition, the on-going uncertainty in Europe and any resulting disruption could adversely impact
our net sales in Europe and globally unless and until economic conditions in that region improve and the prospects of national debt defaults
in Europe decline. Further or future downturns may adversely affect traffic at our on-line sales portals (which currently includes our
own website https://www.connexasports.com/ and could materially and adversely affect our results of operations, financial position and
growth strategy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Likewise,
the current impasse in U.S.-China trade relations has resulted in import duties for all Slinger products into the U.S. being increased
from the previous standard of 5% to 30%. Our management has taken the view that at this time, gaining distribution and share outweighs
the immediate margin consideration and has decided to take the added increase in import tariffs as a margin loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>There
is substantial doubt regarding our ability to continue as a going concern absent obtaining adequate new debt or equity financing and
achieving sufficient sales levels.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s management has determined that there is substantial doubt about the Company&#8217;s ability to continue as a going concern
and the report of our independent registered public accounting firm on our consolidated financial statements for the years ended April
30, 2023 and 2022 included an explanatory paragraph with respect to the foregoing. Our ability to continue as a going concern is dependent
upon our ability to raise additional capital and implement our business plan. This determination was based on the following factors:
(i) the Company has a working capital deficit as of April 30, 2023, used cash in operations for the fiscal year ended April 30, 2023
of $6,365,389 and the Company&#8217;s available cash as of the date of this filing will not be sufficient to fund its anticipated level
of operations for the next 12 months; (ii) the Company will require additional financing for the fiscal year ending April 30, 2023 to
continue at its expected level of operations; and (iii) if the Company fails to obtain the needed capital, it will be forced to delay,
scale back, or eliminate some or all of its development activities or perhaps cease operations. In the opinion of management, these factors,
among others, raise substantial doubt about the ability of the Company to continue as a going concern as of the date of the end of the
period covered by this report and for one year from the issuance of the consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
have limited financial resources. Our independent registered auditors&#8217; report includes an explanatory paragraph stating that there
is substantial doubt about our ability to continue as a going concern.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of our deficiency in working capital on April 30, 2023 and other factors, our auditors have included a paragraph in their audit
report regarding substantial doubt about our ability to continue as a going concern. Our plans in this regard are to increase product
sales, increase production, obtain inventory financing, seek strategic alternatives and to seek additional capital through future equity
private placements or debt facilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have recorded net losses since inception and have significant accumulated deficits. We have relied upon loans and equity financings for
operating capital. Total revenues will be insufficient to pay off existing debt and fund operations. We may be required to rely on further
debt financing, further loans from related parties, and private placements of our common stock for our additional cash needs. Such funding
sources may not be available, or the terms of such funding sources may not be acceptable to the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 21; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
will need additional capital in the future to finance our planned growth, which we may not be able to raise or it may only be available
on terms unfavorable to us or our stockholders, which may result in our inability to fund our working capital requirements and harm our
operational results.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have and expect to continue to have substantial working capital needs. Our cash on hand, together with cash generated from product sales,
services, cash equivalents and short-term investments will not meet our working capital and capital expenditure requirements for the
next twelve months. In fact, we will be required to raise additional funds throughout 2023 or we will need to limit operations until
such time as we can raise substantial funds to meet our working capital needs. In addition, we will need to raise additional funds to
fund our operations and implement our growth strategy, or to respond to competitive pressures and/or perceived opportunities, such as
investment, acquisition, marketing and development activities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we experience operating difficulties or other factors, many of which may be beyond our control, cause our revenues or cash flows from
operations, if any, to decrease, we may be limited in our ability to spend the capital necessary to complete our development, marketing
and growth programs. We require additional financing, in addition to the anticipated cash generated from our operations, to fund our
working capital requirements. Additional financing might not be available on terms favorable to us, or at all. If adequate funds were
not available or were not available on acceptable terms, our ability to fund our operations, take advantage of unanticipated opportunities,
develop or enhance our business or otherwise respond to competitive pressures would be significantly limited. In such a capital restricted
situation, we may curtail our marketing, development, and operational activities or be forced to sell some of our assets on an untimely
or unfavorable basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
internal controls may be inadequate, which could cause our financial reporting to be unreliable and lead to misinformation being disseminated
to the public.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
management is responsible for establishing and maintaining adequate internal control over our financial reporting. As defined in Exchange
Act Rule 13a-15(f), internal control over financial reporting is a process designed by, or under the supervision of, the principal executive
and principal financial officer and effected by the board of directors of the Company (the &#8220;Board of Directors&#8221;), management
and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial
statements for external purposes in accordance with generally accepted accounting principles and includes those policies and procedures
that:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 10.1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">pertain
    to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets
    of the Company;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">provide
    reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with
    generally accepted accounting principles and that receipts and expenditures of the Company are being made only in accordance with
    authorizations of management and/or directors of the Company; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">provide
    reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company&#8217;s
    assets that could have a material effect on the financial statements.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
internal controls may be inadequate or ineffective, which could cause financial reporting to be unreliable and lead to misinformation
being disseminated to the public. Investors relying upon this misinformation may make an uninformed investment decision.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Failure
to achieve and maintain an effective internal control environment could cause us to face regulatory action and also cause investors to
lose confidence in our reported financial information, either of which could have a material adverse effect on the Company&#8217;s business,
financial condition, results of operations and future prospects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">However,
our auditors will not be required to formally attest to the effectiveness of our internal control over financial reporting pursuant to
Section 404 until we are no longer a &#8220;smaller reporting company&#8221;.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 22; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
costs of being a public company could result in us being unable to continue as a going concern.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a public company, we are required to comply with numerous financial reporting and legal requirements, including those pertaining to audits
and internal control. The costs of maintaining public company reporting requirements could be significant and may preclude us from seeking
financing or equity investment on terms acceptable to us and our shareholders. We estimate these costs to be in excess of $500,000 per
year and may be higher if our business volume or business activity increases significantly. Our current estimate of costs does not include
the necessary expenses associated with compliance, documentation and specific reporting requirements of Section 404 as we will not be
subject to the full reporting requirements of Section 404 until we no longer qualify as a &#8220;smaller reporting company&#8221;.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
our revenues are insufficient or non-existent, and/or we cannot satisfy many of these costs through the issuance of shares or debt, we
may be unable to satisfy these costs in the normal course of business. This would certainly result in our being unable to continue as
a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we fail to maintain effective internal controls over financial reporting, then the price of our common stock may be adversely affected.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
internal control over financial reporting may have weaknesses and conditions that could require correction or remediation, the disclosure
of which may have an adverse impact on the price of our common stock. We are required to establish and maintain appropriate internal
controls over financial reporting. Failure to establish those controls, or any failure of those controls once established, could adversely
affect our public disclosures regarding our business, prospects, financial condition or results of operations. In addition, management&#8217;s
assessment of internal controls over financial reporting may identify weaknesses and conditions that need to be addressed in our internal
controls over financial reporting or other matters that may raise concerns for investors. Any actual or perceived weaknesses and conditions
that need to be addressed in our internal control over financial reporting or disclosure of management&#8217;s assessment of our internal
controls over financial reporting may have an adverse impact on the price of our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Any
acquisitions we make could disrupt our business and seriously harm our financial condition.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have in the past made (and may, from time to time, consider) acquisitions of complementary companies, products or technologies. A primary
component of our growth strategy has been to acquire complementary businesses to grow our Company. For example, we acquired the business
of Foundation Sports Systems, LLC, in our fiscal year ended April 30, 2021, and the acquisitions of PlaySight and Gameface closed in
the fiscal year ended April 30, 2022. In the Company&#8217;s fiscal quarter ended January 31, 2023, the Company divested PlaySight and
75% of its interest in Foundation Sports as the required monthly cash burn became increasingly difficult to manage as inflation rose
and the cost of manufacturing the Company&#8217;s non-technological products grew. As a result, the Company sold PlaySight back to its
original owners of in November 2022, and the Company sold most (75%) of Foundation Tennis back to their original owners, with an option
to purchase any remaining interests. We intend to continue to pursue acquisitions of complementary technologies, products and businesses
as a primary component of our growth strategy to enhance the features and functionality of our applications, expand our customer base
and provide access to new markets and increase benefits of scale. Acquisitions involve numerous risks, including difficulties in the
assimilation of the acquired businesses, the diversion of our management&#8217;s attention from other business concerns and potential
adverse effects on existing business relationships could cause our actual growth or operating results to differ from our expectations.
In addition, any acquisitions could involve the incurrence of substantial additional indebtedness. We cannot assure you that we will
be able to successfully integrate any acquisitions that we pursue or that such acquisitions will perform as planned or prove to be beneficial
to our operations and cash flow. Any such failure could seriously harm our business, financial condition and results of operations. In
addition, there might be potential inability or failure to achieve additional sales and enhance our customer base through cross-marketing
of the products to new and existing customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Some
aspects of our business processes include open-source software, which poses risks that could have a material and adverse effect on our
business, financial condition and results of operations. In addition, any failure to comply with the terms of one or more of these open-source
licenses could negatively affect our business.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
incorporate open-source software into processes supporting our business and anticipate using open- source software in the future. Such
open-source software may include software covered by licenses like the GNU General Public License and the Apache License. The terms of
various open-source licenses to which we are subject have not been interpreted by U.S. courts, and there is a risk that such licenses
could be construed in a manner that imposes unanticipated conditions or restrictions on our ability to operate our systems, limits our
use of the software, inhibits certain aspects of our systems and negatively affects our business operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 23; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Some
open-source licenses contain requirements that we make source code modifications or derivative works we create publicly available or
make such modifications or derivative works available on unfavorable terms or at no cost, depending on the type of open-source software
used.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
we monitor our use of open-source software and try to ensure that none is used in a manner that would require us to disclose our proprietary
source code or that would otherwise breach the terms of an open-source license, such use could inadvertently occur, or could be claimed
to have occurred, in part because open-source license terms are often ambiguous. We may face claims from third parties claiming ownership
of, or demanding the release or license of, modifications or derivative works that we have developed using such open-source software
(which could include our proprietary source code or artificial intelligence (&#8220;AI&#8221;) models), or otherwise seeking to enforce
the terms of the applicable open-source license. These claims could result in litigation and if portions of our proprietary AI models
or software are determined to be subject to an open-source license, or if the license terms for the open-source software that we incorporate
change, we could be required to publicly release all or affected portions of our source code, purchase a costly license, cease offering
the implicated products or services unless and until we can re-engineer such source code in a manner that avoids infringement, discontinue
or delay the provision of our offerings if re-engineering could not be accomplished on a timely basis or change our business activities,
any of which could negatively affect our business operations and potentially our intellectual property rights. In addition, the re-engineering
process could require us to expend significant additional research and development resources, and we may not be able to complete the
re-engineering process successfully. If we were required to publicly disclose any portion of our proprietary models, it is possible we
could lose the benefit of trade secret protection for our models.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to risks related to license requirements, the use of certain open-source software can lead to greater risks than the use of
third-party commercial software, as open-source licensors generally do not provide support, warranties, indemnification, controls or
other contractual protections regarding infringement claims or the quality of the origin of the software. There is little legal precedent
in this area, and any actual or claimed requirement to disclose our proprietary source code or pay damages for breach of contract could
harm our business and could help third parties, including our competitors, develop products and services that are similar to or better
than ours. Use of open-source software may also present additional security risks because the public availability of such software may
make it easier for hackers and other third parties to determine how to breach our website and systems that rely on open-source software.
Any of these risks associated with the use of open-source software could be difficult to eliminate or manage, and if not addressed, could
materially and adversely affect our business, financial condition and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Systems
defects, failures or disruptions, including events beyond our control, and resulting interruptions in the availability of our websites,
applications, products, or services could harm our business, harm our reputation, result in significant costs to us, decrease our potential
profitability and expose us to substantial liability.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
use vendors, such as our cloud computing web services provider and third-party software providers, in the operation of our platform.
The satisfactory performance, reliability and availability of our technology and our underlying network and infrastructure are critical
to our operations and reputation and the ability of our platform to attract new and retain existing customers. We rely on these vendors
to protect their systems and facilities against damage or service interruptions from natural disasters, power or telecommunications failures,
air quality issues, environmental conditions, computer viruses or attempts to harm these systems, criminal acts, unauthorized access,
sabotage, acts of vandalism, military actions, negligence, human errors, fraud, spikes in platform use and denial of service issues,
hardware failures, improper operation, cyberattacks, data loss, wars and similar events. If our arrangement with a vendor is terminated
or if there is a lapse of service or damage to its systems or facilities, we could experience interruptions in our ability to operate
our platform. We also may experience increased costs and difficulties in replacing that vendor and replacement services may not be available
on commercially reasonable terms, on a timely basis, or at all.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 24; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, our platform may be accessed by many users at the same time. As we continue to expand the number of our users, and products
and services available through our platform, we may not be able to scale our technology to accommodate the increased capacity requirements.
The failure of data centers, internet service providers or other third- party service providers to meet our capacity requirements could
result in interruptions or delays in access to our platform or impede our ability to grow our business and scale our operations. Any
interruptions or delays in our platform availability, whether as a result of a failure to perform on the part of a vendor, any damage
to one of our vendor&#8217;s systems or facilities, the termination of any of our third-party vendor agreements, software failures, our
or our vendor&#8217;s error, natural disasters, terrorism, other man-made problems, security breaches, whether accidental or willful,
or other factors, could harm our relationships with our customers, prevent our customers from accessing their accounts, damage our reputation
with current and potential customers, expose us to liability, cause us to lose customers, cause the loss of critical data, prevent us
from supporting our platform, products or services or cause us to incur additional expense in arranging for new facilities and support
or otherwise harm our business and also harm our reputation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, we source certain information from third parties. In the event that any third party from which we source information experiences
a service disruption, whether as a result of maintenance, natural disasters, terrorism, or security breaches, whether accidental or willful,
or other factors, the ability to access our platform may be adversely impacted. Additionally, there may be errors contained in the information
provided by third parties. This may result in the inability to approve otherwise qualified applicants through our platform, which may
adversely impact our business by negatively impacting our reputation and reducing our transaction volume.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent we use or are dependent on any particular third-party data, technology, or software, we may also be harmed if such data, technology,
or software becomes non-compliant with existing regulations or industry standards, becomes subject to third-party claims of intellectual
property infringement, misappropriation, or other violation, or malfunctions or functions in a way we did not anticipate. Any loss of
the right to use any of this data, technology, or software could result in delays in the provisioning of our products and services until
equivalent or replacement data, technology, or software is either developed by us, or, if available, is identified, obtained, and integrated,
and there is no guarantee that we would be successful in developing, identifying, obtaining, or integrating equivalent or similar data,
technology, or software, which could result in the loss or limiting of our products, services, or features available in our products
or services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
ability to sell our products and services will be dependent on the quality of our technical support and our failure to deliver high-quality
technical support services could have a material adverse effect on our sales and results of operations.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we do not effectively assist our users in deploying our products and services, succeed in helping our users quickly resolve post-deployment
issues and provide effective ongoing support, or if potential customers perceive that we may not be able to achieve the foregoing, our
ability to sell our products and services would be adversely affected, and our reputation with potential users could be harmed. In addition,
if we expand our operations internationally, our technical support team will face additional challenges, including those associated with
delivering support, training and documentation in languages other than the English language. As a result, our failure to deliver and
maintain high-quality technical support services to our users could result in customers choosing to use our competitors&#8217; products
or services in the future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
Gameface products and services may fail to keep pace with rapidly changing technology and evolving industry standards.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
market in which Gameface operates is characterized by rapid, and sometimes disruptive, technological developments, evolving industry
standards, frequent new product introductions and enhancements and changes in user requirements. In addition, both traditional and new
competitors are investing heavily in our market areas and competing for users. As next-generation video analytics technology continues
to evolve, we must keep pace in order to maintain or expand our market position. If we are not able to successfully add staff resources
with sufficient technical skills to develop and bring new products to market in a timely manner, achieve market acceptance of our products
and services or identify new market opportunities for our products and services, our business and results of operations may be materially
and adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 25; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
business-to-business e-commerce industry is highly competitive, and we may not be able to compete effectively.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
market for business-to-business (&#8220;B2B&#8221;) e-commerce solutions is rapidly changing and intensely competitive. We expect competition
to intensify as the number of entrants and new technologies increases. We may not be able to compete successfully against current or
future competitors. The competitive pressures facing us may harm our business, operating results and financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we are not able to enhance or introduce new products that achieve market acceptance and keep pace with technological developments, our
business, results of operations and financial condition could be harmed.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ability to attract new users and increase revenue from existing customers depends in part on our ability to enhance and improve our platforms,
increase adoption and usage of our products and introduce new products and features. The success of any enhancements or new products
depends on several factors, including timely completion, adequate quality testing, actual performance quality, market-accepted pricing
levels and overall market acceptance and demand. Enhancements and new products that we develop may not be introduced in a timely or cost-effective
manner, may contain defects, may have interoperability difficulties with our platform, or may not achieve the market acceptance necessary
to generate significant revenue. If we are unable to successfully enhance our existing platform and capabilities to meet evolving customer
requirements, increase adoption and usage of our platform, develop new products, or if our efforts to increase the usage of our products
are more expensive than we expect, then our business, results of operations and financial condition could be harmed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Customers
may experience difficulty in integrating Gameface with third-party applications, which would inhibit sales.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gameface
may serve a customer base with a wide variety of constantly changing hardware, operating system software, packaged software applications
and networking platforms. If Gameface fails to gain broad market acceptance due to its inability to support a variety of these platforms,
our operating results may suffer. Our business depends, in part, on the following factors:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 10.1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    ability to integrate Gameface with multiple platforms and existing systems and to modify our product as new versions of packaged
    applications are introduced;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Access
    to application program interfaces for the third-party software products that are integrated with our products; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    ability to anticipate and support new standards.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Lack
of cooperation from Vendors of the software we use in Gameface and other products may interfere with the use of Gameface apps and inhibit
our business.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Application
program interfaces provide the instructions that are required to transfer information into and out of an application and trigger the
specific characteristics of that application. These instructions are needed to create adapters between Gameface and third-party software
products, but access to application program interfaces is controlled by the vendors of these applications. If the application vendor
denies or delays our access to application program interfaces, our business may be harmed. Some application vendors may become competitors
or establish alliances with our competitors, increasing the likelihood that we would not be granted access to their application program
interfaces. Furthermore, we may need to modify Gameface or develop new adapters in the future as new applications or newer versions of
existing applications are introduced. If we fail to continue to develop adapters or respond to new applications or newer versions of
existing applications in a timely manner, our business could suffer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 26; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to the Company&#8217;s Legal and Regulatory Requirements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Failure
to adequately protect our intellectual property and curb the sale of counterfeit merchandise could injure our brand and negatively affect
our sales.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
trademarks, copyrights, patents, designs and other intellectual property rights are important to our success and our competitive position.
We devote significant resources to the registration and protection of our trademarks and patents. In spite of our efforts, counterfeiting
and design copies may still occur. If we are unsuccessful in challenging the usurpation of these rights by third parties, this could
adversely affect our future sales, financial condition and results of operations. Our efforts to enforce our intellectual property rights
can potentially be met with defenses and counterclaims attacking the validity and enforceability of our intellectual property rights.
Unplanned increases in legal fees and other costs associated with protecting our intellectual property rights could result in higher
operating expenses. Additionally, legal regimes outside the U.S., particularly those in Asia, including China, may not always protect
intellectual property rights to the same degree as U.S. laws, or the time required to enforce our intellectual property rights under
these legal regimes may be lengthy and delay our recovery.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may become subject to claims for remuneration or royalties for assigned service invention rights by our employees, which could result
in litigation and adversely affect our business.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
significant portion of our intellectual property has been developed by our employees, or outside consultants in the course of their employment
or retention with us. Under the Israeli Patent Law, 5727-1967, or the Patent Law, inventions conceived by an employee during the scope
of his or her employment with a company are regarded as &#8220;service inventions.&#8221; The Israeli Compensation and Royalties Committee,
or the Committee, a body constituted under the Patent Law, has previously held, in certain cases, that employees may be entitled to remuneration
for service inventions that they develop during their service for a company despite their explicit waiver of such right. Therefore, we
may face claims by employees demanding remuneration beyond their regular salary and benefits.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may be subject to product liability lawsuits or claims, which could harm our financial condition and liquidity if we are not able to
successfully defend or insure against such claims.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may be subject to product liability lawsuits and claims that, individually or in the aggregate, could harm our business, prospects, results
of operations and financial condition. We may face lawsuits or claims if our products do not perform as expected, malfunction or are
used without complying with their specifications. Moreover, a product liability lawsuit or claim, regardless of merit, could generate
negative publicity about our products, which could have a material adverse effect on our brand, business, prospects, results of operations
and financial condition. Any lawsuit or claim seeking monetary damages significantly exceeding our coverage or outside of our coverage
may have a material adverse effect on our business and financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we provide products and services related to sports betting, our business may become subject to a variety of U.S. and foreign laws, many
of which are unsettled and still developing and which could subject us to claims or otherwise harm our business. Any adverse change in
regulations or their interpretation, or the regulatory climate applicable to these contemplated products and services, or changes in
tax rules and regulations or interpretation thereof related to these contemplated products and services, could adversely impact our ability
to operate our business as we seek to operate in the future, which could have a material adverse effect on our financial condition and
results of operations.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business could potentially expand into sports betting, in which case our business partners are generally subject to laws and regulations
in the jurisdictions in which we will conduct our business or in some circumstances, of those jurisdictions in which we offer our services
or those are available, as well as the general laws and regulations that apply to all e-commerce businesses, such as those related to
privacy and personal information, tax and consumer protection. These laws and regulations vary from one jurisdiction to another and future
legislative and regulatory action, court decisions or other governmental action, which may be affected by, among other things, political
pressures, attitudes and climates, as well as personal biases, may at such time have a material impact on our operations and financial
results, or may prevent our business partners from expanding into such businesses entirely and thus, may have impact on our business.
In addition, some jurisdictions in which we may operate could presently be unregulated or partially regulated and therefore more susceptible
to the enactment or change of laws and regulations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of the foregoing, future legislative and regulatory action, and court decisions or other governmental action, may have a material
impact on our business partners&#8217; business and operations, and that may also have an impact on our operations and financial results.
Governmental authorities could view us as having violated local laws, despite efforts to obtain all applicable licenses or approvals.
There is also a risk that civil and criminal proceedings, including class actions brought by or on behalf of prosecutors or public entities
or incumbent monopoly providers, or private individuals, could be initiated against our business partners, us, and others involved in
the sports betting industry. Such potential proceedings could involve substantial litigation expense, penalties, fines, seizure of assets,
injunctions or other restrictions being imposed upon us or our business partners. Such proceedings could have a material adverse effect
on our business, financial condition, results of operations and prospects, as well as impact our reputation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
there can be no assurance that legally enforceable legislation will not be proposed and passed in jurisdictions relevant or potentially
relevant to our business to prohibit, legislate or regulate various aspects of the sports betting industry (or that existing laws in
those jurisdictions will not be interpreted negatively). Compliance with any such legislation may have a material adverse effect on our
business, financial condition and results of operations, either as a result of our determination not to offer products or services in
a jurisdiction or to cease doing so, or because a local license or approval may be costly for us or our business partners to obtain and/or
such licenses or approvals may contain other commercially undesirable conditions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Fluctuations
in our tax obligations and effective tax rate may have a negative effect on our operating results.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may be subject to income taxes in multiple jurisdictions. We record tax expense based on our estimates of future payments, which include
reserves for uncertain tax provisions in multiple tax jurisdictions. At any one time, many tax years may be subject to audit by various
taxing jurisdictions. The results of these audits and negotiations with taxing authorities may affect the ultimate settlement of these
issues. As a result, we expect that throughout the year there could be ongoing variability in our quarterly tax rates as events occur
and exposures are evaluated. Further, our effective tax rate in a given financial period may be materially impacted by changes in mix
and level of earnings or by changes to existing accounting rules or regulations. In addition, tax legislation enacted in the future could
negatively impact our current or future tax structure and effective tax rates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
do not have covenants not to compete in place with our key employees.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
generally do not enter into non-competition agreements as part of our employment agreements with our employees and it may be difficult
for us to restrict our competitors from benefitting from the expertise our former employees or consultants developed while working for
us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
could be subject to changes in tax rates, adoption of new tax laws, additional tax liabilities or increased volatility in our effective
tax rate.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to the tax laws in the U.S. and numerous foreign jurisdictions. Current economic and political conditions make tax laws and
regulations, or their interpretation and application, in any jurisdiction subject to significant change. On December 22, 2017, the U.S.
enacted the Tax Cuts and Jobs Act (the &#8220;Tax Act&#8221;), which includes a number of significant changes to previous U.S. tax laws
that impact us, including provisions for a one-time transition tax on deemed repatriation of undistributed foreign earnings, and a reduction
in the corporate tax rate from 35% to 21% for tax years beginning after December 31, 2017, among other changes. The Tax Act also transitions
U.S. international taxation from a worldwide system to a modified territorial system and includes base erosion prevention measures on
non-U.S. earnings, which has the effect of subjecting certain earnings of our foreign subsidiaries to U.S. taxation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
earn a substantial portion of our income in foreign countries and are subject to the tax laws of those jurisdictions. There have been
proposals to reform foreign tax laws that could significantly impact how U.S. multinational corporations are taxed on foreign earnings.
Although we cannot predict whether or in what form these proposals will pass, several of the proposals considered, if enacted into law,
could have an adverse impact on our income tax expense and cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Portions
of our operations are subject to a reduced tax rate or are free of tax under various tax holidays and rulings. We also utilize tax rulings
and other agreements to obtain certainty in the treatment of certain tax matters. These holidays and rulings expire in whole or in
part from time to time and may be extended when certain conditions are met or terminated if certain conditions are not met. The impact
of any changes in conditions would be the loss of certainty in treatment thus potentially impacting our effective income tax rate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 28; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may also be subject to the examination of our tax returns by the U.S. Internal Revenue Service (&#8220;IRS&#8221;) and other tax authorities.
We regularly assess the likelihood of an adverse outcome resulting from these examinations to determine the adequacy of our provision
for income taxes. Although we believe our tax provisions are adequate, the final determination of tax audits and any related disputes
could be materially different from our historical income tax provisions and accruals. The results of audits or related disputes could
have an adverse effect on our financial statements for the period or periods for which the applicable final determinations are made.
For example, we and our subsidiaries are also engaged in a number of intercompany transactions across multiple tax jurisdictions. Although
we believe we have clearly reflected the economics of these transactions and the proper local transfer pricing documentation is in place,
tax authorities may propose and sustain adjustments that could result in changes that may impact our mix of earnings in countries with
differing statutory tax rates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>To
the extent we may rely on endorsements or testimonials, we will review any relevant relationships for compliance with the Endorsement
Guides and we will otherwise endeavor to follow the FTC Act and other legal standards applicable to our advertising</i>.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
FTC regulates the use of endorsements and testimonials in advertising as well as relationships between advertisers and social media influencers
pursuant to principles described in the FTC&#8217;s Guides Concerning the Use of Endorsements and Testimonials in Advertising, or the
Endorsement Guides. The Endorsement Guides provide that an endorsement must reflect the honest opinion of the endorser and cannot be
used to make a claim about a product that the product&#8217;s marketer couldn&#8217;t legally make. They also say that
if there is a connection between an endorser and the marketer that consumers would not expect and it would affect how consumers evaluate
the endorsement, that connection should be disclosed. Another principle in the Endorsement Guides applies to ads that feature endorsements
from people who achieved exceptional, or even above average, results from using a product. If the advertiser doesn&#8217;t have proof
that the endorser&#8217;s experience represents what people will generally achieve using the product as described in the ad, then an
ad featuring that endorser must make clear to the audience what results they can generally expect to achieve and the advertiser must
have a reasonable basis for its representations regarding those generally expected results. Although the Endorsement Guides are advisory
in nature and do not operate directly with the force of law, they provide guidance about what the FTC staff generally believes the Federal
Trade Commission Act, or FTC Act, requires in the context using of endorsements and testimonials in advertising and any practices inconsistent
with the Endorsement Guides can result in violations of the FTC Act&#8217;s proscription against unfair and deceptive practices.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent we may rely on endorsements or testimonials, we will review any relevant relationships for compliance with the Endorsement
Guides and we will otherwise endeavor to follow the FTC Act and other legal standards applicable to our advertising. However, if our
advertising claims or claims made by our social media influencers or by other endorsers with whom we have a material connection do not
comply with the Endorsement Guides or any requirement of the FTC Act or similar state requirements, the FTC and state consumer protection
authorities could subject us to investigations and enforcement actions, impose penalties, require us to pay monetary consumer redress,
require us to revise our marketing materials and require us to accept burdensome injunctions, all of which could harm our business, reputation,
financial condition and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Failure
of our contractors or our licensees&#8217; contractors to comply with local laws and other standards could harm our business.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
work with contractors outside of the U.S. to manufacture our products. We require the contractors that directly manufacture our products
and our licensees that make products using our intellectual property (including, indirectly, their contract manufacturers) to comply
with environmental, health and safety standards for the benefit of workers. We also require these contractors to comply with applicable
standards for product safety. Notwithstanding their contractual obligations, from time-to-time contractors may not comply with such standards
or applicable local law or our licensees may fail to enforce such standards or applicable local law on their contractors. Significant
or continuing noncompliance with such standards and laws by one or more contractors could harm our reputation or result in a product
recall and, as a result, could have an adverse effect on our sales and financial condition. Negative publicity regarding production methods,
alleged practices or workplace or related conditions of any of our suppliers, manufacturers or licensees could adversely affect our brand
image and sales and force us to locate alternative suppliers, manufacturers or licenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 29; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
could be subject to a change in tax laws, which may impact tax rates or otherwise adversely impact our tax position and may be subject
to a tax audit.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to the tax laws in the U.S. and numerous foreign jurisdictions. Such laws may change as a result of economic and political
conditions, or there may be changes to such laws interpretation and application.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
earn a substantial portion of our income in foreign countries and are subject to the tax laws of those jurisdictions. There have been
proposals to reform foreign tax laws that could significantly impact how U.S. multinational corporations are taxed on foreign earnings.
Although we cannot predict whether or in what form these proposals will pass, several of the proposals considered, if enacted into law,
could have an adverse impact on our income tax expense and cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
are subject to a complex array of laws and regulations, which could have an adverse effect on our business, financial condition and results
of operations.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a global business, we are subject to and must comply with extensive laws and regulations in the U.S. and other jurisdictions in which
we have operations and distribution channels. If we or our employees, agents, suppliers, and other partners fail to comply with any of
these laws or regulations, such failure could subject us to fines, sanctions or other penalties that could negatively affect our reputation,
business, financial condition and results of operations. We may be involved in various types of claims, lawsuits, regulatory proceedings
and government investigations relating to our business, our products and the actions of our employees and representatives, including
contractual and employment relationships, product liability, antitrust, trademark rights and a variety of other matters. It is not possible
to predict with certainty the outcome of any such legal or regulatory proceedings or investigations, and we could in the future incur
judgments, fines or penalties, or enter into settlements of lawsuits and claims that could have a material adverse effect on our business,
financial condition and results of operations and negatively impact our reputation. The global nature of our business means legal and
compliance risks, such as anti-bribery, anti-corruption, fraud, trade, environmental, competition, privacy and other regulatory matters,
will continue to exist and additional legal proceedings and other contingencies will arise from time to time, which could adversely affect
us. In addition, the adoption of new laws or regulations, or changes in the interpretation of existing laws or regulations, may result
in significant unanticipated legal and reputational risks. Any current or future legal or regulatory proceedings could divert management&#8217;s
attention from our operations and result in substantial legal fees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>For
as long as we are a &#8220;smaller reporting company,&#8221; we will not be required to comply with certain reporting requirements that
apply to other publicly reporting companies. We cannot predict whether the reduced disclosure requirements applicable to smaller reporting
companies will make our common shares less attractive to investors.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are currently a &#8220;smaller reporting company.&#8221; For as long as we continue to be a smaller reporting company, we may choose
to take advantage of certain exemptions from reporting requirements applicable to other publicly reporting companies that are not smaller
reporting companies. These include not being required to comply with the auditor attestation requirements for the assessment of our internal
controls over financial reporting provided by Section 404 of the Sarbanes- Oxley Act of 2002, or the Sarbanes-Oxley Act, and not being
required to provide certain disclosure regarding executive compensation required of larger publicly reporting companies. We cannot predict
if investors will find our common shares less attractive if we choose to rely on these exemptions. If some investors find our common
shares less attractive as a result of any choices to reduce future disclosure, there may be a less active trading market for our shares
and our share price may be more volatile. Further, as a result of these scaled regulatory requirements, our disclosure may be more limited
than that of other publicly reporting companies and you may not have the same protections afforded to shareholders of such companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
are subject to the periodic reporting requirements of the Exchange Act that require us to incur audit fees and legal fees in connection
with the preparation of such reports. These additional costs could reduce or eliminate our ability to earn a profit.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are required to file periodic reports with the SEC pursuant to the Exchange Act and the rules and regulations promulgated thereunder.
In order to comply with these requirements, our independent registered public accounting firm will have to review our financial statements
on a quarterly basis and audit our financial statements on an annual basis. Moreover, our legal counsel will have to review and assist
in the preparation of such reports. The costs charged by these professionals for such services cannot be accurately predicted at this
time because factors such as the number and type of transactions that we engage in and the complexity of our reports cannot be determined
at this time and will affect the amount of time to be spent by our auditors and attorneys. However, the incurrence of such costs will
obviously be an expense to our operations and thus have a negative effect on our ability to meet our overhead requirements and earn a
profit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 30; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">However,
for as long as we remain a &#8220;smaller reporting company,&#8221; as defined in in the Jumpstart Our Business Startups Act of 2012,
or JOBS Act, we may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies
that are not emerging growth companies, including, but not limited to, not being required to comply with the auditor attestation requirements
of Section 404 of the Sarbanes-Oxley Act, and reduced disclosure obligations regarding executive compensation in our periodic reports
and proxy statements. We may take advantage of these reporting exemptions until we are no longer an emerging growth company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we cannot provide reliable financial reports or prevent fraud, our business and operating results could be harmed, investors could lose
confidence in our reported financial information, and the trading price of our common stock, if a market ever develops, could drop significantly.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to Ownership of Our Shares</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>There
is currently limited liquidity of shares of our common stock.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
can give no assurance that an active trading market for shares of our common stock will develop on the Nasdaq or if its develops, will
be sustained, or that the shares of common stock will trade at or above the public offering price. Failure to develop or maintain a trading
market could negatively affect its value and make it difficult or impossible for you to sell your shares. Even if a market for common
stock does develop, the market price of common stock may be highly volatile. In addition to the uncertainties relating to future operating
performance and the profitability of operations, factors such as variations in interim financial results or various, as yet unpredictable,
factors, many of which are beyond our control, may have a negative effect on the market price of our common stock. The liquidity of the
shares of our common stock may also be affected adversely by a forward stock split given the reduced number of shares that will be outstanding
following a reverse stock split, especially if the market price of our common stock does not increase as a result of the forward stock
split.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
stock price may be volatile, or may decline regardless of our operating performance, and you could lose all or part of your investment
as a result.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should consider an investment in our securities to be risky, and you should invest in our securities only if you can withstand a significant
loss and wide fluctuation in the market value of your investment. The market price of our common shares could be subject to significant
fluctuations in response to the factors described in this section and other factors, many of which are beyond our control. Among the
factors that could affect our stock price are:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 10.1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Actual
    or anticipated variations in our quarterly and annual operating results or those of companies perceived to be similar to us;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weather
    conditions, particularly during holiday shopping periods;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes
    in expectations as to our future financial performance, including financial estimates by securities analysts and investors, or differences
    between our actual results and those expected by investors and securities analysts;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fluctuations
    in the market valuations of companies perceived by investors to be comparable to us;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    public&#8217;s response to our or our competitors&#8217; filings with the SEC or announcements regarding new products or services,
    enhancements, significant contracts, acquisitions, strategic investments, litigation, restructurings or other significant matters;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Speculation
    about our business in the press or the investment community;</span></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future
    sales of our shares;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Actions
    by our competitors;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additions
    or departures of members of our senior management or other key personnel; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    passage of legislation or other regulatory developments affecting us or our industry.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the securities markets have experienced significant price and volume fluctuations that have affected and continue to affect
the market price of equity securities of many companies. These fluctuations have often been unrelated or disproportionate to the operating
performance of particular companies. These broad market fluctuations, as well as general economic, systemic, political and market conditions,
such as recessions, loss of investor confidence, interest rate changes, or international currency fluctuations, may negatively affect
the market price of our shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of the foregoing occurs, it could cause our stock price to fall and may expose us to securities class action litigation that, even
if unsuccessful, could be costly to defend and a distraction to management.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
trading market for our common shares will be influenced by the research and reports that equity research analysts publish about us and
our business. The price of our common shares could decline if one or more securities analysts downgrade our common shares or if those
analysts issue a sell recommendation or other unfavorable commentary or cease publishing reports about us or our business. If one or
more of the analysts who elect to cover us downgrade our common shares, our share price could decline rapidly. If one or more of these
analysts cease coverage of us, we could lose visibility in the market, which in turn could cause our common share price and trading volume
to decline.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
do not intend to pay dividends on our shares of common stock and under the terms of certain outstanding loans, we are not permitted to
pay any dividends.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to retain all of our earnings, if any, for the foreseeable future to finance the operation and expansion of our business and do
not anticipate paying cash dividends. Any future determination to pay dividends will be at the discretion of our Board of Directors,
subject to compliance with applicable law and any contractual provisions, and will depend on, among other factors, our results of operations,
financial condition, capital requirements and other factors that our Board of Directors deems relevant. In addition, under the terms
of certain loan agreements between the Company and its lenders, the Company, we may not make any distributions until these loan agreements
are repaid in full. At this time, such loans have not been repaid in full. As a result, you should expect to receive a return on your
investment in our common shares only if the market price of our common stock increases, which may never occur.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Future
sales, or the perception of future sales, of our common stock may depress the price of our common stock.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of October 31, 2023, we had 2,372,803 outstanding shares of common stock. Of these shares, 2,068,016 shares were in the public
float. The remaining 304,787 shares common stock outstanding were &#8220;restricted securities&#8221; within the meaning of Rule
144. In addition, on September 8, 2021, we filed a registration statement with the SEC to register an additional 41,000 shares of common
stock, which was declared effective on January 27, 2022. On September 28, 2022, we issued (i) 25,463 shares of common stock and (ii)
pre-funded warrants (the &#8220;Pre-Funded Warrants&#8221;) to purchase an aggregate of 295,051 shares of its common stock, together
with accompanying common stock warrants, at a combined purchase price of $15.60 per share of the common stock and associated common stock
warrant and $15.596 per Pre-Funded Warrant and associated common stock warrants. The Pre-Funded Warrants have an exercise price of $0.00001
per share of common stock and are exercisable until the Pre-Funded Warrants are exercised in full. The shares of common stock and Pre-Funded
Warrants were sold in the offering together with common stock warrants to purchase 320,513 shares of common stock at an exercise price
of $15.596 per share and a term of five years following the initial exercise date (the &#8220;5-Year Warrants&#8221;) and warrants to
purchase 641,026 shares of common stock at an exercise price of $17.20 per share and a term of seven and one half years (the &#8220;7.5-Year
Warrants&#8221;) following the initial exercise date (collectively, the &#8220;September Warrants&#8221;). On January 6, 2023, the Company
issued warrants to purchase 452,489 shares of the Company&#8217;s common stock (the &#8220;January Warrants&#8221;). The January Warrants
have an exercise price per share equal $8.84. The issuance of the January Warrants at an exercise price of $8.84 reset the exercise price
of the Noteholder Warrants (as defined below) to $8.84 per share from the original exercise price of $1,200.00. The exercise price
of the September Warrants and the January Warrants was reset to $3.546 and the Noteholder Warrants to $1.90 in October
2023. On September 25, 2023, as a result of the shareholder approval obtained at the special meeting of stockholders on September
13, 2023 and the Reverse Stock Split, the aggregate number of September Warrants, January Warrants and Pre-Funded Warrants increased
from 1,709,097 to 9,426,952 due to certain adjustments that were required to be made by the terms of the relevant warrants in the event
of receipt of shareholder approval and the occurrence of the Reverse Stock Split. Sales of the shares underlying the Pre-Funded Warrants,
the September Warrants, the January Warrants and the Noteholder Warrants in the public market after October 31, 2023, or the perception
that these sales could occur, could reduce the market price of our common stock. Additional sales of our common stock in the public market
after October 31, 2023, or the perception that these sales could occur, could reduce the market price of our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 32; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
will be required to file an additional registration statement once we regain compliance with the Nasdaq listing requirements.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 8, 2021, we filed a registration statement with the SEC to register 41,000 shares of common stock for resale by certain
selling stockholders, which was declared effective on January 27, 2022. Following our public offering resulting in our common stock being
listed on Nasdaq and once we regain compliance with the Nasdaq listing standards, additional conversion shares need to be registered.
We also have agreed to register additional shares in connection with our recent financing. See section entitled &#8220;Description
of Business&#8212;Recent Developments&#8221; for more information. The new registration statement will cover both the shares originally
registered for resale, the new conversion shares and the recent financing shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Certain
of the Company&#8217;s large shareholders may be able to exert significant influence on the Company and their interests may conflict
with the interests of its other shareholders</i>.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
of the Company&#8217;s large shareholders, including our officers and directors, represented approximately 30% of the Company&#8217;s
voting rights as of April 30, 2023. Therefore, these shareholders would be able to exert significant influence over certain matters,
including matters that must be resolved by the general meeting of shareholders, such as the election of members to the board of directors
or the declaration of dividends or other distributions. To the extent that the interests of these shareholders may differ from the interests
of the Company&#8217;s other shareholders, the Company&#8217;s other shareholders may be disadvantaged by any actions that these shareholders
may seek to pursue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
stockholders may not be able to enforce judgments entered by United States courts against certain of our officers and directors.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are incorporated in the State of Delaware. However, some of our directors and executive officers may reside outside of the U.S. As a
result, our stockholders may not be able to effect service of process upon those persons within the U.S. or enforce against those persons
judgments obtained in U.S. courts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
sale of a large number of shares of common stock by our principal shareholder could depress the market price of our common stock.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of October 31, 2023, Yonah Kalfa beneficially owned approximately 2.14% of our common stock outstanding. The shares
may become available for resale, subject to the requirements of the U.S. securities laws. The sale or prospect of a sale of a substantial
number of these shares could have an adverse effect on the market price of our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Future
sales of our common stock may result in a decrease in the market price of our common stock, even if our business is doing well.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
market price of our common stock could drop due to sales of a large number of shares of our common stock in the market or the perception
that such sales could occur. This could make it more difficult to raise funds through future offerings of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 33; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
our stock trades below $1.00 for 30 consecutive days, we will no longer be in compliance with the Bid-Price Rule and no longer
eligible for a compliance period, which may result in the delisting of our common stock from the Nasdaq.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
our stock trades below $1.00 for 30 consecutive business days, then we will no longer be in compliance with Nasdaq Listing Rule 5450(a)(1)
(the &#8220;Bid Price Rule&#8221;) and given that the Company has already effected two reverse stock splits during the prior two-year
period with a cumulative ratio of 400 shares or more to one, the Company shall not be eligible for any compliance period specified in
Rule 5810(c)(3)(A) and the Listing Qualifications Department shall issue a Staff Delisting Determination under Rule 5810 with respect
to our stock.</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Even if we are nonetheless granted
a compliance period or otherwise effect another reverse split in a timely manner, the effect of a future reverse stock split, if
any, on the market price for our common stock cannot be accurately predicted. In particular, we cannot assure you that the prices for
shares of the common stock after a future reverse stock split will increase proportionately to prices for shares of our common stock
immediately before a reverse stock split. The market price of our common stock may also be affected by other factors which may be unrelated
to a future reverse stock split or the number of shares outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
even if the market price of our common stock does rise following a reverse stock split, we cannot assure you that the market price of
our common stock immediately after a reverse stock split will be maintained for any period of time. Moreover, because some investors
may view a reverse stock split negatively, we cannot assure you that a reverse stock split will not adversely impact the market price
of our common stock. Accordingly, our total market capitalization after a reverse stock split may be lower than the market capitalization
before a reverse stock split.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Shareholders
may be diluted significantly through our efforts to obtain financing, satisfy obligations through issuance of additional shares, or reset
the exercise price of the Warrants.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors has authority, without action or vote of the shareholders, to issue all or part of the authorized 300,000,000 shares
that are not issued or reserved for issuance under convertible or exchangeable instruments. In addition, we may attempt to raise additional
capital by selling shares, possibly at a deep discount to market. These actions will result in dilution of the ownership interests of
existing shareholders, further dilute common stock book value, and that dilution may be material.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Moreover,
the Warrants contain provisions that, subject to certain exceptions,&#160;reset the exercise price of such Warrants if at any time while
such Warrants are outstanding, we sell or issue (or are deemed to sell or issue) shares of our common stock or rights, warrants, options
or other securities or debt convertible, exercisable or exchangeable for shares of our common stock at a price below the then current
exercise price per share for such Warrants. Any future resets to the exercise price of those Warrants to a lower amount may be necessary
in order to induce the Armistice Selling Stockholder to exercise the Warrants or in settlement of outstanding defaults under the
transaction agreements in connection with the September 2022 and January 2023 financings.</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;Please
refer to risk factor entitled <i>&#8220;We may need to reset the exercise price of the Warrants to a materially lower price in order
to induce the Armistice Selling Stockholder to exercise the Warrants or in settlement of outstanding defaults under the
transaction agreements from September 2022 and January 2023.&#8221;</i></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>A
reverse stock split may not help generate additional investor interest.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
can be no assurance that a reverse stock split will result in a per share price that will attract institutional investors or investment
funds or that such share price will satisfy the investing guidelines of institutional investors or investment funds. As a result, the
trading liquidity of our common stock may not necessarily improve.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>There
can be no assurances that our common stock will not be subject to potential delisting if we do not regain compliance with the listing
requirements of the Nasdaq.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have listed the shares of our common stock on the Nasdaq, under the symbol &#8220;CNXA.&#8221; As such we are subject to, among other
things, our fulfilling all of the listing requirements of the Nasdaq. In addition, Nasdaq has rules for continued listing, including,
without limitation, minimum market capitalization and other requirements. As described above in the section entitled &#8220;Description
of Business&#8212;Recent Developments,&#8221; Nasdaq informed us that we are deficient with respect to Minimum Stockholders&#8217; Equity Requirement (as defined below). Failure to maintain our listing (i.e., being de-listed from the Nasdaq), would make it more difficult for shareholders to sell
our common stock and more difficult to obtain accurate price quotations on our common stock. This could have an adverse effect on the
price of our common stock. Our ability to issue additional securities for financing or other purposes, or otherwise to arrange for any
financing we may need in the future, may also be materially and adversely affected if our common stock is not traded on a national securities
exchange.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
have received notices of delinquency from the Nasdaq for violations of listing rules and there is no assurance that we will regain compliance
and maintain our listing on the Nasdaq.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 26, 2023, the Company received a letter from the Listing Qualifications Department of Nasdaq indicating that the Company&#8217;s
stockholders&#8217; equity as reported in its Quarterly Report on Form 10-Q for the quarterly period ended January 31, 2023 did not satisfy
the continued listing requirement under Nasdaq Listing Rule 5550(b)(1), which requires that a listed company&#8217;s stockholders&#8217;
equity be at least $2.5 million (the &#8220;Minimum Stockholders&#8217; Equity Requirement&#8221;). The Company timely submitted a compliance
plan to the Panel and on August 23, 2023 received notice from Nasdaq that it has until January 22, 2024 to demonstrate compliance with
the Minimum Stockholders&#8217; Equity Requirement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
can be no assurance that the Company will be able to satisfy the Nasdaq&#8217;s continued listing requirements, regain compliance with
the Rule, the Minimum Stockholders&#8217; Equity Requirement and maintain compliance with other
Nasdaq listing requirements. If the Company&#8217;s common stock ceases to be listed for trading on the Nasdaq, the Company
would expect that its common stock would be traded on one of the three tiered marketplaces of the OTC Markets Group.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
securities or industry analysts do not publish research or publish inaccurate or unfavorable research about our business, our stock price
and trading volume could decline.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
trading market for our common stock will depend in part on the research and reports that securities or industry analysts publish about
us or our business. Securities and industry analysts do not currently, and may never, publish research on our company. If no securities
or industry analysts commence coverage of our company, the trading price for our stock may be negatively impacted. In the event securities
or industry analysts initiate coverage, if one or more of the analysts who covers us downgrades our stock or publishes inaccurate or
unfavorable research about our business, our stock price may decline. If one or more of these analysts ceases coverage of our company
or fails to publish reports on us regularly, demand for our stock could decrease, which might cause our stock price and trading volume
to decline.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
our shares of common stock become subject to the penny stock rules, it would become more difficult to trade our shares.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
SEC has adopted rules that regulate broker-dealer practices in connection with transactions in penny stocks. Penny stocks are generally
equity securities with a price of less than $5.00, other than securities registered on certain national securities exchanges or authorized
for quotation on certain automated quotation systems, provided that current price and volume information with respect to transactions
in such securities is provided by the exchange or system. If we do not obtain or retain a listing on the Nasdaq and if the price of our
common stock is less than $5.00, our common stock will be deemed a penny stock. The penny stock rules require a broker-dealer, before
a transaction in a penny stock not otherwise exempt from those rules, to deliver a standardized risk disclosure document containing specified
information. In addition, the penny stock rules require that before effecting any transaction in a penny stock not otherwise exempt from
those rules, a broker-dealer must make a special written determination that the penny stock is a suitable investment for the purchaser
and receive (i) the purchaser&#8217;s written acknowledgment of the receipt of a risk disclosure statement; (ii) a written agreement
to transactions involving penny stocks; and (iii) a signed and dated copy of a written suitability statement. These disclosure requirements
may have the effect of reducing the trading activity in the secondary market for our common stock, and therefore stockholders may have
difficulty selling their shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may need to reset the exercise price of the Warrants to a materially lower price in order to induce the Armistice Selling Stockholder
to exercise the Warrants or in settlement of outstanding defaults under the transaction agreements from September 2022 and January
2023.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
October 31, 2023, the exercise price of the Warrants is &#8220;out of the money&#8221;, which would make any exercise of the warrants
impractical. In order to make an exercise of the Warrants economically practical to the Armistice Selling Stockholder, we may
be forced to reduce the exercise price to a point that is &#8220;in the money.&#8221; In such case, we will receive substantially less
funds than if the Warrants were exercised at their current exercise prices of $1.90 and $3.546. Additionally, we are in
default of certain covenants of the September Warrants, the January Warrants and the Pre-Funded Warrants, as well as the transaction
agreements entered into with the Armistice Selling Stockholder in September 2022 and January 2023 and may have to reduce the exercise
price of the Warrants in order to induce the Armistice Selling Stockholder to waive such defaults.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>A
significant portion of our total outstanding shares is restricted from immediate resale but may be sold into the market in the near future,
which could cause the market price of our common stock to decline significantly, even if our business is doing well.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales
of a substantial number of shares of our common stock in the public market could occur at any time. Upon the expiration or early release
of any or all of the lock-up agreements entered into between the Representatives and each of our directors, executive officers and holders
of more than 5% of our outstanding common stock, a significant amount of shares of our common stock may be sold, or there may be a perception
that they will be sold, in the public market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 35; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
upon the (i) expiration of, (ii) early release of, and (iii) terms permitting sales of shares of the Company&#8217;s common stock at
certain times, a significant amount of shares of our common stock may be sold, or there may be a perception that they will be sold, in
the public market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the sale, or the perception that a sale will occur, as described above, our stock price may decline significantly, even if our business
is doing well.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ch_001"></span>USE
OF PROCEEDS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
securities sold pursuant to this prospectus will be offered and sold by the selling stockholders. We will not receive any proceeds
from the sale of common stock offered by the selling stockholders. However, upon the exercise of the Warrants we would receive
aggregate gross proceeds of approximately $9,768,658. Any proceeds from the exercise of the Warrants will be used for working capital
and general corporate purposes. We cannot predict when or if the Warrants will be exercised, and it is possible that the Warrants may
expire and never be exercised or may be exercised pursuant to a cashless exercise. We will bear the out-of-pocket costs, expenses and
fees incurred in connection with the registration of shares of our common stock to be sold by the selling stockholders, including
registration, listing and qualifications fees, printers and accounting fees, and fees and disbursements of counsel, or collectively,
the Registration Expenses. Other than Registration Expenses, the selling stockholders will bear underwriting discounts, commissions,
placement agent fees or other similar expenses payable with respect to sales of shares<b>.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ch_003"></span>MARKET
PRICE OF AND DIVIDENDS ON COMMON STOCK AND RELATED STOCKHOLDER MATTERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Market
Information</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock is quoted on the Nasdaq under the symbol &#8220;CNXA.&#8221; The last reported sales price of our common stock on the
Nasdaq on October 31, 2023 was $0.85.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Holders</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of October 31, 2023, we had approximately 229 holders of our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dividends</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have never declared or paid any cash dividends on our capital stock and do not anticipate paying any cash dividends in the foreseeable
future. We currently expect to retain future earnings, if any, to finance the growth and development of our business. Any future determination
to declare cash dividends will be made at the discretion of our board of directors, subject to applicable laws, and will depend on a
number of factors, including our financial condition, results of operations, capital requirements, contractual restrictions, general
business conditions, and other factors that our board of directors may deem relevant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 36; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ch_004"></span>MANAGEMENT&#8217;S
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
following discussion of our financial condition and results of operations should be read in conjunction with the financial statements
and related notes included elsewhere in this prospectus, our Annual Report on Form 10-K for the year ended April 30, 2023, and our Quarterly
Report on Form 10-Q for the period ended July 31, 2023. Certain statements in this discussion and elsewhere in this report constitute
forward-looking statements. See &#8220;Cautionary Statement Regarding Forward Looking Statements&#8221; elsewhere in this report. Because
this discussion involves risks and uncertainties, our actual results may differ materially from those anticipated in these forward-looking
statements<b>.</b></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lazex
Inc. (&#8220;Lazex&#8221;) was incorporated under the laws of the State of Nevada on July 12, 2015. On August 23, 2019, the majority
owner of Lazex entered into a Stock Purchase Agreement with Slinger Bag Americas Inc., a Delaware corporation (&#8220;Slinger Bag Americas&#8221;),
which was 100% owned by Slinger Bag Ltd. (&#8220;SBL&#8221;), an Israeli company. In connection with the Stock Purchase Agreement, Slinger
Bag Americas acquired 50,000 shares of common stock of Lazex for $332,239. On September 16, 2019, SBL transferred its ownership
of Slinger Bag Americas to Lazex in exchange for the 50,000 shares of Lazex acquired on August 23, 2019. As a result of these
transactions, Lazex owned 100% of Slinger Bag Americas and the sole shareholder of SBL owned 50,000 shares of common stock (approximately
82%) of Lazex. Effective September 13, 2019, Lazex changed its name to Slinger Bag Inc.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 31, 2019, Slinger Bag Americas acquired control of Slinger Bag Canada, Inc., (&#8220;Slinger Bag Canada&#8221;) a Canadian company
incorporated on November 3, 2017. There were no assets, liabilities or historical operational activity of Slinger Bag Canada.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 10, 2020, Slinger Bag Americas became the 100% owner of SBL, along with SBL&#8217;s wholly owned subsidiary Slinger Bag International
(UK) Limited (&#8220;Slinger Bag UK&#8221;), which was formed on April 3, 2019. On February 10, 2021, Zehava Tepler, the owner of SBL,
contributed Slinger Bag UK to Slinger Bag Americas for no consideration.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
February 25, 2020, the Company increased the number of authorized shares of common stock from 75,000,000 to 300,000,000 via a four-to-one
forward split of its outstanding shares of common stock. All share and per share information contained in this report have been retroactively
adjusted to reflect the impact of the stock split.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 21, 2021, Slinger Bag Americas entered into a membership interest purchase agreement with Charles Ruddy to acquire a 100% ownership
stake in Foundation Sports Systems, LLC (&#8220;Foundation Sports&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 2, 2022, the Company entered into a share purchase agreement with Flixsense Pty, Ltd. (&#8220;Gameface&#8221;). As a result
of the share purchase agreement, Gameface would become a wholly owned subsidiary of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 22, 2022, the Company entered into a merger agreement with PlaySight and Rohit Krishnan
(the &#8220;Shareholders&#8217; Representative&#8221;). As a result of the merger agreement, PlaySight became a wholly owned subsidiary
of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 14, 2022, the Company effected a 1-for-10 reverse stock split, where the Company&#8217;s common stock began to trade on a reverse
split adjusted basis. No fractional shares were issued in connection with the reverse stock split and all such fractional interests were
rounded up to the nearest whole number of shares of common stock. All references to the outstanding stock have been retrospectively adjusted
to reflect this reverse stock split. The Company also consummated a public offering of shares of its common stock and the listing
of its common stock on the Nasdaq.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 17, 2022, Gabriel Goldman and Rohit Krishnan resigned from the board of directors of the Company. Gabriel and Rohit were members
of the audit and compensation committees. Gabriel Goldman was a member of the Company&#8217;s Nominating and Corporate Governance Committee.
Neither Gabriel nor Rohit advised the Company of any disagreement with the Company on any matter relating to its operations, policies
or practices.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 5, 2022, the Company assigned 75% of its membership interest in Foundation Sports to Charles Ruddy, its founder and granted
him the right for a period of three years to purchase the remaining 25% of its Foundation Sports membership interests for $500,000 in
cash. As of December 5, 2022, the results of Foundation Sports were no longer consolidated in the Company&#8217;s financial statements,
the Company recorded a loss on the sale and the investment is now accounted for as an equity method investment. On December 5, 2022,
the Company analyzed this investment and established a reserve for the investment at the full amount of $500,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 37; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 27, 2022, the Company entered into a share purchase agreement (the &#8220;Agreement&#8221;) with PlaySight, Chen Shachar and
Evgeni Khazanov (together, the &#8220;Buyer&#8221;) pursuant to which the Buyer purchased 100% of the issued and outstanding shares of
PlaySight from the Company in exchange for (1) releasing the Company from all of PlaySight&#8217;s obligations towards its vendors, employees,
tax authorities and any other (past, current and future) creditors of PlaySight; (2) waiver by the Buyer of 100% of the personal consideration
owed to them under their employment agreements in the total amount of $600,000 (which would have been increased in December 2022
to $800,000); and (3) cash consideration of $2 million to be paid to the Company as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    promissory note in the amount of $2 million issued and delivered to the Company (the &#8220;Promissory Note&#8221;).</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    maturity due date of the Promissory Note is December 31, 2023 subject to a one year extension in the discretion of the Buyer until
    December 31, 2024.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Promissory Note can be partially paid over the time, but in the event it is not paid in full by December 31, 2024, then the remaining
    amount due (i.e. $2 million less any amount paid), will be converted into ordinary shares of PlaySight (the &#8220;Deposited
    Shares&#8221;), which will be deposited with the escrow company of Altshuler Shaham Trust Ltd. (the &#8220;Escrow Agent&#8221;) for
    the benefit of the Company or, at the election of the Company, issued in the form of a stock certificate or recorded in some other
    market-standard format to be held by the Escrow Agent.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    number of the Deposited Shares shall be determined according to the post-money valuation of the last investment round of the Company,
    and in the absence of such investment round, the total number of the Deposited Shares shall be $2 million divided by the Company&#8217;s
    valuation to be determined at that time by a third party appraiser, to be nominated by both the Company and the Buyer (the &#8220;Appraiser&#8221;).
    The Company and the Buyer have agreed that the identity of the Appraiser shall be Murray Devine Valuation Advisers, to the extent
    their cost of the appraisal shall not be higher than the cost of other appraisers from the big 4 accounting firms (i.e., E&amp;Y,
    KPMG, PWC and Deloitte). The Company and the Buyer have agreed to split the cost of the Appraiser.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company also released PlaySight from all of its obligations (except for those created by the Agreement) in respect of the Company, including
any inter-company debts on the books, and the Buyer has released the Company from all of its obligations (except for those created by
the Agreement) in respect of PlaySight and the Buyer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
total loss on disposal of Foundation Sports and PlaySight amounted to $41,413,892 in the year ended April 30, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
April 2023, the Company determined that the technology utilized in Gameface would take substantially more financial resources and more
time to bring to market and achieve profitability than originally anticipated. As a result, the goodwill and intangible assets related
to Gameface were fully impaired as of April 30, 2023, resulting in an impairment loss of $11,421,817. The Company previously classified
Foundation Sports in continuing operations, until December 5, 2022 when they sold 75% of Foundation Sports back to the original owners
at which time it deconsolidated this subsidiary and recorded a loss on the sale. The Company also determined to dispose of the PlaySight
entity during the year ended April 30, 2023. The Company completed the sale in November 2022 and recorded a loss on the sale at that
time. The total loss on disposal of Foundation Sports and PlaySight amounted to $41,413,892 in the year ended April 30, 2023. The Company
impaired all goodwill as of April 30, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 8, 2023, the Company entered into a merchant cash advance agreement with Meged Funding Group (&#8220;Meged&#8221;) pursuant to which
the Company sold $315,689 in future receivables to Meged (the &#8220;Meged Receivables Purchased Amount&#8221;) to in exchange for payment
to the Company of $210,600 in cash less fees of $10,580. The Company agreed to pay Meged $17,538 each week until the Meged Receivables
Purchased Amount is paid in full.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 7, 2023, the Company entered into an agreement with UFS (the &#8220;UFS Agreement&#8221;) pursuant to which the Company sold $797,500
in future receivables (the &#8220;UFS Second Receivables Purchased Amount&#8221;) to UFS in exchange for payment to the Company of $550,000
in cash less fees of $50,000. The Company agreed to pay UFS $30,000 each week until the UFS Second Receivables Purchased Amount is paid
in full.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 38; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to secure payment and performance of the Company&#8217;s obligations to UFS under the UFS Agreement, the Company granted to UFS
a security interest in the following collateral: all accounts receivable and all proceeds as such term is defined by Article 9 of the
UCC. The Company also agreed not to create, incur, assume, or permit to exist, directly or indirectly, any lien on or with respect to
any of such collateral.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 13, 2023, the Company held a special meeting of stockholders in which the following items were approved: (i) the issuance of
(i) 25,463 shares of the our common stock, par value $0.001 per share, that were issued on October 3, 2022, and, (ii) 295,051
shares of our common stock issuable upon exercise of Pre-Funded Warrants at an exercise price of $0.00001 per share, (iii) 320,513
shares of common stock issuable upon the exercise of 5-Year Warrants at an exercise price of $15.60 per share, (iv) 641,026
shares of common stock issuable upon the exercise of 7.5 Year Warrants at an exercise price of $17.20 per share and (v) 452,489
shares of our common stock issuable upon the exercise of 5.5 Year Warrants at an exercise price per share equal to $8.84 per
share to Armistice Capital Master Fund Ltd and (ii) a reverse stock split of our common stock within a range of one (1)-for-ten (10)
to one (1)-for-forty (40) (&#8220;Reverse Stock Split&#8221;), with the Board of Directors of the Company to set the specific ratio and
determine the date for the reverse stock split to be effective and any other action deemed necessary to effectuate the Reverse
Stock Split, without further approval or authorization of stockholders, at any time within 12 months of the special meeting date. The
Company effected a one-for-forty (1-for-40) reverse stock split of its common stock on September 25, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 25, 2023, as a result of the shareholder approval obtained at the special meeting of stockholders on September 13, 2023 and
the Reverse Stock Split, the aggregate number of Pre-Funded Warrants, 5-Year Warrants, 5.5-Year Warrants and 7-Year Warrants increased
from 1,709,097 to 9,426,952 due to certain adjustments that were required to be made by the terms of the relevant warrants in the event
of receipt of shareholder approval and the occurrence of the Reverse Stock Split.</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 19, 2023, the Company entered into an agreement with Meged (the &#8220;Second Meged Agreement&#8221;) pursuant to which the
Company sold $423,000 in future receivables to Meged (the &#8220;Meged Second Receivable Amount&#8221;) in exchange for paying the then
outstanding balance of $70,153.20 of the Meged Receivables Purchased Amount in full with the balance being retained by the Company in
cash for general purposes. The Company agreed to pay Meged $15,107.14 each week until the Meged Second Receivable Amount is paid in full.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to secure payment and performance of the Company&#8217;s obligations to Meged under the Second Meged Agreement, the Company granted
to Meged a security interest in the following collateral: all accounts receivable and all proceeds as such term is defined by Article
9 of the UCC. The Company also agreed not to create, incur, assume, or permit to exist, directly or indirectly, any lien on or with respect
to any of such collateral.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 19, 2023, the Company entered into an agreement with Meged (the &#8220;Second Meged Agreement&#8221;) pursuant to which the
Company sold $423,000 in future receivables to Meged (the &#8220;Meged Second Receivable Amount&#8221;) in exchange for paying the then
outstanding balance of $70,153.20 of the Meged Receivables Purchased Amount in full with the balance being retained by the Company in
cash for general purposes. The Company agreed to pay Meged $15,107.14 each week until the Meged Second Receivable Amount is paid in full.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to secure payment and performance of the Company&#8217;s obligations to Meged under the Second Meged Agreement, the Company granted
to Meged a security interest in the following collateral: all accounts receivable and all proceeds as such term is defined by Article
9 of the UCC. The Company also agreed not to create, incur, assume, or permit to exist, directly or indirectly, any lien on or with respect
to any of such collateral.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 11, 2023, the Company entered into a loan and security modification agreement (the &#8220;Loan and Security Modification Agreement&#8221;)
with a one or more institutional investors (the &#8220;Lenders&#8221;) and a certain institutional investor, as agent for the Lenders
(the &#8220;Agent&#8221;) amending the terms of the Loan and Security Agreement dated January 6, 2023 (the &#8220;LSA&#8221;) by and
among the Company, the Lenders and the Agent to make an additional loan of $1,000,000 and modify the terms of the LSA to reflect the
New Loan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Loan and Security Modification Agreement, the Company agreed to issue to the investor warrants (the &#8220;Common
Warrants&#8221;) to purchase up to 169,196 shares of Common Stock at an exercise price of $1.90 per share. The Common Warrants are exercisable
six months after their issuance and will expire five and one-half years from their date of issuance. The Common Warrants and the shares
of our Common Stock issuable upon the exercise of the Common Warrants are not being registered under the Securities Act, were not offered pursuant to the Registration Statement and were offered pursuant to the exemption
provided in Section 4(a)(2) under the Securities Act, and Rule 506(b) promulgated thereunder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 12, 2023, the Board of Directors of the Company approved an amendment to the Bylaws of the Company to reduce the percentage of
shares of stock, issued and outstanding and entitled to vote, to be present in person or represented by proxy in order to constitute
a quorum for the transaction of any business from a majority to thirty three and one third percent (33 1/3%).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
operations of Slinger Bag Inc., Slinger Bag Americas, Slinger Bag Canada, Slinger Bag UK, SBL and Gameface are collectively referred
to as the &#8220;Company.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company operates in the sports equipment and technology business. The Company is the owner of the Slinger Bag Launcher, which is comprised
of a portable tennis ball launcher, a portable padel tennis ball launcher and a portable pickleball launcher and Gameface AI, providing
AI technology and performance analytics for sports.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Critical
Accounting Policies and Estimates</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
critical accounting policies relate exclusively to our continuing operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Basis
of Presentation</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated financial statements of the Company are presented in accordance with accounting principles generally accepted in the United
States of America (&#8220;GAAP&#8221;). As a result of the transactions described above, the accompanying consolidated financial statements
include the combined results of Slinger Bag Inc., Slinger Bag Americas, Slinger Bag Canada, Slinger Bag UK, SBL and Gameface for the
years ended April 30, 2023 and 2022. All intercompany accounts and transactions have been eliminated in consolidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 39; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Use
of Estimates</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect
the amounts reported in the financial statements and accompanying notes. Accordingly, actual results could differ from those estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Valuation
of Inventory</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory
is valued at the lower of the cost (determined principally on a first-in, first-out basis) or net realizable value. The Company&#8217;s
valuation of inventory includes inventory reserves for inventory that will be sold below cost and the impact of inventory shrink. Inventory
reserves are based on historical information and assumptions about future demand and inventory shrink trends. It is possible that changes
to inventory reserve estimates could be required in future periods due to changes in market conditions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Revenue
Recognition</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes revenue in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 606, the core principle of which
is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects
the consideration to which the entity expects to be entitled to receive in exchange for those goods or services. The Company recognizes
revenue for its performance obligation associated with its contracts with customers at a point in time once products are shipped. Amounts
collected from customers in advance of shipping products ordered are reflected as deferred revenue on the accompanying consolidated balance
sheets. The Company&#8217;s standard terms are non-cancelable and do not provide for the right-of-return, other than for defective merchandise
covered under the Company&#8217;s standard warranty. The Company has not historically experienced any significant returns or warranty
issues.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Business
Combinations</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
acquisition of a company, we determine if the transaction is a business combination, which is accounted for using the acquisition method
of accounting. Under the acquisition method, once control is obtained of a business, the assets acquired, and liabilities assumed, are
recorded at fair value. We use our best estimates and assumptions to assign fair value to the tangible and intangible assets acquired
and liabilities assumed at the acquisition date. One of the most significant estimates relates to the determination of the fair value
of these assets and liabilities. The determination of the fair values is based on estimates and judgments made by management. Our estimates
of fair value are based upon assumptions we believe to be reasonable, but which are inherently uncertain and unpredictable. Measurement
period adjustments are reflected at the time identified, up through the conclusion of the measurement period, which is the time at which
all information for determination of the values of assets acquired and liabilities assumed is received and is not to exceed one year
from the acquisition date. We may record adjustments to the fair value of these tangible and intangible assets acquired and liabilities
assumed, with the corresponding offset to goodwill.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
uncertain tax positions and tax-related valuation allowances are initially recorded in connection with a business combination as of the
acquisition date. We continue to collect information and reevaluate these estimates and assumptions periodically and record any adjustments
to preliminary estimates to goodwill, provided we are within the measurement period. If outside of the measurement period, any subsequent
adjustments are recorded to the consolidated statement of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Fair
Value of Financial Instruments</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
value of financial and non-financial assets and liabilities is defined as an exit price, representing the amount that would be received
to sell an asset or paid to transfer a liability in an orderly transaction between market participants. The three-tier hierarchy for
inputs used in measuring fair value, which prioritizes the inputs used in the methodologies of measuring fair value for assets and liabilities,
is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
1 &#8212; Quoted prices in active markets for identical assets or liabilities</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
2 &#8212; Observable inputs other than quoted prices in active markets for identical assets and liabilities</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
3 &#8212; Unobservable pricing inputs in the market</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 40; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
assets and financial liabilities are classified in their entirety based on the lowest level of input that is significant to the fair
value measurements. Our assessment of the significance of a particular input to the fair value measurements requires judgment and may
affect the valuation of the assets and liabilities being measured and their categorization within the fair value hierarchy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s financial instruments consist of cash and cash equivalents, accounts receivable, and accounts payable. The carrying amount
of these financial instruments approximates fair value due to their short-term maturity. The Company&#8217;s derivative liabilities were
calculated using Level 2 assumptions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s contingent consideration in connection with the acquisition of Gameface and PlaySight were calculated using Level 3 inputs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company estimates the fair value of its intangible assets using Level 3 assumptions, primarily based on the income approach utilizing
the discounted cash flow method.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Income
Taxes</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
taxes are accounted for in accordance with the provisions of ASC 740, Accounting for Income Taxes. Deferred tax assets and liabilities
are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing
assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected
to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred
tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Valuation
allowances are established, when necessary, to reduce deferred tax assets to the amounts that are more likely than not to be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Long-Lived
Assets and Goodwill</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with ASC 360-10, the Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate
that their net book value may not be recoverable. When such factors and circumstances exist, the Company compares the projected undiscounted
future cash flows associated with the related asset or group of assets over their estimated useful lives against their respective carrying
amount. If those net undiscounted cash flows do not exceed the carrying amount, impairment, if any, is based on the excess of the carrying
amount over the fair value, based on market value or discounted expected cash flows of those assets and is recorded in the period in
which the determination is made. Long-lived assets and goodwill related to Gameface in the amount of $11,421,817 were fully impaired
as of April 30, 2023, resulting in an impairment loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for goodwill in accordance with ASC 350, Intangibles - Goodwill and Other (&#8220;ASC 350&#8221;). ASC 350 requires
that goodwill not be amortized, but reviewed for impairment if impairment indicators arise and, at a minimum, annually. The Company records
goodwill as the excess purchase price over assets acquired and includes any work force acquired as goodwill. Goodwill is evaluated for
impairment on an annual basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
the adoption of the ASU 2017-04, which eliminates the second step of the goodwill impairment test, the Company tests impairment of goodwill
in one step. In this step, the Company compares the fair value of each reporting unit with goodwill to its carrying value. The Company
determines the fair value of its reporting units with goodwill using a combination of a discounted cash flow and a market value approach.
If the carrying value of the net assets assigned to the reporting unit exceeds the fair value of the reporting unit, the Company will
record an impairment charge based on the excess of a reporting unit&#8217;s carrying amount over its fair value. If the fair value of
the reporting unit exceeds the carrying value of the net assets assigned to that reporting unit, goodwill is not impaired and the Company
will not record an impairment charge.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Valuation
of Warrants</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company grants warrants to key employees and executives as compensation on a discretionary basis. The Company also grants warrants in
connection with certain note payable agreements and other key arrangements. The Company is required to estimate the fair value of share-based
awards on the measurement date and recognize as expense that value of the portion of the award that is ultimately expected to vest over
the requisite service period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 41; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Recent
Accounting Pronouncements</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Recently
Adopted</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2017, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU No. 2017-04, Intangibles &#8211; Goodwill and
Other (Topic 350): Simplifying the Test for Goodwill Impairment (&#8220;ASU 2017-04&#8221;), which simplifies how an entity is required
to test goodwill for impairment by eliminating Step 2 from the goodwill impairment test. Under ASU 2017-04, goodwill impairment will
be tested by comparing the fair value of a reporting unit with its carrying amount, and recognizing an impairment charge for the amount
by which the carrying amount exceeds the reporting unit&#8217;s fair value. The new guidance must be applied on a prospective basis and
is effective for periods beginning after December 15, 2022, with early adoption permitted. The Company adopted ASU 2017-04 effective
May 1, 2021. The adoption of the new standard did not have a material effect on the Company&#8217;s consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2019, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;), 2019-12, <i>Simplifying the Accounting for Income Taxes</i>,
which amends ASC 740, <i>Income Taxes</i> (ASC 740). This update is intended to simplify accounting for income taxes by removing certain
exceptions to the general principles in ASC 740 and amending existing guidance to improve consistent application of ASC 740. This update
is effective for fiscal years beginning after December 15, 2021. The guidance in this update has various elements, some of which are
applied on a prospective basis and others on a retrospective basis with earlier application permitted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
adoption of the new standard did not have a material effect on the Company&#8217;s consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2020, the FASB issued ASU No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging
Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own
Equity. ASU 2020-06 will simplify the accounting for convertible instruments by reducing the number of accounting models for convertible
debt instruments and convertible preferred stock. Limiting the accounting models results in fewer embedded conversion features being
separately recognized from the host contract as compared with current GAAP. Convertible instruments that continue to be subject to separation
models are (1) those with embedded conversion features that are not clearly and closely related to the host contract, that meet the definition
of a derivative, and that do not qualify for a scope exception from derivative accounting and (2) convertible debt instruments issued
with substantial premiums for which the premiums are recorded as paid-in capital. ASU 2020-06 also amends the guidance for the derivatives
scope exception for contracts in an entity&#8217;s own equity to reduce form-over-substance-based accounting conclusions. ASU 2020-06
will be effective for public companies for fiscal years beginning after December 15, 2023, including interim periods within those fiscal
years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within
those fiscal years. The Company is currently evaluating the impact that the adoption of ASU 2020-06 will have on the Company&#8217;s
consolidated financial statement presentation or disclosures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2016, the FASB issued ASU 2016-13, Financial Instruments &#8211; Credit Losses (Topic 326): Measurement of Credit Losses on Financial
Instruments (&#8220;ASC 326&#8221;). The guidance replaces the incurred loss methodology with an expected loss methodology that is referred
to as the current expected credit loss (&#8220;CECL&#8221;) methodology. The measurement of expected credit losses under the CECL methodology
is applicable to financial assets measured at amortized cost, including loan receivables and held-to-maturity debt securities. It also
applies to off-balance sheet credit exposures not accounted for as insurance (loan commitments, standby letters of credits, financial
guarantees, and other similar instruments) and net investments in leases recognized by a lessor in accordance with Topic 842 on leases.
ASC 326 requires enhanced disclosures related to the significant estimates and judgments used in estimating credit losses as well as
the credit quality and underwriting standards of a company&#8217;s portfolio. In addition, ASC 326 made changes to the accounting for
available-for-sale debt securities. One such change is to require credit losses to be presented as an allowance rather than as a write-down
on available-for-sale debt securities the Company does not intend to sell or believes that it is more likely than not they will be required
to sell. The ASU can be adopted no later than January 1, 2020 for SEC filers and January 1, 2023 for private companies and smaller reporting
companies. The Company has not yet adopted this ASU as it qualifies as a smaller reporting company. The Company does not expect this
ASU will have a material impact on its consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 42; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2021, the FASB issued ASU 2021-08, &#8220;Business Combinations - Accounting for Contract Assets and Contract Liabilities (Topic
805)&#8221;. The amendments in this Update address diversity and inconsistency related to the recognition and measurement of contract
assets and contract liabilities acquired in a business combination. The amendments in this Update require that an acquirer recognize
and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606, Revenue from Contracts
with Customers. ASU 2021-08 is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal
years. The Company does not expect the adoption of this ASU to have a material impact on the Company&#8217;s financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
FASB has issued ASU 2021-04, Earnings Per Share (Topic 260), Debt&#8212;Modifications and Extinguishments (Subtopic 470-50), Compensation&#8212;Stock
Compensation (Topic 718), and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40). ASU 2021-04 provides
guidance that an entity should treat a modification of the terms or conditions or an exchange of a freestanding equity-classified written
call option that remains equity classified after modification or exchange as an exchange of the original instrument for a new instrument.
The standard also provides guidance on how an entity should measure and recognize the effect of a modification or an exchange of a freestanding
equity-classified written call option that remains equity classified. The amendments in this ASU are effective for the Company for fiscal
years beginning after December 15, 2021. Early adoption is permitted for all entities, including adoption in an interim period. The Company
does not expect the adoption of this ASU to have a material impact on the Company&#8217;s financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Results
of Operations for the Three Months Ended July 31, 2023 and 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following are the results of our operations for the three months ended July 31, 2023 as compared to 2022:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Three Months Ended</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">July 31, 2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">July 31, 2022</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Change</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">(Unaudited)</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">(Unaudited)</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left">Net sales</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">3,120,231</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">3,583,336</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">(463,105</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Cost of sales</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,227,482</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,562,044</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(334,562</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Gross Profit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">892,749</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,021,292</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(128,543</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Operating expenses:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Selling and marketing expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">242,353</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">756,823</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(514,470</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">General and administrative expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,505,060</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,314,610</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(809,550</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Research and development costs</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">19,425</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(19,425</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Total operating expenses</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,747,413</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,090,858</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,343,445</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Loss from operations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,845,664</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,069,566</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,214,902</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Other expenses (income):</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Amortization of debt discounts</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(777,192</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,872,222</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,095,030</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Loss on conversion of accounts payable to common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(289,980</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(289,980</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Loss on issuance of convertible notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Gain on change in fair value of derivative liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,144,554</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,687,495</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,542,941</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Interest expense - related party</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(61,121</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">61,121</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Interest expense</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(69,483</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(191,303</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">121,820</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total other (income) expense</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,007,899</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">562,849</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">445,050</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net loss from continuing operations</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(846,765</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(2,506,717</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,659,952</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 43; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Net
sales</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
sales decreased $463,105, or 13%, during the three months ended July 31, 2023 as compared to the three months ended July 31, 2022. The
decrease in our online consumer marketing of Slinger Bag, coupled with the general marketplace impact resulting from the increased consumer
social mobility following the lifting of all covid -related restrictions contributed to the decrease in sales. The reduction in disposable
income resulting from global economic inflationary pressures also impacted on the sales of a product like Slinger Bag, priced to consumers
at a minimum of $500.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Cost
of sales and Gross income</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost
of sales decreased $334,562 during the three months ended July 31, 2023 as compared to the three months ended July 31, 2022, which
is primarily due to the reduction in net sales. Gross income decreased $128,543, or 13%, during the three months ended July 31, 2023
as compared to the three months ended July 31, 2022 due to the decrease in sales resulting from reduced on-line marketing activity
and the general global recessionary economic environment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Selling
and marketing expenses</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling
and marketing expenses decreased $514,470, or 68%, during the three months ended July 31, 2023 as compared to the three months ended
July 31, 2022. This decrease is largely driven by a decrease in social media advertising, sponsorships, and other investments in our
public relations presence based on lower cash flows being generated by lower net sales. In addition, all Slinger Bag ambassador agreements
came to an end contributing to a reduction in marketing expense.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">General
and administrative expenses</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
and administrative expenses, which primarily consist of compensation (including share-based compensation) and other employee-related
costs, as well as legal fees and fees for professional services, decreased $809,550 during the three months ended July 31, 2023 as compared
to the three months ended July 31, 2022. This decrease is primarily driven by a decrease in share-based compensation as well as in both
headcount and legal costs related to the prior year acquisition of PlaySight and Foundation into the Connexa group.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Research
and development costs</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
and development costs decreased $19,425 during the three months ended July 31, 2023 as compared to the three months ended July 31, 2022.
This decrease is primarily driven by our need to pause all development activity in the period due to limited cash flow being available
for investment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Other
expense</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
other expense increased $445,050 during the three months ended July 31, 2023 as compared to the three months ended July 31, 2022. We
recorded a gain in fair value of derivatives of $2,144,554 compared to $3,687,495 in the same period in 2022. Excluding these gains during
the periods to July 31,2023 and 2022, we had other expenses totaling $1,136,655 and $3,124,646, respectively. The increases in other expenses
for the three months ended July 31, 2023 as compared to July 31, 2022 was a reduction in amortization of debt discounts and interest
paid to related parties as well as an expense related to loss on conversion of account payable to common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Discontinued
Operations</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Discontinued
operations incorporate the impact of the divestments of both PlaySight and Gameface during the period to July 31, 2023. Total loss from
discontinued operations was $0 during the three months ended July 31, 2023 as compared to $1,759,714 in the three months ended July 31,
2022. Net cash provided by discontinued operations for the three months ended July 31, 2023 and 2022 amount to $0 and $1,053,121, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company previously classified Foundation Sports in continuing operations, until December 5, 2022 when they sold 75% of Foundation Sports
back to the original owners at which time it deconsolidated this subsidiary and recorded a loss on the sale. The Company also determined
to dispose of the PlaySight entity during the year ended April 30, 2023. The Company completed the sale in November 2022 and recorded
a loss on the sale at that time. The total loss on disposal of Foundation Sports and PlaySight amounted to $41,413,892 was fully recognized
in the year ended April 30, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 44; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Liquidity
and Capital Resources</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
financial statements have been prepared on a going concern basis, which assumes we will be able to realize our assets and discharge our
liabilities in the normal course of business for the foreseeable future. We had an accumulated deficit of $152,597,375 as of July 31,
2023, and more losses are anticipated in the development of the business. Accordingly, there is substantial doubt about our ability to
continue as a going concern. Our financial statements do not include any adjustments related to the recoverability and classification
of assets or the amounts and classification of liabilities that might be necessary should we be unable to continue as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ability to continue as a going concern is dependent upon our generating profitable operations in the future and/or being able to obtain
the necessary financing to meet our obligations and repay our liabilities arising from normal business operations when they become due.
Management intends to finance operating costs over the next twelve months with existing cash on hand, loans from related parties, and/or
private placement of debt and/or common stock. In respect to additional financing, refer to the consolidated financial statements herein.
In the event that the Company is unable to successfully raise capital and/or generate revenues, the Company will likely reduce general
and administrative expenses, and cease or delay its development plan until it is able to obtain sufficient financing. There can be no
assurance that additional funds will be available on terms acceptable to the Company, or at all.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of our cash flows from operating, investing and financing activities for the three months ended July 31, 2023
and 2022:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Three Months Ended</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">July 31, 2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">July 31, 2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Net cash provided by operating activities</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">803,363</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">(3,122,519</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net cash used in investing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net cash (used in) financing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">601,002</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,406,129</td><td style="text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
had cash and cash equivalents of 386,459 as of July 31, 2023, as compared to $202,095 as of April 30, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash provided by operating activities was $803,363 during the three months ended July 31, 2023, as compared to net cash used in operating
activities of $(3,122,519 during the same period in 2022. Our net cash used in operating activities during the three months ended July
31, 2023 was primarily the result of our net loss of $(846,765) for the period, partially offset by our net non-cash expenses of $(404,016),
incorporating the $2,144,554 reduction in change in fair value of derivative liability offset by increases in depreciation, amortization
and impairment expenses, amortization of debt discounts, settlement expense and loss on settlement of accounts payable as well as changes
in our current assets and liabilities related to our operations . The most notable changes occurred in in our inventory and prepaid inventory
where inventory significantly decreased in the three month periods and prepaid inventory increased, as well as significant increases
in accounts payable related to our cash flow issues during the respective periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
net cash used in operating activities during the three months ended July 31, 2022 was primarily the result of our net loss of $(4,266,431)
for the period and our net non-cash expenses of $(500,953) as well as the changes in our operating current assets and liabilities as
indicated above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
incurred no investing activities in either of the three-month periods ended July 31, 2023 and 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash used in financing activities was $(601,002) for the three months ended July 31, 2023, as compared to net cash provided by financing
activities of $(3,406,129) for the same period in 2022. The changes in financing activities for the three months ended July 31,
2023 primarily consisted of $(298,834) for payments of notes payable to related parties and $(302,168) in payments of notes payable.
Changes in financing activities for the three months ended July 31, 2022 consisted of proceeds of $4,195,000 resulting from issuance
of common stock, $925,000 from proceeds of notes payable offset with $(15,386) in payments of notes to related parties and $(1,698,485)
in payment of notes payable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 45; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 8, 2023, the Company entered into a merchant cash advance agreement with Meged Funding Group (&#8220;Meged&#8221;) pursuant to which
the Company sold $315,689 in future receivables to Meged (the &#8220;Meged Receivables Purchased Amount&#8221;) to in exchange for payment
to the Company of $210,600 in cash less fees of $10,580. The Company agreed to pay Meged $17,538 each week until the Meged Receivables
Purchased Amount is paid in full.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 7, 2023, the Company entered into an agreement with UFS (the &#8220;UFS Agreement&#8221;) pursuant to which the Company sold $797,500
in future receivables (the &#8220;UFS Second Receivables Purchased Amount&#8221;) to UFS in exchange for payment to the Company of $550,000
in cash less fees of $50,000. The Company agreed to pay UFS $30,000 each week until the UFS Second Receivables Purchased Amount is paid
in full.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to secure payment and performance of the Company&#8217;s obligations to UFS under the UFS Agreement, the Company granted to UFS
a security interest in the following collateral: all accounts receivable and all proceeds as such term is defined by Article 9 of the
UCC. The Company also agreed not to create, incur, assume, or permit to exist, directly or indirectly, any lien on or with respect to
any of such collateral.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description
of Indebtedness</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Notes
Payable &#8211; Related Party</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 14, 2022, the Company entered into two loan agreements with Yonah Kalfa and Naftali Kalfa, each for $1,000,000, pursuant to which
the Company received a total amount of $2,000,000. The loans bear interest at a rate of 8% per annum and are required to be repaid in
full by July 31, 2024 or such other date as may be accepted by the lenders. The Company is not permitted to make any distribution or
pay any dividends unless or until the loans are repaid in full.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
were $1,655,966 and $1,953,842 in outstanding borrowings from the Company&#8217;s related parties for the period ended July 31, 2023
and 2022, respectively. Accrued interest due to related parties as of July 31, 2023 and 2022 amounted to $917,957 and $917,957, respectively</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 6, 2023, we sold certain of our inventory including all components, parts, additions and accessions thereto to Yonah Kalfa and
Naftali Kalfa who immediately consigned it back to us in exchange for a payment of $103 per ball launcher we sell until we have paid
them an aggregate total of $2,092,700, which represents payment in full of the principal amounts of the Loan Agreements (as defined below)
and certain other expenses they incurred in connection with the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Off-Balance
Sheet Arrangements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have no off-balance sheet arrangements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Effect
of Inflation and Changes in Prices</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not believe that inflation and changes in prices will have a material effect on our operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Going
Concern</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
independent registered public accounting firm auditors&#8217; report accompanying our April 30, 2023 financial statements contained an
explanatory paragraph expressing substantial doubt about our ability to continue as a going concern. The financial statements have been
prepared assuming that we will continue as a going concern, which contemplates that we will realize our assets and satisfy our liabilities
and commitments in the ordinary course of business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 46; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Results
of Operations for the Years Ended April 30, 2023 and 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following are the results of our operations for the year ended April 30, 2023 as compared to April 30, 2022:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the Years Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>April 30,</b></span></p></td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Change ($)</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Change (%)</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left">Net sales</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">9,922,799</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">16,102,672</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(6,179,873</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">-38</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Cost of sales</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,144,335</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,878,010</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4,733,675</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-40</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Gross profit</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,778,464</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,224,662</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,446,198</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-34</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Operating expenses:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Selling and marketing expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,928,198</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,447,570</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,549,372</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-45</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">General and administrative expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22,743,877</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">46,718,986</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(23,975,109</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">49</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Research and development costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">65,164</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">736,141</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(670,977</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-91</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Total operating expenses</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">24,737,239</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">50,932,697</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(26,195,458</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">49</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Loss from operations</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(21,958,775</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(46,708,035</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">24,749,260</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-53</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Other expenses (income):</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Amortization of debt discount</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,095,030</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,150,284</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,055,254</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-50</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Loss on extinguishment of debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(7,096,730</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,096,730</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-100</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Loss on issuance of convertible notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(5,889,369</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,889,369</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-100</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Gain on change in fair value of derivative liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,950,017</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,557,184</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(7,607,167</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-41</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Gain on change in fair value of contingent consideration</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,847,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,847,000</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-100</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Derivative Expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(8,995,962</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(8,995,962</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-100</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Interest expense - related party</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(293,090</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">165,558</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(127,532</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">77</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Interest expense</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(884,985</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,920,183</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,035,198</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-54</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Total other (income) expense</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,319,050</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(182,060</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,501,110</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-1,923</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net loss from Continuing Operations</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(25,227,825</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(46,525,975</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">21,248,150</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">-46</td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Net
sales</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
net sales during the year ended April 30, 2023 were $9,922,799, compared to net sales of $16,102,672, in the same period to April 30,
2022, a reduction of -38%. Net sales consisted partially of shipped orders related to new orders placed and fulfilled to consumers via
our online marketplace and to our international distributors. The significant decrease in our online consumer marketing of Slinger Bag,
coupled with the general marketplace impact resulting from the increased consumer social mobility following the lifting of all covid
-related restrictions contributed to the significant decrease in sales.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Cost
of sales</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
cost of sales during the year ended April 30, 2023 were $7,144,335, compared to $11,878,010 for the period to April 30, 2022, a reduction
of -40%. Cost of Sales represents the costs of units shipped during the period. This reduction in Cost of Sales is a direct result of
the reduction in net sales. This resulted in a gross profit of $2,778,464, or 28.00%. compared to a gross profit of $4,224,622, or 26.24%
for the period to April 30, 2022. The 4.28% in gross profit margin can be attributed to a combination of a reduction in transportation
costs from Asia, compared to the same period in 2022, coupled with a small increase in average selling price of the Slinger Bag units.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Selling
and marketing expenses</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended April 30, 2023, we incurred selling and marketing expenses of $1,928,198 compared with $3,477,570 during the year ended
April 30, 2022, a reduction of -45%. This decrease is largely driven by a decrease in social media advertising, sponsorships, and other
investments in our public relations presence based on lower cash flows being generated by lower sales.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 47; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">General
and administrative expenses</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
and administrative expenses consist primarily of compensation, including share-based compensation, and other employee-related costs,
as well as legal fees and fees for professional services. During the year ended April 30, 2023, we incurred general and administrative
expenses of $22,743,877 compared with $46,718,986 during the year ended April 30, 2022, a reduction of -51%. The decrease in general
and administrative expenses is largely due to a reduction in our share based compensation that resulted in an expense of $31,727,091,
and our impairment loss on the intangible assets and goodwill of Gameface of $11,421,817 in the year ended April 30, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Research
and development costs</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended April 30, 2023, we incurred research and development costs of $65,164 compared with $736,141 during the year ended April
30, 2022. This decrease is mainly driven by our need to pause all development activity in the period due to limited cash flow being available
for investment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Other
expenses</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended April 30, 2023, we recorded a gain on change in fair value of derivatives of $10,950,017, compared to $18,557,184 during
the year ended April 30, 2022. $0 gain on change in fair value of contingent consideration and $4,847,000 was recorded during the years
ended April 30, 2023 and 2022. Excluding the gains, during the years ended April 30, 2023 and 2022, we had other expenses totaling $14,269,067
and $23,222,124, respectively. The decrease in other expenses for the year ended April 30, 2023 as compared to April 30, 2022 was primarily
due a reduction in amortization of discounts and losses incurred on extinguishment of our debt and convertible notes, a decrease in interest
expense from 2022 to 2023 due to changes in our long-term debt, offset by increases in derivative expense and interest to related parties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Discontinued
Operations</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Discontinued
operations incorporates the impact of the divestments of both PlaySight and Gameface during the period to April 30, 2023. Total loss
from discontinued operations was $45,875,860 during the year ended April 30, 2023 compared to $5,247,677 in the year ended April 30,
2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
loss from discontinued operations was $4,461,968 during the period to April 30,2023 compared to $5,247,677 in the period to April 30,
2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company previously classified Foundation Sports in continuing operations, until December 5, 2022 when they sold 75% of Foundation Sports
back to the original owners at which time it deconsolidated this subsidiary and recorded a loss on the sale. The Company also determined
to dispose of the PlaySight entity during the year ended April 30, 2023. The Company completed the sale in November 2022 and recorded
a loss on the sale at that time. The total loss on disposal of Foundation Sports and PlaySight amounted to $41,413,892 in the year ended
April 30, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Liquidity
and Capital Resources</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
financial statements have been prepared on a going concern basis, which assumes we will be able to realize our assets and discharge our
liabilities in the normal course of business for the foreseeable future. We had an accumulated deficit of $151,750,610 as of April 30,
2023, and more losses are anticipated in the development of the business. Accordingly, there is substantial doubt about our ability to
continue as a going concern. Our financial statements do not include any adjustments related to the recoverability and classification
of assets or the amounts and classification of liabilities that might be necessary should we be unable to continue as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ability to continue as a going concern is dependent upon our generating profitable operations in the future and/or being able to obtain
the necessary financing to meet our obligations and repay our liabilities arising from normal business operations when they become due.
Management intends to finance operating costs over the next twelve months with existing cash on hand, loans from related parties, and/or
private placement of debt and/or common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 48; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of our cash flows from operating, investing and financing activities for the years ended April 30, 2023 and 2022:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Years Ended April 30,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Cash flows used in operating activities</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">(6,365,389</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">(12,366,700</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Cash flows used in investing activities</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(1,618,341</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Cash flows provided by financing activities</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">5,700,362</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13,734,286</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
had cash and cash equivalents of $202,095 as of April 30, 2023, as compared to $665,002 as of April 30, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash used in operating activities was $6,365,389 during the year ended April 30, 2023, compared with $12,366,700 during the year ended
April 30, 2022. Our cash used in operating activities during the year ended April 30, 2023 was primarily the result of our net loss of
$71,153,685 for the year which was partially offset by our non-cash expenses of $56,348,619 as well as increases in accounts receivable,
accounts payable, accrued interest and contract liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash used in investing activities was $0 for the year ended April 30, 2023, compared with net cash used in investing activities
of $1,618,341 for the for year ended April 30, 2022. Investing activities for the year ended April, 30 2022 mostly related to the issuance
of a note receivable in the amount of $2,250,000, offset by cash received in acquisitions of the entities acquired in fiscal April 30,
2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash provided by financing activities was $5,821,178 for the year ended April 30 2023, compared with $13,734,286 for the year ended April
30, 2022. Cash provided by financing activities for the year ended April 30, 2023 consisted of proceeds of $8,744,872 from issuance of
common stock, $2,000,000 from notes payable, offset by $4,377,537 in repayments of notes payable and $546,158 in repayments of notes
payable to related parties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
provided by financing activities for the year ended April 30, 2022 consisted of proceeds of $7,500,000 from notes payable and related
party notes payable, $11,000,000 proceeds from convertible notes, offset by $3,965,463 in repayments of notes payable and debt $800,251
of issuance costs on convertible notes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Merchant
Cash Advances</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 29, 2022, the Company entered into two merchant cash advance agreements. The details of the merchant cash advance agreements are
as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>UFS
Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company entered into an agreement with Unique Funding Solutions LLC (&#8220;UFS&#8221;) pursuant to which the Company sold $1,124,250
in future receivables (the &#8220;UFS Receivables Purchased Amount&#8221;) to UFS in exchange for payment to the Company of $750,000
in cash less fees of $60,000. The Company agreed to pay UFS $13,491 each week for the first three weeks and thereafter $44,970 per week
until the UFS Receivables Purchased Amount is paid in full.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cedar
Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company entered into an agreement with Cedar Advance LLC (&#8220;Cedar&#8221;) pursuant to which the Company sold $1,124,250 in future
receivables (the &#8220;Cedar Receivables Purchased Amount&#8221;) to Cedar in exchange for payment to the Company of $750,000 in cash
less fees of $60,000. The Company agreed to pay Cedar $13,491 each week for the first three weeks and thereafter $44,970 per week until
the Cedar Receivables Purchased Amount is paid in full.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Meged
Agreement</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 8, 2023, the Company entered into a merchant cash advance agreement with Meged Funding Group (&#8220;Meged&#8221;) pursuant to which
the Company sold $315,689 in future receivables to Meged (the &#8220;Meged Receivables Purchased Amount&#8221;) to in exchange for payment
to the Company of $210,600 in cash less fees of $10,580. The Company agreed to pay Meged $17,538 each week until the Meged Receivables
Purchased Amount is paid in full.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 49; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>UFS
Agreement</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 7, 2023, the Company entered into an agreement with UFS (the &#8220;UFS Agreement&#8221;) pursuant to which the Company sold $797,500
in future receivables (the &#8220;UFS Second Receivables Purchased Amount&#8221;) to UFS in exchange for payment to the Company of $550,000
in cash less fees of $50,000. The Company has agreed to pay UFS $30,000 each week until the UFS Second Receivables Purchased Amount is
paid in full.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to secure payment and performance of the Company&#8217;s obligations to UFS under the UFS Agreement, the Company granted to UFS
a security interest in the following collateral: all accounts receivable and all proceeds as such term is defined by Article 9 of the
UCC. The Company also agreed not to create, incur, assume, or permit to exist, directly or indirectly, any lien on or with respect to
any of such collateral.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description
of Indebtedness</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Loan
and Security Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 6, 2023, the Company entered into a loan and security agreement (the &#8220;Loan and Security Agreement&#8221;) with one or more
institutional investors (the &#8220;Lenders&#8221;) and Armistice Capital Master Fund Ltd. as agent for the Lenders (the &#8220;Agent&#8221;)
for the issuance and sale of (i) a note in an aggregate principal amount of up to $2,000,000 (the &#8220;Note&#8221;) with the initial
advance under the Loan and Security Agreement being $1,400,000 and (ii) warrants (the &#8220;Warrants&#8221;) to purchase a number of
shares of common stock of the Company equal to 200% of the face amount of the Note divided by the closing price of the common stock of
the Company on the date of the issuance of the Notes (collectively, the &#8220;Initial Issuance&#8221;). The closing price of the Company&#8217;s
common stock on January 6, 2023, as reported by Nasdaq, was $0.221 (or $8.84 after giving effect to the one-for-forty (1-for-40) reverse stock split)
per share, so the Warrants in respect of the initial advance under the Note are exercisable for up to 452,489 shares of the
Company&#8217;s common stock. The Warrants have an exercise price per share equal to the closing price of the common stock of the Company
on the date of the issuance of the Note, or $0.221 (or $8.84 after giving effect to the one-for-forty (1-for-40) reverse stock split) per share
and a term of five- and one-half (5&#189;) years following the initial exercise date. The initial exercise date of the Warrants will
be the date stockholder approval is received and effective allowing exercisability of the Warrants under Nasdaq rules. Pursuant to the
terms of the Loan and Security Agreement, an additional advance of $600,000 may be made by to the Company under the Note. The Company&#8217;s
obligations under the terms of the Loan and Security Agreement are fully and unconditionally guaranteed by all of the Company&#8217;s
subsidiaries (the &#8220;Guarantors&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Notes
Payable - Related Party</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 14, 2022, the Company entered into two loan agreements with Yonah Kalfa and Naftali Kalfa, each for $1,000,000 (together, the
&#8220;Loan Agreements&#8221;), pursuant to which we received a total amount of $2,000,000. The loans bear interest at a rate of 8% per
annum, and we agreed to repay the loans in full by July 3, 2022, or such other date as may be accepted by the lenders. On June 28, 2022,
the Company entered into amendments for the two related party loan agreements with the lenders in which the repayment date was extended
to July 31, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
were $1,953,842 and $2,000,000 in outstanding borrowings from the Company&#8217;s related parties for the years ended April 30, 2023
and 2022, respectively. Accrued interest due to related parties as of April 30, 2023 and 2022 amounted to $917,957 and $908,756, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 6, 2023, we sold certain of our inventory including all components, parts, additions and accessions thereto to Yonah Kalfa and
Naftali Kalfa who immediately consigned it back to us in exchange for a payment of $103 per ball launcher we sell until we have paid
them an aggregate total of $2,092,700, which represents payment in full of the principal amounts of and accrued interest in respect of
the Loan Agreements (as defined above) and certain other expenses they incurred in connection with the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Off-Balance
Sheet Arrangements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have no off-balance sheet arrangements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Effect
of Inflation and Changes in Prices</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not believe that inflation and changes in prices will have a material effect on our operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 50; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ak_001"></span>DESCRIPTION
OF BUSINESS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>History
of our Company</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lazex
Inc. (&#8220;Lazex&#8221;) was incorporated under the laws of the State of Nevada on July 12, 2015. On August 23, 2019, the majority
owner of Lazex entered into a Stock Purchase Agreement with Slinger Bag Americas Inc., a Delaware corporation (&#8220;Slinger Bag Americas&#8221;),
which was 100% owned by Slinger Bag Ltd. (&#8220;SBL&#8221;), an Israeli company. In connection with the Stock Purchase Agreement, Slinger
Bag Americas acquired 2,000,000 shares of common stock of Lazex for $332,239. On September 16, 2019, SBL transferred its ownership of
Slinger Bag Americas to Lazex in exchange for the 200,000 shares of Lazex acquired on August 23, 2019. As a result of these transactions,
Lazex owned 100% of Slinger Bag Americas and the sole shareholder of SBL owned 200,000 shares of common stock (approximately 82%) of
Lazex. Effective September 13, 2019, Lazex changed its name to Slinger Bag Inc.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 31, 2019, Slinger Bag Americas acquired control of Slinger Bag Canada, Inc., (&#8220;Slinger Bag Canada&#8221;) a Canadian company
incorporated on November 3, 2017. There were no assets, liabilities or historical operational activity of Slinger Bag Canada.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 10, 2020, Slinger Bag Americas became the 100% owner of SBL, along with SBL&#8217;s wholly owned subsidiary Slinger Bag International
(UK) Limited (&#8220;Slinger Bag UK&#8221;), which was formed on April 3, 2019. On February 10, 2021, Zehava Tepler, the owner of SBL,
contributed Slinger Bag UK to Slinger Bag Americas for no consideration.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
February 25, 2020, the Company increased the number of authorized shares of common stock from 75,000,000 to 300,000,000 via a four-to-one
forward split of its outstanding shares of common stock. All share and per share information contained in this report have been retroactively
adjusted to reflect the impact of the stock split.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 21, 2021, Slinger Bag Americas entered into a membership interest purchase agreement with Charles Ruddy to acquire a 100% ownership
stake in Foundation Sports Systems, LLC (&#8220;Foundation Sports&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 2, 2022, the Company entered into a share purchase agreement with Flixsense Pty, Ltd. (&#8220;Gameface&#8221;). As a result
of the share purchase agreement, Gameface would become a wholly owned subsidiary of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 22, 2022, the Company entered into a merger agreement with PlaySight  and Rohit Krishnan
(the &#8220;Shareholders&#8217; Representative&#8221;). As a result of the merger agreement, PlaySight would become a wholly owned subsidiary
of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
April 2022, the Company determined that the technology utilized in the Foundation Sports acquired entity would take substantially more
financial resources and more time to bring to market and achieve profitability than originally anticipated. As a result, the goodwill
and intangible assets related to Foundation Sports were fully impaired as of April 30, 2022, resulting in an impairment loss of $3,486,599.
In addition, during April 2022 the Company decided to sell a portion of Foundation Sports. The Company continued to classify Foundation
Sports in continuing operations, until December 5, 2022 when it sold 75% of Foundation Sports back to the original owners at which time
it deconsolidated this subsidiary and recorded a loss on the sale. The Company also determined to dispose of the PlaySight entity during
the year ended April 30, 2023. The Company completed the sale in November 2022 and recorded a loss on the sale at that time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 51; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
April 2022, the Company changed its domicile from Nevada to Delaware. On April 7, 2022, the Company effected a name change to Connexa
Sports Technologies Inc. We also changed our ticker symbol, &#8220;CNXA.&#8221; Connexa is now the holding company under which Slinger
Bag and Gameface reside.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
operations of Slinger Bag Inc., Slinger Bag Americas, Slinger Bag Canada, Slinger Bag UK, SBL and Gameface
are collectively referred to as the &#8220;Company.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 14, 2022, the Company effected a 1-for-10 reverse stock split, where the Company&#8217;s common stock began to trade on a reverse
split adjusted basis. No fractional shares were issued in connection with the reverse stock split and all such fractional interests were
rounded up to the nearest whole number of shares of common stock. All references to the outstanding stock have been retrospectively adjusted
to reflect this reverse stock split. The Company also consummated a public offering of shares of its common stock and the listing
of its common stock on the Nasdaq.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 17, 2022, Gabriel Goldman and Rohit Krishnan resigned from the board of directors of the Company. Gabriel and Rohit were members
of the audit and compensation committees. Gabriel Goldman was a member of the Company&#8217;s Nominating and Corporate Governance Committee.
Neither Gabriel nor Rohit advised the Company of any disagreement with the Company on any matter relating to its operations, policies
or practices.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 27, 2022, the Company entered into a share purchase agreement (the &#8220;Agreement&#8221;) with PlaySight, Chen Shachar and
Evgeni Khazanov (together, the &#8220;Buyer&#8221;) pursuant to which the Buyer purchased 100% of the issued and outstanding shares of
PlaySight from the Company in exchange for (1) releasing the Company from all of PlaySight&#8217;s obligations towards its vendors, employees,
tax authorities and any other (past, current and future) creditors of PlaySight; (2) waiver by the Buyer of 100% of the personal consideration
owed to them under their employment agreements in the total amount of $600,000 (which would have been increased in December 2022
to $800,000); and (3) cash consideration of $2 million to be paid to the Company as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    promissory note in the amount of $2 million issued and delivered to the Company (the &#8220;Promissory Note&#8221;).</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    maturity due date of the Promissory Note is December 31, 2023 subject to a one year extension in the discretion of the Buyer until
    December 31, 2024.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Promissory Note can be partially paid over the time, but in the event it is not paid in full by December 31, 2024, then the remaining
    amount due (i.e. $2 million less any amount paid), will be converted into ordinary shares of PlaySight (the &#8220;Deposited
    Shares&#8221;), which will be deposited with the escrow company of Altshuler Shaham Trust Ltd. (the &#8220;Escrow Agent&#8221;) for
    the benefit of the Company or, at the election of the Company, issued in the form of a stock certificate or recorded in some other
    market-standard format to be held by the Escrow Agent.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    number of the Deposited Shares shall be determined according to the post-money valuation of the last investment round of the Company,
    and in the absence of such investment round, the total number of the Deposited Shares shall be $2 million divided by the Company&#8217;s
    valuation to be determined at that time by a third party appraiser, to be nominated by both the Company and the Buyer (the &#8220;Appraiser&#8221;).
    The Company and the Buyer have agreed that the identity of the Appraiser shall be Murray Devine Valuation Advisers, to the extent
    their cost of the appraisal shall not be higher than the cost of other appraisers from the big 4 accounting firms (i.e. E&amp;Y,
    KPMG, PWC and Deloitte). The Company and the Buyer have agreed to split the cost of the Appraiser.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has also released PlaySight from all of its obligations (except for those created by the Agreement) in respect of the Company,
including any inter-company debts on the books, and the Buyer has released the Company from all of its obligations (except for those
created by the Agreement) in respect of PlaySight and the Buyer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
reason for the entry into the Agreement and the transactions contemplated thereby was to eliminate the need for the Company to provide
further financing for PlaySight&#8217;s operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>


<!-- Field: Page; Sequence: 52; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 5, 2022, the Company assigned 75% of its membership interest in Foundation Sports to Charles Ruddy, its founder and granted
him the right for a period of three years to purchase the remaining 25% of its Foundation Sports membership interests for $500,000 in
cash. As of December 5, 2022, the results of Foundation Sports will no longer be consolidated in the Company&#8217;s financial statements,
and the investment was accounted for as an equity method investment. On December 5, 2022, the Company analyzed this investment and established
a reserve for the investment at the full amount of $500,000. The Company intends to enter into a database access and marketing agreement
with Foundation Sports pursuant to which Foundation Sports will (i) provide the Company with sporting or racquet facility information
and contact data of its customers (subject to applicable law) and (ii) publish any promotional content, call to action, survey or similar
promotional communications provided by the Company to Foundation Sport&#8217;s customers for its Customers to promote said material to
their extended network of consumers in exchange for 7% of any gross revenue to be generated from such activities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 7, 2023, Slinger Bag entered into an exclusive distribution agreement for Padel Tennis with a company located in Valencia,
Spain called with Desarrollo y Promocion de Padel S.L. This agreement is contracted to deliver approximately $20 million in revenue
over a 5-year period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Delinquency
Notices</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 26, 2023, the Company received a letter from the Listing Qualifications Department of Nasdaq indicating that the Company&#8217;s
stockholders&#8217; equity as reported in its Quarterly Report on Form 10-Q for the quarterly period ended January 31, 2023 did not satisfy
the continued listing requirement under Nasdaq Listing Rule 5550(b)(1), which requires that a listed company&#8217;s stockholders&#8217;
equity be at least $2.5 million (the &#8220;Minimum Stockholders&#8217; Equity Requirement&#8221;). The Company timely submitted a compliance
plan to the Panel and on August 23, 2023 received notice from Nasdaq that it has until January 22, 2024 to demonstrate compliance with
the Minimum Stockholders&#8217; Equity Requirement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
can be no assurance that the Company will be able to satisfy the Nasdaq&#8217;s continued listing requirements, regain compliance with
the Rule, the Minimum Stockholders&#8217; Equity Requirement, and maintain compliance with other
Nasdaq listing requirements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Operations</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company operates in the sports equipment and technology business. The Company is the owner of the Slinger Launcher, which is comprised
of a portable tennis ball launcher, a portable padel tennis ball launcher and a portable pickleball launcher and Gameface AI, providing
AI technology and performance analytics.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
inception to date, we have been focused on the ball sport market globally. Our first product, the Slinger Bag Launcher, is a patented,
highly portable, versatile and affordable ball launcher built into an easy to transport wheeled trolley bag.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tennis
ball machines have been around since the 1950&#8217;s when they were introduced by Rene Lacoste. Improvements to performance were made
in the 1970&#8217;s when Prince started its tennis business on the back of its first product &#8211; Little Prince &#8211; which was
a vacuum operated ball machine. In the 1990&#8217;s the first battery operated machines came to the market and since that time very little,
if anything, has changed in the structure of ball machines products outside of added computerization. Typically, the machines being marketed
by traditional ball machine brands are large, cumbersome and awkward to operate. They are also generally expensive &#8211; often well
above $1,000 compared to the entry price of $500 for a Slinger Bag Launcher. We believe that up until the introduction of the Slinger
Bag Launcher, the majority of traditional tennis ball machines were sold to tennis facilities, institutions and tennis teachers, with
only a few being sold directly to tennis playing consumers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 53; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Recent
Developments</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On June 8, 2023, the Company
entered into a merchant cash advance agreement with Meged Funding Group (&#8220;Meged&#8221;) pursuant to which the Company sold $315,689
in future receivables to Meged (the &#8220;Meged Receivables Purchased Amount&#8221;) to in exchange for payment to the Company of $210,600
in cash less fees of $10,580. The Company agreed to pay Meged $17,538 each week until the Meged Receivables Purchased Amount is paid in
full.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On July 26, 2023, the Company
received a letter from the Listing Qualifications Department of Nasdaq indicating that the Company&#8217;s stockholders&#8217; equity
as reported in its Quarterly Report on Form 10-Q for the quarterly period ended January 31, 2023 did not satisfy the continued listing
requirement under Nasdaq Listing Rule 5550(b)(1), which requires that a listed company&#8217;s stockholders&#8217; equity be at least
$2.5 million (the &#8220;Minimum Stockholders&#8217; Equity Requirement&#8221;). The Company timely submitted a compliance plan to the
Panel and on August 23, 2023 received notice from Nasdaq that it has until January 22, 2024 to demonstrate compliance with the Minimum
Stockholders&#8217; Equity Requirement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On August 7, 2023, the Company
entered into an agreement with UFS (the &#8220;UFS Agreement&#8221;) pursuant to which the Company sold $797,500 in future receivables
(the &#8220;UFS Second Receivables Purchased Amount&#8221;) to UFS in exchange for payment to the Company of $550,000 in cash less fees
of $50,000. The Company agreed to pay UFS $30,000 each week until the UFS Second Receivables Purchased Amount is paid in full.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In order to secure payment and
performance of the Company&#8217;s obligations to UFS under the UFS Agreement, the Company granted to UFS a security interest in the following
collateral: all accounts receivable and all proceeds as such term is defined by Article 9 of the UCC. The Company also agreed not to create,
incur, assume, or permit to exist, directly or indirectly, any lien on or with respect to any of such collateral.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On September 13, 2023, the Company
held a special meeting of stockholders in which the following items were approved: (i) the issuance of (i) 25,463 shares of the our common
stock, par value $0.001 per share, that were issued on October 3, 2022, and, (ii) 295,051 shares of our common stock issuable upon exercise
of Pre-Funded Warrants at an exercise price of $0.00001 per share, (iii) 320,513 shares of common stock issuable upon the exercise of
the 5-Year Warrants at an exercise price of $15.60 per share, (iv) 641,026 shares of common stock issuable upon the exercise of the 7.5
Year Warrants at an exercise price of $17.20 per share and (v) 452,489 shares of our common stock issuable upon the exercise of the 5.5
Year Warrants at an exercise price per share equal to $8.84 per share to Armistice Capital Master Fund Ltd and (ii) a reverse stock split
of our common stock within a range of one (1)-for-ten (10) to one (1)-for-forty (40) (&#8220;Reverse Stock Split&#8221;), with the Board
of Directors of the Company to set the specific ratio and determine the date for the reverse split to be effective and any other action
deemed necessary to effectuate the Reverse Stock Split, without further approval or authorization of stockholders, at any time within
12 months of the special meeting date. The Company effected a one-for-forty (1-for-40) reverse stock split of its common stock on September
25, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On September 25, 2023, as a result
of the shareholder approval obtained at the special meeting of stockholders on September 13, 2023 and the Reverse Stock Split, the aggregate
number of Pre-Funded Warrants, 5-Year Warrants, 5.5-Year Warrants and 7-Year Warrants increased from 1,709,097 to 9,426,952 due to certain
adjustments that were required to be made by the terms of the relevant warrants in the event of receipt of shareholder approval and the
occurrence of the Reverse Stock Split.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On September 19, 2023, the Company
entered into an agreement with Meged (the &#8220;Second Meged Agreement&#8221;) pursuant to which the Company sold $423,000 in future
receivables to Meged (the &#8220;Meged Second Receivable Amount&#8221;) in exchange for paying the then outstanding balance of $70,153
of the Meged Receivables Purchased Amount in full with the balance being retained by the Company in cash for general purposes. The Company
agreed to pay Meged $15,107 each week until the Meged Second Receivable Amount is paid in full.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In order to secure payment and
performance of the Company&#8217;s obligations to Meged under the Second Meged Agreement, the Company granted to Meged a security interest
in the following collateral: all accounts receivable and all proceeds as such term is defined by Article 9 of the UCC. The Company also
agreed not to create, incur, assume, or permit to exist, directly or indirectly, any lien on or with respect to any of such collateral.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On October 11, 2023, the Company
entered into a loan and security modification agreement (the &#8220;Loan and Security Modification Agreement&#8221;) with a one or more
institutional investors (the &#8220;Lenders&#8221;) and a certain institutional investor, as agent for the Lenders (the &#8220;Agent&#8221;)
amending the terms of the Loan and Security Agreement dated January 6, 2023 (the &#8220;LSA&#8221;) by and among the Company, the Lenders
and the Agent to make an additional loan of $1,000,000 and modify the terms of the LSA to reflect the New Loan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In connection with the Loan and
Security Modification Agreement, the Company agreed to issue to the investor warrants (the &#8220;Common Warrants&#8221;) to purchase
up to 169,196 shares of Common Stock at an exercise price of $1.90 per share. The Common Warrants are exercisable six months after their
issuance and will expire five and one-half years from their date of issuance. The Common Warrants and the shares of our Common Stock issuable
upon the exercise of the Common Warrants are not being registered under the Securities Act of 1933, as amended (the &#8220;Securities
Act&#8221;), were not offered pursuant to the Registration Statement and were offered pursuant to the exemption provided in Section 4(a)(2)
under the Securities Act, and Rule 506(b) promulgated thereunder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On October 12, 2023, the Board of Directors of the Company approved an
amendment to the Bylaws of the Company to reduce the percentage of shares of stock, issued and outstanding and entitled to vote, to be
present in person or represented by proxy in order to constitute a quorum for the transaction of any business from a majority to thirty
three and one third percent (33 1/3%).</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Industry
Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Over
the next five years, we believe that there will be a significant increase in demand from sports consumers for AI (artificial intelligence)
technology that will play an integral role in supporting their enjoyment of their chosen sport through personalized insights and analytics
and associated self-coaching tools.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Over
the course of the next twelve months, we will be focused on reaching the global tennis, padel tennis and pickleball communities as
our primary target markets. The ITF cites the global tennis market as having 80 million active participants, with many million other
consumers being acknowledged as avid fans of the sport. Pickleball is now widely recognized as the fastest growing sport in the
United States with over 5 million regular players and Padel Tennis is also seeing significant participant growth throughout Europe
and South America primarily. Currently it is estimated that there are up to as many as 10 million padel players globally. In
addition, we will also be looking to introduce to the tennis market an upgraded Tennis Launcher towards the late spring of 2024 and
we aim to be in a final test phase of our Baseball / Softball Launcher consumer testing by summer 2024, as we see this market as a significant
future growth opportunity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Manufacturing
and Distribution</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Production
of the Slinger Bag Launcher is based in southern China. We are engaged with 10 individual part suppliers, and all of these parts come
together at our contracted assembly facility in Xiamen, China, where the Launchers are assembled and quality control checked before being
processed for global distribution.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
manufacturing capacity is estimated at approximately 5,000 units monthly. This capacity will be shared across our three Slinger Bag Launcher
products&#8211; tennis, pickleball, and padel. The pickleball product was introduced to the market in March 2023 and was followed by
Padel Tennis in June 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
developing our Slinger Bag tennis, pickleball and padel launchers, we have designed the three products that share many common parts.
We expect this to aid the efficiency of the production process.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have engaged an independent and experienced vendor management company to manage all of our production activities, our quality control
process and quality assurance activities, both across our individual vendor partners and at the assembly facility. These processes have
been developed together with the Company with a goal of producing consistently high-quality and high performing products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have created a global distribution network, and all shipments of our products made to distributor markets outside of the United States
and Canada are shipped free-on-board (&#8220;FOB&#8221;) from Xiamen, China, at which point they enter into the ownership of the distributors
and become their responsibility. South American distributors are sometimes serviced from our US warehouse locations and European distributors
continue to be able to place replacement orders through a small third-party distribution facility located in Rotterdam, Netherlands.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 54; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
we ship our Slinger-Dunlop co-branded tennis balls produced by Dunlop (the largest global supplier of tennis balls) to the United States
to be sold via our e-commerce platform or directly from source to our distributor network for further distribution around the world.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gameface
is a software-as-a-service company and, as such, has no direct procurement or supply chain requirements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Strategy</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Slinger
Bag Launchers for tennis, pickleball and padel</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
introducing the Slinger Bag Launcher, we saw an opportunity to disrupt the traditional tennis market. Through March 2023 Slinger
Bag has been a single product company marketing its Tennis Launcher for tennis players of all ages and abilities. Currently, approximately
70% of Slinger Bag Tennis Launcher revenues are generated through our direct-to-consumer strategy in North America. We operate a third-party
distributor structure in all markets outside of North America. Distributor partners have exclusive territories and / or product categories.
We endeavor to partner with distributors who have a recognized background within the tennis, pickleball or padel industries for their
respective market, along with them having the requisite financial capacity and service infrastructure to grow the Slinger Bag brand through
a similar go-to-market strategy as is operated directly by the Slinger Bag business in North America. All distributors purchase Slinger
Bag Launchers at a discounted distributor pricing structure, which is considerably lower than the US consumer price, and are responsible
for placing their product orders up to 3 months in advance of their delivery requirement. As part of this distributor program, in April
2023 we appointed a global distribution partner for Padel Tennis - Desarrollo y Promocion de Padel S.L., a division of Manza Sport based
in Valencia, Spain &#8211; a company that has over 20 years of experience in the global Padel market as a leading supplier of Padel courts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
United States market will remain predominantly a direct-to-consumer market for Slinger Bag for all sport verticals.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
the largest tennis and pickleball market in the world with 17.4 million tennis players and over 5 million pickleball players, the
United States is a key market both to establish the Slinger brand and to drive demonstrable growth. Direct-to-consumer e-commerce
sales are further supplemented by one or more third-party internet sites focused on either the tennis or the pickleball market. The
Unites States market is served by third-party logistics facilities in Hagerstown, PA and Reno, Nevada, which are operated by our
third party logistics partner, 1-Click Logistics. All end consumer service support is currently managed by a small service team based in Canada. All
distributor partners are managed and supported by our distributor manager located in Israel.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Gameface</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gameface
will provide the consumer with access to analytics data through a sport specific automated AI platform that analyzes and extracts data
from uploaded consumer or team videos. Gameface has successfully launched this technology previously in Cricket in Australia and is working
to introduce to the market a unique application for Tennis. Once tested and established in Tennis, this technology can easily be adapted
for other racquet sports, baseball, cricket, golf and other sports verticals. Gameface&#8217;s core capabilities are delivered through
a compatible single camera or smart phone, which allows us to build scalable solutions for the sports market without relying on specific
hardware or camera types.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
envision Gameface as a product and technology that will be at the heart of &#8216;powering&#8217; the Connexa portfolio of brands. We
also see Gameface technology as a driver of real-time data and analytics for Connexa&#8217;s core sport focus &#8211; across all racquet
sports, baseball and cricket &#8211; coupled with partnerships with external brands and other strategic partners for its applications
for all other sports, outside of these core categories.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 55; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gameface
initially focused its technology on the cricket and soccer markets, where it has built an automated platform to extract various data
points from live and archived match footage. The Gameface team has been dedicated to building its technology to deliver performance insights
in tennis, which will form the core of our new Slinger app, which is planned to be launched in late 2023. After launching the tennis
app, Gameface plans to revisit the cricket vertical and enhance its technology offering based on the advances made in its tennis AI,
which will broaden and deepen its reach across the cricket world. In 2024 and going forward, Gameface expects to dedicate resources to
baseball analytics and identifying strategic partners for other high-profile team sports such as basketball and soccer. We also intend
to license technology to validated global partners in sports verticals that remain non-core to Connexa with the aim to become the recognized
leader in sports AI globally.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Connexa
Brand Marketing</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
the go-to-market strategy for Slinger Bag focused on its core North American tennis and pickleball markets as a direct-to-consumer business
e-commerce brand, all in-house marketing activity and advertising media is centered around a consumer push to the Slinger Bag e-commerce
platform at https://www.slingerbag.com/ and then working to convert brand or product interest to purchases. Based on the target tennis
and pickleball demographic, our marketing focus centers around three core marketing pillars: digital advertising; influencers and brand
ambassadors. Our marketing efforts also focus on core targeted social media platforms such as Facebook, Google, Instagram and You Tube.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Using
demographic data for tennis and pickleball and following a period of advertising testing, our digital advertising spend is focused mainly
towards Facebook and Google platforms.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to our paid marketing activities, Slinger Bag relies on the expertise of our small internal team to build out a network of &#8216;followers&#8217;
across various social media platforms &#8211; mainly Instagram, Facebook, You Tube and LinkedIn. Slinger Bag has significant numbers
of its consumers who are avid fans of our brand and fully engaged in generating Slinger Bag related social media content through their
own means.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
inception, Slinger Bag has built up a base of in excess of 60,000 users of Slinger Bag. Through our acquisition and retained interest
in Foundation Sports we have access to Foundation&#8217;s database of over 500,000 avid tennis players. We use email marketing to engage
with this groups a few times per annum in order to generate additional sales interest. Ultimately, this group will also form the core
target consumer market for our upcoming launch of the Slinger Tennis App.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Slinger Bag brand ambassador team has also been integral to the overall brand marketing strategy through their support of our product
and by creating and sharing their user content, representing themselves as affiliated with the brand and through their personal appearances
at events, tournaments, etc. During the fiscal year that ended on April 30, 2022, our ambassador team included: Tommy Hass, Robert Bryan,
Darren Cahill, Eugenie Bouchard, Patrick Mouratoglou, Dustin Brown and the Jensen brothers. All ambassador arrangements terminated prior
to October 31, 2023, which means that we no longer have any active tennis ambassadors as we work to negotiate new arrangements with a core team for the future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Similar
prominent ambassadors are being identified for both pickleball in the United States of America and by our exclusive padel distributor
for the global padel market and are expected to be in place and active over the coming months.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outside
of our core marketing strategy, Slinger Bag has taken advantage of numerous opportunities to partner with key brands in the tennis and
pickleball spaces and/or to advertise at key tennis or pickleball related events.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
through our management team&#8217;s close association to the tennis industry, we have been able to provide many touring professionals
with a Slinger Bag Launcher for their personal use. These arrangements were non-contractual product seeding opportunities. Players have
occasionally posted on social media about their use of the Slinger Bag Launcher, which, based on their significant social media followings,
have supported the growth of the Slinger Bag brand awareness.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 56; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
support the Slinger Bag marketing program, we have engaged the following agencies:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ad
    Venture Media Group, a New York based PPC (pay-per-click) agency whose work is grounded in scientific analysis of consumer data and
    consumer trends. Ad Venture Media leads all of our paid digital and social media advertising activities for Slinger Bag on a performance-based
    fee structure.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    have partnered with Team Activations through their Team HQS portal to manage an affiliate marketing program geared towards US-based
    teaching professionals, players, juniors and events, in the United States tennis and pickleball markets. This target market is provided
    with unique affiliate marketing links and encouraged to create content and to share it on their social media accounts and in other
    such communities that they are connected to, in order to receive an affiliate marketing fee based on revenues generated by consumers
    purchasing Slinger Bag products attributable to them, via their direct link.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
distributor is also conducting its own Slinger brand marketing program. All efforts in this regard are aimed at reaching the avid tennis
player directly and are focused on ensuring that the Slinger Bag brand message is consistent around the globe. Slinger Bag supports all
of its brand distributors with full access to all of the company&#8217;s marketing partners and brand assets, as well as with direct
contact to our internal marketing team.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
marketing budget is primarily funded by, or determined in accordance with, the distributor partner and is linked to the distributors
annual purchase objectives. Each distributor executes local grassroots programs, including demonstration days, local teaching pro partnerships,
specialist tennis network communications, providing Slinger Bag product locally as necessary to the local market key influencers across
tennis, pickleball and padel to further increase the intensity of the influencer effort and broaden consumer awareness. Typically, we
support these activities with either discounted products or certain quantities of free products. Distributor marketing budgets are allocated
to Google, Facebook, Instagram, YouTube and other relevant websites or platforms in their region, and several are supported, approved
and /or overseen by AdVenture Media Group where applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Brand
Endorsements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2021 we reached agreements with several globally recognized tennis players and coaches to become brand ambassadors, but those agreements
terminated in the first two calendar quarters of 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are now in the process of re-evaluating this program and of potentially either renewing a select core group or identifying new ambassadors
for our tennis activities and for relevant ambassadors to support our Pickleball and Padel category activities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have also engaged with the following organizations to promote our Slinger brand and products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peter
Burwash International (&#8220;PBI&#8221;), a United States-based, highly respected, global tennis services company set up by Peter Burwash
some 35 years ago. PBI provides tennis programs and other tennis services to over 28 of the global luxury resorts. Slinger Bag Launchers
are available to use at each resort and the PBI team will be actively promoting the Slinger brand as part of our affiliate marketing
activity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Dink &#8211; a leading Pickleball platform with 250,000 active pickleball players on their database.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Strategic
Brand Partnerships</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Slinger
Bag believes that building strong strategic partnerships across the sport of tennis underpins the credibility and awareness of the Slinger
Bag brand. As such, we currently have several strategic partnerships across tennis. We believe these partnerships provide us significant
levels of brand exposure and credibility driving mutually beneficial marketing campaigns aimed at reaching avid tennis players globally.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Details
of such partners announced and active include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dunlop:
    We have entered a strategic partnership with one of the most iconic tennis brands in the world, Dunlop, for the supply of co-branded
    Slinger-Dunlop tennis balls across the globe.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 57; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="forms-1_001.jpg" alt="" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peter
    Burwash International: An organization providing coaching and tennis services to high-level, high-quality hotels, resorts and tennis
    facilities across the globe.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tennis
    Europe: In partnership with our European distributor, Dunlop, Slinger Bag is the official tennis ball launcher of the Tennis Europe
    organization. Tennis Europe provides a platform for 60,000 aspiring junior tennis players to compete in age-group categorized events.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -18.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
a similar vein, we are looking to deliver partnerships for the co-branded supply of Pickle Balls and Padel Tennis Balls.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -18.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Competition</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Slinger
Bag Launcher</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are currently no direct competitors with products that are similar to the Slinger Bag Launcher, based on its affordability and tennis
bag functionality. There are, however, other companies that market traditional tennis ball machines, including the following brands:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nisplay</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Spinshot</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lobster
    Sports &#8211; Tennis, Pickleball and Padel</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Spinfire</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MatchMate</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sports
    Tutor - Tennis, Pickleball and Padel</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Silent
    Partner</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hydrogen
    Proton</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Playmate</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Erne
    Pickleball</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simon
    X Pickleball</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Padelmaster
    - Padel</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 58; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Gameface</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are currently no competitors for our cricket and tennis AI analytics product that are similar to the cricket technique analysis app or
the Slinger app (currently in beta testing), based on functionality and affordability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are, however, other companies that offer analytics using AI across different sports and at different levels, including Track160 (football),
Second Spectrum (basketball), Hawk Eye (tennis/football/cricket), Swing Vision (tennis), Home Court (basketball), and Golf Boost Ai (golf).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Intellectual
Property</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have applied for international design and utility patent protection for our main three products: Slinger Launcher, Slinger Oscillator
and Slinger Telescopic Ball Tube. Our utility patents have been applied for in all key markets including the US, China, Israel, Canada,
Japan, Hong Kong, Australia, and EU, and granted in US and China. Our design patents have been applied for and granted in US, China,
EU, United Kingdom, Canada, Israel, and Japan. Trademark protection has been applied for and/or received in the following countries:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chile</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mexico</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EU</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Russia</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Poland</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Czech
    Republic</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Australia</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    Zealand</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">China</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">South
    Korea</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vietnam</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Singapore</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canada</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">United
    Arab Emirates*</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">South
    Africa*</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Columbia*</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Israel*</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Japan*</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Switzerland*</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indonesia*</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Malaysia*</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thailand*</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Turkey*</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Argentina</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brazil</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*Trademark
protection is pending.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are engaged in ongoing efforts to register more trademarks across an expanding list of products, services and applications, which are
in various stages of the registration process.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
own the rights to its www.connexasports.com domain and other associated and derivative domains.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Gameface</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gameface
is currently working to prepare AI-related patent applications, which are expected to include the United States, EU, China, Japan, India
and Australia.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 59; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Seasonal
Business</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect to experience minor fluctuations in aggregate sales volume during the year. We expect revenues in the first and fourth fiscal
quarters to typically exceed those in the second and third fiscal quarters. However, the mix of product sales across our group may vary
considerably from time to time as a result of changes in seasonal and geographic demand for tennis and other sports equipment and in
connection with the timing of significant sporting events, such as any Grand Slam tennis tournament and, over time, other sports competitions
and in relation to new product market launches.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Costs
and Effects of Complying with Environmental Regulations</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Set
forth below is a detailed chart of all our Product Certifications for key global markets covering battery, remote control (radio wave),
and power charger. In addition, within the United States, we comply with the required California 65 regulations in respect to the materials
used in the construction of its trolley bag.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Government
Regulation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Both
the Slinger Bag Launcher and the Slinger Oscillator meet all the United States government requirements for electrical, radio wave and
battery standards, as well as having all necessary and required certifications to facilitate global marketing and sales of these products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="forms-1_002.jpg" alt="" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 60; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img src="forms-1_003.jpg" alt="" /></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="forms-1_004.jpg" alt="" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 61; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="forms-1_005.jpg" alt="" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Research
and Development</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Slinger
Bag</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Slinger
Bag continues to work with our vendor management partner, Stride Innovation, and our China based vendors to produce ball launchers for
new market segments, such as Pickleball, Padel and Baseball/Softball. These efforts are collaborative and based on a detailed product
brief and in-depth market and consumer research for each product category. The development timetable of the Slinger Bag Launcher for
the new market segments from concept to market launch is approximately 18 months and includes at least 2 rounds or in-market field testing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We introduced
ball launchers for Pickleball and Padel in the Spring of 2023 and are currently field testing our new Baseball / Softball
launchers, which are expected to be introduced to the market in 2024. We plan to introduce similar transportable, versatile and
affordable ball launchers for cricket and other ball sports over the course of the next three years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
regard to development of our pending performance and analytics app, the development team of Gameface is working to create a Tennis specific
analysis code for the app. We have also contracted with a design agency to build the road map for the user experience based on the technology
being developed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Gameface</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gameface
is involved in additional research and development of building methods to extract data reliably and more accurately from videos. A large
part of our research also includes identifying and associating extracted data points of athlete performance. Gameface is currently field
testing its new data visualization techniques to represent data in tennis and cricket, which are expected to be introduced late in 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Quality
Control</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quality
control is a critical function within our company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a relatively new brand in the market, our business enterprise success will in part dependent on the quality and consistency of our products.
Slinger Bag has engaged Stride-Innovation, a company with in-depth experience working with ball sport companies such as ours, has the
knowledge, resources and 20 years of experience in working with Chinese vendors of sports equipment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 62; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
partnership, together, we have created and documented quality guidelines, testing procedures and warranty processes. We have implemented
an agreed quality audit process for all product parts being received and used by our product assembly vendor. All products go through
a rigorous, statistically validated quality control testing approval process before being confirmed as available to be released for shipment
to one of our distribution centers or to any of our distribution partners.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
offer a limited warranty with all purchases in accordance with local market statutory regulations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vendors</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Slinger
Bag works only with and through third-party suppliers. Slinger Bag has a formal supply of service agreement in place with our vendor
management partner, Stride-Innovation, for a wide range of support and services. We have a written agreement in place with our main assembly
vendor partner, Xiamen Ruicheng Industrial Design Co., Ltd.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stride-Innovation
quality control teams regularly visit each of our vendor facilities and monitor production, employee conditions and welfare, and undertake
quality control testing. We do not utilize or condone the use of child labor of any kind in the production of our products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Employees</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
at the date of this report, we have 9 full-time employees spread across Israel, USA, Australia and the UK. Management believes
its relations with employees is good. We also hire part-time employees and engage consultants to support our operations as needed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Facilities</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
principal office is located at 2709 N. Rolling Road, Suite 138, Windsor Mill, Maryland 21244. We entered into a lease for use of
office space at this location effective September 1, 2019. This location is owned by Zeek Logistics, which is a company owned by
Yonah Kalfa, who is a director and Chief Innovation Officer. We do not pay any rent or fee to use this
location.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>COVID-19
Supply Issues</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Slinger
Bag is a business fully reliant on China based vendors for manufacture of its product. Throughout the course of 2022 the flow of production
was occasionally affected as the China government implemented regional lockdowns. As a company in the late part of 2021 we had anticipated
potential issues and made a conscious decision to over produce product to store at our warehouse locations to mitigate any enforced production
shutdowns. Over the course of 2022 and through the date of this report we have not experienced any significant supply chain issues in
the availability of our product.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gameface
is primarily a software based company. As a result of the nature of its business, in the time that that we owned Gameface we have not
seen any material impact on its business because of any Covid related issues.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ukraine
and Israel-Hamas Wars</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
impact of the Ukraine and Israel-Hamas wars has been limited on the Company with the direct impact being seen through those distributors bordering the
war zone who have seen a significant decline in demand.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
wars have not had a known direct impact on Gameface to date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Going
Concern</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
financial statements have been prepared on a going concern basis, which assumes we will be able to realize our assets and discharge its
liabilities in the normal course of business for the foreseeable future. We have an accumulated deficit and more losses are anticipated
in the ongoing development of the business. Accordingly, there is substantial doubt about our ability to continue as a going concern.
These financial statements do not include any adjustments related to the recoverability and classification of assets or the amounts and
classification of liabilities that might be necessary should we be unable to continue as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 63; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ability to continue as a going concern is dependent upon us generating profitable operations in the future and/or being able to obtain
the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they become due.
Management intends to finance operating costs over the next twelve months with existing cash on hand, loans from related parties, and/or
private placement of debt and/or common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
can be no assurance that sufficient funds required during the next year or thereafter will be generated from operations or that funds
will be available from external sources such as debt or equity financings or other potential sources. The lack of additional capital
resulting from the inability to generate cash flow from operations or to raise capital from external sources would force us to curtail
substantially or cease operations and would, therefore, have a material adverse effect on its business. Furthermore, there can be no
assurance that any such required funds, if available, will be available on attractive terms or that they will not have a significant
dilutive effect on our existing stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the Company&#8217;s fiscal quarter ended January 31, 2023, the Company divested PlaySight and 75% of its interest in Foundation Sports
as the required monthly cash burn became increasingly difficult to manage as inflation rose and the cost of manufacturing the Company&#8217;s
non-technological products grew. As a result, the Company sold PlaySight back to its original owners of in November 2022, and the Company
sold most (75%) of Foundation Tennis back to their original owners, with an option to purchase any remaining interests. The Company believes
these divestitures will bring about greater cash flow and result in a reduction in net loss from operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to overcome the circumstances that impact its ability to remain a going concern through a combination of the commencement of revenues,
with interim cash flow deficiencies being addressed through additional equity and debt financing. We anticipate raising additional funds
through public or private financing, strategic relationships or other arrangements in the near future to support its business operations;
however, we may not have commitments from third parties for a sufficient amount of additional capital. We cannot be certain that any
such financing will be available on acceptable terms, or at all, and its failure to raise capital when needed could limit its ability
to continue its operations. Our ability to obtain additional funding will determine its ability to continue as a going concern. Failure
to secure additional financing in a timely manner and on favorable terms would have a material adverse effect on our financial performance,
results of operations and stock price and require it to curtail or cease operations, sell off its assets, seek protection from its creditors
through bankruptcy proceedings, or otherwise. Furthermore, additional equity financing may be dilutive to the holders of shares of our
common stock, and debt financing, if available, may involve restrictive covenants, and strategic relationships, if necessary, to raise
additional funds, and may require that we relinquish valuable rights.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Legal
Proceedings</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 8, 2023, Oasis Capital, LLC (&#8220;Oasis&#8221;) filed a complaint against the Company in the United States District Court
for the Southern District of New York seeking damages (i) in the amount of $764,647.53 in for an alleged breach of the terms of the 8%
senior convertible note and the securities purchase agreement entered into between Oasis and the Company in connection with the Note
(as defined below), which in December 2021 was increased to $600,000 in principal amount (the &#8220;Note&#8221;) and (ii) an unspecified
amount of damage for an alleged breach of the exclusivity provisions of a term sheet that the Company and Oasis entered into on July
7, 2022 plus an actual damages in an amount to be proven at trial, interest and costs, reasonable attorney&#8217;s fees and such other
legal and equitable relief as the court deems just and proper. On June 30, 2023, the United States District Court for the Southern District
of New York granted the Company&#8217;s motion to dismiss this complaint but with leave to amended complaint. On July 31, Oasis filed
an amended complaint against the Company and its Chief Executive Officer, Mike Ballardie, seeking damages in an amount to be proven at
trial, interest and costs for breach of fiduciary duty and violations of Section 10(b) of the Securities and Exchange Act of 1934, as
amended, and Rule 10b-5 thereunder. The Company believes the claims made in the amended complaint are without merit and the Company and
Mike Ballardie are vigorously defending itself.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
for the Oasis lawsuit against Mike Ballardie, we know of no pending proceedings to which any director, member of senior management, or
affiliate is either a party adverse to us or has a material interest adverse to us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None
of our executive officers or directors have (i) been involved in any bankruptcy proceedings within the last five years, (ii) been convicted
in or has pending any criminal proceedings (other than traffic violations and other minor offenses), (iii) been subject to any order,
judgment or decree enjoining, barring, suspending or otherwise limiting involvement in any type of business, securities or banking activity
or (iv) been found to have violated any Federal, state or provincial securities or commodities law and such finding has not been reversed,
suspended or vacated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ak_002"></span>DIRECTORS
AND EXECUTIVE OFFICERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
executive officers and directors and their respective ages as of October 31, 2023 are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 28%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Age</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 56%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Positions
    and Offices*</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mike
    Ballardie</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">62</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">President,
    Chief Executive Officer, Treasurer and Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Juda
    Honickman</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Marketing Officer</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mark
    Radom</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">55</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
    Counsel</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yonah
    Kalfa</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Innovation Officer and Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kirk
    Taylor</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">43</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stephen
    Crummey</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">79</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rodney
    Rapson</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*Paul
McKeown, our former chief business integration officer, resigned in January 2023, and Tom Dye&#8217;s employment agreement terminated
on April 30, 2023. Mr. Dye and Mr. McKeown both continue to provide services to the Company as outside consultants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 64; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 17, 2022, Gabriel Goldman and Rohit Krishnan resigned from the board of directors of the Company. Gabriel and Rohit were members
of the audit and compensation committees. Gabriel Goldman was a member of the Company&#8217;s Nominating and Corporate Governance Committee.
Neither Gabriel nor Rohit advised the Company of any disagreement with the Company on any matter relating to its operations, policies
or practices. On July 14, 2023, Mssrs. Crummey and Rapson joined the Company&#8217;s board of directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
directors named above will serve until the next annual meeting of the shareholders or until his resignation or removal from office. Thereafter,
directors are anticipated to be elected for one-year terms at the annual shareholders&#8217; meeting. Officers will hold their positions
pursuant to their respective service agreements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Set
forth below is a brief description of the background and business experience of our executive officers and directors for the past five
years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Mike
Ballardie</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mike
Ballardie has served as our President, Chief Executive Officer and a Director since June 2019. Mike is an experienced and widely recognized
tennis industry leader with 35 years of experience in tennis as a player, a coach and business leader. Mike started his tennis business
career at Wilson in the late 1980s where he spent 11 years growing and ultimately leading Wilson&#8217;s Europe, Middle East and Africa
Racquet sports division.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2002, Mike joined Prince Sports Europe as vice-president and managing director and stayed in this role through 2012. In 2003, Mike was
part of the management buyout team that acquired the Prince brand from Benetton Sports in partnership with a private equity group. In
2007, after a highly successful business turnaround the business was sold with the management team in place to another U.S. based private
equity group.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2013, Mike became the Chief Executive Officer of Prince Global Sports, a role in which he stayed until 2016.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
Prince Global Sports, Mike owned and operated FED Sports Consulting where he managed all aspects of a major restructuring project involving
Waitt Brands (a holding company for Prince Global Sports) and Trilium Ltd (UK), a childcare business, from 2018 to 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Immediately
prior to joining Prince Sports, Mike worked for VF Corp., where he built the international business for their JanSport brand from scratch.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mike
also served for many years as an Executive Board Director for the Tennis Industry Association (TIA) both in the USA and in the UK. Mike
has been at the forefront of many of the most successful tennis racket innovations over this period and highly regarded across this industry
sector.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 65; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Juda
Honickman</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Juda
Honickman is Chief Marketing Officer for Slinger Bag Inc. Juda joined Slinger Bag Inc in October 2017 to lead product design and overall
strategy for the Company&#8217;s pre-sale crowdfunding initiative which exceeded its goal by 2,600%. He is responsible for overseeing
the planning, development and execution of the Company&#8217;s marketing and advertising initiatives along with ensuring that the Company&#8217;s
offering and brand messaging is distributed across all channels and is effectively targeting audiences in order to meet sales objectives.
In his role, Juda oversees the global communications of Slinger&#8217;s brand, including consumer insights, digital marketing, creative
development, agency management, marketing effectiveness, social responsibility, sponsorships, media and employee communications. Juda
previously served as the Director of Marketing and Strategy for a global legal tech company and before that oversaw marketing and sales
for an innovative consumer tech business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Mark
Radom</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
September 2019, Mark Radom has been general counsel of Slinger Bag Inc. Mr. Radom has also served as general counsel of The Greater Cannabis
Company, Inc. and from February 2010 through July 2015, general counsel and chief carbon officer of Blue Sphere Corporation. From 2009
through 2010, Mr. Radom was managing director of Carbon MPV Limited, a Cyprus company focused on developing renewable energy and carbon
credit projects. From 2007 to 2009, Mr. Radom was general counsel and chief operating officer of Carbon Markets Global Limited, a London-based
carbon credit and renewable energy project developer. Mr. Radom has extensive experience in business development in the renewable energy
and carbon credit sectors. He has sourced over $100,000,000 in renewable energy, industrial gas and carbon credit projects and managed
many complex aspects of their implementation. He was legal counsel for a number of carbon and ecological project developers and was responsible
for structuring joint ventures and advising on developing projects through the CDM/JI registration cycle and emission reduction purchase
agreements under the auspices of the Kyoto Protocol. Prior to this, he worked on Wall Street and in the City of London as a U.S. securities
and capital markets lawyer where he represented sovereigns, global investment banks and fortune 500 companies across a broad range of
capital raising and corporate transactions. He is a graduate of Duke University and Brooklyn Law School. Mr. Radom is admitted to practice
law in New York and New Jersey and speaks fluent Russian.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Yonah Kalfa</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yonah
Kalfa joined Slinger Bag as its Chief Innovation Officer in September 2020. Prior to joining Slinger Bag, Mr. Kalfa owned and operated
NA Dental, a company active in the dental supply business since 2010. Mr. Kalfa is a director of Pharmedica Ltd., Plaqless Ltd., Dusmit
Ltd. and Parasonic Ltd.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Kirk Taylor</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kirk
is the Chief Financial Officer of American Resources Corporation where he conducts all tax and financial accounting roles of the organization,
and has substantial experience in tax credit analysis and financial structure. Kirk&#8217;s main focus over his 13 years in public accounting
had been auditing, tax compliance, financial modeling and reporting on complex real estate and business transactions utilizing
numerous federal and state tax credit and incentive programs. Prior to joining American Resources Corporation, Kirk was Chief Financial
Officer of Quest Energy, Inc., ARC&#8217;s wholly-owned subsidiary. Prior to joining Quest Energy in 2015, he was a Manager at K.B. Parrish
&amp; Co. LLP where he worked since 2014. Prior to that, he worked at Katz Sapper Miller since 2012 as Manager. In addition, Kirk is
an instructor for the CPA examination and has spoken at several training and industry conferences. He received a BS in Accounting and
a BS in Finance from the Kelley School of Business at Indiana University, Bloomington Indiana and is currently completing his Master of Business Administration from the University of Saint Francis at Fort Wayne, Indiana. Kirk serves his community in various ways
including as the board treasurer for a community development corporation in Indianapolis, Indiana. Kirk does not have any family relationships
with any of the Company&#8217;s directors or executive officers. There are no arrangements or understandings between Kirk and any other
persons pursuant to which he was selected as an officer. He has no direct or indirect material interest in any transaction required to
be disclosed pursuant to Item 404(a) of Regulation S-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Stephen
Crummey</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stephen
has served as the senior vice president of Investor Relations at NuEra Capital Corporation since August 2022. Previously, Stephen was
(i) a partner in Covid Rapid Exam from January 2021 to September 2022, (ii) an advisor to IdentifySensors Biologics from September 2021
through August 2022, (iii) an advisor to Cmind AI from 2019 to April 2021 and (iv) chairman of CyVision Technologies, Inc. from August
2017 through March 2021. Stephen does not have any family relationships with any of the Company&#8217;s directors or executive officers.
There are no arrangements or understandings between Stephen and any other persons pursuant to which he was selected as an officer. He
has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 66; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Rodney
Rapson</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Rapson has served as the chief executive officer of Inspiretek Pty Ltd since November 2022, managing director of PlaySight Europe from
January 2027 through January 2022 and managed Base Tennis Academy from September 2010 through December 2022. Rodney does not have any
family relationships with any of the Company&#8217;s directors or executive officers. There are no arrangements or understandings between
Rodney and any other persons pursuant to which he was selected as an officer. He has no direct or indirect material interest in any transaction
required to be disclosed pursuant to Item 404(a) of Regulation S-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TERM
OF OFFICE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
directors hold office until the next annual meeting of the shareholders of the Company and until their successors have been duly elected
and qualified. The Company&#8217;s Bylaws provide that the Board of Directors will consist of no less than three members. Officers are
elected by and serve at the discretion of the Board of Directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DIRECTOR
INDEPENDENCE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors is currently composed of five members. With the exception of Mike Ballardie and Yonah Kalfa, we have determined that
all of the directors are independent as such term is defined under The Nasdaq Stock Market Rules (the &#8220;Nasdaq Rules&#8221;). We
have also determined that as a result of being employed as executive officers, Mssrs. Ballardie and Kalfa are not independent under the
Nasdaq Rules.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table identifies the independent and non-independent current board and committee members:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name:</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Independent</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Audit</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nominating</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mike
    Ballardie</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yonah
    Kalfa</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Steven
    Crummey</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kirk
    Taylor</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rodney
    Rapson</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>COMMITTEES
OF THE BOARD OF DIRECTORS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Audit
Committee</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
has the primary responsibility for the financial statements and the reporting process, including the system of internal controls. The
Audit Committee reviews the Company&#8217;s financial reporting process on behalf of the Board and administers our engagement of the
independent registered public accounting firm. The Audit Committee meets with the independent registered public accounting firm, with
and without management present, to discuss the results of its examinations, the evaluations of our internal controls, and the overall
quality of our financial reporting. Kirk P. Taylor, Stephen Crummey and Rodney Rapson who each satisfies the &#8220;independence&#8221;
requirements of Rule 10A-3 under the Exchange Act and Nasdaq&#8217;s rules, serve on our audit committee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Audit
Committee Financial Expert</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have determined that Kirk Taylor is qualified as an Audit Committee Financial Expert, as that term is defined under the rules of the
SEC and in compliance with the Sarbanes-Oxley Act of 2002.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation
Committee</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
function of the Compensation Committee is to determine the compensation of our executive officers. The Compensation Committee has the
power to set performance targets for determining periodic bonuses payable to executive officers and may review and make recommendations
with respect to shareholder proposals related to compensation matters. Additionally, the Compensation Committee is responsible for administering
the 2020 Global Incentive Plan. Rodney Rapson is the sole independent director on the compensation committee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 67; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nominating
and Corporate Governance Committee</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
responsibilities of the Nominating and Corporate Governance Committee include the identification of individuals qualified to become Board
members, the selection of nominees to stand for election as directors, the oversight of the selection and composition of committees of
the Board, establishing procedures for the nomination process including procedures, oversight of possible conflicts of interests involving
the Board and its members, developing corporate governance principles, and the oversight of the evaluations of the Board and management.
The Nominating and Corporate Governance Committee has not established a policy with regard to the consideration of any candidates recommended
by shareholders. If we receive any shareholder recommended nominations, the Corporate Governance Committee will carefully review the
recommendation(s) and consider such recommendation(s) in good faith.</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kirk
Taylor and Rodney Rapson who satisfy the &#8220;independence&#8221; requirements of Nasdaq&#8217;s rules, serve on our compensation committee
upon their appointment to the board, with Mr. Rapson serving as the chairman.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
and Committee Meetings in the 2023 Fiscal Year</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the 2023 fiscal year, the Board acted by written consent in lieu of having any meetings and there were no committee meetings insofar
as the committees were not established until July 2023, which was after the 2023 fiscal year had ended.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
Diversity</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
we do not have a formal policy on diversity, our Board considers diversity to include the skill set, background, reputation, type and
length of business experience of our Board members as well as a particular nominee&#8217;s contributions to that mix. Our Board believes
that diversity brings a variety of ideas, judgments and considerations that benefit the Company and its shareholders. Although there
are many other factors, the Board seeks individuals with experience on public company boards or the investment community, experience
on operating growing businesses, and experience with online universities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section
16(a) Beneficial Ownership Reporting Compliance</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
16(a) of the Exchange Act requires our directors, executive officers, and persons who own more than 10% of our common stock to file initial
reports of ownership and changes in ownership of our common stock and other equity securities with the SEC. These individuals are required
by the regulations of the SEC to furnish us with copies of all Section 16(a) forms they file. Due to administrative error, the required
forms were filed prior to October 31, 2023, but not prior to the deadline for such forms.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DIRECTOR
COMPENSATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
non-employee director will receive 3,750 shares of common stock on the anniversary date each non-employee director was appointed
to the Board. In the event, a director should resign from the Board mid-year, such director would receive a pro rata issuance of common
stock at their anniversary date based on the number of days of service since their prior anniversary date. No fractional shares will
be issued to non-employee director, and any calculation resulting in a fractional share will be rounded up to the next whole share. Mssrs.
Goldman and Krishnan did not receive any compensation for or in respect of the period during which they served as directors of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>COMPENSATION
COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None
of our officers currently serves, or in the past year has served, as a member of the compensation committee of any entity that has one
or more officers serving on our board of directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 68; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RISK
OVERSIGHT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board will oversee a company-wide approach to risk management. Our Board will determine the appropriate risk level for us generally,
assess the specific risks faced by us and review the steps taken by management to manage those risks. While our Board will have ultimate
oversight responsibility for the risk management process, its committees will oversee risk in certain specified areas.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Specifically,
our compensation committee will be responsible for overseeing the management of risks relating to our executive compensation plans and
arrangements, and the incentives created by the compensation awards it administers. Our audit committee will oversee management of enterprise
risks and financial risks, as well as potential conflicts of interests. Our Board of Directors will be responsible for overseeing the
management of risks associated with the independence of our Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CODE
OF BUSINESS CONDUCT AND ETHICS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
has not adopted a code of ethics that applies to its principal executive officers, principal financial officer, principal accounting
officer or controller, or persons performing similar functions as the Company has only recently commenced operations. Our Board
adopted a code of business conduct and ethics that applies to our directors, officers and employees (the &#8220;Code of Business
Conduct and Ethics&#8221;), A copy of the Code of Business Conduct and Ethics is available on the Company&#8217;s website. The Company intends
to disclose on their website any amendments to the Code of Business Conduct and Ethics and any waivers of the Code of Business
Conduct and Ethics that apply to their principal executive officer, principal financial officer, principal accounting officer,
controller, or persons performing similar functions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CERTAIN
LEGAL PROCEEDINGS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
director, nominee for director, or executive officer of the Company has appeared as a party in any legal proceeding material to an evaluation
of his ability or integrity during the past ten years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNIFICANT
EMPLOYEES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
than our officers and directors, we currently have one other person who became in February 2022 what we consider to be a significant
employee, Jaluluddin Shaik, President of Gameface.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jalaluddin
Shaik founded and became the chief executive officer of Gameface in 2017. Prior to founding Gameface, Mr. Shaik led product teams at
some of the world&#8217;s biggest brands, including Telstra, Sony, and Apple. While at Telstra, Shaik led the creation of the Telstra
video streaming platform &#8216;Presto,&#8217; that reaches over 10M Australians. In addition to his role at Telstra, Shaik was the design
lead on the Apple airplay technology integration to 80% of Tier1 Audio OEM (Original Equipment Manufacturers) such as Denon, Bose, Pioneer,
Yamaha, leading a team of 30 engineers. Previously (2003-2010), Shaik built and deployed various end to end video decoding solutions
at Sony and Intel. Mr. Shaik is a graduate of Visvesvaraya Technological University with a bachelor&#8217;s degree in computer science
with a major in machine learning.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ak_003"></span>EXECUTIVE
COMPENSATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Summary
Compensation Table</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below summarizes all compensation awarded to, earned by, or paid to, our then Officers for all services rendered in all
capacities to us for the fiscal years ended as indicated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 69; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid">Name and Principal Position</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Year ended April 30</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Salary ($)</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Bonus ($)</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Share Awards ($)(1)</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Non-Equity Incentive Plan Compensation ($)</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">All other compensation ($)</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Total ($)</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 37%; text-align: justify">Mike Ballardie (1)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">2023</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">570,169</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">300,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">285,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">105,318</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">1,260,487</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2022</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">571,123</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">277,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,100,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">375,748</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,324,371</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Judah Honickman (2)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">179,502</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">87,400</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27,144</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">294,046</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2022</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">179,312</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">72,150</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">190,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,454</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">451,916</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Paul McKeown (3)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">366,023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">77,411</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">443,434</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2022</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">344,048</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">83,250</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">427,298</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Tom Dye (4)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">160,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">40,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,902</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">216,902</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2022</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">160,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">37,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25,647</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">222,647</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Mark Radom (5)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">150,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">178,500</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2022</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">114,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">23,241</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">137,241</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yonah Kalfa (6<b>) </b></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">495,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">495,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2022</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,100,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">593,250</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,693,250</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Jason Seifert (7)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">35,833</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,442</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">44,275</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Calculated
    in accordance with ASC Topi c 718, consistent with the Company&#8217;s financial statements.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Ballardie has served as the Company&#8217;s Principal Executive Officer and as Chairman of the Board of Directors since September
    16, 2019 and has an address at 2709 N. Rolling Road, Suite 138, Windsor Mill, MD 21244.</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Honickman has served as the Company&#8217;s Chief Marketing Officer since September 16, 2019 and has an address at 2709 N. Rolling
    Road, Suite 138, Windsor Mill, MD 21244.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul
    McKeown served as the Company&#8217;s Chief Financial Officer from April 30, 2020 through July 6, 2021 and from July 6, 2021 to January
    31, 2023 as the Company&#8217;s Chief Business Integration Officer and had an address at 2709 N. Rolling Road, Suite 138, Windsor
    Mill, MD 21244.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tom
    Dye served as the Company&#8217;s Chief Operating Officer from April 30, 2020 through April 30, 2023 and had an address at 2709 N.
    Rolling Road, Suite 138, Windsor Mill, MD 21244.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mark
    Radom has served as the Company&#8217;s General Counsel since September 16, 2019 and has an address at 2709 N. Rolling Road, Suite
    138, Windsor Mill, MD 21244.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yonah
    Kalfa has served as the Company&#8217;s Chief Innovation Officer since September 7, 2020 and has an address at 2709 N. Rolling Road,
    Suite 138, Windsor Mill, MD 21244.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jason
    Seifert served as the Company&#8217;s Chief Financial Officer from July 6, 2021 through June 25, 2022 and had an address at 2709
    N. Rolling Road, Suite 138, Windsor Mill, MD 21244.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SERVICE
AGREEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is a party to service agreements with each of its executive officers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Mike
Ballardie. </i>On April 6, 2020, we entered into a service agreement with our Chief Executive Officer, Mike Ballardie, which was amended
on November 1, 2020. Pursuant to the service agreement, Mr. Ballardie will serve as our Chief Executive Officer for a period of five
years. During the five-year term, Mr. Ballardie receives a monthly base salary of $50,000 and a bonus payment at a minimum of 50% of
the annual base salary. We also issued Mr. Ballardie warrants to purchase 500,000 shares of our common stock. The warrants were exercisable
at issuance at an exercise price of $0.01 per share and have an expiration date of April 6, 2030. We also provide standard indemnification
and directors&#8217; and officers&#8217; insurance. We may terminate Mr. Ballardie&#8217;s employment with cause (as defined under the
agreement) and without cause by giving at least 180 days prior written notice. If we terminate Mr. Ballardie without cause, all his unvested
stock and option compensation of any nature will vest without any further action. Mr. Ballardie may resign for good reason (as defined
under the agreement) or without good reason by giving at least 180 days prior written notice. If we terminate Mr. Ballardie without cause
or he resigns for good reason, we must pay severance in an amount in lieu of base salary and benefits that would have accrued to Mr.
Ballardie for the greater of (a) the unexpired portion of the term of the agreement or (b) two years, to be paid in full within 30 days
of termination. In addition, vesting of all unvested common or preferred shares and options and warrants will continue for 12 months
following such termination if we terminate Mr. Ballardie without cause or he resigns for good reason. Mr. Ballardie is also subject to
standard confidentiality and non-competition provisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 70; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Tom
Dye. </i>On April 30, 2020, we entered into a service agreement with our Chief Operating Officer, Tom Dye. Pursuant to the service agreement,
Mr. Dye served as our Chief Operating Officer for a period of three years. During the three-year term, Mr. Dye received an annual base
salary of $120,000 and a bonus payment at a minimum of 25% of the annual gross base salary. We agreed to issue Mr. Dye warrants to purchase
a total of 125,000 shares of common stock to be issued at the time that certain performance goals are met. The warrants that were issued
to Mr. Dye on April 30, 2020 are exercisable at issuance at an exercise price of $3.00 per share and have an expiration date of April
30, 2030. The warrants that were awarded to Mr. Dye on February 9, 2021 are exercisable at issuance at an exercise price of $39.40 per
share and have an expiration date of February 9, 2031. We also agreed to issue a one-time bonus of 150,000 shares of common stock to
Mr. Dye after the value of the Company&#8217;s outstanding stock equals $100 million. The Company will also provide standard indemnification
and directors&#8217; and officers&#8217; insurance. The Company may terminate Mr. Dye&#8217;s employment with cause (as defined under
the agreement) and without cause by giving at least 60 days prior written notice. If we terminate Mr. Dye without cause, all Mr. Dye&#8217;s
unvested stock and option compensation of any nature will vest without any further action, and we will pay two years base salary severance
within 30 days of termination. In addition, vesting of all unvested common or preferred shares and options and warrants will continue
for 12 months following such termination. Mr. Dye may resign for good reason (as defined under the agreement) or without good reason
by giving at least 30 days prior written notice. Mr. Dye is also subject to standard confidentiality and non-competition provisions.
Since 30 April 2023, Mr. Dye has operated as a consultant to the company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Paul
McKeown. </i>On July 5, 2021, we entered into a service agreement with our former Chief Financial Officer, Paul McKeown. Pursuant to
the service agreement, Mr. McKeown served as our Chief Business Integration Officer until January 31, 2023, when he resigned. During
the term of this agreement, Mr. McKeown received a base salary at an hourly rate of $150 per hour and an annual performance bonus of
at least 30% of the annual gross base salary. and We also issued Mr. McKeown warrants to purchase 150,000 shares of common stock. The
warrants were exercisable at issuance at an exercise price of $0.01 per share and have an expiration date of The Company will also provide
standard indemnification and directors&#8217; and officers&#8217; insurance. Mr. McKeown was also subject to standard confidentiality
and non-competition provisions. Since January 2023, Mr. McKeown has operated as a consultant to the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Juda
Honickman. </i>On April 30, 2020, we entered into a service agreement with Nest Consulting Inc., a Delaware corporation, owned by our
Chief Marketing Officer, Juda Honickman. Pursuant to the service agreement, Mr. Honickman will serve as our Chief Marketing Officer for
a period of three years. During the three-year term, Mr. Honickman receives an annual base salary of $102,000 and a bonus payment at
a minimum of 50% of his annual base salary. We also issued warrants to purchase 250,000 shares of common stock to Mr. Honickman. The
warrants were exercisable at issuance at an exercise price of $3.00 per share and have an expiration date of April 30, 2030. The Company
will also provide standard indemnification and directors&#8217; and officers&#8217; insurance. The Company may terminate Mr. Honickman&#8217;s
employment with cause (as defined under the agreement) and without cause by giving at least 60 days prior written notice. If we terminate
Mr. Honickman without cause, all Mr. Honickman&#8217;s unvested stock and option compensation of any nature will vest without any further
action and will pay two years base salary severance within 30 days of termination. In addition, Mr. vesting of all unvested common or
preferred shares and options and warrants will continue for 12 months following termination. Mr. Honickman may resign for good reason
(as defined under the agreement) or without good reason by giving at least 30 days prior written notice. Mr. Honickman is also subject
to standard confidentiality and non-competition provisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Mark
Radom. </i>On February 1, 2022, we entered into the second amended and restated service agreement with our General Counsel, Mark Radom.
Pursuant to the service agreement, Mr. Radom will serve as General Counsel for a period of two. During the two-year term, we agreed to
pay Mr. Radom a monthly base salary of $12,500 and a bonus payment at a minimum of 25% of the annual base salary. The Company will also
provide standard indemnification and directors&#8217; and officers&#8217; insurance. The Company may terminate Mr. Radom&#8217;s employment
with cause (as defined under the agreement) and without cause by giving at least 60 days prior written notice. If we terminate Mr. Radom
without cause, all Mr. Radom&#8217;s unvested stock and option compensation of any nature will vest without any further action, and we
will pay two years base salary severance within 30 days of termination. In addition, vesting of all unvested common or preferred shares
and options and warrants will continue for 12 months following termination. Mr. Radom may resign for good reason (as defined under the
agreement) or without good reason by giving at least 120 days prior written notice. Mr. Radom is also subject to standard confidentiality
and non-competition provisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Yonah
Kalfa. </i>On September 7, 2020, we entered into a service agreement with our Chief Innovation Officer, Yonah Kalfa. Pursuant to the
service agreement, Mr. Kalfa will serve as our Chief Innovation Officer for a period of three years. During the three-year term, Mr.
Kalfa receives an annual base salary of 1,162,800 Israeli New Shekel (approximately $350,000) and a bonus payment at a minimum of 25%
of the annual gross base salary. Mr. Kalfa agreed to defer receipt of his base salary until otherwise agreed in writing. The Company
will also provide standard indemnification and directors&#8217; and officers&#8217; insurance. The Company may terminate Mr. Kalfa&#8217;s
employment with cause (as defined under the agreement) and without cause by giving at least 60 days prior written notice. If we terminate
Mr. Kalfa without cause, we will pay two years base salary severance within 30 days of termination. Mr. Kalfa may resign for good reason
(as defined under the agreement) or without good reason by giving at least 30 days prior written notice. Mr. Kalfa is also subject to
standard confidentiality and non-competition provisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 71; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DIRECTOR
COMPENSATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth director compensation for the years ended April 30, 2023 and 2022:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 43%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Year
    Ended April 30</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fees
    earned or paid in cash ($)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
    Awards ($)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    ($)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mike
    Ballardie*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kirk
    Taylor*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stephen
    Crummey</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rodney
    Rapson</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>*</i></b>The
Company intended to award Mike Ballardie and Kirk Taylor 150,000 shares of common stock as compensation for their service as directors
for the fiscal year ended April 30, 2023, but has not yet done so. While the Company intended to issue each director 150,000 shares
of its common stock per annum as compensation for serving as directors, it has not yet done so.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Stock
Options/SAR Grants</i></b>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ak_004"></span>CERTAIN
RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 14, 2022, the Company entered into two loan agreements with Yonah Kalfa and Naftali Kalfa (the &#8220;Lenders&#8221;), each for
$1,000,000, pursuant to which the Company received a total amount of $2,000,000. The loans bear interest at a rate of 8% per annum and
are required to be repaid in full by July 31, 2024 or such other date as may be accepted by the Lenders. The Company is not permitted
to make any distribution or pay any dividends unless or until the loans are repaid in full.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
were $1,655,966 and $1,953,842 in outstanding borrowings from the Company&#8217;s related parties for the period ended July 31, 2023
and 2022, respectively. Accrued interest due to related parties as of July 31, 2023 and 2022 amounted to $917,957 and $917,957, respectively</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 6, 2023, we sold certain of our inventory including all components, parts, additions and accessions thereto to Yonah Kalfa and
Naftali Kalfa who immediately consigned it back to us in exchange for a payment of $103 per ball launcher we sell until we have paid
them an aggregate total of $2,092,700, which represents payment in full of the principal amounts of the Loan Agreements (as defined below)
and certain other expenses they incurred in connection with the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Policies
and Procedures for Related Person Transactions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors intends to adopt a written related person policy to set forth the policies and procedures for the review and approval
or ratification of related person transactions. This policy will cover any transaction, arrangement or relationship, or any series of
similar transactions, arrangements or relationships in which we are to be a participant, the amount involved exceeds $100,000 and a related
person had or will have a direct or indirect material interest, including purchases of goods or services by or from the related person
or entities in which the related person has a material interest, indebtedness, guarantees of indebtedness and employment by us of a related
person.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director
Independence</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors has undertaken a review of the independence of each director. Based on information provided by each director concerning
his or her background, employment and affiliations, our board of directors has determined that Kirk Taylor, Steven Crummey and
Rodney Rapson, do not have a relationship that would interfere with the exercise of independent judgment in carrying out the responsibilities
of a director and that each of these directors is &#8220;independent&#8221; as that term is defined under the applicable rules and regulations
of the SEC and the listing standards of Nasdaq. In making these determinations, our board of directors considered the current and prior
relationships that each non-employee director has with our Company and all other facts and circumstances our board of directors deemed
relevant in determining their independence.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 72; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ak_005"></span>SECURITY
OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth certain information, as of October 31, 2023, with respect to any person (including any
&#8220;group&#8221;, as that term is used in Section 13(d)(3) of the Securities Exchange Act of 1934, as amended (the
&#8220;Exchange Act&#8221;)) who is known to us to be the beneficial owner of more than five percent (5%) of any class of our voting
securities, and as to those shares of our equity securities beneficially owned by each of our directors and executive officers and
all of our directors and executive officers as a group. Unless otherwise specified in the table below, such information, other than
information with respect to our directors and executive officers, is based on a review of statements filed with the Securities and
Exchange commission (the &#8220;Commission&#8221;) pursuant to Sections 13 (d), 13 (f), and 13 (g) of the Exchange Act with respect
to our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
number of shares of common stock beneficially owned by each person is determined under the rules of the Commission and the information
is not necessarily indicative of beneficial ownership for any other purpose. Under such rules, beneficial ownership includes any shares
as to which such person has sole or shared voting power or investment power and also any shares which the individual has the right to
acquire within sixty (60) days after October 31, 2023, through the exercise of any stock option, warrant or other right. Unless otherwise
indicated, each person has sole investment and voting power (or shares such power with his or her spouse) with respect to the shares
set forth in the following table. The inclusion herein of any shares deemed beneficially owned does not constitute an admission of beneficial
ownership of those shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table lists, as of October 31, 2023, the number of shares of common stock of our Company that are beneficially owned by (i)
each person or entity known to our Company to be the beneficial owner of more than 5% of the outstanding common stock; (ii) each officer
and director of our Company; and (iii) all officers and directors as a group. Information relating to beneficial ownership of common
stock by our principal shareholders and management is based upon information furnished by each person using &#8220;beneficial ownership&#8221;
concepts under the rules of the Securities and Exchange Commission. Under these rules, a person is deemed to be a beneficial owner of
a security if that person has or shares voting power, which includes the power to vote or direct the voting of the security, or investment
power, which includes the power to vote or direct the voting of the security. The person is also deemed to be a beneficial owner of any
security of which that person has a right to acquire beneficial ownership within 60 days. Under the Securities and Exchange Commission
rules, more than one person may be deemed to be a beneficial owner of the same securities, and a person may be deemed to be a beneficial
owner of securities as to which he or she may not have any pecuniary beneficial interest. Except as noted below, each person has sole
voting and investment power.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Common Stock</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: center">Name</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"># of Shares (1)</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">% of Class (1)</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Yonah Kalfa (3)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">57,237</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">0.5</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2672237 Ontario Ltd. (2)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31,312</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.3</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Mike Ballardie (3)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19,750</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.2</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Judah Honickman (3)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,750</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.1</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Kirk Taylor (3)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Rodney Rapson (3)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,876</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.1</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Mark Radom (3)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,941</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.1</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Steven Crummey (3)</p>
</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">-</p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">All current officers and directors as a group (6 persons) (3)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">137,239</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.3</td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial
    Ownership is determined in accordance with the rules of the Securities and Exchange Commission and generally includes voting or investment
    power with respect to securities. Shares of common stock subject to options, warrants, convertible debt or convertible preferred
    shares currently exercisable or convertible, or exercisable or convertible within 60 days are deemed outstanding for computing the
    percentage of the person holding such option or warrant but are not deemed outstanding for computing the percentage of any other
    person. Percentages are based on a total of shares of common stock outstanding on October 31, 2023, which was 2,372,803,
    and the shares issuable upon exercise of warrants and convertible debt, which is 8,157,949. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 73; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    connection with a note payable issued on June 1, 2019, Mont-Saic Investments received a warrant giving them the right to acquire
    33% of the outstanding shares of the Company for no charge, which amounted to a total of 20,345 shares issuable. Mont-Saic
    subsequently sold it full right, title and interest in that right to 2672237 Ontario. 2672237 Ontario holds an additional 10,967
    shares of the Company&#8217;s common stock from debt to equity conversions and the previous exercise of warrants related to debt
    issuances.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    above officers and directors were granted an aggregate total of 2,813, 1,125, and 2,750 warrants on April 30, 2020,
    February 9, 2021 and September 3, 2021, respectively, as compensation and bonuses. The April 30, 2020 warrants have an exercise price
    of $0.01 per share and the February 9, 2021 warrants have an exercise price of $4.00 per share for non-U.S. employees and
    $1,576 for U.S. employees. All of the warrants have a contractual life of 10 years from the date of issuance and are vested
    immediately upon grant. Additionally, Yonah Kalfa and Mark Radom have 57,237 and 66 shares of common stock of the Company,
    respectively.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Securities
authorized for issuance under equity compensation plans.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below provides information regarding all compensation plans as of the end of the most recently completed fiscal year (including
individual compensation arrangements) under which equity securities of the registrant are authorized for issuance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 11, 2020, the Board of Directors of the Company approved the Slinger Bag Inc. Global Share Incentive Plan (2020), or the 2020
Plan, which was approved by stockholders holding in the aggregate 19,994,700 shares of the Company&#8217;s common stock, or approximately
75.4% of the Company&#8217;s common stock outstanding on such date. The 2020 Plan provides for the grant of awards which are incentive
stock options (&#8220;ISOs&#8221;), non-qualified stock options (&#8220;NQSOs&#8221;), unrestricted stock, restricted stock, restricted
stock units, performance stock and other equity-based and cash awards or any combination of the foregoing, to eligible key management
employees, non-employee directors, and non-employee consultants of the Company or any of its subsidiaries (each a &#8220;participant&#8221;)
(however, solely employees of the Company and its subsidiaries are eligible for incentive stock option awards).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has reserved a total of 37,500 shares of common stock for issuance under awards to be made under the 2020 Plan, all of which
may, but need not, be issued in connection with ISOs. As of October 31, 2023, there are </span><span style="font-family: Times New Roman; font-size: 10pt">27,000
shares of common stock subject to outstanding awards and approximately 10,500 shares of common stock remain available under the 2020
Plan for future awards.</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To the extent that an award
lapses, expires, is canceled, is terminated unexercised or ceases to be exercisable for any reason, or the rights of its holder
terminate, any shares subject to such award shall again be available for the grant of a new award. The 2020 Plan shall continue in
effect, unless sooner terminated, until the tenth anniversary of the date on which it was adopted by the Board of Directors
(except as to awards outstanding on that date). The Board of Directors in its discretion may terminate the 2020 Plan at any time
with respect to any shares for which awards have not theretofore been granted; provided, however, that the 2020 Plan&#8217;s
termination shall not materially and adversely impair the rights of a holder, without the consent of the holder, with respect to any
award previously granted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future
new hires, non-employee directors and additional non-employee consultants are eligible to participate in the 2020 Plan as well. The number
of awards to be granted to officers, non-employee directors, employees and non-employee consultants cannot be determined at this time
as the grant of awards is dependent upon various factors such as hiring requirements and job performance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td colspan="13" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Equity Compensation Plan Information</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Plan Category</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>securities to be</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>issued upon</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>exercise of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>outstanding options,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>warrants and rights</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(a)</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted-</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>price of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>outstanding</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>options,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>warrants</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>and rights</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(b)</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of securities</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>remaining available</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>for future issuance</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>under equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>compensation plans</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(excluding securities</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>reflected in column</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(a)) (c)</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left">Equity compensation plans approved by security holders</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">37,500</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Equity compensation plans not approved by security holders</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">61,258</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">404.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Total</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">61,258</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">404.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">37,500</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 74; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ak_006"></span>SELLING
STOCKHOLDERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
common stock being offered by the selling stockholders consists of those previously issued to the selling stockholders,
and those issuable to the selling stockholders, upon exercise of the Warrants. For additional information regarding the issuances
of those shares of common stock and warrants, see &#8220;Prospectus Summary &#8211; The Offering&#8221; above. We are registering the
shares of common stock in order to permit the selling stockholders to offer the shares for resale from time to time. Except for
the ownership of the shares of common stock and the Warrants, the Armistice Selling Stockholder has not had any material relationship
with us within the past three years. </span>Sapir LLC, the other selling stockholder (the &#8220;Sapir Selling Stockholder&#8221;)
has consulted for the Company since September 16, 2019. When we refer to the &#8220;selling stockholders&#8221; in this prospectus,
we mean the persons listed in the table below, and the pledgees, donees, transferees, assignees, successors, designees and others who
later come to hold any of the selling stockholders&#8217; interest in the common stock other than through a public sale.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below lists the selling stockholders and other information regarding the beneficial ownership of the shares of common stock
by the selling stockholders. The second column lists the number of shares of common stock beneficially owned by the selling stockholders,
based on its ownership of the shares of common stock and warrants, as of October 31, 2023, assuming exercise of the warrants held
by the selling stockholder on that date, without regard to any limitations on exercises.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
third column lists the shares of common stock being offered by this prospectus by the selling stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">In accordance with the terms
of a registration rights agreement with the Armistice Selling Stockholder, this prospectus generally covers the resale of the
sum of (i) the number of shares of common stock issued to the Armistice Selling Stockholder in the &#8220;Prospectus Summary &#8211;
The Offering&#8221; described above and (ii) the maximum number of shares of common stock issuable upon exercise of the related warrants,
determined as if the outstanding warrants were exercised in full as of the trading day immediately preceding the date this registration
statement was initially filed with the SEC, each as of the trading day immediately preceding the applicable date of determination and
all subject to adjustment as provided in the registration right agreement, without regard to any limitations on the exercise of the warrants.
The fourth column assumes the sale of all of the shares offered by the selling stockholders pursuant to this prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">We cannot advise you as to whether
the selling stockholders will in fact sell any or all of such common stock or Warrants. In addition, the selling stockholders
may sell, transfer or otherwise dispose of, at any time and from time to time, the common stock and warrants in transactions exempt
from the registration requirements of the Securities Act after the date of this prospectus. For purposes of this table, we have assumed
that the selling stockholders will have sold all of the securities covered by this prospectus upon the completion of the offering.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Under the terms of the warrants,
the Armistice Selling Stockholder may not exercise the warrants to the extent such exercise would cause the Armistice Selling
Stockholder, together with its affiliates and attribution parties, to beneficially own a number of shares of common stock which would
exceed 4.99% or 9.99%, as applicable, of our then outstanding common stock following such exercise, excluding for purposes of such determination
shares of common stock issuable upon exercise of such warrants which have not been exercised. The number of shares in the second and
fourth columns do not reflect this limitation. The selling stockholders may sell all, some or none of their shares in this offering.
See &#8220;Plan of Distribution.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The table below reflects the
1:40 reverse stock split that was effected on September 25, 2023 and each fractional share resulting from such reverse stock split held
by the Armistice Selling Stockholder was rounded up to the next whole share pursuant to the warrant agreements.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 75; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Name of Selling Stockholder</td>
    <td>&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Number of Shares of Common Stock Beneficially Owned Prior to Offering</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><sup>&#160;</sup></td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Shares of Common Stock Offered Hereby</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><sup>&#160;</sup></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Number of Shares of Common Stock Owned After Offering</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><sup>&#160;</sup></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">%</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><sup>&#160;</sup></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Armistice Capital, LLC<sup>(1)</sup></span></td>
    <td style="width: 2%">&#160;</td><td style="text-align: right; width: 1%">&#160;</td>
    <td style="text-align: right; width: 12%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,967,831
    </span></td><td style="text-align: right; width: 1%"><sup>(2)</sup></td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: right">&#160;</td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,141,399
                                            </span></td><td style="width: 1%; text-align: right"><sup>(3)</sup></td><td style="text-align: right; width: 2%">&#160;</td>
    <td style="width: 1%; text-align: right">&#160;</td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0 <sup></sup></span></td><td style="width: 1%; text-align: right"><sup>(4)</sup></td><td style="text-align: right; width: 2%">&#160;</td>
    <td style="width: 1%; text-align: right">&#160;</td><td style="width: 10%; text-align: right">-</td><td style="width: 1%; text-align: right"><sup>(5)</sup></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sapir LLC<sup>(6)</sup></span></td>
    <td>&#160;</td><td style="text-align: right">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">201 </span></td><td style="text-align: right"><sup>(7)</sup></td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td><td style="text-align: right">224,472</td><td style="text-align: right"><sup>&#160;</sup></td><td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td><td style="text-align: right">201</td><td style="text-align: right"><sup>&#160;</sup></td><td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td><td style="text-align: right">5.5</td><td style="text-align: right"><sup>&#160;</sup></td></tr>
  </table>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<!-- Field: Rule-Page --><div style="width: 15%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-
Less than 1%</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    securities reported herein are held by Armistice Capital Master Fund Ltd., a Cayman Islands exempted company (the &#8220;Master Fund&#8221;),
    and may be deemed to be indirectly beneficially owned by: (i) Armistice Capital , LLC (&#8220;Armistice Capital&#8221;), as the
    investment manager of the Master Fund; and (ii) Steven Boyd, as the Managing Member of Armistice Capital. Armistice Capital and
    Steven Boyd disclaim beneficial ownership of the securities except to the extent of their respective pecuniary interests therein.
    The address of the Master Fund is c/o Armistice Capital, LLC, 510 Madison Ave, 7th Floor, New York, NY 10022.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    of October 31, 2023, the Armistice Selling Stockholder holds (i) 0 shares of our common stock, and (ii) Warrants exercisable
    for 5,141,399 shares of our common stock and subject to a 4.99% Beneficial Ownership Limitation, consisting of (i) 1,410,151 shares
    of common stock issuable upon the exercise of warrants issued on September 28, 2022 each at an exercise price of $3.546 per
    share with a term of five years, (ii) 3,109,563 shares of common stock issuable upon the exercise of warrants issued on September
    28, 2022 each at an exercise price of $3.546 per share with a term of seven and one half years, (iii) 452,489 shares of our
    common stock issuable upon the exercise of warrants issued on January 6, 2023 each at an exercise price of $3.546 per share
    with a term of five and one half years, and (iv) 169,196 shares of common stock issuable upon the exercise of warrants issued on
    October 11, 2023 each at an exercise price of $1.90 per share with a term of five and one half years. Under the terms of the
    Registration Rights Agreement between the Company and the Armistice Selling Stockholder, we are obligated to file this registration
    statement registering all of the shares of our common stock held by the Armistice Selling Stockholder and shares of our common
    stock underlying the Warrants. Under the terms of the Warrants, the Armistice Selling Stockholder shall not have the right
    to exercise any portion of such Warrants, to the extent that after giving effect to such issuance the Armistice Selling Stockholder
    would beneficially own in excess of 9.99% of the number of shares of our common stock outstanding immediately after giving effect
    to the issuance of shares of common stock issuable upon exercise of the Warrants. Under the terms of certain warrants, the
    Beneficial Ownership Limitation is 4.99%, and under the terms of certain other warrants, the Beneficial Ownership Limitation is
    9.99%.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">(3)</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">This is the number of shares of common stock being registered pursuant
to this registration statement.</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assuming
    all shares offered by Armistice Capital hereby are sold and that Armistice Capital buys or sells no additional shares of common stock
    prior to the completion of this offering.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">(5)</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Assuming all shares offered by Armistice Capital hereby
    are sold and that Armistice Capital buys or sells no additional shares of common stock prior to the completion of this offering,
    Armistice Capital still holds additional pre-funded warrants to acquire up to 2,589,791 shares of our common stock,
    which will continue to be subject to the beneficial ownership limitation of 9.99% and, unless exercised, the percentage ownership
    after the offering will be less than 1%.</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">(6)</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The securities reported herein are held by Sapir LLC, a Florida limited liability company and may be deemed to be
indirectly beneficially owned by Aitan Zacharin, a resident of the State of Israel, who is currently providing investor relations service
to the Company on a consulting basis.</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">(7)</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">As of October 31, 2023, the Sapir Selling Stockholder
    holds 201 shares of our common stock. The address of Sapir LLC is 2311 Falls Gable Ln., Baltimore, Maryland, 21209.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
time a selling stockholder sells any shares of common stock offered by this prospectus, it is required to provide you with this prospectus
and the related prospectus supplement, if any, containing specific information about the selling stockholder and the terms of the shares
of common stock being offered in the manner required by the Securities Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
offer or sale may occur unless the registration statement that includes this prospectus has been declared effective by the SEC and remains
effective at the time the selling stockholders offer or sell shares of common stock. We are required, under certain circumstances,
to update, supplement or amend this prospectus to reflect material developments in our business, financial position and results of operations
and may do so by an amendment to this prospectus or a prospectus supplement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ak_007"></span>DESCRIPTION
OF CAPITAL STOCK</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
following discussion is a summary of selected provisions of our certificate of incorporation, bylaws and Delaware General Corporation
Law, as amended (the &#8220;DGCL&#8221;) as in effect on the date of this prospectus relating to us and our capital stock. This summary
does not purport to be complete. This discussion is subject to the relevant provisions of Delaware law and is qualified by reference
to our certificate of incorporation, our bylaws and the provisions of Delaware law. You should read the provisions of our certificate
of incorporation and our bylaws as currently in effect for provisions that may be important to you.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 76; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common
Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are authorized to issue up to 300,000,000 shares of common stock, par value $0.001 per share. As of October 31, 2023, there are
2,372,803 shares of common stock outstanding (which reflects the one-for-forty (1-for-40) reverse stock split that occurred on September 25, 2023). All of the outstanding shares of our common stock are fully paid and non-assessable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
stock is not entitled to preemptive or other similar subscription rights to purchase any of our securities. Common stock is neither convertible
nor redeemable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Voting
Rights</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
holder of common stock is entitled to one vote per share on each matter submitted to a vote of stockholders, as provided by our certificate
of incorporation. Our bylaws provide that the holders of a majority of the capital stock issued and outstanding and entitled to vote
thereat, present in person or represented by proxy, will constitute a quorum at all meetings of the stockholders for the transaction
of business. When a quorum is present, the affirmative vote of a majority of the votes cast is required to take action, unless otherwise
specified by law, our Bylaws or our Certificate of incorporation, and except for the election of directors, which is determined by a
plurality vote. There are no cumulative voting rights.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dividend
Rights</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
holder of shares of our capital stock is entitled to the payment of dividends and other distributions as may be declared by our Board
of Directors from time to time out of our assets or funds legally available for dividends or other distributions. These rights are subject
to any contractual limitations on our ability to declare and pay dividends. In this regard, under the terms of the loan agreements between
the Company and Yonah Kalfa and Naftali Kalfa and between the Company, we may not make any distributions on our common stock until these
loans made under the loan agreements are repaid in full. At this time, such loans have not been repaid in full.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Liquidation
Rights</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we are involved in voluntary or involuntary liquidation, dissolution or winding up of our affairs, or a similar event, each holder of
common stock will participate pro rata in all assets remaining after payment of liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dividend
Policy</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not paid and do not expect to declare or pay any cash dividends on our common stock in the foreseeable future. We currently expect
to retain all future earnings for use in the operation and expansion of our business. The declaration and payment of any cash dividends
in the future will be determined by our Board of Directors, in its discretion, and will depend on a number of factors, including our
earnings, capital requirements, overall financial condition and contractual restrictions, if any. In this regard, under the terms of
the loan agreements between the Company and Yonah Kalfa and Naftali Kalfa and between the Company, we may not make any distributions
on our common stock until the loans made under these loan agreements are repaid in full. At this time, such loans have not been repaid
in full.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Market
for Shares of Common Stock</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
of our common stock are quoted on Nasdaq under the symbol &#8220;CNXA.&#8221; On October 31, 2023, the closing price per
share of our common stock as reported by Nasdaq was $0.85.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 77; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Listing</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock is listed on the Nasdaq under the symbol &#8220;CNXA.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Transfer
Agent</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
transfer agent and registrar for our common stock is Worldwide Stock Transfer, LLC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Preferred
Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not have any authorized shares of preferred stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Warrants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 2, 2022, the Company issued warrants to purchase 1,196 shares of the Company&#8217;s common stock at $0.01 per share
to a Gameface shareholder in connection with the Gameface acquisition. The warrants
will expire on January 31, 2032.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 6, 2021, the Company consummated a private placement, and at the closing, the Company sold (i) 8% Senior Convertible Notes in
an aggregate principal amount of $11 million and (ii) warrants to purchase up to 18,334 shares of our common stock. The warrants
are exercisable for five years from August 6, 2021, at an exercise price equal to $1.90.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
warrants contain certain price protection provisions providing for adjustment of the amount of securities issuable upon exercise of the
Warrants in case of certain future dilutive events or stock-splits and dividends, including the 1-for-10 reverse stock split to be effectuated
prior to or upon the effectiveness of the registration statement of which this prospectus forms a part. As part of this transaction the
lead placement agent was granted 667 warrants that are exercisable for five years from August 6, 2021, at an exercise price equal to
the $1.90.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company grants warrants to key employees, executives, advisory board members and ambassadors as compensation on a discretionary basis.
As of October 31, 2023, the Company had granted warrants to purchase 7,327 shares of common stock, with an average exercise
price of $276.80. All of the warrants have a contractual life of 10 years from the date of issuance and are vested immediately upon
grant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Options</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 21, 2022, the Company issued to certain PlaySight employees the options to purchase up to 358 shares of Company common
stock in connection with the PlaySight acquisition. The PlaySight employee options vest at issuance, have an exercise price of $0.01
per share, and expire 10 years from issuance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 11, 2020, our Board of Directors approved the 2020 Plan, which provides for the grant of awards which are incentive stock options
(&#8220;ISOs&#8221;), non-qualified stock options, unrestricted stock, restricted stock, restricted stock units, performance stock and
other equity-based and cash awards or any combination of the foregoing, to eligible key management employees, non-employee directors,
and non-employee consultants of the Company or any of its subsidiaries (each a &#8220;participant&#8221;). Only the employees of the
Company and its subsidiaries are eligible for incentive stock option awards. The Company has reserved a total of 37,500 shares for issuance under awards to be made under the 2020 Plan, all of
which may, but need not, be issued in connection with ISOs. As of October 31, 2023, there are 27,000
shares of subject to outstanding awards and approximately 10,500 shares remain available under the 2020 Plan for future awards.  To the extent that an award lapses, expires, is canceled, is terminated unexercised or ceases to be
exercisable for any reason, or the rights of its holder terminate, any shares subject to such award shall again be available for the
grant of a new award. The 2020 Plan shall continue in effect, unless sooner terminated, until the tenth (10<sup>th</sup>) anniversary
of the date on which it was adopted by the Board of Directors (except as to awards outstanding on that date). The Board of Directors
in its discretion may terminate the 2020 Plan at any time with respect to any shares for which awards have not theretofore been granted;
provided, however, that the 2020 Plan&#8217;s termination shall not materially and adversely impair the rights of a holder, without the
consent of the holder, with respect to any award previously granted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 78; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Certain
Anti-Takeover Provisions of Delaware Law, Our Certificate of Incorporation and Our Bylaws</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
203 of the DGCL provides that if a person acquires 15% or more of the voting stock of a Delaware corporation, such person becomes an
&#8220;interested stockholder&#8221; and may not engage in certain &#8220;Business Combinations&#8221; with such corporation for a period
of three years from the time such person acquired 15% or more of such corporation&#8217;s voting stock, unless: (1) the board of directors
of such corporation approves the acquisition of stock or the merger transaction before the time that the person becomes an interested
stockholder, (2) the interested stockholder owns at least 85% of the outstanding voting stock of such corporation at the time the merger
transaction commences (excluding voting stock owned by directors who are also officers and certain employee stock plans), or (3) the
merger transaction is approved by the board of directors and at a meeting of stockholders, not by written consent, by the affirmative
vote of 2/3 of the outstanding voting stock which is not owned by the interested stockholder. A Delaware corporation may elect in its
certificate of incorporation or Bylaws not to be governed by this particular Delaware law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
certificate of incorporation, our bylaws and the DGCL contain provisions that could have the effect of rendering more difficult, delaying,
or preventing an acquisition deemed undesirable by our board of directors. These provisions could also make it difficult for stockholders
to take certain actions, including electing directors who are not nominated by the members of our board of directors or taking other
corporate actions, including effecting changes in our management. For instance, our certificate of incorporation does not provide for
cumulative voting in the election of directors. Our board of directors are empowered to elect a director to fill a vacancy created by
the expansion of the board of directors or the resignation, death, or removal of a director in certain circumstances; and our advance
notice provisions in our bylaws require that stockholders must comply with certain procedures in order to nominate candidates to our
board of directors or to propose matters to be acted upon at a stockholders&#8217; meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
authorized but unissued common stock will be available for future issuances without stockholder approval and could be utilized for a
variety of corporate purposes, including future offerings to raise additional capital, acquisitions and employee benefit plans. The existence
of authorized but unissued and unreserved common stock could render more difficult or discourage an attempt to obtain control of us by
means of a proxy contest, tender offer, merger or otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Certificate
of incorporation and Bylaws</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Among
other things, our certificate of incorporation and our bylaws:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">do
    not provide for cumulative voting in the election of directors;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">provides
    for the exclusive right of the board of directors to elect a director to fill a vacancy created by the expansion of the board of
    directors or the resignation, death, or removal of a director by stockholders;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Requires
    that a special meeting of stockholders may be called only by the Board of Directors, or by a committee of the Board of Directors
    that has been designated by the Board of Directors;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">limits
    the liability of, and providing indemnification to, our directors and officers;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">controls
    the procedures for the conduct and scheduling of stockholder meetings;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">grants
    the ability to remove directors only for cause by the affirmative vote of at least two-thirds of the voting power of all of the then
    outstanding shares of voting stock of the Company entitled to vote at an election of directors;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">provides
    for advance notice procedures that stockholders must comply with in order to nominate candidates to the board of directors or to
    propose matters to be acted upon at a stockholders&#8217; meeting</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 79; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
combination of these provisions will make it more difficult for our existing stockholders to replace our board of directors as well as
for another party to obtain control of us by replacing our board of directors. Since our board of directors has the power to retain and
discharge our officers, these provisions could also make it more difficult for existing stockholders or another party to effect a change
in management.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
provisions are intended to enhance the likelihood of continued stability in the composition of our board of directors and its policies
and to discourage coercive takeover practices and inadequate takeover bids. These provisions are also designed to reduce our vulnerability
to hostile takeovers and to discourage certain tactics that may be used in proxy fights. However, such provisions could have the effect
of discouraging others from making tender offers for our shares of common stock and may have the effect of delaying changes in our control
or management. As a consequence, these provisions may also inhibit fluctuations in the market price of our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Limitation
of Liability and Indemnification</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
bylaws provide that we will indemnify our directors to the fullest extent authorized or permitted by applicable law. Under our Bylaws,
we are required to indemnify each of our directors and officers if the basis of the indemnitee&#8217;s involvement was by reason of the
fact that the indemnitee is or was our director or officer or was serving at our request as a director, officer, employee or agent for
another entity. We must indemnify our officers and directors against all expenses (including attorneys&#8217; fees), judgments, fines
and amounts paid in settlement actually and reasonably incurred by the indemnitee in connection with such action, suit or proceeding
if the indemnitee acted in good faith and in a manner the indemnitee reasonably believed to be in or not opposed to the best interests
of the Company, and, with respect to any criminal action or proceeding, had no reasonable cause to believe the indemnitee&#8217;s conduct
was unlawful. Our bylaws also require us to advance expenses (including attorneys&#8217; fees) incurred by a director or officer in defending
any civil, criminal, administrative or investigative action, suit or proceeding, provided that such person will repay any such advance
if it is ultimately determined that such person is not entitled to indemnification by us. Any claims for indemnification by our directors
and officers may reduce our available funds to satisfy successful third-party claims against us and may reduce the amount of money available
to us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ak_008"></span>PLAN
OF DISTRIBUTION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
selling stockholder of the securities and any of their pledgees, assignees and successors-in-interest may, from time to time, sell any
or all of their securities covered hereby on the principal Trading Market or any other stock exchange, market or trading facility on
which the securities are traded or in private transactions. These sales may be at fixed or negotiated prices. A selling stockholder may
use any one or more of the following methods when selling securities:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary
    brokerage transactions and transactions in which the broker-dealer solicits purchasers;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">block
    trades in which the broker-dealer will attempt to sell the securities as agent but may position and resell a portion of the block
    as principal to facilitate the transaction;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">purchases
    by a broker-dealer as principal and resale by the broker-dealer for its account;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    exchange distribution in accordance with the rules of the applicable exchange;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">privately
    negotiated transactions;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">settlement
    of short sales;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
    transactions through broker-dealers that agree with the selling stockholders to sell a specified number of such securities
    at a stipulated price per security;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">through
    the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    combination of any such methods of sale; or</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    other method permitted pursuant to applicable law.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 80; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
selling stockholders may also sell securities under Rule 144 or any other exemption from registration under the Securities Act,
if available, rather than under this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Broker-dealers
engaged by the selling stockholders may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive
commissions or discounts from the selling stockholders (or, if any broker-dealer acts as agent for the purchaser of securities,
from the purchaser) in amounts to be negotiated, but except as set forth in a supplement to this prospectus, in the case of an agency
transaction not in excess of a customary brokerage commission in compliance with FINRA Rule 2121; and in the case of a principal transaction
a markup or markdown in compliance with FINRA Rule 2121.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the sale of the securities or interests therein, the selling stockholders may enter into hedging transactions
with broker-dealers or other financial institutions, which may in turn engage in short sales of the securities in the course of hedging
the positions they assume. The selling stockholders may also sell securities short and deliver these securities to close out their
short positions, or loan or pledge the securities to broker-dealers that in turn may sell these securities. The selling stockholders
may also enter into option or other transactions with broker-dealers or other financial institutions or create one or more derivative
securities which require the delivery to such broker-dealer or other financial institution of securities offered by this prospectus,
which securities such broker-dealer or other financial institution may resell pursuant to this prospectus (as supplemented or amended
to reflect such transaction).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
selling stockholders and any broker-dealers or agents that are involved in selling the securities may be deemed to be &#8220;underwriters&#8221;
within the meaning of the Securities Act in connection with such sales. In such an event, any commissions received by such broker-dealers
or agents and any profit on the resale of the securities purchased by them may be deemed to be underwriting commissions or discounts
under the Securities Act. Each selling stockholder has informed the Company that it does not have any written or oral agreement or understanding,
directly or indirectly, with any person to distribute the securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 20.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is required to pay certain fees and expenses incurred by the Company incident to the registration of the securities. The Company
has agreed to indemnify the Armistice Selling Stockholder against certain losses, claims, damages and liabilities, including
liabilities under the Securities Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
agreed to keep this prospectus effective until the earlier of (i) the date on which the securities may be resold by the selling stockholders
without registration and without regard to any volume or manner-of-sale limitations by reason of Rule 144, without the requirement
for the Company to be in compliance with the current public information under Rule 144 under the Securities Act or any other rule of
similar effect or (ii) all of the securities have been sold pursuant to this prospectus or Rule 144 under the Securities Act or any other
rule of similar effect. The resale securities will be sold only through registered or licensed brokers or dealers if required under applicable
state securities laws. In addition, in certain states, the resale securities covered hereby may not be sold unless they have been registered
or qualified for sale in the applicable state or an exemption from the registration or qualification requirement is available and is
complied with.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
applicable rules and regulations under the Exchange Act, any person engaged in the distribution of the resale securities may not simultaneously
engage in market making activities with respect to the shares of common stock for the applicable restricted period, as defined in Regulation
M, prior to the commencement of the distribution. In addition, the selling stockholders will be subject to applicable provisions
of the Exchange Act and the rules and regulations thereunder, including Regulation M, which may limit the timing of purchases and sales
of the shares of Common Stock by the selling stockholders or any other person. We will make copies of this prospectus available
to the selling stockholders and have informed them of the need to deliver a copy of this prospectus to each purchaser at or prior
to the time of the sale (including by compliance with Rule 172 under the Securities Act).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 81; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ak_009"></span>LEGAL
MATTERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lucosky
Brookman, LLP, Woodbridge, New Jersey, will pass upon the validity of the shares of our common stock offered hereby.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ak_010"></span>EXPERTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial statements as of and for the years ended April 30, 2023 and 2022 of Connexa Sports Technologies, Inc. have been audited
by Olayinka Oyebola &amp; Co. (&#8220;OOC&#8221;), an independent registered public accounting firm, and have been included on the authority
of said firm as experts in auditing and accounting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
named experts under this section or under Legal Matters own any shares of our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ak_011"></span>CHANGE
IN CERTIFYING ACCOUNTANT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 28, 2022, the Board of Directors and the audit committee of Connex Sports Technologies Inc. (the &#8220;Company&#8221;) approved
the re-engagement of Mac Accounting Group, LLP (&#8220;Mac&#8221;) as the Company&#8217;s independent registered public accounting firm
for the fiscal year ended April 30, 2023, effective immediately, and dismissed WithumSmith + Brown, PC (&#8220;Withum&#8221;) as the
Company&#8217;s independent registered public accounting firm.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Until
Withum was engaged on February 17, 2022, Mac was the Company&#8217;s auditor and had audited the Company&#8217;s consolidated financial
statements for the fiscal years ended April 30, 2022 and 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Withum
never issued an audit opinion on our financial statements, and during the course of their engagement <span style="background-color: white">there
were no disagreements with Withum on any matters of accounting principles or practices, financial statement disclosure or auditing scope
and procedures which, if not resolved to the satisfaction of Withum, would have caused Withum to make reference to the matter in their
audit opinion, if issued. There were no reportable events (as that term is described in Item 304(a)(1)(v) of Regulation S-K) during the
period Withum was engaged as the Company&#8217;s auditor.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 21, 2023, the Board of Directors and the audit committee of the Company approved the engagement of Olayinka Oyebola &amp; Co. (&#8220;OOC&#8221;)
as the Company&#8217;s independent registered public accounting firm for the fiscal year ended April 30, 2023, effective immediately,
and dismissed Mac Accounting Group, LLP (&#8220;Mac&#8221;) as the Company&#8217;s independent registered public accounting firm.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Until
OOC was engaged on March 21, 2023, Mac was the Company&#8217;s auditor and had audited the Company&#8217;s consolidated financial statements
for the fiscal years ended April 30, 2022 and 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mac
never issued an audit opinion on our financial statements for the fiscal year ended April 30, 2023, and during the course of their engagement
there were no disagreements with Mac on any matters of accounting principles or practices, financial statement disclosure or auditing
scope and procedures which, if not resolved to the satisfaction of Mac, would have caused Mac to make reference to the matter in their
audit opinion, if issued. There were no reportable events (as that term is described in Item 304(a)(1)(v) of Regulation S-K) during the
period Mac was engaged as the Company&#8217;s auditor.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ak_012"></span>WHERE
YOU CAN FIND MORE INFORMATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
further information with respect to our company and the securities being offered hereby, reference is hereby made to the registration
statement, including the exhibits thereto and the financial statements, notes, and schedules filed as a part thereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
person is authorized to give you any information or make any representation other than those contained or incorporated by reference in
this prospectus. Any such information or representation must not be relied upon as having been authorized. Neither the delivery of this
prospectus nor any sale made hereunder shall, under any circumstances, create any implication that there has been no change in our affairs
since the date of the prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to the informational requirements of the Exchange Act, and must file reports, proxy statements and other information with
the SEC, such as current, quarterly and annual reports on Forms 8-K, 10-Q and 10-K. These filings will be a matter of public record and
any person may read and copy any materials we file with the SEC at the SEC&#8217;s Public Reference Room at 100 F Street N.E., Washington,
D.C. 20549. You may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. Further, the
SEC maintains an Internet web site at http://www.sec.gov that contains reports, proxy and information statements, and other information
regarding issuers, including us, that file electronically with the SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 82; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="SA_001"></span>CONNEXA
SPORTS TECHNOLOGIES, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FINANCIAL
STATEMENTS<br />
JULY 31, 2023 AND DECEMBER 31, 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#MS_001"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSOLIDATED BALANCE SHEETS (UNAUDITED)</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-2</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#MS_002"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-3</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#MS_003"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY (DEFICIT) (UNAUDITED)</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-4</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#MS_004"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-5</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#MS_005"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-6</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FINANCIAL
STATEMENTS<br />
APRIL 30, 2023 AND 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ss_001">REPORT
    OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM (PCAOB ID: 5968) in respect of the fiscal year ended April 30, 2023</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-23</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ss_002">CONSOLIDATED
    BALANCE SHEETS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-25</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ss_003">CONSOLIDATED
    STATEMENTS OF OPERATIONS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-26</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ss_004">CONSOLIDATED
    STATEMENTS OF CHANGES IN STOCKHOLDERS&#8217; EQUITY (DEFICIT)</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-27</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ss_005">CONSOLIDATED
    STATEMENTS OF CASH FLOWS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-28</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ss_006">NOTES
    TO CONSOLIDATED FINANCIAL STATEMENTS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-29</span></td></tr>
  </table>
<p style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 83; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="MS_001"></span>CONNEXA
SPORTS TECHNOLOGIES, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONSOLIDATED
BALANCE SHEETS (IN US$)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>JULY
31, 2023 (UNAUDITED) AND APRIL 30, 2023 </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30D_111_z5TI34jy842d" summary="xdx: Statement - Consolidated Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_494_20230731_zluN236BTRbf" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">JULY 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49E_20230430_zkU7r4OAjGs3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">APRIL 30, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">(UNAUDITED)</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--AssetsAbstract_iB_zUvgFv0PDaVe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-decoration: underline; font-weight: bold; text-align: center">ASSETS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AssetsCurrentAbstract_i01B_zTKvh2YHWyS2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Current Assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i02I_maACzTxh_zOR60QyO9nWb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; width: 64%; text-align: left">Cash and cash equivalents</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">386,459</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">202,095</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--AccountsReceivableNetCurrent_i02I_maACzTxh_ztENAEEB8ute" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Accounts receivable, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">444,622</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">399,680</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--InventoryNet_i02I_maACzTxh_zpTx9ZqbUqK" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Inventories, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,336,918</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,189,766</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--PrepaidInventoryCurrent_i02I_maACzTxh_zngDMh3mKwI4" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Prepaid inventory</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="CNXA:PrepaidInventoryCurrent" contextRef="AsOf2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,134,368</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="CNXA:PrepaidInventoryCurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">936,939</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--CommodityContractAssetCurrent_i02I_maACzTxh_zpVyPWoX0f81" style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Contract assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_i02I_maACzTxh_zovZuEdkh002" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Prepaid expenses and other current assets</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">280,820</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">263,020</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_i02I_maACzTxh_zdus5yB0ZsCc" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Current assets of discontinued operations</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AssetsCurrent_i02TI_mtACzTxh_maAzpAm_zkWUrPD6lDZ2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Total Current Assets</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,583,187</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,991,500</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AssetsNoncurrentAbstract_i01B_zslRhPaUVb2l" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Non-Current Assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--OtherReceivables_i02I_maANzw0c_zW51ch635hU8" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Note receivable - former subsidiary</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherReceivables" contextRef="AsOf2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,000,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherReceivables" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,000,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentNet_i02I_maANzw0c_ziQE9pP3vbM5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Fixed assets, net of depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0070">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,791</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsNet_i02I_maANzw0c_zY3NS7P65M04" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Intangible assets, net of amortization</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">101,281</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--Goodwill_i02I_maANzw0c_zE0KlPEYReD7" style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Goodwill</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent_i02I_maANzw0c_zPTRPOATjOx6" style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Non-current assets of discontinued operations</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--AssetsNoncurrent_i02TI_mtANzw0c_maAzpAm_zsyMuFUG7oE2" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Total Non-Current Assets</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsNoncurrent" contextRef="AsOf2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,001,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsNoncurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,116,072</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--Assets_i01TI_mtAzpAm_zOy7dEZc3ood" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">TOTAL ASSETS</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,584,187</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,107,572</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB_zPj4I9AqsMV5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-decoration: underline; font-weight: bold; text-align: center">LIABILITIES AND SHAREHOLDERS&#8217; EQUITY (DEFICIT)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--LiabilitiesAbstract_i01B_zqE7o5I4yLch" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">LIABILITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--LiabilitiesCurrentAbstract_i02B_zqAjQJ4O9178" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Current Liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--AccountsPayableCurrent_i03I_maLCz79k_zsDuQqcUfSnh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Accounts payable</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,087,311</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,496,629</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AccruedLiabilitiesCurrent_i03I_maLCz79k_zIzHTvWZCgvf" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,197,460</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,911,839</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--PurchaseObligation_i03I_maLCz79k_zCrygTgYNvr2" style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Related party purchase obligation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--ContractWithCustomerLiabilityCurrent_i03I_maLCz79k_zJB0JKZvVnC5" style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Contract liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--InterestPayableCurrent_i03I_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--NonrelatedPartyMember_znhjq88hCLn8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Accrued interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestPayableCurrent" contextRef="AsOf2023-07-31_us-gaap_NonrelatedPartyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">41,522</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestPayableCurrent" contextRef="AsOf2023-04-30_us-gaap_NonrelatedPartyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,387</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--InterestPayableCurrent_i03I_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_maLCz79k_zpdkPD5amY64" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Accrued interest - related party</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestPayableCurrent" contextRef="AsOf2023-07-31_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">917,957</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestPayableCurrent" contextRef="AsOf2023-04-30_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">917,957</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--InterestPayableCurrent_i03I_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zhjDXfFYFbvj" style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Accrued interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestPayableCurrent" contextRef="AsOf2023-07-31_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">917,957</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestPayableCurrent" contextRef="AsOf2023-04-30_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">917,957</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--OtherNotesPayableCurrent_i03I_maLCz79k_zOkYORvEXHI4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Current portion of notes payable, net of discount</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherNotesPayableCurrent" contextRef="AsOf2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,959,671</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherNotesPayableCurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,484,647</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--ConvertibleNotesPayableCurrent_i03I_maLCz79k_zoZc8UT92oLc" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Current portion of convertible notes payable, net of discount</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DerivativeLiabilitiesCurrent_i03I_maLCz79k_z5YgYB02ao0f" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Derivative liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DerivativeLiabilitiesCurrent" contextRef="AsOf2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,345,052</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DerivativeLiabilitiesCurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,489,606</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--BusinessCombinationContingentConsiderationLiabilityCurrent_i03I_maLCz79k_zwakOuqg2Okc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Contingent consideration</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" contextRef="AsOf2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">418,455</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">418,455</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--OtherLiabilitiesCurrent_i03I_maLCz79k_z80kg1u4lpmj" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Other current liabilities</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">330,065</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">22,971</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_i03I_maLCz79k_zynLLs5ovtde" style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Current liabilities of discontinued operations</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--LiabilitiesCurrent_i02TI_maLzPc6_mtLCz79k_zuUC0sA9Dni6" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Total Current Liabilities</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">23,297,493</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">23,767,491</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--LiabilitiesNoncurrentAbstract_i02B_zJHAMAYzEPMa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Long-Term Liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--LongTermNotesPayable_i02I_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_maLNzUUB_zU1Ype039T9k" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Notes payable related parties, net of current portion</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:LongTermNotesPayable" contextRef="AsOf2023-07-31_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,655,966</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:LongTermNotesPayable" contextRef="AsOf2023-04-30_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,953,842</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent_i02I_maLNzUUB_zA4INw2K65x6" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Non-current liabilities of discontinued operations</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--LiabilitiesNoncurrent_i02TI_mtLNzUUB_maLzPc6_zIMqMYZ52CXe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Total Long-Term Liabilities</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesNoncurrent" contextRef="AsOf2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,655,966</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesNoncurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,953,842</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--Liabilities_i01TI_maLASEzPPI_mtLzPc6_zPDNBz0B3CF2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; font-weight: bold; text-align: left">Total Liabilities</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,953,459</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,721,333</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--CommitmentsAndContingencies_i01I_maLASEzPPI_z7qKlAj9Y9qh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Commitments and contingency</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0154">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0155">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--StockholdersEquityAbstract_i01B_zfaYWl5nQTQi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">SHAREHOLDERS&#8217; EQUITY (DEFICIT)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--CommonStockValue_i02I_maSEzqAS_zNA1RbOapy6l" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Common stock, par value, $<span id="xdx_90A_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20230731_znHQ2dTe2592" title="Common stock, par value"><span id="xdx_907_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20230430_ziP1GAvyPMfh" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2023-07-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></ix:nonFraction></span></span>, <span id="xdx_90D_eus-gaap--CommonStockSharesAuthorized_iI_c20230731_zraXJzmlXuyb" title="Common stock, shares authorized"><span id="xdx_90C_eus-gaap--CommonStockSharesAuthorized_iI_c20230430_zB4bth5KJn2e" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2023-07-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">300,000,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized, <span id="xdx_908_eus-gaap--CommonStockSharesIssued_iI_c20230731_ztgp5oasLk62" title="Common stock, shares issued"><span id="xdx_900_eus-gaap--CommonStockSharesOutstanding_iI_c20230731_zxYtsn8JnXnl" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2023-07-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-07-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">528,297</ix:nonFraction></ix:nonFraction></span></span> and <span id="xdx_903_eus-gaap--CommonStockSharesIssued_iI_c20230430_za2ARfJ62zR" title="Common stock, shares issued"><span id="xdx_905_eus-gaap--CommonStockSharesOutstanding_iI_c20230430_z2o8OCpRU3la" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">338,579</ix:nonFraction></ix:nonFraction></span></span> shares issued and outstanding as of July 31,
    2023 and April 30, 2023, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">528</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">339</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AdditionalPaidInCapitalCommonStock_i02I_maSEzqAS_zqNScoUWcwva" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Additional paid in capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapitalCommonStock" contextRef="AsOf2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">134,112,083</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapitalCommonStock" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">132,993,998</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--RetainedEarningsAccumulatedDeficit_i02I_maSEzqAS_z1PXlsAxp6i2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Accumulated deficit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2023-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">152,597,375</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">151,750,610</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_400_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_i02I_maSEzqAS_zs6w6QWRlVsi" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Accumulated other comprehensive income (loss)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">115,492</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">142,512</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--StockholdersEquity_i02TI_maLASEzPPI_mtSEzqAS_zIKZs171Xkvd" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold; text-align: left">Total Stockholders&#8217; Equity (Deficit)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">18,369,272</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">18,613,761</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_mtLASEzPPI_zSIQFOf5Ojmf" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">TOTAL LIABILITIES AND STOCKHOLDERS&#8217; EQUITY (DEFICIT)</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,584,187</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,107,572</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these unaudited consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 84; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="MS_002"></span>CONNEXA
SPORTS TECHNOLOGIES, INC</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONSOLIDATED
STATEMENTS OF OPERATIONS (IN US$) (UNAUDITED)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THREE
MONTHS ENDED JULY 31, 2023 AND 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30E_113_za02R5Bd4eR3" summary="xdx: Statement - Consolidated Statements of Operations (Unaudited)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49C_20230501__20230731_zlNa1KgSCGb5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_491_20220501__20220731_zkbwtIxwyIic" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_maGPzw77_zsqZRVgdaRLg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; font-weight: bold; text-align: left">NET SALES</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,120,231</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-05-012022-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,583,336</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--CostOfGoodsAndServicesSold_msGPzw77_zmDdmhGXWoZc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">COST OF SALES</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSold" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,227,482</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSold" contextRef="From2022-05-012022-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,562,044</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;. </span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--GrossProfit_iT_mtGPzw77_maOILzILl_zkRsrGLQKHd8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">GROSS PROFIT</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">892,749</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2022-05-012022-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,021,292</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--OperatingExpensesAbstract_iB_zmp1KpXav2s1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">OPERATING EXPENSES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--SellingAndMarketingExpense_i01_maOEz6hA_znf7cYa0nru6" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Selling and marketing expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">242,353</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2022-05-012022-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">756,823</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--GeneralAndAdministrativeExpense_i01_maOEz6hA_zjUzyEOKtywi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">General and administrative expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,505,060</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2022-05-012022-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,314,610</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--ResearchAndDevelopmentExpense_i01_maOEz6hA_z3X0fZ5hbfG6" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Research and development costs</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0212">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2022-05-012022-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">19,425</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--OperatingExpenses_i01T_mtOEz6hA_msOILzILl_zhduFaJfcICf" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Total Operating Expenses</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,747,413</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2022-05-012022-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,090,858</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--OperatingIncomeLoss_iT_mtOILzILl_maILFCOz2bn_zGFI38RNyZ0d" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">OPERATING LOSS</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,854,664</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2022-05-012022-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,069,566</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--NonoperatingIncomeExpenseAbstract_iB_zzF4n4LL8OVg" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">NON-OPERATING INCOME (EXPENSE)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--AmortizationOfFinancingCostsAndDiscounts_i01N_di_msNIEzR1U_zj9kpx71fJAb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Amortization of debt discounts</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">777,192</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" contextRef="From2022-05-012022-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,872,222</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_400_eus-gaap--GainsLossesOnExtinguishmentOfDebt_i01_maNIEzR1U_z02SuQ4qsIP6" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Loss on extinguishment of debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--GainLossOnIssuanceOfConvertibleNotes_i01_maNIEzR1U_zU4FCQVyJa47" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Loss on issuance of convertible notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--GainLossOnChangeInFairValueOfContingentConsideration_i01_maNIEzR1U_zdWZFcnVhBxa" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Gain on change in fair value of contingent consideration</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--LossOnConversionOfAccountsPayableToCommonStock_i01_msNIEzR1U_zUhC63da4W41" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Loss on conversion of accounts payable to common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="CNXA:LossOnConversionOfAccountsPayableToCommonStock" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">289,980</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0237">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--GainLossOnChangeInFairValueOfDerivativesLiability_i01_maNIEzR1U_zxYIX2Z5t3x4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Change in fair value of derivative liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="CNXA:GainLossOnChangeInFairValueOfDerivativesLiability" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,144,554</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="CNXA:GainLossOnChangeInFairValueOfDerivativesLiability" contextRef="From2022-05-012022-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,687,495</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--DerivativeExpense_i01N_di_msNIEzR1U_zQFHABeeE1W3" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Derivative expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--InterestExpense_i01N_di_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--NonrelatedPartyMember_msNIEzR1U_zqbIkKhKWm48" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Interest expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2023-05-012023-07-31_us-gaap_NonrelatedPartyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">69,483</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2022-05-012022-07-31_us-gaap_NonrelatedPartyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">191,303</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40F_eus-gaap--InterestExpense_i01N_di_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_msNIEzR1U_zE0WH5lk2bxl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Interest expense - related party</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0248">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2022-05-012022-07-31_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">61,121</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--InterestExpense_i01N_di_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_msNIEzR1U_zrAAMWJVK0Il" style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Interest expense</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0251">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2022-05-012022-07-31_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">61,121</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--NonoperatingIncomeExpense_i01T_maILFCOz2bn_mtNIEzR1U_zTuNdeNy5Pfg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Total Non-Operating Income (Expenses)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,007,899</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2022-05-012022-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">562,849</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_mtILFCOz2bn_maILFCOzMFw_ztg72KXA3603" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><b>NET LOSS FROM CONTINUING OPERATIONS BEFORE</b> <b>PROVISION FOR INCOME TAXES</b></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">846,765</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2022-05-012022-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,506,717</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">DISCONTINUED OPERATIONS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_maDOAOAzvP5_z8Dd01bBhaJ6" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Loss from discontinued operations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0260">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" contextRef="From2022-05-012022-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,759,714</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_400_eus-gaap--DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_maDOAOAzvP5_zoGC9vkvmHg9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Loss on disposal of subsidiaries</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0263">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_iT_mtDOAOAzvP5_maILFCOzMFw_zQ4n5b0Cd8x3" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">LOSS FROM DISCONTINUED OPERATIONS</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0266">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" contextRef="From2022-05-012022-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,759,714</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--IncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_maNILz4yl_mtILFCOzMFw_zqHPcfrfi1Nc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><b>NET LOSS FROM OPERATIONS BEFORE</b> <b>PROVISION FOR INCOME TAXES</b></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="CNXA:IncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">846,765</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="CNXA:IncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2022-05-012022-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,266,431</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--IncomeTaxExpenseBenefit_msNILz4yl_zaA1linuFABa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Provision for income taxes</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0272">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0273">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--NetIncomeLoss_iT_maCINOTzyea_mtNILz4yl_zUod7jkUsZE3" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">NET LOSS</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">846,765</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-05-012022-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,266,431</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_iB_znu8ydZ4GHJ6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Other comprehensive income (loss)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_maCINOTzyea_ziE3DZElV6L1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Foreign currency translations adjustment</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">27,020</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2022-05-012022-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">58,139</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--ComprehensiveIncomeNetOfTax_iT_mtCINOTzyea_zIAKxiNlluH5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Comprehensive income (loss)</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">873,785</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2022-05-012022-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,208,292</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--NetIncomeLossPerOutstandingLimitedPartnershipAndGeneralPartnershipUnitBasicAndDilutedAbstract_iB_zcOM6ntB0W08" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Net income (loss) per share - basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Continuing operations</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_901_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pid_c20230501__20230731_zNlRZp8eomz2" title="Continuing operations basic" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_"><span id="xdx_905_eus-gaap--IncomeLossFromContinuingOperationsPerDilutedShare_pid_c20230501__20230731_zp2WlQ3hivi2" title="Continuing operations diluted" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">1.93</ix:nonFraction></ix:nonFraction></span></span></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90C_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pid_c20220501__20220731_zxnHcnUnvr8" title="Continuing operations basic" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_"><span id="xdx_90D_eus-gaap--IncomeLossFromContinuingOperationsPerDilutedShare_pid_c20220501__20220731_z2CpVZ2lQAmf" title="Continuing operations diluted" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2022-05-012022-07-31" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" contextRef="From2022-05-012022-07-31" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">14.27</ix:nonFraction></ix:nonFraction></span></span></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Discontinued operations</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_90A_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_pid_c20230501__20230731_zxbRGXYtARyb" title="Discontinued operations basic" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_"><span id="xdx_90C_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_pid_c20230501__20230731_zFm4cj8Zubub" title="Discontinued operations diluted" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_"><span style="-sec-ix-hidden: xdx2ixbrl0298"><span style="-sec-ix-hidden: xdx2ixbrl0300">-</span></span></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_905_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_pid_c20220501__20220731_zKcf54MkZTvj" title="Discontinued operations basic" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_"><span id="xdx_902_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_pid_c20220501__20220731_zA7r3mUlkAC1" title="Discontinued operations diluted" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_">(<ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" contextRef="From2022-05-012022-07-31" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" contextRef="From2022-05-012022-07-31" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">10.02</ix:nonFraction></ix:nonFraction></span></span></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Net loss per share - basic and diluted</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90E_eus-gaap--EarningsPerShareBasic_pid_c20230501__20230731_z3nlM3I5TBrd" title="Net loss per share - basic" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_"><span id="xdx_903_eus-gaap--EarningsPerShareDiluted_pid_c20230501__20230731_z3NDhjw8y5o1" title="Net loss per share - diluted" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">1.93</ix:nonFraction></ix:nonFraction></span></span></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_900_eus-gaap--EarningsPerShareBasic_pid_c20220501__20220731_z4p4KJ8bXj2b" title="Net loss per share - basic" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_"><span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pid_c20220501__20220731_zbp5DuE64Pc5" title="Net loss per share - diluted" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2022-05-012022-07-31" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2022-05-012022-07-31" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">24.29</ix:nonFraction></ix:nonFraction></span></span></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Weighted average common shares outstanding - basic and diluted</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20230501__20230731_zExeUCWGtMpd" title="Weighted average common shares outstanding - basic" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_"><span id="xdx_90F_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20230501__20230731_z6JR3gLNYXT6" title="Weighted average common shares outstanding - diluted" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">438,354</ix:nonFraction></ix:nonFraction></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20220501__20220731_zqsc2qKwqUed" title="Weighted average common shares outstanding - basic" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_"><span id="xdx_903_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20220501__20220731_zhp7ll40gqQ5" title="Weighted average common shares outstanding - diluted" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-05-012022-07-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2022-05-012022-07-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">175,653</ix:nonFraction></ix:nonFraction></span></span></td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these unaudited consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 85; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="MS_003"></span>CONNEXA
SPORTS TECHNOLOGIES, INC</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONSOLIDATED
STATEMENT OF CHANGES IN SHAREHOLDERS&#8217; EQUITY (DEFICIT) (IN US$) (UNAUDITED)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE THREE MONTHS ENDED JULY 31, 2023 AND 2022 </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_309_114_z7PFduDxTGi9" summary="xdx: Statement - Consolidated Statement of Changes in Shareholders&apos; Equity (Deficit) (Unaudited)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_4BC_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zw3J7gqKl6B6">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_4BB_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_z6NK0sYGHV71">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_4B4_us-gaap--StatementEquityComponentsAxis_us-gaap--AccumulatedOtherComprehensiveIncomeMember_zvJuriuE9zE8" style="font-weight: bold; text-align: center">Accumulated</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_4B5_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zItU17tkpoie">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_4B6_zRGBPljsfUB1">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="6">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Additional</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Other</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Common Stock</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Paid-In</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Comprehensive</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Accumulated</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Capital</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Income (Loss)</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Deficit</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_437_c20220501__20220731_eus-gaap--StockholdersEquity_iS_z5g1lDMPNmT9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%">Balance - May 1, 2022</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--SharesOutstanding_iS_c20220501__20220731__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zXjpTEd8bcA7" title="Balance, shares" style="width: 6%; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-04-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">104,871</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-04-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">105</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-04-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">113,053,790</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">54,962</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-04-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">80,596,925</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">32,511,932</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--StockIssuedDuringPeriodForAbstract_iB_zyYWxxEbxmx1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stock issued for:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--StockIssuedDuringPeriodValueConversionOfUnits_zzbmgsEvZdOd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Conversion of notes payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesConversionOfUnits_c20220501__20220731__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z7aBlRIUHJ69" title="Conversion of notes payable, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits" contextRef="From2022-05-012022-07-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">109,737</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" contextRef="From2022-05-012022-07-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">110</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" contextRef="From2022-05-012022-07-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,046,190</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0338">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0339">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" contextRef="From2022-05-012022-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,046,300</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_zVMPhrKmbUd3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Acquisition</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20220501__20220731__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zymMotqL0Urj" title="Acquisitions, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" contextRef="From2022-05-012022-07-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">14,960</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2022-05-012022-07-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2022-05-012022-07-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">915,530</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0346">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0347">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2022-05-012022-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">915,545</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_zKLxgJbh3Fii" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20220501__20220731__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zYmsNlFQp80e" title="Services, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2022-05-012022-07-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">625</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-05-012022-07-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-05-012022-07-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,249</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0354">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0355">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-05-012022-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,250</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--StockIssuedDuringPeriodValueNewIssues_zBFXFgXZ2cL8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Cash</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220501__20220731__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zwcWe8xYWpV" title="Cash, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-05-012022-07-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">26,219</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-05-012022-07-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-05-012022-07-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,194,974</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0362">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0363">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-05-012022-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,195,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--StockIssuedDuringPeriodValueOther_z1JrlqdYzPp4" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Fractional share issuance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesOther_c20220501__20220731__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zjkwGZ4B3dU6" title="Fractional share issuance, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesOther" contextRef="From2022-05-012022-07-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">38</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0368">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0369">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0370">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0371">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0372">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_zToMUUwRPZN3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Share-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0376">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2022-05-012022-07-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">277,625</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0378">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0379">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2022-05-012022-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">277,625</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_zeoddQHdp394" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Change in comprehensive income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0382">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0383">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2022-05-012022-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">58,139</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0385">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2022-05-012022-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">58,139</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_zN0M5MlfG6jk" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left">Change in comprehensive income (loss)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0388">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0389">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2022-05-012022-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">58,139</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0391">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2022-05-012022-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">58,139</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--NetIncomeLoss_zLOrJQRujy1e" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net loss for the period</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0394">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0395">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0396">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-05-012022-07-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,266,431</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-05-012022-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,266,431</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_438_c20220501__20220731_eus-gaap--StockholdersEquity_iE_zU6rDCpE2dIk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Balance - July 31, 2022</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SharesOutstanding_iE_c20220501__20220731__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zmoTRlR2dbJ8" title="Balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-07-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">256,450</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-07-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">257</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-07-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">132,523,358</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">113,101</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-07-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">84,863,356</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">47,773,360</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_43B_c20230501__20230731_eus-gaap--StockholdersEquity_iS_zQ1O12YoCCF6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Balance - May 1, 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--SharesOutstanding_iS_c20230501__20230731__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zX5DoisgyKsg" title="Balance, shares" style="text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-04-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">338,579</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-04-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">339</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-04-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">132,993,998</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">142,512</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-04-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">151,750,610</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">18,613,761</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_432_c20230501__20230731_eus-gaap--StockholdersEquity_iS_z4BYGBQMqcxk" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Balance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SharesOutstanding_iS_c20230501__20230731__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zW8ycVgVVged" title="Balance, shares" style="text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-04-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">338,579</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-04-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">339</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-04-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">132,993,998</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">142,512</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-04-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">151,750,610</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">18,613,761</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--StockIssuedDuringPeriodForAbstract_iB_zIOJ1ROoRmb5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stock issued for:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_zv1a6ChLD88k" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20230501__20230731__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zrKi4BfmWk38" title="Services, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2023-05-012023-07-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">188</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0430">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0431">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0432">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0433">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0434">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--StockIssuedDuringPeriodValueAccountsPayable_ztX6qxcWYPo2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Accounts payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--StockIssuedDuringPeriodSharesAccountsPayable_c20230501__20230731__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zrT944qsogEl" title="Accounts payable, shares" style="text-align: right"><ix:nonFraction name="CNXA:StockIssuedDuringPeriodSharesAccountsPayable" contextRef="From2023-05-012023-07-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">67,500</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="CNXA:StockIssuedDuringPeriodValueAccountsPayable" contextRef="From2023-05-012023-07-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">67</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="CNXA:StockIssuedDuringPeriodValueAccountsPayable" contextRef="From2023-05-012023-07-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">559,913</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0440">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0441">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="CNXA:StockIssuedDuringPeriodValueAccountsPayable" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">559,980</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_zV56MQfYRn37" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Acquisition</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20230501__20230731__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zBiPs2CHZLH6" title="Acquisitions, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" contextRef="From2023-05-012023-07-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,350</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2023-05-012023-07-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2023-05-012023-07-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0448">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0449">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0450">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--StockIssuedDuringPeriodValueCashlessExerciseOfWarrants_zea7ZeaOeFxa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Cashless exercise of warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--StockIssuedDuringPeriodCashlessExerciseOfWarrantsShares_c20230501__20230731__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_znw82xEMBknb" title="Cashless exercise of warrants, shares" style="text-align: right"><ix:nonFraction name="CNXA:StockIssuedDuringPeriodCashlessExerciseOfWarrantsShares" contextRef="From2023-05-012023-07-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">27,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="CNXA:StockIssuedDuringPeriodValueCashlessExerciseOfWarrants" contextRef="From2023-05-012023-07-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">27</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="CNXA:StockIssuedDuringPeriodValueCashlessExerciseOfWarrants" contextRef="From2023-05-012023-07-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">27</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0456">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0457">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0458">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--StockIssuedDuringPeriodValueSatisfactionOfProfitGuaranteeOnNotePayable_zUiRPyOcVCAa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Satisfaction of profit guarantee on note payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_ecustom--StockIssuedDuringPeriodSharesSatisfactionOfProfitGuaranteeOnNotePayable_c20230501__20230731__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z40bnvk1GIge" title="Satisfaction of profit guarantee on note payable, shares" style="text-align: right"><ix:nonFraction name="CNXA:StockIssuedDuringPeriodSharesSatisfactionOfProfitGuaranteeOnNotePayable" contextRef="From2023-05-012023-07-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">93,680</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="CNXA:StockIssuedDuringPeriodValueSatisfactionOfProfitGuaranteeOnNotePayable" contextRef="From2023-05-012023-07-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">94</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="CNXA:StockIssuedDuringPeriodValueSatisfactionOfProfitGuaranteeOnNotePayable" contextRef="From2023-05-012023-07-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">558,200</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0464">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0465">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="CNXA:StockIssuedDuringPeriodValueSatisfactionOfProfitGuaranteeOnNotePayable" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">558,294</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_zKj7IGpcPPHl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Share-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0470">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0471">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0472">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0473">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0474">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_zRFbhaBluhx1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Change in comprehensive income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0476">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0477">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2023-05-012023-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">27,020</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0479">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">27,020</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_400_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_zPydk9KIViH5" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left">Change in comprehensive income (loss)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0482">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0483">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2023-05-012023-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">27,020</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0485">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">27,020</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_40C_eus-gaap--NetIncomeLoss_zZxSzOydsb0g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net loss for the period</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0488">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0489">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0490">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-05-012023-07-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">846,765</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">846,765</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_437_c20230501__20230731_eus-gaap--StockholdersEquity_iE_zqGxQ4llpyn6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Balance - July 31, 2023</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--SharesOutstanding_iE_c20230501__20230731__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zaLUmyRP5WL" title="Balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-07-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">528,297</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-07-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">528</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-07-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">134,112,083</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">115,492</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-07-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">152,597,375</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">18,369,272</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_43E_c20230501__20230731_eus-gaap--StockholdersEquity_iE_zeDWyv9o9DMe" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Balance</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--SharesOutstanding_iE_c20230501__20230731__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z50mFULCWBka" title="Balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-07-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">528,297</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-07-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">528</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-07-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">134,112,083</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">115,492</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-07-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">152,597,375</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">18,369,272</ix:nonFraction></td><td style="text-align: left">)</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these unaudited consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 86; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="MS_004"></span>CONNEXA SPORTS TECHNOLOGIES, INC</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONSOLIDATED STATEMENTS OF CASH FLOWS (IN US$) (UNAUDITED)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THREE MONTHS ENDED JULY 31, 2023 AND 2022</b></span></p>



<p style="text-align: center; margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_305_112_zBCWozjaClW9" summary="xdx: Statement - Consolidated Statements of Cash Flows (Unaudited)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_494_20230501__20230731_zp2YF9BbgX2k" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49A_20220501__20220731_zNi0j4XkxKe3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_zuuJYYyiWeEf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">CASH FLOW FROM OPERATING ACTIVITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--NetIncomeLoss_i01_maNCPBUzqTM_z1KckvpMLuw7" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 64%; text-align: left">Net loss</td><td style="width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">846,765</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-05-012022-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,266,431</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B_z7GWfHqSVWP1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Adjustments to reconcile net loss to net cash used in operating activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DepreciationAndAmortization_i02_maATRNIzVvB_zKdVp7NDCKx1" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Depreciation, amortization and impairment expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">115,072</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0520">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--DerivativeGainLossOnDerivativeNet_i02N_di_msATRNIzVvB_zdktORHao5th" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Change in fair value of derivative liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,144,554</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2022-05-012022-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,687,495</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_400_eus-gaap--IssuanceOfStockAndWarrantsForServicesOrClaims_i02_maATRNIzVvB_zrg7hz155Tq5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Shares and warrants issued for services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0525">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" contextRef="From2022-05-012022-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,250</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--ShareBasedCompensation_i02_maATRNIzVvB_zgdx1VlEofje" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Share-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0528">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2022-05-012022-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">277,625</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--GainLossOnSaleOfOtherAssets_i02N_di_msATRNIzVvB_z5cTwvy9PKX2" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Loss on disposal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--GainLossOnChangeInFairValueOfContingentConsideration_i02N_di_msATRNIzVvB_zPHYntRJFyji" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Change in fair value of contingent consideration</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--GainsLossesOnExtinguishmentOfDebt_i02N_di_msATRNIzVvB_zEP5E9JDqwOc" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Loss on extinguishment of debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--AmortizationOfDebtDiscountPremium_i02_maATRNIzVvB_zCLg35uDCOVc" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Amortization of debt discounts</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">777,192</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2022-05-012022-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,872,222</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--DerivativeExpense_i02_maATRNIzVvB_z7NdayAzRbnl" style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Derivative expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--NoncashTransactionCosts_i02_maATRNIzVvB_zWW9ZyRlmcti" style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Non-cash transaction costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--SettlementExpense_i02_maATRNIzVvB_zV8fr4XiOIh3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Settlement expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="CNXA:SettlementExpense" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">558,294</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0550">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--LossOnSettlementOfAccountsPayable_i02_maATRNIzVvB_zqIxY4UFBLxj" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Loss on settlement of accounts payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="CNXA:LossOnSettlementOfAccountsPayable" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">289,980</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0553">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--GainLossOnIssuanceOfConvertibleNotes_i02N_di_msATRNIzVvB_zr1z4IUQLQF3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Loss on conversion of convertible notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0555">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0556">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i02B_z546nAmJUmh3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; font-weight: bold; text-align: left">Changes in assets and liabilities, net of acquired amounts</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--IncreaseDecreaseInAccountsReceivable_i03N_di_msATRNIzVvB_zfuLYOT4Xtf" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Accounts receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">265,992</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0562">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--IncreaseDecreaseInInventories_i03N_di_msATRNIzVvB_zl4x917AV6Vb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt">Inventories</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">852,848</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0565">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--IncreaseDecreaseInPrepaidInventory_i03N_di_msATRNIzVvB_zEwwfE3KFxK9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Prepaid inventory</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="CNXA:IncreaseDecreaseInPrepaidInventory" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">197,429</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0568">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_i03N_di_msATRNIzVvB_zvX7AeiCjzm3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Prepaid expenses and other current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,316</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0571">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_i03_maATRNIzVvB_zX5BpnPdvDJa" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Accounts payable and accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">255,199</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0574">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--IncreaseDecreaseInContractWithCustomerLiability_i03_maATRNIzVvB_zsBoMnnbHGIf" style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Contract liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--IncreaseDecreaseInOtherCurrentLiabilities_i03_maATRNIzVvB_zxsOUBqrWxS1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Other current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">326,550</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0580">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--IncreaseDecreaseInInterestPayableNet_i03_maATRNIzVvB_zaftxttmkxy8" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Accrued interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInInterestPayableNet" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,135</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0583">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--IncreaseDecreaseInInterestPayableRelatedParty_i03_maATRNIzVvB_zg7zS7xndWA" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Accrued interest - related parties</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0585">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0586">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_i03T_mtATRNIzVvB_maNCPBUzqTM_zKqdyKQG4QU7" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Total adjustments</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,113,963</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" contextRef="From2022-05-012022-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">502,398</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_iT_maNCPBUzqeE_mtNCPBUzqTM_zMsxeM3cZIQ4" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold; text-align: left">Net cash used in operating activities of continuing operations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">267,198</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" contextRef="From2022-05-012022-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,768,829</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_maNCPBUzqeE_zpGA7832g4wk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; font-weight: bold; text-align: left">Net cash provided by operating activities of discontinued operations</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0594">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0595">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iT_mtNCPBUzqeE_maCCERCzQ9U_zFrfycGDsXd5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold; text-align: left">Net cash used in operating activities</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">267,198</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2022-05-012022-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,768,829</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_z35dO6WYCXnf" style="display: none; vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">CASH FLOWS FROM INVESTING ACTIVITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--CashAcquiredFromAcquisition_i01_maNCPBUzksP_z87gKBnCI79l" style="display: none; vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Cash acquired as part of Gameface acquisition</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--PaymentsToAcquireNotesReceivable_i01N_di_msNCPBUzksP_z2H2f3pvdYy2" style="display: none; vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Note receivable issuance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_i01T_mtNCPBUzksP_maNCPBUzaFo_zCiH0OZAByE1" style="display: none; vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Net cash used in investing activities of continuing operations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_i01_maNCPBUzaFo_zEARsCGYgXl2" style="display: none; vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Net cash provided by operating activities of discontinued operations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_mtNCPBUzaFo_maCCERCzQ9U_zsrTDRA6m9Qi" style="display: none; vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Net cash used in investing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zda1MRA4apr8" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">CASH FLOWS FROM FINANCING ACTIVITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--ProceedsFromIssuanceOfCommonStock_i01_maNCPBUzeDS_z6UxQmLvUzl4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Proceeds from issuance of common stock for cash</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0621">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2022-05-012022-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,195,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--PaymentsOfDebtIssuanceCosts_i01N_di_msNCPBUzeDS_zfk40LdMqbd5" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Debt issuance costs on convertible notes payable and other financing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--ProceedsFromNotesPayable_i01_maNCPBUzeDS_zAiNkz044uQ" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Proceeds from notes payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0627">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromNotesPayable" contextRef="From2022-05-012022-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">925,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--ProceedsFromRelatedPartyDebt_i01_maNCPBUzeDS_zXg69A02l2cc" style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Proceeds from related party notes payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--ProceedsFromConvertibleDebt_i01_maNCPBUzeDS_zg6RchKFrNn5" style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Proceeds from convertible notes payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--RepaymentsOfRelatedPartyDebt_i01N_di_msNCPBUzeDS_zv2By6H0EZl1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Payments of notes payable - related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfRelatedPartyDebt" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">298,834</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfRelatedPartyDebt" contextRef="From2022-05-012022-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,386</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40F_eus-gaap--RepaymentsOfNotesPayable_i01N_di_msNCPBUzeDS_zHU9bS0WiQK3" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Payments of notes payable</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfNotesPayable" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">302,168</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfNotesPayable" contextRef="From2022-05-012022-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,698,485</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_405_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_mtNCPBUzeDS_maCCERCzQ9U_zHq1ll8araIg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; font-weight: bold; text-align: left">Net cash provided by financing activities</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">601,002</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2022-05-012022-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,406,129</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_maCCERCzQ9U_zhhqzjkLoHi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Effect of exchange rate fluctuations on cash and cash equivalents</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">17,996</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="From2022-05-012022-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">67,357</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_mtCCERCzQ9U_zWNrbzZdWCWj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">NET DECREASE IN CASH AND RESTRICTED CASH</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">351,800</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2022-05-012022-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,295,343</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iS_zZZ3uQaGZNLl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">CASH AND RESTRICTED CASH - BEGINNING OF PERIOD</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">202,095</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">665,002</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iNE_di_z5ZRLZ9j3ws7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">CASH AND RESTRICTED CASH - END OF PERIOD</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">149,705</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2022-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">630,341</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--SupplementalCashFlowInformationAbstract_iB_z5P9rtKU4gT4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">CASH PAID DURING THE PERIOD FOR:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--InterestPaidNet_i01_z883DE64RG9a" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Interest expense</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0660">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0661">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--IncomeTaxesPaidNet_i01_zTSwvLxkK32" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Income taxes</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0663">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0664">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--NoncashInvestingAndFinancingItemsAbstract_iB_zLZrjJNJCey1" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">SUPPLEMENTAL INFORMATION - NON-CASH INVESTING AND FINANCING ACTIVITIES:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--StockIssued1_i01_z1W35OyWlxe" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left">Shares issued in connection with acquisition</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--ConversionOfConvertibleNotesPayableAndAccruedInterestToCommonStock_i01_zh9cvzy75gwj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Conversion of convertible notes payable and accrued interest to common stock</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0672">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="CNXA:ConversionOfConvertibleNotesPayableAndAccruedInterestToCommonStock" contextRef="From2022-05-012022-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,046,300</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--SharesIssuedForContingentConsideration_i01_zG2fUEe9m9E9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Shares issued for contingent consideration</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0675">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="CNXA:SharesIssuedForContingentConsideration" contextRef="From2022-05-012022-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">915,545</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--EliminationOfRelatedPartyDerivativeLiabilities_i01_zFtjcT0cshx8" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Elimination of related party derivative liabilities</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--DerivativeLiabilitiesRecordedAsDebtDiscountsOfConvertibleNotes_i01_zPJszI09VWnh" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Derivative liabilities recorded as debt discounts of convertible notes</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--DerivativeLiabilityRecordedForSharesAndWarrantsIssuedInPrivatePlacement_i01_zZHYmnTb2hSl" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Derivative liability recorded for shares and warrants issued in private placement</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--SharesIssuedForSettlementOfAccountsPayable_i01_z1u5mhlRC7N8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Shares issued for settlement of accounts payable</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="CNXA:SharesIssuedForSettlementOfAccountsPayable" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">270,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0688">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--NotesIssued1_i01_z6SZg2UJcSh3" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left">Note receivable issued in sale of PlaySight</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these unaudited consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 87; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_04E_c20230501__20230731_z7R1eQwzK5uf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="MS_005"></span>CONNEXA
SPORTS TECHNOLOGIES INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<ix:nonNumeric contextRef="From2023-05-01to2023-07-31" escape="true" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"><p id="xdx_80C_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zIECnxm6DOkj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
1: <span id="xdx_82C_z9SjvE1EOv06">ORGANIZATION AND NATURE OF BUSINESS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Organization</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lazex
Inc. (&#8220;Lazex&#8221;) was incorporated under the laws of the State of Nevada on July 12, 2015. On August 23, 2019, the majority
owner of Lazex entered into a Stock Purchase Agreement with Slinger Bag Americas Inc., a Delaware corporation (&#8220;Slinger Bag Americas&#8221;),
which was <span id="xdx_908_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20190823__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SlingerBagAmericasIncMember_zb0Kp5zOX4h1" title="Percentage of ownership"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2019-08-23_custom_SlingerBagAmericasIncMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% owned by Slinger Bag Ltd. (&#8220;SBL&#8221;), an Israeli company. In connection with the Stock Purchase Agreement, Slinger
Bag Americas acquired <span id="xdx_900_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_pid_c20190823__20190823__us-gaap--BusinessAcquisitionAxis__custom--SlingerBagAmericasIncMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember_zWW7shUyWnLf" title="Number of shares issued for acquisition"><ix:nonFraction name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" contextRef="From2019-08-232019-08-23_custom_SlingerBagAmericasIncMember_custom_StockPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,000</ix:nonFraction></span> shares of common stock of Lazex for $<span id="xdx_90B_eus-gaap--BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_iI_c20190823__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--SlingerBagAmericasIncMember_z5FRoT0zmPo6" title="Number of value issued for acquisition"><ix:nonFraction name="us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" contextRef="AsOf2019-08-23_custom_StockPurchaseAgreementMember_custom_SlingerBagAmericasIncMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">332,239</ix:nonFraction></span>. On September 16, 2019, SBL transferred its ownership of Slinger
Bag Americas to Lazex in exchange for the <span id="xdx_90D_ecustom--NumberOfSharesExchanged_pid_c20190916__20190916__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SlingerBagAmericasIncMember_z14jzn0f0qY7" title="Number of shares exchanged"><ix:nonFraction name="CNXA:NumberOfSharesExchanged" contextRef="From2019-09-162019-09-16_custom_SlingerBagAmericasIncMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,000</ix:nonFraction></span> shares of Lazex acquired on August 23, 2019. As a result of these transactions, Lazex
owned <span id="xdx_904_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20190916__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SlingerBagAmericasIncMember_zQHBxu41BHwi" title="Percentage of ownership"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2019-09-16_custom_SlingerBagAmericasIncMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of Slinger Bag Americas and the sole shareholder of SBL owned <span id="xdx_907_ecustom--NumberOfSharesOwned_pid_c20190916__20190916__us-gaap--BusinessAcquisitionAxis__custom--SoleShareholderofSBLMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember_zLZixwULw6f4" title="Number of shares owned"><ix:nonFraction name="CNXA:NumberOfSharesOwned" contextRef="From2019-09-162019-09-16_custom_SoleShareholderofSBLMember_custom_StockPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,000</ix:nonFraction></span> shares of common stock (approximately <span id="xdx_905_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20190916__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SoleShareholderofSBLMember_zwL9qIftaEje" title="Percentage of ownership"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2019-09-16_custom_SoleShareholderofSBLMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">82</ix:nonFraction></span>%) of Lazex.
Effective September 13, 2019, Lazex changed its name to Slinger Bag Inc.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 31, 2019, Slinger Bag Americas acquired control of Slinger Bag Canada, Inc., (&#8220;Slinger Bag Canada&#8221;) a Canadian company
incorporated on November 3, 2017. There were no assets, liabilities or historical operational activity of Slinger Bag Canada.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 10, 2020, Slinger Bag Americas became the <span id="xdx_90F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20200210__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SlingerBagAmericasIncMember_zZjqFjug4zXk" title="Percentage of ownership"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2020-02-10_custom_SlingerBagAmericasIncMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% owner of SBL, along with SBL&#8217;s wholly owned subsidiary Slinger Bag International
(UK) Limited (&#8220;Slinger Bag UK&#8221;), which was formed on April 3, 2019. On February 10, 2020, the owner of SBL, contributed Slinger
Bag UK to Slinger Bag Americas for no consideration.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 21, 2021, Slinger Bag Americas entered into a membership interest purchase agreement with Charles Ruddy to acquire a <span id="xdx_90E_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20210621__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FoundationSportsSystemsLLCMember__srt--TitleOfIndividualAxis__custom--CharlesRuddyMember_z48w02DFsOwd" title="Percentage of ownership"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2021-06-21_custom_FoundationSportsSystemsLLCMember_custom_CharlesRuddyMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% ownership
stake in Foundation Sports Systems, LLC (&#8220;Foundation Sports&#8221;). On December 5, 2022, the Company sold <span id="xdx_90C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20221205__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FoundationSportsSystemsLLCMember_zBYj7LVgJNwa" title="Percentage of ownership"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2022-12-05_custom_FoundationSportsSystemsLLCMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">75</ix:nonFraction></span>% of Foundation Sports
back to the original sellers. As a result, at that time, the Company recorded a loss on the sale and deconsolidated Foundation Sports.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 2, 2022, the Company entered into a share purchase agreement with Flixsense Pty, Ltd. (&#8220;Gameface&#8221;). As a result
of the share purchase agreement, Gameface would become a wholly owned subsidiary of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 22, 2022, the Company entered into a merger agreement with PlaySight Interactive Ltd. (&#8220;PlaySight&#8221;) and Rohit Krishnan
(the &#8220;Shareholders&#8217; Representative&#8221;). As a result of the merger agreement, PlaySight would become a wholly owned subsidiary
of the Company. In November 2022, the Company sold PlaySight and recorded a loss on the sale.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 16, 2022, the Company changed its domicile from Nevada to Delaware. On April 7, 2022, the Company effected a name change to Connexa
Sports Technologies Inc. We also changed our ticker symbol, &#8220;CNXA.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 14, 2022, the Company effected a <span id="xdx_90F_eus-gaap--StockholdersEquityReverseStockSplit_c20220614__20220614_zWD2L7dicP9i"><ix:nonNumeric contextRef="From2022-06-142022-06-14" name="us-gaap:StockholdersEquityReverseStockSplit">1-for-10
reverse stock split</ix:nonNumeric></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, where the Company&#8217;s
common stock began to trade on a reverse split adjusted basis. No fractional shares were issued in connection with the reverse stock
split and all such fractional interests were rounded up to the nearest whole number of shares of common stock. All references to the
outstanding stock have been retrospectively adjusted to reflect this reverse stock split. The Company also consummated a public offering
of shares of its common stock and the listing of its common stock on the Nasdaq.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 88; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 26, 2023, the Company received a letter from the Listing Qualifications Department of Nasdaq indicating that the Company&#8217;s
stockholders&#8217; equity as reported in its Quarterly Report on Form 10-Q for the quarterly period ended January 31, 2023 did not satisfy
the continued listing requirement under Nasdaq Listing Rule 5550(b)(1), which requires that a listed company&#8217;s stockholders&#8217;
equity be at least $<span id="xdx_909_eus-gaap--StockholdersEquity_iI_pn5n6_c20230726__srt--RangeAxis__srt--MinimumMember_z8jBgES4xAuh" title="Stockholders equity"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-07-26_srt_MinimumMember" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">2.5</ix:nonFraction></span> million (the &#8220;Minimum Stockholders&#8217; Equity Requirement&#8221;). In addition, the Company did not
meet the alternatives of listed securities or net income from continuing operations as of the date of the letter. The Company timely
submitted a compliance plan to the Panel and on August 23, 2023 received notice from Nasdaq that it has until January 22, 2024 to demonstrate
compliance with the Minimum Stockholders&#8217; Equity Requirement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
can be no assurance that the Company will be able to satisfy the Nasdaq&#8217;s continued listing requirements, regain compliance
with the Rule, the Minimum Stockholders&#8217; Equity Requirement and maintain compliance
with other Nasdaq listing requirements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
further details on PlaySight and Foundation Sports, we refer you to our Annual Report on Form 10-K for the year ended April 30,
2023, filed with the Securities and Exchange Commission on September 14, 2023. This Form 10-K and the consolidated financial statements
will concentrate on our existing business as reflected in the following paragraph.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company operates in the sport equipment and technology business. The Company is the owner of the Slinger Launcher, which is a portable
tennis ball launcher as well as other associated tennis accessories and Gameface AI an Australian artificial intelligence sports software
company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
operations of Slinger Bag Inc., Slinger Bag Americas, Slinger Bag Canada, Slinger Bag UK, SBL, and Gameface are collectively referred
to as the &#8220;Company.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Basis
of Presentation</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying condensed consolidated financial statements of the Company are presented in accordance with accounting principles generally
accepted in the United States of America (&#8220;GAAP&#8221;). As a result of the transactions described above, the accompanying consolidated
financial statements include the combined results of Slinger Bag Inc., Slinger Bag Americas, Slinger Bag Canada, Slinger Bag UK, SBL,
and Gameface for the periods ended July 31, 2023 and 2022. The operations of Foundation Sports and PlaySight are included as discontinued
operations in our statements of operations as these entities were sold in November 2022 and December 2022 for the period ended July 31,
2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Impact
of COVID-19 Pandemic</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company continues to carefully monitor the global COVID-19 pandemic status and its impact on its business. In that regard, while the
Company has continued to sell its products it has previously experienced certain minor disruptions in its supply chains. The Company
expects the significance of the COVID-19 pandemic, including the extent of its effect on the Company&#8217;s financial and operational
results, to be dictated by, among other things, the on-going global efforts to contain it. While the Company has not experienced any
material disruptions to its business and operations as a result of the COVID-19 pandemic, it is possible such disruptions may occur in
the future which may impact its financial and operational results, and which could be material.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 89; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Impact
of Russian and Ukrainian Conflict</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. We are closely monitoring
the unfolding events due to the Russia-Ukraine conflict and its regional and global ramifications. We have one distributor in Russia,
which is not material to our overall financial results. We do not currently have operations in Ukraine or Belarus. We are monitoring
any broader economic impact from the current crisis. The specific impact on the Company&#8217;s financial condition, results of operations,
and cash flows is also not determinable as of the date of these financial statements. However, to the extent that such military action
spreads to other countries, intensifies, or otherwise remains active, such action could have a material adverse effect on our financial
condition, results of operations, and cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-05-01to2023-07-31" escape="true" name="us-gaap:SubstantialDoubtAboutGoingConcernTextBlock"><p id="xdx_804_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zo5YW9xYk8ce" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2: <span id="xdx_82B_zfEFiCkxTaI">GOING CONCERN</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial statements have been prepared on a going concern basis, which assumes the Company will be able to realize its assets and discharge
its liabilities in the normal course of business for the foreseeable future. The Company has an accumulated deficit of $<span id="xdx_909_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_di_c20230731_zvrO36LP53Sc" title="Accumulated deficit"><ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2023-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">152,597,375</ix:nonFraction></span> as
of July 31, 2023, and more losses are anticipated in the development of the business. Accordingly, there is substantial doubt about the
Company&#8217;s ability to continue as a going concern. These financial statements do not include any adjustments related to the recoverability
and classification of assets or the amounts and classification of liabilities that might be necessary should the Company be unable to
continue as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/or being able
to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they
become due. Management intends to finance operating costs over the next twelve months with existing cash on hand, loans from related
parties, and/or private placement of debt and/or common stock. In the event that the Company is unable to successfully raise capital
and/or generate revenues, the Company will likely reduce general and administrative expenses, and cease or delay its development plan
until it is able to obtain sufficient financing. The Company has begun reducing operating expenses and cash outflows by selling PlaySight,
as well as selling <span id="xdx_909_ecustom--DisposalEquityInterestOwnershipInterestPercentage_iI_pid_dp_uPure_c20221130__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--PlaySightMember__us-gaap--BusinessAcquisitionAxis__custom--FoundationSportsSystemsLLCMember_z3siq21eHoRb" title="Discontinuing operations percentage"><span id="xdx_90B_ecustom--DisposalEquityInterestOwnershipInterestPercentage_iI_pid_dp_uPure_c20221231__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--PlaySightMember__us-gaap--BusinessAcquisitionAxis__custom--FoundationSportsSystemsLLCMember_zQKpHzjcrJr1" title="Discontinuing operations percentage"><ix:nonFraction name="CNXA:DisposalEquityInterestOwnershipInterestPercentage" contextRef="AsOf2022-11-30_custom_PlaySightMember_custom_FoundationSportsSystemsLLCMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure"><ix:nonFraction name="CNXA:DisposalEquityInterestOwnershipInterestPercentage" contextRef="AsOf2022-12-31_custom_PlaySightMember_custom_FoundationSportsSystemsLLCMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">75</ix:nonFraction></ix:nonFraction></span></span>% of Foundation Sports in November and December 2022, respectively to the former shareholders of those companies.
There can be no assurance that additional funds will be available on terms acceptable to the Company, or at all. We have recorded the
<span id="xdx_900_eus-gaap--DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal_pid_dp_uPure_c20230501__20230731__us-gaap--BusinessAcquisitionAxis__custom--FoundationSportsSystemsLLCMember_zRIWUx4TSfs2" title="Investment retained after disposal, ownership interest after disposal"><ix:nonFraction name="us-gaap:DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal" contextRef="From2023-05-012023-07-31_custom_FoundationSportsSystemsLLCMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">25</ix:nonFraction></span>% investment in Foundation Sprots at $<span id="xdx_90B_eus-gaap--AlternativeInvestment_iI_dp_c20230731__us-gaap--BusinessAcquisitionAxis__custom--FoundationSportsSystemsLLCMember_zP3AoFqVMwt8" title="Investment amount"><ix:nonFraction name="us-gaap:AlternativeInvestment" contextRef="AsOf2023-07-31_custom_FoundationSportsSystemsLLCMember" format="ixt:numdotdecimal" decimals="0" scale="-2" unitRef="USD">0</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-05-01to2023-07-31" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_80D_eus-gaap--SignificantAccountingPoliciesTextBlock_zcgpH5YnIzIh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
3: <span id="xdx_827_zryQOHZAwtc6">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<ix:nonNumeric contextRef="From2023-05-01to2023-07-31" escape="true" name="CNXA:InterimFinancialStatementsPolicyTextBlock"><p id="xdx_84B_ecustom--InterimFinancialStatementsPolicyTextBlock_z3ReT6v36Rv2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_863_zq2qmsTvlyJ8">Interim
Financial Statements</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying condensed financial statements of the Company have been prepared without audit, pursuant to the rules and regulations of
the Securities and Exchange Commission. Certain information and disclosures required by accounting principles generally accepted in the
United States have been condensed or omitted pursuant to such rules and regulations. These condensed financial statements reflect all
adjustments that, in the opinion of management, are necessary to present fairly the results of operations of the Company for the period
presented. The results of operations for the three months ended July 31, 2023, are not necessarily indicative of the results that may
be expected for any future period or the fiscal year ending April 30, 2024 and should be read in conjunction with the Company&#8217;s
Annual Report on Form 10-K for the year ended April 30, 2023, filed with the Securities and Exchange Commission on September 14, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-05-01to2023-07-31" escape="true" name="us-gaap:UseOfEstimates"><p id="xdx_843_eus-gaap--UseOfEstimates_zIkrIaVahK7d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86C_zzrlLoow2ZNe">Use
of Estimates</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect
the amounts reported in the financial statements and accompanying notes. Accordingly, actual results could differ from those estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-05-01to2023-07-31" escape="true" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription"><p id="xdx_84A_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zr5w94rNkM43" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86F_zbnq689LntWg">Financial
Statement Reclassification</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
prior year amounts within accounts payable, accrued expenses, and certain operating expenses have been reclassified for consistency with
the current year presentation and had no effect on the Company&#8217;s balance sheet, net loss, shareholders&#8217; deficit or cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 90; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-05-01to2023-07-31" escape="true" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock"><p id="xdx_84B_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zhD2tR7itqmd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_861_zSHAEa0JHxjh">Cash
and Cash Equivalents</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents.
The majority of payments due from banks for credit card transactions process within 24 to 48 hours and are accordingly classified as
cash and cash equivalents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-05-01to2023-07-31" escape="true" name="us-gaap:TradeAndOtherAccountsReceivablePolicy"><p id="xdx_841_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zPN1BOFN4m35" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_863_zPz2KWLalQB8">Accounts
Receivable</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s accounts receivable are non-interest bearing trade receivables resulting from the sale of products and payable over terms
ranging from 15 to 60 days. The Company provides an allowance for doubtful accounts at the point when collection is considered doubtful.
Once all collection efforts have been exhausted, the Company charges-off the receivable with the allowance for doubtful accounts. The
Company recorded $<span id="xdx_907_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pdp0_do_c20230731_zhmumFZM17wi" title="Allowance for doubtful accounts"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" contextRef="AsOf2023-07-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">200,000</ix:nonFraction></span> and $<span id="xdx_90D_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pdp0_do_c20230430_zHacZLXt7vVi" title="Allowance for doubtful accounts"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">209,690</ix:nonFraction></span> in allowance for doubtful accounts as of July 31, 2023 and April 30, 2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-05-01to2023-07-31" escape="true" name="us-gaap:InventoryPolicyTextBlock"><p id="xdx_840_eus-gaap--InventoryPolicyTextBlock_zRZiyRgkdyL" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_861_zAr5yrHEeHy7">Inventory</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory
is valued at the lower of the cost (determined principally on a first-in, first-out basis) or net realizable value. The Company&#8217;s
valuation of inventory includes inventory reserves for inventory that will be sold below cost and the impact of inventory shrink. Inventory
reserves are based on historical information and assumptions about future demand and inventory shrink trends. The Company&#8217;s inventory
as of July 31, 2023 and April 30, 2023 consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2023-05-01to2023-07-31" escape="true" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock"><p id="xdx_890_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zf97HVif52hc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B6_zoqiVAt0juPa" style="display: none">SCHEDULE OF INVENTORY</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_491_20230731_zE6h5LaOen1g" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">July 31, 2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_492_20230430_ziGSNULllzaa" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">April 30, 2023</td><td style="font-weight: bold">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--InventoryFinishedGoods_iI_maINzzOV_zXcYG5jS1aEb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Finished Goods</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:InventoryFinishedGoods" contextRef="AsOf2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">400,598</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:InventoryFinishedGoods" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,509,985</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--InventoryRawMaterialsAndSupplies_iI_maINzzOV_z45YZrOaZ1fb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Component/Replacement Parts</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InventoryRawMaterialsAndSupplies" contextRef="AsOf2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,064,041</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InventoryRawMaterialsAndSupplies" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,712,553</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--CapitalizedDutyAndFreight_iI_maINzzOV_zqWK1brM4sCc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Capitalized Duty/Freight</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="CNXA:CapitalizedDutyAndFreight" contextRef="AsOf2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">47,279</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="CNXA:CapitalizedDutyAndFreight" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">517,228</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--InventoryAdjustments_iNI_di_msINzzOV_ztNimEQags14" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Inventory Reserve</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:InventoryAdjustments" contextRef="AsOf2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">175,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:InventoryAdjustments" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">550,000</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--InventoryNet_iTI_mtINzzOV_zZKqAyFQU6p8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Total</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,336,918</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,189,766</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A2_zHURQhQOcA4b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-05-01to2023-07-31" escape="true" name="CNXA:PrepaidInventoryPolicyTextBlock"><p id="xdx_84D_ecustom--PrepaidInventoryPolicyTextBlock_zmMnuOG8vY0f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_864_zDDc8lVOgI7j">Prepaid
Inventory</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid
inventory represents inventory that is in-transit that has been paid for but not received from the Company&#8217;s third-party vendors.
The Company typically prepays for the purchase of materials and receives the products within three months after making payments. The
Company continuously monitors delivery from, and payments to, the vendors. If the Company has difficulty receiving products from a vendor,
the Company would cease purchasing products from such vendors in future periods. The Company has not had difficulty receiving products
during the reporting periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-05-01to2023-07-31" escape="true" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock"><p id="xdx_84B_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zRJYPi8gDXoi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86A_zm2FNh7RXyGh">Property
and equipment</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment acquired through business combinations are stated at the estimated fair value at the date of the acquisition. Purchases
of property and equipment are stated at cost, net of accumulated depreciation and impairment losses. Expenditures that materially increase
the useful life of the assets are capitalized. Ordinary repairs and maintenance are expensed as incurred. Depreciation and amortization
are computed using the straight-line method over the estimated useful lives of the related assets, which is an average of <span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230731_zi4ZPPFFOzyh" title="Property plant and equipment, useful life"><ix:nonNumeric contextRef="AsOf2023-07-31" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">5</ix:nonNumeric></span> years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-05-01to2023-07-31" escape="true" name="us-gaap:ConcentrationRiskCreditRisk"><p id="xdx_840_eus-gaap--ConcentrationRiskCreditRisk_zcbmzjBRP1f3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_866_zuHXeODpB3a4">Concentration
of Credit Risk</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company maintains its cash in bank deposit accounts, the balances of which at times may exceed insured limits. The Company continually
monitors its banking relationships and consequently has not experienced any losses in such accounts. While we may be exposed to credit
risk, we consider the risk remote and do not expect that any such risk would result in a significant effect on our results of operations
or financial condition. See Note 4 for further details on the Company&#8217;s concentration of credit risk as well as other risks and
uncertainties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 91; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-05-01to2023-07-31" escape="true" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock"><p id="xdx_84E_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zy1IUkRinSj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_867_zw8cnRxFDc0e">Revenue
Recognition</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes revenue for their continuing operations in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 606,
the core principle of which is that an entity should recognize revenue to depict the transfer of promised goods or services to customers
in an amount that reflects the consideration to which the entity expects to be entitled to receive in exchange for those goods or services.
The Company recognizes revenue for its performance obligation associated with its contracts with customers at a point in time once products
are shipped. Amounts collected from customers in advance of shipping products ordered are reflected as contract liabilities on the accompanying
consolidated balance sheets. The Company&#8217;s standard terms are non-cancelable and do not provide for the right-of-return, other
than for defective merchandise covered under the Company&#8217;s standard warranty. The Company has not historically experienced any
significant returns or warranty issues.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes revenue under ASC 606, &#8220;Revenue from Contracts with Customers&#8221;. The core principle of this revenue standard
is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects
the consideration to which the company expects to be entitled in exchange for those goods or services. The following five steps are applied
to achieve that core principle:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step
1: Identify the contract with the customer</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company determines that it has a contract with a customer when each party&#8217;s rights regarding the products or services to be transferred
can be identified, the payment terms for the services can be identified, the Company has determined the customer has the ability and
intent to pay, and the contract has commercial substance. At contract inception, the Company evaluates whether two or more contracts
should be combined and accounted for as a single contract and whether the combined or single contract includes more than one performance
obligation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step
2: Identify the performance obligations in the contract</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s customers are buying an integrated system. In evaluating whether the equipment is a separate performance obligation,
the Company&#8217;s management considered the customer&#8217;s ability to benefit from the equipment on its own or together with other
readily available resources and if so, whether the service and equipment are separately identifiable (i.e., is the service highly dependent
on, or highly interrelated with the equipment). Because the Products and Services included in the customer&#8217;s contract are integrated
and highly interdependent, and because they must work together to deliver the Solution, the Company has concluded that Products installed
on customer&#8217;s premise and Services contracted for by the customer are generally not distinct within the context of the contract
and, therefore, constitute a single, combined performance obligation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step
3: Determine the transaction price</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
transaction price is the amount of consideration to which an entity expects to be entitled in exchange for transferring promised goods
or services to a customer. The consideration promised in a contract with a customer includes predetermined fixed amounts, variable amounts,
or both. The Company&#8217;s contracts do not include any rights of returns or refunds.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company collects each year&#8217;s service fees in advance and should therefore consider the existence of a significant financing component.
However, due to the fact that the payments are provided for the service of a one-year term, the Company elected to apply the practical
expedient under ASC 606 which exempts the adjustment of the consideration for the existence of a significant financing component when
the period between the transfer of the services and the payment for such services is one year or less.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step
4: Allocate the transaction price to the performance obligations in the contract</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contracts
that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on
each performance obligation&#8217;s relative standalone selling price (&#8220;SSP&#8221;). The Company has identified a single performance
obligation in the contract, and therefore, the allocation provisions under ASC 606 do not apply to the Company&#8217;s contracts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 92; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step
5: Recognize revenue when the Company satisfies a performance obligation</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues
for the Company&#8217;s single, combined performance obligation are recognized on a straight-line basis over the customer&#8217;s contract
term, which is the period in which the parties to the contract have enforceable rights and obligations (Typically 3-4 years).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-05-01to2023-07-31" escape="true" name="us-gaap:BusinessCombinationsPolicy"><p id="xdx_84E_eus-gaap--BusinessCombinationsPolicy_zMxLHHnW5pb1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_868_zraUzDeO6OYj">Business
Combinations</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
acquisition of a company, we determine if the transaction is a business combination, which is accounted for using the acquisition method
of accounting. Under the acquisition method, once control is obtained of a business, the assets acquired, and liabilities assumed, are
recorded at fair value. We use our best estimates and assumptions to assign fair value to the tangible and intangible assets acquired
and liabilities assumed at the acquisition date. One of the most significant estimates relates to the determination of the fair value
of these assets and liabilities. The determination of the fair values is based on estimates and judgments made by management. Our estimates
of fair value are based upon assumptions we believe to be reasonable, but which are inherently uncertain and unpredictable. Measurement
period adjustments are reflected at the time identified, up through the conclusion of the measurement period, which is the time at which
all information for determination of the values of assets acquired and liabilities assumed is received and is not to exceed one year
from the acquisition date. We may record adjustments to the fair value of these tangible and intangible assets acquired and liabilities
assumed, with the corresponding offset to goodwill. The Company elected to apply pushdown accounting to all entities acquired.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
uncertain tax positions and tax-related valuation allowances are initially recorded in connection with a business combination as of the
acquisition date. We continue to collect information and reevaluate these estimates and assumptions periodically and record any adjustments
to preliminary estimates to goodwill, provided we are within the measurement period. If outside of the measurement period, any subsequent
adjustments are recorded to the consolidated statement of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-05-01to2023-07-31" escape="true" name="us-gaap:FairValueOfFinancialInstrumentsPolicy"><p id="xdx_845_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zWhCbAGBHus2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86E_zaoTLTt5EeV3">Fair
Value of Financial Instruments</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
value of financial and non-financial assets and liabilities is defined as an exit price, representing the amount that would be received
to sell an asset or paid to transfer a liability in an orderly transaction between market participants. The three-tier hierarchy for
inputs used in measuring fair value, which prioritizes the inputs used in the methodologies of measuring fair value for assets and liabilities,
is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
1 &#8212; Quoted prices in active markets for identical assets or liabilities</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
2 &#8212; Observable inputs other than quoted prices in active markets for identical assets and liabilities</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
3 &#8212; Unobservable pricing inputs in the market</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
assets and financial liabilities are classified in their entirety based on the lowest level of input that is significant to the fair
value measurements. Our assessment of the significance of a particular input to the fair value measurements requires judgment and may
affect the valuation of the assets and liabilities being measured and their categorization within the fair value hierarchy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s financial instruments consist of cash and cash equivalents, accounts receivable, and accounts payable. The carrying amount
of these financial instruments approximates fair value due to their short-term maturity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s contingent consideration in connection with the acquisition of Gameface was calculated using Level 3 inputs. The fair
value of contingent consideration as of July 31, 2023 and April 30, 2023 was $<span id="xdx_90D_eus-gaap--BusinessCombinationConsiderationTransferred1_c20230501__20230731__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zAYKla0QEGTb" title="Fair value of contingent consideration"><ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferred1" contextRef="From2023-05-012023-07-31_us-gaap_FairValueInputsLevel3Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD">418,455</ix:nonFraction></span> and $<span id="xdx_908_eus-gaap--BusinessCombinationConsiderationTransferred1_c20220501__20230430__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z2qpHLFJ4zb1" title="Fair value of contingent consideration"><ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferred1" contextRef="From2022-05-012023-04-30_us-gaap_FairValueInputsLevel3Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD">418,455</ix:nonFraction></span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company estimates the fair value of its intangible assets using Level 3 assumptions, primarily based on the income approach utilizing
the discounted cash flow method.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 93; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s derivative liabilities were calculated using Level 2 assumptions on the issuance and balance sheet dates via a Black-Scholes
option pricing model and consisted of the following ending balances and gain amounts as of and for the three months ended July 31, 2023:</span></p>

<ix:nonNumeric contextRef="From2023-05-01to2023-07-31" escape="true" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock"><p id="xdx_89F_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_zv0dvk3LFGO3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BB_zkFsh03XdvSa" style="display: none">SCHEDULE OF DERIVATIVE LIABILITIES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Note derivative is related to</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">July 31, 2023</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">ending balance</p></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">(Gain) loss for the</p>
                                                                                                    <p style="margin-top: 0; margin-bottom: 0">three months ended</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">July 31, 2023</p></td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">4/11/21 profit guaranty</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--ProfitGuarantyMember_zDJadryzbuC2" title="Note derivative balance" style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:DerivativeInstrumentsAndHedgesLiabilities" contextRef="AsOf2023-07-31_custom_ProfitGuarantyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,456,854</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20230501__20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--ProfitGuarantyMember_zHh9mPuqcsS7" title="Note derivative (gain) loss" style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0787">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">8/6/21 convertible notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--ConvertibleNotesMember_zcQdpsaz83l1" title="Note derivative balance" style="text-align: right"><ix:nonFraction name="us-gaap:DerivativeInstrumentsAndHedgesLiabilities" contextRef="AsOf2023-07-31_custom_ConvertibleNotesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">74,958</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20230501__20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--ConvertibleNotesMember_zJ1AURkaGhUa" title="Note derivative (gain) loss" style="text-align: right">(<ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2023-05-012023-07-31_custom_ConvertibleNotesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,966</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">6/17/22 underwriter warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--UnderwriterWarrantsMember_z67ge1gtPjuh" title="Underwriter warrants" style="text-align: right"><ix:nonFraction name="us-gaap:DerivativeInstrumentsAndHedgesLiabilities" contextRef="AsOf2023-07-31_custom_UnderwriterWarrantsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,966</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20230501__20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--UnderwriterWarrantsMember_zPpqveywdCy" title="Note derivative (gain) loss" style="text-align: right">(<ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2023-05-012023-07-31_custom_UnderwriterWarrantsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,565</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">9/30/22 warrants issued with common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsIssuedWithCommonStockMember_zxe6iTEE7M98" title="Other derivative liabilities eliminated in uplist" style="text-align: right"><ix:nonFraction name="us-gaap:DerivativeInstrumentsAndHedgesLiabilities" contextRef="AsOf2023-07-31_custom_WarrantsIssuedWithCommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,668,608</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20230501__20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsIssuedWithCommonStockMember_zzgik92kwAIf" title="Note derivative (gain) loss" style="text-align: right">(<ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2023-05-012023-07-31_custom_WarrantsIssuedWithCommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,440,951</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">1/6/2023 warrants issued with note payable</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsIssuedWithNotesPayableMember_zCWepP1a6mqg" title="Other derivative liabilities eliminated in uplist" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:DerivativeInstrumentsAndHedgesLiabilities" contextRef="AsOf2023-07-31_custom_WarrantsIssuedWithNotesPayableMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,139,666</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20230501__20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsIssuedWithNotesPayableMember_zunZlzLuQT98" title="Note derivative (gain) loss" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2023-05-012023-07-31_custom_WarrantsIssuedWithNotesPayableMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">675,072</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">Total</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230731_zLRaRIC2AP9a" title="Note derivative balance" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:DerivativeInstrumentsAndHedgesLiabilities" contextRef="AsOf2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,345,052</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20230501__20230731_zyUgb91QhYpb" title="Note derivative (gain) loss" style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,144,554</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A0_zeamAmoTTs8i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Black-Scholes option pricing model assumptions for the derivative liabilities during the periods ended July 31, 2023 and 2022 consisted
of the following:</span></p>

<ix:nonNumeric contextRef="From2023-05-01to2023-07-31" escape="true" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"><p id="xdx_894_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zxJveoNkqJJ3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B1_zmeSKHeg1jZ8" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE
OF DERIVATIVE AND WARRANTS GRANTED VALUATION USING BLACK-SCHOLES PRICING METHOD</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Period Ended</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">July 31, 2023</p></td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Period Ended</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">July 31, 2022</p></td><td style="font-weight: bold">&#160;</td>
    </tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected life in years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecustom--DerivativeLiabilitiesMeasurementInputTerm_dtY_c20230501__20230731__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zOM7Nc73Uq2c" title="Derivative liabilities Measurement input, term"><ix:nonNumeric contextRef="From2023-05-012023-07-31_srt_MinimumMember_us-gaap_MeasurementInputExpectedTermMember_us-gaap_ValuationTechniqueOptionPricingModelMember" format="ixt-sec:duryear" name="CNXA:DerivativeLiabilitiesMeasurementInputTerm">0.7</ix:nonNumeric></span>-<span id="xdx_906_ecustom--DerivativeLiabilitiesMeasurementInputTerm_dtY_c20230501__20230731__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zRXshLS2zzR2" title="Derivative liabilities Measurement input, term"><ix:nonNumeric contextRef="From2023-05-012023-07-31_srt_MaximumMember_us-gaap_MeasurementInputExpectedTermMember_us-gaap_ValuationTechniqueOptionPricingModelMember" format="ixt-sec:duryear" name="CNXA:DerivativeLiabilitiesMeasurementInputTerm">10</ix:nonNumeric></span> years</span></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_ecustom--DerivativeLiabilitiesMeasurementInputTerm_dtY_c20220501__20220731__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_z0nVauo9IEb6" title="Derivative liabilities measurement input"><ix:nonNumeric contextRef="From2022-05-012022-07-31_srt_MinimumMember_us-gaap_MeasurementInputExpectedTermMember_us-gaap_ValuationTechniqueOptionPricingModelMember" format="ixt-sec:duryear" name="CNXA:DerivativeLiabilitiesMeasurementInputTerm">4</ix:nonNumeric></span>-<span id="xdx_90D_ecustom--DerivativeLiabilitiesMeasurementInputTerm_dtY_c20220501__20220731__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zqEOo8AIaq2c" title="Derivative liabilities measurement input"><ix:nonNumeric contextRef="From2022-05-012022-07-31_srt_MaximumMember_us-gaap_MeasurementInputExpectedTermMember_us-gaap_ValuationTechniqueOptionPricingModelMember" format="ixt-sec:duryear" name="CNXA:DerivativeLiabilitiesMeasurementInputTerm">4.3</ix:nonNumeric></span> years</span></td><td style="text-align: left">&#160;</td>
    </tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 64%">Stock price volatility</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><span id="xdx_904_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230731__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zeMg7ysdKVnf" title="Derivative liability measurement input"><ix:nonFraction name="us-gaap:DerivativeLiabilityMeasurementInput" contextRef="AsOf2023-07-31_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ValuationTechniqueOptionPricingModelMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">150</ix:nonFraction></span></td><td style="width: 1%; text-align: left">%</td>
    <td style="width: 2%; text-align: left">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220731__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__srt--RangeAxis__srt--MinimumMember_zUAxzfGuc3k8" title="Derivative liability measurement input"><ix:nonFraction name="us-gaap:DerivativeLiabilityMeasurementInput" contextRef="AsOf2022-07-31_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ValuationTechniqueOptionPricingModelMember_srt_MinimumMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">50</ix:nonFraction></span>-<span id="xdx_903_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220731__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__srt--RangeAxis__srt--MaximumMember_z9VBkbRCPujc" title="Derivative liability measurement input"><ix:nonFraction name="us-gaap:DerivativeLiabilityMeasurementInput" contextRef="AsOf2022-07-31_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ValuationTechniqueOptionPricingModelMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">148</ix:nonFraction></span></span></td><td style="width: 1%; text-align: left">%</td>
    </tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Risk free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230731__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zYWf0ns4haFi" title="Derivative liability measurement input"><ix:nonFraction name="us-gaap:DerivativeLiabilityMeasurementInput" contextRef="AsOf2023-07-31_srt_MinimumMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_us-gaap_ValuationTechniqueOptionPricingModelMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">4.08</ix:nonFraction></span>%-<span id="xdx_90F_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230731__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zJhudoQoifl" title="Derivative liability measurement input"><ix:nonFraction name="us-gaap:DerivativeLiabilityMeasurementInput" contextRef="AsOf2023-07-31_srt_MaximumMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_us-gaap_ValuationTechniqueOptionPricingModelMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">5.37</ix:nonFraction></span></span></td><td style="text-align: left">%</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220731__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_za4ttfqB5Tdj" title="Derivative liability measurement input"><ix:nonFraction name="us-gaap:DerivativeLiabilityMeasurementInput" contextRef="AsOf2022-07-31_srt_MinimumMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_us-gaap_ValuationTechniqueOptionPricingModelMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">2.90</ix:nonFraction></span>%-<span id="xdx_90A_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220731__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zGntoDYd2FDl" title="Derivative liability measurement input"><ix:nonFraction name="us-gaap:DerivativeLiabilityMeasurementInput" contextRef="AsOf2022-07-31_srt_MaximumMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_us-gaap_ValuationTechniqueOptionPricingModelMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">3.27</ix:nonFraction></span></span></td><td style="text-align: left">%</td>
    </tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Expected dividends</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_902_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230731__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zD8ftCahm3Xa" title="Derivative liability measurement input"><ix:nonFraction name="us-gaap:DerivativeLiabilityMeasurementInput" contextRef="AsOf2023-07-31_us-gaap_MeasurementInputExpectedDividendRateMember_us-gaap_ValuationTechniqueOptionPricingModelMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">0</ix:nonFraction></span></td><td style="text-align: left">%</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220731__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_z2f9hunjDTE8" title="Derivative liability measurement input"><ix:nonFraction name="us-gaap:DerivativeLiabilityMeasurementInput" contextRef="AsOf2022-07-31_us-gaap_MeasurementInputExpectedDividendRateMember_us-gaap_ValuationTechniqueOptionPricingModelMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">0</ix:nonFraction></span></td><td style="text-align: left">%</td>
    </tr>
  </table>

</ix:nonNumeric><p id="xdx_8AC_zQYg66YFzXs6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-05-01to2023-07-31" escape="true" name="us-gaap:IncomeTaxPolicyTextBlock"><p id="xdx_844_eus-gaap--IncomeTaxPolicyTextBlock_zppSzQX0t9Vg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_863_zaywpz6ou28f">Income
Taxes</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
taxes are accounted for in accordance with the provisions of ASC 740, Accounting for Income Taxes. Deferred tax assets and liabilities
are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing
assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected
to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred
tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Valuation
allowances are established, when necessary, to reduce deferred tax assets to the amounts that are more likely than not to be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-05-01to2023-07-31" escape="true" name="us-gaap:IntangibleAssetsFiniteLivedPolicy"><p id="xdx_84E_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zesjwOfLxi9d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86A_zD5DR2xEc4E2">Intangible
Assets</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets relate to the &#8220;Slinger&#8221; technology trademark, which the Company purchased on November 10, 2020. The Company also acquired
intangible assets as a part of the Gameface acquisition. These intangible assets include tradenames, internally developed software, and
customer relationships. The acquired intangible assets are amortized based on the estimated present value of cash flows of each class
of intangible assets in order to determine their economic useful life. During the three months ended July 31, 2023, the Company impaired
their intangible assets down to a nominal value of $<span id="xdx_900_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20230731_zzrz3YtscFX9" title="Impaired intangible assets"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,000</ix:nonFraction></span> as the technology has changed and Management determined the value to be greater
than the fair value of those assets. Refer to Note 5 for more information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-05-01to2023-07-31" escape="true" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"><p id="xdx_847_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zxm3S6rGta88" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_866_z6N84RRVYQK1">Impairment
of Long-Lived Assets</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with ASC 360-10, the Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate
that their net book value may not be recoverable. Factors which could trigger impairment review include significant underperformance
relative to historical or projected future operating results, significant changes in the manner of use of the assets or the strategy
for the overall business, a significant decrease in the market value of the assets or significant negative industry or economic trends.
When such factors and circumstances exist, the Company compares the projected undiscounted future cash flows associated with the related
asset or group of assets over their estimated useful lives against their respective carrying amount. If those net undiscounted cash flows
do not exceed the carrying amount, impairment, if any, is based on the excess of the carrying amount over the fair value based on the
market value or discounted expected cash flows of those assets and is recorded in the period in which the determination is made. The
Company impaired $<span id="xdx_905_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_c20230501__20230731_zfr6CP7eOfEf" title="Impairment of intangible assets"><ix:nonFraction name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">100,281</ix:nonFraction></span> in intangible assets and $<span id="xdx_901_eus-gaap--AssetImpairmentCharges_c20230501__20230731_z5FvrWnHNQ4i" title="Impairment of fixed assets"><ix:nonFraction name="us-gaap:AssetImpairmentCharges" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,791</ix:nonFraction></span> in fixed assets during the three months ended July 31, 2023. Refer to Note
5 for more information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 94; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-05-01to2023-07-31" escape="true" name="us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy"><p id="xdx_843_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_zeF6mMKwyE08" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_863_zUOK4TBL5uS5">Goodwill</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for goodwill in accordance with ASC 350, Intangibles &#8211; Goodwill and Other (&#8220;ASC 350&#8221;). ASC 350 requires
that goodwill not be amortized, but reviewed for impairment if impairment indicators arise and, at a minimum, annually. The Company records
goodwill as the excess purchase price over assets acquired and includes any work force acquired as goodwill. Goodwill is evaluated for
impairment on an annual basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
the adoption of the ASU 2017-04, which eliminates the second step of the goodwill impairment test, the Company tests impairment of goodwill
in one step. In this step, the Company compares the fair value of each reporting unit with goodwill to its carrying value. The Company
determines the fair value of its reporting units with goodwill using a combination of a discounted cash flow and a market value approach.
If the carrying value of the net assets assigned to the reporting unit exceeds the fair value of the reporting unit, the Company will
record an impairment charge based on the excess of a reporting unit&#8217;s carrying amount over its fair value. If the fair value of
the reporting unit exceeds the carrying value of the net assets assigned to that reporting unit, goodwill is not impaired and the Company
will not record an impairment charge.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company impaired all goodwill as of April 30, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-05-01to2023-07-31" escape="true" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy"><p id="xdx_843_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zrn4WeDCwaa8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86A_zXggy9lV9VBf">Share-Based
Payment</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for share-based compensation in accordance with ASC 718, Compensation-Stock Compensation (ASC 718). Under the fair value
recognition provisions of this topic, stock-based compensation cost is measured at the grant date based on the fair value of the award
and is recognized as an expense on a straight-line basis over the requisite service period, which is the vesting period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-05-01to2023-07-31" escape="true" name="CNXA:WarrantsPolicyTextBlock"><p id="xdx_846_ecustom--WarrantsPolicyTextBlock_zQgLZsdCZl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_861_zAmNMHbm5Z9f">Warrants</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company grants warrants to key employees and executives as compensation on a discretionary basis. The Company also grants warrants in
connection with certain note payable agreements and other key arrangements. The Company is required to estimate the fair value of share-based
awards on the measurement date and recognize as expense that value of the portion of the award that is ultimately expected to vest over
the requisite service period. Warrants granted in connection with ongoing arrangements are more fully described in Note 11.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
warrants granted during the periods ended July 31, 2023 and 2022 were valued using a Black-Scholes option pricing model on the date of
grant using the following assumptions:</span></p>

<ix:nonNumeric contextRef="From2023-05-012023-07-31_us-gaap_WarrantMember" escape="true" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"><p id="xdx_89A_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_hus-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_zwUBj2Ktlrbc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B7_zevv4dX2q55a" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE
OF WARRANTS GRANTED VALUATION USING BLACK-SCHOLES PRICING METHOD</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Period Ended</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">July 31, 2023</p></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Period Ended</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">July 31, 2022</p></td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected life in years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;&#160;<span id="xdx_90A_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dxL_c20230731__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_z3Rj0J3GgEx8" title="Warrants measurement input, term::XDX::P0Y"><span style="-sec-ix-hidden: xdx2ixbrl0857">-</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220731__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MinimumMember_z6lktadzpOMc" title="Warrants measurement input, term"><ix:nonNumeric contextRef="AsOf2022-07-31_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputExpectedTermMember_srt_MinimumMember" format="ixt-sec:duryear" name="us-gaap:WarrantsAndRightsOutstandingTerm">5</ix:nonNumeric></span> &#8211; <span id="xdx_90F_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220731__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MaximumMember_zv1e5yHUtgVg" title="Warrants measurement input, term"><ix:nonNumeric contextRef="AsOf2022-07-31_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputExpectedTermMember_srt_MaximumMember" format="ixt-sec:duryear" name="us-gaap:WarrantsAndRightsOutstandingTerm">10</ix:nonNumeric></span> years</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Stock price volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230731__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_zrSfyLGPFr61" title="Warrants measurement input, rate"><span style="-sec-ix-hidden: xdx2ixbrl0863">-</span></span></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220731__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_z5u1bPOjwnR7" title="Warrants measurement input, rate"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2022-07-31_srt_MinimumMember_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">50</ix:nonFraction></span>% - <span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220731__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_z96TgwhrYCQl" title="Warrants measurement input, rate"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2022-07-31_srt_MaximumMember_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">148</ix:nonFraction></span></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Risk free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230731__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zRAoz5ytefj6" title="Warrants measurement input, rate"><span style="-sec-ix-hidden: xdx2ixbrl0869">-</span></span></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220731__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember_zNyzrC9VnPcf" title="Warrants measurement input, rate"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2022-07-31_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MinimumMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">2.50</ix:nonFraction></span>% - <span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220731__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember_zJu0UEQstGkg" title="Warrants measurement input, rate"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2022-07-31_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">3.50</ix:nonFraction></span></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 64%; text-align: left">Expected dividends</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230731__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zIeSl2LJtWth" title="Warrants measurement input, rate"><span style="-sec-ix-hidden: xdx2ixbrl0875">-</span></span></span></td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><span id="xdx_909_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220731__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zrjwzYtj2Wk1" title="Warrants measurement input, rate"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2022-07-31_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputExpectedDividendRateMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">0</ix:nonFraction></span></td><td style="width: 1%; text-align: left">%</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AA_z1yeXYmEtQW8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-05-01to2023-07-31" escape="true" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"><p id="xdx_842_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zdQ42ttIlWX2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Foreign
Currency Translation</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
functional currency is the U.S. dollar. The functional currency of our foreign operations, generally, is the respective local currency
for each foreign subsidiary. Assets and liabilities of foreign operations denominated in local currencies are translated at the spot
rate in effect at the applicable reporting date. Our consolidated statements of comprehensive loss are translated at the weighted average
rate of exchange during the applicable period. The resulting unrealized cumulative translation adjustment is recorded as a component
of accumulated other comprehensive loss in shareholders&#8217; equity. Realized and unrealized transaction gains and losses generated
by transactions denominated in a currency different from the functional currency of the applicable entity are recorded in other income
(loss) in the period in which they occur.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 95; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-05-01to2023-07-31" escape="true" name="us-gaap:EarningsPerSharePolicyTextBlock"><p id="xdx_84F_eus-gaap--EarningsPerSharePolicyTextBlock_za4e88dFSBw" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_867_z8WUWUMhtAEk">Earnings
Per Share</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
earnings per share are calculated by dividing the income available to shareholders by the weighted-average number of common shares
outstanding during each period. Diluted earnings per share are computed using the weighted average number of common and dilutive common
share equivalents outstanding during the period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
common stock equivalents such as shares to be issued for the conversion of notes payable and warrants were excluded from the calculation
of diluted earnings per share as the effect is antidilutive. As a result, the basic and diluted earnings per share are the same for each
of the periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-05-01to2023-07-31" escape="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_842_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zJ7cZEIBYy9i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_868_z6X96o6xT916">Recent
Accounting Pronouncements</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Recently
Adopted</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2017, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU No. 2017-04, Intangibles &#8211; Goodwill and
Other (Topic 350): Simplifying the Test for Goodwill Impairment (&#8220;ASU 2017-04&#8221;), which simplifies how an entity is required
to test goodwill for impairment by eliminating Step 2 from the goodwill impairment test. Under ASU 2017-04, goodwill impairment will
be tested by comparing the fair value of a reporting unit with its carrying amount, and recognizing an impairment charge for the amount
by which the carrying amount exceeds the reporting unit&#8217;s fair value. The new guidance must be applied on a prospective basis and
is effective for periods beginning after December 15, 2022, with early adoption permitted. The Company adopted ASU 2017-04 effective
May 1, 2021. The adoption of the new standard did not have a material effect on the Company&#8217;s consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2019, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;), 2019-12, <i>Simplifying the Accounting for Income Taxes</i>,
which amends ASC 740, <i>Income Taxes</i> (ASC 740). This update is intended to simplify accounting for income taxes by removing certain
exceptions to the general principles in ASC 740 and amending existing guidance to improve consistent application of ASC 740. This update
is effective for fiscal years beginning after December 15, 2021. The guidance in this update has various elements, some of which are
applied on a prospective basis and others on a retrospective basis with earlier application permitted. The adoption of the new standard
did not have a material effect on the Company&#8217;s consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2020, the FASB issued ASU No. 2020-06, Debt &#8211; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives
and Hedging Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s
Own Equity. ASU 2020-06 will simplify the accounting for convertible instruments by reducing the number of accounting models for convertible
debt instruments and convertible preferred stock. Limiting the accounting models results in fewer embedded conversion features being
separately recognized from the host contract as compared with current GAAP. Convertible instruments that continue to be subject to separation
models are (1) those with embedded conversion features that are not clearly and closely related to the host contract, that meet the definition
of a derivative, and that do not qualify for a scope exception from derivative accounting and (2) convertible debt instruments issued
with substantial premiums for which the premiums are recorded as paid-in capital. ASU 2020-06 also amends the guidance for the derivatives
scope exception for contracts in an entity&#8217;s own equity to reduce form-over-substance-based accounting conclusions. ASU 2020-06
will be effective for public companies for fiscal years beginning after December 15, 2023, including interim periods within those fiscal
years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within
those fiscal years. The Company is currently evaluating the impact that the adoption of ASU 2020-06 will have on the Company&#8217;s
consolidated financial statement presentation or disclosures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 96; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2016, the FASB issued ASU 2016-13, Financial Instruments &#8211; Credit Losses (Topic 326): Measurement of Credit Losses on Financial
Instruments (&#8220;ASC 326&#8221;). The guidance replaces the incurred loss methodology with an expected loss methodology that is referred
to as the current expected credit loss (&#8220;CECL&#8221;) methodology. The measurement of expected credit losses under the CECL methodology
is applicable to financial assets measured at amortized cost, including loan receivables and held-to-maturity debt securities. It also
applies to off-balance sheet credit exposures not accounted for as insurance (loan commitments, standby letters of credits, financial
guarantees, and other similar instruments) and net investments in leases recognized by a lessor in accordance with Topic 842 on leases.
ASC 326 requires enhanced disclosures related to the significant estimates and judgments used in estimating credit losses as well as
the credit quality and underwriting standards of a company&#8217;s portfolio. In addition, ASC 326 made changes to the accounting for
available-for-sale debt securities. One such change is to require credit losses to be presented as an allowance rather than as a write-down
on available-for-sale debt securities the Company does not intend to sell or believes that it is more likely than not they will be required
to sell. The ASU can be adopted no later than January 1, 2020 for SEC filers and January 1, 2023 for private companies and smaller reporting
companies. The adoption of the new standard did not have a material effect on the Company&#8217;s consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2021, the FASB issued ASU 2021-08, &#8220;Business Combinations &#8211; Accounting for Contract Assets and Contract Liabilities
(Topic 805)&#8221;. The amendments in this Update address diversity and inconsistency related to the recognition and measurement of contract
assets and contract liabilities acquired in a business combination. The amendments in this Update require that an acquirer recognize
and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606, Revenue from Contracts
with Customers. ASU 2021-08 is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal
years. The adoption of the new standard did not have a material effect on the Company&#8217;s consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
FASB has issued ASU 2021-04, Earnings Per Share (Topic 260), Debt&#8212;Modifications and Extinguishments (Subtopic 470-50), Compensation&#8212;Stock
Compensation (Topic 718), and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40). ASU 2021-04 provides
guidance that an entity should treat a modification of the terms or conditions or an exchange of a freestanding equity-classified written
call option that remains equity classified after modification or exchange as an exchange of the original instrument for a new instrument.
The standard also provides guidance on how an entity should measure and recognize the effect of a modification or an exchange of a freestanding
equity-classified written call option that remains equity classified. The amendments in this ASU are effective for the Company for fiscal
years beginning after December 15, 2021. Early adoption is permitted for all entities, including adoption in an interim period. The adoption
of the new standard did not have a material effect on the Company&#8217;s consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
recently issued accounting pronouncements did not, or are not believed by management to, have a material effect on the Company&#8217;s
present or future consolidated financial statements.</span></p>
<!-- Field: Split-Segment; Name: 001 -->
</ix:nonNumeric><p id="xdx_855_zTHea6aTALfi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-05-01to2023-07-31" escape="true" name="us-gaap:ConcentrationRiskDisclosureTextBlock"><p id="xdx_80F_eus-gaap--ConcentrationRiskDisclosureTextBlock_zHm4faf0TNh6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
4</b>: <b><span id="xdx_827_zS0gHlITecGd">CONCENTRATION OF CREDIT RISK AND OTHER RISKS AND UNCERTAINTIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Accounts
Receivable Concentration</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of July 31, 2023 and April 30, 2023, the Company had two customers that accounted for <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230501__20230731__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CreditConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zWzcr1YPamI9"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2023-05-012023-07-31_us-gaap_AccountsReceivableMember_us-gaap_CreditConcentrationRiskMember_custom_CustomerTwoMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">50</ix:nonFraction></span>% and <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220501__20230430__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CreditConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_ziGcEZALq1J8"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-05-012023-04-30_us-gaap_AccountsReceivableMember_us-gaap_CreditConcentrationRiskMember_custom_CustomerTwoMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">47</ix:nonFraction></span>% of the Company&#8217;s trade receivables
balance, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Accounts
Payable Concentration</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of July 31, 2023 and April 30, 2023, the Company had four significant suppliers that accounted for <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230501__20230731__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--LenderConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerFourMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember_z0yGgWWhmXfg" title="Accounts payable concentration percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2023-05-012023-07-31_us-gaap_LenderConcentrationRiskMember_custom_CustomerFourMember_us-gaap_AccountsPayableMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">60</ix:nonFraction></span>%, and <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220501__20230430__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--LenderConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerFourMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember_zlpWrIsMZOjl" title="Accounts payable concentration percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-05-012023-04-30_us-gaap_LenderConcentrationRiskMember_custom_CustomerFourMember_us-gaap_AccountsPayableMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">59</ix:nonFraction></span>% of the Company&#8217;s
trade payables balances, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-05-01to2023-07-31" escape="true" name="us-gaap:IntangibleAssetsDisclosureTextBlock"><p id="xdx_801_eus-gaap--IntangibleAssetsDisclosureTextBlock_zVU1pdktvOEh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
5: <span id="xdx_82B_zvFeVTNqg97j">INTANGIBLE ASSETS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<ix:nonNumeric contextRef="From2023-05-01to2023-07-31" escape="true" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock"><p id="xdx_89E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_zdEzhIregm3k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets reflect only those intangible assets of our continuing operations, and consist of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BB_zvVdOUPUW9F9" style="display: none">SCHEDULE
OF INTANGIBLE ASSETS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(in years)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_485_eus-gaap--FiniteLivedIntangibleAssetsGross_iE_zAMiHKf66H3b" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_486_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iE_zn4EwGG06JF" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amortization</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_48B_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_zeA61Y01H2y4" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Loss</b></span></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_485_eus-gaap--FiniteLivedIntangibleAssetsNet_iE_z7YLFPhaw6S5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="14" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Average Period</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">July 31, 2023</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Amortization</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">(in years)</p></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Carrying</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Value</p></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Accumulated</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Amortization</p></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Impairment</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Loss</p></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Net Carrying</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Value</p></td><td style="font-weight: bold">&#160;</td></tr>
  <tr id="xdx_410_20230501__20230731__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TradeNamesAndPatentsMember_zaNuV3NGaLb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 34%; text-align: left">Tradenames and patents</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: center"><span id="xdx_901_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20230731__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TradeNamesAndPatentsMember_z15UgE7F6uN3" title="Weighted average amortization"><ix:nonNumeric contextRef="AsOf2023-07-31_custom_TradeNamesAndPatentsMember" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1">15.26</ix:nonNumeric></span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2023-07-31_custom_TradeNamesAndPatentsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">385,582</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2023-07-31_custom_TradeNamesAndPatentsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,031</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" contextRef="From2023-05-012023-07-31_custom_TradeNamesAndPatentsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">360,551</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2023-07-31_custom_TradeNamesAndPatentsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_418_20230501__20230731__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zmmmos5dRDHh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Customer relationships</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span id="xdx_90F_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20230731__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zqRBMbGreqdd" title="Weighted average amortization"><ix:nonNumeric contextRef="AsOf2023-07-31_us-gaap_CustomerRelationshipsMember" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1">9.92</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2023-07-31_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,930,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2023-07-31_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,038</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" contextRef="From2023-05-012023-07-31_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,879,962</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0905">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_41C_20230501__20230731__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zsfso3WFD4Rf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Internally developed software</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span id="xdx_90E_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20230731__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zDZ7wlhv6lS3" title="Weighted average amortization"><ix:nonNumeric contextRef="AsOf2023-07-31_us-gaap_ComputerSoftwareIntangibleAssetMember" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1">4.91</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2023-07-31_us-gaap_ComputerSoftwareIntangibleAssetMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">580,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2023-07-31_us-gaap_ComputerSoftwareIntangibleAssetMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">79,608</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" contextRef="From2023-05-012023-07-31_us-gaap_ComputerSoftwareIntangibleAssetMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">500,392</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0911">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_418_20230501__20230731__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangiableAssetMember_z8yKTM7fUQr2" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Total intangible assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2023-07-31_custom_IntangiableAssetMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,895,582</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2023-07-31_custom_IntangiableAssetMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">153,677</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" contextRef="From2023-05-012023-07-31_custom_IntangiableAssetMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,740,905</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2023-07-31_custom_IntangiableAssetMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 97; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(in years)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_486_eus-gaap--FiniteLivedIntangibleAssetsGross_iE_zrmAEid9knCg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_482_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iE_zCIJrg6DzlS4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amortization</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_481_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_zywsPGGp4Jp7" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Loss</b></span></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_480_eus-gaap--FiniteLivedIntangibleAssetsNet_iE_zbstifZDGLHa" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="14" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Average Period</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">April 30, 2023</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Amortization</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">(in years)</p></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Carrying</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Value</p></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Accumulated</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Amortization</p></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Impairment</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Loss</p></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Net Carrying</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Value</p></td><td style="font-weight: bold">&#160;</td></tr>
  <tr id="xdx_418_20220501__20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TradeNamesAndPatentsMember_zUXbS0TrERQi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 34%; text-align: left">Tradenames and patents</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 9%; text-align: center"><span id="xdx_908_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TradeNamesAndPatentsMember_zxdUY4D2xPT6" title="Weighted average amortization"><ix:nonNumeric contextRef="AsOf2023-04-30_custom_TradeNamesAndPatentsMember" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1">15.26</ix:nonNumeric></span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2023-04-30_custom_TradeNamesAndPatentsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">385,582</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2023-04-30_custom_TradeNamesAndPatentsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,031</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" contextRef="From2022-05-012023-04-30_custom_TradeNamesAndPatentsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">260,270</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2023-04-30_custom_TradeNamesAndPatentsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">101,281</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_41A_20220501__20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zMmZ6D87bZDl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Customer relationships</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_z4ku75IpaXC7" title="Weighted average amortization"><ix:nonNumeric contextRef="AsOf2023-04-30_us-gaap_CustomerRelationshipsMember" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1">9.92</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2023-04-30_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,930,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2023-04-30_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,038</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" contextRef="From2022-05-012023-04-30_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,879,962</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0927">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_416_20220501__20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_za6FJOcFioy8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Internally developed software</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zrhiKnlnaysi" title="Weighted average amortization"><ix:nonNumeric contextRef="AsOf2023-04-30_us-gaap_ComputerSoftwareIntangibleAssetMember" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1">4.91</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2023-04-30_us-gaap_ComputerSoftwareIntangibleAssetMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">580,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2023-04-30_us-gaap_ComputerSoftwareIntangibleAssetMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">79,608</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" contextRef="From2022-05-012023-04-30_us-gaap_ComputerSoftwareIntangibleAssetMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">500,392</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0933">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_411_20220501__20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangiableAssetMember_z1lHJnMQjOM3" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Total intangible assets</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2023-04-30_custom_IntangiableAssetMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,895,582</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2023-04-30_custom_IntangiableAssetMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">153,677</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" contextRef="From2022-05-012023-04-30_custom_IntangiableAssetMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,640,624</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2023-04-30_custom_IntangiableAssetMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">101,281</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AF_zYT6wIoYj7ze" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization
expense for the three months ended July 31, 2023 and 2022 was approximately $<span id="xdx_903_eus-gaap--AmortizationOfIntangibleAssets_c20230501__20230731_zjqve7B0YdP3" title="Amortization expense"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></span> and $<span id="xdx_903_eus-gaap--AmortizationOfIntangibleAssets_c20220501__20220731_zcIkcSC8Qh5k" title="Amortization expense"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2022-05-012022-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,445</ix:nonFraction></span>, respectively. The Company impaired $<span id="xdx_903_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_iN_di_c20230501__20230731__dei--LegalEntityAxis__custom--FoundationSportsSystemsLLCMember_zvekOeYPzmz" title="Impairment loss"><ix:nonFraction name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" contextRef="From2023-05-012023-07-31_custom_FoundationSportsSystemsLLCMember30673109" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">100,281</ix:nonFraction></span>
in the three months ended July 31, 2023. The remaining $<span id="xdx_902_eus-gaap--OtherIntangibleAssetsNet_iI_c20230731__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zHmwc2OGK7e3" title="Other intangible assets"><ix:nonFraction name="us-gaap:OtherIntangibleAssetsNet" contextRef="AsOf2023-07-31_us-gaap_PatentsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,000</ix:nonFraction></span> is a nominal value related to the Company&#8217;s patents. This amount
is not expected to be amortized any further.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-05-01to2023-07-31" escape="true" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"><p id="xdx_80E_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zWm9muZZGcYh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
6</b>: <b><span id="xdx_827_zribUoJTNjt8">ACCRUED EXPENSES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-05-01to2023-07-31" escape="true" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock"><p id="xdx_89B_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_z16P7oj1WSEf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
composition of accrued expenses is summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_z0Lf5A9wMVac" style="display: none">SCHEDULE
OF ACCRUED EXPENSES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_490_20230731_zA4I6a2iRVk7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">July 31, 2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_493_20230430_zgHAdCwGXbea" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">April 30, 2023</td><td style="font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--AccruedPayrollTaxesCurrent_iI_maALCzIie_zgsakoVu0Rhl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Accrued payroll</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:AccruedPayrollTaxesCurrent" contextRef="AsOf2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,754,936</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:AccruedPayrollTaxesCurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,535,186</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AccruedBonusesCurrent_iI_maALCzIie_zVAUtZkGQhRi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accrued bonus</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedBonusesCurrent" contextRef="AsOf2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,829,604</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedBonusesCurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,720,606</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--AccruedProfessionalFeesCurrent_iI_maALCzIie_zOd59yZFR5qh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accrued professional fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrent" contextRef="AsOf2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">490,424</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AccountsPayableOtherCurrent_iI_maALCzIie_zlN7830IRz81" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Other accrued expenses</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableOtherCurrent" contextRef="AsOf2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,577,920</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableOtherCurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,165,623</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AccruedLiabilitiesCurrent_iTI_mtALCzIie_zQqIU9SIRQHi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Total</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,197,460</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,911,839</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A9_z2b3GRh7pzRa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-05-01to2023-07-31" escape="true" name="us-gaap:DebtDisclosureTextBlock"><p id="xdx_806_eus-gaap--DebtDisclosureTextBlock_zQvQCyP8YwC" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
7: <span id="xdx_82C_zP6VnEk0igv6">NOTE PAYABLE &#8211; RELATED PARTY</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
discussion of note payable &#8211; related party only includes those that existed as of April 30, 2023. For a discussion of all prior
note payable &#8211; related party we refer you to the Annual Report on Form 10-K filed September 14, 2023 for the fiscal year end April
30, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 14, 2022, the Company entered into two loan agreements with related party lenders, each for $<span id="xdx_905_eus-gaap--LoansPayable_iI_c20220114__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zOuZbdwjQKyd" title="Loans payable"><ix:nonFraction name="us-gaap:LoansPayable" contextRef="AsOf2022-01-14_custom_LoanAgreementsMember_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,000,000</ix:nonFraction></span>, pursuant to which the
Company received a total amount of $<span id="xdx_904_eus-gaap--ProceedsFromRelatedPartyDebt_c20220113__20220114__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zStnO0B0KIy" title="Proceeds from related party debt"><ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="From2022-01-132022-01-14_custom_LoanAgreementsMember_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,000,000</ix:nonFraction></span>. The loans bear interest at a rate of <span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20220114__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zIAMsQ4zg99e" title="Interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2022-01-14_custom_LoanAgreementsMember_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8</ix:nonFraction></span>% per annum and are required to be repaid in full
by April 30, 2022 or such other date as may be accepted by the lenders. The Company is not permitted to make any distribution or pay
any dividends unless or until the loans are repaid in full. On June 28, 2022, the Company entered into amendments for the two related
party loan agreements with the lenders in which the repayment date was extended to July 31, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
was $<span id="xdx_900_eus-gaap--NotesPayable_iI_c20230731__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zHiDvsuEX3E8" title="Outstanding borrowings"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2023-07-31_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,655,966</ix:nonFraction></span> and $<span id="xdx_901_eus-gaap--NotesPayable_iI_c20230430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z8btvF5Q4S7f" title="Outstanding borrowings"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2023-04-30_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,953,842</ix:nonFraction></span> in outstanding borrowings from related parties as of July 31, 2023 and April 30, 2023. Interest expense
related to the related parties for the three months ended July 31, 2023 and 2022 amounted to $<span id="xdx_90F_eus-gaap--InterestExpense_pp0p0_dxL_c20230501__20230731__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zo8hpH2syyhc" title="Interest expense::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl0980">0</span></span> and $<span id="xdx_90F_eus-gaap--InterestExpense_pp0p0_c20220501__20220731__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zpHx78pL61v1" title="Interest expense"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2022-05-012022-07-31_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">61,121</ix:nonFraction></span>, respectively. Accrued interest
due to related parties as of July 31, 2023 and April 30, 2023 amounted to $<span id="xdx_909_eus-gaap--InterestPayableCurrent_iI_c20230731__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zrnaeNlv0Wy5" title="Accrued interest"><ix:nonFraction name="us-gaap:InterestPayableCurrent" contextRef="AsOf2023-07-31_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">917,957</ix:nonFraction></span> and $<span id="xdx_90B_eus-gaap--InterestPayableCurrent_iI_c20230430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zk3QkPxIbLP" title="Accrued interest"><ix:nonFraction name="us-gaap:InterestPayableCurrent" contextRef="AsOf2023-04-30_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">917,957</ix:nonFraction></span>, respectively. The accrued interest includes
notes that were either repaid or converted but the interest remained.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 6, 2023, we sold certain of our inventory including all components, parts, additions and accessions thereto to Yonah Kalfa and
Naftali Kalfa who immediately consigned it back to us in exchange for a payment of $<span id="xdx_902_ecustom--PaymentForExchangeOfNotesPayable_c20230106__20230106__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zVDx7hTo7wFc" title="Payment of exchange"><ix:nonFraction name="CNXA:PaymentForExchangeOfNotesPayable" contextRef="From2023-01-062023-01-06_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">103</ix:nonFraction></span> per ball launcher we sell until we have paid
them an aggregate total of $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_c20230106_z5yDxH0EXo4j" title="Debt instrumental"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2023-01-06" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,092,700</ix:nonFraction></span>, which represents payment in full of the principal amounts of and accrued interest in respect of
the Loan Agreements (as defined above) and certain other expenses they incurred in connection with the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 98; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-05-01to2023-07-31" escape="true" name="us-gaap:ShortTermDebtTextBlock"><p id="xdx_80F_eus-gaap--ShortTermDebtTextBlock_zCrPA7zh49d3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
8: <span id="xdx_82D_zqG1bvJTPy9d">CONVERTIBLE NOTES PAYABLE</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
discussion of convertible notes payable only includes those that existed as of April 30, 2023. For a discussion of all prior convertible
notes payable we refer you to the Annual Report on Form 10-K filed September 14, 2023 for the fiscal year end April 30, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of April 30, 2023, all outstanding convertible notes payable had been fully converted into outstanding common shares. On June 17, 2022,
the Company issued <span id="xdx_90D_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20220617__20220617_z2oJMUksGX4k" title="Debt conversion"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" contextRef="From2022-06-172022-06-17" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">109,737</ix:nonFraction></span> shares of common stock in conversion of the $<span id="xdx_907_eus-gaap--DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1_c20220617__20220617_z1zUGkrQexg7" title="Debt conversion shares issued"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1" contextRef="From2022-06-172022-06-17" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">13,200,000</ix:nonFraction></span> in convertible notes payable and $<span id="xdx_90D_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20220617_zeC5KRWRMXS1" title="Interest payable"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2022-06-17" format="ixt:numdotdecimal" decimals="0" unitRef="USD">846,301</ix:nonFraction></span> in accrued
interest. In addition, the remaining $<span id="xdx_901_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20220731_z56BNFizMO4h" title="Unamortizated discount"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="AsOf2022-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">122,222</ix:nonFraction></span> of unamortized discount on the convertible notes payable was amortized and included in
our consolidated statements of operations for the three months ended July 31, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-05-01to2023-07-31" escape="true" name="us-gaap:LongTermDebtTextBlock"><p id="xdx_804_eus-gaap--LongTermDebtTextBlock_zTHbqlGRBac5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
9: <span id="xdx_823_zta9wt3wCcm8">NOTES PAYABLE</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
discussion of notes payable only includes those that existed as of April 30, 2023. For a discussion of all prior notes payable we refer
you to the Annual Report on Form 10-K filed September 14, 2023 for the fiscal year end April 30, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 11, 2021, the Company and the lender entered into an agreement whereby the lender converted the promissory note into <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210410__20210411__us-gaap--DebtInstrumentAxis__custom--PromissoryNotePayableMember_zqXwU2pav0Y8" title="Shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-04-102021-04-11_custom_PromissoryNotePayableMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">681</ix:nonFraction></span> shares
of Company stock, which were issued to the lender at a <span id="xdx_90F_eus-gaap--DebtConversionOriginalDebtInterestRateOfDebt_pid_dp_uPure_c20210410__20210411__us-gaap--DebtInstrumentAxis__custom--PromissoryNotePayableMember_zPgxUkLNBCee" title="Interest rate"><ix:nonFraction name="us-gaap:DebtConversionOriginalDebtInterestRateOfDebt" contextRef="From2021-04-102021-04-11_custom_PromissoryNotePayableMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">20</ix:nonFraction></span>% discount from the closing price of the stock on the day prior to the conversion.
In addition to the discount, the agreement contains a guarantee that the aggregate gross sales of the shares by the lender will be no
less than $<span id="xdx_904_eus-gaap--DebtInstrumentCarryingAmount_iI_c20210411__us-gaap--DebtInstrumentAxis__custom--PromissoryNotePayableMember_zN8QfdijfQGc" title="Payables"><ix:nonFraction name="us-gaap:DebtInstrumentCarryingAmount" contextRef="AsOf2021-04-11_custom_PromissoryNotePayableMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,500,000</ix:nonFraction></span> over the next three years and if the aggregate gross sales are less than $<span id="xdx_90D_eus-gaap--DebtInstrumentCarryingAmount_iI_c20210411__us-gaap--DebtInstrumentAxis__custom--PromissoryNotePayableMember_zH0mZoFFRUi" title="Payables"><ix:nonFraction name="us-gaap:DebtInstrumentCarryingAmount" contextRef="AsOf2021-04-11_custom_PromissoryNotePayableMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,500,000</ix:nonFraction></span> the Company will issue additional
shares of common stock to the lender for the difference between the total gross proceeds and $<span id="xdx_902_eus-gaap--DebtInstrumentCarryingAmount_iI_c20210411__us-gaap--DebtInstrumentAxis__custom--PromissoryNotePayableMember_zj3Clgvchjs9" title="Payables"><ix:nonFraction name="us-gaap:DebtInstrumentCarryingAmount" contextRef="AsOf2021-04-11_custom_PromissoryNotePayableMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,500,000</ix:nonFraction></span>, which could result in an infinite
number of shares being required to be issued.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluated the conversion option of the note payable to shares under the guidance in ASC 815-40, Derivatives and Hedging, and
determined the conversion option qualified for equity classification. The Company also evaluated the profit guarantee under ASC 815,
Derivatives and Hedging, and determined it to be a make-whole provision, which is an embedded derivative within the host instrument.
As the economic characteristics are dissimilar to the host instrument, the profit guarantee was bifurcated from the host instrument and
stated as a separate derivative liability, which is marked to market at the end of each reporting period with the non-cash gain or loss
recorded in the period as a gain or loss on derivative.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
the date of conversion, the Company recognized a $<span id="xdx_903_eus-gaap--GainsLossesOnExtinguishmentOfDebt_c20210410__20210411_zA0krLbTwjYa" title="Extinguishment of debt"><ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="From2021-04-102021-04-11" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,501,914</ix:nonFraction></span> loss on extinguishment of debt, which represented the difference between
the promissory note and the fair value of the shares issued of $<span id="xdx_902_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20210410__20210411_zeP0eupTgEqc" title="Debt conversion, amount"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2021-04-102021-04-11" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,250,004</ix:nonFraction></span>, which were recorded in shares issued in connection with conversion
of note payable within shareholders&#8217; equity, as well as the derivative liability of $<span id="xdx_906_eus-gaap--DerivativeLiabilities_iI_c20210411__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zvHEfMyShSb9" title="Derivative liability"><ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="AsOf2021-04-11_us-gaap_ValuationTechniqueOptionPricingModelMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,251,910</ix:nonFraction></span>, which was valued using a Black-Scholes
option pricing model.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the derivative liability was $<span id="xdx_90A_eus-gaap--DerivativeFairValueOfDerivativeNet_iI_c20230430__us-gaap--DebtInstrumentAxis__custom--PromissoryNotePayableMember_z6m9qlpUXks2" title="Fair value of derivative liability"><ix:nonFraction name="us-gaap:DerivativeFairValueOfDerivativeNet" contextRef="AsOf2023-04-30_custom_PromissoryNotePayableMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,456,854</ix:nonFraction></span> and $<span id="xdx_901_eus-gaap--DerivativeFairValueOfDerivativeNet_iI_c20220430__us-gaap--DebtInstrumentAxis__custom--PromissoryNotePayableMember_z1zs54G7Hadg" title="Fair value of derivative liability"><ix:nonFraction name="us-gaap:DerivativeFairValueOfDerivativeNet" contextRef="AsOf2022-04-30_custom_PromissoryNotePayableMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,456,854</ix:nonFraction></span> as of April 30, 2023 and 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 15, 2022, for and in consideration of $<span id="xdx_908_eus-gaap--BusinessCombinationConsiderationTransferredOther1_c20220214__20220215_zaULfRNOH1rg" title="Consideration"><ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferredOther1" contextRef="From2022-02-142022-02-15" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,000,000</ix:nonFraction></span> the Company conveyed, sold, transferred, set over, assigned and delivered to
Slinger Bag Consignment, LLC, a Virginia limited liability company (&#8220;Consignor&#8221;), all of the Company&#8217;s right, title
and interest in and to <span id="xdx_903_ecustom--NumberOfConsignedGoods_pid_uInteger_c20220214__20220215_z4pgX4UCYwWk" title="Consignment units"><ix:nonFraction name="CNXA:NumberOfConsignedGoods" contextRef="From2022-02-142022-02-15" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">13,000</ix:nonFraction></span> units of certain surplus inventory, including all components, parts, additions and accessions thereto (collectively,
the &#8220;Consigned Goods&#8221;). The Company has repaid the $<span id="xdx_903_ecustom--PaymentsOfRelatedPartyDebt_c20220501__20230430_zi7g2gY8Cxp8" title="Repayments of notes - related party"><ix:nonFraction name="CNXA:PaymentsOfRelatedPartyDebt" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,000,000</ix:nonFraction></span> as of April 30, 2023 ($<span id="xdx_908_ecustom--PaymentsOfRelatedPartyDebt_c20210501__20220731_zv6Hf1DF2Omg" title="Repayments of notes - related party"><ix:nonFraction name="CNXA:PaymentsOfRelatedPartyDebt" contextRef="From2021-05-012022-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,559,109</ix:nonFraction></span> as of July 31, 2022).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 1, 2022, the Company entered into a $<span id="xdx_90A_eus-gaap--NotesPayable_iI_c20220401__us-gaap--DebtInstrumentAxis__custom--NotesPayableMember_ziA7qzQb1Gz4" title="Note payable"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2022-04-01_custom_NotesPayableMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">500,000</ix:nonFraction></span> note payable. The note was to mature on <span id="xdx_903_eus-gaap--DebtInstrumentMaturityDate_c20220401__20220401_zcAyOTLmHl2a" title="Debt maturity date"><ix:nonNumeric contextRef="From2022-04-012022-04-01" format="ixt:datemonthdayyearen" name="us-gaap:DebtInstrumentMaturityDate">July 1, 2022</ix:nonNumeric></span> and bears interest at eight percent
(<span id="xdx_902_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20220401__us-gaap--DebtInstrumentAxis__custom--NotesPayableMember_zgkIjEQs4XKa" title="Interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2022-04-01_custom_NotesPayableMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8</ix:nonFraction></span>%) per year. The Company pays interest monthly and will pay all accrued and unpaid interest on the maturity date in which the outstanding
principal is due. On August 1, 2022, the Company repaid the $<span id="xdx_90B_ecustom--PaymentsOfRelatedPartyDebt_c20220801__20220801_zxkzaF0ou8T8" title="Repayments of notes - related party"><ix:nonFraction name="CNXA:PaymentsOfRelatedPartyDebt" contextRef="From2022-08-012022-08-01" format="ixt:numdotdecimal" decimals="0" unitRef="USD">500,000</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 99; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Cash
Advance Agreements</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 29, 2022, the Company entered into two merchant cash advance agreements. The details of the merchant cash advance agreements are
as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>UFS
Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company entered into an agreement (the &#8220;UFS Agreement&#8221;) with Unique Funding Solutions LLC (&#8220;UFS&#8221;) pursuant to
which the Company sold $<span id="xdx_90B_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20220729__20220729__us-gaap--TypeOfArrangementAxis__custom--UFSAgreementMember_zYzhCY1HgIak" title="Sale of consideration received"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedPerTransaction" contextRef="From2022-07-292022-07-29_custom_UFSAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,124,250</ix:nonFraction></span> in future receivables (the &#8220;UFS Receivables Purchased Amount&#8221;) to UFS in exchange for payment
to the Company of $<span id="xdx_90D_eus-gaap--PaymentsToAcquireReceivables_c20220729__20220729__us-gaap--TypeOfArrangementAxis__custom--UFSAgreementMember_z8hPL08hXBWk" title="Payment for exchange received amount"><ix:nonFraction name="us-gaap:PaymentsToAcquireReceivables" contextRef="From2022-07-292022-07-29_custom_UFSAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">750,000</ix:nonFraction></span> in cash less fees of $<span id="xdx_903_ecustom--CashLessFees_c20220729__20220729__us-gaap--TypeOfArrangementAxis__custom--UFSAgreementMember_zEFetVEIdivg" title="Cash less fees"><ix:nonFraction name="CNXA:CashLessFees" contextRef="From2022-07-292022-07-29_custom_UFSAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">60,000</ix:nonFraction></span>. The Company agreed to pay UFS $<span id="xdx_902_eus-gaap--PaymentsToAcquireReceivables_c20220729__20220729__us-gaap--TypeOfArrangementAxis__custom--UFSAgreementMember__srt--StatementScenarioAxis__custom--EachWeekForNextThreeWeeksMember_zFMezKZhuWqg" title="Payment for exchange received amount"><ix:nonFraction name="us-gaap:PaymentsToAcquireReceivables" contextRef="From2022-07-292022-07-29_custom_UFSAgreementMember_custom_EachWeekForNextThreeWeeksMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,491</ix:nonFraction></span> each week for the first three weeks and
thereafter $<span id="xdx_90C_eus-gaap--PaymentsToAcquireReceivables_c20220729__20220729__us-gaap--TypeOfArrangementAxis__custom--UFSAgreementMember__srt--StatementScenarioAxis__custom--ThereafterPerWeekMember_zdClw0NkQkf8" title="Payment for exchange received amount"><ix:nonFraction name="us-gaap:PaymentsToAcquireReceivables" contextRef="From2022-07-292022-07-29_custom_UFSAgreementMember_custom_ThereafterPerWeekMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">44,970</ix:nonFraction></span> per week until the UFS Receivables Purchased Amount is paid in full.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to secure payment and performance of the Company&#8217;s obligations to UFS under the UFS Agreement, the Company granted to UFS
a security interest in the following collateral: all accounts receivable and all proceeds as such term is defined by Article 9 of the
UCC. The Company also agreed not to create, incur, assume, or permit to exist, directly or indirectly, any lien on or with respect to
any of such collateral.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cedar
Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company entered into an agreement (the &#8220;Cedar Agreement&#8221;) with Cedar Advance LLC (&#8220;Cedar&#8221;) pursuant to which
the Company sold $<span id="xdx_906_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20220729__20220729__us-gaap--TypeOfArrangementAxis__custom--CedarAgreementMember_zarWIa63UrLb" title="Sale of consideration received"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedPerTransaction" contextRef="From2022-07-292022-07-29_custom_CedarAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,124,250</ix:nonFraction></span> in future receivables (the &#8220;Cedar Receivables Purchased Amount&#8221;) to Cedar in exchange for payment
to the Company of $<span id="xdx_900_eus-gaap--PaymentsToAcquireReceivables_c20220729__20220729__us-gaap--TypeOfArrangementAxis__custom--CedarAgreementMember_zZARwyKrSCg1" title="Payment for exchange received amount"><ix:nonFraction name="us-gaap:PaymentsToAcquireReceivables" contextRef="From2022-07-292022-07-29_custom_CedarAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">750,000</ix:nonFraction></span> in cash less fees of $<span id="xdx_902_ecustom--CashLessFees_c20220729__20220729__us-gaap--TypeOfArrangementAxis__custom--CedarAgreementMember_zHoK88Cw3Lwj" title="Cash less fees"><ix:nonFraction name="CNXA:CashLessFees" contextRef="From2022-07-292022-07-29_custom_CedarAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">60,000</ix:nonFraction></span>. The Company agreed to pay Cedar $<span id="xdx_907_eus-gaap--PaymentsToAcquireReceivables_c20220729__20220729__us-gaap--TypeOfArrangementAxis__custom--CedarAgreementMember__srt--StatementScenarioAxis__custom--EachWeekForNextThreeWeeksMember_z1CQEw0pw4u4" title="Payment for exchange received amount"><ix:nonFraction name="us-gaap:PaymentsToAcquireReceivables" contextRef="From2022-07-292022-07-29_custom_CedarAgreementMember_custom_EachWeekForNextThreeWeeksMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,491</ix:nonFraction></span> each week for the first three weeks
and thereafter $<span id="xdx_90E_eus-gaap--PaymentsToAcquireReceivables_c20220729__20220729__us-gaap--TypeOfArrangementAxis__custom--CedarAgreementMember__srt--StatementScenarioAxis__custom--ThereafterPerWeekMember_zoy8lLUdqCfc" title="Payment for exchange received amount"><ix:nonFraction name="us-gaap:PaymentsToAcquireReceivables" contextRef="From2022-07-292022-07-29_custom_CedarAgreementMember_custom_ThereafterPerWeekMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">44,970</ix:nonFraction></span> per week until the Cedar Receivables Purchased Amount is paid in full.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to secure payment and performance of the Company&#8217;s obligations to Cedar under the Cedar Agreement, the Company granted to
Cedar a security interest in the following collateral: all accounts, including without limitation, all deposit accounts, accounts receivable
and other receivables, chattel paper, documents, equipment, instruments and inventory as those terms are defined by Article 9 of the
UCC. The Company also agreed not to create, incur, assume, or permit to exist, directly or indirectly, any lien on or with respect to
any of such collateral.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 6, 2023, the Company entered into a loan and security agreement (the &#8220;Loan and Security Agreement&#8221;) with one or more
institutional investors (the &#8220;Lenders&#8221;) and Armistice Capital Master Fund Ltd. as agent for the Lenders (the &#8220;Agent&#8221;)
for the issuance and sale of (i) a note in an aggregate principal amount of up to $<span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_c20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember__srt--RangeAxis__srt--MaximumMember_zZRDGUDFGRR9" title="Aggregate principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2023-01-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,000,000</ix:nonFraction></span> (the &#8220;Note&#8221;) with the initial
advance under the Loan and Security Agreement being $<span id="xdx_904_eus-gaap--ProceedsFromNotesPayable_c20230104__20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember__us-gaap--ShortTermDebtTypeAxis__custom--NotesMember_zf6uRhIQrfub" title="Borrowing from notes payable"><ix:nonFraction name="us-gaap:ProceedsFromNotesPayable" contextRef="From2023-01-042023-01-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember_custom_NotesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,400,000</ix:nonFraction></span> and (ii) warrants (the &#8220;Warrants&#8221;) to purchase a number of
shares of common stock of the Company equal to 200% of the face amount of the Note divided by the closing price of the common stock of
the Company on the date of the issuance of the Notes (collectively, the &#8220;Initial Issuance&#8221;). The closing price of the Company&#8217;s
common stock on January 6, 2023, as reported by Nasdaq, was $<span id="xdx_90A_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember_zWA1WpfI1wR1" title="Shares issued price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2023-01-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">8.84</ix:nonFraction></span> per share, so the Warrants in respect of the initial advance under
the Note are exercisable for up to <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember__srt--RangeAxis__srt--MaximumMember_zxtYxxbFu9tl" title="Common stock exercisable, shares"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2023-01-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">452,489</ix:nonFraction></span> shares of the Company&#8217;s common stock. The Warrants have an exercise price per share
equal to the closing price of the common stock of the Company on the date of the issuance of the Note, or $<span id="xdx_906_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember_zCdtAyhcOnB3" title="Shares issued price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2023-01-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">8.84</ix:nonFraction></span> per share and a term
of five- and one-half (5&#189;) years following the initial exercise date. The initial exercise date of the Warrants will be the date
stockholder approval is received and effective allowing exercisability of the Warrants under Nasdaq rules. Pursuant to the terms of the
Loan and Security Agreement, an additional advance of $<span id="xdx_903_eus-gaap--ProceedsFromNotesPayable_c20230104__20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember_zWGho3kkU7pj" title="Proceeds from notes payable"><ix:nonFraction name="us-gaap:ProceedsFromNotesPayable" contextRef="From2023-01-042023-01-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">600,000</ix:nonFraction></span> may be made to the Company under the Note. The Company&#8217;s obligations
under the terms of the Loan and Security Agreement are fully and unconditionally guaranteed by all of the Company&#8217;s subsidiaries
(the &#8220;Guarantors&#8221;). The Company measured the warrants granted on January 6, 2023 at $<span id="xdx_909_eus-gaap--AdjustmentOfWarrantsGrantedForServices_c20230106__20230106__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember_zVK9ReFSDJd5" title="Warrants granted"><ix:nonFraction name="us-gaap:AdjustmentOfWarrantsGrantedForServices" contextRef="From2023-01-062023-01-06_us-gaap_WarrantMember_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,715,557</ix:nonFraction></span>, and discounted the note payable
to $<span id="xdx_90B_eus-gaap--NotesPayable_iI_c20230106__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember_z2H7vrJjgBTd" title="Notes payable"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2023-01-06_us-gaap_WarrantMember_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></span> and recorded a derivative expense of $<span id="xdx_907_ecustom--DerivativeExpense_c20230731__20230731__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember_z15ZE4xrE1r4" title="Derivative expense"><ix:nonFraction name="CNXA:DerivativeExpense" contextRef="From2023-07-312023-07-31_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,715,557</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
derivative liability was valued at $<span id="xdx_90C_eus-gaap--DerivativeLiabilityFairValueOfCollateral_iI_c20230731__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember_zrnSzUdYfaj7" title="Fair value derivate liability"><ix:nonFraction name="us-gaap:DerivativeLiabilityFairValueOfCollateral" contextRef="AsOf2023-07-31_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,139,666</ix:nonFraction></span> and $<span id="xdx_90C_eus-gaap--DerivativeLiabilityFairValueOfCollateral_iI_c20230430__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember_zLGpciGq1FP2" title="Fair value derivate liability"><ix:nonFraction name="us-gaap:DerivativeLiabilityFairValueOfCollateral" contextRef="AsOf2023-04-30_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,814,738</ix:nonFraction></span> as of July 31, 2023 and April 30, 2023, respectively. The Company recognized
a gain on the change in fair value of the derivative liability when remeasured for the three months ended July 31, 2023 of $<span id="xdx_904_ecustom--IncreaseDecreaseInDerivativeFairValueLiability_c20230501__20230731_zYMfT4btlKLa" title="Derivative liability"><ix:nonFraction name="CNXA:IncreaseDecreaseInDerivativeFairValueLiability" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">675,072</ix:nonFraction></span>.
In addition, the Company recognized $<span id="xdx_90B_eus-gaap--AmortizationOfDebtDiscountPremium_c20230501__20230731__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember_zzLDniOtYGIi" title="Amortization of debt discount"><ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2023-05-012023-07-31_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">777,192</ix:nonFraction></span> in amortization of debt discount for the three months ended July 31, 2023. On July 6, 2023,
the Company failed to repay the note and is currently in default. The interest rate has since increased to <span id="xdx_900_eus-gaap--DebtInstrumentInterestRateIncreaseDecrease_dp_c20230501__20230731_z5iwB9SBnLJb" title="Interest rate, increase"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateIncreaseDecrease" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">6.43</ix:nonFraction></span>% per annum.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 100; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Meged
Agreement</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 8, 2023, the Company entered into a merchant cash advance agreement with Meged Funding Group (&#8220;Meged&#8221;) pursuant to which
the Company sold $<span id="xdx_903_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20230608__20230608__us-gaap--TypeOfArrangementAxis__custom--MegedAgreementMember_zcNcGV8iRhV6" title="Sale of stock"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedPerTransaction" contextRef="From2023-06-082023-06-08_custom_MegedAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">315,689</ix:nonFraction></span> in future receivables to Meged (the &#8220;Meged Receivables Purchased Amount&#8221;) to in exchange for payment
to the Company of $<span id="xdx_908_eus-gaap--StockRedeemedOrCalledDuringPeriodValue_c20230608__20230608__us-gaap--TypeOfArrangementAxis__custom--MegedAgreementMember_zlvtKtDWDJX1" title="Stock redeemed value"><ix:nonFraction name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" contextRef="From2023-06-082023-06-08_custom_MegedAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">210,600</ix:nonFraction></span> in cash less fees of $<span id="xdx_904_eus-gaap--LegalFees_c20230608__20230608__us-gaap--TypeOfArrangementAxis__custom--MegedAgreementMember_zkJCMoIB6TYf" title="Legal fees"><ix:nonFraction name="us-gaap:LegalFees" contextRef="From2023-06-082023-06-08_custom_MegedAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,580</ix:nonFraction></span>. The Company agreed to pay Meged $<span id="xdx_902_eus-gaap--RepaymentsOfOtherDebt_c20230608__20230608__us-gaap--TypeOfArrangementAxis__custom--MegedAgreementMember_zmzFEul5yRE9" title="Debt repayment"><ix:nonFraction name="us-gaap:RepaymentsOfOtherDebt" contextRef="From2023-06-082023-06-08_custom_MegedAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,538</ix:nonFraction></span> each week until the Meged Receivables
Purchased Amount is paid in full.</span></p>
<!-- Field: Split-Segment; Name: 002 -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-05-01to2023-07-31" escape="true" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p id="xdx_808_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_ztX1anZXdfRb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
10: <span id="xdx_820_zXFBXyalPQY9">RELATED PARTY TRANSACTIONS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
support of the Company&#8217;s efforts and cash requirements, it may rely on advances from related parties until such time that the Company
can support its operations or attain adequate financing through sales of its equity or traditional debt financing. There is no formal
written commitment for continued support by officers, directors, or shareholders. Amounts represent advances, amounts paid in satisfaction
of liabilities, or accrued compensation that has been deferred. The advances are considered temporary in nature and have not been formalized
by a promissory note.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has outstanding notes payable of <span style="background-color: white">$<span id="xdx_909_eus-gaap--NotesPayable_iI_pp0p0_c20230731__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zMDSztotECJ2" title="Outstanding notes payable"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2023-07-31_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,655,966</ix:nonFraction></span> and $<span id="xdx_90C_eus-gaap--NotesPayable_iI_pp0p0_c20230430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zfieMaFOM2O7" title="Outstanding notes payable"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2023-04-30_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,953,842</ix:nonFraction></span></span> and accrued interest
of $<span id="xdx_90F_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20230731__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zyXBQqWdPbz6" title="Accrued interest - related party"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2023-07-31_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">917,957</ix:nonFraction></span> and $<span id="xdx_906_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20230430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zgplJo3AVHTe" title="Accrued interest - related party"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2023-04-30_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">917,957</ix:nonFraction></span> due to a related party as of July 31, 2023 and April 30, 2023, respectively (see Note 7).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognized net sales of $<span id="xdx_904_eus-gaap--Revenues_pp0p0_c20230501__20230731__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zCWCen2MXLa9" title="Revenue from related parties"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-05-012023-07-31_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">50,900</ix:nonFraction></span> and $<span id="xdx_90F_eus-gaap--Revenues_pp0p0_c20220501__20220731__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zk3PxjAjZKHb" title="Revenue from related parties"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-05-012022-07-31_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">91,200</ix:nonFraction></span> during the three months ended July 31, 2023 and 2022, respectively, to related parties.
As of July 31, 2023 and 2022, related parties had accounts receivable due to the Company of $<span id="xdx_90F_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20230731__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zkS3JQ5C1Yx3" title="Outstanding accounts receivable"><ix:nonFraction name="us-gaap:AccountsReceivableNet" contextRef="AsOf2023-07-31_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">28,800</ix:nonFraction></span> and $<span id="xdx_90E_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20220731__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zeaL1kmQS1m9" title="Outstanding accounts receivable"><ix:nonFraction name="us-gaap:AccountsReceivableNet" contextRef="AsOf2022-07-31_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">28,800</ix:nonFraction></span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-05-01to2023-07-31" escape="true" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock"><p id="xdx_804_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zFiOa0dq6LO1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
11: <span id="xdx_829_zBTlGZIYTUa">SHAREHOLDERS&#8217; EQUITY (DEFICIT)</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Common
Stock</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has <span id="xdx_905_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20230731_z6u19YQESDOj" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2023-07-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">300,000,000</ix:nonFraction></span> shares of common stock authorized with a par value of $<span id="xdx_907_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20230731_zqGmQen3E37i" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2023-07-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></span> per share. As of July 31, 2023 and April 30, 2023,
the Company had <span id="xdx_900_eus-gaap--CommonStockSharesIssued_iI_c20230731_zPMbFx0yGZze" title="Common stock, shares issued"><span id="xdx_90F_eus-gaap--CommonStockSharesOutstanding_iI_c20230731_zFwg4tf7gOb4" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2023-07-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-07-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">528,297</ix:nonFraction></ix:nonFraction></span></span> and <span id="xdx_903_eus-gaap--CommonStockSharesIssued_iI_c20230430_z6cRESjqlU1l" title="Common stock, shares issued"><span id="xdx_90C_eus-gaap--CommonStockSharesOutstanding_iI_c20230430_zA0238zczz3" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">338,579</ix:nonFraction></ix:nonFraction></span></span> shares of common stock issued and outstanding, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the period May 1, 2023 through July 31, 2023, the Company issued <span id="xdx_90C_eus-gaap--SharesIssued_iI_c20230731_zGB3SCqNKyZh" title="Shares, issued"><ix:nonFraction name="us-gaap:SharesIssued" contextRef="AsOf2023-07-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">189,718</ix:nonFraction></span> shares of common stock to ambassadors under their agreements
(<span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230501__20230731_zqFXHEaRPRK2" title="Number of shares issued during the period"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">188</ix:nonFraction></span>), to vendors in settlement of accounts payable (<span id="xdx_90B_ecustom--StockIssuedDuringPeriodSharesIssuedSettlementOfAccountsPayable_c20230501__20230731_zWaxfldn73B4" title="Stock issued during period, shares, issued for settlement of accounts payable"><ix:nonFraction name="CNXA:StockIssuedDuringPeriodSharesIssuedSettlementOfAccountsPayable" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">67,500</ix:nonFraction></span>), for settlement with former owners of FSS (<span id="xdx_90C_ecustom--StockIssuedDuringPeriodSharesIssuedSettlementWithFormerOwners_c20230501__20230731_zPQkhnUJULai" title="Stock issued during period, shares, issued for settlement with former owners"><ix:nonFraction name="CNXA:StockIssuedDuringPeriodSharesIssuedSettlementWithFormerOwners" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,350</ix:nonFraction></span>), for the exercise of warrants
(<span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20230501__20230731_zcW8tZjeITub" title="Exercise of warrants, shares"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">27,000</ix:nonFraction></span>) and to satisfy the profit guarantee on a note (<span id="xdx_906_ecustom--StockIssuedDuringPeriodSharesIssuedProfitGuaranteeOnNote_c20230501__20230731_zxKbEevQ2QL9" title="Profit guarantee on note, shares"><ix:nonFraction name="CNXA:StockIssuedDuringPeriodSharesIssuedProfitGuaranteeOnNote" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">93,680</ix:nonFraction></span>).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Equity
Transactions During the Year Ended April 30, 2023</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has issued an aggregate of <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220501__20230430_zLMHSjhBqfZ1" title="Number of common stock, shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">151,579</ix:nonFraction></span> shares of its common stock consisting of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    June 15, 2022, the Company issued <span id="xdx_901_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pid_c20220615__20220615_zVVN5WVq72t1" title="Debt conversion of convertible notes, shares"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" contextRef="From2022-06-152022-06-15" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">109,737</ix:nonFraction></span> shares of common stock to the Convertible Noteholders upon conversion of convertible notes.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    June 15, 2022, the Company issued <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220615__20220615__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_z5EW015SOjxb" title="Number of common stock, shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-06-152022-06-15_us-gaap_InvestorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">26,219</ix:nonFraction></span> shares to investors who participated in the Company&#8217;s Nasdaq uplist round.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    June 27, 2022, the Company issued <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20220627__20220627__srt--TitleOfIndividualAxis__custom--GabrielGoldmanMember_zOyzqycg5le5" title="Number of common stock, shares for services"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2022-06-272022-06-27_custom_GabrielGoldmanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">625</ix:nonFraction></span> shares of common stock to Gabriel Goldman for consulting services performed in the first quarter
    of calendar 2022. Gabriel Goldman became a director of the Company on June 15, 2022.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    June 27, 2022, the Company issued <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220627__20220627__dei--LegalEntityAxis__custom--GamefaceAIMember_z8US1zG0EuV7" title="Number of common stock, shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-06-272022-06-27_custom_GamefaceAIMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">14,960</ix:nonFraction></span> shares of common stock to the former Gameface shareholders in connection with the purchase
    of Gameface. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 101; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            August 25, 2022, the Company issued <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220825__20220825__dei--LegalEntityAxis__custom--MidcityCapitalLtdMember_zqAbEvmelHXb" title="Number of common stock, shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-08-252022-08-25_custom_MidcityCapitalLtdMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">750</ix:nonFraction></span> shares of common stock to Midcity Capital Ltd (&#8220;Midcity&#8221;)
                                            pursuant to a cashless conversion of warrants Midcity received from its warrant agreement
                                            with the Company dated March 2020.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    September 28, 2022, the Company entered into a securities purchase agreement (the &#8220;Securities Purchase Agreement&#8221;) with
    a single institutional investor (the &#8220;Investor&#8221;) for the issuance and sale of (i) <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220928__20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zEAr7Dn7PT73"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-09-282022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">25,463</ix:nonFraction>
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock and (ii) pre-funded
    warrants (the &#8220;Pre-Funded Warrants&#8221;) to purchase an aggregate of <span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zNRWXEzs1sBc"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">295,050</ix:nonFraction>
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of its common stock, together with
    accompanying common stock warrants, at a combined purchase price of $<span id="xdx_904_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zNSKTWMy3mV"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">15.60</ix:nonFraction>
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share of the common stock and associated
    common stock warrant and $<span id="xdx_904_ecustom--WarrantPerShare_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_ziC3L3Msqypi"><ix:nonFraction name="CNXA:WarrantPerShare" contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">15.596</ix:nonFraction>
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per Pre-Funded Warrant and associated common
    stock warrants for an aggregate amount of approximately $<span id="xdx_904_eus-gaap--WarrantsAndRightsOutstanding_iI_pn5n6_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zZBbxXyALJQf"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">5.0</ix:nonFraction>
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million (the &#8220;Offering&#8221;). The
    Pre-Funded Warrants have an exercise price of $<span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zt1R1zNansKf"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0004</ix:nonFraction>
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share of common stock and are exercisable
    until the Pre-Funded Warrants are exercised in full. The shares of common stock and Pre-Funded Warrants were sold in the offering
    together with common stock warrants to purchase <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--FiveYearWarrantsMember_zFl047dNUglc"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_custom_FiveYearWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">320,513</ix:nonFraction>
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock at an exercise price
    of $<span id="xdx_904_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--FiveYearWarrantsMember_zTy7fFHPKFs4"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_custom_FiveYearWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">15.60</ix:nonFraction>
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share and a term of five years following
    the initial exercise date (the &#8220;5-Year Warrants&#8221;) and <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220928__20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--SevenYearWarrantsMember_z1W8xEemzbS"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-09-282022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_custom_SevenYearWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">641,026</ix:nonFraction>
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">common stock warrants to purchase <span id="xdx_904_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--SevenPointFiveYearWarrantsMember_zWrUgZEuscf6"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_custom_SevenPointFiveYearWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">641,026</ix:nonFraction>
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock at an exercise price
    of $<span id="xdx_905_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--SevenPointFiveYearWarrantsMember_zRt6LcJKfH3j"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_custom_SevenPointFiveYearWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">17.20</ix:nonFraction>
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share and a term of seven and one half
    years (the &#8220;7.5-Year Warrants&#8221;) following the initial exercise date (collectively, the &#8220;Warrants&#8221;). The Warrants
    issued in the Offering contain variable pricing features. The Warrants and Pre-Funded Warrants will be exercisable beginning on the
    date stockholder approval is received and effective allowing exercisability of the Warrants and Pre-Funded Warrants under Nasdaq
    rules. Net proceeds to the Company were $<span id="xdx_907_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20220928__20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zLxJbyF4qYA9"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2022-09-282022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,549,882</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    October 12, 2022, the Company issued <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20221012__20221012_zqqGfJFPVi4j" title="Shares issued for acquisition"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" contextRef="From2022-10-122022-10-12" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">48,098</ix:nonFraction></span> shares of common stock, on November 21, 2022 issued <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20221121__20221121_zn5om8i945bi" title="Shares issued for acquisition"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" contextRef="From2022-11-212022-11-21" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">675</ix:nonFraction></span> shares of common stock and January
    26, 2023 issued <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20230126__20230126_zEJqt4NF9Ff9" title="Shares issued for acquisition"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" contextRef="From2023-01-262023-01-26" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,993</ix:nonFraction></span> shares of common stock in connection with the acquisition of PlaySight.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    January 26, 2023, the Company issued <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20230126__20230126_zbzEyY8oED56" title="Shares issued for services"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2023-01-262023-01-26" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">150</ix:nonFraction></span> shares of common stock for services rendered to their ambassadors.</span></p></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has not granted any warrants for the three months ended July 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Warrants
Granted During the Year Ended April 30, 2023</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 28, 2022, the Company entered into a securities purchase agreement (the &#8220;Securities Purchase Agreement&#8221;) with a
single institutional investor (the &#8220;Investor&#8221;) for the issuance and sale of (i) <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220928__20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zPBVO4Wkbcof"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-09-282022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">25,463</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock and (ii) pre-funded warrants
(the &#8220;Pre-Funded Warrants&#8221;) to purchase an aggregate of <span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zj75Eba8GHT5"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">295,050</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of its common stock, together with accompanying
common stock warrants, at a combined purchase price of $<span id="xdx_904_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_z5d0PNcEZor3"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">15.60</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share of the common stock and associated
common stock warrant and $<span id="xdx_90C_ecustom--WarrantPerShare_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zYbOSycnhwCk"><ix:nonFraction name="CNXA:WarrantPerShare" contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">15.596</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per Pre-Funded Warrant and associated common
stock warrants for an aggregate amount of approximately $<span id="xdx_903_eus-gaap--WarrantsAndRightsOutstanding_iI_pn5n6_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zhEGqkHNs4q2"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">5.0</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million (the &#8220;Offering&#8221;). The Pre-Funded
Warrants have an exercise price of $<span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zZVaxX3BNoJk"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0004</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share of common stock and are exercisable
until the Pre-Funded Warrants are exercised in full. The shares of common stock and Pre-Funded Warrants were sold in the offering together
with common stock warrants to purchase <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--FiveYearWarrantsMember_z1zWWlUQIkN8"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_custom_FiveYearWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">320,513</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock at an exercise price of
$<span id="xdx_904_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--FiveYearWarrantsMember_zQNCYbEegTS8"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_custom_FiveYearWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">15.60</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share and a term of five years following
the initial exercise date (the &#8220;5-Year Warrants&#8221;) and <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220928__20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--SevenPointFiveYearWarrantsMember_z0Az8mwMhSa"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-09-282022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_custom_SevenPointFiveYearWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">641,026</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">common stock warrants to purchase <span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--SevenPointFiveYearWarrantsMember_zXB6PPbx2At4"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_custom_SevenPointFiveYearWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">641,026</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock at an exercise price of
$<span id="xdx_905_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--SevenPointFiveYearWarrantsMember_zL0xkE54lbMg"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_custom_SevenPointFiveYearWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">17.20</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share and a term of seven and one half years
(the &#8220;7.5-Year Warrants&#8221;) following the initial exercise date (collectively, the &#8220;Warrants&#8221;). The Warrants issued
in the Offering contain variable pricing features. The Warrants and Pre-Funded Warrants became exercisable beginning on the date stockholder
approval was received and effective allowing exercisability of the Warrants and Pre-Funded Warrants under Nasdaq rules. The exercise
price of the Warrants was reset in January 2023 to $<span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230131__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_z0dqSJawS6I1"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2023-01-31_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">8.84</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share and in October 2023 to $<span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20231031__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zULTXh6WUJN1"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2023-10-31_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.55</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 6, 2023, the Company entered into a loan and security agreement (the &#8220;Loan and Security Agreement&#8221;) with one or more
institutional investors (the &#8220;Lenders&#8221;) and Armistice Capital Master Fund Ltd. as agent for the Lenders (the &#8220;Agent&#8221;)
for the issuance and sale of (i) a note in an aggregate principal amount of up to $<span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_c20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember__srt--RangeAxis__srt--MaximumMember_zGvlCOUpRUx5"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2023-01-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,000,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(the &#8220;Note&#8221;) at <span id="xdx_907_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember__srt--RangeAxis__srt--MaximumMember_z0n0MFoFxKzk"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" contextRef="AsOf2023-01-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.33</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
interest per annum unless in default, with the initial advance under the Loan and Security Agreement being $<span id="xdx_902_eus-gaap--ProceedsFromNotesPayable_c20230104__20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember__us-gaap--ShortTermDebtTypeAxis__custom--NotesMember_zESWNTzFj6bj"><ix:nonFraction name="us-gaap:ProceedsFromNotesPayable" contextRef="From2023-01-042023-01-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember_custom_NotesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,400,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and (ii) warrants (the &#8220;Warrants&#8221;)
to purchase a number of shares of common stock of the Company equal to 200% of the face amount of the Note divided by the closing price
of the common stock of the Company on the date of the issuance of the Notes (collectively, the &#8220;Initial Issuance&#8221;). The closing
price of the Company&#8217;s common stock on January 6, 2023, as reported by Nasdaq, was $<span id="xdx_903_ecustom--SharesIssuedPricePerShares_iI_pid_c20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember_zCyflaimytJb"><ix:nonFraction name="CNXA:SharesIssuedPricePerShares" contextRef="AsOf2023-01-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.221</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share (or <span id="xdx_903_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember_zkI6lBmBM1if"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2023-01-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">8.84</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share after adjusting for the one-for-forty
(1-for-40) reverse stock split), so the Warrants in respect of the initial advance under the Note are exercisable for up to <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember__srt--RangeAxis__srt--MaximumMember_zkYf6spSb78g"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2023-01-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">452,489</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the Company&#8217;s common stock. The
Warrants have an exercise price per share equal to the closing price of the common stock of the Company on the date of the issuance of
the Note, or $<span id="xdx_909_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember_zH3PN1RLgy08"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2023-01-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">8.84</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share and a term of five- and one-half (5&#189;)
years following the initial exercise date. The exercise price of the Warrants was reset in October 2023 to $<span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember_zcg7OOrczYg4"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2023-01-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.55</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share The initial exercise date of the
Warrants was the date stockholder approval was received and effective allowing exercisability of the Warrants under Nasdaq rules. Pursuant
to the terms of the Loan and Security Agreement, an additional advance of $<span id="xdx_90E_eus-gaap--ProceedsFromNotesPayable_c20230104__20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember_z1gwHaLonZWi"><ix:nonFraction name="us-gaap:ProceedsFromNotesPayable" contextRef="From2023-01-042023-01-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">600,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">was made to the Company under the Note which
occurred on February 2, 2023. The Company&#8217;s obligations under the terms of the Loan and Security Agreement are fully and unconditionally
guaranteed by all of the Company&#8217;s subsidiaries (the &#8220;Guarantors&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 102; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-05-01to2023-07-31" escape="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p id="xdx_80F_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zolbRweiCHJ5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
12: <span id="xdx_82E_zSVzlluGIHLg">COMMITMENTS AND CONTINGENCIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Leases</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company leases office space under short-term leases with terms under a year. Total rent expense for the three months ended July 31, 2023
and 2022 amounted to $<span id="xdx_90A_eus-gaap--PaymentsForRent_pp0p0_c20230501__20230731_zIpgkLfFn7w4" title="Rent expense"><ix:nonFraction name="us-gaap:PaymentsForRent" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,969</ix:nonFraction></span> and $<span id="xdx_900_eus-gaap--PaymentsForRent_pp0p0_c20220501__20220731_zkgi2HQTfDj5" title="Rent expense"><ix:nonFraction name="us-gaap:PaymentsForRent" contextRef="From2022-05-012022-07-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">700</ix:nonFraction></span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Contingencies</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Gameface acquisition on February 2, 2022, the Company agreed to earn-out consideration of common shares of the Company&#8217;s
common stock with a fair value of $<span id="xdx_908_ecustom--FairValueOfCommonStock_iI_pp0p0_c20230131_z2y6ACVWCork" title="Fair value of common stock"><ix:nonFraction name="CNXA:FairValueOfCommonStock" contextRef="AsOf2023-01-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,334,000</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company issued <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20220601__20220630_zjiLZiKbQykd" title="Number of stock issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" contextRef="From2022-06-012022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">14,960</ix:nonFraction></span> common shares to the former Gameface shareholders in June 2022. The balance of the contingent consideration as
of July 31, 2023 and April 30, 2023 is $<span id="xdx_900_eus-gaap--BusinessCombinationContingentConsiderationLiability_iI_c20230731_ztO2Gf9dLNn6" title="Balance of contingent consideration"><span id="xdx_90B_eus-gaap--BusinessCombinationContingentConsiderationLiability_iI_c20230430_zT4nkbrpaxj5" title="Balance of contingent consideration"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiability" contextRef="AsOf2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiability" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">418,455</ix:nonFraction></ix:nonFraction></span></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, the Company may become involved in legal proceedings arising in the ordinary course of business. The Company is not presently
a party to any legal proceedings that it currently believes would individually or taken together have a material adverse effect on the
Company&#8217;s business or financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Nasdaq
Compliance</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 26, 2023, the Company received a letter from the Listing Qualifications Department of Nasdaq indicating that the Company&#8217;s
stockholders&#8217; equity as reported in its Quarterly Report on Form 10-Q for the quarterly period ended January 31, 2023 did not satisfy
the continued listing requirement under Nasdaq Listing Rule 5550(b)(1), which requires that a listed company&#8217;s stockholders&#8217;
equity be at least $<span id="xdx_903_eus-gaap--StockholdersEquity_iI_pn5n6_c20230131__srt--RangeAxis__srt--MinimumMember_zAMGyi7Eedjf" title="Stockholders equity"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-01-31_srt_MinimumMember" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">2.5</ix:nonFraction></span> million (the &#8220;Minimum Stockholders&#8217; Equity Requirement&#8221;). As reported in its Form 10-Q for
the period ended January 31, 2023, the Company&#8217;s stockholders&#8217; equity as of January 31, 2023 was approximately $(<span id="xdx_902_eus-gaap--StockholdersEquity_iI_pn5n6_c20230131_zqYuvOsXPlHl" title="Stockholders equity"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-01-31" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">11.7</ix:nonFraction></span>) million.
In addition, the Company did not meet the alternatives of listed securities or net income from continuing operations as of the date of
the letter. The Nasdaq has given the Company until January 22, 2024 to regain compliance with the Minimum Stockholders&#8217; Equity
Requirement and net income from continuing operations requirement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company offers no assurance that it will regain compliance with the Minimum Stockholders&#8217; Equity Requirement
and/or any other delinquency in a timely manner.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-05-01to2023-07-31" escape="true" name="us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"><p id="xdx_80A_eus-gaap--DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_zqsTLSMtcog6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
13</b>: <b><span id="xdx_822_zOLqE3kwNLeh">DISCONTINUED OPERATIONS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 27, 2022, the Company entered into a share purchase agreement (the &#8220;Agreement&#8221;) with PlaySight, Chen Shachar and
Evgeni Khazanov (together, the &#8220;Buyer&#8221;) pursuant to which the Buyer purchased <span id="xdx_90D_ecustom--SharesIssuedAndOutstandingPercentage_pid_dp_uPure_c20221125__20221127__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember_zJU0KbEi8TAb" title="Shares issued and outstanding percentage"><ix:nonFraction name="CNXA:SharesIssuedAndOutstandingPercentage" contextRef="From2022-11-252022-11-27_custom_SharePurchaseAgreementMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of the issued and outstanding shares of
PlaySight from the Company in exchange for <span id="xdx_905_eus-gaap--DisposalGroupIncludingDiscontinuedOperationDescriptionAndTimingOfDisposal_c20221125__20221127__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember_zG6yH5PSSKy8" title="Discontinued operation description"><ix:nonNumeric contextRef="From2022-11-252022-11-27_custom_SharePurchaseAgreementMember" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationDescriptionAndTimingOfDisposal">(1) releasing the Company from all of PlaySight&#8217;s obligations towards its vendors, employees,
tax authorities and any other (past, current and future) creditors of PlaySight; (2) waiver by the Buyer of 100% of the personal consideration
owed to them under their employment agreements in the total amount of $<span id="xdx_909_eus-gaap--DisposalGroupIncludingDiscontinuedOperationConsideration_iI_c20221127__us-gaap--TypeOfArrangementAxis__custom--EmployeeAgreementMember_zAV7iMwVqdic" title="Personal consideration"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" contextRef="AsOf2022-11-27_custom_EmployeeAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">600,000</ix:nonFraction></span>; and (3) cash consideration of $<span id="xdx_906_eus-gaap--DisposalGroupIncludingDiscontinuedOperationConsideration_iI_c20221127__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember_ztSWoFANk2h3" title="Cash consideration"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" contextRef="AsOf2022-11-27_custom_SharePurchaseAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,000,000</ix:nonFraction></span> to be paid to
the Company in the form of a promissory note that matures on December 31, 2023.</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 5, 2022, the Company assigned <span id="xdx_90A_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20221205__srt--OwnershipAxis__custom--FoundationSportsToCharlesRuddyMember_ziH1sCbkdwfd" title="Ownership percentage by parrent"><ix:nonFraction name="us-gaap:MinorityInterestOwnershipPercentageByParent" contextRef="AsOf2022-12-05_custom_FoundationSportsToCharlesRuddyMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">75</ix:nonFraction></span>% of its membership interest in Foundation Sports to Charles Ruddy, its founder and granted
him the right for a period of three years to purchase the remaining <span id="xdx_901_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_iI_pid_dp_uPure_c20221205__srt--OwnershipAxis__custom--FoundationSportsToCharlesRuddyMember_zKu9bTBjuC3h" title="Ownership percentage by non-controlling owners"><ix:nonFraction name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" contextRef="AsOf2022-12-05_custom_FoundationSportsToCharlesRuddyMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">25</ix:nonFraction></span>% of its Foundation Sports membership interests for $<span id="xdx_90F_eus-gaap--Cash_iI_c20221205_z77Df8HlJ1E4" title="Cash"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2022-12-05" format="ixt:numdotdecimal" decimals="0" unitRef="USD">500,000</ix:nonFraction></span> in
cash. As of December 5, 2022, the results of Foundation Sports will no longer be consolidated in the Company&#8217;s financial statements,
and the investment was accounted for as an equity method investment. On December 5, 2022, the Company analyzed this investment and established
a reserve for the investment at the full amount of $<span id="xdx_90A_eus-gaap--Investments_iI_c20221205_zKUuewtlAQVk" title="Investments"><ix:nonFraction name="us-gaap:Investments" contextRef="AsOf2022-12-05" format="ixt:numdotdecimal" decimals="0" unitRef="USD">500,000</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounted for these sales as a disposal of a business under ASC 205-20-50-1(a). The Company had reclassified the operations of
PlaySight and Foundation Sports as discontinued operations as the disposal represents a strategic shift that will have a major effect
on the Company&#8217;s operations and financial results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-05-01to2023-07-31" escape="true" name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"><p id="xdx_897_eus-gaap--ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_zD9USQreYrA2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company reclassified the following operations to discontinued operations for the three months ended July 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;<span id="xdx_8BF_zlX69MpnFq96" style="display: none">SCHEDULE OF DISCONTINUED OPERATIONS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49B_20230501__20230731_z6vBlsAeZem6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--DisposalGroupIncludingDiscontinuedOperationRevenue_maDGIDOzOqT_zTX4Zsk8tpa8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 78%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,363,113</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOperatingExpense_msDGIDOzOqT_zN6SKIa4H6Ua" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,278,269</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_407_ecustom--DisposalGroupIncludingDiscontinuedOperationOtherIncomeLoss_msDGIDOzOqT_zt6ZTRD3r8wb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other (income) loss</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="CNXA:DisposalGroupIncludingDiscontinuedOperationOtherIncomeLoss" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">155,442</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_401_ecustom--DisposalGroupIncludingDiscontinuedOperationNetIncomeLoss_iT_mtDGIDOzOqT_zYbWwszeHEt3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net loss from discontinued
    operations</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="CNXA:DisposalGroupIncludingDiscontinuedOperationNetIncomeLoss" contextRef="From2023-05-01to2023-07-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,759,714</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AE_znieVEgpL9ag" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-05-01to2023-07-31" escape="true" name="us-gaap:SubsequentEventsTextBlock"><p id="xdx_805_eus-gaap--SubsequentEventsTextBlock_zwySO9EnbtKi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
14: <span id="xdx_829_zEX5YMHawsth">SUBSEQUENT EVENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
August 1, 2023 through the date hereof, the Company issued the following shares of common stock:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 1, 2023, the Company issued <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230801__20230801__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zy8F1mTvx409" title="Shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-08-012023-08-01_us-gaap_CommonStockMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">31,042</ix:nonFraction></span> shares of common stock to Armistice upon the exercise of its Pre-Funded Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 17, 2023, the Company issued <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230817__20230817__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RodneyRapsonMember_zwKXAt1sXCP1" title="Shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-08-172023-08-17_us-gaap_CommonStockMember_us-gaap_SubsequentEventMember_custom_RodneyRapsonMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,876</ix:nonFraction></span> shares of common stock to Rodney Rapson as compensation for Mr. Rapson&#8217;s advisory services
under the advisory agreement between the Company and Mr. Rapson.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 31, 2023, the Company issued <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20230831__20230831__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zzcDYDKRgBqc" title="Conversion of convertible securities"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2023-08-312023-08-31_us-gaap_CommonStockMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">42,500</ix:nonFraction></span> shares of common stock to the Lender (as defined below) in connection with the Conversion
(as defined below).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 18, 2023, the Company issued <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230918__20230918__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zjELcZ0dh7qk" title="Shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-09-182023-09-18_us-gaap_CommonStockMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">125,134</ix:nonFraction></span> shares of common stock to Armistice upon the exercise of its Pre-Funded Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 19, 2023, the Company issued <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230919__20230919__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zfkU79xTYOBa" title="Shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-09-192023-09-19_us-gaap_CommonStockMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,444</ix:nonFraction></span> shares of common stock to Armistice upon the exercise of its Pre-Funded Warrants.</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 103; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>UFS
Agreement</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 7, 2023, the Company entered into an agreement with UFS (the &#8220;UFS Agreement&#8221;) pursuant to which the Company sold $<span id="xdx_90C_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20230807__20230807__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--UFSAgreementMember_zlzl3d4gVVS2" title="Sale of consideration received"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedPerTransaction" contextRef="From2023-08-072023-08-07_us-gaap_SubsequentEventMember_custom_UFSAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">797,500</ix:nonFraction></span>
in future receivables (the &#8220;UFS Second Receivables Purchased Amount&#8221;) to UFS in exchange for payment to the Company of $<span id="xdx_900_eus-gaap--PaymentsToAcquireReceivables_c20230807__20230807__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--UFSAgreementMember_zsK9iEPe5qtf" title="Payment for exchange received amount"><ix:nonFraction name="us-gaap:PaymentsToAcquireReceivables" contextRef="From2023-08-072023-08-07_us-gaap_SubsequentEventMember_custom_UFSAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">550,000</ix:nonFraction></span>
in cash less fees of $<span id="xdx_90C_ecustom--CashLessFees_c20230807__20230807__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--UFSAgreementMember_zkiL1HtQX6Mj" title="Cash less fees"><ix:nonFraction name="CNXA:CashLessFees" contextRef="From2023-08-072023-08-07_us-gaap_SubsequentEventMember_custom_UFSAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,000</ix:nonFraction></span>. The Company agreed to pay UFS $<span id="xdx_903_eus-gaap--PaymentsToAcquireReceivables_c20230807__20230807__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--UFSAgreementMember__srt--StatementScenarioAxis__custom--EachWeekForNextThreeWeeksMember_zE0DtvmpYZz6" title="Payment for exchange received amount"><ix:nonFraction name="us-gaap:PaymentsToAcquireReceivables" contextRef="From2023-08-072023-08-07_us-gaap_SubsequentEventMember_custom_UFSAgreementMember_custom_EachWeekForNextThreeWeeksMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30,000</ix:nonFraction></span> each week until the UFS Second Receivables Purchased Amount is paid
in full.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to secure payment and performance of the Company&#8217;s obligations to UFS under the UFS Agreement, the Company granted to UFS
a security interest in the following collateral: all accounts receivable and all proceeds as such term is defined by Article 9 of the
UCC. The Company also agreed not to create, incur, assume, or permit to exist, directly or indirectly, any lien on or with respect to
any of such collateral.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 21, 2023, the Company amended its arrangement with MidCity and agreed to issue <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230821__20230821__us-gaap--TypeOfArrangementAxis__custom--AmendedUFSAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zqqJzfmOueFa" title="Shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-08-212023-08-21_custom_AmendedUFSAgreementMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">42,500</ix:nonFraction></span> shares of stock monthly for eight months
to settle the profit guarantee under its prior note arrangement from April 2020. The parties agreed to a one-time true-up at March 31,
2024 if any further amounts are due MidCity at that time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 19, 2023, the Company entered into an agreement with Meged (the &#8220;Second Meged Agreement&#8221;) pursuant to which the
Company sold $<span id="xdx_90D_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20230919__20230919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecondMegedAgreementMember_zQXZfHWwcmr4" title="Sale of consideration received"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedPerTransaction" contextRef="From2023-09-192023-09-19_us-gaap_SubsequentEventMember_custom_SecondMegedAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">423,000</ix:nonFraction></span> in future receivables to Meged (the &#8220;Meged Second Receivable Amount&#8221;) in exchange for paying the then
outstanding balance of $<span id="xdx_90A_eus-gaap--PaymentsToAcquireReceivables_pp2d_c20230919__20230919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecondMegedAgreementMember_zr2zndDoqNxi" title="Outstanding balance receivable"><ix:nonFraction name="us-gaap:PaymentsToAcquireReceivables" contextRef="From2023-09-192023-09-19_us-gaap_SubsequentEventMember_custom_SecondMegedAgreementMember" format="ixt:numdotdecimal" decimals="2" unitRef="USD">70,153.20</ix:nonFraction></span> of the Meged Receivables Purchased Amount in full with the balance being retained by the Company in
cash for general purposes. The Company agreed to pay Meged $<span id="xdx_90C_eus-gaap--PaymentsToAcquireReceivables_pp2d_c20230919__20230919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecondMegedAgreementMember__srt--StatementScenarioAxis__custom--EachWeekForNextThreeWeeksMember_zIuYNxo8FP7k" title="Payment for exchange received amount"><ix:nonFraction name="us-gaap:PaymentsToAcquireReceivables" contextRef="From2023-09-192023-09-19_us-gaap_SubsequentEventMember_custom_SecondMegedAgreementMember_custom_EachWeekForNextThreeWeeksMember" format="ixt:numdotdecimal" decimals="2" unitRef="USD">15,107.14</ix:nonFraction></span> each week until the Meged Second Receivable Amount is paid in full.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to secure payment and performance of the Company&#8217;s obligations to Meged under the Second Meged Agreement, the Company granted
to Meged a security interest in the following collateral: all accounts receivable and all proceeds as such term is defined by Article
9 of the UCC. The Company also agreed not to create, incur, assume, or permit to exist, directly or indirectly, any lien on or with respect
to any of such collateral.</span></p>

</ix:nonNumeric><p id="xdx_816_zZwAHMCd8pRh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 104; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ss_001"></span><span id="k_001"></span>Report
of Independent Registered Public Accounting Firm</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board of Directors and Stockholders of</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONNEXA
SPORTS TECHNOLOGIES INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Opinion
on the Financial Statements</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have audited the accompanying consolidated balance sheets of Connexa Sports Technologies Inc (the &#8216;Company&#8217;) as of April
30, 2023, and the related consolidated statements of operations and comprehensive loss, changes in stockholders&#8217; equity and cash
flows for the year ended April 30, 2023, and the related notes (collectively referred to as the &#8220;financial statements&#8221;).
In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company
as of April 30, 2023, and the results of its operations and its cash flows for the year ended April 30, 2023, in conformity with accounting
principles generally accepted in the United States of America.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Going
Concern</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed
in Note 2, the Company suffered an accumulated deficit of $(151,750,610), net loss of $(71,153,685) and a negative working capital of $(18,775,991). These matters
raise substantial doubt about the Company&#8217;s ability to continue as a going concern. Management&#8217;s plans with regards to these
matters are also described in Note 2 to the financial statements. These financial statements do not include any adjustments that might
result from the outcome of this uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Basis
for Opinion</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s
financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board
(United States) (&#8220;PCAOB&#8221;) and are required to be independent with respect to the Company in accordance with the U.S. federal
securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain
reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company
is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits,
we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion
on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error
or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding
the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant
estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits
provide a reasonable basis for our opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Critical
Audit Matters</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Critical
audit matters are matters arising from the current period audit of the financial statements that were communicated or required to be
communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and
(2) involved our especially challenging, subjective, or complex judgments. Communication of critical audit matters does not alter in
any way our opinion on the financial statements taken as a whole and we are not, by communicating the critical audit matters, providing
separate opinions on the critical audit matter or on the accounts or disclosures to which they relate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 105; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Complex Debt and Equity Transaction on disposal of
PlaySight.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As disclosed in Note 16, on November 27, 2022, the
company disposed of one of its subsidiaries, and the Company entered into debt and/or equity transactions and agreements that contained
terms and provisions that were uncommon in practice. Due to the unusual nature of the agreements, ensuring the accounting for the transactions
was challenging, subjective, and required complex auditor judgment, including detailed analysis and interpretation of accounting standards.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In order to audit these significant unusual transactions,
we reviewed the Company analysis and had to perform a significant amount of research in order to gain comfort in the accounting for each.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>OLAYINKA
OYEBOLA &amp; CO.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Chartered
Accountants)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lagos,
Nigeria</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have served as the Company&#8217;s auditor since 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
14, 2023</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 106; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 100%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ss_002"></span><span id="k_002"></span>CONNEXA
    SPORTS TECHNOLOGIES, INC.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONSOLIDATED
    BALANCE SHEETS (IN US$)</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>APRIL
    30, 2023 AND 2022</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_302_111_zPt3o6nHyFWa" summary="xdx: Statement - Consolidated Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20230430_z3VeJ4xKluJg" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">APRIL 30, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20220430_zwh44yPLcpMh" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">APRIL 30, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--AssetsAbstract_iB_zuF9phVEBSQj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><b><span style="text-decoration: underline">ASSETS</span></b></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AssetsCurrentAbstract_i01B_zkbyMFXCjGHl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Current Assets:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i02I_zD0FrthQL3E5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 60%; text-align: left">Cash and cash equivalents</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">202,095</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">665,002</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--AccountsReceivableNetCurrent_i02I_zZDqHCze3tgb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Accounts receivable, net</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">399,680</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,033,390</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--InventoryNet_i02I_z6pONwCNQnT" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Inventories, net</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,189,766</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,861,837</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--PrepaidInventoryCurrent_i02I_zTVCmg0Xj0v6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Prepaid inventory</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="CNXA:PrepaidInventoryCurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">936,939</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="CNXA:PrepaidInventoryCurrent" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">499,353</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--CommodityContractAssetCurrent_i02I_z43qQiWx8euk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Contract assets</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1286">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:CommodityContractAssetCurrent" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">235,526</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_i02I_zgFaCq0jYvc8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Prepaid expenses and other current assets</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">263,020</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">272,670</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_i02I_zKF6DdJeV9Th" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 10pt; text-align: left">Current assets of discontinued operations</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1292">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,258,318</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--AssetsCurrent_i02TI_zgKa5x1Fhqh5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 20pt; text-align: left">Total Current Assets</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,991,500</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,826,096</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AssetsNoncurrentAbstract_i01B_zMNIdyagPYwa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Non-Current Assets:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--OtherReceivables_i02I_zyKBaNP3N7Ya" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Note receivable - former subsidiary</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OtherReceivables" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,000,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1302">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--PropertyPlantAndEquipmentNet_i02I_z21NhlWsA1E4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Fixed assets, net of depreciation</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,791</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">47,355</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsNet_i02I_zFaqVblMqFme" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Intangible assets, net of amortization</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">101,281</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,842,856</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--Goodwill_i02I_zfVoURAWIVy9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">Goodwill</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1310">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,781,193</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent_i02I_zlEDXwMDS1B8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 10pt; text-align: left">Non-current assets of discontinued operations</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1313">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,365,446</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--AssetsNoncurrent_i02TI_zlfUu5iTbmV2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 20pt; text-align: left">Total Non-Current Assets</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AssetsNoncurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,116,072</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AssetsNoncurrent" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">62,036,850</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--Assets_i01TI_zpFdOqZndSN3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">TOTAL ASSETS</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,107,572</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">74,862,946</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB_zE6GpoarCno5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-decoration: underline; text-align: center">LIABILITIES AND SHAREHOLDERS&#8217; EQUITY (DEFICIT)</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--LiabilitiesAbstract_i01B_zXQ4am3msZQa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif">LIABILITIES</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--LiabilitiesCurrentAbstract_i02B_zh2xnWSC6Dk8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Current Liabilities:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--AccountsPayableCurrent_i03I_zEHPIXS26dDg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Accounts payable</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,496,629</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,252,665</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--AccruedLiabilitiesCurrent_i03I_zqkhRB6Kfksb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Accrued expenses</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,911,839</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,381,901</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--PurchaseObligation_i03I_zUaZRGR7FTUd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Related party purchase obligation</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1337">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:PurchaseObligation" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">500,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--ContractWithCustomerLiabilityCurrent_i03I_zhIyPPqha6Ai" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Contract liabilities</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1340">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">111,506</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--InterestPayableCurrent_i03I_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--NonrelatedPartyMember_zYFij5JAEw19" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Accrued interest</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:InterestPayableCurrent" contextRef="AsOf2023-04-30_us-gaap_NonrelatedPartyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,387</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:InterestPayableCurrent" contextRef="AsOf2022-04-30_us-gaap_NonrelatedPartyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">708,677</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--InterestPayableCurrent_i03I_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zT3UhwTp02Wj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Accrued interest - related party</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:InterestPayableCurrent" contextRef="AsOf2023-04-30_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">917,957</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:InterestPayableCurrent" contextRef="AsOf2022-04-30_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">908,756</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--InterestPayableCurrent_i03I_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zlpqNsI3AiC3" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Accrued interest</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:InterestPayableCurrent" contextRef="AsOf2023-04-30_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">917,957</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:InterestPayableCurrent" contextRef="AsOf2022-04-30_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">908,756</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--OtherNotesPayableCurrent_i03I_z5j3mwbD45Pk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Current portion of notes payable, net of discount</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OtherNotesPayableCurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,484,647</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OtherNotesPayableCurrent" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,639,376</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--ConvertibleNotesPayableCurrent_i03I_ziJnMbzSgsN1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Current portion of convertible notes payable, net of discount</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1355">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ConvertibleNotesPayableCurrent" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,327,778</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--DerivativeLiabilitiesCurrent_i03I_z3wJ5YufR0sl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Derivative liabilities</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DerivativeLiabilitiesCurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,489,606</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DerivativeLiabilitiesCurrent" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,443,779</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--BusinessCombinationContingentConsiderationLiabilityCurrent_i03I_zBMF0s4JnfU1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Contingent consideration</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">418,455</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,334,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--OtherLiabilitiesCurrent_i03I_znFnzG44e0m8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Other current liabilities</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">22,971</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">156,862</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_i03I_zyY4DbSNfec3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 10pt; text-align: left">Current liabilities of discontinued operations</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1367">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,215,222</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--LiabilitiesCurrent_i02TI_zst3XqIgK1El" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 20pt; text-align: left">Total Current Liabilities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">23,767,491</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">38,980,522</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--LiabilitiesNoncurrentAbstract_i02B_zPvdccgteYn9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Long-Term Liabilities:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--LongTermNotesPayable_i02I_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zV2E7BRjAjA" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Notes payable related parties, net of current portion</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:LongTermNotesPayable" contextRef="AsOf2023-04-30_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,953,842</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:LongTermNotesPayable" contextRef="AsOf2022-04-30_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,000,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent_i02I_zXasFcNTqSCd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 10pt; text-align: left">Non-current liabilities of discontinued operations</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1379">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,370,492</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--LiabilitiesNoncurrent_i02TI_zSN9WjNNwlV4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 20pt; text-align: left">Total Long-Term Liabilities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesNoncurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,953,842</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesNoncurrent" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,370,492</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--Liabilities_i01TI_z44HKqKIplEd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 20pt; text-align: left">Total Liabilities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,721,333</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">42,351,014</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--CommitmentsAndContingencies_i01I_zFmSmYUGk29g" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Commitments and contingency</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1388">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1389">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--StockholdersEquityAbstract_i01B_zpHNNhpCn2rl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">SHAREHOLDERS&#8217; EQUITY (DEFICIT)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">Common stock, par value, $<span id="xdx_903_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20230430_zCCmkAoEZd81" title="Common stock, par value"><span id="xdx_905_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20220430_zYQRS848kBo9" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></ix:nonFraction></span></span>, <span id="xdx_906_eus-gaap--CommonStockSharesAuthorized_iI_c20230430_zV8vcBO6Jx68" title="Common stock, shares authorized"><span id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_iI_c20220430_zCxGaEsbPWXh" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">300,000,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized, 13,543,155 and <span id="xdx_903_eus-gaap--CommonStockSharesIssued_iI_c20220430_zIXOGMPyPLlh" title="Common stock, shares issued"><span id="xdx_90B_eus-gaap--CommonStockSharesOutstanding_iI_c20220430_zIVZ6tN2N3Vi" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,194,836</ix:nonFraction></ix:nonFraction></span></span> shares
    issued and outstanding as of April 30, 2023 and 2022, respectively</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--CommonStockValue_iI_c20230430__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z59jSwkCVmS7" title="Common stock value" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2023-04-30_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,544</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--CommonStockValue_iI_c20220430_z05KFKGffYe2" title="Common stock value" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,195</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--AdditionalPaidInCapitalCommonStock_i02I_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zRzUCn0qJAy3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Additional paid in capital</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapitalCommonStock" contextRef="AsOf2023-04-30_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">132,980,793</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapitalCommonStock" contextRef="AsOf2022-04-30_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">113,049,700</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--RetainedEarningsAccumulatedDeficit_i02I_zCVOqKz1Hula" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Accumulated deficit</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">151,750,610</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">80,596,925</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_400_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_i02I_zbHQmjr8xHed" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 10pt; text-align: left">Accumulated other comprehensive income (loss)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">142,512</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">54,962</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--StockholdersEquity_i02TI_zKjZTuXzxOUk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 30pt; text-align: left">Total Stockholders&#8217; Equity (Deficit)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">18,613,761</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">32,511,932</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_zEb8wTyLojp" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">TOTAL LIABILITIES AND STOCKHOLDERS&#8217; EQUITY (DEFICIT)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,107,572</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">74,862,946</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 107; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 100%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ss_003"></span><span id="k_003"></span>CONNEXA
    SPORTS TECHNOLOGIES, INC</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONSOLIDATED
    STATEMENTS OF OPERATIONS (IN US$) </b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>YEARS
    ENDED APRIL 30, 2023 AND 2022</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_308_113_zQ3Q7RvK31A5" summary="xdx: Statement - Consolidated Statements of Operations (Unaudited)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20220501__20230430_zevncAzw3wE2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_494_20210501__20220430_zUqGqkoIcIU9" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zAddEl72ZjE8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 64%; text-align: left">NET SALES</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,922,799</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,102,672</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--CostOfGoodsAndServicesSold_zecqVBOyDkkb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">COST OF SALES</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSold" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,144,335</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSold" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,878,010</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--GrossProfit_iT_zzGUxLzb9Jhb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">GROSS PROFIT</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,778,464</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,224,662</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--OperatingExpensesAbstract_iB_z0zWhPC3YQx8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">OPERATING EXPENSES</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--SellingAndMarketingExpense_i01_ztoWbA9WLjud" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Selling and marketing expenses</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,928,198</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,477,570</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--GeneralAndAdministrativeExpense_i01_zoSWemkeTTVg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">General and administrative expenses</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">22,743,877</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">46,718,986</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--ResearchAndDevelopmentExpense_i01_zmPtDTBxVuYf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Research and development costs</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">65,164</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">736,141</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--OperatingExpenses_i01T_zAgDOVwDqKW9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Total Operating Expenses</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,737,239</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,932,697</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--OperatingIncomeLoss_iT_zCQKXd5LufS" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">OPERATING LOSS</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">21,958,775</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">46,708,035</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--NonoperatingIncomeExpenseAbstract_iB_zgFUqIx6jJe7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">NON-OPERATING INCOME (EXPENSE)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--AmortizationOfFinancingCostsAndDiscounts_i01N_di_zvGXT69Dq995" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Amortization of debt discounts</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,095,030</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,150,284</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--GainsLossesOnExtinguishmentOfDebt_i01_zkHm7j37Zesd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Loss on extinguishment of debt</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1458">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,096,730</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_40B_ecustom--GainLossOnIssuanceOfConvertibleNotes_i01_zPKzkiuiUvuf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Loss on issuance of convertible notes</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1461">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="CNXA:GainLossOnIssuanceOfConvertibleNotes" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,889,369</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_40A_ecustom--GainLossOnChangeInFairValueOfContingentConsideration_i01_zPpsj5GDLde3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Gain on change in fair value of contingent consideration</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1464">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="CNXA:GainLossOnChangeInFairValueOfContingentConsideration" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,847,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--GainLossOnChangeInFairValueOfDerivativesLiability_i01_zWtcdlhs18tl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Change in fair value of derivative liability</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="CNXA:GainLossOnChangeInFairValueOfDerivativesLiability" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,950,017</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="CNXA:GainLossOnChangeInFairValueOfDerivativesLiability" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,557,184</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--DerivativeExpense_i01N_di_zcC0HsPIj2Qh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Derivative expense</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="CNXA:DerivativeExpense" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,995,962</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1471">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--InterestExpense_i01N_di_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--NonrelatedPartyMember_zjKqaFjyk2C6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Interest expense</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2022-05-012023-04-30_us-gaap_NonrelatedPartyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">884,985</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2021-05-012022-04-30_us-gaap_NonrelatedPartyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,920,183</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_402_eus-gaap--InterestExpense_i01N_di_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zGzuY5OcTJf1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Interest expense - related party</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2022-05-012023-04-30_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">293,090</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2021-05-012022-04-30_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">165,558</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_406_eus-gaap--InterestExpense_i01N_di_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zHpnnb1oWXPk" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Interest expense </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2022-05-012023-04-30_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">293,090</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2021-05-012022-04-30_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">165,558</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--NonoperatingIncomeExpense_i01T_pp0p0_zQERUm5NVi2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Total Non-Operating Income (Expenses)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">3,319,050</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">182,060</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_zVu2CcAL7Uh5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0pt; text-align: left">NET LOSS FROM CONTINUING OPERATIONS BEFORE PROVISION FOR INCOME
    TAXES</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">25,277,825</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">46,525,975</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">DISCONTINUED OPERATIONS</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_zC3Bw4ZqRAJc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Loss from discontinued operations</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,461,968</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,247,677</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_z3MdOQ7HpDG2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Loss on disposal of subsidiaries</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">41,413,892</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1492">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_iT_ztP8m96mmfF7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">LOSS FROM DISCONTINUED OPERATIONS</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">45,875,860</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,247,677</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--IncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_z1wQE2QbWKr" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0pt; text-align: left">NET LOSS FROM OPERATIONS BEFORE PROVISION FOR INCOME TAXES</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="CNXA:IncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">71,153,685</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="CNXA:IncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">51,773,652</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--IncomeTaxExpenseBenefit_zCU64g19GjQd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Provision for income taxes</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1500">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1501">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--NetIncomeLoss_iT_zLF3PTaMhk6i" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">NET LOSS</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">71,153,685</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">51,773,652</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_iB_zpUXlIiRRXEe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Other comprehensive income (loss)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_zLdLX3KpJMFk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Foreign currency translations adjustment</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">87,550</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">75,132</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--ComprehensiveIncomeNetOfTax_iT_zDVx2uewJiN5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Comprehensive income (loss)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">71,066,135</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">51,698,520</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--NetIncomeLossPerOutstandingLimitedPartnershipAndGeneralPartnershipUnitBasicAndDilutedAbstract_iB_zbnMJ6PLcPx3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Net income (loss) per share - basic and diluted</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Continuing operations</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pid_c20220501__20230430_z867aPdlUWLl" title="Continuing operations basic" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_"><span id="xdx_902_eus-gaap--IncomeLossFromContinuingOperationsPerDilutedShare_pid_c20220501__20230430_zR5mU6Hrlyee" title="Continuing operations diluted" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">2.26</ix:nonFraction></ix:nonFraction></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pid_c20210501__20220430_zUMBEXrh5uD9" title="Continuing operations basic" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_"><span id="xdx_902_eus-gaap--IncomeLossFromContinuingOperationsPerDilutedShare_pid_c20210501__20220430_z1zuXBe5F3Kl" title="Continuing operations diluted" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">12.09</ix:nonFraction></ix:nonFraction></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Discontinued operations</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_pid_c20220501__20230430_zaKKMOdUktTa" title="Discontinued operations basic" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_"><span id="xdx_90F_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_pid_c20220501__20230430_z2T3edKSNAsk" title="Discontinued operations diluted" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_">(<ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">4.10</ix:nonFraction></ix:nonFraction></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_903_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_pid_c20210501__20220430_zrTf36ELolHl" title="Discontinued operations basic" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_"><span id="xdx_906_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_pid_c20210501__20220430_zeFEiYXIXg29" title="Discontinued operations diluted" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_">(<ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">1.36</ix:nonFraction></ix:nonFraction></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Net loss per share - basic and diluted</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_eus-gaap--EarningsPerShareBasic_pid_c20220501__20230430_zlHf000WTgF8" title="Net loss per share - basic" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_"><span id="xdx_90B_eus-gaap--EarningsPerShareDiluted_pid_c20220501__20230430_zdpnSSaqkaQd" title="Net loss per share - diluted" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">6.36</ix:nonFraction></ix:nonFraction></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_eus-gaap--EarningsPerShareBasic_c20210501__20220430_zmxRXXodJqB8" title="Net loss per share - basic" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_"><span id="xdx_90E_eus-gaap--EarningsPerShareDiluted_c20210501__20220430_z1qmTFwi7z4" title="Net loss per share - diluted" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">13.46</ix:nonFraction></ix:nonFraction></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Weighted average common shares outstanding - basic and diluted</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20220501__20230430_ze1OkgOQw1jd" title="Weighted average common shares outstanding - basic" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_"><span id="xdx_90B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20220501__20230430_zsrtE9SpLd9l" title="Weighted average common shares outstanding - diluted" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,195,345</ix:nonFraction></ix:nonFraction></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_904_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20210501__20220430_zI257TCjleIh" title="Weighted average common shares outstanding - basic" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_"><span id="xdx_908_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20210501__20220430_z3zzHoR74ti1" title="Weighted average common shares outstanding - diluted" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucyAoVW5hdWRpdGVkKQA_"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,847,672</ix:nonFraction></ix:nonFraction></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these financial statements.</span></p>
<!-- Field: Split-Segment; Name: 001 -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 108; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" id="xdx_11A_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zx8KKM6cszZ9" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 100%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ss_004"></span><span id="k_004"></span>CONNEXA
    SPORTS TECHNOLOGIES, INC</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONSOLIDATED
    STATEMENT OF CHANGES IN SHAREHOLDERS&#8217; EQUITY (DEFICIT) (IN US$)</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
    THE YEARS ENDED APRIL 30, 2023 AND 2022 </b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30D_114_zYTWeXeG64We" summary="xdx: Statement - Consolidated Statement of Changes in Shareholders&apos; Equity (Deficit) (Unaudited)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" id="xdx_4BC_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zvoSZWILLhEj" style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" id="xdx_4BB_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zau64s8s66Rl" style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" id="xdx_4B4_us-gaap--StatementEquityComponentsAxis_us-gaap--AccumulatedOtherComprehensiveIncomeMember_zpCZ8wY1ylM8" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Accumulated</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" id="xdx_4B5_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zmyy94Khuqq7" style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" id="xdx_4B6_z5wGaS1WZis" style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="6" style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Additional</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Other</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Common Stock</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Paid-In</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Comprehensive</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Accumulated</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Shares</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Amount</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Capital</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Income (Loss)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Deficit</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Total</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr id="xdx_43B_c20210501__20220430_eus-gaap--StockholdersEquity_iS_zWCW2dTOdhQ6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 40%">Balance - May 1, 2021</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--SharesOutstanding_iS_c20210501__20220430__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zm2nuMvAG9vc" title="Balance, shares" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">69,108</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,764</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,389,935</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">20,170</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">28,823,273</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-04-30_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">18,450,744</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--StockIssuedDuringPeriodForAbstract_iB_zUzyJKaG8wT3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Stock issued for:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--StockIssuedDuringPeriodValueConversionofNotesPayableRelatedParties_zGr8qxMyxmx9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Conversion of notes payable - related parties</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98B_ecustom--StockIssuedDuringPeriodShareConversionofNotesPayableRelatedParties_c20210501__20220430__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zxaIaExwKDz9" title="Conversion of notes payable - related parties, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="CNXA:StockIssuedDuringPeriodShareConversionofNotesPayableRelatedParties" contextRef="From2021-05-012022-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,093</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="CNXA:StockIssuedDuringPeriodValueConversionofNotesPayableRelatedParties" contextRef="From2021-05-012022-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">164</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="CNXA:StockIssuedDuringPeriodValueConversionofNotesPayableRelatedParties" contextRef="From2021-05-012022-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,219,838</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1566">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1567">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="CNXA:StockIssuedDuringPeriodValueConversionofNotesPayableRelatedParties" contextRef="From2021-05-012022-04-30_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,220,002</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_zcrMc8uYOkU4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">Acquisition</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20210501__20220430__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zjmyOWEPZ6H3" title="Acquisitions, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" contextRef="From2021-05-012022-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,350</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2021-05-012022-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">54</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2021-05-012022-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,549,946</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1574">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1575">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2021-05-012022-04-30_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,550,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--StockIssuedDuringPeriodValueConversionOfUnits_zZBZ2NKYmby3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">Conversion of shares issuable (liability)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesConversionOfUnits_c20210501__20220430__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zvkPf15hLmm5" title="Conversion of shares issuable (liability), shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits" contextRef="From2021-05-012022-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">17,304</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" contextRef="From2021-05-012022-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">692</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" contextRef="From2021-05-012022-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,229</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1582">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1583">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" contextRef="From2021-05-012022-04-30_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,921</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--StockIssuedDuringPeriodValueOther_zjeAR8ol15Qb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">Conversion of warrants</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesOther_c20210501__20220430__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zFWocIx5ZZe5" title="Conversion of warrants, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesOther" contextRef="From2021-05-012022-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">12,375</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2021-05-012022-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">495</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2021-05-012022-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,255</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1590">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1591">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2021-05-012022-04-30_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,750</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_zF6daXdymnH" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">Services</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20210501__20220430__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z6KHVWml2Rhf" title="Services, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2021-05-012022-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">518</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2021-05-012022-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">21</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2021-05-012022-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,003,362</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1598">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1599">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2021-05-012022-04-30_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,003,383</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_zawjZqfED9x1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Share-based compensation</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_c20210501__20220430__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zzzgYrcVxoZk" title="Share-based compensation, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" contextRef="From2021-05-012022-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">126</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2021-05-012022-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2021-05-012022-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">32,473,597</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1606">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1607">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2021-05-012022-04-30_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">32,473,602</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--AdjustmentsToAdditionalPaidInCapitalOther_zqa2qDltH6Sa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Elimination of related party derivative liability</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1612">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" contextRef="From2021-05-012022-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,754,538</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1614">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1615">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" contextRef="From2021-05-012022-04-30_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,754,538</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_hus-gaap--BusinessAcquisitionAxis__custom--GamefaceLtdMember_zSEe6hZw6768" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Shares issuable in connection with Gameface acquisition</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1618">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2021-05-012022-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember_custom_GamefaceLtdMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,700,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1620">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1621">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2021-05-012022-04-30_srt_ScenarioPreviouslyReportedMember_custom_GamefaceLtdMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,700,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_hus-gaap--BusinessAcquisitionAxis__custom--PlaySightInteractiveLtdMember_zDMnZqoWPFU7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Shares issuable in connection with PlaySight acquisition</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1624">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2021-05-012022-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember_custom_PlaySightInteractiveLtdMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">39,950,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1626">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1627">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2021-05-012022-04-30_srt_ScenarioPreviouslyReportedMember_custom_PlaySightInteractiveLtdMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">39,950,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_zzGtLcxwVXpj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Change in comprehensive income (loss)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1630">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1631">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2021-05-012022-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">75,132</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1633">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2021-05-012022-04-30_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">75,132</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--NetIncomeLoss_zIVn2QUjY2P4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Net loss for the period</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1636">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1637">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1638">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-05-012022-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">51,773,652</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-05-012022-04-30_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">51,773,652</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_431_c20210501__20220430_eus-gaap--StockholdersEquity_iE_z55qAglPjFx9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Balance - April 30, 2022</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--SharesOutstanding_iE_c20210501__20220430__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z6EzDlaEnop2" title="Balance, shares" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">104,872</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,195</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">113,049,700</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">54,962</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">80,596,925</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-04-30_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">32,511,932</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_435_c20220501__20230430_eus-gaap--StockholdersEquity_iS_zGiYjwipj0Tk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">Balance - May 1, 2022</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--SharesOutstanding_iS_c20220501__20230430__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zDzA3poHJKQh" title="Balance, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">104,872</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,195</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">113,049,700</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">54,962</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">80,596,925</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-04-30_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">32,511,932</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--StockIssuedDuringPeriodForAbstract_iB_zAUNS5q9Ie0e" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Stock issued for:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_zyLBosmHf8fh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Conversion of notes payable</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20220501__20230430__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zZ2og0jIU85c" title="Conversion of notes payable, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2022-05-012023-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">109,737</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2022-05-012023-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,389</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2022-05-012023-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,041,911</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1666">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1667">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2022-05-012023-04-30_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,046,300</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_zRGi9JJsoNf1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">Acquisition</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20220501__20230430__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zWXfuwyD4gS3" title="Acquisitions, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" contextRef="From2022-05-012023-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">70,727</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2022-05-012023-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,829</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2022-05-012023-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">912,716</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1674">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1675">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2022-05-012023-04-30_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">915,545</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_zXdn1AKYUmFl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">Services</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20220501__20230430__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zcfuetL6oi7e" title="Services, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2022-05-012023-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">775</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-05-012023-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">31</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-05-012023-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">37,055</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1682">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1683">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-05-012023-04-30_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">37,086</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--StockIssuedDuringPeriodValueNewIssues_zaWtqP5zIcn2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">Cash</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220501__20230430__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zZ80sD9GHkq9" title="Cash, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-05-012023-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">51,682</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-05-012023-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,068</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-05-012023-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,192,932</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1690">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1691">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-05-012023-04-30_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,195,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--StockIssuedDuringPeriodValueCashlessExerciseOfWarrants_zhAJyM99SYhb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">Cashless exercise of warrants</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_982_ecustom--StockIssuedDuringPeriodCashlessExerciseOfWarrantsShares_c20220501__20230430__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zdj8nmT1CaT" title="Cashless exercise of warrants, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="CNXA:StockIssuedDuringPeriodCashlessExerciseOfWarrantsShares" contextRef="From2022-05-012023-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">750</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="CNXA:StockIssuedDuringPeriodValueCashlessExerciseOfWarrants" contextRef="From2022-05-012023-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="CNXA:StockIssuedDuringPeriodValueCashlessExerciseOfWarrants" contextRef="From2022-05-012023-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">30</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1698">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1699">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1700">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--StockIssuedDuringPeriodValueOther_zjKk7dIg4bK6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">Fractional share issuance</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesOther_c20220501__20230430__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zWNtP1xoeJdj" title="Fractional share issuance, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesOther" contextRef="From2022-05-012023-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">39</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2022-05-012023-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2022-05-012023-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1706">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1707">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1708">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_zTbSpgFTuXV9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Share-based compensation</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1712">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2022-05-012023-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">746,511</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1714">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1715">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2022-05-012023-04-30_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">746,511</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_zbl8plxKT6I" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Change in comprehensive income</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1718">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1719">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2022-05-012023-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">87,550</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1721">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2022-05-012023-04-30_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">87,550</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_zhTruH9cFpgf" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Change in comprehensive income (loss)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1724">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1725">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2022-05-012023-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">87,550</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1727">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="From2022-05-012023-04-30_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">87,550</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--NetIncomeLoss_zXsxJYDFvG8h" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Net loss for the period</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1730">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1731">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1732">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-05-012023-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">71,153,685</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-05-012023-04-30_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">71,153,685</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_43D_c20220501__20230430_eus-gaap--StockholdersEquity_iE_z6IGlsjgfdSd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Balance - April 30, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--SharesOutstanding_iE_c20220501__20230430__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zbBzWroBJUu5" title="Balance, shares" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">338,579</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,544</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">132,980,793</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">142,512</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">151,750,610</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-04-30_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">18,613,761</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these financial statements.</span></p>

<p id="xdx_115_z4r7FABGLVJd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 109; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 100%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ss_005"></span><span id="k_005"></span>CONNEXA
    SPORTS TECHNOLOGIES, INC</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONSOLIDATED
    STATEMENTS OF CASH FLOWS (IN US$) </b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>YEARS
    ENDED APRIL 30, 2023 AND 2022</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30C_112_zbzNkA41RAOh" summary="xdx: Statement - Consolidated Statements of Cash Flows (Unaudited)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_491_20220501__20230430_zv2cNJwCcKwc" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20210501__20220430_zUu1Mpo4tGTa" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_zHjTNYBRsNLc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">CASH FLOW FROM OPERTING ACTIVIITES</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--NetIncomeLoss_i01_zHxrvResZUDd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 68%; text-align: left; padding-bottom: 1.5pt">Net loss</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">71,153,685</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">51,773,652</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B_zsSlEjKpgmp6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Adjustments to reconcile net loss to net cash used in operating activities</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DepreciationAndAmortization_i02_zUjMxItEjnx2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Depreciation, amortization and impairment expense</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,555,332</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">43,534</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--DerivativeGainLossOnDerivativeNet_i02N_di_z5oFB6lytaze" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Change in fair value of derivative liability</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,950,017</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,557,184</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_406_eus-gaap--IssuanceOfStockAndWarrantsForServicesOrClaims_i02_zTv68P7QvFC1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Shares and warrants issued for services</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">37,086</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,010,304</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--ShareBasedCompensation_i02_z2TZ5QwdTw14" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Share-based compensation</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">746,511</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">32,473,602</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--GainLossOnSaleOfOtherAssets_i02N_di_z7skW6yRMnf5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Loss on disposal</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:GainLossOnSaleOfOtherAssets" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">41,413,892</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1766">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--GainLossOnChangeInFairValueOfContingentConsideration_i02N_di_z0vkNQas0BP1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Change in fair value of contingent consideration</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1768">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="CNXA:GainLossOnChangeInFairValueOfContingentConsideration" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,847,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--GainsLossesOnExtinguishmentOfDebt_i02N_di_zVPhoTah9Isk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Loss on extinguishment of debt</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1771">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,096,730</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--AmortizationOfDebtDiscountPremium_i02_z4Ox15pbN1dl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Amortization of debt discounts</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,095,030</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,150,284</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--DerivativeExpense_i02_ziERGnTW3lQd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Derivative expense</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="CNXA:DerivativeExpense" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,995,962</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1778">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--NoncashTransactionCosts_i02_zP4t6ADIAtEe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Non-cash transaction costs</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="CNXA:NoncashTransactionCosts" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">454,823</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="CNXA:NoncashTransactionCosts" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,250,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--GainLossOnIssuanceOfConvertibleNotes_i02N_di_z7BgKRNeAhy3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Loss on conversion of convertible notes</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1783">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="CNXA:GainLossOnIssuanceOfConvertibleNotes" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,889,369</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i02B_zc7FOuVPlWNl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Changes in assets and liabilities, net of acquired amounts</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--IncreaseDecreaseInAccountsReceivable_i03N_di_zHqgznqvDC2f" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Accounts receivable</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,368,643</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">268,930</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--IncreaseDecreaseInInventories_i03N_di_zlHrstIJBadb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt">Inventories</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,413,056</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,186,493</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_40E_ecustom--IncreaseDecreaseInPrepaidInventory_i03N_di_zrA1t9u08W75" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Prepaid inventory</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="CNXA:IncreaseDecreaseInPrepaidInventory" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">138,308</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="CNXA:IncreaseDecreaseInPrepaidInventory" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">520,580</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_400_eus-gaap--IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_i03N_di_zdreE4uK4QZh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Prepaid expenses and other current assets</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">430,193</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">320,679</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_i03_zSbniIeBWTj7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Accounts payable and accrued expenses</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">598,814</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,087,601</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--IncreaseDecreaseInContractWithCustomerLiability_i03_zRwQj3P1XoF" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Contract liabilities</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">53,287</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">41,451</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_409_eus-gaap--IncreaseDecreaseInOtherCurrentLiabilities_i03_zEAoupuiMll9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Other current liabilities</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,126,123</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,978,265</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--IncreaseDecreaseInInterestPayableNet_i03_zZzQxP9Mh485" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Accrued interest</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInInterestPayableNet" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">158,187</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInInterestPayableNet" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,813,516</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--IncreaseDecreaseInInterestPayableRelatedParty_i03_zvfwH6OqV6T8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Accrued interest - related parties</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="CNXA:IncreaseDecreaseInInterestPayableRelatedParty" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,201</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="CNXA:IncreaseDecreaseInInterestPayableRelatedParty" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">161,120</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_i03T_zauM8nIiUKye" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Total adjustments</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">60,326,327</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">34,255,478</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_iT_z7BhFeet5yBc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Net cash used in operating activities of continuing operations</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">10,827,358</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">17,518,174</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_407_eus-gaap--CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_zSaaJX0TnWK3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Net cash provided by operating activities of discontinued operations</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,461,969</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,151,474</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iT_zZryYs2utcPj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Net cash used in operating activities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,365,389</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">12,366,700</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_zyTbWybJma0a" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">CASH FLOWS FROM INVESTING ACTIVITIES</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--CashAcquiredFromAcquisition_i01_zHpfrMi5EvH7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Cash acquired as part of Gameface acquisition</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1831">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:CashAcquiredFromAcquisition" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">125,659</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--PaymentsToAcquireNotesReceivable_i01N_di_zXeYgsu9k1U9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Note receivable issuance</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1834">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquireNotesReceivable" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,250,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_407_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_i01T_zvENXJDhzhLi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Net cash used in investing activities of continuing operations</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1837">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,124,341</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_406_eus-gaap--CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_i01_z8CIExhiHD6h" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Net cash provided by operating activities of discontinued operations</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1840">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">506,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_zVHx4XHdia6g" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Net cash used in investing activities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1843">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,618,341</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zwS4VbQLfH0b" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">CASH FLOWS FROM FINANCING ACTIVITES</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--ProceedsFromIssuanceOfCommonStock_i01_zxA8Ka3aeAXd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Proceeds from issuance of common stock for cash</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,744,882</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1850">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--PaymentsOfDebtIssuanceCosts_i01N_di_zmyB2ZZefjRk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Debt issuance costs on convertible notes payable and other financing activities</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1852">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsOfDebtIssuanceCosts" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">800,251</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_405_eus-gaap--ProceedsFromNotesPayable_i01_z1PnjxkzuXCg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Proceeds from notes payable</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromNotesPayable" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,000,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromNotesPayable" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,500,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--ProceedsFromRelatedPartyDebt_i01_z93pTcQjhwF6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Proceeds from related party notes payable</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1858">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,000,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--ProceedsFromConvertibleDebt_i01_zFb1skMdzPE8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Proceeds from convertible notes payable</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1861">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,000,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--RepaymentsOfRelatedPartyDebt_i01N_di_zKrvAN6kSFXe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Payments of notes payable - related parties</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfRelatedPartyDebt" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">546,158</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1865">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--RepaymentsOfNotesPayable_i01N_di_z2aR1urGB61e" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Payments of notes payable</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfNotesPayable" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,377,537</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfNotesPayable" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,965,463</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_400_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_zaZ88eyfCxR7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Net cash provided by financing activities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,821,187</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,734,286</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_zUqJwrYWMo07" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Effect of exchange rate fluctuations on cash and cash equivalents</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">81,295</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">193</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_zSqo8m2W6KD9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">NET DECREASE IN CASH AND RESTRICTED CASH</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">462,907</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">250,948</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iS_zTKbvSEZ1Gk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">CASH AND RESTRICTED CASH - BEGINNING OF PERIOD</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">665,002</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2021-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">915,950</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iE_ztfMDnSaqWpc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">CASH AND RESTRICTED CASH - END OF PERIOD</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">202,095</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">665,002</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--SupplementalCashFlowInformationAbstract_iB_z3xyFdsvy7mb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">CASH PAID DURING THE PERIOD FOR:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--InterestPaidNet_i01_zXs81BQMbzh5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Interest expense</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">482,687</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">222,210</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--IncomeTaxesPaidNet_i01_zrtTFbGHzqWf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Income taxes</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1891">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">111,105</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--NoncashInvestingAndFinancingItemsAbstract_iB_zA1zz6H3l625" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">SUPPLEMENTAL INFORMATION - NON-CASH INVESTING AND FINANCING ACTIVITIES:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--StockIssued1_i01_zYkW1CaG8d29" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Shares issued in connection with acquisition</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1897">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssued1" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,550,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--ConversionOfConvertibleNotesPayableAndAccruedInterestToCommonStock_i01_zcDSeaAWJEea" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Conversion of convertible notes payable and accrued interest to common stock</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="CNXA:ConversionOfConvertibleNotesPayableAndAccruedInterestToCommonStock" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,046,300</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="CNXA:ConversionOfConvertibleNotesPayableAndAccruedInterestToCommonStock" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,220,003</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--SharesIssuedForContingentConsideration_i01_zZSb3xWHGPki" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Shares issued for contingent consideration</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="CNXA:SharesIssuedForContingentConsideration" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">915,545</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1904">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--EliminationOfRelatedPartyDerivativeLiabilities_i01_zDrgOHJk2Hc9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Elimination of related party derivative liabilities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1906">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="CNXA:EliminationOfRelatedPartyDerivativeLiabilities" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,754,538</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--DerivativeLiabilitiesRecordedAsDebtDiscountsOfConvertibleNotes_i01_zrueiwYRSmze" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Derivative liabilities recorded as debt discounts of convertible notes</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1909">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="CNXA:DerivativeLiabilitiesRecordedAsDebtDiscountsOfConvertibleNotes" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,199,749</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--DerivativeLiabilityRecordedForSharesAndWarrantsIssuedInPrivatePlacement_i01_zlETdwONra31" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Derivative liability recorded for shares and warrants issued in private placement</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="CNXA:DerivativeLiabilityRecordedForSharesAndWarrantsIssuedInPrivatePlacement" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,999,882</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1913">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--NotesIssued1_i01_zx4X8IFcwL03" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Note receivable issued in sale of PlaySight</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:NotesIssued1" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,000,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1916">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 110; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&#160;</p>

<p id="xdx_04E_c20220501__20230430_zD0oQLM7H7se" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ss_006"></span><span id="k_006"></span>CONNEXA
SPORTS TECHNOLOGIES INC. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-05-012023-04-30" escape="true" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"><p id="xdx_80C_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zm2Szh295vD6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
1: <span id="xdx_82A_zQEqeRaIBLnf">ORGANIZATION AND NATURE OF BUSINESS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Organization</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lazex
Inc. (&#8220;Lazex&#8221;) was incorporated under the laws of the State of Nevada on July 12, 2015. On August 23, 2019, the majority
owner of Lazex entered into a Stock Purchase Agreement with Slinger Bag Americas Inc., a Delaware corporation (&#8220;Slinger Bag Americas&#8221;),
which was <span id="xdx_908_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20190823__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SlingerBagAmericasIncMember_zuJJRIEOBcO6" title="Percentage of ownership"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2019-08-23_custom_SlingerBagAmericasIncMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction>%</span> owned by Slinger Bag Ltd. (&#8220;SBL&#8221;), an Israeli company. In connection with the Stock Purchase Agreement, Slinger
Bag Americas acquired <span id="xdx_90B_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_pid_c20190823__20190823__us-gaap--BusinessAcquisitionAxis__custom--SlingerBagAmericasIncMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z74SFsgzmyN6" title="Number of shares issued for acquisition"><ix:nonFraction name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" contextRef="From2019-08-232019-08-23_custom_SlingerBagAmericasIncMember_custom_StockPurchaseAgreementMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,000,000</ix:nonFraction></span> shares of common stock of Lazex for $<span id="xdx_90B_eus-gaap--BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_iI_c20190823__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--SlingerBagAmericasIncMember_zxFpsS5Rx3he" title="Number of value issued for acquisition"><ix:nonFraction name="us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" contextRef="AsOf2019-08-23_custom_StockPurchaseAgreementMember_custom_SlingerBagAmericasIncMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">332,239</ix:nonFraction></span>. On September 16, 2019, SBL transferred its ownership of
Slinger Bag Americas to Lazex in exchange for the <span id="xdx_90F_ecustom--NumberOfSharesExchanged_pid_c20190916__20190916__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SlingerBagAmericasIncMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zBIHrv8YkQN2" title="Number of shares exchanged"><ix:nonFraction name="CNXA:NumberOfSharesExchanged" contextRef="From2019-09-162019-09-16_custom_SlingerBagAmericasIncMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,000,000</ix:nonFraction></span> shares of Lazex acquired on August 23, 2019. As a result of these transactions,
Lazex owned <span id="xdx_904_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20190916__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SlingerBagAmericasIncMember_zjiGqxtJqpd2" title="Percentage of ownership"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2019-09-16_custom_SlingerBagAmericasIncMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction>%</span> of Slinger Bag Americas and the sole shareholder of SBL owned <span id="xdx_903_ecustom--NumberOfSharesOwned_pid_c20190916__20190916__us-gaap--BusinessAcquisitionAxis__custom--SoleShareholderofSBLMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zFqgF6v8K853" title="Number of shares owned"><ix:nonFraction name="CNXA:NumberOfSharesOwned" contextRef="From2019-09-162019-09-16_custom_SoleShareholderofSBLMember_custom_StockPurchaseAgreementMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,000,000</ix:nonFraction></span> shares of common stock (approximately <span id="xdx_905_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20190916__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SoleShareholderofSBLMember_zakPiRUvDj14" title="Percentage of ownership"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2019-09-16_custom_SoleShareholderofSBLMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">82</ix:nonFraction>%</span>) of
Lazex. Effective September 13, 2019, Lazex changed its name to Slinger Bag Inc.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 31, 2019, Slinger Bag Americas acquired control of Slinger Bag Canada, Inc., (&#8220;Slinger Bag Canada&#8221;) a Canadian company
incorporated on November 3, 2017. There were no assets, liabilities or historical operational activity of Slinger Bag Canada.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 10, 2020, Slinger Bag Americas became the <span id="xdx_90F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20200210__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SlingerBagAmericasIncMember_zWucosLaeuR" title="Percentage of ownership"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2020-02-10_custom_SlingerBagAmericasIncMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction>%</span> owner of SBL, along with SBL&#8217;s wholly owned subsidiary Slinger Bag International
(UK) Limited (&#8220;Slinger Bag UK&#8221;), which was formed on April 3, 2019. On February 10, 2020, the owner of SBL, contributed Slinger
Bag UK to Slinger Bag Americas for no consideration.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 21, 2021, Slinger Bag Americas entered into a membership interest purchase agreement with Charles Ruddy to acquire a <span id="xdx_90E_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20210621__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FoundationSportsSystemsLLCMember__srt--TitleOfIndividualAxis__custom--CharlesRuddyMember_z3e8zpAeBDw3" title="Percentage of ownership"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2021-06-21_custom_FoundationSportsSystemsLLCMember_custom_CharlesRuddyMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction>%</span> ownership
stake in Foundation Sports Systems, LLC (&#8220;Foundation Sports&#8221;). On December 5, 2022, the Company sold <span id="xdx_90C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20221205__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FoundationSportsSystemsLLCMember_zJIsmcdKQusc" title="Percentage of ownership"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2022-12-05_custom_FoundationSportsSystemsLLCMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">75</ix:nonFraction>%</span> of Foundation Sports
back to the original sellers. As a result, at that time, the Company recorded a loss on the sale and deconsolidated Foundation Sports.
(refer to Note 5 and Note 16). During the year ended April 30, 2022, the Company impaired certain intangible assets and goodwill in the
amount of $<span id="xdx_90E_eus-gaap--GoodwillImpairedAccumulatedImpairmentLoss_iI_c20220430_zQajjfPuYy31" title="Impaired of intangible assets and goodwill amount"><ix:nonFraction name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,486,599</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 2, 2022, the Company entered into a share purchase agreement with Flixsense Pty, Ltd. (&#8220;Gameface&#8221;). As a result
of the share purchase agreement, Gameface would become a wholly owned subsidiary of the Company (refer to Note 5).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 22, 2022, the Company entered into a merger agreement with PlaySight Interactive Ltd. (&#8220;PlaySight&#8221;) and Rohit Krishnan
(the &#8220;Shareholders&#8217; Representative&#8221;). As a result of the merger agreement, PlaySight would become a wholly owned subsidiary
of the Company (refer to Note 5). In November 2022, the Company sold PlaySight and recorded a loss on the sale. See Note 16 for further
details on the sale of PlaySight.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 16, 2022, the Company changed its domicile from Nevada to Delaware. On April 7, 2022, the Company effected a name change to Connexa
Sports Technologies Inc. We also changed our ticker symbol, &#8220;CNXA.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
operations of Slinger Bag Inc., Slinger Bag Americas, Slinger Bag Canada, Slinger Bag UK, SBL, and Gameface are collectively referred
to as the &#8220;Company.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 14, 2022, the Company effected a <span id="xdx_90F_eus-gaap--StockholdersEquityReverseStockSplit_c20220614__20220614_z6QItGR6YtTg"><ix:nonNumeric contextRef="From2022-06-142022-06-14" name="us-gaap:StockholdersEquityReverseStockSplit">1-for-10
reverse stock split</ix:nonNumeric></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, where the Company&#8217;s
common stock began to trade on a reverse split adjusted basis. No fractional shares were issued in connection with the reverse stock
split and all such fractional interests were rounded up to the nearest whole number of shares of common stock. All references herein
to the outstanding stock have been retrospectively adjusted to reflect this reverse stock split. The Company also consummated a public
offering of shares of its common stock and the listing of its common stock on the Nasdaq.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
further details on PlaySight and Foundation Sports we refer you to our Annual Report on Form 10-K for the year ended April 30, 2022,
filed with the Securities and Exchange Commission on May 17, 2023. This Form 10-K and the consolidated financial statements will concentrate
on our existing business as reflected in the following paragraph.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 111; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company operates in the sport equipment and technology business. The Company is the owner of the Slinger Launcher, which is a portable
tennis ball launcher as well as other associated tennis accessories and Gameface AI an Australian artificial intelligence sports software
company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Basis
of Presentation</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements of the Company are presented in accordance with accounting principles generally
accepted in the United States of America (&#8220;GAAP&#8221;). As a result of the transactions described above, the accompanying consolidated financial statements include the combined results of Slinger Bag Inc., Slinger Bag Americas, Slinger Bag Canada, Slinger
Bag UK, SBL, and Gameface for the years ended April 30, 2023 and 2022. The operations of Foundation Sports and PlaySight are included
as discontinued operations in our statements of operations as these entities were sold in November 2022 and December 2022 as disclosed
in Note 16.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company reports Gameface on a one-month calendar lag allowing for the timely preparation of financial statements. Gameface operates on
fiscal year end periods as of December 31. This one-month reporting lag is with the exception of significant transactions or events that
occur during the intervening period. The Company did not identify any significant transactions during the one month ended April 30, 2023
at Gameface that would need to be disclosed as not included within the Company&#8217;s consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Impact
of COVID-19 Pandemic</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has been carefully monitoring the COVID-19 pandemic and its impact on its business. In that regard, while the Company has continued
to sell its products and grow its business it did experience certain disruptions in its supply chains. The Company expects the significance
of the COVID-19 pandemic, including the extent of its effect on the Company&#8217;s financial and operational results, to be dictated
by, among other things, its duration, the success of efforts to contain it and the impact of actions taken in response. While the Company
has not experienced any material disruptions to its business and operations as a result of the COVID-19 pandemic, it is possible such
disruptions may occur in the future which may impact its financial and operational results, and which could be material.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Impact
of Russian and Ukrainian Conflict</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. We are closely monitoring
the unfolding events due to the Russia-Ukraine conflict and its regional and global ramifications. We have one distributor in Russia,
which is not material to our overall financial results. We do not have operations in Ukraine or Belarus. We are monitoring any broader
economic impact from the current crisis. The specific impact on the Company&#8217;s financial condition, results of operations, and cash
flows is also not determinable as of the date of these financial statements. However, to the extent that such military action spreads
to other countries, intensifies, or otherwise remains active, such action could have a material adverse effect on our financial condition,
results of operations, and cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-05-012023-04-30" escape="true" name="us-gaap:SubstantialDoubtAboutGoingConcernTextBlock"><p id="xdx_804_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_z5JGZe90xVX1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2: <span id="xdx_820_zpx4tnGNlCs8">GOING CONCERN</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial statements have been prepared on a going concern basis, which assumes the Company will be able to realize its assets and discharge
its liabilities in the normal course of business for the foreseeable future. The Company has an accumulated deficit of $<span id="xdx_907_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_di_c20230430_zdxGomWt0Ou7" title="Accumulated deficit"><ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">151,750,610</ix:nonFraction></span> as
of April 30, 2023, and more losses are anticipated in the development of the business. Accordingly, there is substantial doubt about
the Company&#8217;s ability to continue as a going concern. These financial statements do not include any adjustments related to the
recoverability and classification of assets or the amounts and classification of liabilities that might be necessary should the Company
be unable to continue as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/or being able
to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they
become due. Management intends to finance operating costs over the next twelve months with existing cash on hand, loans from related
parties, and/or private placement of debt and/or common stock. In the event that the Company is unable to successfully raise capital
and/or generate revenues, the Company will likely reduce general and administrative expenses, and cease or delay its development plan
until it is able to obtain sufficient financing. The Company has begun reducing operating expenses and cash outflows by selling PlaySight,
as well as selling <span id="xdx_903_ecustom--DisposalEquityInterestOwnershipInterestPercentage_iI_pid_dp_uPure_c20221130__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--PlaySightMember__us-gaap--BusinessAcquisitionAxis__custom--FoundationSportsSystemsLLCMember_z03WAVdg00xj" title="Discontinuing operations percentage"><span id="xdx_907_ecustom--DisposalEquityInterestOwnershipInterestPercentage_iI_pid_dp_uPure_c20221231__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--PlaySightMember__us-gaap--BusinessAcquisitionAxis__custom--FoundationSportsSystemsLLCMember_z2ZaThKYhH2e" title="Discontinuing operations percentage"><ix:nonFraction name="CNXA:DisposalEquityInterestOwnershipInterestPercentage" contextRef="AsOf2022-11-30_custom_PlaySightMember_custom_FoundationSportsSystemsLLCMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure"><ix:nonFraction name="CNXA:DisposalEquityInterestOwnershipInterestPercentage" contextRef="AsOf2022-12-31_custom_PlaySightMember_custom_FoundationSportsSystemsLLCMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">75</ix:nonFraction></ix:nonFraction>%</span></span> of Foundation Sports in November and December 2022, respectively to the former shareholders of those companies.
There can be no assurance that additional funds will be available on terms acceptable to the Company, or at all. We have recorded the
<span id="xdx_903_eus-gaap--DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal_pid_dp_uPure_c20220501__20230430__us-gaap--BusinessAcquisitionAxis__custom--FoundationSportsSystemsLLCMember_zgm6FrBTUnee" title="Investment retained after disposal, ownership interest after disposal"><ix:nonFraction name="us-gaap:DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal" contextRef="From2022-05-012023-04-30_custom_FoundationSportsSystemsLLCMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">25</ix:nonFraction>%</span> investment in Foundation Sprots at $<span id="xdx_906_eus-gaap--AlternativeInvestment_iI_dp_c20230430__us-gaap--BusinessAcquisitionAxis__custom--FoundationSportsSystemsLLCMember_zd8gDelqxUG" title="Investment amount"><ix:nonFraction name="us-gaap:AlternativeInvestment" contextRef="AsOf2023-04-30_custom_FoundationSportsSystemsLLCMember" format="ixt:numdotdecimal" decimals="0" scale="-2" unitRef="USD">0</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 112; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-05-012023-04-30" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_80D_eus-gaap--SignificantAccountingPoliciesTextBlock_zx7LYYX5i9v6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
3: <span id="xdx_823_zCwfPw8bDz02">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-05-012023-04-30" escape="true" name="us-gaap:UseOfEstimates"><p id="xdx_845_eus-gaap--UseOfEstimates_zbweqBbIOfHj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_869_zZphjCY6iJMd">Use
of Estimates</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect
the amounts reported in the financial statements and accompanying notes. Accordingly, actual results could differ from those estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-05-012023-04-30" escape="true" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription"><p id="xdx_84A_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zmBTVTVg1Vzh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86D_z4iek6XCOzT7">Financial
Statement Reclassification</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
prior year amounts within accounts payable, accrued expenses, and certain operating expenses have been reclassified for consistency with
the current year presentation and had no effect on the Company&#8217;s balance sheet, net loss, shareholders&#8217; deficit or cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-05-012023-04-30" escape="true" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock"><p id="xdx_84F_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zBSpXuLMoEBl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_867_zQa3IPLkAvBk">Cash
and Cash Equivalents</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents.
The majority of payments due from banks for credit card transactions process within 24 to 48 hours and are accordingly classified as
cash and cash equivalents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-05-012023-04-30" escape="true" name="us-gaap:TradeAndOtherAccountsReceivablePolicy"><p id="xdx_845_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zHA0nqyIm9Y3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86E_zuXjhSOa7Vce">Accounts
Receivable</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s accounts receivable are non-interest bearing trade receivables resulting from the sale of products and payable over terms
ranging from 15 to 60 days. The Company provides an allowance for doubtful accounts at the point when collection is considered doubtful.
Once all collection efforts have been exhausted, the Company charges-off the receivable with the allowance for doubtful accounts. The
Company recorded $<span id="xdx_909_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pdp0_do_c20230430_zVJAPCDSDaJ1" title="Allowance for doubtful accounts"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">209,690</ix:nonFraction> </span>and $<span id="xdx_90F_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pdp0_do_c20220430_zQbRZFlenFp1" title="Allowance for doubtful accounts"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">175,000</ix:nonFraction> </span>in allowance for doubtful accounts for the years ended April 30, 2023 and 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-05-012023-04-30" escape="true" name="us-gaap:InventoryPolicyTextBlock"><p id="xdx_844_eus-gaap--InventoryPolicyTextBlock_z4GZIc49tAJc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_860_zJHbInc5rlCg">Inventory</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory
is valued at the lower of the cost (determined principally on a first-in, first-out basis) or net realizable value. The Company&#8217;s
valuation of inventory includes inventory reserves for inventory that will be sold below cost and the impact of inventory shrink. Inventory
reserves are based on historical information and assumptions about future demand and inventory shrink trends. The Company&#8217;s inventory
as of April 30, 2023 and April 30, 2022 consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-05-012023-04-30" escape="true" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock"><p id="xdx_896_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zrmeoIreLo6e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_zOGEgcyNOtTi" style="display: none">SCHEDULE OF INVENTORY</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_492_20230430_zCNs6Kvremrg" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">April 30, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20220430_zUbYmp0KTAV2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">April 30, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--InventoryFinishedGoods_iI_maINzzOV_zgpMKI5OqRDg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left">Finished Goods</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><ix:nonFraction name="us-gaap:InventoryFinishedGoods" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,509,985</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><ix:nonFraction name="us-gaap:InventoryFinishedGoods" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,073,791</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--InventoryRawMaterialsAndSupplies_iI_maINzzOV_zA8Ecmzavp07" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Component/Replacement Parts</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:InventoryRawMaterialsAndSupplies" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,712,553</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:InventoryRawMaterialsAndSupplies" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,559,848</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--CapitalizedDutyAndFreight_iI_maINzzOV_zJz4ApKsSv12" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Capitalized Duty/Freight</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="CNXA:CapitalizedDutyAndFreight" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">517,228</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="CNXA:CapitalizedDutyAndFreight" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,328,198</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--InventoryAdjustments_iNI_di_msINzzOV_zMRWSmi26TMa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Inventory Reserve</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:InventoryAdjustments" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">550,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:InventoryAdjustments" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">100,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--InventoryNet_iTI_mtINzzOV_zaS27xIt7Avl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Total</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,189,766</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,861,837</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A4_zFzPuYXmiymi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-05-012023-04-30" escape="true" name="CNXA:PrepaidInventoryPolicyTextBlock"><p id="xdx_840_ecustom--PrepaidInventoryPolicyTextBlock_zd7vebe9uPi3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_867_zPvsYKuKBeq9">Prepaid
Inventory</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid
inventory represents inventory that is in-transit that has been paid for but not received from the Company&#8217;s third-party vendors.
The Company typically prepays for the purchase of materials and receives the products within three months after making payments. The
Company continuously monitors delivery from, and payments to, the vendors. If the Company has difficulty receiving products from a vendor,
the Company would cease purchasing products from such vendors in future periods. The Company has not had difficulty receiving products
during the reporting periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 113; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-05-012023-04-30" escape="true" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock"><p id="xdx_840_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zinPRBGbmrKh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_865_zvMa9q1QY8T1">Property
and equipment</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment acquired through business combinations are stated at the estimated fair value at the date of the acquisition. Purchases
of property and equipment are stated at cost, net of accumulated depreciation and impairment losses. Expenditures that materially increase
the useful life of the assets are capitalized. Ordinary repairs and maintenance are expensed as incurred. Depreciation and amortization
are computed using the straight-line method over the estimated useful lives of the related assets, which is an average of <span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230430_zLmLxV15L8H2" title="Property plant and equipment, useful life"><ix:nonNumeric contextRef="AsOf2023-04-30" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">5</ix:nonNumeric></span> years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-05-012023-04-30" escape="true" name="us-gaap:ConcentrationRiskCreditRisk"><p id="xdx_844_eus-gaap--ConcentrationRiskCreditRisk_zd7FSsePjhgi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86D_z14jdvKg80tl">Concentration
of Credit Risk</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company maintains its cash in bank deposit accounts, the balances of which at times may exceed insured limits. The Company continually
monitors its banking relationships and consequently has not experienced any losses in such accounts. While we may be exposed to credit
risk, we consider the risk remote and do not expect that any such risk would result in a significant effect on our results of operations
or financial condition. See Note 4 for further details on the Company&#8217;s concentration of credit risk as well as other risks and
uncertainties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-05-012023-04-30" escape="true" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock"><p id="xdx_84C_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_z413dCELoeZj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_862_z1ghWZ0Zkwn3">Revenue
Recognition</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes revenue for their continuing operations in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 606,
the core principle of which is that an entity should recognize revenue to depict the transfer of promised goods or services to customers
in an amount that reflects the consideration to which the entity expects to be entitled to receive in exchange for those goods or services.
The Company recognizes revenue for its performance obligation associated with its contracts with customers at a point in time once products
are shipped. Amounts collected from customers in advance of shipping products ordered are reflected as contract liabilities on the accompanying
consolidated balance sheets. The Company&#8217;s standard terms are non-cancelable and do not provide for the right-of-return, other
than for defective merchandise covered under the Company&#8217;s standard warranty. The Company has not historically experienced any
significant returns or warranty issues.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes revenue under ASC 606, &#8220;Revenue from Contracts with Customers&#8221;. The core principle of this revenue standard
is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects
the consideration to which the company expects to be entitled in exchange for those goods or services. The following five steps are applied
to achieve that core principle:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step
1: Identify the contract with the customer</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company determines that it has a contract with a customer when each party&#8217;s rights regarding the products or services to be transferred
can be identified, the payment terms for the services can be identified, the Company has determined the customer has the ability and
intent to pay, and the contract has commercial substance. At contract inception, the Company evaluates whether two or more contracts
should be combined and accounted for as a single contract and whether the combined or single contract includes more than one performance
obligation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step
2: Identify the performance obligations in the contract</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s customers are buying an integrated system. In evaluating whether the equipment is a separate performance obligation,
the Company&#8217;s management considered the customer&#8217;s ability to benefit from the equipment on its own or together with other
readily available resources and if so, whether the service and equipment are separately identifiable (i.e., is the service highly dependent
on, or highly interrelated with the equipment). Because the Products and Services included in the customer&#8217;s contract are integrated
and highly interdependent, and because they must work together to deliver the Solution, the Company has concluded that Products installed
on customer&#8217;s premise and Services contracted for by the customer are generally not distinct within the context of the contract
and, therefore, constitute a single, combined performance obligation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 114; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step
3: Determine the transaction price</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
transaction price is the amount of consideration to which an entity expects to be entitled in exchange for transferring promised goods
or services to a customer. The consideration promised in a contract with a customer includes predetermined fixed amounts, variable amounts,
or both. The Company&#8217;s contracts do not include any rights of returns or refunds.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company collects each year&#8217;s service fees in advance and should therefore consider the existence of a significant financing component.
However, due to the fact that the payments are provided for the service of a one-year term, the Company elected to apply the practical
expedient under ASC 606 which exempts the adjustment of the consideration for the existence of a significant financing component when
the period between the transfer of the services and the payment for such services is one year or less.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step
4: Allocate the transaction price to the performance obligations in the contract</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contracts
that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on
each performance obligation&#8217;s relative standalone selling price (&#8220;SSP&#8221;). The Company has identified a single performance
obligation in the contract, and therefore, the allocation provisions under ASC 606 do not apply to the Company&#8217;s contracts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step
5: Recognize revenue when the Company satisfies a performance obligation</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues
for the Company&#8217;s single, combined performance obligation are recognized on a straight-line basis over the customer&#8217;s contract
term, which is the period in which the parties to the contract have enforceable rights and obligations (Typically 3-4 years).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-05-012023-04-30" escape="true" name="us-gaap:BusinessCombinationsPolicy"><p id="xdx_84E_eus-gaap--BusinessCombinationsPolicy_z0ZRa7SHCO76" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86A_zbCzDWV4khLc">Business
Combinations</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
acquisition of a company, we determine if the transaction is a business combination, which is accounted for using the acquisition method
of accounting. Under the acquisition method, once control is obtained of a business, the assets acquired, and liabilities assumed, are
recorded at fair value. We use our best estimates and assumptions to assign fair value to the tangible and intangible assets acquired
and liabilities assumed at the acquisition date. One of the most significant estimates relates to the determination of the fair value
of these assets and liabilities. The determination of the fair values is based on estimates and judgments made by management. Our estimates
of fair value are based upon assumptions we believe to be reasonable, but which are inherently uncertain and unpredictable. Measurement
period adjustments are reflected at the time identified, up through the conclusion of the measurement period, which is the time at which
all information for determination of the values of assets acquired and liabilities assumed is received and is not to exceed one year
from the acquisition date. We may record adjustments to the fair value of these tangible and intangible assets acquired and liabilities
assumed, with the corresponding offset to goodwill. The Company elected to apply pushdown accounting to all entities acquired.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
uncertain tax positions and tax-related valuation allowances are initially recorded in connection with a business combination as of the
acquisition date. We continue to collect information and reevaluate these estimates and assumptions periodically and record any adjustments
to preliminary estimates to goodwill, provided we are within the measurement period. If outside of the measurement period, any subsequent
adjustments are recorded to the consolidated statement of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-05-012023-04-30" escape="true" name="us-gaap:FairValueOfFinancialInstrumentsPolicy"><p id="xdx_842_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zsR4gXGRnvj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_867_zSfb8dCDzeK1">Fair
Value of Financial Instruments</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
value of financial and non-financial assets and liabilities is defined as an exit price, representing the amount that would be received
to sell an asset or paid to transfer a liability in an orderly transaction between market participants. The three-tier hierarchy for
inputs used in measuring fair value, which prioritizes the inputs used in the methodologies of measuring fair value for assets and liabilities,
is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
1 &#8212; Quoted prices in active markets for identical assets or liabilities</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
2 &#8212; Observable inputs other than quoted prices in active markets for identical assets and liabilities</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
3 &#8212; Unobservable pricing inputs in the market</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 115; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
assets and financial liabilities are classified in their entirety based on the lowest level of input that is significant to the fair
value measurements. Our assessment of the significance of a particular input to the fair value measurements requires judgment and may
affect the valuation of the assets and liabilities being measured and their categorization within the fair value hierarchy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s financial instruments consist of cash and cash equivalents, accounts receivable, and accounts payable. The carrying amount
of these financial instruments approximates fair value due to their short-term maturity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s contingent consideration in connection with the acquisition of Gameface was calculated using Level 3 inputs. The fair
value of contingent consideration as of April 30, 2023 and 2022 was $<span id="xdx_908_eus-gaap--BusinessCombinationConsiderationTransferred1_c20220501__20230430__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zWAvbj1aT4ua" title="Fair value of contingent consideration"><ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferred1" contextRef="From2022-05-012023-04-30_us-gaap_FairValueInputsLevel3Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD">418,455</ix:nonFraction></span> and $<span id="xdx_905_eus-gaap--BusinessCombinationConsiderationTransferred1_c20210501__20220430__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zMgFaUDRB6Ii" title="Fair value of contingent consideration"><ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferred1" contextRef="From2021-05-012022-04-30_us-gaap_FairValueInputsLevel3Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,334,000</ix:nonFraction></span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company estimates the fair value of its intangible assets using Level 3 assumptions, primarily based on the income approach utilizing
the discounted cash flow method.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s derivative liabilities were calculated using Level 2 assumptions on the issuance and balance sheet dates via a Black-Scholes
option pricing model and consisted of the following ending balances and gain amounts as of and for the year ended April 30, 2023:</span></p>

<ix:nonNumeric contextRef="From2022-05-012023-04-30" escape="true" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock"><p id="xdx_895_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_zKdxFAaIrev6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BC_zth2ZPbd4ldg" style="display: none">SCHEDULE OF DERIVATIVE LIABILITIES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">April 30, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">(Gain) loss for the year</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Note derivative is related to</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">ending balance</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">ended April 30, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 58%; text-align: left">4/11/21 profit guaranty</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--ProfitGuarantyMember_zLoVdfg4BcMg" title="Note derivative balance" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><ix:nonFraction name="us-gaap:DerivativeInstrumentsAndHedgesLiabilities" contextRef="AsOf2023-04-30_custom_ProfitGuarantyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,456,854</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20220501__20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--ProfitGuarantyMember_ztU1z71Fcr69" title="Note derivative (gain) loss" style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2022-05-012023-04-30_custom_ProfitGuarantyMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">395,304</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">8/6/21 convertible notes</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--ConvertibleNotesMember_za5ouNOASKYj" title="Note derivative balance" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DerivativeInstrumentsAndHedgesLiabilities" contextRef="AsOf2023-04-30_custom_ConvertibleNotesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">101,924</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20220501__20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--ConvertibleNotesMember_zbyjmW8ypLJi" title="Note derivative (gain) loss" style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2022-05-012023-04-30_custom_ConvertibleNotesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,611,410</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">6/17/22 underwriter warrants</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--UnderwriterWarrantsMember_zk2QYBRehJBf" title="Underwriter warrants" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DerivativeInstrumentsAndHedgesLiabilities" contextRef="AsOf2023-04-30_custom_UnderwriterWarrantsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,531</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20220501__20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--UnderwriterWarrantsMember_z2kIb4szkMl9" title="Note derivative (gain) loss" style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2022-05-012023-04-30_custom_UnderwriterWarrantsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">57,951</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Other derivative liabilities eliminated in uplist</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--OtherDerivativeLiabilitiesMember_zJoLszxw8Ko5" title="Other derivative liabilities eliminated in uplist" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2020">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20220501__20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--OtherDerivativeLiabilitiesMember_zZaELMDW4F8" title="Note derivative (gain) loss" style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2022-05-012023-04-30_custom_OtherDerivativeLiabilitiesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,604,413</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">9/30/22 warrants issued with common stock</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsIssuedWithCommonStockMember_zSHGxJ6QgJva" title="Other derivative liabilities eliminated in uplist" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DerivativeInstrumentsAndHedgesLiabilities" contextRef="AsOf2023-04-30_custom_WarrantsIssuedWithCommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,109,559</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20220501__20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsIssuedWithCommonStockMember_zDUauxaNsYN3" title="Note derivative (gain) loss" style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2022-05-012023-04-30_custom_WarrantsIssuedWithCommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,170,728</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">1/6/2023 warrants issued with note payable</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsIssuedWithNotesPayableMember_zDflVje0ufDd" title="Other derivative liabilities eliminated in uplist" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DerivativeInstrumentsAndHedgesLiabilities" contextRef="AsOf2023-04-30_custom_WarrantsIssuedWithNotesPayableMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,814,738</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20220501__20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsIssuedWithNotesPayableMember_zWeXeUvmeepj" title="Note derivative (gain) loss" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2022-05-012023-04-30_custom_WarrantsIssuedWithNotesPayableMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">900,819</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Total</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230430_zQU5Cl2xeNz7" title="Note derivative balance" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DerivativeInstrumentsAndHedgesLiabilities" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,489,606</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_980_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20220501__20230430_zRROsfnxGTP5" title="Note derivative (gain) loss" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,950,017</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A1_zXI5Tz8hx0v2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company also recognized derivative expense of $<span id="xdx_901_ecustom--RecognizedDerivativeExpense_c20220501__20230430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zeDeQ562lBAa" title="Recognized derivative expense"><ix:nonFraction name="CNXA:RecognizedDerivativeExpense" contextRef="From2022-05-012023-04-30_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,280,405</ix:nonFraction></span> at inception on the warrants issued in connection with a funding on September
30, 2022 and $<span id="xdx_906_ecustom--RecognizedDerivativeExpense_c20230106__20230106__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zLga0pE9MI41" title="Recognized derivative expense"><ix:nonFraction name="CNXA:RecognizedDerivativeExpense" contextRef="From2023-01-062023-01-06_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,715,557</ix:nonFraction></span> at inception on the warrants issued in connection with a funding on January 6, 2023. The Black-Scholes option
pricing model assumptions for the derivative liabilities during the years ended April 30, 2023 and 2022 consisted of the following:</span></p>

<ix:nonNumeric contextRef="From2022-05-012023-04-30" escape="true" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"><p id="xdx_892_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_z4Bz6LcfV8Y7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B1_zSBUudjmpz4c" style="display: none">SCHEDULE
OF DERIVATIVE AND WARRANTS GRANTED VALUATION USING BLACK-SCHOLES PRICING METHOD</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Year Ended April 30, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Year Ended April 30, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Expected life in years</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--DerivativeLiabilitiesMeasurementInputTerm_dtY_c20220501__20230430__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zExvjDnpbI51" title="Derivative liabilities Measurement input, term"><ix:nonNumeric contextRef="From2022-05-012023-04-30_srt_MinimumMember_us-gaap_MeasurementInputExpectedTermMember_us-gaap_ValuationTechniqueOptionPricingModelMember" format="ixt-sec:duryear" name="CNXA:DerivativeLiabilitiesMeasurementInputTerm">3.25</ix:nonNumeric></span>-<span id="xdx_902_ecustom--DerivativeLiabilitiesMeasurementInputTerm_dtY_c20220501__20230430__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zp2qcuPMSE22" title="Derivative liabilities Measurement input, term"><ix:nonNumeric contextRef="From2022-05-012023-04-30_srt_MaximumMember_us-gaap_MeasurementInputExpectedTermMember_us-gaap_ValuationTechniqueOptionPricingModelMember" format="ixt-sec:duryear" name="CNXA:DerivativeLiabilitiesMeasurementInputTerm">10</ix:nonNumeric></span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecustom--DerivativeLiabilitiesMeasurementInputTerm_dtY_c20210501__20220430__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_z6yeJH9ymBcl" title="Derivative liabilities measurement input"><ix:nonNumeric contextRef="From2021-05-012022-04-30_srt_MinimumMember_us-gaap_MeasurementInputExpectedTermMember_us-gaap_ValuationTechniqueOptionPricingModelMember" format="ixt-sec:duryear" name="CNXA:DerivativeLiabilitiesMeasurementInputTerm">1.95</ix:nonNumeric></span>-<span id="xdx_90E_ecustom--DerivativeLiabilitiesMeasurementInputTerm_dtY_c20210501__20220430__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zWD6oIs7ALNd" title="Derivative liabilities measurement input"><ix:nonNumeric contextRef="From2021-05-012022-04-30_srt_MaximumMember_us-gaap_MeasurementInputExpectedTermMember_us-gaap_ValuationTechniqueOptionPricingModelMember" format="ixt-sec:duryear" name="CNXA:DerivativeLiabilitiesMeasurementInputTerm">4.3</ix:nonNumeric></span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 68%">Stock price volatility</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230430__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__srt--RangeAxis__srt--MinimumMember_zDuwBbVQde9c" title="Derivative liability measurement input"><ix:nonFraction name="us-gaap:DerivativeLiabilityMeasurementInput" contextRef="AsOf2023-04-30_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ValuationTechniqueOptionPricingModelMember_srt_MinimumMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">50</ix:nonFraction></span> - <span id="xdx_90D_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230430__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__srt--RangeAxis__srt--MaximumMember_ziEpBdVqYX01" title="Derivative liability measurement input"><ix:nonFraction name="us-gaap:DerivativeLiabilityMeasurementInput" contextRef="AsOf2023-04-30_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ValuationTechniqueOptionPricingModelMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">150</ix:nonFraction></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span id="xdx_90A_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220430__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zLjQhYmj1Zt6" title="Derivative liability measurement input"><ix:nonFraction name="us-gaap:DerivativeLiabilityMeasurementInput" contextRef="AsOf2022-04-30_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ValuationTechniqueOptionPricingModelMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">50</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Risk free interest rate</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230430__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zJAEIQfPKexl" title="Derivative liability measurement input"><ix:nonFraction name="us-gaap:DerivativeLiabilityMeasurementInput" contextRef="AsOf2023-04-30_srt_MinimumMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_us-gaap_ValuationTechniqueOptionPricingModelMember" format="ixt:numunitdecimalin" decimals="INF" unitRef="Pure">2.90</ix:nonFraction>%</span>-<span id="xdx_908_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230430__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zhWQyeeXjsV1" title="Derivative liability measurement input"><ix:nonFraction name="us-gaap:DerivativeLiabilityMeasurementInput" contextRef="AsOf2023-04-30_srt_MaximumMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_us-gaap_ValuationTechniqueOptionPricingModelMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">4.34</ix:nonFraction></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220430__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zMfFROROnH6l" title="Derivative liability measurement input"><ix:nonFraction name="us-gaap:DerivativeLiabilityMeasurementInput" contextRef="AsOf2022-04-30_srt_MinimumMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_us-gaap_ValuationTechniqueOptionPricingModelMember" format="ixt:numunitdecimalin" decimals="INF" unitRef="Pure">2.67</ix:nonFraction>%</span>-<span id="xdx_908_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220430__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zawH3Uq2Hv7e" title="Derivative liability measurement input"><ix:nonFraction name="us-gaap:DerivativeLiabilityMeasurementInput" contextRef="AsOf2022-04-30_srt_MaximumMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_us-gaap_ValuationTechniqueOptionPricingModelMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">2.90</ix:nonFraction></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Expected dividends</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230430__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_z7qeqaaslk7j" title="Derivative liability measurement input"><ix:nonFraction name="us-gaap:DerivativeLiabilityMeasurementInput" contextRef="AsOf2023-04-30_us-gaap_MeasurementInputExpectedDividendRateMember_us-gaap_ValuationTechniqueOptionPricingModelMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">0</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220430__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zakTy1zyVZ3h" title="Derivative liability measurement input"><ix:nonFraction name="us-gaap:DerivativeLiabilityMeasurementInput" contextRef="AsOf2022-04-30_us-gaap_MeasurementInputExpectedDividendRateMember_us-gaap_ValuationTechniqueOptionPricingModelMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">0</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A5_zgqcHLHfEXN5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Refer
to Note 10 and Note 11 for more information regarding the derivative instruments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-05-012023-04-30" escape="true" name="us-gaap:IncomeTaxPolicyTextBlock"><p id="xdx_843_eus-gaap--IncomeTaxPolicyTextBlock_z5WkW3YJHNGa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_863_zwElE196j3Sc">Income
Taxes</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
taxes are accounted for in accordance with the provisions of ASC 740, Accounting for Income Taxes. Deferred tax assets and liabilities
are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing
assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected
to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred
tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Valuation
allowances are established, when necessary, to reduce deferred tax assets to the amounts that are more likely than not to be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 116; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-05-012023-04-30" escape="true" name="us-gaap:IntangibleAssetsFiniteLivedPolicy"><p id="xdx_84E_eus-gaap--IntangibleAssetsFiniteLivedPolicy_ztN5wHRUMbGb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_864_zxZ4eLNANbOd">Intangible
Assets</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets relate to the &#8220;Slinger&#8221; technology trademark, which the Company purchased on November 10, 2020. The Company also acquired
intangible assets as a part of the Gameface acquisition. These intangible assets include tradenames, internally developed software, and
customer relationships. The acquired intangible assets are amortized based on the estimated present value of cash flows of each class
of intangible assets in order to determine their economic useful life. All intangible assets acquired with the PlaySight transaction
are included in discontinued operations. Refer to Note 6 for more information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-05-012023-04-30" escape="true" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"><p id="xdx_842_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zaGl9aLjyzXj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86C_zcm7DRP8PEHj">Impairment
of Long-Lived Assets</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with ASC 360-10, the Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate
that their net book value may not be recoverable. Factors which could trigger impairment review include significant underperformance
relative to historical or projected future operating results, significant changes in the manner of use of the assets or the strategy
for the overall business, a significant decrease in the market value of the assets or significant negative industry or economic trends.
When such factors and circumstances exist, the Company compares the projected undiscounted future cash flows associated with the related
asset or group of assets over their estimated useful lives against their respective carrying amount. If those net undiscounted cash flows
do not exceed the carrying amount, impairment, if any, is based on the excess of the carrying amount over the fair value based on the
market value or discounted expected cash flows of those assets and is recorded in the period in which the determination is made. There
was impairment of long-lived assets identified during the year ended April 30, 2023 and 2022 in our continuing operations. Refer to Note
6 for more information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-05-012023-04-30" escape="true" name="us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy"><p id="xdx_848_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_zdtNV2nGJ5md" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_864_z8EmZ71508Hl">Goodwill</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for goodwill in accordance with ASC 350, Intangibles - Goodwill and Other (&#8220;ASC 350&#8221;). ASC 350 requires
that goodwill not be amortized, but reviewed for impairment if impairment indicators arise and, at a minimum, annually. The Company records
goodwill as the excess purchase price over assets acquired and includes any work force acquired as goodwill. Goodwill is evaluated for
impairment on an annual basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
the adoption of the ASU 2017-04, which eliminates the second step of the goodwill impairment test, the Company tests impairment of goodwill
in one step. In this step, the Company compares the fair value of each reporting unit with goodwill to its carrying value. The Company
determines the fair value of its reporting units with goodwill using a combination of a discounted cash flow and a market value approach.
If the carrying value of the net assets assigned to the reporting unit exceeds the fair value of the reporting unit, the Company will
record an impairment charge based on the excess of a reporting unit&#8217;s carrying amount over its fair value. If the fair value of
the reporting unit exceeds the carrying value of the net assets assigned to that reporting unit, goodwill is not impaired and the Company
will not record an impairment charge.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company impaired the remaining $<span id="xdx_905_eus-gaap--GoodwillImpairmentLoss_c20220501__20230430_zRpSVtbWOkhh" title="Goodwill impairment charges"><ix:nonFraction name="us-gaap:GoodwillImpairmentLoss" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,781,193</ix:nonFraction></span> of goodwill as of April 30, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-05-012023-04-30" escape="true" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy"><p id="xdx_84D_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zATxgYgULnF" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86F_zoExeEVYsUjb">Share-Based
Payment</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for share-based compensation in accordance with ASC 718, Compensation-Stock Compensation (ASC 718). Under the fair value
recognition provisions of this topic, stock-based compensation cost is measured at the grant date based on the fair value of the award
and is recognized as an expense on a straight-line basis over the requisite service period, which is the vesting period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-05-012023-04-30" escape="true" name="CNXA:WarrantsPolicyTextBlock"><p id="xdx_841_ecustom--WarrantsPolicyTextBlock_z8UZfjEmf8Bh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86F_z4dLffk0HYub">Warrants</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company grants warrants to key employees and executives as compensation on a discretionary basis. The Company also grants warrants in
connection with certain note payable agreements and other key arrangements. The Company is required to estimate the fair value of share-based
awards on the measurement date and recognize as expense that value of the portion of the award that is ultimately expected to vest over
the requisite service period. Warrants granted in connection with ongoing arrangements are more fully described in Note 11 and Note 14.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 117; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
warrants granted during the years ended April 30, 2023 and 2022 were valued using a Black-Scholes option pricing model on the date of
grant using the following assumptions:</span></p>

<ix:nonNumeric contextRef="From2022-05-012023-04-30_us-gaap_WarrantMember30671140" escape="true" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"><p id="xdx_899_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_hus-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_zzz3XHpZ7AW7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B9_zSnX45WTkLQ7" style="display: none">SCHEDULE OF WARRANTS GRANTED VALUATION USING BLACK-SCHOLES PRICING
METHOD</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">Year Ended</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">April 30, 2023</p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">Year Ended</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">April 30, 2022</p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Expected life in years</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20230430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MinimumMember_z39j4GVFPZU2" title="Warrants measurement input, term"><ix:nonNumeric contextRef="AsOf2023-04-30_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputExpectedTermMember_srt_MinimumMember" format="ixt-sec:duryear" name="us-gaap:WarrantsAndRightsOutstandingTerm">5</ix:nonNumeric></span> &#8211; <span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20230430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MaximumMember_zxLRWNDFvyMe" title="Warrants measurement input, term"><ix:nonNumeric contextRef="AsOf2023-04-30_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputExpectedTermMember_srt_MaximumMember" format="ixt-sec:duryear" name="us-gaap:WarrantsAndRightsOutstandingTerm">10</ix:nonNumeric></span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MinimumMember_zQGYyHPQeRa2" title="Warrants measurement input, term"><ix:nonNumeric contextRef="AsOf2022-04-30_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputExpectedTermMember_srt_MinimumMember" format="ixt-sec:duryear" name="us-gaap:WarrantsAndRightsOutstandingTerm">5</ix:nonNumeric></span> &#8211; <span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MaximumMember_zuhSHLVH1bph" title="Warrants measurement input, term"><ix:nonNumeric contextRef="AsOf2022-04-30_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputExpectedTermMember_srt_MaximumMember" format="ixt-sec:duryear" name="us-gaap:WarrantsAndRightsOutstandingTerm">10</ix:nonNumeric></span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">Stock price volatility</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230430__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_zVgcGSscX8Rd" title="Warrants measurement input, rate"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2023-04-30_srt_MinimumMember_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">50</ix:nonFraction></span>% - <span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230430__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_zTqr0kjgX1B3" title="Warrants measurement input, rate"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2023-04-30_srt_MaximumMember_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">150</ix:nonFraction></span>%</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220430__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_zB8DinQqZMWj" title="Warrants measurement input, rate"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2022-04-30_srt_MinimumMember_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">50</ix:nonFraction></span>% - <span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220430__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_zyePRTOpLbxf" title="Warrants measurement input, rate"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2022-04-30_srt_MaximumMember_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">148</ix:nonFraction></span></span>%</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Risk free interest rate</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember_zFCjvCwWOVDe" title="Warrants measurement input, rate"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2023-04-30_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MinimumMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">2.50</ix:nonFraction></span>% - <span id="xdx_909_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember_zVHayA4Yshze" title="Warrants measurement input, rate"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2023-04-30_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">4.68</ix:nonFraction></span>%</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember_zcX2q7oqNHhb" title="Warrants measurement input, rate"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2022-04-30_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MinimumMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">0.77</ix:nonFraction></span>% - <span id="xdx_90F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember_zriimxW75qde" title="Warrants measurement input, rate"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2022-04-30_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">1.63</ix:nonFraction></span></span>%</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left">Expected dividends</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: center"><span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zpCT0ha2u6w" title="Warrants measurement input, rate"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2023-04-30_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputExpectedDividendRateMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">0</ix:nonFraction></span>%</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: center"><span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zselrYextILl" title="Warrants measurement input, rate"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2022-04-30_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputExpectedDividendRateMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">0</ix:nonFraction></span>%</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A0_zvMHtNt7z2Aj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-05-012023-04-30" escape="true" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"><p id="xdx_84F_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zYoHJGrSLQRa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_860_zQ4xReBtLj69">Foreign
Currency Translation</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
functional currency is the U.S. dollar. The functional currency of our foreign operations, generally, is the respective local currency
for each foreign subsidiary. Assets and liabilities of foreign operations denominated in local currencies are translated at the spot
rate in effect at the applicable reporting date. Our consolidated statements of comprehensive loss are translated at the weighted average
rate of exchange during the applicable period. The resulting unrealized cumulative translation adjustment is recorded as a component
of accumulated other comprehensive loss in shareholders&#8217; equity. Realized and unrealized transaction gains and losses generated
by transactions denominated in a currency different from the functional currency of the applicable entity are recorded in other income
(loss) in the period in which they occur.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-05-012023-04-30" escape="true" name="us-gaap:EarningsPerSharePolicyTextBlock"><p id="xdx_84C_eus-gaap--EarningsPerSharePolicyTextBlock_z6hMfSfComha" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_862_zeDZCwcJ1dj3">Earnings
Per Share</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
earnings per share are calculated by dividing the income available to shareholders by the weighted-average number of common shares
outstanding during each period. Diluted earnings per share are computed using the weighted average number of common and dilutive common
share equivalents outstanding during the period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
common stock equivalents such as shares to be issued for the conversion of notes payable and warrants were excluded from the calculation
of diluted earnings per share as the effect is antidilutive. As a result, the basic and diluted earnings per share are the same for each
of the periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-05-012023-04-30" escape="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_844_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zWCSSiuretbd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_862_z6AWpOXz8wfd">Recent
Accounting Pronouncements</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Recently
Adopted</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2017, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU No. 2017-04, Intangibles &#8211; Goodwill and
Other (Topic 350): Simplifying the Test for Goodwill Impairment (&#8220;ASU 2017-04&#8221;), which simplifies how an entity is required
to test goodwill for impairment by eliminating Step 2 from the goodwill impairment test. Under ASU 2017-04, goodwill impairment will
be tested by comparing the fair value of a reporting unit with its carrying amount, and recognizing an impairment charge for the amount
by which the carrying amount exceeds the reporting unit&#8217;s fair value. The new guidance must be applied on a prospective basis and
is effective for periods beginning after December 15, 2022, with early adoption permitted. The Company adopted ASU 2017-04 effective
May 1, 2021. The adoption of the new standard did not have a material effect on the Company&#8217;s consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2019, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;), 2019-12, <i>Simplifying the Accounting for Income Taxes</i>,
which amends ASC 740, <i>Income Taxes</i> (ASC 740). This update is intended to simplify accounting for income taxes by removing certain
exceptions to the general principles in ASC 740 and amending existing guidance to improve consistent application of ASC 740. This update
is effective for fiscal years beginning after December 15, 2021. The guidance in this update has various elements, some of which are
applied on a prospective basis and others on a retrospective basis with earlier application permitted. The adoption of the new standard
did not have a material effect on the Company&#8217;s consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 118; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2020, the FASB issued ASU No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging
Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own
Equity. ASU 2020-06 will simplify the accounting for convertible instruments by reducing the number of accounting models for convertible
debt instruments and convertible preferred stock. Limiting the accounting models results in fewer embedded conversion features being
separately recognized from the host contract as compared with current GAAP. Convertible instruments that continue to be subject to separation
models are (1) those with embedded conversion features that are not clearly and closely related to the host contract, that meet the definition
of a derivative, and that do not qualify for a scope exception from derivative accounting and (2) convertible debt instruments issued
with substantial premiums for which the premiums are recorded as paid-in capital. ASU 2020-06 also amends the guidance for the derivatives
scope exception for contracts in an entity&#8217;s own equity to reduce form-over-substance-based accounting conclusions. ASU 2020-06
will be effective for public companies for fiscal years beginning after December 15, 2023, including interim periods within those fiscal
years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within
those fiscal years. The Company is currently evaluating the impact that the adoption of ASU 2020-06 will have on the Company&#8217;s
consolidated financial statement presentation or disclosures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2016, the FASB issued ASU 2016-13, Financial Instruments &#8211; Credit Losses (Topic 326): Measurement of Credit Losses on Financial
Instruments (&#8220;ASC 326&#8221;). The guidance replaces the incurred loss methodology with an expected loss methodology that is referred
to as the current expected credit loss (&#8220;CECL&#8221;) methodology. The measurement of expected credit losses under the CECL methodology
is applicable to financial assets measured at amortized cost, including loan receivables and held-to-maturity debt securities. It also
applies to off-balance sheet credit exposures not accounted for as insurance (loan commitments, standby letters of credits, financial
guarantees, and other similar instruments) and net investments in leases recognized by a lessor in accordance with Topic 842 on leases.
ASC 326 requires enhanced disclosures related to the significant estimates and judgments used in estimating credit losses as well as
the credit quality and underwriting standards of a company&#8217;s portfolio. In addition, ASC 326 made changes to the accounting for
available-for-sale debt securities. One such change is to require credit losses to be presented as an allowance rather than as a write-down
on available-for-sale debt securities the Company does not intend to sell or believes that it is more likely than not they will be required
to sell. The ASU can be adopted no later than January 1, 2020 for SEC filers and January 1, 2023 for private companies and smaller reporting
companies. The Company has not yet adopted this ASU as it qualifies as a smaller reporting company. The Company does not expect this
ASU will have a material impact on its consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2021, the FASB issued ASU 2021-08, &#8220;Business Combinations - Accounting for Contract Assets and Contract Liabilities (Topic
805)&#8221;. The amendments in this Update address diversity and inconsistency related to the recognition and measurement of contract
assets and contract liabilities acquired in a business combination. The amendments in this Update require that an acquirer recognize
and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606, Revenue from Contracts
with Customers. ASU 2021-08 is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal
years. The Company does not expect the adoption of this ASU to have a material impact on the Company&#8217;s financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
FASB has issued ASU 2021-04, Earnings Per Share (Topic 260), Debt&#8212;Modifications and Extinguishments (Subtopic 470-50), Compensation&#8212;Stock
Compensation (Topic 718), and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40). ASU 2021-04 provides
guidance that an entity should treat a modification of the terms or conditions or an exchange of a freestanding equity-classified written
call option that remains equity classified after modification or exchange as an exchange of the original instrument for a new instrument.
The standard also provides guidance on how an entity should measure and recognize the effect of a modification or an exchange of a freestanding
equity-classified written call option that remains equity classified. The amendments in this ASU are effective for the Company for fiscal
years beginning after December 15, 2021. Early adoption is permitted for all entities, including adoption in an interim period. The adoption
of the new standard did not have a material effect on the Company&#8217;s consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
recently issued accounting pronouncements did not, or are not believed by management to, have a material effect on the Company&#8217;s
present or future consolidated financial statements.</span></p>

</ix:nonNumeric><p id="xdx_85A_zZcFC4aQkV58" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 119; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-05-012023-04-30" escape="true" name="us-gaap:ConcentrationRiskDisclosureTextBlock"><p id="xdx_80D_eus-gaap--ConcentrationRiskDisclosureTextBlock_zLeGex0IoJid" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
4</b>: <b><span id="xdx_823_zPTOk1EbAPB2">CONCENTRATION OF CREDIT RISK AND OTHER RISKS AND UNCERTAINTIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Accounts
Receivable Concentration</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of April 30, 2023 and 2022, the Company had two customers that accounted for <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220501__20230430__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CreditConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_z6rKEuRzHNU4" title="Concentration risk, percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-05-012023-04-30_us-gaap_AccountsReceivableMember_us-gaap_CreditConcentrationRiskMember_custom_CustomerOneMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">47</ix:nonFraction>%</span>
and <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210501__20220430__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CreditConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zHcqTZpR9yM7" title="Concentration risk, percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-05-012022-04-30_us-gaap_AccountsReceivableMember_us-gaap_CreditConcentrationRiskMember_custom_CustomerTwoMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">43</ix:nonFraction></span>%
of the Company&#8217;s trade receivables balance, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Accounts
Payable Concentration</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of April 30, 2023 and 2022, the Company had four significant suppliers that accounted for <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220501__20230430__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--LenderConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerFourMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember_zeclT50hbYDk" title="Concentration risk, percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-05-012023-04-30_us-gaap_LenderConcentrationRiskMember_custom_CustomerFourMember_us-gaap_AccountsPayableMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">59</ix:nonFraction>%</span>
and <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210501__20220430__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--LenderConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerFourMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember_zrje7zCfKgHj" title="Concentration risk, percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-05-012022-04-30_us-gaap_LenderConcentrationRiskMember_custom_CustomerFourMember_us-gaap_AccountsPayableMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">59</ix:nonFraction></span>% of the Company&#8217;s trade payables balances, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-05-012023-04-30" escape="true" name="us-gaap:BusinessCombinationDisclosureTextBlock"><p id="xdx_804_eus-gaap--BusinessCombinationDisclosureTextBlock_zIBVLAVytOQ9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
5: <span id="xdx_824_z7eVkjqDa1v8">ACQUISITIONS AND BUSINESS COMBINATIONS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the year ended April 30, 2022, the Company acquired three entities in accordance with ASC 805. A full description of those transactions
is reflected in the audited financial statements contained in our Annual Report on Form 10-K filed with the Securities and Exchange
Commission on May 17, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has elected to apply pushdown accounting to each of the entities acquired.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
Foundation Sports as referred to in Note 16, the Company disposed of <span id="xdx_900_ecustom--DisposalEquityInterestOwnershipInterestPercentage_iI_pid_dp_uPure_c20221231__us-gaap--BusinessAcquisitionAxis__custom--FoundationSportsMember_zZqNxeNgxswg" title="Disposal equity interest percentage"><ix:nonFraction name="CNXA:DisposalEquityInterestOwnershipInterestPercentage" contextRef="AsOf2022-12-31_custom_FoundationSportsMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">75</ix:nonFraction>%</span> of this entity in December 2022. The company has valued the
<span id="xdx_904_eus-gaap--DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal_pid_dp_uPure_c20220501__20230430__us-gaap--BusinessAcquisitionAxis__custom--FoundationSportsSystemsLLCMember_z8mHPy8uk5J9" title="Discontinuing operations percentage"><ix:nonFraction name="us-gaap:DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal" contextRef="From2022-05-012023-04-30_custom_FoundationSportsSystemsLLCMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">25</ix:nonFraction>%</span> they continue to own in Foundation Sports at $<span id="xdx_907_eus-gaap--AlternativeInvestment_iI_dp_c20230430__us-gaap--BusinessAcquisitionAxis__custom--FoundationSportsSystemsLLCMember_zPj3kCTGBYG8" title="Investments"><ix:nonFraction name="us-gaap:AlternativeInvestment" contextRef="AsOf2023-04-30_custom_FoundationSportsSystemsLLCMember" format="ixt:numdotdecimal" decimals="0" scale="-2" unitRef="USD">0</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
PlaySight as referred to in Note 16, the Company sold back to the original shareholders <span id="xdx_90C_ecustom--DisposalEquityInterestOwnershipInterestPercentage_iI_pid_dp_c20221130__us-gaap--BusinessAcquisitionAxis__custom--PlaySightMember_zbvbEbOGXx6b" title="Disposal equity interest percentage"><ix:nonFraction name="CNXA:DisposalEquityInterestOwnershipInterestPercentage" contextRef="AsOf2022-11-30_custom_PlaySightMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of this entity in November 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pro
Forma Results</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following pro forma financial information presents the results of operations of the Company as of the year ended April 30, 2022, respectively,
as if the acquisitions of Gameface had occurred as of the beginning of the first period presented instead of February 2022.</span></p>

<ix:nonNumeric contextRef="From2022-05-012023-04-30" escape="true" name="us-gaap:BusinessAcquisitionProFormaInformationTextBlock"><p id="xdx_898_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_zyENlt8bYm4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B7_zFAhyN7MQ28c" style="display: none">SCHEDULE OF PROFORMA FINANCIAL INFORMATION</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_495_20220501__20230430__us-gaap--BusinessAcquisitionAxis__custom--PlaySightAndGameFaceMember_zVxQYrY8QOx8" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--BusinessAcquisitionsProFormaRevenue_zM2xjz0arDz" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 80%">Revenues</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><ix:nonFraction name="us-gaap:BusinessAcquisitionsProFormaRevenue" contextRef="From2022-05-012023-04-30_custom_PlaySightAndGameFaceMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,102,672</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_zN8TPAqShFb8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Net loss</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" contextRef="From2022-05-012023-04-30_custom_PlaySightAndGameFaceMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">53,069,215</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Basic and diluted earnings (loss) per share</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_903_eus-gaap--BusinessAcquisitionProFormaEarningsPerShareBasic_pid_c20220501__20230430__us-gaap--BusinessAcquisitionAxis__custom--PlaySightAndGameFaceMember_zDPrP6mamX03" title="Basic earnings (loss) per share"><span id="xdx_90D_eus-gaap--BusinessAcquisitionProFormaEarningsPerShareDiluted_pid_c20220501__20230430__us-gaap--BusinessAcquisitionAxis__custom--PlaySightAndGameFaceMember_zFKKqatP7QUb" title="Diluted earnings (loss) per share">(<ix:nonFraction name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic" contextRef="From2022-05-012023-04-30_custom_PlaySightAndGameFaceMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted" contextRef="From2022-05-012023-04-30_custom_PlaySightAndGameFaceMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">13.79</ix:nonFraction></ix:nonFraction></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  </table>
<!-- Field: Split-Segment; Name: 002 -->
</ix:nonNumeric><p id="xdx_8A1_zLsYqKyzO9he" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-05-012023-04-30" escape="true" name="us-gaap:IntangibleAssetsDisclosureTextBlock"><p id="xdx_80C_eus-gaap--IntangibleAssetsDisclosureTextBlock_z2hMHofx60R5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
6: <span id="xdx_822_zGpW20ub859g">INTANGIBLE ASSETS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-05-012023-04-30" escape="true" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock"><p id="xdx_898_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_zdr9hxZMF1qc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets reflect only those intangible assets of our continuing operations, and consist of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BC_zLJRfJD0K8e9" style="display: none">SCHEDULE
OF INTANGIBLE ASSETS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Amortization (in years)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_484_eus-gaap--FiniteLivedIntangibleAssetsGross_iE_zrSxTrqNDeLh" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Carrying Value</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_486_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iE_z2DiURFhwMZg" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Accumulated Amortization</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_480_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_zGoK4o3VPHci" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Impairment Loss</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_489_eus-gaap--FiniteLivedIntangibleAssetsNet_iE_zOmVLXhWvedh" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Net Carrying Value</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="14" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center">Average Period</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">April 30, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Amortization (in years)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Carrying Value</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Accumulated Amortization</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Impairment Loss</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Net Carrying Value</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_414_20220501__20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zFDBZ3AM1HT6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: left">Tradenames and patents</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: center"><span id="xdx_90E_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zx6h3gqzWEL5" title="Weighted average amortization"><ix:nonNumeric contextRef="AsOf2023-04-30_us-gaap_TradeNamesMember" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1">15.26</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2023-04-30_us-gaap_TradeNamesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">385,582</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2023-04-30_us-gaap_TradeNamesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,031</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><ix:nonFraction name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" contextRef="From2022-05-012023-04-30_us-gaap_TradeNamesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">260,270</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2023-04-30_us-gaap_TradeNamesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">101,281</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_417_20220501__20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zAsmufx8AcW1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Customer relationships</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zwD9Z1VsmnG3" title="Weighted average amortization"><ix:nonNumeric contextRef="AsOf2023-04-30_us-gaap_CustomerRelationshipsMember" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1">9.92</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2023-04-30_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,930,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2023-04-30_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,038</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" contextRef="From2022-05-012023-04-30_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,879,962</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2160">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_414_20220501__20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zikGWA91n2t9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Internally developed software</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_z7pg1tb3zqug" title="Weighted average amortization"><ix:nonNumeric contextRef="AsOf2023-04-30_us-gaap_ComputerSoftwareIntangibleAssetMember" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1">4.91</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2023-04-30_us-gaap_ComputerSoftwareIntangibleAssetMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">580,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2023-04-30_us-gaap_ComputerSoftwareIntangibleAssetMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">79,608</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" contextRef="From2022-05-012023-04-30_us-gaap_ComputerSoftwareIntangibleAssetMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">500,392</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2166">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_417_20220501__20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangiableAssetMember_zXx2lvZtMOkf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Total intangible assets</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2023-04-30_custom_IntangiableAssetMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,895,582</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2023-04-30_custom_IntangiableAssetMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">153,677</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" contextRef="From2022-05-012023-04-30_custom_IntangiableAssetMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,640,624</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2023-04-30_custom_IntangiableAssetMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">101,281</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 120; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Amortization (in years)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_48B_eus-gaap--FiniteLivedIntangibleAssetsGross_iE_zUNr6toUcijk" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Carrying Value</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_486_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iE_zOV8G52KINe9" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Accumulated Amortization</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_485_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_zUmOVotCGov3" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Impairment Loss</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_487_eus-gaap--FiniteLivedIntangibleAssetsNet_iE_zGiQqowKXHbe" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Net Carrying Value</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="14" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center">Average Period</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">April 30, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Amortization (in years)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Carrying Value</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Accumulated Amortization</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Impairment Loss</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Net Carrying Value</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_419_20210501__20220430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zAgrvwPJvN0b" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%">Tradenames</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: center"><span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20220430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zbXyobP3JYwi" title="Weighted average amortization"><ix:nonNumeric contextRef="AsOf2022-04-30_us-gaap_TradeNamesMember" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1">15.26</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2022-04-30_us-gaap_TradeNamesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">385,582</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2022-04-30_us-gaap_TradeNamesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,478</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl2175">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2022-04-30_us-gaap_TradeNamesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">376,104</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_419_20210501__20220430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zDeHVQJJ5QD1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Customer relationships</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_901_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20220430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zP4mPbnhLrR4" title="Weighted average amortization"><ix:nonNumeric contextRef="AsOf2022-04-30_us-gaap_CustomerRelationshipsMember" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1">9.92</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2022-04-30_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,930,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2022-04-30_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">33,749</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2181">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2022-04-30_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,896,251</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_418_20210501__20220430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zrzQlmK69ly3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Internally developed software</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span id="xdx_90C_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20220430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zcIkXcNe90Of" title="Weighted average period amortization (in years)"><ix:nonNumeric contextRef="AsOf2022-04-30_us-gaap_ComputerSoftwareIntangibleAssetMember" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1">4.91</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2022-04-30_us-gaap_ComputerSoftwareIntangibleAssetMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">580,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2022-04-30_us-gaap_ComputerSoftwareIntangibleAssetMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,499</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2187">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2022-04-30_us-gaap_ComputerSoftwareIntangibleAssetMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">570,501</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_417_20210501__20220430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangiableAssetMember_zxTxREyI4cf2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Total intangible assets</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2022-04-30_custom_IntangiableAssetMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,895,582</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2022-04-30_custom_IntangiableAssetMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">52,726</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2193">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2022-04-30_custom_IntangiableAssetMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,842,856</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A1_zKvgv438iZql" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization
expense for the years ended April 30, 2023 and 2022 was approximately $<span id="xdx_903_eus-gaap--AmortizationOfIntangibleAssets_c20220501__20230430_zNGo9DG5knV1" title="Amortization expense"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">100,951</ix:nonFraction></span> and $<span id="xdx_908_eus-gaap--AmortizationOfIntangibleAssets_c20210501__20220430_zPjA4M57wJEl" title="Amortization expense"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">49,983</ix:nonFraction></span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-05-012023-04-30" escape="true" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"><p id="xdx_89A_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zH05izqLdxi5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of April 30, 2023, the estimated future amortization expense associated with the Company&#8217;s intangible assets for each of the five
succeeding fiscal years is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B6_zB85NosWLREd" style="display: none">SCHEDULE
OF ESTIMATED FUTURE AMORTIZATION</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">For the Periods Ended April 30,</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20230430_zSqYeLWsNuG" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Amortization Expense</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_maFLIANz0wb_zvOaBo4f6dU9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 83%; text-align: left">2024</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,780</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_maFLIANz0wb_ze3pjAkRb9Gd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">2025</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,780</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_maFLIANz0wb_z3V7ftmG7Me9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">2026</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,780</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_maFLIANz0wb_zXxqRIFFMZb9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">2027</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,780</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_maFLIANz0wb_zQReO9dlgiN1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">2028</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,780</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_maFLIANz0wb_z7NR33BokaSh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thereafter</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">72,381</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_mtFLIANz0wb_z9mqaNM9uZv6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">101,281</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A6_zp6xsGpTZQ53" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-05-012023-04-30" escape="true" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"><p id="xdx_808_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_z01754R0hRVb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
7</b>: <b><span id="xdx_82C_z9nDJ29Hm4q2">ACCRUED EXPENSES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-05-012023-04-30" escape="true" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock"><p id="xdx_89E_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_zI2oQEiZV7X6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
composition of accrued expenses is summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B8_zZslrlmApOp" style="display: none">SCHEDULE
OF ACCRUED EXPENSES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_492_20230430_zqbAUjkkGpMk" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">April 30, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20220430_zZfgJFMt77n8" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">April 30, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--AccruedPayrollTaxesCurrent_iI_maALCzIie_zJwwlQCiGI93" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left">Accrued payroll</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:AccruedPayrollTaxesCurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,535,186</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:AccruedPayrollTaxesCurrent" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">921,759</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AccruedBonusesCurrent_iI_maALCzIie_znHv2XcDokc9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accrued bonus</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AccruedBonusesCurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,720,606</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AccruedBonusesCurrent" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,014,833</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--AccruedProfessionalFeesCurrent_iI_maALCzIie_z5moAxsGpls1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accrued professional fees</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">490,424</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrent" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,706,560</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AccountsPayableOtherCurrent_iI_maALCzIie_zVSMdWQ8Rqb1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Other accrued expenses</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableOtherCurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,165,623</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableOtherCurrent" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">738,749</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AccruedLiabilitiesCurrent_iTI_mtALCzIie_zF0V6kHDPthf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Total</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,911,839</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,381,901</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AE_z0anScNuiLtl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-05-012023-04-30" escape="true" name="us-gaap:DebtDisclosureTextBlock"><p id="xdx_808_eus-gaap--DebtDisclosureTextBlock_zE2tKhk8jNYg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
8: <span id="xdx_82D_zPX7pZTZMBLd">NOTE PAYABLE - RELATED PARTY</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
discussion of note payable &#8211; related party only includes those that existed as of April 30, 2022. For a discussion of all prior
note payable &#8211; related party we refer you to the Annual Report on Form 10-K filed May 17, 2023 for the fiscal year end April 30,
2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 14, 2022, the Company entered into two loan agreements with related party lenders, each for $<span id="xdx_905_eus-gaap--LoansPayable_iI_c20220114__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zknIW0cVSOA4" title="Loans payable"><ix:nonFraction name="us-gaap:LoansPayable" contextRef="AsOf2022-01-14_custom_LoanAgreementsMember_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,000,000</ix:nonFraction></span>, pursuant to which the
Company received a total amount of $<span id="xdx_90E_eus-gaap--ProceedsFromRelatedPartyDebt_c20220113__20220114__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z1ZXDkC7dw0k" title="Proceeds from related party debt"><ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="From2022-01-132022-01-14_custom_LoanAgreementsMember_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,000,000</ix:nonFraction></span>. The loans bear interest at a rate of <span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20220114__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zXrfT5xWDzJk" title="Interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2022-01-14_custom_LoanAgreementsMember_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8</ix:nonFraction></span>% per annum and are required to be repaid in full
by April 30, 2022 or such other date as may be accepted by the lenders. The Company is not permitted to make any distribution or pay
any dividends unless or until the loans are repaid in full. On June 28, 2022, the Company entered into amendments for the two related
party loan agreements with the lenders in which the repayment date was extended to July 31, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 121; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
was $<span id="xdx_901_eus-gaap--NotesPayable_iI_c20230430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zUJQdH3WxUi6" title="Outstanding borrowings"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2023-04-30_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,953,842</ix:nonFraction></span> and $<span id="xdx_90A_eus-gaap--NotesPayable_iI_c20220430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zRh3CbhqFaI1" title="Outstanding borrowings"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2022-04-30_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,000,000</ix:nonFraction></span> in outstanding borrowings from related parties as of April 30, 2023 and 2022. Interest expense related
to the related parties for the years ended April 30, 2023 and 2022 amounted to $<span id="xdx_909_eus-gaap--InterestExpense_pp0p0_c20220501__20230430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zHcrAstEdSV5" title="Interest expense"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2022-05-012023-04-30_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">293,090</ix:nonFraction></span> &#160;and $<span id="xdx_906_eus-gaap--InterestExpense_pp0p0_c20210501__20220430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zeGFhLF6sECh" title="Interest expense"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2021-05-012022-04-30_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">165,558</ix:nonFraction></span>, respectively. Accrued interest
due to related parties as of April 30, 2023 and 2022 amounted to $<span id="xdx_90B_eus-gaap--InterestPayableCurrent_iI_c20230430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zHubxdAVsj6h" title="Accrued interest"><ix:nonFraction name="us-gaap:InterestPayableCurrent" contextRef="AsOf2023-04-30_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">917,957</ix:nonFraction></span> and $<span id="xdx_909_eus-gaap--InterestPayableCurrent_iI_c20220430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zB7X8pl0mUFl" title="Accrued interest"><ix:nonFraction name="us-gaap:InterestPayableCurrent" contextRef="AsOf2022-04-30_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">908,756</ix:nonFraction></span>, respectively. The accrued interest includes notes
that were either repaid or converted but the interest remained.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-05-012023-04-30" escape="true" name="us-gaap:ShortTermDebtTextBlock"><p id="xdx_805_eus-gaap--ShortTermDebtTextBlock_zZg2EFNe9WUe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
9: <span id="xdx_825_z9za7CMUsoc7">CONVERTIBLE NOTES PAYABLE</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
discussion of convertible notes payable only includes those that existed as of April 30, 2022. For a discussion of all prior convertible
notes payable we refer you to the Annual Report on Form 10-K filed May 17, 2023 for the fiscal year end April 30, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 6, 2021, the Company consummated the closing (the &#8220;Closing&#8221;) of a private placement offering (the &#8220;Offering&#8221;)
pursuant to the terms and conditions of that certain Securities Purchase Agreement, dated as of August 6, 2021 (the &#8220;Purchase Agreement&#8221;),
between the Company and certain accredited investors (the &#8220;Purchasers&#8221;). At the Closing, the Company sold to the Purchasers
(i) <span id="xdx_903_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20210806__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zBiTTA4ayfVb" title="Interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2021-08-06_custom_SecuritiesPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8</ix:nonFraction></span>% Senior Convertible Notes (the &#8220;Convertible Notes&#8221;) in an aggregate principal amount of $<span id="xdx_904_eus-gaap--ConvertibleNotesPayable_iI_c20210806__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zTbcFdEVILq8" title="Senior convertible notes"><ix:nonFraction name="us-gaap:ConvertibleNotesPayable" contextRef="AsOf2021-08-06_custom_SecuritiesPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,000,000</ix:nonFraction></span> and (ii) warrants
to purchase up to <span id="xdx_909_ecustom--WarrantsIssuedToPurchaseOfCommonStockShares_iI_c20210806__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zttmeYU0NQJ" title="Warrants issued to purchase of common stock, shares"><ix:nonFraction name="CNXA:WarrantsIssuedToPurchaseOfCommonStockShares" contextRef="AsOf2021-08-06_custom_SecuritiesPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">733,333</ix:nonFraction></span> shares of common stock of the Company (the &#8220;Warrants&#8221; and together with the Convertible Notes,
the &#8220;Securities&#8221;). The Company received an aggregate of $<span id="xdx_902_eus-gaap--ProceedsFromConvertibleDebt_c20210805__20210806__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zbyM1DZwDJyl" title="Gross proceeds from issuance of senior convertible notes"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2021-08-052021-08-06_custom_SecuritiesPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,000,000</ix:nonFraction></span> in gross proceeds from the Offering, before deducting
offering expenses and commissions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Convertible Notes were to mature on <span id="xdx_90F_eus-gaap--DebtInstrumentMaturityDate_c20210805__20210806__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zuXH8J103QN9" title="Convertible notes maturity date"><ix:nonNumeric contextRef="From2021-08-052021-08-06_custom_SecuritiesPurchaseAgreementMember" format="ixt:datemonthdayyearen" name="us-gaap:DebtInstrumentMaturityDate">August 6, 2022</ix:nonNumeric></span> (the &#8220;Maturity Date&#8221;) and bear interest at <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20210806__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zALpwTS2F6L4" title="Debt interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2021-08-06_custom_SecuritiesPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8</ix:nonFraction></span>% per annum payable on each
conversion date (as to that principal amount then being converted), on each redemption date as well as mandatory redemption date (as
to that principal amount then being redeemed) and on the Maturity Date, in cash. The Convertible Notes are convertible into shares of
the Company&#8217;s common stock at any time following the date of issuance and prior to Mandatory Conversion (as defined in the Convertible
Notes) at the conversion price equal to the lesser of: (i) $<span id="xdx_904_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_uUSDPShares_c20210806__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zAurl4ys3mpl" title="Conversion price"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="AsOf2021-08-06_custom_SecuritiesPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.00</ix:nonFraction></span>, subject to adjustment set forth in the Convertible Notes and (ii) in
the case of an uplist to the NASDAQ, the Uplist Conversion Price (as defined in the Convertible Notes) of the Company&#8217;s common
stock during the two Trading Day (as defined in the Convertible Notes) period after each conversion date; provided, however, that at
any time from and after December 31, 2021 or an Event of Default (as defined in the Convertible Notes), the holder of the Convertible
Notes may, by delivery of written notice to the Company, elect to cause all, or any part, of the Convertible Notes to be converted, at
any time thereafter, each an &#8220;Alternate Conversion&#8221;, pursuant to the Section 4(f) of the Convertible Notes, all, or any part
of, the then outstanding aggregate principal amount of the Convertible Notes into shares of Common Stock at the Alternate Conversion
price. The Convertible Notes rank pari passu with all other notes now or thereafter issued under the terms set forth in the Convertible
Notes. The Convertible Notes contain certain price protection provisions providing for adjustment of the number of shares of common stock
issuable upon conversion of the Convertible Notes in case of certain future dilutive events or stock-splits and dividends.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrants are exercisable for <span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_c20210806__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zfDV65DqD9wh" title="Warrants and rights outstanding, term"><ix:nonNumeric contextRef="AsOf2021-08-06_custom_SecuritiesPurchaseAgreementMember" format="ixt-sec:durwordsen" name="us-gaap:WarrantsAndRightsOutstandingTerm">five years</ix:nonNumeric></span> from <span id="xdx_905_eus-gaap--ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable_c20210805__20210806__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zw4y00KGtM74" title="Warrants rights date from which warrants exercisable"><ix:nonNumeric contextRef="From2021-08-052021-08-06_custom_SecuritiesPurchaseAgreementMember" format="ixt:datemonthdayyearen" name="us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable">August 6, 2021</ix:nonNumeric></span>, at an exercise price equal to the lesser of $<span id="xdx_903_ecustom--WarrantsExercisePrice_iI_pid_uUSDPShares_c20210806__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zvVuwaxlDfCi" title="Warrants exercise price"><ix:nonFraction name="CNXA:WarrantsExercisePrice" contextRef="AsOf2021-08-06_custom_SecuritiesPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.00</ix:nonFraction></span> or a 20% discount to the
public offering price that a share of the Company&#8217;s common stock or unit (if units are offered) is offered to the public resulting
in the commencement of trading of the Company&#8217;s common stock on the NASDAQ, New York Stock Exchange or NYSE American. The Warrants
contain certain price protection provisions providing for adjustment of the amount of securities issuable upon exercise of the Warrants
in case of certain future dilutive events or stock-splits and dividends.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluated the Warrants and the conversion options under the guidance in ASC 815 and determined they represent derivative liabilities
given the variability in the exercise and conversion prices upon the event of an up list to the NASDAQ. The Company also evaluated the
other embedded features in the agreement and determined the interest make-whole provision and the subsequent financing redemption represent
put features that are also accounted for as derivative liabilities. The derivative liabilities are marked to market at the end of each
reporting period with the non-cash gain or loss recorded in the period as a gain or loss on derivative (see Note 3).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrants were valued at $<span id="xdx_909_eus-gaap--WarrantsAndRightsOutstanding_iI_c20230430__us-gaap--ValuationTechniqueAxis__custom--MonteCarloSimulationMember_zCVDZn3Z7VXf" title="Warrants"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="AsOf2023-04-30_custom_MonteCarloSimulationMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,026,668</ix:nonFraction></span> on the date of issuance using a Monte Carlo simulation that accounted for the variability in the
exercise price upon the event of an up list based on the Company&#8217;s expected future stock prices over the <span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dxL_c20230430__us-gaap--ValuationTechniqueAxis__custom--MonteCarloSimulationMember_zvPWagmPeYb8" title="Warrants term::XDX::P5Y"><span style="-sec-ix-hidden: xdx2ixbrl2279">five</span></span>-year term using inputs
in line with those listed in Note 3. The remaining derivatives were valued at $<span id="xdx_908_ecustom--RemainingDerivativeLiabilities_iI_c20230430_zw2q7Jxutnh2" title="Derivative liabilities"><ix:nonFraction name="CNXA:RemainingDerivativeLiabilities" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,862,450</ix:nonFraction></span> on the issuance date based on the present value
of their weighted average probability value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 122; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
part of the issuance of the Convertible Notes, the Company incurred and capitalized debt issuance costs of $<span id="xdx_900_eus-gaap--DeferredFinanceCostsNet_iI_c20211031_zUkH6AyAiIR6" title="Debt issuance cost"><ix:nonFraction name="us-gaap:DeferredFinanceCostsNet" contextRef="AsOf2021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">800,251</ix:nonFraction></span> related to brokerage
and legal fees that met the debt issuance cost capitalization criteria of ASC 835. The total discount related to the Convertible Notes
on the date of issuance of $<span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodValueConversionOfUnits_c20210801__20211031_zI7D8tKTnTmh" title="Stock issued during period value conversion of units"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" contextRef="From2021-08-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,689,369</ix:nonFraction></span> exceeded their value, which resulted in the Company recognizing a $<span id="xdx_909_ecustom--LossOnIssuanceOfConvertibleNotes_c20210801__20211031_zV9ejW3oug93" title="Loss on issuance of convertible notes"><ix:nonFraction name="CNXA:LossOnIssuanceOfConvertibleNotes" contextRef="From2021-08-012021-10-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,689,369</ix:nonFraction></span> loss on the issuance
of the Convertible Notes during the three months ended October 31, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--SecuritiesOutstandingRateConvertibleNotesDescripition_c20211230__20211231_zmhLvShVygu3" title="Convertible note description"><ix:nonNumeric contextRef="From2021-12-302021-12-31" name="CNXA:SecuritiesOutstandingRateConvertibleNotesDescripition">On
December 31, 2021, the Company entered into an Omnibus Amendment Agreement (the &#8220;Omnibus Agreement&#8221;) with certain Purchasers
who are collectively holders of 67% or more of the Securities outstanding related to the August 6, 2021 Convertible Notes, amending each
of (i) the Purchase Agreement and (ii) the Registration Rights Agreement. Simultaneously with the execution of the Omnibus Agreement,
the Company issued to each Purchaser a Replacement Note (as defined below) in replacement of the Convertible Note held prior to December
31, 2021 by such Purchaser (each, an &#8220;Existing Note&#8221;).</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Purchase Agreement was amended to, among other things, (i) delete Exhibit A and replace it in its entirety with the 8% Senior Convertible
Note (the &#8220;Replacement Note&#8221;) filed as Exhibit 10.2 to the Company&#8217;s current report on Form 8-K dated January 5, 2021,
(ii) add a new definition of &#8220;Inventory Financing&#8221;, (iii) amend Section 4.18 to add at the end of Section 4.18 before the
final period &#8220;, it being agreed that the provisions of this Section 4.18 shall not apply to the Qualified Subsequent Financing
expected to occur after the date hereof&#8221;, (iv) delete Section 4.20 and replace it in its entirety with substantially the same text,
including the following after the period, replacing the period with a semicolon: &#8220;; provided that the provisions of this Section
4.20 shall not apply to (i) in respect of any Holder to the extent that such Holder is an investor or a purchaser of the securities offered
pursuant such Subsequent Financing, and (ii) with respect to an Inventory Financing.&#8221;, and (v) add a new Section 4.21. Most-Favored
Nation provision.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Registration Rights Agreement was amended to, among other things, (i) delete the definition &#8220;Effectiveness Date&#8221; in Section
1 and replace it in its entirety with substantially the same text but revise the definition of &#8220;Effectiveness Date&#8221; causing
the Initial Registration Statement required to be filed by January 31, 2022, and (ii) delete Section 2(d) and replace it in its entirety
with substantially the same text but revised to delete the following &#8220;(2) no liquidated damages shall accrue or be payable hereunder
with respect to any day on which the high price of the Common Stock on the Trading Market on which the Common Stock is then listed or
traded is less than the then-applicable Conversion Price,&#8221; resulting in renumbering the text that follows as (2) instead of (3).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
consideration for entering into the Omnibus Agreement, the outstanding principal balance of the Existing Note held by each Purchaser
was increased by twenty percent (<span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20220430__us-gaap--TypeOfArrangementAxis__custom--OmnibusAgreementMember_zCJxZ8aLkdad" title="Debt interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2022-04-30_custom_OmnibusAgreementMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">20</ix:nonFraction></span>%) and such increased principal balance is reflected on the Replacement Note issued to each Purchaser.
The Company recognized a $<span id="xdx_900_ecustom--LossOnIssuanceOfConvertibleNotes_c20210501__20220430__us-gaap--TypeOfArrangementAxis__custom--OmnibusAgreementMember_zrdmHI8zpYc4" title="Loss on issuance of convertible notes"><ix:nonFraction name="CNXA:LossOnIssuanceOfConvertibleNotes" contextRef="From2021-05-012022-04-30_custom_OmnibusAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,200,000</ix:nonFraction></span> loss on issuance of convertible notes during the year ended April 30, 2022 related to this amendment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 17, 2022, the Company issued <span id="xdx_903_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pid_c20220616__20220617_zGJKBhq34c2"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" contextRef="From2022-06-162022-06-17" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">109,737</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
of common stock in conversion of the $<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_c20220617_zzirrAZ9RC19"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2022-06-17" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,200,000</ix:nonFraction></span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
convertible notes payable and $<span id="xdx_90B_eus-gaap--DebtInstrumentIncreaseAccruedInterest_c20220617__20220617_z8pbSFkQO4N3"><ix:nonFraction name="us-gaap:DebtInstrumentIncreaseAccruedInterest" contextRef="From2022-06-172022-06-17" format="ixt:numdotdecimal" decimals="0" unitRef="USD">846,301</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
accrued interest. In addition, the remaining $<span id="xdx_904_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20220617__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_zZCYFzYl8xHc"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="AsOf2022-06-17_custom_ConvertibleNotesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">122,222</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
unamortized discount on the convertible notes payable was amortized and included in our consolidated statements of operations for
the three months ended July 31, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
outstanding borrowings related to the Convertible Notes as of April 30, 2023 and 2022 were $<span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_c20230430_zJLub0fi5g0i" title="Convertiable notes"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></span> and $<span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_c20220430_zuwuCuKqygQj" title="Convertiable notes"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,200,000</ix:nonFraction></span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-05-012023-04-30" escape="true" name="us-gaap:LongTermDebtTextBlock"><p id="xdx_80A_eus-gaap--LongTermDebtTextBlock_zBTxIeLApvnf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
10: <span id="xdx_829_zE2AOCxhpB7i">NOTES PAYABLE</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
discussion of notes payable only includes those that existed as of April 30, 2022. For a discussion of all prior notes payable we refer
you to the Annual Report on Form 10-K filed May 17, 2023 for the fiscal year end April 30, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 30, 2020, the Company entered into a loan agreement with Mont-Saic to borrow $<span id="xdx_905_eus-gaap--NotesPayable_iI_c20200630__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MontsaicInvestmentsLLCMember_zoteNowX5UJ9" title="Note payable"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2020-06-30_custom_LoanAgreementMember_custom_MontsaicInvestmentsLLCMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">120,000</ix:nonFraction></span>. This loan bears interest at an annual rate
of <span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20200630__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MontsaicInvestmentsLLCMember_zo9D2Si9ZPD9" title="Interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2020-06-30_custom_LoanAgreementMember_custom_MontsaicInvestmentsLLCMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12.6</ix:nonFraction></span>% and was required to be repaid in full, together with all accrued, but unpaid, interest by June 30, 2021. On December 3, 2020,
Mont-Saic entered into an Assignment and Conveyance Agreement with the Company&#8217;s exiting related party lender wherein Mont-Saic
sold its full right, title and interest in this note to the Company&#8217;s related party lender (see Note 8).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 123; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 24, 2020, the Company entered into a promissory note with a third-party to borrow $<span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_c20201224__us-gaap--DebtInstrumentAxis__custom--PromissoryNotePayableMember__srt--TitleOfIndividualAxis__custom--ThirdPartyMember_zanRRvdMUk8d" title="Note payable"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2020-12-24_custom_PromissoryNotePayableMember_custom_ThirdPartyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,000,000</ix:nonFraction></span>. The promissory note bore interest
at <span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20201224__us-gaap--DebtInstrumentAxis__custom--PromissoryNotePayableMember__srt--TitleOfIndividualAxis__custom--ThirdPartyMember_zmvIth3CiWf1" title="Interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2020-12-24_custom_PromissoryNotePayableMember_custom_ThirdPartyMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">2.25</ix:nonFraction></span>% and was due February 8, 2021. On February 2, 2021, the Company and the third-party entered into an amendment to extend the promissory
note to April 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 11, 2021, the Company and the lender entered into an agreement whereby the lender converted the promissory note into <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210410__20210411__us-gaap--DebtInstrumentAxis__custom--PromissoryNotePayableMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zEsgCNZLEoZf" title="Shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-04-102021-04-11_custom_PromissoryNotePayableMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">27,233</ix:nonFraction></span> shares
of Company stock, which were issued to the lender at a <span id="xdx_90F_eus-gaap--DebtConversionOriginalDebtInterestRateOfDebt_pid_dp_uPure_c20210410__20210411__us-gaap--DebtInstrumentAxis__custom--PromissoryNotePayableMember_zbF7x755FSCh" title="Interest rate"><ix:nonFraction name="us-gaap:DebtConversionOriginalDebtInterestRateOfDebt" contextRef="From2021-04-102021-04-11_custom_PromissoryNotePayableMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">20</ix:nonFraction></span>% discount from the closing price of the stock on the day prior to the conversion.
In addition to the discount, the agreement contains a guarantee that the aggregate gross sales of the shares by the lender will be no
less than $<span id="xdx_904_eus-gaap--DebtInstrumentCarryingAmount_iI_c20210411__us-gaap--DebtInstrumentAxis__custom--PromissoryNotePayableMember_zcx25JH5PYN8" title="Payables"><ix:nonFraction name="us-gaap:DebtInstrumentCarryingAmount" contextRef="AsOf2021-04-11_custom_PromissoryNotePayableMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,500,000</ix:nonFraction></span> over the next three years and if the aggregate gross sales are less than $<span id="xdx_90D_eus-gaap--DebtInstrumentCarryingAmount_iI_c20210411__us-gaap--DebtInstrumentAxis__custom--PromissoryNotePayableMember_zNW4l3Zl8nvg" title="Payables"><ix:nonFraction name="us-gaap:DebtInstrumentCarryingAmount" contextRef="AsOf2021-04-11_custom_PromissoryNotePayableMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,500,000</ix:nonFraction></span> the Company will issue additional
shares of common stock to the lender for the difference between the total gross proceeds and $<span id="xdx_902_eus-gaap--DebtInstrumentCarryingAmount_iI_c20210411__us-gaap--DebtInstrumentAxis__custom--PromissoryNotePayableMember_z6BtwefdLto8" title="Payables"><ix:nonFraction name="us-gaap:DebtInstrumentCarryingAmount" contextRef="AsOf2021-04-11_custom_PromissoryNotePayableMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,500,000</ix:nonFraction></span>, which could result in an infinite
number of shares being required to be issued.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluated the conversion option of the note payable to shares under the guidance in ASC 815-40, Derivatives and Hedging, and
determined the conversion option qualified for equity classification. The Company also evaluated the profit guarantee under ASC 815,
Derivatives and Hedging, and determined it to be a make-whole provision, which is an embedded derivative within the host instrument.
As the economic characteristics are dissimilar to the host instrument, the profit guarantee was bifurcated from the host instrument and
stated as a separate derivative liability, which is marked to market at the end of each reporting period with the non-cash gain or loss
recorded in the period as a gain or loss on derivative.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
the date of conversion, the Company recognized a $<span id="xdx_90A_eus-gaap--GainsLossesOnExtinguishmentOfDebt_c20210410__20210411_z8Lc6fqHODRb" title="Extinguishment of debt"><ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="From2021-04-102021-04-11" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,501,914</ix:nonFraction></span> loss on extinguishment of debt, which represented the difference between
the promissory note and the fair value of the shares issued of $<span id="xdx_907_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20210410__20210411_zUozt4HNRf86" title="Debt conversion, amount"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2021-04-102021-04-11" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,250,004</ix:nonFraction></span>, which were recorded in shares issued in connection with conversion
of note payable within shareholders&#8217; equity, as well as the derivative liability of $<span id="xdx_903_eus-gaap--DerivativeAssetsLiabilitiesAtFairValueNet_iNI_di_c20210411__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zczkEipKH3Ej" title="Derivative liability"><ix:nonFraction name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" contextRef="AsOf2021-04-11_us-gaap_ValuationTechniqueOptionPricingModelMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,251,910</ix:nonFraction></span>, which was valued using a Black-Scholes
option pricing model.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the derivative liability was $<span id="xdx_908_eus-gaap--DerivativeFairValueOfDerivativeNet_iI_c20230430__us-gaap--DebtInstrumentAxis__custom--PromissoryNotePayableMember_zFc9FtAfuw0k" title="Fair value of derivative liability"><ix:nonFraction name="us-gaap:DerivativeFairValueOfDerivativeNet" contextRef="AsOf2023-04-30_custom_PromissoryNotePayableMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,456,854</ix:nonFraction></span> and $<span id="xdx_90C_eus-gaap--DerivativeFairValueOfDerivativeNet_iI_c20220430__us-gaap--DebtInstrumentAxis__custom--PromissoryNotePayableMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zZbh8GzQEV92" title="Fair value of derivative liability"><ix:nonFraction name="us-gaap:DerivativeFairValueOfDerivativeNet" contextRef="AsOf2022-04-30_custom_PromissoryNotePayableMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,061,550</ix:nonFraction></span> as of April 30, 2023 and 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 15, 2022, for and in consideration of $<span id="xdx_908_eus-gaap--BusinessCombinationConsiderationTransferredOther1_c20220214__20220215_zEeuLSMBbypf" title="Consideration"><ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferredOther1" contextRef="From2022-02-142022-02-15" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,000,000</ix:nonFraction></span> the Company conveyed, sold, transferred, set over, assigned and delivered to
Slinger Bag Consignment, LLC, a Virginia limited liability company (&#8220;Consignor&#8221;), all of the Company&#8217;s right, title
and interest in and to <span id="xdx_903_ecustom--NumberOfConsignedGoods_pid_uInteger_c20220214__20220215_zA8VM9RYlhA8" title="Consignment units"><ix:nonFraction name="CNXA:NumberOfConsignedGoods" contextRef="From2022-02-142022-02-15" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">13,000</ix:nonFraction></span> units of certain surplus inventory, including all components, parts, additions and accessions thereto (collectively,
the &#8220;Consigned Goods&#8221;). The Company has repaid the $<span id="xdx_90A_eus-gaap--RepaymentsOfDebt_c20230430__20230430_zLQH2mtVVX04" title="Repayment of debt"><ix:nonFraction name="us-gaap:RepaymentsOfDebt" contextRef="From2023-04-302023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,000,000</ix:nonFraction></span> as of April 30, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 1, 2022, the Company entered into a $<span id="xdx_90E_eus-gaap--NotesPayable_iI_c20220401__us-gaap--DebtInstrumentAxis__custom--NotesPayableMember_z2NpV8Vsevbi" title="Note payable"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2022-04-01_custom_NotesPayableMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">500,000</ix:nonFraction></span> note payable. The note was to mature on July 1, 2022 and bears interest at eight percent
(<span id="xdx_903_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20220401__us-gaap--DebtInstrumentAxis__custom--NotesPayableMember_zU4cLmz9kGU6" title="Interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2022-04-01_custom_NotesPayableMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8</ix:nonFraction></span>%) per year. The Company pays interest monthly and will pay all accrued and unpaid interest on the maturity date in which the outstanding
principal is due. On August 1, 2022, the Company repaid the $<span id="xdx_909_eus-gaap--RepaymentsOfDebt_c20220801__20220801_z7VEEvywDAd1" title="Repayment of debt"><ix:nonFraction name="us-gaap:RepaymentsOfDebt" contextRef="From2022-08-012022-08-01" format="ixt:numdotdecimal" decimals="0" unitRef="USD">500,000</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Cash
Advance Agreements</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 29, 2022, the Company entered into two merchant cash advance agreements. The details of the merchant cash advance agreements are
as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>UFS
Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company entered into an agreement (the &#8220;UFS Agreement&#8221;) with Unique Funding Solutions LLC (&#8220;UFS&#8221;) pursuant to
which the Company sold $<span id="xdx_904_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20220729__20220729__us-gaap--TypeOfArrangementAxis__custom--UFSAgreementMember_zLVFM1X7PA78" title="Sale of consideration received"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedPerTransaction" contextRef="From2022-07-292022-07-29_custom_UFSAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,124,250</ix:nonFraction></span> in future receivables (the &#8220;UFS Receivables Purchased Amount&#8221;) to UFS in exchange for payment
to the Company of $<span id="xdx_90D_eus-gaap--PaymentsToAcquireReceivables_c20220729__20220729__us-gaap--TypeOfArrangementAxis__custom--UFSAgreementMember_zT1QyV4J1BZb" title="Payment for exchange received amount"><ix:nonFraction name="us-gaap:PaymentsToAcquireReceivables" contextRef="From2022-07-292022-07-29_custom_UFSAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">750,000</ix:nonFraction> </span>in cash less fees of $<span id="xdx_903_ecustom--CashLessFees_c20220729__20220729__us-gaap--TypeOfArrangementAxis__custom--UFSAgreementMember_z7FqlReXkhRc" title="Cash less fees"><ix:nonFraction name="CNXA:CashLessFees" contextRef="From2022-07-292022-07-29_custom_UFSAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">60,000</ix:nonFraction></span>. The Company has agreed to pay UFS $<span id="xdx_902_eus-gaap--PaymentsToAcquireReceivables_c20220729__20220729__us-gaap--TypeOfArrangementAxis__custom--UFSAgreementMember__srt--StatementScenarioAxis__custom--EachWeekForNextThreeWeeksMember_zGxFz9L8ZRQ3" title="Payment for exchange received amount"><ix:nonFraction name="us-gaap:PaymentsToAcquireReceivables" contextRef="From2022-07-292022-07-29_custom_UFSAgreementMember_custom_EachWeekForNextThreeWeeksMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,491</ix:nonFraction></span> each week for the next three weeks
and thereafter $<span id="xdx_90C_eus-gaap--PaymentsToAcquireReceivables_c20220729__20220729__us-gaap--TypeOfArrangementAxis__custom--UFSAgreementMember__srt--StatementScenarioAxis__custom--ThereafterPerWeekMember_zed8zPDVpG8k" title="Payment for exchange received amount"><ix:nonFraction name="us-gaap:PaymentsToAcquireReceivables" contextRef="From2022-07-292022-07-29_custom_UFSAgreementMember_custom_ThereafterPerWeekMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">44,970</ix:nonFraction></span> per week until the UFS Receivables Purchased Amount is paid in full.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to secure payment and performance of the Company&#8217;s obligations to UFS under the UFS Agreement, the Company granted to UFS
a security interest in the following collateral: all accounts receivable and all proceeds as such term is defined by Article 9 of the
UCC. The Company also agreed not to create, incur, assume, or permit to exist, directly or indirectly, any lien on or with respect to
any of such collateral.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 124; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cedar
Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company entered into an agreement (the &#8220;Cedar Agreement&#8221;) with Cedar Advance LLC (&#8220;Cedar&#8221;) pursuant to which
the Company sold $<span id="xdx_906_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20220729__20220729__us-gaap--TypeOfArrangementAxis__custom--CedarAgreementMember_zQlFW56NWmH2" title="Sale of consideration received"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedPerTransaction" contextRef="From2022-07-292022-07-29_custom_CedarAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,124,250</ix:nonFraction></span> in future receivables (the &#8220;Cedar Receivables Purchased Amount&#8221;) to Cedar in exchange for payment
to the Company of $<span id="xdx_900_eus-gaap--PaymentsToAcquireReceivables_c20220729__20220729__us-gaap--TypeOfArrangementAxis__custom--CedarAgreementMember_z8QFhAdToDba" title="Payment for exchange received amount"><ix:nonFraction name="us-gaap:PaymentsToAcquireReceivables" contextRef="From2022-07-292022-07-29_custom_CedarAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">750,000</ix:nonFraction></span> in cash less fees of $<span id="xdx_902_ecustom--CashLessFees_c20220729__20220729__us-gaap--TypeOfArrangementAxis__custom--CedarAgreementMember_zBojFB1XDxx7" title="Cash less fees"><ix:nonFraction name="CNXA:CashLessFees" contextRef="From2022-07-292022-07-29_custom_CedarAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">60,000</ix:nonFraction></span>. The Company has agreed to pay Cedar $<span id="xdx_907_eus-gaap--PaymentsToAcquireReceivables_c20220729__20220729__us-gaap--TypeOfArrangementAxis__custom--CedarAgreementMember__srt--StatementScenarioAxis__custom--EachWeekForNextThreeWeeksMember_z9iGNFWnnEH2" title="Payment for exchange received amount"><ix:nonFraction name="us-gaap:PaymentsToAcquireReceivables" contextRef="From2022-07-292022-07-29_custom_CedarAgreementMember_custom_EachWeekForNextThreeWeeksMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,491</ix:nonFraction></span> each week for the next three weeks
and thereafter $<span id="xdx_90E_eus-gaap--PaymentsToAcquireReceivables_c20220729__20220729__us-gaap--TypeOfArrangementAxis__custom--CedarAgreementMember__srt--StatementScenarioAxis__custom--ThereafterPerWeekMember_z2iL2d5r30dk" title="Payment for exchange received amount"><ix:nonFraction name="us-gaap:PaymentsToAcquireReceivables" contextRef="From2022-07-292022-07-29_custom_CedarAgreementMember_custom_ThereafterPerWeekMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">44,970</ix:nonFraction></span> per week until the Cedar Receivables Purchased Amount is paid in full.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to secure payment and performance of the Company&#8217;s obligations to Cedar under the Cedar Agreement, the Company granted to
Cedar a security interest in the following collateral: all accounts, including without limitation, all deposit accounts, accounts receivable
and other receivables, chattel paper, documents, equipment, instruments and inventory as those terms are defined by Article 9 of the
UCC. The Company also agreed not to create, incur, assume, or permit to exist, directly or indirectly, any lien on or with respect to
any of such collateral.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 6, 2023, the Company entered into a loan and security agreement (the &#8220;Loan and Security Agreement&#8221;) with one or more
institutional investors (the &#8220;Lenders&#8221;) and Armistice Capital Master Fund Ltd. as agent for the Lenders (the &#8220;Agent&#8221;)
for the issuance and sale of (i) a note in an aggregate principal amount of up to $<span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_c20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember__srt--RangeAxis__srt--MaximumMember_z6Ynvbr25hwj"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2023-01-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,000,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(the &#8220;Note&#8221;) with the initial advance
under the Loan and Security Agreement being $<span id="xdx_904_eus-gaap--ProceedsFromNotesPayable_c20230104__20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember__us-gaap--ShortTermDebtTypeAxis__custom--NotesMember_zZKkzHHFgqSa"><ix:nonFraction name="us-gaap:ProceedsFromNotesPayable" contextRef="From2023-01-042023-01-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember_custom_NotesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,400,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and (ii) warrants (the &#8220;Warrants&#8221;)
to purchase a number of shares of common stock of the Company equal to 200% of the face amount of the Note divided by the closing price
of the common stock of the Company on the date of the issuance of the Notes (collectively, the &#8220;Initial Issuance&#8221;). The closing
price of the Company&#8217;s common stock on January 6, 2023, as reported by Nasdaq, was $<span id="xdx_90E_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z34WMk8rSla5"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2023-01-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.221</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share (or <span id="xdx_90E_eus-gaap--StockholdersEquityNoteStockSplit_c20230106__20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zl3dmHBzyy0a"><ix:nonNumeric contextRef="From2023-01-062023-01-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember_srt_ScenarioPreviouslyReportedMember" name="us-gaap:StockholdersEquityNoteStockSplit">8.84
per share after adjusting for the one-for-forty (1-for-40) reverse stock split</ix:nonNumeric></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">),
so the Warrants in respect of the initial advance under the Note are exercisable for up to <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember__srt--RangeAxis__srt--MaximumMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z9hn0lal8S43"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2023-01-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember_srt_MaximumMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">452,489</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the Company&#8217;s common stock. The
Warrants have an exercise price per share equal to the closing price of the common stock of the Company on the date of the issuance of
the Note, or $<span id="xdx_904_ecustom--SharesIssuedPricePerShares_iI_pid_c20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z9WpX9SA0ZEf"><ix:nonFraction name="CNXA:SharesIssuedPricePerShares" contextRef="AsOf2023-01-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">8.84</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share (which has subsequently been
reset to $3.55 per share) and a term of five- and one-half (5&#189;) years following the initial exercise date. The initial exercise
date of the Warrants will be the date stockholder approval is received and effective allowing exercisability of the Warrants under Nasdaq
rules. Pursuant to the terms of the Loan and Security Agreement, an additional advance of $<span id="xdx_903_eus-gaap--ProceedsFromNotesPayable_c20230104__20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember_zKFvDA9Bi5Ae"><ix:nonFraction name="us-gaap:ProceedsFromNotesPayable" contextRef="From2023-01-042023-01-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">600,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">may be made to the Company under the Note. The
Company&#8217;s obligations under the terms of the Loan and Security Agreement are fully and unconditionally guaranteed by all of the
Company&#8217;s subsidiaries (the &#8220;Guarantors&#8221;). The Company measured the warrants granted on January 6, 2023 at $<span id="xdx_909_eus-gaap--AdjustmentOfWarrantsGrantedForServices_c20230106__20230106__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember_zlO5YFV5hht3"><ix:nonFraction name="us-gaap:AdjustmentOfWarrantsGrantedForServices" contextRef="From2023-01-062023-01-06_us-gaap_WarrantMember_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,715,557</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
and discounted the note payable to $<span id="xdx_90B_eus-gaap--NotesPayable_iI_c20230106__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember_zWYPV1vDOvMe"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2023-01-06_us-gaap_WarrantMember_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and recorded a derivative expense of $<span id="xdx_90E_ecustom--DerivativeExpense_c20230430__20230430__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember_zRDsIHRUejDb"><ix:nonFraction name="CNXA:DerivativeExpense" contextRef="From2023-04-302023-04-30_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,715,557</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
The Company recognized a gain on the change in fair value of the derivative liability when remeasured through April 30, 2023 of $<span id="xdx_908_eus-gaap--DerivativeLiabilityFairValueOfCollateral_iI_c20230430__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zlQmSX59yxTb"><ix:nonFraction name="us-gaap:DerivativeLiabilityFairValueOfCollateral" contextRef="AsOf2023-04-30_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">900,819</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to bring the derivative liability to $<span id="xdx_901_eus-gaap--IncreaseDecreaseInDerivativeLiabilities_c20230430__20230430__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember_z6WmcFMEXmyl"><ix:nonFraction name="us-gaap:IncreaseDecreaseInDerivativeLiabilities" contextRef="From2023-04-302023-04-30_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,814,738</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at April 30, 2023. In addition, the Company recognized
$<span id="xdx_900_eus-gaap--AmortizationOfDebtDiscountPremium_c20220501__20230430__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember_zQbAkVwTsTc8"><ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2022-05-012023-04-30_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,222,808</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in amortization of debt discount for the year
ended April 30, 2023. On July 6, 2023, the Company failed to repay the note and is currently in default. The interest rate has since
increased to <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20230706__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zRJ4AKv90xZc"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2023-07-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">6.43</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
per annum.</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-05-012023-04-30" escape="true" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p id="xdx_808_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zofGkOILqKg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
11: <span><span id="xdx_824_z9LZWLKdBDYh">RELATED PARTY TRANSACTIONS</span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
support of the Company&#8217;s efforts and cash requirements, it may rely on advances from related parties until such time that the Company
can support its operations or attain adequate financing through sales of its equity or traditional debt financing. There is no formal
written commitment for continued support by officers, directors, or shareholders. Amounts represent advances, amounts paid in satisfaction
of liabilities, or accrued compensation that has been deferred. The advances are considered temporary in nature and have not been formalized
by a promissory note.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has outstanding notes payable of <span style="background-color: white"><span style="background-color: white">$<span id="xdx_90C_eus-gaap--NotesPayable_iI_pp0p0_c20230430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zbKrLVDiBMgk" title="Outstanding notes payable"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2023-04-30_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,953,842</ix:nonFraction></span> </span> and $<span id="xdx_908_eus-gaap--NotesPayable_iI_pp0p0_c20220430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zH14YqEaxkol" title="Outstanding notes payable"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2022-04-30_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,000,000</ix:nonFraction></span></span> and accrued interest
of $<span id="xdx_906_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20230430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zSzgnnFlxtOi" title="Accrued interest - related party"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2023-04-30_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">917,957</ix:nonFraction></span> and $<span id="xdx_909_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20220430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zRX25uk8IQnf" title="Accrued interest - related party"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2022-04-30_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">908,756</ix:nonFraction></span> due to a related party as of April 30, 2023 and 2022, respectively (see Note 8).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognized net sales of $<span id="xdx_90C_eus-gaap--Revenues_pp0p0_c20220501__20230430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zNLFQJGsyzS3" title="Revenue from related parties"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-05-012023-04-30_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">164,661</ix:nonFraction></span> and $<span id="xdx_90C_eus-gaap--Revenues_pp0p0_c20210501__20220430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z1L1W8td9grd" title="Revenue from related parties"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-05-012022-04-30_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">368,164</ix:nonFraction></span> during the years ended April 30, 2023 and 2022, respectively, to related parties.
As of April 30, 2023 and 2022, related parties had accounts receivable due to the Company of $<span id="xdx_901_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20230430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zQlsAFDzmKy4" title="Outstanding accounts receivable"><ix:nonFraction name="us-gaap:AccountsReceivableNet" contextRef="AsOf2023-04-30_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">28,800</ix:nonFraction></span> and $<span id="xdx_900_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20220430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zH7NQHkKmOIa" title="Outstanding accounts receivable"><ix:nonFraction name="us-gaap:AccountsReceivableNet" contextRef="AsOf2022-04-30_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">93,535</ix:nonFraction></span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 125; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-05-012023-04-30" escape="true" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock"><p id="xdx_804_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_z7wvekueFLv1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
12: <span id="xdx_829_zan7toDLg2li">SHAREHOLDERS&#8217; EQUITY (DEFICIT)</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Common
Stock</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has <span id="xdx_90D_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20230430_zNgnpQRUOS5i"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">300,000,000</ix:nonFraction></span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
of common stock authorized with a par value of $<span id="xdx_907_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20220430_zWttYdquPUy3"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per
share. As of April 30, 2023 and 2022, the Company had <span><span id="xdx_908_eus-gaap--CommonStockSharesOutstanding_iI_c20230430_zimqsfw9jli1"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">338,579</ix:nonFraction></span> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and <span><span id="xdx_903_eus-gaap--CommonStockSharesOutstanding_iI_dxL_c20220430_zBaH6DRfJUN1" title="::XDX::4194836"><span style="-sec-ix-hidden: xdx2ixbrl2401">104,871</span></span> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
of common stock issued and outstanding, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Equity
Transactions During the Year Ended April 30, 2023</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
May 1, 2022, the Company has issued an aggregate of <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220501__20220501_zZR0ZBJOEit9"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-05-012022-05-01" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">151,579</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
of its common stock consisting of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    June 15, 2022, the Company issued <span id="xdx_906_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pid_c20220615__20220615__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zTGeJZaJvHA5"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" contextRef="From2022-06-152022-06-15_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">109,740</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
    of common stock to the Convertible Noteholders upon conversion of convertible notes.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    June 15, 2022, the Company issued <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220615__20220615__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zP6WKji4yMQc"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-06-152022-06-15_us-gaap_InvestorMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">26,219</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
    to investors who participated in the Company&#8217;s Nasdaq uplist round.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    June 27, 2022, the Company issued <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20220627__20220627__srt--TitleOfIndividualAxis__custom--GabrielGoldmanMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zWy6fWc9WSg9"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2022-06-272022-06-27_custom_GabrielGoldmanMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">625</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock to Gabriel Goldman
    for consulting services performed in the first quarter of calendar 2022. Gabriel Goldman became a director of the Company on June
    15, 2022.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    June 27, 2022, the Company issued <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220627__20220627__dei--LegalEntityAxis__custom--GamefaceAIMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zTfHCLfsOAr5"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-06-272022-06-27_custom_GamefaceAIMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">14,960</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
    of common stock to the former Gameface shareholders in connection with the purchase of Gameface. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                                         August 25, 2022, the Company issued <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220825__20220825__dei--LegalEntityAxis__custom--MidcityCapitalLtdMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z4JuHQWxP8A4"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-08-252022-08-25_custom_MidcityCapitalLtdMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">750</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
                                                         of common stock to Midcity Capital Ltd (&#8220;Midcity&#8221;) pursuant to a cashless conversion of warrants Midcity received from
                                                         its warrant agreement with the Company dated March 2020.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    September 28, 2022, the Company entered into a securities purchase agreement (the &#8220;Securities Purchase Agreement&#8221;) with
    a single institutional investor (the &#8220;Investor&#8221;) for the issuance and sale of (i) <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220928__20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_ztJedXL1arxd"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-09-282022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">25,463</ix:nonFraction>
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock and (ii) pre-funded
    warrants (the &#8220;Pre-Funded Warrants&#8221;) to purchase an aggregate of <span id="xdx_909_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zbytUP6eKPKg"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">295,050</ix:nonFraction>
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of its common stock, together with
    accompanying common stock warrants, at a combined purchase price of $<span id="xdx_90B_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zit6bfviuTTc"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">15.60</ix:nonFraction>
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share of the common stock and associated
    common stock warrant and $<span id="xdx_90C_ecustom--WarrantPerShare_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zIETuCcBezL3"><ix:nonFraction name="CNXA:WarrantPerShare" contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">15.596</ix:nonFraction>
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per Pre-Funded Warrant and associated common
    stock warrants for an aggregate amount of approximately $<span id="xdx_904_eus-gaap--WarrantsAndRightsOutstanding_iI_pn5n6_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_ztyF8X0dbXG7"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">5.0</ix:nonFraction>
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million (the &#8220;Offering&#8221;). The
    Pre-Funded Warrants have an exercise price of $<span id="xdx_900_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zThepsd0uimb"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0004</ix:nonFraction>
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share of common stock and are exercisable
    until the Pre-Funded Warrants are exercised in full. The shares of common stock and Pre-Funded Warrants were sold in the offering
    together with common stock warrants to purchase <span id="xdx_908_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--FiveYearWarrantsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z1WPdsDCFjMb"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_custom_FiveYearWarrantsMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">320,513</ix:nonFraction>
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock at an exercise price
    of $<span id="xdx_908_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--FiveYearWarrantsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zuOOWVGCsS74"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_custom_FiveYearWarrantsMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">15.60</ix:nonFraction>
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share and a term of five years following
    the initial exercise date (the &#8220;5-Year Warrants&#8221;) and <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220928__20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--SevenYearWarrantsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zabgtiPUHrl4"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-09-282022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_custom_SevenYearWarrantsMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">641,026</ix:nonFraction>
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">common stock warrants to purchase <span id="xdx_903_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--SevenPointFiveYearWarrantsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zfP624qt3dXk"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_custom_SevenPointFiveYearWarrantsMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">641,026</ix:nonFraction>
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock at an exercise price
    of $<span id="xdx_901_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--SevenPointFiveYearWarrantsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zHHQ0i3eZvca"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_custom_SevenPointFiveYearWarrantsMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">17.20</ix:nonFraction>
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share and a term of seven and one half
    years (the &#8220;7.5-Year Warrants&#8221;) following the initial exercise date (collectively, the &#8220;Warrants&#8221;). The Warrants
    issued in the Offering contain variable pricing features. The Warrants and Pre-Funded Warrants became exercisable beginning on the
    date stockholder approval was received and effective allowing exercisability of the Warrants and Pre-Funded Warrants under Nasdaq
    rules. The exercise price of the Warrants was reset in October 2023 to $<span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20231031__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zg4tqKHduW6f"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2023-10-31_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.55</ix:nonFraction>
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share. Net proceeds to the Company
    were $<span id="xdx_907_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20220928__20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_z2orhv5fqdp5"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2022-09-282022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,549,882</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    October 12, 2022, the Company issued <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20221012__20221012__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zXa09UsKfjob"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" contextRef="From2022-10-122022-10-12_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">48,098</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
    of common stock, on November 21, 2022 issued <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20221121__20221121__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zDgtZ5o0OnFh"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" contextRef="From2022-11-212022-11-21_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">675</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
    of common stock and January 26, 2023 issued <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20230126__20230126__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zDQcinvmexk3"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" contextRef="From2023-01-262023-01-26_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,994</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
    of common stock in connection with the acquisition of PlaySight.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    January 26, 2023, the Company issued <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20230126__20230126__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zdiNGy78zM54"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2023-01-262023-01-26_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">150</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
    of common stock for services rendered to their ambassadors.</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 126; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Equity
Transactions During the Year Ended April 30, 2022</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 26, 2021, the Company issued <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_pid_c20210525__20210526__srt--TitleOfIndividualAxis__custom--RelatedPartyLenderMember_zU1NFjCdfgpb"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2021-05-252021-05-26_custom_RelatedPartyLenderMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,093</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
of its common stock for the conversion of related party notes payable (see Note 8). The fair value of the common stock was $<span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_pp0p0_c20210525__20210526__srt--TitleOfIndividualAxis__custom--RelatedPartyLenderMember_ziTL6cMDO1Q7"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2021-05-252021-05-26_custom_RelatedPartyLenderMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,220,000</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 23, 2021, the Company issued <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20210622__20210623__us-gaap--BusinessAcquisitionAxis__custom--FoundationSportsSystemsLLCMember_zr4DltCaxwWl"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" contextRef="From2021-06-222021-06-23_custom_FoundationSportsSystemsLLCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,350</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
of its common stock as partial consideration for the acquisition of Foundation Sports (see Note 5). The fair value of the total
shares of common stock to be issued related to the acquisition was $<span id="xdx_900_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_pp0p0_c20210622__20210623__us-gaap--BusinessAcquisitionAxis__custom--FoundationSportsSystemsLLCMember_zAW4RBNwVWDl"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2021-06-222021-06-23_custom_FoundationSportsSystemsLLCMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,550,000</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 6, 2021, the Company issued <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationGross_pid_c20210705__20210706__srt--ProductOrServiceAxis__custom--ServicesRenderedInLieuOfCashMember__srt--TitleOfIndividualAxis__custom--TwoEmployeesMember_zMwNANWjBFQe"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross" contextRef="From2021-07-052021-07-06_custom_ServicesRenderedInLieuOfCashMember_custom_TwoEmployeesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">126</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
of its common stock to two employees as compensation for services rendered in lieu of cash, which resulted in $<span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensationGross_pp0p0_c20210501__20220430__srt--ProductOrServiceAxis__custom--ServicesRenderedInLieuOfCashMember__srt--TitleOfIndividualAxis__custom--TwoEmployeesMember_zongsT59d4Nh"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross" contextRef="From2021-05-012022-04-30_custom_ServicesRenderedInLieuOfCashMember_custom_TwoEmployeesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">187,803</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
share-based compensation expense for the year ended April 30, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 11, 2021, the Company issued <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationGross_pid_c20210709__20210711__srt--ProductOrServiceAxis__custom--MarketingAndAdvisoryServicesMember__srt--TitleOfIndividualAxis__custom--VendorMember_zGDxXFOPz7T7"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross" contextRef="From2021-07-092021-07-11_custom_MarketingAndAdvisoryServicesMember_custom_VendorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">47</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
of its common stock to a vendor as compensation for marketing and other services rendered, which resulted in $<span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensationGross_pp0p0_c20210501__20220430__srt--ProductOrServiceAxis__custom--MarketingAndAdvisoryServicesMember__srt--TitleOfIndividualAxis__custom--VendorMember_zX7EB2hprSja"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross" contextRef="From2021-05-012022-04-30_custom_MarketingAndAdvisoryServicesMember_custom_VendorMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">16,875</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
operating expenses for the year ended April 30, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the three months ended July 31, 2021, the Company granted an aggregate total of <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20210501__20210731__srt--StatementScenarioAxis__custom--AsCompensationMember__srt--TitleOfIndividualAxis__custom--SixNewBrandAmbassadorsMember__us-gaap--AwardTypeAxis__us-gaap--CommonStockMember_z25MJlpQ5jWb"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-05-012021-07-31_custom_AsCompensationMember_custom_SixNewBrandAmbassadorsMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">228</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
of its common stock and equity options to purchase up to <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20210501__20210731__srt--RangeAxis__srt--MaximumMember__srt--StatementScenarioAxis__custom--AsCompensationMember__srt--TitleOfIndividualAxis__custom--SixNewBrandAmbassadorsMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zZl9X5Zj71jl"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-05-012021-07-31_srt_MaximumMember_custom_AsCompensationMember_custom_SixNewBrandAmbassadorsMember_us-gaap_EmployeeStockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">150</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
(which are now expired) to six new brand ambassadors as compensation for services. The expense related to the issuance of the shares
and equity options is being recognized over the service agreements, similar to the warrants and equity options issued to the four
other brand ambassadors in the prior year. During the year ended April 30, 2022, the Company recognized $<span id="xdx_90E_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210501__20220430__srt--TitleOfIndividualAxis__custom--BrandAmbassadorsMember_zK0XkliXXZee"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2021-05-012022-04-30_custom_BrandAmbassadorsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">907,042</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
operating expenses related to the shares, warrants and equity options granted to brand ambassadors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 6, 2021, the Note payable holder exercised its right to convert its <span id="xdx_902_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_pid_c20210806__us-gaap--DebtInstrumentAxis__custom--NotePayableHolderMember_ze7Nk0K78s27"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" contextRef="AsOf2021-08-06_custom_NotePayableHolderMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,500</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">outstanding
warrants into <span id="xdx_90B_eus-gaap--ConversionOfStockSharesConverted1_pid_c20210805__20210806__us-gaap--DebtInstrumentAxis__custom--NotePayableHolderMember_zOSIJ5Y2M6Q7"><ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" contextRef="From2021-08-052021-08-06_custom_NotePayableHolderMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">12,375</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
of common stock of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 6, 2021, the Company&#8217;s related party lender exercised its right to convert its <span id="xdx_900_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_pid_c20210806__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RelatedPartyLenderMember_zewAwfI4XsG1"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" contextRef="AsOf2021-08-06_custom_RelatedPartyLenderMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">688</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">outstanding
warrants and <span id="xdx_901_eus-gaap--CommonStockSharesIssued_iI_pid_c20210806__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RelatedPartyLenderMember_zeMhRNxuuKRe"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-08-06_custom_RelatedPartyLenderMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">17,304</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">common
shares issuable into <span id="xdx_908_eus-gaap--ConversionOfStockSharesConverted1_pid_c20210805__20210806__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RelatedPartyLenderMember_z64oRc5JCQk4"><ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" contextRef="From2021-08-052021-08-06_custom_RelatedPartyLenderMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">17,992</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
of common stock of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 11, 2021, the Company issued <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationGross_pid_c20211010__20211011__srt--ProductOrServiceAxis__custom--MarketingAndAdvisoryServicesMember__srt--TitleOfIndividualAxis__custom--VendorMember_zBMcv9cEsP3a"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross" contextRef="From2021-10-102021-10-11_custom_MarketingAndAdvisoryServicesMember_custom_VendorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">47</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
of its common stock to a vendor as compensation for marketing and other services rendered, which resulted in $<span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensationGross_pp0p0_c20210501__20220430__srt--ProductOrServiceAxis__custom--MarketingAndAdvisoryServicesMember__srt--TitleOfIndividualAxis__custom--VendorMember_zp5dRQCQ1YLb"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross" contextRef="From2021-05-012022-04-30_custom_MarketingAndAdvisoryServicesMember_custom_VendorMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">16,875</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
operating expenses during the year ended April 30, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 11, 2022, the Company issued <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationGross_pid_c20220110__20220111__srt--ProductOrServiceAxis__custom--MarketingAndAdvisoryServicesMember__srt--TitleOfIndividualAxis__custom--VendorMember_zHaEy3mvPpmg"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross" contextRef="From2022-01-102022-01-11_custom_MarketingAndAdvisoryServicesMember_custom_VendorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">47</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
of its common stock to a vendor as compensation for marketing and other services rendered, which resulted in $<span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensationGross_pp0p0_c20210501__20220430__srt--ProductOrServiceAxis__custom--MarketingAndAdvisoryServicesMember__srt--TitleOfIndividualAxis__custom--VendorOneMember_zQ8DczK3bz3e"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross" contextRef="From2021-05-012022-04-30_custom_MarketingAndAdvisoryServicesMember_custom_VendorOneMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">16,874</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
operating expenses during the year ended April 30, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
April 2022, the Company granted an aggregate total of <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20220401__20220430__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--KeyEmployeesAndOfficersMember_zEedkoPR0xe4"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2022-04-012022-04-30_us-gaap_CommonStockMember_custom_KeyEmployeesAndOfficersMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">150</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
of its common stock to 6 new brand ambassadors as compensation for services. During the year ended April 30, 2022, the Company
recognized $<span id="xdx_906_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210501__20220430__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--KeyEmployeesAndOfficersMember_zXAK6CpkWXB3"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2021-05-012022-04-30_us-gaap_CommonStockMember_custom_KeyEmployeesAndOfficersMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">255,124</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
operating expenses related to the shares granted to brand ambassadors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Warrants
Issued and Expensed During the Years Ended April 30, 2023 and 2022</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 28, 2020, the Company granted <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20201027__20201028__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--ServiceProviderMember_ze6p6EUMyXVe"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2020-10-272020-10-28_us-gaap_WarrantMember_custom_ServiceProviderMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrants to a service provider for advertising
services over the next year. The warrants have an exercise price of $<span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20201028__srt--TitleOfIndividualAxis__custom--ServiceProviderMember_z3wiMCubfNJc"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2020-10-28_custom_ServiceProviderMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">30</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share, a contractual life of <span id="xdx_909_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20201028__srt--TitleOfIndividualAxis__custom--ServiceProviderMember_zhH2RHAAvdu7"><ix:nonNumeric contextRef="AsOf2020-10-28_custom_ServiceProviderMember" format="ixt-sec:duryear" name="us-gaap:WarrantsAndRightsOutstandingTerm">10</ix:nonNumeric>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years from the date of issuance, and vest quarterly
over a year from the grant date. The warrants were valued using a Black-Scholes option pricing model and the expense related to the issuance
of the warrants is being recognized over the service agreement. The Company recognized $<span id="xdx_908_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210501__20220131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--ThreeMembersMember_z5sTUPP27Xf4"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2021-05-012022-01-31_us-gaap_WarrantMember_custom_ThreeMembersMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">214,552</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of operating expenses related to this agreement
during the nine months ended January 31, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with the October 29, 2020 agreement with three members of the advisory board mentioned above, <span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_iI_pp0p0_c20201029__srt--StatementScenarioAxis__custom--AsCompensationMember__srt--TitleOfIndividualAxis__custom--ThreeMembersMember_zJ6xz2vSDvUj"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" contextRef="AsOf2020-10-29_custom_AsCompensationMember_custom_ThreeMembersMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,152</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrants
were issued during the year ended April 30, 2022. The warrants were valued using a Black-Scholes option pricing model on the grant
date, which resulted in operating expenses of $<span id="xdx_905_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20220501__20230131__srt--StatementScenarioAxis__custom--AsCompensationMember__srt--TitleOfIndividualAxis__custom--ThreeMembersMember_zbVYIYQ1cF84"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2022-05-012023-01-31_custom_AsCompensationMember_custom_ThreeMembersMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">67,500</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and
$<span id="xdx_904_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210501__20220430__srt--StatementScenarioAxis__custom--AsCompensationMember__srt--TitleOfIndividualAxis__custom--ThreeMembersMember_zUK5Z22devCc"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2021-05-012022-04-30_custom_AsCompensationMember_custom_ThreeMembersMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">87,656</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">during
the nine months ended January 31, 2023 and year ended April 30, 2022, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 6, 2021, in connection with the Convertible Notes issuance the Company issued warrants to purchase up to <span id="xdx_90A_ecustom--WarrantsIssuedToPurchaseOfCommonStockShares_iI_c20210806__srt--StatementScenarioAxis__custom--SecuritiesPurchaseAgreementMember_z07ekRxcuFZ"><ix:nonFraction name="CNXA:WarrantsIssuedToPurchaseOfCommonStockShares" contextRef="AsOf2021-08-06_custom_SecuritiesPurchaseAgreementMember30681312" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">18.334</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
of common stock of the Company to the Purchasers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 6, 2021, in connection with the Convertible Notes issuance the Company also granted the lead placement agent for the Offering <span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20210806__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--LeadPlacementAgentMember_z3c6J0dGTXZk"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2021-08-06_us-gaap_WarrantMember_custom_LeadPlacementAgentMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">667</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrants
that are exercisable for five years from August 6, 2021, at an exercise price of $<span id="xdx_900_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20210806__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--LeadPlacementAgentMember_zWwRLcrjX1of"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-08-06_us-gaap_WarrantMember_custom_LeadPlacementAgentMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.90</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(subject
to adjustment as set forth in the Convertible Notes per the terms of the agreement) and are vested immediately. The warrants were
valued using a Black-Scholes option pricing model on the grant date and the Company recognized $<span id="xdx_907_eus-gaap--OperatingExpenses_pp0p0_c20210501__20220430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--LeadPlacementAgentMember_z61oUlLOS4D6"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2021-05-012022-04-30_us-gaap_WarrantMember_custom_LeadPlacementAgentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">376,000</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
operating expenses related to them during the year ended April 30, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 127; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 3, 2021, the Company granted an aggregate total of <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210903__20210903__srt--StatementScenarioAxis__custom--AsCompensationMember__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z8shZD5eGAxh"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-09-032021-09-03_custom_AsCompensationMember_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,525</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrants
to key employees and officers of the Company as compensation. The warrants have an exercise price of $<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20210903__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--KeyEmployeesAndOfficersMember__srt--StatementScenarioAxis__custom--ExercisePriceOneMember_zI7sj2bVHmph"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-09-03_us-gaap_WarrantMember_custom_KeyEmployeesAndOfficersMember_custom_ExercisePriceOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.4</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per
share for <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20210903__20210903__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--LeadPlacementAgentMember__srt--StatementScenarioAxis__custom--ExercisePriceOneMember_ziei92n21Ktk"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2021-09-032021-09-03_us-gaap_WarrantMember_custom_LeadPlacementAgentMember_custom_ExercisePriceOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
the warrants and $<span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20210903__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--KeyEmployeesAndOfficersMember__srt--StatementScenarioAxis__custom--ExercisePriceTwoMember_z7PWwbPIvgrb"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-09-03_us-gaap_WarrantMember_custom_KeyEmployeesAndOfficersMember_custom_ExercisePriceTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1,368</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20210903__20210903__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--KeyEmployeesAndOfficersMember__srt--StatementScenarioAxis__custom--ExercisePriceTwoMember_zA1bojVCtdRe"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2021-09-032021-09-03_us-gaap_WarrantMember_custom_KeyEmployeesAndOfficersMember_custom_ExercisePriceTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,000</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
the warrants, a contractual life of <span id="xdx_902_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20210903__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--KeyEmployeesAndOfficersMember_zCUyfXy34qQi"><ix:nonNumeric contextRef="AsOf2021-09-03_us-gaap_WarrantMember_custom_KeyEmployeesAndOfficersMember" format="ixt-sec:duryear" name="us-gaap:WarrantsAndRightsOutstandingTerm">10</ix:nonNumeric> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years
from the date of issuance and are vested immediately upon grant. The warrants were valued using a Black-Scholes option pricing model
on the grant date and the Company recognized $<span id="xdx_906_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210501__20220430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--KeyEmployeesAndOfficersMember_z7AGpZpAHoJk"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2021-05-012022-04-30_us-gaap_WarrantMember_custom_KeyEmployeesAndOfficersMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">32,381,309</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
share-based compensation expense related to them during the year ended April 30, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 2, 2022, in connection with the Gameface acquisition the Company issued warrants to purchase up to <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20220202__20220202__us-gaap--BusinessAcquisitionAxis__custom--GamefaceMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zu7Cf2m94XIi"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" contextRef="From2022-02-022022-02-02_custom_GamefaceMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,196</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
of common stock of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 28, 2022, the Company entered into a securities purchase agreement (the &#8220;Securities Purchase Agreement&#8221;) with a
single institutional investor (the &#8220;Investor&#8221;) for the issuance and sale of (i) <span id="xdx_909_eus-gaap--CommonStockSharesIssued_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zhceaBX3I4eh"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">25,463</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock and (ii) pre-funded warrants
(the &#8220;Pre-Funded Warrants&#8221;) to purchase an aggregate of <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zHc0Gah5qQH"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">295,050</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of its common stock, together with accompanying
common stock warrants, at a combined purchase price of $<span id="xdx_905_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zAu4uF3JObG2"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">15.60</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share of the common stock and associated
common stock warrant and $<span id="xdx_90C_ecustom--WarrantPerShare_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z8N6sFZfVCej"><ix:nonFraction name="CNXA:WarrantPerShare" contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">15.596</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per Pre-Funded Warrant and associated common
stock warrants for an aggregate amount of approximately $<span id="xdx_904_eus-gaap--WarrantsAndRightsOutstanding_iI_pn5n6_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zuJN6iVZXW67"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">5.0</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million (the &#8220;Offering&#8221;). The Pre-Funded
Warrants have an exercise price of $<span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z2y1DsgmO2Ql"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0004</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share of common stock and are exercisable
until the Pre-Funded Warrants are exercised in full. The shares of common stock and Pre-Funded Warrants were sold in the offering together
with common stock warrants to purchase <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--FiveYearWarrantsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zgHWEcULfNed"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_custom_FiveYearWarrantsMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">320,513</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock at an exercise price of
$<span id="xdx_905_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--FiveYearWarrantsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zmMDkHHCGfT8"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_custom_FiveYearWarrantsMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">15.60</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share and a term of five years following
the initial exercise date (the &#8220;5-Year Warrants&#8221;) and <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220928__20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--SevenYearWarrantsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zkWnLw8e1tAb"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-09-282022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_custom_SevenYearWarrantsMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">641,026</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">common stock warrants to purchase <span id="xdx_903_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--SevenYearWarrantsMember_zDSMdE3r6Ese"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_custom_SevenYearWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">641,026</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock at an exercise price of
$<span id="xdx_90B_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--SevenYearWarrantsMember_zZE0ovrtL4bg"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_custom_SevenYearWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">17.20</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share and a term of seven and one half years
(the &#8220;7.5-Year Warrants&#8221;) following the initial exercise date (collectively, the &#8220;Warrants&#8221;). The Warrants issued
in the Offering contain variable pricing features. The exercise price of the Warrants was reset in October 2023 to $<span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20231031__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z9i3Baalyxol"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2023-10-31_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.55</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-05-012023-04-30" escape="true" name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"><p id="xdx_891_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zfYvdOdwoDS3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following represents a summary of the warrants:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B7_zHSt7Ikw6fI7" style="display: none">SCHEDULE OF WARRANTS ISSUED, EXERCISED AND EXPIRED</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Year Ended April 30, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Year Ended April 30, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Number</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted<br /> Average<br /> Exercise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Price</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Number</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted<br /> Average<br /> Exercise <br /> Price</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 44%; text-align: left; padding-left: 10pt">Beginning balance</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20220501__20230430_zQS3EBU3QrYf" title="Warrants Shares, Beginning Balance" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">97,075</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_iS_c20220501__20230430_zy4gGvH51cl9" title="Weighted Avg. Exercise Price Warrant, Beginning Balance" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><ix:nonFraction name="CNXA:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">444.50</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20210501__20220430_zm8N1W04iELd" title="Warrants Shares, Beginning Balance" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2021-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">47,633</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_iS_c20210501__20220430_zyqVXmwwiRL5" title="Weighted Avg. Exercise Price Warrant, Beginning Balance" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><ix:nonFraction name="CNXA:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding" contextRef="AsOf2021-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">205.156</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">Granted</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20220501__20230430_zfcqRTePcdxf" title="Warrants Shares, Granted" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,714,127</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceIssued_c20220501__20230430_zkW5YL7VJ1T7" title="Weighted Avg. Exercise Price Warrant, Issued" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="CNXA:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceIssued" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.696</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20210501__20220430_zmpBNxMzqr3a" title="Warrants Shares, Granted" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">49,442</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceIssued_c20210501__20220430_ztppr5zG0k5b" title="Weighted Avg. Exercise Price Warrant, Issued" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="CNXA:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceIssued" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">139.344</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">Exercised</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20220501__20230430_zvkZc9JU4MBj" title="Warrants Shares, Exercised" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2497">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised_c20220501__20230430_zhXg1c5J2b3b" title="Weighted Avg. Exercise Price Warrant, Exercised" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2499">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20210501__20220430_zwQRqeahawA9" title="Warrants Shares, Exercised" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2501">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised_c20210501__20220430_z7KnUWuTYoo4" title="Weighted Avg. Exercise Price Warrant, Exercised" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2503">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">Forfeited</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_c20220501__20230430_z3vgb86jfu07" title="Warrants Shares, Forfeited" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2505">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceForfeited_c20220501__20230430_zG3sPPIIrK96" title="Weighted Avg. Exercise Price Warrant, Forfeited" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2507">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_c20210501__20220430_zdGNprtYwxL1" title="Warrants Shares, Forfeited" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2509">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceForfeited_c20210501__20220430_ziZC4Fb2tKtj" title="Weighted Avg. Exercise Price Warrant, Forfeited" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2511">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 10pt">Expired</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_di_c20220501__20230430_zMGNuIwZQRea" title="Warrants Shares, Expired" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">18,750</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExpired_c20220501__20230430_z3sI9I6OFO24" title="Weighted Avg. Exercise Price Warrant, Expired" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2515">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_c20210501__20220430_z8nTdQWi32Lc" title="Warrants Shares, Expired" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2517">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExpired_c20210501__20220430_zgoMBBv2B5V4" title="Weighted Avg. Exercise Price Warrant, Expired" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2519">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; padding-left: 10pt">Ending balance</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20220501__20230430_zBS45zMYqtQj" title="Warrants Shares, Ending Balance" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,792,451</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_iE_c20220501__20230430_zXXTZbbs6uq3" title="Weighted Avg. Exercise Price Warrant, Ending Balance" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="CNXA:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">34.208</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20210501__20220430_zPV3Wt3KFUV4" title="Warrants Shares, Ending Balance" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">97,075</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_iE_c20210501__20220430_zoNIGys6szG5" title="Weighted Avg. Exercise Price Warrant, Ending Balance" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="CNXA:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">444.50</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">Intrinsic value of warrants</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_eus-gaap--WarrantsAndRightsOutstanding_iI_c20230430_zHoXi7XU4vB2" title="Intrinsic value of warrants" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,344,529</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_eus-gaap--WarrantsAndRightsOutstanding_iI_c20220430_zhyimSuk9F14" title="Intrinsic value of warrants" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">33,752,623</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Weighted Average Remaining Contractual Life (Years)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20220501__20230430_z2dE7b7khvp9" title="Weighted Average Remaining Contractual Life (Years)"><ix:nonNumeric contextRef="From2022-05-012023-04-30" format="ixt-sec:duryear" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms">6.45</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20210501__20220430_zrBNJ9rRDBJl" title="Weighted Average Remaining Contractual Life (Years)"><ix:nonNumeric contextRef="From2021-05-012022-04-30" format="ixt-sec:duryear" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms">6.50</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p></ix:nonNumeric><p id="xdx_8A8_zV1NM4fwcgGf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of April 30, 2023, <span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20220501__20230430_zjYi84YwUvyj" title="Warrants vested"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">71,698,014</ix:nonFraction></span> warrants are vested.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<ix:exclude><!-- Field: Page; Sequence: 128; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-05-012023-04-30" escape="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p id="xdx_80F_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zjWPmYMu9nQi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
13: <span id="xdx_82B_zjiePuo1q2af">COMMITMENTS AND CONTINGENCIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Leases</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company leases office space under short-term leases with terms under a year. Total rent expense for the years ended April 30, 2023 and
2022 amounted to $<span id="xdx_905_eus-gaap--PaymentsForRent_pp0p0_c20220501__20230430_zNEXEyQmS4fk" title="Rent expense"><ix:nonFraction name="us-gaap:PaymentsForRent" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,900</ix:nonFraction></span> and $<span id="xdx_908_eus-gaap--PaymentsForRent_pp0p0_c20210501__20220430_zSXcB4bFqmj9" title="Rent expense"><ix:nonFraction name="us-gaap:PaymentsForRent" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">22,176</ix:nonFraction></span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Contingencies</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Gameface acquisition on February 2, 2022, the Company agreed to earn-out consideration of common shares of the Company&#8217;s
common stock with a fair value of $<span id="xdx_909_ecustom--FairValueOfCommonStock_iI_pp0p0_c20230131_z9QURvQkW99e" title="Fair value of common stock"><span id="xdx_901_ecustom--FairValueOfCommonStock_iI_pp0p0_c20220430_zpRgqrLPkkeb" title="Fair value of common stock"><ix:nonFraction name="CNXA:FairValueOfCommonStock" contextRef="AsOf2023-01-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD"><ix:nonFraction name="CNXA:FairValueOfCommonStock" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,334,000</ix:nonFraction></ix:nonFraction></span></span> which is included as a current liability on the Company&#8217;s consolidated balance sheet
as of January 31, 2023 and April 30, 2022. The Company issued <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20220601__20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zM5bJm1NXWqd" title="Number of stock issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" contextRef="From2022-06-012022-06-30_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">598,396</ix:nonFraction></span> common shares to the former Gameface shareholders in June 2022.
The balance of the contingent consideration as of April 30, 2023 is $<span id="xdx_90F_eus-gaap--BusinessCombinationContingentConsiderationLiability_iI_c20230430_zI3he9HkvW3l" title="Balance of contingent consideration"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiability" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">418,455</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, the Company may become involved in legal proceedings arising in the ordinary course of business. The Company is not presently
a party to any legal proceedings that it currently believes would individually or taken together have a material adverse effect on the
Company&#8217;s business or financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Nasdaq
Compliance</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 26, 2023, the Company received a letter from the Listing Qualifications Department of Nasdaq indicating that the Company&#8217;s
stockholders&#8217; equity as reported in its Quarterly Report on Form 10-Q for the quarterly period ended January 31, 2023 did not satisfy
the continued listing requirement under Nasdaq Listing Rule 5550(b)(1), which requires that a listed company&#8217;s stockholders&#8217;
equity be at least $<span id="xdx_903_eus-gaap--StockholdersEquity_iI_pn5n6_c20230131__srt--RangeAxis__srt--MinimumMember_zY8omWpaUswe" title="Stockholders equity"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-01-31_srt_MinimumMember" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">2.5</ix:nonFraction></span> million (the &#8220;Minimum Stockholders&#8217; Equity Requirement&#8221;). As reported in its Form 10-Q for
the period ended January 31, 2023, the Company&#8217;s stockholders&#8217; equity as of January 31, 2023 was approximately $(<span id="xdx_902_eus-gaap--StockholdersEquity_iI_pn5n6_c20230131_zd3uUfSphxl8" title="Stockholders equity"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-01-31" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">11.7</ix:nonFraction></span>) million.
In addition, the Company did not meet the alternatives of listed securities or net income from continuing operations as of the date of
the letter. The Nasdaq has given the Company until January 22, 2024 to regain compliance with the Minimum Stockholders&#8217;
Equity Requirement and net income from continuing operations requirement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company offers no assurance that it will regain compliance with the Minimum Stockholders&#8217; Equity Requirement and/or any other delinquency in a timely manner.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-05-012023-04-30" escape="true" name="us-gaap:IncomeTaxDisclosureTextBlock"><p id="xdx_809_eus-gaap--IncomeTaxDisclosureTextBlock_zQr52uY46vGb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
14: <span id="xdx_820_zu7xp3b83Ga8">INCOME TAXES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company does business in the US through its subsidiaries Slinger Bag Inc. and Slinger Bag Americas. It also does business in Israel through
SBL whose operations are reflected in the Company&#8217;s consolidated financial statements. The Company&#8217;s operations in Canada,
Israel, and the UK were immaterial for the years ended April 30, 2023 and 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
deferred tax assets from operations in the US, using an effective tax rate of <span id="xdx_900_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_uPure_c20220501__20230430__srt--StatementGeographicalAxis__country--US_zr0xM8rJmrf5" title="Effective tax rate"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2022-05-012023-04-30_country_US" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">21</ix:nonFraction></span>%, consisted of the following:</span></p>

<ix:nonNumeric contextRef="From2022-05-012023-04-30" escape="true" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"><p id="xdx_89B_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_z2AE3kOtBPR6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BF_zRjK5fgziMnf" style="display: none">SCHEDULE OF NET DEFERRED TAX ASSETS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20230430_zUhHvHnWkzui" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20220430_zLOZcy4LIYvh" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Deferred tax assets:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_maDTANzBNt_zT5aGXx64QK6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left">Loss carryforwards</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,049,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,166,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--DeferredTaxAssetsStockOptions_iI_maDTANzBNt_zro8rrgGG2y6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Stock options</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="CNXA:DeferredTaxAssetsStockOptions" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,454,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="CNXA:DeferredTaxAssetsStockOptions" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,259,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--DeferredTaxAssetsAccruedPayroll_iI_maDTANzBNt_zkbAOTiKWbpf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Capital loss carryforward/Disposal</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><ix:nonFraction name="CNXA:DeferredTaxAssetsAccruedPayroll" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,039,000</ix:nonFraction></p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2570">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--DeferredTaxAssetsRelatedPartyAccruals_iI_maDTANzBNt_zju1Q1RMXwu5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Related party accruals</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="CNXA:DeferredTaxAssetsRelatedPartyAccruals" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,001,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="CNXA:DeferredTaxAssetsRelatedPartyAccruals" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">799,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--DeferredTaxAssetsInventory_iI_maDTANzBNt_z3d7L5uivjz4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Inventory reserve</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsInventory" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">133,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsInventory" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">100,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--DeferredTaxAssetsInterestDeferral_iI_maDTANzBNt_zzCDf3sfSZ56" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Interest deferral</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="CNXA:DeferredTaxAssetsInterestDeferral" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">221,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="CNXA:DeferredTaxAssetsInterestDeferral" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">191,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--DeferredTaxAssetsStartupCosts_iI_maDTANzBNt_zqK7gkOdlDXb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Start-up costs</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="CNXA:DeferredTaxAssetsStartupCosts" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">81,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="CNXA:DeferredTaxAssetsStartupCosts" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">84,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--DeferredTaxAssetsOther_iI_maDTANzBNt_ziLxY4zPKx7c" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">Other</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOther" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">131,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOther" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">57,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTANzBNt_zDi0uPryjKWh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Valuation allowance</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,109,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,656,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_406_eus-gaap--DeferredTaxAssetsNet_iTI_mtDTANzBNt_zrTfHcLACBXe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Net deferred tax assets</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2590">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2591">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AF_z6Mqu2TwSjfb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
income tax provision differs from the amount of income tax determined by applying the applicable statutory income tax rate to pretax
loss due to the following for the years ended April 30, 2023 and 2022:</span></p>

<ix:nonNumeric contextRef="From2022-05-012023-04-30" escape="true" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"><p id="xdx_89B_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zZdbK7C9StIe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B4_z277PxFE5MX9" style="display: none">SCHEDULE OF INCOME TAX PROVISION</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20220501__20230430_zSYkEArpVZ7c" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20210501__20220430_zDOpuxbJ3qYf" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_zqZyBjHRvqPj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left">Income tax benefit based on book loss at US statutory rate</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">10,983,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">10,259,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_403_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_zhri02ZJ9u3d" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Share-based compensation and shares for services</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2598">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2599">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--IncomeTaxReconciliationDebtDiscountAmortization_zXBZ5ejqgJbd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Debt discount amortization</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="CNXA:IncomeTaxReconciliationDebtDiscountAmortization" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">860,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="CNXA:IncomeTaxReconciliationDebtDiscountAmortization" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,841,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--IncomeTaxReconciliationRelatedPartyAccruals_z8zDNlxx4Auj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Related party accruals</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="CNXA:IncomeTaxReconciliationRelatedPartyAccruals" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">226,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="CNXA:IncomeTaxReconciliationRelatedPartyAccruals" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">150,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--IncomeTaxReconciliationStartUpCosts_ziAUtmiEoAR1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Stock options</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="CNXA:IncomeTaxReconciliationStartUpCosts" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">145,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="CNXA:IncomeTaxReconciliationStartUpCosts" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,815,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--IncomeTaxRecociliationInterestExpense_zbhxuvvHojKi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Interest expense</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="CNXA:IncomeTaxRecociliationInterestExpense" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">79,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="CNXA:IncomeTaxRecociliationInterestExpense" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseDepreciation_zyQtSeco2zoc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">Depreciation</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseDepreciation" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">18,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseDepreciation" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">21,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--IncomeTaxRecociliationInventoryReserve_zmD0Ipxqcx9l" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Inventory reserve</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="CNXA:IncomeTaxRecociliationInventoryReserve" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="CNXA:IncomeTaxRecociliationInventoryReserve" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">55,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--IncomeTaxRecociliationInterestDeferral_zhhT14nkNcra" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Interest deferral</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="CNXA:IncomeTaxRecociliationInterestDeferral" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="CNXA:IncomeTaxRecociliationInterestDeferral" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--IncomeTaxRecociliationAcquisitionCosts_zzwAJg20p5t5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Acquisition costs</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="CNXA:IncomeTaxRecociliationAcquisitionCosts" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">260,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="CNXA:IncomeTaxRecociliationAcquisitionCosts" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,268,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--IncomeTaxRecociliationAccruedLegal_zXbwDQZrYnSh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accrued legal</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="CNXA:IncomeTaxRecociliationAccruedLegal" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">76,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="CNXA:IncomeTaxRecociliationAccruedLegal" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">76,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--IncomeTaxRecociliationLossOnExtinguishmentOfDebt_zu0MXotoIhv" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Loss on sale of capital assets</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="CNXA:IncomeTaxRecociliationLossOnExtinguishmentOfDebt" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,713,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2629">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--IncomeTaxRecociliationAccruedPayroll_zENPJxtZd2E9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accrued payroll</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2631">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2632">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--IncomeTaxRecociliationGainOnChangeInFairValueOfDerivatives_zOI3YqG0zZTh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Change in fair value of derivatives</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="CNXA:IncomeTaxRecociliationGainOnChangeInFairValueOfDerivatives" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">481,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="CNXA:IncomeTaxRecociliationGainOnChangeInFairValueOfDerivatives" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,298,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_406_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseOther_z2SFeyKefiN8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">Other</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">40,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">29,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_zfdO8oJRg5Xj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Valuation allowance</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">542,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,342,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--IncomeTaxExpenseBenefit_iT_zBfcCPiEPHC4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Total income tax provision</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2643">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2644">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AA_zIXoZIxQmxba" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 129; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company had net operating loss carryforwards of $<span id="xdx_90C_eus-gaap--OperatingLossCarryforwards_iI_c20230430__srt--StatementGeographicalAxis__country--US_z6ZgIGiLu6z7" title="Operating loss carryforwards"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2023-04-30_country_US" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,038,000</ix:nonFraction></span> and $<span id="xdx_906_eus-gaap--OperatingLossCarryforwards_iI_c20220430__srt--StatementGeographicalAxis__country--US_zpxAZTuJeEY7" title="Operating loss carryforwards"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2022-04-30_country_US" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,366,000</ix:nonFraction></span> as of April 30, 2023 and 2022, respectively, which may be
available to be used to offset future taxable income in the US for the years ended 2024 through 2042. The utilization of the Company&#8217;s
net operating losses may be subject to a U.S. federal limitation due to the &#8220;change in ownership provisions&#8221; under Section
382 of the Internal Revenue Code and other similar limitations in various state jurisdictions. Such limitations may result in a reduction
of the amount of net operating loss carryforwards in future years and possibly the expiration of certain net operating loss carryforwards
before their utilization. The Company has not completed a full study to assess whether an &#8220;ownership change&#8221; as defined in
Section 382 has occurred or whether there have been multiple ownership changes since inception. Future changes in the Company&#8217;s
stock ownership, which may be outside of the Company&#8217;s control, may trigger an &#8220;ownership change.&#8221; In addition, future
equity offerings or acquisitions that have equity as a component of the purchase price could result in an &#8220;ownership change.&#8221;
Tax years that remain subject to examination are 2018 and forward.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
deferred tax assets from operations in Israel, using an effective tax rate of <span id="xdx_90C_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_uPure_c20210501__20220430__srt--StatementGeographicalAxis__country--IL_z3D5aGPRhYrh" title="Effective tax rate" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBERUZFUlJFRCBUQVggQVNTRVRTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2021-05-012022-04-30_country_IL" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">23</ix:nonFraction></span>%, consisted of the following:</span></p>

<ix:nonNumeric contextRef="From2022-05-012023-04-30_country_IL" escape="true" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"><p id="xdx_89F_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_hsrt--StatementGeographicalAxis__country--IL_zkQP64j9UtEl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BB_zaO9Oav9nn7i" style="display: none">SCHEDULE OF NET DEFERRED TAX ASSETS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20230430__srt--StatementGeographicalAxis__country--IL_zrQ3hHo4o6me" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_494_20220430__srt--StatementGeographicalAxis__country--IL_zolONJx3g3ic" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Deferred tax assets:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_iI_maDTANzt5N_zzRXV9umt465" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left">Loss carryforwards</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign" contextRef="AsOf2023-04-30_country_IL" format="ixt:numdotdecimal" decimals="0" unitRef="USD">241,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign" contextRef="AsOf2022-04-30_country_IL" format="ixt:numdotdecimal" decimals="0" unitRef="USD">234,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--DeferredTaxAssetsStartupCostsForeign_iI_maDTANzt5N_zlH8a3Ay7mCl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Start-up costs</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2657">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2658">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--DeferredTaxAssetsInProcessResearchAndDevelopmentCosts_iNI_di_maDTANzt5N_zLdCDmopdcA2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Research and development costs</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="CNXA:DeferredTaxAssetsInProcessResearchAndDevelopmentCosts" contextRef="AsOf2023-04-30_country_IL" format="ixt:numdotdecimal" decimals="0" unitRef="USD">113,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="CNXA:DeferredTaxAssetsInProcessResearchAndDevelopmentCosts" contextRef="AsOf2022-04-30_country_IL" format="ixt:numdotdecimal" decimals="0" unitRef="USD">113,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTANzt5N_z5PyGyR1v4hk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Valuation allowance</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2023-04-30_country_IL" format="ixt:numdotdecimal" decimals="0" unitRef="USD">128,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2022-04-30_country_IL" format="ixt:numdotdecimal" decimals="0" unitRef="USD">121,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsNet_iTI_mtDTANzt5N_zo2uxdV8AiT6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Net deferred tax assets</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2666">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2667">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AF_zaEtbFcxJ7h2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
income tax provision differs from the amount of income tax determined by applying the applicable Israeli statutory income tax rate of
<span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_uPure_c20220501__20230430__srt--StatementGeographicalAxis__country--IL_zQ6OZxXo7yr8" title="Effective tax rate" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIElOQ09NRSBUQVggUFJPVklTSU9OIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2022-05-012023-04-30_country_IL" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">23</ix:nonFraction></span>% due to the following for the years ended April 30, 2023 and 2022:</span></p>

<ix:nonNumeric contextRef="From2022-05-012023-04-30_country_IL" escape="true" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"><p id="xdx_893_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_hsrt--StatementGeographicalAxis__country--IL_zGiHqeY3bNT9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B6_zcbxKGXTalUh" style="display: none">SCHEDULE OF INCOME TAX PROVISION</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20220501__20230430__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--IsraelTaxAuthorityMember_zzbqXDH4Buuk" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_490_20210501__20220430__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--IsraelTaxAuthorityMember_zEPgXcUk1VY5" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_maCITEBzAlg_zMdAlHiNqyX8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left">Income tax provision (benefit) based on book income (loss) at Israeli statutory rate</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" contextRef="From2022-05-012023-04-30_us-gaap_IsraelTaxAuthorityMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">54,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" contextRef="From2021-05-012022-04-30_us-gaap_IsraelTaxAuthorityMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">56,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_maCITEBzAlg_zEliVMCQHBcf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">Valuation allowance</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2022-05-012023-04-30_us-gaap_IsraelTaxAuthorityMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">54,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2021-05-012022-04-30_us-gaap_IsraelTaxAuthorityMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">56,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--IncomeTaxExpenseBenefit_mtCITEBzAlg_zlY9ZPEkmuv5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Total income tax provision</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2679">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2680">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AF_zbThvKQwT2yh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company had net operating loss carryforwards of approximately $<span id="xdx_904_eus-gaap--OperatingLossCarryforwards_iI_c20230430_zPaHsgNRFA3c" title="Operating loss carryforwards"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,049,000</ix:nonFraction></span> and $<span id="xdx_90C_eus-gaap--OperatingLossCarryforwards_iI_c20220430_zxITfjTmQRc9" title="Operating loss carryforwards"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,020,000</ix:nonFraction></span> as of April 30, 2023 and 2022, respectively,
which may be available to be used to offset future taxable income in Israel. All of the Company&#8217;s tax years since inception are
open for examination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s policy is to record interest and penalties on uncertain tax positions as income tax expense. There were no interest or
penalties recognized in the accompanying consolidated statements of comprehensive loss for the years ended April 30, 2023 and 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-05-012023-04-30" escape="true" name="us-gaap:SegmentReportingDisclosureTextBlock"><p id="xdx_808_eus-gaap--SegmentReportingDisclosureTextBlock_zoL5sEzZ72a4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
15</b>: <b><span id="xdx_828_zCOawe9I3Zf9">SEGMENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
the disposal of Foundation Sports and PlaySight in November 2022 and December 2022, the Company has ceased reporting two segments. The
Company now only operates in the equipment segment. For previous segment reporting we refer you to our previously filed Annual Report
on Form 10-K filed May 17, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 130; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-05-012023-04-30" escape="true" name="us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"><p id="xdx_80A_eus-gaap--DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_zwsZSvFZtAk4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
16</b>: <b><span id="xdx_828_z23vD9hsucn1">DISCONTINUED OPERATIONS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 27, 2022, the Company entered into a share purchase agreement (the &#8220;Agreement&#8221;) with PlaySight, Chen Shachar and
Evgeni Khazanov (together, the &#8220;Buyer&#8221;) pursuant to which the Buyer purchased <span id="xdx_90C_ecustom--SharesIssuedAndOutstandingPercentage_pid_dp_uPure_c20221125__20221127__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember_zjOgkC4qRdQ3" title="Shares issued and outstanding percentage"><ix:nonFraction name="CNXA:SharesIssuedAndOutstandingPercentage" contextRef="From2022-11-252022-11-27_custom_SharePurchaseAgreementMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of the issued and outstanding shares of
PlaySight from the Company in exchange for <span id="xdx_905_eus-gaap--DisposalGroupIncludingDiscontinuedOperationDescriptionAndTimingOfDisposal_c20221125__20221127__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember_zZuZe1JBGEa2" title="Discontinued operation description"><ix:nonNumeric contextRef="From2022-11-252022-11-27_custom_SharePurchaseAgreementMember" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationDescriptionAndTimingOfDisposal">(1) releasing the Company from all of PlaySight&#8217;s obligations towards its vendors, employees,
tax authorities and any other (past, current and future) creditors of PlaySight; (2) waiver by the Buyer of 100% of the personal consideration
owed to them under their employment agreements in the total amount of $<span id="xdx_90C_eus-gaap--DisposalGroupIncludingDiscontinuedOperationConsideration_iI_c20221127__us-gaap--TypeOfArrangementAxis__custom--EmployeeAgreementMember_z5TZaBZUjYu8" title="Personal consideration"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" contextRef="AsOf2022-11-27_custom_EmployeeAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">600,000</ix:nonFraction></span>; and (3) cash consideration of $<span id="xdx_906_eus-gaap--DisposalGroupIncludingDiscontinuedOperationConsideration_iI_c20221127__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember_zHoboyNdfP0b" title="Cash consideration"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" contextRef="AsOf2022-11-27_custom_SharePurchaseAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,000,000</ix:nonFraction></span> to be paid to
the Company in the form of a promissory note that matures on December 31, 2023.</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 5, 2022, the Company assigned <span id="xdx_90A_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20221205__srt--OwnershipAxis__custom--FoundationSportsToCharlesRuddyMember_z6yOhx9vHuv7" title="Ownership percentage by parrent"><ix:nonFraction name="us-gaap:MinorityInterestOwnershipPercentageByParent" contextRef="AsOf2022-12-05_custom_FoundationSportsToCharlesRuddyMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">75</ix:nonFraction></span>% of its membership interest in Foundation Sports to Charles Ruddy, its founder and granted
him the right for a period of three years to purchase the remaining <span id="xdx_901_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_iI_pid_dp_uPure_c20221205__srt--OwnershipAxis__custom--FoundationSportsToCharlesRuddyMember_zcGeYGz2HuQ3" title="Ownership percentage by non-controlling owners"><ix:nonFraction name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" contextRef="AsOf2022-12-05_custom_FoundationSportsToCharlesRuddyMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">25</ix:nonFraction></span>% of its Foundation Sports membership interests for $<span id="xdx_90F_eus-gaap--Cash_iI_c20221205_zgZgBFBsMjhc" title="Cash"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2022-12-05" format="ixt:numdotdecimal" decimals="0" unitRef="USD">500,000</ix:nonFraction></span> in
cash. As of December 5, 2022, the results of Foundation Sports will no longer be consolidated in the Company&#8217;s financial statements,
and the investment was accounted for as an equity method investment. On December 5, 2022, the Company analyzed this investment and established
a reserve for the investment at the full amount of $<span id="xdx_90A_eus-gaap--Investments_iI_c20221205_zei3nOBfOUDg" title="Investments"><ix:nonFraction name="us-gaap:Investments" contextRef="AsOf2022-12-05" format="ixt:numdotdecimal" decimals="0" unitRef="USD">500,000</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounted for these sales as a disposal of a business under ASC 205-20-50-1(a). The Company had reclassified the operations of
PlaySight and Foundation Sports as discontinued operations as the disposal represents a strategic shift that will have a major effect
on the Company&#8217;s operations and financial results. Under ASC 855-10-55, the Company has reflected the reclassification of assets
and liabilities of these entities as held for sale and the operations as discontinued operations as of and for the year ended April 30,
2022 as well as for the period May 1, 2022 through the date of disposal for each company. As a result of this reclassification, the Company
identified the following assets and liabilities that were reclassified from continuing operations to discontinued operations as they
are discontinued.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-05-012023-04-30" escape="true" name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"><p id="xdx_897_eus-gaap--ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_zr6y7QmCcvs3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current
assets as of April 30, 2022 &#8211; Discontinued Operations:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BF_zS55T0AWOdM3" style="display: none">SCHEDULE OF DISCONTINUED OPERATIONS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20220430_zAXYTYYV3Pne" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">April 30, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_iI_maAODGIzvOg_zNbesnP5QK2k" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: left">Cash and restricted cash</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">916,082</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_iI_maAODGIzvOg_zdDC2skQzck8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accounts receivable</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">288,980</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_iI_maAODGIzvOg_zlLcREfZLJ4h" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">Inventory</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">323,307</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesCurrent_iI_maAODGIzvOg_zGlG9f4oYRSh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Right of use asset &#8211; operating leases</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="CNXA:DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesCurrent" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">239,689</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_iI_maAODGIzvOg_zsJimypo1AG2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Prepaid expenses</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">490,260</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_iI_mtAODGIzvOg_z3FiX2D68ymj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Current Asset</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,258,318</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-current
assets as of April 30, 2022 &#8211; Discontinued Operations:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20220430_zGKs8tZid6s3" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">April 30, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent_iI_maDGIDOzWYq_zVWAQYz7uwB7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 80%">Goodwill</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,862,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent_iI_maDGIDOzWYq_zys3pYq034kc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Property and equipment, net</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">126,862</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent_iI_maDGIDOzWYq_zeQRqCFy3RE7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Intangible assets, net</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">19,473,646</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets_iI_maDGIDOzWYq_z4dQgbkQTPF6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Contract assets, net of current portion</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">209,363</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--DisposalGroupIncludingDiscontinuedOperationInventoryNoncurrent_iI_maDGIDOzWYq_zKzdc3EJ5mP2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Finished products used in operations, net</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryNoncurrent" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,693,575</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent_iTI_mtDGIDOzWYq_zOlJYK0X4Esl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-current Asset</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,365,446</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current
liabilities as of April 30, 2022 &#8211; Discontinued Operations:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_490_20220430_z3C8XOSHfqid" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">April 30, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent_iI_maLODGIzSPI_zeW9FtDqNNx9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: left">Accounts payable and accrued expenses</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,432,818</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityOperatingLeasesCurrent_iI_maLODGIzSPI_z1fKG0C7uLzd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Lease liability &#8211; operating leases</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="CNXA:DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityOperatingLeasesCurrent" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">237,204</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_iI_maLODGIzSPI_z5oXsB11HdIe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Contract liabilities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,545,200</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_iTI_mtLODGIzSPI_zyAFqNfeWXy5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Current Liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,215,222</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 131; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-current
liabilities as of April 30, 2022 &#8211; Discontinued Operations:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20220430_zhtEx84wNVr3" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">April 30, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities_iI_z16OtV0zyiT8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: left">Contract liabilities, net of current portion</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,370,492</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent_iTI_zqQDyCr2mKQf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Current Liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent" contextRef="AsOf2022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,370,492</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company reclassified the following operations to discontinued operations for the years ended April 30, 2023 and 2022, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_499_20220501__20230430_zDERT3DSewv8" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20210501__20220430_zJapoXaVfHd7" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--DisposalGroupIncludingDiscontinuedOperationRevenue_maDGIDOzOqT_zeWuCX7w9BJa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 64%">Revenue</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,954,149</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">728,805</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOperatingExpense_msDGIDOzOqT_zr3tWtPGQDgc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Operating expenses</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,416,117</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,948,508</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--DisposalGroupIncludingDiscontinuedOperationOtherIncomeLoss_msDGIDOzOqT_zYceM7Z9yMs5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Other (income) loss</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2750">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="CNXA:DisposalGroupIncludingDiscontinuedOperationOtherIncomeLoss" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">27,974</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--DisposalGroupIncludingDiscontinuedOperationNetIncomeLoss_iT_mtDGIDOzOqT_zRg2zyDOURul" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Net loss from discontinued operations</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="CNXA:DisposalGroupIncludingDiscontinuedOperationNetIncomeLoss" contextRef="From2022-05-012023-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,461,968</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="CNXA:DisposalGroupIncludingDiscontinuedOperationNetIncomeLoss" contextRef="From2021-05-012022-04-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,247,677</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>


</ix:nonNumeric><p id="xdx_8A6_zoBsu1uVpcY2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:nonNumeric contextRef="From2022-05-012023-04-30" escape="true" name="CNXA:ScheduleOfCalculationOfTheLossOnDisposalTableTextBlock"><p id="xdx_892_ecustom--ScheduleOfCalculationOfTheLossOnDisposalTableTextBlock_za4oTSQUDTGb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following represents the calculation of the loss on disposal of PlaySight and Foundation Sports:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BD_zTqKPL8EhYYa" style="display: none">SCHEDULE OF CALCULATION OF THE LOSS ON DISPOSAL</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_49C_20230430__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--PlaySightAndFoundationSportsMember_zK9sBTh5L6z7" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_iI_zn03MDRPyxcl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 84%; text-align: left">Note receivable</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" contextRef="AsOf2023-04-30_custom_PlaySightAndFoundationSportsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,000,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_iNI_di_zkUH2AW88oId" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Cash and restricted cash</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" contextRef="AsOf2023-04-30_custom_PlaySightAndFoundationSportsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">714,507</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_40B_ecustom--DisposalGroupIncludingDiscontinuedOperationAccountsReceivable_iI_zZFpJqoLXvxf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accounts receivable</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="CNXA:DisposalGroupIncludingDiscontinuedOperationAccountsReceivable" contextRef="AsOf2023-04-30_custom_PlaySightAndFoundationSportsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">411,249</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_iNI_di_zl12gf6FqCTi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Prepaid expenses</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" contextRef="AsOf2023-04-30_custom_PlaySightAndFoundationSportsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">106,031</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--DisposalGroupIncludingDiscontinuedOperationInventory1_iNI_di_za1eheOaBBYk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">Inventory</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1" contextRef="AsOf2023-04-30_custom_PlaySightAndFoundationSportsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">296,920</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherAssets_iNI_di_zg0Yzds1vmu2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Finished products used in operations</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets" contextRef="AsOf2023-04-30_custom_PlaySightAndFoundationSportsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,117,986</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_40B_ecustom--DisposalGroupIncludingDiscontinuedOperationContractAssets_iI_zCLtxuXTSZak" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Contract assets</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="CNXA:DisposalGroupIncludingDiscontinuedOperationContractAssets" contextRef="AsOf2023-04-30_custom_PlaySightAndFoundationSportsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">298,162</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_40C_ecustom--DisposalGroupIncludingDiscontinuedOperationRightOfUseAsset_iI_zGWJgZuu6w8b" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Right of use asset</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="CNXA:DisposalGroupIncludingDiscontinuedOperationRightOfUseAsset" contextRef="AsOf2023-04-30_custom_PlaySightAndFoundationSportsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">103,228</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--DisposalGroupIncludingDiscontinuedOperationGoodwill1_iNI_di_zPLmUSwo4hPf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">Goodwill</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1" contextRef="AsOf2023-04-30_custom_PlaySightAndFoundationSportsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,862,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_407_eus-gaap--DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_iNI_di_zeJH3gAdTAt7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Property and equipment</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" contextRef="AsOf2023-04-30_custom_PlaySightAndFoundationSportsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">116,505</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_40F_eus-gaap--DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_iNI_di_zkLVx0OIHIp6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Intangible assets</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" contextRef="AsOf2023-04-30_custom_PlaySightAndFoundationSportsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,576,475</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_405_ecustom--DisposalGroupIncludingDiscontinuedOperationContractLiabilities_iI_zFHdNclfSDc5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Contract liabilities</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="CNXA:DisposalGroupIncludingDiscontinuedOperationContractLiabilities" contextRef="AsOf2023-04-30_custom_PlaySightAndFoundationSportsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,785,408</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_iI_z9Yd9DZxM7l1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Lease liabilities</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" contextRef="AsOf2023-04-30_custom_PlaySightAndFoundationSportsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">78,016</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_iI_zb9hKD2ofYD2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Accounts payable and accrued expenses</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" contextRef="AsOf2023-04-30_custom_PlaySightAndFoundationSportsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,325,747</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--DisposalGroupIncludingDiscontinuedOperationLossOnDisposalOfDiscontinuedOperations_iI_z9xd8SmzKwz1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Loss on disposal of discontinued operations</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="CNXA:DisposalGroupIncludingDiscontinuedOperationLossOnDisposalOfDiscontinuedOperations" contextRef="AsOf2023-04-30_custom_PlaySightAndFoundationSportsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">41,413,892</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AC_zPuTFFglNmvf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-05-012023-04-30" escape="true" name="us-gaap:SubsequentEventsTextBlock"><p id="xdx_805_eus-gaap--SubsequentEventsTextBlock_z9wH6lRDqGE7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
17: <span id="xdx_82F_zMPsKc3EwkGh">SUBSEQUENT EVENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
May 1, 2023 through the date hereof, the Company issued <span id="xdx_909_eus-gaap--SharesIssued_iI_c20230501__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zJhRcohjUOX8"><ix:nonFraction name="us-gaap:SharesIssued" contextRef="AsOf2023-05-01_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">220,760</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock to ambassadors under
their agreements (<span id="xdx_903_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230501__20230501__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zMy6hNdawBng"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-05-012023-05-01_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">188</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">),
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to vendors in settlement of accounts payable (<span id="xdx_907_ecustom--StockIssuedDuringPeriodSharesIssuedSettlementOfAccountsPayable_c20230501__20230501__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zWoqslG9CPc5"><ix:nonFraction name="CNXA:StockIssuedDuringPeriodSharesIssuedSettlementOfAccountsPayable" contextRef="From2023-05-012023-05-01_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">67,500</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">),
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for settlement with former owners of FSS (<span id="xdx_900_ecustom--StockIssuedDuringPeriodSharesIssuedSettlementWithFormerOwners_c20230501__20230501__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zTri4ZwSMI6"><ix:nonFraction name="CNXA:StockIssuedDuringPeriodSharesIssuedSettlementWithFormerOwners" contextRef="From2023-05-012023-05-01_us-gaap_SubsequentEventMember" format="ixt:numcommadecimal" decimals="INF" unitRef="Shares">1,3500</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">),
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for the exercise of warrants (<span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20230501__20230501__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zg0K9SOpZya4"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2023-05-012023-05-01_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">58,042</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and to satisfy the profit guarantee on a note (<span id="xdx_908_ecustom--StockIssuedDuringPeriodSharesIssuedProfitGuaranteeOnNote_c20230501__20230501__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zjnsMR0ms818"><ix:nonFraction name="CNXA:StockIssuedDuringPeriodSharesIssuedProfitGuaranteeOnNote" contextRef="From2023-05-012023-05-01_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">93,681</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Meged
Agreement </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 8, 2023, the Company entered into a merchant cash advance agreement with Meged Funding Group (&#8220;Meged&#8221;) pursuant to which
the Company sold $<span id="xdx_901_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_pp2d_c20230608__20230608__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--MegedAgreementMember_z2iV8onaWnQ8" title="Sale of consideration received"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedPerTransaction" contextRef="From2023-06-082023-06-08_us-gaap_SubsequentEventMember_custom_MegedAgreementMember" format="ixt:numdotdecimal" decimals="2" unitRef="USD">315,689</ix:nonFraction></span> in future receivables to Meged (the &#8220;Meged Receivables Purchased Amount&#8221;) to in exchange for
payment to the Company of $<span id="xdx_909_eus-gaap--PaymentsToAcquireReceivables_c20230608__20230608__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--MegedAgreementMember_zQKlZyehrFNe" title="Payment for exchange received amount"><ix:nonFraction name="us-gaap:PaymentsToAcquireReceivables" contextRef="From2023-06-082023-06-08_us-gaap_SubsequentEventMember_custom_MegedAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">210,600</ix:nonFraction></span> in cash less fees of $<span id="xdx_904_ecustom--CashLessFees_c20230608__20230608__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--MegedAgreementMember_zqSryT44Kf4i" title="Cash less fees"><ix:nonFraction name="CNXA:CashLessFees" contextRef="From2023-06-082023-06-08_us-gaap_SubsequentEventMember_custom_MegedAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,580</ix:nonFraction></span>. The Company has agreed to pay Meged $<span id="xdx_908_eus-gaap--PaymentsToAcquireReceivables_pp2d_c20230608__20230608__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--MegedAgreementMember__srt--StatementScenarioAxis__custom--EachWeekForNextThreeWeeksMember_zusOWbSpxus5" title="Payment for exchange received amount"><ix:nonFraction name="us-gaap:PaymentsToAcquireReceivables" contextRef="From2023-06-082023-06-08_us-gaap_SubsequentEventMember_custom_MegedAgreementMember_custom_EachWeekForNextThreeWeeksMember" format="ixt:numdotdecimal" decimals="2" unitRef="USD">17,538</ix:nonFraction></span> each week until the Meged
Receivables Purchased Amount is paid in full.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>UFS
Agreement</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 7, 2023, the Company entered into an agreement with UFS (the &#8220;UFS Agreement&#8221;) pursuant to which the Company sold $<span id="xdx_906_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20230807__20230807__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--UFSAgreementMember_zaAOwptmUE7i" title="Sale of consideration received"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedPerTransaction" contextRef="From2023-08-072023-08-07_us-gaap_SubsequentEventMember_custom_UFSAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">797,500</ix:nonFraction></span>
in future receivables (the &#8220;UFS Second Receivables Purchased Amount&#8221;) to UFS in exchange for payment to the Company of $<span id="xdx_90F_eus-gaap--PaymentsToAcquireReceivables_c20230807__20230807__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--UFSAgreementMember_zBeAXivopmge" title="Payment for exchange received amount"><ix:nonFraction name="us-gaap:PaymentsToAcquireReceivables" contextRef="From2023-08-072023-08-07_us-gaap_SubsequentEventMember_custom_UFSAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">550,000</ix:nonFraction></span>
in cash less fees of $<span id="xdx_90C_ecustom--CashLessFees_c20230807__20230807__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--UFSAgreementMember_zzVSmgVgr7n6" title="Cash less fees"><ix:nonFraction name="CNXA:CashLessFees" contextRef="From2023-08-072023-08-07_us-gaap_SubsequentEventMember_custom_UFSAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,000</ix:nonFraction></span>. The Company has agreed to pay UFS $<span id="xdx_903_eus-gaap--PaymentsToAcquireReceivables_c20230807__20230807__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--UFSAgreementMember__srt--StatementScenarioAxis__custom--EachWeekForNextThreeWeeksMember_zsSFQkWW9IXf" title="Payment for exchange received amount"><ix:nonFraction name="us-gaap:PaymentsToAcquireReceivables" contextRef="From2023-08-072023-08-07_us-gaap_SubsequentEventMember_custom_UFSAgreementMember_custom_EachWeekForNextThreeWeeksMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30,000</ix:nonFraction></span> each week until the UFS Second Receivables Purchased Amount is
paid in full.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to secure payment and performance of the Company&#8217;s obligations to UFS under the UFS Agreement, the Company granted to UFS
a security interest in the following collateral: all accounts receivable and all proceeds as such term is defined by Article 9 of the
UCC. The Company also agreed not to create, incur, assume, or permit to exist, directly or indirectly, any lien on or with respect to
any of such collateral.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 13, the Company held a special meeting
of stockholders in which the following items were approved: (i) the issuance of (i) <span id="xdx_909_eus-gaap--StockRepurchasedDuringPeriodShares_c20230912__20230913__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zLV1jyoeypKk"><ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodShares" contextRef="From2023-09-122023-09-13_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,018,510</ix:nonFraction> </span>shares of the our common stock, par value
$<span id="xdx_900_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20230913__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zKjOVtyCWTb8"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2023-09-13_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></span> per share, that were issued on October 3, 2022, and, (ii) <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20221002__20221003__us-gaap--AwardTypeAxis__custom--PreFundedWarrantMember_zlTLu0CsA2lk"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2022-10-022022-10-03_custom_PreFundedWarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,802,002</ix:nonFraction></span> shares of our common stock issuable upon exercise of Pre-Funded
Warrants at an exercise price of $<span id="xdx_902_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20221003__us-gaap--AwardTypeAxis__custom--PreFundedWarrantMember_zcFRp7Ya7Fp4"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2022-10-03_custom_PreFundedWarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.00001</ix:nonFraction></span> per share, (iii) <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20221002__20221003__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zluBkmRJAQz8"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2022-10-022022-10-03_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">12,820,512</ix:nonFraction></span> shares of common stock issuable upon the exercise of <span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20221003__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zzzhDKH1IaR4"><ix:nonNumeric contextRef="AsOf2022-10-03_us-gaap_CommonStockMember" format="ixt-sec:duryear" name="us-gaap:WarrantsAndRightsOutstandingTerm">5</ix:nonNumeric></span>-Year Warrants
at an exercise price of $<span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20221003__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zqB7XjdJPAM6"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2022-10-03_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.39</ix:nonFraction></span> per share, (iv) <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20221002__20221003__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember_zbnfyzkndwwd"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2022-10-022022-10-03_custom_WarrantOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">25,641,024</ix:nonFraction></span> shares of common stock issuable upon the exercise of <span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20221003__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember_zHx51HB4Kmre"><ix:nonNumeric contextRef="AsOf2022-10-03_custom_WarrantOneMember" format="ixt-sec:duryear" name="us-gaap:WarrantsAndRightsOutstandingTerm">7.5</ix:nonNumeric></span> Year Warrants at an
exercise price of $<span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20221003__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zNPVLHhdh6xi"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2022-10-03_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.43</ix:nonFraction></span> per share and (v) <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20221002__20221003__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember_z30auCts6hli"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2022-10-022022-10-03_custom_WarrantTwoMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">18,099,548</ix:nonFraction></span> shares of our common stock issuable upon the exercise of <span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20221003__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember_zflm2AWE4bik"><ix:nonNumeric contextRef="AsOf2022-10-03_custom_WarrantTwoMember" format="ixt-sec:duryear" name="us-gaap:WarrantsAndRightsOutstandingTerm">5.5</ix:nonNumeric></span> Year Warrants at an exercise price per share equal to $<span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20221003_zqC1WoDZDr1k"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2022-10-03" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.221</ix:nonFraction></span> per share to Armistice Capital Master Fund Ltd and (ii) a reverse stock split of our common
stock within a range of one (1)-for-ten (10) to one (1)-for-forty (40) (&#8220;Reverse Stock Split&#8221;), with the Board of Directors
of the Company to set the specific ratio and determine the date for the reverse split to be effective and any other action deemed necessary
to effectuate the Reverse Stock Split, without further approval or authorization of stockholders, at any time within 12 months of the
special meeting date.</p>

</ix:nonNumeric><p id="xdx_811_zRKnA2gAK6B3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 132; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="su_001"></span>PART
II &#8212; INFORMATION NOT REQUIRED IN PROSPECTUS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
13. Other Expenses of Issuance and Distribution.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the estimated expenses to be borne by the registrant in connection with the issuance and distribution of the
shares of common stock being registered hereby.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: left">SEC Filing Fee</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> &#160;</span></td><td style="width: 1%; text-align: left">&#160;&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Legal Fees and Expenses</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left">*</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accounting Fees and Expenses</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left">*</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Miscellaneous Fees and Expenses</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left">*</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Total</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="vertical-align: bottom; text-align: left">*</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated
    expenses.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
14. Indemnification of Directors and Officers.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">Our bylaws provide
that we will indemnify our directors to the fullest extent authorized or permitted by applicable law. Under our Bylaws, we are required
to indemnify each of our directors and officers if the basis of the indemnitee&#8217;s involvement was by reason of the fact that the
indemnitee is or was our director or officer or was serving at our request as a director, officer, employee or agent for another entity.
We must indemnify our officers and directors against all expenses (including attorneys&#8217; fees), judgments, fines and amounts paid
in settlement actually and reasonably incurred by the indemnitee in connection with such action, suit or proceeding if the indemnitee
acted in good faith and in a manner the indemnitee reasonably believed to be in or not opposed to the best interests of the Company,
and, with respect to any criminal action or proceeding, had no reasonable cause to believe the indemnitee&#8217;s conduct was unlawful.
Our bylaws also require us to advance expenses (including attorneys&#8217; fees) incurred by a director or officer in defending any civil,
criminal, administrative or investigative action, suit or proceeding, provided that such person will repay any such advance if it is
ultimately determined that such person is not entitled to indemnification by us. Any claims for indemnification by our directors and
officers may reduce our available funds to satisfy successful third-party claims against us and may reduce the amount of money available
to us.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
15<i>.</i> Recent Sales of Unregistered Securities.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following information relates to all securities issued or sold by us within the past three years and not registered under the Securities
Act. Each of the transactions described below was conducted in reliance upon the exemptions from registration provided in Section 4(a)(2)
of the Securities Act and the rules and regulations promulgated thereunder. There were no underwriters employed in connection with any
of the transactions set forth in this Item 15.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>On
September 20, 2023, the Registrant filed a Certificate of Amendment to its Articles of Incorporation, as amended, to effect a one-for-forty
(1-for-40) reverse stock split effective September 25, 2023. All share and per share information in this Item 15 has been adjusted to
reflect this reverse stock split.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
May 1, 2022, the Company has issued an aggregate of 194,079 shares of its common stock consisting of:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 15, 2022, the Company issued 109,740 shares of common stock to the Convertible Noteholders upon conversion of convertible notes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 15, 2022, the Company issued 26,219 shares to investors who participated in the Company&#8217;s Nasdaq uplist round.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 27, 2022, the Company issued 625 shares of common stock to Gabriel Goldman for consulting services performed in the first quarter
of calendar 2022. Gabriel Goldman became a director of the Company on June 15, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 27, 2022, the Company issued 14,960 shares of common stock to the former Gameface shareholders in connection with the purchase of
Gameface.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 25, 2022, the Company issued 750 shares of common stock to Midcity Capital Ltd (&#8220;Midcity&#8221;) pursuant to a cashless
conversion of warrants Midcity received from its warrant agreement with the Company dated March 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 28, 2022, the Company entered into a securities purchase agreement (the &#8220;Securities Purchase Agreement&#8221;) with a
single institutional investor (the &#8220;Investor&#8221;) for the issuance and sale of (i) 25,463 shares of common stock and (ii) pre-funded
warrants (the &#8220;Pre-Funded Warrants&#8221;) to purchase an aggregate of 295,050 shares of its common stock, together with accompanying
common stock warrants, at a combined purchase price of $15.60 per share of the common stock and associated common stock warrant and $15.596
per Pre-Funded Warrant and associated common stock warrants for an aggregate amount of approximately $5.0 million (the &#8220;Offering&#8221;).
The Pre-Funded Warrants have an exercise price of $0.0004 per share of common stock and are exercisable until the Pre-Funded Warrants
are exercised in full. The shares of common stock and Pre-Funded Warrants were sold in the offering together with common stock warrants
to purchase 320,513 shares of common stock at an exercise price of $15.60 per share and a term of five years following the initial exercise
date (the &#8220;5-Year Warrants&#8221;) and 641,026 common stock warrants to purchase 641,026 shares of common stock at an exercise
price of $17.20 per share and a term of seven and one half years (the &#8220;7.5-Year Warrants&#8221;) following the initial exercise
date (collectively, the &#8220;Warrants&#8221;). The Warrants issued in the Offering contain variable pricing features. The Warrants
and Pre-Funded Warrants became exercisable beginning on the date stockholder approval was received and effective allowing exercisability
of the Warrants and Pre-Funded Warrants under Nasdaq rules. The exercise price of the Warrants was reset in October 2023 to $3.55
per share.Net proceeds to the Company were $4,549,882.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 12, 2022, the Company issued 48,098 shares of common stock, on November 21, 2022 issued 675 shares of common stock and January
26, 2023 issued 6,994 shares of common stock in connection with the acquisition of PlaySight.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 26, 2023, the Company issued 150 shares of common stock for services rendered to their ambassadors</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 133; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 28, 2022, the Company and the Investor entered into a registration rights agreement (the &#8220;Registration Rights Agreement&#8221;).
The Registration Rights Agreement provides that the Company shall file a registration statement with the Securities and Exchange Commission
(&#8220;SEC&#8221;) covering the resale of the unregistered shares of common stock and the shares of common stock issuable upon exercise
of the Warrants and Pre-Funded Warrants no later than December 20, 2022 (the &#8220;Filing Date&#8221;) and to use best efforts to have
the registration statement declared effective as promptly as practical thereafter, and in any event no later than sixty (60) days after
the Filing Date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 6, 2023, the Company entered into a loan and security agreement (the &#8220;Loan and Security Agreement&#8221;)
with one or more institutional investors (the &#8220;Lenders&#8221;) and Armistice Capital Master Fund Ltd. as agent for the Lenders (the
&#8220;Agent&#8221;) for the issuance and sale of (i) a note in an aggregate principal amount of up to $2,000,000 (the &#8220;Note&#8221;)
at 4.33% interest per annum unless in default, with the initial advance under the Loan and Security Agreement being $1,400,000 and (ii)
warrants (the &#8220;Warrants&#8221;) to purchase a number of shares of common stock of the Company equal to 200% of the face amount of
the Note divided by the closing price of the common stock of the Company on the date of the issuance of the Notes (collectively, the &#8220;Initial
Issuance&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
closing price of the Company&#8217;s common stock on January 6, 2023, as reported by Nasdaq, was $0.221 per share (or $8.84 as adjusted
for the one-for-forty (1-for-40) reverse stock split), so the Warrants in respect of the initial advance under the Note are exercisable
for up to 18,099,548 shares of the Company&#8217;s common stock. The Warrants have an exercise price per share equal to the closing price
of the common stock of the Company on the date of the issuance of the Note, or $8.84 per share and a term of five- and one-half (5&#189;)
years following the initial exercise date. The exercise price of the Warrants was reset in October 2023 to $3.55 per share. The
initial exercise date of the Warrants was the date stockholder approval is received and effective allowing exercisability of the Warrants
under Nasdaq rules. Pursuant to the terms of the Loan and Security Agreement, an additional advance of $600,000 was made to the Company
under the Note on February 2, 2023. The Company&#8217;s obligations under the terms of the Loan and Security Agreement are fully and
unconditionally guaranteed by all of the Company&#8217;s subsidiaries (the &#8220;Guarantors&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Loan and Security Agreement, the Company and each of the Guarantors entered into a pledge and security agreement
with the Agent (the &#8220;Pledge and Security Agreements&#8221;). The Pledge and Security Agreements provide that the Company and the
Guarantors will grant the Agent a security interest in all of the Company&#8217;s and each Guarantor&#8217;s respective assets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company used the net proceeds from the Loan and Security Agreement to pay expenses, including accounting and legal fees, relating to
the registration of certain previously issued securities of the Company, which securities were issued to an affiliate of the Agent, and
following the payment of such expenses, to fund the Company&#8217;s operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 23, 2023, Connexa Sports Technologies Inc. (the &#8220;Company&#8221;) issued the following shares of its common stock (&#8220;Shares&#8221;)
to the following persons in transactions that were exempt from registration under the Securities Act, pursuant to Section 4(a)(2) of the Securities Act as transactions by an issuer not involving any public offering:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">67,500 </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
    to vendors in exchange for a reduction of $270,000 in the amount owed to such vendors;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,750 </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
    to Mike Ballardie, the Company&#8217;s chief executive officer and director, pursuant to an exercise of warrants by Mr.
    Ballardie;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,250
    </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares to Yona Kalfa, the Company&#8217;s chief
    innovation officer and director, pursuant to an exercise of warrants by Mr. Kalfa;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">150
    </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares to ambassadors as compensation to such
    ambassadors under their ambassador agreements; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,350
    </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares to the former owner and staff of Foundation
    Sports Systems, LLC (&#8220;Foundation&#8221;) as final payment to such persons for 100% of the membership interests of Foundation
    pursuant to the Membership Interest Purchase Agreement between the Company and Charlie Ruddy dated June 18, 2021.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 8, 2023, the Company issued (i) 38 shares to an ambassador as compensation to such ambassador under its ambassador agreement
and (ii) 43,437 shares to a lender (the &#8220;Lender&#8221;) in connection with the conversion of the outstanding principal
amount of a $1,000,000 2.25% Promissory Note due April 30, 2021 into shares of common stock of the Company in exchange for a sufficient
amount of shares of the Company to realize $1,500,000 in proceeds from the sale of shares of the Company&#8217;s common stock (the &#8220;Lender&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 20, 2023, the Company issued 6,809 shares of common stock to the Lender in connection with the Conversion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 134; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 26, 2023, the Company issued 43,437 shares of common stock to the Lender in connection with the Conversion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 1, 2023, the Company issued 31,042  shares of common stock to Armistice upon the exercise of its Pre-Funded
Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 17, 2023, the Company issued 1,876 shares of common stock to Rodney Rapson as compensation for Mr. Rapson&#8217;s advisory
services under the advisory agreement between the Company and Mr. Rapson.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 31, 2023, the Company issued 42,500 shares of common stock to the Lender in connection with the Conversion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 23, 2023, the Company issued 1,676 shares to the former shareholders of Gameface pursuant to the terms of the share purchase
agreement signed between the Company and such shareholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 27, 2023, the Company issued 42,500 shares of common stock to the Lender in connection with the Conversion.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
company used the net proceeds it received from its registered offering on June 14, 2022 (i.e., $4,195,000) for the following purposes
(dollars in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Use of Net Proceeds</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: left">Working Capital</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">3,195</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Repayment of Midcity Capital loan <sup>(1)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">500</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment to Mr. Shaik <sup>(2)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">500</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="width: 0.1in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    more information, see &#8220;Management&#8217;s Discussion and Analysis of Results of Operations and Financial Condition&#8212;Description
    of Indebtedness&#8212;Loan Agreements<i>.&#8221;</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    more information, see &#8220;<i>Management&#8217;s Discussion and Analysis of Results of Operations and Financial Condition&#8212;Overview&#8212;Gameface
    Acquisition.&#8221;</i></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Issuer
Purchases of Equity Securities</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise stated, the sales of the below securities were deemed to be exempt from registration under the Securities Act in reliance upon
Section 4 (a)(2) of the Securities Act (or Regulation D or Regulation S promulgated thereunder), or Rule 701 promulgated under Section
3(b) of the Securities Act as transactions by an issuer not involving any public offering or pursuant to benefit plans and contracts
relating to compensation as provided under Rule 701. The recipients of the securities in each of these transactions represented their
intentions to acquire the securities for investment only and not with a view to or for sale in connection with any distribution thereof,
and appropriate legends were placed upon the stock certificates issued in these transactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>


<!-- Field: Page; Sequence: 135; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
16. Exhibits and Financial Statement Schedules.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(a)
Exhibits</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 0.7in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
    Number</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1674440/000149315222013931/ex2-1.htm" style="-sec-extract: exhibit">Articles of Incorporation (Incorporated by reference to the Registrant&#8217;s Form S-1 (File No. 333-259487), filed on June 14, 2022)</a></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1674440/000149315223037285/ex-3.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bylaws (Incorporated by reference to Exhibit 3 to Current Report on Form 8-K filed on October 16, 2023)</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">5.1**</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Opinion of Lucosky Brookman <span style="font-family: Times New Roman, Times, Serif">LLP</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">10.1</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1674440/000149315223036865/ex10-1.htm" style="-sec-extract: exhibit">Loan and Security Modification Agreement dated October 11, 2023 between the Company, its subsidiaries and Armistice Capital Master Fund Ltd. (Incorporated by reference to the Company&#8217;s Current Report as previously filed on Form 8-K on October 11 2023)</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">10.2</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1674440/000149315223036865/ex4-1.htm" style="-sec-extract: exhibit">Form of 5.5 Year Warrant (Incorporated by reference to Exhibit 4.1 to Current Report on Form 8-K filed on October 11 2023)</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1674440/000149315223001023/ex10-1.htm" style="-sec-extract: exhibit">Loan and Security Agreement dated January 6, 2023 between the Company, its subsidiaries and Armistice Capital Master Fund Ltd. (Incorporated by reference to the Company&#8217;s Current Report as previously filed on Form 8-K on January 6, 2023)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1674440/000149315223001023/ex10-4.htm" style="-sec-extract: exhibit">Pledge and Security Agreement dated January 6, 2023 between the Company, its subsidiaries and Armistice Capital Master Fund Ltd. (Incorporated by reference to the Company&#8217;s Current Report as previously filed on Form 8-K on January 6, 2023)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1674440/000149315223001023/ex10-3.htm" style="-sec-extract: exhibit">Warrant dated January 6, 2023 from the Company to Armistice Capital Master Fund Ltd. (Incorporated by reference to the Company&#8217;s Current Report as previously filed on Form 8-K on January 6, 2023)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1674440/000149315223001023/ex10-2.htm" style="-sec-extract: exhibit">Note dated January 6, 2023 from the Company to Armistice Capital Master Fund Ltd. (Incorporated by reference to the Company&#8217;s Current Report as previously filed on Form 8-K on January 6, 2023)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1674440/000149315222027448/ex10-1.htm" style="-sec-extract: exhibit">Form of Securities Purchase Agreement (Incorporated by reference to the Company&#8217;s Current Report on Form 8-K filed on October 3, 2022)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.8</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1674440/000149315222027448/ex10-2.htm" style="-sec-extract: exhibit">Form of 5-Year Warrant (Incorporated by reference to the Company&#8217;s Current Report on Form 8-K filed on October 3, 2022)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.9</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1674440/000149315222027448/ex10-3.htm" style="-sec-extract: exhibit">Form of 7.5-Year Warrant (Incorporated by reference to the Company&#8217;s Current Report on Form 8-K filed on October 3, 2022)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.10</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1674440/000149315222027448/ex10-4.htm" style="-sec-extract: exhibit">Form of Pre-Funded Warrant (Incorporated by reference to the Company&#8217;s Current Report on Form 8-K filed on October 3, 2022)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.11</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1674440/000149315222027448/ex10-5.htm" style="-sec-extract: exhibit">Form of Registration Rights Agreement (Incorporated by reference to the Company&#8217;s Current Report on Form 8-K filed on October 3, 2022)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.12</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1674440/000149315222027448/ex10-6.htm" style="-sec-extract: exhibit">Form of Placement Agent Warrant (Incorporated by reference to the Company&#8217;s Current Report on Form 8-K filed on October 3, 2022)</a></span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.13</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1674440/000149315222021411/ex10-1.htm" style="-sec-extract: exhibit">Standard Merchant Cash Advance Agreement, dated July 29, 2022, Unique Funding Solutions LLC and Connexa Sports Technologies Inc. (Incorporated by reference to the Company&#8217;s Current Report on Form 8-K filed on August 5, 2022</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.14*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex10-14.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Standard Merchant Cash Advance Agreement, dated July 29, 2022, Cedar Advance LLC and Connexa Sports Technologies Inc.</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.15</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1674440/000149315222034095/ex10-1.htm" style="-sec-extract: exhibit">Share Purchase Agreement dated November 27, 2022 by and among Connexa Sports Technologies Inc., PlaySight Interactive Ltd. and Chen Shachar and Evgeni Khazanov (Incorporated by reference to the Company&#8217;s Current Report on Form 8-K filed on December 1 2022)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.16</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1674440/000149315222034095/ex10-2.htm" style="-sec-extract: exhibit">Promissory Note <span>dated November 27, 2022 by and among Connexa Sports Technologies Inc., PlaySight Interactive Ltd. and Chen Shachar and Evgeni Khazanov</span> (Incorporated by reference to the Company&#8217;s Current Report on Form 8-K filed on December 1 2022)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.17</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1674440/000149315223007476/ex10-1.htm" style="-sec-extract: exhibit">Distribution
    Agreement (Incorporated by reference to the Company&#8217;s Current Report on Form 8-K filed on March 14, 2023)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.1*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex21-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">List of Subsidiaries</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex23-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of OLAYINKA OYEBOLA &amp; CO</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">23.2**</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Consent of Lucosky Brookman LLP (included in Exhibit 5.1)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.INS</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Instance Document</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.SCH</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Taxonomy Extension Schema Document</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.CAL</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.LAB</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Taxonomy Extension Label Linkbase Document</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.PRE</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.DEF</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Taxonomy Extension Definition Linkbase Definition</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">107*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex107.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filing Fee Table</span></a></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">*Filed herewith</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">**To be filed by amendment</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>


<!-- Field: Page; Sequence: 136; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(b) </i>Financial
Statement Schedules</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedules
have been omitted because the information required to be set forth therein is not applicable or is shown in the financial statements
or notes thereto.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
17<i>. Undertakings.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned Registrant hereby undertakes:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
To file, during any period in which offers or sales are being made, a post-effective amendment to this registration
statement:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
to include any prospectus required by Section 10(a)(3) of the Securities Act;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
to reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent
post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set
forth in the Registration Statement. Notwithstanding the foregoing, any increase or decrease in volume of shares of common stock
offered (if the total dollar value of shares of common stock offered would not exceed that which was registered) and any deviation
from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the
Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the
maximum aggregate offering price set forth in the &#8220;Calculation of Registration Fee&#8221; table in the effective registration
statement; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
to include any material information with respect to the plan of distribution not previously disclosed in the registration statement
or any material change to such information in the registration statement; provided, however, that (i) and (ii) do not apply if the
registration statement is on Form S-3 or Form S-8, and the information required to be included in a post- effective amendment by (i)
and (ii) is contained in periodic reports filed with or furnished to the Commission by the registrant pursuant to Section 13 or
Section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the registration statement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be
deemed to be a new registration statement relating to the shares of common stock offered therein, and the offering of such shares of
common stock at that time shall be deemed to be the initial bona fide offering thereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
To remove from registration by means of a post-effective amendment any of the shares of common stock being registered which remain
unsold at the termination of the offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
prospectus filed pursuant to Rule 424(b) as part of a registration statement relating to an offering, other than registration statements
relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration
statement as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement
or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into
the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of
sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part
of the registration statement or made in any such document immediately prior to such date of first use.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insofar
as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons
of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the
Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is,
therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the
registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of
any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the shares of common
stock being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling
precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as
expressed in the Securities Act and will be governed by the final adjudication of such issue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>


<!-- Field: Page; Sequence: 137; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="su_002"></span>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all
of the requirements for filing on Form S-1 and has duly caused this Registration Statement to be signed on its behalf by the undersigned,
thereunto duly authorized, in the City of Windsor Hill, State of Maryland, on November 8, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2" style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONNEXA SPORTS TECHNOLOGIES, INC.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2" style="font: 11pt Calibri, Helvetica, Sans-Serif">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 50%; padding-bottom: 1.5pt">&#160;</td>
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1.5pt solid; width: 47%; font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/ Mike Ballardie&#160;&#160;&#160;&#160;</i></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mike Ballardie</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>POWER
OF ATTORNEY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">KNOW
ALL MEN BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Mike Ballardie as his or her true
and lawful attorney-in-fact, with full power of substitution and resubstitution for him or her and in his or her name, place and stead,
in any and all capacities to sign any and all amendments including pre- and post-effective amendments to this registration statement,
any subsequent registration statement for the same offering which may be filed pursuant to Rule 462(b) under the Securities Act of 1933,
as amended, and pre- or post-effective amendments thereto, and to file the same, with all exhibits thereto, and other documents in connection
therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that said attorney-in-fact or his substitute,
each acting alone, may lawfully do or cause to be done by virtue thereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
required under the Securities Act of 1933, this registration statement has been signed below by the following persons in the capacities
and on the dates indicated:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NAME</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TITLE</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 24%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DATE</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Mike Ballardie</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer and Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">November
    8, 2023</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mike
    Ballardie</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    executive officer)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Mike Ballardie</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">November
    8, 2023</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mike
    Ballardie</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    financial and accounting officer)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Yonah Kalfa</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">November
    8, 2023</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yonah
    Kalfa</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Kirk Taylor</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">November
    8, 2023</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kirk
    Taylor</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Rodney Rapson</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">November
    8, 2023</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rodney
    Rapson</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Steve Crummey</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">November
    8, 2023</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Steve
    Crummey</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 138; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.14
<SEQUENCE>2
<FILENAME>ex10-14.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.14</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex10-14_001.jpg" ALT=""></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">CEDAR
ADVANCE LLC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2917
Ave I, Brooklyn, NY 11210</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(718)
400-9030</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>STANDARD
MERCHANT CASH ADVANCE AGREEMENT</U></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
is an Agreement dated <U>07/26/2022</U> by and between CEDAR ADVANCE LLC (&ldquo;CEDAR&rdquo;) and each merchant listed below (&ldquo;Merchant&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Merchant&rsquo;s
Legal Name: <U>SLINGER BAG AMERICAS INC / SLINGER BAG INC / CONNEXA SPORTS TECHNOLOGIES INC</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>D/B/A/:
</U>&nbsp;<U>SLINGER BAG AMERICAS/ SLINGER BAG</U>________________________________&nbsp; <U>Fed ID #: </U>&nbsp; <U>61-1789640</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Type
of Entity:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 14%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;
    Corporation </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 22%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;
    Limited Liability Company</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;
    Limited Partnership</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 22%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;
    Limited Liability Partnership </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 22%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;
    Sole Proprietor Business</FONT></TD>
    </TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 16%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 26%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2709
    N ROLLING ROAD STE 138</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 12%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">City:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 16%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WINDSOR
    MILL</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 6%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">State:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 6%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MD</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 6%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Zip:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 6%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21244</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contact
    Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22
    BLUE FLAX LN</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">City:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LANGHORNE</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">State:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PA</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Zip:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19047</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail
    Address: </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone
    Number: </FONT></TD>
    <TD COLSPAN="7" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: italic 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 80%; text-align: left"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Purchase
                                            Price</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 16%; text-align: right"></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: italic 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>This
    is the amount being paid to Merchant(s) for the Receivables Purchased Amount (defined below).</I></FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">750,000.00</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: italic 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: italic 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Receivables
                                            Purchased Amount</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: italic 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>This
    is the amount of Receivables (defined in Section 1 below) being sold.</I></FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,124,250.00</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: italic 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: italic 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Specified
                                            Percentage</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: italic 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>This
    is the percentage of Receivables (defined below) to be delivered until the Receivables Purchased Amount is paid in full.</I></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: italic 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: italic 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Net
                                            Funds Provided</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: italic 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>This
    is the net amount being paid to or on behalf of Merchant(s) after deduction of applicable fees listed in Section 2 below.</I></FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">712,500.00
                                            &nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: italic 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: italic 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Initial
    Estimated Payment</B></FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>This
                                            is only applicable if an Addendum for Estimated Payments is being signed. This is the initial
                                            amount of periodic payments collected from Merchant(s) as an approximation of no more than
                                            the Specified Percentage of the Receivables and is subject to</I></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>reconciliation
                                            as set forth in Section 4 below. </I></FONT></P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>44,970.00</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>per
                                            </B>WEEK</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>TERMS
AND CONDITIONS</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>1.</U>&nbsp;<U>Sale
of Future Receipts.</U></B> Merchant(s) hereby sell, assign, and transfer to CEDAR (making CEDAR the absolute owner) in consideration
of the funds provided (&ldquo;Purchase Price&rdquo;) specified above, all of each Merchant&rsquo;s future accounts, contract rights,
and other obligations arising from or relating to the payment of monies from each Merchant&rsquo;s customers and/or other third party
payors (the &ldquo;Receivables&rdquo;, defined as all payments made by cash, check, credit or debit card, electronic transfer, or other
form of monetary payment in the ordinary course of each merchant&rsquo;s business), for the payment of each Merchant&rsquo;s sale of
goods or services until the amount specified above (the &ldquo;Receivables Purchased Amount&rdquo;) has been delivered by Merchant(s)
to CEDAR. Each Merchant hereby acknowledges that until the Receivables Purchased Amount has been received in full by CEDAR, each Merchant&rsquo;s
Receivables, up to the balance of the Receivables Purchased Amount, are the property of CEDAR and not the property of any Merchant. Each
Merchant agrees that it is a fiduciary for CEDAR and that each Merchant will hold Receivables in trust for CEDAR in its capacity as a
fiduciary for CEDAR.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="4" STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
    have read and agree to the terms and conditions set forth above:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 14%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 24%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="4" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    and Title: </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THOMAS
    EDWIN DYE JR</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">07/26/2022</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page
<B>2</B> of <B>16</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 25.8pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>STANDARD
MERCHANT CASH ADVANCE AGREEMENT</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Receivables Purchased Amount shall be paid to CEDAR by each Merchant irrevocably authorizing only one depositing account acceptable to
CEDAR (the &ldquo;Account&rdquo;) to remit the percentage specified above (the &ldquo;Specified Percentage&rdquo;) of each Merchant&rsquo;s
settlement amounts due from each transaction, until such time as CEDAR receives payment in full of the Receivables Purchased Amount.
Each Merchant hereby authorizes CEDAR to ACH debit the specified remittances from the Account on a daily basis as of the next business
day after the date of this Agreement and will provide CEDAR with all required access codes and monthly bank statements. Each Merchant
understands that it will be held responsible for any fees resulting from a rejected ACH attempt or an Event of Default (see Section 2).
CEDAR is not responsible for any overdrafts or rejected transactions that may result from CEDAR&rsquo;s ACH debiting the Specified Percentage
amounts under the terms of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>2.</U>&nbsp;<U>Additional
Fees.</U></B> In addition to the Receivables Purchased Amount, each Merchant will be held responsible to CEDAR for the following fees,
where applicable:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.
$<U>35,000.00</U> - to cover underwriting and the ACH debit program, as well as related expenses. This will be deducted from payment of
the Purchase Price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.Wire
Fee - Merchant(s) shall receive funding electronically to the Account and will be charged $50.00 for a Fed Wire or $0.00 for a bank
ACH. This will be deducted from payment of the Purchase Price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.
Blocked Account/Default - $2,500.00 - If CEDAR considers an Event of Default to have taken place under Section 34.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.
UCC Fee - $195.00 &ndash; to cover CEDAR filing a UCC-1 financing statement to secure its interest in the Receivables</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchased
Amount. A $195.00 UCC termination fee will be charged if a UCC filing is terminated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.Court
costs, arbitration fees, collection agency fees, attorney fees, expert fees, and any other expenses incurred in litigation, arbitration,
or the enforcement of any of CEDAR&rsquo;s legal or contractual rights against each Merchant and/or each Guarantor, if required, as explained
in other Sections of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>3.</U>&nbsp;<U>Cap
on Collection of the Receivables Purchased Amount.</U></B> The amount that CEDAR will collect from Merchant(s) towards the Receivables
Purchased Amount during any specific <U>WEEK</U> will be capped at $<U>44,970.00</U> (the &ldquo;Cap&rdquo;). If the Specified Percentage
of all Receivables for a specific <U>WEEK</U> is less than the Cap, then in addition to the Specified Percentage of Receivables for that
<U>WEEK </U>, CEDAR will be permitted to collect any Receivables it did not previously collect due to the Cap such that the total amount
collected during that <U>WEEK </U>does not exceed the Cap. The Cap is not applicable to make up for a business day on which CEDAR is
closed and does not ACH debit the Account, to subsequent attempts to collect a rejected or blocked ACH payment, or for the collection
of any of the fees listed in Section 2 or if any Event of Default listed in Section 34 is considered by CEDAR to have taken place.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>4.</U>&nbsp;<U>Reconciliations</U></B>.
Any Merchant may give written notice to CEDAR requesting that CEDAR conduct a reconciliation in order to ensure that the amount that
CEDAR has collected equals the Specified Percentage of Merchant(s)&rsquo;s Receivables under this Agreement. A reconciliation may also
be requested by e-mail to reconciliations@cedaradvance.com. Once, notified of a request for reconciliation, CEDAR will instruct it&rsquo;s
ACH processor to pause ACH debits from Merchant&rsquo;s account until the reconciliation process is complete. </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">If
such reconciliation determines that CEDAR collected more than it was entitled to, then CEDAR will credit to the Account all amounts to
which CEDAR was not entitled within three business days thereafter If such reconciliation determines that CEDAR collected less than it
was entitled to, then CEDAR will debit from the Account all additional amounts to which CEDAR was entitled within days thereafter. In
order to effectuate this reconciliation, any Merchant must produce with it&rsquo;s request any <FONT STYLE="font-size: 10pt">and all
bank statements and merchant statements covering the period from the date of this Agreement through the date of the request for a reconciliation.
CEDAR will complete each such reconciliation within two business days after receipt of a written request for one accompanied by the information
and documents required for it. Nothing herein limits the amount of times that such a reconciliation may be requested.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>5.</U>&nbsp;<U>Prepayments.</U></B>
Although there is no obligation to do so, any Merchant may prepay any amount towards the Receivables Purchased Amount. There will be
no penalty for any prepayment made by any Merchant. Any Merchant may elect to terminate this Agreement by prepaying CEDAR the amount
of the balance of the Receivables Purchased Amount at that time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="4" STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
    have read and agree to the terms and conditions set forth above:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 14%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 24%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="4" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    and Title: </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THOMAS
    EDWIN DYE JR</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">07/26/2022</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page
<B>3</B> of <B>16</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 25.8pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>STANDARD
MERCHANT CASH ADVANCE AGREEMENT</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>6.</U>&nbsp;<U>Merchant
Deposit Agreement.</U></B> Merchant(s) shall appoint a bank acceptable to CEDAR, to obtain electronic fund transfer services and/or &ldquo;ACH&rdquo;
payments. Merchant(s) shall provide CEDAR and/or its authorized agent with all of the information, authorizations, and passwords necessary
to verify each Merchant&rsquo;s Receivables. Merchant(s) shall authorize CEDAR and/or its agent(s) to deduct the amounts owed to CEDAR
for the Receivables as specified herein from settlement amounts which would otherwise be due to each Merchant and to pay such amounts
to CEDAR by permitting CEDAR to withdraw the Specified Percentage by ACH debiting of the account. The authorization shall be irrevocable
absent CEDAR&rsquo;s written consent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>7.</U>&nbsp;<U>Term
of Agreement.</U></B> The term of this Agreement is indefinite and shall continue until CEDAR receives the full Receivables Purchased
Amount, or earlier if terminated pursuant to any provision of this Agreement. The provisions of Sections 4, 6, 7, 8, 10, 11, 13, 14,
15, 17, 18, 19, 22, 23, 28, 31, 32, 33, 34, 35, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">48,
49, 50, 51, 52, 53, 54, 55, 56, 57, and 58 shall survive any termination of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>8.</U>&nbsp;<U>Ordinary
Course of Business.</U></B> Each Merchant acknowledges that it is entering into this Agreement in the ordinary course of its business
and that the payments to be made from each Merchant to CEDAR under this Agreement are being made in the ordinary course of each Merchant&rsquo;s
business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>9.</U>&nbsp;<U>Financial
Condition.</U></B> Each Merchant and each Guarantor (Guarantor being defined as each signatory to the Guarantee of this Agreement) authorizes
CEDAR and its agent(s) to investigate each Merchant&rsquo;s financial responsibility and history, and will provide to CEDAR any bank
or financial statements, tax returns, and other documents and records, as CEDAR deems necessary prior to or at any time after execution
of this Agreement. A photocopy of this authorization will be deemed as acceptable for release of financial information. CEDAR is authorized
to update such information and financial profiles from time to time as it deems appropriate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>10.&nbsp;Monitoring,
Recording, and Electronic Communications.</U></B> CEDAR may choose to monitor and/or record telephone calls with any Merchant and its
owners, employees, and agents. By signing this Agreement, each Merchant agrees that any call between CEDAR and any Merchant or its representatives
may be monitored and/or recorded. Each Merchant and each Guarantor grants access for CEDAR to enter any Merchant&rsquo;s premises and
to observe any Merchant&rsquo;s premises without any prior notice to any Merchant at any time after execution of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEDAR
may use automated telephone dialing, text messaging systems, and e-mail to provide messages to Merchant(s), Owner(s) (Owner being defined
as each person who signs this Agreement on behalf of a Merchant), and Guarantor(s) about Merchant(s)&rsquo;s account. Telephone messages
may be played by a machine automatically when the telephone is answered, whether answered by an Owner, a Guarantor, or someone else.
These messages may also be recorded by the recipient&rsquo;s answering machine or voice mail. Each Merchant, each Owner, and each Guarantor
gives CEDAR permission to call or send a text message to any telephone number given to CEDAR in connection with this Agreement and to
play pre-recorded messages and/or send text messages with information about this Agreement and/or any Merchant&rsquo;s account over the
phone. Each Merchant, each Owner, and each Guarantor also gives CEDAR permission to communicate such information to them by e-mail. Each
Merchant, each Owner, and each Guarantor agree that CEDAR will not be liable to any of them for any such calls or electronic communications,
even if information is communicated to an unintended recipient. Each Merchant, each Owner, and each Guarantor acknowledge that when they
receive such calls or electronic communications, they may incur a charge from the company that provides them with telecommunications,
wireless, and/or Internet services, and that CEDAR has no liability for any such charges.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>11.</U>&nbsp;<U>Accuracy
of Information Furnished by Merchant and Investigation Thereof.</U></B> To the extent set forth herein, each of the parties is obligated
upon his, her, or its execution of the Agreement to all terms of the Agreement. Each Merchant and each Owner signing this Agreement represent
that he or she is authorized to sign this Agreement for each Merchant, legally binding said Merchant to its obligations under this Agreement
and that the information provided herein and in all of CEDAR&rsquo;s documents, forms, and recorded interview(s) is true, accurate, and
complete in all respects. CEDAR may produce a monthly statement reflecting the delivery of the Specified Percentage of Receivables from
Merchant(s) to CEDAR. An investigative report may be made in connection with the Agreement. Each Merchant and each Owner signing this
Agreement authorize CEDAR, its agents and representatives, and any credit-reporting agency engaged by CEDAR, to (i) investigate any references
given or any other statements obtained from or about each Merchant or any of its Owners for the purpose of this Agreement, and (ii) pull
credit report at any time now or for so long as any Merchant and/or Owners(s) continue to have any obligation to CEDAR under this Agreement
or for CEDAR&rsquo;s ability to determine any Merchant&rsquo;s eligibility to enter into any future agreement with CEDAR. Any misrepresentation
made by any Merchant or Owner in connection with this Agreement may constitute a separate claim for fraud or intentional misrepresentation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="4" STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
    have read and agree to the terms and conditions set forth above:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 14%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 24%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="4" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    and Title: </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THOMAS
    EDWIN DYE JR</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">07/26/2022</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page
<B>4</B> of <B>16</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 25.8pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>STANDARD
MERCHANT CASH ADVANCE AGREEMENT</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Authorization
for soft pulls: </I>Each Merchant and each Owner understands that by signing this Agreement, they are providing &lsquo;written instructions&rsquo;
to CEDAR under the Fair Credit Reporting Act, authorizing CEDAR to obtain information from their personal credit profile or other information
from Experian, TransUnion, and Equifax. Each Merchant and each Guarantor authorizes CEDAR to obtain such information solely to conduct
a pre-qualification for credit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Authorization
for hard pulls:</I> Each Merchant and each Owner understands that by signing this Agreement, they are providing &lsquo;written instructions&rsquo;
to CEDAR under the Fair Credit Reporting Act, authorizing CEDAR to obtain information from their personal credit profile or other information
from Experian, TransUnion, and Equifax. Each Merchant and each Guarantor authorizes CEDAR to obtain such information in accordance with
a merchant cash advance application.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>12.&nbsp;Transactional
History.</U></B> Each Merchant authorizes its bank to provide CEDAR with its banking and/or credit card processing history.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>13.</U>&nbsp;<U>Indemnification.</U></B>
Each Merchant and each Guarantor jointly and severally indemnify and hold harmless each Merchant&rsquo;s credit card and check
processors (collectively, &ldquo;Processor&rdquo;) and Processor&rsquo;s officers, directors, and shareholders against all losses,
damages, claims, liabilities, and expenses (including reasonable attorney and expert fees) incurred by Processor resulting from (a)
claims asserted by CEDAR for monies owed to CEDAR from any Merchant and (b) actions taken by any Processor in reliance upon
information or instructions provided by CEDAR.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>14.</U>&nbsp;<U>No
Liability.</U></B> In no event will CEDAR be liable for any claims asserted by any Merchant under any legal theory for lost profits,
lost revenues, lost business opportunities, exemplary, punitive, special, incidental, indirect, or consequential damages, each of which
is waived by each Merchant and each Guarantor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>15.</U>&nbsp;<U>Sale
of Receivables.</U></B> Each Merchant and CEDAR agree that the Purchase Price under this Agreement is in exchange for the Receivables
Purchased Amount and that such Purchase Price is not intended to be, nor shall it be construed as a loan from CEDAR to any Merchant.
CEDAR is entering into this Agreement knowing the risks that each Merchant&rsquo;s business may decline or fail, resulting in CEDAR not
receiving the Receivables Purchased Amount. Each Merchant agrees that the Purchase Price in exchange for the Receivables pursuant to
this Agreement equals the fair market value of such Receivables. CEDAR has purchased and shall own all the Receivables described in this
Agreement up to the full Receivables Purchased Amount as the Receivables are created. Payments made to CEDAR in respect to the full amount
of the Receivables shall be conditioned upon each Merchant&rsquo;s sale of products and services and the payment therefor by each Merchant&rsquo;s
customers in the manner provided in this Agreement. Although certain jurisdictions require the disclosure of an Annual Percentage Rate
or APR in connection with this Agreement, those disclosures do not change the fact that the transaction encompassed by this Agreement
is not a loan and does not have an interest rate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>16.</U>&nbsp;<U>Power
of Attorney.</U></B> Each Merchant irrevocably appoints CEDAR as its agent and attorney-in-fact with full authority to take any action
or execute any instrument or document to settle all obligations due to CEDAR, or, if CEDAR considers an Event of Default to have taken
place under Section 34, to settle all obligations due to CEDAR from each Merchant, including without limitation (i) to obtain and adjust
insurance; (ii) to collect monies due or to become due under or in respect of any of the Collateral (which is defined in Section 33);
(iii) to receive, endorse and collect any checks, notes, drafts, instruments, documents, or chattel paper in connection with clause (i)
or clause (ii) above; (iv) to sign each Merchant&rsquo;s name on any invoice, bill of lading, or assignment directing customers or account
debtors to make payment directly to CEDAR; and (v) to file any claims or take any action or institute any proceeding which CEDAR may
deem necessary for the collection of any of the unpaid Receivables Purchased Amount from the Collateral, or otherwise to enforce its
rights with respect to payment of the Receivables Purchased Amount.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="4" STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
    have read and agree to the terms and conditions set forth above:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 14%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 24%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="4" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    and Title: </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THOMAS
    EDWIN DYE JR</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">07/26/2022</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page
<B>5</B> of <B>16</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 25.8pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>STANDARD
MERCHANT CASH ADVANCE AGREEMENT</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>17.</U>&nbsp;<U>Protections
Against Default.</U></B> The following Protections 1 through 7 may be invoked by CEDAR, immediately and without notice to any Merchant
in the event:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 35.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)Any
Merchant takes any action to discourage the use of methods of payment ordinarily and customarily used by its customers or permits any
event to occur that could have an adverse effect on the use, acceptance, or authorization of checks and credit cards for the purchase
of any Merchant&rsquo;s services and products;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 35.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 35.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Any Merchant changes its arrangements with any Processor in any way that is adverse to CEDAR;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 35.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 35.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)Any
Merchant changes any Processor through which the Receivables are settled to another electronic check and/or credit card processor or
permits any event to occur that could cause diversion of any Merchant&rsquo;s check and/or credit card transactions to another such processor;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 35.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 35.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)Any
Merchant interrupts the operation of its business (other than adverse weather, natural disasters, or acts of God) or transfers, moves,
sells, disposes, or otherwise conveys its business or assets without (i) the express prior written consent of CEDAR and (ii) the written
agreement of any purchaser or transferee to the assumption of all of any Merchant&rsquo;s obligations under this Agreement pursuant to
documentation satisfactory to CEDAR; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 35.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 35.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)Any
Merchant takes any action, fails to take any action, or offers any incentive&mdash;economic or otherwise&mdash;the result of which will
be to induce any customer or customers to pay for any Merchant&rsquo;s goods or services with any means other than checks and/or credit
cards that are settled through Processor. These protections are in addition to any other remedies available to CEDAR at law, in equity,
or otherwise available pursuant to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 35.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 35.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
CEDAR considers any Event of Default listed in Section 34 to have taken place.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 35.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 35.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Protection
1: The full uncollected Receivables Purchased Amount plus all fees due under this Agreement may become due and payable in full immediately.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 35.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 35.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Protection
2. CEDAR may enforce the provisions of the Guarantee against Guarantor. Protection 3. CEDAR may enforce its security interest in the
Collateral identified in Section 33.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 60.95pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 35.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Protection
4. CEDAR may proceed to protect and enforce its rights and remedies by litigation or arbitration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 60.95pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 35.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Protection
5. If requested by CEDAR, Merchant shall deliver to CEDAR an executed assignment of lease of each Merchant&rsquo;s premises in favor
of CEDAR. Upon breach of any provision in this Section 17, CEDAR may exercise its rights under such assignment of lease.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 24.85pt; text-align: justify; text-indent: 35.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 35.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Protection
6. CEDAR may debit any Merchant&rsquo;s depository accounts wherever situated by means of ACH debit or electronic or facsimile signature
on a computer-generated check drawn on any Merchant&rsquo;s bank account or otherwise, in an amount consistent with the terms of this
Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 24.85pt; text-align: justify; text-indent: 35.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 35.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Protection
7. CEDAR will have the right, without waiving any of its rights and remedies and without notice to any Merchant and/or Guarantor, to
notify each Merchant&rsquo;s credit card and/or check processor of the sale of Receivables hereunder and to direct such credit card processor
to make payment to CEDAR of all or any portion of the amounts received by such credit card processor on behalf of each Merchant. Each
Merchant hereby grants to CEDAR an irrevocable power- of-attorney, which power-of-attorney will be coupled with an interest, and hereby
appoints CEDAR and its representatives as each Merchant&rsquo;s attorney-in-fact to take any and all action necessary to direct such
new or additional credit card and/or check processor to make payment to CEDAR as contemplated by this Section.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>18.</U>&nbsp;<U>Protection
of Information.</U></B> Each Merchant and each person signing this Agreement on behalf of each Merchant and/or as Owner, in respect of
himself or herself personally, authorizes CEDAR to disclose information concerning each Merchant, Owner and/or Guarantor&rsquo;s credit
standing and business conduct to agents, affiliates, subsidiaries, and credit reporting bureaus. Each Merchant, Guarantor, and Owner
hereby waives to the maximum extent permitted by law any claim for damages against CEDAR or any of its affiliates relating to any (i)
investigation undertaken by or on behalf of CEDAR as permitted by this Agreement or (ii) disclosure of information as permitted by this
Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>19.</U>&nbsp;<U>Confidentiality.</U></B>
Each Merchant understands and agrees that the terms and conditions of the products and services offered by CEDAR, including this
Agreement and any other CEDAR documents (collectively, &ldquo;Confidential Information&rdquo;) are proprietary and confidential
information of CEDAR. Accordingly, unless disclosure is required by law or court order, Merchant(s) shall not disclose Confidential
Information of CEDAR to any person other than an attorney, accountant, financial advisor, or employee of any Merchant who needs to
know such information for the purpose of advising any Merchant (&ldquo;Advisor&rdquo;), provided such Advisor uses such information
solely for the purpose of advising any Merchant and first agrees in writing to be bound by the terms of this Section 19.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>20.</U>&nbsp;<U>D/B/As.</U></B>
Each Merchant hereby acknowledges and agrees that CEDAR may be using &ldquo;doing business as&rdquo; or &ldquo;d/b/a&rdquo; names in
connection with various matters relating to the transaction between CEDAR and each Merchant, including the filing of UCC-1 financing
statements and other notices or filings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="4" STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
    have read and agree to the terms and conditions set forth above:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 14%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 24%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="4" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    and Title: </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THOMAS
    EDWIN DYE JR</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">07/26/2022</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page
<B>6</B> of <B>16</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 25.8pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>STANDARD
MERCHANT CASH ADVANCE AGREEMENT</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>21.</U>&nbsp;<U>Financial
Condition and Financial Information.</U></B> Each Merchant represents, warrants, and covenants that its bank and financial statements,
copies of which have been furnished to CEDAR, and future statements which will be furnished hereafter at the request of CEDAR, fairly
represent the financial condition of each Merchant at such dates, and that since those dates there have been no material adverse changes,
financial or otherwise, in such condition, operation, or ownership of any Merchant. Each Merchant has a continuing affirmative obligation
to advise CEDAR of any material adverse change in its financial condition, operation, or ownership.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>22.</U>&nbsp;<U>Governmental
Approvals.</U></B> Each Merchant represents, warrants, and covenants that it is in compliance and shall comply with all laws and has
valid permits, authorizations, and licenses to own, operate, and lease its properties and to conduct the business in which it is presently
engaged.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>23.</U>&nbsp;<U>Authorization.</U></B>
Each Merchant represents, warrants, and covenants that it and each person signing this Agreement on behalf of each Merchant has full
power and authority to incur and perform the obligations under this Agreement, all of which have been duly authorized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>24.</U>&nbsp;<U>Insurance.</U></B>
Each Merchant represents, warrants, and covenants that it will maintain business-interruption insurance naming CEDAR as loss payee
and additional insured in amounts and against risks as are satisfactory to CEDAR and shall provide CEDAR proof of such insurance
upon request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>25.</U>&nbsp;<U>Electronic
Check Processing Agreement.</U></B> Each Merchant represents, warrants, and covenants that it will not, without CEDAR&rsquo;s prior written
consent, change its Processor, add terminals, change its financial institution or bank account, or take any other action that could have
any adverse effect upon any Merchant&rsquo;s obligations under this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>26.</U>&nbsp;<U>Change
of Name or Location.</U></B> Each Merchant represents, warrants, and covenants that it will not conduct its business under any name other
than as disclosed to CEDAR or change any place(s) of its business without prior written consent from CEDAR.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>27.</U>&nbsp;<U>Estoppel
Certificate.</U></B> Each Merchant represents, warrants, and covenants that it will, at any time, and from time to time, upon at least
two day&rsquo;s prior notice from CEDAR to that Merchant, execute, acknowledge, and deliver to CEDAR and/or to any other person or entity
specified by CEDAR, a statement certifying that this Agreement is unmodified and in full force and effect (or, if there have been modifications,
that the same is in full force and effect as modified and stating the modifications) and stating the dates which the Receivables Purchased
Amount or any portion thereof have been paid.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>28.</U>&nbsp;<U>No
Bankruptcy.</U></B> Each Merchant represents, warrants, and covenants that as of the date of this Agreement, it does not contemplate
and has not filed any petition for bankruptcy protection under Title 11 of the United States Code and there has been no involuntary petition
brought or pending against any Merchant. Each Merchant further warrants that it does not anticipate filing any such bankruptcy petition
and it does not anticipate that an involuntary petition will be filed against it. Each Merchant further warrants that there will be no
statutory presumption that it would have been insolvent on the date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>29.</U>&nbsp;<U>Unencumbered
Receivables.</U></B> Each Merchant represents, warrants, and covenants that it has good, complete, and marketable title to all Receivables,
free and clear of any and all liabilities, liens, claims, changes, restrictions, conditions, options, rights, mortgages, security interests,
equities, pledges, and encumbrances of any kind or nature whatsoever or any other rights or interests that may be inconsistent with this
Agreement or adverse to the interests of CEDAR, other than any for which CEDAR has actual or constructive knowledge as of the date of
this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>30.</U>&nbsp;<U>Stacking.</U></B>
Each Merchant represents, warrants, and covenants that it will not enter into with any party other than CEDAR any arrangement,
agreement, or commitment that relates to or involves the Receivables, whether in the form of a purchase of, a loan against,
collateral against, or the sale or purchase of credits against Receivables without the prior written consent of CEDAR.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="4" STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
    have read and agree to the terms and conditions set forth above:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 14%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 24%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="4" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    and Title: </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THOMAS
    EDWIN DYE JR</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">07/26/2022</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page
<B>7</B> of <B>16</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 25.8pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>STANDARD
MERCHANT CASH ADVANCE AGREEMENT</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>31.</U>&nbsp;<U>Business
Purpose.</U></B> Each Merchant represents, warrants, and covenants that it is a valid business in good standing under the laws of the
jurisdictions in which it is organized and/or operates, and each Merchant is entering into this Agreement for business purposes and not
as a consumer for personal, family, or household purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>32.</U>&nbsp;<U>Default
Under Other Contracts.</U></B> Each Merchant represents, warrants, and covenants that its execution of and/or performance under this
Agreement will not cause or create an event of default by any Merchant under any contract with another person or entity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>33.</U>&nbsp;<U>Security
Interest.</U></B> To secure each Merchant&rsquo;s payment and performance obligations to CEDAR under this Agreement and any future agreement
with CEDAR, each Merchant hereby grants to CEDAR a security interest in collateral (the &ldquo;Collateral&rdquo;), that is defined as
collectively: (a) all accounts, including without limitation, all deposit accounts, accounts- receivable, and other receivables, chattel
paper, documents, equipment, instruments, and inventory, as those terms are defined by Article 9 of the Uniform Commercial Code (the
&ldquo;UCC&rdquo;), now or hereafter owned or acquired by any Merchant; and (b) all proceeds, as that term is defined by Article 9 of
the UCC. The parties acknowledge and agree that any security interest granted to CEDAR under any other agreement between any Merchant
or Guarantor and CEDAR (the &ldquo;Cross-Collateral&rdquo;) will secure the obligations hereunder and under this Agreement. Negative
Pledge: Each Merchant agrees not to create, incur, assume, or permit to exist, directly or indirectly, any lien on or with respect to
any of the Collateral or the Cross-Collateral, as applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Merchant agrees to execute any documents or take any action in connection with this Agreement as CEDAR deems necessary to perfect or
maintain CEDAR&rsquo;s first priority security interest in the Collateral and the Cross-Collateral, including the execution of any account
control agreements. Each Merchant hereby authorizes CEDAR to file any financing statements deemed necessary by CEDAR to perfect or maintain
CEDAR&rsquo;s security interest, which financing statements may contain notification that each Merchant has granted a negative pledge
to CEDAR with respect to the Collateral and the Cross-Collateral, and that any subsequent lienor may be tortiously interfering with CEDAR&rsquo;s
rights. Each Merchant shall be liable for and CEDAR may charge and collect all costs and expenses, including but not limited to attorney
fees, which may be incurred by CEDAR in protecting, preserving, and enforcing CEDAR&rsquo;s security interest and rights. Each Merchant
further acknowledges that CEDAR may use another legal name and/or D/B/A or an agent when designating the Secured Party when CEDAR files
the above-referenced financing statement(s).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>34.
Events of Default.</U></B> An &ldquo;Event of Default&rdquo; may be considered to have taken place if any of the following occur:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
Any Merchant violates any term or covenant in this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Any representation or warranty by any Merchant in any Agreement with CEDAR that has not been terminated proves to have been incorrect,
false, or misleading in any material respect when made;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
Any Merchant fails to provide CEDAR with written notice of any material change in its financial condition, operation, or ownership within
seven days thereafter (unless a different notice period is specifically provided for elsewhere in this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
the sending of notice of termination by any Merchant or Guarantor;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)
Any Merchant transports, moves, interrupts, suspends, dissolves, or terminates its business without the prior written consent of CEDAR
other than a bankruptcy filing;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)
Any Merchant transfers or sells all or substantially all of its assets without the prior written consent of CEDAR;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)
Any Merchant makes or sends notice of any intended bulk sale or transfer by any Merchant without the prior written consent of CEDAR;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)
Any Merchant uses multiple depository accounts without the prior written consent of CEDAR;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)
Any Merchant changes the Account without the prior written consent of CEDAR;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10)
CEDAR is not provided with updated login or password information for the Account within one business day after any such change is made
by any Merchant;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11)
Any Merchant fails to send bank statements, merchant account statements, or bank login information for the Account within two business
days after a written request for same is made by CEDAR;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(12)
Any Merchant performs any act that reduces the value of any Collateral granted under this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(13)
Any Merchant fails to deposit its Receivables into the Account;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="4" STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
    have read and agree to the terms and conditions set forth above:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 14%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 24%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="4" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    and Title: </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THOMAS
    EDWIN DYE JR</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">07/26/2022</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page
<B>8</B> of <B>16</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 25.8pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>STANDARD
MERCHANT CASH ADVANCE AGREEMENT</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14)
Any Merchant causes any ACH debit to the Account by CEDAR to be blocked or stopped without providing any advance written notice to CEDAR,
which notice may be given by e-mail to reconciliations@cedaradvance.com; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(15)
Any Merchant prevents CEDAR from collecting any part of the Receivables Purchased Amount;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(16)
Any Merchant causes any ACH debit to the Account to be stopped or otherwise returned that would result in an ACH Return Code of R08,
R10, or R29 and that Merchant does not within two business days thereafter provide CEDAR with written notice thereof explaining why that
Merchant caused the ACH debit to be stopped or otherwise returned, which notice may be given by e-mail to reconciliations@cedaradvance.com;
or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(17)
Any Merchant defaults under any of the terms, covenants, and conditions of any other agreement with CEDAR.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>35.</U>&nbsp;<U>Remedies.</U></B>
In case any Event of Default occurs and is not waived, CEDAR may proceed to protect and enforce its rights or remedies by suit in
equity or by action at law, or both, whether for the specific performance of any covenant, agreement, or other provision contained
herein, or to enforce the discharge of each Merchant&rsquo;s obligations hereunder, or any other legal or equitable right or remedy.
All rights, powers, and remedies of CEDAR in connection with this Agreement, including each Protection listed in Section 17, may be
exercised at any time by CEDAR after the occurrence of an Event of Default, are cumulative and not exclusive, and will be in
addition to any other rights, powers, or remedies provided by law or equity. In addition to the foregoing, in case any Event of
Default occurs and is not waived, CEDAR will be entitled to the issuance of an injunction, restraining order, or other equitable
relief in CEDAR&rsquo;s favor, subject to court or arbitrator approval, restraining each Merchant&rsquo;s accounts and/or
receivables up to the amount due to CEDAR as a result of the Event of Default, and each Merchant will be deemed to have consented to
the granting of an application for the same to any court or arbitral tribunal of competent jurisdiction without any prior notice to
any Merchant or Guarantor and without CEDAR being required to furnish a bond or other undertaking in connection with the
application.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>36.</U>&nbsp;<U>Required
Notifications.</U></B> Each Merchant is required to give CEDAR written notice at least one day prior to any filing under Title 11 of
the United States Code. Merchant(s) are required to give CEDAR at least seven days&rsquo; written notice prior to the closing of any
sale of all or substantially all of any Merchant&rsquo;s assets or stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>37.</U>&nbsp;<U>Assignment.</U></B>
This Agreement shall be binding upon and inure to the benefit of the parties and their respective successors and assigns, except
that Merchant(s) shall not have the right to assign its rights hereunder or any interest herein without the prior written consent of
CEDAR, which consent may be withheld in CEDAR&rsquo;s sole discretion. CEDAR may assign, transfer, or sell its rights under this
Agreement, including, without limitation, its rights to receive the Receivables Purchased Amount, and its rights under Section 33 of
this Agreement, the Guarantee, and any other agreement, instrument, or document executed in connection with the transactions
contemplated by this Agreement (a &ldquo;Related Agreement&rdquo;), or delegate its duties hereunder or thereunder, either in whole
or in part. From and after the effective date of any such assignment or transfer by CEDAR, whether or not any Merchant has actual
notice thereof, this Agreement and each Related Agreement shall be deemed amended and modified (without the need for any further
action on the part of any Merchant or CEDAR) such that the assignee shall be deemed a party to this Agreement and any such Related
Agreement and, to the extent provided in the assignment document between CEDAR and such assignee (the &ldquo;Assignment
Agreement&rdquo;), have the rights and obligations of CEDAR under this Agreement and such Related Agreements with respect to the
portion of the Receivables Purchased Amount set forth in such Assignment Agreement, including but not limited to rights in the
Receivables, Collateral and Additional Collateral, the benefit of each Guarantor&rsquo;s guaranty regarding the full and prompt
performance of every obligation that is a subject of the Guarantee, CEDAR&rsquo;s rights under Section 17 of this Agreement
(Protections Against Default), and to receive damages from any Merchant following a breach of this Agreement by any Merchant. In
connection with such assignment, CEDAR may disclose all information that CEDAR has relating to any Merchant or its business. Each
Merchant agrees to acknowledge any such assignment in writing upon CEDAR&rsquo;s request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>38.</U>&nbsp;<U>Notices.</U></B>
All notices, requests, consents, demands, and other communications hereunder shall be delivered by certified mail, return receipt
requested, or by overnight delivery with signature confirmation to the respective parties to this Agreement at their addresses set
forth in this Agreement and shall become effective only upon receipt. Written notice may also be given to any Merchant or Guarantor
by e-mail to the E-mail Address listed on the first page of this Agreement. Each Merchant must set its spam or junk mail filter to
accept e-mails sent by reconciliations@cedaradvance.com and its domain. This Section is not applicable to service of process or
notices in any legal proceedings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="4" STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
    have read and agree to the terms and conditions set forth above:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 14%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 24%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="4" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    and Title: </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THOMAS
    EDWIN DYE JR</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">07/26/2022</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 240.95pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page
<B>9</B> of <B>16</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 25.8pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>STANDARD
MERCHANT CASH ADVANCE AGREEMENT</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>39.</U>&nbsp;<U>Choice
of Law.</U></B> Each Merchant acknowledges and agrees that this Agreement was made in the State of New </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">York,
that the Purchase Price is being paid by CEDAR in the State of New York, that the Receivables Purchased Amount is being delivered to
CEDAR in the State of New York, and that the State of New York has a reasonable relationship to the transactions encompassed by this
Agreement. This Agreement and the relationship between CEDAR, each Merchant, and each Guarantor will be governed by and construed in
accordance with the laws of the State of New York, without regard to any applicable principles of conflict of laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>40.</U>&nbsp;<U>Forum
and Venue Selection.</U></B> Any litigation relating to this Agreement or involving CEDAR on one side and any Merchant or any Guarantor
on the other must be commenced and maintained in any court located in the Counties of Nassau, New York, or Sullivan in the State of New
York (the &ldquo;Acceptable Forums&rdquo;). The parties agree that the Acceptable Forums are convenient, submit to the jurisdiction of
the Acceptable Forums, and waive any and all objections to the jurisdiction or venue of the Acceptable Forums. If any litigation is initiated
in any other venue or forum, the parties waive any right to oppose any motion or application made by any party to transfer such litigation
to an Acceptable Forum. The parties agree that this Agreement encompasses the transaction of business within the City of New York and
that the Civil Court of the City of New York (&ldquo;Civil Court&rdquo;) will have jurisdiction over any litigation relating to this
Agreement that is within the jurisdictional limit of the Civil Court. In addition to the Acceptable Forums, any action or proceeding
to enforce a judgment or arbitration award against any Merchant or Guarantor or to restrain or collect any amount due to CEDAR may be
commenced and maintained in any other court of competent jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>41.</U>&nbsp;<U>Jury
Waiver.</U></B> The parties agree to waive trial by jury in any dispute between them.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>42.</U>&nbsp;<U>Counterclaim
Waiver.</U></B> In any litigation or arbitration commenced by CEDAR, each Merchant and each Guarantor will not be permitted to interpose
any counterclaim.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>43.</U>&nbsp;<U>Statutes
of Limitations.</U></B> Each Merchant and each Guarantor agree that any claim that is not asserted against CEDAR within one year of its
accrual will be time barred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>44.</U>&nbsp;<U>Costs.</U></B>
Each Merchant and each Guarantor must pay all of CEDAR&rsquo;s reasonable costs associated with a breach by any Merchant of the
covenants in this Agreement and the enforcement thereof, including but not limited to collection agency fees, attorney fees, which
may include a contingency fee of up to 40% of the amount claimed, expert witness fees, and costs of suit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>45.</U>&nbsp;<U>Prejudgment
and Postjudgment Interest.</U></B> If CEDAR becomes entitled to the entry of a judgment against any Merchant or any Guarantor, then CEDAR
will be entitled to the recovery of prejudgment interest at a rate of 24% per annum (or 16% per annum if any Merchant is a sole proprietorship),
or the maximum rate permitted by applicable law if less, and upon entry of any such judgment, it will accrue interest at a postjudgment
rate of 24% per annum (or 16% per annum if any Merchant is a sole proprietorship), or the maximum rate permitted by applicable law if
less, which rate will govern over the statutory rate of interest up until actual satisfaction of the judgment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>46.</U>&nbsp;<U>Legal
Fees.</U></B> If CEDAR prevails in any litigation or arbitration with any Merchant or any Guarantor, then that Merchant and/or Guarantor
must pay CEDAR&rsquo;s reasonable attorney fees, which may include a contingency fee of up to 40% of the amount claimed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>47.</U>&nbsp;<U>Class
Action Waiver.</U></B> CEDAR, each Merchant, and each Guarantor agree that they may bring claims against each other relating to this
Agreement only in their individual capacities, and not as a plaintiff or class action member in any purported class or representative
proceedings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="4" STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
    have read and agree to the terms and conditions set forth above:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 14%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 24%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="4" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    and Title: </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THOMAS
    EDWIN DYE JR</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">07/26/2022</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page
<B>10</B> of <B>16</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 25.8pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">STANDARD
MERCHANT CASH ADVANCE AGREEMENT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>48.</U>&nbsp;<U>Arbitration.</U></B>
Any action or dispute relating to this Agreement or involving CEDAR on one side and any Merchant or any Guarantor on the other,
including, but not limited to issues of arbitrability, will, at the option of any party to such action or dispute, be determined by
arbitration before a single arbitrator. The arbitration will be administered either by Arbitration Services, Inc. under its
Commercial Arbitration Rules as are in effect at that time, which rules are available at www.arbitrationservicesinc.com, or by
Mediation &amp; Commercial Arbitration, Inc. under its Commercial Arbitration Rules as are in effect at that time, which rules are
available at www.mcarbitration.org. Once an arbitration is initiated with one of these arbitral forums, it must be maintained
exclusively before that arbitral forum and the other arbitral forum specified herein may </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">not
be used. Any arbitration relating to this Agreement must be conducted in the Counties of Nassau, New York, Queens, or Kings in the
State of New York. Notwithstanding any provision of any applicable arbitration rules, any witness in an arbitration who does not
reside in or have a place for the regular transaction of business located in New York City or the Counties of Nassau, Suffolk, or
Westchester in the State of New York will be permitted to appear and testify remotely by telephone or video conferencing. In case
any Event of Default occurs and is not waived, each Merchant and each Guarantor consents to CEDAR making an application to the
arbitrator, without notice to any Merchant or any Guarantor, for the issuance of an injunction, restraining order, or other
equitable relief in CEDAR&rsquo;s favor, subject to court or arbitrator approval, restraining each Merchant&rsquo;s accounts and/or
receivables up to the amount due to CEDAR as a result of the Event of Default. Each Merchant acknowledges and agrees that this
Agreement is the product of communications conducted by telephone and the Internet, which are instrumentalities of interstate
commerce, that the transactions contemplated under this Agreement will be made by wire transfer and ACH, which are also
instrumentalities of interstate commerce, and that this Agreement therefore evidences a transaction affecting interstate commerce.
Accordingly, notwithstanding any provision in this Agreement to the contrary, all matters of arbitration relating to this Agreement
will be governed by and construed in accordance with the provisions of the Federal Arbitration Act, codified as Title 9 of the
United States Code, however any application for injunctive relief in aid of arbitration or to confirm an arbitration award may be
made under Article 75 of the New York Civil Practice Law and Rules. The arbitration agreement contained in this Section may also be
enforced by any</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">employee,
agent, attorney, member, manager, officer, subsidiary, affiliate entity, successor, or assign of CEDAR.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>49.</U>&nbsp;<U>Service
of Process.</U></B> Each Merchant and each Guarantor consent to service of process and legal notices made by First Class or Priority
Mail delivered by the United States Postal Service and addressed to the Contact Address set forth on the first page of this Agreement
or any other address(es) provided in writing to CEDAR by any Merchant or any Guarantor, and unless applicable law or rules provide otherwise,
any such service will be deemed complete upon dispatch. Each Merchant and each Guarantor agrees that it will be precluded from asserting
that it did not receive service of process or any other notice mailed to the Contact Address set forth on the first page of this Agreement
if it does not furnish a certified mail return receipt signed by CEDAR demonstrating that CEDAR was provided with notice of a change
in the Contact Address.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>50.</U>&nbsp;<U>Survival
of Representation, etc.</U></B> All representations, warranties, and covenants herein shall survive the execution and delivery of this
Agreement and shall continue in full force until all obligations under this Agreement shall have been satisfied in full and this Agreement
shall have terminated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>51.</U>&nbsp;<U>Waiver.</U></B>
No failure on the part of CEDAR to exercise, and no delay in exercising, any right under this Agreement, shall operate as a waiver
thereof, nor shall any single or partial exercise of any right under this Agreement preclude any other or further exercise thereof
or the exercise of any other right. The remedies provided hereunder are cumulative and not exclusive of any remedies provided by law
or equity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>52.</U>&nbsp;<U>Independent
Sales Organizations/Brokers.</U></B> Each Merchant and each Guarantor acknowledge that it may have been introduced to CEDAR by or received
assistance in entering into this Agreement or its Guarantee from an independent sales organization or broker (&ldquo;ISO&rdquo;). Each
Merchant and each Guarantor agree that any ISO is separate from and is not an agent or representative of CEDAR. Each Merchant and each
Guarantor acknowledge that CEDAR is not bound by any promises or agreements made by any ISO that are not contained within this Agreement.
Each Merchant and each Guarantor exculpate from liability and agree to hold harmless and indemnify CEDAR and its officers, directors,
members, shareholders, employees, and agents from and against all losses, damages, claims, liabilities, and expenses (including reasonable
attorney and expert fees) incurred by any Merchant or any Guarantor resulting from any act or omission by any ISO. Each Merchant and
each Guarantor acknowledge that any fee that they paid to any ISO for its services is separate and apart from any payment under this
Agreement. Each Merchant and each Guarantor acknowledge that CEDAR does not in any way require the use of an ISO and that any fees charged
by any ISO are not required as a condition or incident to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>53.</U>&nbsp;<U>Modifications;
Agreements.</U></B> No modification, amendment, waiver, or consent of any provision of this Agreement shall be effective unless the same
shall be in writing and signed by all parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="4" STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
    have read and agree to the terms and conditions set forth above:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 14%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 24%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="4" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    and Title: </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THOMAS
    EDWIN DYE JR</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">07/26/2022</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page
<B>11</B> of <B>16</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 25.8pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>STANDARD
MERCHANT CASH ADVANCE AGREEMENT</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>54.</U>&nbsp;<U>Severability.</U></B>
If any provision of this Agreement is deemed invalid or unenforceable as written, it will be construed, to the greatest extent
possible, in a manner which will render it valid and enforceable, and any limitation on the scope or duration of any such provision
necessary to make it valid and enforceable will be deemed to be part thereof. If any provision of this Agreement is deemed void, all
other provisions will remain in effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>55.</U>&nbsp;<U>Headings.</U></B>
Headings of the various articles and/or sections of this Agreement are for convenience only and do not necessarily define, limit,
describe, or construe the contents of such articles or sections.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>56.</U>&nbsp;<U>Attorney
Review.</U></B> Each Merchant acknowledges that it has had an opportunity to review this Agreement and all addenda with counsel of its
choosing before signing the documents or has chosen not to avail itself of the opportunity to do so.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>57.</U>&nbsp;<U>Entire
Agreement.</U></B> This Agreement, inclusive of all addenda, if any, executed simultaneously herewith constitutes the full understanding
of the parties to the transaction herein and may not be amended, modified, or canceled except in writing signed by all parties. Should
there arise any conflict between this Agreement and any other document preceding it, this Agreement will govern. This Agreement does
not affect any previous agreement between the parties unless such an agreement is specifically referenced herein. This Agreement will
not be affected by any subsequent agreement between the parties unless this Agreement is specifically referenced therein. CEDAR will
not be permitted to enforce any of its rights under this Agreement if so expressed by in writing by Gene Rosen&rsquo;s Law Firm.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>58.</U>&nbsp;<U>Counterparts;
Fax and Electronic Signatures.</U></B> This Agreement may be executed electronically and in counterparts. Facsimile and electronic copies
of this Agreement will have the full force and effect of an original.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EACH
UNDERSIGNED HEREBY ACCEPTS THE TERMS OF THIS AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="4" STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">FOR
    THE MERCHANT/OWNER (#1)</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THOMAS
    EDWIN DYE JR</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Print
    Name and Title)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Signature)</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SS#
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">###-##-####</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Driver
    License Number ______________________________</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="4" STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
    THE MERCHANT/OWNER (#2)</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Print
    Name and Title)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Signature)</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SS#
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Driver
    License Number ______________________________</FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approved
for CEDAR ADVANCE LLC by: ________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page
<B>12</B> of <B>16</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 25.8pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>STANDARD
MERCHANT CASH ADVANCE AGREEMENT</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>GUARANTEE</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>G1.
Personal Guarantee of Performance.</U></B> <STRIKE>This is a personal guaranty of performance, dated 07/26/2022 , of the Standard Merchant
Cash Advance Agreement, dated 07/26/2022 (&ldquo;Agreement&rdquo;), inclusive of all addenda, if any, executed simultaneously therewith,
by and between CEDAR ADVANCE LLC (&ldquo;CEDAR&rdquo;) and SLINGER BAG AMERICAS INC / SLINGER BAG INC / CONNEXA SPORTS TECHNOLOGIES INC
(&ldquo;Merchant&rdquo;). Each undersigned Guarantor hereby guarantees each Merchant&rsquo;s performance of all of the representations,
warranties, and covenants made by each Merchant to CEDAR in the Agreement, inclusive of all addenda, if any, executed simultaneously
herewith, as the Agreement may be renewed, amended, extended, or otherwise modified (the &ldquo;Guaranteed Obligations&rdquo;). Each
Guarantor&rsquo;s obligations are due at the time of any breach by any Merchant of any representation, warranty, or covenant made by
any Merchant in the Agreement.</STRIKE></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><STRIKE>G2.
Communications.</STRIKE></B><STRIKE> CEDAR may use automated telephone dialing, text messaging systems, and e-mail to provide messages
to Guarantor(s) about Merchant(s)&rsquo;s account. Telephone messages may be played by a machine automatically when the telephone is
answered, whether answered by an Owner, a Guarantor, or someone else. These messages may also be recorded by the recipient&rsquo;s answering
machine or voice mail. Each Guarantor gives CEDAR permission to call or send a text message to any telephone number given to CEDAR in
connection with this Agreement and to play pre-recorded messages and/or send text messages with information about this Agreement and/or
any Merchant&rsquo;s account over the phone. Each Guarantor also gives CEDAR permission to communicate such information to them by e-
mail. Each Guarantor agrees that CEDAR will not be liable to any of them for any such calls or electronic communications, even if information
is communicated to an unintended recipient. Each Guarantor acknowledges that when they receive such calls or electronic communications,
they may incur a charge from the company that provides them with telecommunications, wireless, and/or Internet services, and that CEDAR
has no liability for any such charges.</STRIKE></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><STRIKE>G3.
Guarantor Waivers.</STRIKE></B><STRIKE> If CEDAR considers any Event of Default to have taken place under the Agreement, then CEDAR may
enforce its rights under this Guarantee without first seeking to obtain payment from any Merchant, any other guarantor, or any Collateral,
Additional Collateral, or Cross-Collateral CEDAR may hold pursuant to this Guarantee or any other agreement or guarantee. CEDAR does
not have to notify any Guarantor of any of the following events and Guarantor(s) will not be released from its obligations under this
Guarantee even if it is not notified of: (i) any Merchant&rsquo;s failure to pay timely any amount owed under the Agreement; (ii) any
adverse change in any Merchant&rsquo;s financial condition or business; (iii) any sale or other disposition of any collateral securing
the Guaranteed Obligations or any other guarantee of the Guaranteed Obligations; (iv) CEDAR&rsquo;s acceptance of the Agreement with
any Merchant; and (v) any renewal, extension, or other modification of the Agreement or any Merchant&rsquo;s other obligations to CEDAR.
In addition, CEDAR may take any of the following actions without releasing any Guarantor from any obligations under this Guarantee: (i)
renew, extend, or otherwise modify the Agreement or any Merchant&rsquo;s other obligations to CEDAR; (ii) if there is more than one Merchant,
release a Merchant from its obligations to CEDAR such that at least one Merchant remains obligated to CEDAR; (iii) sell, release, impair,
waive, or otherwise fail to realize upon any collateral securing the Guaranteed Obligations or any other guarantee of the Guaranteed
Obligations; and (iv) foreclose on any collateral securing the Guaranteed Obligations or any other guarantee of the Guaranteed Obligations
in a manner that impairs or precludes the right of Guarantor to obtain reimbursement for payment under the Agreement. Until the Receivables
Purchased Amount and each Merchant&rsquo;s other obligations to CEDAR under the Agreement and this Guarantee are paid in full, each Guarantor
shall not seek reimbursement from any Merchant or any other guarantor for any amounts paid by it under the Agreement. Each Guarantor
permanently waives and shall not seek to exercise any of the following rights that it may have against any Merchant, any other guarantor,
or any collateral provided by any Merchant or any other guarantor, for any amounts paid by it or acts performed by it under this Guarantee:
(i) subrogation; (ii) reimbursement; (iii) performance; (iv) indemnification; or (v) contribution.</STRIKE></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><STRIKE>G4.
Joint and Several Liability.</STRIKE></B><STRIKE> The obligations hereunder of the persons or entities constituting each Guarantor under
this Guarantee are joint and several.</STRIKE></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><STRIKE>G5.
Injunctive Relief.</STRIKE></B><STRIKE> In case any Event of Default occurs and is not waived, CEDAR will be entitled to the issuance
of an injunction, restraining order, or other equitable relief in CEDAR&rsquo;s favor, subject to court or arbitrator approval, restraining
each Guarantor&rsquo;s accounts and/or receivables up to the amount due to CEDAR as a result of the Event of Default, and each Guarantor
will be deemed to have consented to the granting of an application for the same to any court or arbitral tribunal of competent jurisdiction
without any prior notice to any Merchant or Guarantor and without CEDAR being required to furnish a bond or other undertaking in connection
with the application.</STRIKE></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="4" STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
    have read and agree to the terms and conditions set forth above:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 14%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 24%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="4" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    and Title: </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THOMAS
    EDWIN DYE JR</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">07/26/2022</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page
<B>13</B> of <B>16</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 25.8pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>STANDARD
MERCHANT CASH ADVANCE AGREEMENT</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>G6.
Choice of Law.</U></B> Each Guarantor acknowledges and agrees that the Agreement and this Guarantee were made in the State of New York,
that the Purchase Price is being paid by CEDAR in the State of New York, that the Receivables Purchased Amount is being delivered to
CEDAR in the State of New York, and that the State of New York has a reasonable relationship to the transactions encompassed by the Agreement
and this Guarantee. This Guarantee and the relationship between CEDAR, each Merchant, and each Guarantor will be governed by and construed
in accordance with the laws of the State of New York, without regard to any applicable principles of conflict of laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>G7.
Forum and Venue Selection.</U></B> Any litigation relating to this Agreement <STRIKE>or this Guarantee</STRIKE> or involving CEDAR on
one side and any Merchant or any Guarantor on the other must be commenced and maintained in any court located in the Counties of Nassau,
New York, or Sullivan in the State of New York (the &ldquo;Acceptable Forums&rdquo;). The parties agree that the Acceptable Forums are
convenient, submit to the jurisdiction of the Acceptable Forums, and waive any and all objections to the jurisdiction or venue of the
Acceptable Forums. If any litigation is initiated in any other venue or forum, the parties waive any right to oppose any motion or application
made by any party to transfer such litigation to an Acceptable Forum. The parties agree that this Guarantee encompasses the transaction
of business within the City of New York and that the Civil Court of the City of New York (&ldquo;Civil Court&rdquo;) will have jurisdiction
over any litigation relating to this Guarantee that is within the jurisdictional limit of the Civil Court. In addition to the Acceptable
Forums, any action or proceeding to enforce a judgment or arbitration award against any Merchant or Guarantor or to restrain or collect
any amount due to CEDAR may be commenced and maintained in any other court of competent jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U><STRIKE>G8.
Jury Waiver.</STRIKE></U></B> <STRIKE>Each Guarantor agrees to waive trial by jury in any dispute with CEDAR</STRIKE>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>G9.
Counterclaim Waiver.</U></B> In any litigation or arbitration commenced by CEDAR, each Merchant and each Guarantor will not be permitted
to interpose any counterclaim.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>G10.
Statutes of Limitations.</U></B> Each Merchant and each Guarantor agree that any claim that is not asserted against CEDAR within one
year of its accrual will be time barred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>G11.
Costs.</U></B> Each Merchant <STRIKE>and each Guarantor</STRIKE> must pay all of CEDAR&rsquo;s reasonable costs associated with a breach
by any Merchant of the covenants in this Agreement <STRIKE>or this Guarantee</STRIKE> and the enforcement thereof, including but not
limited to collection agency fees, expert witness fees, and costs of suit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>G12.
Prejudgment and Postjudgment Interest.</U></B> If CEDAR becomes entitled to the entry of a judgment against any Merchant or any Guarantor,
then CEDAR will be entitled to the recovery of prejudgment interest at a rate of 24% per annum (or 16% per annum if any Merchant is a
sole proprietorship), or the maximum rate permitted by applicable law if less, and upon entry of any such judgment, it will accrue interest
at a postjudgment rate of 24% per annum (or 16% per annum if any Merchant is a sole proprietorship), or the maximum rate permitted by
applicable law if less, which rate will govern over the statutory rate of interest up until actual satisfaction of the judgment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>G13.
Legal Fees.</U></B> If CEDAR prevails in any litigation or arbitration with any Merchant <STRIKE>or any Guarantor</STRIKE>, then that
Merchant and/or Guarantor must pay CEDAR&rsquo;s reasonable attorney fees, which may include a contingency fee of up to 40% of the amount
claimed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>G14.
Class Action Waiver.</U></B> CEDAR, each Merchant, <STRIKE>and each Guarantor</STRIKE> agree that they may bring claims against each
other relating to this Agreement only in their individual capacities, and not as a plaintiff or class action member in any purported
class or representative proceedings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="4" STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
    have read and agree to the terms and conditions set forth above:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 14%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 24%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="4" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    and Title: </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THOMAS
    EDWIN DYE JR</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">07/26/2022</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page
<B>14</B> of <B>16</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 25.8pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>STANDARD
MERCHANT CASH ADVANCE AGREEMENT</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><U>G15.
Arbitration.</U></B> Any action or dispute relating to this Agreement or this Guarantee or involving CEDAR on one side and any Merchant
<STRIKE>or any Guarantor </STRIKE>on the other, including, but not limited to issues of arbitrability, will, at the option of any party
to such action or dispute, be determined by arbitration before a single arbitrator. The arbitration will be <FONT STYLE="font-size: 10pt">administered
either by Arbitration Services, Inc. under its Commercial Arbitration Rules as are in effect at that time, which rules are available
at www.arbitrationservicesinc.com, or by Mediation &amp; Commercial Arbitration, Inc. under its Commercial Arbitration Rules as are in
effect at that time, which rules are available at www.mcarbitration.org. Once an arbitration is initiated with one of these arbitral
forums, it must be maintained exclusively before that arbitral forum and the other arbitral forum specified herein may not be used. Any
arbitration relating to this Agreement or this Guarantee must be conducted in the Counties of Nassau, New York, Queens, or Kings in the
State of New York. Notwithstanding any provision of any applicable arbitration rules, any witness in an arbitration who does not reside
in or have a place for the regular transaction of business located in New York City or the Counties of Nassau, Suffolk, or Westchester
in the State of New York will be permitted to appear and testify remotely by telephone or video conferencing. In case any Event of Default
occurs and is not waived, each Guarantor consents to CEDAR making an application to the arbitrator, without notice to any Merchant or
any Guarantor, for the issuance of an injunction, restraining order, or other equitable relief in CEDAR&rsquo;s favor, subject to court
or arbitrator approval, restraining each Guarantor&rsquo;s accounts and/or receivables up to the amount due to CEDAR as a result of the
Event of Default.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Guarantor acknowledges and agrees that the Agreement and this Guarantee are the product of communications conducted by telephone and
the Internet, which are instrumentalities of interstate commerce, that the transactions contemplated under the Agreement and this Guarantee
will be made by wire transfer and ACH, which are also instrumentalities of interstate commerce, and that the Agreement and this Guarantee
therefore evidence a transaction affecting interstate commerce. Accordingly, notwithstanding any provision in the Agreement or this Guarantee
to the contrary, all matters of arbitration relating to the Agreement or this Guarantee will be governed by and construed in accordance
with the provisions of the Federal Arbitration Act, codified as Title 9 of the United States Code, however any application for injunctive
relief in aid of arbitration or to confirm an arbitration award may be made under Article 75 of the New York Civil Practice Law and Rules.
The arbitration agreement contained in this Section may also be enforced by any employee, agent, attorney, member, manager, officer,
subsidiary, affiliate entity, successor, or assign of CEDAR.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>G16.
Service of Process.</U></B> Each Merchant and each Guarantor consent to service of process and legal notices made by First Class or Priority
Mail delivered by the United States Postal Service and addressed to the Contact Address set forth on the first page of the Agreement
or any other address(es) provided in writing to CEDAR by any Merchant or any Guarantor, and unless applicable law or rules provide otherwise,
any such service will be deemed complete upon dispatch. Each Merchant and each Guarantor agrees that it will be precluded from asserting
that it did not receive service of process or any other notice mailed to the Contact Address set forth on the first page of the Agreement
if it does not furnish a certified mail return receipt signed by CEDAR demonstrating that CEDAR was provided with notice of a change
in the Contact Address.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U><STRIKE>G17.
Severability. </STRIKE></U></B><STRIKE>If any provision of this Guarantee is deemed invalid or unenforceable as written, it will be construed,
to the greatest extent possible, in a manner which will render it valid and enforceable, and any limitation on the scope or duration
of any such provision necessary to make it valid and enforceable will be deemed to be part thereof. If any provision of this Guarantee
is deemed void, all other provisions will remain in effect</STRIKE>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>G18.
Survival.</U></B> The provisions of Sections G2, G3, G4, G5, G6, G7, G8, G9, G10, G11, G12, G13, G14, G15, G16, G17, G18, G19, G20, G21,
and G22 shall survive any termination of this Guarantee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>G19.
Headings.</U></B> Headings of the various articles and/or sections of this Guarantee are for convenience only and do not necessarily
define, limit, describe, or construe the contents of such articles or sections.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>G20.
Attorney Review.</U></B> Each Guarantor acknowledges that it has had an opportunity to review this Guarantee, the Agreement, and all
addenda with counsel of its choosing before signing the documents or has chosen not to avail itself of the opportunity to do so.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="4" STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
    have read and agree to the terms and conditions set forth above:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 14%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 24%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="4" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    and Title: </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THOMAS
    EDWIN DYE JR</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">07/26/2022</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page
<B>15</B> of <B>16</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 25.8pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">STANDARD
MERCHANT CASH ADVANCE AGREEMENT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U><STRIKE>G21.
Entire Agreement. </STRIKE></U></B><STRIKE>This Guarantee, inclusive of all addenda, if any, executed simultaneously herewith may not
be amended, modified, or canceled except in writing signed by all parties. Should there arise any conflict between this Guarantee and
any other document preceding it, this Guarantee will govern. This Guarantee does not affect any previous agreement between the parties
unless such an agreement is specifically referenced in the Agreement or herein. This Guarantee will not be affected by any subsequent
agreement between the parties unless this Guarantee is specificall</STRIKE>y <STRIKE>referenced therein.</STRIKE></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>G22.
Counterparts; Fax and Electronic Signatures.</U></B> This Guarantee may be executed electronically and in counterparts. Facsimile and
electronic copies of this Guarantee will have the full force and effect of an original.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE
TERMS, DEFINITIONS, CONDITIONS AND INFORMATION SET FORTH IN THE &ldquo;STANDARD MERCHANT CASH ADVANCE AGREEMENT&rdquo;, INCLUDING THE
&ldquo;TERMS AND CONDITIONS&rdquo;, ARE HEREBY INCORPORATED IN AND MADE A PART OF THIS GUARANTEE. CAPITALIZED TERMS NOT DEFINED IN THIS
GUARANTEE SHALL HAVE THE MEANING SET FORTH IN THE STANDARD MERCHANT CASH ADVANCE AGREEMENT, INCLUDING THE TERMS AND CONDITIONS.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 25.8pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EACH
UNDERSIGNED HEREBY ACCEPTS THE TERMS OF THIS GUARANTEE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="4" STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>GUARANTOR
    (#1)</B></FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THOMAS
    EDWIN DYE JR</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Print
    Name )</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Signature)</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SS#
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">###-##-####</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Driver
    License Number ______________________________</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="4" STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>GUARANTOR
    (#2)</B></FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Print
    Name )</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Signature)</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SS#
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Driver
    License Number ______________________________</FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page
<B>16</B> of <B>16</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 26.55pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>STANDARD
MERCHANT CASH ADVANCE AGREEMENT</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>BANK
INFORMATION</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dear
Merchant,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thank
you for accepting this offer from CEDAR ADVANCE LLC. We look forward to being your funding partner.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
authorize CEDAR ADVANCE LLC to collect the Receivables Purchased Amount under this Agreement by ACH debiting your bank account with the
bank listed below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEDAR
ADVANCE LLC will require viewing access to your bank account each business day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEDAR
ADVANCE LLC will also require viewing access to your bank account, prior to funding, as part of our underwriting process.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
fill out the form below with the information necessary to access your account.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">*
Be sure to indicate capital or lower case letters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of bank: ____________________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of account: __________________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Account
number: ______________________________&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Routing number: ___________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bank
portal website: _______________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Username:
_______________________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Password:
_______________________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security
Question/Answer 1: _________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security
Question/Answer 2: _________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security
Question/Answer 3: _________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
other information necessary to access your account: ___________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 60.95pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you have any questions please feel free to contact us directly at (718) 400-9030.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="4" STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
    have read and agree to the terms and conditions set forth above:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 14%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 24%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="4" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    and Title: </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THOMAS
    EDWIN DYE JR</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">07/26/2022</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ADDENDUM
TO STANDARD MERCHANT CASH ADVANCE AGREEMENT</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>FOR
ESTIMATED PAYMENTS</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
is an Addendum, dated 7/29/2022, to the Standard Merchant Cash Advance Agreement (&ldquo;Agreement&rdquo;), dated 7/29/2022, between
CEDAR ADVANCE LLC (&ldquo;CEDAR&rdquo;) and SLINGER BAG AMERICAS INC / SLINGER BAG INC / CONNEXA SPORTS </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">TECHNOLOGIES
INC. (&ldquo;Merchant&rdquo;). This Addendum incorporates the Agreement by reference. The terms of this Addendum will control to the
extent they conflict with any of the terms in the Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 61pt; text-align: justify; text-indent: 36.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Instead
of debiting the 10% Specified Percentage of Merchant&rsquo;s Receivables, CEDAR may instead debit $44,970.00 (&ldquo;Estimated Payment&rdquo;)
from the Account every WEEK. The Estimated Payment is intended to be an approximation of no more than the Specified Percentage.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 61pt; text-align: justify; text-indent: 36.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
Merchant may give written notice to CEDAR requesting that CEDAR conduct a reconciliation in order to ensure that the amount that CEDAR
has collected equals the Specified Percentage of Merchant(s)&rsquo;s Receivables under this Agreement. Any Merchant may give written
notice requesting a reconciliation. A request for reconciliation may also be made by e-mail to reconciliations@cedaradvance.com. If such
reconciliation determines that CEDAR collected more than it was entitled to, then within three business days thereafter, CEDAR will credit
to the Account all amounts to which CEDAR was not entitled and decrease the Estimated Payment so that it is consistent with the Specified
Percentage of Merchant(s)&rsquo;s Receivables from the date of the Agreement through the date of the reconciliation. If such reconciliation
determines that CEDAR collected less than it was entitled to, then within three business days thereafter, CEDAR will debit from the Account
all additional amounts to which CEDAR was entitled and increase the Estimated Payment so that it is consistent with the Specified Percentage
of Merchant(s)&rsquo;s Receivables from the date of the Agreement through the date of the reconciliation, with the increase being subject
to any Cap in place on collections. In order to effectuate this reconciliation, any Merchant must produce with its request any and all
bank statements and merchant statements covering the period from the date of this Agreement through the date of the request for a reconciliation.
CEDAR will complete each such reconciliation within two business days after receipt of a written request for one accompanied by the information
and documents required for it. Nothing herein limits the amount of times that such a reconciliation may be requested.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
THE MERCHANT/OWNER (#1)</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Print Name and Title)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Signature)</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
    THE MERCHANT/OWNER (#2)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Print Name and Title)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Signature)</FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex10-14_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>ADDENDUM
TO STANDARD MERCHANT CASH ADVANCE AGREEMENT</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
is an Addendum, dated 7/29/2022, to the Standard Merchant Cash Advance Agreement (&ldquo;Agreement&rdquo;), dated 7/29/2022, between
CEDAR ADVANCE LLC (&ldquo;CEDAR&rdquo;) and SLINGER BAG AMERICAS INC / SLINGER BAG INC / CONNEXA SPORTS TECHNOLOGIES INC. (&ldquo;Merchant&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Merchant Agreement, the Buyer is entitled to the Specified Percentage of Seller&rsquo;s revenue (10%) until the Purchased Amount
is paid. However, for the first three weeks CEDAR is only purchasing 3.3% of Merchant&rsquo;s Receivables, and the Estimated Payment
shall be $13,491.00</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none"><B>FOR
    THE MERCHANT/OWNER (#1)</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thomas
    Dye</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Print Name and Title)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Signature)</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; "><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
    THE MERCHANT/OWNER (#2)</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; "><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; "><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; "><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; "><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; "><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Print Name and Title)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Signature)</FONT></TD>
    </TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="ex10-14_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; color: #010101"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PURCHASED
AMOUNT ADDENDUM</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; color: #010101"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
addendum is made as of <U>07/29/2022</U> (the &ldquo;Addendum&rdquo;) to the Agreement for the Purchase and Sale of Future Receipts between
CEDAR ADVANCE LLC (the &ldquo;Buyer&rdquo;) and THE (the &ldquo;Seller&rdquo;) <U>SLINGER BAG AMERICAS INc1SLINGER BAG INc 1coNNExA seoRTs
TECHNOL0GIEs INc </U>Dated <U>7/29/2022</U> (the &ldquo;Agreement&rdquo;)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.05pt; color: #010101"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Buyer
and Seller are sometimes referred to herein collectively as the &ldquo;parties&rdquo; and each as a &ldquo;Party&rdquo;. Whereas, the
Parties desire to add certain terms to the Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.05pt; color: #010101"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
consideration of the above promises, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged,
the Parties hereto, intending to be legally bound, do hereby agree and add terms to the Agreement as follows,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchased
amount shall be defined as: <U>$855,000.00</U> if Seller delivers the Future Receipts within 45 calendar days of the Purchase Price being
paid by the Buyer</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchased
amount shall be defined as: $ _________ if Seller delivers the Future Receipts within 60 calendar days of the Purchase Price being paid
by the Buyer</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SELLER:
</B>SLINGER BAG AMERICAS INC&rsquo; SLINGER BAG INC I CONNEXA SPORTS TECHNOLOGIES INC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 126.7pt; text-align: justify; color: #010101"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 7%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NAME</B></FONT></TD>
    <TD STYLE="width: 43%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thomas Dye</FONT></TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SIGNATURE:</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 25.8pt; text-align: center; color: gray"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Cedar
Advance, LLC- 2917 AVE I BROOKLYN, NY 11210-T: 718-400-9030</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; color: gray"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>3
<FILENAME>ex21-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-right: 0pt; margin-bottom: 0pt"></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: right; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
21.1</B></FONT></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><BR>
List of Subsidiaries of the Registrant as at the date of this Report</B></FONT></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Jurisdiction
    of Incorporation</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Percentage
    of Voting Securities Owned directly or indirectly by the Registrant</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Slinger Bag Americas, Inc.</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delaware</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Slinger Bag Ltd.</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Israel</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Flixsense Pty Ltd</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New South Wales</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Slinger Bag Europe B.V.</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Netherlands</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Slinger Bag International
    (UK) Limited</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">England</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Slinger Bag Canada Inc.</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ontario</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foundation Sports Systems
    LLC</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Massachusetts</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25%</FONT></TD></TR>
  </TABLE>
<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>ex23-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: right; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit 23.1</B></FONT></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><IMG SRC="ex23-1_001.jpg" ALT=""></B></FONT></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; color: Red; margin-right: 0pt; margin-bottom: 0pt"></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</B></FONT></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-transform: uppercase; text-align: justify; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; text-transform: none">To
The Shareholders and Board of Directors of Connexa Sports Technologies, Inc.</FONT></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
consent to the inclusion in the Form S-1 Registration Statement under the Securities Act of 1933 of Connexa Sports Technologies, Inc.
of our report dated September 14th, 2023, of the balance sheet and the related statements of operations, stockholders&rsquo; equity,
and cashflows for the year ended April 30, 2023, and 2022</FONT></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/S/
Olayinka Oyebola </I></FONT></P>

<P STYLE="text-align: justify; margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OLAYINKA
OYEBOLA &amp; CO</B></FONT></P>

<P STYLE="text-align: justify; margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chartered
Accountant</FONT></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PCAOB
No:5968</FONT></P>

<P STYLE="text-align: justify; margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Lagos,
Nigeria</B></FONT></P>

<P STYLE="text-align: justify; margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">November
8, 2023</FONT></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; font: 10pt/107% Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>5
<FILENAME>ex107.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-right: 0pt; margin-bottom: 0pt"></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: right; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
107</B></FONT></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Calculation
of Filing Fee Tables</B></FONT></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FORM
S-1</B></FONT></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Form
Type)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Connexa
Sports Technologies, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
Name of Registrant as Specified in its Charter)</FONT></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-right: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Table
1: Securities to Be Registered and Carry Forward Securities</B></FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-right: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Security
    Type</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Security
    Class Title</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fee
    Calculation Rule</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amount
    to Be Registered<SUP>(1)</SUP></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proposed
    Maximum Offering Price <SUP>(2)</SUP></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proposed</B></FONT></P>
    <P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Maximum
    Aggregate Offering Price <SUP>(3)</SUP></B></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fee
    Rate</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amount
    of Registration Fee</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 9%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 9%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants
    to purchase shares of Common Stock, par value $0.001 per share (Common Stock)<SUP>(4)</SUP></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">457</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,519,714</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.77</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,480,179.78<FONT STYLE="font-size: 10pt">&nbsp;</FONT></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.00014760</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">513.67</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants
    to purchase shares of Common Stock<SUP>(5)</SUP></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">457</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">452,489</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.77</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">348,416.53<FONT STYLE="font-size: 10pt">&nbsp;</FONT></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.00014760</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">51.43</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants
    to purchase shares of Common Stock</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">457</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">169,196</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.77</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">130,280.92<FONT STYLE="font-size: 10pt">&nbsp;</FONT></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.00014760</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.23</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">Equity</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">Common Stock of the Sapir Selling Stockholder<SUP>(7)</SUP></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><P STYLE="margin: 0">457</P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">(o)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><P STYLE="margin: 0">224,472</P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">$</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><P STYLE="margin: 0">0.77</P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">$</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><P STYLE="margin: 0">172,843.44</P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><P STYLE="margin: 0">$</P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><P STYLE="margin: 0">0.00014760</P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">$</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><P STYLE="margin: 0">25.51</P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD COLSPAN="10" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total
    Offering Amounts</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,131,720.67</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.00014760</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">609.84</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD COLSPAN="10" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total
    Fees Previously Paid</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD COLSPAN="10" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total
    Fee Offsets</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD COLSPAN="10" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Net
    Fee Due</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT>609.84</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-right: 0pt; margin-bottom: 0pt"></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-right: 0pt; margin-bottom: 0pt"></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
    to Rule 416 under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), the securities being registered hereunder
    include such indeterminate number of additional shares of Common Stock as may from time to time be issued after the date hereof as
    a result of stock splits, stock dividends, recapitalizations or other similar transactions.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    accordance with Rule 457(c) under the Securities Act, the aggregate offering price for the shares to be sold by the selling
    stockholders is calculated based on a price of $0.77, the closing price reported on The Nasdaq Stock Market for November 2,
    2023.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Calculated
    pursuant to Rule 457(o) based on an estimate of the proposed maximum aggregate offering price of the securities registered hereunder
    to be sold by the registrant.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
    warrants are referred to in the Registration Statement as the 5-Year Warrants and the 7.5-Year Warrants, and were originally issued
    by the Company on September 8, 2022.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
    warrants are referred to in the Registration Statement as the January Warrants, and were originally issued by the Company on January
    6, 2023.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
    warrants are referred to in the Registration Statement as the Common Warrants, and were originally issued by the Company on October
    11, 2023.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">(7)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">Estimated solely for purposes of calculating the amount
    of the registration fee pursuant to Rule 457(o) under the Securities Act.&nbsp;</TD></TR>
  </TABLE>
<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>forms-1_001.jpg
<TEXT>
begin 644 forms-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $R ;0# 2(  A$! Q$!_\0
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M48JD!'BD(J4K3=M R(@4F*D*TA6I B(IJK^\6IB*0+\XH 1AS1BI67#&F[:
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MZ?I%YJ@<VT>X)C<<XI2:2NQI-Z(IYS3ATK:'A35?^>2_]]BJ]WH-_86YFGC
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MLE^?;-/W8C(S["L33"EM$]TY'F,=B8_A'<_TJ5]1QG!_*FH.1QUZ_)HC=,B
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MR%=CEG&,%&Z;>)#T]/I36:!R&=9\],[P::4=#\T;CZJ:C+#U%%@NR?;;,/\
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M5 V.M=CCW9R7+XO;:,?Z/IELOO*6D/Z\5+-J][!9/(L@C"KG;$H0?H*JI&H
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ML\D_E2^0,>WO5@<X  I"AS_K #Z4KL=D0&!?PHP!QBGMQWS3<T!L,(7LG-(
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MI\D?Y4/E.1'@&('/]OZU_P!_E_\ B:7_ (0*/_H8-;_[_K_\376\4AJ7"/\
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)%, HHHIB/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>forms-1_002.jpg
<TEXT>
begin 644 forms-1_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $5 ?8# 2(  A$! Q$!_\0
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MPZ%"UO)+#<R'[Q0O'@84X()['TKD^I4>LF=?]J8BR:BOO/3/^$JT/_H*VO\
MW\H_X2G0_P#H*VO_ '\KSN[\.Q+9?N#(9XO,+$Q\R8(' ].>M-'AV&&]@AN)
M9G$TICS&O  ]3V/M2^J4+?$P>9XE?87WGHO_  E6A_\ 05MO^_E*/%.ADX_M
M2VS_ -=*\:F0)-(BYVAB!O&#^-(F/-3_ 'Q76LIBU?F.1Y]53MRH]F_X2C1.
M<ZI:Y'_32C_A*M#_ .@I;?\ ?RO)=-MHKW5HK>7/ELQSCJ<<X'UJY'I,5S:R
MW31&P .T1G)YP3DYYQVK&> I0=G)F\,XK35XQ1Z=_P )3HG_ $%+;_OY2_\
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MALP^E16ZDK.^PEB<#D@XX-'UNMW#^S<-_*1'X?Z\=^=;MCN^]F.3GZ_/2?\
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M2,2R)V,AZ?D/YU[KUKY<\;R23^,M5G?)$MRVPGT!V\?E7;@8IU;OH<^(;43
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M%_[^T>;>_P#/HO\ W]JY10!2\V]_Y]%_[^TOFWO_ #Z+_P!_:N44 4_.O?\
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ML=3C 9K6828/<=_TKZ5LO&/AZ]L5NX]6M$B*!R))0A4>X/2OEM<[1]*-H/4
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M %ADA8H0 \?RA!DYZMCO0!V8I:HSZKIUK(R7%[!$ZKYA#R 87IFF_P!LZ:"
M;^VR9!'_ *P?>(R!^1% &C124M !1110 4444 %%%% !1110 4444 %%%% !
M1110 56O_P#D'W7_ %R;^56:K7__ "#[K_KDW\J (M&_Y EA_P!>T?\ Z"**
M-&_Y EA_U[1_^@BB@"[VKEO&WAZ77=!D%D?+U&W!>U=3@YQ@KGT(R*ZJD-.+
M:=T)JY\?,CPR/%+&8Y(SM9".5([4VO<?B+\-?[7,FL:(@&H=9H!P)_<>C?SK
MQ.XMIK.XDMKF&2&XC^_'(N"/PKZ+#XB%5>9Y52DX,ZSX87-E:^/+-KPE2ZM'
M 1TWGIFOH\XQR*^0X9I;:>.XMY#'-$P:-QU4CH:].G^-5^VDK!!IJK?>4%:Y
M>3C=CE@N*X\9A9U*BE$WH5E%69J>/]7M=<\36G@QL0P?:$FNKN20#9QG"Y]J
M\M\0OI\FMW$>E1A+"'$,!'_+0+QN)[DFL^>:6[GDFN)&EED<M([\DDTMM;W%
MY<1VUK#)//(<+%&F2?PKIHT516K,*DW4$AAEN)XX8(VEED(5(T&2Q/85]*^!
M/"R>%?#L5LX!NY?WMRP[N>WT%<W\._AO_8;1ZQK*JVI%?W</40?CW:O3@,5Y
MV,Q/M'RQV.RA2Y=6%+24M<!U$-S_ ,>TW^X?Y5Q=M_QZQ?[@KL[G_CUF_P!P
M_P JXRV_X]8O]P5T4.IRU^A+11174<X4444 7]$OEMHKI&AG/[\\I'D=!6M_
M:T7_ #[W7_?HUB:5_JKK_KL?Y"M"N1P39UJ;L6_[6A_Y][K_ +]&C^UH?^?>
MZ_[]&JE%3[-#YV6_[6A_Y][K_OT:/[6A_P"?>Z_[]&JE%'LT'.RW_:T/_/O=
M?]^C5>\U6)K*<?9[KF)O^61]*945Q_QZS?\ 7-_Y4>S0<[+=OJL0MH1]GNON
M#_ED?2I?[6A_Y][K_OT:H6__ ![Q?]<Q_*I*/9H.=EO^UXO^>%U_WZ--_M>+
M_GVN_P#OT:JUS6J>([VVN]92SMK5H='MA/.;B0JTA*D@*!VXZFDXI#4FSL/[
M7B_Y][K_ +]&C^UHO^?>Z_[]&N7\*:]-K]C<275LMM<P2B-XAD<%0P.#R,@U
MO4^1"YV6_P"UH?\ GWNO^_1K*UR2RU?3Q87EK=/;SN%D785)'U%6JS=:M9KR
MP%M;WLMG-+* MS$ 6C/J,T>S0<[(;K1=,NKJYE>"\\JXBABDC\KM$?EP>M1P
M:)86ZZ>$?4MUC&8E=D_U@SGYO7D_C4-WH&H7&J372:@PCDA6,<\A@I4MCIUY
MXJ231K]H]+$<L4!LS^]"L2). -WN>#Q[TN4KF&KX=LE2"/??Y@P8OW &&'&?
MR'2I-+T'3=)M_)M%U' B\F/?'G"\\$?Q?>/6H#X?O=L42E5C4RB1//;]Y&22
MJ@]B"1S[8I-/\/ZG:ZG<WES?B2.>(1F,=#TX [9QR?RHY0YBX-(L1:6EHIU
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M=EO^UH?^?>Z_[]&C^UH?^?>Z_P"_1JI11[-!SLM_VM#_ ,^]U_WZ-']K0_\
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MW#_*N,MO^/6+_<%=G<_\>LW^X?Y5QEM_QZQ?[@KHH=3EK]"6BBBNHYPHHHH
MM:3_ *NZ_P"NQ_D*T*S])_U=U_UV/\A6A7.]S=;!1114C"BBB@ J.X_X]9O^
MN;?RJ2H[C_CUF_ZYM_*J @@O$%O%^ZG_ -6/^61]*=]L3_GC<_\ ?HU+!_Q[
MP_\ 7,?RJ2@"M]L3_GC<_P#?JL^^TW1M3NDN;[23/,L9C$CQ'.WT/K^-;-%2
M%S+TVWT[2+3[-I]A+;0YSL2(\GW)Y-6_MB?\\;G_ +]&K-%4!6^UK_SQG_[]
M5GZU))>60AMIKNSF:0".XCAR8SZ@'K6S6?J\$]S9K#;7<EG-)* EQ&H8QGU
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M;[8O_/"?_OT:/MB?\\;G_OT:LT4 5OMB?\\;G_OT:/MB_P#/"?\ []&K-&:
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M(4@=".._6J/_  E^IF6:*+P_)))%M5@'/RD\ACQ]T_G189%#I]S%9PVXL-0
MC@$1_<2?,X^ZW7C;^M/T^TU"PMM00QZC<378^^]EP6YR2,\#GH.]:%OK^I3Z
MC);G19(X8I #*Y/*G&<<=03^E(=:U*$$M8F:4RLGV<1D>4 >!N_C+=1VH I7
MME)/8Z?;06.JQ_9%*AV@)*@KMP#GGUJ*?3[JZT^&RGM=2,4<AD)2!E9>NT Y
MZ#/XXYJ^OB34I(A*N@RE1@,AR&!(SQQT!X-+-JNL!=1=(5 BCB-NXA)4DL Q
M'<X!-38##3P_.)9))8M5;<?,V+;, I"XP.?NGJ1ZUH7-A>7&GQ61.L>4NT_\
M>?(9!QCGINYJR->UJ.*8G2#/M^Z<%=PS@''ZGT%/DUO6G ,.E1QGG,4@8R @
MC ].<FJ ?I#RZ;]N\W3=1?[3=&X'EVIP,@ CKZC/XUI?VH?^@7JO_@+_ /7J
MC9ZY?7-TZ3:3+:VWD&43$$D>@V^O'2LP:YXA\F4FVBR('DC?[,W)QE2>>I/!
M6@1T/]JG_H%ZK_X"_P#UZ7^U3_T"]5_\!?\ Z]9EQJU^LT]O!'')<&13"GED
M9C$>Z3ZG/'XU6BUK5FX>([YE\N$?9\;9<XW-_LGM].: -S^U3_T"]5_\!?\
MZ])_:I_Z!>J_^ O_ ->L.VU;7VM(3+"LES*2NP6Y 4B7&#S_ '>:LW7B#4HM
M1:V@T.26(2E?-)/"C/)XZGM]: L:?]JG_H%ZK_X"_P#UZ/[5/_0+U7_P%_\
MKUF7.K:Q;ZG,%TU9K6&20;(P=TB +M(/3.2?RJ*XUS6_[-L;V#22'+L;FV W
M,4'3![$T!8V?[5/_ $"]5_\  7_Z]']JG_H%ZK_X"_\ UZQAXBU>1K3&B>5Y
MN#)O+':.>.!P> /QI9M=UB*.4#2X_-!0J"&*D$C.,#MDYH"QL?VJ?^@7JO\
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M"A(LX<C.#@\5)9W$E_!YUO>*T8D:/F$CD'!X- C&DU?7H+T$V9FB$LT90#:
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M5[W3[T6-R?M,/^J;_ED?0^]2YH.1FAHW_($L/^O:/_T$44FC?\@2P_Z]H_\
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MY5R*:#XE06X;5E)MS\N&(##81^G'\ZUK"RU&UTZ\?4KPSR/$=J;LB,8/'O\
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M3IGBI'\/:T$8)KTFY]S;F).UR"-P]AQQTIW]@:/_ - R#\C_ (TO]@:1_P!
MV#\C_C1[-A[0O:%I6H::SB]U)[Q#&H'F'D$5NY'J*Y3^P-&_Z!MO^1_QI/[
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M;2#@J#CT/.<GM5:"2-IK:*31-/):_>"41PGY8^S#^IZ5TO\ 8FD]/[,M,?\
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MU1J!?R/5?S%0W9'V*?D?ZINX]*K?V%I'_0*L_P#OU4-UH>DBSG(TRT!$3?\
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MCIZ*Y4ZWX@A$B1:3)<QQH<2S#;)*^>,*!TJ>XU/7AI"7L6G$3K<C-JD>6DB
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M59?^ Z?X444 ']B:1_T"K+_P'3_"C^Q-(_Z!5E_X#I_A110 ?V)I'_0*LO\
MP'3_  H_L32/^@59?^ Z?X444 ']B:1_T"K+_P !T_PH_L32/^@59?\ @.G^
M%%% !_8FD?\ 0*LO_ =/\*/[$TC_ *!5E_X#I_A110 ?V)I'_0*LO_ =/\*:
EVAZ0R[#I5EAA@_N$_P ***8%Z")((EBC4+'&H10.P%%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>forms-1_003.jpg
<TEXT>
begin 644 forms-1_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $; @4# 2(  A$! Q$!_\0
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M,UB:"T444 )3&=54EN .M/JM=#_1)_\ </\ *A;DR=D4_P#A(='_ .@E:_\
M?P4?\)%H_P#T$K;_ +^"O)]/L87TB:[^R&\F641^4"1M'][BM*W\+6VR":YD
MG"R\&(1C.=I(Q7I/"48[R9X$<SKR^&*/2/\ A(M'_P"@E;?]_!1_PD.C_P#0
M1MO^_@KS+_A%4V6Q%RQDFP=IBZ @D8/KQS2#PW;N)#'<RG!(!\GA2%R=Q[#M
M3^K4/YG]P?VCB?Y%]YZ9_P )%H__ $$;;_OX*=_;^D8#?VA;X/ /F"O+E\/6
M\D\L$=V3+ J/-OC  4C)(]<5CN%^Q18''FM_(5K#+Z<W[LC"IG%:"O**/:/^
M$BT?_H(VW_?P4?\ "0Z1_P!!"V_[^"O$,+Z"CY?05T_V1'^8P_U@G_*>W?\
M"1:/_P!!&U_[^"E_X2'1O^@E;?\ ?P5YHFE:5+::?"<17=U&A#KDGJ<DCIC
MJ*+PY;W%L)H;J3$@9HWDBPH ./F/8UP_5*/5O[CN_M.OTBG\ST__ (2'1_\
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M-!Q^ZCXZ?(.* *ND74U]I<%U<1"*29=^P=@>GZ8J_0!BEH 2BEHH 3%%+10
ME%+10 F*,4M% "8HI:* $HQ2T4 )BC%+10 E4M9_Y >H?]>TG_H)J]5'6/\
MD":A_P!>TG_H)H 31O\ D!:?_P!>T?\ Z"**71?^0%I__7M'_P"@BB@"[7*?
M$"+/AM9NUO=P3-]!(,_SKJZS=<TU=8T.^T]QD7$+(/8XX_6G%V9+5T?-/BW1
M;C0O$M[:3K@-(987[/&3D$5T/PO\7V_AO5Y[74)C%8W8&'_ACD'<U)\0]0FU
M30_#4LT0$L,<MO<'^(3+@,I_+/XUY_7O4U[>C:1YLG[.I='U!;^.?#-U<PV\
M&M6DDLQQ&BOUKH58,H(P0>A%?'I P:^E_AYK=OKG@^SD@7RWMU$$L9.<.O\
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M?^_C?XU;TWPQI.DW1N;*S\J8KMW;B>/Q-;5%2YR?4M48)W2"J6K_ /((O/\
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MN[8B8BXB(@_UIWC]W]?2@"6BJZWUF[!$NH6)Q@)(#G/3\ZL4 %%%% !1110
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M5O;B]-^5^V(J$9!!QG&#^/2K5AHJ65TS6\UJQ$*0$;>?+Y+9]222<FD&AO\
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M]]B@"6EJ'[5;_P#/Q%_WV*/M5O\ \_$7_?8H FHJ'[5;_P#/Q%_WV*/M5O\
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M^!I+;5M8-SID<D/F"6YEBN66$@!!G:V.W;FNLZT 9O\ PC^D?] ZW_[]T?\
M"/Z1_P! ZW_[]UIT4 9G_"/Z1_T#K?\ []T?\(_I'_0.M_\ OW6G10!F?\(_
MI'_0.M_^_='_  C^D?\ 0.M_^_=:=% &9_PC^D?] ZW_ ._='_"/Z1_T#K?_
M +]UIT4 9G_"/Z1_T#K?_OW1_P (_I'_ $#K?_OW6G10!F?\(_I'_0.M_P#O
MW1_PC^D?] ZW_P"_=:=% &9_PC^D?] ZW_[]T?\ "/Z1_P! ZW_[]UIT4 9G
M_"/Z1_T#K?\ []T?\(_I'_0.M_\ OW6G10!F?\(_I'_0.M_^_='_  C^D?\
M0.M_^_=:=% &9_PC^D?] ZW_ ._=4]6T'24T:_=;" $6TA!V_P"R:WZHZQ_R
M!-0_Z]I/_030 W1A_P 2+3_^O:/_ -!%%+HW_("T_P#Z]H__ $$44 7Z***
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C&>Y! K9I:.=A[-%"P1K72[.&4[9(X51@/4  T5?HJ#0__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>forms-1_004.jpg
<TEXT>
begin 644 forms-1_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $  ?L# 2(  A$! Q$!_\0
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M8ME_?0 _*Z]/,C/=3^E=-FN9JQNF+1110 4444 %%%% !1110 4444 %%%%
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M(XC\NWH!2:A/<WFKF^DM9HH01C,9 516T9*]I)&4Z<TKPYKE%KJY$C_Z5/\
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M[TX('7O5E=*UEK,3;KSS3)M6+S3DC&<]:GEN-<F@,/\ 9$JH5:/Y(".H /\
M*GB]UX%2='D)#AF/DL"Q P"?PH=67]T:I:_:_$P6N+Q&*-<SAU."/./^-)]K
MNO\ GZN/^_K?XU:GTS59YY)FTRZ#.Q8@0D"H_P"Q]3_Z!MW_ -^C7?&>'MK8
M\Z5/%7T3_$A^V77_ #]7'_?UO\:/M5W_ ,_5Q_W]?_&IO['U3_H&W?\ WZ-'
M]CZK_P! V[_[]&JYL-W0O98OL_Q.M^',TLFH7RR2RN B??<G')KT;(KSKP!!
M-9ZK=17<$L$DT0:-95(+ 'G'TR*]%Q7S&.:==\FQ]KE:FL,O:;CJXWQ,W]A>
M(-.\3X_T4+]BOR/X8F.5?Z!_YUV0JIJ-A;ZIIUQ8W2>9!/&8Y$]0:Y5HST6B
MPDB2HKHP92,@CH11(2L;%%RP!('J:XG1=0E\*W,/AK69?]&^YIM^W"RIVC<]
MI!^M=QFAJP)W/DS6KF[O->O[G4(_*NWG8RQXQM.>F*CT[4;O2;V*ZLKB6&1)
M W[MB V/7UKU/XL^";:".Z\46UP4D9E$T!'#D\9![&O(21U/2OH*$H5:1Y=1
M.$SW'P]\9+'4+B"TU2PFM9YI!&C0_O(R3T]Q7J0KP_X4^#K_ /MI==U&S:&V
MAC)MO.7EV;^(#V%>TSW$5I;O//(L44:[F=S@ >YKQL2J<:EJ9WT7)QO(RO%6
MIC1O#6H7?F!95A98<]Y",*![DUG_  ^\/2>'/"EO:W&[[9-F>XSVD;J/PJA;
MQS>.]6M=1EC:+P[92^;:(ZX:\E'20CL@[>M=V!6+=E8M:NX4445)9R$Y(O;O
MG_ELW]*CR?4T^X_X_KO_ *^'_I4==]/X4<$OC89/K2Y/J:2BK(%R?4U5U,G^
MR;WG_EB]6:JZG_R"KS_KB:'L..YV]K_QZ0_]<U_E4U16G_'I!_US7^53UYIZ
M W%+CZ4M% Q,>PIN/K3Z* &\T4ZB@!O-58<_VE=?[L?]:N5EF6=-4N/(MO-R
MB9/F 8ZT :>*,52^TWW_ $#_ /R,*/M-]_T#_P#R,* +N*,"J7VF^_Z!_P#Y
M&%'VF^_Z!_\ Y&% %W'TI"#ZU3^TWW_0/_\ (PI#<7Q_YA__ )&% 'G^F^,-
M:OC8I<W4%@M[-<8NY[<"(+$<!5^?DGU..AKH_"VMW6MS7<MQ=VPV2R1BQC3$
MD05L!B<Y.<9Z=ZLW.CVEUIJ:=<>'K>6S23S4A=UVALYS^9JQ!9):ZC<ZA!H<
M27ER LTRR*&D Z9H V<&BJ?VF^_Z!_\ Y&%'VF^_Z!__ )&% 6+F*7%4OM-]
M_P! _P#\C"C[3??] _\ \C"@+%VDJG]IOO\ H'_^1A1]IO<_\>'_ )&% &3X
M0N))M&V26TL*Q32*CL1B4;C\PQV^M5H_$NH,T^_3O*$33[ ^<S"-B %]SCO5
MCPS<70T& +9!L-)_RV']\U;&LAY5C6* R.Q"J+A<D@X/Z@C\* *-SKM]!:6,
MT-K'</,&DE$>[$:  G\>>]/L?$YU&2#R-/N%BDE\IY)?EV]><?A^M3OXAA@D
M>.1;>-XV$;AKE1ACT%1KXGM&^ZUL0%=^+D<!>IH BM?$%Y+?F&:VB6);MK8E
M"2W^R<>GJ:K7/BVXM+>[6:Q?[7&Y6(1J6C/.!SWXY/I6NNM!Q;LL,)%SQ;D3
MK^]XSQ^%*=6\NY-JUO"MPJ^88S.H.WUH Q8O'=NQF5]/NQ)#&K. F<DC/ ].
M.M6+GQ1.EE=7$&FRGRK62>/S#R[+CY<?C5B34K73[F\NIK6"&41J;F0SCA>B
MYJ4Z_$MPL#) DS() C7"C(/2@"DGB:XF\+R:BMO$E[&0);9B?DR?;GIS26WB
M6]N;;4I18>6UO&7BW9VD\_*Q]>!T]:TH;_(::&T@VR$%F$Z\]A_*EN=9^R2Q
M1W,$4+RY\L23J,XZT 4M1\03VL5H]O;^;)*A9HRI' &2P/H,UFMXNU(6UVR:
M:DTD4#21"/=B0AB,].%P,^M:X\0VYA:7_1O*6+SB_P!I7 CZ;O89J6?65MMO
MGQ01EHS*@>X494=3].10!FW'BBZMY;M38-MB@C>-MIYD=2<'V&*CM/%ERT D
MN=/D7;Y>XJI^;(YP.P![UL+K*R+;%882+K_4G[0O[W SQZU"?$5OMA;; 8YP
MQC<3J0P'!Y^M #]+UP:E/Y0L[B'*E@TB\'!P?_K5M5D'6,7:6WV=/.9?,""=
M>F<9_/BIAJ$^=OV5,YQC[0N<T :6*,5DMJS(P1H80QX ^TKGTJ9;ZZ?[MDIX
MSQ.IXH T,4E4_M-]_P! _P#\C"C[3??] _\ \C"@"E=<>+=,_P"O2?\ G'6U
M7/O+._B[3O.M_*_T2?'[P'/,==!0 M(:*H/JUC%J"6#W40NV&5B)^8TTF]B6
MTMPU+2[/5[)[._MH[B"3[T<@X^OL:YA-,\3>&%"Z1*NLZ<IXM+R39/&/19>A
M'UKM<T=:$[#L>-_$SQ#-K'A6*Q_LG4K.Z%PC3136YP  >CC@\XK%\+Z%X.T^
M:"_UW6X[R889+2*%R@;WX^>O?2N1@\CWIGDQCGRU!_W16RKN,.1&3I)RYF<F
M_C&>["IH/AZ_OVQQ(Z?9XE_%_P"E-3PKJ&N3177BRZ6>-3N33+;(ME/^WWD/
MUXKIIM2M+>]ALI;B-+F<$Q1$\L!UQ5L&L;VV1>XB((U"*H50,  <"GT9HI%A
M1110!Q]Q_P ?UW_UV?\ I4=27'_']=_]=G_I4==\?A1P2^)A1115D!574_\
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M^%O#4T'VA;DR12X;+S#&=NQ3CL0.!4]QX=T$/!'+/)EAY$*I)SC'(XZ\=2:
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MQ,O6T_)J +M%4O\ B9>MI^34?\3+UM/R:@"[15+_ (F7K:?DU'_$R];3\FH
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MGX7L-563SMZ.RHJ.AP8PC9&/ZU57P5I\*?Z---!(8Y(C*N"Q#XSU'7@5N?\
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M-[_UQ:K55=3_ .03>_\ 7%J705]3<M_%5BMK"/L^H\1C_ESD]/I4O_"5V/\
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M,O\ S_W7YK_A1]AE_P"?^Z_-?\*M^:G]]?SH\U/[Z_G0!4^PR_\ /_=?FO\
MA1]AE_Y_[K\U_P *M^:G]]?SH\U/[Z_G0!@O \/B[3M\\LF;2?[^..8ZZ"L2
MY8-XNTS!!_T2?H?>.MO- "T444 %%%% !2;AZT5X1!?.]U#!JEW,FA2^)+U+
MR1Y2JY 'E(S=0N?PH ]WS2UC^'AI7]DH-%E62Q#-L99"Z]>0">U;% !1110
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M='Y4;$_NC\J/:!R&!]MM?^?B/\Z/MMK_ ,_$?YUO[$_NC\J-B?W1^5'M Y#
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MM1A-I*KY$O'WQ[5/J?A;6;OQ-8WEA;+8W,4T+76L+=G-S$BX*&+U/3FO1Z*
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(-;N*6B@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>forms-1_005.jpg
<TEXT>
begin 644 forms-1_005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $0 ? # 2(  A$! Q$!_\0
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M<1:W6@0W$-TJ1Q2J02"&(&">GOC%1%_#XM@[&.2Y^8XVL,G'&?QKN_\ A!=
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MN*N_^1GUC_MW_P#037:]ZXJ[_P"1GUC_ +=__033H_$36^$****[3C"BBB@
M'_'Q:_\ 7Q'_ #KM1TKBE_X^+;_KO'_.NU'2N2M\1UT=A**6BL#<2BEHH 2E
MHHH *S]6<)9HQR0)HN@S_&*T*HZI_P >T?\ UWB_]#% #O[1B_YXW'_?HT?V
MC%_SQN/^_1JY10!3_M&+_GC<?]^C2?VC%_SQN/\ OT:NT4 4O[1B_P">-Q_W
MZ-']HQ?\\;C_ +]&KM)0!RNJZ!HNMZE'?WUI=O/'%Y2%5<83/(_')!]15W2(
M;?1[,6L37\L* +&)D+;%' 4<=!6T709RP^7KSTI0Z%MH8;NN,T 5O[1C_P">
M-Q_WZ-)_:,7_ #QN/^_1J[10!3_M&+_GC<?]^C1_:,7_ #QN/^_1JY10!3_M
M&+_GC<?]^C6'XMO(I_"]]&8IL$)G=$<??%=17/\ C,,?"5^%;:Q50&QG!W#F
M@">ZCT^[T]].FLI?LC#88EA(7'IQVK,;0-%D@CA>VO7BCD,D:'<=I/4BM6[M
M;]]%%M'=^9>A5_?8V;B#R<#I6%;V/C,7(:XU. KD X"]-V2<8ZXX^E %Y-,L
M(XT15O\ ")(O*')#?>SQR31'I6EPQRI'#>+OA$&]0^Y8QT /XGFJ4-MXP)\M
M[Z/<JKYDA1=N2<G9QV]Z8]GXV!21-0MWD< ,A"A5Y.2..>,4 7Y=*T^:5"R7
M7DB&.(PB'Y6VDX)X]S48T323&(V@O2JJ$ 92<8QC'N,#GVJ"VT_Q9 =AU&)T
M*<R.06+8QD\?EC\:=+IOB@W=O<1:BF1 (I>1@D.3N QC)&,_I0!=;3=+*H/L
MUV-B[<JK GKR??DU9L$MM/WB""ZV-M4)Y)^4*, 5E:EH_B6YM;9K;4Q'="*5
M)B3A3YGH .J]C5:P\,ZNMDOVZ[EDO%D+>8+EL$>7@?K0!U?]HQ?\\;C_ +]&
ME_M&/_GA<?\ ?HU@W6F:Z^H)/:W?E855,C29&W;@C;C&<\YJM'I?BF.ZN9_[
M27=(PV$D$8 Z8Q@9- '3?VC%_P \;C_OT:7^T8O^>-Q_WZ-<^MOXN<,YO;9#
M\^$&".>G..W;]<U++!XF%K=B&[A,K,H@W;<J@ZD\8W'\J -K^T4_YX7'_?DT
M?VC%_P \;C_OT:YI-#UC^RH_.O-^HI<RS;O-(3GH..HSC@U*^G^)I/(D;4$\
MV$@Y&T*PQ@@C'?O^F* .A_M&/_GC<?\ ?HT?VC'_ ,\;C_OT:YPV?BJ-XW^V
MPR;5.X\ L>H'3&,Y]^E:/AZTU6V^U2:K,LLTS(1L;(&$ /';D4 :7]HQ?\\;
MC_OT:/[1B_YXW'_?HU;S2T 4O[1B_P">-Q_WZ-1Z=*)I;U@& \[^(8/W%K1J
MG9_\?5[_ -=O_9%H N4E+10!P_Q.T6;5?";7%FI:]T^47<..OR]1^5;OA?78
M/$GA^UU.!@/-0;U[JPZ@UL.@="K#((P17D\@N/A5XCEG6)Y?"E_)EPG/V20_
MT_I6D?>CR]3-Z.YZU0>E5K*]M[^TBNK29)K>4;HY(SD$59K,T.0\1ZQX9\(V
M;F[BBADN5)6&!,/-CZ>_K7E$_P 3KK4Y([6_M(XM&$;++:1CS?-[C);GKCI7
MIOC'P&?&.L6D]U??9[.UB*A8DS(Y)YR3P!Q7FGB3X87^G:_;V.D%;F"['[HS
M2 -N'WL^PKOP_L+>_N<E7VGV=CU/X<7]IJ7A"VGMA$DN2+F.(8"R]\#MVK<U
M[6;?0=#N]3N641P1%AG^(]A^)KC-#-CX&T&XTG3I5OM3B_?74AXAC<_WVZ(
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MNS-I-&EN%(F?[LF?3Z4K,'-&E7%W?_(SZQ_V[_\ H)KL4D5URK CV-<9=?\
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MNQQG)S6G]KG_ .?&;\U_QH^US_\ /C-^:_XT 7**H)?RN6"V4WRG!Y'^-/\
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M#UK3TSQK%J?BPZ; (CI\L>+2X!.990H9AZ8P>/H:5HCO(Z+_ (G?_08C_P#
M0?XT8UO_ *#,?_@(/\:M44^5"YF5<:W_ -!F/_P$'^-&-;_Z#,?_ ("#_&K5
M%'*@YF5<:U_T&8__  $'^-97B2/5G\/W8FU967"Y M0,_,/>M^LKQ.N_PU?Q
MY(W(%RAP1\PZ4.*!29+?6&I7MM+:7.JQM"WRE/LH'ZYJ@OAYH/,?[= '>-XF
MDDM@2RL<D$D^HK0OM,W:'-IBWLT:^48GN9'W2!>Y)]<=ZQ;+1Q97D .IP3V<
M?EM<J[Y:3'^J/MGCV.*FR'=DQ\* L'-Y%D(J\P<8'3O[G/KDYJ6#P[);2I+!
M>0+)&201:C_'MV';M61_PCUK:74TDVMVTEM<2 R0S2X&X,QP#GC)(_*M)=*3
MR=,/]JJ4@$BQYD^64'M_M8'&319!=DYT.Y:"YA.IJ5N&\R7]P,L?KGI[5#+X
M7>::226_4M(H0_N>,9R,#/%55TFUB@C3^UX%*PQ@D7!P2#\K=>/3W[U)'HZ0
M:1>VS:M!(LURK-*[_P"KD# XZ\?2BR"[+,?AN6"<RIJ*AO,$I7R?ER!@?+G'
M'I2W'AV2Z#"6\M@6^7?':"-@,8P"#D#':H]4TD7-S-)-J,$($8&"YRN<\MSZ
MGCZ54C\/1V=Y [ZX(VM  09,,<C 9LGJ?YT6079;E\,23MOFU'<?+\OYXNWY
M_K2IX:DBG-PM]&&W*Q!@RN5&%^7...U0R:&7GESK4<\EQ"+79*1DF/!SP>6'
M/'O4M]I$TE['<MKOER6\WVD138VKNP-IZ?+U'XT60[LEN?#]S?)&MSJ0EV2&
M6-S;_,K$YR#GCH*0^'9&MI;5KZ(P2R"1X_LPP&]1SQ_7FHIO#LG]EO8G5I+4
M3HRR!/NDEMS%0?;C'85:TFQ%J9;]]1CN8Y88XC*#\IV\;L] 3WJK(F[*R>%Y
M(B#'J17;(TBA(B "PP<#/Z5)%X<E@SY5]&N83#_Q[ X4]0.>,]SWK:6:*621
M$EC9XSA@#DK]:DHY4',SF_\ A%#Y=M&;\LEN,1(\9( QC'7GCUIZ^&GC*;;Z
M,!8_+ ^S\$;MW(SSSSFNAHHY4',RIC6_^@U'_P" B_XTN-;_ .@S'_X"#_&K
M5%'*@YF5<:W_ -!F/_P$'^-7=#%PJW8N;@3R^?S((]F?E':F58TG_E[_ .NW
M_LHJ)))%Q;;-.BBBLS0Q_$L\]OHDWV1]EQ*4AC?^Z68#/ZUPUUI>H_\ ":3V
M.B)=1&Q%H8Y5N-D$*'._='_RT+ 'MWKOM<T\ZII,]K&^R4X:-O1P<C]17(>*
M]3GU/PO)%813PZL)H?M5HA*S; WS?=Y*^X[4 9>FP1WGCF_T^]\Z\^U23B26
M.XD!C Y42Q$87'\++WKN=)EEFTO3C,YDE20Q,YZOMR,_I63I&K+I_A^VMH8#
M)JSH1':[G+]3@L9/F"^YK:LK1]/T_3K>9@\L9_>,HX9B"3C\: ,[Q9>7$RV^
M@:>Y2\U(E6D7K! /]9)[<<#W-.\*7\OD7&BWSL;_ $M_*9FZS1?\LY/Q'ZBN
M)EU+Q1)K=Y?VNE7]K=7$ABR]CYI6!?\ 5A3G SR3GUJ_I5CXIM?$-OK5Y:7]
MS^[\AU::$$QD]U ['GK6SA:-F8\VIW#WRV;31JIEN)9B(HAU8X'Z#N:Y^>^N
MT-Y<75I<_:K:>.&.>(X3YNNQ>X'?/6NC>RCO?/5LJZS925>&0X'(K&DAU5?$
M-M<2PB:2. Q+LW!&.?O>@]P?PK$V)M8O6?1KNTNE"7B(K8'W9!N'S+_GBNF%
M<WJ]@T&AW<T[F:\<*&EQ_M#A1V%=)0(*XN[_ .1GUC_MW_\ 037:5Q=W_P C
M/K'_ &[_ /H)K6C\1E6^$**:2!C) SP,]Z?@^E=IQB44A8"41$CS&&0G<CUI
MV,4 1/\ >M_^NR?SK>[FL%_O6_\ UV3^=;W<UC4W-J>P4445)04444 %%%%
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M?\^5K_WY7_"BP7,O2;2QTN>>8ZO#<--'''EW48"]._)K4_M&R_Y_;7_O\O\
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M/+;W1B5@%"),0I(!Q)CM@XX[@57TS1->M]3L;BYU#=;PC]\GGEO,8CYC^)Y
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ME 'V:YR0'P.!'+C('8T >M44@I: "BBB@!*XN[_Y&?6/^W?_ -!-=I7%W?\
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M4DKM/Z;AT]Z=#XFU@&2&30[B26+:#*%*K(<?-@?R]:'\61(T0_M:S<3$J'2
MD CU^>K'_"02,08K^VECVF1I8X<HB@X))W^M/E8N9"7.LZR^FW/V/3 +\-&(
M4?E#GJ2>.@!_2I++7]2N;ZW6XTQK6WD\P2%P2R$8V^W.3^54I_%D,#JIU6UD
M<@G]W;L>F.IS[BIH/$OG1>8VIVD6%#,KPG*@]"?FXI\K*N=917'1>+H)E=_[
M7LXU +9D@(X!P3]_VJ9_$J1VJ7#:Q8>4^=I$)^;'7'STN5BYD=717(?\)0%?
M9/?V\!\M)<RP$##=,?/S^'2I!XE1\^5K%A,0,D1Q$\>OWNE/E8<R.KJG9_\
M'S??]=O_ &1:Q+76Y[VYN+>VOK:5H "[+;G'.>/O]>*T]),S?;&F=7D,W)5<
M#[H[9J;6&G<U:***0PHHHH 2N1U?PC=7.ORZWI6OS:3<SPI!/M@242*I./O=
M.M=?7*:K8P:OXPM[*^C,UI%8M,L)8A?,\P#) Z\4 <W>_#&^U&[-U=>+IFE.
M-Q2TC02?[X!PWXUH7'@35-5M5T_4_%L]SIF4,EJEI%'O"D$#(Z#@=*Y7Q!8Q
MVVN:M#;6T-K)9)$]C8>07-\#]XYSZ\<=*[9]#T_2Y=&O;*Q6RNWNHTD",>C*
M=RGGFFXV5R%)-V.Q4   =!3J2EI%A1110 E<7=_\C/K'_;O_ .@FNUKBKO\
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MN>^-WF8_[Z.:=:^'=)L;F&XM;(0RPH(U,;$#';(Z'KU-39CT-.BBBJ$%%%%
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M;E2VA 888",8(]*6*VMX 1#;Q1@C:0B@<>E%@N<I>7F@6T>F17&DR$7BB2
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MG_E[_P"NW_LHJO5C2O\ E[_Z[?\ LHJ*FQ4-S3HHHK(V"BBB@ KGW_Y'Z/\
M[!;?^C1705B:MHLE]?0WMI?S6-Y$AB\V-0X9#S@@\=10!P'BYA>>(-2OOF,>
MC&%Y8Y)MK>NZ'NA_0UW.JS"XMM%G4,%DO86 8<\@]:S+OP3<7M['>W6LK-<Q
M_=D>QB)]JT8= O6O;:?4=<GO$MW\R.'R(XUW8P"<#)QFC4N332LCHJ6DI:"
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#/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>ex10-14_001.jpg
<TEXT>
begin 644 ex10-14_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !R ((# 2(  A$! Q$!_\0
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M/FG%6N[PBG9R6C:NTTG9JS/>?V3?^"M?[)7A_P#9W_9S^'WQ2?XYZ+XZ\)_
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ML&F6%KIZ7&IW7@'6!<ZC/!:P0QR7%S&ELTMR5,D]P)_,)9*_#S_@UXL[.Y^
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>ex23-1_001.jpg
<TEXT>
begin 644 ex23-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !: GT# 2(  A$! Q$!_\0
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MAN._)W8/...F*+@>AT444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MN"[FV],5WQ@B.,Q(<,&&5'!' /UJO>Z79:C:-:W5NDD#C#)RH(SG'';/;H:
M.6\1>(=53PEISV<;6^L:EM:)(8C,8U WD[<9/ "GC@M52S\5ZO?:VDUFL$UG
M>/:PPP2.4\G?"TLC' Y8;2,>P%=]L3*G:,J,*<=![4U88E.5C0'.>%'7_)-
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M'D5L5B^%-'&@>&;73UM4MVC#,\23&4!V8LWS$#.22>@ZUM#I0 4444 %%%%
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M![!I[<6\BK,+8KYY>01E(T51N#;>H_N_C6A&/"6H:I<68L%^T7WRRE[=U5W
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "J>JZ?%JVD7FGS<1W,+1$XSC(QG\.M
M7** /.8?A+9QZ7=63ZG/(T\D#^<R?,NW/F@<_P#+0M(3Z;N]%Q\);2;2[.T7
M5)XY;8SMYZI\SLY!C)Y_Y9E5QZ[>U>C44K(#AI_AU]HGLR^IKY-LD4"H+5=R
MPQN'0(V<JV0<L.H/3BJX^&IBFM9Y+\7B6D+HMJ\6P2!EE!7=GY0?,YR#T_"O
M0:*+ >=Z=\-&_L[2QJ-XCW,*H]VIC\P3.)EE.2<9X4+TZ"EM_A>;.3SK;6GB
MG^QFRW"W! C*D' )X.2.?0$=Z]#HHL!Y[;_"Z.'[.#J8*+)NE46P^[YWF@1D
ML3&<\$\Y%5+;X6M<V*F\N1;3_:Y7\I?WJK;M@)%GY>551@CIDUZ;118#SY_A
MB)+B>9M43)EDF@ M%X9YEEQ+S^]4%0,''>B7X8;K*2V35RHFC595^SC8Q#RN
M<*"-JYEX4'C:.M>@T46 \\?X7^;=I-/J_G*L4<.U[<'*KY7RGYL$?NO3^(YS
MBGGX81BX@>/4E2))5=T%LNX*LSR*L;9S'Q(0<=<"O0**+ >?2?#+S--@LVU.
M#;#&]N&%@@S"ZJIR,_ZW"#$G7D\5?N_ LM]>S3W.JAQ<6S6LI-JI<1C>$\MR
M<H0'P2/O8SQ79446 \\D^%D-Q$_VF_A>617#;+-4C4D1*"J X4@1<^I8UU^@
MZ+'H5E-:Q.IC>YFG550($#N6V@#L,XK4HHL 4444P"BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
..**** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>13
<FILENAME>cnxa-20230731.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.20b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaSGWbP9z5Z8iekhvWB3bYlq3ykrxyJktyZX/J92EaIA -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:CNXA="http://connexasports.com/20230731" elementFormDefault="qualified" targetNamespace="http://connexasports.com/20230731">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://connexasports.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/BalanceSheets" id="BalanceSheets">
          <link:definition>00000002 - Statement - Consolidated Balance Sheets</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical">
          <link:definition>00000003 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/StatementsOfOperations" id="StatementsOfOperations">
          <link:definition>00000004 - Statement - Consolidated Statements of Operations (Unaudited)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/StatementOfChangesInShareholdersEquityDeficit" id="StatementOfChangesInShareholdersEquityDeficit">
          <link:definition>00000005 - Statement - Consolidated Statement of Changes in Shareholders' Equity (Deficit) (Unaudited)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/StatementsOfCashFlows" id="StatementsOfCashFlows">
          <link:definition>00000006 - Statement - Consolidated Statements of Cash Flows (Unaudited)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/OrganizationAndNatureOfBusiness" id="OrganizationAndNatureOfBusiness">
          <link:definition>00000007 - Disclosure - ORGANIZATION AND NATURE OF BUSINESS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/GoingConcern" id="GoingConcern">
          <link:definition>00000008 - Disclosure - GOING CONCERN</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
          <link:definition>00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/ConcentrationOfCreditRiskAndOtherRisksAndUncertainties" id="ConcentrationOfCreditRiskAndOtherRisksAndUncertainties">
          <link:definition>00000010 - Disclosure - CONCENTRATION OF CREDIT RISK AND OTHER RISKS AND UNCERTAINTIES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/IntangibleAssets" id="IntangibleAssets">
          <link:definition>00000011 - Disclosure - INTANGIBLE ASSETS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/AccruedExpenses" id="AccruedExpenses">
          <link:definition>00000012 - Disclosure - ACCRUED EXPENSES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/NotePayableRelatedParty" id="NotePayableRelatedParty">
          <link:definition>00000013 - Disclosure - NOTE PAYABLE &#8211; RELATED PARTY</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/ConvertibleNotesPayable" id="ConvertibleNotesPayable">
          <link:definition>00000014 - Disclosure - CONVERTIBLE NOTES PAYABLE</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/NotesPayable" id="NotesPayable">
          <link:definition>00000015 - Disclosure - NOTES PAYABLE</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/RelatedPartyTransactions" id="RelatedPartyTransactions">
          <link:definition>00000016 - Disclosure - RELATED PARTY TRANSACTIONS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/ShareholdersEquityDeficit" id="ShareholdersEquityDeficit">
          <link:definition>00000017 - Disclosure - SHAREHOLDERS&#8217; EQUITY (DEFICIT)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
          <link:definition>00000018 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/DiscontinuedOperations" id="DiscontinuedOperations">
          <link:definition>00000019 - Disclosure - DISCONTINUED OPERATIONS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/SubsequentEvents" id="SubsequentEvents">
          <link:definition>00000020 - Disclosure - SUBSEQUENT EVENTS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/AcquisitionsAndBusinessCombinations" id="AcquisitionsAndBusinessCombinations">
          <link:definition>00000021 - Disclosure - ACQUISITIONS AND BUSINESS COMBINATIONS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/NotePayable-RelatedParty" id="NotePayable-RelatedParty">
          <link:definition>00000022 - Disclosure - NOTE PAYABLE - RELATED PARTY</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/IncomeTaxes" id="IncomeTaxes">
          <link:definition>00000023 - Disclosure - INCOME TAXES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/Segments" id="Segments">
          <link:definition>00000024 - Disclosure - SEGMENTS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
          <link:definition>00000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesTables" id="SummaryOfSignificantAccountingPoliciesTables">
          <link:definition>00000026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/IntangibleAssetsTables" id="IntangibleAssetsTables">
          <link:definition>00000027 - Disclosure - INTANGIBLE ASSETS (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/AccruedExpensesTables" id="AccruedExpensesTables">
          <link:definition>00000028 - Disclosure - ACCRUED EXPENSES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/DiscontinuedOperationsTables" id="DiscontinuedOperationsTables">
          <link:definition>00000029 - Disclosure - DISCONTINUED OPERATIONS (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/AcquisitionsAndBusinessCombinationsTables" id="AcquisitionsAndBusinessCombinationsTables">
          <link:definition>00000030 - Disclosure - ACQUISITIONS AND BUSINESS COMBINATIONS (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/NotePayable-RelatedPartyTables" id="NotePayable-RelatedPartyTables">
          <link:definition>00000031 - Disclosure - NOTE PAYABLE - RELATED PARTY (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/IncomeTaxesTables" id="IncomeTaxesTables">
          <link:definition>00000032 - Disclosure - INCOME TAXES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/OrganizationAndNatureOfBusinessDetailsNarrative" id="OrganizationAndNatureOfBusinessDetailsNarrative">
          <link:definition>00000033 - Disclosure - ORGANIZATION AND NATURE OF BUSINESS (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/GoingConcernDetailsNarrative" id="GoingConcernDetailsNarrative">
          <link:definition>00000034 - Disclosure - GOING CONCERN (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/ScheduleOfInventoryDetails" id="ScheduleOfInventoryDetails">
          <link:definition>00000035 - Disclosure - SCHEDULE OF INVENTORY (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/ScheduleOfDerivativeLiabilitiesDetails" id="ScheduleOfDerivativeLiabilitiesDetails">
          <link:definition>00000036 - Disclosure - SCHEDULE OF DERIVATIVE LIABILITIES (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/ScheduleOfDerivativeAndWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails" id="ScheduleOfDerivativeAndWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails">
          <link:definition>00000037 - Disclosure - SCHEDULE OF DERIVATIVE AND WARRANTS GRANTED VALUATION USING BLACK-SCHOLES PRICING METHOD (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/ScheduleOfWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails" id="ScheduleOfWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails">
          <link:definition>00000038 - Disclosure - SCHEDULE OF WARRANTS GRANTED VALUATION USING BLACK-SCHOLES PRICING METHOD (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" id="SummaryOfSignificantAccountingPoliciesDetailsNarrative">
          <link:definition>00000039 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/ConcentrationOfCreditRiskAndOtherRisksAndUncertaintiesDetailsNarrative" id="ConcentrationOfCreditRiskAndOtherRisksAndUncertaintiesDetailsNarrative">
          <link:definition>00000040 - Disclosure - CONCENTRATION OF CREDIT RISK AND OTHER RISKS AND UNCERTAINTIES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/ScheduleOfIntangibleAssetsDetails" id="ScheduleOfIntangibleAssetsDetails">
          <link:definition>00000041 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/IntangibleAssetsDetailsNarrative" id="IntangibleAssetsDetailsNarrative">
          <link:definition>00000042 - Disclosure - INTANGIBLE ASSETS (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/ScheduleOfAccruedExpensesDetails" id="ScheduleOfAccruedExpensesDetails">
          <link:definition>00000043 - Disclosure - SCHEDULE OF ACCRUED EXPENSES (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/NotePayableRelatedPartyDetailsNarrative" id="NotePayableRelatedPartyDetailsNarrative">
          <link:definition>00000044 - Disclosure - NOTE PAYABLE &#8211; RELATED PARTY (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/ConvertibleNotesPayableDetailsNarrative" id="ConvertibleNotesPayableDetailsNarrative">
          <link:definition>00000045 - Disclosure - CONVERTIBLE NOTES PAYABLE (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/NotesPayableDetailsNarrative" id="NotesPayableDetailsNarrative">
          <link:definition>00000046 - Disclosure - NOTES PAYABLE (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/RelatedPartyTransactionsDetailsNarrative" id="RelatedPartyTransactionsDetailsNarrative">
          <link:definition>00000047 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative" id="ShareholdersEquityDeficitDetailsNarrative">
          <link:definition>00000048 - Disclosure - SHAREHOLDERS&#8217; EQUITY (DEFICIT) (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/CommitmentsAndContingenciesDetailsNarrative" id="CommitmentsAndContingenciesDetailsNarrative">
          <link:definition>00000049 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/ScheduleOfDiscontinuedOperationsDetails" id="ScheduleOfDiscontinuedOperationsDetails">
          <link:definition>00000050 - Disclosure - SCHEDULE OF DISCONTINUED OPERATIONS (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/DiscontinuedOperationsDetailsNarrative" id="DiscontinuedOperationsDetailsNarrative">
          <link:definition>00000051 - Disclosure - DISCONTINUED OPERATIONS (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/SubsequentEventsDetailsNarrative" id="SubsequentEventsDetailsNarrative">
          <link:definition>00000052 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/ScheduleOfProformaFinancialInformationDetails" id="ScheduleOfProformaFinancialInformationDetails">
          <link:definition>00000053 - Disclosure - SCHEDULE OF PROFORMA FINANCIAL INFORMATION (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/ScheduleOfEstimatedFutureAmortizationDetails" id="ScheduleOfEstimatedFutureAmortizationDetails">
          <link:definition>00000054 - Disclosure - SCHEDULE OF ESTIMATED FUTURE AMORTIZATION (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/AcquisitionsAndBusinessCombinationsDetailsNarrative" id="AcquisitionsAndBusinessCombinationsDetailsNarrative">
          <link:definition>00000055 - Disclosure - ACQUISITIONS AND BUSINESS COMBINATIONS (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/ScheduleOfWarrantsIssuedExercisedAndExpiredDetails" id="ScheduleOfWarrantsIssuedExercisedAndExpiredDetails">
          <link:definition>00000056 - Disclosure - SCHEDULE OF WARRANTS ISSUED, EXERCISED AND EXPIRED (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/NotePayable-RelatedPartyDetailsNarrative" id="NotePayable-RelatedPartyDetailsNarrative">
          <link:definition>00000057 - Disclosure - NOTE PAYABLE - RELATED PARTY (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/ScheduleOfNetDeferredTaxAssetsDetails" id="ScheduleOfNetDeferredTaxAssetsDetails">
          <link:definition>00000058 - Disclosure - SCHEDULE OF NET DEFERRED TAX ASSETS (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/ScheduleOfIncomeTaxProvisionDetails" id="ScheduleOfIncomeTaxProvisionDetails">
          <link:definition>00000059 - Disclosure - SCHEDULE OF INCOME TAX PROVISION (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/ScheduleOfNetDeferredTaxAssetsDetailsParenthetical" id="ScheduleOfNetDeferredTaxAssetsDetailsParenthetical">
          <link:definition>00000060 - Disclosure - SCHEDULE OF NET DEFERRED TAX ASSETS (Details) (Parenthetical)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/ScheduleOfIncomeTaxProvisionDetailsParenthetical" id="ScheduleOfIncomeTaxProvisionDetailsParenthetical">
          <link:definition>00000061 - Disclosure - SCHEDULE OF INCOME TAX PROVISION (Details) (Parenthetical)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/IncomeTaxesDetailsNarrative" id="IncomeTaxesDetailsNarrative">
          <link:definition>00000062 - Disclosure - INCOME TAXES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://connexasports.com/role/ScheduleOfCalculationOfLossOnDisposalDetails" id="ScheduleOfCalculationOfLossOnDisposalDetails">
          <link:definition>00000063 - Disclosure - SCHEDULE OF CALCULATION OF THE LOSS ON DISPOSAL (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="cnxa-20230731_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="cnxa-20230731_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="cnxa-20230731_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="cnxa-20230731_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
    <element id="CNXA_GamefaceLtdMember" name="GamefaceLtdMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_PlaySightInteractiveLtdMember" name="PlaySightInteractiveLtdMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_SlingerBagAmericasIncMember" name="SlingerBagAmericasIncMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_StockPurchaseAgreementMember" name="StockPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_SoleShareholderofSBLMember" name="SoleShareholderofSBLMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_FoundationSportsSystemsLLCMember" name="FoundationSportsSystemsLLCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_CharlesRuddyMember" name="CharlesRuddyMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_PlaySightMember" name="PlaySightMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_ProfitGuarantyMember" name="ProfitGuarantyMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_ConvertibleNotesMember" name="ConvertibleNotesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_UnderwriterWarrantsMember" name="UnderwriterWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_WarrantsIssuedWithCommonStockMember" name="WarrantsIssuedWithCommonStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_WarrantsIssuedWithNotesPayableMember" name="WarrantsIssuedWithNotesPayableMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_OtherDerivativeLiabilitiesMember" name="OtherDerivativeLiabilitiesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_CustomerTwoMember" name="CustomerTwoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_CustomerFourMember" name="CustomerFourMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_CustomerOneMember" name="CustomerOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_TradeNamesAndPatentsMember" name="TradeNamesAndPatentsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_IntangiableAssetMember" name="IntangiableAssetMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_LoanAgreementsMember" name="LoanAgreementsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_SecuritiesPurchaseAgreementMember" name="SecuritiesPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_MonteCarloSimulationMember" name="MonteCarloSimulationMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_OmnibusAgreementMember" name="OmnibusAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_PromissoryNotePayableMember" name="PromissoryNotePayableMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_NotesPayableMember" name="NotesPayableMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_UFSAgreementMember" name="UFSAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_EachWeekForNextThreeWeeksMember" name="EachWeekForNextThreeWeeksMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_ThereafterPerWeekMember" name="ThereafterPerWeekMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_CedarAgreementMember" name="CedarAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_LoanAndSecurityAgreementMember" name="LoanAndSecurityAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_ArmisticeCapitalMasterFundLtdMember" name="ArmisticeCapitalMasterFundLtdMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_NotesMember" name="NotesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_MegedAgreementMember" name="MegedAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_LoanAgreementMember" name="LoanAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_MontsaicInvestmentsLLCMember" name="MontsaicInvestmentsLLCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_ThirdPartyMember" name="ThirdPartyMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_GabrielGoldmanMember" name="GabrielGoldmanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_GamefaceAIMember" name="GamefaceAIMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_MidcityCapitalLtdMember" name="MidcityCapitalLtdMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_FiveYearWarrantsMember" name="FiveYearWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_SevenYearWarrantsMember" name="SevenYearWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_SevenPointFiveYearWarrantsMember" name="SevenPointFiveYearWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_RelatedPartyLenderMember" name="RelatedPartyLenderMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_ServicesRenderedInLieuOfCashMember" name="ServicesRenderedInLieuOfCashMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_TwoEmployeesMember" name="TwoEmployeesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_MarketingAndAdvisoryServicesMember" name="MarketingAndAdvisoryServicesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_VendorMember" name="VendorMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_AsCompensationMember" name="AsCompensationMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_SixNewBrandAmbassadorsMember" name="SixNewBrandAmbassadorsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_BrandAmbassadorsMember" name="BrandAmbassadorsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_NotePayableHolderMember" name="NotePayableHolderMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_VendorOneMember" name="VendorOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_KeyEmployeesAndOfficersMember" name="KeyEmployeesAndOfficersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_ServiceProviderMember" name="ServiceProviderMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_ThreeMembersMember" name="ThreeMembersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_LeadPlacementAgentMember" name="LeadPlacementAgentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_ExercisePriceOneMember" name="ExercisePriceOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_ExercisePriceTwoMember" name="ExercisePriceTwoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_GamefaceMember" name="GamefaceMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_SharePurchaseAgreementMember" name="SharePurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_EmployeeAgreementMember" name="EmployeeAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_FoundationSportsToCharlesRuddyMember" name="FoundationSportsToCharlesRuddyMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_RodneyRapsonMember" name="RodneyRapsonMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_AmendedUFSAgreementMember" name="AmendedUFSAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_SecondMegedAgreementMember" name="SecondMegedAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_PreFundedWarrantMember" name="PreFundedWarrantMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_WarrantOneMember" name="WarrantOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_WarrantTwoMember" name="WarrantTwoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_FoundationSportsMember" name="FoundationSportsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_PlaySightAndGameFaceMember" name="PlaySightAndGameFaceMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_PlaySightAndFoundationSportsMember" name="PlaySightAndFoundationSportsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_PrepaidInventoryCurrent" name="PrepaidInventoryCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_GainLossOnIssuanceOfConvertibleNotes" name="GainLossOnIssuanceOfConvertibleNotes" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_GainLossOnChangeInFairValueOfContingentConsideration" name="GainLossOnChangeInFairValueOfContingentConsideration" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_LossOnConversionOfAccountsPayableToCommonStock" name="LossOnConversionOfAccountsPayableToCommonStock" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_GainLossOnChangeInFairValueOfDerivativesLiability" name="GainLossOnChangeInFairValueOfDerivativesLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_DerivativeExpense" name="DerivativeExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_IncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" name="IncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_StockIssuedDuringPeriodForAbstract" name="StockIssuedDuringPeriodForAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_StockIssuedDuringPeriodValueAccountsPayable" name="StockIssuedDuringPeriodValueAccountsPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_StockIssuedDuringPeriodSharesAccountsPayable" name="StockIssuedDuringPeriodSharesAccountsPayable" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_StockIssuedDuringPeriodValueCashlessExerciseOfWarrants" name="StockIssuedDuringPeriodValueCashlessExerciseOfWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_StockIssuedDuringPeriodCashlessExerciseOfWarrantsShares" name="StockIssuedDuringPeriodCashlessExerciseOfWarrantsShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_StockIssuedDuringPeriodValueSatisfactionOfProfitGuaranteeOnNotePayable" name="StockIssuedDuringPeriodValueSatisfactionOfProfitGuaranteeOnNotePayable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_StockIssuedDuringPeriodSharesSatisfactionOfProfitGuaranteeOnNotePayable" name="StockIssuedDuringPeriodSharesSatisfactionOfProfitGuaranteeOnNotePayable" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_StockIssuedDuringPeriodValueConversionofNotesPayableRelatedParties" name="StockIssuedDuringPeriodValueConversionofNotesPayableRelatedParties" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_StockIssuedDuringPeriodShareConversionofNotesPayableRelatedParties" name="StockIssuedDuringPeriodShareConversionofNotesPayableRelatedParties" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_NoncashTransactionCosts" name="NoncashTransactionCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_SettlementExpense" name="SettlementExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_LossOnSettlementOfAccountsPayable" name="LossOnSettlementOfAccountsPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_IncreaseDecreaseInPrepaidInventory" name="IncreaseDecreaseInPrepaidInventory" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_IncreaseDecreaseInInterestPayableRelatedParty" name="IncreaseDecreaseInInterestPayableRelatedParty" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_ConversionOfConvertibleNotesPayableAndAccruedInterestToCommonStock" name="ConversionOfConvertibleNotesPayableAndAccruedInterestToCommonStock" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_SharesIssuedForContingentConsideration" name="SharesIssuedForContingentConsideration" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_EliminationOfRelatedPartyDerivativeLiabilities" name="EliminationOfRelatedPartyDerivativeLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_DerivativeLiabilitiesRecordedAsDebtDiscountsOfConvertibleNotes" name="DerivativeLiabilitiesRecordedAsDebtDiscountsOfConvertibleNotes" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_DerivativeLiabilityRecordedForSharesAndWarrantsIssuedInPrivatePlacement" name="DerivativeLiabilityRecordedForSharesAndWarrantsIssuedInPrivatePlacement" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_SharesIssuedForSettlementOfAccountsPayable" name="SharesIssuedForSettlementOfAccountsPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_InterimFinancialStatementsPolicyTextBlock" name="InterimFinancialStatementsPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_PrepaidInventoryPolicyTextBlock" name="PrepaidInventoryPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_WarrantsPolicyTextBlock" name="WarrantsPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_ScheduleOfCalculationOfTheLossOnDisposalTableTextBlock" name="ScheduleOfCalculationOfTheLossOnDisposalTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_NumberOfSharesExchanged" name="NumberOfSharesExchanged" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_NumberOfSharesOwned" name="NumberOfSharesOwned" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_DisposalEquityInterestOwnershipInterestPercentage" name="DisposalEquityInterestOwnershipInterestPercentage" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_CapitalizedDutyAndFreight" name="CapitalizedDutyAndFreight" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_DerivativeLiabilitiesMeasurementInputTerm" name="DerivativeLiabilitiesMeasurementInputTerm" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_RecognizedDerivativeExpense" name="RecognizedDerivativeExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_PaymentForExchangeOfNotesPayable" name="PaymentForExchangeOfNotesPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_WarrantsIssuedToPurchaseOfCommonStockShares" name="WarrantsIssuedToPurchaseOfCommonStockShares" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_WarrantsExercisePrice" name="WarrantsExercisePrice" nillable="true" xbrli:periodType="instant" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_RemainingDerivativeLiabilities" name="RemainingDerivativeLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_LossOnIssuanceOfConvertibleNotes" name="LossOnIssuanceOfConvertibleNotes" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_SecuritiesOutstandingRateConvertibleNotesDescripition" name="SecuritiesOutstandingRateConvertibleNotesDescripition" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_NumberOfConsignedGoods" name="NumberOfConsignedGoods" nillable="true" xbrli:periodType="duration" type="xbrli:integerItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_PaymentsOfRelatedPartyDebt" name="PaymentsOfRelatedPartyDebt" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_CashLessFees" name="CashLessFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_IncreaseDecreaseInDerivativeFairValueLiability" name="IncreaseDecreaseInDerivativeFairValueLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_SharesIssuedPricePerShares" name="SharesIssuedPricePerShares" nillable="true" xbrli:periodType="instant" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_StockIssuedDuringPeriodSharesIssuedSettlementOfAccountsPayable" name="StockIssuedDuringPeriodSharesIssuedSettlementOfAccountsPayable" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_StockIssuedDuringPeriodSharesIssuedSettlementWithFormerOwners" name="StockIssuedDuringPeriodSharesIssuedSettlementWithFormerOwners" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_StockIssuedDuringPeriodSharesIssuedProfitGuaranteeOnNote" name="StockIssuedDuringPeriodSharesIssuedProfitGuaranteeOnNote" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_WarrantPerShare" name="WarrantPerShare" nillable="true" xbrli:periodType="instant" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_FairValueOfCommonStock" name="FairValueOfCommonStock" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_DisposalGroupIncludingDiscontinuedOperationOtherIncomeLoss" name="DisposalGroupIncludingDiscontinuedOperationOtherIncomeLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_DisposalGroupIncludingDiscontinuedOperationNetIncomeLoss" name="DisposalGroupIncludingDiscontinuedOperationNetIncomeLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesCurrent" name="DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityOperatingLeasesCurrent" name="DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityOperatingLeasesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_SharesIssuedAndOutstandingPercentage" name="SharesIssuedAndOutstandingPercentage" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding" nillable="true" xbrli:periodType="instant" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceIssued" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceIssued" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceForfeited" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceForfeited" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExpired" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExpired" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_DeferredTaxAssetsStockOptions" name="DeferredTaxAssetsStockOptions" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_DeferredTaxAssetsAccruedPayroll" name="DeferredTaxAssetsAccruedPayroll" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_DeferredTaxAssetsRelatedPartyAccruals" name="DeferredTaxAssetsRelatedPartyAccruals" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_DeferredTaxAssetsInterestDeferral" name="DeferredTaxAssetsInterestDeferral" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_DeferredTaxAssetsStartupCosts" name="DeferredTaxAssetsStartupCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_DeferredTaxAssetsStartupCostsForeign" name="DeferredTaxAssetsStartupCostsForeign" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_DeferredTaxAssetsInProcessResearchAndDevelopmentCosts" name="DeferredTaxAssetsInProcessResearchAndDevelopmentCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_IncomeTaxReconciliationDebtDiscountAmortization" name="IncomeTaxReconciliationDebtDiscountAmortization" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_IncomeTaxReconciliationRelatedPartyAccruals" name="IncomeTaxReconciliationRelatedPartyAccruals" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_IncomeTaxReconciliationStartUpCosts" name="IncomeTaxReconciliationStartUpCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_IncomeTaxRecociliationInterestExpense" name="IncomeTaxRecociliationInterestExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_IncomeTaxRecociliationInventoryReserve" name="IncomeTaxRecociliationInventoryReserve" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_IncomeTaxRecociliationInterestDeferral" name="IncomeTaxRecociliationInterestDeferral" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_IncomeTaxRecociliationAcquisitionCosts" name="IncomeTaxRecociliationAcquisitionCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_IncomeTaxRecociliationAccruedLegal" name="IncomeTaxRecociliationAccruedLegal" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_IncomeTaxRecociliationLossOnExtinguishmentOfDebt" name="IncomeTaxRecociliationLossOnExtinguishmentOfDebt" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_IncomeTaxRecociliationAccruedPayroll" name="IncomeTaxRecociliationAccruedPayroll" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_IncomeTaxRecociliationGainOnChangeInFairValueOfDerivatives" name="IncomeTaxRecociliationGainOnChangeInFairValueOfDerivatives" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_DisposalGroupIncludingDiscontinuedOperationAccountsReceivable" name="DisposalGroupIncludingDiscontinuedOperationAccountsReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_DisposalGroupIncludingDiscontinuedOperationContractAssets" name="DisposalGroupIncludingDiscontinuedOperationContractAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_DisposalGroupIncludingDiscontinuedOperationRightOfUseAsset" name="DisposalGroupIncludingDiscontinuedOperationRightOfUseAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_DisposalGroupIncludingDiscontinuedOperationContractLiabilities" name="DisposalGroupIncludingDiscontinuedOperationContractLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_DisposalGroupIncludingDiscontinuedOperationLossOnDisposalOfDiscontinuedOperations" name="DisposalGroupIncludingDiscontinuedOperationLossOnDisposalOfDiscontinuedOperations" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_NotesPayableCurrentExcludingConvertibleNotesPayableNet" name="NotesPayableCurrentExcludingConvertibleNotesPayableNet" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_MinimumBidPrice" name="MinimumBidPrice" nillable="true" xbrli:periodType="instant" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="CNXA_SingleInstitutionalInvestorMember" name="SingleInstitutionalInvestorMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>14
<FILENAME>cnxa-20230731_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.20b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://connexasports.com/role/Cover" xlink:href="cnxa-20230731.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/BalanceSheets" xlink:href="cnxa-20230731.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/BalanceSheetsParenthetical" xlink:href="cnxa-20230731.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/StatementsOfOperations" xlink:href="cnxa-20230731.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/StatementOfChangesInShareholdersEquityDeficit" xlink:href="cnxa-20230731.xsd#StatementOfChangesInShareholdersEquityDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/StatementsOfCashFlows" xlink:href="cnxa-20230731.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/OrganizationAndNatureOfBusiness" xlink:href="cnxa-20230731.xsd#OrganizationAndNatureOfBusiness" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/GoingConcern" xlink:href="cnxa-20230731.xsd#GoingConcern" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="cnxa-20230731.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ConcentrationOfCreditRiskAndOtherRisksAndUncertainties" xlink:href="cnxa-20230731.xsd#ConcentrationOfCreditRiskAndOtherRisksAndUncertainties" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/IntangibleAssets" xlink:href="cnxa-20230731.xsd#IntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/AccruedExpenses" xlink:href="cnxa-20230731.xsd#AccruedExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/NotePayableRelatedParty" xlink:href="cnxa-20230731.xsd#NotePayableRelatedParty" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ConvertibleNotesPayable" xlink:href="cnxa-20230731.xsd#ConvertibleNotesPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/NotesPayable" xlink:href="cnxa-20230731.xsd#NotesPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/RelatedPartyTransactions" xlink:href="cnxa-20230731.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ShareholdersEquityDeficit" xlink:href="cnxa-20230731.xsd#ShareholdersEquityDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/CommitmentsAndContingencies" xlink:href="cnxa-20230731.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/DiscontinuedOperations" xlink:href="cnxa-20230731.xsd#DiscontinuedOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/SubsequentEvents" xlink:href="cnxa-20230731.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/AcquisitionsAndBusinessCombinations" xlink:href="cnxa-20230731.xsd#AcquisitionsAndBusinessCombinations" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/NotePayable-RelatedParty" xlink:href="cnxa-20230731.xsd#NotePayable-RelatedParty" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/IncomeTaxes" xlink:href="cnxa-20230731.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/Segments" xlink:href="cnxa-20230731.xsd#Segments" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="cnxa-20230731.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="cnxa-20230731.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/IntangibleAssetsTables" xlink:href="cnxa-20230731.xsd#IntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/AccruedExpensesTables" xlink:href="cnxa-20230731.xsd#AccruedExpensesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/DiscontinuedOperationsTables" xlink:href="cnxa-20230731.xsd#DiscontinuedOperationsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/AcquisitionsAndBusinessCombinationsTables" xlink:href="cnxa-20230731.xsd#AcquisitionsAndBusinessCombinationsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/NotePayable-RelatedPartyTables" xlink:href="cnxa-20230731.xsd#NotePayable-RelatedPartyTables" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/IncomeTaxesTables" xlink:href="cnxa-20230731.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/OrganizationAndNatureOfBusinessDetailsNarrative" xlink:href="cnxa-20230731.xsd#OrganizationAndNatureOfBusinessDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/GoingConcernDetailsNarrative" xlink:href="cnxa-20230731.xsd#GoingConcernDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ScheduleOfInventoryDetails" xlink:href="cnxa-20230731.xsd#ScheduleOfInventoryDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ScheduleOfDerivativeLiabilitiesDetails" xlink:href="cnxa-20230731.xsd#ScheduleOfDerivativeLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ScheduleOfDerivativeAndWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails" xlink:href="cnxa-20230731.xsd#ScheduleOfDerivativeAndWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ScheduleOfWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails" xlink:href="cnxa-20230731.xsd#ScheduleOfWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="cnxa-20230731.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ConcentrationOfCreditRiskAndOtherRisksAndUncertaintiesDetailsNarrative" xlink:href="cnxa-20230731.xsd#ConcentrationOfCreditRiskAndOtherRisksAndUncertaintiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ScheduleOfIntangibleAssetsDetails" xlink:href="cnxa-20230731.xsd#ScheduleOfIntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/IntangibleAssetsDetailsNarrative" xlink:href="cnxa-20230731.xsd#IntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ScheduleOfAccruedExpensesDetails" xlink:href="cnxa-20230731.xsd#ScheduleOfAccruedExpensesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/NotePayableRelatedPartyDetailsNarrative" xlink:href="cnxa-20230731.xsd#NotePayableRelatedPartyDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ConvertibleNotesPayableDetailsNarrative" xlink:href="cnxa-20230731.xsd#ConvertibleNotesPayableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/NotesPayableDetailsNarrative" xlink:href="cnxa-20230731.xsd#NotesPayableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="cnxa-20230731.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative" xlink:href="cnxa-20230731.xsd#ShareholdersEquityDeficitDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="cnxa-20230731.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ScheduleOfDiscontinuedOperationsDetails" xlink:href="cnxa-20230731.xsd#ScheduleOfDiscontinuedOperationsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/DiscontinuedOperationsDetailsNarrative" xlink:href="cnxa-20230731.xsd#DiscontinuedOperationsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/SubsequentEventsDetailsNarrative" xlink:href="cnxa-20230731.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ScheduleOfProformaFinancialInformationDetails" xlink:href="cnxa-20230731.xsd#ScheduleOfProformaFinancialInformationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ScheduleOfEstimatedFutureAmortizationDetails" xlink:href="cnxa-20230731.xsd#ScheduleOfEstimatedFutureAmortizationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/AcquisitionsAndBusinessCombinationsDetailsNarrative" xlink:href="cnxa-20230731.xsd#AcquisitionsAndBusinessCombinationsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ScheduleOfWarrantsIssuedExercisedAndExpiredDetails" xlink:href="cnxa-20230731.xsd#ScheduleOfWarrantsIssuedExercisedAndExpiredDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/NotePayable-RelatedPartyDetailsNarrative" xlink:href="cnxa-20230731.xsd#NotePayable-RelatedPartyDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ScheduleOfNetDeferredTaxAssetsDetails" xlink:href="cnxa-20230731.xsd#ScheduleOfNetDeferredTaxAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ScheduleOfIncomeTaxProvisionDetails" xlink:href="cnxa-20230731.xsd#ScheduleOfIncomeTaxProvisionDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ScheduleOfNetDeferredTaxAssetsDetailsParenthetical" xlink:href="cnxa-20230731.xsd#ScheduleOfNetDeferredTaxAssetsDetailsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ScheduleOfIncomeTaxProvisionDetailsParenthetical" xlink:href="cnxa-20230731.xsd#ScheduleOfIncomeTaxProvisionDetailsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/IncomeTaxesDetailsNarrative" xlink:href="cnxa-20230731.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ScheduleOfCalculationOfLossOnDisposalDetails" xlink:href="cnxa-20230731.xsd#ScheduleOfCalculationOfLossOnDisposalDetails" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_PrepaidInventoryCurrent" xlink:label="loc_CNXAPrepaidInventoryCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_CNXAPrepaidInventoryCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommodityContractAssetCurrent" xlink:label="loc_us-gaapCommodityContractAssetCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCommodityContractAssetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:label="loc_us-gaapAssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaapAssetsNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivables" xlink:label="loc_us-gaapOtherReceivables" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapOtherReceivables" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PurchaseObligation" xlink:label="loc_us-gaapPurchaseObligation" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapPurchaseObligation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaapContractWithCustomerLiabilityCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapContractWithCustomerLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPayableCurrent" xlink:label="loc_us-gaapInterestPayableCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapInterestPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNotesPayableCurrent" xlink:label="loc_us-gaapOtherNotesPayableCurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOtherNotesPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleNotesPayableCurrent" xlink:label="loc_us-gaapConvertibleNotesPayableCurrent" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapConvertibleNotesPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilitiesCurrent" xlink:label="loc_us-gaapDerivativeLiabilitiesCurrent" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDerivativeLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:label="loc_us-gaapBusinessCombinationContingentConsiderationLiabilityCurrent" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapBusinessCombinationContingentConsiderationLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:label="loc_us-gaapLiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapLiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermNotesPayable" xlink:label="loc_us-gaapLongTermNotesPayable" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapLongTermNotesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent" xlink:label="loc_us-gaapLiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapLiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaapAdditionalPaidInCapitalCommonStock" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapitalCommonStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Consolidated Statements of Operations (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaapCostOfGoodsAndServicesSold" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapCostOfGoodsAndServicesSold" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaapSellingAndMarketingExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapSellingAndMarketingExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="loc_us-gaapAmortizationOfFinancingCostsAndDiscounts" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapAmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_GainLossOnIssuanceOfConvertibleNotes" xlink:label="loc_CNXAGainLossOnIssuanceOfConvertibleNotes" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_CNXAGainLossOnIssuanceOfConvertibleNotes" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_GainLossOnChangeInFairValueOfContingentConsideration" xlink:label="loc_CNXAGainLossOnChangeInFairValueOfContingentConsideration" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_CNXAGainLossOnChangeInFairValueOfContingentConsideration" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_LossOnConversionOfAccountsPayableToCommonStock" xlink:label="loc_CNXALossOnConversionOfAccountsPayableToCommonStock" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_CNXALossOnConversionOfAccountsPayableToCommonStock" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_GainLossOnChangeInFairValueOfDerivativesLiability" xlink:label="loc_CNXAGainLossOnChangeInFairValueOfDerivativesLiability" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_CNXAGainLossOnChangeInFairValueOfDerivativesLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DerivativeExpense" xlink:label="loc_CNXADerivativeExpense" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_CNXADerivativeExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:label="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" xlink:label="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:to="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" xlink:label="loc_us-gaapDiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:to="loc_us-gaapDiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_IncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_CNXAIncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_CNXAIncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_CNXAIncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_CNXAIncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/StatementOfChangesInShareholdersEquityDeficit" xlink:title="00000005 - Statement - Consolidated Statement of Changes in Shareholders&apos; Equity (Deficit) (Unaudited)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Consolidated Statements of Cash Flows (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaapDerivativeGainLossOnDerivativeNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDerivativeGainLossOnDerivativeNet" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfOtherAssets" xlink:label="loc_us-gaapGainLossOnSaleOfOtherAssets" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapGainLossOnSaleOfOtherAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_GainLossOnChangeInFairValueOfContingentConsideration" xlink:label="loc_CNXAGainLossOnChangeInFairValueOfContingentConsideration" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="loc_CNXAGainLossOnChangeInFairValueOfContingentConsideration" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DerivativeExpense" xlink:label="loc_CNXADerivativeExpense" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="loc_CNXADerivativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_NoncashTransactionCosts" xlink:label="loc_CNXANoncashTransactionCosts" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="loc_CNXANoncashTransactionCosts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_SettlementExpense" xlink:label="loc_CNXASettlementExpense" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="loc_CNXASettlementExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_LossOnSettlementOfAccountsPayable" xlink:label="loc_CNXALossOnSettlementOfAccountsPayable" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="loc_CNXALossOnSettlementOfAccountsPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_GainLossOnIssuanceOfConvertibleNotes" xlink:label="loc_CNXAGainLossOnIssuanceOfConvertibleNotes" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="loc_CNXAGainLossOnIssuanceOfConvertibleNotes" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_IncreaseDecreaseInPrepaidInventory" xlink:label="loc_CNXAIncreaseDecreaseInPrepaidInventory" />
      <link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="loc_CNXAIncreaseDecreaseInPrepaidInventory" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:calculationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="loc_us-gaapIncreaseDecreaseInContractWithCustomerLiability" />
      <link:calculationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" />
      <link:calculationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:label="loc_us-gaapIncreaseDecreaseInInterestPayableNet" />
      <link:calculationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInInterestPayableNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_IncreaseDecreaseInInterestPayableRelatedParty" xlink:label="loc_CNXAIncreaseDecreaseInInterestPayableRelatedParty" />
      <link:calculationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="loc_CNXAIncreaseDecreaseInInterestPayableRelatedParty" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:label="loc_us-gaapCashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapCashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:label="loc_us-gaapCashAcquiredFromAcquisition" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="loc_us-gaapCashAcquiredFromAcquisition" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireNotesReceivable" xlink:label="loc_us-gaapPaymentsToAcquireNotesReceivable" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="loc_us-gaapPaymentsToAcquireNotesReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" xlink:label="loc_us-gaapCashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapCashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfDebtIssuanceCosts" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsOfDebtIssuanceCosts" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaapProceedsFromNotesPayable" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromNotesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromConvertibleDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapRepaymentsOfRelatedPartyDebt" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfRelatedPartyDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaapRepaymentsOfNotesPayable" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfNotesPayable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/OrganizationAndNatureOfBusiness" xlink:title="00000007 - Disclosure - ORGANIZATION AND NATURE OF BUSINESS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/GoingConcern" xlink:title="00000008 - Disclosure - GOING CONCERN" />
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/ConcentrationOfCreditRiskAndOtherRisksAndUncertainties" xlink:title="00000010 - Disclosure - CONCENTRATION OF CREDIT RISK AND OTHER RISKS AND UNCERTAINTIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/IntangibleAssets" xlink:title="00000011 - Disclosure - INTANGIBLE ASSETS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/AccruedExpenses" xlink:title="00000012 - Disclosure - ACCRUED EXPENSES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/NotePayableRelatedParty" xlink:title="00000013 - Disclosure - NOTE PAYABLE &#8211; RELATED PARTY" />
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/ConvertibleNotesPayable" xlink:title="00000014 - Disclosure - CONVERTIBLE NOTES PAYABLE" />
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/NotesPayable" xlink:title="00000015 - Disclosure - NOTES PAYABLE" />
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/RelatedPartyTransactions" xlink:title="00000016 - Disclosure - RELATED PARTY TRANSACTIONS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/ShareholdersEquityDeficit" xlink:title="00000017 - Disclosure - SHAREHOLDERS&#8217; EQUITY (DEFICIT)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/CommitmentsAndContingencies" xlink:title="00000018 - Disclosure - COMMITMENTS AND CONTINGENCIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/DiscontinuedOperations" xlink:title="00000019 - Disclosure - DISCONTINUED OPERATIONS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/SubsequentEvents" xlink:title="00000020 - Disclosure - SUBSEQUENT EVENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/AcquisitionsAndBusinessCombinations" xlink:title="00000021 - Disclosure - ACQUISITIONS AND BUSINESS COMBINATIONS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/NotePayable-RelatedParty" xlink:title="00000022 - Disclosure - NOTE PAYABLE - RELATED PARTY" />
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/IncomeTaxes" xlink:title="00000023 - Disclosure - INCOME TAXES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/Segments" xlink:title="00000024 - Disclosure - SEGMENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/IntangibleAssetsTables" xlink:title="00000027 - Disclosure - INTANGIBLE ASSETS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/AccruedExpensesTables" xlink:title="00000028 - Disclosure - ACCRUED EXPENSES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/DiscontinuedOperationsTables" xlink:title="00000029 - Disclosure - DISCONTINUED OPERATIONS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/AcquisitionsAndBusinessCombinationsTables" xlink:title="00000030 - Disclosure - ACQUISITIONS AND BUSINESS COMBINATIONS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/NotePayable-RelatedPartyTables" xlink:title="00000031 - Disclosure - NOTE PAYABLE - RELATED PARTY (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/IncomeTaxesTables" xlink:title="00000032 - Disclosure - INCOME TAXES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/OrganizationAndNatureOfBusinessDetailsNarrative" xlink:title="00000033 - Disclosure - ORGANIZATION AND NATURE OF BUSINESS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/GoingConcernDetailsNarrative" xlink:title="00000034 - Disclosure - GOING CONCERN (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/ScheduleOfInventoryDetails" xlink:title="00000035 - Disclosure - SCHEDULE OF INVENTORY (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaapInventoryFinishedGoods" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryFinishedGoods" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterialsAndSupplies" xlink:label="loc_us-gaapInventoryRawMaterialsAndSupplies" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryRawMaterialsAndSupplies" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_CapitalizedDutyAndFreight" xlink:label="loc_CNXACapitalizedDutyAndFreight" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_CNXACapitalizedDutyAndFreight" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryAdjustments" xlink:label="loc_us-gaapInventoryAdjustments" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryAdjustments" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/ScheduleOfDerivativeLiabilitiesDetails" xlink:title="00000036 - Disclosure - SCHEDULE OF DERIVATIVE LIABILITIES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/ScheduleOfDerivativeAndWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails" xlink:title="00000037 - Disclosure - SCHEDULE OF DERIVATIVE AND WARRANTS GRANTED VALUATION USING BLACK-SCHOLES PRICING METHOD (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/ScheduleOfWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails" xlink:title="00000038 - Disclosure - SCHEDULE OF WARRANTS GRANTED VALUATION USING BLACK-SCHOLES PRICING METHOD (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000039 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/ConcentrationOfCreditRiskAndOtherRisksAndUncertaintiesDetailsNarrative" xlink:title="00000040 - Disclosure - CONCENTRATION OF CREDIT RISK AND OTHER RISKS AND UNCERTAINTIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/ScheduleOfIntangibleAssetsDetails" xlink:title="00000041 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/IntangibleAssetsDetailsNarrative" xlink:title="00000042 - Disclosure - INTANGIBLE ASSETS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/ScheduleOfAccruedExpensesDetails" xlink:title="00000043 - Disclosure - SCHEDULE OF ACCRUED EXPENSES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedPayrollTaxesCurrent" xlink:label="loc_us-gaapAccruedPayrollTaxesCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedPayrollTaxesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedBonusesCurrent" xlink:label="loc_us-gaapAccruedBonusesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedBonusesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="loc_us-gaapAccruedProfessionalFeesCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedProfessionalFeesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableOtherCurrent" xlink:label="loc_us-gaapAccountsPayableOtherCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableOtherCurrent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/NotePayableRelatedPartyDetailsNarrative" xlink:title="00000044 - Disclosure - NOTE PAYABLE &#8211; RELATED PARTY (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/ConvertibleNotesPayableDetailsNarrative" xlink:title="00000045 - Disclosure - CONVERTIBLE NOTES PAYABLE (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/NotesPayableDetailsNarrative" xlink:title="00000046 - Disclosure - NOTES PAYABLE (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000047 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative" xlink:title="00000048 - Disclosure - SHAREHOLDERS&#8217; EQUITY (DEFICIT) (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000049 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/ScheduleOfDiscontinuedOperationsDetails" xlink:title="00000050 - Disclosure - SCHEDULE OF DISCONTINUED OPERATIONS (Details)">
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DisposalGroupIncludingDiscontinuedOperationNetIncomeLoss" xlink:label="loc_CNXADisposalGroupIncludingDiscontinuedOperationNetIncomeLoss" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationRevenue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_CNXADisposalGroupIncludingDiscontinuedOperationNetIncomeLoss" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationRevenue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOperatingExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_CNXADisposalGroupIncludingDiscontinuedOperationNetIncomeLoss" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DisposalGroupIncludingDiscontinuedOperationOtherIncomeLoss" xlink:label="loc_CNXADisposalGroupIncludingDiscontinuedOperationOtherIncomeLoss" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_CNXADisposalGroupIncludingDiscontinuedOperationNetIncomeLoss" xlink:to="loc_CNXADisposalGroupIncludingDiscontinuedOperationOtherIncomeLoss" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:label="loc_us-gaapAssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationInventoryCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesCurrent" xlink:label="loc_CNXADisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="loc_CNXADisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryNoncurrent" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationInventoryNoncurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationInventoryNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:label="loc_us-gaapLiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityOperatingLeasesCurrent" xlink:label="loc_CNXADisposalGroupIncludingDiscontinuedOperationLeaseLiabilityOperatingLeasesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="loc_CNXADisposalGroupIncludingDiscontinuedOperationLeaseLiabilityOperatingLeasesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/DiscontinuedOperationsDetailsNarrative" xlink:title="00000051 - Disclosure - DISCONTINUED OPERATIONS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000052 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/ScheduleOfProformaFinancialInformationDetails" xlink:title="00000053 - Disclosure - SCHEDULE OF PROFORMA FINANCIAL INFORMATION (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/ScheduleOfEstimatedFutureAmortizationDetails" xlink:title="00000054 - Disclosure - SCHEDULE OF ESTIMATED FUTURE AMORTIZATION (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFive" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/AcquisitionsAndBusinessCombinationsDetailsNarrative" xlink:title="00000055 - Disclosure - ACQUISITIONS AND BUSINESS COMBINATIONS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/ScheduleOfWarrantsIssuedExercisedAndExpiredDetails" xlink:title="00000056 - Disclosure - SCHEDULE OF WARRANTS ISSUED, EXERCISED AND EXPIRED (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/NotePayable-RelatedPartyDetailsNarrative" xlink:title="00000057 - Disclosure - NOTE PAYABLE - RELATED PARTY (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/ScheduleOfNetDeferredTaxAssetsDetails" xlink:title="00000058 - Disclosure - SCHEDULE OF NET DEFERRED TAX ASSETS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DeferredTaxAssetsStockOptions" xlink:label="loc_CNXADeferredTaxAssetsStockOptions" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_CNXADeferredTaxAssetsStockOptions" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DeferredTaxAssetsAccruedPayroll" xlink:label="loc_CNXADeferredTaxAssetsAccruedPayroll" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_CNXADeferredTaxAssetsAccruedPayroll" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DeferredTaxAssetsRelatedPartyAccruals" xlink:label="loc_CNXADeferredTaxAssetsRelatedPartyAccruals" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_CNXADeferredTaxAssetsRelatedPartyAccruals" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsInventory" xlink:label="loc_us-gaapDeferredTaxAssetsInventory" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsInventory" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DeferredTaxAssetsInterestDeferral" xlink:label="loc_CNXADeferredTaxAssetsInterestDeferral" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_CNXADeferredTaxAssetsInterestDeferral" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DeferredTaxAssetsStartupCosts" xlink:label="loc_CNXADeferredTaxAssetsStartupCosts" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_CNXADeferredTaxAssetsStartupCosts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="loc_us-gaapDeferredTaxAssetsOther" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsOther" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/ScheduleOfIncomeTaxProvisionDetails" xlink:title="00000059 - Disclosure - SCHEDULE OF INCOME TAX PROVISION (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapIncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapIncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/ScheduleOfNetDeferredTaxAssetsDetailsParenthetical" xlink:title="00000060 - Disclosure - SCHEDULE OF NET DEFERRED TAX ASSETS (Details) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/ScheduleOfIncomeTaxProvisionDetailsParenthetical" xlink:title="00000061 - Disclosure - SCHEDULE OF INCOME TAX PROVISION (Details) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000062 - Disclosure - INCOME TAXES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://connexasports.com/role/ScheduleOfCalculationOfLossOnDisposalDetails" xlink:title="00000063 - Disclosure - SCHEDULE OF CALCULATION OF THE LOSS ON DISPOSAL (Details)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>15
<FILENAME>cnxa-20230731_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.20b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://connexasports.com/role/Cover" xlink:href="cnxa-20230731.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/BalanceSheets" xlink:href="cnxa-20230731.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/BalanceSheetsParenthetical" xlink:href="cnxa-20230731.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/StatementsOfOperations" xlink:href="cnxa-20230731.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/StatementOfChangesInShareholdersEquityDeficit" xlink:href="cnxa-20230731.xsd#StatementOfChangesInShareholdersEquityDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/StatementsOfCashFlows" xlink:href="cnxa-20230731.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/OrganizationAndNatureOfBusiness" xlink:href="cnxa-20230731.xsd#OrganizationAndNatureOfBusiness" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/GoingConcern" xlink:href="cnxa-20230731.xsd#GoingConcern" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="cnxa-20230731.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ConcentrationOfCreditRiskAndOtherRisksAndUncertainties" xlink:href="cnxa-20230731.xsd#ConcentrationOfCreditRiskAndOtherRisksAndUncertainties" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/IntangibleAssets" xlink:href="cnxa-20230731.xsd#IntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/AccruedExpenses" xlink:href="cnxa-20230731.xsd#AccruedExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/NotePayableRelatedParty" xlink:href="cnxa-20230731.xsd#NotePayableRelatedParty" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ConvertibleNotesPayable" xlink:href="cnxa-20230731.xsd#ConvertibleNotesPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/NotesPayable" xlink:href="cnxa-20230731.xsd#NotesPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/RelatedPartyTransactions" xlink:href="cnxa-20230731.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ShareholdersEquityDeficit" xlink:href="cnxa-20230731.xsd#ShareholdersEquityDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/CommitmentsAndContingencies" xlink:href="cnxa-20230731.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/DiscontinuedOperations" xlink:href="cnxa-20230731.xsd#DiscontinuedOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/SubsequentEvents" xlink:href="cnxa-20230731.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/AcquisitionsAndBusinessCombinations" xlink:href="cnxa-20230731.xsd#AcquisitionsAndBusinessCombinations" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/NotePayable-RelatedParty" xlink:href="cnxa-20230731.xsd#NotePayable-RelatedParty" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/IncomeTaxes" xlink:href="cnxa-20230731.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/Segments" xlink:href="cnxa-20230731.xsd#Segments" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="cnxa-20230731.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="cnxa-20230731.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/IntangibleAssetsTables" xlink:href="cnxa-20230731.xsd#IntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/AccruedExpensesTables" xlink:href="cnxa-20230731.xsd#AccruedExpensesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/DiscontinuedOperationsTables" xlink:href="cnxa-20230731.xsd#DiscontinuedOperationsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/AcquisitionsAndBusinessCombinationsTables" xlink:href="cnxa-20230731.xsd#AcquisitionsAndBusinessCombinationsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/NotePayable-RelatedPartyTables" xlink:href="cnxa-20230731.xsd#NotePayable-RelatedPartyTables" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/IncomeTaxesTables" xlink:href="cnxa-20230731.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/OrganizationAndNatureOfBusinessDetailsNarrative" xlink:href="cnxa-20230731.xsd#OrganizationAndNatureOfBusinessDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/GoingConcernDetailsNarrative" xlink:href="cnxa-20230731.xsd#GoingConcernDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ScheduleOfInventoryDetails" xlink:href="cnxa-20230731.xsd#ScheduleOfInventoryDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ScheduleOfDerivativeLiabilitiesDetails" xlink:href="cnxa-20230731.xsd#ScheduleOfDerivativeLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ScheduleOfDerivativeAndWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails" xlink:href="cnxa-20230731.xsd#ScheduleOfDerivativeAndWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ScheduleOfWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails" xlink:href="cnxa-20230731.xsd#ScheduleOfWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="cnxa-20230731.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ConcentrationOfCreditRiskAndOtherRisksAndUncertaintiesDetailsNarrative" xlink:href="cnxa-20230731.xsd#ConcentrationOfCreditRiskAndOtherRisksAndUncertaintiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ScheduleOfIntangibleAssetsDetails" xlink:href="cnxa-20230731.xsd#ScheduleOfIntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/IntangibleAssetsDetailsNarrative" xlink:href="cnxa-20230731.xsd#IntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ScheduleOfAccruedExpensesDetails" xlink:href="cnxa-20230731.xsd#ScheduleOfAccruedExpensesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/NotePayableRelatedPartyDetailsNarrative" xlink:href="cnxa-20230731.xsd#NotePayableRelatedPartyDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ConvertibleNotesPayableDetailsNarrative" xlink:href="cnxa-20230731.xsd#ConvertibleNotesPayableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/NotesPayableDetailsNarrative" xlink:href="cnxa-20230731.xsd#NotesPayableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="cnxa-20230731.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative" xlink:href="cnxa-20230731.xsd#ShareholdersEquityDeficitDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="cnxa-20230731.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ScheduleOfDiscontinuedOperationsDetails" xlink:href="cnxa-20230731.xsd#ScheduleOfDiscontinuedOperationsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/DiscontinuedOperationsDetailsNarrative" xlink:href="cnxa-20230731.xsd#DiscontinuedOperationsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/SubsequentEventsDetailsNarrative" xlink:href="cnxa-20230731.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ScheduleOfProformaFinancialInformationDetails" xlink:href="cnxa-20230731.xsd#ScheduleOfProformaFinancialInformationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ScheduleOfEstimatedFutureAmortizationDetails" xlink:href="cnxa-20230731.xsd#ScheduleOfEstimatedFutureAmortizationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/AcquisitionsAndBusinessCombinationsDetailsNarrative" xlink:href="cnxa-20230731.xsd#AcquisitionsAndBusinessCombinationsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ScheduleOfWarrantsIssuedExercisedAndExpiredDetails" xlink:href="cnxa-20230731.xsd#ScheduleOfWarrantsIssuedExercisedAndExpiredDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/NotePayable-RelatedPartyDetailsNarrative" xlink:href="cnxa-20230731.xsd#NotePayable-RelatedPartyDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ScheduleOfNetDeferredTaxAssetsDetails" xlink:href="cnxa-20230731.xsd#ScheduleOfNetDeferredTaxAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ScheduleOfIncomeTaxProvisionDetails" xlink:href="cnxa-20230731.xsd#ScheduleOfIncomeTaxProvisionDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ScheduleOfNetDeferredTaxAssetsDetailsParenthetical" xlink:href="cnxa-20230731.xsd#ScheduleOfNetDeferredTaxAssetsDetailsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ScheduleOfIncomeTaxProvisionDetailsParenthetical" xlink:href="cnxa-20230731.xsd#ScheduleOfIncomeTaxProvisionDetailsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/IncomeTaxesDetailsNarrative" xlink:href="cnxa-20230731.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ScheduleOfCalculationOfLossOnDisposalDetails" xlink:href="cnxa-20230731.xsd#ScheduleOfCalculationOfLossOnDisposalDetails" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesLineItems" xlink:label="loc_deiEntityAddressesLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesTable" xlink:label="loc_deiEntityAddressesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_deiEntityAddressesAddressTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_deiEntityAddressesTable" xlink:to="loc_deiEntityAddressesAddressTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain" xlink:label="loc_deiAddressTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiEntityAddressesAddressTypeAxis" xlink:to="loc_deiAddressTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain" xlink:label="loc_deiAddressTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiEntityAddressesAddressTypeAxis" xlink:to="loc_deiAddressTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_BusinessContactMember" xlink:label="loc_deiBusinessContactMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiAddressTypeDomain" xlink:to="loc_deiBusinessContactMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentType_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentFlag_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentDescription_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentRegistrationStatement_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAnnualReport_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentQuarterlyReport_30" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentTransitionReport_30" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyReport_30" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_30" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodStartDate_30" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodEndDate_30" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_30" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_30" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_30" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFileNumber_30" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityRegistrantName_30" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCentralIndexKey_30" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPrimarySicNumber_30" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_30" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_30" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine1_30" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine2_30" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine3_30" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCityOrTown_30" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_30" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCountry_30" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_30" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCountryRegion_30" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCityAreaCode_30" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiLocalPhoneNumber_30" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiExtension_30" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiWrittenCommunications_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSolicitingMaterial_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementTenderOffer_30" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_30" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12bTitle_30" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiNoTradingSymbolFlag_30" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiTradingSymbol_30" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityExchangeName_30" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12gTitle_30" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityReportingObligation_30" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAnnualInformationForm_30" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_30" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_30" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityVoluntaryFilers_30" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_30" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_30" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFilerCategory_30" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntitySmallBusiness_30" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_30" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityExTransitionPeriod_30" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAccountingStandard_30" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_30" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityShellCompany_30" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPublicFloat_30" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_30" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_30" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_30" xlink:type="arc" order="57" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ContactPersonnelName" xlink:label="loc_deiContactPersonnelName_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiContactPersonnelName_30" xlink:type="arc" order="58" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonrelatedPartyMember" xlink:label="loc_us-gaapNonrelatedPartyMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapNonrelatedPartyMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaapRelatedPartyMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapRelatedPartyMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAxis" xlink:label="loc_srtRestatementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRestatementAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain" xlink:label="loc_srtRestatementDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRestatementAxis" xlink:to="loc_srtRestatementDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain" xlink:label="loc_srtRestatementDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRestatementAxis" xlink:to="loc_srtRestatementDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="loc_srtScenarioPreviouslyReportedMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRestatementDomain" xlink:to="loc_srtScenarioPreviouslyReportedMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsAbstract_120" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_120" xlink:to="loc_us-gaapAssetsCurrentAbstract_120" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_120" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_120" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_120" xlink:to="loc_us-gaapAccountsReceivableNetCurrent_120" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_120" xlink:to="loc_us-gaapInventoryNet_120" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_PrepaidInventoryCurrent" xlink:label="loc_CNXAPrepaidInventoryCurrent_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_120" xlink:to="loc_CNXAPrepaidInventoryCurrent_120" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommodityContractAssetCurrent" xlink:label="loc_us-gaapCommodityContractAssetCurrent_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_120" xlink:to="loc_us-gaapCommodityContractAssetCurrent_120" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_120" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent_120" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:label="loc_us-gaapAssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_120" xlink:to="loc_us-gaapAssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_120" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_120" xlink:to="loc_us-gaapAssetsCurrent_120" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="loc_us-gaapAssetsNoncurrentAbstract_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_120" xlink:to="loc_us-gaapAssetsNoncurrentAbstract_120" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivables" xlink:label="loc_us-gaapOtherReceivables_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsNoncurrentAbstract_120" xlink:to="loc_us-gaapOtherReceivables_120" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsNoncurrentAbstract_120" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_120" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsNoncurrentAbstract_120" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet_120" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsNoncurrentAbstract_120" xlink:to="loc_us-gaapGoodwill_120" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsNoncurrentAbstract_120" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent_120" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaapAssetsNoncurrent_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsNoncurrentAbstract_120" xlink:to="loc_us-gaapAssetsNoncurrent_120" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_120" xlink:to="loc_us-gaapAssets_120" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_120" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAbstract" xlink:label="loc_us-gaapLiabilitiesAbstract_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_120" xlink:to="loc_us-gaapLiabilitiesAbstract_120" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAbstract_120" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract_120" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_120" xlink:to="loc_us-gaapAccountsPayableCurrent_120" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_120" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent_120" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PurchaseObligation" xlink:label="loc_us-gaapPurchaseObligation_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_120" xlink:to="loc_us-gaapPurchaseObligation_120" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaapContractWithCustomerLiabilityCurrent_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_120" xlink:to="loc_us-gaapContractWithCustomerLiabilityCurrent_120" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPayableCurrent" xlink:label="loc_us-gaapInterestPayableCurrent_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_120" xlink:to="loc_us-gaapInterestPayableCurrent_120" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNotesPayableCurrent" xlink:label="loc_us-gaapOtherNotesPayableCurrent_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_120" xlink:to="loc_us-gaapOtherNotesPayableCurrent_120" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleNotesPayableCurrent" xlink:label="loc_us-gaapConvertibleNotesPayableCurrent_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_120" xlink:to="loc_us-gaapConvertibleNotesPayableCurrent_120" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilitiesCurrent" xlink:label="loc_us-gaapDerivativeLiabilitiesCurrent_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_120" xlink:to="loc_us-gaapDerivativeLiabilitiesCurrent_120" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:label="loc_us-gaapBusinessCombinationContingentConsiderationLiabilityCurrent_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_120" xlink:to="loc_us-gaapBusinessCombinationContingentConsiderationLiabilityCurrent_120" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_120" xlink:to="loc_us-gaapOtherLiabilitiesCurrent_120" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:label="loc_us-gaapLiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_120" xlink:to="loc_us-gaapLiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_120" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAbstract_120" xlink:to="loc_us-gaapLiabilitiesCurrent_120" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaapLiabilitiesNoncurrentAbstract_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAbstract_120" xlink:to="loc_us-gaapLiabilitiesNoncurrentAbstract_120" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermNotesPayable" xlink:label="loc_us-gaapLongTermNotesPayable_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAbstract_120" xlink:to="loc_us-gaapLongTermNotesPayable_120" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent" xlink:label="loc_us-gaapLiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAbstract_120" xlink:to="loc_us-gaapLiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent_120" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAbstract_120" xlink:to="loc_us-gaapLiabilitiesNoncurrent_120" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_120" xlink:to="loc_us-gaapLiabilities_120" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_120" xlink:to="loc_us-gaapCommitmentsAndContingencies_120" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_120" xlink:to="loc_us-gaapStockholdersEquityAbstract_120" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_120" xlink:to="loc_us-gaapCommonStockValue_120" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaapAdditionalPaidInCapitalCommonStock_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_120" xlink:to="loc_us-gaapAdditionalPaidInCapitalCommonStock_120" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_120" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_120" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_120" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax_120" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_120" xlink:to="loc_us-gaapStockholdersEquity_120" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_120" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity_120" xlink:type="arc" order="45" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Consolidated Statements of Operations (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonrelatedPartyMember" xlink:label="loc_us-gaapNonrelatedPartyMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapNonrelatedPartyMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaapRelatedPartyMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapRelatedPartyMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaapCostOfGoodsAndServicesSold_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapCostOfGoodsAndServicesSold_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapGrossProfit_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapOperatingExpensesAbstract_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaapSellingAndMarketingExpense_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingExpensesAbstract_130" xlink:to="loc_us-gaapSellingAndMarketingExpense_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingExpensesAbstract_130" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense_130" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingExpensesAbstract_130" xlink:to="loc_us-gaapResearchAndDevelopmentExpense_130" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingExpensesAbstract_130" xlink:to="loc_us-gaapOperatingExpenses_130" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapOperatingIncomeLoss_130" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapNonoperatingIncomeExpenseAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapNonoperatingIncomeExpenseAbstract_130" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="loc_us-gaapAmortizationOfFinancingCostsAndDiscounts_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_130" xlink:to="loc_us-gaapAmortizationOfFinancingCostsAndDiscounts_130" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_130" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt_130" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_GainLossOnIssuanceOfConvertibleNotes" xlink:label="loc_CNXAGainLossOnIssuanceOfConvertibleNotes_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_130" xlink:to="loc_CNXAGainLossOnIssuanceOfConvertibleNotes_130" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_GainLossOnChangeInFairValueOfContingentConsideration" xlink:label="loc_CNXAGainLossOnChangeInFairValueOfContingentConsideration_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_130" xlink:to="loc_CNXAGainLossOnChangeInFairValueOfContingentConsideration_130" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_LossOnConversionOfAccountsPayableToCommonStock" xlink:label="loc_CNXALossOnConversionOfAccountsPayableToCommonStock_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_130" xlink:to="loc_CNXALossOnConversionOfAccountsPayableToCommonStock_130" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_GainLossOnChangeInFairValueOfDerivativesLiability" xlink:label="loc_CNXAGainLossOnChangeInFairValueOfDerivativesLiability_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_130" xlink:to="loc_CNXAGainLossOnChangeInFairValueOfDerivativesLiability_130" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DerivativeExpense" xlink:label="loc_CNXADerivativeExpense_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_130" xlink:to="loc_CNXADerivativeExpense_130" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_130" xlink:to="loc_us-gaapInterestExpense_130" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_130" xlink:to="loc_us-gaapNonoperatingIncomeExpense_130" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_130" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" xlink:label="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_130" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" xlink:label="loc_us-gaapDiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_130" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:label="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_130" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_IncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_CNXAIncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_CNXAIncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_130" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit_130" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapNetIncomeLoss_130" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_130" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_130" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTax_130" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossPerOutstandingLimitedPartnershipAndGeneralPartnershipUnitBasicAndDilutedAbstract" xlink:label="loc_us-gaapNetIncomeLossPerOutstandingLimitedPartnershipAndGeneralPartnershipUnitBasicAndDilutedAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapNetIncomeLossPerOutstandingLimitedPartnershipAndGeneralPartnershipUnitBasicAndDilutedAbstract_130" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsPerBasicShare_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsPerBasicShare_130" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsPerDilutedShare_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsPerDilutedShare_130" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_130" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_130" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapEarningsPerShareBasic_130" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted_130" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_130" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_130" xlink:type="arc" order="37" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/StatementOfChangesInShareholdersEquityDeficit" xlink:title="00000005 - Statement - Consolidated Statement of Changes in Shareholders&apos; Equity (Deficit) (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAxis" xlink:label="loc_srtRestatementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRestatementAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain" xlink:label="loc_srtRestatementDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRestatementAxis" xlink:to="loc_srtRestatementDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain" xlink:label="loc_srtRestatementDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRestatementAxis" xlink:to="loc_srtRestatementDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="loc_srtScenarioPreviouslyReportedMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRestatementDomain" xlink:to="loc_srtScenarioPreviouslyReportedMember_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_GamefaceLtdMember" xlink:label="loc_CNXAGamefaceLtdMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_CNXAGamefaceLtdMember_100" xlink:type="arc" order="103" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_PlaySightInteractiveLtdMember" xlink:label="loc_CNXAPlaySightInteractiveLtdMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_CNXAPlaySightInteractiveLtdMember_150" xlink:type="arc" order="153" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_210" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_210" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_StockIssuedDuringPeriodForAbstract" xlink:label="loc_CNXAStockIssuedDuringPeriodForAbstract_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_CNXAStockIssuedDuringPeriodForAbstract_210" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfUnits_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfUnits_210" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfUnits_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfUnits_210" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions_210" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_210" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_210" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_210" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_210" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_210" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueOther_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueOther_210" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther_210" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation_210" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_210" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_210" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_StockIssuedDuringPeriodValueAccountsPayable" xlink:label="loc_CNXAStockIssuedDuringPeriodValueAccountsPayable_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_CNXAStockIssuedDuringPeriodValueAccountsPayable_210" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_StockIssuedDuringPeriodSharesAccountsPayable" xlink:label="loc_CNXAStockIssuedDuringPeriodSharesAccountsPayable_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_CNXAStockIssuedDuringPeriodSharesAccountsPayable_210" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_StockIssuedDuringPeriodValueCashlessExerciseOfWarrants" xlink:label="loc_CNXAStockIssuedDuringPeriodValueCashlessExerciseOfWarrants_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_CNXAStockIssuedDuringPeriodValueCashlessExerciseOfWarrants_210" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_StockIssuedDuringPeriodCashlessExerciseOfWarrantsShares" xlink:label="loc_CNXAStockIssuedDuringPeriodCashlessExerciseOfWarrantsShares_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_CNXAStockIssuedDuringPeriodCashlessExerciseOfWarrantsShares_210" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_StockIssuedDuringPeriodValueSatisfactionOfProfitGuaranteeOnNotePayable" xlink:label="loc_CNXAStockIssuedDuringPeriodValueSatisfactionOfProfitGuaranteeOnNotePayable_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_CNXAStockIssuedDuringPeriodValueSatisfactionOfProfitGuaranteeOnNotePayable_210" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_StockIssuedDuringPeriodSharesSatisfactionOfProfitGuaranteeOnNotePayable" xlink:label="loc_CNXAStockIssuedDuringPeriodSharesSatisfactionOfProfitGuaranteeOnNotePayable_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_CNXAStockIssuedDuringPeriodSharesSatisfactionOfProfitGuaranteeOnNotePayable_210" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_StockIssuedDuringPeriodValueConversionofNotesPayableRelatedParties" xlink:label="loc_CNXAStockIssuedDuringPeriodValueConversionofNotesPayableRelatedParties_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_CNXAStockIssuedDuringPeriodValueConversionofNotesPayableRelatedParties_210" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_StockIssuedDuringPeriodShareConversionofNotesPayableRelatedParties" xlink:label="loc_CNXAStockIssuedDuringPeriodShareConversionofNotesPayableRelatedParties_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_CNXAStockIssuedDuringPeriodShareConversionofNotesPayableRelatedParties_210" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation_210" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalOther_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalOther_210" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_210" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_210" xlink:type="arc" order="28" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Consolidated Statements of Cash Flows (Unaudited)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/OrganizationAndNatureOfBusiness" xlink:title="00000007 - Disclosure - ORGANIZATION AND NATURE OF BUSINESS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/GoingConcern" xlink:title="00000008 - Disclosure - GOING CONCERN" />
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/ConcentrationOfCreditRiskAndOtherRisksAndUncertainties" xlink:title="00000010 - Disclosure - CONCENTRATION OF CREDIT RISK AND OTHER RISKS AND UNCERTAINTIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/IntangibleAssets" xlink:title="00000011 - Disclosure - INTANGIBLE ASSETS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/AccruedExpenses" xlink:title="00000012 - Disclosure - ACCRUED EXPENSES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/NotePayableRelatedParty" xlink:title="00000013 - Disclosure - NOTE PAYABLE &#8211; RELATED PARTY" />
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/ConvertibleNotesPayable" xlink:title="00000014 - Disclosure - CONVERTIBLE NOTES PAYABLE" />
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/NotesPayable" xlink:title="00000015 - Disclosure - NOTES PAYABLE" />
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/RelatedPartyTransactions" xlink:title="00000016 - Disclosure - RELATED PARTY TRANSACTIONS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/ShareholdersEquityDeficit" xlink:title="00000017 - Disclosure - SHAREHOLDERS&#8217; EQUITY (DEFICIT)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/CommitmentsAndContingencies" xlink:title="00000018 - Disclosure - COMMITMENTS AND CONTINGENCIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/DiscontinuedOperations" xlink:title="00000019 - Disclosure - DISCONTINUED OPERATIONS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/SubsequentEvents" xlink:title="00000020 - Disclosure - SUBSEQUENT EVENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/AcquisitionsAndBusinessCombinations" xlink:title="00000021 - Disclosure - ACQUISITIONS AND BUSINESS COMBINATIONS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/NotePayable-RelatedParty" xlink:title="00000022 - Disclosure - NOTE PAYABLE - RELATED PARTY" />
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/IncomeTaxes" xlink:title="00000023 - Disclosure - INCOME TAXES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/Segments" xlink:title="00000024 - Disclosure - SEGMENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:label="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:label="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_us-gaapWarrantMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" xlink:label="loc_us-gaapFairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapFairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_50" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/IntangibleAssetsTables" xlink:title="00000027 - Disclosure - INTANGIBLE ASSETS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/AccruedExpensesTables" xlink:title="00000028 - Disclosure - ACCRUED EXPENSES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/DiscontinuedOperationsTables" xlink:title="00000029 - Disclosure - DISCONTINUED OPERATIONS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/AcquisitionsAndBusinessCombinationsTables" xlink:title="00000030 - Disclosure - ACQUISITIONS AND BUSINESS COMBINATIONS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/NotePayable-RelatedPartyTables" xlink:title="00000031 - Disclosure - NOTE PAYABLE - RELATED PARTY (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/IncomeTaxesTables" xlink:title="00000032 - Disclosure - INCOME TAXES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementGeographicalAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IL" xlink:label="loc_countryIL_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryIL_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_40" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/OrganizationAndNatureOfBusinessDetailsNarrative" xlink:title="00000033 - Disclosure - ORGANIZATION AND NATURE OF BUSINESS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="loc_srtEquityMethodInvesteeNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="loc_srtEquityMethodInvesteeNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="loc_srtEquityMethodInvesteeNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="loc_srtEquityMethodInvesteeNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_SlingerBagAmericasIncMember" xlink:label="loc_CNXASlingerBagAmericasIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtEquityMethodInvesteeNameDomain" xlink:to="loc_CNXASlingerBagAmericasIncMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_SoleShareholderofSBLMember" xlink:label="loc_CNXASoleShareholderofSBLMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtEquityMethodInvesteeNameDomain" xlink:to="loc_CNXASoleShareholderofSBLMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_FoundationSportsSystemsLLCMember" xlink:label="loc_CNXAFoundationSportsSystemsLLCMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtEquityMethodInvesteeNameDomain" xlink:to="loc_CNXAFoundationSportsSystemsLLCMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_SlingerBagAmericasIncMember" xlink:label="loc_CNXASlingerBagAmericasIncMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_CNXASlingerBagAmericasIncMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_SoleShareholderofSBLMember" xlink:label="loc_CNXASoleShareholderofSBLMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_CNXASoleShareholderofSBLMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_StockPurchaseAgreementMember" xlink:label="loc_CNXAStockPurchaseAgreementMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_CNXAStockPurchaseAgreementMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_CharlesRuddyMember" xlink:label="loc_CNXACharlesRuddyMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_CNXACharlesRuddyMember_80" xlink:type="arc" order="82" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAxis" xlink:label="loc_srtRestatementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_srtRestatementAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain" xlink:label="loc_srtRestatementDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRestatementAxis" xlink:to="loc_srtRestatementDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain" xlink:label="loc_srtRestatementDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRestatementAxis" xlink:to="loc_srtRestatementDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="loc_srtScenarioPreviouslyReportedMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRestatementDomain" xlink:to="loc_srtScenarioPreviouslyReportedMember_120" xlink:type="arc" order="123" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_170" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="loc_us-gaapBusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapBusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_170" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:label="loc_us-gaapBusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapBusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_170" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_NumberOfSharesExchanged" xlink:label="loc_CNXANumberOfSharesExchanged_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_CNXANumberOfSharesExchanged_170" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_NumberOfSharesOwned" xlink:label="loc_CNXANumberOfSharesOwned_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_CNXANumberOfSharesOwned_170" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_us-gaapStockholdersEquityReverseStockSplit_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapStockholdersEquityReverseStockSplit_170" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapStockholdersEquity_170" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:label="loc_us-gaapGoodwillImpairedAccumulatedImpairmentLoss_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapGoodwillImpairedAccumulatedImpairmentLoss_170" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/GoingConcernDetailsNarrative" xlink:title="00000034 - Disclosure - GOING CONCERN (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MultiemployerPlansLineItems" xlink:label="loc_us-gaapMultiemployerPlansLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfMultiemployerPlansTable" xlink:label="loc_us-gaapScheduleOfMultiemployerPlansTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapMultiemployerPlansLineItems" xlink:to="loc_us-gaapScheduleOfMultiemployerPlansTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfMultiemployerPlansTable" xlink:to="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_PlaySightMember" xlink:label="loc_CNXAPlaySightMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="loc_CNXAPlaySightMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfMultiemployerPlansTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_FoundationSportsSystemsLLCMember" xlink:label="loc_CNXAFoundationSportsSystemsLLCMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_CNXAFoundationSportsSystemsLLCMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMultiemployerPlansLineItems" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DisposalEquityInterestOwnershipInterestPercentage" xlink:label="loc_CNXADisposalEquityInterestOwnershipInterestPercentage_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMultiemployerPlansLineItems" xlink:to="loc_CNXADisposalEquityInterestOwnershipInterestPercentage_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal" xlink:label="loc_us-gaapDiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMultiemployerPlansLineItems" xlink:to="loc_us-gaapDiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AlternativeInvestment" xlink:label="loc_us-gaapAlternativeInvestment_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMultiemployerPlansLineItems" xlink:to="loc_us-gaapAlternativeInvestment_90" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/ScheduleOfInventoryDetails" xlink:title="00000035 - Disclosure - SCHEDULE OF INVENTORY (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/ScheduleOfDerivativeLiabilitiesDetails" xlink:title="00000036 - Disclosure - SCHEDULE OF DERIVATIVE LIABILITIES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingAssetsLineItems" xlink:label="loc_us-gaapOffsettingAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingAssetsTable" xlink:label="loc_us-gaapOffsettingAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_us-gaapOffsettingAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaapDerivativeInstrumentRiskAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapOffsettingAssetsTable" xlink:to="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_ProfitGuarantyMember" xlink:label="loc_CNXAProfitGuarantyMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_CNXAProfitGuarantyMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_ConvertibleNotesMember" xlink:label="loc_CNXAConvertibleNotesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_CNXAConvertibleNotesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_UnderwriterWarrantsMember" xlink:label="loc_CNXAUnderwriterWarrantsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_CNXAUnderwriterWarrantsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_WarrantsIssuedWithCommonStockMember" xlink:label="loc_CNXAWarrantsIssuedWithCommonStockMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_CNXAWarrantsIssuedWithCommonStockMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_WarrantsIssuedWithNotesPayableMember" xlink:label="loc_CNXAWarrantsIssuedWithNotesPayableMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_CNXAWarrantsIssuedWithNotesPayableMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_OtherDerivativeLiabilitiesMember" xlink:label="loc_CNXAOtherDerivativeLiabilitiesMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_CNXAOtherDerivativeLiabilitiesMember_180" xlink:type="arc" order="181" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgesLiabilities" xlink:label="loc_us-gaapDerivativeInstrumentsAndHedgesLiabilities_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_us-gaapDerivativeInstrumentsAndHedgesLiabilities_270" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaapDerivativeGainLossOnDerivativeNet_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_us-gaapDerivativeGainLossOnDerivativeNet_270" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/ScheduleOfDerivativeAndWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails" xlink:title="00000037 - Disclosure - SCHEDULE OF DERIVATIVE AND WARRANTS GRANTED VALUATION USING BLACK-SCHOLES PRICING METHOD (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="loc_us-gaapMeasurementInputExpectedTermMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedTermMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaapMeasurementInputPriceVolatilityMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputPriceVolatilityMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaapMeasurementInputRiskFreeInterestRateMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputRiskFreeInterestRateMember_70" xlink:type="arc" order="72" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="loc_us-gaapMeasurementInputExpectedDividendRateMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedDividendRateMember_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="loc_us-gaapValuationTechniqueAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapValuationTechniqueAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:label="loc_us-gaapValuationTechniqueOptionPricingModelMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapValuationTechniqueDomain" xlink:to="loc_us-gaapValuationTechniqueOptionPricingModelMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DerivativeLiabilitiesMeasurementInputTerm" xlink:label="loc_CNXADerivativeLiabilitiesMeasurementInputTerm_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_CNXADerivativeLiabilitiesMeasurementInputTerm_270" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilityMeasurementInput" xlink:label="loc_us-gaapDerivativeLiabilityMeasurementInput_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapDerivativeLiabilityMeasurementInput_270" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/ScheduleOfWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails" xlink:title="00000038 - Disclosure - SCHEDULE OF WARRANTS GRANTED VALUATION USING BLACK-SCHOLES PRICING METHOD (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_us-gaapWarrantMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="loc_us-gaapValuationTechniqueAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapValuationTechniqueAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:label="loc_us-gaapValuationTechniqueOptionPricingModelMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapValuationTechniqueDomain" xlink:to="loc_us-gaapValuationTechniqueOptionPricingModelMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="loc_us-gaapMeasurementInputExpectedTermMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedTermMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaapMeasurementInputPriceVolatilityMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputPriceVolatilityMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaapMeasurementInputRiskFreeInterestRateMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputRiskFreeInterestRateMember_60" xlink:type="arc" order="63" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="loc_us-gaapMeasurementInputExpectedDividendRateMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedDividendRateMember_90" xlink:type="arc" order="93" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_10" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_20" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingTerm_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingTerm_260" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingMeasurementInput_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingMeasurementInput_260" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000039 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_PlatformOperatorCryptoAssetLineItems" xlink:label="loc_srtPlatformOperatorCryptoAssetLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_PlatformOperatorCryptoAssetTable" xlink:label="loc_srtPlatformOperatorCryptoAssetTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_srtPlatformOperatorCryptoAssetTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srtPlatformOperatorCryptoAssetTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srtPlatformOperatorCryptoAssetTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferred1_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferred1_110" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet_110" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="loc_us-gaapImpairmentOfIntangibleAssetsFinitelived_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapImpairmentOfIntangibleAssetsFinitelived_110" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetImpairmentCharges" xlink:label="loc_us-gaapAssetImpairmentCharges_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapAssetImpairmentCharges_110" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_RecognizedDerivativeExpense" xlink:label="loc_CNXARecognizedDerivativeExpense_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_CNXARecognizedDerivativeExpense_110" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaapGoodwillImpairmentLoss_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapGoodwillImpairmentLoss_110" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/ConcentrationOfCreditRiskAndOtherRisksAndUncertaintiesDetailsNarrative" xlink:title="00000040 - Disclosure - CONCENTRATION OF CREDIT RISK AND OTHER RISKS AND UNCERTAINTIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="loc_us-gaapConcentrationRiskLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTable" xlink:label="loc_us-gaapConcentrationRiskTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskLineItems" xlink:to="loc_us-gaapConcentrationRiskTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapAccountsReceivableMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableMember" xlink:label="loc_us-gaapAccountsPayableMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapAccountsPayableMember_20" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditConcentrationRiskMember" xlink:label="loc_us-gaapCreditConcentrationRiskMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapCreditConcentrationRiskMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LenderConcentrationRiskMember" xlink:label="loc_us-gaapLenderConcentrationRiskMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapLenderConcentrationRiskMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_srtMajorCustomersAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_CustomerTwoMember" xlink:label="loc_CNXACustomerTwoMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_CNXACustomerTwoMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_CustomerFourMember" xlink:label="loc_CNXACustomerFourMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_CNXACustomerFourMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_CustomerOneMember" xlink:label="loc_CNXACustomerOneMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_CNXACustomerOneMember_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1_80" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/ScheduleOfIntangibleAssetsDetails" xlink:title="00000041 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_TradeNamesAndPatentsMember" xlink:label="loc_CNXATradeNamesAndPatentsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_CNXATradeNamesAndPatentsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:label="loc_us-gaapComputerSoftwareIntangibleAssetMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapComputerSoftwareIntangibleAssetMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_IntangiableAssetMember" xlink:label="loc_CNXAIntangiableAssetMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_CNXAIntangiableAssetMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradeNamesMember" xlink:label="loc_us-gaapTradeNamesMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapTradeNamesMember_160" xlink:type="arc" order="161" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross_270" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_270" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="loc_us-gaapImpairmentOfIntangibleAssetsFinitelived_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapImpairmentOfIntangibleAssetsFinitelived_270" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet_270" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_270" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaapImpairmentOfIntangibleAssetsExcludingGoodwill_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapImpairmentOfIntangibleAssetsExcludingGoodwill_270" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/IntangibleAssetsDetailsNarrative" xlink:title="00000042 - Disclosure - INTANGIBLE ASSETS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_FoundationSportsSystemsLLCMember" xlink:label="loc_CNXAFoundationSportsSystemsLLCMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_CNXAFoundationSportsSystemsLLCMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PatentsMember" xlink:label="loc_us-gaapPatentsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapPatentsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="loc_us-gaapImpairmentOfIntangibleAssetsFinitelived_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapImpairmentOfIntangibleAssetsFinitelived_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIntangibleAssetsNet" xlink:label="loc_us-gaapOtherIntangibleAssetsNet_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapOtherIntangibleAssetsNet_70" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/ScheduleOfAccruedExpensesDetails" xlink:title="00000043 - Disclosure - SCHEDULE OF ACCRUED EXPENSES (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/NotePayableRelatedPartyDetailsNarrative" xlink:title="00000044 - Disclosure - NOTE PAYABLE &#8211; RELATED PARTY (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_LoanAgreementsMember" xlink:label="loc_CNXALoanAgreementsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_CNXALoanAgreementsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaapRelatedPartyMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapRelatedPartyMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LoansPayable" xlink:label="loc_us-gaapLoansPayable_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapLoansPayable_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapNotesPayable_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapInterestExpense_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPayableCurrent" xlink:label="loc_us-gaapInterestPayableCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapInterestPayableCurrent_90" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_PaymentForExchangeOfNotesPayable" xlink:label="loc_CNXAPaymentForExchangeOfNotesPayable_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_CNXAPaymentForExchangeOfNotesPayable_90" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_90" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/ConvertibleNotesPayableDetailsNarrative" xlink:title="00000045 - Disclosure - CONVERTIBLE NOTES PAYABLE (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_SecuritiesPurchaseAgreementMember" xlink:label="loc_CNXASecuritiesPurchaseAgreementMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_CNXASecuritiesPurchaseAgreementMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_OmnibusAgreementMember" xlink:label="loc_CNXAOmnibusAgreementMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_CNXAOmnibusAgreementMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="loc_us-gaapValuationTechniqueAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapValuationTechniqueAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_MonteCarloSimulationMember" xlink:label="loc_CNXAMonteCarloSimulationMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapValuationTechniqueDomain" xlink:to="loc_CNXAMonteCarloSimulationMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_ConvertibleNotesMember" xlink:label="loc_CNXAConvertibleNotesMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_CNXAConvertibleNotesMember_130" xlink:type="arc" order="131" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1_160" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentWarrantsOrOptionsIssued1_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentWarrantsOrOptionsIssued1_160" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapInterestPayableCurrentAndNoncurrent_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapInterestPayableCurrentAndNoncurrent_160" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscount_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscount_160" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_160" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleNotesPayable" xlink:label="loc_us-gaapConvertibleNotesPayable_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapConvertibleNotesPayable_160" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_WarrantsIssuedToPurchaseOfCommonStockShares" xlink:label="loc_CNXAWarrantsIssuedToPurchaseOfCommonStockShares_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_CNXAWarrantsIssuedToPurchaseOfCommonStockShares_160" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapProceedsFromConvertibleDebt_160" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate_160" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_160" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingTerm_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingTerm_160" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable" xlink:label="loc_us-gaapClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable_160" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_WarrantsExercisePrice" xlink:label="loc_CNXAWarrantsExercisePrice_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_CNXAWarrantsExercisePrice_160" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaapWarrantsAndRightsOutstanding_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstanding_160" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_RemainingDerivativeLiabilities" xlink:label="loc_CNXARemainingDerivativeLiabilities_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_CNXARemainingDerivativeLiabilities_160" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFinanceCostsNet" xlink:label="loc_us-gaapDeferredFinanceCostsNet_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDeferredFinanceCostsNet_160" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfUnits_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfUnits_160" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_LossOnIssuanceOfConvertibleNotes" xlink:label="loc_CNXALossOnIssuanceOfConvertibleNotes_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_CNXALossOnIssuanceOfConvertibleNotes_160" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_SecuritiesOutstandingRateConvertibleNotesDescripition" xlink:label="loc_CNXASecuritiesOutstandingRateConvertibleNotesDescripition_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_CNXASecuritiesOutstandingRateConvertibleNotesDescripition_160" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_160" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:label="loc_us-gaapDebtInstrumentIncreaseAccruedInterest_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentIncreaseAccruedInterest_160" xlink:type="arc" order="20" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/NotesPayableDetailsNarrative" xlink:title="00000046 - Disclosure - NOTES PAYABLE (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_PromissoryNotePayableMember" xlink:label="loc_CNXAPromissoryNotePayableMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_CNXAPromissoryNotePayableMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_NotesPayableMember" xlink:label="loc_CNXANotesPayableMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_CNXANotesPayableMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="loc_us-gaapValuationTechniqueAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapValuationTechniqueAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:label="loc_us-gaapValuationTechniqueOptionPricingModelMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapValuationTechniqueDomain" xlink:to="loc_us-gaapValuationTechniqueOptionPricingModelMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_UFSAgreementMember" xlink:label="loc_CNXAUFSAgreementMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_CNXAUFSAgreementMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_CedarAgreementMember" xlink:label="loc_CNXACedarAgreementMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_CNXACedarAgreementMember_150" xlink:type="arc" order="151" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_LoanAndSecurityAgreementMember" xlink:label="loc_CNXALoanAndSecurityAgreementMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_CNXALoanAndSecurityAgreementMember_180" xlink:type="arc" order="181" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_MegedAgreementMember" xlink:label="loc_CNXAMegedAgreementMember_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_CNXAMegedAgreementMember_290" xlink:type="arc" order="291" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_LoanAgreementMember" xlink:label="loc_CNXALoanAgreementMember_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_CNXALoanAgreementMember_300" xlink:type="arc" order="301" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_EachWeekForNextThreeWeeksMember" xlink:label="loc_CNXAEachWeekForNextThreeWeeksMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_CNXAEachWeekForNextThreeWeeksMember_130" xlink:type="arc" order="132" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_ThereafterPerWeekMember" xlink:label="loc_CNXAThereafterPerWeekMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_CNXAThereafterPerWeekMember_140" xlink:type="arc" order="142" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_ArmisticeCapitalMasterFundLtdMember" xlink:label="loc_CNXAArmisticeCapitalMasterFundLtdMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_CNXAArmisticeCapitalMasterFundLtdMember_180" xlink:type="arc" order="182" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_180" xlink:type="arc" order="183" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaapShortTermDebtTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapShortTermDebtTypeAxis" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_NotesMember" xlink:label="loc_CNXANotesMember_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_CNXANotesMember_190" xlink:type="arc" order="193" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember_220" xlink:type="arc" order="221" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_MontsaicInvestmentsLLCMember" xlink:label="loc_CNXAMontsaicInvestmentsLLCMember_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_CNXAMontsaicInvestmentsLLCMember_300" xlink:type="arc" order="302" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_ThirdPartyMember" xlink:label="loc_CNXAThirdPartyMember_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_CNXAThirdPartyMember_310" xlink:type="arc" order="312" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAxis" xlink:label="loc_srtRestatementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_srtRestatementAxis" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain" xlink:label="loc_srtRestatementDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRestatementAxis" xlink:to="loc_srtRestatementDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain" xlink:label="loc_srtRestatementDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRestatementAxis" xlink:to="loc_srtRestatementDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="loc_srtScenarioPreviouslyReportedMember_320" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRestatementDomain" xlink:to="loc_srtScenarioPreviouslyReportedMember_320" xlink:type="arc" order="322" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_410" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_410" xlink:type="arc" order="413" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_430" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionOriginalDebtInterestRateOfDebt" xlink:label="loc_us-gaapDebtConversionOriginalDebtInterestRateOfDebt_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtConversionOriginalDebtInterestRateOfDebt_430" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="loc_us-gaapDebtInstrumentCarryingAmount_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentCarryingAmount_430" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt_430" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentAmount1_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentAmount1_430" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilities" xlink:label="loc_us-gaapDerivativeLiabilities_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDerivativeLiabilities_430" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeNet" xlink:label="loc_us-gaapDerivativeFairValueOfDerivativeNet_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDerivativeFairValueOfDerivativeNet_430" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferredOther1" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferredOther1_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferredOther1_430" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_NumberOfConsignedGoods" xlink:label="loc_CNXANumberOfConsignedGoods_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_CNXANumberOfConsignedGoods_430" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_PaymentsOfRelatedPartyDebt" xlink:label="loc_CNXAPaymentsOfRelatedPartyDebt_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_CNXAPaymentsOfRelatedPartyDebt_430" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapNotesPayable_430" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate_430" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_430" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedPerTransaction_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedPerTransaction_430" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireReceivables" xlink:label="loc_us-gaapPaymentsToAcquireReceivables_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapPaymentsToAcquireReceivables_430" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_CashLessFees" xlink:label="loc_CNXACashLessFees_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_CNXACashLessFees_430" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_430" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaapProceedsFromNotesPayable_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapProceedsFromNotesPayable_430" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_430" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_430" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentOfWarrantsGrantedForServices" xlink:label="loc_us-gaapAdjustmentOfWarrantsGrantedForServices_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapAdjustmentOfWarrantsGrantedForServices_430" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DerivativeExpense" xlink:label="loc_CNXADerivativeExpense_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_CNXADerivativeExpense_430" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilityFairValueOfCollateral" xlink:label="loc_us-gaapDerivativeLiabilityFairValueOfCollateral_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDerivativeLiabilityFairValueOfCollateral_430" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_IncreaseDecreaseInDerivativeFairValueLiability" xlink:label="loc_CNXAIncreaseDecreaseInDerivativeFairValueLiability_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_CNXAIncreaseDecreaseInDerivativeFairValueLiability_430" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium_430" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateIncreaseDecrease" xlink:label="loc_us-gaapDebtInstrumentInterestRateIncreaseDecrease_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateIncreaseDecrease_430" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:label="loc_us-gaapStockRedeemedOrCalledDuringPeriodValue_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapStockRedeemedOrCalledDuringPeriodValue_430" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LegalFees" xlink:label="loc_us-gaapLegalFees_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapLegalFees_430" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfOtherDebt" xlink:label="loc_us-gaapRepaymentsOfOtherDebt_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapRepaymentsOfOtherDebt_430" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:label="loc_us-gaapDerivativeAssetsLiabilitiesAtFairValueNet_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDerivativeAssetsLiabilitiesAtFairValueNet_430" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfDebt" xlink:label="loc_us-gaapRepaymentsOfDebt_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapRepaymentsOfDebt_430" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteStockSplit" xlink:label="loc_us-gaapStockholdersEquityNoteStockSplit_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapStockholdersEquityNoteStockSplit_430" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_SharesIssuedPricePerShares" xlink:label="loc_CNXASharesIssuedPricePerShares_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_CNXASharesIssuedPricePerShares_430" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDerivativeLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInDerivativeLiabilities_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapIncreaseDecreaseInDerivativeLiabilities_430" xlink:type="arc" order="33" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000047 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaapRelatedPartyTransactionLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaapRelatedPartyMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapRelatedPartyMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapNotesPayable_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapInterestPayableCurrentAndNoncurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapInterestPayableCurrentAndNoncurrent_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapRevenues_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNet" xlink:label="loc_us-gaapAccountsReceivableNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapAccountsReceivableNet_90" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative" xlink:title="00000048 - Disclosure - SHAREHOLDERS&#8217; EQUITY (DEFICIT) (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestorMember" xlink:label="loc_us-gaapInvestorMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_us-gaapInvestorMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_GabrielGoldmanMember" xlink:label="loc_CNXAGabrielGoldmanMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_CNXAGabrielGoldmanMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_RelatedPartyLenderMember" xlink:label="loc_CNXARelatedPartyLenderMember_410" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_CNXARelatedPartyLenderMember_410" xlink:type="arc" order="411" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_TwoEmployeesMember" xlink:label="loc_CNXATwoEmployeesMember_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_CNXATwoEmployeesMember_430" xlink:type="arc" order="432" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_VendorMember" xlink:label="loc_CNXAVendorMember_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_CNXAVendorMember_450" xlink:type="arc" order="452" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_SixNewBrandAmbassadorsMember" xlink:label="loc_CNXASixNewBrandAmbassadorsMember_470" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_CNXASixNewBrandAmbassadorsMember_470" xlink:type="arc" order="472" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_BrandAmbassadorsMember" xlink:label="loc_CNXABrandAmbassadorsMember_490" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_CNXABrandAmbassadorsMember_490" xlink:type="arc" order="491" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_VendorOneMember" xlink:label="loc_CNXAVendorOneMember_560" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_CNXAVendorOneMember_560" xlink:type="arc" order="562" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_KeyEmployeesAndOfficersMember" xlink:label="loc_CNXAKeyEmployeesAndOfficersMember_570" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_CNXAKeyEmployeesAndOfficersMember_570" xlink:type="arc" order="572" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_ServiceProviderMember" xlink:label="loc_CNXAServiceProviderMember_590" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_CNXAServiceProviderMember_590" xlink:type="arc" order="592" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_ThreeMembersMember" xlink:label="loc_CNXAThreeMembersMember_610" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_CNXAThreeMembersMember_610" xlink:type="arc" order="612" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_LeadPlacementAgentMember" xlink:label="loc_CNXALeadPlacementAgentMember_660" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_CNXALeadPlacementAgentMember_660" xlink:type="arc" order="662" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_GamefaceAIMember" xlink:label="loc_CNXAGamefaceAIMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_CNXAGamefaceAIMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_MidcityCapitalLtdMember" xlink:label="loc_CNXAMidcityCapitalLtdMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_CNXAMidcityCapitalLtdMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_ArmisticeCapitalMasterFundLtdMember" xlink:label="loc_CNXAArmisticeCapitalMasterFundLtdMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_CNXAArmisticeCapitalMasterFundLtdMember_200" xlink:type="arc" order="202" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_SecuritiesPurchaseAgreementMember" xlink:label="loc_CNXASecuritiesPurchaseAgreementMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_CNXASecuritiesPurchaseAgreementMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_LoanAndSecurityAgreementMember" xlink:label="loc_CNXALoanAndSecurityAgreementMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_CNXALoanAndSecurityAgreementMember_200" xlink:type="arc" order="201" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_FiveYearWarrantsMember" xlink:label="loc_CNXAFiveYearWarrantsMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_CNXAFiveYearWarrantsMember_110" xlink:type="arc" order="113" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_SevenYearWarrantsMember" xlink:label="loc_CNXASevenYearWarrantsMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_CNXASevenYearWarrantsMember_120" xlink:type="arc" order="123" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_SevenPointFiveYearWarrantsMember" xlink:label="loc_CNXASevenPointFiveYearWarrantsMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_CNXASevenPointFiveYearWarrantsMember_130" xlink:type="arc" order="133" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_200" xlink:type="arc" order="203" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaapShortTermDebtTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapShortTermDebtTypeAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_NotesMember" xlink:label="loc_CNXANotesMember_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_CNXANotesMember_210" xlink:type="arc" order="213" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAxis" xlink:label="loc_srtRestatementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRestatementAxis" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain" xlink:label="loc_srtRestatementDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRestatementAxis" xlink:to="loc_srtRestatementDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain" xlink:label="loc_srtRestatementDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRestatementAxis" xlink:to="loc_srtRestatementDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="loc_srtScenarioPreviouslyReportedMember_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRestatementDomain" xlink:to="loc_srtScenarioPreviouslyReportedMember_260" xlink:type="arc" order="261" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_FoundationSportsSystemsLLCMember" xlink:label="loc_CNXAFoundationSportsSystemsLLCMember_420" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_CNXAFoundationSportsSystemsLLCMember_420" xlink:type="arc" order="421" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_GamefaceMember" xlink:label="loc_CNXAGamefaceMember_750" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_CNXAGamefaceMember_750" xlink:type="arc" order="751" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtProductOrServiceAxis" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_ServicesRenderedInLieuOfCashMember" xlink:label="loc_CNXAServicesRenderedInLieuOfCashMember_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_CNXAServicesRenderedInLieuOfCashMember_430" xlink:type="arc" order="431" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_MarketingAndAdvisoryServicesMember" xlink:label="loc_CNXAMarketingAndAdvisoryServicesMember_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_CNXAMarketingAndAdvisoryServicesMember_450" xlink:type="arc" order="451" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_AsCompensationMember" xlink:label="loc_CNXAAsCompensationMember_470" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_CNXAAsCompensationMember_470" xlink:type="arc" order="471" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_SecuritiesPurchaseAgreementMember" xlink:label="loc_CNXASecuritiesPurchaseAgreementMember_650" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_CNXASecuritiesPurchaseAgreementMember_650" xlink:type="arc" order="651" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_ExercisePriceOneMember" xlink:label="loc_CNXAExercisePriceOneMember_690" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_CNXAExercisePriceOneMember_690" xlink:type="arc" order="693" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_ExercisePriceTwoMember" xlink:label="loc_CNXAExercisePriceTwoMember_710" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_CNXAExercisePriceTwoMember_710" xlink:type="arc" order="713" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_470" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapCommonStockMember_470" xlink:type="arc" order="473" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaapEmployeeStockOptionMember_480" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapEmployeeStockOptionMember_480" xlink:type="arc" order="484" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_680" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapWarrantMember_680" xlink:type="arc" order="682" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_NotePayableHolderMember" xlink:label="loc_CNXANotePayableHolderMember_500" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_CNXANotePayableHolderMember_500" xlink:type="arc" order="501" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_RelatedPartyLenderMember" xlink:label="loc_CNXARelatedPartyLenderMember_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_CNXARelatedPartyLenderMember_520" xlink:type="arc" order="521" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_570" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_570" xlink:type="arc" order="571" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_590" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember_590" xlink:type="arc" order="591" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_780" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_780" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_780" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_780" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_780" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_780" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_780" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_780" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaapSharesIssued_780" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssued_780" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_780" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_780" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_StockIssuedDuringPeriodSharesIssuedSettlementOfAccountsPayable" xlink:label="loc_CNXAStockIssuedDuringPeriodSharesIssuedSettlementOfAccountsPayable_780" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_CNXAStockIssuedDuringPeriodSharesIssuedSettlementOfAccountsPayable_780" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_StockIssuedDuringPeriodSharesIssuedSettlementWithFormerOwners" xlink:label="loc_CNXAStockIssuedDuringPeriodSharesIssuedSettlementWithFormerOwners_780" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_CNXAStockIssuedDuringPeriodSharesIssuedSettlementWithFormerOwners_780" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_780" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_780" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_StockIssuedDuringPeriodSharesIssuedProfitGuaranteeOnNote" xlink:label="loc_CNXAStockIssuedDuringPeriodSharesIssuedProfitGuaranteeOnNote_780" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_CNXAStockIssuedDuringPeriodSharesIssuedProfitGuaranteeOnNote_780" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_780" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_780" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1_780" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1_780" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_780" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_780" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_780" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_780" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_WarrantPerShare" xlink:label="loc_CNXAWarrantPerShare_780" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_CNXAWarrantPerShare_780" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaapWarrantsAndRightsOutstanding_780" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstanding_780" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_780" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_780" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock_780" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock_780" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_780" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_780" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_780" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_780" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateEffectivePercentage_780" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateEffectivePercentage_780" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaapProceedsFromNotesPayable_780" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromNotesPayable_780" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_SharesIssuedPricePerShares" xlink:label="loc_CNXASharesIssuedPricePerShares_780" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_CNXASharesIssuedPricePerShares_780" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_780" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_780" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_780" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_780" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_780" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_780" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_780" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_780" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions_780" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions_780" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensationGross_780" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensationGross_780" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensationGross_780" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensationGross_780" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense_780" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense_780" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_780" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_780" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="loc_us-gaapConversionOfStockSharesConverted1_780" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConversionOfStockSharesConverted1_780" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_780" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_780" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingTerm_780" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingTerm_780" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_780" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_780" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_WarrantsIssuedToPurchaseOfCommonStockShares" xlink:label="loc_CNXAWarrantsIssuedToPurchaseOfCommonStockShares_780" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_CNXAWarrantsIssuedToPurchaseOfCommonStockShares_780" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses_780" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingExpenses_780" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_780" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_780" xlink:type="arc" order="38" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000049 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesLineItems" xlink:label="loc_us-gaapLossContingenciesLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesTable" xlink:label="loc_us-gaapLossContingenciesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapLossContingenciesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapLossContingenciesTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAxis" xlink:label="loc_srtRestatementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapLossContingenciesTable" xlink:to="loc_srtRestatementAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain" xlink:label="loc_srtRestatementDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRestatementAxis" xlink:to="loc_srtRestatementDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain" xlink:label="loc_srtRestatementDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRestatementAxis" xlink:to="loc_srtRestatementDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="loc_srtScenarioPreviouslyReportedMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRestatementDomain" xlink:to="loc_srtScenarioPreviouslyReportedMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRent" xlink:label="loc_us-gaapPaymentsForRent_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapPaymentsForRent_120" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_FairValueOfCommonStock" xlink:label="loc_CNXAFairValueOfCommonStock_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_CNXAFairValueOfCommonStock_120" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_120" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaapBusinessCombinationContingentConsiderationLiability_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapBusinessCombinationContingentConsiderationLiability_120" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapStockholdersEquity_120" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/ScheduleOfDiscontinuedOperationsDetails" xlink:title="00000050 - Disclosure - SCHEDULE OF DISCONTINUED OPERATIONS (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/DiscontinuedOperationsDetailsNarrative" xlink:title="00000051 - Disclosure - DISCONTINUED OPERATIONS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_SharePurchaseAgreementMember" xlink:label="loc_CNXASharePurchaseAgreementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_CNXASharePurchaseAgreementMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_EmployeeAgreementMember" xlink:label="loc_CNXAEmployeeAgreementMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_CNXAEmployeeAgreementMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipAxis" xlink:label="loc_srtOwnershipAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_srtOwnershipAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain" xlink:label="loc_srtOwnershipDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtOwnershipAxis" xlink:to="loc_srtOwnershipDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain" xlink:label="loc_srtOwnershipDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtOwnershipAxis" xlink:to="loc_srtOwnershipDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_FoundationSportsToCharlesRuddyMember" xlink:label="loc_CNXAFoundationSportsToCharlesRuddyMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtOwnershipDomain" xlink:to="loc_CNXAFoundationSportsToCharlesRuddyMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_SharesIssuedAndOutstandingPercentage" xlink:label="loc_CNXASharesIssuedAndOutstandingPercentage_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_CNXASharesIssuedAndOutstandingPercentage_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDescriptionAndTimingOfDisposal" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationDescriptionAndTimingOfDisposal_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationDescriptionAndTimingOfDisposal_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationConsideration_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationConsideration_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="loc_us-gaapMinorityInterestOwnershipPercentageByParent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapMinorityInterestOwnershipPercentageByParent_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:label="loc_us-gaapMinorityInterestOwnershipPercentageByNoncontrollingOwners_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapMinorityInterestOwnershipPercentageByNoncontrollingOwners_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapCash_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Investments" xlink:label="loc_us-gaapInvestments_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapInvestments_60" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000052 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSubsequentEventTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_WarrantOneMember" xlink:label="loc_CNXAWarrantOneMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_CNXAWarrantOneMember_200" xlink:type="arc" order="201" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember_220" xlink:type="arc" order="221" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_WarrantTwoMember" xlink:label="loc_CNXAWarrantTwoMember_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_CNXAWarrantTwoMember_230" xlink:type="arc" order="231" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_RodneyRapsonMember" xlink:label="loc_CNXARodneyRapsonMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_CNXARodneyRapsonMember_10" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_UFSAgreementMember" xlink:label="loc_CNXAUFSAgreementMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_CNXAUFSAgreementMember_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_AmendedUFSAgreementMember" xlink:label="loc_CNXAAmendedUFSAgreementMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_CNXAAmendedUFSAgreementMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_SecondMegedAgreementMember" xlink:label="loc_CNXASecondMegedAgreementMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_CNXASecondMegedAgreementMember_80" xlink:type="arc" order="82" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_MegedAgreementMember" xlink:label="loc_CNXAMegedAgreementMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_CNXAMegedAgreementMember_120" xlink:type="arc" order="122" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_EachWeekForNextThreeWeeksMember" xlink:label="loc_CNXAEachWeekForNextThreeWeeksMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_CNXAEachWeekForNextThreeWeeksMember_60" xlink:type="arc" order="63" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_PreFundedWarrantMember" xlink:label="loc_CNXAPreFundedWarrantMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_CNXAPreFundedWarrantMember_160" xlink:type="arc" order="161" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_270" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_270" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedPerTransaction_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedPerTransaction_270" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireReceivables" xlink:label="loc_us-gaapPaymentsToAcquireReceivables_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapPaymentsToAcquireReceivables_270" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_CashLessFees" xlink:label="loc_CNXACashLessFees_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_CNXACashLessFees_270" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaapSharesIssued_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSharesIssued_270" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_270" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_StockIssuedDuringPeriodSharesIssuedSettlementOfAccountsPayable" xlink:label="loc_CNXAStockIssuedDuringPeriodSharesIssuedSettlementOfAccountsPayable_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_CNXAStockIssuedDuringPeriodSharesIssuedSettlementOfAccountsPayable_270" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_StockIssuedDuringPeriodSharesIssuedSettlementWithFormerOwners" xlink:label="loc_CNXAStockIssuedDuringPeriodSharesIssuedSettlementWithFormerOwners_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_CNXAStockIssuedDuringPeriodSharesIssuedSettlementWithFormerOwners_270" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_270" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_StockIssuedDuringPeriodSharesIssuedProfitGuaranteeOnNote" xlink:label="loc_CNXAStockIssuedDuringPeriodSharesIssuedProfitGuaranteeOnNote_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_CNXAStockIssuedDuringPeriodSharesIssuedProfitGuaranteeOnNote_270" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares_270" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_270" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_270" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_270" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingTerm_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingTerm_270" xlink:type="arc" order="15" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/ScheduleOfProformaFinancialInformationDetails" xlink:title="00000053 - Disclosure - SCHEDULE OF PROFORMA FINANCIAL INFORMATION (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaapBusinessAcquisitionLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_PlaySightAndGameFaceMember" xlink:label="loc_CNXAPlaySightAndGameFaceMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_CNXAPlaySightAndGameFaceMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="loc_us-gaapBusinessAcquisitionsProFormaRevenue_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessAcquisitionsProFormaRevenue_20" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="loc_us-gaapBusinessAcquisitionsProFormaNetIncomeLoss_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessAcquisitionsProFormaNetIncomeLoss_20" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:label="loc_us-gaapBusinessAcquisitionProFormaEarningsPerShareBasic_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessAcquisitionProFormaEarningsPerShareBasic_20" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:label="loc_us-gaapBusinessAcquisitionProFormaEarningsPerShareDiluted_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessAcquisitionProFormaEarningsPerShareDiluted_20" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/ScheduleOfEstimatedFutureAmortizationDetails" xlink:title="00000054 - Disclosure - SCHEDULE OF ESTIMATED FUTURE AMORTIZATION (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/AcquisitionsAndBusinessCombinationsDetailsNarrative" xlink:title="00000055 - Disclosure - ACQUISITIONS AND BUSINESS COMBINATIONS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaapBusinessAcquisitionLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_FoundationSportsMember" xlink:label="loc_CNXAFoundationSportsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_CNXAFoundationSportsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_FoundationSportsSystemsLLCMember" xlink:label="loc_CNXAFoundationSportsSystemsLLCMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_CNXAFoundationSportsSystemsLLCMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_PlaySightMember" xlink:label="loc_CNXAPlaySightMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_CNXAPlaySightMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DisposalEquityInterestOwnershipInterestPercentage" xlink:label="loc_CNXADisposalEquityInterestOwnershipInterestPercentage_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_CNXADisposalEquityInterestOwnershipInterestPercentage_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal" xlink:label="loc_us-gaapDiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapDiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AlternativeInvestment" xlink:label="loc_us-gaapAlternativeInvestment_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapAlternativeInvestment_50" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/ScheduleOfWarrantsIssuedExercisedAndExpiredDetails" xlink:title="00000056 - Disclosure - SCHEDULE OF WARRANTS ISSUED, EXERCISED AND EXPIRED (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/NotePayable-RelatedPartyDetailsNarrative" xlink:title="00000057 - Disclosure - NOTE PAYABLE - RELATED PARTY (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_LoanAgreementsMember" xlink:label="loc_CNXALoanAgreementsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_CNXALoanAgreementsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaapRelatedPartyMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapRelatedPartyMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LoansPayable" xlink:label="loc_us-gaapLoansPayable_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapLoansPayable_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapNotesPayable_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapInterestExpense_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPayableCurrent" xlink:label="loc_us-gaapInterestPayableCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapInterestPayableCurrent_70" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/ScheduleOfNetDeferredTaxAssetsDetails" xlink:title="00000058 - Disclosure - SCHEDULE OF NET DEFERRED TAX ASSETS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementGeographicalAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IL" xlink:label="loc_countryIL_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryIL_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DeferredTaxAssetsStockOptions" xlink:label="loc_CNXADeferredTaxAssetsStockOptions_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_CNXADeferredTaxAssetsStockOptions_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DeferredTaxAssetsAccruedPayroll" xlink:label="loc_CNXADeferredTaxAssetsAccruedPayroll_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_CNXADeferredTaxAssetsAccruedPayroll_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DeferredTaxAssetsRelatedPartyAccruals" xlink:label="loc_CNXADeferredTaxAssetsRelatedPartyAccruals_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_CNXADeferredTaxAssetsRelatedPartyAccruals_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsInventory" xlink:label="loc_us-gaapDeferredTaxAssetsInventory_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsInventory_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DeferredTaxAssetsInterestDeferral" xlink:label="loc_CNXADeferredTaxAssetsInterestDeferral_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_CNXADeferredTaxAssetsInterestDeferral_50" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DeferredTaxAssetsStartupCosts" xlink:label="loc_CNXADeferredTaxAssetsStartupCosts_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_CNXADeferredTaxAssetsStartupCosts_50" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="loc_us-gaapDeferredTaxAssetsOther_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsOther_50" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance_50" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsNet_50" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsForeign_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsForeign_50" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DeferredTaxAssetsStartupCostsForeign" xlink:label="loc_CNXADeferredTaxAssetsStartupCostsForeign_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_CNXADeferredTaxAssetsStartupCostsForeign_50" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DeferredTaxAssetsInProcessResearchAndDevelopmentCosts" xlink:label="loc_CNXADeferredTaxAssetsInProcessResearchAndDevelopmentCosts_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_CNXADeferredTaxAssetsInProcessResearchAndDevelopmentCosts_50" xlink:type="arc" order="12" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/ScheduleOfIncomeTaxProvisionDetails" xlink:title="00000059 - Disclosure - SCHEDULE OF INCOME TAX PROVISION (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="loc_us-gaapOperatingLossCarryforwardsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="loc_us-gaapOperatingLossCarryforwardsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwardsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_us-gaapIncomeTaxAuthorityNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeTaxAuthorityNameAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeTaxAuthorityNameAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IsraelTaxAuthorityMember" xlink:label="loc_us-gaapIsraelTaxAuthorityMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityNameDomain" xlink:to="loc_us-gaapIsraelTaxAuthorityMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapIncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapIncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_IncomeTaxReconciliationDebtDiscountAmortization" xlink:label="loc_CNXAIncomeTaxReconciliationDebtDiscountAmortization_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_CNXAIncomeTaxReconciliationDebtDiscountAmortization_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_IncomeTaxReconciliationRelatedPartyAccruals" xlink:label="loc_CNXAIncomeTaxReconciliationRelatedPartyAccruals_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_CNXAIncomeTaxReconciliationRelatedPartyAccruals_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_IncomeTaxReconciliationStartUpCosts" xlink:label="loc_CNXAIncomeTaxReconciliationStartUpCosts_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_CNXAIncomeTaxReconciliationStartUpCosts_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_IncomeTaxRecociliationInterestExpense" xlink:label="loc_CNXAIncomeTaxRecociliationInterestExpense_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_CNXAIncomeTaxRecociliationInterestExpense_50" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseDepreciation" xlink:label="loc_us-gaapIncomeTaxReconciliationNondeductibleExpenseDepreciation_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapIncomeTaxReconciliationNondeductibleExpenseDepreciation_50" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_IncomeTaxRecociliationInventoryReserve" xlink:label="loc_CNXAIncomeTaxRecociliationInventoryReserve_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_CNXAIncomeTaxRecociliationInventoryReserve_50" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_IncomeTaxRecociliationInterestDeferral" xlink:label="loc_CNXAIncomeTaxRecociliationInterestDeferral_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_CNXAIncomeTaxRecociliationInterestDeferral_50" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_IncomeTaxRecociliationAcquisitionCosts" xlink:label="loc_CNXAIncomeTaxRecociliationAcquisitionCosts_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_CNXAIncomeTaxRecociliationAcquisitionCosts_50" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_IncomeTaxRecociliationAccruedLegal" xlink:label="loc_CNXAIncomeTaxRecociliationAccruedLegal_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_CNXAIncomeTaxRecociliationAccruedLegal_50" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_IncomeTaxRecociliationLossOnExtinguishmentOfDebt" xlink:label="loc_CNXAIncomeTaxRecociliationLossOnExtinguishmentOfDebt_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_CNXAIncomeTaxRecociliationLossOnExtinguishmentOfDebt_50" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_IncomeTaxRecociliationAccruedPayroll" xlink:label="loc_CNXAIncomeTaxRecociliationAccruedPayroll_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_CNXAIncomeTaxRecociliationAccruedPayroll_50" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_IncomeTaxRecociliationGainOnChangeInFairValueOfDerivatives" xlink:label="loc_CNXAIncomeTaxRecociliationGainOnChangeInFairValueOfDerivatives_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_CNXAIncomeTaxRecociliationGainOnChangeInFairValueOfDerivatives_50" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:label="loc_us-gaapIncomeTaxReconciliationNondeductibleExpenseOther_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapIncomeTaxReconciliationNondeductibleExpenseOther_50" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_50" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit_50" xlink:type="arc" order="16" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/ScheduleOfNetDeferredTaxAssetsDetailsParenthetical" xlink:title="00000060 - Disclosure - SCHEDULE OF NET DEFERRED TAX ASSETS (Details) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementGeographicalAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IL" xlink:label="loc_countryIL_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryIL_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_20" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/ScheduleOfIncomeTaxProvisionDetailsParenthetical" xlink:title="00000061 - Disclosure - SCHEDULE OF INCOME TAX PROVISION (Details) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementGeographicalAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IL" xlink:label="loc_countryIL_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryIL_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_20" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000062 - Disclosure - INCOME TAXES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementGeographicalAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US" xlink:label="loc_countryUS_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryUS_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwards_60" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://connexasports.com/role/ScheduleOfCalculationOfLossOnDisposalDetails" xlink:title="00000063 - Disclosure - SCHEDULE OF CALCULATION OF THE LOSS ON DISPOSAL (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MultiemployerPlansLineItems" xlink:label="loc_us-gaapMultiemployerPlansLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfMultiemployerPlansTable" xlink:label="loc_us-gaapScheduleOfMultiemployerPlansTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapMultiemployerPlansLineItems" xlink:to="loc_us-gaapScheduleOfMultiemployerPlansTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfMultiemployerPlansTable" xlink:to="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_PlaySightAndFoundationSportsMember" xlink:label="loc_CNXAPlaySightAndFoundationSportsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="loc_CNXAPlaySightAndFoundationSportsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMultiemployerPlansLineItems" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_20" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMultiemployerPlansLineItems" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_20" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DisposalGroupIncludingDiscontinuedOperationAccountsReceivable" xlink:label="loc_CNXADisposalGroupIncludingDiscontinuedOperationAccountsReceivable_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMultiemployerPlansLineItems" xlink:to="loc_CNXADisposalGroupIncludingDiscontinuedOperationAccountsReceivable_20" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMultiemployerPlansLineItems" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_20" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationInventory1_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMultiemployerPlansLineItems" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationInventory1_20" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOtherAssets_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMultiemployerPlansLineItems" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOtherAssets_20" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DisposalGroupIncludingDiscontinuedOperationContractAssets" xlink:label="loc_CNXADisposalGroupIncludingDiscontinuedOperationContractAssets_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMultiemployerPlansLineItems" xlink:to="loc_CNXADisposalGroupIncludingDiscontinuedOperationContractAssets_20" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DisposalGroupIncludingDiscontinuedOperationRightOfUseAsset" xlink:label="loc_CNXADisposalGroupIncludingDiscontinuedOperationRightOfUseAsset_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMultiemployerPlansLineItems" xlink:to="loc_CNXADisposalGroupIncludingDiscontinuedOperationRightOfUseAsset_20" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationGoodwill1_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMultiemployerPlansLineItems" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationGoodwill1_20" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMultiemployerPlansLineItems" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_20" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationIntangibleAssets_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMultiemployerPlansLineItems" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationIntangibleAssets_20" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DisposalGroupIncludingDiscontinuedOperationContractLiabilities" xlink:label="loc_CNXADisposalGroupIncludingDiscontinuedOperationContractLiabilities_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMultiemployerPlansLineItems" xlink:to="loc_CNXADisposalGroupIncludingDiscontinuedOperationContractLiabilities_20" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOtherLiabilities_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMultiemployerPlansLineItems" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOtherLiabilities_20" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMultiemployerPlansLineItems" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_20" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DisposalGroupIncludingDiscontinuedOperationLossOnDisposalOfDiscontinuedOperations" xlink:label="loc_CNXADisposalGroupIncludingDiscontinuedOperationLossOnDisposalOfDiscontinuedOperations_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMultiemployerPlansLineItems" xlink:to="loc_CNXADisposalGroupIncludingDiscontinuedOperationLossOnDisposalOfDiscontinuedOperations_20" xlink:type="arc" order="14" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>16
<FILENAME>cnxa-20230731_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.20b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="dei_EntityAddressesAddressTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_EntityAddressesAddressTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesAddressTypeAxis_lbl" xml:lang="en-US">Entity Addresses, Address Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_BusinessContactMember" xlink:label="dei_BusinessContactMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_BusinessContactMember" xlink:to="dei_BusinessContactMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_BusinessContactMember_lbl" xml:lang="en-US">Business Contact [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related Party, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonrelatedPartyMember" xlink:label="us-gaap_NonrelatedPartyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonrelatedPartyMember" xlink:to="us-gaap_NonrelatedPartyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonrelatedPartyMember_lbl" xml:lang="en-US">Nonrelated Party [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember" xlink:label="us-gaap_RelatedPartyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyMember" xlink:to="us-gaap_RelatedPartyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyMember_lbl" xml:lang="en-US">Related Party [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAxis" xlink:label="srt_RestatementAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RestatementAxis_lbl" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="srt_ScenarioPreviouslyReportedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioPreviouslyReportedMember" xlink:to="srt_ScenarioPreviouslyReportedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScenarioPreviouslyReportedMember_lbl" xml:lang="en-US">Previously Reported [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xml:lang="en-US">Business Acquisition [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_GamefaceLtdMember" xlink:label="CNXA_GamefaceLtdMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_GamefaceLtdMember" xlink:to="CNXA_GamefaceLtdMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_GamefaceLtdMember_lbl" xml:lang="en-US">Gameface Ltd [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_PlaySightInteractiveLtdMember" xlink:label="CNXA_PlaySightInteractiveLtdMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_PlaySightInteractiveLtdMember" xlink:to="CNXA_PlaySightInteractiveLtdMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_PlaySightInteractiveLtdMember_lbl" xml:lang="en-US">Play Sight Interactive Ltd [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" xml:lang="en-US">Investment, Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_SlingerBagAmericasIncMember" xlink:label="CNXA_SlingerBagAmericasIncMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_SlingerBagAmericasIncMember" xlink:to="CNXA_SlingerBagAmericasIncMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_SlingerBagAmericasIncMember_lbl" xml:lang="en-US">Slinger Bag Americas Inc [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_StockPurchaseAgreementMember" xlink:label="CNXA_StockPurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_StockPurchaseAgreementMember" xlink:to="CNXA_StockPurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_StockPurchaseAgreementMember_lbl" xml:lang="en-US">Stock Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_SoleShareholderofSBLMember" xlink:label="CNXA_SoleShareholderofSBLMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_SoleShareholderofSBLMember" xlink:to="CNXA_SoleShareholderofSBLMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_SoleShareholderofSBLMember_lbl" xml:lang="en-US">Sole Shareholder of SBL [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_FoundationSportsSystemsLLCMember" xlink:label="CNXA_FoundationSportsSystemsLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_FoundationSportsSystemsLLCMember" xlink:to="CNXA_FoundationSportsSystemsLLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_FoundationSportsSystemsLLCMember_lbl" xml:lang="en-US">Foundation Sports Systems LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US">Title of Individual [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_CharlesRuddyMember" xlink:label="CNXA_CharlesRuddyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_CharlesRuddyMember" xlink:to="CNXA_CharlesRuddyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_CharlesRuddyMember_lbl" xml:lang="en-US">Charles Ruddy [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_lbl" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_PlaySightMember" xlink:label="CNXA_PlaySightMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_PlaySightMember" xlink:to="CNXA_PlaySightMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_PlaySightMember_lbl" xml:lang="en-US">Play Sight [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US">Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_FinancialInstrumentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancialInstrumentAxis_lbl" xml:lang="en-US">Financial Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="us-gaap_DerivativeInstrumentRiskAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentRiskAxis" xlink:to="us-gaap_DerivativeInstrumentRiskAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentRiskAxis_lbl" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_ProfitGuarantyMember" xlink:label="CNXA_ProfitGuarantyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_ProfitGuarantyMember" xlink:to="CNXA_ProfitGuarantyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_ProfitGuarantyMember_lbl" xml:lang="en-US">Profit Guaranty [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_ConvertibleNotesMember" xlink:label="CNXA_ConvertibleNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_ConvertibleNotesMember" xlink:to="CNXA_ConvertibleNotesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_ConvertibleNotesMember_lbl" xml:lang="en-US">Convertible Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_UnderwriterWarrantsMember" xlink:label="CNXA_UnderwriterWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_UnderwriterWarrantsMember" xlink:to="CNXA_UnderwriterWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_UnderwriterWarrantsMember_lbl" xml:lang="en-US">Underwriter Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_WarrantsIssuedWithCommonStockMember" xlink:label="CNXA_WarrantsIssuedWithCommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_WarrantsIssuedWithCommonStockMember" xlink:to="CNXA_WarrantsIssuedWithCommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_WarrantsIssuedWithCommonStockMember_lbl" xml:lang="en-US">Warrants Issued With Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_WarrantsIssuedWithNotesPayableMember" xlink:label="CNXA_WarrantsIssuedWithNotesPayableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_WarrantsIssuedWithNotesPayableMember" xlink:to="CNXA_WarrantsIssuedWithNotesPayableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_WarrantsIssuedWithNotesPayableMember_lbl" xml:lang="en-US">Warrants Issued With Notes Payable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_OtherDerivativeLiabilitiesMember" xlink:label="CNXA_OtherDerivativeLiabilitiesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_OtherDerivativeLiabilitiesMember" xlink:to="CNXA_OtherDerivativeLiabilitiesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_OtherDerivativeLiabilitiesMember_lbl" xml:lang="en-US">Other Derivative Liabilities [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="us-gaap_MeasurementInputTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputTypeAxis_lbl" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="us-gaap_MeasurementInputExpectedTermMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExpectedTermMember" xlink:to="us-gaap_MeasurementInputExpectedTermMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputExpectedTermMember_lbl" xml:lang="en-US">Measurement Input, Expected Term [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="us-gaap_ValuationTechniqueAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationTechniqueAxis" xlink:to="us-gaap_ValuationTechniqueAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationTechniqueAxis_lbl" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:label="us-gaap_ValuationTechniqueOptionPricingModelMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:to="us-gaap_ValuationTechniqueOptionPricingModelMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationTechniqueOptionPricingModelMember_lbl" xml:lang="en-US">Valuation Technique, Option Pricing Model [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputPriceVolatilityMember" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember_lbl" xml:lang="en-US">Measurement Input, Price Volatility [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" xml:lang="en-US">Measurement Input, Risk Free Interest Rate [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExpectedDividendRateMember" xlink:to="us-gaap_MeasurementInputExpectedDividendRateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember_lbl" xml:lang="en-US">Measurement Input, Expected Dividend Rate [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableMember" xlink:label="us-gaap_AccountsReceivableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableMember" xlink:to="us-gaap_AccountsReceivableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableMember_lbl" xml:lang="en-US">Accounts Receivable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_lbl" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditConcentrationRiskMember" xlink:label="us-gaap_CreditConcentrationRiskMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CreditConcentrationRiskMember" xlink:to="us-gaap_CreditConcentrationRiskMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CreditConcentrationRiskMember_lbl" xml:lang="en-US">Credit Concentration Risk [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis" xlink:label="srt_MajorCustomersAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_MajorCustomersAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MajorCustomersAxis_lbl" xml:lang="en-US">Customer [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_CustomerTwoMember" xlink:label="CNXA_CustomerTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_CustomerTwoMember" xlink:to="CNXA_CustomerTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_CustomerTwoMember_lbl" xml:lang="en-US">Customer Two [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LenderConcentrationRiskMember" xlink:label="us-gaap_LenderConcentrationRiskMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LenderConcentrationRiskMember" xlink:to="us-gaap_LenderConcentrationRiskMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LenderConcentrationRiskMember_lbl" xml:lang="en-US">Lender Concentration Risk [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_CustomerFourMember" xlink:label="CNXA_CustomerFourMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_CustomerFourMember" xlink:to="CNXA_CustomerFourMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_CustomerFourMember_lbl" xml:lang="en-US">Customer Four [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableMember" xlink:label="us-gaap_AccountsPayableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableMember" xlink:to="us-gaap_AccountsPayableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableMember_lbl" xml:lang="en-US">Accounts Payable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_CustomerOneMember" xlink:label="CNXA_CustomerOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_CustomerOneMember" xlink:to="CNXA_CustomerOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_CustomerOneMember_lbl" xml:lang="en-US">Customer One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_TradeNamesAndPatentsMember" xlink:label="CNXA_TradeNamesAndPatentsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_TradeNamesAndPatentsMember" xlink:to="CNXA_TradeNamesAndPatentsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_TradeNamesAndPatentsMember_lbl" xml:lang="en-US">Trade Names And Patents [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="us-gaap_CustomerRelationshipsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerRelationshipsMember" xlink:to="us-gaap_CustomerRelationshipsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerRelationshipsMember_lbl" xml:lang="en-US">Customer Relationships [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:label="us-gaap_ComputerSoftwareIntangibleAssetMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:to="us-gaap_ComputerSoftwareIntangibleAssetMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComputerSoftwareIntangibleAssetMember_lbl" xml:lang="en-US">Computer Software, Intangible Asset [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_IntangiableAssetMember" xlink:label="CNXA_IntangiableAssetMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_IntangiableAssetMember" xlink:to="CNXA_IntangiableAssetMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_IntangiableAssetMember_lbl" xml:lang="en-US">Intangiable Asset [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradeNamesMember" xlink:label="us-gaap_TradeNamesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradeNamesMember" xlink:to="us-gaap_TradeNamesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TradeNamesMember_lbl" xml:lang="en-US">Trade Names [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LegalEntityAxis_lbl" xml:lang="en-US">Legal Entity [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PatentsMember" xlink:label="us-gaap_PatentsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PatentsMember" xlink:to="us-gaap_PatentsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PatentsMember_lbl" xml:lang="en-US">Patents [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_LoanAgreementsMember" xlink:label="CNXA_LoanAgreementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_LoanAgreementsMember" xlink:to="CNXA_LoanAgreementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_LoanAgreementsMember_lbl" xml:lang="en-US">Loan Agreements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_SecuritiesPurchaseAgreementMember" xlink:label="CNXA_SecuritiesPurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_SecuritiesPurchaseAgreementMember" xlink:to="CNXA_SecuritiesPurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_SecuritiesPurchaseAgreementMember_lbl" xml:lang="en-US">Securities Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_MonteCarloSimulationMember" xlink:label="CNXA_MonteCarloSimulationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_MonteCarloSimulationMember" xlink:to="CNXA_MonteCarloSimulationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_MonteCarloSimulationMember_lbl" xml:lang="en-US">Monte Carlo Simulation [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_OmnibusAgreementMember" xlink:label="CNXA_OmnibusAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_OmnibusAgreementMember" xlink:to="CNXA_OmnibusAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_OmnibusAgreementMember_lbl" xml:lang="en-US">Omnibus Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xml:lang="en-US">Debt Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_PromissoryNotePayableMember" xlink:label="CNXA_PromissoryNotePayableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_PromissoryNotePayableMember" xlink:to="CNXA_PromissoryNotePayableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_PromissoryNotePayableMember_lbl" xml:lang="en-US">Promissory Note Payable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_NotesPayableMember" xlink:label="CNXA_NotesPayableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_NotesPayableMember" xlink:to="CNXA_NotesPayableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_NotesPayableMember_lbl" xml:lang="en-US">Notes Payable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_UFSAgreementMember" xlink:label="CNXA_UFSAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_UFSAgreementMember" xlink:to="CNXA_UFSAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_UFSAgreementMember_lbl" xml:lang="en-US">UFS Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementScenarioAxis_lbl" xml:lang="en-US">Scenario [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_EachWeekForNextThreeWeeksMember" xlink:label="CNXA_EachWeekForNextThreeWeeksMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_EachWeekForNextThreeWeeksMember" xlink:to="CNXA_EachWeekForNextThreeWeeksMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_EachWeekForNextThreeWeeksMember_lbl" xml:lang="en-US">Each Week for Next Three Weeks [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_ThereafterPerWeekMember" xlink:label="CNXA_ThereafterPerWeekMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_ThereafterPerWeekMember" xlink:to="CNXA_ThereafterPerWeekMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_ThereafterPerWeekMember_lbl" xml:lang="en-US">Thereafter Per Week [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_CedarAgreementMember" xlink:label="CNXA_CedarAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_CedarAgreementMember" xlink:to="CNXA_CedarAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_CedarAgreementMember_lbl" xml:lang="en-US">Cedar Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_LoanAndSecurityAgreementMember" xlink:label="CNXA_LoanAndSecurityAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_LoanAndSecurityAgreementMember" xlink:to="CNXA_LoanAndSecurityAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_LoanAndSecurityAgreementMember_lbl" xml:lang="en-US">Loan and Security Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_ArmisticeCapitalMasterFundLtdMember" xlink:label="CNXA_ArmisticeCapitalMasterFundLtdMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_ArmisticeCapitalMasterFundLtdMember" xlink:to="CNXA_ArmisticeCapitalMasterFundLtdMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_ArmisticeCapitalMasterFundLtdMember_lbl" xml:lang="en-US">Armistice Capital Master Fund Ltd [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="us-gaap_ShortTermDebtTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermDebtTypeAxis_lbl" xml:lang="en-US">Short-Term Debt, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_NotesMember" xlink:label="CNXA_NotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_NotesMember" xlink:to="CNXA_NotesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_NotesMember_lbl" xml:lang="en-US">Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_MegedAgreementMember" xlink:label="CNXA_MegedAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_MegedAgreementMember" xlink:to="CNXA_MegedAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_MegedAgreementMember_lbl" xml:lang="en-US">Meged Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_LoanAgreementMember" xlink:label="CNXA_LoanAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_LoanAgreementMember" xlink:to="CNXA_LoanAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_LoanAgreementMember_lbl" xml:lang="en-US">Loan Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_MontsaicInvestmentsLLCMember" xlink:label="CNXA_MontsaicInvestmentsLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_MontsaicInvestmentsLLCMember" xlink:to="CNXA_MontsaicInvestmentsLLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_MontsaicInvestmentsLLCMember_lbl" xml:lang="en-US">Montsaic Investments, LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_ThirdPartyMember" xlink:label="CNXA_ThirdPartyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_ThirdPartyMember" xlink:to="CNXA_ThirdPartyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_ThirdPartyMember_lbl" xml:lang="en-US">Third Party [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestorMember" xlink:label="us-gaap_InvestorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestorMember" xlink:to="us-gaap_InvestorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestorMember_lbl" xml:lang="en-US">Investor [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_GabrielGoldmanMember" xlink:label="CNXA_GabrielGoldmanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_GabrielGoldmanMember" xlink:to="CNXA_GabrielGoldmanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_GabrielGoldmanMember_lbl" xml:lang="en-US">Gabriel Goldman [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_GamefaceAIMember" xlink:label="CNXA_GamefaceAIMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_GamefaceAIMember" xlink:to="CNXA_GamefaceAIMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_GamefaceAIMember_lbl" xml:lang="en-US">Gameface AI [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_MidcityCapitalLtdMember" xlink:label="CNXA_MidcityCapitalLtdMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_MidcityCapitalLtdMember" xlink:to="CNXA_MidcityCapitalLtdMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_MidcityCapitalLtdMember_lbl" xml:lang="en-US">Midcity Capital Ltd [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_lbl" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_FiveYearWarrantsMember" xlink:label="CNXA_FiveYearWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_FiveYearWarrantsMember" xlink:to="CNXA_FiveYearWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_FiveYearWarrantsMember_lbl" xml:lang="en-US">5-Year Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_SevenYearWarrantsMember" xlink:label="CNXA_SevenYearWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_SevenYearWarrantsMember" xlink:to="CNXA_SevenYearWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_SevenYearWarrantsMember_lbl" xml:lang="en-US">7-Year Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_SevenPointFiveYearWarrantsMember" xlink:label="CNXA_SevenPointFiveYearWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_SevenPointFiveYearWarrantsMember" xlink:to="CNXA_SevenPointFiveYearWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_SevenPointFiveYearWarrantsMember_lbl" xml:lang="en-US">7.5 -Year Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_RelatedPartyLenderMember" xlink:label="CNXA_RelatedPartyLenderMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_RelatedPartyLenderMember" xlink:to="CNXA_RelatedPartyLenderMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_RelatedPartyLenderMember_lbl" xml:lang="en-US">Related Party Lender [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ProductOrServiceAxis_lbl" xml:lang="en-US">Product and Service [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_ServicesRenderedInLieuOfCashMember" xlink:label="CNXA_ServicesRenderedInLieuOfCashMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_ServicesRenderedInLieuOfCashMember" xlink:to="CNXA_ServicesRenderedInLieuOfCashMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_ServicesRenderedInLieuOfCashMember_lbl" xml:lang="en-US">Services rendered in lieu of cash [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_TwoEmployeesMember" xlink:label="CNXA_TwoEmployeesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_TwoEmployeesMember" xlink:to="CNXA_TwoEmployeesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_TwoEmployeesMember_lbl" xml:lang="en-US">Two Employees [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_MarketingAndAdvisoryServicesMember" xlink:label="CNXA_MarketingAndAdvisoryServicesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_MarketingAndAdvisoryServicesMember" xlink:to="CNXA_MarketingAndAdvisoryServicesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_MarketingAndAdvisoryServicesMember_lbl" xml:lang="en-US">Marketing And Advisory Services [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_VendorMember" xlink:label="CNXA_VendorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_VendorMember" xlink:to="CNXA_VendorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_VendorMember_lbl" xml:lang="en-US">Vendor [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_AsCompensationMember" xlink:label="CNXA_AsCompensationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_AsCompensationMember" xlink:to="CNXA_AsCompensationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_AsCompensationMember_lbl" xml:lang="en-US">As Compensation [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_SixNewBrandAmbassadorsMember" xlink:label="CNXA_SixNewBrandAmbassadorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_SixNewBrandAmbassadorsMember" xlink:to="CNXA_SixNewBrandAmbassadorsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_SixNewBrandAmbassadorsMember_lbl" xml:lang="en-US">Six New Brand Ambassadors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_BrandAmbassadorsMember" xlink:label="CNXA_BrandAmbassadorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_BrandAmbassadorsMember" xlink:to="CNXA_BrandAmbassadorsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_BrandAmbassadorsMember_lbl" xml:lang="en-US">Brand Ambassadors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_NotePayableHolderMember" xlink:label="CNXA_NotePayableHolderMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_NotePayableHolderMember" xlink:to="CNXA_NotePayableHolderMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_NotePayableHolderMember_lbl" xml:lang="en-US">Note Payable Holder [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_VendorOneMember" xlink:label="CNXA_VendorOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_VendorOneMember" xlink:to="CNXA_VendorOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_VendorOneMember_lbl" xml:lang="en-US">Vendor One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_KeyEmployeesAndOfficersMember" xlink:label="CNXA_KeyEmployeesAndOfficersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_KeyEmployeesAndOfficersMember" xlink:to="CNXA_KeyEmployeesAndOfficersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_KeyEmployeesAndOfficersMember_lbl" xml:lang="en-US">Key Employees and Officers [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_ServiceProviderMember" xlink:label="CNXA_ServiceProviderMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_ServiceProviderMember" xlink:to="CNXA_ServiceProviderMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_ServiceProviderMember_lbl" xml:lang="en-US">Service Provider [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_ThreeMembersMember" xlink:label="CNXA_ThreeMembersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_ThreeMembersMember" xlink:to="CNXA_ThreeMembersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_ThreeMembersMember_lbl" xml:lang="en-US">Three Members [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_LeadPlacementAgentMember" xlink:label="CNXA_LeadPlacementAgentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_LeadPlacementAgentMember" xlink:to="CNXA_LeadPlacementAgentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_LeadPlacementAgentMember_lbl" xml:lang="en-US">Lead Placement Agent [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_ExercisePriceOneMember" xlink:label="CNXA_ExercisePriceOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_ExercisePriceOneMember" xlink:to="CNXA_ExercisePriceOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_ExercisePriceOneMember_lbl" xml:lang="en-US">Exercise Price One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_ExercisePriceTwoMember" xlink:label="CNXA_ExercisePriceTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_ExercisePriceTwoMember" xlink:to="CNXA_ExercisePriceTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_ExercisePriceTwoMember_lbl" xml:lang="en-US">Exercise Price Two [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_GamefaceMember" xlink:label="CNXA_GamefaceMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_GamefaceMember" xlink:to="CNXA_GamefaceMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_GamefaceMember_lbl" xml:lang="en-US">Gameface [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_SharePurchaseAgreementMember" xlink:label="CNXA_SharePurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_SharePurchaseAgreementMember" xlink:to="CNXA_SharePurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_SharePurchaseAgreementMember_lbl" xml:lang="en-US">Share Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_EmployeeAgreementMember" xlink:label="CNXA_EmployeeAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_EmployeeAgreementMember" xlink:to="CNXA_EmployeeAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_EmployeeAgreementMember_lbl" xml:lang="en-US">Employee Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipAxis" xlink:label="srt_OwnershipAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_OwnershipAxis" xlink:to="srt_OwnershipAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_OwnershipAxis_lbl" xml:lang="en-US">Ownership [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_FoundationSportsToCharlesRuddyMember" xlink:label="CNXA_FoundationSportsToCharlesRuddyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_FoundationSportsToCharlesRuddyMember" xlink:to="CNXA_FoundationSportsToCharlesRuddyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_FoundationSportsToCharlesRuddyMember_lbl" xml:lang="en-US">Foundation Sports To Charles Ruddy [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_RodneyRapsonMember" xlink:label="CNXA_RodneyRapsonMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_RodneyRapsonMember" xlink:to="CNXA_RodneyRapsonMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_RodneyRapsonMember_lbl" xml:lang="en-US">Rodney Rapson [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_AmendedUFSAgreementMember" xlink:label="CNXA_AmendedUFSAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_AmendedUFSAgreementMember" xlink:to="CNXA_AmendedUFSAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_AmendedUFSAgreementMember_lbl" xml:lang="en-US">Amended U F S Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_SecondMegedAgreementMember" xlink:label="CNXA_SecondMegedAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_SecondMegedAgreementMember" xlink:to="CNXA_SecondMegedAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_SecondMegedAgreementMember_lbl" xml:lang="en-US">Second Meged Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_PreFundedWarrantMember" xlink:label="CNXA_PreFundedWarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_PreFundedWarrantMember" xlink:to="CNXA_PreFundedWarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_PreFundedWarrantMember_lbl" xml:lang="en-US">Pre Funded Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_WarrantOneMember" xlink:label="CNXA_WarrantOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_WarrantOneMember" xlink:to="CNXA_WarrantOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_WarrantOneMember_lbl" xml:lang="en-US">Warrant One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_WarrantTwoMember" xlink:label="CNXA_WarrantTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_WarrantTwoMember" xlink:to="CNXA_WarrantTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_WarrantTwoMember_lbl" xml:lang="en-US">Warrant Two [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_FoundationSportsMember" xlink:label="CNXA_FoundationSportsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_FoundationSportsMember" xlink:to="CNXA_FoundationSportsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_FoundationSportsMember_lbl" xml:lang="en-US">Foundation Sports [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_PlaySightAndGameFaceMember" xlink:label="CNXA_PlaySightAndGameFaceMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_PlaySightAndGameFaceMember" xlink:to="CNXA_PlaySightAndGameFaceMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_PlaySightAndGameFaceMember_lbl" xml:lang="en-US">Play Sight And Game Face [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementGeographicalAxis_lbl" xml:lang="en-US">Geographical [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US" xlink:label="country_US" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_US" xlink:to="country_US_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_US_lbl" xml:lang="en-US">UNITED STATES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IL" xlink:label="country_IL" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_IL" xlink:to="country_IL_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_IL_lbl" xml:lang="en-US">ISRAEL</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="us-gaap_IncomeTaxAuthorityNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="us-gaap_IncomeTaxAuthorityNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxAuthorityNameAxis_lbl" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IsraelTaxAuthorityMember" xlink:label="us-gaap_IsraelTaxAuthorityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IsraelTaxAuthorityMember" xlink:to="us-gaap_IsraelTaxAuthorityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IsraelTaxAuthorityMember_lbl" xml:lang="en-US">Israel Tax Authority [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_PlaySightAndFoundationSportsMember" xlink:label="CNXA_PlaySightAndFoundationSportsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_PlaySightAndFoundationSportsMember" xlink:to="CNXA_PlaySightAndFoundationSportsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_PlaySightAndFoundationSportsMember_lbl" xml:lang="en-US">Play Sight And Foundation Sports [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesTable" xlink:label="dei_EntityAddressesTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesTable" xlink:to="dei_EntityAddressesTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesTable_lbl" xml:lang="en-US">Entity Addresses [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesLineItems" xlink:label="dei_EntityAddressesLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityAddressesLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesLineItems_lbl" xml:lang="en-US">Entity Addresses [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ContactPersonnelName" xlink:label="dei_ContactPersonnelName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_ContactPersonnelName" xlink:to="dei_ContactPersonnelName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_ContactPersonnelName_lbl" xml:lang="en-US">Contact Personnel Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current Assets:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US">Accounts receivable, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryNet_lbl" xml:lang="en-US">Inventories, net</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_PrepaidInventoryCurrent" xlink:label="CNXA_PrepaidInventoryCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_PrepaidInventoryCurrent" xlink:to="CNXA_PrepaidInventoryCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_PrepaidInventoryCurrent_lbl" xml:lang="en-US">Prepaid inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommodityContractAssetCurrent" xlink:label="us-gaap_CommodityContractAssetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommodityContractAssetCurrent" xlink:to="us-gaap_CommodityContractAssetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommodityContractAssetCurrent_lbl" xml:lang="en-US">Contract assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:label="us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_lbl" xml:lang="en-US">Current assets of discontinued operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="us-gaap_AssetsNoncurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_AssetsNoncurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNoncurrentAbstract_lbl" xml:lang="en-US">Non-Current Assets:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivables" xlink:label="us-gaap_OtherReceivables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherReceivables" xlink:to="us-gaap_OtherReceivables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherReceivables_lbl" xml:lang="en-US">Note receivable - former subsidiary</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Fixed assets, net of depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xml:lang="en-US">Intangible assets, net of amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Goodwill_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent_lbl" xml:lang="en-US">Non-current assets of discontinued operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent" xlink:label="us-gaap_AssetsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_AssetsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsNoncurrent_lbl" xml:lang="en-US">Total Non-Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">TOTAL ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">LIABILITIES AND SHAREHOLDERS&#8217; EQUITY (DEFICIT)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAbstract" xlink:label="us-gaap_LiabilitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_LiabilitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAbstract_lbl" xml:lang="en-US">LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current Liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PurchaseObligation" xlink:label="us-gaap_PurchaseObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PurchaseObligation" xlink:to="us-gaap_PurchaseObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PurchaseObligation_lbl" xml:lang="en-US">Related party purchase obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" xml:lang="en-US">Contract liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPayableCurrent" xlink:label="us-gaap_InterestPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPayableCurrent" xlink:to="us-gaap_InterestPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPayableCurrent_lbl" xml:lang="en-US">Accrued interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNotesPayableCurrent" xlink:label="us-gaap_OtherNotesPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNotesPayableCurrent" xlink:to="us-gaap_OtherNotesPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNotesPayableCurrent_lbl" xml:lang="en-US">Current portion of notes payable, net of discount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleNotesPayableCurrent" xlink:label="us-gaap_ConvertibleNotesPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleNotesPayableCurrent" xlink:to="us-gaap_ConvertibleNotesPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleNotesPayableCurrent_lbl" xml:lang="en-US">Current portion of convertible notes payable, net of discount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilitiesCurrent" xlink:label="us-gaap_DerivativeLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLiabilitiesCurrent" xlink:to="us-gaap_DerivativeLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeLiabilitiesCurrent_lbl" xml:lang="en-US">Derivative liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:to="us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_lbl" xml:lang="en-US">Contingent consideration</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xml:lang="en-US">Other current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:label="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_lbl" xml:lang="en-US">Current liabilities of discontinued operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total Current Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xml:lang="en-US">Long-Term Liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermNotesPayable" xlink:label="us-gaap_LongTermNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermNotesPayable" xlink:to="us-gaap_LongTermNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermNotesPayable_lbl" xml:lang="en-US">Notes payable related parties, net of current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent" xlink:label="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent" xlink:to="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent_lbl" xml:lang="en-US">Non-current liabilities of discontinued operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="us-gaap_LiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesNoncurrent_lbl" xml:lang="en-US">Total Long-Term Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and contingency</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">SHAREHOLDERS&#8217; EQUITY (DEFICIT)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xml:lang="en-US">Additional paid in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-US">Accumulated other comprehensive income (loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total Stockholders&#8217; Equity (Deficit)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">TOTAL LIABILITIES AND STOCKHOLDERS&#8217; EQUITY (DEFICIT)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_lbl" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="us-gaap_DefinedBenefitPlanDisclosureLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="us-gaap_DefinedBenefitPlanDisclosureLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanDisclosureLineItems_lbl" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xml:lang="en-US">NET SALES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="us-gaap_CostOfGoodsAndServicesSold" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSold" xlink:to="us-gaap_CostOfGoodsAndServicesSold_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfGoodsAndServicesSold_lbl" xml:lang="en-US">COST OF SALES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_GrossProfit_lbl" xml:lang="en-US">GROSS PROFIT</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">OPERATING EXPENSES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="us-gaap_SellingAndMarketingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpense" xlink:to="us-gaap_SellingAndMarketingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingAndMarketingExpense_lbl" xml:lang="en-US">Selling and marketing expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US">Total Operating Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">OPERATING LOSS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US">NON-OPERATING INCOME (EXPENSE)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl" xml:lang="en-US">Amortization of debt discounts</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xml:lang="en-US">Loss on extinguishment of debt</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_GainLossOnIssuanceOfConvertibleNotes" xlink:label="CNXA_GainLossOnIssuanceOfConvertibleNotes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_GainLossOnIssuanceOfConvertibleNotes" xlink:to="CNXA_GainLossOnIssuanceOfConvertibleNotes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_GainLossOnIssuanceOfConvertibleNotes_lbl" xml:lang="en-US">Loss on issuance of convertible notes</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_GainLossOnChangeInFairValueOfContingentConsideration" xlink:label="CNXA_GainLossOnChangeInFairValueOfContingentConsideration" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_GainLossOnChangeInFairValueOfContingentConsideration" xlink:to="CNXA_GainLossOnChangeInFairValueOfContingentConsideration_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_GainLossOnChangeInFairValueOfContingentConsideration_lbl" xml:lang="en-US">Gain on change in fair value of contingent consideration</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_LossOnConversionOfAccountsPayableToCommonStock" xlink:label="CNXA_LossOnConversionOfAccountsPayableToCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_LossOnConversionOfAccountsPayableToCommonStock" xlink:to="CNXA_LossOnConversionOfAccountsPayableToCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_LossOnConversionOfAccountsPayableToCommonStock_lbl" xml:lang="en-US">Loss on conversion of accounts payable to common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_GainLossOnChangeInFairValueOfDerivativesLiability" xlink:label="CNXA_GainLossOnChangeInFairValueOfDerivativesLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_GainLossOnChangeInFairValueOfDerivativesLiability" xlink:to="CNXA_GainLossOnChangeInFairValueOfDerivativesLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_GainLossOnChangeInFairValueOfDerivativesLiability_lbl" xml:lang="en-US">Change in fair value of derivative liability</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DerivativeExpense" xlink:label="CNXA_DerivativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_DerivativeExpense" xlink:to="CNXA_DerivativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="CNXA_DerivativeExpense_lbl" xml:lang="en-US">Derivative expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestExpense_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US">Total Non-Operating Income (Expenses)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">NET LOSS FROM CONTINUING OPERATIONS BEFORE PROVISION FOR INCOME TAXES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" xlink:label="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" xlink:to="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_lbl" xml:lang="en-US">Loss from discontinued operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" xlink:label="us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" xlink:to="us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_lbl" xml:lang="en-US">Loss on disposal of subsidiaries</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:label="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:to="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_lbl" xml:lang="en-US">LOSS FROM DISCONTINUED OPERATIONS</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_IncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="CNXA_IncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_IncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="CNXA_IncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="CNXA_IncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">NET LOSS FROM OPERATIONS BEFORE PROVISION FOR INCOME TAXES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Provision for income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">NET LOSS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_lbl" xml:lang="en-US">Other comprehensive income (loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl" xml:lang="en-US">Foreign currency translations adjustment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xml:lang="en-US">Comprehensive income (loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossPerOutstandingLimitedPartnershipAndGeneralPartnershipUnitBasicAndDilutedAbstract" xlink:label="us-gaap_NetIncomeLossPerOutstandingLimitedPartnershipAndGeneralPartnershipUnitBasicAndDilutedAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossPerOutstandingLimitedPartnershipAndGeneralPartnershipUnitBasicAndDilutedAbstract" xlink:to="us-gaap_NetIncomeLossPerOutstandingLimitedPartnershipAndGeneralPartnershipUnitBasicAndDilutedAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossPerOutstandingLimitedPartnershipAndGeneralPartnershipUnitBasicAndDilutedAbstract_lbl" xml:lang="en-US">Net income (loss) per share - basic and diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:label="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:to="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_lbl" xml:lang="en-US">Continuing operations basic</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:label="us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:to="us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_lbl" xml:lang="en-US">Continuing operations diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:to="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_lbl" xml:lang="en-US">Discontinued operations basic</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:to="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_lbl" xml:lang="en-US">Discontinued operations diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Net loss per share - basic</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Net loss per share - diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Weighted average common shares outstanding - basic</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Weighted average common shares outstanding - diluted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Balance - May 1, 2022</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_StockIssuedDuringPeriodForAbstract" xlink:label="CNXA_StockIssuedDuringPeriodForAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_StockIssuedDuringPeriodForAbstract" xlink:to="CNXA_StockIssuedDuringPeriodForAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_StockIssuedDuringPeriodForAbstract_lbl" xml:lang="en-US">Stock issued for:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_lbl" xml:lang="en-US">Conversion of shares issuable (liability)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_lbl" xml:lang="en-US">Conversion of shares issuable (liability), shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl" xml:lang="en-US">Acquisition</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" xml:lang="en-US">Acquisitions, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xml:lang="en-US">Services</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xml:lang="en-US">Services, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Cash, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xml:lang="en-US">Fractional share issuance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xml:lang="en-US">Fractional share issuance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl" xml:lang="en-US">Share-based compensation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_lbl" xml:lang="en-US">Change in comprehensive income (loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net loss for the period</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_StockIssuedDuringPeriodValueAccountsPayable" xlink:label="CNXA_StockIssuedDuringPeriodValueAccountsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_StockIssuedDuringPeriodValueAccountsPayable" xlink:to="CNXA_StockIssuedDuringPeriodValueAccountsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="CNXA_StockIssuedDuringPeriodValueAccountsPayable_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_StockIssuedDuringPeriodSharesAccountsPayable" xlink:label="CNXA_StockIssuedDuringPeriodSharesAccountsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_StockIssuedDuringPeriodSharesAccountsPayable" xlink:to="CNXA_StockIssuedDuringPeriodSharesAccountsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_StockIssuedDuringPeriodSharesAccountsPayable_lbl" xml:lang="en-US">Accounts payable, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_StockIssuedDuringPeriodValueCashlessExerciseOfWarrants" xlink:label="CNXA_StockIssuedDuringPeriodValueCashlessExerciseOfWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_StockIssuedDuringPeriodValueCashlessExerciseOfWarrants" xlink:to="CNXA_StockIssuedDuringPeriodValueCashlessExerciseOfWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_StockIssuedDuringPeriodValueCashlessExerciseOfWarrants_lbl" xml:lang="en-US">Cashless exercise of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_StockIssuedDuringPeriodCashlessExerciseOfWarrantsShares" xlink:label="CNXA_StockIssuedDuringPeriodCashlessExerciseOfWarrantsShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_StockIssuedDuringPeriodCashlessExerciseOfWarrantsShares" xlink:to="CNXA_StockIssuedDuringPeriodCashlessExerciseOfWarrantsShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_StockIssuedDuringPeriodCashlessExerciseOfWarrantsShares_lbl" xml:lang="en-US">Cashless exercise of warrants, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_StockIssuedDuringPeriodValueSatisfactionOfProfitGuaranteeOnNotePayable" xlink:label="CNXA_StockIssuedDuringPeriodValueSatisfactionOfProfitGuaranteeOnNotePayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_StockIssuedDuringPeriodValueSatisfactionOfProfitGuaranteeOnNotePayable" xlink:to="CNXA_StockIssuedDuringPeriodValueSatisfactionOfProfitGuaranteeOnNotePayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_StockIssuedDuringPeriodValueSatisfactionOfProfitGuaranteeOnNotePayable_lbl" xml:lang="en-US">Satisfaction of profit guarantee on note payable</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_StockIssuedDuringPeriodSharesSatisfactionOfProfitGuaranteeOnNotePayable" xlink:label="CNXA_StockIssuedDuringPeriodSharesSatisfactionOfProfitGuaranteeOnNotePayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_StockIssuedDuringPeriodSharesSatisfactionOfProfitGuaranteeOnNotePayable" xlink:to="CNXA_StockIssuedDuringPeriodSharesSatisfactionOfProfitGuaranteeOnNotePayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_StockIssuedDuringPeriodSharesSatisfactionOfProfitGuaranteeOnNotePayable_lbl" xml:lang="en-US">Satisfaction of profit guarantee on note payable, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_StockIssuedDuringPeriodValueConversionofNotesPayableRelatedParties" xlink:label="CNXA_StockIssuedDuringPeriodValueConversionofNotesPayableRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_StockIssuedDuringPeriodValueConversionofNotesPayableRelatedParties" xlink:to="CNXA_StockIssuedDuringPeriodValueConversionofNotesPayableRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_StockIssuedDuringPeriodValueConversionofNotesPayableRelatedParties_lbl" xml:lang="en-US">Conversion of notes payable - related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_StockIssuedDuringPeriodShareConversionofNotesPayableRelatedParties" xlink:label="CNXA_StockIssuedDuringPeriodShareConversionofNotesPayableRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_StockIssuedDuringPeriodShareConversionofNotesPayableRelatedParties" xlink:to="CNXA_StockIssuedDuringPeriodShareConversionofNotesPayableRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_StockIssuedDuringPeriodShareConversionofNotesPayableRelatedParties_lbl" xml:lang="en-US">Conversion of notes payable - related parties, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl" xml:lang="en-US">Share-based compensation, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_lbl" xml:lang="en-US">Elimination of related party derivative liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xml:lang="en-US">Conversion of notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xml:lang="en-US">Conversion of notes payable, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_3_lbl" xml:lang="en-US">Balance - April 30, 2023</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_2_lbl" xml:lang="en-US">Balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOW FROM OPERTING ACTIVIITES</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLoss_3_lbl" xml:lang="en-US">Net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortization" xlink:to="us-gaap_DepreciationAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xml:lang="en-US">Depreciation, amortization and impairment expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="us-gaap_DerivativeGainLossOnDerivativeNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="us-gaap_DerivativeGainLossOnDerivativeNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DerivativeGainLossOnDerivativeNet_lbl" xml:lang="en-US">Change in fair value of derivative liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl" xml:lang="en-US">Shares and warrants issued for services</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Share-based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfOtherAssets" xlink:label="us-gaap_GainLossOnSaleOfOtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfOtherAssets" xlink:to="us-gaap_GainLossOnSaleOfOtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainLossOnSaleOfOtherAssets_lbl" xml:lang="en-US">Loss on disposal</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_GainLossOnChangeInFairValueOfContingentConsideration" xlink:to="CNXA_GainLossOnChangeInFairValueOfContingentConsideration_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="CNXA_GainLossOnChangeInFairValueOfContingentConsideration_2_lbl" xml:lang="en-US">Change in fair value of contingent consideration</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_2_lbl" xml:lang="en-US">Loss on extinguishment of debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium_lbl" xml:lang="en-US">Amortization of debt discounts</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_DerivativeExpense" xlink:to="CNXA_DerivativeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_DerivativeExpense_2_lbl" xml:lang="en-US">Derivative expense</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_NoncashTransactionCosts" xlink:label="CNXA_NoncashTransactionCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_NoncashTransactionCosts" xlink:to="CNXA_NoncashTransactionCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_NoncashTransactionCosts_lbl" xml:lang="en-US">Non-cash transaction costs</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_SettlementExpense" xlink:label="CNXA_SettlementExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_SettlementExpense" xlink:to="CNXA_SettlementExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_SettlementExpense_lbl" xml:lang="en-US">Settlement expense</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_LossOnSettlementOfAccountsPayable" xlink:label="CNXA_LossOnSettlementOfAccountsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_LossOnSettlementOfAccountsPayable" xlink:to="CNXA_LossOnSettlementOfAccountsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_LossOnSettlementOfAccountsPayable_lbl" xml:lang="en-US">Loss on settlement of accounts payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_GainLossOnIssuanceOfConvertibleNotes" xlink:to="CNXA_GainLossOnIssuanceOfConvertibleNotes_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="CNXA_GainLossOnIssuanceOfConvertibleNotes_2_lbl" xml:lang="en-US">Loss on conversion of convertible notes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Changes in assets and liabilities, net of acquired amounts</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_IncreaseDecreaseInPrepaidInventory" xlink:label="CNXA_IncreaseDecreaseInPrepaidInventory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_IncreaseDecreaseInPrepaidInventory" xlink:to="CNXA_IncreaseDecreaseInPrepaidInventory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="CNXA_IncreaseDecreaseInPrepaidInventory_lbl" xml:lang="en-US">Prepaid inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl" xml:lang="en-US">Contract liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_lbl" xml:lang="en-US">Other current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:label="us-gaap_IncreaseDecreaseInInterestPayableNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:to="us-gaap_IncreaseDecreaseInInterestPayableNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInInterestPayableNet_lbl" xml:lang="en-US">Accrued interest</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_IncreaseDecreaseInInterestPayableRelatedParty" xlink:label="CNXA_IncreaseDecreaseInInterestPayableRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_IncreaseDecreaseInInterestPayableRelatedParty" xlink:to="CNXA_IncreaseDecreaseInInterestPayableRelatedParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_IncreaseDecreaseInInterestPayableRelatedParty_lbl" xml:lang="en-US">Accrued interest - related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Total adjustments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_lbl" xml:lang="en-US">Net cash used in operating activities of continuing operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:label="us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:to="us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_lbl" xml:lang="en-US">Net cash provided by operating activities of discontinued operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash used in operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM INVESTING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:label="us-gaap_CashAcquiredFromAcquisition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAcquiredFromAcquisition" xlink:to="us-gaap_CashAcquiredFromAcquisition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAcquiredFromAcquisition_lbl" xml:lang="en-US">Cash acquired as part of Gameface acquisition</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireNotesReceivable" xlink:label="us-gaap_PaymentsToAcquireNotesReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireNotesReceivable" xlink:to="us-gaap_PaymentsToAcquireNotesReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireNotesReceivable_lbl" xml:lang="en-US">Note receivable issuance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_lbl" xml:lang="en-US">Net cash used in investing activities of continuing operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" xlink:label="us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" xlink:to="us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_lbl" xml:lang="en-US">Net cash provided by operating activities of discontinued operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash used in investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Proceeds from issuance of common stock for cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="us-gaap_PaymentsOfDebtIssuanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts_lbl" xml:lang="en-US">Debt issuance costs on convertible notes payable and other financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="us-gaap_ProceedsFromNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromNotesPayable" xlink:to="us-gaap_ProceedsFromNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromNotesPayable_lbl" xml:lang="en-US">Proceeds from notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRelatedPartyDebt" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xml:lang="en-US">Proceeds from related party notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="us-gaap_ProceedsFromConvertibleDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromConvertibleDebt" xlink:to="us-gaap_ProceedsFromConvertibleDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromConvertibleDebt_lbl" xml:lang="en-US">Proceeds from convertible notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfRelatedPartyDebt" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt_lbl" xml:lang="en-US">Payments of notes payable - related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="us-gaap_RepaymentsOfNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfNotesPayable_lbl" xml:lang="en-US">Payments of notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xml:lang="en-US">Effect of exchange rate fluctuations on cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US">NET DECREASE IN CASH AND RESTRICTED CASH</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xml:lang="en-US">CASH AND RESTRICTED CASH - BEGINNING OF PERIOD</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_lbl" xml:lang="en-US">CASH AND RESTRICTED CASH - END OF PERIOD</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US">CASH PAID DURING THE PERIOD FOR:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="us-gaap_IncomeTaxesPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaidNet" xlink:to="us-gaap_IncomeTaxesPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl" xml:lang="en-US">Income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xml:lang="en-US">SUPPLEMENTAL INFORMATION - NON-CASH INVESTING AND FINANCING ACTIVITIES:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssued1" xlink:label="us-gaap_StockIssued1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssued1" xlink:to="us-gaap_StockIssued1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssued1_lbl" xml:lang="en-US">Shares issued in connection with acquisition</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_ConversionOfConvertibleNotesPayableAndAccruedInterestToCommonStock" xlink:label="CNXA_ConversionOfConvertibleNotesPayableAndAccruedInterestToCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_ConversionOfConvertibleNotesPayableAndAccruedInterestToCommonStock" xlink:to="CNXA_ConversionOfConvertibleNotesPayableAndAccruedInterestToCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_ConversionOfConvertibleNotesPayableAndAccruedInterestToCommonStock_lbl" xml:lang="en-US">Conversion of convertible notes payable and accrued interest to common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_SharesIssuedForContingentConsideration" xlink:label="CNXA_SharesIssuedForContingentConsideration" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_SharesIssuedForContingentConsideration" xlink:to="CNXA_SharesIssuedForContingentConsideration_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_SharesIssuedForContingentConsideration_lbl" xml:lang="en-US">Shares issued for contingent consideration</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_EliminationOfRelatedPartyDerivativeLiabilities" xlink:label="CNXA_EliminationOfRelatedPartyDerivativeLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_EliminationOfRelatedPartyDerivativeLiabilities" xlink:to="CNXA_EliminationOfRelatedPartyDerivativeLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_EliminationOfRelatedPartyDerivativeLiabilities_lbl" xml:lang="en-US">Elimination of related party derivative liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DerivativeLiabilitiesRecordedAsDebtDiscountsOfConvertibleNotes" xlink:label="CNXA_DerivativeLiabilitiesRecordedAsDebtDiscountsOfConvertibleNotes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_DerivativeLiabilitiesRecordedAsDebtDiscountsOfConvertibleNotes" xlink:to="CNXA_DerivativeLiabilitiesRecordedAsDebtDiscountsOfConvertibleNotes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_DerivativeLiabilitiesRecordedAsDebtDiscountsOfConvertibleNotes_lbl" xml:lang="en-US">Derivative liabilities recorded as debt discounts of convertible notes</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DerivativeLiabilityRecordedForSharesAndWarrantsIssuedInPrivatePlacement" xlink:label="CNXA_DerivativeLiabilityRecordedForSharesAndWarrantsIssuedInPrivatePlacement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_DerivativeLiabilityRecordedForSharesAndWarrantsIssuedInPrivatePlacement" xlink:to="CNXA_DerivativeLiabilityRecordedForSharesAndWarrantsIssuedInPrivatePlacement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_DerivativeLiabilityRecordedForSharesAndWarrantsIssuedInPrivatePlacement_lbl" xml:lang="en-US">Derivative liability recorded for shares and warrants issued in private placement</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_SharesIssuedForSettlementOfAccountsPayable" xlink:label="CNXA_SharesIssuedForSettlementOfAccountsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_SharesIssuedForSettlementOfAccountsPayable" xlink:to="CNXA_SharesIssuedForSettlementOfAccountsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_SharesIssuedForSettlementOfAccountsPayable_lbl" xml:lang="en-US">Shares issued for settlement of accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesIssued1" xlink:label="us-gaap_NotesIssued1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesIssued1" xlink:to="us-gaap_NotesIssued1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesIssued1_lbl" xml:lang="en-US">Note receivable issued in sale of PlaySight</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_lbl" xml:lang="en-US">CASH AND RESTRICTED CASH - END OF PERIOD</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xml:lang="en-US">ORGANIZATION AND NATURE OF BUSINESS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:label="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:to="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock_lbl" xml:lang="en-US">GOING CONCERN</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="us-gaap_RisksAndUncertaintiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RisksAndUncertaintiesAbstract" xlink:to="us-gaap_RisksAndUncertaintiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RisksAndUncertaintiesAbstract_lbl" xml:lang="en-US">Risks and Uncertainties [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:to="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl" xml:lang="en-US">CONCENTRATION OF CREDIT RISK AND OTHER RISKS AND UNCERTAINTIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US">INTANGIBLE ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US">ACCRUED EXPENSES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xml:lang="en-US">NOTE PAYABLE &#8211; RELATED PARTY</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTextBlock" xlink:label="us-gaap_ShortTermDebtTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtTextBlock" xlink:to="us-gaap_ShortTermDebtTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermDebtTextBlock_lbl" xml:lang="en-US">CONVERTIBLE NOTES PAYABLE</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtTextBlock" xlink:label="us-gaap_LongTermDebtTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtTextBlock" xlink:to="us-gaap_LongTermDebtTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtTextBlock_lbl" xml:lang="en-US">NOTES PAYABLE</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">RELATED PARTY TRANSACTIONS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US">Equity [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">SHAREHOLDERS&#8217; EQUITY (DEFICIT)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:label="us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_lbl" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:label="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:to="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_lbl" xml:lang="en-US">DISCONTINUED OPERATIONS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">SUBSEQUENT EVENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_lbl" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xml:lang="en-US">ACQUISITIONS AND BUSINESS COMBINATIONS</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtDisclosureTextBlock_2_lbl" xml:lang="en-US">NOTE PAYABLE - RELATED PARTY</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">INCOME TAXES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingAbstract_lbl" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xml:lang="en-US">SEGMENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_InterimFinancialStatementsPolicyTextBlock" xlink:label="CNXA_InterimFinancialStatementsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_InterimFinancialStatementsPolicyTextBlock" xlink:to="CNXA_InterimFinancialStatementsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_InterimFinancialStatementsPolicyTextBlock_lbl" xml:lang="en-US">Interim Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl" xml:lang="en-US">Financial Statement Reclassification</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and Cash Equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl" xml:lang="en-US">Accounts Receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="us-gaap_InventoryPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl" xml:lang="en-US">Inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_PrepaidInventoryPolicyTextBlock" xlink:label="CNXA_PrepaidInventoryPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_PrepaidInventoryPolicyTextBlock" xlink:to="CNXA_PrepaidInventoryPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_PrepaidInventoryPolicyTextBlock_lbl" xml:lang="en-US">Prepaid Inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US">Property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US">Concentration of Credit Risk</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xml:lang="en-US">Revenue Recognition</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationsPolicy" xlink:label="us-gaap_BusinessCombinationsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationsPolicy" xlink:to="us-gaap_BusinessCombinationsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationsPolicy_lbl" xml:lang="en-US">Business Combinations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:to="us-gaap_IntangibleAssetsFiniteLivedPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy_lbl" xml:lang="en-US">Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xml:lang="en-US">Impairment of Long-Lived Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US">Share-Based Payment</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_WarrantsPolicyTextBlock" xlink:label="CNXA_WarrantsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_WarrantsPolicyTextBlock" xlink:to="CNXA_WarrantsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_WarrantsPolicyTextBlock_lbl" xml:lang="en-US">Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xml:lang="en-US">Foreign Currency Translation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Earnings Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:label="us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:to="us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable_lbl" xml:lang="en-US">Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:label="us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems_lbl" xml:lang="en-US">Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF INVENTORY</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" xlink:label="us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" xlink:to="us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF DERIVATIVE LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF WARRANTS GRANTED VALUATION USING BLACK-SCHOLES PRICING METHOD</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF INTANGIBLE ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF ESTIMATED FUTURE AMORTIZATION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF ACCRUED EXPENSES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:label="us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:to="us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_lbl" xml:lang="en-US">SCHEDULE OF DISCONTINUED OPERATIONS</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_ScheduleOfCalculationOfTheLossOnDisposalTableTextBlock" xlink:label="CNXA_ScheduleOfCalculationOfTheLossOnDisposalTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_ScheduleOfCalculationOfTheLossOnDisposalTableTextBlock" xlink:to="CNXA_ScheduleOfCalculationOfTheLossOnDisposalTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_ScheduleOfCalculationOfTheLossOnDisposalTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF CALCULATION OF THE LOSS ON DISPOSAL</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:label="us-gaap_BusinessAcquisitionProFormaInformationTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:to="us-gaap_BusinessAcquisitionProFormaInformationTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionProFormaInformationTextBlock_lbl" xml:lang="en-US">SCHEDULE OF PROFORMA FINANCIAL INFORMATION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xml:lang="en-US">SCHEDULE OF WARRANTS ISSUED, EXERCISED AND EXPIRED</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF NET DEFERRED TAX ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF INCOME TAX PROVISION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xml:lang="en-US">Percentage of ownership</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl" xml:lang="en-US">Number of shares issued for acquisition</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:label="us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:to="us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_lbl" xml:lang="en-US">Number of value issued for acquisition</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_NumberOfSharesExchanged" xlink:label="CNXA_NumberOfSharesExchanged" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_NumberOfSharesExchanged" xlink:to="CNXA_NumberOfSharesExchanged_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_NumberOfSharesExchanged_lbl" xml:lang="en-US">Number of shares exchanged</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_NumberOfSharesOwned" xlink:label="CNXA_NumberOfSharesOwned" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_NumberOfSharesOwned" xlink:to="CNXA_NumberOfSharesOwned_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_NumberOfSharesOwned_lbl" xml:lang="en-US">Number of shares owned</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="us-gaap_StockholdersEquityReverseStockSplit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityReverseStockSplit" xlink:to="us-gaap_StockholdersEquityReverseStockSplit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityReverseStockSplit_lbl" xml:lang="en-US">Stockholders' Equity, Reverse Stock Split</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_4_lbl" xml:lang="en-US">Stockholders equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:label="us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:to="us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_lbl" xml:lang="en-US">Impaired of intangible assets and goodwill amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfMultiemployerPlansTable" xlink:label="us-gaap_ScheduleOfMultiemployerPlansTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfMultiemployerPlansTable" xlink:to="us-gaap_ScheduleOfMultiemployerPlansTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfMultiemployerPlansTable_lbl" xml:lang="en-US">Multiemployer Plan [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MultiemployerPlansLineItems" xlink:label="us-gaap_MultiemployerPlansLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MultiemployerPlansLineItems" xlink:to="us-gaap_MultiemployerPlansLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MultiemployerPlansLineItems_lbl" xml:lang="en-US">Multiemployer Plan [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_2_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DisposalEquityInterestOwnershipInterestPercentage" xlink:label="CNXA_DisposalEquityInterestOwnershipInterestPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_DisposalEquityInterestOwnershipInterestPercentage" xlink:to="CNXA_DisposalEquityInterestOwnershipInterestPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_DisposalEquityInterestOwnershipInterestPercentage_lbl" xml:lang="en-US">Discontinuing operations percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal" xlink:label="us-gaap_DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal" xlink:to="us-gaap_DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal_lbl" xml:lang="en-US">Investment retained after disposal, ownership interest after disposal</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AlternativeInvestment" xlink:label="us-gaap_AlternativeInvestment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AlternativeInvestment" xlink:to="us-gaap_AlternativeInvestment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AlternativeInvestment_lbl" xml:lang="en-US">Investment amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoods" xlink:label="us-gaap_InventoryFinishedGoods" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoods" xlink:to="us-gaap_InventoryFinishedGoods_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryFinishedGoods_lbl" xml:lang="en-US">Finished Goods</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterialsAndSupplies" xlink:label="us-gaap_InventoryRawMaterialsAndSupplies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryRawMaterialsAndSupplies" xlink:to="us-gaap_InventoryRawMaterialsAndSupplies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryRawMaterialsAndSupplies_lbl" xml:lang="en-US">Component/Replacement Parts</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_CapitalizedDutyAndFreight" xlink:label="CNXA_CapitalizedDutyAndFreight" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_CapitalizedDutyAndFreight" xlink:to="CNXA_CapitalizedDutyAndFreight_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_CapitalizedDutyAndFreight_lbl" xml:lang="en-US">Capitalized Duty/Freight</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryAdjustments" xlink:label="us-gaap_InventoryAdjustments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryAdjustments" xlink:to="us-gaap_InventoryAdjustments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InventoryAdjustments_lbl" xml:lang="en-US">Inventory Reserve</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_InventoryNet_2_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingAssetsTable" xlink:label="us-gaap_OffsettingAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OffsettingAssetsTable" xlink:to="us-gaap_OffsettingAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OffsettingAssetsTable_lbl" xml:lang="en-US">Offsetting Assets [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingAssetsLineItems" xlink:label="us-gaap_OffsettingAssetsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OffsettingAssetsLineItems" xlink:to="us-gaap_OffsettingAssetsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OffsettingAssetsLineItems_lbl" xml:lang="en-US">Offsetting Assets [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgesLiabilities" xlink:label="us-gaap_DerivativeInstrumentsAndHedgesLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsAndHedgesLiabilities" xlink:to="us-gaap_DerivativeInstrumentsAndHedgesLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentsAndHedgesLiabilities_lbl" xml:lang="en-US">Note derivative balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="us-gaap_DerivativeGainLossOnDerivativeNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_DerivativeGainLossOnDerivativeNet_2_lbl" xml:lang="en-US">Note derivative (gain) loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DerivativeLiabilitiesMeasurementInputTerm" xlink:label="CNXA_DerivativeLiabilitiesMeasurementInputTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_DerivativeLiabilitiesMeasurementInputTerm" xlink:to="CNXA_DerivativeLiabilitiesMeasurementInputTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_DerivativeLiabilitiesMeasurementInputTerm_lbl" xml:lang="en-US">Derivative liabilities measurement input</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilityMeasurementInput" xlink:label="us-gaap_DerivativeLiabilityMeasurementInput" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLiabilityMeasurementInput" xlink:to="us-gaap_DerivativeLiabilityMeasurementInput_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeLiabilityMeasurementInput_lbl" xml:lang="en-US">Derivative liability measurement input</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xml:lang="en-US">Warrants measurement input, term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="us-gaap_WarrantsAndRightsOutstandingMeasurementInput" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:to="us-gaap_WarrantsAndRightsOutstandingMeasurementInput_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstandingMeasurementInput_lbl" xml:lang="en-US">Warrants measurement input, rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_PlatformOperatorCryptoAssetTable" xlink:label="srt_PlatformOperatorCryptoAssetTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_PlatformOperatorCryptoAssetTable" xlink:to="srt_PlatformOperatorCryptoAssetTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_PlatformOperatorCryptoAssetTable_lbl" xml:lang="en-US">Platform Operator, Crypto-Asset [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_PlatformOperatorCryptoAssetLineItems" xlink:label="srt_PlatformOperatorCryptoAssetLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_PlatformOperatorCryptoAssetLineItems" xlink:to="srt_PlatformOperatorCryptoAssetLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_PlatformOperatorCryptoAssetLineItems_lbl" xml:lang="en-US">Platform Operator, Crypto-Asset [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xml:lang="en-US">Allowance for doubtful accounts</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xml:lang="en-US">Property plant and equipment, useful life</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1_lbl" xml:lang="en-US">Fair value of contingent consideration</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_2_lbl" xml:lang="en-US">Impaired intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsFinitelived_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived_lbl" xml:lang="en-US">Impairment of intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetImpairmentCharges" xlink:label="us-gaap_AssetImpairmentCharges" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetImpairmentCharges" xlink:to="us-gaap_AssetImpairmentCharges_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetImpairmentCharges_lbl" xml:lang="en-US">Impairment of fixed assets</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_RecognizedDerivativeExpense" xlink:label="CNXA_RecognizedDerivativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_RecognizedDerivativeExpense" xlink:to="CNXA_RecognizedDerivativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_RecognizedDerivativeExpense_lbl" xml:lang="en-US">Recognized derivative expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="us-gaap_GoodwillImpairmentLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillImpairmentLoss" xlink:to="us-gaap_GoodwillImpairmentLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillImpairmentLoss_lbl" xml:lang="en-US">Goodwill impairment charges</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTable" xlink:label="us-gaap_ConcentrationRiskTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskTable" xlink:to="us-gaap_ConcentrationRiskTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskTable_lbl" xml:lang="en-US">Concentration Risk [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="us-gaap_ConcentrationRiskLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskLineItems" xlink:to="us-gaap_ConcentrationRiskLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskLineItems_lbl" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xml:lang="en-US">Concentration risk, percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsFinitelived_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived_2_lbl" xml:lang="en-US">Impairment of Intangible Assets, Finite-Lived</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_3_lbl" xml:lang="en-US">Finite-Lived Intangible Assets, Net, Ending Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:label="us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:to="us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_lbl" xml:lang="en-US">Weighted average period amortization (in years)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_lbl" xml:lang="en-US">Impairment of Intangible Assets (Excluding Goodwill)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US">Amortization expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsFinitelived_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived_3_lbl" xml:lang="en-US">Impairment loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIntangibleAssetsNet" xlink:label="us-gaap_OtherIntangibleAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIntangibleAssetsNet" xlink:to="us-gaap_OtherIntangibleAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherIntangibleAssetsNet_lbl" xml:lang="en-US">Other intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedPayrollTaxesCurrent" xlink:label="us-gaap_AccruedPayrollTaxesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedPayrollTaxesCurrent" xlink:to="us-gaap_AccruedPayrollTaxesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedPayrollTaxesCurrent_lbl" xml:lang="en-US">Accrued payroll</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedBonusesCurrent" xlink:label="us-gaap_AccruedBonusesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedBonusesCurrent" xlink:to="us-gaap_AccruedBonusesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedBonusesCurrent_lbl" xml:lang="en-US">Accrued bonus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedProfessionalFeesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xml:lang="en-US">Accrued professional fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableOtherCurrent" xlink:label="us-gaap_AccountsPayableOtherCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableOtherCurrent" xlink:to="us-gaap_AccountsPayableOtherCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableOtherCurrent_lbl" xml:lang="en-US">Other accrued expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AccruedLiabilitiesCurrent_2_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LoansPayable" xlink:label="us-gaap_LoansPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansPayable" xlink:to="us-gaap_LoansPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LoansPayable_lbl" xml:lang="en-US">Loans payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRelatedPartyDebt" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt_2_lbl" xml:lang="en-US">Proceeds from related party debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xml:lang="en-US">Interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayable" xlink:label="us-gaap_NotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayable" xlink:to="us-gaap_NotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayable_lbl" xml:lang="en-US">Outstanding borrowings</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InterestExpense_2_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_PaymentForExchangeOfNotesPayable" xlink:label="CNXA_PaymentForExchangeOfNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_PaymentForExchangeOfNotesPayable" xlink:to="CNXA_PaymentForExchangeOfNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_PaymentForExchangeOfNotesPayable_lbl" xml:lang="en-US">Payment of exchange</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US">Debt instrumental</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="us-gaap_ScheduleOfShortTermDebtTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShortTermDebtTable" xlink:to="us-gaap_ScheduleOfShortTermDebtTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShortTermDebtTable_lbl" xml:lang="en-US">Schedule of Short-Term Debt [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="us-gaap_ShortTermDebtLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_ShortTermDebtLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermDebtLineItems_lbl" xml:lang="en-US">Short-Term Debt [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_lbl" xml:lang="en-US">Debt conversion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1" xlink:label="us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1" xlink:to="us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1_lbl" xml:lang="en-US">Debt conversion shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPayableCurrentAndNoncurrent" xlink:label="us-gaap_InterestPayableCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPayableCurrentAndNoncurrent" xlink:to="us-gaap_InterestPayableCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPayableCurrentAndNoncurrent_lbl" xml:lang="en-US">Interest payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xml:lang="en-US">Unamortizated discount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_2_lbl" xml:lang="en-US">Debt interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleNotesPayable" xlink:label="us-gaap_ConvertibleNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleNotesPayable" xlink:to="us-gaap_ConvertibleNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleNotesPayable_lbl" xml:lang="en-US">Senior convertible notes</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_WarrantsIssuedToPurchaseOfCommonStockShares" xlink:label="CNXA_WarrantsIssuedToPurchaseOfCommonStockShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_WarrantsIssuedToPurchaseOfCommonStockShares" xlink:to="CNXA_WarrantsIssuedToPurchaseOfCommonStockShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_WarrantsIssuedToPurchaseOfCommonStockShares_lbl" xml:lang="en-US">Warrants issued to purchase of common stock, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromConvertibleDebt" xlink:to="us-gaap_ProceedsFromConvertibleDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromConvertibleDebt_2_lbl" xml:lang="en-US">Gross proceeds from issuance of senior convertible notes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xml:lang="en-US">Convertible notes maturity date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xml:lang="en-US">Conversion price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm_2_lbl" xml:lang="en-US">Warrants term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable" xlink:label="us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable" xlink:to="us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable_lbl" xml:lang="en-US">Warrants rights date from which warrants exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_WarrantsExercisePrice" xlink:label="CNXA_WarrantsExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_WarrantsExercisePrice" xlink:to="CNXA_WarrantsExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_WarrantsExercisePrice_lbl" xml:lang="en-US">Warrants exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="us-gaap_WarrantsAndRightsOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstanding" xlink:to="us-gaap_WarrantsAndRightsOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WarrantsAndRightsOutstanding_lbl" xml:lang="en-US">Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_RemainingDerivativeLiabilities" xlink:label="CNXA_RemainingDerivativeLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_RemainingDerivativeLiabilities" xlink:to="CNXA_RemainingDerivativeLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="CNXA_RemainingDerivativeLiabilities_lbl" xml:lang="en-US">Derivative liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFinanceCostsNet" xlink:label="us-gaap_DeferredFinanceCostsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFinanceCostsNet" xlink:to="us-gaap_DeferredFinanceCostsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFinanceCostsNet_lbl" xml:lang="en-US">Debt issuance cost</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_2_lbl" xml:lang="en-US">Stock issued during period value conversion of units</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_LossOnIssuanceOfConvertibleNotes" xlink:label="CNXA_LossOnIssuanceOfConvertibleNotes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_LossOnIssuanceOfConvertibleNotes" xlink:to="CNXA_LossOnIssuanceOfConvertibleNotes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="CNXA_LossOnIssuanceOfConvertibleNotes_lbl" xml:lang="en-US">Loss on issuance of convertible notes</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_SecuritiesOutstandingRateConvertibleNotesDescripition" xlink:label="CNXA_SecuritiesOutstandingRateConvertibleNotesDescripition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_SecuritiesOutstandingRateConvertibleNotesDescripition" xlink:to="CNXA_SecuritiesOutstandingRateConvertibleNotesDescripition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_SecuritiesOutstandingRateConvertibleNotesDescripition_lbl" xml:lang="en-US">Convertible note description</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentFaceAmount_2_lbl" xml:lang="en-US">Convertiable notes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:label="us-gaap_DebtInstrumentIncreaseAccruedInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:to="us-gaap_DebtInstrumentIncreaseAccruedInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentIncreaseAccruedInterest_lbl" xml:lang="en-US">Debt Instrument, Increase, Accrued Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xml:lang="en-US">Shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionOriginalDebtInterestRateOfDebt" xlink:label="us-gaap_DebtConversionOriginalDebtInterestRateOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionOriginalDebtInterestRateOfDebt" xlink:to="us-gaap_DebtConversionOriginalDebtInterestRateOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtConversionOriginalDebtInterestRateOfDebt_lbl" xml:lang="en-US">Interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_DebtInstrumentCarryingAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl" xml:lang="en-US">Payables</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_3_lbl" xml:lang="en-US">Extinguishment of debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl" xml:lang="en-US">Debt conversion, amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilities" xlink:label="us-gaap_DerivativeLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLiabilities" xlink:to="us-gaap_DerivativeLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeLiabilities_lbl" xml:lang="en-US">Derivative liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeNet" xlink:label="us-gaap_DerivativeFairValueOfDerivativeNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeFairValueOfDerivativeNet" xlink:to="us-gaap_DerivativeFairValueOfDerivativeNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeFairValueOfDerivativeNet_lbl" xml:lang="en-US">Fair value of derivative liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferredOther1" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredOther1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferredOther1" xlink:to="us-gaap_BusinessCombinationConsiderationTransferredOther1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredOther1_lbl" xml:lang="en-US">Consideration</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_NumberOfConsignedGoods" xlink:label="CNXA_NumberOfConsignedGoods" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_NumberOfConsignedGoods" xlink:to="CNXA_NumberOfConsignedGoods_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_NumberOfConsignedGoods_lbl" xml:lang="en-US">Consignment units</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_PaymentsOfRelatedPartyDebt" xlink:label="CNXA_PaymentsOfRelatedPartyDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_PaymentsOfRelatedPartyDebt" xlink:to="CNXA_PaymentsOfRelatedPartyDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_PaymentsOfRelatedPartyDebt_lbl" xml:lang="en-US">Repayments of notes - related party</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayable" xlink:to="us-gaap_NotesPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NotesPayable_2_lbl" xml:lang="en-US">Note payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentMaturityDate_2_lbl" xml:lang="en-US">Debt maturity date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:label="us-gaap_SaleOfStockConsiderationReceivedPerTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:to="us-gaap_SaleOfStockConsiderationReceivedPerTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockConsiderationReceivedPerTransaction_lbl" xml:lang="en-US">Sale of consideration received</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireReceivables" xlink:label="us-gaap_PaymentsToAcquireReceivables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireReceivables" xlink:to="us-gaap_PaymentsToAcquireReceivables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireReceivables_lbl" xml:lang="en-US">Payment for exchange received amount</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_CashLessFees" xlink:label="CNXA_CashLessFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_CashLessFees" xlink:to="CNXA_CashLessFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_CashLessFees_lbl" xml:lang="en-US">Cash less fees</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentFaceAmount_3_lbl" xml:lang="en-US">Note payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xml:lang="en-US">Shares issued price per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US">Common stock exercisable, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentOfWarrantsGrantedForServices" xlink:label="us-gaap_AdjustmentOfWarrantsGrantedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentOfWarrantsGrantedForServices" xlink:to="us-gaap_AdjustmentOfWarrantsGrantedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentOfWarrantsGrantedForServices_lbl" xml:lang="en-US">Warrants granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilityFairValueOfCollateral" xlink:label="us-gaap_DerivativeLiabilityFairValueOfCollateral" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLiabilityFairValueOfCollateral" xlink:to="us-gaap_DerivativeLiabilityFairValueOfCollateral_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeLiabilityFairValueOfCollateral_lbl" xml:lang="en-US">Fair value derivate liability</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_IncreaseDecreaseInDerivativeFairValueLiability" xlink:label="CNXA_IncreaseDecreaseInDerivativeFairValueLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_IncreaseDecreaseInDerivativeFairValueLiability" xlink:to="CNXA_IncreaseDecreaseInDerivativeFairValueLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="CNXA_IncreaseDecreaseInDerivativeFairValueLiability_lbl" xml:lang="en-US">Derivative liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium_2_lbl" xml:lang="en-US">Amortization of debt discount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateIncreaseDecrease" xlink:label="us-gaap_DebtInstrumentInterestRateIncreaseDecrease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateIncreaseDecrease" xlink:to="us-gaap_DebtInstrumentInterestRateIncreaseDecrease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateIncreaseDecrease_lbl" xml:lang="en-US">Interest rate, increase</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:to="us-gaap_StockRedeemedOrCalledDuringPeriodValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodValue_lbl" xml:lang="en-US">Stock redeemed value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LegalFees" xlink:label="us-gaap_LegalFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LegalFees" xlink:to="us-gaap_LegalFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LegalFees_lbl" xml:lang="en-US">Legal fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfOtherDebt" xlink:label="us-gaap_RepaymentsOfOtherDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfOtherDebt" xlink:to="us-gaap_RepaymentsOfOtherDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfOtherDebt_lbl" xml:lang="en-US">Debt repayment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:label="us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:to="us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_lbl" xml:lang="en-US">Derivative liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfDebt" xlink:label="us-gaap_RepaymentsOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfDebt" xlink:to="us-gaap_RepaymentsOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfDebt_lbl" xml:lang="en-US">Repayment of debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteStockSplit" xlink:label="us-gaap_StockholdersEquityNoteStockSplit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteStockSplit" xlink:to="us-gaap_StockholdersEquityNoteStockSplit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteStockSplit_lbl" xml:lang="en-US">Stockholders' Equity Note, Stock Split</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_SharesIssuedPricePerShares" xlink:label="CNXA_SharesIssuedPricePerShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_SharesIssuedPricePerShares" xlink:to="CNXA_SharesIssuedPricePerShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_SharesIssuedPricePerShares_lbl" xml:lang="en-US">[custom:SharesIssuedPricePerShares-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDerivativeLiabilities" xlink:label="us-gaap_IncreaseDecreaseInDerivativeLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDerivativeLiabilities" xlink:to="us-gaap_IncreaseDecreaseInDerivativeLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDerivativeLiabilities_lbl" xml:lang="en-US">Increase (Decrease) in Derivative Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayable" xlink:to="us-gaap_NotesPayable_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NotesPayable_3_lbl" xml:lang="en-US">Outstanding notes payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPayableCurrentAndNoncurrent" xlink:to="us-gaap_InterestPayableCurrentAndNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InterestPayableCurrentAndNoncurrent_2_lbl" xml:lang="en-US">Accrued interest - related party</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Revenue from related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNet" xlink:label="us-gaap_AccountsReceivableNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNet" xlink:to="us-gaap_AccountsReceivableNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNet_lbl" xml:lang="en-US">Outstanding accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssued" xlink:label="us-gaap_SharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssued_lbl" xml:lang="en-US">Shares, issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_2_lbl" xml:lang="en-US">Number of shares issued during the period</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_StockIssuedDuringPeriodSharesIssuedSettlementOfAccountsPayable" xlink:label="CNXA_StockIssuedDuringPeriodSharesIssuedSettlementOfAccountsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_StockIssuedDuringPeriodSharesIssuedSettlementOfAccountsPayable" xlink:to="CNXA_StockIssuedDuringPeriodSharesIssuedSettlementOfAccountsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_StockIssuedDuringPeriodSharesIssuedSettlementOfAccountsPayable_lbl" xml:lang="en-US">Stock issued during period, shares, issued for settlement of accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_StockIssuedDuringPeriodSharesIssuedSettlementWithFormerOwners" xlink:label="CNXA_StockIssuedDuringPeriodSharesIssuedSettlementWithFormerOwners" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_StockIssuedDuringPeriodSharesIssuedSettlementWithFormerOwners" xlink:to="CNXA_StockIssuedDuringPeriodSharesIssuedSettlementWithFormerOwners_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_StockIssuedDuringPeriodSharesIssuedSettlementWithFormerOwners_lbl" xml:lang="en-US">Stock issued during period, shares, issued for settlement with former owners</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_lbl" xml:lang="en-US">Exercise of warrants, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_StockIssuedDuringPeriodSharesIssuedProfitGuaranteeOnNote" xlink:label="CNXA_StockIssuedDuringPeriodSharesIssuedProfitGuaranteeOnNote" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_StockIssuedDuringPeriodSharesIssuedProfitGuaranteeOnNote" xlink:to="CNXA_StockIssuedDuringPeriodSharesIssuedProfitGuaranteeOnNote_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_StockIssuedDuringPeriodSharesIssuedProfitGuaranteeOnNote_lbl" xml:lang="en-US">Profit guarantee on note, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_3_lbl" xml:lang="en-US">Number of common stock, shares issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_2_lbl" xml:lang="en-US">Debt conversion of convertible notes, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_2_lbl" xml:lang="en-US">Shares issued for services</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_WarrantPerShare" xlink:label="CNXA_WarrantPerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_WarrantPerShare" xlink:to="CNXA_WarrantPerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_WarrantPerShare_lbl" xml:lang="en-US">[custom:WarrantPerShare-0]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstanding" xlink:to="us-gaap_WarrantsAndRightsOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstanding_2_lbl" xml:lang="en-US">Warrants and Rights Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_2_lbl" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_2_lbl" xml:lang="en-US">Shares issued for acquisition</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="us-gaap_DebtInstrumentInterestRateEffectivePercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage_lbl" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromNotesPayable" xlink:to="us-gaap_ProceedsFromNotesPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromNotesPayable_2_lbl" xml:lang="en-US">Proceeds from Notes Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharesIssuedPricePerShare_2_lbl" xml:lang="en-US">Shares Issued, Price Per Share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_2_lbl" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_2_lbl" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Convertible Securities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions_2_lbl" xml:lang="en-US">Stock Issued During Period, Value, Acquisitions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_lbl" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, before Forfeiture</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross_lbl" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, before Forfeiture</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Each Warrant or Right</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="us-gaap_ConversionOfStockSharesConverted1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesConverted1" xlink:to="us-gaap_ConversionOfStockSharesConverted1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockSharesConverted1_lbl" xml:lang="en-US">Conversion of Stock, Shares Converted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm_3_lbl" xml:lang="en-US">Warrants and Rights Outstanding, Term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_WarrantsIssuedToPurchaseOfCommonStockShares" xlink:to="CNXA_WarrantsIssuedToPurchaseOfCommonStockShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="CNXA_WarrantsIssuedToPurchaseOfCommonStockShares_2_lbl" xml:lang="en-US">[custom:WarrantsIssuedToPurchaseOfCommonStockShares-0]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_2_lbl" xml:lang="en-US">Operating Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl" xml:lang="en-US">Warrants vested</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesTable" xlink:label="us-gaap_LossContingenciesTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_LossContingenciesTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LossContingenciesTable_lbl" xml:lang="en-US">Loss Contingencies [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesLineItems" xlink:label="us-gaap_LossContingenciesLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LossContingenciesLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LossContingenciesLineItems_lbl" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRent" xlink:label="us-gaap_PaymentsForRent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRent" xlink:to="us-gaap_PaymentsForRent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForRent_lbl" xml:lang="en-US">Rent expense</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_FairValueOfCommonStock" xlink:label="CNXA_FairValueOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_FairValueOfCommonStock" xlink:to="CNXA_FairValueOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_FairValueOfCommonStock_lbl" xml:lang="en-US">Fair value of common stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_3_lbl" xml:lang="en-US">Number of stock issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="us-gaap_BusinessCombinationContingentConsiderationLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiability_lbl" xml:lang="en-US">Balance of contingent consideration</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_lbl" xml:lang="en-US">Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_lbl" xml:lang="en-US">Operating expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DisposalGroupIncludingDiscontinuedOperationOtherIncomeLoss" xlink:label="CNXA_DisposalGroupIncludingDiscontinuedOperationOtherIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_DisposalGroupIncludingDiscontinuedOperationOtherIncomeLoss" xlink:to="CNXA_DisposalGroupIncludingDiscontinuedOperationOtherIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_DisposalGroupIncludingDiscontinuedOperationOtherIncomeLoss_lbl" xml:lang="en-US">Other (income) loss</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DisposalGroupIncludingDiscontinuedOperationNetIncomeLoss" xlink:label="CNXA_DisposalGroupIncludingDiscontinuedOperationNetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_DisposalGroupIncludingDiscontinuedOperationNetIncomeLoss" xlink:to="CNXA_DisposalGroupIncludingDiscontinuedOperationNetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="CNXA_DisposalGroupIncludingDiscontinuedOperationNetIncomeLoss_lbl" xml:lang="en-US">Net loss from discontinued operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_lbl" xml:lang="en-US">Cash and restricted cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_lbl" xml:lang="en-US">Inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesCurrent" xlink:label="CNXA_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesCurrent" xlink:to="CNXA_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesCurrent_lbl" xml:lang="en-US">Right of use asset &#8211; operating leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepaid expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_2_lbl" xml:lang="en-US">Current Asset</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent_lbl" xml:lang="en-US">Property and equipment, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent_lbl" xml:lang="en-US">Intangible assets, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets_lbl" xml:lang="en-US">Contract assets, net of current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryNoncurrent" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryNoncurrent" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryNoncurrent_lbl" xml:lang="en-US">Finished products used in operations, net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent_2_lbl" xml:lang="en-US">Non-current Asset</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityOperatingLeasesCurrent" xlink:label="CNXA_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityOperatingLeasesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityOperatingLeasesCurrent" xlink:to="CNXA_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityOperatingLeasesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityOperatingLeasesCurrent_lbl" xml:lang="en-US">Lease liability &#8211; operating leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_lbl" xml:lang="en-US">Contract liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_2_lbl" xml:lang="en-US">Current Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities_lbl" xml:lang="en-US">Contract liabilities, net of current portion</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent" xlink:to="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent_2_lbl" xml:lang="en-US">Non-Current Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_SharesIssuedAndOutstandingPercentage" xlink:label="CNXA_SharesIssuedAndOutstandingPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_SharesIssuedAndOutstandingPercentage" xlink:to="CNXA_SharesIssuedAndOutstandingPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_SharesIssuedAndOutstandingPercentage_lbl" xml:lang="en-US">Shares issued and outstanding percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDescriptionAndTimingOfDisposal" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationDescriptionAndTimingOfDisposal" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationDescriptionAndTimingOfDisposal" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationDescriptionAndTimingOfDisposal_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationDescriptionAndTimingOfDisposal_lbl" xml:lang="en-US">Discontinued operation description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_lbl" xml:lang="en-US">Cash consideration</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:to="us-gaap_MinorityInterestOwnershipPercentageByParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent_lbl" xml:lang="en-US">Ownership percentage by parrent</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:to="us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_lbl" xml:lang="en-US">Ownership percentage by non-controlling owners</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_Cash_lbl" xml:lang="en-US">Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Investments" xlink:label="us-gaap_Investments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Investments" xlink:to="us-gaap_Investments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Investments_lbl" xml:lang="en-US">Investments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTable_lbl" xml:lang="en-US">Subsequent Event [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_3_lbl" xml:lang="en-US">Conversion of convertible securities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharesIssued_2_lbl" xml:lang="en-US">Shares, Issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_3_lbl" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_StockIssuedDuringPeriodSharesIssuedSettlementOfAccountsPayable" xlink:to="CNXA_StockIssuedDuringPeriodSharesIssuedSettlementOfAccountsPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="CNXA_StockIssuedDuringPeriodSharesIssuedSettlementOfAccountsPayable_2_lbl" xml:lang="en-US">[custom:StockIssuedDuringPeriodSharesIssuedSettlementOfAccountsPayable]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_StockIssuedDuringPeriodSharesIssuedSettlementWithFormerOwners" xlink:to="CNXA_StockIssuedDuringPeriodSharesIssuedSettlementWithFormerOwners_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="CNXA_StockIssuedDuringPeriodSharesIssuedSettlementWithFormerOwners_2_lbl" xml:lang="en-US">[custom:StockIssuedDuringPeriodSharesIssuedSettlementWithFormerOwners]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_StockIssuedDuringPeriodSharesIssuedProfitGuaranteeOnNote" xlink:to="CNXA_StockIssuedDuringPeriodSharesIssuedProfitGuaranteeOnNote_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="CNXA_StockIssuedDuringPeriodSharesIssuedProfitGuaranteeOnNote_2_lbl" xml:lang="en-US">[custom:StockIssuedDuringPeriodSharesIssuedProfitGuaranteeOnNote]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_2_lbl" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionLineItems_lbl" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="us-gaap_BusinessAcquisitionsProFormaRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="us-gaap_BusinessAcquisitionsProFormaRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionsProFormaRevenue_lbl" xml:lang="en-US">Revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:to="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_lbl" xml:lang="en-US">Net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:label="us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:to="us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_lbl" xml:lang="en-US">Basic earnings (loss) per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:label="us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:to="us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_lbl" xml:lang="en-US">Diluted earnings (loss) per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xml:lang="en-US">2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xml:lang="en-US">2025</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xml:lang="en-US">2026</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xml:lang="en-US">2027</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" xml:lang="en-US">2028</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl" xml:lang="en-US">Thereafter</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_4_lbl" xml:lang="en-US">Total</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_DisposalEquityInterestOwnershipInterestPercentage" xlink:to="CNXA_DisposalEquityInterestOwnershipInterestPercentage_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="CNXA_DisposalEquityInterestOwnershipInterestPercentage_2_lbl" xml:lang="en-US">Disposal equity interest percentage</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal" xlink:to="us-gaap_DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal_2_lbl" xml:lang="en-US">Discontinuing operations percentage</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AlternativeInvestment" xlink:to="us-gaap_AlternativeInvestment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AlternativeInvestment_2_lbl" xml:lang="en-US">Investments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_lbl" xml:lang="en-US">Warrants Shares, Beginning Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding" xlink:label="CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding" xlink:to="CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_lbl" xml:lang="en-US">Weighted Avg. Exercise Price Warrant, Beginning Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_2_lbl" xml:lang="en-US">Warrants Shares, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceIssued" xlink:label="CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceIssued" xlink:to="CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceIssued_lbl" xml:lang="en-US">Weighted Avg. Exercise Price Warrant, Issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_3_lbl" xml:lang="en-US">Warrants Shares, Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised" xlink:label="CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised" xlink:to="CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised_lbl" xml:lang="en-US">Weighted Avg. Exercise Price Warrant, Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_lbl" xml:lang="en-US">Warrants Shares, Forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceForfeited" xlink:label="CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceForfeited" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceForfeited" xlink:to="CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceForfeited_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceForfeited_lbl" xml:lang="en-US">Weighted Avg. Exercise Price Warrant, Forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_lbl" xml:lang="en-US">Warrants Shares, Expired</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExpired" xlink:label="CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExpired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExpired" xlink:to="CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExpired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExpired_lbl" xml:lang="en-US">Weighted Avg. Exercise Price Warrant, Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_2_lbl" xml:lang="en-US">Warrants Shares, Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2_lbl" xml:lang="en-US">Warrants Shares, Ending Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding" xlink:to="CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_2_lbl" xml:lang="en-US">Weighted Avg. Exercise Price Warrant, Ending Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstanding" xlink:to="us-gaap_WarrantsAndRightsOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WarrantsAndRightsOutstanding_3_lbl" xml:lang="en-US">Intrinsic value of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Life (Years)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xml:lang="en-US">Loss carryforwards</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DeferredTaxAssetsStockOptions" xlink:label="CNXA_DeferredTaxAssetsStockOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_DeferredTaxAssetsStockOptions" xlink:to="CNXA_DeferredTaxAssetsStockOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_DeferredTaxAssetsStockOptions_lbl" xml:lang="en-US">Stock options</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DeferredTaxAssetsAccruedPayroll" xlink:label="CNXA_DeferredTaxAssetsAccruedPayroll" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_DeferredTaxAssetsAccruedPayroll" xlink:to="CNXA_DeferredTaxAssetsAccruedPayroll_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_DeferredTaxAssetsAccruedPayroll_lbl" xml:lang="en-US">Capital loss carryforward/Disposal</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DeferredTaxAssetsRelatedPartyAccruals" xlink:label="CNXA_DeferredTaxAssetsRelatedPartyAccruals" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_DeferredTaxAssetsRelatedPartyAccruals" xlink:to="CNXA_DeferredTaxAssetsRelatedPartyAccruals_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_DeferredTaxAssetsRelatedPartyAccruals_lbl" xml:lang="en-US">Related party accruals</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsInventory" xlink:label="us-gaap_DeferredTaxAssetsInventory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsInventory" xlink:to="us-gaap_DeferredTaxAssetsInventory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsInventory_lbl" xml:lang="en-US">Inventory reserve</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DeferredTaxAssetsInterestDeferral" xlink:label="CNXA_DeferredTaxAssetsInterestDeferral" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_DeferredTaxAssetsInterestDeferral" xlink:to="CNXA_DeferredTaxAssetsInterestDeferral_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_DeferredTaxAssetsInterestDeferral_lbl" xml:lang="en-US">Interest deferral</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DeferredTaxAssetsStartupCosts" xlink:label="CNXA_DeferredTaxAssetsStartupCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_DeferredTaxAssetsStartupCosts" xlink:to="CNXA_DeferredTaxAssetsStartupCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_DeferredTaxAssetsStartupCosts_lbl" xml:lang="en-US">Start-up costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xml:lang="en-US">Net deferred tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_lbl" xml:lang="en-US">Loss carryforwards</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DeferredTaxAssetsStartupCostsForeign" xlink:label="CNXA_DeferredTaxAssetsStartupCostsForeign" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_DeferredTaxAssetsStartupCostsForeign" xlink:to="CNXA_DeferredTaxAssetsStartupCostsForeign_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="CNXA_DeferredTaxAssetsStartupCostsForeign_lbl" xml:lang="en-US">Start-up costs</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DeferredTaxAssetsInProcessResearchAndDevelopmentCosts" xlink:label="CNXA_DeferredTaxAssetsInProcessResearchAndDevelopmentCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_DeferredTaxAssetsInProcessResearchAndDevelopmentCosts" xlink:to="CNXA_DeferredTaxAssetsInProcessResearchAndDevelopmentCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="CNXA_DeferredTaxAssetsInProcessResearchAndDevelopmentCosts_lbl" xml:lang="en-US">Research and development costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="us-gaap_OperatingLossCarryforwardsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwardsTable" xlink:to="us-gaap_OperatingLossCarryforwardsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwardsTable_lbl" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="us-gaap_OperatingLossCarryforwardsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_OperatingLossCarryforwardsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwardsLineItems_lbl" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Income tax provision (benefit) based on book income (loss) at Israeli statutory rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_lbl" xml:lang="en-US">Share-based compensation and shares for services</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_IncomeTaxReconciliationDebtDiscountAmortization" xlink:label="CNXA_IncomeTaxReconciliationDebtDiscountAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_IncomeTaxReconciliationDebtDiscountAmortization" xlink:to="CNXA_IncomeTaxReconciliationDebtDiscountAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_IncomeTaxReconciliationDebtDiscountAmortization_lbl" xml:lang="en-US">Debt discount amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_IncomeTaxReconciliationRelatedPartyAccruals" xlink:label="CNXA_IncomeTaxReconciliationRelatedPartyAccruals" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_IncomeTaxReconciliationRelatedPartyAccruals" xlink:to="CNXA_IncomeTaxReconciliationRelatedPartyAccruals_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="CNXA_IncomeTaxReconciliationRelatedPartyAccruals_lbl" xml:lang="en-US">Related party accruals</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_IncomeTaxReconciliationStartUpCosts" xlink:label="CNXA_IncomeTaxReconciliationStartUpCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_IncomeTaxReconciliationStartUpCosts" xlink:to="CNXA_IncomeTaxReconciliationStartUpCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="CNXA_IncomeTaxReconciliationStartUpCosts_lbl" xml:lang="en-US">Stock options</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_IncomeTaxRecociliationInterestExpense" xlink:label="CNXA_IncomeTaxRecociliationInterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_IncomeTaxRecociliationInterestExpense" xlink:to="CNXA_IncomeTaxRecociliationInterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="CNXA_IncomeTaxRecociliationInterestExpense_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseDepreciation" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseDepreciation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationNondeductibleExpenseDepreciation" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpenseDepreciation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseDepreciation_lbl" xml:lang="en-US">Depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_IncomeTaxRecociliationInventoryReserve" xlink:label="CNXA_IncomeTaxRecociliationInventoryReserve" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_IncomeTaxRecociliationInventoryReserve" xlink:to="CNXA_IncomeTaxRecociliationInventoryReserve_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="CNXA_IncomeTaxRecociliationInventoryReserve_lbl" xml:lang="en-US">Inventory reserve</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_IncomeTaxRecociliationInterestDeferral" xlink:label="CNXA_IncomeTaxRecociliationInterestDeferral" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_IncomeTaxRecociliationInterestDeferral" xlink:to="CNXA_IncomeTaxRecociliationInterestDeferral_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="CNXA_IncomeTaxRecociliationInterestDeferral_lbl" xml:lang="en-US">Interest deferral</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_IncomeTaxRecociliationAcquisitionCosts" xlink:label="CNXA_IncomeTaxRecociliationAcquisitionCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_IncomeTaxRecociliationAcquisitionCosts" xlink:to="CNXA_IncomeTaxRecociliationAcquisitionCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_IncomeTaxRecociliationAcquisitionCosts_lbl" xml:lang="en-US">Acquisition costs</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_IncomeTaxRecociliationAccruedLegal" xlink:label="CNXA_IncomeTaxRecociliationAccruedLegal" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_IncomeTaxRecociliationAccruedLegal" xlink:to="CNXA_IncomeTaxRecociliationAccruedLegal_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_IncomeTaxRecociliationAccruedLegal_lbl" xml:lang="en-US">Accrued legal</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_IncomeTaxRecociliationLossOnExtinguishmentOfDebt" xlink:label="CNXA_IncomeTaxRecociliationLossOnExtinguishmentOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_IncomeTaxRecociliationLossOnExtinguishmentOfDebt" xlink:to="CNXA_IncomeTaxRecociliationLossOnExtinguishmentOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_IncomeTaxRecociliationLossOnExtinguishmentOfDebt_lbl" xml:lang="en-US">Loss on sale of capital assets</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_IncomeTaxRecociliationAccruedPayroll" xlink:label="CNXA_IncomeTaxRecociliationAccruedPayroll" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_IncomeTaxRecociliationAccruedPayroll" xlink:to="CNXA_IncomeTaxRecociliationAccruedPayroll_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="CNXA_IncomeTaxRecociliationAccruedPayroll_lbl" xml:lang="en-US">Accrued payroll</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_IncomeTaxRecociliationGainOnChangeInFairValueOfDerivatives" xlink:label="CNXA_IncomeTaxRecociliationGainOnChangeInFairValueOfDerivatives" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_IncomeTaxRecociliationGainOnChangeInFairValueOfDerivatives" xlink:to="CNXA_IncomeTaxRecociliationGainOnChangeInFairValueOfDerivatives_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_IncomeTaxRecociliationGainOnChangeInFairValueOfDerivatives_lbl" xml:lang="en-US">Change in fair value of derivatives</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Valuation allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Total income tax provision</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_3_lbl" xml:lang="en-US">Total income tax provision</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Effective tax rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US">Operating loss carryforwards</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_2_lbl" xml:lang="en-US">Note receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_2_lbl" xml:lang="en-US">Cash and restricted cash</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DisposalGroupIncludingDiscontinuedOperationAccountsReceivable" xlink:label="CNXA_DisposalGroupIncludingDiscontinuedOperationAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_DisposalGroupIncludingDiscontinuedOperationAccountsReceivable" xlink:to="CNXA_DisposalGroupIncludingDiscontinuedOperationAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="CNXA_DisposalGroupIncludingDiscontinuedOperationAccountsReceivable_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_lbl" xml:lang="en-US">Prepaid expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_lbl" xml:lang="en-US">Inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_lbl" xml:lang="en-US">Finished products used in operations</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DisposalGroupIncludingDiscontinuedOperationContractAssets" xlink:label="CNXA_DisposalGroupIncludingDiscontinuedOperationContractAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_DisposalGroupIncludingDiscontinuedOperationContractAssets" xlink:to="CNXA_DisposalGroupIncludingDiscontinuedOperationContractAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="CNXA_DisposalGroupIncludingDiscontinuedOperationContractAssets_lbl" xml:lang="en-US">Contract assets</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DisposalGroupIncludingDiscontinuedOperationRightOfUseAsset" xlink:label="CNXA_DisposalGroupIncludingDiscontinuedOperationRightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_DisposalGroupIncludingDiscontinuedOperationRightOfUseAsset" xlink:to="CNXA_DisposalGroupIncludingDiscontinuedOperationRightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_DisposalGroupIncludingDiscontinuedOperationRightOfUseAsset_lbl" xml:lang="en-US">Right of use asset</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_lbl" xml:lang="en-US">Intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DisposalGroupIncludingDiscontinuedOperationContractLiabilities" xlink:label="CNXA_DisposalGroupIncludingDiscontinuedOperationContractLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_DisposalGroupIncludingDiscontinuedOperationContractLiabilities" xlink:to="CNXA_DisposalGroupIncludingDiscontinuedOperationContractLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="CNXA_DisposalGroupIncludingDiscontinuedOperationContractLiabilities_lbl" xml:lang="en-US">Contract liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_lbl" xml:lang="en-US">Lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DisposalGroupIncludingDiscontinuedOperationLossOnDisposalOfDiscontinuedOperations" xlink:label="CNXA_DisposalGroupIncludingDiscontinuedOperationLossOnDisposalOfDiscontinuedOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_DisposalGroupIncludingDiscontinuedOperationLossOnDisposalOfDiscontinuedOperations" xlink:to="CNXA_DisposalGroupIncludingDiscontinuedOperationLossOnDisposalOfDiscontinuedOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_DisposalGroupIncludingDiscontinuedOperationLossOnDisposalOfDiscontinuedOperations_lbl" xml:lang="en-US">Loss on disposal of discontinued operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_StockIssuedDuringPeriodForAbstract" xlink:to="CNXA_StockIssuedDuringPeriodForAbstract_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_StockIssuedDuringPeriodForAbstract_doc" xml:lang="en-US">Stock issued during period for abstract</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_StockIssuedDuringPeriodValueConversionofNotesPayableRelatedParties" xlink:to="CNXA_StockIssuedDuringPeriodValueConversionofNotesPayableRelatedParties_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_StockIssuedDuringPeriodValueConversionofNotesPayableRelatedParties_doc" xml:lang="en-US">Stock issued during period value conversion of notes payable related parties</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_IntangiableAssetMember" xlink:to="CNXA_IntangiableAssetMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_IntangiableAssetMember_doc" xml:lang="en-US">Intangiable Asset [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_NotesPayableCurrentExcludingConvertibleNotesPayableNet" xlink:label="CNXA_NotesPayableCurrentExcludingConvertibleNotesPayableNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_NotesPayableCurrentExcludingConvertibleNotesPayableNet" xlink:to="CNXA_NotesPayableCurrentExcludingConvertibleNotesPayableNet_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_NotesPayableCurrentExcludingConvertibleNotesPayableNet_doc" xml:lang="en-US">Notes payable current excluding convertible notes payable net.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_StockIssuedDuringPeriodShareConversionofNotesPayableRelatedParties" xlink:to="CNXA_StockIssuedDuringPeriodShareConversionofNotesPayableRelatedParties_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_StockIssuedDuringPeriodShareConversionofNotesPayableRelatedParties_doc" xml:lang="en-US">Stock issued during period share conversion of notes payable related parties</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_SecuritiesPurchaseAgreementMember" xlink:to="CNXA_SecuritiesPurchaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_SecuritiesPurchaseAgreementMember_doc" xml:lang="en-US">Securities Purchase Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_WarrantsIssuedToPurchaseOfCommonStockShares" xlink:to="CNXA_WarrantsIssuedToPurchaseOfCommonStockShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_WarrantsIssuedToPurchaseOfCommonStockShares_doc" xml:lang="en-US">Warrants issued to purchase of common stock shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_WarrantsExercisePrice" xlink:to="CNXA_WarrantsExercisePrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_WarrantsExercisePrice_doc" xml:lang="en-US">Warrants exercise price.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_RemainingDerivativeLiabilities" xlink:to="CNXA_RemainingDerivativeLiabilities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_RemainingDerivativeLiabilities_doc" xml:lang="en-US">Remaining derivative liabilities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_StockIssuedDuringPeriodValueCashlessExerciseOfWarrants" xlink:to="CNXA_StockIssuedDuringPeriodValueCashlessExerciseOfWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_StockIssuedDuringPeriodValueCashlessExerciseOfWarrants_doc" xml:lang="en-US">Stock issued during period value cashless exercise of warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_StockIssuedDuringPeriodCashlessExerciseOfWarrantsShares" xlink:to="CNXA_StockIssuedDuringPeriodCashlessExerciseOfWarrantsShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_StockIssuedDuringPeriodCashlessExerciseOfWarrantsShares_doc" xml:lang="en-US">Stock issued during period cashless exercise of warrants shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_LossOnIssuanceOfConvertibleNotes" xlink:to="CNXA_LossOnIssuanceOfConvertibleNotes_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_LossOnIssuanceOfConvertibleNotes_doc" xml:lang="en-US">Loss on issuance of convertible notes.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_DerivativeExpense" xlink:to="CNXA_DerivativeExpense_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_DerivativeExpense_doc" xml:lang="en-US">Derivative expense.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_SecuritiesOutstandingRateConvertibleNotesDescripition" xlink:to="CNXA_SecuritiesOutstandingRateConvertibleNotesDescripition_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_SecuritiesOutstandingRateConvertibleNotesDescripition_doc" xml:lang="en-US">Securities outstanding rate convertible notes descripition.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_IncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="CNXA_IncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_IncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_doc" xml:lang="en-US">Income loss from operations before income taxes extraordinary items noncontrolling interest.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_OmnibusAgreementMember" xlink:to="CNXA_OmnibusAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_OmnibusAgreementMember_doc" xml:lang="en-US">Omnibus Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_ConvertibleNotesMember" xlink:to="CNXA_ConvertibleNotesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_ConvertibleNotesMember_doc" xml:lang="en-US">Convertible Notes [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_LoanAgreementMember" xlink:to="CNXA_LoanAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_LoanAgreementMember_doc" xml:lang="en-US">Loan Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_MontsaicInvestmentsLLCMember" xlink:to="CNXA_MontsaicInvestmentsLLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_MontsaicInvestmentsLLCMember_doc" xml:lang="en-US">Montsaic Investments, LLC [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_PromissoryNotePayableMember" xlink:to="CNXA_PromissoryNotePayableMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_PromissoryNotePayableMember_doc" xml:lang="en-US">Promissory Note Payable [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_ThirdPartyMember" xlink:to="CNXA_ThirdPartyMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_ThirdPartyMember_doc" xml:lang="en-US">Third Party [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_NumberOfConsignedGoods" xlink:to="CNXA_NumberOfConsignedGoods_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_NumberOfConsignedGoods_doc" xml:lang="en-US">Number of consigned goods.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_NotesPayableMember" xlink:to="CNXA_NotesPayableMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_NotesPayableMember_doc" xml:lang="en-US">Notes Payable [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_UFSAgreementMember" xlink:to="CNXA_UFSAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_UFSAgreementMember_doc" xml:lang="en-US">UFS Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_CashLessFees" xlink:to="CNXA_CashLessFees_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_CashLessFees_doc" xml:lang="en-US">Cash less fees.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_EachWeekForNextThreeWeeksMember" xlink:to="CNXA_EachWeekForNextThreeWeeksMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_EachWeekForNextThreeWeeksMember_doc" xml:lang="en-US">Each Week for Next Three Weeks [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_ThereafterPerWeekMember" xlink:to="CNXA_ThereafterPerWeekMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_ThereafterPerWeekMember_doc" xml:lang="en-US">Thereafter Per Week [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_CedarAgreementMember" xlink:to="CNXA_CedarAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_CedarAgreementMember_doc" xml:lang="en-US">Cedar Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_NoncashTransactionCosts" xlink:to="CNXA_NoncashTransactionCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_NoncashTransactionCosts_doc" xml:lang="en-US">Noncash transaction costs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_IncreaseDecreaseInPrepaidInventory" xlink:to="CNXA_IncreaseDecreaseInPrepaidInventory_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_IncreaseDecreaseInPrepaidInventory_doc" xml:lang="en-US">Increase decrease in prepaid inventory.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_LoanAndSecurityAgreementMember" xlink:to="CNXA_LoanAndSecurityAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_LoanAndSecurityAgreementMember_doc" xml:lang="en-US">Loan and Security Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_ArmisticeCapitalMasterFundLtdMember" xlink:to="CNXA_ArmisticeCapitalMasterFundLtdMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_ArmisticeCapitalMasterFundLtdMember_doc" xml:lang="en-US">Armistice Capital Master Fund Ltd [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_NotesMember" xlink:to="CNXA_NotesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_NotesMember_doc" xml:lang="en-US">Notes [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_IncreaseDecreaseInInterestPayableRelatedParty" xlink:to="CNXA_IncreaseDecreaseInInterestPayableRelatedParty_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_IncreaseDecreaseInInterestPayableRelatedParty_doc" xml:lang="en-US">Increase decrease in interest payable related party.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_ConversionOfConvertibleNotesPayableAndAccruedInterestToCommonStock" xlink:to="CNXA_ConversionOfConvertibleNotesPayableAndAccruedInterestToCommonStock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_ConversionOfConvertibleNotesPayableAndAccruedInterestToCommonStock_doc" xml:lang="en-US">Conversion of convertible notes payable and accrued interest to common stock.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_SharesIssuedForContingentConsideration" xlink:to="CNXA_SharesIssuedForContingentConsideration_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_SharesIssuedForContingentConsideration_doc" xml:lang="en-US">Shares issued for contingent consideration</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_EliminationOfRelatedPartyDerivativeLiabilities" xlink:to="CNXA_EliminationOfRelatedPartyDerivativeLiabilities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_EliminationOfRelatedPartyDerivativeLiabilities_doc" xml:lang="en-US">Elimination of related party derivative liabilities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_DerivativeLiabilitiesRecordedAsDebtDiscountsOfConvertibleNotes" xlink:to="CNXA_DerivativeLiabilitiesRecordedAsDebtDiscountsOfConvertibleNotes_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_DerivativeLiabilitiesRecordedAsDebtDiscountsOfConvertibleNotes_doc" xml:lang="en-US">Derivative liabilities recorded as debt discounts of convertible notes.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_DerivativeLiabilityRecordedForSharesAndWarrantsIssuedInPrivatePlacement" xlink:to="CNXA_DerivativeLiabilityRecordedForSharesAndWarrantsIssuedInPrivatePlacement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_DerivativeLiabilityRecordedForSharesAndWarrantsIssuedInPrivatePlacement_doc" xml:lang="en-US">Derivative liability recorded for shares and warrants issued in private placement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_SlingerBagAmericasIncMember" xlink:to="CNXA_SlingerBagAmericasIncMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_SlingerBagAmericasIncMember_doc" xml:lang="en-US">Slinger Bag Americas Inc [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_StockPurchaseAgreementMember" xlink:to="CNXA_StockPurchaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_StockPurchaseAgreementMember_doc" xml:lang="en-US">Stock Purchase Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_NumberOfSharesExchanged" xlink:to="CNXA_NumberOfSharesExchanged_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_NumberOfSharesExchanged_doc" xml:lang="en-US">Number of shares exchanged.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_NumberOfSharesOwned" xlink:to="CNXA_NumberOfSharesOwned_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_NumberOfSharesOwned_doc" xml:lang="en-US">Number of shares owned.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_SoleShareholderofSBLMember" xlink:to="CNXA_SoleShareholderofSBLMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_SoleShareholderofSBLMember_doc" xml:lang="en-US">Sole Shareholder of SBL [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_FoundationSportsSystemsLLCMember" xlink:to="CNXA_FoundationSportsSystemsLLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_FoundationSportsSystemsLLCMember_doc" xml:lang="en-US">Foundation Sports Systems LLC [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_CharlesRuddyMember" xlink:to="CNXA_CharlesRuddyMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_CharlesRuddyMember_doc" xml:lang="en-US">Charles Ruddy [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_PlaySightMember" xlink:to="CNXA_PlaySightMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_PlaySightMember_doc" xml:lang="en-US">Play Sight [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_CustomerTwoMember" xlink:to="CNXA_CustomerTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_CustomerTwoMember_doc" xml:lang="en-US">Customer Two [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_CustomerFourMember" xlink:to="CNXA_CustomerFourMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_CustomerFourMember_doc" xml:lang="en-US">Customer Four [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_DisposalEquityInterestOwnershipInterestPercentage" xlink:to="CNXA_DisposalEquityInterestOwnershipInterestPercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_DisposalEquityInterestOwnershipInterestPercentage_doc" xml:lang="en-US">Disposal equity interest ownership interest percentage.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_FoundationSportsMember" xlink:to="CNXA_FoundationSportsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_FoundationSportsMember_doc" xml:lang="en-US">Foundation Sports [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_PlaySightAndGameFaceMember" xlink:to="CNXA_PlaySightAndGameFaceMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_PlaySightAndGameFaceMember_doc" xml:lang="en-US">Play Sight And Game Face [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_CapitalizedDutyAndFreight" xlink:to="CNXA_CapitalizedDutyAndFreight_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_CapitalizedDutyAndFreight_doc" xml:lang="en-US">Capitalized duty and freight.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_PrepaidInventoryPolicyTextBlock" xlink:to="CNXA_PrepaidInventoryPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_PrepaidInventoryPolicyTextBlock_doc" xml:lang="en-US">Prepaid Inventory Policy [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_ProfitGuarantyMember" xlink:to="CNXA_ProfitGuarantyMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_ProfitGuarantyMember_doc" xml:lang="en-US">Profit Guaranty [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_UnderwriterWarrantsMember" xlink:to="CNXA_UnderwriterWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_UnderwriterWarrantsMember_doc" xml:lang="en-US">Underwriter Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_OtherDerivativeLiabilitiesMember" xlink:to="CNXA_OtherDerivativeLiabilitiesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_OtherDerivativeLiabilitiesMember_doc" xml:lang="en-US">Other Derivative Liabilities [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_WarrantsIssuedWithCommonStockMember" xlink:to="CNXA_WarrantsIssuedWithCommonStockMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_WarrantsIssuedWithCommonStockMember_doc" xml:lang="en-US">Warrants Issued With Common Stock [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_WarrantsIssuedWithNotesPayableMember" xlink:to="CNXA_WarrantsIssuedWithNotesPayableMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_WarrantsIssuedWithNotesPayableMember_doc" xml:lang="en-US">Warrants Issued With Notes Payable [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_DerivativeLiabilitiesMeasurementInputTerm" xlink:to="CNXA_DerivativeLiabilitiesMeasurementInputTerm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_DerivativeLiabilitiesMeasurementInputTerm_doc" xml:lang="en-US">Derivative liabilities measurement inpu term.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_WarrantsPolicyTextBlock" xlink:to="CNXA_WarrantsPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_WarrantsPolicyTextBlock_doc" xml:lang="en-US">Warrants Policy [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_GabrielGoldmanMember" xlink:to="CNXA_GabrielGoldmanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_GabrielGoldmanMember_doc" xml:lang="en-US">Gabriel Goldman [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_GamefaceAIMember" xlink:to="CNXA_GamefaceAIMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_GamefaceAIMember_doc" xml:lang="en-US">Gameface AI [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_MidcityCapitalLtdMember" xlink:to="CNXA_MidcityCapitalLtdMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_MidcityCapitalLtdMember_doc" xml:lang="en-US">Midcity Capital Ltd [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_WarrantPerShare" xlink:to="CNXA_WarrantPerShare_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_WarrantPerShare_doc" xml:lang="en-US">Warrant per share.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_FiveYearWarrantsMember" xlink:to="CNXA_FiveYearWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_FiveYearWarrantsMember_doc" xml:lang="en-US">5-Year Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_SevenYearWarrantsMember" xlink:to="CNXA_SevenYearWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_SevenYearWarrantsMember_doc" xml:lang="en-US">7-Year Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_RelatedPartyLenderMember" xlink:to="CNXA_RelatedPartyLenderMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_RelatedPartyLenderMember_doc" xml:lang="en-US">Related Party Lender [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_ServicesRenderedInLieuOfCashMember" xlink:to="CNXA_ServicesRenderedInLieuOfCashMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_ServicesRenderedInLieuOfCashMember_doc" xml:lang="en-US">Services rendered in lieu of cash [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_TwoEmployeesMember" xlink:to="CNXA_TwoEmployeesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_TwoEmployeesMember_doc" xml:lang="en-US">Two Employees [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_MarketingAndAdvisoryServicesMember" xlink:to="CNXA_MarketingAndAdvisoryServicesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_MarketingAndAdvisoryServicesMember_doc" xml:lang="en-US">Marketing And Advisory Services [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_VendorMember" xlink:to="CNXA_VendorMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_VendorMember_doc" xml:lang="en-US">Vendor [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_AsCompensationMember" xlink:to="CNXA_AsCompensationMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_AsCompensationMember_doc" xml:lang="en-US">As Compensation [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_SixNewBrandAmbassadorsMember" xlink:to="CNXA_SixNewBrandAmbassadorsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_SixNewBrandAmbassadorsMember_doc" xml:lang="en-US">Six New Brand Ambassadors [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_BrandAmbassadorsMember" xlink:to="CNXA_BrandAmbassadorsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_BrandAmbassadorsMember_doc" xml:lang="en-US">Brand Ambassadors [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_NotePayableHolderMember" xlink:to="CNXA_NotePayableHolderMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_NotePayableHolderMember_doc" xml:lang="en-US">Note Payable Holder [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_VendorOneMember" xlink:to="CNXA_VendorOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_VendorOneMember_doc" xml:lang="en-US">Vendor One [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_KeyEmployeesAndOfficersMember" xlink:to="CNXA_KeyEmployeesAndOfficersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_KeyEmployeesAndOfficersMember_doc" xml:lang="en-US">Key Employees and Officers [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_ServiceProviderMember" xlink:to="CNXA_ServiceProviderMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_ServiceProviderMember_doc" xml:lang="en-US">Service Provider [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_ThreeMembersMember" xlink:to="CNXA_ThreeMembersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_ThreeMembersMember_doc" xml:lang="en-US">Three Members [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_LeadPlacementAgentMember" xlink:to="CNXA_LeadPlacementAgentMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_LeadPlacementAgentMember_doc" xml:lang="en-US">Lead Placement Agent [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_ExercisePriceOneMember" xlink:to="CNXA_ExercisePriceOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_ExercisePriceOneMember_doc" xml:lang="en-US">Exercise Price One [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_ExercisePriceTwoMember" xlink:to="CNXA_ExercisePriceTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_ExercisePriceTwoMember_doc" xml:lang="en-US">Exercise Price Two [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_GamefaceMember" xlink:to="CNXA_GamefaceMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_GamefaceMember_doc" xml:lang="en-US">Gameface [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding" xlink:to="CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_doc" xml:lang="en-US">Weighted Avg. Exercise Price Warrant, Balance.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceIssued" xlink:to="CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceIssued_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceIssued_doc" xml:lang="en-US">Weighted Avg. Exercise Price Warrant, Issued.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised" xlink:to="CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised_doc" xml:lang="en-US">Weighted Avg. Exercise Price Warrant, Exercised.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExpired" xlink:to="CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExpired_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExpired_doc" xml:lang="en-US">Weighted Avg. Exercise Price Warrant, Expired.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceForfeited" xlink:to="CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceForfeited_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceForfeited_doc" xml:lang="en-US">Share based compensation arrangement by share based payment award non option equity instruments weighted average exercise price forfeited.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_FairValueOfCommonStock" xlink:to="CNXA_FairValueOfCommonStock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_FairValueOfCommonStock_doc" xml:lang="en-US">Fair value of common stock.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_DeferredTaxAssetsStockOptions" xlink:to="CNXA_DeferredTaxAssetsStockOptions_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_DeferredTaxAssetsStockOptions_doc" xml:lang="en-US">Deferred tax assets stock options.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_DeferredTaxAssetsAccruedPayroll" xlink:to="CNXA_DeferredTaxAssetsAccruedPayroll_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_DeferredTaxAssetsAccruedPayroll_doc" xml:lang="en-US">Deferred tax assets accrued payroll.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_DeferredTaxAssetsRelatedPartyAccruals" xlink:to="CNXA_DeferredTaxAssetsRelatedPartyAccruals_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_DeferredTaxAssetsRelatedPartyAccruals_doc" xml:lang="en-US">Deferred tax assets related party accruals.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_DeferredTaxAssetsInterestDeferral" xlink:to="CNXA_DeferredTaxAssetsInterestDeferral_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_DeferredTaxAssetsInterestDeferral_doc" xml:lang="en-US">Deferred tax assets interest deferral.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_DeferredTaxAssetsStartupCosts" xlink:to="CNXA_DeferredTaxAssetsStartupCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_DeferredTaxAssetsStartupCosts_doc" xml:lang="en-US">Deferred tax assets start up costs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_IncomeTaxReconciliationDebtDiscountAmortization" xlink:to="CNXA_IncomeTaxReconciliationDebtDiscountAmortization_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_IncomeTaxReconciliationDebtDiscountAmortization_doc" xml:lang="en-US">Income tax reconciliation debt discount amortization.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_IncomeTaxReconciliationRelatedPartyAccruals" xlink:to="CNXA_IncomeTaxReconciliationRelatedPartyAccruals_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_IncomeTaxReconciliationRelatedPartyAccruals_doc" xml:lang="en-US">Income tax reconciliation, related party accruals.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_IncomeTaxReconciliationStartUpCosts" xlink:to="CNXA_IncomeTaxReconciliationStartUpCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_IncomeTaxReconciliationStartUpCosts_doc" xml:lang="en-US">Income tax reconciliation, start up costs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_IncomeTaxRecociliationInterestExpense" xlink:to="CNXA_IncomeTaxRecociliationInterestExpense_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_IncomeTaxRecociliationInterestExpense_doc" xml:lang="en-US">Income tax reconciliation, Interest expense.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_IncomeTaxRecociliationInventoryReserve" xlink:to="CNXA_IncomeTaxRecociliationInventoryReserve_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_IncomeTaxRecociliationInventoryReserve_doc" xml:lang="en-US">Income tax recociliation inventory reserve.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_IncomeTaxRecociliationInterestDeferral" xlink:to="CNXA_IncomeTaxRecociliationInterestDeferral_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_IncomeTaxRecociliationInterestDeferral_doc" xml:lang="en-US">Income tax recociliation interest deferral.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_IncomeTaxRecociliationAcquisitionCosts" xlink:to="CNXA_IncomeTaxRecociliationAcquisitionCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_IncomeTaxRecociliationAcquisitionCosts_doc" xml:lang="en-US">Income tax recociliation acquisition costs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_IncomeTaxRecociliationAccruedLegal" xlink:to="CNXA_IncomeTaxRecociliationAccruedLegal_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_IncomeTaxRecociliationAccruedLegal_doc" xml:lang="en-US">Income tax recociliation accrued legal.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_IncomeTaxRecociliationLossOnExtinguishmentOfDebt" xlink:to="CNXA_IncomeTaxRecociliationLossOnExtinguishmentOfDebt_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_IncomeTaxRecociliationLossOnExtinguishmentOfDebt_doc" xml:lang="en-US">Income tax recociliation loss on extinguishment of debt.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_IncomeTaxRecociliationAccruedPayroll" xlink:to="CNXA_IncomeTaxRecociliationAccruedPayroll_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_IncomeTaxRecociliationAccruedPayroll_doc" xml:lang="en-US">Income tax recociliation accrued payroll.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_IncomeTaxRecociliationGainOnChangeInFairValueOfDerivatives" xlink:to="CNXA_IncomeTaxRecociliationGainOnChangeInFairValueOfDerivatives_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_IncomeTaxRecociliationGainOnChangeInFairValueOfDerivatives_doc" xml:lang="en-US">Income tax recociliation gain on change in fair value of derivatives.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_DeferredTaxAssetsStartupCostsForeign" xlink:to="CNXA_DeferredTaxAssetsStartupCostsForeign_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_DeferredTaxAssetsStartupCostsForeign_doc" xml:lang="en-US">Deferred tax assets startup costs foreign.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_DeferredTaxAssetsInProcessResearchAndDevelopmentCosts" xlink:to="CNXA_DeferredTaxAssetsInProcessResearchAndDevelopmentCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_DeferredTaxAssetsInProcessResearchAndDevelopmentCosts_doc" xml:lang="en-US">Deferred tax assets in process research and development costs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_SharesIssuedAndOutstandingPercentage" xlink:to="CNXA_SharesIssuedAndOutstandingPercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_SharesIssuedAndOutstandingPercentage_doc" xml:lang="en-US">Shares issued and outstanding percentage.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_SharePurchaseAgreementMember" xlink:to="CNXA_SharePurchaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_SharePurchaseAgreementMember_doc" xml:lang="en-US">Share Purchase Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_EmployeeAgreementMember" xlink:to="CNXA_EmployeeAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_EmployeeAgreementMember_doc" xml:lang="en-US">Employee Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_FoundationSportsToCharlesRuddyMember" xlink:to="CNXA_FoundationSportsToCharlesRuddyMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_FoundationSportsToCharlesRuddyMember_doc" xml:lang="en-US">Foundation Sports To Charles Ruddy [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesCurrent" xlink:to="CNXA_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesCurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesCurrent_doc" xml:lang="en-US">Right of use asset &#8211; operating leases.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityOperatingLeasesCurrent" xlink:to="CNXA_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityOperatingLeasesCurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityOperatingLeasesCurrent_doc" xml:lang="en-US">Lease liability &#8211; operating leases.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_DisposalGroupIncludingDiscontinuedOperationOtherIncomeLoss" xlink:to="CNXA_DisposalGroupIncludingDiscontinuedOperationOtherIncomeLoss_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_DisposalGroupIncludingDiscontinuedOperationOtherIncomeLoss_doc" xml:lang="en-US">Other income loss.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_DisposalGroupIncludingDiscontinuedOperationNetIncomeLoss" xlink:to="CNXA_DisposalGroupIncludingDiscontinuedOperationNetIncomeLoss_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_DisposalGroupIncludingDiscontinuedOperationNetIncomeLoss_doc" xml:lang="en-US">Net income loss.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_ScheduleOfCalculationOfTheLossOnDisposalTableTextBlock" xlink:to="CNXA_ScheduleOfCalculationOfTheLossOnDisposalTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_ScheduleOfCalculationOfTheLossOnDisposalTableTextBlock_doc" xml:lang="en-US">Schedule of calculation of the loss on disposal (Table Text Block)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_PlaySightAndFoundationSportsMember" xlink:to="CNXA_PlaySightAndFoundationSportsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_PlaySightAndFoundationSportsMember_doc" xml:lang="en-US">Play Sight And Foundation Sports [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_DisposalGroupIncludingDiscontinuedOperationAccountsReceivable" xlink:to="CNXA_DisposalGroupIncludingDiscontinuedOperationAccountsReceivable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_DisposalGroupIncludingDiscontinuedOperationAccountsReceivable_doc" xml:lang="en-US">Accounts receivable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_DisposalGroupIncludingDiscontinuedOperationContractAssets" xlink:to="CNXA_DisposalGroupIncludingDiscontinuedOperationContractAssets_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_DisposalGroupIncludingDiscontinuedOperationContractAssets_doc" xml:lang="en-US">Contract assets.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_DisposalGroupIncludingDiscontinuedOperationRightOfUseAsset" xlink:to="CNXA_DisposalGroupIncludingDiscontinuedOperationRightOfUseAsset_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_DisposalGroupIncludingDiscontinuedOperationRightOfUseAsset_doc" xml:lang="en-US">Right of use asset.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_DisposalGroupIncludingDiscontinuedOperationContractLiabilities" xlink:to="CNXA_DisposalGroupIncludingDiscontinuedOperationContractLiabilities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_DisposalGroupIncludingDiscontinuedOperationContractLiabilities_doc" xml:lang="en-US">Contract liabilities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_DisposalGroupIncludingDiscontinuedOperationLossOnDisposalOfDiscontinuedOperations" xlink:to="CNXA_DisposalGroupIncludingDiscontinuedOperationLossOnDisposalOfDiscontinuedOperations_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_DisposalGroupIncludingDiscontinuedOperationLossOnDisposalOfDiscontinuedOperations_doc" xml:lang="en-US">Loss on disposal of discontinued operations.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_StockIssuedDuringPeriodSharesIssuedSettlementOfAccountsPayable" xlink:to="CNXA_StockIssuedDuringPeriodSharesIssuedSettlementOfAccountsPayable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_StockIssuedDuringPeriodSharesIssuedSettlementOfAccountsPayable_doc" xml:lang="en-US">Stock issued during period shares issued settlement of accounts payable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_StockIssuedDuringPeriodSharesIssuedSettlementWithFormerOwners" xlink:to="CNXA_StockIssuedDuringPeriodSharesIssuedSettlementWithFormerOwners_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_StockIssuedDuringPeriodSharesIssuedSettlementWithFormerOwners_doc" xml:lang="en-US">Stock issued during period shares issued settlement with former owners.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_StockIssuedDuringPeriodSharesIssuedProfitGuaranteeOnNote" xlink:to="CNXA_StockIssuedDuringPeriodSharesIssuedProfitGuaranteeOnNote_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_StockIssuedDuringPeriodSharesIssuedProfitGuaranteeOnNote_doc" xml:lang="en-US">Stock issued during period shares issued profit guarantee on note.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_MonteCarloSimulationMember" xlink:to="CNXA_MonteCarloSimulationMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_MonteCarloSimulationMember_doc" xml:lang="en-US">Monte Carlo Simulation [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_MinimumBidPrice" xlink:label="CNXA_MinimumBidPrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_MinimumBidPrice" xlink:to="CNXA_MinimumBidPrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_MinimumBidPrice_doc" xml:lang="en-US">Minimum bid price.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_GamefaceLtdMember" xlink:to="CNXA_GamefaceLtdMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_GamefaceLtdMember_doc" xml:lang="en-US">Gameface Ltd [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_PlaySightInteractiveLtdMember" xlink:to="CNXA_PlaySightInteractiveLtdMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_PlaySightInteractiveLtdMember_doc" xml:lang="en-US">Play Sight Interactive Ltd [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_PrepaidInventoryCurrent" xlink:to="CNXA_PrepaidInventoryCurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_PrepaidInventoryCurrent_doc" xml:lang="en-US">Prepaid inventory current.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_GainLossOnIssuanceOfConvertibleNotes" xlink:to="CNXA_GainLossOnIssuanceOfConvertibleNotes_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_GainLossOnIssuanceOfConvertibleNotes_doc" xml:lang="en-US">Gain (Loss) on issuance of convertible notes.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_GainLossOnChangeInFairValueOfContingentConsideration" xlink:to="CNXA_GainLossOnChangeInFairValueOfContingentConsideration_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_GainLossOnChangeInFairValueOfContingentConsideration_doc" xml:lang="en-US">Gain (Loss) on change in fair value of contingent consideration.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_GainLossOnChangeInFairValueOfDerivativesLiability" xlink:to="CNXA_GainLossOnChangeInFairValueOfDerivativesLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_GainLossOnChangeInFairValueOfDerivativesLiability_doc" xml:lang="en-US">Gain (Loss) on change in fair value of derivatives liability.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_RecognizedDerivativeExpense" xlink:to="CNXA_RecognizedDerivativeExpense_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_RecognizedDerivativeExpense_doc" xml:lang="en-US">Recognized derivative expense.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_LoanAgreementsMember" xlink:to="CNXA_LoanAgreementsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_LoanAgreementsMember_doc" xml:lang="en-US">Loan Agreements [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_SevenPointFiveYearWarrantsMember" xlink:to="CNXA_SevenPointFiveYearWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_SevenPointFiveYearWarrantsMember_doc" xml:lang="en-US">7.5 -Year Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_InterimFinancialStatementsPolicyTextBlock" xlink:to="CNXA_InterimFinancialStatementsPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_InterimFinancialStatementsPolicyTextBlock_doc" xml:lang="en-US">Interim Financial Statements Policy [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_SingleInstitutionalInvestorMember" xlink:label="CNXA_SingleInstitutionalInvestorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_SingleInstitutionalInvestorMember" xlink:to="CNXA_SingleInstitutionalInvestorMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CNXA_SingleInstitutionalInvestorMember_doc" xml:lang="en-US">Single Institutional Investor [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_AssetsNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNoncurrent_2_lbl" xml:lang="en-US">Assets, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrent_2_lbl" xml:lang="en-US">Liabilities, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrossProfit_2_lbl" xml:lang="en-US">Gross Profit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_2_lbl" xml:lang="en-US">Operating Income (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts_2_lbl" xml:lang="en-US">Amortization of Debt Issuance Costs and Discounts</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpense_3_lbl" xml:lang="en-US">Interest Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_2_lbl" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:to="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_2_lbl" xml:lang="en-US">Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_IncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="CNXA_IncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_IncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_lbl" xml:lang="en-US">IncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_2_lbl" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_3_lbl" xml:lang="en-US">Shares, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_StockIssuedDuringPeriodValueAccountsPayable" xlink:to="CNXA_StockIssuedDuringPeriodValueAccountsPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_StockIssuedDuringPeriodValueAccountsPayable_2_lbl" xml:lang="en-US">StockIssuedDuringPeriodValueAccountsPayable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="us-gaap_DerivativeGainLossOnDerivativeNet_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeGainLossOnDerivativeNet_3_lbl" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_2_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfOtherAssets" xlink:to="us-gaap_GainLossOnSaleOfOtherAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnSaleOfOtherAssets_2_lbl" xml:lang="en-US">Gain (Loss) on Disposition of Other Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInventories_2_lbl" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_IncreaseDecreaseInPrepaidInventory" xlink:to="CNXA_IncreaseDecreaseInPrepaidInventory_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_IncreaseDecreaseInPrepaidInventory_3_lbl" xml:lang="en-US">IncreaseDecreaseInPrepaidInventory</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_2_lbl" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Current Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:to="us-gaap_IncreaseDecreaseInInterestPayableNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInterestPayableNet_2_lbl" xml:lang="en-US">Increase (Decrease) in Interest Payable, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities, Continuing Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireNotesReceivable" xlink:to="us-gaap_PaymentsToAcquireNotesReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireNotesReceivable_2_lbl" xml:lang="en-US">Payments to Acquire Notes Receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities, Continuing Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" xlink:to="us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_2_lbl" xml:lang="en-US">Cash Provided by (Used in) Investing Activities, Discontinued Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="us-gaap_PaymentsOfDebtIssuanceCosts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts_2_lbl" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfRelatedPartyDebt" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt_2_lbl" xml:lang="en-US">Repayments of Related Party Debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfNotesPayable_2_lbl" xml:lang="en-US">Repayments of Notes Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_4_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_2_lbl" xml:lang="en-US">Equity [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_2_lbl" xml:lang="en-US">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryAdjustments" xlink:to="us-gaap_InventoryAdjustments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryAdjustments_2_lbl" xml:lang="en-US">Inventory Adjustments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_2_lbl" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_2_lbl" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_RemainingDerivativeLiabilities" xlink:to="CNXA_RemainingDerivativeLiabilities_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_RemainingDerivativeLiabilities_3_lbl" xml:lang="en-US">RemainingDerivativeLiabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_LossOnIssuanceOfConvertibleNotes" xlink:to="CNXA_LossOnIssuanceOfConvertibleNotes_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_LossOnIssuanceOfConvertibleNotes_3_lbl" xml:lang="en-US">LossOnIssuanceOfConvertibleNotes</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionOriginalDebtInterestRateOfDebt" xlink:to="us-gaap_DebtConversionOriginalDebtInterestRateOfDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionOriginalDebtInterestRateOfDebt_2_lbl" xml:lang="en-US">Debt Conversion, Original Debt, Interest Rate of Debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_IncreaseDecreaseInDerivativeFairValueLiability" xlink:to="CNXA_IncreaseDecreaseInDerivativeFairValueLiability_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_IncreaseDecreaseInDerivativeFairValueLiability_2_lbl" xml:lang="en-US">IncreaseDecreaseInDerivativeFairValueLiability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:to="us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_2_lbl" xml:lang="en-US">Derivative Assets (Liabilities), at Fair Value, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_DisposalGroupIncludingDiscontinuedOperationNetIncomeLoss" xlink:to="CNXA_DisposalGroupIncludingDiscontinuedOperationNetIncomeLoss_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_DisposalGroupIncludingDiscontinuedOperationNetIncomeLoss_3_lbl" xml:lang="en-US">DisposalGroupIncludingDiscontinuedOperationNetIncomeLoss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_2_lbl" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Inventory, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent_2_lbl" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Goodwill, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent_2_lbl" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_2_lbl" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Cash_2_lbl" xml:lang="en-US">Cash [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_3_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding" xlink:to="CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_4_lbl" xml:lang="en-US">Weighted Avg. Exercise Price Warrant, Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNet_2_lbl" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_2_lbl" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Foreign</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_DeferredTaxAssetsStartupCostsForeign" xlink:to="CNXA_DeferredTaxAssetsStartupCostsForeign_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_DeferredTaxAssetsStartupCostsForeign_3_lbl" xml:lang="en-US">DeferredTaxAssetsStartupCostsForeign</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_DeferredTaxAssetsInProcessResearchAndDevelopmentCosts" xlink:to="CNXA_DeferredTaxAssetsInProcessResearchAndDevelopmentCosts_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_DeferredTaxAssetsInProcessResearchAndDevelopmentCosts_3_lbl" xml:lang="en-US">DeferredTaxAssetsInProcessResearchAndDevelopmentCosts</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_IncomeTaxReconciliationRelatedPartyAccruals" xlink:to="CNXA_IncomeTaxReconciliationRelatedPartyAccruals_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_IncomeTaxReconciliationRelatedPartyAccruals_3_lbl" xml:lang="en-US">Related party accruals [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_IncomeTaxReconciliationStartUpCosts" xlink:to="CNXA_IncomeTaxReconciliationStartUpCosts_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_IncomeTaxReconciliationStartUpCosts_3_lbl" xml:lang="en-US">Start up costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_IncomeTaxRecociliationInterestExpense" xlink:to="CNXA_IncomeTaxRecociliationInterestExpense_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_IncomeTaxRecociliationInterestExpense_3_lbl" xml:lang="en-US">IncomeTaxRecociliationInterestExpense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_IncomeTaxRecociliationInventoryReserve" xlink:to="CNXA_IncomeTaxRecociliationInventoryReserve_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_IncomeTaxRecociliationInventoryReserve_3_lbl" xml:lang="en-US">IncomeTaxRecociliationInventoryReserve</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_IncomeTaxRecociliationInterestDeferral" xlink:to="CNXA_IncomeTaxRecociliationInterestDeferral_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_IncomeTaxRecociliationInterestDeferral_3_lbl" xml:lang="en-US">IncomeTaxRecociliationInterestDeferral</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_IncomeTaxRecociliationAccruedPayroll" xlink:to="CNXA_IncomeTaxRecociliationAccruedPayroll_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_IncomeTaxRecociliationAccruedPayroll_3_lbl" xml:lang="en-US">IncomeTaxRecociliationAccruedPayroll</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_2_lbl" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_DisposalGroupIncludingDiscontinuedOperationAccountsReceivable" xlink:to="CNXA_DisposalGroupIncludingDiscontinuedOperationAccountsReceivable_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_DisposalGroupIncludingDiscontinuedOperationAccountsReceivable_3_lbl" xml:lang="en-US">DisposalGroupIncludingDiscontinuedOperationAccountsReceivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_2_lbl" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Prepaid and Other Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_2_lbl" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Inventory</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_2_lbl" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_DisposalGroupIncludingDiscontinuedOperationContractAssets" xlink:to="CNXA_DisposalGroupIncludingDiscontinuedOperationContractAssets_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_DisposalGroupIncludingDiscontinuedOperationContractAssets_3_lbl" xml:lang="en-US">DisposalGroupIncludingDiscontinuedOperationContractAssets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_2_lbl" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Goodwill</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Property, Plant and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_2_lbl" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Intangible Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CNXA_DisposalGroupIncludingDiscontinuedOperationContractLiabilities" xlink:to="CNXA_DisposalGroupIncludingDiscontinuedOperationContractLiabilities_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CNXA_DisposalGroupIncludingDiscontinuedOperationContractLiabilities_3_lbl" xml:lang="en-US">DisposalGroupIncludingDiscontinuedOperationContractLiabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_2_lbl" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>17
<FILENAME>cnxa-20230731_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.20b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://connexasports.com/role/Cover" xlink:href="cnxa-20230731.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/BalanceSheets" xlink:href="cnxa-20230731.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/BalanceSheetsParenthetical" xlink:href="cnxa-20230731.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/StatementsOfOperations" xlink:href="cnxa-20230731.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/StatementOfChangesInShareholdersEquityDeficit" xlink:href="cnxa-20230731.xsd#StatementOfChangesInShareholdersEquityDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/StatementsOfCashFlows" xlink:href="cnxa-20230731.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/OrganizationAndNatureOfBusiness" xlink:href="cnxa-20230731.xsd#OrganizationAndNatureOfBusiness" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/GoingConcern" xlink:href="cnxa-20230731.xsd#GoingConcern" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="cnxa-20230731.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ConcentrationOfCreditRiskAndOtherRisksAndUncertainties" xlink:href="cnxa-20230731.xsd#ConcentrationOfCreditRiskAndOtherRisksAndUncertainties" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/IntangibleAssets" xlink:href="cnxa-20230731.xsd#IntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/AccruedExpenses" xlink:href="cnxa-20230731.xsd#AccruedExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/NotePayableRelatedParty" xlink:href="cnxa-20230731.xsd#NotePayableRelatedParty" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ConvertibleNotesPayable" xlink:href="cnxa-20230731.xsd#ConvertibleNotesPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/NotesPayable" xlink:href="cnxa-20230731.xsd#NotesPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/RelatedPartyTransactions" xlink:href="cnxa-20230731.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ShareholdersEquityDeficit" xlink:href="cnxa-20230731.xsd#ShareholdersEquityDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/CommitmentsAndContingencies" xlink:href="cnxa-20230731.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/DiscontinuedOperations" xlink:href="cnxa-20230731.xsd#DiscontinuedOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/SubsequentEvents" xlink:href="cnxa-20230731.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/AcquisitionsAndBusinessCombinations" xlink:href="cnxa-20230731.xsd#AcquisitionsAndBusinessCombinations" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/NotePayable-RelatedParty" xlink:href="cnxa-20230731.xsd#NotePayable-RelatedParty" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/IncomeTaxes" xlink:href="cnxa-20230731.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/Segments" xlink:href="cnxa-20230731.xsd#Segments" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="cnxa-20230731.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="cnxa-20230731.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/IntangibleAssetsTables" xlink:href="cnxa-20230731.xsd#IntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/AccruedExpensesTables" xlink:href="cnxa-20230731.xsd#AccruedExpensesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/DiscontinuedOperationsTables" xlink:href="cnxa-20230731.xsd#DiscontinuedOperationsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/AcquisitionsAndBusinessCombinationsTables" xlink:href="cnxa-20230731.xsd#AcquisitionsAndBusinessCombinationsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/NotePayable-RelatedPartyTables" xlink:href="cnxa-20230731.xsd#NotePayable-RelatedPartyTables" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/IncomeTaxesTables" xlink:href="cnxa-20230731.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/OrganizationAndNatureOfBusinessDetailsNarrative" xlink:href="cnxa-20230731.xsd#OrganizationAndNatureOfBusinessDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/GoingConcernDetailsNarrative" xlink:href="cnxa-20230731.xsd#GoingConcernDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ScheduleOfInventoryDetails" xlink:href="cnxa-20230731.xsd#ScheduleOfInventoryDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ScheduleOfDerivativeLiabilitiesDetails" xlink:href="cnxa-20230731.xsd#ScheduleOfDerivativeLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ScheduleOfDerivativeAndWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails" xlink:href="cnxa-20230731.xsd#ScheduleOfDerivativeAndWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ScheduleOfWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails" xlink:href="cnxa-20230731.xsd#ScheduleOfWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="cnxa-20230731.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ConcentrationOfCreditRiskAndOtherRisksAndUncertaintiesDetailsNarrative" xlink:href="cnxa-20230731.xsd#ConcentrationOfCreditRiskAndOtherRisksAndUncertaintiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ScheduleOfIntangibleAssetsDetails" xlink:href="cnxa-20230731.xsd#ScheduleOfIntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/IntangibleAssetsDetailsNarrative" xlink:href="cnxa-20230731.xsd#IntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ScheduleOfAccruedExpensesDetails" xlink:href="cnxa-20230731.xsd#ScheduleOfAccruedExpensesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/NotePayableRelatedPartyDetailsNarrative" xlink:href="cnxa-20230731.xsd#NotePayableRelatedPartyDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ConvertibleNotesPayableDetailsNarrative" xlink:href="cnxa-20230731.xsd#ConvertibleNotesPayableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/NotesPayableDetailsNarrative" xlink:href="cnxa-20230731.xsd#NotesPayableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="cnxa-20230731.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative" xlink:href="cnxa-20230731.xsd#ShareholdersEquityDeficitDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="cnxa-20230731.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ScheduleOfDiscontinuedOperationsDetails" xlink:href="cnxa-20230731.xsd#ScheduleOfDiscontinuedOperationsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/DiscontinuedOperationsDetailsNarrative" xlink:href="cnxa-20230731.xsd#DiscontinuedOperationsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/SubsequentEventsDetailsNarrative" xlink:href="cnxa-20230731.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ScheduleOfProformaFinancialInformationDetails" xlink:href="cnxa-20230731.xsd#ScheduleOfProformaFinancialInformationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ScheduleOfEstimatedFutureAmortizationDetails" xlink:href="cnxa-20230731.xsd#ScheduleOfEstimatedFutureAmortizationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/AcquisitionsAndBusinessCombinationsDetailsNarrative" xlink:href="cnxa-20230731.xsd#AcquisitionsAndBusinessCombinationsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ScheduleOfWarrantsIssuedExercisedAndExpiredDetails" xlink:href="cnxa-20230731.xsd#ScheduleOfWarrantsIssuedExercisedAndExpiredDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/NotePayable-RelatedPartyDetailsNarrative" xlink:href="cnxa-20230731.xsd#NotePayable-RelatedPartyDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ScheduleOfNetDeferredTaxAssetsDetails" xlink:href="cnxa-20230731.xsd#ScheduleOfNetDeferredTaxAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ScheduleOfIncomeTaxProvisionDetails" xlink:href="cnxa-20230731.xsd#ScheduleOfIncomeTaxProvisionDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ScheduleOfNetDeferredTaxAssetsDetailsParenthetical" xlink:href="cnxa-20230731.xsd#ScheduleOfNetDeferredTaxAssetsDetailsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ScheduleOfIncomeTaxProvisionDetailsParenthetical" xlink:href="cnxa-20230731.xsd#ScheduleOfIncomeTaxProvisionDetailsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/IncomeTaxesDetailsNarrative" xlink:href="cnxa-20230731.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://connexasports.com/role/ScheduleOfCalculationOfLossOnDisposalDetails" xlink:href="cnxa-20230731.xsd#ScheduleOfCalculationOfLossOnDisposalDetails" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesTable" xlink:label="loc_deiEntityAddressesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesLineItems" xlink:label="loc_deiEntityAddressesLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesTable" xlink:to="loc_deiEntityAddressesLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_deiEntityAddressesAddressTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesTable" xlink:to="loc_deiEntityAddressesAddressTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain" xlink:label="loc_deiAddressTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesAddressTypeAxis" xlink:to="loc_deiAddressTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_BusinessContactMember" xlink:label="loc_deiBusinessContactMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiAddressTypeDomain" xlink:to="loc_deiBusinessContactMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ContactPersonnelName" xlink:label="loc_deiContactPersonnelName" />
      <link:presentationArc order="580" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiContactPersonnelName" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonrelatedPartyMember" xlink:label="loc_us-gaapNonrelatedPartyMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapNonrelatedPartyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaapRelatedPartyMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapRelatedPartyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAxis" xlink:label="loc_srtRestatementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRestatementAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain" xlink:label="loc_srtRestatementDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRestatementAxis" xlink:to="loc_srtRestatementDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="loc_srtScenarioPreviouslyReportedMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRestatementDomain" xlink:to="loc_srtScenarioPreviouslyReportedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_PrepaidInventoryCurrent" xlink:label="loc_CNXAPrepaidInventoryCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_CNXAPrepaidInventoryCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommodityContractAssetCurrent" xlink:label="loc_us-gaapCommodityContractAssetCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCommodityContractAssetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:label="loc_us-gaapAssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="loc_us-gaapAssetsNoncurrentAbstract" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsNoncurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivables" xlink:label="loc_us-gaapOtherReceivables" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapOtherReceivables" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaapAssetsNoncurrent" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapAssetsNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAbstract" xlink:label="loc_us-gaapLiabilitiesAbstract" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PurchaseObligation" xlink:label="loc_us-gaapPurchaseObligation" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapPurchaseObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaapContractWithCustomerLiabilityCurrent" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapContractWithCustomerLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPayableCurrent" xlink:label="loc_us-gaapInterestPayableCurrent" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapInterestPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNotesPayableCurrent" xlink:label="loc_us-gaapOtherNotesPayableCurrent" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOtherNotesPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleNotesPayableCurrent" xlink:label="loc_us-gaapConvertibleNotesPayableCurrent" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapConvertibleNotesPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilitiesCurrent" xlink:label="loc_us-gaapDerivativeLiabilitiesCurrent" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapDerivativeLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:label="loc_us-gaapBusinessCombinationContingentConsiderationLiabilityCurrent" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapBusinessCombinationContingentConsiderationLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:label="loc_us-gaapLiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaapLiabilitiesNoncurrentAbstract" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAbstract" xlink:to="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermNotesPayable" xlink:label="loc_us-gaapLongTermNotesPayable" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAbstract" xlink:to="loc_us-gaapLongTermNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent" xlink:label="loc_us-gaapLiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAbstract" xlink:to="loc_us-gaapLiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAbstract" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaapAdditionalPaidInCapitalCommonStock" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapitalCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Consolidated Statements of Operations (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonrelatedPartyMember" xlink:label="loc_us-gaapNonrelatedPartyMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapNonrelatedPartyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaapRelatedPartyMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapRelatedPartyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaapCostOfGoodsAndServicesSold" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapCostOfGoodsAndServicesSold" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapOperatingExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaapSellingAndMarketingExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapSellingAndMarketingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapNonoperatingIncomeExpenseAbstract" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="loc_us-gaapAmortizationOfFinancingCostsAndDiscounts" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapAmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_GainLossOnIssuanceOfConvertibleNotes" xlink:label="loc_CNXAGainLossOnIssuanceOfConvertibleNotes" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_CNXAGainLossOnIssuanceOfConvertibleNotes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_GainLossOnChangeInFairValueOfContingentConsideration" xlink:label="loc_CNXAGainLossOnChangeInFairValueOfContingentConsideration" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_CNXAGainLossOnChangeInFairValueOfContingentConsideration" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_LossOnConversionOfAccountsPayableToCommonStock" xlink:label="loc_CNXALossOnConversionOfAccountsPayableToCommonStock" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_CNXALossOnConversionOfAccountsPayableToCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_GainLossOnChangeInFairValueOfDerivativesLiability" xlink:label="loc_CNXAGainLossOnChangeInFairValueOfDerivativesLiability" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_CNXAGainLossOnChangeInFairValueOfDerivativesLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DerivativeExpense" xlink:label="loc_CNXADerivativeExpense" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_CNXADerivativeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" xlink:label="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" xlink:label="loc_us-gaapDiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:label="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_IncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_CNXAIncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_CNXAIncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossPerOutstandingLimitedPartnershipAndGeneralPartnershipUnitBasicAndDilutedAbstract" xlink:label="loc_us-gaapNetIncomeLossPerOutstandingLimitedPartnershipAndGeneralPartnershipUnitBasicAndDilutedAbstract" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapNetIncomeLossPerOutstandingLimitedPartnershipAndGeneralPartnershipUnitBasicAndDilutedAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsPerBasicShare" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsPerBasicShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsPerDilutedShare" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsPerDilutedShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/StatementOfChangesInShareholdersEquityDeficit" xlink:title="00000005 - Statement - Consolidated Statement of Changes in Shareholders&apos; Equity (Deficit) (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAxis" xlink:label="loc_srtRestatementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRestatementAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain" xlink:label="loc_srtRestatementDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRestatementAxis" xlink:to="loc_srtRestatementDomain" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="loc_srtScenarioPreviouslyReportedMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRestatementAxis" xlink:to="loc_srtScenarioPreviouslyReportedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="50" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_GamefaceLtdMember" xlink:label="loc_CNXAGamefaceLtdMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_CNXAGamefaceLtdMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_PlaySightInteractiveLtdMember" xlink:label="loc_CNXAPlaySightInteractiveLtdMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_CNXAPlaySightInteractiveLtdMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_StockIssuedDuringPeriodForAbstract" xlink:label="loc_CNXAStockIssuedDuringPeriodForAbstract" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_CNXAStockIssuedDuringPeriodForAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfUnits" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfUnits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfUnits" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfUnits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueOther" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_StockIssuedDuringPeriodValueAccountsPayable" xlink:label="loc_CNXAStockIssuedDuringPeriodValueAccountsPayable" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_CNXAStockIssuedDuringPeriodValueAccountsPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_StockIssuedDuringPeriodSharesAccountsPayable" xlink:label="loc_CNXAStockIssuedDuringPeriodSharesAccountsPayable" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_CNXAStockIssuedDuringPeriodSharesAccountsPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_StockIssuedDuringPeriodValueCashlessExerciseOfWarrants" xlink:label="loc_CNXAStockIssuedDuringPeriodValueCashlessExerciseOfWarrants" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_CNXAStockIssuedDuringPeriodValueCashlessExerciseOfWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_StockIssuedDuringPeriodCashlessExerciseOfWarrantsShares" xlink:label="loc_CNXAStockIssuedDuringPeriodCashlessExerciseOfWarrantsShares" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_CNXAStockIssuedDuringPeriodCashlessExerciseOfWarrantsShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_StockIssuedDuringPeriodValueSatisfactionOfProfitGuaranteeOnNotePayable" xlink:label="loc_CNXAStockIssuedDuringPeriodValueSatisfactionOfProfitGuaranteeOnNotePayable" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_CNXAStockIssuedDuringPeriodValueSatisfactionOfProfitGuaranteeOnNotePayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_StockIssuedDuringPeriodSharesSatisfactionOfProfitGuaranteeOnNotePayable" xlink:label="loc_CNXAStockIssuedDuringPeriodSharesSatisfactionOfProfitGuaranteeOnNotePayable" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_CNXAStockIssuedDuringPeriodSharesSatisfactionOfProfitGuaranteeOnNotePayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_StockIssuedDuringPeriodValueConversionofNotesPayableRelatedParties" xlink:label="loc_CNXAStockIssuedDuringPeriodValueConversionofNotesPayableRelatedParties" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_CNXAStockIssuedDuringPeriodValueConversionofNotesPayableRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_StockIssuedDuringPeriodShareConversionofNotesPayableRelatedParties" xlink:label="loc_CNXAStockIssuedDuringPeriodShareConversionofNotesPayableRelatedParties" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_CNXAStockIssuedDuringPeriodShareConversionofNotesPayableRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalOther" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_2" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Consolidated Statements of Cash Flows (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaapDerivativeGainLossOnDerivativeNet" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDerivativeGainLossOnDerivativeNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfOtherAssets" xlink:label="loc_us-gaapGainLossOnSaleOfOtherAssets" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapGainLossOnSaleOfOtherAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_GainLossOnChangeInFairValueOfContingentConsideration" xlink:label="loc_CNXAGainLossOnChangeInFairValueOfContingentConsideration" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_CNXAGainLossOnChangeInFairValueOfContingentConsideration" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DerivativeExpense" xlink:label="loc_CNXADerivativeExpense" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_CNXADerivativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_NoncashTransactionCosts" xlink:label="loc_CNXANoncashTransactionCosts" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_CNXANoncashTransactionCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_SettlementExpense" xlink:label="loc_CNXASettlementExpense" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_CNXASettlementExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_LossOnSettlementOfAccountsPayable" xlink:label="loc_CNXALossOnSettlementOfAccountsPayable" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_CNXALossOnSettlementOfAccountsPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_GainLossOnIssuanceOfConvertibleNotes" xlink:label="loc_CNXAGainLossOnIssuanceOfConvertibleNotes" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_CNXAGainLossOnIssuanceOfConvertibleNotes" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_IncreaseDecreaseInPrepaidInventory" xlink:label="loc_CNXAIncreaseDecreaseInPrepaidInventory" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_CNXAIncreaseDecreaseInPrepaidInventory" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="loc_us-gaapIncreaseDecreaseInContractWithCustomerLiability" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:label="loc_us-gaapIncreaseDecreaseInInterestPayableNet" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInInterestPayableNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_IncreaseDecreaseInInterestPayableRelatedParty" xlink:label="loc_CNXAIncreaseDecreaseInInterestPayableRelatedParty" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_CNXAIncreaseDecreaseInInterestPayableRelatedParty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:label="loc_us-gaapCashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:label="loc_us-gaapCashAcquiredFromAcquisition" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapCashAcquiredFromAcquisition" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireNotesReceivable" xlink:label="loc_us-gaapPaymentsToAcquireNotesReceivable" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquireNotesReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" xlink:label="loc_us-gaapCashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapCashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfDebtIssuanceCosts" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsOfDebtIssuanceCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaapProceedsFromNotesPayable" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromConvertibleDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapRepaymentsOfRelatedPartyDebt" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapRepaymentsOfRelatedPartyDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaapRepaymentsOfNotesPayable" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapRepaymentsOfNotesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaapSupplementalCashFlowInformationAbstract" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaapInterestPaidNet" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapInterestPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="loc_us-gaapIncomeTaxesPaidNet" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapIncomeTaxesPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssued1" xlink:label="loc_us-gaapStockIssued1" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_us-gaapStockIssued1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_ConversionOfConvertibleNotesPayableAndAccruedInterestToCommonStock" xlink:label="loc_CNXAConversionOfConvertibleNotesPayableAndAccruedInterestToCommonStock" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_CNXAConversionOfConvertibleNotesPayableAndAccruedInterestToCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_SharesIssuedForContingentConsideration" xlink:label="loc_CNXASharesIssuedForContingentConsideration" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_CNXASharesIssuedForContingentConsideration" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_EliminationOfRelatedPartyDerivativeLiabilities" xlink:label="loc_CNXAEliminationOfRelatedPartyDerivativeLiabilities" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_CNXAEliminationOfRelatedPartyDerivativeLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DerivativeLiabilitiesRecordedAsDebtDiscountsOfConvertibleNotes" xlink:label="loc_CNXADerivativeLiabilitiesRecordedAsDebtDiscountsOfConvertibleNotes" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_CNXADerivativeLiabilitiesRecordedAsDebtDiscountsOfConvertibleNotes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DerivativeLiabilityRecordedForSharesAndWarrantsIssuedInPrivatePlacement" xlink:label="loc_CNXADerivativeLiabilityRecordedForSharesAndWarrantsIssuedInPrivatePlacement" />
      <link:presentationArc order="580" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_CNXADerivativeLiabilityRecordedForSharesAndWarrantsIssuedInPrivatePlacement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_SharesIssuedForSettlementOfAccountsPayable" xlink:label="loc_CNXASharesIssuedForSettlementOfAccountsPayable" />
      <link:presentationArc order="590" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_CNXASharesIssuedForSettlementOfAccountsPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesIssued1" xlink:label="loc_us-gaapNotesIssued1" />
      <link:presentationArc order="600" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_us-gaapNotesIssued1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3" />
      <link:presentationArc order="610" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/OrganizationAndNatureOfBusiness" xlink:title="00000007 - Disclosure - ORGANIZATION AND NATURE OF BUSINESS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/GoingConcern" xlink:title="00000008 - Disclosure - GOING CONCERN">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:label="loc_us-gaapSubstantialDoubtAboutGoingConcernTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapSubstantialDoubtAboutGoingConcernTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/ConcentrationOfCreditRiskAndOtherRisksAndUncertainties" xlink:title="00000010 - Disclosure - CONCENTRATION OF CREDIT RISK AND OTHER RISKS AND UNCERTAINTIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="loc_us-gaapRisksAndUncertaintiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:label="loc_us-gaapConcentrationRiskDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRisksAndUncertaintiesAbstract" xlink:to="loc_us-gaapConcentrationRiskDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/IntangibleAssets" xlink:title="00000011 - Disclosure - INTANGIBLE ASSETS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaapIntangibleAssetsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapIntangibleAssetsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/AccruedExpenses" xlink:title="00000012 - Disclosure - ACCRUED EXPENSES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/NotePayableRelatedParty" xlink:title="00000013 - Disclosure - NOTE PAYABLE &#8211; RELATED PARTY">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaapDebtDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/ConvertibleNotesPayable" xlink:title="00000014 - Disclosure - CONVERTIBLE NOTES PAYABLE">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTextBlock" xlink:label="loc_us-gaapShortTermDebtTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapShortTermDebtTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/NotesPayable" xlink:title="00000015 - Disclosure - NOTES PAYABLE">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtTextBlock" xlink:label="loc_us-gaapLongTermDebtTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLongTermDebtTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/RelatedPartyTransactions" xlink:title="00000016 - Disclosure - RELATED PARTY TRANSACTIONS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/ShareholdersEquityDeficit" xlink:title="00000017 - Disclosure - SHAREHOLDERS&#8217; EQUITY (DEFICIT)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/CommitmentsAndContingencies" xlink:title="00000018 - Disclosure - COMMITMENTS AND CONTINGENCIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/DiscontinuedOperations" xlink:title="00000019 - Disclosure - DISCONTINUED OPERATIONS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:label="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:label="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/SubsequentEvents" xlink:title="00000020 - Disclosure - SUBSEQUENT EVENTS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/AcquisitionsAndBusinessCombinations" xlink:title="00000021 - Disclosure - ACQUISITIONS AND BUSINESS COMBINATIONS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="loc_us-gaapBusinessCombinationDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessCombinationDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/NotePayable-RelatedParty" xlink:title="00000022 - Disclosure - NOTE PAYABLE - RELATED PARTY">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaapDebtDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/IncomeTaxes" xlink:title="00000023 - Disclosure - INCOME TAXES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/Segments" xlink:title="00000024 - Disclosure - SEGMENTS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaapSegmentReportingDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapSegmentReportingDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_InterimFinancialStatementsPolicyTextBlock" xlink:label="loc_CNXAInterimFinancialStatementsPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_CNXAInterimFinancialStatementsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="loc_us-gaapPriorPeriodReclassificationAdjustmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapPriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:label="loc_us-gaapTradeAndOtherAccountsReceivablePolicy" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapTradeAndOtherAccountsReceivablePolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="loc_us-gaapInventoryPolicyTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapInventoryPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_PrepaidInventoryPolicyTextBlock" xlink:label="loc_CNXAPrepaidInventoryPolicyTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_CNXAPrepaidInventoryPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaapConcentrationRiskCreditRisk" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConcentrationRiskCreditRisk" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="loc_us-gaapRevenueFromContractWithCustomerPolicyTextBlock" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationsPolicy" xlink:label="loc_us-gaapBusinessCombinationsPolicy" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBusinessCombinationsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:label="loc_us-gaapIntangibleAssetsFiniteLivedPolicy" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIntangibleAssetsFiniteLivedPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsGoodwillPolicy" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapGoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_WarrantsPolicyTextBlock" xlink:label="loc_CNXAWarrantsPolicyTextBlock" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_CNXAWarrantsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="loc_us-gaapForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:label="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:label="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:to="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" xlink:label="loc_us-gaapFairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapFairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/IntangibleAssetsTables" xlink:title="00000027 - Disclosure - INTANGIBLE ASSETS (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="loc_us-gaapScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/AccruedExpensesTables" xlink:title="00000028 - Disclosure - ACCRUED EXPENSES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfAccruedLiabilitiesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/DiscontinuedOperationsTables" xlink:title="00000029 - Disclosure - DISCONTINUED OPERATIONS (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:label="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:label="loc_us-gaapScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_ScheduleOfCalculationOfTheLossOnDisposalTableTextBlock" xlink:label="loc_CNXAScheduleOfCalculationOfTheLossOnDisposalTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_CNXAScheduleOfCalculationOfTheLossOnDisposalTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/AcquisitionsAndBusinessCombinationsTables" xlink:title="00000030 - Disclosure - ACQUISITIONS AND BUSINESS COMBINATIONS (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:label="loc_us-gaapBusinessAcquisitionProFormaInformationTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessAcquisitionProFormaInformationTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/NotePayable-RelatedPartyTables" xlink:title="00000031 - Disclosure - NOTE PAYABLE - RELATED PARTY (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/IncomeTaxesTables" xlink:title="00000032 - Disclosure - INCOME TAXES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementGeographicalAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IL" xlink:label="loc_countryIL" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryIL" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/OrganizationAndNatureOfBusinessDetailsNarrative" xlink:title="00000033 - Disclosure - ORGANIZATION AND NATURE OF BUSINESS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="loc_srtEquityMethodInvesteeNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="loc_srtEquityMethodInvesteeNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_SlingerBagAmericasIncMember" xlink:label="loc_CNXASlingerBagAmericasIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtEquityMethodInvesteeNameDomain" xlink:to="loc_CNXASlingerBagAmericasIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_SoleShareholderofSBLMember" xlink:label="loc_CNXASoleShareholderofSBLMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtEquityMethodInvesteeNameDomain" xlink:to="loc_CNXASoleShareholderofSBLMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_FoundationSportsSystemsLLCMember" xlink:label="loc_CNXAFoundationSportsSystemsLLCMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtEquityMethodInvesteeNameDomain" xlink:to="loc_CNXAFoundationSportsSystemsLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_SlingerBagAmericasIncMember" xlink:label="loc_CNXASlingerBagAmericasIncMember_2" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_CNXASlingerBagAmericasIncMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_SoleShareholderofSBLMember" xlink:label="loc_CNXASoleShareholderofSBLMember_2" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_CNXASoleShareholderofSBLMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_StockPurchaseAgreementMember" xlink:label="loc_CNXAStockPurchaseAgreementMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_CNXAStockPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_srtTitleOfIndividualAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_CharlesRuddyMember" xlink:label="loc_CNXACharlesRuddyMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_CNXACharlesRuddyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_srtRangeAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAxis" xlink:label="loc_srtRestatementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_srtRestatementAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain" xlink:label="loc_srtRestatementDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRestatementAxis" xlink:to="loc_srtRestatementDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="loc_srtScenarioPreviouslyReportedMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRestatementDomain" xlink:to="loc_srtScenarioPreviouslyReportedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="loc_us-gaapBusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapBusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:label="loc_us-gaapBusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapBusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_NumberOfSharesExchanged" xlink:label="loc_CNXANumberOfSharesExchanged" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_CNXANumberOfSharesExchanged" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_NumberOfSharesOwned" xlink:label="loc_CNXANumberOfSharesOwned" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_CNXANumberOfSharesOwned" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_us-gaapStockholdersEquityReverseStockSplit" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapStockholdersEquityReverseStockSplit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:label="loc_us-gaapGoodwillImpairedAccumulatedImpairmentLoss" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapGoodwillImpairedAccumulatedImpairmentLoss" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/GoingConcernDetailsNarrative" xlink:title="00000034 - Disclosure - GOING CONCERN (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfMultiemployerPlansTable" xlink:label="loc_us-gaapScheduleOfMultiemployerPlansTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapScheduleOfMultiemployerPlansTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MultiemployerPlansLineItems" xlink:label="loc_us-gaapMultiemployerPlansLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfMultiemployerPlansTable" xlink:to="loc_us-gaapMultiemployerPlansLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfMultiemployerPlansTable" xlink:to="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_PlaySightMember" xlink:label="loc_CNXAPlaySightMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="loc_CNXAPlaySightMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfMultiemployerPlansTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_FoundationSportsSystemsLLCMember" xlink:label="loc_CNXAFoundationSportsSystemsLLCMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_CNXAFoundationSportsSystemsLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMultiemployerPlansLineItems" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DisposalEquityInterestOwnershipInterestPercentage" xlink:label="loc_CNXADisposalEquityInterestOwnershipInterestPercentage" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMultiemployerPlansLineItems" xlink:to="loc_CNXADisposalEquityInterestOwnershipInterestPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal" xlink:label="loc_us-gaapDiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMultiemployerPlansLineItems" xlink:to="loc_us-gaapDiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AlternativeInvestment" xlink:label="loc_us-gaapAlternativeInvestment" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMultiemployerPlansLineItems" xlink:to="loc_us-gaapAlternativeInvestment" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/ScheduleOfInventoryDetails" xlink:title="00000035 - Disclosure - SCHEDULE OF INVENTORY (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaapInventoryFinishedGoods" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapInventoryFinishedGoods" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterialsAndSupplies" xlink:label="loc_us-gaapInventoryRawMaterialsAndSupplies" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapInventoryRawMaterialsAndSupplies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_CapitalizedDutyAndFreight" xlink:label="loc_CNXACapitalizedDutyAndFreight" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_CNXACapitalizedDutyAndFreight" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryAdjustments" xlink:label="loc_us-gaapInventoryAdjustments" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapInventoryAdjustments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/ScheduleOfDerivativeLiabilitiesDetails" xlink:title="00000036 - Disclosure - SCHEDULE OF DERIVATIVE LIABILITIES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingAssetsTable" xlink:label="loc_us-gaapOffsettingAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapOffsettingAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingAssetsLineItems" xlink:label="loc_us-gaapOffsettingAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsTable" xlink:to="loc_us-gaapOffsettingAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaapDerivativeInstrumentRiskAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsTable" xlink:to="loc_us-gaapDerivativeInstrumentRiskAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_ProfitGuarantyMember" xlink:label="loc_CNXAProfitGuarantyMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_CNXAProfitGuarantyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_ConvertibleNotesMember" xlink:label="loc_CNXAConvertibleNotesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_CNXAConvertibleNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_UnderwriterWarrantsMember" xlink:label="loc_CNXAUnderwriterWarrantsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_CNXAUnderwriterWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_WarrantsIssuedWithCommonStockMember" xlink:label="loc_CNXAWarrantsIssuedWithCommonStockMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_CNXAWarrantsIssuedWithCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_WarrantsIssuedWithNotesPayableMember" xlink:label="loc_CNXAWarrantsIssuedWithNotesPayableMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_CNXAWarrantsIssuedWithNotesPayableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_OtherDerivativeLiabilitiesMember" xlink:label="loc_CNXAOtherDerivativeLiabilitiesMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_CNXAOtherDerivativeLiabilitiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgesLiabilities" xlink:label="loc_us-gaapDerivativeInstrumentsAndHedgesLiabilities" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_us-gaapDerivativeInstrumentsAndHedgesLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaapDerivativeGainLossOnDerivativeNet" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_us-gaapDerivativeGainLossOnDerivativeNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/ScheduleOfDerivativeAndWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails" xlink:title="00000037 - Disclosure - SCHEDULE OF DERIVATIVE AND WARRANTS GRANTED VALUATION USING BLACK-SCHOLES PRICING METHOD (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_srtRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="loc_us-gaapMeasurementInputExpectedTermMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedTermMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaapMeasurementInputPriceVolatilityMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputPriceVolatilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaapMeasurementInputRiskFreeInterestRateMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputRiskFreeInterestRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="loc_us-gaapMeasurementInputExpectedDividendRateMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedDividendRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="loc_us-gaapValuationTechniqueAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapValuationTechniqueAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:label="loc_us-gaapValuationTechniqueOptionPricingModelMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationTechniqueDomain" xlink:to="loc_us-gaapValuationTechniqueOptionPricingModelMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DerivativeLiabilitiesMeasurementInputTerm" xlink:label="loc_CNXADerivativeLiabilitiesMeasurementInputTerm" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_CNXADerivativeLiabilitiesMeasurementInputTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilityMeasurementInput" xlink:label="loc_us-gaapDerivativeLiabilityMeasurementInput" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapDerivativeLiabilityMeasurementInput" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/ScheduleOfWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails" xlink:title="00000038 - Disclosure - SCHEDULE OF WARRANTS GRANTED VALUATION USING BLACK-SCHOLES PRICING METHOD (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="loc_us-gaapValuationTechniqueAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapValuationTechniqueAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:label="loc_us-gaapValuationTechniqueOptionPricingModelMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationTechniqueDomain" xlink:to="loc_us-gaapValuationTechniqueOptionPricingModelMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="loc_us-gaapMeasurementInputExpectedTermMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedTermMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaapMeasurementInputPriceVolatilityMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputPriceVolatilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaapMeasurementInputRiskFreeInterestRateMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputRiskFreeInterestRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="loc_us-gaapMeasurementInputExpectedDividendRateMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedDividendRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_srtRangeAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingTerm" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingMeasurementInput" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingMeasurementInput" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000039 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_PlatformOperatorCryptoAssetTable" xlink:label="loc_srtPlatformOperatorCryptoAssetTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_srtPlatformOperatorCryptoAssetTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_PlatformOperatorCryptoAssetLineItems" xlink:label="loc_srtPlatformOperatorCryptoAssetLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtPlatformOperatorCryptoAssetTable" xlink:to="loc_srtPlatformOperatorCryptoAssetLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtPlatformOperatorCryptoAssetTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtPlatformOperatorCryptoAssetTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferred1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferred1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="loc_us-gaapImpairmentOfIntangibleAssetsFinitelived" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapImpairmentOfIntangibleAssetsFinitelived" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetImpairmentCharges" xlink:label="loc_us-gaapAssetImpairmentCharges" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapAssetImpairmentCharges" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_RecognizedDerivativeExpense" xlink:label="loc_CNXARecognizedDerivativeExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_CNXARecognizedDerivativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaapGoodwillImpairmentLoss" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapGoodwillImpairmentLoss" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/ConcentrationOfCreditRiskAndOtherRisksAndUncertaintiesDetailsNarrative" xlink:title="00000040 - Disclosure - CONCENTRATION OF CREDIT RISK AND OTHER RISKS AND UNCERTAINTIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="loc_us-gaapRisksAndUncertaintiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTable" xlink:label="loc_us-gaapConcentrationRiskTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRisksAndUncertaintiesAbstract" xlink:to="loc_us-gaapConcentrationRiskTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="loc_us-gaapConcentrationRiskLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapConcentrationRiskLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapAccountsReceivableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableMember" xlink:label="loc_us-gaapAccountsPayableMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapAccountsPayableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditConcentrationRiskMember" xlink:label="loc_us-gaapCreditConcentrationRiskMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapCreditConcentrationRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LenderConcentrationRiskMember" xlink:label="loc_us-gaapLenderConcentrationRiskMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapLenderConcentrationRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_srtMajorCustomersAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_CustomerTwoMember" xlink:label="loc_CNXACustomerTwoMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_CNXACustomerTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_CustomerFourMember" xlink:label="loc_CNXACustomerFourMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_CNXACustomerFourMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_CustomerOneMember" xlink:label="loc_CNXACustomerOneMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_CNXACustomerOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/ScheduleOfIntangibleAssetsDetails" xlink:title="00000041 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_TradeNamesAndPatentsMember" xlink:label="loc_CNXATradeNamesAndPatentsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_CNXATradeNamesAndPatentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:label="loc_us-gaapComputerSoftwareIntangibleAssetMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapComputerSoftwareIntangibleAssetMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_IntangiableAssetMember" xlink:label="loc_CNXAIntangiableAssetMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_CNXAIntangiableAssetMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradeNamesMember" xlink:label="loc_us-gaapTradeNamesMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapTradeNamesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="loc_us-gaapImpairmentOfIntangibleAssetsFinitelived" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapImpairmentOfIntangibleAssetsFinitelived" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaapImpairmentOfIntangibleAssetsExcludingGoodwill" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/IntangibleAssetsDetailsNarrative" xlink:title="00000042 - Disclosure - INTANGIBLE ASSETS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_FoundationSportsSystemsLLCMember" xlink:label="loc_CNXAFoundationSportsSystemsLLCMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_CNXAFoundationSportsSystemsLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PatentsMember" xlink:label="loc_us-gaapPatentsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapPatentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="loc_us-gaapImpairmentOfIntangibleAssetsFinitelived" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapImpairmentOfIntangibleAssetsFinitelived" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIntangibleAssetsNet" xlink:label="loc_us-gaapOtherIntangibleAssetsNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapOtherIntangibleAssetsNet" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/ScheduleOfAccruedExpensesDetails" xlink:title="00000043 - Disclosure - SCHEDULE OF ACCRUED EXPENSES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedPayrollTaxesCurrent" xlink:label="loc_us-gaapAccruedPayrollTaxesCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedPayrollTaxesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedBonusesCurrent" xlink:label="loc_us-gaapAccruedBonusesCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedBonusesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="loc_us-gaapAccruedProfessionalFeesCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedProfessionalFeesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableOtherCurrent" xlink:label="loc_us-gaapAccountsPayableOtherCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableOtherCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/NotePayableRelatedPartyDetailsNarrative" xlink:title="00000044 - Disclosure - NOTE PAYABLE &#8211; RELATED PARTY (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_LoanAgreementsMember" xlink:label="loc_CNXALoanAgreementsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_CNXALoanAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaapRelatedPartyMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapRelatedPartyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LoansPayable" xlink:label="loc_us-gaapLoansPayable" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapLoansPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPayableCurrent" xlink:label="loc_us-gaapInterestPayableCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapInterestPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_PaymentForExchangeOfNotesPayable" xlink:label="loc_CNXAPaymentForExchangeOfNotesPayable" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_CNXAPaymentForExchangeOfNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/ConvertibleNotesPayableDetailsNarrative" xlink:title="00000045 - Disclosure - CONVERTIBLE NOTES PAYABLE (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapShortTermDebtLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_SecuritiesPurchaseAgreementMember" xlink:label="loc_CNXASecuritiesPurchaseAgreementMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_CNXASecuritiesPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_OmnibusAgreementMember" xlink:label="loc_CNXAOmnibusAgreementMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_CNXAOmnibusAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="loc_us-gaapValuationTechniqueAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapValuationTechniqueAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_MonteCarloSimulationMember" xlink:label="loc_CNXAMonteCarloSimulationMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationTechniqueDomain" xlink:to="loc_CNXAMonteCarloSimulationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_ConvertibleNotesMember" xlink:label="loc_CNXAConvertibleNotesMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_CNXAConvertibleNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentWarrantsOrOptionsIssued1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentWarrantsOrOptionsIssued1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapInterestPayableCurrentAndNoncurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapInterestPayableCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscount" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleNotesPayable" xlink:label="loc_us-gaapConvertibleNotesPayable" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapConvertibleNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_WarrantsIssuedToPurchaseOfCommonStockShares" xlink:label="loc_CNXAWarrantsIssuedToPurchaseOfCommonStockShares" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_CNXAWarrantsIssuedToPurchaseOfCommonStockShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapProceedsFromConvertibleDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingTerm" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingTerm" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable" xlink:label="loc_us-gaapClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_WarrantsExercisePrice" xlink:label="loc_CNXAWarrantsExercisePrice" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_CNXAWarrantsExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaapWarrantsAndRightsOutstanding" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_RemainingDerivativeLiabilities" xlink:label="loc_CNXARemainingDerivativeLiabilities" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_CNXARemainingDerivativeLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFinanceCostsNet" xlink:label="loc_us-gaapDeferredFinanceCostsNet" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDeferredFinanceCostsNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfUnits" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfUnits" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_LossOnIssuanceOfConvertibleNotes" xlink:label="loc_CNXALossOnIssuanceOfConvertibleNotes" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_CNXALossOnIssuanceOfConvertibleNotes" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_SecuritiesOutstandingRateConvertibleNotesDescripition" xlink:label="loc_CNXASecuritiesOutstandingRateConvertibleNotesDescripition" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_CNXASecuritiesOutstandingRateConvertibleNotesDescripition" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:label="loc_us-gaapDebtInstrumentIncreaseAccruedInterest" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentIncreaseAccruedInterest" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/NotesPayableDetailsNarrative" xlink:title="00000046 - Disclosure - NOTES PAYABLE (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapShortTermDebtLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_PromissoryNotePayableMember" xlink:label="loc_CNXAPromissoryNotePayableMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_CNXAPromissoryNotePayableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_NotesPayableMember" xlink:label="loc_CNXANotesPayableMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_CNXANotesPayableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="loc_us-gaapValuationTechniqueAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapValuationTechniqueAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:label="loc_us-gaapValuationTechniqueOptionPricingModelMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationTechniqueDomain" xlink:to="loc_us-gaapValuationTechniqueOptionPricingModelMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_UFSAgreementMember" xlink:label="loc_CNXAUFSAgreementMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_CNXAUFSAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_CedarAgreementMember" xlink:label="loc_CNXACedarAgreementMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_CNXACedarAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_LoanAndSecurityAgreementMember" xlink:label="loc_CNXALoanAndSecurityAgreementMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_CNXALoanAndSecurityAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_MegedAgreementMember" xlink:label="loc_CNXAMegedAgreementMember" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_CNXAMegedAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_LoanAgreementMember" xlink:label="loc_CNXALoanAgreementMember" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_CNXALoanAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_srtStatementScenarioAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_EachWeekForNextThreeWeeksMember" xlink:label="loc_CNXAEachWeekForNextThreeWeeksMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_CNXAEachWeekForNextThreeWeeksMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_ThereafterPerWeekMember" xlink:label="loc_CNXAThereafterPerWeekMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_CNXAThereafterPerWeekMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_deiLegalEntityAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_ArmisticeCapitalMasterFundLtdMember" xlink:label="loc_CNXAArmisticeCapitalMasterFundLtdMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_CNXAArmisticeCapitalMasterFundLtdMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_srtRangeAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaapShortTermDebtTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapShortTermDebtTypeAxis" order="70" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_NotesMember" xlink:label="loc_CNXANotesMember" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_CNXANotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="80" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="90" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_MontsaicInvestmentsLLCMember" xlink:label="loc_CNXAMontsaicInvestmentsLLCMember" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_CNXAMontsaicInvestmentsLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_srtTitleOfIndividualAxis" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_ThirdPartyMember" xlink:label="loc_CNXAThirdPartyMember" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_CNXAThirdPartyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAxis" xlink:label="loc_srtRestatementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_srtRestatementAxis" order="110" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain" xlink:label="loc_srtRestatementDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRestatementAxis" xlink:to="loc_srtRestatementDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="loc_srtScenarioPreviouslyReportedMember" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRestatementDomain" xlink:to="loc_srtScenarioPreviouslyReportedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="120" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionOriginalDebtInterestRateOfDebt" xlink:label="loc_us-gaapDebtConversionOriginalDebtInterestRateOfDebt" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtConversionOriginalDebtInterestRateOfDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="loc_us-gaapDebtInstrumentCarryingAmount" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentCarryingAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentAmount1" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentAmount1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilities" xlink:label="loc_us-gaapDerivativeLiabilities" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDerivativeLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeNet" xlink:label="loc_us-gaapDerivativeFairValueOfDerivativeNet" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDerivativeFairValueOfDerivativeNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferredOther1" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferredOther1" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferredOther1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_NumberOfConsignedGoods" xlink:label="loc_CNXANumberOfConsignedGoods" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_CNXANumberOfConsignedGoods" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_PaymentsOfRelatedPartyDebt" xlink:label="loc_CNXAPaymentsOfRelatedPartyDebt" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_CNXAPaymentsOfRelatedPartyDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapNotesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedPerTransaction" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedPerTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireReceivables" xlink:label="loc_us-gaapPaymentsToAcquireReceivables" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapPaymentsToAcquireReceivables" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_CashLessFees" xlink:label="loc_CNXACashLessFees" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_CNXACashLessFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaapProceedsFromNotesPayable" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapProceedsFromNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentOfWarrantsGrantedForServices" xlink:label="loc_us-gaapAdjustmentOfWarrantsGrantedForServices" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapAdjustmentOfWarrantsGrantedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DerivativeExpense" xlink:label="loc_CNXADerivativeExpense" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_CNXADerivativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilityFairValueOfCollateral" xlink:label="loc_us-gaapDerivativeLiabilityFairValueOfCollateral" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDerivativeLiabilityFairValueOfCollateral" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_IncreaseDecreaseInDerivativeFairValueLiability" xlink:label="loc_CNXAIncreaseDecreaseInDerivativeFairValueLiability" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_CNXAIncreaseDecreaseInDerivativeFairValueLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateIncreaseDecrease" xlink:label="loc_us-gaapDebtInstrumentInterestRateIncreaseDecrease" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateIncreaseDecrease" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:label="loc_us-gaapStockRedeemedOrCalledDuringPeriodValue" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapStockRedeemedOrCalledDuringPeriodValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LegalFees" xlink:label="loc_us-gaapLegalFees" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapLegalFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfOtherDebt" xlink:label="loc_us-gaapRepaymentsOfOtherDebt" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapRepaymentsOfOtherDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:label="loc_us-gaapDerivativeAssetsLiabilitiesAtFairValueNet" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDerivativeAssetsLiabilitiesAtFairValueNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfDebt" xlink:label="loc_us-gaapRepaymentsOfDebt" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapRepaymentsOfDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteStockSplit" xlink:label="loc_us-gaapStockholdersEquityNoteStockSplit" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapStockholdersEquityNoteStockSplit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_SharesIssuedPricePerShares" xlink:label="loc_CNXASharesIssuedPricePerShares" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_CNXASharesIssuedPricePerShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDerivativeLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInDerivativeLiabilities" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapIncreaseDecreaseInDerivativeLiabilities" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000047 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaapRelatedPartyTransactionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaapRelatedPartyMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapRelatedPartyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapNotesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapInterestPayableCurrentAndNoncurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapInterestPayableCurrentAndNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapRevenues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNet" xlink:label="loc_us-gaapAccountsReceivableNet" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapAccountsReceivableNet" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative" xlink:title="00000048 - Disclosure - SHAREHOLDERS&#8217; EQUITY (DEFICIT) (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestorMember" xlink:label="loc_us-gaapInvestorMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_us-gaapInvestorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_GabrielGoldmanMember" xlink:label="loc_CNXAGabrielGoldmanMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_CNXAGabrielGoldmanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_RelatedPartyLenderMember" xlink:label="loc_CNXARelatedPartyLenderMember" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_CNXARelatedPartyLenderMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_TwoEmployeesMember" xlink:label="loc_CNXATwoEmployeesMember" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_CNXATwoEmployeesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_VendorMember" xlink:label="loc_CNXAVendorMember" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_CNXAVendorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_SixNewBrandAmbassadorsMember" xlink:label="loc_CNXASixNewBrandAmbassadorsMember" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_CNXASixNewBrandAmbassadorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_BrandAmbassadorsMember" xlink:label="loc_CNXABrandAmbassadorsMember" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_CNXABrandAmbassadorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_VendorOneMember" xlink:label="loc_CNXAVendorOneMember" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_CNXAVendorOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_KeyEmployeesAndOfficersMember" xlink:label="loc_CNXAKeyEmployeesAndOfficersMember" />
      <link:presentationArc order="580" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_CNXAKeyEmployeesAndOfficersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_ServiceProviderMember" xlink:label="loc_CNXAServiceProviderMember" />
      <link:presentationArc order="600" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_CNXAServiceProviderMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_ThreeMembersMember" xlink:label="loc_CNXAThreeMembersMember" />
      <link:presentationArc order="620" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_CNXAThreeMembersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_LeadPlacementAgentMember" xlink:label="loc_CNXALeadPlacementAgentMember" />
      <link:presentationArc order="670" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_CNXALeadPlacementAgentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_GamefaceAIMember" xlink:label="loc_CNXAGamefaceAIMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_CNXAGamefaceAIMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_MidcityCapitalLtdMember" xlink:label="loc_CNXAMidcityCapitalLtdMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_CNXAMidcityCapitalLtdMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_ArmisticeCapitalMasterFundLtdMember" xlink:label="loc_CNXAArmisticeCapitalMasterFundLtdMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_CNXAArmisticeCapitalMasterFundLtdMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_SecuritiesPurchaseAgreementMember" xlink:label="loc_CNXASecuritiesPurchaseAgreementMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_CNXASecuritiesPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_LoanAndSecurityAgreementMember" xlink:label="loc_CNXALoanAndSecurityAgreementMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_CNXALoanAndSecurityAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_FiveYearWarrantsMember" xlink:label="loc_CNXAFiveYearWarrantsMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_CNXAFiveYearWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_SevenYearWarrantsMember" xlink:label="loc_CNXASevenYearWarrantsMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_CNXASevenYearWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_SevenPointFiveYearWarrantsMember" xlink:label="loc_CNXASevenPointFiveYearWarrantsMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_CNXASevenPointFiveYearWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaapShortTermDebtTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapShortTermDebtTypeAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_NotesMember" xlink:label="loc_CNXANotesMember" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_CNXANotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAxis" xlink:label="loc_srtRestatementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRestatementAxis" order="70" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain" xlink:label="loc_srtRestatementDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRestatementAxis" xlink:to="loc_srtRestatementDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="loc_srtScenarioPreviouslyReportedMember" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRestatementDomain" xlink:to="loc_srtScenarioPreviouslyReportedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="80" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_FoundationSportsSystemsLLCMember" xlink:label="loc_CNXAFoundationSportsSystemsLLCMember" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_CNXAFoundationSportsSystemsLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_GamefaceMember" xlink:label="loc_CNXAGamefaceMember" />
      <link:presentationArc order="760" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_CNXAGamefaceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtProductOrServiceAxis" order="90" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_ServicesRenderedInLieuOfCashMember" xlink:label="loc_CNXAServicesRenderedInLieuOfCashMember" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_CNXAServicesRenderedInLieuOfCashMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_MarketingAndAdvisoryServicesMember" xlink:label="loc_CNXAMarketingAndAdvisoryServicesMember" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_CNXAMarketingAndAdvisoryServicesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_AsCompensationMember" xlink:label="loc_CNXAAsCompensationMember" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_CNXAAsCompensationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_SecuritiesPurchaseAgreementMember" xlink:label="loc_CNXASecuritiesPurchaseAgreementMember_2" />
      <link:presentationArc order="660" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_CNXASecuritiesPurchaseAgreementMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_ExercisePriceOneMember" xlink:label="loc_CNXAExercisePriceOneMember" />
      <link:presentationArc order="700" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_CNXAExercisePriceOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_ExercisePriceTwoMember" xlink:label="loc_CNXAExercisePriceTwoMember" />
      <link:presentationArc order="720" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_CNXAExercisePriceTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="110" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaapEmployeeStockOptionMember" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapEmployeeStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="690" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="120" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_NotePayableHolderMember" xlink:label="loc_CNXANotePayableHolderMember" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_CNXANotePayableHolderMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="130" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_RelatedPartyLenderMember" xlink:label="loc_CNXARelatedPartyLenderMember_2" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_CNXARelatedPartyLenderMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="140" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_2" />
      <link:presentationArc order="580" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_2" />
      <link:presentationArc order="600" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaapSharesIssued" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_StockIssuedDuringPeriodSharesIssuedSettlementOfAccountsPayable" xlink:label="loc_CNXAStockIssuedDuringPeriodSharesIssuedSettlementOfAccountsPayable" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_CNXAStockIssuedDuringPeriodSharesIssuedSettlementOfAccountsPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_StockIssuedDuringPeriodSharesIssuedSettlementWithFormerOwners" xlink:label="loc_CNXAStockIssuedDuringPeriodSharesIssuedSettlementWithFormerOwners" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_CNXAStockIssuedDuringPeriodSharesIssuedSettlementWithFormerOwners" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_StockIssuedDuringPeriodSharesIssuedProfitGuaranteeOnNote" xlink:label="loc_CNXAStockIssuedDuringPeriodSharesIssuedProfitGuaranteeOnNote" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_CNXAStockIssuedDuringPeriodSharesIssuedProfitGuaranteeOnNote" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_WarrantPerShare" xlink:label="loc_CNXAWarrantPerShare" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_CNXAWarrantPerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaapWarrantsAndRightsOutstanding" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateEffectivePercentage" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaapProceedsFromNotesPayable" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromNotesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_SharesIssuedPricePerShares" xlink:label="loc_CNXASharesIssuedPricePerShares" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_CNXASharesIssuedPricePerShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensationGross" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensationGross" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="loc_us-gaapConversionOfStockSharesConverted1" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConversionOfStockSharesConverted1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingTerm" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingTerm" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_WarrantsIssuedToPurchaseOfCommonStockShares" xlink:label="loc_CNXAWarrantsIssuedToPurchaseOfCommonStockShares" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_CNXAWarrantsIssuedToPurchaseOfCommonStockShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000049 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesTable" xlink:label="loc_us-gaapLossContingenciesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLossContingenciesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesLineItems" xlink:label="loc_us-gaapLossContingenciesLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesTable" xlink:to="loc_us-gaapLossContingenciesLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesTable" xlink:to="loc_srtRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAxis" xlink:label="loc_srtRestatementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesTable" xlink:to="loc_srtRestatementAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain" xlink:label="loc_srtRestatementDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRestatementAxis" xlink:to="loc_srtRestatementDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="loc_srtScenarioPreviouslyReportedMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRestatementDomain" xlink:to="loc_srtScenarioPreviouslyReportedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRent" xlink:label="loc_us-gaapPaymentsForRent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapPaymentsForRent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_FairValueOfCommonStock" xlink:label="loc_CNXAFairValueOfCommonStock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_CNXAFairValueOfCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaapBusinessCombinationContingentConsiderationLiability" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapBusinessCombinationContingentConsiderationLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/ScheduleOfDiscontinuedOperationsDetails" xlink:title="00000050 - Disclosure - SCHEDULE OF DISCONTINUED OPERATIONS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:label="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationRevenue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOperatingExpense" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DisposalGroupIncludingDiscontinuedOperationOtherIncomeLoss" xlink:label="loc_CNXADisposalGroupIncludingDiscontinuedOperationOtherIncomeLoss" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_CNXADisposalGroupIncludingDiscontinuedOperationOtherIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DisposalGroupIncludingDiscontinuedOperationNetIncomeLoss" xlink:label="loc_CNXADisposalGroupIncludingDiscontinuedOperationNetIncomeLoss" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_CNXADisposalGroupIncludingDiscontinuedOperationNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationInventoryCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesCurrent" xlink:label="loc_CNXADisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesCurrent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_CNXADisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:label="loc_us-gaapAssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapAssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryNoncurrent" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationInventoryNoncurrent" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationInventoryNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityOperatingLeasesCurrent" xlink:label="loc_CNXADisposalGroupIncludingDiscontinuedOperationLeaseLiabilityOperatingLeasesCurrent" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_CNXADisposalGroupIncludingDiscontinuedOperationLeaseLiabilityOperatingLeasesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:label="loc_us-gaapLiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapLiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent" xlink:label="loc_us-gaapLiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapLiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/DiscontinuedOperationsDetailsNarrative" xlink:title="00000051 - Disclosure - DISCONTINUED OPERATIONS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:label="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_SharePurchaseAgreementMember" xlink:label="loc_CNXASharePurchaseAgreementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_CNXASharePurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_EmployeeAgreementMember" xlink:label="loc_CNXAEmployeeAgreementMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_CNXAEmployeeAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipAxis" xlink:label="loc_srtOwnershipAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_srtOwnershipAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain" xlink:label="loc_srtOwnershipDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtOwnershipAxis" xlink:to="loc_srtOwnershipDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_FoundationSportsToCharlesRuddyMember" xlink:label="loc_CNXAFoundationSportsToCharlesRuddyMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtOwnershipDomain" xlink:to="loc_CNXAFoundationSportsToCharlesRuddyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_SharesIssuedAndOutstandingPercentage" xlink:label="loc_CNXASharesIssuedAndOutstandingPercentage" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_CNXASharesIssuedAndOutstandingPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDescriptionAndTimingOfDisposal" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationDescriptionAndTimingOfDisposal" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationDescriptionAndTimingOfDisposal" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationConsideration" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationConsideration" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="loc_us-gaapMinorityInterestOwnershipPercentageByParent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapMinorityInterestOwnershipPercentageByParent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:label="loc_us-gaapMinorityInterestOwnershipPercentageByNoncontrollingOwners" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapMinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapCash" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Investments" xlink:label="loc_us-gaapInvestments" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapInvestments" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000052 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_WarrantOneMember" xlink:label="loc_CNXAWarrantOneMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_CNXAWarrantOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_WarrantTwoMember" xlink:label="loc_CNXAWarrantTwoMember" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_CNXAWarrantTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_RodneyRapsonMember" xlink:label="loc_CNXARodneyRapsonMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_CNXARodneyRapsonMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_UFSAgreementMember" xlink:label="loc_CNXAUFSAgreementMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_CNXAUFSAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_AmendedUFSAgreementMember" xlink:label="loc_CNXAAmendedUFSAgreementMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_CNXAAmendedUFSAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_SecondMegedAgreementMember" xlink:label="loc_CNXASecondMegedAgreementMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_CNXASecondMegedAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_MegedAgreementMember" xlink:label="loc_CNXAMegedAgreementMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_CNXAMegedAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_srtStatementScenarioAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_EachWeekForNextThreeWeeksMember" xlink:label="loc_CNXAEachWeekForNextThreeWeeksMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_CNXAEachWeekForNextThreeWeeksMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapAwardTypeAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_PreFundedWarrantMember" xlink:label="loc_CNXAPreFundedWarrantMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_CNXAPreFundedWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedPerTransaction" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedPerTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireReceivables" xlink:label="loc_us-gaapPaymentsToAcquireReceivables" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapPaymentsToAcquireReceivables" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_CashLessFees" xlink:label="loc_CNXACashLessFees" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_CNXACashLessFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaapSharesIssued" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSharesIssued" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_StockIssuedDuringPeriodSharesIssuedSettlementOfAccountsPayable" xlink:label="loc_CNXAStockIssuedDuringPeriodSharesIssuedSettlementOfAccountsPayable" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_CNXAStockIssuedDuringPeriodSharesIssuedSettlementOfAccountsPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_StockIssuedDuringPeriodSharesIssuedSettlementWithFormerOwners" xlink:label="loc_CNXAStockIssuedDuringPeriodSharesIssuedSettlementWithFormerOwners" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_CNXAStockIssuedDuringPeriodSharesIssuedSettlementWithFormerOwners" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_StockIssuedDuringPeriodSharesIssuedProfitGuaranteeOnNote" xlink:label="loc_CNXAStockIssuedDuringPeriodSharesIssuedProfitGuaranteeOnNote" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_CNXAStockIssuedDuringPeriodSharesIssuedProfitGuaranteeOnNote" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingTerm" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingTerm" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/ScheduleOfProformaFinancialInformationDetails" xlink:title="00000053 - Disclosure - SCHEDULE OF PROFORMA FINANCIAL INFORMATION (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaapBusinessAcquisitionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_PlaySightAndGameFaceMember" xlink:label="loc_CNXAPlaySightAndGameFaceMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_CNXAPlaySightAndGameFaceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="loc_us-gaapBusinessAcquisitionsProFormaRevenue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessAcquisitionsProFormaRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="loc_us-gaapBusinessAcquisitionsProFormaNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessAcquisitionsProFormaNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:label="loc_us-gaapBusinessAcquisitionProFormaEarningsPerShareBasic" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessAcquisitionProFormaEarningsPerShareBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:label="loc_us-gaapBusinessAcquisitionProFormaEarningsPerShareDiluted" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/ScheduleOfEstimatedFutureAmortizationDetails" xlink:title="00000054 - Disclosure - SCHEDULE OF ESTIMATED FUTURE AMORTIZATION (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFive" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/AcquisitionsAndBusinessCombinationsDetailsNarrative" xlink:title="00000055 - Disclosure - ACQUISITIONS AND BUSINESS COMBINATIONS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaapBusinessAcquisitionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_FoundationSportsMember" xlink:label="loc_CNXAFoundationSportsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_CNXAFoundationSportsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_FoundationSportsSystemsLLCMember" xlink:label="loc_CNXAFoundationSportsSystemsLLCMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_CNXAFoundationSportsSystemsLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_PlaySightMember" xlink:label="loc_CNXAPlaySightMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_CNXAPlaySightMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DisposalEquityInterestOwnershipInterestPercentage" xlink:label="loc_CNXADisposalEquityInterestOwnershipInterestPercentage" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_CNXADisposalEquityInterestOwnershipInterestPercentage" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal" xlink:label="loc_us-gaapDiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapDiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AlternativeInvestment" xlink:label="loc_us-gaapAlternativeInvestment" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapAlternativeInvestment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/ScheduleOfWarrantsIssuedExercisedAndExpiredDetails" xlink:title="00000056 - Disclosure - SCHEDULE OF WARRANTS ISSUED, EXERCISED AND EXPIRED (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding" xlink:label="loc_CNXAShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_CNXAShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceIssued" xlink:label="loc_CNXAShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceIssued" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_CNXAShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised" xlink:label="loc_CNXAShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_CNXAShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceForfeited" xlink:label="loc_CNXAShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceForfeited" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_CNXAShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceForfeited" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExpired" xlink:label="loc_CNXAShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExpired" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_CNXAShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExpired" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_2" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding" xlink:label="loc_CNXAShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_2" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_CNXAShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaapWarrantsAndRightsOutstanding" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapWarrantsAndRightsOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/NotePayable-RelatedPartyDetailsNarrative" xlink:title="00000057 - Disclosure - NOTE PAYABLE - RELATED PARTY (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_LoanAgreementsMember" xlink:label="loc_CNXALoanAgreementsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_CNXALoanAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaapRelatedPartyMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapRelatedPartyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LoansPayable" xlink:label="loc_us-gaapLoansPayable" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapLoansPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPayableCurrent" xlink:label="loc_us-gaapInterestPayableCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapInterestPayableCurrent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/ScheduleOfNetDeferredTaxAssetsDetails" xlink:title="00000058 - Disclosure - SCHEDULE OF NET DEFERRED TAX ASSETS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementGeographicalAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IL" xlink:label="loc_countryIL" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryIL" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DeferredTaxAssetsStockOptions" xlink:label="loc_CNXADeferredTaxAssetsStockOptions" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_CNXADeferredTaxAssetsStockOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DeferredTaxAssetsAccruedPayroll" xlink:label="loc_CNXADeferredTaxAssetsAccruedPayroll" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_CNXADeferredTaxAssetsAccruedPayroll" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DeferredTaxAssetsRelatedPartyAccruals" xlink:label="loc_CNXADeferredTaxAssetsRelatedPartyAccruals" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_CNXADeferredTaxAssetsRelatedPartyAccruals" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsInventory" xlink:label="loc_us-gaapDeferredTaxAssetsInventory" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsInventory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DeferredTaxAssetsInterestDeferral" xlink:label="loc_CNXADeferredTaxAssetsInterestDeferral" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_CNXADeferredTaxAssetsInterestDeferral" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DeferredTaxAssetsStartupCosts" xlink:label="loc_CNXADeferredTaxAssetsStartupCosts" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_CNXADeferredTaxAssetsStartupCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="loc_us-gaapDeferredTaxAssetsOther" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsForeign" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DeferredTaxAssetsStartupCostsForeign" xlink:label="loc_CNXADeferredTaxAssetsStartupCostsForeign" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_CNXADeferredTaxAssetsStartupCostsForeign" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DeferredTaxAssetsInProcessResearchAndDevelopmentCosts" xlink:label="loc_CNXADeferredTaxAssetsInProcessResearchAndDevelopmentCosts" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_CNXADeferredTaxAssetsInProcessResearchAndDevelopmentCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/ScheduleOfIncomeTaxProvisionDetails" xlink:title="00000059 - Disclosure - SCHEDULE OF INCOME TAX PROVISION (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="loc_us-gaapOperatingLossCarryforwardsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapOperatingLossCarryforwardsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="loc_us-gaapOperatingLossCarryforwardsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_us-gaapOperatingLossCarryforwardsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_us-gaapIncomeTaxAuthorityNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityNameAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IsraelTaxAuthorityMember" xlink:label="loc_us-gaapIsraelTaxAuthorityMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityNameDomain" xlink:to="loc_us-gaapIsraelTaxAuthorityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapIncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapIncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_IncomeTaxReconciliationDebtDiscountAmortization" xlink:label="loc_CNXAIncomeTaxReconciliationDebtDiscountAmortization" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_CNXAIncomeTaxReconciliationDebtDiscountAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_IncomeTaxReconciliationRelatedPartyAccruals" xlink:label="loc_CNXAIncomeTaxReconciliationRelatedPartyAccruals" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_CNXAIncomeTaxReconciliationRelatedPartyAccruals" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_IncomeTaxReconciliationStartUpCosts" xlink:label="loc_CNXAIncomeTaxReconciliationStartUpCosts" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_CNXAIncomeTaxReconciliationStartUpCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_IncomeTaxRecociliationInterestExpense" xlink:label="loc_CNXAIncomeTaxRecociliationInterestExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_CNXAIncomeTaxRecociliationInterestExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseDepreciation" xlink:label="loc_us-gaapIncomeTaxReconciliationNondeductibleExpenseDepreciation" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapIncomeTaxReconciliationNondeductibleExpenseDepreciation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_IncomeTaxRecociliationInventoryReserve" xlink:label="loc_CNXAIncomeTaxRecociliationInventoryReserve" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_CNXAIncomeTaxRecociliationInventoryReserve" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_IncomeTaxRecociliationInterestDeferral" xlink:label="loc_CNXAIncomeTaxRecociliationInterestDeferral" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_CNXAIncomeTaxRecociliationInterestDeferral" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_IncomeTaxRecociliationAcquisitionCosts" xlink:label="loc_CNXAIncomeTaxRecociliationAcquisitionCosts" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_CNXAIncomeTaxRecociliationAcquisitionCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_IncomeTaxRecociliationAccruedLegal" xlink:label="loc_CNXAIncomeTaxRecociliationAccruedLegal" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_CNXAIncomeTaxRecociliationAccruedLegal" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_IncomeTaxRecociliationLossOnExtinguishmentOfDebt" xlink:label="loc_CNXAIncomeTaxRecociliationLossOnExtinguishmentOfDebt" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_CNXAIncomeTaxRecociliationLossOnExtinguishmentOfDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_IncomeTaxRecociliationAccruedPayroll" xlink:label="loc_CNXAIncomeTaxRecociliationAccruedPayroll" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_CNXAIncomeTaxRecociliationAccruedPayroll" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_IncomeTaxRecociliationGainOnChangeInFairValueOfDerivatives" xlink:label="loc_CNXAIncomeTaxRecociliationGainOnChangeInFairValueOfDerivatives" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_CNXAIncomeTaxRecociliationGainOnChangeInFairValueOfDerivatives" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:label="loc_us-gaapIncomeTaxReconciliationNondeductibleExpenseOther" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapIncomeTaxReconciliationNondeductibleExpenseOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit_2" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/ScheduleOfNetDeferredTaxAssetsDetailsParenthetical" xlink:title="00000060 - Disclosure - SCHEDULE OF NET DEFERRED TAX ASSETS (Details) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementGeographicalAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IL" xlink:label="loc_countryIL" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryIL" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/ScheduleOfIncomeTaxProvisionDetailsParenthetical" xlink:title="00000061 - Disclosure - SCHEDULE OF INCOME TAX PROVISION (Details) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementGeographicalAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IL" xlink:label="loc_countryIL" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryIL" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000062 - Disclosure - INCOME TAXES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementGeographicalAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US" xlink:label="loc_countryUS" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryUS" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwards" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://connexasports.com/role/ScheduleOfCalculationOfLossOnDisposalDetails" xlink:title="00000063 - Disclosure - SCHEDULE OF CALCULATION OF THE LOSS ON DISPOSAL (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfMultiemployerPlansTable" xlink:label="loc_us-gaapScheduleOfMultiemployerPlansTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfMultiemployerPlansTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MultiemployerPlansLineItems" xlink:label="loc_us-gaapMultiemployerPlansLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfMultiemployerPlansTable" xlink:to="loc_us-gaapMultiemployerPlansLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfMultiemployerPlansTable" xlink:to="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_PlaySightAndFoundationSportsMember" xlink:label="loc_CNXAPlaySightAndFoundationSportsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="loc_CNXAPlaySightAndFoundationSportsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMultiemployerPlansLineItems" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMultiemployerPlansLineItems" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DisposalGroupIncludingDiscontinuedOperationAccountsReceivable" xlink:label="loc_CNXADisposalGroupIncludingDiscontinuedOperationAccountsReceivable" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMultiemployerPlansLineItems" xlink:to="loc_CNXADisposalGroupIncludingDiscontinuedOperationAccountsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMultiemployerPlansLineItems" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationInventory1" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMultiemployerPlansLineItems" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationInventory1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOtherAssets" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMultiemployerPlansLineItems" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DisposalGroupIncludingDiscontinuedOperationContractAssets" xlink:label="loc_CNXADisposalGroupIncludingDiscontinuedOperationContractAssets" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMultiemployerPlansLineItems" xlink:to="loc_CNXADisposalGroupIncludingDiscontinuedOperationContractAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DisposalGroupIncludingDiscontinuedOperationRightOfUseAsset" xlink:label="loc_CNXADisposalGroupIncludingDiscontinuedOperationRightOfUseAsset" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMultiemployerPlansLineItems" xlink:to="loc_CNXADisposalGroupIncludingDiscontinuedOperationRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationGoodwill1" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMultiemployerPlansLineItems" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMultiemployerPlansLineItems" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationIntangibleAssets" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMultiemployerPlansLineItems" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DisposalGroupIncludingDiscontinuedOperationContractLiabilities" xlink:label="loc_CNXADisposalGroupIncludingDiscontinuedOperationContractLiabilities" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMultiemployerPlansLineItems" xlink:to="loc_CNXADisposalGroupIncludingDiscontinuedOperationContractLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOtherLiabilities" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMultiemployerPlansLineItems" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMultiemployerPlansLineItems" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="cnxa-20230731.xsd#CNXA_DisposalGroupIncludingDiscontinuedOperationLossOnDisposalOfDiscontinuedOperations" xlink:label="loc_CNXADisposalGroupIncludingDiscontinuedOperationLossOnDisposalOfDiscontinuedOperations" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMultiemployerPlansLineItems" xlink:to="loc_CNXADisposalGroupIncludingDiscontinuedOperationLossOnDisposalOfDiscontinuedOperations" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007863106608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jul. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesLineItems', window );"><strong>Entity Addresses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">S-1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CONNEXA
SPORTS TECHNOLOGIES, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001674440<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">61-1789640<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2709
N. Rolling Road<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 138<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Windsor
Mill<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MD<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">21244<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(443)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">407-7564<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember', window );">Business Contact [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesLineItems', window );"><strong>Entity Addresses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1013
Centre Road<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 403-B<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Wilmington<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">19805<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(888)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">528-2677<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelName', window );">Contact Personnel Name</a></td>
<td class="text">Vcorp
Services LLC<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of contact personnel</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007860347280">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br></strong></div></th>
<th class="th"><div>Jul. 31, 2023</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 386,459<span></span>
</td>
<td class="nump">$ 202,095<span></span>
</td>
<td class="nump">$ 665,002<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">444,622<span></span>
</td>
<td class="nump">399,680<span></span>
</td>
<td class="nump">1,033,390<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories, net</a></td>
<td class="nump">2,336,918<span></span>
</td>
<td class="nump">3,189,766<span></span>
</td>
<td class="nump">7,861,837<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_PrepaidInventoryCurrent', window );">Prepaid inventory</a></td>
<td class="nump">1,134,368<span></span>
</td>
<td class="nump">936,939<span></span>
</td>
<td class="nump">499,353<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommodityContractAssetCurrent', window );">Contract assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">235,526<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">280,820<span></span>
</td>
<td class="nump">263,020<span></span>
</td>
<td class="nump">272,670<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Current assets of discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,258,318<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
<td class="nump">4,583,187<span></span>
</td>
<td class="nump">4,991,500<span></span>
</td>
<td class="nump">12,826,096<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>Non-Current Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivables', window );">Note receivable - former subsidiary</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Fixed assets, net of depreciation</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">14,791<span></span>
</td>
<td class="nump">47,355<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets, net of amortization</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">101,281<span></span>
</td>
<td class="nump">4,842,856<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">6,781,193<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent', window );">Non-current assets of discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">50,365,446<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total Non-Current Assets</a></td>
<td class="nump">2,001,000<span></span>
</td>
<td class="nump">2,116,072<span></span>
</td>
<td class="nump">62,036,850<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">6,584,187<span></span>
</td>
<td class="nump">7,107,572<span></span>
</td>
<td class="nump">74,862,946<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">6,087,311<span></span>
</td>
<td class="nump">5,496,629<span></span>
</td>
<td class="nump">5,252,665<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">5,197,460<span></span>
</td>
<td class="nump">4,911,839<span></span>
</td>
<td class="nump">4,381,901<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PurchaseObligation', window );">Related party purchase obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Contract liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">111,506<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNotesPayableCurrent', window );">Current portion of notes payable, net of discount</a></td>
<td class="nump">1,959,671<span></span>
</td>
<td class="nump">1,484,647<span></span>
</td>
<td class="nump">4,639,376<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayableCurrent', window );">Current portion of convertible notes payable, net of discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">10,327,778<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesCurrent', window );">Derivative liabilities</a></td>
<td class="nump">8,345,052<span></span>
</td>
<td class="nump">10,489,606<span></span>
</td>
<td class="nump">5,443,779<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent', window );">Contingent consideration</a></td>
<td class="nump">418,455<span></span>
</td>
<td class="nump">418,455<span></span>
</td>
<td class="nump">1,334,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">330,065<span></span>
</td>
<td class="nump">22,971<span></span>
</td>
<td class="nump">156,862<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Current liabilities of discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">5,215,222<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current Liabilities</a></td>
<td class="nump">23,297,493<span></span>
</td>
<td class="nump">23,767,491<span></span>
</td>
<td class="nump">38,980,522<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Long-Term Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent', window );">Non-current liabilities of discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,370,492<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total Long-Term Liabilities</a></td>
<td class="nump">1,655,966<span></span>
</td>
<td class="nump">1,953,842<span></span>
</td>
<td class="nump">3,370,492<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="nump">24,953,459<span></span>
</td>
<td class="nump">25,721,333<span></span>
</td>
<td class="nump">42,351,014<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingency</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>SHAREHOLDERS&#8217; EQUITY (DEFICIT)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock value</a></td>
<td class="nump">528<span></span>
</td>
<td class="nump">339<span></span>
</td>
<td class="nump">4,195<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid in capital</a></td>
<td class="nump">134,112,083<span></span>
</td>
<td class="nump">132,993,998<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(152,597,375)<span></span>
</td>
<td class="num">(151,750,610)<span></span>
</td>
<td class="num">(80,596,925)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income (loss)</a></td>
<td class="nump">115,492<span></span>
</td>
<td class="nump">142,512<span></span>
</td>
<td class="nump">54,962<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Stockholders&#8217; Equity (Deficit)</a></td>
<td class="num">(18,369,272)<span></span>
</td>
<td class="num">(18,613,761)<span></span>
</td>
<td class="nump">32,511,932<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND STOCKHOLDERS&#8217; EQUITY (DEFICIT)</a></td>
<td class="nump">6,584,187<span></span>
</td>
<td class="nump">7,107,572<span></span>
</td>
<td class="nump">74,862,946<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>SHAREHOLDERS&#8217; EQUITY (DEFICIT)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,544<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">132,980,793<span></span>
</td>
<td class="nump">113,049,700<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Stockholders&#8217; Equity (Deficit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18,613,761)<span></span>
</td>
<td class="nump">32,511,932<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_NonrelatedPartyMember', window );">Nonrelated Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Accrued interest</a></td>
<td class="nump">41,522<span></span>
</td>
<td class="nump">25,387<span></span>
</td>
<td class="nump">708,677<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Accrued interest</a></td>
<td class="nump">917,957<span></span>
</td>
<td class="nump">917,957<span></span>
</td>
<td class="nump">908,756<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Long-Term Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermNotesPayable', window );">Notes payable related parties, net of current portion</a></td>
<td class="nump">$ 1,655,966<span></span>
</td>
<td class="nump">$ 1,953,842<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_PrepaidInventoryCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid inventory current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_PrepaidInventoryCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5C<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-9<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479668/805-30-25-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479613/805-30-35-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommodityContractAssetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the asset arising from commodity contracts such as futures contracts tied to the movement of a particular commodity, which are expected to be converted into cash or otherwise disposed of within a year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommodityContractAssetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 23: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5C<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-9<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term notes classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from parties in nontrade transactions, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(5)(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_NonrelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_NonrelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007866037104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Jul. 31, 2023</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">300,000,000<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">528,297<span></span>
</td>
<td class="nump">338,579<span></span>
</td>
<td class="nump">4,194,836<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">528,297<span></span>
</td>
<td class="nump">338,579<span></span>
</td>
<td class="nump">4,194,836<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007860715040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations (Unaudited) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2023</div></th>
<th class="th"><div>Jul. 31, 2022</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">NET SALES</a></td>
<td class="nump">$ 3,120,231<span></span>
</td>
<td class="nump">$ 3,583,336<span></span>
</td>
<td class="nump">$ 9,922,799<span></span>
</td>
<td class="nump">$ 16,102,672<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">COST OF SALES</a></td>
<td class="nump">2,227,482<span></span>
</td>
<td class="nump">2,562,044<span></span>
</td>
<td class="nump">7,144,335<span></span>
</td>
<td class="nump">11,878,010<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">GROSS PROFIT</a></td>
<td class="nump">892,749<span></span>
</td>
<td class="nump">1,021,292<span></span>
</td>
<td class="nump">2,778,464<span></span>
</td>
<td class="nump">4,224,662<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>OPERATING EXPENSES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Selling and marketing expenses</a></td>
<td class="nump">242,353<span></span>
</td>
<td class="nump">756,823<span></span>
</td>
<td class="nump">1,928,198<span></span>
</td>
<td class="nump">3,477,570<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="nump">2,505,060<span></span>
</td>
<td class="nump">3,314,610<span></span>
</td>
<td class="nump">22,743,877<span></span>
</td>
<td class="nump">46,718,986<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development costs</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">19,425<span></span>
</td>
<td class="nump">65,164<span></span>
</td>
<td class="nump">736,141<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total Operating Expenses</a></td>
<td class="nump">2,747,413<span></span>
</td>
<td class="nump">4,090,858<span></span>
</td>
<td class="nump">24,737,239<span></span>
</td>
<td class="nump">50,932,697<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">OPERATING LOSS</a></td>
<td class="num">(1,854,664)<span></span>
</td>
<td class="num">(3,069,566)<span></span>
</td>
<td class="num">(21,958,775)<span></span>
</td>
<td class="num">(46,708,035)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>NON-OPERATING INCOME (EXPENSE)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt discounts</a></td>
<td class="num">(777,192)<span></span>
</td>
<td class="num">(2,872,222)<span></span>
</td>
<td class="num">(4,095,030)<span></span>
</td>
<td class="num">(8,150,284)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(7,096,730)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_GainLossOnIssuanceOfConvertibleNotes', window );">Loss on issuance of convertible notes</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(5,889,369)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_GainLossOnChangeInFairValueOfContingentConsideration', window );">Gain on change in fair value of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">4,847,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_LossOnConversionOfAccountsPayableToCommonStock', window );">Loss on conversion of accounts payable to common stock</a></td>
<td class="num">(289,980)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_GainLossOnChangeInFairValueOfDerivativesLiability', window );">Change in fair value of derivative liability</a></td>
<td class="nump">2,144,554<span></span>
</td>
<td class="nump">3,687,495<span></span>
</td>
<td class="nump">10,950,017<span></span>
</td>
<td class="nump">18,557,184<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_DerivativeExpense', window );">Derivative expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,995,962)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total Non-Operating Income (Expenses)</a></td>
<td class="nump">1,007,899<span></span>
</td>
<td class="nump">562,849<span></span>
</td>
<td class="num">(3,319,050)<span></span>
</td>
<td class="nump">182,060<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">NET LOSS FROM CONTINUING OPERATIONS BEFORE PROVISION FOR INCOME TAXES</a></td>
<td class="num">(846,765)<span></span>
</td>
<td class="num">(2,506,717)<span></span>
</td>
<td class="num">(25,277,825)<span></span>
</td>
<td class="num">(46,525,975)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax', window );">Loss from discontinued operations</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(1,759,714)<span></span>
</td>
<td class="num">(4,461,968)<span></span>
</td>
<td class="num">(5,247,677)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax', window );">Loss on disposal of subsidiaries</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(41,413,892)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax', window );">LOSS FROM DISCONTINUED OPERATIONS</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(1,759,714)<span></span>
</td>
<td class="num">(45,875,860)<span></span>
</td>
<td class="num">(5,247,677)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_IncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">NET LOSS FROM OPERATIONS BEFORE PROVISION FOR INCOME TAXES</a></td>
<td class="num">(846,765)<span></span>
</td>
<td class="num">(4,266,431)<span></span>
</td>
<td class="num">(71,153,685)<span></span>
</td>
<td class="num">(51,773,652)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">NET LOSS</a></td>
<td class="num">(846,765)<span></span>
</td>
<td class="num">(4,266,431)<span></span>
</td>
<td class="num">(71,153,685)<span></span>
</td>
<td class="num">(51,773,652)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Other comprehensive income (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translations adjustment</a></td>
<td class="num">(27,020)<span></span>
</td>
<td class="nump">58,139<span></span>
</td>
<td class="nump">87,550<span></span>
</td>
<td class="nump">75,132<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income (loss)</a></td>
<td class="num">$ (873,785)<span></span>
</td>
<td class="num">$ (4,208,292)<span></span>
</td>
<td class="num">$ (71,066,135)<span></span>
</td>
<td class="num">$ (51,698,520)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossPerOutstandingLimitedPartnershipAndGeneralPartnershipUnitBasicAndDilutedAbstract', window );"><strong>Net income (loss) per share - basic and diluted</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Continuing operations basic</a></td>
<td class="num">$ (1.93)<span></span>
</td>
<td class="num">$ (14.27)<span></span>
</td>
<td class="num">$ (2.26)<span></span>
</td>
<td class="num">$ (12.09)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Continuing operations diluted</a></td>
<td class="num">(1.93)<span></span>
</td>
<td class="num">(14.27)<span></span>
</td>
<td class="num">(2.26)<span></span>
</td>
<td class="num">(12.09)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare', window );">Discontinued operations basic</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(10.02)<span></span>
</td>
<td class="num">(4.10)<span></span>
</td>
<td class="num">(1.36)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare', window );">Discontinued operations diluted</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(10.02)<span></span>
</td>
<td class="num">(4.10)<span></span>
</td>
<td class="num">(1.36)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share - basic</a></td>
<td class="num">(1.93)<span></span>
</td>
<td class="num">(24.29)<span></span>
</td>
<td class="num">(6.36)<span></span>
</td>
<td class="num">(13.46)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share - diluted</a></td>
<td class="num">$ (1.93)<span></span>
</td>
<td class="num">$ (24.29)<span></span>
</td>
<td class="num">$ (6.36)<span></span>
</td>
<td class="num">$ (13.46)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding - basic</a></td>
<td class="nump">438,354<span></span>
</td>
<td class="nump">175,653<span></span>
</td>
<td class="nump">11,195,345<span></span>
</td>
<td class="nump">3,847,672<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares outstanding - diluted</a></td>
<td class="nump">438,354<span></span>
</td>
<td class="nump">175,653<span></span>
</td>
<td class="nump">11,195,345<span></span>
</td>
<td class="nump">3,847,672<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_NonrelatedPartyMember', window );">Nonrelated Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>NON-OPERATING INCOME (EXPENSE)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">$ (69,483)<span></span>
</td>
<td class="num">$ (191,303)<span></span>
</td>
<td class="num">$ (884,985)<span></span>
</td>
<td class="num">$ (1,920,183)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>NON-OPERATING INCOME (EXPENSE)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="text"> <span></span>
</td>
<td class="num">$ (61,121)<span></span>
</td>
<td class="num">$ (293,090)<span></span>
</td>
<td class="num">$ (165,558)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_DerivativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_DerivativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_GainLossOnChangeInFairValueOfContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) on change in fair value of contingent consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_GainLossOnChangeInFairValueOfContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_GainLossOnChangeInFairValueOfDerivativesLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) on change in fair value of derivatives liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_GainLossOnChangeInFairValueOfDerivativesLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_GainLossOnIssuanceOfConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) on issuance of convertible notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_GainLossOnIssuanceOfConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_IncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income loss from operations before income taxes extraordinary items noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_IncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_LossOnConversionOfAccountsPayableToCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_LossOnConversionOfAccountsPayableToCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of gain (loss) not previously recognized resulting from the disposal of a discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-3B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-3A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-3B<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of income (loss) from operations classified as a discontinued operation. Excludes gain (loss) on disposal and provision for gain (loss) until its disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-3A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481303/470-50-40-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481303/470-50-40-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 940<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481913/940-20-25-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 5.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479836/810-10-S99-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossPerOutstandingLimitedPartnershipAndGeneralPartnershipUnitBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossPerOutstandingLimitedPartnershipAndGeneralPartnershipUnitBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482916/730-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482517/912-730-25-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_NonrelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_NonrelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007855012032">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statement of Changes in Shareholders' Equity (Deficit) (Unaudited) - USD ($)<br></strong></div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th">
<div>Common Stock [Member] </div>
<div>Previously Reported [Member]</div>
</th>
<th class="th">
<div>Common Stock [Member] </div>
<div>Previously Reported [Member] </div>
<div>Gameface Ltd [Member]</div>
</th>
<th class="th">
<div>Common Stock [Member] </div>
<div>Previously Reported [Member] </div>
<div>Play Sight Interactive Ltd [Member]</div>
</th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th">
<div>Additional Paid-in Capital [Member] </div>
<div>Previously Reported [Member]</div>
</th>
<th class="th">
<div>Additional Paid-in Capital [Member] </div>
<div>Previously Reported [Member] </div>
<div>Gameface Ltd [Member]</div>
</th>
<th class="th">
<div>Additional Paid-in Capital [Member] </div>
<div>Previously Reported [Member] </div>
<div>Play Sight Interactive Ltd [Member]</div>
</th>
<th class="th"><div>AOCI Attributable to Parent [Member]</div></th>
<th class="th">
<div>AOCI Attributable to Parent [Member] </div>
<div>Previously Reported [Member]</div>
</th>
<th class="th">
<div>AOCI Attributable to Parent [Member] </div>
<div>Previously Reported [Member] </div>
<div>Gameface Ltd [Member]</div>
</th>
<th class="th">
<div>AOCI Attributable to Parent [Member] </div>
<div>Previously Reported [Member] </div>
<div>Play Sight Interactive Ltd [Member]</div>
</th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th">
<div>Retained Earnings [Member] </div>
<div>Previously Reported [Member]</div>
</th>
<th class="th">
<div>Retained Earnings [Member] </div>
<div>Previously Reported [Member] </div>
<div>Gameface Ltd [Member]</div>
</th>
<th class="th">
<div>Retained Earnings [Member] </div>
<div>Previously Reported [Member] </div>
<div>Play Sight Interactive Ltd [Member]</div>
</th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Previously Reported [Member]</div></th>
<th class="th">
<div>Previously Reported [Member] </div>
<div>Gameface Ltd [Member]</div>
</th>
<th class="th">
<div>Previously Reported [Member] </div>
<div>Play Sight Interactive Ltd [Member]</div>
</th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance - May 1, 2022 at Apr. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,764<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,389,935<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (20,170)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,823,273)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (18,450,744)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Apr. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69,108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_StockIssuedDuringPeriodForAbstract', window );"><strong>Stock issued for:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits', window );">Conversion of shares issuable (liability)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 692<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,229<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,921<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits', window );">Conversion of shares issuable (liability), shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,304<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 54<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,549,946<span></span>
</td>
<td class="nump">$ 9,700,000<span></span>
</td>
<td class="nump">$ 39,950,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,550,000<span></span>
</td>
<td class="nump">$ 9,700,000<span></span>
</td>
<td class="nump">$ 39,950,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Acquisitions, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,003,362<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,003,383<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Services, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">518<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Fractional share issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 495<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,255<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Fractional share issuance, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,473,597<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,473,602<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Change in comprehensive income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,132<span></span>
</td>
<td class="nump">75,132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss for the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(51,773,652)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(51,773,652)<span></span>
</td>
<td class="num">(51,773,652)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_StockIssuedDuringPeriodValueConversionofNotesPayableRelatedParties', window );">Conversion of notes payable - related parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 164<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,219,838<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,220,002<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_StockIssuedDuringPeriodShareConversionofNotesPayableRelatedParties', window );">Conversion of notes payable - related parties, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,093<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Share-based compensation, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">126<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther', window );">Elimination of related party derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,754,538<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,754,538<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance - April 30, 2023 at Apr. 30, 2022</a></td>
<td class="nump">$ 105<span></span>
</td>
<td class="nump">$ 4,195<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 113,053,790<span></span>
</td>
<td class="nump">113,049,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 54,962<span></span>
</td>
<td class="nump">54,962<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (80,596,925)<span></span>
</td>
<td class="num">(80,596,925)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,511,932<span></span>
</td>
<td class="nump">32,511,932<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Apr. 30, 2022</a></td>
<td class="nump">104,871<span></span>
</td>
<td class="nump">104,872<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_StockIssuedDuringPeriodForAbstract', window );"><strong>Stock issued for:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits', window );">Conversion of shares issuable (liability)</a></td>
<td class="nump">$ 110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,046,190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,046,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits', window );">Conversion of shares issuable (liability), shares</a></td>
<td class="nump">109,737<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Acquisition</a></td>
<td class="nump">$ 15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">915,530<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">915,545<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Acquisitions, shares</a></td>
<td class="nump">14,960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Services</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,249<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Services, shares</a></td>
<td class="nump">625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Cash</a></td>
<td class="nump">$ 26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,194,974<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,195,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Cash, shares</a></td>
<td class="nump">26,219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Fractional share issuance</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Fractional share issuance, shares</a></td>
<td class="nump">38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">277,625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">277,625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Change in comprehensive income (loss)</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss for the period</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,266,431)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,266,431)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance - April 30, 2023 at Jul. 31, 2022</a></td>
<td class="nump">$ 257<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">132,523,358<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">113,101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(84,863,356)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47,773,360<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Jul. 31, 2022</a></td>
<td class="nump">256,450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance - May 1, 2022 at Apr. 30, 2022</a></td>
<td class="nump">$ 105<span></span>
</td>
<td class="nump">$ 4,195<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">113,053,790<span></span>
</td>
<td class="nump">113,049,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54,962<span></span>
</td>
<td class="nump">54,962<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(80,596,925)<span></span>
</td>
<td class="num">(80,596,925)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32,511,932<span></span>
</td>
<td class="nump">32,511,932<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Apr. 30, 2022</a></td>
<td class="nump">104,871<span></span>
</td>
<td class="nump">104,872<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_StockIssuedDuringPeriodForAbstract', window );"><strong>Stock issued for:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,829<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">912,716<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">915,545<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Acquisitions, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70,727<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,055<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,086<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Services, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">775<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,068<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,192,932<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,195,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Cash, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,682<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">151,579<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Fractional share issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Fractional share issuance, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">746,511<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">746,511<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Change in comprehensive income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">87,550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 87,550<span></span>
</td>
<td class="nump">87,550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss for the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(71,153,685)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(71,153,685)<span></span>
</td>
<td class="num">(71,153,685)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_StockIssuedDuringPeriodValueCashlessExerciseOfWarrants', window );">Cashless exercise of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(30)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_StockIssuedDuringPeriodCashlessExerciseOfWarrantsShares', window );">Cashless exercise of warrants, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversion of notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,389<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,041,911<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,046,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of notes payable, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">109,737<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance - April 30, 2023 at Apr. 30, 2023</a></td>
<td class="nump">$ 339<span></span>
</td>
<td class="nump">$ 13,544<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">132,993,998<span></span>
</td>
<td class="nump">$ 132,980,793<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">142,512<span></span>
</td>
<td class="nump">$ 142,512<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(151,750,610)<span></span>
</td>
<td class="num">$ (151,750,610)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18,613,761)<span></span>
</td>
<td class="num">$ (18,613,761)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Apr. 30, 2023</a></td>
<td class="nump">338,579<span></span>
</td>
<td class="nump">338,579<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_StockIssuedDuringPeriodForAbstract', window );"><strong>Stock issued for:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Acquisition</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Acquisitions, shares</a></td>
<td class="nump">1,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Services</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Services, shares</a></td>
<td class="nump">188<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">188<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Change in comprehensive income (loss)</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(27,020)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(27,020)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss for the period</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(846,765)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(846,765)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_StockIssuedDuringPeriodValueAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">$ 67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">559,913<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">559,980<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_StockIssuedDuringPeriodSharesAccountsPayable', window );">Accounts payable, shares</a></td>
<td class="nump">67,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_StockIssuedDuringPeriodValueCashlessExerciseOfWarrants', window );">Cashless exercise of warrants</a></td>
<td class="nump">$ 27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(27)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_StockIssuedDuringPeriodCashlessExerciseOfWarrantsShares', window );">Cashless exercise of warrants, shares</a></td>
<td class="nump">27,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_StockIssuedDuringPeriodValueSatisfactionOfProfitGuaranteeOnNotePayable', window );">Satisfaction of profit guarantee on note payable</a></td>
<td class="nump">$ 94<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">558,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">558,294<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_StockIssuedDuringPeriodSharesSatisfactionOfProfitGuaranteeOnNotePayable', window );">Satisfaction of profit guarantee on note payable, shares</a></td>
<td class="nump">93,680<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance - April 30, 2023 at Jul. 31, 2023</a></td>
<td class="nump">$ 528<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 134,112,083<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 115,492<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (152,597,375)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (18,369,272)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Jul. 31, 2023</a></td>
<td class="nump">528,297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_StockIssuedDuringPeriodCashlessExerciseOfWarrantsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period cashless exercise of warrants shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_StockIssuedDuringPeriodCashlessExerciseOfWarrantsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_StockIssuedDuringPeriodForAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period for abstract</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_StockIssuedDuringPeriodForAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_StockIssuedDuringPeriodShareConversionofNotesPayableRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period share conversion of notes payable related parties</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_StockIssuedDuringPeriodShareConversionofNotesPayableRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_StockIssuedDuringPeriodSharesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_StockIssuedDuringPeriodSharesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_StockIssuedDuringPeriodSharesSatisfactionOfProfitGuaranteeOnNotePayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_StockIssuedDuringPeriodSharesSatisfactionOfProfitGuaranteeOnNotePayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_StockIssuedDuringPeriodValueAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_StockIssuedDuringPeriodValueAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_StockIssuedDuringPeriodValueCashlessExerciseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value cashless exercise of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_StockIssuedDuringPeriodValueCashlessExerciseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_StockIssuedDuringPeriodValueConversionofNotesPayableRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value conversion of notes payable related parties</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_StockIssuedDuringPeriodValueConversionofNotesPayableRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_StockIssuedDuringPeriodValueSatisfactionOfProfitGuaranteeOnNotePayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_StockIssuedDuringPeriodValueSatisfactionOfProfitGuaranteeOnNotePayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other increase (decrease) in additional paid in capital (APIC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007853565536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows (Unaudited) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2023</div></th>
<th class="th"><div>Jul. 31, 2022</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOW FROM OPERTING ACTIVIITES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (846,765)<span></span>
</td>
<td class="num">$ (4,266,431)<span></span>
</td>
<td class="num">$ (71,153,685)<span></span>
</td>
<td class="num">$ (51,773,652)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation, amortization and impairment expense</a></td>
<td class="nump">115,072<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">11,555,332<span></span>
</td>
<td class="nump">43,534<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Change in fair value of derivative liability</a></td>
<td class="num">(2,144,554)<span></span>
</td>
<td class="num">(3,687,495)<span></span>
</td>
<td class="num">(10,950,017)<span></span>
</td>
<td class="num">(18,557,184)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims', window );">Shares and warrants issued for services</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">35,250<span></span>
</td>
<td class="nump">37,086<span></span>
</td>
<td class="nump">2,010,304<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">277,625<span></span>
</td>
<td class="nump">746,511<span></span>
</td>
<td class="nump">32,473,602<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfOtherAssets', window );">Loss on disposal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,413,892<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_GainLossOnChangeInFairValueOfContingentConsideration', window );">Change in fair value of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(4,847,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">7,096,730<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discounts</a></td>
<td class="nump">777,192<span></span>
</td>
<td class="nump">2,872,222<span></span>
</td>
<td class="nump">4,095,030<span></span>
</td>
<td class="nump">8,150,284<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_DerivativeExpense', window );">Derivative expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,995,962<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_NoncashTransactionCosts', window );">Non-cash transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">454,823<span></span>
</td>
<td class="nump">2,250,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_SettlementExpense', window );">Settlement expense</a></td>
<td class="nump">558,294<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_LossOnSettlementOfAccountsPayable', window );">Loss on settlement of accounts payable</a></td>
<td class="nump">289,980<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_GainLossOnIssuanceOfConvertibleNotes', window );">Loss on conversion of convertible notes</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">5,889,369<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in assets and liabilities, net of acquired amounts</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">265,992<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,368,643)<span></span>
</td>
<td class="num">(268,930)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="nump">852,848<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">4,413,056<span></span>
</td>
<td class="num">(4,186,493)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_IncreaseDecreaseInPrepaidInventory', window );">Prepaid inventory</a></td>
<td class="num">(197,429)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(138,308)<span></span>
</td>
<td class="num">(520,580)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(1,316)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">430,193<span></span>
</td>
<td class="num">(320,679)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">255,199<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(598,814)<span></span>
</td>
<td class="nump">6,087,601<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Contract liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(53,287)<span></span>
</td>
<td class="num">(41,451)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities', window );">Other current liabilities</a></td>
<td class="nump">326,550<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,126,123<span></span>
</td>
<td class="num">(2,978,265)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInterestPayableNet', window );">Accrued interest</a></td>
<td class="nump">16,135<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">158,187<span></span>
</td>
<td class="nump">1,813,516<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_IncreaseDecreaseInInterestPayableRelatedParty', window );">Accrued interest - related parties</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">9,201<span></span>
</td>
<td class="nump">161,120<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities', window );">Total adjustments</a></td>
<td class="nump">1,113,963<span></span>
</td>
<td class="num">(502,398)<span></span>
</td>
<td class="nump">60,326,327<span></span>
</td>
<td class="nump">34,255,478<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations', window );">Net cash used in operating activities of continuing operations</a></td>
<td class="nump">267,198<span></span>
</td>
<td class="num">(4,768,829)<span></span>
</td>
<td class="num">(10,827,358)<span></span>
</td>
<td class="num">(17,518,174)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations', window );">Net cash provided by operating activities of discontinued operations</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">4,461,969<span></span>
</td>
<td class="nump">5,151,474<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="nump">267,198<span></span>
</td>
<td class="num">(4,768,829)<span></span>
</td>
<td class="num">(6,365,389)<span></span>
</td>
<td class="num">(12,366,700)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Cash acquired as part of Gameface acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">125,659<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireNotesReceivable', window );">Note receivable issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(2,250,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations', window );">Net cash used in investing activities of continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(2,124,341)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations', window );">Net cash provided by operating activities of discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">506,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,618,341)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock for cash</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">4,195,000<span></span>
</td>
<td class="nump">8,744,882<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Debt issuance costs on convertible notes payable and other financing activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(800,251)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds from notes payable</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">925,000<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="nump">5,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Proceeds from related party notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from convertible notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">11,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Payments of notes payable - related parties</a></td>
<td class="num">(298,834)<span></span>
</td>
<td class="num">(15,386)<span></span>
</td>
<td class="num">(546,158)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Payments of notes payable</a></td>
<td class="num">(302,168)<span></span>
</td>
<td class="num">(1,698,485)<span></span>
</td>
<td class="num">(4,377,537)<span></span>
</td>
<td class="num">(3,965,463)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="num">(601,002)<span></span>
</td>
<td class="nump">3,406,129<span></span>
</td>
<td class="nump">5,821,187<span></span>
</td>
<td class="nump">13,734,286<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Effect of exchange rate fluctuations on cash and cash equivalents</a></td>
<td class="num">(17,996)<span></span>
</td>
<td class="nump">67,357<span></span>
</td>
<td class="nump">81,295<span></span>
</td>
<td class="num">(193)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">NET DECREASE IN CASH AND RESTRICTED CASH</a></td>
<td class="num">(351,800)<span></span>
</td>
<td class="num">(1,295,343)<span></span>
</td>
<td class="num">(462,907)<span></span>
</td>
<td class="num">(250,948)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">CASH AND RESTRICTED CASH - BEGINNING OF PERIOD</a></td>
<td class="nump">202,095<span></span>
</td>
<td class="nump">665,002<span></span>
</td>
<td class="nump">665,002<span></span>
</td>
<td class="nump">915,950<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">CASH AND RESTRICTED CASH - END OF PERIOD</a></td>
<td class="num">(149,705)<span></span>
</td>
<td class="num">(630,341)<span></span>
</td>
<td class="num">(202,095)<span></span>
</td>
<td class="num">(665,002)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>CASH PAID DURING THE PERIOD FOR:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest expense</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">482,687<span></span>
</td>
<td class="nump">222,210<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">111,105<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>SUPPLEMENTAL INFORMATION - NON-CASH INVESTING AND FINANCING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Shares issued in connection with acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,550,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_ConversionOfConvertibleNotesPayableAndAccruedInterestToCommonStock', window );">Conversion of convertible notes payable and accrued interest to common stock</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">14,046,300<span></span>
</td>
<td class="nump">14,046,300<span></span>
</td>
<td class="nump">6,220,003<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_SharesIssuedForContingentConsideration', window );">Shares issued for contingent consideration</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">915,545<span></span>
</td>
<td class="nump">915,545<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_EliminationOfRelatedPartyDerivativeLiabilities', window );">Elimination of related party derivative liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">8,754,538<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_DerivativeLiabilitiesRecordedAsDebtDiscountsOfConvertibleNotes', window );">Derivative liabilities recorded as debt discounts of convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">10,199,749<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_DerivativeLiabilityRecordedForSharesAndWarrantsIssuedInPrivatePlacement', window );">Derivative liability recorded for shares and warrants issued in private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,999,882<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_SharesIssuedForSettlementOfAccountsPayable', window );">Shares issued for settlement of accounts payable</a></td>
<td class="nump">270,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesIssued1', window );">Note receivable issued in sale of PlaySight</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">CASH AND RESTRICTED CASH - END OF PERIOD</a></td>
<td class="nump">$ 149,705<span></span>
</td>
<td class="nump">$ 630,341<span></span>
</td>
<td class="nump">$ 202,095<span></span>
</td>
<td class="nump">$ 665,002<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_ConversionOfConvertibleNotesPayableAndAccruedInterestToCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Conversion of convertible notes payable and accrued interest to common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_ConversionOfConvertibleNotesPayableAndAccruedInterestToCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_DerivativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_DerivativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_DerivativeLiabilitiesRecordedAsDebtDiscountsOfConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative liabilities recorded as debt discounts of convertible notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_DerivativeLiabilitiesRecordedAsDebtDiscountsOfConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_DerivativeLiabilityRecordedForSharesAndWarrantsIssuedInPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative liability recorded for shares and warrants issued in private placement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_DerivativeLiabilityRecordedForSharesAndWarrantsIssuedInPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_EliminationOfRelatedPartyDerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Elimination of related party derivative liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_EliminationOfRelatedPartyDerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_GainLossOnChangeInFairValueOfContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) on change in fair value of contingent consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_GainLossOnChangeInFairValueOfContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_GainLossOnIssuanceOfConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) on issuance of convertible notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_GainLossOnIssuanceOfConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_IncreaseDecreaseInInterestPayableRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase decrease in interest payable related party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_IncreaseDecreaseInInterestPayableRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_IncreaseDecreaseInPrepaidInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase decrease in prepaid inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_IncreaseDecreaseInPrepaidInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_LossOnSettlementOfAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_LossOnSettlementOfAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_NoncashTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncash transaction costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_NoncashTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_SettlementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_SettlementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_SharesIssuedForContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares issued for contingent consideration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_SharesIssuedForContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_SharesIssuedForSettlementOfAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_SharesIssuedForSettlementOfAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of adjustments which are added to or deducted from net income or loss, including the portion attributable to noncontrolling interest, to reflect cash provided by or used in operating activities, in accordance with the indirect cash flow method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-1A<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAcquiredFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAcquiredFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of investing activities of discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of operating activities of discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of other assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481303/470-50-40-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481303/470-50-40-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482312/912-310-45-11<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInterestPayableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInterestPayableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of notes issued in noncash investing and financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireNotesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire an agreement for an unconditional promise by the maker to pay the entity (holder) a definite sum of money at a future date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireNotesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of stock issued in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007866046384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ORGANIZATION AND NATURE OF BUSINESS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2023</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">ORGANIZATION AND NATURE OF BUSINESS</a></td>
<td class="text"><p id="xdx_80C_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zIECnxm6DOkj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
1: <span id="xdx_82C_z9SjvE1EOv06">ORGANIZATION AND NATURE OF BUSINESS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Organization</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lazex
Inc. (&#8220;Lazex&#8221;) was incorporated under the laws of the State of Nevada on July 12, 2015. On August 23, 2019, the majority
owner of Lazex entered into a Stock Purchase Agreement with Slinger Bag Americas Inc., a Delaware corporation (&#8220;Slinger Bag Americas&#8221;),
which was <span id="xdx_908_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20190823__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SlingerBagAmericasIncMember_zb0Kp5zOX4h1" title="Percentage of ownership">100</span>% owned by Slinger Bag Ltd. (&#8220;SBL&#8221;), an Israeli company. In connection with the Stock Purchase Agreement, Slinger
Bag Americas acquired <span id="xdx_900_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_pid_c20190823__20190823__us-gaap--BusinessAcquisitionAxis__custom--SlingerBagAmericasIncMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember_zWW7shUyWnLf" title="Number of shares issued for acquisition">50,000</span> shares of common stock of Lazex for $<span id="xdx_90B_eus-gaap--BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_iI_c20190823__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--SlingerBagAmericasIncMember_z5FRoT0zmPo6" title="Number of value issued for acquisition">332,239</span>. On September 16, 2019, SBL transferred its ownership of Slinger
Bag Americas to Lazex in exchange for the <span id="xdx_90D_ecustom--NumberOfSharesExchanged_pid_c20190916__20190916__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SlingerBagAmericasIncMember_z14jzn0f0qY7" title="Number of shares exchanged">50,000</span> shares of Lazex acquired on August 23, 2019. As a result of these transactions, Lazex
owned <span id="xdx_904_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20190916__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SlingerBagAmericasIncMember_zQHBxu41BHwi" title="Percentage of ownership">100</span>% of Slinger Bag Americas and the sole shareholder of SBL owned <span id="xdx_907_ecustom--NumberOfSharesOwned_pid_c20190916__20190916__us-gaap--BusinessAcquisitionAxis__custom--SoleShareholderofSBLMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember_zLZixwULw6f4" title="Number of shares owned">50,000</span> shares of common stock (approximately <span id="xdx_905_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20190916__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SoleShareholderofSBLMember_zwL9qIftaEje" title="Percentage of ownership">82</span>%) of Lazex.
Effective September 13, 2019, Lazex changed its name to Slinger Bag Inc.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 31, 2019, Slinger Bag Americas acquired control of Slinger Bag Canada, Inc., (&#8220;Slinger Bag Canada&#8221;) a Canadian company
incorporated on November 3, 2017. There were no assets, liabilities or historical operational activity of Slinger Bag Canada.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 10, 2020, Slinger Bag Americas became the <span id="xdx_90F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20200210__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SlingerBagAmericasIncMember_zZjqFjug4zXk" title="Percentage of ownership">100</span>% owner of SBL, along with SBL&#8217;s wholly owned subsidiary Slinger Bag International
(UK) Limited (&#8220;Slinger Bag UK&#8221;), which was formed on April 3, 2019. On February 10, 2020, the owner of SBL, contributed Slinger
Bag UK to Slinger Bag Americas for no consideration.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 21, 2021, Slinger Bag Americas entered into a membership interest purchase agreement with Charles Ruddy to acquire a <span id="xdx_90E_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20210621__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FoundationSportsSystemsLLCMember__srt--TitleOfIndividualAxis__custom--CharlesRuddyMember_z48w02DFsOwd" title="Percentage of ownership">100</span>% ownership
stake in Foundation Sports Systems, LLC (&#8220;Foundation Sports&#8221;). On December 5, 2022, the Company sold <span id="xdx_90C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20221205__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FoundationSportsSystemsLLCMember_zBYj7LVgJNwa" title="Percentage of ownership">75</span>% of Foundation Sports
back to the original sellers. As a result, at that time, the Company recorded a loss on the sale and deconsolidated Foundation Sports.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 2, 2022, the Company entered into a share purchase agreement with Flixsense Pty, Ltd. (&#8220;Gameface&#8221;). As a result
of the share purchase agreement, Gameface would become a wholly owned subsidiary of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 22, 2022, the Company entered into a merger agreement with PlaySight Interactive Ltd. (&#8220;PlaySight&#8221;) and Rohit Krishnan
(the &#8220;Shareholders&#8217; Representative&#8221;). As a result of the merger agreement, PlaySight would become a wholly owned subsidiary
of the Company. In November 2022, the Company sold PlaySight and recorded a loss on the sale.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 16, 2022, the Company changed its domicile from Nevada to Delaware. On April 7, 2022, the Company effected a name change to Connexa
Sports Technologies Inc. We also changed our ticker symbol, &#8220;CNXA.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 14, 2022, the Company effected a <span id="xdx_90F_eus-gaap--StockholdersEquityReverseStockSplit_c20220614__20220614_zWD2L7dicP9i">1-for-10
reverse stock split</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, where the Company&#8217;s
common stock began to trade on a reverse split adjusted basis. No fractional shares were issued in connection with the reverse stock
split and all such fractional interests were rounded up to the nearest whole number of shares of common stock. All references to the
outstanding stock have been retrospectively adjusted to reflect this reverse stock split. The Company also consummated a public offering
of shares of its common stock and the listing of its common stock on the Nasdaq.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 26, 2023, the Company received a letter from the Listing Qualifications Department of Nasdaq indicating that the Company&#8217;s
stockholders&#8217; equity as reported in its Quarterly Report on Form 10-Q for the quarterly period ended January 31, 2023 did not satisfy
the continued listing requirement under Nasdaq Listing Rule 5550(b)(1), which requires that a listed company&#8217;s stockholders&#8217;
equity be at least $<span id="xdx_909_eus-gaap--StockholdersEquity_iI_pn5n6_c20230726__srt--RangeAxis__srt--MinimumMember_z8jBgES4xAuh" title="Stockholders equity">2.5</span> million (the &#8220;Minimum Stockholders&#8217; Equity Requirement&#8221;). In addition, the Company did not
meet the alternatives of listed securities or net income from continuing operations as of the date of the letter. The Company timely
submitted a compliance plan to the Panel and on August 23, 2023 received notice from Nasdaq that it has until January 22, 2024 to demonstrate
compliance with the Minimum Stockholders&#8217; Equity Requirement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
can be no assurance that the Company will be able to satisfy the Nasdaq&#8217;s continued listing requirements, regain compliance
with the Rule, the Minimum Stockholders&#8217; Equity Requirement and maintain compliance
with other Nasdaq listing requirements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
further details on PlaySight and Foundation Sports, we refer you to our Annual Report on Form 10-K for the year ended April 30,
2023, filed with the Securities and Exchange Commission on September 14, 2023. This Form 10-K and the consolidated financial statements
will concentrate on our existing business as reflected in the following paragraph.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company operates in the sport equipment and technology business. The Company is the owner of the Slinger Launcher, which is a portable
tennis ball launcher as well as other associated tennis accessories and Gameface AI an Australian artificial intelligence sports software
company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
operations of Slinger Bag Inc., Slinger Bag Americas, Slinger Bag Canada, Slinger Bag UK, SBL, and Gameface are collectively referred
to as the &#8220;Company.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Basis
of Presentation</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying condensed consolidated financial statements of the Company are presented in accordance with accounting principles generally
accepted in the United States of America (&#8220;GAAP&#8221;). As a result of the transactions described above, the accompanying consolidated
financial statements include the combined results of Slinger Bag Inc., Slinger Bag Americas, Slinger Bag Canada, Slinger Bag UK, SBL,
and Gameface for the periods ended July 31, 2023 and 2022. The operations of Foundation Sports and PlaySight are included as discontinued
operations in our statements of operations as these entities were sold in November 2022 and December 2022 for the period ended July 31,
2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Impact
of COVID-19 Pandemic</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company continues to carefully monitor the global COVID-19 pandemic status and its impact on its business. In that regard, while the
Company has continued to sell its products it has previously experienced certain minor disruptions in its supply chains. The Company
expects the significance of the COVID-19 pandemic, including the extent of its effect on the Company&#8217;s financial and operational
results, to be dictated by, among other things, the on-going global efforts to contain it. While the Company has not experienced any
material disruptions to its business and operations as a result of the COVID-19 pandemic, it is possible such disruptions may occur in
the future which may impact its financial and operational results, and which could be material.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Impact
of Russian and Ukrainian Conflict</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. We are closely monitoring
the unfolding events due to the Russia-Ukraine conflict and its regional and global ramifications. We have one distributor in Russia,
which is not material to our overall financial results. We do not currently have operations in Ukraine or Belarus. We are monitoring
any broader economic impact from the current crisis. The specific impact on the Company&#8217;s financial condition, results of operations,
and cash flows is also not determinable as of the date of these financial statements. However, to the extent that such military action
spreads to other countries, intensifies, or otherwise remains active, such action could have a material adverse effect on our financial
condition, results of operations, and cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_80C_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zm2Szh295vD6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
1: <span id="xdx_82A_zQEqeRaIBLnf">ORGANIZATION AND NATURE OF BUSINESS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Organization</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lazex
Inc. (&#8220;Lazex&#8221;) was incorporated under the laws of the State of Nevada on July 12, 2015. On August 23, 2019, the majority
owner of Lazex entered into a Stock Purchase Agreement with Slinger Bag Americas Inc., a Delaware corporation (&#8220;Slinger Bag Americas&#8221;),
which was <span id="xdx_908_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20190823__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SlingerBagAmericasIncMember_zuJJRIEOBcO6" title="Percentage of ownership">100%</span> owned by Slinger Bag Ltd. (&#8220;SBL&#8221;), an Israeli company. In connection with the Stock Purchase Agreement, Slinger
Bag Americas acquired <span id="xdx_90B_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_pid_c20190823__20190823__us-gaap--BusinessAcquisitionAxis__custom--SlingerBagAmericasIncMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z74SFsgzmyN6" title="Number of shares issued for acquisition">2,000,000</span> shares of common stock of Lazex for $<span id="xdx_90B_eus-gaap--BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_iI_c20190823__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--SlingerBagAmericasIncMember_zxFpsS5Rx3he" title="Number of value issued for acquisition">332,239</span>. On September 16, 2019, SBL transferred its ownership of
Slinger Bag Americas to Lazex in exchange for the <span id="xdx_90F_ecustom--NumberOfSharesExchanged_pid_c20190916__20190916__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SlingerBagAmericasIncMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zBIHrv8YkQN2" title="Number of shares exchanged">2,000,000</span> shares of Lazex acquired on August 23, 2019. As a result of these transactions,
Lazex owned <span id="xdx_904_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20190916__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SlingerBagAmericasIncMember_zjiGqxtJqpd2" title="Percentage of ownership">100%</span> of Slinger Bag Americas and the sole shareholder of SBL owned <span id="xdx_903_ecustom--NumberOfSharesOwned_pid_c20190916__20190916__us-gaap--BusinessAcquisitionAxis__custom--SoleShareholderofSBLMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zFqgF6v8K853" title="Number of shares owned">2,000,000</span> shares of common stock (approximately <span id="xdx_905_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20190916__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SoleShareholderofSBLMember_zakPiRUvDj14" title="Percentage of ownership">82%</span>) of
Lazex. Effective September 13, 2019, Lazex changed its name to Slinger Bag Inc.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 31, 2019, Slinger Bag Americas acquired control of Slinger Bag Canada, Inc., (&#8220;Slinger Bag Canada&#8221;) a Canadian company
incorporated on November 3, 2017. There were no assets, liabilities or historical operational activity of Slinger Bag Canada.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 10, 2020, Slinger Bag Americas became the <span id="xdx_90F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20200210__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SlingerBagAmericasIncMember_zWucosLaeuR" title="Percentage of ownership">100%</span> owner of SBL, along with SBL&#8217;s wholly owned subsidiary Slinger Bag International
(UK) Limited (&#8220;Slinger Bag UK&#8221;), which was formed on April 3, 2019. On February 10, 2020, the owner of SBL, contributed Slinger
Bag UK to Slinger Bag Americas for no consideration.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 21, 2021, Slinger Bag Americas entered into a membership interest purchase agreement with Charles Ruddy to acquire a <span id="xdx_90E_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20210621__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FoundationSportsSystemsLLCMember__srt--TitleOfIndividualAxis__custom--CharlesRuddyMember_z3e8zpAeBDw3" title="Percentage of ownership">100%</span> ownership
stake in Foundation Sports Systems, LLC (&#8220;Foundation Sports&#8221;). On December 5, 2022, the Company sold <span id="xdx_90C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20221205__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FoundationSportsSystemsLLCMember_zJIsmcdKQusc" title="Percentage of ownership">75%</span> of Foundation Sports
back to the original sellers. As a result, at that time, the Company recorded a loss on the sale and deconsolidated Foundation Sports.
(refer to Note 5 and Note 16). During the year ended April 30, 2022, the Company impaired certain intangible assets and goodwill in the
amount of $<span id="xdx_90E_eus-gaap--GoodwillImpairedAccumulatedImpairmentLoss_iI_c20220430_zQajjfPuYy31" title="Impaired of intangible assets and goodwill amount">3,486,599</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 2, 2022, the Company entered into a share purchase agreement with Flixsense Pty, Ltd. (&#8220;Gameface&#8221;). As a result
of the share purchase agreement, Gameface would become a wholly owned subsidiary of the Company (refer to Note 5).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 22, 2022, the Company entered into a merger agreement with PlaySight Interactive Ltd. (&#8220;PlaySight&#8221;) and Rohit Krishnan
(the &#8220;Shareholders&#8217; Representative&#8221;). As a result of the merger agreement, PlaySight would become a wholly owned subsidiary
of the Company (refer to Note 5). In November 2022, the Company sold PlaySight and recorded a loss on the sale. See Note 16 for further
details on the sale of PlaySight.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 16, 2022, the Company changed its domicile from Nevada to Delaware. On April 7, 2022, the Company effected a name change to Connexa
Sports Technologies Inc. We also changed our ticker symbol, &#8220;CNXA.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
operations of Slinger Bag Inc., Slinger Bag Americas, Slinger Bag Canada, Slinger Bag UK, SBL, and Gameface are collectively referred
to as the &#8220;Company.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 14, 2022, the Company effected a <span id="xdx_90F_eus-gaap--StockholdersEquityReverseStockSplit_c20220614__20220614_z6QItGR6YtTg">1-for-10
reverse stock split</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, where the Company&#8217;s
common stock began to trade on a reverse split adjusted basis. No fractional shares were issued in connection with the reverse stock
split and all such fractional interests were rounded up to the nearest whole number of shares of common stock. All references herein
to the outstanding stock have been retrospectively adjusted to reflect this reverse stock split. The Company also consummated a public
offering of shares of its common stock and the listing of its common stock on the Nasdaq.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
further details on PlaySight and Foundation Sports we refer you to our Annual Report on Form 10-K for the year ended April 30, 2022,
filed with the Securities and Exchange Commission on May 17, 2023. This Form 10-K and the consolidated financial statements will concentrate
on our existing business as reflected in the following paragraph.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company operates in the sport equipment and technology business. The Company is the owner of the Slinger Launcher, which is a portable
tennis ball launcher as well as other associated tennis accessories and Gameface AI an Australian artificial intelligence sports software
company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Basis
of Presentation</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements of the Company are presented in accordance with accounting principles generally
accepted in the United States of America (&#8220;GAAP&#8221;). As a result of the transactions described above, the accompanying consolidated financial statements include the combined results of Slinger Bag Inc., Slinger Bag Americas, Slinger Bag Canada, Slinger
Bag UK, SBL, and Gameface for the years ended April 30, 2023 and 2022. The operations of Foundation Sports and PlaySight are included
as discontinued operations in our statements of operations as these entities were sold in November 2022 and December 2022 as disclosed
in Note 16.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company reports Gameface on a one-month calendar lag allowing for the timely preparation of financial statements. Gameface operates on
fiscal year end periods as of December 31. This one-month reporting lag is with the exception of significant transactions or events that
occur during the intervening period. The Company did not identify any significant transactions during the one month ended April 30, 2023
at Gameface that would need to be disclosed as not included within the Company&#8217;s consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Impact
of COVID-19 Pandemic</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has been carefully monitoring the COVID-19 pandemic and its impact on its business. In that regard, while the Company has continued
to sell its products and grow its business it did experience certain disruptions in its supply chains. The Company expects the significance
of the COVID-19 pandemic, including the extent of its effect on the Company&#8217;s financial and operational results, to be dictated
by, among other things, its duration, the success of efforts to contain it and the impact of actions taken in response. While the Company
has not experienced any material disruptions to its business and operations as a result of the COVID-19 pandemic, it is possible such
disruptions may occur in the future which may impact its financial and operational results, and which could be material.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Impact
of Russian and Ukrainian Conflict</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. We are closely monitoring
the unfolding events due to the Russia-Ukraine conflict and its regional and global ramifications. We have one distributor in Russia,
which is not material to our overall financial results. We do not have operations in Ukraine or Belarus. We are monitoring any broader
economic impact from the current crisis. The specific impact on the Company&#8217;s financial condition, results of operations, and cash
flows is also not determinable as of the date of these financial statements. However, to the extent that such military action spreads
to other countries, intensifies, or otherwise remains active, such action could have a material adverse effect on our financial condition,
results of operations, and cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480424/946-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480424/946-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//810/tableOfContent<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007864961744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOING CONCERN<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2023</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock', window );">GOING CONCERN</a></td>
<td class="text"><p id="xdx_804_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zo5YW9xYk8ce" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2: <span id="xdx_82B_zfEFiCkxTaI">GOING CONCERN</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial statements have been prepared on a going concern basis, which assumes the Company will be able to realize its assets and discharge
its liabilities in the normal course of business for the foreseeable future. The Company has an accumulated deficit of $<span id="xdx_909_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_di_c20230731_zvrO36LP53Sc" title="Accumulated deficit">152,597,375</span> as
of July 31, 2023, and more losses are anticipated in the development of the business. Accordingly, there is substantial doubt about the
Company&#8217;s ability to continue as a going concern. These financial statements do not include any adjustments related to the recoverability
and classification of assets or the amounts and classification of liabilities that might be necessary should the Company be unable to
continue as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/or being able
to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they
become due. Management intends to finance operating costs over the next twelve months with existing cash on hand, loans from related
parties, and/or private placement of debt and/or common stock. In the event that the Company is unable to successfully raise capital
and/or generate revenues, the Company will likely reduce general and administrative expenses, and cease or delay its development plan
until it is able to obtain sufficient financing. The Company has begun reducing operating expenses and cash outflows by selling PlaySight,
as well as selling <span id="xdx_909_ecustom--DisposalEquityInterestOwnershipInterestPercentage_iI_pid_dp_uPure_c20221130__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--PlaySightMember__us-gaap--BusinessAcquisitionAxis__custom--FoundationSportsSystemsLLCMember_z3siq21eHoRb" title="Discontinuing operations percentage"><span id="xdx_90B_ecustom--DisposalEquityInterestOwnershipInterestPercentage_iI_pid_dp_uPure_c20221231__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--PlaySightMember__us-gaap--BusinessAcquisitionAxis__custom--FoundationSportsSystemsLLCMember_zQKpHzjcrJr1" title="Discontinuing operations percentage">75</span></span>% of Foundation Sports in November and December 2022, respectively to the former shareholders of those companies.
There can be no assurance that additional funds will be available on terms acceptable to the Company, or at all. We have recorded the
<span id="xdx_900_eus-gaap--DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal_pid_dp_uPure_c20230501__20230731__us-gaap--BusinessAcquisitionAxis__custom--FoundationSportsSystemsLLCMember_zRIWUx4TSfs2" title="Investment retained after disposal, ownership interest after disposal">25</span>% investment in Foundation Sprots at $<span id="xdx_90B_eus-gaap--AlternativeInvestment_iI_dp_c20230731__us-gaap--BusinessAcquisitionAxis__custom--FoundationSportsSystemsLLCMember_zP3AoFqVMwt8" title="Investment amount">0</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_804_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_z5JGZe90xVX1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2: <span id="xdx_820_zpx4tnGNlCs8">GOING CONCERN</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial statements have been prepared on a going concern basis, which assumes the Company will be able to realize its assets and discharge
its liabilities in the normal course of business for the foreseeable future. The Company has an accumulated deficit of $<span id="xdx_907_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_di_c20230430_zdxGomWt0Ou7" title="Accumulated deficit">151,750,610</span> as
of April 30, 2023, and more losses are anticipated in the development of the business. Accordingly, there is substantial doubt about
the Company&#8217;s ability to continue as a going concern. These financial statements do not include any adjustments related to the
recoverability and classification of assets or the amounts and classification of liabilities that might be necessary should the Company
be unable to continue as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/or being able
to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they
become due. Management intends to finance operating costs over the next twelve months with existing cash on hand, loans from related
parties, and/or private placement of debt and/or common stock. In the event that the Company is unable to successfully raise capital
and/or generate revenues, the Company will likely reduce general and administrative expenses, and cease or delay its development plan
until it is able to obtain sufficient financing. The Company has begun reducing operating expenses and cash outflows by selling PlaySight,
as well as selling <span id="xdx_903_ecustom--DisposalEquityInterestOwnershipInterestPercentage_iI_pid_dp_uPure_c20221130__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--PlaySightMember__us-gaap--BusinessAcquisitionAxis__custom--FoundationSportsSystemsLLCMember_z03WAVdg00xj" title="Discontinuing operations percentage"><span id="xdx_907_ecustom--DisposalEquityInterestOwnershipInterestPercentage_iI_pid_dp_uPure_c20221231__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--PlaySightMember__us-gaap--BusinessAcquisitionAxis__custom--FoundationSportsSystemsLLCMember_z2ZaThKYhH2e" title="Discontinuing operations percentage">75%</span></span> of Foundation Sports in November and December 2022, respectively to the former shareholders of those companies.
There can be no assurance that additional funds will be available on terms acceptable to the Company, or at all. We have recorded the
<span id="xdx_903_eus-gaap--DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal_pid_dp_uPure_c20220501__20230430__us-gaap--BusinessAcquisitionAxis__custom--FoundationSportsSystemsLLCMember_zgm6FrBTUnee" title="Investment retained after disposal, ownership interest after disposal">25%</span> investment in Foundation Sprots at $<span id="xdx_906_eus-gaap--AlternativeInvestment_iI_dp_c20230430__us-gaap--BusinessAcquisitionAxis__custom--FoundationSportsSystemsLLCMember_zd8gDelqxUG" title="Investment amount">0</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//205-40/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubstantialDoubtAboutGoingConcernTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007860609376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2023</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><p id="xdx_80D_eus-gaap--SignificantAccountingPoliciesTextBlock_zcgpH5YnIzIh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
3: <span id="xdx_827_zryQOHZAwtc6">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_84B_ecustom--InterimFinancialStatementsPolicyTextBlock_z3ReT6v36Rv2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_863_zq2qmsTvlyJ8">Interim
Financial Statements</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying condensed financial statements of the Company have been prepared without audit, pursuant to the rules and regulations of
the Securities and Exchange Commission. Certain information and disclosures required by accounting principles generally accepted in the
United States have been condensed or omitted pursuant to such rules and regulations. These condensed financial statements reflect all
adjustments that, in the opinion of management, are necessary to present fairly the results of operations of the Company for the period
presented. The results of operations for the three months ended July 31, 2023, are not necessarily indicative of the results that may
be expected for any future period or the fiscal year ending April 30, 2024 and should be read in conjunction with the Company&#8217;s
Annual Report on Form 10-K for the year ended April 30, 2023, filed with the Securities and Exchange Commission on September 14, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_843_eus-gaap--UseOfEstimates_zIkrIaVahK7d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86C_zzrlLoow2ZNe">Use
of Estimates</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect
the amounts reported in the financial statements and accompanying notes. Accordingly, actual results could differ from those estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84A_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zr5w94rNkM43" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86F_zbnq689LntWg">Financial
Statement Reclassification</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
prior year amounts within accounts payable, accrued expenses, and certain operating expenses have been reclassified for consistency with
the current year presentation and had no effect on the Company&#8217;s balance sheet, net loss, shareholders&#8217; deficit or cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84B_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zhD2tR7itqmd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_861_zSHAEa0JHxjh">Cash
and Cash Equivalents</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents.
The majority of payments due from banks for credit card transactions process within 24 to 48 hours and are accordingly classified as
cash and cash equivalents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_841_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zPN1BOFN4m35" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_863_zPz2KWLalQB8">Accounts
Receivable</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s accounts receivable are non-interest bearing trade receivables resulting from the sale of products and payable over terms
ranging from 15 to 60 days. The Company provides an allowance for doubtful accounts at the point when collection is considered doubtful.
Once all collection efforts have been exhausted, the Company charges-off the receivable with the allowance for doubtful accounts. The
Company recorded $<span id="xdx_907_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pdp0_do_c20230731_zhmumFZM17wi" title="Allowance for doubtful accounts">200,000</span> and $<span id="xdx_90D_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pdp0_do_c20230430_zHacZLXt7vVi" title="Allowance for doubtful accounts">209,690</span> in allowance for doubtful accounts as of July 31, 2023 and April 30, 2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_840_eus-gaap--InventoryPolicyTextBlock_zRZiyRgkdyL" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_861_zAr5yrHEeHy7">Inventory</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory
is valued at the lower of the cost (determined principally on a first-in, first-out basis) or net realizable value. The Company&#8217;s
valuation of inventory includes inventory reserves for inventory that will be sold below cost and the impact of inventory shrink. Inventory
reserves are based on historical information and assumptions about future demand and inventory shrink trends. The Company&#8217;s inventory
as of July 31, 2023 and April 30, 2023 consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p id="xdx_890_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zf97HVif52hc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B6_zoqiVAt0juPa" style="display: none">SCHEDULE OF INVENTORY</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_491_20230731_zE6h5LaOen1g" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">July 31, 2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_492_20230430_ziGSNULllzaa" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">April 30, 2023</td><td style="font-weight: bold">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--InventoryFinishedGoods_iI_maINzzOV_zXcYG5jS1aEb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Finished Goods</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">400,598</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">1,509,985</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--InventoryRawMaterialsAndSupplies_iI_maINzzOV_z45YZrOaZ1fb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Component/Replacement Parts</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,064,041</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,712,553</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--CapitalizedDutyAndFreight_iI_maINzzOV_zqWK1brM4sCc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Capitalized Duty/Freight</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">47,279</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">517,228</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--InventoryAdjustments_iNI_di_msINzzOV_ztNimEQags14" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Inventory Reserve</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(175,000</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(550,000</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--InventoryNet_iTI_mtINzzOV_zZKqAyFQU6p8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Total</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,336,918</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,189,766</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A2_zHURQhQOcA4b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84D_ecustom--PrepaidInventoryPolicyTextBlock_zmMnuOG8vY0f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_864_zDDc8lVOgI7j">Prepaid
Inventory</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid
inventory represents inventory that is in-transit that has been paid for but not received from the Company&#8217;s third-party vendors.
The Company typically prepays for the purchase of materials and receives the products within three months after making payments. The
Company continuously monitors delivery from, and payments to, the vendors. If the Company has difficulty receiving products from a vendor,
the Company would cease purchasing products from such vendors in future periods. The Company has not had difficulty receiving products
during the reporting periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84B_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zRJYPi8gDXoi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86A_zm2FNh7RXyGh">Property
and equipment</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment acquired through business combinations are stated at the estimated fair value at the date of the acquisition. Purchases
of property and equipment are stated at cost, net of accumulated depreciation and impairment losses. Expenditures that materially increase
the useful life of the assets are capitalized. Ordinary repairs and maintenance are expensed as incurred. Depreciation and amortization
are computed using the straight-line method over the estimated useful lives of the related assets, which is an average of <span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230731_zi4ZPPFFOzyh" title="Property plant and equipment, useful life">5</span> years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_840_eus-gaap--ConcentrationRiskCreditRisk_zcbmzjBRP1f3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_866_zuHXeODpB3a4">Concentration
of Credit Risk</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company maintains its cash in bank deposit accounts, the balances of which at times may exceed insured limits. The Company continually
monitors its banking relationships and consequently has not experienced any losses in such accounts. While we may be exposed to credit
risk, we consider the risk remote and do not expect that any such risk would result in a significant effect on our results of operations
or financial condition. See Note 4 for further details on the Company&#8217;s concentration of credit risk as well as other risks and
uncertainties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84E_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zy1IUkRinSj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_867_zw8cnRxFDc0e">Revenue
Recognition</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes revenue for their continuing operations in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 606,
the core principle of which is that an entity should recognize revenue to depict the transfer of promised goods or services to customers
in an amount that reflects the consideration to which the entity expects to be entitled to receive in exchange for those goods or services.
The Company recognizes revenue for its performance obligation associated with its contracts with customers at a point in time once products
are shipped. Amounts collected from customers in advance of shipping products ordered are reflected as contract liabilities on the accompanying
consolidated balance sheets. The Company&#8217;s standard terms are non-cancelable and do not provide for the right-of-return, other
than for defective merchandise covered under the Company&#8217;s standard warranty. The Company has not historically experienced any
significant returns or warranty issues.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes revenue under ASC 606, &#8220;Revenue from Contracts with Customers&#8221;. The core principle of this revenue standard
is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects
the consideration to which the company expects to be entitled in exchange for those goods or services. The following five steps are applied
to achieve that core principle:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step
1: Identify the contract with the customer</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company determines that it has a contract with a customer when each party&#8217;s rights regarding the products or services to be transferred
can be identified, the payment terms for the services can be identified, the Company has determined the customer has the ability and
intent to pay, and the contract has commercial substance. At contract inception, the Company evaluates whether two or more contracts
should be combined and accounted for as a single contract and whether the combined or single contract includes more than one performance
obligation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step
2: Identify the performance obligations in the contract</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s customers are buying an integrated system. In evaluating whether the equipment is a separate performance obligation,
the Company&#8217;s management considered the customer&#8217;s ability to benefit from the equipment on its own or together with other
readily available resources and if so, whether the service and equipment are separately identifiable (i.e., is the service highly dependent
on, or highly interrelated with the equipment). Because the Products and Services included in the customer&#8217;s contract are integrated
and highly interdependent, and because they must work together to deliver the Solution, the Company has concluded that Products installed
on customer&#8217;s premise and Services contracted for by the customer are generally not distinct within the context of the contract
and, therefore, constitute a single, combined performance obligation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step
3: Determine the transaction price</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
transaction price is the amount of consideration to which an entity expects to be entitled in exchange for transferring promised goods
or services to a customer. The consideration promised in a contract with a customer includes predetermined fixed amounts, variable amounts,
or both. The Company&#8217;s contracts do not include any rights of returns or refunds.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company collects each year&#8217;s service fees in advance and should therefore consider the existence of a significant financing component.
However, due to the fact that the payments are provided for the service of a one-year term, the Company elected to apply the practical
expedient under ASC 606 which exempts the adjustment of the consideration for the existence of a significant financing component when
the period between the transfer of the services and the payment for such services is one year or less.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step
4: Allocate the transaction price to the performance obligations in the contract</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contracts
that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on
each performance obligation&#8217;s relative standalone selling price (&#8220;SSP&#8221;). The Company has identified a single performance
obligation in the contract, and therefore, the allocation provisions under ASC 606 do not apply to the Company&#8217;s contracts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step
5: Recognize revenue when the Company satisfies a performance obligation</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues
for the Company&#8217;s single, combined performance obligation are recognized on a straight-line basis over the customer&#8217;s contract
term, which is the period in which the parties to the contract have enforceable rights and obligations (Typically 3-4 years).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84E_eus-gaap--BusinessCombinationsPolicy_zMxLHHnW5pb1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_868_zraUzDeO6OYj">Business
Combinations</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
acquisition of a company, we determine if the transaction is a business combination, which is accounted for using the acquisition method
of accounting. Under the acquisition method, once control is obtained of a business, the assets acquired, and liabilities assumed, are
recorded at fair value. We use our best estimates and assumptions to assign fair value to the tangible and intangible assets acquired
and liabilities assumed at the acquisition date. One of the most significant estimates relates to the determination of the fair value
of these assets and liabilities. The determination of the fair values is based on estimates and judgments made by management. Our estimates
of fair value are based upon assumptions we believe to be reasonable, but which are inherently uncertain and unpredictable. Measurement
period adjustments are reflected at the time identified, up through the conclusion of the measurement period, which is the time at which
all information for determination of the values of assets acquired and liabilities assumed is received and is not to exceed one year
from the acquisition date. We may record adjustments to the fair value of these tangible and intangible assets acquired and liabilities
assumed, with the corresponding offset to goodwill. The Company elected to apply pushdown accounting to all entities acquired.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
uncertain tax positions and tax-related valuation allowances are initially recorded in connection with a business combination as of the
acquisition date. We continue to collect information and reevaluate these estimates and assumptions periodically and record any adjustments
to preliminary estimates to goodwill, provided we are within the measurement period. If outside of the measurement period, any subsequent
adjustments are recorded to the consolidated statement of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_845_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zWhCbAGBHus2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86E_zaoTLTt5EeV3">Fair
Value of Financial Instruments</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
value of financial and non-financial assets and liabilities is defined as an exit price, representing the amount that would be received
to sell an asset or paid to transfer a liability in an orderly transaction between market participants. The three-tier hierarchy for
inputs used in measuring fair value, which prioritizes the inputs used in the methodologies of measuring fair value for assets and liabilities,
is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
1 &#8212; Quoted prices in active markets for identical assets or liabilities</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
2 &#8212; Observable inputs other than quoted prices in active markets for identical assets and liabilities</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
3 &#8212; Unobservable pricing inputs in the market</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
assets and financial liabilities are classified in their entirety based on the lowest level of input that is significant to the fair
value measurements. Our assessment of the significance of a particular input to the fair value measurements requires judgment and may
affect the valuation of the assets and liabilities being measured and their categorization within the fair value hierarchy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s financial instruments consist of cash and cash equivalents, accounts receivable, and accounts payable. The carrying amount
of these financial instruments approximates fair value due to their short-term maturity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s contingent consideration in connection with the acquisition of Gameface was calculated using Level 3 inputs. The fair
value of contingent consideration as of July 31, 2023 and April 30, 2023 was $<span id="xdx_90D_eus-gaap--BusinessCombinationConsiderationTransferred1_c20230501__20230731__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zAYKla0QEGTb" title="Fair value of contingent consideration">418,455</span> and $<span id="xdx_908_eus-gaap--BusinessCombinationConsiderationTransferred1_c20220501__20230430__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z2qpHLFJ4zb1" title="Fair value of contingent consideration">418,455</span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company estimates the fair value of its intangible assets using Level 3 assumptions, primarily based on the income approach utilizing
the discounted cash flow method.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s derivative liabilities were calculated using Level 2 assumptions on the issuance and balance sheet dates via a Black-Scholes
option pricing model and consisted of the following ending balances and gain amounts as of and for the three months ended July 31, 2023:</span></p>

<p id="xdx_89F_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_zv0dvk3LFGO3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BB_zkFsh03XdvSa" style="display: none">SCHEDULE OF DERIVATIVE LIABILITIES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Note derivative is related to</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">July 31, 2023</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">ending balance</p></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">(Gain) loss for the</p>
                                                                                                    <p style="margin-top: 0; margin-bottom: 0">three months ended</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">July 31, 2023</p></td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">4/11/21 profit guaranty</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--ProfitGuarantyMember_zDJadryzbuC2" style="width: 14%; text-align: right" title="Note derivative balance">1,456,854</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20230501__20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--ProfitGuarantyMember_zHh9mPuqcsS7" style="width: 14%; text-align: right" title="Note derivative (gain) loss"><span style="-sec-ix-hidden: xdx2ixbrl0787">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">8/6/21 convertible notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--ConvertibleNotesMember_zcQdpsaz83l1" style="text-align: right" title="Note derivative balance">74,958</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20230501__20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--ConvertibleNotesMember_zJ1AURkaGhUa" style="text-align: right" title="Note derivative (gain) loss">(26,966</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">6/17/22 underwriter warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--UnderwriterWarrantsMember_z67ge1gtPjuh" style="text-align: right" title="Underwriter warrants">4,966</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20230501__20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--UnderwriterWarrantsMember_zPpqveywdCy" style="text-align: right" title="Note derivative (gain) loss">(1,565</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">9/30/22 warrants issued with common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsIssuedWithCommonStockMember_zxe6iTEE7M98" style="text-align: right" title="Other derivative liabilities eliminated in uplist">4,668,608</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20230501__20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsIssuedWithCommonStockMember_zzgik92kwAIf" style="text-align: right" title="Note derivative (gain) loss">(1,440,951</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">1/6/2023 warrants issued with note payable</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsIssuedWithNotesPayableMember_zCWepP1a6mqg" style="border-bottom: Black 1.5pt solid; text-align: right" title="Other derivative liabilities eliminated in uplist">2,139,666</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20230501__20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsIssuedWithNotesPayableMember_zunZlzLuQT98" style="border-bottom: Black 1.5pt solid; text-align: right" title="Note derivative (gain) loss">(675,072</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">Total</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230731_zLRaRIC2AP9a" style="border-bottom: Black 2.5pt double; text-align: right" title="Note derivative balance">8,345,052</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20230501__20230731_zyUgb91QhYpb" style="border-bottom: Black 2.5pt double; text-align: right" title="Note derivative (gain) loss">(2,144,554</td><td style="text-align: left">)</td></tr>
  </table>

<p id="xdx_8A0_zeamAmoTTs8i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Black-Scholes option pricing model assumptions for the derivative liabilities during the periods ended July 31, 2023 and 2022 consisted
of the following:</span></p>

<p id="xdx_894_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zxJveoNkqJJ3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B1_zmeSKHeg1jZ8" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE
OF DERIVATIVE AND WARRANTS GRANTED VALUATION USING BLACK-SCHOLES PRICING METHOD</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Period Ended</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">July 31, 2023</p></td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Period Ended</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">July 31, 2022</p></td><td style="font-weight: bold">&#160;</td>
    </tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected life in years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecustom--DerivativeLiabilitiesMeasurementInputTerm_dtY_c20230501__20230731__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zOM7Nc73Uq2c" title="Derivative liabilities Measurement input, term">0.7</span>-<span id="xdx_906_ecustom--DerivativeLiabilitiesMeasurementInputTerm_dtY_c20230501__20230731__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zRXshLS2zzR2" title="Derivative liabilities Measurement input, term">10</span> years</span></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_ecustom--DerivativeLiabilitiesMeasurementInputTerm_dtY_c20220501__20220731__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_z0nVauo9IEb6" title="Derivative liabilities measurement input">4</span>-<span id="xdx_90D_ecustom--DerivativeLiabilitiesMeasurementInputTerm_dtY_c20220501__20220731__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zqEOo8AIaq2c" title="Derivative liabilities measurement input">4.3</span> years</span></td><td style="text-align: left">&#160;</td>
    </tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 64%">Stock price volatility</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><span id="xdx_904_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230731__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zeMg7ysdKVnf" title="Derivative liability measurement input">150</span></td><td style="width: 1%; text-align: left">%</td>
    <td style="width: 2%; text-align: left">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220731__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__srt--RangeAxis__srt--MinimumMember_zUAxzfGuc3k8" title="Derivative liability measurement input">50</span>-<span id="xdx_903_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220731__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__srt--RangeAxis__srt--MaximumMember_z9VBkbRCPujc" title="Derivative liability measurement input">148</span></span></td><td style="width: 1%; text-align: left">%</td>
    </tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Risk free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230731__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zYWf0ns4haFi" title="Derivative liability measurement input">4.08</span>%-<span id="xdx_90F_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230731__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zJhudoQoifl" title="Derivative liability measurement input">5.37</span></span></td><td style="text-align: left">%</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220731__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_za4ttfqB5Tdj" title="Derivative liability measurement input">2.90</span>%-<span id="xdx_90A_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220731__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zGntoDYd2FDl" title="Derivative liability measurement input">3.27</span></span></td><td style="text-align: left">%</td>
    </tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Expected dividends</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_902_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230731__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zD8ftCahm3Xa" title="Derivative liability measurement input">0</span></td><td style="text-align: left">%</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220731__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_z2f9hunjDTE8" title="Derivative liability measurement input">0</span></td><td style="text-align: left">%</td>
    </tr>
  </table>

<p id="xdx_8AC_zQYg66YFzXs6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_844_eus-gaap--IncomeTaxPolicyTextBlock_zppSzQX0t9Vg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_863_zaywpz6ou28f">Income
Taxes</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
taxes are accounted for in accordance with the provisions of ASC 740, Accounting for Income Taxes. Deferred tax assets and liabilities
are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing
assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected
to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred
tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Valuation
allowances are established, when necessary, to reduce deferred tax assets to the amounts that are more likely than not to be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84E_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zesjwOfLxi9d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86A_zD5DR2xEc4E2">Intangible
Assets</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets relate to the &#8220;Slinger&#8221; technology trademark, which the Company purchased on November 10, 2020. The Company also acquired
intangible assets as a part of the Gameface acquisition. These intangible assets include tradenames, internally developed software, and
customer relationships. The acquired intangible assets are amortized based on the estimated present value of cash flows of each class
of intangible assets in order to determine their economic useful life. During the three months ended July 31, 2023, the Company impaired
their intangible assets down to a nominal value of $<span id="xdx_900_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20230731_zzrz3YtscFX9" title="Impaired intangible assets">1,000</span> as the technology has changed and Management determined the value to be greater
than the fair value of those assets. Refer to Note 5 for more information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_847_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zxm3S6rGta88" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_866_z6N84RRVYQK1">Impairment
of Long-Lived Assets</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with ASC 360-10, the Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate
that their net book value may not be recoverable. Factors which could trigger impairment review include significant underperformance
relative to historical or projected future operating results, significant changes in the manner of use of the assets or the strategy
for the overall business, a significant decrease in the market value of the assets or significant negative industry or economic trends.
When such factors and circumstances exist, the Company compares the projected undiscounted future cash flows associated with the related
asset or group of assets over their estimated useful lives against their respective carrying amount. If those net undiscounted cash flows
do not exceed the carrying amount, impairment, if any, is based on the excess of the carrying amount over the fair value based on the
market value or discounted expected cash flows of those assets and is recorded in the period in which the determination is made. The
Company impaired $<span id="xdx_905_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_c20230501__20230731_zfr6CP7eOfEf" title="Impairment of intangible assets">100,281</span> in intangible assets and $<span id="xdx_901_eus-gaap--AssetImpairmentCharges_c20230501__20230731_z5FvrWnHNQ4i" title="Impairment of fixed assets">14,791</span> in fixed assets during the three months ended July 31, 2023. Refer to Note
5 for more information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_843_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_zeF6mMKwyE08" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_863_zUOK4TBL5uS5">Goodwill</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for goodwill in accordance with ASC 350, Intangibles &#8211; Goodwill and Other (&#8220;ASC 350&#8221;). ASC 350 requires
that goodwill not be amortized, but reviewed for impairment if impairment indicators arise and, at a minimum, annually. The Company records
goodwill as the excess purchase price over assets acquired and includes any work force acquired as goodwill. Goodwill is evaluated for
impairment on an annual basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
the adoption of the ASU 2017-04, which eliminates the second step of the goodwill impairment test, the Company tests impairment of goodwill
in one step. In this step, the Company compares the fair value of each reporting unit with goodwill to its carrying value. The Company
determines the fair value of its reporting units with goodwill using a combination of a discounted cash flow and a market value approach.
If the carrying value of the net assets assigned to the reporting unit exceeds the fair value of the reporting unit, the Company will
record an impairment charge based on the excess of a reporting unit&#8217;s carrying amount over its fair value. If the fair value of
the reporting unit exceeds the carrying value of the net assets assigned to that reporting unit, goodwill is not impaired and the Company
will not record an impairment charge.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company impaired all goodwill as of April 30, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_843_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zrn4WeDCwaa8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86A_zXggy9lV9VBf">Share-Based
Payment</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for share-based compensation in accordance with ASC 718, Compensation-Stock Compensation (ASC 718). Under the fair value
recognition provisions of this topic, stock-based compensation cost is measured at the grant date based on the fair value of the award
and is recognized as an expense on a straight-line basis over the requisite service period, which is the vesting period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_846_ecustom--WarrantsPolicyTextBlock_zQgLZsdCZl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_861_zAmNMHbm5Z9f">Warrants</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company grants warrants to key employees and executives as compensation on a discretionary basis. The Company also grants warrants in
connection with certain note payable agreements and other key arrangements. The Company is required to estimate the fair value of share-based
awards on the measurement date and recognize as expense that value of the portion of the award that is ultimately expected to vest over
the requisite service period. Warrants granted in connection with ongoing arrangements are more fully described in Note 11.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
warrants granted during the periods ended July 31, 2023 and 2022 were valued using a Black-Scholes option pricing model on the date of
grant using the following assumptions:</span></p>

<p id="xdx_89A_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_hus-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_zwUBj2Ktlrbc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B7_zevv4dX2q55a" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE
OF WARRANTS GRANTED VALUATION USING BLACK-SCHOLES PRICING METHOD</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Period Ended</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">July 31, 2023</p></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Period Ended</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">July 31, 2022</p></td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected life in years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;&#160;<span id="xdx_90A_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dxL_c20230731__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_z3Rj0J3GgEx8" title="Warrants measurement input, term::XDX::P0Y"><span style="-sec-ix-hidden: xdx2ixbrl0857">-</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220731__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MinimumMember_z6lktadzpOMc" title="Warrants measurement input, term">5</span> &#8211; <span id="xdx_90F_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220731__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MaximumMember_zv1e5yHUtgVg" title="Warrants measurement input, term">10</span> years</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Stock price volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230731__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_zrSfyLGPFr61" title="Warrants measurement input, rate"><span style="-sec-ix-hidden: xdx2ixbrl0863">-</span></span></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220731__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_z5u1bPOjwnR7" title="Warrants measurement input, rate">50</span>% - <span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220731__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_z96TgwhrYCQl" title="Warrants measurement input, rate">148</span></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Risk free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230731__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zRAoz5ytefj6" title="Warrants measurement input, rate"><span style="-sec-ix-hidden: xdx2ixbrl0869">-</span></span></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220731__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember_zNyzrC9VnPcf" title="Warrants measurement input, rate">2.50</span>% - <span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220731__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember_zJu0UEQstGkg" title="Warrants measurement input, rate">3.50</span></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 64%; text-align: left">Expected dividends</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230731__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zIeSl2LJtWth" title="Warrants measurement input, rate"><span style="-sec-ix-hidden: xdx2ixbrl0875">-</span></span></span></td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><span id="xdx_909_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220731__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zrjwzYtj2Wk1" title="Warrants measurement input, rate">0</span></td><td style="width: 1%; text-align: left">%</td></tr>
  </table>

<p id="xdx_8AA_z1yeXYmEtQW8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_842_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zdQ42ttIlWX2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Foreign
Currency Translation</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
functional currency is the U.S. dollar. The functional currency of our foreign operations, generally, is the respective local currency
for each foreign subsidiary. Assets and liabilities of foreign operations denominated in local currencies are translated at the spot
rate in effect at the applicable reporting date. Our consolidated statements of comprehensive loss are translated at the weighted average
rate of exchange during the applicable period. The resulting unrealized cumulative translation adjustment is recorded as a component
of accumulated other comprehensive loss in shareholders&#8217; equity. Realized and unrealized transaction gains and losses generated
by transactions denominated in a currency different from the functional currency of the applicable entity are recorded in other income
(loss) in the period in which they occur.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84F_eus-gaap--EarningsPerSharePolicyTextBlock_za4e88dFSBw" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_867_z8WUWUMhtAEk">Earnings
Per Share</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
earnings per share are calculated by dividing the income available to shareholders by the weighted-average number of common shares
outstanding during each period. Diluted earnings per share are computed using the weighted average number of common and dilutive common
share equivalents outstanding during the period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
common stock equivalents such as shares to be issued for the conversion of notes payable and warrants were excluded from the calculation
of diluted earnings per share as the effect is antidilutive. As a result, the basic and diluted earnings per share are the same for each
of the periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_842_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zJ7cZEIBYy9i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_868_z6X96o6xT916">Recent
Accounting Pronouncements</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Recently
Adopted</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2017, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU No. 2017-04, Intangibles &#8211; Goodwill and
Other (Topic 350): Simplifying the Test for Goodwill Impairment (&#8220;ASU 2017-04&#8221;), which simplifies how an entity is required
to test goodwill for impairment by eliminating Step 2 from the goodwill impairment test. Under ASU 2017-04, goodwill impairment will
be tested by comparing the fair value of a reporting unit with its carrying amount, and recognizing an impairment charge for the amount
by which the carrying amount exceeds the reporting unit&#8217;s fair value. The new guidance must be applied on a prospective basis and
is effective for periods beginning after December 15, 2022, with early adoption permitted. The Company adopted ASU 2017-04 effective
May 1, 2021. The adoption of the new standard did not have a material effect on the Company&#8217;s consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2019, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;), 2019-12, <i>Simplifying the Accounting for Income Taxes</i>,
which amends ASC 740, <i>Income Taxes</i> (ASC 740). This update is intended to simplify accounting for income taxes by removing certain
exceptions to the general principles in ASC 740 and amending existing guidance to improve consistent application of ASC 740. This update
is effective for fiscal years beginning after December 15, 2021. The guidance in this update has various elements, some of which are
applied on a prospective basis and others on a retrospective basis with earlier application permitted. The adoption of the new standard
did not have a material effect on the Company&#8217;s consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2020, the FASB issued ASU No. 2020-06, Debt &#8211; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives
and Hedging Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s
Own Equity. ASU 2020-06 will simplify the accounting for convertible instruments by reducing the number of accounting models for convertible
debt instruments and convertible preferred stock. Limiting the accounting models results in fewer embedded conversion features being
separately recognized from the host contract as compared with current GAAP. Convertible instruments that continue to be subject to separation
models are (1) those with embedded conversion features that are not clearly and closely related to the host contract, that meet the definition
of a derivative, and that do not qualify for a scope exception from derivative accounting and (2) convertible debt instruments issued
with substantial premiums for which the premiums are recorded as paid-in capital. ASU 2020-06 also amends the guidance for the derivatives
scope exception for contracts in an entity&#8217;s own equity to reduce form-over-substance-based accounting conclusions. ASU 2020-06
will be effective for public companies for fiscal years beginning after December 15, 2023, including interim periods within those fiscal
years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within
those fiscal years. The Company is currently evaluating the impact that the adoption of ASU 2020-06 will have on the Company&#8217;s
consolidated financial statement presentation or disclosures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2016, the FASB issued ASU 2016-13, Financial Instruments &#8211; Credit Losses (Topic 326): Measurement of Credit Losses on Financial
Instruments (&#8220;ASC 326&#8221;). The guidance replaces the incurred loss methodology with an expected loss methodology that is referred
to as the current expected credit loss (&#8220;CECL&#8221;) methodology. The measurement of expected credit losses under the CECL methodology
is applicable to financial assets measured at amortized cost, including loan receivables and held-to-maturity debt securities. It also
applies to off-balance sheet credit exposures not accounted for as insurance (loan commitments, standby letters of credits, financial
guarantees, and other similar instruments) and net investments in leases recognized by a lessor in accordance with Topic 842 on leases.
ASC 326 requires enhanced disclosures related to the significant estimates and judgments used in estimating credit losses as well as
the credit quality and underwriting standards of a company&#8217;s portfolio. In addition, ASC 326 made changes to the accounting for
available-for-sale debt securities. One such change is to require credit losses to be presented as an allowance rather than as a write-down
on available-for-sale debt securities the Company does not intend to sell or believes that it is more likely than not they will be required
to sell. The ASU can be adopted no later than January 1, 2020 for SEC filers and January 1, 2023 for private companies and smaller reporting
companies. The adoption of the new standard did not have a material effect on the Company&#8217;s consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2021, the FASB issued ASU 2021-08, &#8220;Business Combinations &#8211; Accounting for Contract Assets and Contract Liabilities
(Topic 805)&#8221;. The amendments in this Update address diversity and inconsistency related to the recognition and measurement of contract
assets and contract liabilities acquired in a business combination. The amendments in this Update require that an acquirer recognize
and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606, Revenue from Contracts
with Customers. ASU 2021-08 is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal
years. The adoption of the new standard did not have a material effect on the Company&#8217;s consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
FASB has issued ASU 2021-04, Earnings Per Share (Topic 260), Debt&#8212;Modifications and Extinguishments (Subtopic 470-50), Compensation&#8212;Stock
Compensation (Topic 718), and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40). ASU 2021-04 provides
guidance that an entity should treat a modification of the terms or conditions or an exchange of a freestanding equity-classified written
call option that remains equity classified after modification or exchange as an exchange of the original instrument for a new instrument.
The standard also provides guidance on how an entity should measure and recognize the effect of a modification or an exchange of a freestanding
equity-classified written call option that remains equity classified. The amendments in this ASU are effective for the Company for fiscal
years beginning after December 15, 2021. Early adoption is permitted for all entities, including adoption in an interim period. The adoption
of the new standard did not have a material effect on the Company&#8217;s consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
recently issued accounting pronouncements did not, or are not believed by management to, have a material effect on the Company&#8217;s
present or future consolidated financial statements.</span></p>

<p id="xdx_855_zTHea6aTALfi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_80D_eus-gaap--SignificantAccountingPoliciesTextBlock_zx7LYYX5i9v6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
3: <span id="xdx_823_zCwfPw8bDz02">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_845_eus-gaap--UseOfEstimates_zbweqBbIOfHj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_869_zZphjCY6iJMd">Use
of Estimates</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect
the amounts reported in the financial statements and accompanying notes. Accordingly, actual results could differ from those estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84A_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zmBTVTVg1Vzh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86D_z4iek6XCOzT7">Financial
Statement Reclassification</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
prior year amounts within accounts payable, accrued expenses, and certain operating expenses have been reclassified for consistency with
the current year presentation and had no effect on the Company&#8217;s balance sheet, net loss, shareholders&#8217; deficit or cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84F_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zBSpXuLMoEBl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_867_zQa3IPLkAvBk">Cash
and Cash Equivalents</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents.
The majority of payments due from banks for credit card transactions process within 24 to 48 hours and are accordingly classified as
cash and cash equivalents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_845_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zHA0nqyIm9Y3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86E_zuXjhSOa7Vce">Accounts
Receivable</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s accounts receivable are non-interest bearing trade receivables resulting from the sale of products and payable over terms
ranging from 15 to 60 days. The Company provides an allowance for doubtful accounts at the point when collection is considered doubtful.
Once all collection efforts have been exhausted, the Company charges-off the receivable with the allowance for doubtful accounts. The
Company recorded $<span id="xdx_909_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pdp0_do_c20230430_zVJAPCDSDaJ1" title="Allowance for doubtful accounts">209,690 </span>and $<span id="xdx_90F_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pdp0_do_c20220430_zQbRZFlenFp1" title="Allowance for doubtful accounts">175,000 </span>in allowance for doubtful accounts for the years ended April 30, 2023 and 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_844_eus-gaap--InventoryPolicyTextBlock_z4GZIc49tAJc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_860_zJHbInc5rlCg">Inventory</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory
is valued at the lower of the cost (determined principally on a first-in, first-out basis) or net realizable value. The Company&#8217;s
valuation of inventory includes inventory reserves for inventory that will be sold below cost and the impact of inventory shrink. Inventory
reserves are based on historical information and assumptions about future demand and inventory shrink trends. The Company&#8217;s inventory
as of April 30, 2023 and April 30, 2022 consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_896_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zrmeoIreLo6e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_zOGEgcyNOtTi" style="display: none">SCHEDULE OF INVENTORY</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_492_20230430_zCNs6Kvremrg" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">April 30, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20220430_zUbYmp0KTAV2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">April 30, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--InventoryFinishedGoods_iI_maINzzOV_zgpMKI5OqRDg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left">Finished Goods</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">1,509,985</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">4,073,791</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--InventoryRawMaterialsAndSupplies_iI_maINzzOV_zA8Ecmzavp07" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Component/Replacement Parts</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,712,553</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2,559,848</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--CapitalizedDutyAndFreight_iI_maINzzOV_zJz4ApKsSv12" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Capitalized Duty/Freight</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">517,228</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,328,198</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--InventoryAdjustments_iNI_di_msINzzOV_zMRWSmi26TMa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Inventory Reserve</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(550,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(100,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--InventoryNet_iTI_mtINzzOV_zaS27xIt7Avl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Total</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">3,189,766</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">7,861,837</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A4_zFzPuYXmiymi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_840_ecustom--PrepaidInventoryPolicyTextBlock_zd7vebe9uPi3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_867_zPvsYKuKBeq9">Prepaid
Inventory</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid
inventory represents inventory that is in-transit that has been paid for but not received from the Company&#8217;s third-party vendors.
The Company typically prepays for the purchase of materials and receives the products within three months after making payments. The
Company continuously monitors delivery from, and payments to, the vendors. If the Company has difficulty receiving products from a vendor,
the Company would cease purchasing products from such vendors in future periods. The Company has not had difficulty receiving products
during the reporting periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_840_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zinPRBGbmrKh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_865_zvMa9q1QY8T1">Property
and equipment</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment acquired through business combinations are stated at the estimated fair value at the date of the acquisition. Purchases
of property and equipment are stated at cost, net of accumulated depreciation and impairment losses. Expenditures that materially increase
the useful life of the assets are capitalized. Ordinary repairs and maintenance are expensed as incurred. Depreciation and amortization
are computed using the straight-line method over the estimated useful lives of the related assets, which is an average of <span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230430_zLmLxV15L8H2" title="Property plant and equipment, useful life">5</span> years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_844_eus-gaap--ConcentrationRiskCreditRisk_zd7FSsePjhgi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86D_z14jdvKg80tl">Concentration
of Credit Risk</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company maintains its cash in bank deposit accounts, the balances of which at times may exceed insured limits. The Company continually
monitors its banking relationships and consequently has not experienced any losses in such accounts. While we may be exposed to credit
risk, we consider the risk remote and do not expect that any such risk would result in a significant effect on our results of operations
or financial condition. See Note 4 for further details on the Company&#8217;s concentration of credit risk as well as other risks and
uncertainties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84C_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_z413dCELoeZj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_862_z1ghWZ0Zkwn3">Revenue
Recognition</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes revenue for their continuing operations in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 606,
the core principle of which is that an entity should recognize revenue to depict the transfer of promised goods or services to customers
in an amount that reflects the consideration to which the entity expects to be entitled to receive in exchange for those goods or services.
The Company recognizes revenue for its performance obligation associated with its contracts with customers at a point in time once products
are shipped. Amounts collected from customers in advance of shipping products ordered are reflected as contract liabilities on the accompanying
consolidated balance sheets. The Company&#8217;s standard terms are non-cancelable and do not provide for the right-of-return, other
than for defective merchandise covered under the Company&#8217;s standard warranty. The Company has not historically experienced any
significant returns or warranty issues.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes revenue under ASC 606, &#8220;Revenue from Contracts with Customers&#8221;. The core principle of this revenue standard
is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects
the consideration to which the company expects to be entitled in exchange for those goods or services. The following five steps are applied
to achieve that core principle:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step
1: Identify the contract with the customer</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company determines that it has a contract with a customer when each party&#8217;s rights regarding the products or services to be transferred
can be identified, the payment terms for the services can be identified, the Company has determined the customer has the ability and
intent to pay, and the contract has commercial substance. At contract inception, the Company evaluates whether two or more contracts
should be combined and accounted for as a single contract and whether the combined or single contract includes more than one performance
obligation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step
2: Identify the performance obligations in the contract</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s customers are buying an integrated system. In evaluating whether the equipment is a separate performance obligation,
the Company&#8217;s management considered the customer&#8217;s ability to benefit from the equipment on its own or together with other
readily available resources and if so, whether the service and equipment are separately identifiable (i.e., is the service highly dependent
on, or highly interrelated with the equipment). Because the Products and Services included in the customer&#8217;s contract are integrated
and highly interdependent, and because they must work together to deliver the Solution, the Company has concluded that Products installed
on customer&#8217;s premise and Services contracted for by the customer are generally not distinct within the context of the contract
and, therefore, constitute a single, combined performance obligation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step
3: Determine the transaction price</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
transaction price is the amount of consideration to which an entity expects to be entitled in exchange for transferring promised goods
or services to a customer. The consideration promised in a contract with a customer includes predetermined fixed amounts, variable amounts,
or both. The Company&#8217;s contracts do not include any rights of returns or refunds.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company collects each year&#8217;s service fees in advance and should therefore consider the existence of a significant financing component.
However, due to the fact that the payments are provided for the service of a one-year term, the Company elected to apply the practical
expedient under ASC 606 which exempts the adjustment of the consideration for the existence of a significant financing component when
the period between the transfer of the services and the payment for such services is one year or less.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step
4: Allocate the transaction price to the performance obligations in the contract</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contracts
that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on
each performance obligation&#8217;s relative standalone selling price (&#8220;SSP&#8221;). The Company has identified a single performance
obligation in the contract, and therefore, the allocation provisions under ASC 606 do not apply to the Company&#8217;s contracts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step
5: Recognize revenue when the Company satisfies a performance obligation</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues
for the Company&#8217;s single, combined performance obligation are recognized on a straight-line basis over the customer&#8217;s contract
term, which is the period in which the parties to the contract have enforceable rights and obligations (Typically 3-4 years).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84E_eus-gaap--BusinessCombinationsPolicy_z0ZRa7SHCO76" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86A_zbCzDWV4khLc">Business
Combinations</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
acquisition of a company, we determine if the transaction is a business combination, which is accounted for using the acquisition method
of accounting. Under the acquisition method, once control is obtained of a business, the assets acquired, and liabilities assumed, are
recorded at fair value. We use our best estimates and assumptions to assign fair value to the tangible and intangible assets acquired
and liabilities assumed at the acquisition date. One of the most significant estimates relates to the determination of the fair value
of these assets and liabilities. The determination of the fair values is based on estimates and judgments made by management. Our estimates
of fair value are based upon assumptions we believe to be reasonable, but which are inherently uncertain and unpredictable. Measurement
period adjustments are reflected at the time identified, up through the conclusion of the measurement period, which is the time at which
all information for determination of the values of assets acquired and liabilities assumed is received and is not to exceed one year
from the acquisition date. We may record adjustments to the fair value of these tangible and intangible assets acquired and liabilities
assumed, with the corresponding offset to goodwill. The Company elected to apply pushdown accounting to all entities acquired.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
uncertain tax positions and tax-related valuation allowances are initially recorded in connection with a business combination as of the
acquisition date. We continue to collect information and reevaluate these estimates and assumptions periodically and record any adjustments
to preliminary estimates to goodwill, provided we are within the measurement period. If outside of the measurement period, any subsequent
adjustments are recorded to the consolidated statement of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_842_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zsR4gXGRnvj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_867_zSfb8dCDzeK1">Fair
Value of Financial Instruments</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
value of financial and non-financial assets and liabilities is defined as an exit price, representing the amount that would be received
to sell an asset or paid to transfer a liability in an orderly transaction between market participants. The three-tier hierarchy for
inputs used in measuring fair value, which prioritizes the inputs used in the methodologies of measuring fair value for assets and liabilities,
is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
1 &#8212; Quoted prices in active markets for identical assets or liabilities</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
2 &#8212; Observable inputs other than quoted prices in active markets for identical assets and liabilities</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
3 &#8212; Unobservable pricing inputs in the market</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
assets and financial liabilities are classified in their entirety based on the lowest level of input that is significant to the fair
value measurements. Our assessment of the significance of a particular input to the fair value measurements requires judgment and may
affect the valuation of the assets and liabilities being measured and their categorization within the fair value hierarchy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s financial instruments consist of cash and cash equivalents, accounts receivable, and accounts payable. The carrying amount
of these financial instruments approximates fair value due to their short-term maturity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s contingent consideration in connection with the acquisition of Gameface was calculated using Level 3 inputs. The fair
value of contingent consideration as of April 30, 2023 and 2022 was $<span id="xdx_908_eus-gaap--BusinessCombinationConsiderationTransferred1_c20220501__20230430__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zWAvbj1aT4ua" title="Fair value of contingent consideration">418,455</span> and $<span id="xdx_905_eus-gaap--BusinessCombinationConsiderationTransferred1_c20210501__20220430__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zMgFaUDRB6Ii" title="Fair value of contingent consideration">1,334,000</span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company estimates the fair value of its intangible assets using Level 3 assumptions, primarily based on the income approach utilizing
the discounted cash flow method.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s derivative liabilities were calculated using Level 2 assumptions on the issuance and balance sheet dates via a Black-Scholes
option pricing model and consisted of the following ending balances and gain amounts as of and for the year ended April 30, 2023:</span></p>

<p id="xdx_895_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_zKdxFAaIrev6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BC_zth2ZPbd4ldg" style="display: none">SCHEDULE OF DERIVATIVE LIABILITIES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">April 30, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">(Gain) loss for the year</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Note derivative is related to</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">ending balance</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">ended April 30, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 58%; text-align: left">4/11/21 profit guaranty</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--ProfitGuarantyMember_zLoVdfg4BcMg" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Note derivative balance">1,456,854</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20220501__20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--ProfitGuarantyMember_ztU1z71Fcr69" style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right" title="Note derivative (gain) loss">395,304</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">8/6/21 convertible notes</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--ConvertibleNotesMember_za5ouNOASKYj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Note derivative balance">101,924</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20220501__20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--ConvertibleNotesMember_zbyjmW8ypLJi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Note derivative (gain) loss">(2,611,410</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">6/17/22 underwriter warrants</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--UnderwriterWarrantsMember_zk2QYBRehJBf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Underwriter warrants">6,531</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20220501__20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--UnderwriterWarrantsMember_z2kIb4szkMl9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Note derivative (gain) loss">(57,951</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Other derivative liabilities eliminated in uplist</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--OtherDerivativeLiabilitiesMember_zJoLszxw8Ko5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other derivative liabilities eliminated in uplist"><span style="-sec-ix-hidden: xdx2ixbrl2020">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20220501__20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--OtherDerivativeLiabilitiesMember_zZaELMDW4F8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Note derivative (gain) loss">(1,604,413</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">9/30/22 warrants issued with common stock</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsIssuedWithCommonStockMember_zSHGxJ6QgJva" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other derivative liabilities eliminated in uplist">6,109,559</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20220501__20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsIssuedWithCommonStockMember_zDUauxaNsYN3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Note derivative (gain) loss">(6,170,728</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">1/6/2023 warrants issued with note payable</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsIssuedWithNotesPayableMember_zDflVje0ufDd" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other derivative liabilities eliminated in uplist">2,814,738</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20220501__20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsIssuedWithNotesPayableMember_zWeXeUvmeepj" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Note derivative (gain) loss">(900,819</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Total</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230430_zQU5Cl2xeNz7" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Note derivative balance">10,489,606</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_980_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20220501__20230430_zRROsfnxGTP5" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Note derivative (gain) loss">(10,950,017</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

<p id="xdx_8A1_zXI5Tz8hx0v2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company also recognized derivative expense of $<span id="xdx_901_ecustom--RecognizedDerivativeExpense_c20220501__20230430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zeDeQ562lBAa" title="Recognized derivative expense">7,280,405</span> at inception on the warrants issued in connection with a funding on September
30, 2022 and $<span id="xdx_906_ecustom--RecognizedDerivativeExpense_c20230106__20230106__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zLga0pE9MI41" title="Recognized derivative expense">1,715,557</span> at inception on the warrants issued in connection with a funding on January 6, 2023. The Black-Scholes option
pricing model assumptions for the derivative liabilities during the years ended April 30, 2023 and 2022 consisted of the following:</span></p>

<p id="xdx_892_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_z4Bz6LcfV8Y7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B1_zSBUudjmpz4c" style="display: none">SCHEDULE
OF DERIVATIVE AND WARRANTS GRANTED VALUATION USING BLACK-SCHOLES PRICING METHOD</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Year Ended April 30, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Year Ended April 30, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Expected life in years</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--DerivativeLiabilitiesMeasurementInputTerm_dtY_c20220501__20230430__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zExvjDnpbI51" title="Derivative liabilities Measurement input, term">3.25</span>-<span id="xdx_902_ecustom--DerivativeLiabilitiesMeasurementInputTerm_dtY_c20220501__20230430__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zp2qcuPMSE22" title="Derivative liabilities Measurement input, term">10</span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecustom--DerivativeLiabilitiesMeasurementInputTerm_dtY_c20210501__20220430__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_z6yeJH9ymBcl" title="Derivative liabilities measurement input">1.95</span>-<span id="xdx_90E_ecustom--DerivativeLiabilitiesMeasurementInputTerm_dtY_c20210501__20220430__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zWD6oIs7ALNd" title="Derivative liabilities measurement input">4.3</span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 68%">Stock price volatility</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230430__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__srt--RangeAxis__srt--MinimumMember_zDuwBbVQde9c" title="Derivative liability measurement input">50</span> - <span id="xdx_90D_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230430__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__srt--RangeAxis__srt--MaximumMember_ziEpBdVqYX01" title="Derivative liability measurement input">150</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span id="xdx_90A_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220430__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zLjQhYmj1Zt6" title="Derivative liability measurement input">50</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Risk free interest rate</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230430__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zJAEIQfPKexl" title="Derivative liability measurement input">2.90%</span>-<span id="xdx_908_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230430__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zhWQyeeXjsV1" title="Derivative liability measurement input">4.34</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220430__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zMfFROROnH6l" title="Derivative liability measurement input">2.67%</span>-<span id="xdx_908_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220430__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zawH3Uq2Hv7e" title="Derivative liability measurement input">2.90</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Expected dividends</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230430__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_z7qeqaaslk7j" title="Derivative liability measurement input">0</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220430__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zakTy1zyVZ3h" title="Derivative liability measurement input">0</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A5_zgqcHLHfEXN5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Refer
to Note 10 and Note 11 for more information regarding the derivative instruments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_843_eus-gaap--IncomeTaxPolicyTextBlock_z5WkW3YJHNGa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_863_zwElE196j3Sc">Income
Taxes</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
taxes are accounted for in accordance with the provisions of ASC 740, Accounting for Income Taxes. Deferred tax assets and liabilities
are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing
assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected
to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred
tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Valuation
allowances are established, when necessary, to reduce deferred tax assets to the amounts that are more likely than not to be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84E_eus-gaap--IntangibleAssetsFiniteLivedPolicy_ztN5wHRUMbGb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_864_zxZ4eLNANbOd">Intangible
Assets</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets relate to the &#8220;Slinger&#8221; technology trademark, which the Company purchased on November 10, 2020. The Company also acquired
intangible assets as a part of the Gameface acquisition. These intangible assets include tradenames, internally developed software, and
customer relationships. The acquired intangible assets are amortized based on the estimated present value of cash flows of each class
of intangible assets in order to determine their economic useful life. All intangible assets acquired with the PlaySight transaction
are included in discontinued operations. Refer to Note 6 for more information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_842_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zaGl9aLjyzXj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86C_zcm7DRP8PEHj">Impairment
of Long-Lived Assets</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with ASC 360-10, the Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate
that their net book value may not be recoverable. Factors which could trigger impairment review include significant underperformance
relative to historical or projected future operating results, significant changes in the manner of use of the assets or the strategy
for the overall business, a significant decrease in the market value of the assets or significant negative industry or economic trends.
When such factors and circumstances exist, the Company compares the projected undiscounted future cash flows associated with the related
asset or group of assets over their estimated useful lives against their respective carrying amount. If those net undiscounted cash flows
do not exceed the carrying amount, impairment, if any, is based on the excess of the carrying amount over the fair value based on the
market value or discounted expected cash flows of those assets and is recorded in the period in which the determination is made. There
was impairment of long-lived assets identified during the year ended April 30, 2023 and 2022 in our continuing operations. Refer to Note
6 for more information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_848_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_zdtNV2nGJ5md" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_864_z8EmZ71508Hl">Goodwill</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for goodwill in accordance with ASC 350, Intangibles - Goodwill and Other (&#8220;ASC 350&#8221;). ASC 350 requires
that goodwill not be amortized, but reviewed for impairment if impairment indicators arise and, at a minimum, annually. The Company records
goodwill as the excess purchase price over assets acquired and includes any work force acquired as goodwill. Goodwill is evaluated for
impairment on an annual basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
the adoption of the ASU 2017-04, which eliminates the second step of the goodwill impairment test, the Company tests impairment of goodwill
in one step. In this step, the Company compares the fair value of each reporting unit with goodwill to its carrying value. The Company
determines the fair value of its reporting units with goodwill using a combination of a discounted cash flow and a market value approach.
If the carrying value of the net assets assigned to the reporting unit exceeds the fair value of the reporting unit, the Company will
record an impairment charge based on the excess of a reporting unit&#8217;s carrying amount over its fair value. If the fair value of
the reporting unit exceeds the carrying value of the net assets assigned to that reporting unit, goodwill is not impaired and the Company
will not record an impairment charge.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company impaired the remaining $<span id="xdx_905_eus-gaap--GoodwillImpairmentLoss_c20220501__20230430_zRpSVtbWOkhh" title="Goodwill impairment charges">6,781,193</span> of goodwill as of April 30, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84D_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zATxgYgULnF" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86F_zoExeEVYsUjb">Share-Based
Payment</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for share-based compensation in accordance with ASC 718, Compensation-Stock Compensation (ASC 718). Under the fair value
recognition provisions of this topic, stock-based compensation cost is measured at the grant date based on the fair value of the award
and is recognized as an expense on a straight-line basis over the requisite service period, which is the vesting period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_841_ecustom--WarrantsPolicyTextBlock_z8UZfjEmf8Bh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86F_z4dLffk0HYub">Warrants</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company grants warrants to key employees and executives as compensation on a discretionary basis. The Company also grants warrants in
connection with certain note payable agreements and other key arrangements. The Company is required to estimate the fair value of share-based
awards on the measurement date and recognize as expense that value of the portion of the award that is ultimately expected to vest over
the requisite service period. Warrants granted in connection with ongoing arrangements are more fully described in Note 11 and Note 14.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
warrants granted during the years ended April 30, 2023 and 2022 were valued using a Black-Scholes option pricing model on the date of
grant using the following assumptions:</span></p>

<p id="xdx_899_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_hus-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_zzz3XHpZ7AW7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B9_zSnX45WTkLQ7" style="display: none">SCHEDULE OF WARRANTS GRANTED VALUATION USING BLACK-SCHOLES PRICING
METHOD</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">Year Ended</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">April 30, 2023</p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">Year Ended</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">April 30, 2022</p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Expected life in years</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20230430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MinimumMember_z39j4GVFPZU2" title="Warrants measurement input, term">5</span> &#8211; <span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20230430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MaximumMember_zxLRWNDFvyMe" title="Warrants measurement input, term">10</span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MinimumMember_zQGYyHPQeRa2" title="Warrants measurement input, term">5</span> &#8211; <span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MaximumMember_zuhSHLVH1bph" title="Warrants measurement input, term">10</span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">Stock price volatility</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230430__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_zVgcGSscX8Rd" title="Warrants measurement input, rate">50</span>% - <span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230430__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_zTqr0kjgX1B3" title="Warrants measurement input, rate">150</span>%</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220430__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_zB8DinQqZMWj" title="Warrants measurement input, rate">50</span>% - <span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220430__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_zyePRTOpLbxf" title="Warrants measurement input, rate">148</span></span>%</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Risk free interest rate</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember_zFCjvCwWOVDe" title="Warrants measurement input, rate">2.50</span>% - <span id="xdx_909_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember_zVHayA4Yshze" title="Warrants measurement input, rate">4.68</span>%</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember_zcX2q7oqNHhb" title="Warrants measurement input, rate">0.77</span>% - <span id="xdx_90F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember_zriimxW75qde" title="Warrants measurement input, rate">1.63</span></span>%</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left">Expected dividends</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: center"><span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zpCT0ha2u6w" title="Warrants measurement input, rate">0</span>%</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: center"><span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zselrYextILl" title="Warrants measurement input, rate">0</span>%</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"></td></tr>
  </table>

<p id="xdx_8A0_zvMHtNt7z2Aj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84F_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zYoHJGrSLQRa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_860_zQ4xReBtLj69">Foreign
Currency Translation</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
functional currency is the U.S. dollar. The functional currency of our foreign operations, generally, is the respective local currency
for each foreign subsidiary. Assets and liabilities of foreign operations denominated in local currencies are translated at the spot
rate in effect at the applicable reporting date. Our consolidated statements of comprehensive loss are translated at the weighted average
rate of exchange during the applicable period. The resulting unrealized cumulative translation adjustment is recorded as a component
of accumulated other comprehensive loss in shareholders&#8217; equity. Realized and unrealized transaction gains and losses generated
by transactions denominated in a currency different from the functional currency of the applicable entity are recorded in other income
(loss) in the period in which they occur.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84C_eus-gaap--EarningsPerSharePolicyTextBlock_z6hMfSfComha" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_862_zeDZCwcJ1dj3">Earnings
Per Share</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
earnings per share are calculated by dividing the income available to shareholders by the weighted-average number of common shares
outstanding during each period. Diluted earnings per share are computed using the weighted average number of common and dilutive common
share equivalents outstanding during the period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
common stock equivalents such as shares to be issued for the conversion of notes payable and warrants were excluded from the calculation
of diluted earnings per share as the effect is antidilutive. As a result, the basic and diluted earnings per share are the same for each
of the periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_844_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zWCSSiuretbd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_862_z6AWpOXz8wfd">Recent
Accounting Pronouncements</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Recently
Adopted</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2017, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU No. 2017-04, Intangibles &#8211; Goodwill and
Other (Topic 350): Simplifying the Test for Goodwill Impairment (&#8220;ASU 2017-04&#8221;), which simplifies how an entity is required
to test goodwill for impairment by eliminating Step 2 from the goodwill impairment test. Under ASU 2017-04, goodwill impairment will
be tested by comparing the fair value of a reporting unit with its carrying amount, and recognizing an impairment charge for the amount
by which the carrying amount exceeds the reporting unit&#8217;s fair value. The new guidance must be applied on a prospective basis and
is effective for periods beginning after December 15, 2022, with early adoption permitted. The Company adopted ASU 2017-04 effective
May 1, 2021. The adoption of the new standard did not have a material effect on the Company&#8217;s consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2019, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;), 2019-12, <i>Simplifying the Accounting for Income Taxes</i>,
which amends ASC 740, <i>Income Taxes</i> (ASC 740). This update is intended to simplify accounting for income taxes by removing certain
exceptions to the general principles in ASC 740 and amending existing guidance to improve consistent application of ASC 740. This update
is effective for fiscal years beginning after December 15, 2021. The guidance in this update has various elements, some of which are
applied on a prospective basis and others on a retrospective basis with earlier application permitted. The adoption of the new standard
did not have a material effect on the Company&#8217;s consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2020, the FASB issued ASU No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging
Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own
Equity. ASU 2020-06 will simplify the accounting for convertible instruments by reducing the number of accounting models for convertible
debt instruments and convertible preferred stock. Limiting the accounting models results in fewer embedded conversion features being
separately recognized from the host contract as compared with current GAAP. Convertible instruments that continue to be subject to separation
models are (1) those with embedded conversion features that are not clearly and closely related to the host contract, that meet the definition
of a derivative, and that do not qualify for a scope exception from derivative accounting and (2) convertible debt instruments issued
with substantial premiums for which the premiums are recorded as paid-in capital. ASU 2020-06 also amends the guidance for the derivatives
scope exception for contracts in an entity&#8217;s own equity to reduce form-over-substance-based accounting conclusions. ASU 2020-06
will be effective for public companies for fiscal years beginning after December 15, 2023, including interim periods within those fiscal
years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within
those fiscal years. The Company is currently evaluating the impact that the adoption of ASU 2020-06 will have on the Company&#8217;s
consolidated financial statement presentation or disclosures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2016, the FASB issued ASU 2016-13, Financial Instruments &#8211; Credit Losses (Topic 326): Measurement of Credit Losses on Financial
Instruments (&#8220;ASC 326&#8221;). The guidance replaces the incurred loss methodology with an expected loss methodology that is referred
to as the current expected credit loss (&#8220;CECL&#8221;) methodology. The measurement of expected credit losses under the CECL methodology
is applicable to financial assets measured at amortized cost, including loan receivables and held-to-maturity debt securities. It also
applies to off-balance sheet credit exposures not accounted for as insurance (loan commitments, standby letters of credits, financial
guarantees, and other similar instruments) and net investments in leases recognized by a lessor in accordance with Topic 842 on leases.
ASC 326 requires enhanced disclosures related to the significant estimates and judgments used in estimating credit losses as well as
the credit quality and underwriting standards of a company&#8217;s portfolio. In addition, ASC 326 made changes to the accounting for
available-for-sale debt securities. One such change is to require credit losses to be presented as an allowance rather than as a write-down
on available-for-sale debt securities the Company does not intend to sell or believes that it is more likely than not they will be required
to sell. The ASU can be adopted no later than January 1, 2020 for SEC filers and January 1, 2023 for private companies and smaller reporting
companies. The Company has not yet adopted this ASU as it qualifies as a smaller reporting company. The Company does not expect this
ASU will have a material impact on its consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2021, the FASB issued ASU 2021-08, &#8220;Business Combinations - Accounting for Contract Assets and Contract Liabilities (Topic
805)&#8221;. The amendments in this Update address diversity and inconsistency related to the recognition and measurement of contract
assets and contract liabilities acquired in a business combination. The amendments in this Update require that an acquirer recognize
and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606, Revenue from Contracts
with Customers. ASU 2021-08 is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal
years. The Company does not expect the adoption of this ASU to have a material impact on the Company&#8217;s financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
FASB has issued ASU 2021-04, Earnings Per Share (Topic 260), Debt&#8212;Modifications and Extinguishments (Subtopic 470-50), Compensation&#8212;Stock
Compensation (Topic 718), and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40). ASU 2021-04 provides
guidance that an entity should treat a modification of the terms or conditions or an exchange of a freestanding equity-classified written
call option that remains equity classified after modification or exchange as an exchange of the original instrument for a new instrument.
The standard also provides guidance on how an entity should measure and recognize the effect of a modification or an exchange of a freestanding
equity-classified written call option that remains equity classified. The amendments in this ASU are effective for the Company for fiscal
years beginning after December 15, 2021. Early adoption is permitted for all entities, including adoption in an interim period. The adoption
of the new standard did not have a material effect on the Company&#8217;s consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
recently issued accounting pronouncements did not, or are not believed by management to, have a material effect on the Company&#8217;s
present or future consolidated financial statements.</span></p>

<p id="xdx_85A_zZcFC4aQkV58" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007866700480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONCENTRATION OF CREDIT RISK AND OTHER RISKS AND UNCERTAINTIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2023</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RisksAndUncertaintiesAbstract', window );"><strong>Risks and Uncertainties [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskDisclosureTextBlock', window );">CONCENTRATION OF CREDIT RISK AND OTHER RISKS AND UNCERTAINTIES</a></td>
<td class="text"><p id="xdx_80F_eus-gaap--ConcentrationRiskDisclosureTextBlock_zHm4faf0TNh6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
4</b>: <b><span id="xdx_827_zS0gHlITecGd">CONCENTRATION OF CREDIT RISK AND OTHER RISKS AND UNCERTAINTIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Accounts
Receivable Concentration</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of July 31, 2023 and April 30, 2023, the Company had two customers that accounted for <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230501__20230731__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CreditConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zWzcr1YPamI9">50</span>% and <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220501__20230430__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CreditConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_ziGcEZALq1J8">47</span>% of the Company&#8217;s trade receivables
balance, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Accounts
Payable Concentration</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of July 31, 2023 and April 30, 2023, the Company had four significant suppliers that accounted for <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230501__20230731__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--LenderConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerFourMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember_z0yGgWWhmXfg" title="Accounts payable concentration percentage">60</span>%, and <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220501__20230430__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--LenderConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerFourMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember_zlpWrIsMZOjl" title="Accounts payable concentration percentage">59</span>% of the Company&#8217;s
trade payables balances, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_80D_eus-gaap--ConcentrationRiskDisclosureTextBlock_zLeGex0IoJid" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
4</b>: <b><span id="xdx_823_zPTOk1EbAPB2">CONCENTRATION OF CREDIT RISK AND OTHER RISKS AND UNCERTAINTIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Accounts
Receivable Concentration</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of April 30, 2023 and 2022, the Company had two customers that accounted for <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220501__20230430__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CreditConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_z6rKEuRzHNU4" title="Concentration risk, percentage">47%</span>
and <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210501__20220430__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CreditConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zHcqTZpR9yM7" title="Concentration risk, percentage">43</span>%
of the Company&#8217;s trade receivables balance, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Accounts
Payable Concentration</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of April 30, 2023 and 2022, the Company had four significant suppliers that accounted for <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220501__20230430__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--LenderConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerFourMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember_zeclT50hbYDk" title="Concentration risk, percentage">59%</span>
and <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210501__20220430__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--LenderConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerFourMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember_zrje7zCfKgHj" title="Concentration risk, percentage">59</span>% of the Company&#8217;s trade payables balances, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 275<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//275/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RisksAndUncertaintiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RisksAndUncertaintiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007866500560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INTANGIBLE ASSETS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2023</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">INTANGIBLE ASSETS</a></td>
<td class="text"><p id="xdx_801_eus-gaap--IntangibleAssetsDisclosureTextBlock_zVU1pdktvOEh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
5: <span id="xdx_82B_zvFeVTNqg97j">INTANGIBLE ASSETS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_89E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_zdEzhIregm3k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets reflect only those intangible assets of our continuing operations, and consist of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BB_zvVdOUPUW9F9" style="display: none">SCHEDULE
OF INTANGIBLE ASSETS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(in years)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_485_eus-gaap--FiniteLivedIntangibleAssetsGross_iE_zAMiHKf66H3b" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_486_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iE_zn4EwGG06JF" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amortization</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_48B_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_zeA61Y01H2y4" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Loss</b></span></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_485_eus-gaap--FiniteLivedIntangibleAssetsNet_iE_z7YLFPhaw6S5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="14" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Average Period</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">July 31, 2023</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Amortization</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">(in years)</p></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Carrying</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Value</p></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Accumulated</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Amortization</p></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Impairment</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Loss</p></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Net Carrying</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Value</p></td><td style="font-weight: bold">&#160;</td></tr>
  <tr id="xdx_410_20230501__20230731__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TradeNamesAndPatentsMember_zaNuV3NGaLb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 34%; text-align: left">Tradenames and patents</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: center"><span id="xdx_901_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20230731__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TradeNamesAndPatentsMember_z15UgE7F6uN3" title="Weighted average amortization">15.26</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">385,582</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">24,031</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">360,551</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">1,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_418_20230501__20230731__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zmmmos5dRDHh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Customer relationships</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span id="xdx_90F_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20230731__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zqRBMbGreqdd" title="Weighted average amortization">9.92</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,930,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50,038</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,879,962</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0905">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_41C_20230501__20230731__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zsfso3WFD4Rf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Internally developed software</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span id="xdx_90E_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20230731__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zDZ7wlhv6lS3" title="Weighted average amortization">4.91</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">580,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">79,608</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">500,392</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0911">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_418_20230501__20230731__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangiableAssetMember_z8yKTM7fUQr2" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Total intangible assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,895,582</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">153,677</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,740,905</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,000</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(in years)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_486_eus-gaap--FiniteLivedIntangibleAssetsGross_iE_zrmAEid9knCg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_482_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iE_zCIJrg6DzlS4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amortization</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_481_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_zywsPGGp4Jp7" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Loss</b></span></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_480_eus-gaap--FiniteLivedIntangibleAssetsNet_iE_zbstifZDGLHa" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="14" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Average Period</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">April 30, 2023</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Amortization</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">(in years)</p></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Carrying</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Value</p></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Accumulated</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Amortization</p></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Impairment</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Loss</p></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Net Carrying</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Value</p></td><td style="font-weight: bold">&#160;</td></tr>
  <tr id="xdx_418_20220501__20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TradeNamesAndPatentsMember_zUXbS0TrERQi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 34%; text-align: left">Tradenames and patents</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 9%; text-align: center"><span id="xdx_908_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TradeNamesAndPatentsMember_zxdUY4D2xPT6" title="Weighted average amortization">15.26</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">385,582</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">24,031</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">260,270</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">101,281</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_41A_20220501__20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zMmZ6D87bZDl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Customer relationships</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_z4ku75IpaXC7" title="Weighted average amortization">9.92</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,930,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50,038</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,879,962</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0927">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_416_20220501__20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_za6FJOcFioy8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Internally developed software</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zrhiKnlnaysi" title="Weighted average amortization">4.91</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">580,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">79,608</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">500,392</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0933">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_411_20220501__20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangiableAssetMember_z1lHJnMQjOM3" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Total intangible assets</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,895,582</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">153,677</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,640,624</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">101,281</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AF_zYT6wIoYj7ze" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization
expense for the three months ended July 31, 2023 and 2022 was approximately $<span id="xdx_903_eus-gaap--AmortizationOfIntangibleAssets_c20230501__20230731_zjqve7B0YdP3" title="Amortization expense">0</span> and $<span id="xdx_903_eus-gaap--AmortizationOfIntangibleAssets_c20220501__20220731_zcIkcSC8Qh5k" title="Amortization expense">1,445</span>, respectively. The Company impaired $<span id="xdx_903_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_iN_di_c20230501__20230731__dei--LegalEntityAxis__custom--FoundationSportsSystemsLLCMember_zvekOeYPzmz" title="Impairment loss">100,281</span>
in the three months ended July 31, 2023. The remaining $<span id="xdx_902_eus-gaap--OtherIntangibleAssetsNet_iI_c20230731__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zHmwc2OGK7e3" title="Other intangible assets">1,000</span> is a nominal value related to the Company&#8217;s patents. This amount
is not expected to be amortized any further.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_80C_eus-gaap--IntangibleAssetsDisclosureTextBlock_z2hMHofx60R5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
6: <span id="xdx_822_zGpW20ub859g">INTANGIBLE ASSETS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_898_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_zdr9hxZMF1qc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets reflect only those intangible assets of our continuing operations, and consist of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BC_zLJRfJD0K8e9" style="display: none">SCHEDULE
OF INTANGIBLE ASSETS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Amortization (in years)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_484_eus-gaap--FiniteLivedIntangibleAssetsGross_iE_zrSxTrqNDeLh" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Carrying Value</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_486_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iE_z2DiURFhwMZg" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Accumulated Amortization</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_480_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_zGoK4o3VPHci" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Impairment Loss</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_489_eus-gaap--FiniteLivedIntangibleAssetsNet_iE_zOmVLXhWvedh" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Net Carrying Value</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="14" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center">Average Period</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">April 30, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Amortization (in years)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Carrying Value</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Accumulated Amortization</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Impairment Loss</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Net Carrying Value</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_414_20220501__20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zFDBZ3AM1HT6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: left">Tradenames and patents</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: center"><span id="xdx_90E_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zx6h3gqzWEL5" title="Weighted average amortization">15.26</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">385,582</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">24,031</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">260,270</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">101,281</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_417_20220501__20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zAsmufx8AcW1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Customer relationships</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zwD9Z1VsmnG3" title="Weighted average amortization">9.92</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3,930,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">50,038</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3,879,962</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2160">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_414_20220501__20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zikGWA91n2t9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Internally developed software</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_z7pg1tb3zqug" title="Weighted average amortization">4.91</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">580,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">79,608</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">500,392</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2166">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_417_20220501__20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangiableAssetMember_zXx2lvZtMOkf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Total intangible assets</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">4,895,582</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">153,677</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">4,640,624</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">101,281</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Amortization (in years)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_48B_eus-gaap--FiniteLivedIntangibleAssetsGross_iE_zUNr6toUcijk" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Carrying Value</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_486_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iE_zOV8G52KINe9" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Accumulated Amortization</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_485_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_zUmOVotCGov3" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Impairment Loss</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_487_eus-gaap--FiniteLivedIntangibleAssetsNet_iE_zGiQqowKXHbe" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Net Carrying Value</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="14" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center">Average Period</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">April 30, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Amortization (in years)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Carrying Value</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Accumulated Amortization</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Impairment Loss</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Net Carrying Value</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_419_20210501__20220430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zAgrvwPJvN0b" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%">Tradenames</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: center"><span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20220430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zbXyobP3JYwi" title="Weighted average amortization">15.26</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">385,582</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">9,478</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl2175">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">376,104</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_419_20210501__20220430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zDeHVQJJ5QD1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Customer relationships</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_901_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20220430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zP4mPbnhLrR4" title="Weighted average amortization">9.92</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3,930,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">33,749</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2181">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3,896,251</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_418_20210501__20220430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zrzQlmK69ly3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Internally developed software</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span id="xdx_90C_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20220430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zcIkXcNe90Of" title="Weighted average period amortization (in years)">4.91</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">580,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">9,499</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2187">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">570,501</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_417_20210501__20220430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangiableAssetMember_zxTxREyI4cf2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Total intangible assets</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">4,895,582</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">52,726</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2193">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">4,842,856</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A1_zKvgv438iZql" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization
expense for the years ended April 30, 2023 and 2022 was approximately $<span id="xdx_903_eus-gaap--AmortizationOfIntangibleAssets_c20220501__20230430_zNGo9DG5knV1" title="Amortization expense">100,951</span> and $<span id="xdx_908_eus-gaap--AmortizationOfIntangibleAssets_c20210501__20220430_zPjA4M57wJEl" title="Amortization expense">49,983</span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89A_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zH05izqLdxi5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of April 30, 2023, the estimated future amortization expense associated with the Company&#8217;s intangible assets for each of the five
succeeding fiscal years is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B6_zB85NosWLREd" style="display: none">SCHEDULE
OF ESTIMATED FUTURE AMORTIZATION</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">For the Periods Ended April 30,</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20230430_zSqYeLWsNuG" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Amortization Expense</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_maFLIANz0wb_zvOaBo4f6dU9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 83%; text-align: left">2024</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">5,780</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_maFLIANz0wb_ze3pjAkRb9Gd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">2025</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">5,780</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_maFLIANz0wb_z3V7ftmG7Me9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">2026</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">5,780</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_maFLIANz0wb_zXxqRIFFMZb9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">2027</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">5,780</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_maFLIANz0wb_zQReO9dlgiN1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">2028</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">5,780</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_maFLIANz0wb_z7NR33BokaSh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thereafter</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">72,381</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_mtFLIANz0wb_z9mqaNM9uZv6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">101,281</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A6_zp6xsGpTZQ53" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//350-30/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007864725616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCRUED EXPENSES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2023</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">ACCRUED EXPENSES</a></td>
<td class="text"><p id="xdx_80E_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zWm9muZZGcYh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
6</b>: <b><span id="xdx_827_zribUoJTNjt8">ACCRUED EXPENSES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89B_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_z16P7oj1WSEf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
composition of accrued expenses is summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_z0Lf5A9wMVac" style="display: none">SCHEDULE
OF ACCRUED EXPENSES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_490_20230731_zA4I6a2iRVk7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">July 31, 2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_493_20230430_zgHAdCwGXbea" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">April 30, 2023</td><td style="font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--AccruedPayrollTaxesCurrent_iI_maALCzIie_zgsakoVu0Rhl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Accrued payroll</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">1,754,936</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">1,535,186</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AccruedBonusesCurrent_iI_maALCzIie_zVAUtZkGQhRi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accrued bonus</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,829,604</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,720,606</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--AccruedProfessionalFeesCurrent_iI_maALCzIie_zOd59yZFR5qh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accrued professional fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">35,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">490,424</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AccountsPayableOtherCurrent_iI_maALCzIie_zlN7830IRz81" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Other accrued expenses</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,577,920</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,165,623</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AccruedLiabilitiesCurrent_iTI_mtALCzIie_zQqIU9SIRQHi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Total</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,197,460</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,911,839</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A9_z2b3GRh7pzRa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_808_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_z01754R0hRVb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
7</b>: <b><span id="xdx_82C_z9nDJ29Hm4q2">ACCRUED EXPENSES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89E_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_zI2oQEiZV7X6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
composition of accrued expenses is summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B8_zZslrlmApOp" style="display: none">SCHEDULE
OF ACCRUED EXPENSES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_492_20230430_zqbAUjkkGpMk" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">April 30, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20220430_zZfgJFMt77n8" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">April 30, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--AccruedPayrollTaxesCurrent_iI_maALCzIie_zJwwlQCiGI93" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left">Accrued payroll</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">1,535,186</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">921,759</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AccruedBonusesCurrent_iI_maALCzIie_znHv2XcDokc9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accrued bonus</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,720,606</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,014,833</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--AccruedProfessionalFeesCurrent_iI_maALCzIie_z5moAxsGpls1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accrued professional fees</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">490,424</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,706,560</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AccountsPayableOtherCurrent_iI_maALCzIie_zVSMdWQ8Rqb1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Other accrued expenses</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,165,623</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">738,749</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AccruedLiabilitiesCurrent_iTI_mtALCzIie_zF0V6kHDPthf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Total</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">4,911,839</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">4,381,901</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AE_z0anScNuiLtl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007866471840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE PAYABLE &#8211; RELATED PARTY<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2023</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">NOTE PAYABLE &#8211; RELATED PARTY</a></td>
<td class="text"><p id="xdx_806_eus-gaap--DebtDisclosureTextBlock_zQvQCyP8YwC" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
7: <span id="xdx_82C_zP6VnEk0igv6">NOTE PAYABLE &#8211; RELATED PARTY</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
discussion of note payable &#8211; related party only includes those that existed as of April 30, 2023. For a discussion of all prior
note payable &#8211; related party we refer you to the Annual Report on Form 10-K filed September 14, 2023 for the fiscal year end April
30, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 14, 2022, the Company entered into two loan agreements with related party lenders, each for $<span id="xdx_905_eus-gaap--LoansPayable_iI_c20220114__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zOuZbdwjQKyd" title="Loans payable">1,000,000</span>, pursuant to which the
Company received a total amount of $<span id="xdx_904_eus-gaap--ProceedsFromRelatedPartyDebt_c20220113__20220114__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zStnO0B0KIy" title="Proceeds from related party debt">2,000,000</span>. The loans bear interest at a rate of <span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20220114__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zIAMsQ4zg99e" title="Interest rate">8</span>% per annum and are required to be repaid in full
by April 30, 2022 or such other date as may be accepted by the lenders. The Company is not permitted to make any distribution or pay
any dividends unless or until the loans are repaid in full. On June 28, 2022, the Company entered into amendments for the two related
party loan agreements with the lenders in which the repayment date was extended to July 31, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
was $<span id="xdx_900_eus-gaap--NotesPayable_iI_c20230731__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zHiDvsuEX3E8" title="Outstanding borrowings">1,655,966</span> and $<span id="xdx_901_eus-gaap--NotesPayable_iI_c20230430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z8btvF5Q4S7f" title="Outstanding borrowings">1,953,842</span> in outstanding borrowings from related parties as of July 31, 2023 and April 30, 2023. Interest expense
related to the related parties for the three months ended July 31, 2023 and 2022 amounted to $<span id="xdx_90F_eus-gaap--InterestExpense_pp0p0_dxL_c20230501__20230731__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zo8hpH2syyhc" title="Interest expense::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl0980">0</span></span> and $<span id="xdx_90F_eus-gaap--InterestExpense_pp0p0_c20220501__20220731__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zpHx78pL61v1" title="Interest expense">61,121</span>, respectively. Accrued interest
due to related parties as of July 31, 2023 and April 30, 2023 amounted to $<span id="xdx_909_eus-gaap--InterestPayableCurrent_iI_c20230731__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zrnaeNlv0Wy5" title="Accrued interest">917,957</span> and $<span id="xdx_90B_eus-gaap--InterestPayableCurrent_iI_c20230430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zk3QkPxIbLP" title="Accrued interest">917,957</span>, respectively. The accrued interest includes
notes that were either repaid or converted but the interest remained.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 6, 2023, we sold certain of our inventory including all components, parts, additions and accessions thereto to Yonah Kalfa and
Naftali Kalfa who immediately consigned it back to us in exchange for a payment of $<span id="xdx_902_ecustom--PaymentForExchangeOfNotesPayable_c20230106__20230106__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zVDx7hTo7wFc" title="Payment of exchange">103</span> per ball launcher we sell until we have paid
them an aggregate total of $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_c20230106_z5yDxH0EXo4j" title="Debt instrumental">2,092,700</span>, which represents payment in full of the principal amounts of and accrued interest in respect of
the Loan Agreements (as defined above) and certain other expenses they incurred in connection with the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
<td class="text"><p id="xdx_808_eus-gaap--DebtDisclosureTextBlock_zE2tKhk8jNYg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
8: <span id="xdx_82D_zPX7pZTZMBLd">NOTE PAYABLE - RELATED PARTY</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
discussion of note payable &#8211; related party only includes those that existed as of April 30, 2022. For a discussion of all prior
note payable &#8211; related party we refer you to the Annual Report on Form 10-K filed May 17, 2023 for the fiscal year end April 30,
2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 14, 2022, the Company entered into two loan agreements with related party lenders, each for $<span id="xdx_905_eus-gaap--LoansPayable_iI_c20220114__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zknIW0cVSOA4" title="Loans payable">1,000,000</span>, pursuant to which the
Company received a total amount of $<span id="xdx_90E_eus-gaap--ProceedsFromRelatedPartyDebt_c20220113__20220114__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z1ZXDkC7dw0k" title="Proceeds from related party debt">2,000,000</span>. The loans bear interest at a rate of <span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20220114__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zXrfT5xWDzJk" title="Interest rate">8</span>% per annum and are required to be repaid in full
by April 30, 2022 or such other date as may be accepted by the lenders. The Company is not permitted to make any distribution or pay
any dividends unless or until the loans are repaid in full. On June 28, 2022, the Company entered into amendments for the two related
party loan agreements with the lenders in which the repayment date was extended to July 31, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
was $<span id="xdx_901_eus-gaap--NotesPayable_iI_c20230430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zUJQdH3WxUi6" title="Outstanding borrowings">1,953,842</span> and $<span id="xdx_90A_eus-gaap--NotesPayable_iI_c20220430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zRh3CbhqFaI1" title="Outstanding borrowings">2,000,000</span> in outstanding borrowings from related parties as of April 30, 2023 and 2022. Interest expense related
to the related parties for the years ended April 30, 2023 and 2022 amounted to $<span id="xdx_909_eus-gaap--InterestExpense_pp0p0_c20220501__20230430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zHcrAstEdSV5" title="Interest expense">293,090</span> &#160;and $<span id="xdx_906_eus-gaap--InterestExpense_pp0p0_c20210501__20220430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zeGFhLF6sECh" title="Interest expense">165,558</span>, respectively. Accrued interest
due to related parties as of April 30, 2023 and 2022 amounted to $<span id="xdx_90B_eus-gaap--InterestPayableCurrent_iI_c20230430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zHubxdAVsj6h" title="Accrued interest">917,957</span> and $<span id="xdx_909_eus-gaap--InterestPayableCurrent_iI_c20220430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zB7X8pl0mUFl" title="Accrued interest">908,756</span>, respectively. The accrued interest includes notes
that were either repaid or converted but the interest remained.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//470/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007869351008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONVERTIBLE NOTES PAYABLE<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2023</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTextBlock', window );">CONVERTIBLE NOTES PAYABLE</a></td>
<td class="text"><p id="xdx_80F_eus-gaap--ShortTermDebtTextBlock_zCrPA7zh49d3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
8: <span id="xdx_82D_zqG1bvJTPy9d">CONVERTIBLE NOTES PAYABLE</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
discussion of convertible notes payable only includes those that existed as of April 30, 2023. For a discussion of all prior convertible
notes payable we refer you to the Annual Report on Form 10-K filed September 14, 2023 for the fiscal year end April 30, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of April 30, 2023, all outstanding convertible notes payable had been fully converted into outstanding common shares. On June 17, 2022,
the Company issued <span id="xdx_90D_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20220617__20220617_z2oJMUksGX4k" title="Debt conversion">109,737</span> shares of common stock in conversion of the $<span id="xdx_907_eus-gaap--DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1_c20220617__20220617_z1zUGkrQexg7" title="Debt conversion shares issued">13,200,000</span> in convertible notes payable and $<span id="xdx_90D_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20220617_zeC5KRWRMXS1" title="Interest payable">846,301</span> in accrued
interest. In addition, the remaining $<span id="xdx_901_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20220731_z56BNFizMO4h" title="Unamortizated discount">122,222</span> of unamortized discount on the convertible notes payable was amortized and included in
our consolidated statements of operations for the three months ended July 31, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_805_eus-gaap--ShortTermDebtTextBlock_zZg2EFNe9WUe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
9: <span id="xdx_825_z9za7CMUsoc7">CONVERTIBLE NOTES PAYABLE</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
discussion of convertible notes payable only includes those that existed as of April 30, 2022. For a discussion of all prior convertible
notes payable we refer you to the Annual Report on Form 10-K filed May 17, 2023 for the fiscal year end April 30, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 6, 2021, the Company consummated the closing (the &#8220;Closing&#8221;) of a private placement offering (the &#8220;Offering&#8221;)
pursuant to the terms and conditions of that certain Securities Purchase Agreement, dated as of August 6, 2021 (the &#8220;Purchase Agreement&#8221;),
between the Company and certain accredited investors (the &#8220;Purchasers&#8221;). At the Closing, the Company sold to the Purchasers
(i) <span id="xdx_903_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20210806__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zBiTTA4ayfVb" title="Interest rate">8</span>% Senior Convertible Notes (the &#8220;Convertible Notes&#8221;) in an aggregate principal amount of $<span id="xdx_904_eus-gaap--ConvertibleNotesPayable_iI_c20210806__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zTbcFdEVILq8" title="Senior convertible notes">11,000,000</span> and (ii) warrants
to purchase up to <span id="xdx_909_ecustom--WarrantsIssuedToPurchaseOfCommonStockShares_iI_c20210806__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zttmeYU0NQJ" title="Warrants issued to purchase of common stock, shares">733,333</span> shares of common stock of the Company (the &#8220;Warrants&#8221; and together with the Convertible Notes,
the &#8220;Securities&#8221;). The Company received an aggregate of $<span id="xdx_902_eus-gaap--ProceedsFromConvertibleDebt_c20210805__20210806__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zbyM1DZwDJyl" title="Gross proceeds from issuance of senior convertible notes">11,000,000</span> in gross proceeds from the Offering, before deducting
offering expenses and commissions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Convertible Notes were to mature on <span id="xdx_90F_eus-gaap--DebtInstrumentMaturityDate_c20210805__20210806__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zuXH8J103QN9" title="Convertible notes maturity date">August 6, 2022</span> (the &#8220;Maturity Date&#8221;) and bear interest at <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20210806__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zALpwTS2F6L4" title="Debt interest rate">8</span>% per annum payable on each
conversion date (as to that principal amount then being converted), on each redemption date as well as mandatory redemption date (as
to that principal amount then being redeemed) and on the Maturity Date, in cash. The Convertible Notes are convertible into shares of
the Company&#8217;s common stock at any time following the date of issuance and prior to Mandatory Conversion (as defined in the Convertible
Notes) at the conversion price equal to the lesser of: (i) $<span id="xdx_904_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_uUSDPShares_c20210806__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zAurl4ys3mpl" title="Conversion price">3.00</span>, subject to adjustment set forth in the Convertible Notes and (ii) in
the case of an uplist to the NASDAQ, the Uplist Conversion Price (as defined in the Convertible Notes) of the Company&#8217;s common
stock during the two Trading Day (as defined in the Convertible Notes) period after each conversion date; provided, however, that at
any time from and after December 31, 2021 or an Event of Default (as defined in the Convertible Notes), the holder of the Convertible
Notes may, by delivery of written notice to the Company, elect to cause all, or any part, of the Convertible Notes to be converted, at
any time thereafter, each an &#8220;Alternate Conversion&#8221;, pursuant to the Section 4(f) of the Convertible Notes, all, or any part
of, the then outstanding aggregate principal amount of the Convertible Notes into shares of Common Stock at the Alternate Conversion
price. The Convertible Notes rank pari passu with all other notes now or thereafter issued under the terms set forth in the Convertible
Notes. The Convertible Notes contain certain price protection provisions providing for adjustment of the number of shares of common stock
issuable upon conversion of the Convertible Notes in case of certain future dilutive events or stock-splits and dividends.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrants are exercisable for <span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_c20210806__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zfDV65DqD9wh" title="Warrants and rights outstanding, term">five years</span> from <span id="xdx_905_eus-gaap--ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable_c20210805__20210806__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zw4y00KGtM74" title="Warrants rights date from which warrants exercisable">August 6, 2021</span>, at an exercise price equal to the lesser of $<span id="xdx_903_ecustom--WarrantsExercisePrice_iI_pid_uUSDPShares_c20210806__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zvVuwaxlDfCi" title="Warrants exercise price">3.00</span> or a 20% discount to the
public offering price that a share of the Company&#8217;s common stock or unit (if units are offered) is offered to the public resulting
in the commencement of trading of the Company&#8217;s common stock on the NASDAQ, New York Stock Exchange or NYSE American. The Warrants
contain certain price protection provisions providing for adjustment of the amount of securities issuable upon exercise of the Warrants
in case of certain future dilutive events or stock-splits and dividends.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluated the Warrants and the conversion options under the guidance in ASC 815 and determined they represent derivative liabilities
given the variability in the exercise and conversion prices upon the event of an up list to the NASDAQ. The Company also evaluated the
other embedded features in the agreement and determined the interest make-whole provision and the subsequent financing redemption represent
put features that are also accounted for as derivative liabilities. The derivative liabilities are marked to market at the end of each
reporting period with the non-cash gain or loss recorded in the period as a gain or loss on derivative (see Note 3).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrants were valued at $<span id="xdx_909_eus-gaap--WarrantsAndRightsOutstanding_iI_c20230430__us-gaap--ValuationTechniqueAxis__custom--MonteCarloSimulationMember_zCVDZn3Z7VXf" title="Warrants">12,026,668</span> on the date of issuance using a Monte Carlo simulation that accounted for the variability in the
exercise price upon the event of an up list based on the Company&#8217;s expected future stock prices over the <span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dxL_c20230430__us-gaap--ValuationTechniqueAxis__custom--MonteCarloSimulationMember_zvPWagmPeYb8" title="Warrants term::XDX::P5Y"><span style="-sec-ix-hidden: xdx2ixbrl2279">five</span></span>-year term using inputs
in line with those listed in Note 3. The remaining derivatives were valued at $<span id="xdx_908_ecustom--RemainingDerivativeLiabilities_iI_c20230430_zw2q7Jxutnh2" title="Derivative liabilities">1,862,450</span> on the issuance date based on the present value
of their weighted average probability value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
part of the issuance of the Convertible Notes, the Company incurred and capitalized debt issuance costs of $<span id="xdx_900_eus-gaap--DeferredFinanceCostsNet_iI_c20211031_zUkH6AyAiIR6" title="Debt issuance cost">800,251</span> related to brokerage
and legal fees that met the debt issuance cost capitalization criteria of ASC 835. The total discount related to the Convertible Notes
on the date of issuance of $<span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodValueConversionOfUnits_c20210801__20211031_zI7D8tKTnTmh" title="Stock issued during period value conversion of units">14,689,369</span> exceeded their value, which resulted in the Company recognizing a $<span id="xdx_909_ecustom--LossOnIssuanceOfConvertibleNotes_c20210801__20211031_zV9ejW3oug93" title="Loss on issuance of convertible notes">3,689,369</span> loss on the issuance
of the Convertible Notes during the three months ended October 31, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--SecuritiesOutstandingRateConvertibleNotesDescripition_c20211230__20211231_zmhLvShVygu3" title="Convertible note description">On
December 31, 2021, the Company entered into an Omnibus Amendment Agreement (the &#8220;Omnibus Agreement&#8221;) with certain Purchasers
who are collectively holders of 67% or more of the Securities outstanding related to the August 6, 2021 Convertible Notes, amending each
of (i) the Purchase Agreement and (ii) the Registration Rights Agreement. Simultaneously with the execution of the Omnibus Agreement,
the Company issued to each Purchaser a Replacement Note (as defined below) in replacement of the Convertible Note held prior to December
31, 2021 by such Purchaser (each, an &#8220;Existing Note&#8221;).</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Purchase Agreement was amended to, among other things, (i) delete Exhibit A and replace it in its entirety with the 8% Senior Convertible
Note (the &#8220;Replacement Note&#8221;) filed as Exhibit 10.2 to the Company&#8217;s current report on Form 8-K dated January 5, 2021,
(ii) add a new definition of &#8220;Inventory Financing&#8221;, (iii) amend Section 4.18 to add at the end of Section 4.18 before the
final period &#8220;, it being agreed that the provisions of this Section 4.18 shall not apply to the Qualified Subsequent Financing
expected to occur after the date hereof&#8221;, (iv) delete Section 4.20 and replace it in its entirety with substantially the same text,
including the following after the period, replacing the period with a semicolon: &#8220;; provided that the provisions of this Section
4.20 shall not apply to (i) in respect of any Holder to the extent that such Holder is an investor or a purchaser of the securities offered
pursuant such Subsequent Financing, and (ii) with respect to an Inventory Financing.&#8221;, and (v) add a new Section 4.21. Most-Favored
Nation provision.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Registration Rights Agreement was amended to, among other things, (i) delete the definition &#8220;Effectiveness Date&#8221; in Section
1 and replace it in its entirety with substantially the same text but revise the definition of &#8220;Effectiveness Date&#8221; causing
the Initial Registration Statement required to be filed by January 31, 2022, and (ii) delete Section 2(d) and replace it in its entirety
with substantially the same text but revised to delete the following &#8220;(2) no liquidated damages shall accrue or be payable hereunder
with respect to any day on which the high price of the Common Stock on the Trading Market on which the Common Stock is then listed or
traded is less than the then-applicable Conversion Price,&#8221; resulting in renumbering the text that follows as (2) instead of (3).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
consideration for entering into the Omnibus Agreement, the outstanding principal balance of the Existing Note held by each Purchaser
was increased by twenty percent (<span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20220430__us-gaap--TypeOfArrangementAxis__custom--OmnibusAgreementMember_zCJxZ8aLkdad" title="Debt interest rate">20</span>%) and such increased principal balance is reflected on the Replacement Note issued to each Purchaser.
The Company recognized a $<span id="xdx_900_ecustom--LossOnIssuanceOfConvertibleNotes_c20210501__20220430__us-gaap--TypeOfArrangementAxis__custom--OmnibusAgreementMember_zrdmHI8zpYc4" title="Loss on issuance of convertible notes">2,200,000</span> loss on issuance of convertible notes during the year ended April 30, 2022 related to this amendment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 17, 2022, the Company issued <span id="xdx_903_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pid_c20220616__20220617_zGJKBhq34c2">109,737 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
of common stock in conversion of the $<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_c20220617_zzirrAZ9RC19">13,200,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
convertible notes payable and $<span id="xdx_90B_eus-gaap--DebtInstrumentIncreaseAccruedInterest_c20220617__20220617_z8pbSFkQO4N3">846,301 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
accrued interest. In addition, the remaining $<span id="xdx_904_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20220617__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_zZCYFzYl8xHc">122,222 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
unamortized discount on the convertible notes payable was amortized and included in our consolidated statements of operations for
the three months ended July 31, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
outstanding borrowings related to the Convertible Notes as of April 30, 2023 and 2022 were $<span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_c20230430_zJLub0fi5g0i" title="Convertiable notes">0</span> and $<span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_c20220430_zuwuCuKqygQj" title="Convertiable notes">13,200,000</span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for short-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//470/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007864796576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTES PAYABLE<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2023</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">NOTES PAYABLE</a></td>
<td class="text"><p id="xdx_804_eus-gaap--LongTermDebtTextBlock_zTHbqlGRBac5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
9: <span id="xdx_823_zta9wt3wCcm8">NOTES PAYABLE</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
discussion of notes payable only includes those that existed as of April 30, 2023. For a discussion of all prior notes payable we refer
you to the Annual Report on Form 10-K filed September 14, 2023 for the fiscal year end April 30, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 11, 2021, the Company and the lender entered into an agreement whereby the lender converted the promissory note into <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210410__20210411__us-gaap--DebtInstrumentAxis__custom--PromissoryNotePayableMember_zqXwU2pav0Y8" title="Shares issued">681</span> shares
of Company stock, which were issued to the lender at a <span id="xdx_90F_eus-gaap--DebtConversionOriginalDebtInterestRateOfDebt_pid_dp_uPure_c20210410__20210411__us-gaap--DebtInstrumentAxis__custom--PromissoryNotePayableMember_zPgxUkLNBCee" title="Interest rate">20</span>% discount from the closing price of the stock on the day prior to the conversion.
In addition to the discount, the agreement contains a guarantee that the aggregate gross sales of the shares by the lender will be no
less than $<span id="xdx_904_eus-gaap--DebtInstrumentCarryingAmount_iI_c20210411__us-gaap--DebtInstrumentAxis__custom--PromissoryNotePayableMember_zN8QfdijfQGc" title="Payables">1,500,000</span> over the next three years and if the aggregate gross sales are less than $<span id="xdx_90D_eus-gaap--DebtInstrumentCarryingAmount_iI_c20210411__us-gaap--DebtInstrumentAxis__custom--PromissoryNotePayableMember_zH0mZoFFRUi" title="Payables">1,500,000</span> the Company will issue additional
shares of common stock to the lender for the difference between the total gross proceeds and $<span id="xdx_902_eus-gaap--DebtInstrumentCarryingAmount_iI_c20210411__us-gaap--DebtInstrumentAxis__custom--PromissoryNotePayableMember_zj3Clgvchjs9" title="Payables">1,500,000</span>, which could result in an infinite
number of shares being required to be issued.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluated the conversion option of the note payable to shares under the guidance in ASC 815-40, Derivatives and Hedging, and
determined the conversion option qualified for equity classification. The Company also evaluated the profit guarantee under ASC 815,
Derivatives and Hedging, and determined it to be a make-whole provision, which is an embedded derivative within the host instrument.
As the economic characteristics are dissimilar to the host instrument, the profit guarantee was bifurcated from the host instrument and
stated as a separate derivative liability, which is marked to market at the end of each reporting period with the non-cash gain or loss
recorded in the period as a gain or loss on derivative.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
the date of conversion, the Company recognized a $<span id="xdx_903_eus-gaap--GainsLossesOnExtinguishmentOfDebt_c20210410__20210411_zA0krLbTwjYa" title="Extinguishment of debt">1,501,914</span> loss on extinguishment of debt, which represented the difference between
the promissory note and the fair value of the shares issued of $<span id="xdx_902_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20210410__20210411_zeP0eupTgEqc" title="Debt conversion, amount">1,250,004</span>, which were recorded in shares issued in connection with conversion
of note payable within shareholders&#8217; equity, as well as the derivative liability of $<span id="xdx_906_eus-gaap--DerivativeLiabilities_iI_c20210411__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zvHEfMyShSb9" title="Derivative liability">1,251,910</span>, which was valued using a Black-Scholes
option pricing model.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the derivative liability was $<span id="xdx_90A_eus-gaap--DerivativeFairValueOfDerivativeNet_iI_c20230430__us-gaap--DebtInstrumentAxis__custom--PromissoryNotePayableMember_z6m9qlpUXks2" title="Fair value of derivative liability">1,456,854</span> and $<span id="xdx_901_eus-gaap--DerivativeFairValueOfDerivativeNet_iI_c20220430__us-gaap--DebtInstrumentAxis__custom--PromissoryNotePayableMember_z1zs54G7Hadg" title="Fair value of derivative liability">1,456,854</span> as of April 30, 2023 and 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 15, 2022, for and in consideration of $<span id="xdx_908_eus-gaap--BusinessCombinationConsiderationTransferredOther1_c20220214__20220215_zaULfRNOH1rg" title="Consideration">4,000,000</span> the Company conveyed, sold, transferred, set over, assigned and delivered to
Slinger Bag Consignment, LLC, a Virginia limited liability company (&#8220;Consignor&#8221;), all of the Company&#8217;s right, title
and interest in and to <span id="xdx_903_ecustom--NumberOfConsignedGoods_pid_uInteger_c20220214__20220215_z4pgX4UCYwWk" title="Consignment units">13,000</span> units of certain surplus inventory, including all components, parts, additions and accessions thereto (collectively,
the &#8220;Consigned Goods&#8221;). The Company has repaid the $<span id="xdx_903_ecustom--PaymentsOfRelatedPartyDebt_c20220501__20230430_zi7g2gY8Cxp8" title="Repayments of notes - related party">4,000,000</span> as of April 30, 2023 ($<span id="xdx_908_ecustom--PaymentsOfRelatedPartyDebt_c20210501__20220731_zv6Hf1DF2Omg" title="Repayments of notes - related party">1,559,109</span> as of July 31, 2022).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 1, 2022, the Company entered into a $<span id="xdx_90A_eus-gaap--NotesPayable_iI_c20220401__us-gaap--DebtInstrumentAxis__custom--NotesPayableMember_ziA7qzQb1Gz4" title="Note payable">500,000</span> note payable. The note was to mature on <span id="xdx_903_eus-gaap--DebtInstrumentMaturityDate_c20220401__20220401_zcAyOTLmHl2a" title="Debt maturity date">July 1, 2022</span> and bears interest at eight percent
(<span id="xdx_902_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20220401__us-gaap--DebtInstrumentAxis__custom--NotesPayableMember_zgkIjEQs4XKa" title="Interest rate">8</span>%) per year. The Company pays interest monthly and will pay all accrued and unpaid interest on the maturity date in which the outstanding
principal is due. On August 1, 2022, the Company repaid the $<span id="xdx_90B_ecustom--PaymentsOfRelatedPartyDebt_c20220801__20220801_zxkzaF0ou8T8" title="Repayments of notes - related party">500,000</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Cash
Advance Agreements</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 29, 2022, the Company entered into two merchant cash advance agreements. The details of the merchant cash advance agreements are
as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>UFS
Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company entered into an agreement (the &#8220;UFS Agreement&#8221;) with Unique Funding Solutions LLC (&#8220;UFS&#8221;) pursuant to
which the Company sold $<span id="xdx_90B_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20220729__20220729__us-gaap--TypeOfArrangementAxis__custom--UFSAgreementMember_zYzhCY1HgIak" title="Sale of consideration received">1,124,250</span> in future receivables (the &#8220;UFS Receivables Purchased Amount&#8221;) to UFS in exchange for payment
to the Company of $<span id="xdx_90D_eus-gaap--PaymentsToAcquireReceivables_c20220729__20220729__us-gaap--TypeOfArrangementAxis__custom--UFSAgreementMember_z8hPL08hXBWk" title="Payment for exchange received amount">750,000</span> in cash less fees of $<span id="xdx_903_ecustom--CashLessFees_c20220729__20220729__us-gaap--TypeOfArrangementAxis__custom--UFSAgreementMember_zEFetVEIdivg" title="Cash less fees">60,000</span>. The Company agreed to pay UFS $<span id="xdx_902_eus-gaap--PaymentsToAcquireReceivables_c20220729__20220729__us-gaap--TypeOfArrangementAxis__custom--UFSAgreementMember__srt--StatementScenarioAxis__custom--EachWeekForNextThreeWeeksMember_zFMezKZhuWqg" title="Payment for exchange received amount">13,491</span> each week for the first three weeks and
thereafter $<span id="xdx_90C_eus-gaap--PaymentsToAcquireReceivables_c20220729__20220729__us-gaap--TypeOfArrangementAxis__custom--UFSAgreementMember__srt--StatementScenarioAxis__custom--ThereafterPerWeekMember_zdClw0NkQkf8" title="Payment for exchange received amount">44,970</span> per week until the UFS Receivables Purchased Amount is paid in full.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to secure payment and performance of the Company&#8217;s obligations to UFS under the UFS Agreement, the Company granted to UFS
a security interest in the following collateral: all accounts receivable and all proceeds as such term is defined by Article 9 of the
UCC. The Company also agreed not to create, incur, assume, or permit to exist, directly or indirectly, any lien on or with respect to
any of such collateral.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cedar
Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company entered into an agreement (the &#8220;Cedar Agreement&#8221;) with Cedar Advance LLC (&#8220;Cedar&#8221;) pursuant to which
the Company sold $<span id="xdx_906_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20220729__20220729__us-gaap--TypeOfArrangementAxis__custom--CedarAgreementMember_zarWIa63UrLb" title="Sale of consideration received">1,124,250</span> in future receivables (the &#8220;Cedar Receivables Purchased Amount&#8221;) to Cedar in exchange for payment
to the Company of $<span id="xdx_900_eus-gaap--PaymentsToAcquireReceivables_c20220729__20220729__us-gaap--TypeOfArrangementAxis__custom--CedarAgreementMember_zZARwyKrSCg1" title="Payment for exchange received amount">750,000</span> in cash less fees of $<span id="xdx_902_ecustom--CashLessFees_c20220729__20220729__us-gaap--TypeOfArrangementAxis__custom--CedarAgreementMember_zHoK88Cw3Lwj" title="Cash less fees">60,000</span>. The Company agreed to pay Cedar $<span id="xdx_907_eus-gaap--PaymentsToAcquireReceivables_c20220729__20220729__us-gaap--TypeOfArrangementAxis__custom--CedarAgreementMember__srt--StatementScenarioAxis__custom--EachWeekForNextThreeWeeksMember_z1CQEw0pw4u4" title="Payment for exchange received amount">13,491</span> each week for the first three weeks
and thereafter $<span id="xdx_90E_eus-gaap--PaymentsToAcquireReceivables_c20220729__20220729__us-gaap--TypeOfArrangementAxis__custom--CedarAgreementMember__srt--StatementScenarioAxis__custom--ThereafterPerWeekMember_zoy8lLUdqCfc" title="Payment for exchange received amount">44,970</span> per week until the Cedar Receivables Purchased Amount is paid in full.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to secure payment and performance of the Company&#8217;s obligations to Cedar under the Cedar Agreement, the Company granted to
Cedar a security interest in the following collateral: all accounts, including without limitation, all deposit accounts, accounts receivable
and other receivables, chattel paper, documents, equipment, instruments and inventory as those terms are defined by Article 9 of the
UCC. The Company also agreed not to create, incur, assume, or permit to exist, directly or indirectly, any lien on or with respect to
any of such collateral.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 6, 2023, the Company entered into a loan and security agreement (the &#8220;Loan and Security Agreement&#8221;) with one or more
institutional investors (the &#8220;Lenders&#8221;) and Armistice Capital Master Fund Ltd. as agent for the Lenders (the &#8220;Agent&#8221;)
for the issuance and sale of (i) a note in an aggregate principal amount of up to $<span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_c20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember__srt--RangeAxis__srt--MaximumMember_zZRDGUDFGRR9" title="Aggregate principal amount">2,000,000</span> (the &#8220;Note&#8221;) with the initial
advance under the Loan and Security Agreement being $<span id="xdx_904_eus-gaap--ProceedsFromNotesPayable_c20230104__20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember__us-gaap--ShortTermDebtTypeAxis__custom--NotesMember_zf6uRhIQrfub" title="Borrowing from notes payable">1,400,000</span> and (ii) warrants (the &#8220;Warrants&#8221;) to purchase a number of
shares of common stock of the Company equal to 200% of the face amount of the Note divided by the closing price of the common stock of
the Company on the date of the issuance of the Notes (collectively, the &#8220;Initial Issuance&#8221;). The closing price of the Company&#8217;s
common stock on January 6, 2023, as reported by Nasdaq, was $<span id="xdx_90A_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember_zWA1WpfI1wR1" title="Shares issued price per share">8.84</span> per share, so the Warrants in respect of the initial advance under
the Note are exercisable for up to <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember__srt--RangeAxis__srt--MaximumMember_zxtYxxbFu9tl" title="Common stock exercisable, shares">452,489</span> shares of the Company&#8217;s common stock. The Warrants have an exercise price per share
equal to the closing price of the common stock of the Company on the date of the issuance of the Note, or $<span id="xdx_906_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember_zCdtAyhcOnB3" title="Shares issued price per share">8.84</span> per share and a term
of five- and one-half (5&#189;) years following the initial exercise date. The initial exercise date of the Warrants will be the date
stockholder approval is received and effective allowing exercisability of the Warrants under Nasdaq rules. Pursuant to the terms of the
Loan and Security Agreement, an additional advance of $<span id="xdx_903_eus-gaap--ProceedsFromNotesPayable_c20230104__20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember_zWGho3kkU7pj" title="Proceeds from notes payable">600,000</span> may be made to the Company under the Note. The Company&#8217;s obligations
under the terms of the Loan and Security Agreement are fully and unconditionally guaranteed by all of the Company&#8217;s subsidiaries
(the &#8220;Guarantors&#8221;). The Company measured the warrants granted on January 6, 2023 at $<span id="xdx_909_eus-gaap--AdjustmentOfWarrantsGrantedForServices_c20230106__20230106__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember_zVK9ReFSDJd5" title="Warrants granted">3,715,557</span>, and discounted the note payable
to $<span id="xdx_90B_eus-gaap--NotesPayable_iI_c20230106__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember_z2H7vrJjgBTd" title="Notes payable">0</span> and recorded a derivative expense of $<span id="xdx_907_ecustom--DerivativeExpense_c20230731__20230731__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember_z15ZE4xrE1r4" title="Derivative expense">1,715,557</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
derivative liability was valued at $<span id="xdx_90C_eus-gaap--DerivativeLiabilityFairValueOfCollateral_iI_c20230731__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember_zrnSzUdYfaj7" title="Fair value derivate liability">2,139,666</span> and $<span id="xdx_90C_eus-gaap--DerivativeLiabilityFairValueOfCollateral_iI_c20230430__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember_zLGpciGq1FP2" title="Fair value derivate liability">2,814,738</span> as of July 31, 2023 and April 30, 2023, respectively. The Company recognized
a gain on the change in fair value of the derivative liability when remeasured for the three months ended July 31, 2023 of $<span id="xdx_904_ecustom--IncreaseDecreaseInDerivativeFairValueLiability_c20230501__20230731_zYMfT4btlKLa" title="Derivative liability">675,072</span>.
In addition, the Company recognized $<span id="xdx_90B_eus-gaap--AmortizationOfDebtDiscountPremium_c20230501__20230731__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember_zzLDniOtYGIi" title="Amortization of debt discount">777,192</span> in amortization of debt discount for the three months ended July 31, 2023. On July 6, 2023,
the Company failed to repay the note and is currently in default. The interest rate has since increased to <span id="xdx_900_eus-gaap--DebtInstrumentInterestRateIncreaseDecrease_dp_c20230501__20230731_z5iwB9SBnLJb" title="Interest rate, increase">6.43</span>% per annum.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Meged
Agreement</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 8, 2023, the Company entered into a merchant cash advance agreement with Meged Funding Group (&#8220;Meged&#8221;) pursuant to which
the Company sold $<span id="xdx_903_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20230608__20230608__us-gaap--TypeOfArrangementAxis__custom--MegedAgreementMember_zcNcGV8iRhV6" title="Sale of stock">315,689</span> in future receivables to Meged (the &#8220;Meged Receivables Purchased Amount&#8221;) to in exchange for payment
to the Company of $<span id="xdx_908_eus-gaap--StockRedeemedOrCalledDuringPeriodValue_c20230608__20230608__us-gaap--TypeOfArrangementAxis__custom--MegedAgreementMember_zlvtKtDWDJX1" title="Stock redeemed value">210,600</span> in cash less fees of $<span id="xdx_904_eus-gaap--LegalFees_c20230608__20230608__us-gaap--TypeOfArrangementAxis__custom--MegedAgreementMember_zkJCMoIB6TYf" title="Legal fees">10,580</span>. The Company agreed to pay Meged $<span id="xdx_902_eus-gaap--RepaymentsOfOtherDebt_c20230608__20230608__us-gaap--TypeOfArrangementAxis__custom--MegedAgreementMember_zmzFEul5yRE9" title="Debt repayment">17,538</span> each week until the Meged Receivables
Purchased Amount is paid in full.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_80A_eus-gaap--LongTermDebtTextBlock_zBTxIeLApvnf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
10: <span id="xdx_829_zE2AOCxhpB7i">NOTES PAYABLE</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
discussion of notes payable only includes those that existed as of April 30, 2022. For a discussion of all prior notes payable we refer
you to the Annual Report on Form 10-K filed May 17, 2023 for the fiscal year end April 30, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 30, 2020, the Company entered into a loan agreement with Mont-Saic to borrow $<span id="xdx_905_eus-gaap--NotesPayable_iI_c20200630__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MontsaicInvestmentsLLCMember_zoteNowX5UJ9" title="Note payable">120,000</span>. This loan bears interest at an annual rate
of <span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20200630__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MontsaicInvestmentsLLCMember_zo9D2Si9ZPD9" title="Interest rate">12.6</span>% and was required to be repaid in full, together with all accrued, but unpaid, interest by June 30, 2021. On December 3, 2020,
Mont-Saic entered into an Assignment and Conveyance Agreement with the Company&#8217;s exiting related party lender wherein Mont-Saic
sold its full right, title and interest in this note to the Company&#8217;s related party lender (see Note 8).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 24, 2020, the Company entered into a promissory note with a third-party to borrow $<span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_c20201224__us-gaap--DebtInstrumentAxis__custom--PromissoryNotePayableMember__srt--TitleOfIndividualAxis__custom--ThirdPartyMember_zanRRvdMUk8d" title="Note payable">1,000,000</span>. The promissory note bore interest
at <span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20201224__us-gaap--DebtInstrumentAxis__custom--PromissoryNotePayableMember__srt--TitleOfIndividualAxis__custom--ThirdPartyMember_zmvIth3CiWf1" title="Interest rate">2.25</span>% and was due February 8, 2021. On February 2, 2021, the Company and the third-party entered into an amendment to extend the promissory
note to April 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 11, 2021, the Company and the lender entered into an agreement whereby the lender converted the promissory note into <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210410__20210411__us-gaap--DebtInstrumentAxis__custom--PromissoryNotePayableMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zEsgCNZLEoZf" title="Shares issued">27,233</span> shares
of Company stock, which were issued to the lender at a <span id="xdx_90F_eus-gaap--DebtConversionOriginalDebtInterestRateOfDebt_pid_dp_uPure_c20210410__20210411__us-gaap--DebtInstrumentAxis__custom--PromissoryNotePayableMember_zbF7x755FSCh" title="Interest rate">20</span>% discount from the closing price of the stock on the day prior to the conversion.
In addition to the discount, the agreement contains a guarantee that the aggregate gross sales of the shares by the lender will be no
less than $<span id="xdx_904_eus-gaap--DebtInstrumentCarryingAmount_iI_c20210411__us-gaap--DebtInstrumentAxis__custom--PromissoryNotePayableMember_zcx25JH5PYN8" title="Payables">1,500,000</span> over the next three years and if the aggregate gross sales are less than $<span id="xdx_90D_eus-gaap--DebtInstrumentCarryingAmount_iI_c20210411__us-gaap--DebtInstrumentAxis__custom--PromissoryNotePayableMember_zNW4l3Zl8nvg" title="Payables">1,500,000</span> the Company will issue additional
shares of common stock to the lender for the difference between the total gross proceeds and $<span id="xdx_902_eus-gaap--DebtInstrumentCarryingAmount_iI_c20210411__us-gaap--DebtInstrumentAxis__custom--PromissoryNotePayableMember_z6BtwefdLto8" title="Payables">1,500,000</span>, which could result in an infinite
number of shares being required to be issued.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluated the conversion option of the note payable to shares under the guidance in ASC 815-40, Derivatives and Hedging, and
determined the conversion option qualified for equity classification. The Company also evaluated the profit guarantee under ASC 815,
Derivatives and Hedging, and determined it to be a make-whole provision, which is an embedded derivative within the host instrument.
As the economic characteristics are dissimilar to the host instrument, the profit guarantee was bifurcated from the host instrument and
stated as a separate derivative liability, which is marked to market at the end of each reporting period with the non-cash gain or loss
recorded in the period as a gain or loss on derivative.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
the date of conversion, the Company recognized a $<span id="xdx_90A_eus-gaap--GainsLossesOnExtinguishmentOfDebt_c20210410__20210411_z8Lc6fqHODRb" title="Extinguishment of debt">1,501,914</span> loss on extinguishment of debt, which represented the difference between
the promissory note and the fair value of the shares issued of $<span id="xdx_907_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20210410__20210411_zUozt4HNRf86" title="Debt conversion, amount">1,250,004</span>, which were recorded in shares issued in connection with conversion
of note payable within shareholders&#8217; equity, as well as the derivative liability of $<span id="xdx_903_eus-gaap--DerivativeAssetsLiabilitiesAtFairValueNet_iNI_di_c20210411__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zczkEipKH3Ej" title="Derivative liability">1,251,910</span>, which was valued using a Black-Scholes
option pricing model.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the derivative liability was $<span id="xdx_908_eus-gaap--DerivativeFairValueOfDerivativeNet_iI_c20230430__us-gaap--DebtInstrumentAxis__custom--PromissoryNotePayableMember_zFc9FtAfuw0k" title="Fair value of derivative liability">1,456,854</span> and $<span id="xdx_90C_eus-gaap--DerivativeFairValueOfDerivativeNet_iI_c20220430__us-gaap--DebtInstrumentAxis__custom--PromissoryNotePayableMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zZbh8GzQEV92" title="Fair value of derivative liability">1,061,550</span> as of April 30, 2023 and 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 15, 2022, for and in consideration of $<span id="xdx_908_eus-gaap--BusinessCombinationConsiderationTransferredOther1_c20220214__20220215_zEeuLSMBbypf" title="Consideration">4,000,000</span> the Company conveyed, sold, transferred, set over, assigned and delivered to
Slinger Bag Consignment, LLC, a Virginia limited liability company (&#8220;Consignor&#8221;), all of the Company&#8217;s right, title
and interest in and to <span id="xdx_903_ecustom--NumberOfConsignedGoods_pid_uInteger_c20220214__20220215_zA8VM9RYlhA8" title="Consignment units">13,000</span> units of certain surplus inventory, including all components, parts, additions and accessions thereto (collectively,
the &#8220;Consigned Goods&#8221;). The Company has repaid the $<span id="xdx_90A_eus-gaap--RepaymentsOfDebt_c20230430__20230430_zLQH2mtVVX04" title="Repayment of debt">4,000,000</span> as of April 30, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 1, 2022, the Company entered into a $<span id="xdx_90E_eus-gaap--NotesPayable_iI_c20220401__us-gaap--DebtInstrumentAxis__custom--NotesPayableMember_z2NpV8Vsevbi" title="Note payable">500,000</span> note payable. The note was to mature on July 1, 2022 and bears interest at eight percent
(<span id="xdx_903_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20220401__us-gaap--DebtInstrumentAxis__custom--NotesPayableMember_zU4cLmz9kGU6" title="Interest rate">8</span>%) per year. The Company pays interest monthly and will pay all accrued and unpaid interest on the maturity date in which the outstanding
principal is due. On August 1, 2022, the Company repaid the $<span id="xdx_909_eus-gaap--RepaymentsOfDebt_c20220801__20220801_z7VEEvywDAd1" title="Repayment of debt">500,000</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Cash
Advance Agreements</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 29, 2022, the Company entered into two merchant cash advance agreements. The details of the merchant cash advance agreements are
as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>UFS
Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company entered into an agreement (the &#8220;UFS Agreement&#8221;) with Unique Funding Solutions LLC (&#8220;UFS&#8221;) pursuant to
which the Company sold $<span id="xdx_904_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20220729__20220729__us-gaap--TypeOfArrangementAxis__custom--UFSAgreementMember_zLVFM1X7PA78" title="Sale of consideration received">1,124,250</span> in future receivables (the &#8220;UFS Receivables Purchased Amount&#8221;) to UFS in exchange for payment
to the Company of $<span id="xdx_90D_eus-gaap--PaymentsToAcquireReceivables_c20220729__20220729__us-gaap--TypeOfArrangementAxis__custom--UFSAgreementMember_zT1QyV4J1BZb" title="Payment for exchange received amount">750,000 </span>in cash less fees of $<span id="xdx_903_ecustom--CashLessFees_c20220729__20220729__us-gaap--TypeOfArrangementAxis__custom--UFSAgreementMember_z7FqlReXkhRc" title="Cash less fees">60,000</span>. The Company has agreed to pay UFS $<span id="xdx_902_eus-gaap--PaymentsToAcquireReceivables_c20220729__20220729__us-gaap--TypeOfArrangementAxis__custom--UFSAgreementMember__srt--StatementScenarioAxis__custom--EachWeekForNextThreeWeeksMember_zGxFz9L8ZRQ3" title="Payment for exchange received amount">13,491</span> each week for the next three weeks
and thereafter $<span id="xdx_90C_eus-gaap--PaymentsToAcquireReceivables_c20220729__20220729__us-gaap--TypeOfArrangementAxis__custom--UFSAgreementMember__srt--StatementScenarioAxis__custom--ThereafterPerWeekMember_zed8zPDVpG8k" title="Payment for exchange received amount">44,970</span> per week until the UFS Receivables Purchased Amount is paid in full.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to secure payment and performance of the Company&#8217;s obligations to UFS under the UFS Agreement, the Company granted to UFS
a security interest in the following collateral: all accounts receivable and all proceeds as such term is defined by Article 9 of the
UCC. The Company also agreed not to create, incur, assume, or permit to exist, directly or indirectly, any lien on or with respect to
any of such collateral.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cedar
Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company entered into an agreement (the &#8220;Cedar Agreement&#8221;) with Cedar Advance LLC (&#8220;Cedar&#8221;) pursuant to which
the Company sold $<span id="xdx_906_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20220729__20220729__us-gaap--TypeOfArrangementAxis__custom--CedarAgreementMember_zQlFW56NWmH2" title="Sale of consideration received">1,124,250</span> in future receivables (the &#8220;Cedar Receivables Purchased Amount&#8221;) to Cedar in exchange for payment
to the Company of $<span id="xdx_900_eus-gaap--PaymentsToAcquireReceivables_c20220729__20220729__us-gaap--TypeOfArrangementAxis__custom--CedarAgreementMember_z8QFhAdToDba" title="Payment for exchange received amount">750,000</span> in cash less fees of $<span id="xdx_902_ecustom--CashLessFees_c20220729__20220729__us-gaap--TypeOfArrangementAxis__custom--CedarAgreementMember_zBojFB1XDxx7" title="Cash less fees">60,000</span>. The Company has agreed to pay Cedar $<span id="xdx_907_eus-gaap--PaymentsToAcquireReceivables_c20220729__20220729__us-gaap--TypeOfArrangementAxis__custom--CedarAgreementMember__srt--StatementScenarioAxis__custom--EachWeekForNextThreeWeeksMember_z9iGNFWnnEH2" title="Payment for exchange received amount">13,491</span> each week for the next three weeks
and thereafter $<span id="xdx_90E_eus-gaap--PaymentsToAcquireReceivables_c20220729__20220729__us-gaap--TypeOfArrangementAxis__custom--CedarAgreementMember__srt--StatementScenarioAxis__custom--ThereafterPerWeekMember_z2iL2d5r30dk" title="Payment for exchange received amount">44,970</span> per week until the Cedar Receivables Purchased Amount is paid in full.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to secure payment and performance of the Company&#8217;s obligations to Cedar under the Cedar Agreement, the Company granted to
Cedar a security interest in the following collateral: all accounts, including without limitation, all deposit accounts, accounts receivable
and other receivables, chattel paper, documents, equipment, instruments and inventory as those terms are defined by Article 9 of the
UCC. The Company also agreed not to create, incur, assume, or permit to exist, directly or indirectly, any lien on or with respect to
any of such collateral.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 6, 2023, the Company entered into a loan and security agreement (the &#8220;Loan and Security Agreement&#8221;) with one or more
institutional investors (the &#8220;Lenders&#8221;) and Armistice Capital Master Fund Ltd. as agent for the Lenders (the &#8220;Agent&#8221;)
for the issuance and sale of (i) a note in an aggregate principal amount of up to $<span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_c20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember__srt--RangeAxis__srt--MaximumMember_z6Ynvbr25hwj">2,000,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(the &#8220;Note&#8221;) with the initial advance
under the Loan and Security Agreement being $<span id="xdx_904_eus-gaap--ProceedsFromNotesPayable_c20230104__20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember__us-gaap--ShortTermDebtTypeAxis__custom--NotesMember_zZKkzHHFgqSa">1,400,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and (ii) warrants (the &#8220;Warrants&#8221;)
to purchase a number of shares of common stock of the Company equal to 200% of the face amount of the Note divided by the closing price
of the common stock of the Company on the date of the issuance of the Notes (collectively, the &#8220;Initial Issuance&#8221;). The closing
price of the Company&#8217;s common stock on January 6, 2023, as reported by Nasdaq, was $<span id="xdx_90E_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z34WMk8rSla5">0.221
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share (or <span id="xdx_90E_eus-gaap--StockholdersEquityNoteStockSplit_c20230106__20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zl3dmHBzyy0a">8.84
per share after adjusting for the one-for-forty (1-for-40) reverse stock split</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">),
so the Warrants in respect of the initial advance under the Note are exercisable for up to <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember__srt--RangeAxis__srt--MaximumMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z9hn0lal8S43">452,489
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the Company&#8217;s common stock. The
Warrants have an exercise price per share equal to the closing price of the common stock of the Company on the date of the issuance of
the Note, or $<span id="xdx_904_ecustom--SharesIssuedPricePerShares_iI_pid_c20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z9WpX9SA0ZEf">8.84
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share (which has subsequently been
reset to $3.55 per share) and a term of five- and one-half (5&#189;) years following the initial exercise date. The initial exercise
date of the Warrants will be the date stockholder approval is received and effective allowing exercisability of the Warrants under Nasdaq
rules. Pursuant to the terms of the Loan and Security Agreement, an additional advance of $<span id="xdx_903_eus-gaap--ProceedsFromNotesPayable_c20230104__20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember_zKFvDA9Bi5Ae">600,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">may be made to the Company under the Note. The
Company&#8217;s obligations under the terms of the Loan and Security Agreement are fully and unconditionally guaranteed by all of the
Company&#8217;s subsidiaries (the &#8220;Guarantors&#8221;). The Company measured the warrants granted on January 6, 2023 at $<span id="xdx_909_eus-gaap--AdjustmentOfWarrantsGrantedForServices_c20230106__20230106__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember_zlO5YFV5hht3">3,715,557</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
and discounted the note payable to $<span id="xdx_90B_eus-gaap--NotesPayable_iI_c20230106__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember_zWYPV1vDOvMe">0
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and recorded a derivative expense of $<span id="xdx_90E_ecustom--DerivativeExpense_c20230430__20230430__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember_zRDsIHRUejDb">1,715,557</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
The Company recognized a gain on the change in fair value of the derivative liability when remeasured through April 30, 2023 of $<span id="xdx_908_eus-gaap--DerivativeLiabilityFairValueOfCollateral_iI_c20230430__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zlQmSX59yxTb">900,819
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to bring the derivative liability to $<span id="xdx_901_eus-gaap--IncreaseDecreaseInDerivativeLiabilities_c20230430__20230430__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember_z6WmcFMEXmyl">2,814,738
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at April 30, 2023. In addition, the Company recognized
$<span id="xdx_900_eus-gaap--AmortizationOfDebtDiscountPremium_c20220501__20230430__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember_zQbAkVwTsTc8">1,222,808
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in amortization of debt discount for the year
ended April 30, 2023. On July 6, 2023, the Company failed to repay the note and is currently in default. The interest rate has since
increased to <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20230706__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zRJ4AKv90xZc">6.43</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
per annum.</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//470/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007864491328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2023</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">RELATED PARTY TRANSACTIONS</a></td>
<td class="text"><p id="xdx_808_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_ztX1anZXdfRb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
10: <span id="xdx_820_zXFBXyalPQY9">RELATED PARTY TRANSACTIONS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
support of the Company&#8217;s efforts and cash requirements, it may rely on advances from related parties until such time that the Company
can support its operations or attain adequate financing through sales of its equity or traditional debt financing. There is no formal
written commitment for continued support by officers, directors, or shareholders. Amounts represent advances, amounts paid in satisfaction
of liabilities, or accrued compensation that has been deferred. The advances are considered temporary in nature and have not been formalized
by a promissory note.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has outstanding notes payable of <span style="background-color: white">$<span id="xdx_909_eus-gaap--NotesPayable_iI_pp0p0_c20230731__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zMDSztotECJ2" title="Outstanding notes payable">1,655,966</span> and $<span id="xdx_90C_eus-gaap--NotesPayable_iI_pp0p0_c20230430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zfieMaFOM2O7" title="Outstanding notes payable">1,953,842</span></span> and accrued interest
of $<span id="xdx_90F_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20230731__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zyXBQqWdPbz6" title="Accrued interest - related party">917,957</span> and $<span id="xdx_906_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20230430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zgplJo3AVHTe" title="Accrued interest - related party">917,957</span> due to a related party as of July 31, 2023 and April 30, 2023, respectively (see Note 7).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognized net sales of $<span id="xdx_904_eus-gaap--Revenues_pp0p0_c20230501__20230731__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zCWCen2MXLa9" title="Revenue from related parties">50,900</span> and $<span id="xdx_90F_eus-gaap--Revenues_pp0p0_c20220501__20220731__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zk3PxjAjZKHb" title="Revenue from related parties">91,200</span> during the three months ended July 31, 2023 and 2022, respectively, to related parties.
As of July 31, 2023 and 2022, related parties had accounts receivable due to the Company of $<span id="xdx_90F_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20230731__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zkS3JQ5C1Yx3" title="Outstanding accounts receivable">28,800</span> and $<span id="xdx_90E_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20220731__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zeaL1kmQS1m9" title="Outstanding accounts receivable">28,800</span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_808_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zofGkOILqKg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
11: <span><span id="xdx_824_z9LZWLKdBDYh">RELATED PARTY TRANSACTIONS</span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
support of the Company&#8217;s efforts and cash requirements, it may rely on advances from related parties until such time that the Company
can support its operations or attain adequate financing through sales of its equity or traditional debt financing. There is no formal
written commitment for continued support by officers, directors, or shareholders. Amounts represent advances, amounts paid in satisfaction
of liabilities, or accrued compensation that has been deferred. The advances are considered temporary in nature and have not been formalized
by a promissory note.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has outstanding notes payable of <span style="background-color: white"><span style="background-color: white">$<span id="xdx_90C_eus-gaap--NotesPayable_iI_pp0p0_c20230430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zbKrLVDiBMgk" title="Outstanding notes payable">1,953,842</span> </span> and $<span id="xdx_908_eus-gaap--NotesPayable_iI_pp0p0_c20220430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zH14YqEaxkol" title="Outstanding notes payable">2,000,000</span></span> and accrued interest
of $<span id="xdx_906_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20230430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zSzgnnFlxtOi" title="Accrued interest - related party">917,957</span> and $<span id="xdx_909_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20220430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zRX25uk8IQnf" title="Accrued interest - related party">908,756</span> due to a related party as of April 30, 2023 and 2022, respectively (see Note 8).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognized net sales of $<span id="xdx_90C_eus-gaap--Revenues_pp0p0_c20220501__20230430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zNLFQJGsyzS3" title="Revenue from related parties">164,661</span> and $<span id="xdx_90C_eus-gaap--Revenues_pp0p0_c20210501__20220430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z1L1W8td9grd" title="Revenue from related parties">368,164</span> during the years ended April 30, 2023 and 2022, respectively, to related parties.
As of April 30, 2023 and 2022, related parties had accounts receivable due to the Company of $<span id="xdx_901_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20230430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zQlsAFDzmKy4" title="Outstanding accounts receivable">28,800</span> and $<span id="xdx_900_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20220430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zH7NQHkKmOIa" title="Outstanding accounts receivable">93,535</span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//850/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007863106272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS&#8217; EQUITY (DEFICIT)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2023</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">SHAREHOLDERS&#8217; EQUITY (DEFICIT)</a></td>
<td class="text"><p id="xdx_804_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zFiOa0dq6LO1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
11: <span id="xdx_829_zBTlGZIYTUa">SHAREHOLDERS&#8217; EQUITY (DEFICIT)</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Common
Stock</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has <span id="xdx_905_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20230731_z6u19YQESDOj" title="Common stock, shares authorized">300,000,000</span> shares of common stock authorized with a par value of $<span id="xdx_907_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20230731_zqGmQen3E37i" title="Common stock, par value">0.001</span> per share. As of July 31, 2023 and April 30, 2023,
the Company had <span id="xdx_900_eus-gaap--CommonStockSharesIssued_iI_c20230731_zPMbFx0yGZze" title="Common stock, shares issued"><span id="xdx_90F_eus-gaap--CommonStockSharesOutstanding_iI_c20230731_zFwg4tf7gOb4" title="Common stock, shares outstanding">528,297</span></span> and <span id="xdx_903_eus-gaap--CommonStockSharesIssued_iI_c20230430_z6cRESjqlU1l" title="Common stock, shares issued"><span id="xdx_90C_eus-gaap--CommonStockSharesOutstanding_iI_c20230430_zA0238zczz3" title="Common stock, shares outstanding">338,579</span></span> shares of common stock issued and outstanding, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the period May 1, 2023 through July 31, 2023, the Company issued <span id="xdx_90C_eus-gaap--SharesIssued_iI_c20230731_zGB3SCqNKyZh" title="Shares, issued">189,718</span> shares of common stock to ambassadors under their agreements
(<span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230501__20230731_zqFXHEaRPRK2" title="Number of shares issued during the period">188</span>), to vendors in settlement of accounts payable (<span id="xdx_90B_ecustom--StockIssuedDuringPeriodSharesIssuedSettlementOfAccountsPayable_c20230501__20230731_zWaxfldn73B4" title="Stock issued during period, shares, issued for settlement of accounts payable">67,500</span>), for settlement with former owners of FSS (<span id="xdx_90C_ecustom--StockIssuedDuringPeriodSharesIssuedSettlementWithFormerOwners_c20230501__20230731_zPQkhnUJULai" title="Stock issued during period, shares, issued for settlement with former owners">1,350</span>), for the exercise of warrants
(<span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20230501__20230731_zcW8tZjeITub" title="Exercise of warrants, shares">27,000</span>) and to satisfy the profit guarantee on a note (<span id="xdx_906_ecustom--StockIssuedDuringPeriodSharesIssuedProfitGuaranteeOnNote_c20230501__20230731_zxKbEevQ2QL9" title="Profit guarantee on note, shares">93,680</span>).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Equity
Transactions During the Year Ended April 30, 2023</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has issued an aggregate of <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220501__20230430_zLMHSjhBqfZ1" title="Number of common stock, shares issued">151,579</span> shares of its common stock consisting of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    June 15, 2022, the Company issued <span id="xdx_901_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pid_c20220615__20220615_zVVN5WVq72t1" title="Debt conversion of convertible notes, shares">109,737</span> shares of common stock to the Convertible Noteholders upon conversion of convertible notes.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    June 15, 2022, the Company issued <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220615__20220615__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_z5EW015SOjxb" title="Number of common stock, shares issued">26,219</span> shares to investors who participated in the Company&#8217;s Nasdaq uplist round.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    June 27, 2022, the Company issued <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20220627__20220627__srt--TitleOfIndividualAxis__custom--GabrielGoldmanMember_zOyzqycg5le5" title="Number of common stock, shares for services">625</span> shares of common stock to Gabriel Goldman for consulting services performed in the first quarter
    of calendar 2022. Gabriel Goldman became a director of the Company on June 15, 2022.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    June 27, 2022, the Company issued <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220627__20220627__dei--LegalEntityAxis__custom--GamefaceAIMember_z8US1zG0EuV7" title="Number of common stock, shares issued">14,960</span> shares of common stock to the former Gameface shareholders in connection with the purchase
    of Gameface. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            August 25, 2022, the Company issued <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220825__20220825__dei--LegalEntityAxis__custom--MidcityCapitalLtdMember_zqAbEvmelHXb" title="Number of common stock, shares issued">750</span> shares of common stock to Midcity Capital Ltd (&#8220;Midcity&#8221;)
                                            pursuant to a cashless conversion of warrants Midcity received from its warrant agreement
                                            with the Company dated March 2020.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    September 28, 2022, the Company entered into a securities purchase agreement (the &#8220;Securities Purchase Agreement&#8221;) with
    a single institutional investor (the &#8220;Investor&#8221;) for the issuance and sale of (i) <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220928__20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zEAr7Dn7PT73">25,463
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock and (ii) pre-funded
    warrants (the &#8220;Pre-Funded Warrants&#8221;) to purchase an aggregate of <span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zNRWXEzs1sBc">295,050
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of its common stock, together with
    accompanying common stock warrants, at a combined purchase price of $<span id="xdx_904_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zNSKTWMy3mV">15.60
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share of the common stock and associated
    common stock warrant and $<span id="xdx_904_ecustom--WarrantPerShare_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_ziC3L3Msqypi">15.596
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per Pre-Funded Warrant and associated common
    stock warrants for an aggregate amount of approximately $<span id="xdx_904_eus-gaap--WarrantsAndRightsOutstanding_iI_pn5n6_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zZBbxXyALJQf">5.0
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million (the &#8220;Offering&#8221;). The
    Pre-Funded Warrants have an exercise price of $<span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zt1R1zNansKf">0.0004
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share of common stock and are exercisable
    until the Pre-Funded Warrants are exercised in full. The shares of common stock and Pre-Funded Warrants were sold in the offering
    together with common stock warrants to purchase <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--FiveYearWarrantsMember_zFl047dNUglc">320,513
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock at an exercise price
    of $<span id="xdx_904_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--FiveYearWarrantsMember_zTy7fFHPKFs4">15.60
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share and a term of five years following
    the initial exercise date (the &#8220;5-Year Warrants&#8221;) and <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220928__20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--SevenYearWarrantsMember_z1W8xEemzbS">641,026
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">common stock warrants to purchase <span id="xdx_904_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--SevenPointFiveYearWarrantsMember_zWrUgZEuscf6">641,026
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock at an exercise price
    of $<span id="xdx_905_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--SevenPointFiveYearWarrantsMember_zRt6LcJKfH3j">17.20
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share and a term of seven and one half
    years (the &#8220;7.5-Year Warrants&#8221;) following the initial exercise date (collectively, the &#8220;Warrants&#8221;). The Warrants
    issued in the Offering contain variable pricing features. The Warrants and Pre-Funded Warrants will be exercisable beginning on the
    date stockholder approval is received and effective allowing exercisability of the Warrants and Pre-Funded Warrants under Nasdaq
    rules. Net proceeds to the Company were $<span id="xdx_907_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20220928__20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zLxJbyF4qYA9">4,549,882</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    October 12, 2022, the Company issued <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20221012__20221012_zqqGfJFPVi4j" title="Shares issued for acquisition">48,098</span> shares of common stock, on November 21, 2022 issued <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20221121__20221121_zn5om8i945bi" title="Shares issued for acquisition">675</span> shares of common stock and January
    26, 2023 issued <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20230126__20230126_zEJqt4NF9Ff9" title="Shares issued for acquisition">6,993</span> shares of common stock in connection with the acquisition of PlaySight.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    January 26, 2023, the Company issued <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20230126__20230126_zbzEyY8oED56" title="Shares issued for services">150</span> shares of common stock for services rendered to their ambassadors.</span></p></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has not granted any warrants for the three months ended July 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Warrants
Granted During the Year Ended April 30, 2023</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 28, 2022, the Company entered into a securities purchase agreement (the &#8220;Securities Purchase Agreement&#8221;) with a
single institutional investor (the &#8220;Investor&#8221;) for the issuance and sale of (i) <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220928__20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zPBVO4Wkbcof">25,463
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock and (ii) pre-funded warrants
(the &#8220;Pre-Funded Warrants&#8221;) to purchase an aggregate of <span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zj75Eba8GHT5">295,050
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of its common stock, together with accompanying
common stock warrants, at a combined purchase price of $<span id="xdx_904_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_z5d0PNcEZor3">15.60
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share of the common stock and associated
common stock warrant and $<span id="xdx_90C_ecustom--WarrantPerShare_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zYbOSycnhwCk">15.596
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per Pre-Funded Warrant and associated common
stock warrants for an aggregate amount of approximately $<span id="xdx_903_eus-gaap--WarrantsAndRightsOutstanding_iI_pn5n6_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zhEGqkHNs4q2">5.0
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million (the &#8220;Offering&#8221;). The Pre-Funded
Warrants have an exercise price of $<span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zZVaxX3BNoJk">0.0004
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share of common stock and are exercisable
until the Pre-Funded Warrants are exercised in full. The shares of common stock and Pre-Funded Warrants were sold in the offering together
with common stock warrants to purchase <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--FiveYearWarrantsMember_z1zWWlUQIkN8">320,513
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock at an exercise price of
$<span id="xdx_904_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--FiveYearWarrantsMember_zQNCYbEegTS8">15.60
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share and a term of five years following
the initial exercise date (the &#8220;5-Year Warrants&#8221;) and <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220928__20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--SevenPointFiveYearWarrantsMember_z0Az8mwMhSa">641,026
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">common stock warrants to purchase <span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--SevenPointFiveYearWarrantsMember_zXB6PPbx2At4">641,026
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock at an exercise price of
$<span id="xdx_905_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--SevenPointFiveYearWarrantsMember_zL0xkE54lbMg">17.20
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share and a term of seven and one half years
(the &#8220;7.5-Year Warrants&#8221;) following the initial exercise date (collectively, the &#8220;Warrants&#8221;). The Warrants issued
in the Offering contain variable pricing features. The Warrants and Pre-Funded Warrants became exercisable beginning on the date stockholder
approval was received and effective allowing exercisability of the Warrants and Pre-Funded Warrants under Nasdaq rules. The exercise
price of the Warrants was reset in January 2023 to $<span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230131__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_z0dqSJawS6I1">8.84
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share and in October 2023 to $<span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20231031__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zULTXh6WUJN1">3.55
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 6, 2023, the Company entered into a loan and security agreement (the &#8220;Loan and Security Agreement&#8221;) with one or more
institutional investors (the &#8220;Lenders&#8221;) and Armistice Capital Master Fund Ltd. as agent for the Lenders (the &#8220;Agent&#8221;)
for the issuance and sale of (i) a note in an aggregate principal amount of up to $<span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_c20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember__srt--RangeAxis__srt--MaximumMember_zGvlCOUpRUx5">2,000,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(the &#8220;Note&#8221;) at <span id="xdx_907_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember__srt--RangeAxis__srt--MaximumMember_z0n0MFoFxKzk">4.33</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
interest per annum unless in default, with the initial advance under the Loan and Security Agreement being $<span id="xdx_902_eus-gaap--ProceedsFromNotesPayable_c20230104__20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember__us-gaap--ShortTermDebtTypeAxis__custom--NotesMember_zESWNTzFj6bj">1,400,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and (ii) warrants (the &#8220;Warrants&#8221;)
to purchase a number of shares of common stock of the Company equal to 200% of the face amount of the Note divided by the closing price
of the common stock of the Company on the date of the issuance of the Notes (collectively, the &#8220;Initial Issuance&#8221;). The closing
price of the Company&#8217;s common stock on January 6, 2023, as reported by Nasdaq, was $<span id="xdx_903_ecustom--SharesIssuedPricePerShares_iI_pid_c20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember_zCyflaimytJb">0.221
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share (or <span id="xdx_903_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember_zkI6lBmBM1if">8.84
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share after adjusting for the one-for-forty
(1-for-40) reverse stock split), so the Warrants in respect of the initial advance under the Note are exercisable for up to <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember__srt--RangeAxis__srt--MaximumMember_zkYf6spSb78g">452,489
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the Company&#8217;s common stock. The
Warrants have an exercise price per share equal to the closing price of the common stock of the Company on the date of the issuance of
the Note, or $<span id="xdx_909_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember_zH3PN1RLgy08">8.84
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share and a term of five- and one-half (5&#189;)
years following the initial exercise date. The exercise price of the Warrants was reset in October 2023 to $<span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember_zcg7OOrczYg4">3.55
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share The initial exercise date of the
Warrants was the date stockholder approval was received and effective allowing exercisability of the Warrants under Nasdaq rules. Pursuant
to the terms of the Loan and Security Agreement, an additional advance of $<span id="xdx_90E_eus-gaap--ProceedsFromNotesPayable_c20230104__20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember_z1gwHaLonZWi">600,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">was made to the Company under the Note which
occurred on February 2, 2023. The Company&#8217;s obligations under the terms of the Loan and Security Agreement are fully and unconditionally
guaranteed by all of the Company&#8217;s subsidiaries (the &#8220;Guarantors&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
<td class="text"><p id="xdx_804_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_z7wvekueFLv1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
12: <span id="xdx_829_zan7toDLg2li">SHAREHOLDERS&#8217; EQUITY (DEFICIT)</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Common
Stock</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has <span id="xdx_90D_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20230430_zNgnpQRUOS5i">300,000,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
of common stock authorized with a par value of $<span id="xdx_907_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20220430_zWttYdquPUy3">0.001 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per
share. As of April 30, 2023 and 2022, the Company had <span><span id="xdx_908_eus-gaap--CommonStockSharesOutstanding_iI_c20230430_zimqsfw9jli1">338,579</span> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and <span><span id="xdx_903_eus-gaap--CommonStockSharesOutstanding_iI_dxL_c20220430_zBaH6DRfJUN1" title="::XDX::4194836"><span style="-sec-ix-hidden: xdx2ixbrl2401">104,871</span></span> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
of common stock issued and outstanding, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Equity
Transactions During the Year Ended April 30, 2023</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
May 1, 2022, the Company has issued an aggregate of <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220501__20220501_zZR0ZBJOEit9">151,579 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
of its common stock consisting of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    June 15, 2022, the Company issued <span id="xdx_906_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pid_c20220615__20220615__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zTGeJZaJvHA5">109,740 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
    of common stock to the Convertible Noteholders upon conversion of convertible notes.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    June 15, 2022, the Company issued <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220615__20220615__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zP6WKji4yMQc">26,219 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
    to investors who participated in the Company&#8217;s Nasdaq uplist round.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    June 27, 2022, the Company issued <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20220627__20220627__srt--TitleOfIndividualAxis__custom--GabrielGoldmanMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zWy6fWc9WSg9">625 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock to Gabriel Goldman
    for consulting services performed in the first quarter of calendar 2022. Gabriel Goldman became a director of the Company on June
    15, 2022.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    June 27, 2022, the Company issued <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220627__20220627__dei--LegalEntityAxis__custom--GamefaceAIMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zTfHCLfsOAr5">14,960 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
    of common stock to the former Gameface shareholders in connection with the purchase of Gameface. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                                         August 25, 2022, the Company issued <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220825__20220825__dei--LegalEntityAxis__custom--MidcityCapitalLtdMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z4JuHQWxP8A4">750 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
                                                         of common stock to Midcity Capital Ltd (&#8220;Midcity&#8221;) pursuant to a cashless conversion of warrants Midcity received from
                                                         its warrant agreement with the Company dated March 2020.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    September 28, 2022, the Company entered into a securities purchase agreement (the &#8220;Securities Purchase Agreement&#8221;) with
    a single institutional investor (the &#8220;Investor&#8221;) for the issuance and sale of (i) <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220928__20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_ztJedXL1arxd">25,463
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock and (ii) pre-funded
    warrants (the &#8220;Pre-Funded Warrants&#8221;) to purchase an aggregate of <span id="xdx_909_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zbytUP6eKPKg">295,050
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of its common stock, together with
    accompanying common stock warrants, at a combined purchase price of $<span id="xdx_90B_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zit6bfviuTTc">15.60
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share of the common stock and associated
    common stock warrant and $<span id="xdx_90C_ecustom--WarrantPerShare_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zIETuCcBezL3">15.596
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per Pre-Funded Warrant and associated common
    stock warrants for an aggregate amount of approximately $<span id="xdx_904_eus-gaap--WarrantsAndRightsOutstanding_iI_pn5n6_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_ztyF8X0dbXG7">5.0
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million (the &#8220;Offering&#8221;). The
    Pre-Funded Warrants have an exercise price of $<span id="xdx_900_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zThepsd0uimb">0.0004
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share of common stock and are exercisable
    until the Pre-Funded Warrants are exercised in full. The shares of common stock and Pre-Funded Warrants were sold in the offering
    together with common stock warrants to purchase <span id="xdx_908_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--FiveYearWarrantsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z1WPdsDCFjMb">320,513
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock at an exercise price
    of $<span id="xdx_908_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--FiveYearWarrantsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zuOOWVGCsS74">15.60
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share and a term of five years following
    the initial exercise date (the &#8220;5-Year Warrants&#8221;) and <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220928__20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--SevenYearWarrantsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zabgtiPUHrl4">641,026
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">common stock warrants to purchase <span id="xdx_903_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--SevenPointFiveYearWarrantsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zfP624qt3dXk">641,026
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock at an exercise price
    of $<span id="xdx_901_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--SevenPointFiveYearWarrantsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zHHQ0i3eZvca">17.20
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share and a term of seven and one half
    years (the &#8220;7.5-Year Warrants&#8221;) following the initial exercise date (collectively, the &#8220;Warrants&#8221;). The Warrants
    issued in the Offering contain variable pricing features. The Warrants and Pre-Funded Warrants became exercisable beginning on the
    date stockholder approval was received and effective allowing exercisability of the Warrants and Pre-Funded Warrants under Nasdaq
    rules. The exercise price of the Warrants was reset in October 2023 to $<span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20231031__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zg4tqKHduW6f">3.55
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share. Net proceeds to the Company
    were $<span id="xdx_907_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20220928__20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_z2orhv5fqdp5">4,549,882</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    October 12, 2022, the Company issued <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20221012__20221012__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zXa09UsKfjob">48,098 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
    of common stock, on November 21, 2022 issued <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20221121__20221121__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zDgtZ5o0OnFh">675 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
    of common stock and January 26, 2023 issued <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20230126__20230126__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zDQcinvmexk3">6,994 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
    of common stock in connection with the acquisition of PlaySight.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    January 26, 2023, the Company issued <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20230126__20230126__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zdiNGy78zM54">150 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
    of common stock for services rendered to their ambassadors.</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Equity
Transactions During the Year Ended April 30, 2022</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 26, 2021, the Company issued <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_pid_c20210525__20210526__srt--TitleOfIndividualAxis__custom--RelatedPartyLenderMember_zU1NFjCdfgpb">4,093 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
of its common stock for the conversion of related party notes payable (see Note 8). The fair value of the common stock was $<span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_pp0p0_c20210525__20210526__srt--TitleOfIndividualAxis__custom--RelatedPartyLenderMember_ziTL6cMDO1Q7">6,220,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 23, 2021, the Company issued <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20210622__20210623__us-gaap--BusinessAcquisitionAxis__custom--FoundationSportsSystemsLLCMember_zr4DltCaxwWl">1,350 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
of its common stock as partial consideration for the acquisition of Foundation Sports (see Note 5). The fair value of the total
shares of common stock to be issued related to the acquisition was $<span id="xdx_900_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_pp0p0_c20210622__20210623__us-gaap--BusinessAcquisitionAxis__custom--FoundationSportsSystemsLLCMember_zAW4RBNwVWDl">3,550,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 6, 2021, the Company issued <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationGross_pid_c20210705__20210706__srt--ProductOrServiceAxis__custom--ServicesRenderedInLieuOfCashMember__srt--TitleOfIndividualAxis__custom--TwoEmployeesMember_zMwNANWjBFQe">126 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
of its common stock to two employees as compensation for services rendered in lieu of cash, which resulted in $<span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensationGross_pp0p0_c20210501__20220430__srt--ProductOrServiceAxis__custom--ServicesRenderedInLieuOfCashMember__srt--TitleOfIndividualAxis__custom--TwoEmployeesMember_zongsT59d4Nh">187,803 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
share-based compensation expense for the year ended April 30, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 11, 2021, the Company issued <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationGross_pid_c20210709__20210711__srt--ProductOrServiceAxis__custom--MarketingAndAdvisoryServicesMember__srt--TitleOfIndividualAxis__custom--VendorMember_zGDxXFOPz7T7">47 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
of its common stock to a vendor as compensation for marketing and other services rendered, which resulted in $<span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensationGross_pp0p0_c20210501__20220430__srt--ProductOrServiceAxis__custom--MarketingAndAdvisoryServicesMember__srt--TitleOfIndividualAxis__custom--VendorMember_zX7EB2hprSja">16,875 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
operating expenses for the year ended April 30, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the three months ended July 31, 2021, the Company granted an aggregate total of <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20210501__20210731__srt--StatementScenarioAxis__custom--AsCompensationMember__srt--TitleOfIndividualAxis__custom--SixNewBrandAmbassadorsMember__us-gaap--AwardTypeAxis__us-gaap--CommonStockMember_z25MJlpQ5jWb">228 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
of its common stock and equity options to purchase up to <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20210501__20210731__srt--RangeAxis__srt--MaximumMember__srt--StatementScenarioAxis__custom--AsCompensationMember__srt--TitleOfIndividualAxis__custom--SixNewBrandAmbassadorsMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zZl9X5Zj71jl">150 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
(which are now expired) to six new brand ambassadors as compensation for services. The expense related to the issuance of the shares
and equity options is being recognized over the service agreements, similar to the warrants and equity options issued to the four
other brand ambassadors in the prior year. During the year ended April 30, 2022, the Company recognized $<span id="xdx_90E_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210501__20220430__srt--TitleOfIndividualAxis__custom--BrandAmbassadorsMember_zK0XkliXXZee">907,042 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
operating expenses related to the shares, warrants and equity options granted to brand ambassadors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 6, 2021, the Note payable holder exercised its right to convert its <span id="xdx_902_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_pid_c20210806__us-gaap--DebtInstrumentAxis__custom--NotePayableHolderMember_ze7Nk0K78s27">5,500 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">outstanding
warrants into <span id="xdx_90B_eus-gaap--ConversionOfStockSharesConverted1_pid_c20210805__20210806__us-gaap--DebtInstrumentAxis__custom--NotePayableHolderMember_zOSIJ5Y2M6Q7">12,375 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
of common stock of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 6, 2021, the Company&#8217;s related party lender exercised its right to convert its <span id="xdx_900_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_pid_c20210806__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RelatedPartyLenderMember_zewAwfI4XsG1">688 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">outstanding
warrants and <span id="xdx_901_eus-gaap--CommonStockSharesIssued_iI_pid_c20210806__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RelatedPartyLenderMember_zeMhRNxuuKRe">17,304 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">common
shares issuable into <span id="xdx_908_eus-gaap--ConversionOfStockSharesConverted1_pid_c20210805__20210806__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RelatedPartyLenderMember_z64oRc5JCQk4">17,992 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
of common stock of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 11, 2021, the Company issued <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationGross_pid_c20211010__20211011__srt--ProductOrServiceAxis__custom--MarketingAndAdvisoryServicesMember__srt--TitleOfIndividualAxis__custom--VendorMember_zBMcv9cEsP3a">47 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
of its common stock to a vendor as compensation for marketing and other services rendered, which resulted in $<span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensationGross_pp0p0_c20210501__20220430__srt--ProductOrServiceAxis__custom--MarketingAndAdvisoryServicesMember__srt--TitleOfIndividualAxis__custom--VendorMember_zp5dRQCQ1YLb">16,875 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
operating expenses during the year ended April 30, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 11, 2022, the Company issued <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationGross_pid_c20220110__20220111__srt--ProductOrServiceAxis__custom--MarketingAndAdvisoryServicesMember__srt--TitleOfIndividualAxis__custom--VendorMember_zHaEy3mvPpmg">47 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
of its common stock to a vendor as compensation for marketing and other services rendered, which resulted in $<span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensationGross_pp0p0_c20210501__20220430__srt--ProductOrServiceAxis__custom--MarketingAndAdvisoryServicesMember__srt--TitleOfIndividualAxis__custom--VendorOneMember_zQ8DczK3bz3e">16,874 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
operating expenses during the year ended April 30, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
April 2022, the Company granted an aggregate total of <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20220401__20220430__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--KeyEmployeesAndOfficersMember_zEedkoPR0xe4">150 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
of its common stock to 6 new brand ambassadors as compensation for services. During the year ended April 30, 2022, the Company
recognized $<span id="xdx_906_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210501__20220430__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--KeyEmployeesAndOfficersMember_zXAK6CpkWXB3">255,124 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
operating expenses related to the shares granted to brand ambassadors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Warrants
Issued and Expensed During the Years Ended April 30, 2023 and 2022</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 28, 2020, the Company granted <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20201027__20201028__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--ServiceProviderMember_ze6p6EUMyXVe">1,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrants to a service provider for advertising
services over the next year. The warrants have an exercise price of $<span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20201028__srt--TitleOfIndividualAxis__custom--ServiceProviderMember_z3wiMCubfNJc">30
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share, a contractual life of <span id="xdx_909_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20201028__srt--TitleOfIndividualAxis__custom--ServiceProviderMember_zhH2RHAAvdu7">10
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years from the date of issuance, and vest quarterly
over a year from the grant date. The warrants were valued using a Black-Scholes option pricing model and the expense related to the issuance
of the warrants is being recognized over the service agreement. The Company recognized $<span id="xdx_908_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210501__20220131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--ThreeMembersMember_z5sTUPP27Xf4">214,552
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of operating expenses related to this agreement
during the nine months ended January 31, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with the October 29, 2020 agreement with three members of the advisory board mentioned above, <span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_iI_pp0p0_c20201029__srt--StatementScenarioAxis__custom--AsCompensationMember__srt--TitleOfIndividualAxis__custom--ThreeMembersMember_zJ6xz2vSDvUj">1,152 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrants
were issued during the year ended April 30, 2022. The warrants were valued using a Black-Scholes option pricing model on the grant
date, which resulted in operating expenses of $<span id="xdx_905_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20220501__20230131__srt--StatementScenarioAxis__custom--AsCompensationMember__srt--TitleOfIndividualAxis__custom--ThreeMembersMember_zbVYIYQ1cF84">67,500 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and
$<span id="xdx_904_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210501__20220430__srt--StatementScenarioAxis__custom--AsCompensationMember__srt--TitleOfIndividualAxis__custom--ThreeMembersMember_zUK5Z22devCc">87,656 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">during
the nine months ended January 31, 2023 and year ended April 30, 2022, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 6, 2021, in connection with the Convertible Notes issuance the Company issued warrants to purchase up to <span id="xdx_90A_ecustom--WarrantsIssuedToPurchaseOfCommonStockShares_iI_c20210806__srt--StatementScenarioAxis__custom--SecuritiesPurchaseAgreementMember_z07ekRxcuFZ">18.334 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
of common stock of the Company to the Purchasers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 6, 2021, in connection with the Convertible Notes issuance the Company also granted the lead placement agent for the Offering <span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20210806__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--LeadPlacementAgentMember_z3c6J0dGTXZk">667 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrants
that are exercisable for five years from August 6, 2021, at an exercise price of $<span id="xdx_900_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20210806__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--LeadPlacementAgentMember_zWwRLcrjX1of">1.90 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(subject
to adjustment as set forth in the Convertible Notes per the terms of the agreement) and are vested immediately. The warrants were
valued using a Black-Scholes option pricing model on the grant date and the Company recognized $<span id="xdx_907_eus-gaap--OperatingExpenses_pp0p0_c20210501__20220430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--LeadPlacementAgentMember_z61oUlLOS4D6">376,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
operating expenses related to them during the year ended April 30, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 3, 2021, the Company granted an aggregate total of <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210903__20210903__srt--StatementScenarioAxis__custom--AsCompensationMember__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z8shZD5eGAxh">2,525 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrants
to key employees and officers of the Company as compensation. The warrants have an exercise price of $<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20210903__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--KeyEmployeesAndOfficersMember__srt--StatementScenarioAxis__custom--ExercisePriceOneMember_zI7sj2bVHmph">0.4 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per
share for <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20210903__20210903__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--LeadPlacementAgentMember__srt--StatementScenarioAxis__custom--ExercisePriceOneMember_ziei92n21Ktk">1,000,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
the warrants and $<span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20210903__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--KeyEmployeesAndOfficersMember__srt--StatementScenarioAxis__custom--ExercisePriceTwoMember_z7PWwbPIvgrb">1,368 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20210903__20210903__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--KeyEmployeesAndOfficersMember__srt--StatementScenarioAxis__custom--ExercisePriceTwoMember_zA1bojVCtdRe">10,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
the warrants, a contractual life of <span id="xdx_902_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20210903__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--KeyEmployeesAndOfficersMember_zCUyfXy34qQi">10 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years
from the date of issuance and are vested immediately upon grant. The warrants were valued using a Black-Scholes option pricing model
on the grant date and the Company recognized $<span id="xdx_906_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210501__20220430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--KeyEmployeesAndOfficersMember_z7AGpZpAHoJk">32,381,309 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
share-based compensation expense related to them during the year ended April 30, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 2, 2022, in connection with the Gameface acquisition the Company issued warrants to purchase up to <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20220202__20220202__us-gaap--BusinessAcquisitionAxis__custom--GamefaceMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zu7Cf2m94XIi">1,196 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
of common stock of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 28, 2022, the Company entered into a securities purchase agreement (the &#8220;Securities Purchase Agreement&#8221;) with a
single institutional investor (the &#8220;Investor&#8221;) for the issuance and sale of (i) <span id="xdx_909_eus-gaap--CommonStockSharesIssued_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zhceaBX3I4eh">25,463
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock and (ii) pre-funded warrants
(the &#8220;Pre-Funded Warrants&#8221;) to purchase an aggregate of <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zHc0Gah5qQH">295,050
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of its common stock, together with accompanying
common stock warrants, at a combined purchase price of $<span id="xdx_905_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zAu4uF3JObG2">15.60
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share of the common stock and associated
common stock warrant and $<span id="xdx_90C_ecustom--WarrantPerShare_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z8N6sFZfVCej">15.596
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per Pre-Funded Warrant and associated common
stock warrants for an aggregate amount of approximately $<span id="xdx_904_eus-gaap--WarrantsAndRightsOutstanding_iI_pn5n6_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zuJN6iVZXW67">5.0
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million (the &#8220;Offering&#8221;). The Pre-Funded
Warrants have an exercise price of $<span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z2y1DsgmO2Ql">0.0004
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share of common stock and are exercisable
until the Pre-Funded Warrants are exercised in full. The shares of common stock and Pre-Funded Warrants were sold in the offering together
with common stock warrants to purchase <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--FiveYearWarrantsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zgHWEcULfNed">320,513
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock at an exercise price of
$<span id="xdx_905_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--FiveYearWarrantsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zmMDkHHCGfT8">15.60
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share and a term of five years following
the initial exercise date (the &#8220;5-Year Warrants&#8221;) and <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220928__20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--SevenYearWarrantsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zkWnLw8e1tAb">641,026
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">common stock warrants to purchase <span id="xdx_903_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--SevenYearWarrantsMember_zDSMdE3r6Ese">641,026
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock at an exercise price of
$<span id="xdx_90B_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--SevenYearWarrantsMember_zZE0ovrtL4bg">17.20
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share and a term of seven and one half years
(the &#8220;7.5-Year Warrants&#8221;) following the initial exercise date (collectively, the &#8220;Warrants&#8221;). The Warrants issued
in the Offering contain variable pricing features. The exercise price of the Warrants was reset in October 2023 to $<span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20231031__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z9i3Baalyxol">3.55
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_891_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zfYvdOdwoDS3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following represents a summary of the warrants:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B7_zHSt7Ikw6fI7" style="display: none">SCHEDULE OF WARRANTS ISSUED, EXERCISED AND EXPIRED</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Year Ended April 30, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Year Ended April 30, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Number</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted<br/> Average<br/> Exercise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Price</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Number</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted<br/> Average<br/> Exercise <br/> Price</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 44%; text-align: left; padding-left: 10pt">Beginning balance</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20220501__20230430_zQS3EBU3QrYf" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Warrants Shares, Beginning Balance">97,075</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_iS_c20220501__20230430_zy4gGvH51cl9" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Weighted Avg. Exercise Price Warrant, Beginning Balance">444.50</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20210501__20220430_zm8N1W04iELd" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Warrants Shares, Beginning Balance">47,633</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_iS_c20210501__20220430_zyqVXmwwiRL5" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Weighted Avg. Exercise Price Warrant, Beginning Balance">205.156</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">Granted</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20220501__20230430_zfcqRTePcdxf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Shares, Granted">1,714,127</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceIssued_c20220501__20230430_zkW5YL7VJ1T7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Avg. Exercise Price Warrant, Issued">11.696</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20210501__20220430_zmpBNxMzqr3a" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Shares, Granted">49,442</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceIssued_c20210501__20220430_ztppr5zG0k5b" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Avg. Exercise Price Warrant, Issued">139.344</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">Exercised</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20220501__20230430_zvkZc9JU4MBj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Shares, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl2497">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised_c20220501__20230430_zhXg1c5J2b3b" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Avg. Exercise Price Warrant, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl2499">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20210501__20220430_zwQRqeahawA9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Shares, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl2501">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised_c20210501__20220430_z7KnUWuTYoo4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Avg. Exercise Price Warrant, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl2503">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">Forfeited</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_c20220501__20230430_z3vgb86jfu07" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Shares, Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl2505">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceForfeited_c20220501__20230430_zG3sPPIIrK96" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Avg. Exercise Price Warrant, Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl2507">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_c20210501__20220430_zdGNprtYwxL1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Shares, Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl2509">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceForfeited_c20210501__20220430_ziZC4Fb2tKtj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Avg. Exercise Price Warrant, Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl2511">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 10pt">Expired</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_di_c20220501__20230430_zMGNuIwZQRea" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Shares, Expired">(18,750</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExpired_c20220501__20230430_z3sI9I6OFO24" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Avg. Exercise Price Warrant, Expired"><span style="-sec-ix-hidden: xdx2ixbrl2515">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_c20210501__20220430_z8nTdQWi32Lc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Shares, Expired"><span style="-sec-ix-hidden: xdx2ixbrl2517">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExpired_c20210501__20220430_zgoMBBv2B5V4" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Avg. Exercise Price Warrant, Expired"><span style="-sec-ix-hidden: xdx2ixbrl2519">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; padding-left: 10pt">Ending balance</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20220501__20230430_zBS45zMYqtQj" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Shares, Ending Balance">1,792,451</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_iE_c20220501__20230430_zXXTZbbs6uq3" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Avg. Exercise Price Warrant, Ending Balance">34.208</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20210501__20220430_zPV3Wt3KFUV4" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Shares, Ending Balance">97,075</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_iE_c20210501__20220430_zoNIGys6szG5" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Avg. Exercise Price Warrant, Ending Balance">444.50</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">Intrinsic value of warrants</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_eus-gaap--WarrantsAndRightsOutstanding_iI_c20230430_zHoXi7XU4vB2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intrinsic value of warrants">2,344,529</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_eus-gaap--WarrantsAndRightsOutstanding_iI_c20220430_zhyimSuk9F14" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intrinsic value of warrants">33,752,623</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Weighted Average Remaining Contractual Life (Years)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20220501__20230430_z2dE7b7khvp9" title="Weighted Average Remaining Contractual Life (Years)">6.45</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20210501__20220430_zrBNJ9rRDBJl" title="Weighted Average Remaining Contractual Life (Years)">6.50</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p><p id="xdx_8A8_zV1NM4fwcgGf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of April 30, 2023, <span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20220501__20230430_zjYi84YwUvyj" title="Warrants vested">71,698,014</span> warrants are vested.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007870308368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2023</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text"><p id="xdx_80F_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zolbRweiCHJ5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
12: <span id="xdx_82E_zSVzlluGIHLg">COMMITMENTS AND CONTINGENCIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Leases</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company leases office space under short-term leases with terms under a year. Total rent expense for the three months ended July 31, 2023
and 2022 amounted to $<span id="xdx_90A_eus-gaap--PaymentsForRent_pp0p0_c20230501__20230731_zIpgkLfFn7w4" title="Rent expense">1,969</span> and $<span id="xdx_900_eus-gaap--PaymentsForRent_pp0p0_c20220501__20220731_zkgi2HQTfDj5" title="Rent expense">700</span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Contingencies</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Gameface acquisition on February 2, 2022, the Company agreed to earn-out consideration of common shares of the Company&#8217;s
common stock with a fair value of $<span id="xdx_908_ecustom--FairValueOfCommonStock_iI_pp0p0_c20230131_z2y6ACVWCork" title="Fair value of common stock">1,334,000</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company issued <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20220601__20220630_zjiLZiKbQykd" title="Number of stock issued">14,960</span> common shares to the former Gameface shareholders in June 2022. The balance of the contingent consideration as
of July 31, 2023 and April 30, 2023 is $<span id="xdx_900_eus-gaap--BusinessCombinationContingentConsiderationLiability_iI_c20230731_ztO2Gf9dLNn6" title="Balance of contingent consideration"><span id="xdx_90B_eus-gaap--BusinessCombinationContingentConsiderationLiability_iI_c20230430_zT4nkbrpaxj5" title="Balance of contingent consideration">418,455</span></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, the Company may become involved in legal proceedings arising in the ordinary course of business. The Company is not presently
a party to any legal proceedings that it currently believes would individually or taken together have a material adverse effect on the
Company&#8217;s business or financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Nasdaq
Compliance</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 26, 2023, the Company received a letter from the Listing Qualifications Department of Nasdaq indicating that the Company&#8217;s
stockholders&#8217; equity as reported in its Quarterly Report on Form 10-Q for the quarterly period ended January 31, 2023 did not satisfy
the continued listing requirement under Nasdaq Listing Rule 5550(b)(1), which requires that a listed company&#8217;s stockholders&#8217;
equity be at least $<span id="xdx_903_eus-gaap--StockholdersEquity_iI_pn5n6_c20230131__srt--RangeAxis__srt--MinimumMember_zAMGyi7Eedjf" title="Stockholders equity">2.5</span> million (the &#8220;Minimum Stockholders&#8217; Equity Requirement&#8221;). As reported in its Form 10-Q for
the period ended January 31, 2023, the Company&#8217;s stockholders&#8217; equity as of January 31, 2023 was approximately $(<span id="xdx_902_eus-gaap--StockholdersEquity_iI_pn5n6_c20230131_zqYuvOsXPlHl" title="Stockholders equity">11.7</span>) million.
In addition, the Company did not meet the alternatives of listed securities or net income from continuing operations as of the date of
the letter. The Nasdaq has given the Company until January 22, 2024 to regain compliance with the Minimum Stockholders&#8217; Equity
Requirement and net income from continuing operations requirement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company offers no assurance that it will regain compliance with the Minimum Stockholders&#8217; Equity Requirement
and/or any other delinquency in a timely manner.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_80F_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zjWPmYMu9nQi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
13: <span id="xdx_82B_zjiePuo1q2af">COMMITMENTS AND CONTINGENCIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Leases</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company leases office space under short-term leases with terms under a year. Total rent expense for the years ended April 30, 2023 and
2022 amounted to $<span id="xdx_905_eus-gaap--PaymentsForRent_pp0p0_c20220501__20230430_zNEXEyQmS4fk" title="Rent expense">4,900</span> and $<span id="xdx_908_eus-gaap--PaymentsForRent_pp0p0_c20210501__20220430_zSXcB4bFqmj9" title="Rent expense">22,176</span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Contingencies</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Gameface acquisition on February 2, 2022, the Company agreed to earn-out consideration of common shares of the Company&#8217;s
common stock with a fair value of $<span id="xdx_909_ecustom--FairValueOfCommonStock_iI_pp0p0_c20230131_z9QURvQkW99e" title="Fair value of common stock"><span id="xdx_901_ecustom--FairValueOfCommonStock_iI_pp0p0_c20220430_zpRgqrLPkkeb" title="Fair value of common stock">1,334,000</span></span> which is included as a current liability on the Company&#8217;s consolidated balance sheet
as of January 31, 2023 and April 30, 2022. The Company issued <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20220601__20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zM5bJm1NXWqd" title="Number of stock issued">598,396</span> common shares to the former Gameface shareholders in June 2022.
The balance of the contingent consideration as of April 30, 2023 is $<span id="xdx_90F_eus-gaap--BusinessCombinationContingentConsiderationLiability_iI_c20230430_zI3he9HkvW3l" title="Balance of contingent consideration">418,455</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, the Company may become involved in legal proceedings arising in the ordinary course of business. The Company is not presently
a party to any legal proceedings that it currently believes would individually or taken together have a material adverse effect on the
Company&#8217;s business or financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Nasdaq
Compliance</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 26, 2023, the Company received a letter from the Listing Qualifications Department of Nasdaq indicating that the Company&#8217;s
stockholders&#8217; equity as reported in its Quarterly Report on Form 10-Q for the quarterly period ended January 31, 2023 did not satisfy
the continued listing requirement under Nasdaq Listing Rule 5550(b)(1), which requires that a listed company&#8217;s stockholders&#8217;
equity be at least $<span id="xdx_903_eus-gaap--StockholdersEquity_iI_pn5n6_c20230131__srt--RangeAxis__srt--MinimumMember_zY8omWpaUswe" title="Stockholders equity">2.5</span> million (the &#8220;Minimum Stockholders&#8217; Equity Requirement&#8221;). As reported in its Form 10-Q for
the period ended January 31, 2023, the Company&#8217;s stockholders&#8217; equity as of January 31, 2023 was approximately $(<span id="xdx_902_eus-gaap--StockholdersEquity_iI_pn5n6_c20230131_zd3uUfSphxl8" title="Stockholders equity">11.7</span>) million.
In addition, the Company did not meet the alternatives of listed securities or net income from continuing operations as of the date of
the letter. The Nasdaq has given the Company until January 22, 2024 to regain compliance with the Minimum Stockholders&#8217;
Equity Requirement and net income from continuing operations requirement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company offers no assurance that it will regain compliance with the Minimum Stockholders&#8217; Equity Requirement and/or any other delinquency in a timely manner.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//450/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480327/954-440-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007864491328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DISCONTINUED OPERATIONS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2023</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock', window );">DISCONTINUED OPERATIONS</a></td>
<td class="text"><p id="xdx_80A_eus-gaap--DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_zqsTLSMtcog6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
13</b>: <b><span id="xdx_822_zOLqE3kwNLeh">DISCONTINUED OPERATIONS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 27, 2022, the Company entered into a share purchase agreement (the &#8220;Agreement&#8221;) with PlaySight, Chen Shachar and
Evgeni Khazanov (together, the &#8220;Buyer&#8221;) pursuant to which the Buyer purchased <span id="xdx_90D_ecustom--SharesIssuedAndOutstandingPercentage_pid_dp_uPure_c20221125__20221127__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember_zJU0KbEi8TAb" title="Shares issued and outstanding percentage">100</span>% of the issued and outstanding shares of
PlaySight from the Company in exchange for <span id="xdx_905_eus-gaap--DisposalGroupIncludingDiscontinuedOperationDescriptionAndTimingOfDisposal_c20221125__20221127__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember_zG6yH5PSSKy8" title="Discontinued operation description">(1) releasing the Company from all of PlaySight&#8217;s obligations towards its vendors, employees,
tax authorities and any other (past, current and future) creditors of PlaySight; (2) waiver by the Buyer of 100% of the personal consideration
owed to them under their employment agreements in the total amount of $<span id="xdx_909_eus-gaap--DisposalGroupIncludingDiscontinuedOperationConsideration_iI_c20221127__us-gaap--TypeOfArrangementAxis__custom--EmployeeAgreementMember_zAV7iMwVqdic" title="Personal consideration">600,000</span>; and (3) cash consideration of $<span id="xdx_906_eus-gaap--DisposalGroupIncludingDiscontinuedOperationConsideration_iI_c20221127__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember_ztSWoFANk2h3" title="Cash consideration">2,000,000</span> to be paid to
the Company in the form of a promissory note that matures on December 31, 2023.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 5, 2022, the Company assigned <span id="xdx_90A_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20221205__srt--OwnershipAxis__custom--FoundationSportsToCharlesRuddyMember_ziH1sCbkdwfd" title="Ownership percentage by parrent">75</span>% of its membership interest in Foundation Sports to Charles Ruddy, its founder and granted
him the right for a period of three years to purchase the remaining <span id="xdx_901_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_iI_pid_dp_uPure_c20221205__srt--OwnershipAxis__custom--FoundationSportsToCharlesRuddyMember_zKu9bTBjuC3h" title="Ownership percentage by non-controlling owners">25</span>% of its Foundation Sports membership interests for $<span id="xdx_90F_eus-gaap--Cash_iI_c20221205_z77Df8HlJ1E4" title="Cash">500,000</span> in
cash. As of December 5, 2022, the results of Foundation Sports will no longer be consolidated in the Company&#8217;s financial statements,
and the investment was accounted for as an equity method investment. On December 5, 2022, the Company analyzed this investment and established
a reserve for the investment at the full amount of $<span id="xdx_90A_eus-gaap--Investments_iI_c20221205_zKUuewtlAQVk" title="Investments">500,000</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounted for these sales as a disposal of a business under ASC 205-20-50-1(a). The Company had reclassified the operations of
PlaySight and Foundation Sports as discontinued operations as the disposal represents a strategic shift that will have a major effect
on the Company&#8217;s operations and financial results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_897_eus-gaap--ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_zD9USQreYrA2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company reclassified the following operations to discontinued operations for the three months ended July 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;<span id="xdx_8BF_zlX69MpnFq96" style="display: none">SCHEDULE OF DISCONTINUED OPERATIONS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49B_20230501__20230731_z6vBlsAeZem6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--DisposalGroupIncludingDiscontinuedOperationRevenue_maDGIDOzOqT_zTX4Zsk8tpa8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 78%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,363,113</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOperatingExpense_msDGIDOzOqT_zN6SKIa4H6Ua" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,278,269</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_407_ecustom--DisposalGroupIncludingDiscontinuedOperationOtherIncomeLoss_msDGIDOzOqT_zt6ZTRD3r8wb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other (income) loss</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(155,442</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_401_ecustom--DisposalGroupIncludingDiscontinuedOperationNetIncomeLoss_iT_mtDGIDOzOqT_zYbWwszeHEt3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net loss from discontinued
    operations</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,759,714</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  </table>

<p id="xdx_8AE_znieVEgpL9ag" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_80A_eus-gaap--DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_zwsZSvFZtAk4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
16</b>: <b><span id="xdx_828_z23vD9hsucn1">DISCONTINUED OPERATIONS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 27, 2022, the Company entered into a share purchase agreement (the &#8220;Agreement&#8221;) with PlaySight, Chen Shachar and
Evgeni Khazanov (together, the &#8220;Buyer&#8221;) pursuant to which the Buyer purchased <span id="xdx_90C_ecustom--SharesIssuedAndOutstandingPercentage_pid_dp_uPure_c20221125__20221127__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember_zjOgkC4qRdQ3" title="Shares issued and outstanding percentage">100</span>% of the issued and outstanding shares of
PlaySight from the Company in exchange for <span id="xdx_905_eus-gaap--DisposalGroupIncludingDiscontinuedOperationDescriptionAndTimingOfDisposal_c20221125__20221127__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember_zZuZe1JBGEa2" title="Discontinued operation description">(1) releasing the Company from all of PlaySight&#8217;s obligations towards its vendors, employees,
tax authorities and any other (past, current and future) creditors of PlaySight; (2) waiver by the Buyer of 100% of the personal consideration
owed to them under their employment agreements in the total amount of $<span id="xdx_90C_eus-gaap--DisposalGroupIncludingDiscontinuedOperationConsideration_iI_c20221127__us-gaap--TypeOfArrangementAxis__custom--EmployeeAgreementMember_z5TZaBZUjYu8" title="Personal consideration">600,000</span>; and (3) cash consideration of $<span id="xdx_906_eus-gaap--DisposalGroupIncludingDiscontinuedOperationConsideration_iI_c20221127__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember_zHoboyNdfP0b" title="Cash consideration">2,000,000</span> to be paid to
the Company in the form of a promissory note that matures on December 31, 2023.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 5, 2022, the Company assigned <span id="xdx_90A_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20221205__srt--OwnershipAxis__custom--FoundationSportsToCharlesRuddyMember_z6yOhx9vHuv7" title="Ownership percentage by parrent">75</span>% of its membership interest in Foundation Sports to Charles Ruddy, its founder and granted
him the right for a period of three years to purchase the remaining <span id="xdx_901_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_iI_pid_dp_uPure_c20221205__srt--OwnershipAxis__custom--FoundationSportsToCharlesRuddyMember_zcGeYGz2HuQ3" title="Ownership percentage by non-controlling owners">25</span>% of its Foundation Sports membership interests for $<span id="xdx_90F_eus-gaap--Cash_iI_c20221205_zgZgBFBsMjhc" title="Cash">500,000</span> in
cash. As of December 5, 2022, the results of Foundation Sports will no longer be consolidated in the Company&#8217;s financial statements,
and the investment was accounted for as an equity method investment. On December 5, 2022, the Company analyzed this investment and established
a reserve for the investment at the full amount of $<span id="xdx_90A_eus-gaap--Investments_iI_c20221205_zei3nOBfOUDg" title="Investments">500,000</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounted for these sales as a disposal of a business under ASC 205-20-50-1(a). The Company had reclassified the operations of
PlaySight and Foundation Sports as discontinued operations as the disposal represents a strategic shift that will have a major effect
on the Company&#8217;s operations and financial results. Under ASC 855-10-55, the Company has reflected the reclassification of assets
and liabilities of these entities as held for sale and the operations as discontinued operations as of and for the year ended April 30,
2022 as well as for the period May 1, 2022 through the date of disposal for each company. As a result of this reclassification, the Company
identified the following assets and liabilities that were reclassified from continuing operations to discontinued operations as they
are discontinued.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_897_eus-gaap--ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_zr6y7QmCcvs3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current
assets as of April 30, 2022 &#8211; Discontinued Operations:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BF_zS55T0AWOdM3" style="display: none">SCHEDULE OF DISCONTINUED OPERATIONS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20220430_zAXYTYYV3Pne" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">April 30, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_iI_maAODGIzvOg_zNbesnP5QK2k" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: left">Cash and restricted cash</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">916,082</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_iI_maAODGIzvOg_zdDC2skQzck8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accounts receivable</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">288,980</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_iI_maAODGIzvOg_zlLcREfZLJ4h" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">Inventory</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">323,307</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesCurrent_iI_maAODGIzvOg_zGlG9f4oYRSh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Right of use asset &#8211; operating leases</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">239,689</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_iI_maAODGIzvOg_zsJimypo1AG2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Prepaid expenses</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">490,260</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_iI_mtAODGIzvOg_z3FiX2D68ymj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Current Asset</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">2,258,318</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-current
assets as of April 30, 2022 &#8211; Discontinued Operations:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20220430_zGKs8tZid6s3" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">April 30, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent_iI_maDGIDOzWYq_zVWAQYz7uwB7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 80%">Goodwill</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">25,862,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent_iI_maDGIDOzWYq_zys3pYq034kc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Property and equipment, net</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">126,862</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent_iI_maDGIDOzWYq_zeQRqCFy3RE7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Intangible assets, net</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">19,473,646</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets_iI_maDGIDOzWYq_z4dQgbkQTPF6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Contract assets, net of current portion</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">209,363</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--DisposalGroupIncludingDiscontinuedOperationInventoryNoncurrent_iI_maDGIDOzWYq_zKzdc3EJ5mP2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Finished products used in operations, net</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">4,693,575</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent_iTI_mtDGIDOzWYq_zOlJYK0X4Esl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-current Asset</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">50,365,446</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current
liabilities as of April 30, 2022 &#8211; Discontinued Operations:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_490_20220430_z3C8XOSHfqid" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">April 30, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent_iI_maLODGIzSPI_zeW9FtDqNNx9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: left">Accounts payable and accrued expenses</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">2,432,818</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityOperatingLeasesCurrent_iI_maLODGIzSPI_z1fKG0C7uLzd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Lease liability &#8211; operating leases</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">237,204</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_iI_maLODGIzSPI_z5oXsB11HdIe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Contract liabilities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">2,545,200</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_iTI_mtLODGIzSPI_zyAFqNfeWXy5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Current Liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">5,215,222</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-current
liabilities as of April 30, 2022 &#8211; Discontinued Operations:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20220430_zhtEx84wNVr3" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">April 30, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities_iI_z16OtV0zyiT8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: left">Contract liabilities, net of current portion</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">1,370,492</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent_iTI_zqQDyCr2mKQf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Current Liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">1,370,492</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company reclassified the following operations to discontinued operations for the years ended April 30, 2023 and 2022, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_499_20220501__20230430_zDERT3DSewv8" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20210501__20220430_zJapoXaVfHd7" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--DisposalGroupIncludingDiscontinuedOperationRevenue_maDGIDOzOqT_zeWuCX7w9BJa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 64%">Revenue</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">3,954,149</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">728,805</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOperatingExpense_msDGIDOzOqT_zr3tWtPGQDgc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Operating expenses</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">8,416,117</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">5,948,508</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--DisposalGroupIncludingDiscontinuedOperationOtherIncomeLoss_msDGIDOzOqT_zYceM7Z9yMs5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Other (income) loss</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2750">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">27,974</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--DisposalGroupIncludingDiscontinuedOperationNetIncomeLoss_iT_mtDGIDOzOqT_zRg2zyDOURul" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Net loss from discontinued operations</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(4,461,968</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(5,247,677</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>


<p id="xdx_8A6_zoBsu1uVpcY2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p id="xdx_892_ecustom--ScheduleOfCalculationOfTheLossOnDisposalTableTextBlock_za4oTSQUDTGb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following represents the calculation of the loss on disposal of PlaySight and Foundation Sports:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BD_zTqKPL8EhYYa" style="display: none">SCHEDULE OF CALCULATION OF THE LOSS ON DISPOSAL</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_49C_20230430__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--PlaySightAndFoundationSportsMember_zK9sBTh5L6z7" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_iI_zn03MDRPyxcl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 84%; text-align: left">Note receivable</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">2,000,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_iNI_di_zkUH2AW88oId" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Cash and restricted cash</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(714,507</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_40B_ecustom--DisposalGroupIncludingDiscontinuedOperationAccountsReceivable_iI_zZFpJqoLXvxf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accounts receivable</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(411,249</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_iNI_di_zl12gf6FqCTi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Prepaid expenses</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(106,031</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--DisposalGroupIncludingDiscontinuedOperationInventory1_iNI_di_za1eheOaBBYk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">Inventory</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(296,920</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherAssets_iNI_di_zg0Yzds1vmu2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Finished products used in operations</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(4,117,986</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_40B_ecustom--DisposalGroupIncludingDiscontinuedOperationContractAssets_iI_zCLtxuXTSZak" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Contract assets</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(298,162</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_40C_ecustom--DisposalGroupIncludingDiscontinuedOperationRightOfUseAsset_iI_zGWJgZuu6w8b" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Right of use asset</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(103,228</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--DisposalGroupIncludingDiscontinuedOperationGoodwill1_iNI_di_zPLmUSwo4hPf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">Goodwill</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(25,862,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_407_eus-gaap--DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_iNI_di_zeJH3gAdTAt7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Property and equipment</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(116,505</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_40F_eus-gaap--DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_iNI_di_zkLVx0OIHIp6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Intangible assets</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(18,576,475</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_405_ecustom--DisposalGroupIncludingDiscontinuedOperationContractLiabilities_iI_zFHdNclfSDc5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Contract liabilities</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3,785,408</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_iI_z9Yd9DZxM7l1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Lease liabilities</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">78,016</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_iI_zb9hKD2ofYD2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Accounts payable and accrued expenses</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">3,325,747</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--DisposalGroupIncludingDiscontinuedOperationLossOnDisposalOfDiscontinuedOperations_iI_z9xd8SmzKwz1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Loss on disposal of discontinued operations</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(41,413,892</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

<p id="xdx_8AC_zPuTFFglNmvf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//205-20/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//360/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007864570784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2023</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text"><p id="xdx_805_eus-gaap--SubsequentEventsTextBlock_zwySO9EnbtKi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
14: <span id="xdx_829_zEX5YMHawsth">SUBSEQUENT EVENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
August 1, 2023 through the date hereof, the Company issued the following shares of common stock:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 1, 2023, the Company issued <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230801__20230801__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zy8F1mTvx409" title="Shares issued">31,042</span> shares of common stock to Armistice upon the exercise of its Pre-Funded Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 17, 2023, the Company issued <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230817__20230817__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RodneyRapsonMember_zwKXAt1sXCP1" title="Shares issued">1,876</span> shares of common stock to Rodney Rapson as compensation for Mr. Rapson&#8217;s advisory services
under the advisory agreement between the Company and Mr. Rapson.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 31, 2023, the Company issued <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20230831__20230831__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zzcDYDKRgBqc" title="Conversion of convertible securities">42,500</span> shares of common stock to the Lender (as defined below) in connection with the Conversion
(as defined below).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 18, 2023, the Company issued <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230918__20230918__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zjELcZ0dh7qk" title="Shares issued">125,134</span> shares of common stock to Armistice upon the exercise of its Pre-Funded Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 19, 2023, the Company issued <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230919__20230919__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zfkU79xTYOBa" title="Shares issued">9,444</span> shares of common stock to Armistice upon the exercise of its Pre-Funded Warrants.</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>UFS
Agreement</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 7, 2023, the Company entered into an agreement with UFS (the &#8220;UFS Agreement&#8221;) pursuant to which the Company sold $<span id="xdx_90C_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20230807__20230807__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--UFSAgreementMember_zlzl3d4gVVS2" title="Sale of consideration received">797,500</span>
in future receivables (the &#8220;UFS Second Receivables Purchased Amount&#8221;) to UFS in exchange for payment to the Company of $<span id="xdx_900_eus-gaap--PaymentsToAcquireReceivables_c20230807__20230807__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--UFSAgreementMember_zsK9iEPe5qtf" title="Payment for exchange received amount">550,000</span>
in cash less fees of $<span id="xdx_90C_ecustom--CashLessFees_c20230807__20230807__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--UFSAgreementMember_zkiL1HtQX6Mj" title="Cash less fees">50,000</span>. The Company agreed to pay UFS $<span id="xdx_903_eus-gaap--PaymentsToAcquireReceivables_c20230807__20230807__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--UFSAgreementMember__srt--StatementScenarioAxis__custom--EachWeekForNextThreeWeeksMember_zE0DtvmpYZz6" title="Payment for exchange received amount">30,000</span> each week until the UFS Second Receivables Purchased Amount is paid
in full.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to secure payment and performance of the Company&#8217;s obligations to UFS under the UFS Agreement, the Company granted to UFS
a security interest in the following collateral: all accounts receivable and all proceeds as such term is defined by Article 9 of the
UCC. The Company also agreed not to create, incur, assume, or permit to exist, directly or indirectly, any lien on or with respect to
any of such collateral.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 21, 2023, the Company amended its arrangement with MidCity and agreed to issue <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230821__20230821__us-gaap--TypeOfArrangementAxis__custom--AmendedUFSAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zqqJzfmOueFa" title="Shares issued">42,500</span> shares of stock monthly for eight months
to settle the profit guarantee under its prior note arrangement from April 2020. The parties agreed to a one-time true-up at March 31,
2024 if any further amounts are due MidCity at that time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 19, 2023, the Company entered into an agreement with Meged (the &#8220;Second Meged Agreement&#8221;) pursuant to which the
Company sold $<span id="xdx_90D_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20230919__20230919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecondMegedAgreementMember_zQXZfHWwcmr4" title="Sale of consideration received">423,000</span> in future receivables to Meged (the &#8220;Meged Second Receivable Amount&#8221;) in exchange for paying the then
outstanding balance of $<span id="xdx_90A_eus-gaap--PaymentsToAcquireReceivables_pp2d_c20230919__20230919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecondMegedAgreementMember_zr2zndDoqNxi" title="Outstanding balance receivable">70,153.20</span> of the Meged Receivables Purchased Amount in full with the balance being retained by the Company in
cash for general purposes. The Company agreed to pay Meged $<span id="xdx_90C_eus-gaap--PaymentsToAcquireReceivables_pp2d_c20230919__20230919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecondMegedAgreementMember__srt--StatementScenarioAxis__custom--EachWeekForNextThreeWeeksMember_zIuYNxo8FP7k" title="Payment for exchange received amount">15,107.14</span> each week until the Meged Second Receivable Amount is paid in full.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to secure payment and performance of the Company&#8217;s obligations to Meged under the Second Meged Agreement, the Company granted
to Meged a security interest in the following collateral: all accounts receivable and all proceeds as such term is defined by Article
9 of the UCC. The Company also agreed not to create, incur, assume, or permit to exist, directly or indirectly, any lien on or with respect
to any of such collateral.</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_805_eus-gaap--SubsequentEventsTextBlock_z9wH6lRDqGE7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
17: <span id="xdx_82F_zMPsKc3EwkGh">SUBSEQUENT EVENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
May 1, 2023 through the date hereof, the Company issued <span id="xdx_909_eus-gaap--SharesIssued_iI_c20230501__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zJhRcohjUOX8">220,760
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock to ambassadors under
their agreements (<span id="xdx_903_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230501__20230501__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zMy6hNdawBng">188</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">),
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to vendors in settlement of accounts payable (<span id="xdx_907_ecustom--StockIssuedDuringPeriodSharesIssuedSettlementOfAccountsPayable_c20230501__20230501__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zWoqslG9CPc5">67,500</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">),
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for settlement with former owners of FSS (<span id="xdx_900_ecustom--StockIssuedDuringPeriodSharesIssuedSettlementWithFormerOwners_c20230501__20230501__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zTri4ZwSMI6">1,3500</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">),
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for the exercise of warrants (<span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20230501__20230501__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zg0K9SOpZya4">58,042</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and to satisfy the profit guarantee on a note (<span id="xdx_908_ecustom--StockIssuedDuringPeriodSharesIssuedProfitGuaranteeOnNote_c20230501__20230501__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zjnsMR0ms818">93,681</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Meged
Agreement </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 8, 2023, the Company entered into a merchant cash advance agreement with Meged Funding Group (&#8220;Meged&#8221;) pursuant to which
the Company sold $<span id="xdx_901_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_pp2d_c20230608__20230608__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--MegedAgreementMember_z2iV8onaWnQ8" title="Sale of consideration received">315,689</span> in future receivables to Meged (the &#8220;Meged Receivables Purchased Amount&#8221;) to in exchange for
payment to the Company of $<span id="xdx_909_eus-gaap--PaymentsToAcquireReceivables_c20230608__20230608__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--MegedAgreementMember_zQKlZyehrFNe" title="Payment for exchange received amount">210,600</span> in cash less fees of $<span id="xdx_904_ecustom--CashLessFees_c20230608__20230608__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--MegedAgreementMember_zqSryT44Kf4i" title="Cash less fees">10,580</span>. The Company has agreed to pay Meged $<span id="xdx_908_eus-gaap--PaymentsToAcquireReceivables_pp2d_c20230608__20230608__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--MegedAgreementMember__srt--StatementScenarioAxis__custom--EachWeekForNextThreeWeeksMember_zusOWbSpxus5" title="Payment for exchange received amount">17,538</span> each week until the Meged
Receivables Purchased Amount is paid in full.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>UFS
Agreement</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 7, 2023, the Company entered into an agreement with UFS (the &#8220;UFS Agreement&#8221;) pursuant to which the Company sold $<span id="xdx_906_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20230807__20230807__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--UFSAgreementMember_zaAOwptmUE7i" title="Sale of consideration received">797,500</span>
in future receivables (the &#8220;UFS Second Receivables Purchased Amount&#8221;) to UFS in exchange for payment to the Company of $<span id="xdx_90F_eus-gaap--PaymentsToAcquireReceivables_c20230807__20230807__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--UFSAgreementMember_zBeAXivopmge" title="Payment for exchange received amount">550,000</span>
in cash less fees of $<span id="xdx_90C_ecustom--CashLessFees_c20230807__20230807__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--UFSAgreementMember_zzVSmgVgr7n6" title="Cash less fees">50,000</span>. The Company has agreed to pay UFS $<span id="xdx_903_eus-gaap--PaymentsToAcquireReceivables_c20230807__20230807__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--UFSAgreementMember__srt--StatementScenarioAxis__custom--EachWeekForNextThreeWeeksMember_zsSFQkWW9IXf" title="Payment for exchange received amount">30,000</span> each week until the UFS Second Receivables Purchased Amount is
paid in full.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to secure payment and performance of the Company&#8217;s obligations to UFS under the UFS Agreement, the Company granted to UFS
a security interest in the following collateral: all accounts receivable and all proceeds as such term is defined by Article 9 of the
UCC. The Company also agreed not to create, incur, assume, or permit to exist, directly or indirectly, any lien on or with respect to
any of such collateral.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 13, the Company held a special meeting
of stockholders in which the following items were approved: (i) the issuance of (i) <span id="xdx_909_eus-gaap--StockRepurchasedDuringPeriodShares_c20230912__20230913__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zLV1jyoeypKk">1,018,510 </span>shares of the our common stock, par value
$<span id="xdx_900_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20230913__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zKjOVtyCWTb8">0.001</span> per share, that were issued on October 3, 2022, and, (ii) <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20221002__20221003__us-gaap--AwardTypeAxis__custom--PreFundedWarrantMember_zlTLu0CsA2lk">11,802,002</span> shares of our common stock issuable upon exercise of Pre-Funded
Warrants at an exercise price of $<span id="xdx_902_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20221003__us-gaap--AwardTypeAxis__custom--PreFundedWarrantMember_zcFRp7Ya7Fp4">0.00001</span> per share, (iii) <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20221002__20221003__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zluBkmRJAQz8">12,820,512</span> shares of common stock issuable upon the exercise of <span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20221003__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zzzhDKH1IaR4">5</span>-Year Warrants
at an exercise price of $<span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20221003__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zqB7XjdJPAM6">0.39</span> per share, (iv) <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20221002__20221003__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember_zbnfyzkndwwd">25,641,024</span> shares of common stock issuable upon the exercise of <span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20221003__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember_zHx51HB4Kmre">7.5</span> Year Warrants at an
exercise price of $<span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20221003__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zNPVLHhdh6xi">0.43</span> per share and (v) <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20221002__20221003__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember_z30auCts6hli">18,099,548</span> shares of our common stock issuable upon the exercise of <span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20221003__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember_zflm2AWE4bik">5.5</span> Year Warrants at an exercise price per share equal to $<span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20221003_zqC1WoDZDr1k">0.221</span> per share to Armistice Capital Master Fund Ltd and (ii) a reverse stock split of our common
stock within a range of one (1)-for-ten (10) to one (1)-for-forty (40) (&#8220;Reverse Stock Split&#8221;), with the Board of Directors
of the Company to set the specific ratio and determine the date for the reverse split to be effective and any other action deemed necessary
to effectuate the Reverse Stock Split, without further approval or authorization of stockholders, at any time within 12 months of the
special meeting date.</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007864473664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS AND BUSINESS COMBINATIONS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">ACQUISITIONS AND BUSINESS COMBINATIONS</a></td>
<td class="text"><p id="xdx_804_eus-gaap--BusinessCombinationDisclosureTextBlock_zIBVLAVytOQ9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
5: <span id="xdx_824_z7eVkjqDa1v8">ACQUISITIONS AND BUSINESS COMBINATIONS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the year ended April 30, 2022, the Company acquired three entities in accordance with ASC 805. A full description of those transactions
is reflected in the audited financial statements contained in our Annual Report on Form 10-K filed with the Securities and Exchange
Commission on May 17, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has elected to apply pushdown accounting to each of the entities acquired.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
Foundation Sports as referred to in Note 16, the Company disposed of <span id="xdx_900_ecustom--DisposalEquityInterestOwnershipInterestPercentage_iI_pid_dp_uPure_c20221231__us-gaap--BusinessAcquisitionAxis__custom--FoundationSportsMember_zZqNxeNgxswg" title="Disposal equity interest percentage">75%</span> of this entity in December 2022. The company has valued the
<span id="xdx_904_eus-gaap--DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal_pid_dp_uPure_c20220501__20230430__us-gaap--BusinessAcquisitionAxis__custom--FoundationSportsSystemsLLCMember_z8mHPy8uk5J9" title="Discontinuing operations percentage">25%</span> they continue to own in Foundation Sports at $<span id="xdx_907_eus-gaap--AlternativeInvestment_iI_dp_c20230430__us-gaap--BusinessAcquisitionAxis__custom--FoundationSportsSystemsLLCMember_zPj3kCTGBYG8" title="Investments">0</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
PlaySight as referred to in Note 16, the Company sold back to the original shareholders <span id="xdx_90C_ecustom--DisposalEquityInterestOwnershipInterestPercentage_iI_pid_dp_c20221130__us-gaap--BusinessAcquisitionAxis__custom--PlaySightMember_zbvbEbOGXx6b" title="Disposal equity interest percentage">100</span>% of this entity in November 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pro
Forma Results</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following pro forma financial information presents the results of operations of the Company as of the year ended April 30, 2022, respectively,
as if the acquisitions of Gameface had occurred as of the beginning of the first period presented instead of February 2022.</span></p>

<p id="xdx_898_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_zyENlt8bYm4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B7_zFAhyN7MQ28c" style="display: none">SCHEDULE OF PROFORMA FINANCIAL INFORMATION</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_495_20220501__20230430__us-gaap--BusinessAcquisitionAxis__custom--PlaySightAndGameFaceMember_zVxQYrY8QOx8" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--BusinessAcquisitionsProFormaRevenue_zM2xjz0arDz" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 80%">Revenues</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">16,102,672</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_zN8TPAqShFb8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Net loss</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(53,069,215</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Basic and diluted earnings (loss) per share</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_903_eus-gaap--BusinessAcquisitionProFormaEarningsPerShareBasic_pid_c20220501__20230430__us-gaap--BusinessAcquisitionAxis__custom--PlaySightAndGameFaceMember_zDPrP6mamX03" title="Basic earnings (loss) per share"><span id="xdx_90D_eus-gaap--BusinessAcquisitionProFormaEarningsPerShareDiluted_pid_c20220501__20230430__us-gaap--BusinessAcquisitionAxis__custom--PlaySightAndGameFaceMember_zFKKqatP7QUb" title="Diluted earnings (loss) per share">(13.79</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  </table>

<p id="xdx_8A1_zLsYqKyzO9he" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//805/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007864478160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE PAYABLE - RELATED PARTY<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2023</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">NOTE PAYABLE - RELATED PARTY</a></td>
<td class="text"><p id="xdx_806_eus-gaap--DebtDisclosureTextBlock_zQvQCyP8YwC" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
7: <span id="xdx_82C_zP6VnEk0igv6">NOTE PAYABLE &#8211; RELATED PARTY</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
discussion of note payable &#8211; related party only includes those that existed as of April 30, 2023. For a discussion of all prior
note payable &#8211; related party we refer you to the Annual Report on Form 10-K filed September 14, 2023 for the fiscal year end April
30, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 14, 2022, the Company entered into two loan agreements with related party lenders, each for $<span id="xdx_905_eus-gaap--LoansPayable_iI_c20220114__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zOuZbdwjQKyd" title="Loans payable">1,000,000</span>, pursuant to which the
Company received a total amount of $<span id="xdx_904_eus-gaap--ProceedsFromRelatedPartyDebt_c20220113__20220114__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zStnO0B0KIy" title="Proceeds from related party debt">2,000,000</span>. The loans bear interest at a rate of <span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20220114__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zIAMsQ4zg99e" title="Interest rate">8</span>% per annum and are required to be repaid in full
by April 30, 2022 or such other date as may be accepted by the lenders. The Company is not permitted to make any distribution or pay
any dividends unless or until the loans are repaid in full. On June 28, 2022, the Company entered into amendments for the two related
party loan agreements with the lenders in which the repayment date was extended to July 31, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
was $<span id="xdx_900_eus-gaap--NotesPayable_iI_c20230731__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zHiDvsuEX3E8" title="Outstanding borrowings">1,655,966</span> and $<span id="xdx_901_eus-gaap--NotesPayable_iI_c20230430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z8btvF5Q4S7f" title="Outstanding borrowings">1,953,842</span> in outstanding borrowings from related parties as of July 31, 2023 and April 30, 2023. Interest expense
related to the related parties for the three months ended July 31, 2023 and 2022 amounted to $<span id="xdx_90F_eus-gaap--InterestExpense_pp0p0_dxL_c20230501__20230731__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zo8hpH2syyhc" title="Interest expense::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl0980">0</span></span> and $<span id="xdx_90F_eus-gaap--InterestExpense_pp0p0_c20220501__20220731__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zpHx78pL61v1" title="Interest expense">61,121</span>, respectively. Accrued interest
due to related parties as of July 31, 2023 and April 30, 2023 amounted to $<span id="xdx_909_eus-gaap--InterestPayableCurrent_iI_c20230731__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zrnaeNlv0Wy5" title="Accrued interest">917,957</span> and $<span id="xdx_90B_eus-gaap--InterestPayableCurrent_iI_c20230430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zk3QkPxIbLP" title="Accrued interest">917,957</span>, respectively. The accrued interest includes
notes that were either repaid or converted but the interest remained.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 6, 2023, we sold certain of our inventory including all components, parts, additions and accessions thereto to Yonah Kalfa and
Naftali Kalfa who immediately consigned it back to us in exchange for a payment of $<span id="xdx_902_ecustom--PaymentForExchangeOfNotesPayable_c20230106__20230106__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zVDx7hTo7wFc" title="Payment of exchange">103</span> per ball launcher we sell until we have paid
them an aggregate total of $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_c20230106_z5yDxH0EXo4j" title="Debt instrumental">2,092,700</span>, which represents payment in full of the principal amounts of and accrued interest in respect of
the Loan Agreements (as defined above) and certain other expenses they incurred in connection with the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
<td class="text"><p id="xdx_808_eus-gaap--DebtDisclosureTextBlock_zE2tKhk8jNYg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
8: <span id="xdx_82D_zPX7pZTZMBLd">NOTE PAYABLE - RELATED PARTY</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
discussion of note payable &#8211; related party only includes those that existed as of April 30, 2022. For a discussion of all prior
note payable &#8211; related party we refer you to the Annual Report on Form 10-K filed May 17, 2023 for the fiscal year end April 30,
2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 14, 2022, the Company entered into two loan agreements with related party lenders, each for $<span id="xdx_905_eus-gaap--LoansPayable_iI_c20220114__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zknIW0cVSOA4" title="Loans payable">1,000,000</span>, pursuant to which the
Company received a total amount of $<span id="xdx_90E_eus-gaap--ProceedsFromRelatedPartyDebt_c20220113__20220114__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z1ZXDkC7dw0k" title="Proceeds from related party debt">2,000,000</span>. The loans bear interest at a rate of <span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20220114__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zXrfT5xWDzJk" title="Interest rate">8</span>% per annum and are required to be repaid in full
by April 30, 2022 or such other date as may be accepted by the lenders. The Company is not permitted to make any distribution or pay
any dividends unless or until the loans are repaid in full. On June 28, 2022, the Company entered into amendments for the two related
party loan agreements with the lenders in which the repayment date was extended to July 31, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
was $<span id="xdx_901_eus-gaap--NotesPayable_iI_c20230430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zUJQdH3WxUi6" title="Outstanding borrowings">1,953,842</span> and $<span id="xdx_90A_eus-gaap--NotesPayable_iI_c20220430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zRh3CbhqFaI1" title="Outstanding borrowings">2,000,000</span> in outstanding borrowings from related parties as of April 30, 2023 and 2022. Interest expense related
to the related parties for the years ended April 30, 2023 and 2022 amounted to $<span id="xdx_909_eus-gaap--InterestExpense_pp0p0_c20220501__20230430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zHcrAstEdSV5" title="Interest expense">293,090</span> &#160;and $<span id="xdx_906_eus-gaap--InterestExpense_pp0p0_c20210501__20220430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zeGFhLF6sECh" title="Interest expense">165,558</span>, respectively. Accrued interest
due to related parties as of April 30, 2023 and 2022 amounted to $<span id="xdx_90B_eus-gaap--InterestPayableCurrent_iI_c20230430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zHubxdAVsj6h" title="Accrued interest">917,957</span> and $<span id="xdx_909_eus-gaap--InterestPayableCurrent_iI_c20220430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zB7X8pl0mUFl" title="Accrued interest">908,756</span>, respectively. The accrued interest includes notes
that were either repaid or converted but the interest remained.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//470/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007864771648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text"><p id="xdx_809_eus-gaap--IncomeTaxDisclosureTextBlock_zQr52uY46vGb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
14: <span id="xdx_820_zu7xp3b83Ga8">INCOME TAXES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company does business in the US through its subsidiaries Slinger Bag Inc. and Slinger Bag Americas. It also does business in Israel through
SBL whose operations are reflected in the Company&#8217;s consolidated financial statements. The Company&#8217;s operations in Canada,
Israel, and the UK were immaterial for the years ended April 30, 2023 and 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
deferred tax assets from operations in the US, using an effective tax rate of <span id="xdx_900_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_uPure_c20220501__20230430__srt--StatementGeographicalAxis__country--US_zr0xM8rJmrf5" title="Effective tax rate">21</span>%, consisted of the following:</span></p>

<p id="xdx_89B_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_z2AE3kOtBPR6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BF_zRjK5fgziMnf" style="display: none">SCHEDULE OF NET DEFERRED TAX ASSETS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20230430_zUhHvHnWkzui" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20220430_zLOZcy4LIYvh" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Deferred tax assets:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_maDTANzBNt_zT5aGXx64QK6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left">Loss carryforwards</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">3,049,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">2,166,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--DeferredTaxAssetsStockOptions_iI_maDTANzBNt_zro8rrgGG2y6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Stock options</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">8,454,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">8,259,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--DeferredTaxAssetsAccruedPayroll_iI_maDTANzBNt_zkbAOTiKWbpf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Capital loss carryforward/Disposal</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">11,039,000</p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2570">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--DeferredTaxAssetsRelatedPartyAccruals_iI_maDTANzBNt_zju1Q1RMXwu5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Related party accruals</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,001,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">799,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--DeferredTaxAssetsInventory_iI_maDTANzBNt_z3d7L5uivjz4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Inventory reserve</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">133,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">100,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--DeferredTaxAssetsInterestDeferral_iI_maDTANzBNt_zzCDf3sfSZ56" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Interest deferral</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">221,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">191,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--DeferredTaxAssetsStartupCosts_iI_maDTANzBNt_zqK7gkOdlDXb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Start-up costs</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">81,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">84,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--DeferredTaxAssetsOther_iI_maDTANzBNt_ziLxY4zPKx7c" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">Other</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">131,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">57,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTANzBNt_zDi0uPryjKWh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Valuation allowance</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(24,109,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(11,656,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_406_eus-gaap--DeferredTaxAssetsNet_iTI_mtDTANzBNt_zrTfHcLACBXe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Net deferred tax assets</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2590">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2591">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AF_z6Mqu2TwSjfb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
income tax provision differs from the amount of income tax determined by applying the applicable statutory income tax rate to pretax
loss due to the following for the years ended April 30, 2023 and 2022:</span></p>

<p id="xdx_89B_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zZdbK7C9StIe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B4_z277PxFE5MX9" style="display: none">SCHEDULE OF INCOME TAX PROVISION</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20220501__20230430_zSYkEArpVZ7c" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20210501__20220430_zDOpuxbJ3qYf" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_zqZyBjHRvqPj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left">Income tax benefit based on book loss at US statutory rate</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">(10,983,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">(10,259,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_403_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_zhri02ZJ9u3d" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Share-based compensation and shares for services</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2598">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2599">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--IncomeTaxReconciliationDebtDiscountAmortization_zXBZ5ejqgJbd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Debt discount amortization</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">860,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,841,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--IncomeTaxReconciliationRelatedPartyAccruals_z8zDNlxx4Auj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Related party accruals</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">226,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">150,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--IncomeTaxReconciliationStartUpCosts_ziAUtmiEoAR1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Stock options</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(145,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">6,815,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--IncomeTaxRecociliationInterestExpense_zbhxuvvHojKi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Interest expense</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">79,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">5,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseDepreciation_zyQtSeco2zoc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">Depreciation</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(18,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">21,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--IncomeTaxRecociliationInventoryReserve_zmD0Ipxqcx9l" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Inventory reserve</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">26,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">55,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--IncomeTaxRecociliationInterestDeferral_zhhT14nkNcra" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Interest deferral</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(5,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">13,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--IncomeTaxRecociliationAcquisitionCosts_zzwAJg20p5t5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Acquisition costs</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">260,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,268,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--IncomeTaxRecociliationAccruedLegal_zXbwDQZrYnSh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accrued legal</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(76,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">76,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--IncomeTaxRecociliationLossOnExtinguishmentOfDebt_zu0MXotoIhv" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Loss on sale of capital assets</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">8,713,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2629">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--IncomeTaxRecociliationAccruedPayroll_zENPJxtZd2E9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accrued payroll</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2631">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2632">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--IncomeTaxRecociliationGainOnChangeInFairValueOfDerivatives_zOI3YqG0zZTh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Change in fair value of derivatives</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">481,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(1,298,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_406_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseOther_z2SFeyKefiN8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">Other</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">40,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(29,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_zfdO8oJRg5Xj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Valuation allowance</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">542,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,342,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--IncomeTaxExpenseBenefit_iT_zBfcCPiEPHC4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Total income tax provision</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2643">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2644">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AA_zIXoZIxQmxba" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company had net operating loss carryforwards of $<span id="xdx_90C_eus-gaap--OperatingLossCarryforwards_iI_c20230430__srt--StatementGeographicalAxis__country--US_z6ZgIGiLu6z7" title="Operating loss carryforwards">17,038,000</span> and $<span id="xdx_906_eus-gaap--OperatingLossCarryforwards_iI_c20220430__srt--StatementGeographicalAxis__country--US_zpxAZTuJeEY7" title="Operating loss carryforwards">12,366,000</span> as of April 30, 2023 and 2022, respectively, which may be
available to be used to offset future taxable income in the US for the years ended 2024 through 2042. The utilization of the Company&#8217;s
net operating losses may be subject to a U.S. federal limitation due to the &#8220;change in ownership provisions&#8221; under Section
382 of the Internal Revenue Code and other similar limitations in various state jurisdictions. Such limitations may result in a reduction
of the amount of net operating loss carryforwards in future years and possibly the expiration of certain net operating loss carryforwards
before their utilization. The Company has not completed a full study to assess whether an &#8220;ownership change&#8221; as defined in
Section 382 has occurred or whether there have been multiple ownership changes since inception. Future changes in the Company&#8217;s
stock ownership, which may be outside of the Company&#8217;s control, may trigger an &#8220;ownership change.&#8221; In addition, future
equity offerings or acquisitions that have equity as a component of the purchase price could result in an &#8220;ownership change.&#8221;
Tax years that remain subject to examination are 2018 and forward.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
deferred tax assets from operations in Israel, using an effective tax rate of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBERUZFUlJFRCBUQVggQVNTRVRTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90C_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_uPure_c20210501__20220430__srt--StatementGeographicalAxis__country--IL_z3D5aGPRhYrh" title="Effective tax rate">23</span>%, consisted of the following:</span></p>

<p id="xdx_89F_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_hsrt--StatementGeographicalAxis__country--IL_zkQP64j9UtEl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BB_zaO9Oav9nn7i" style="display: none">SCHEDULE OF NET DEFERRED TAX ASSETS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20230430__srt--StatementGeographicalAxis__country--IL_zrQ3hHo4o6me" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_494_20220430__srt--StatementGeographicalAxis__country--IL_zolONJx3g3ic" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Deferred tax assets:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_iI_maDTANzt5N_zzRXV9umt465" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left">Loss carryforwards</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">241,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">234,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--DeferredTaxAssetsStartupCostsForeign_iI_maDTANzt5N_zlH8a3Ay7mCl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Start-up costs</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2657">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2658">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--DeferredTaxAssetsInProcessResearchAndDevelopmentCosts_iNI_di_maDTANzt5N_zLdCDmopdcA2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Research and development costs</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(113,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(113,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTANzt5N_z5PyGyR1v4hk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Valuation allowance</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(128,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(121,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsNet_iTI_mtDTANzt5N_zo2uxdV8AiT6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Net deferred tax assets</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2666">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2667">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AF_zaEtbFcxJ7h2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
income tax provision differs from the amount of income tax determined by applying the applicable Israeli statutory income tax rate of
<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIElOQ09NRSBUQVggUFJPVklTSU9OIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_905_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_uPure_c20220501__20230430__srt--StatementGeographicalAxis__country--IL_zQ6OZxXo7yr8" title="Effective tax rate">23</span>% due to the following for the years ended April 30, 2023 and 2022:</span></p>

<p id="xdx_893_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_hsrt--StatementGeographicalAxis__country--IL_zGiHqeY3bNT9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B6_zcbxKGXTalUh" style="display: none">SCHEDULE OF INCOME TAX PROVISION</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20220501__20230430__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--IsraelTaxAuthorityMember_zzbqXDH4Buuk" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_490_20210501__20220430__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--IsraelTaxAuthorityMember_zEPgXcUk1VY5" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_maCITEBzAlg_zMdAlHiNqyX8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left">Income tax provision (benefit) based on book income (loss) at Israeli statutory rate</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">(54,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">(56,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_maCITEBzAlg_zEliVMCQHBcf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">Valuation allowance</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">54,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">56,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--IncomeTaxExpenseBenefit_mtCITEBzAlg_zlY9ZPEkmuv5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Total income tax provision</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2679">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2680">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AF_zbThvKQwT2yh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company had net operating loss carryforwards of approximately $<span id="xdx_904_eus-gaap--OperatingLossCarryforwards_iI_c20230430_zPaHsgNRFA3c" title="Operating loss carryforwards">1,049,000</span> and $<span id="xdx_90C_eus-gaap--OperatingLossCarryforwards_iI_c20220430_zxITfjTmQRc9" title="Operating loss carryforwards">1,020,000</span> as of April 30, 2023 and 2022, respectively,
which may be available to be used to offset future taxable income in Israel. All of the Company&#8217;s tax years since inception are
open for examination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s policy is to record interest and penalties on uncertain tax positions as income tax expense. There were no interest or
penalties recognized in the accompanying consolidated statements of comprehensive loss for the years ended April 30, 2023 and 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//740/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-21<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482526/740-270-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007864485760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGMENTS</a></td>
<td class="text"><p id="xdx_808_eus-gaap--SegmentReportingDisclosureTextBlock_zoL5sEzZ72a4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
15</b>: <b><span id="xdx_828_zCOawe9I3Zf9">SEGMENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
the disposal of Foundation Sports and PlaySight in November 2022 and December 2022, the Company has ceased reporting two segments. The
Company now only operates in the equipment segment. For previous segment reporting we refer you to our previously filed Annual Report
on Form 10-K filed May 17, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//280/tableOfContent<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-26<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-34<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007860683984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2023</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_InterimFinancialStatementsPolicyTextBlock', window );">Interim Financial Statements</a></td>
<td class="text"><p id="xdx_84B_ecustom--InterimFinancialStatementsPolicyTextBlock_z3ReT6v36Rv2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_863_zq2qmsTvlyJ8">Interim
Financial Statements</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying condensed financial statements of the Company have been prepared without audit, pursuant to the rules and regulations of
the Securities and Exchange Commission. Certain information and disclosures required by accounting principles generally accepted in the
United States have been condensed or omitted pursuant to such rules and regulations. These condensed financial statements reflect all
adjustments that, in the opinion of management, are necessary to present fairly the results of operations of the Company for the period
presented. The results of operations for the three months ended July 31, 2023, are not necessarily indicative of the results that may
be expected for any future period or the fiscal year ending April 30, 2024 and should be read in conjunction with the Company&#8217;s
Annual Report on Form 10-K for the year ended April 30, 2023, filed with the Securities and Exchange Commission on September 14, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p id="xdx_843_eus-gaap--UseOfEstimates_zIkrIaVahK7d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86C_zzrlLoow2ZNe">Use
of Estimates</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect
the amounts reported in the financial statements and accompanying notes. Accordingly, actual results could differ from those estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_845_eus-gaap--UseOfEstimates_zbweqBbIOfHj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_869_zZphjCY6iJMd">Use
of Estimates</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect
the amounts reported in the financial statements and accompanying notes. Accordingly, actual results could differ from those estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Financial Statement Reclassification</a></td>
<td class="text"><p id="xdx_84A_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zr5w94rNkM43" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86F_zbnq689LntWg">Financial
Statement Reclassification</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
prior year amounts within accounts payable, accrued expenses, and certain operating expenses have been reclassified for consistency with
the current year presentation and had no effect on the Company&#8217;s balance sheet, net loss, shareholders&#8217; deficit or cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_84A_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zmBTVTVg1Vzh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86D_z4iek6XCOzT7">Financial
Statement Reclassification</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
prior year amounts within accounts payable, accrued expenses, and certain operating expenses have been reclassified for consistency with
the current year presentation and had no effect on the Company&#8217;s balance sheet, net loss, shareholders&#8217; deficit or cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p id="xdx_84B_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zhD2tR7itqmd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_861_zSHAEa0JHxjh">Cash
and Cash Equivalents</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents.
The majority of payments due from banks for credit card transactions process within 24 to 48 hours and are accordingly classified as
cash and cash equivalents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_84F_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zBSpXuLMoEBl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_867_zQa3IPLkAvBk">Cash
and Cash Equivalents</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents.
The majority of payments due from banks for credit card transactions process within 24 to 48 hours and are accordingly classified as
cash and cash equivalents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy', window );">Accounts Receivable</a></td>
<td class="text"><p id="xdx_841_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zPN1BOFN4m35" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_863_zPz2KWLalQB8">Accounts
Receivable</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s accounts receivable are non-interest bearing trade receivables resulting from the sale of products and payable over terms
ranging from 15 to 60 days. The Company provides an allowance for doubtful accounts at the point when collection is considered doubtful.
Once all collection efforts have been exhausted, the Company charges-off the receivable with the allowance for doubtful accounts. The
Company recorded $<span id="xdx_907_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pdp0_do_c20230731_zhmumFZM17wi" title="Allowance for doubtful accounts">200,000</span> and $<span id="xdx_90D_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pdp0_do_c20230430_zHacZLXt7vVi" title="Allowance for doubtful accounts">209,690</span> in allowance for doubtful accounts as of July 31, 2023 and April 30, 2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_845_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zHA0nqyIm9Y3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86E_zuXjhSOa7Vce">Accounts
Receivable</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s accounts receivable are non-interest bearing trade receivables resulting from the sale of products and payable over terms
ranging from 15 to 60 days. The Company provides an allowance for doubtful accounts at the point when collection is considered doubtful.
Once all collection efforts have been exhausted, the Company charges-off the receivable with the allowance for doubtful accounts. The
Company recorded $<span id="xdx_909_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pdp0_do_c20230430_zVJAPCDSDaJ1" title="Allowance for doubtful accounts">209,690 </span>and $<span id="xdx_90F_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pdp0_do_c20220430_zQbRZFlenFp1" title="Allowance for doubtful accounts">175,000 </span>in allowance for doubtful accounts for the years ended April 30, 2023 and 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventory</a></td>
<td class="text"><p id="xdx_840_eus-gaap--InventoryPolicyTextBlock_zRZiyRgkdyL" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_861_zAr5yrHEeHy7">Inventory</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory
is valued at the lower of the cost (determined principally on a first-in, first-out basis) or net realizable value. The Company&#8217;s
valuation of inventory includes inventory reserves for inventory that will be sold below cost and the impact of inventory shrink. Inventory
reserves are based on historical information and assumptions about future demand and inventory shrink trends. The Company&#8217;s inventory
as of July 31, 2023 and April 30, 2023 consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p id="xdx_890_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zf97HVif52hc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B6_zoqiVAt0juPa" style="display: none">SCHEDULE OF INVENTORY</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_491_20230731_zE6h5LaOen1g" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">July 31, 2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_492_20230430_ziGSNULllzaa" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">April 30, 2023</td><td style="font-weight: bold">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--InventoryFinishedGoods_iI_maINzzOV_zXcYG5jS1aEb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Finished Goods</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">400,598</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">1,509,985</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--InventoryRawMaterialsAndSupplies_iI_maINzzOV_z45YZrOaZ1fb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Component/Replacement Parts</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,064,041</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,712,553</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--CapitalizedDutyAndFreight_iI_maINzzOV_zqWK1brM4sCc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Capitalized Duty/Freight</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">47,279</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">517,228</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--InventoryAdjustments_iNI_di_msINzzOV_ztNimEQags14" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Inventory Reserve</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(175,000</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(550,000</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--InventoryNet_iTI_mtINzzOV_zZKqAyFQU6p8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Total</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,336,918</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,189,766</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A2_zHURQhQOcA4b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_844_eus-gaap--InventoryPolicyTextBlock_z4GZIc49tAJc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_860_zJHbInc5rlCg">Inventory</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory
is valued at the lower of the cost (determined principally on a first-in, first-out basis) or net realizable value. The Company&#8217;s
valuation of inventory includes inventory reserves for inventory that will be sold below cost and the impact of inventory shrink. Inventory
reserves are based on historical information and assumptions about future demand and inventory shrink trends. The Company&#8217;s inventory
as of April 30, 2023 and April 30, 2022 consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_896_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zrmeoIreLo6e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_zOGEgcyNOtTi" style="display: none">SCHEDULE OF INVENTORY</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_492_20230430_zCNs6Kvremrg" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">April 30, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20220430_zUbYmp0KTAV2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">April 30, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--InventoryFinishedGoods_iI_maINzzOV_zgpMKI5OqRDg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left">Finished Goods</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">1,509,985</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">4,073,791</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--InventoryRawMaterialsAndSupplies_iI_maINzzOV_zA8Ecmzavp07" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Component/Replacement Parts</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,712,553</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2,559,848</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--CapitalizedDutyAndFreight_iI_maINzzOV_zJz4ApKsSv12" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Capitalized Duty/Freight</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">517,228</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,328,198</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--InventoryAdjustments_iNI_di_msINzzOV_zMRWSmi26TMa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Inventory Reserve</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(550,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(100,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--InventoryNet_iTI_mtINzzOV_zaS27xIt7Avl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Total</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">3,189,766</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">7,861,837</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A4_zFzPuYXmiymi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_PrepaidInventoryPolicyTextBlock', window );">Prepaid Inventory</a></td>
<td class="text"><p id="xdx_84D_ecustom--PrepaidInventoryPolicyTextBlock_zmMnuOG8vY0f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_864_zDDc8lVOgI7j">Prepaid
Inventory</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid
inventory represents inventory that is in-transit that has been paid for but not received from the Company&#8217;s third-party vendors.
The Company typically prepays for the purchase of materials and receives the products within three months after making payments. The
Company continuously monitors delivery from, and payments to, the vendors. If the Company has difficulty receiving products from a vendor,
the Company would cease purchasing products from such vendors in future periods. The Company has not had difficulty receiving products
during the reporting periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_840_ecustom--PrepaidInventoryPolicyTextBlock_zd7vebe9uPi3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_867_zPvsYKuKBeq9">Prepaid
Inventory</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid
inventory represents inventory that is in-transit that has been paid for but not received from the Company&#8217;s third-party vendors.
The Company typically prepays for the purchase of materials and receives the products within three months after making payments. The
Company continuously monitors delivery from, and payments to, the vendors. If the Company has difficulty receiving products from a vendor,
the Company would cease purchasing products from such vendors in future periods. The Company has not had difficulty receiving products
during the reporting periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and equipment</a></td>
<td class="text"><p id="xdx_84B_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zRJYPi8gDXoi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86A_zm2FNh7RXyGh">Property
and equipment</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment acquired through business combinations are stated at the estimated fair value at the date of the acquisition. Purchases
of property and equipment are stated at cost, net of accumulated depreciation and impairment losses. Expenditures that materially increase
the useful life of the assets are capitalized. Ordinary repairs and maintenance are expensed as incurred. Depreciation and amortization
are computed using the straight-line method over the estimated useful lives of the related assets, which is an average of <span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230731_zi4ZPPFFOzyh" title="Property plant and equipment, useful life">5</span> years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_840_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zinPRBGbmrKh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_865_zvMa9q1QY8T1">Property
and equipment</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment acquired through business combinations are stated at the estimated fair value at the date of the acquisition. Purchases
of property and equipment are stated at cost, net of accumulated depreciation and impairment losses. Expenditures that materially increase
the useful life of the assets are capitalized. Ordinary repairs and maintenance are expensed as incurred. Depreciation and amortization
are computed using the straight-line method over the estimated useful lives of the related assets, which is an average of <span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230430_zLmLxV15L8H2" title="Property plant and equipment, useful life">5</span> years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text"><p id="xdx_840_eus-gaap--ConcentrationRiskCreditRisk_zcbmzjBRP1f3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_866_zuHXeODpB3a4">Concentration
of Credit Risk</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company maintains its cash in bank deposit accounts, the balances of which at times may exceed insured limits. The Company continually
monitors its banking relationships and consequently has not experienced any losses in such accounts. While we may be exposed to credit
risk, we consider the risk remote and do not expect that any such risk would result in a significant effect on our results of operations
or financial condition. See Note 4 for further details on the Company&#8217;s concentration of credit risk as well as other risks and
uncertainties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_844_eus-gaap--ConcentrationRiskCreditRisk_zd7FSsePjhgi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86D_z14jdvKg80tl">Concentration
of Credit Risk</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company maintains its cash in bank deposit accounts, the balances of which at times may exceed insured limits. The Company continually
monitors its banking relationships and consequently has not experienced any losses in such accounts. While we may be exposed to credit
risk, we consider the risk remote and do not expect that any such risk would result in a significant effect on our results of operations
or financial condition. See Note 4 for further details on the Company&#8217;s concentration of credit risk as well as other risks and
uncertainties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><p id="xdx_84E_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zy1IUkRinSj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_867_zw8cnRxFDc0e">Revenue
Recognition</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes revenue for their continuing operations in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 606,
the core principle of which is that an entity should recognize revenue to depict the transfer of promised goods or services to customers
in an amount that reflects the consideration to which the entity expects to be entitled to receive in exchange for those goods or services.
The Company recognizes revenue for its performance obligation associated with its contracts with customers at a point in time once products
are shipped. Amounts collected from customers in advance of shipping products ordered are reflected as contract liabilities on the accompanying
consolidated balance sheets. The Company&#8217;s standard terms are non-cancelable and do not provide for the right-of-return, other
than for defective merchandise covered under the Company&#8217;s standard warranty. The Company has not historically experienced any
significant returns or warranty issues.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes revenue under ASC 606, &#8220;Revenue from Contracts with Customers&#8221;. The core principle of this revenue standard
is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects
the consideration to which the company expects to be entitled in exchange for those goods or services. The following five steps are applied
to achieve that core principle:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step
1: Identify the contract with the customer</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company determines that it has a contract with a customer when each party&#8217;s rights regarding the products or services to be transferred
can be identified, the payment terms for the services can be identified, the Company has determined the customer has the ability and
intent to pay, and the contract has commercial substance. At contract inception, the Company evaluates whether two or more contracts
should be combined and accounted for as a single contract and whether the combined or single contract includes more than one performance
obligation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step
2: Identify the performance obligations in the contract</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s customers are buying an integrated system. In evaluating whether the equipment is a separate performance obligation,
the Company&#8217;s management considered the customer&#8217;s ability to benefit from the equipment on its own or together with other
readily available resources and if so, whether the service and equipment are separately identifiable (i.e., is the service highly dependent
on, or highly interrelated with the equipment). Because the Products and Services included in the customer&#8217;s contract are integrated
and highly interdependent, and because they must work together to deliver the Solution, the Company has concluded that Products installed
on customer&#8217;s premise and Services contracted for by the customer are generally not distinct within the context of the contract
and, therefore, constitute a single, combined performance obligation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step
3: Determine the transaction price</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
transaction price is the amount of consideration to which an entity expects to be entitled in exchange for transferring promised goods
or services to a customer. The consideration promised in a contract with a customer includes predetermined fixed amounts, variable amounts,
or both. The Company&#8217;s contracts do not include any rights of returns or refunds.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company collects each year&#8217;s service fees in advance and should therefore consider the existence of a significant financing component.
However, due to the fact that the payments are provided for the service of a one-year term, the Company elected to apply the practical
expedient under ASC 606 which exempts the adjustment of the consideration for the existence of a significant financing component when
the period between the transfer of the services and the payment for such services is one year or less.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step
4: Allocate the transaction price to the performance obligations in the contract</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contracts
that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on
each performance obligation&#8217;s relative standalone selling price (&#8220;SSP&#8221;). The Company has identified a single performance
obligation in the contract, and therefore, the allocation provisions under ASC 606 do not apply to the Company&#8217;s contracts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step
5: Recognize revenue when the Company satisfies a performance obligation</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues
for the Company&#8217;s single, combined performance obligation are recognized on a straight-line basis over the customer&#8217;s contract
term, which is the period in which the parties to the contract have enforceable rights and obligations (Typically 3-4 years).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_84C_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_z413dCELoeZj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_862_z1ghWZ0Zkwn3">Revenue
Recognition</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes revenue for their continuing operations in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 606,
the core principle of which is that an entity should recognize revenue to depict the transfer of promised goods or services to customers
in an amount that reflects the consideration to which the entity expects to be entitled to receive in exchange for those goods or services.
The Company recognizes revenue for its performance obligation associated with its contracts with customers at a point in time once products
are shipped. Amounts collected from customers in advance of shipping products ordered are reflected as contract liabilities on the accompanying
consolidated balance sheets. The Company&#8217;s standard terms are non-cancelable and do not provide for the right-of-return, other
than for defective merchandise covered under the Company&#8217;s standard warranty. The Company has not historically experienced any
significant returns or warranty issues.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes revenue under ASC 606, &#8220;Revenue from Contracts with Customers&#8221;. The core principle of this revenue standard
is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects
the consideration to which the company expects to be entitled in exchange for those goods or services. The following five steps are applied
to achieve that core principle:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step
1: Identify the contract with the customer</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company determines that it has a contract with a customer when each party&#8217;s rights regarding the products or services to be transferred
can be identified, the payment terms for the services can be identified, the Company has determined the customer has the ability and
intent to pay, and the contract has commercial substance. At contract inception, the Company evaluates whether two or more contracts
should be combined and accounted for as a single contract and whether the combined or single contract includes more than one performance
obligation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step
2: Identify the performance obligations in the contract</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s customers are buying an integrated system. In evaluating whether the equipment is a separate performance obligation,
the Company&#8217;s management considered the customer&#8217;s ability to benefit from the equipment on its own or together with other
readily available resources and if so, whether the service and equipment are separately identifiable (i.e., is the service highly dependent
on, or highly interrelated with the equipment). Because the Products and Services included in the customer&#8217;s contract are integrated
and highly interdependent, and because they must work together to deliver the Solution, the Company has concluded that Products installed
on customer&#8217;s premise and Services contracted for by the customer are generally not distinct within the context of the contract
and, therefore, constitute a single, combined performance obligation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step
3: Determine the transaction price</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
transaction price is the amount of consideration to which an entity expects to be entitled in exchange for transferring promised goods
or services to a customer. The consideration promised in a contract with a customer includes predetermined fixed amounts, variable amounts,
or both. The Company&#8217;s contracts do not include any rights of returns or refunds.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company collects each year&#8217;s service fees in advance and should therefore consider the existence of a significant financing component.
However, due to the fact that the payments are provided for the service of a one-year term, the Company elected to apply the practical
expedient under ASC 606 which exempts the adjustment of the consideration for the existence of a significant financing component when
the period between the transfer of the services and the payment for such services is one year or less.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step
4: Allocate the transaction price to the performance obligations in the contract</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contracts
that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on
each performance obligation&#8217;s relative standalone selling price (&#8220;SSP&#8221;). The Company has identified a single performance
obligation in the contract, and therefore, the allocation provisions under ASC 606 do not apply to the Company&#8217;s contracts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step
5: Recognize revenue when the Company satisfies a performance obligation</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues
for the Company&#8217;s single, combined performance obligation are recognized on a straight-line basis over the customer&#8217;s contract
term, which is the period in which the parties to the contract have enforceable rights and obligations (Typically 3-4 years).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsPolicy', window );">Business Combinations</a></td>
<td class="text"><p id="xdx_84E_eus-gaap--BusinessCombinationsPolicy_zMxLHHnW5pb1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_868_zraUzDeO6OYj">Business
Combinations</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
acquisition of a company, we determine if the transaction is a business combination, which is accounted for using the acquisition method
of accounting. Under the acquisition method, once control is obtained of a business, the assets acquired, and liabilities assumed, are
recorded at fair value. We use our best estimates and assumptions to assign fair value to the tangible and intangible assets acquired
and liabilities assumed at the acquisition date. One of the most significant estimates relates to the determination of the fair value
of these assets and liabilities. The determination of the fair values is based on estimates and judgments made by management. Our estimates
of fair value are based upon assumptions we believe to be reasonable, but which are inherently uncertain and unpredictable. Measurement
period adjustments are reflected at the time identified, up through the conclusion of the measurement period, which is the time at which
all information for determination of the values of assets acquired and liabilities assumed is received and is not to exceed one year
from the acquisition date. We may record adjustments to the fair value of these tangible and intangible assets acquired and liabilities
assumed, with the corresponding offset to goodwill. The Company elected to apply pushdown accounting to all entities acquired.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
uncertain tax positions and tax-related valuation allowances are initially recorded in connection with a business combination as of the
acquisition date. We continue to collect information and reevaluate these estimates and assumptions periodically and record any adjustments
to preliminary estimates to goodwill, provided we are within the measurement period. If outside of the measurement period, any subsequent
adjustments are recorded to the consolidated statement of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_84E_eus-gaap--BusinessCombinationsPolicy_z0ZRa7SHCO76" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86A_zbCzDWV4khLc">Business
Combinations</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
acquisition of a company, we determine if the transaction is a business combination, which is accounted for using the acquisition method
of accounting. Under the acquisition method, once control is obtained of a business, the assets acquired, and liabilities assumed, are
recorded at fair value. We use our best estimates and assumptions to assign fair value to the tangible and intangible assets acquired
and liabilities assumed at the acquisition date. One of the most significant estimates relates to the determination of the fair value
of these assets and liabilities. The determination of the fair values is based on estimates and judgments made by management. Our estimates
of fair value are based upon assumptions we believe to be reasonable, but which are inherently uncertain and unpredictable. Measurement
period adjustments are reflected at the time identified, up through the conclusion of the measurement period, which is the time at which
all information for determination of the values of assets acquired and liabilities assumed is received and is not to exceed one year
from the acquisition date. We may record adjustments to the fair value of these tangible and intangible assets acquired and liabilities
assumed, with the corresponding offset to goodwill. The Company elected to apply pushdown accounting to all entities acquired.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
uncertain tax positions and tax-related valuation allowances are initially recorded in connection with a business combination as of the
acquisition date. We continue to collect information and reevaluate these estimates and assumptions periodically and record any adjustments
to preliminary estimates to goodwill, provided we are within the measurement period. If outside of the measurement period, any subsequent
adjustments are recorded to the consolidated statement of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><p id="xdx_845_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zWhCbAGBHus2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86E_zaoTLTt5EeV3">Fair
Value of Financial Instruments</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
value of financial and non-financial assets and liabilities is defined as an exit price, representing the amount that would be received
to sell an asset or paid to transfer a liability in an orderly transaction between market participants. The three-tier hierarchy for
inputs used in measuring fair value, which prioritizes the inputs used in the methodologies of measuring fair value for assets and liabilities,
is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
1 &#8212; Quoted prices in active markets for identical assets or liabilities</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
2 &#8212; Observable inputs other than quoted prices in active markets for identical assets and liabilities</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
3 &#8212; Unobservable pricing inputs in the market</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
assets and financial liabilities are classified in their entirety based on the lowest level of input that is significant to the fair
value measurements. Our assessment of the significance of a particular input to the fair value measurements requires judgment and may
affect the valuation of the assets and liabilities being measured and their categorization within the fair value hierarchy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s financial instruments consist of cash and cash equivalents, accounts receivable, and accounts payable. The carrying amount
of these financial instruments approximates fair value due to their short-term maturity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s contingent consideration in connection with the acquisition of Gameface was calculated using Level 3 inputs. The fair
value of contingent consideration as of July 31, 2023 and April 30, 2023 was $<span id="xdx_90D_eus-gaap--BusinessCombinationConsiderationTransferred1_c20230501__20230731__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zAYKla0QEGTb" title="Fair value of contingent consideration">418,455</span> and $<span id="xdx_908_eus-gaap--BusinessCombinationConsiderationTransferred1_c20220501__20230430__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z2qpHLFJ4zb1" title="Fair value of contingent consideration">418,455</span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company estimates the fair value of its intangible assets using Level 3 assumptions, primarily based on the income approach utilizing
the discounted cash flow method.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s derivative liabilities were calculated using Level 2 assumptions on the issuance and balance sheet dates via a Black-Scholes
option pricing model and consisted of the following ending balances and gain amounts as of and for the three months ended July 31, 2023:</span></p>

<p id="xdx_89F_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_zv0dvk3LFGO3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BB_zkFsh03XdvSa" style="display: none">SCHEDULE OF DERIVATIVE LIABILITIES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Note derivative is related to</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">July 31, 2023</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">ending balance</p></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">(Gain) loss for the</p>
                                                                                                    <p style="margin-top: 0; margin-bottom: 0">three months ended</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">July 31, 2023</p></td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">4/11/21 profit guaranty</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--ProfitGuarantyMember_zDJadryzbuC2" style="width: 14%; text-align: right" title="Note derivative balance">1,456,854</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20230501__20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--ProfitGuarantyMember_zHh9mPuqcsS7" style="width: 14%; text-align: right" title="Note derivative (gain) loss"><span style="-sec-ix-hidden: xdx2ixbrl0787">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">8/6/21 convertible notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--ConvertibleNotesMember_zcQdpsaz83l1" style="text-align: right" title="Note derivative balance">74,958</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20230501__20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--ConvertibleNotesMember_zJ1AURkaGhUa" style="text-align: right" title="Note derivative (gain) loss">(26,966</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">6/17/22 underwriter warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--UnderwriterWarrantsMember_z67ge1gtPjuh" style="text-align: right" title="Underwriter warrants">4,966</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20230501__20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--UnderwriterWarrantsMember_zPpqveywdCy" style="text-align: right" title="Note derivative (gain) loss">(1,565</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">9/30/22 warrants issued with common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsIssuedWithCommonStockMember_zxe6iTEE7M98" style="text-align: right" title="Other derivative liabilities eliminated in uplist">4,668,608</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20230501__20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsIssuedWithCommonStockMember_zzgik92kwAIf" style="text-align: right" title="Note derivative (gain) loss">(1,440,951</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">1/6/2023 warrants issued with note payable</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsIssuedWithNotesPayableMember_zCWepP1a6mqg" style="border-bottom: Black 1.5pt solid; text-align: right" title="Other derivative liabilities eliminated in uplist">2,139,666</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20230501__20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsIssuedWithNotesPayableMember_zunZlzLuQT98" style="border-bottom: Black 1.5pt solid; text-align: right" title="Note derivative (gain) loss">(675,072</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">Total</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230731_zLRaRIC2AP9a" style="border-bottom: Black 2.5pt double; text-align: right" title="Note derivative balance">8,345,052</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20230501__20230731_zyUgb91QhYpb" style="border-bottom: Black 2.5pt double; text-align: right" title="Note derivative (gain) loss">(2,144,554</td><td style="text-align: left">)</td></tr>
  </table>

<p id="xdx_8A0_zeamAmoTTs8i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Black-Scholes option pricing model assumptions for the derivative liabilities during the periods ended July 31, 2023 and 2022 consisted
of the following:</span></p>

<p id="xdx_894_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zxJveoNkqJJ3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B1_zmeSKHeg1jZ8" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE
OF DERIVATIVE AND WARRANTS GRANTED VALUATION USING BLACK-SCHOLES PRICING METHOD</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Period Ended</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">July 31, 2023</p></td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Period Ended</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">July 31, 2022</p></td><td style="font-weight: bold">&#160;</td>
    </tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected life in years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecustom--DerivativeLiabilitiesMeasurementInputTerm_dtY_c20230501__20230731__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zOM7Nc73Uq2c" title="Derivative liabilities Measurement input, term">0.7</span>-<span id="xdx_906_ecustom--DerivativeLiabilitiesMeasurementInputTerm_dtY_c20230501__20230731__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zRXshLS2zzR2" title="Derivative liabilities Measurement input, term">10</span> years</span></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_ecustom--DerivativeLiabilitiesMeasurementInputTerm_dtY_c20220501__20220731__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_z0nVauo9IEb6" title="Derivative liabilities measurement input">4</span>-<span id="xdx_90D_ecustom--DerivativeLiabilitiesMeasurementInputTerm_dtY_c20220501__20220731__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zqEOo8AIaq2c" title="Derivative liabilities measurement input">4.3</span> years</span></td><td style="text-align: left">&#160;</td>
    </tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 64%">Stock price volatility</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><span id="xdx_904_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230731__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zeMg7ysdKVnf" title="Derivative liability measurement input">150</span></td><td style="width: 1%; text-align: left">%</td>
    <td style="width: 2%; text-align: left">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220731__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__srt--RangeAxis__srt--MinimumMember_zUAxzfGuc3k8" title="Derivative liability measurement input">50</span>-<span id="xdx_903_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220731__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__srt--RangeAxis__srt--MaximumMember_z9VBkbRCPujc" title="Derivative liability measurement input">148</span></span></td><td style="width: 1%; text-align: left">%</td>
    </tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Risk free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230731__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zYWf0ns4haFi" title="Derivative liability measurement input">4.08</span>%-<span id="xdx_90F_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230731__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zJhudoQoifl" title="Derivative liability measurement input">5.37</span></span></td><td style="text-align: left">%</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220731__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_za4ttfqB5Tdj" title="Derivative liability measurement input">2.90</span>%-<span id="xdx_90A_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220731__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zGntoDYd2FDl" title="Derivative liability measurement input">3.27</span></span></td><td style="text-align: left">%</td>
    </tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Expected dividends</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_902_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230731__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zD8ftCahm3Xa" title="Derivative liability measurement input">0</span></td><td style="text-align: left">%</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220731__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_z2f9hunjDTE8" title="Derivative liability measurement input">0</span></td><td style="text-align: left">%</td>
    </tr>
  </table>

<p id="xdx_8AC_zQYg66YFzXs6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_842_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zsR4gXGRnvj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_867_zSfb8dCDzeK1">Fair
Value of Financial Instruments</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
value of financial and non-financial assets and liabilities is defined as an exit price, representing the amount that would be received
to sell an asset or paid to transfer a liability in an orderly transaction between market participants. The three-tier hierarchy for
inputs used in measuring fair value, which prioritizes the inputs used in the methodologies of measuring fair value for assets and liabilities,
is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
1 &#8212; Quoted prices in active markets for identical assets or liabilities</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
2 &#8212; Observable inputs other than quoted prices in active markets for identical assets and liabilities</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
3 &#8212; Unobservable pricing inputs in the market</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
assets and financial liabilities are classified in their entirety based on the lowest level of input that is significant to the fair
value measurements. Our assessment of the significance of a particular input to the fair value measurements requires judgment and may
affect the valuation of the assets and liabilities being measured and their categorization within the fair value hierarchy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s financial instruments consist of cash and cash equivalents, accounts receivable, and accounts payable. The carrying amount
of these financial instruments approximates fair value due to their short-term maturity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s contingent consideration in connection with the acquisition of Gameface was calculated using Level 3 inputs. The fair
value of contingent consideration as of April 30, 2023 and 2022 was $<span id="xdx_908_eus-gaap--BusinessCombinationConsiderationTransferred1_c20220501__20230430__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zWAvbj1aT4ua" title="Fair value of contingent consideration">418,455</span> and $<span id="xdx_905_eus-gaap--BusinessCombinationConsiderationTransferred1_c20210501__20220430__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zMgFaUDRB6Ii" title="Fair value of contingent consideration">1,334,000</span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company estimates the fair value of its intangible assets using Level 3 assumptions, primarily based on the income approach utilizing
the discounted cash flow method.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s derivative liabilities were calculated using Level 2 assumptions on the issuance and balance sheet dates via a Black-Scholes
option pricing model and consisted of the following ending balances and gain amounts as of and for the year ended April 30, 2023:</span></p>

<p id="xdx_895_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_zKdxFAaIrev6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BC_zth2ZPbd4ldg" style="display: none">SCHEDULE OF DERIVATIVE LIABILITIES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">April 30, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">(Gain) loss for the year</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Note derivative is related to</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">ending balance</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">ended April 30, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 58%; text-align: left">4/11/21 profit guaranty</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--ProfitGuarantyMember_zLoVdfg4BcMg" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Note derivative balance">1,456,854</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20220501__20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--ProfitGuarantyMember_ztU1z71Fcr69" style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right" title="Note derivative (gain) loss">395,304</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">8/6/21 convertible notes</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--ConvertibleNotesMember_za5ouNOASKYj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Note derivative balance">101,924</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20220501__20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--ConvertibleNotesMember_zbyjmW8ypLJi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Note derivative (gain) loss">(2,611,410</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">6/17/22 underwriter warrants</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--UnderwriterWarrantsMember_zk2QYBRehJBf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Underwriter warrants">6,531</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20220501__20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--UnderwriterWarrantsMember_z2kIb4szkMl9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Note derivative (gain) loss">(57,951</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Other derivative liabilities eliminated in uplist</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--OtherDerivativeLiabilitiesMember_zJoLszxw8Ko5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other derivative liabilities eliminated in uplist"><span style="-sec-ix-hidden: xdx2ixbrl2020">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20220501__20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--OtherDerivativeLiabilitiesMember_zZaELMDW4F8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Note derivative (gain) loss">(1,604,413</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">9/30/22 warrants issued with common stock</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsIssuedWithCommonStockMember_zSHGxJ6QgJva" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other derivative liabilities eliminated in uplist">6,109,559</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20220501__20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsIssuedWithCommonStockMember_zDUauxaNsYN3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Note derivative (gain) loss">(6,170,728</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">1/6/2023 warrants issued with note payable</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsIssuedWithNotesPayableMember_zDflVje0ufDd" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other derivative liabilities eliminated in uplist">2,814,738</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20220501__20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsIssuedWithNotesPayableMember_zWeXeUvmeepj" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Note derivative (gain) loss">(900,819</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Total</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230430_zQU5Cl2xeNz7" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Note derivative balance">10,489,606</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_980_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20220501__20230430_zRROsfnxGTP5" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Note derivative (gain) loss">(10,950,017</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

<p id="xdx_8A1_zXI5Tz8hx0v2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company also recognized derivative expense of $<span id="xdx_901_ecustom--RecognizedDerivativeExpense_c20220501__20230430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zeDeQ562lBAa" title="Recognized derivative expense">7,280,405</span> at inception on the warrants issued in connection with a funding on September
30, 2022 and $<span id="xdx_906_ecustom--RecognizedDerivativeExpense_c20230106__20230106__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zLga0pE9MI41" title="Recognized derivative expense">1,715,557</span> at inception on the warrants issued in connection with a funding on January 6, 2023. The Black-Scholes option
pricing model assumptions for the derivative liabilities during the years ended April 30, 2023 and 2022 consisted of the following:</span></p>

<p id="xdx_892_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_z4Bz6LcfV8Y7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B1_zSBUudjmpz4c" style="display: none">SCHEDULE
OF DERIVATIVE AND WARRANTS GRANTED VALUATION USING BLACK-SCHOLES PRICING METHOD</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Year Ended April 30, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Year Ended April 30, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Expected life in years</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--DerivativeLiabilitiesMeasurementInputTerm_dtY_c20220501__20230430__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zExvjDnpbI51" title="Derivative liabilities Measurement input, term">3.25</span>-<span id="xdx_902_ecustom--DerivativeLiabilitiesMeasurementInputTerm_dtY_c20220501__20230430__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zp2qcuPMSE22" title="Derivative liabilities Measurement input, term">10</span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecustom--DerivativeLiabilitiesMeasurementInputTerm_dtY_c20210501__20220430__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_z6yeJH9ymBcl" title="Derivative liabilities measurement input">1.95</span>-<span id="xdx_90E_ecustom--DerivativeLiabilitiesMeasurementInputTerm_dtY_c20210501__20220430__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zWD6oIs7ALNd" title="Derivative liabilities measurement input">4.3</span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 68%">Stock price volatility</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230430__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__srt--RangeAxis__srt--MinimumMember_zDuwBbVQde9c" title="Derivative liability measurement input">50</span> - <span id="xdx_90D_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230430__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__srt--RangeAxis__srt--MaximumMember_ziEpBdVqYX01" title="Derivative liability measurement input">150</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span id="xdx_90A_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220430__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zLjQhYmj1Zt6" title="Derivative liability measurement input">50</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Risk free interest rate</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230430__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zJAEIQfPKexl" title="Derivative liability measurement input">2.90%</span>-<span id="xdx_908_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230430__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zhWQyeeXjsV1" title="Derivative liability measurement input">4.34</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220430__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zMfFROROnH6l" title="Derivative liability measurement input">2.67%</span>-<span id="xdx_908_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220430__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zawH3Uq2Hv7e" title="Derivative liability measurement input">2.90</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Expected dividends</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230430__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_z7qeqaaslk7j" title="Derivative liability measurement input">0</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220430__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zakTy1zyVZ3h" title="Derivative liability measurement input">0</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A5_zgqcHLHfEXN5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Refer
to Note 10 and Note 11 for more information regarding the derivative instruments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p id="xdx_844_eus-gaap--IncomeTaxPolicyTextBlock_zppSzQX0t9Vg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_863_zaywpz6ou28f">Income
Taxes</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
taxes are accounted for in accordance with the provisions of ASC 740, Accounting for Income Taxes. Deferred tax assets and liabilities
are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing
assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected
to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred
tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Valuation
allowances are established, when necessary, to reduce deferred tax assets to the amounts that are more likely than not to be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_843_eus-gaap--IncomeTaxPolicyTextBlock_z5WkW3YJHNGa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_863_zwElE196j3Sc">Income
Taxes</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
taxes are accounted for in accordance with the provisions of ASC 740, Accounting for Income Taxes. Deferred tax assets and liabilities
are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing
assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected
to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred
tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Valuation
allowances are established, when necessary, to reduce deferred tax assets to the amounts that are more likely than not to be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsFiniteLivedPolicy', window );">Intangible Assets</a></td>
<td class="text"><p id="xdx_84E_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zesjwOfLxi9d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86A_zD5DR2xEc4E2">Intangible
Assets</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets relate to the &#8220;Slinger&#8221; technology trademark, which the Company purchased on November 10, 2020. The Company also acquired
intangible assets as a part of the Gameface acquisition. These intangible assets include tradenames, internally developed software, and
customer relationships. The acquired intangible assets are amortized based on the estimated present value of cash flows of each class
of intangible assets in order to determine their economic useful life. During the three months ended July 31, 2023, the Company impaired
their intangible assets down to a nominal value of $<span id="xdx_900_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20230731_zzrz3YtscFX9" title="Impaired intangible assets">1,000</span> as the technology has changed and Management determined the value to be greater
than the fair value of those assets. Refer to Note 5 for more information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
<td class="text"><p id="xdx_84E_eus-gaap--IntangibleAssetsFiniteLivedPolicy_ztN5wHRUMbGb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_864_zxZ4eLNANbOd">Intangible
Assets</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets relate to the &#8220;Slinger&#8221; technology trademark, which the Company purchased on November 10, 2020. The Company also acquired
intangible assets as a part of the Gameface acquisition. These intangible assets include tradenames, internally developed software, and
customer relationships. The acquired intangible assets are amortized based on the estimated present value of cash flows of each class
of intangible assets in order to determine their economic useful life. All intangible assets acquired with the PlaySight transaction
are included in discontinued operations. Refer to Note 6 for more information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long-Lived Assets</a></td>
<td class="text"><p id="xdx_847_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zxm3S6rGta88" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_866_z6N84RRVYQK1">Impairment
of Long-Lived Assets</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with ASC 360-10, the Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate
that their net book value may not be recoverable. Factors which could trigger impairment review include significant underperformance
relative to historical or projected future operating results, significant changes in the manner of use of the assets or the strategy
for the overall business, a significant decrease in the market value of the assets or significant negative industry or economic trends.
When such factors and circumstances exist, the Company compares the projected undiscounted future cash flows associated with the related
asset or group of assets over their estimated useful lives against their respective carrying amount. If those net undiscounted cash flows
do not exceed the carrying amount, impairment, if any, is based on the excess of the carrying amount over the fair value based on the
market value or discounted expected cash flows of those assets and is recorded in the period in which the determination is made. The
Company impaired $<span id="xdx_905_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_c20230501__20230731_zfr6CP7eOfEf" title="Impairment of intangible assets">100,281</span> in intangible assets and $<span id="xdx_901_eus-gaap--AssetImpairmentCharges_c20230501__20230731_z5FvrWnHNQ4i" title="Impairment of fixed assets">14,791</span> in fixed assets during the three months ended July 31, 2023. Refer to Note
5 for more information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_842_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zaGl9aLjyzXj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86C_zcm7DRP8PEHj">Impairment
of Long-Lived Assets</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with ASC 360-10, the Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate
that their net book value may not be recoverable. Factors which could trigger impairment review include significant underperformance
relative to historical or projected future operating results, significant changes in the manner of use of the assets or the strategy
for the overall business, a significant decrease in the market value of the assets or significant negative industry or economic trends.
When such factors and circumstances exist, the Company compares the projected undiscounted future cash flows associated with the related
asset or group of assets over their estimated useful lives against their respective carrying amount. If those net undiscounted cash flows
do not exceed the carrying amount, impairment, if any, is based on the excess of the carrying amount over the fair value based on the
market value or discounted expected cash flows of those assets and is recorded in the period in which the determination is made. There
was impairment of long-lived assets identified during the year ended April 30, 2023 and 2022 in our continuing operations. Refer to Note
6 for more information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy', window );">Goodwill</a></td>
<td class="text"><p id="xdx_843_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_zeF6mMKwyE08" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_863_zUOK4TBL5uS5">Goodwill</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for goodwill in accordance with ASC 350, Intangibles &#8211; Goodwill and Other (&#8220;ASC 350&#8221;). ASC 350 requires
that goodwill not be amortized, but reviewed for impairment if impairment indicators arise and, at a minimum, annually. The Company records
goodwill as the excess purchase price over assets acquired and includes any work force acquired as goodwill. Goodwill is evaluated for
impairment on an annual basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
the adoption of the ASU 2017-04, which eliminates the second step of the goodwill impairment test, the Company tests impairment of goodwill
in one step. In this step, the Company compares the fair value of each reporting unit with goodwill to its carrying value. The Company
determines the fair value of its reporting units with goodwill using a combination of a discounted cash flow and a market value approach.
If the carrying value of the net assets assigned to the reporting unit exceeds the fair value of the reporting unit, the Company will
record an impairment charge based on the excess of a reporting unit&#8217;s carrying amount over its fair value. If the fair value of
the reporting unit exceeds the carrying value of the net assets assigned to that reporting unit, goodwill is not impaired and the Company
will not record an impairment charge.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company impaired all goodwill as of April 30, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_848_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_zdtNV2nGJ5md" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_864_z8EmZ71508Hl">Goodwill</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for goodwill in accordance with ASC 350, Intangibles - Goodwill and Other (&#8220;ASC 350&#8221;). ASC 350 requires
that goodwill not be amortized, but reviewed for impairment if impairment indicators arise and, at a minimum, annually. The Company records
goodwill as the excess purchase price over assets acquired and includes any work force acquired as goodwill. Goodwill is evaluated for
impairment on an annual basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
the adoption of the ASU 2017-04, which eliminates the second step of the goodwill impairment test, the Company tests impairment of goodwill
in one step. In this step, the Company compares the fair value of each reporting unit with goodwill to its carrying value. The Company
determines the fair value of its reporting units with goodwill using a combination of a discounted cash flow and a market value approach.
If the carrying value of the net assets assigned to the reporting unit exceeds the fair value of the reporting unit, the Company will
record an impairment charge based on the excess of a reporting unit&#8217;s carrying amount over its fair value. If the fair value of
the reporting unit exceeds the carrying value of the net assets assigned to that reporting unit, goodwill is not impaired and the Company
will not record an impairment charge.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company impaired the remaining $<span id="xdx_905_eus-gaap--GoodwillImpairmentLoss_c20220501__20230430_zRpSVtbWOkhh" title="Goodwill impairment charges">6,781,193</span> of goodwill as of April 30, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-Based Payment</a></td>
<td class="text"><p id="xdx_843_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zrn4WeDCwaa8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86A_zXggy9lV9VBf">Share-Based
Payment</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for share-based compensation in accordance with ASC 718, Compensation-Stock Compensation (ASC 718). Under the fair value
recognition provisions of this topic, stock-based compensation cost is measured at the grant date based on the fair value of the award
and is recognized as an expense on a straight-line basis over the requisite service period, which is the vesting period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_84D_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zATxgYgULnF" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86F_zoExeEVYsUjb">Share-Based
Payment</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for share-based compensation in accordance with ASC 718, Compensation-Stock Compensation (ASC 718). Under the fair value
recognition provisions of this topic, stock-based compensation cost is measured at the grant date based on the fair value of the award
and is recognized as an expense on a straight-line basis over the requisite service period, which is the vesting period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_WarrantsPolicyTextBlock', window );">Warrants</a></td>
<td class="text"><p id="xdx_846_ecustom--WarrantsPolicyTextBlock_zQgLZsdCZl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_861_zAmNMHbm5Z9f">Warrants</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company grants warrants to key employees and executives as compensation on a discretionary basis. The Company also grants warrants in
connection with certain note payable agreements and other key arrangements. The Company is required to estimate the fair value of share-based
awards on the measurement date and recognize as expense that value of the portion of the award that is ultimately expected to vest over
the requisite service period. Warrants granted in connection with ongoing arrangements are more fully described in Note 11.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
warrants granted during the periods ended July 31, 2023 and 2022 were valued using a Black-Scholes option pricing model on the date of
grant using the following assumptions:</span></p>

<p id="xdx_89A_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_hus-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_zwUBj2Ktlrbc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B7_zevv4dX2q55a" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE
OF WARRANTS GRANTED VALUATION USING BLACK-SCHOLES PRICING METHOD</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Period Ended</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">July 31, 2023</p></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Period Ended</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">July 31, 2022</p></td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected life in years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;&#160;<span id="xdx_90A_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dxL_c20230731__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_z3Rj0J3GgEx8" title="Warrants measurement input, term::XDX::P0Y"><span style="-sec-ix-hidden: xdx2ixbrl0857">-</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220731__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MinimumMember_z6lktadzpOMc" title="Warrants measurement input, term">5</span> &#8211; <span id="xdx_90F_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220731__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MaximumMember_zv1e5yHUtgVg" title="Warrants measurement input, term">10</span> years</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Stock price volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230731__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_zrSfyLGPFr61" title="Warrants measurement input, rate"><span style="-sec-ix-hidden: xdx2ixbrl0863">-</span></span></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220731__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_z5u1bPOjwnR7" title="Warrants measurement input, rate">50</span>% - <span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220731__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_z96TgwhrYCQl" title="Warrants measurement input, rate">148</span></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Risk free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230731__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zRAoz5ytefj6" title="Warrants measurement input, rate"><span style="-sec-ix-hidden: xdx2ixbrl0869">-</span></span></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220731__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember_zNyzrC9VnPcf" title="Warrants measurement input, rate">2.50</span>% - <span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220731__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember_zJu0UEQstGkg" title="Warrants measurement input, rate">3.50</span></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 64%; text-align: left">Expected dividends</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230731__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zIeSl2LJtWth" title="Warrants measurement input, rate"><span style="-sec-ix-hidden: xdx2ixbrl0875">-</span></span></span></td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><span id="xdx_909_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220731__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zrjwzYtj2Wk1" title="Warrants measurement input, rate">0</span></td><td style="width: 1%; text-align: left">%</td></tr>
  </table>

<p id="xdx_8AA_z1yeXYmEtQW8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_841_ecustom--WarrantsPolicyTextBlock_z8UZfjEmf8Bh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86F_z4dLffk0HYub">Warrants</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company grants warrants to key employees and executives as compensation on a discretionary basis. The Company also grants warrants in
connection with certain note payable agreements and other key arrangements. The Company is required to estimate the fair value of share-based
awards on the measurement date and recognize as expense that value of the portion of the award that is ultimately expected to vest over
the requisite service period. Warrants granted in connection with ongoing arrangements are more fully described in Note 11 and Note 14.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
warrants granted during the years ended April 30, 2023 and 2022 were valued using a Black-Scholes option pricing model on the date of
grant using the following assumptions:</span></p>

<p id="xdx_899_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_hus-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_zzz3XHpZ7AW7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B9_zSnX45WTkLQ7" style="display: none">SCHEDULE OF WARRANTS GRANTED VALUATION USING BLACK-SCHOLES PRICING
METHOD</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">Year Ended</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">April 30, 2023</p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">Year Ended</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">April 30, 2022</p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Expected life in years</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20230430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MinimumMember_z39j4GVFPZU2" title="Warrants measurement input, term">5</span> &#8211; <span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20230430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MaximumMember_zxLRWNDFvyMe" title="Warrants measurement input, term">10</span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MinimumMember_zQGYyHPQeRa2" title="Warrants measurement input, term">5</span> &#8211; <span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MaximumMember_zuhSHLVH1bph" title="Warrants measurement input, term">10</span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">Stock price volatility</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230430__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_zVgcGSscX8Rd" title="Warrants measurement input, rate">50</span>% - <span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230430__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_zTqr0kjgX1B3" title="Warrants measurement input, rate">150</span>%</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220430__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_zB8DinQqZMWj" title="Warrants measurement input, rate">50</span>% - <span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220430__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_zyePRTOpLbxf" title="Warrants measurement input, rate">148</span></span>%</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Risk free interest rate</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember_zFCjvCwWOVDe" title="Warrants measurement input, rate">2.50</span>% - <span id="xdx_909_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember_zVHayA4Yshze" title="Warrants measurement input, rate">4.68</span>%</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember_zcX2q7oqNHhb" title="Warrants measurement input, rate">0.77</span>% - <span id="xdx_90F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember_zriimxW75qde" title="Warrants measurement input, rate">1.63</span></span>%</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left">Expected dividends</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: center"><span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zpCT0ha2u6w" title="Warrants measurement input, rate">0</span>%</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: center"><span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zselrYextILl" title="Warrants measurement input, rate">0</span>%</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"></td></tr>
  </table>

<p id="xdx_8A0_zvMHtNt7z2Aj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Translation</a></td>
<td class="text"><p id="xdx_842_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zdQ42ttIlWX2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Foreign
Currency Translation</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
functional currency is the U.S. dollar. The functional currency of our foreign operations, generally, is the respective local currency
for each foreign subsidiary. Assets and liabilities of foreign operations denominated in local currencies are translated at the spot
rate in effect at the applicable reporting date. Our consolidated statements of comprehensive loss are translated at the weighted average
rate of exchange during the applicable period. The resulting unrealized cumulative translation adjustment is recorded as a component
of accumulated other comprehensive loss in shareholders&#8217; equity. Realized and unrealized transaction gains and losses generated
by transactions denominated in a currency different from the functional currency of the applicable entity are recorded in other income
(loss) in the period in which they occur.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_84F_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zYoHJGrSLQRa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_860_zQ4xReBtLj69">Foreign
Currency Translation</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
functional currency is the U.S. dollar. The functional currency of our foreign operations, generally, is the respective local currency
for each foreign subsidiary. Assets and liabilities of foreign operations denominated in local currencies are translated at the spot
rate in effect at the applicable reporting date. Our consolidated statements of comprehensive loss are translated at the weighted average
rate of exchange during the applicable period. The resulting unrealized cumulative translation adjustment is recorded as a component
of accumulated other comprehensive loss in shareholders&#8217; equity. Realized and unrealized transaction gains and losses generated
by transactions denominated in a currency different from the functional currency of the applicable entity are recorded in other income
(loss) in the period in which they occur.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Share</a></td>
<td class="text"><p id="xdx_84F_eus-gaap--EarningsPerSharePolicyTextBlock_za4e88dFSBw" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_867_z8WUWUMhtAEk">Earnings
Per Share</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
earnings per share are calculated by dividing the income available to shareholders by the weighted-average number of common shares
outstanding during each period. Diluted earnings per share are computed using the weighted average number of common and dilutive common
share equivalents outstanding during the period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
common stock equivalents such as shares to be issued for the conversion of notes payable and warrants were excluded from the calculation
of diluted earnings per share as the effect is antidilutive. As a result, the basic and diluted earnings per share are the same for each
of the periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_84C_eus-gaap--EarningsPerSharePolicyTextBlock_z6hMfSfComha" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_862_zeDZCwcJ1dj3">Earnings
Per Share</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
earnings per share are calculated by dividing the income available to shareholders by the weighted-average number of common shares
outstanding during each period. Diluted earnings per share are computed using the weighted average number of common and dilutive common
share equivalents outstanding during the period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
common stock equivalents such as shares to be issued for the conversion of notes payable and warrants were excluded from the calculation
of diluted earnings per share as the effect is antidilutive. As a result, the basic and diluted earnings per share are the same for each
of the periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><p id="xdx_842_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zJ7cZEIBYy9i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_868_z6X96o6xT916">Recent
Accounting Pronouncements</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Recently
Adopted</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2017, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU No. 2017-04, Intangibles &#8211; Goodwill and
Other (Topic 350): Simplifying the Test for Goodwill Impairment (&#8220;ASU 2017-04&#8221;), which simplifies how an entity is required
to test goodwill for impairment by eliminating Step 2 from the goodwill impairment test. Under ASU 2017-04, goodwill impairment will
be tested by comparing the fair value of a reporting unit with its carrying amount, and recognizing an impairment charge for the amount
by which the carrying amount exceeds the reporting unit&#8217;s fair value. The new guidance must be applied on a prospective basis and
is effective for periods beginning after December 15, 2022, with early adoption permitted. The Company adopted ASU 2017-04 effective
May 1, 2021. The adoption of the new standard did not have a material effect on the Company&#8217;s consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2019, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;), 2019-12, <i>Simplifying the Accounting for Income Taxes</i>,
which amends ASC 740, <i>Income Taxes</i> (ASC 740). This update is intended to simplify accounting for income taxes by removing certain
exceptions to the general principles in ASC 740 and amending existing guidance to improve consistent application of ASC 740. This update
is effective for fiscal years beginning after December 15, 2021. The guidance in this update has various elements, some of which are
applied on a prospective basis and others on a retrospective basis with earlier application permitted. The adoption of the new standard
did not have a material effect on the Company&#8217;s consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2020, the FASB issued ASU No. 2020-06, Debt &#8211; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives
and Hedging Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s
Own Equity. ASU 2020-06 will simplify the accounting for convertible instruments by reducing the number of accounting models for convertible
debt instruments and convertible preferred stock. Limiting the accounting models results in fewer embedded conversion features being
separately recognized from the host contract as compared with current GAAP. Convertible instruments that continue to be subject to separation
models are (1) those with embedded conversion features that are not clearly and closely related to the host contract, that meet the definition
of a derivative, and that do not qualify for a scope exception from derivative accounting and (2) convertible debt instruments issued
with substantial premiums for which the premiums are recorded as paid-in capital. ASU 2020-06 also amends the guidance for the derivatives
scope exception for contracts in an entity&#8217;s own equity to reduce form-over-substance-based accounting conclusions. ASU 2020-06
will be effective for public companies for fiscal years beginning after December 15, 2023, including interim periods within those fiscal
years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within
those fiscal years. The Company is currently evaluating the impact that the adoption of ASU 2020-06 will have on the Company&#8217;s
consolidated financial statement presentation or disclosures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2016, the FASB issued ASU 2016-13, Financial Instruments &#8211; Credit Losses (Topic 326): Measurement of Credit Losses on Financial
Instruments (&#8220;ASC 326&#8221;). The guidance replaces the incurred loss methodology with an expected loss methodology that is referred
to as the current expected credit loss (&#8220;CECL&#8221;) methodology. The measurement of expected credit losses under the CECL methodology
is applicable to financial assets measured at amortized cost, including loan receivables and held-to-maturity debt securities. It also
applies to off-balance sheet credit exposures not accounted for as insurance (loan commitments, standby letters of credits, financial
guarantees, and other similar instruments) and net investments in leases recognized by a lessor in accordance with Topic 842 on leases.
ASC 326 requires enhanced disclosures related to the significant estimates and judgments used in estimating credit losses as well as
the credit quality and underwriting standards of a company&#8217;s portfolio. In addition, ASC 326 made changes to the accounting for
available-for-sale debt securities. One such change is to require credit losses to be presented as an allowance rather than as a write-down
on available-for-sale debt securities the Company does not intend to sell or believes that it is more likely than not they will be required
to sell. The ASU can be adopted no later than January 1, 2020 for SEC filers and January 1, 2023 for private companies and smaller reporting
companies. The adoption of the new standard did not have a material effect on the Company&#8217;s consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2021, the FASB issued ASU 2021-08, &#8220;Business Combinations &#8211; Accounting for Contract Assets and Contract Liabilities
(Topic 805)&#8221;. The amendments in this Update address diversity and inconsistency related to the recognition and measurement of contract
assets and contract liabilities acquired in a business combination. The amendments in this Update require that an acquirer recognize
and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606, Revenue from Contracts
with Customers. ASU 2021-08 is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal
years. The adoption of the new standard did not have a material effect on the Company&#8217;s consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
FASB has issued ASU 2021-04, Earnings Per Share (Topic 260), Debt&#8212;Modifications and Extinguishments (Subtopic 470-50), Compensation&#8212;Stock
Compensation (Topic 718), and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40). ASU 2021-04 provides
guidance that an entity should treat a modification of the terms or conditions or an exchange of a freestanding equity-classified written
call option that remains equity classified after modification or exchange as an exchange of the original instrument for a new instrument.
The standard also provides guidance on how an entity should measure and recognize the effect of a modification or an exchange of a freestanding
equity-classified written call option that remains equity classified. The amendments in this ASU are effective for the Company for fiscal
years beginning after December 15, 2021. Early adoption is permitted for all entities, including adoption in an interim period. The adoption
of the new standard did not have a material effect on the Company&#8217;s consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
recently issued accounting pronouncements did not, or are not believed by management to, have a material effect on the Company&#8217;s
present or future consolidated financial statements.</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_844_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zWCSSiuretbd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_862_z6AWpOXz8wfd">Recent
Accounting Pronouncements</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Recently
Adopted</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2017, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU No. 2017-04, Intangibles &#8211; Goodwill and
Other (Topic 350): Simplifying the Test for Goodwill Impairment (&#8220;ASU 2017-04&#8221;), which simplifies how an entity is required
to test goodwill for impairment by eliminating Step 2 from the goodwill impairment test. Under ASU 2017-04, goodwill impairment will
be tested by comparing the fair value of a reporting unit with its carrying amount, and recognizing an impairment charge for the amount
by which the carrying amount exceeds the reporting unit&#8217;s fair value. The new guidance must be applied on a prospective basis and
is effective for periods beginning after December 15, 2022, with early adoption permitted. The Company adopted ASU 2017-04 effective
May 1, 2021. The adoption of the new standard did not have a material effect on the Company&#8217;s consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2019, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;), 2019-12, <i>Simplifying the Accounting for Income Taxes</i>,
which amends ASC 740, <i>Income Taxes</i> (ASC 740). This update is intended to simplify accounting for income taxes by removing certain
exceptions to the general principles in ASC 740 and amending existing guidance to improve consistent application of ASC 740. This update
is effective for fiscal years beginning after December 15, 2021. The guidance in this update has various elements, some of which are
applied on a prospective basis and others on a retrospective basis with earlier application permitted. The adoption of the new standard
did not have a material effect on the Company&#8217;s consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2020, the FASB issued ASU No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging
Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own
Equity. ASU 2020-06 will simplify the accounting for convertible instruments by reducing the number of accounting models for convertible
debt instruments and convertible preferred stock. Limiting the accounting models results in fewer embedded conversion features being
separately recognized from the host contract as compared with current GAAP. Convertible instruments that continue to be subject to separation
models are (1) those with embedded conversion features that are not clearly and closely related to the host contract, that meet the definition
of a derivative, and that do not qualify for a scope exception from derivative accounting and (2) convertible debt instruments issued
with substantial premiums for which the premiums are recorded as paid-in capital. ASU 2020-06 also amends the guidance for the derivatives
scope exception for contracts in an entity&#8217;s own equity to reduce form-over-substance-based accounting conclusions. ASU 2020-06
will be effective for public companies for fiscal years beginning after December 15, 2023, including interim periods within those fiscal
years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within
those fiscal years. The Company is currently evaluating the impact that the adoption of ASU 2020-06 will have on the Company&#8217;s
consolidated financial statement presentation or disclosures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2016, the FASB issued ASU 2016-13, Financial Instruments &#8211; Credit Losses (Topic 326): Measurement of Credit Losses on Financial
Instruments (&#8220;ASC 326&#8221;). The guidance replaces the incurred loss methodology with an expected loss methodology that is referred
to as the current expected credit loss (&#8220;CECL&#8221;) methodology. The measurement of expected credit losses under the CECL methodology
is applicable to financial assets measured at amortized cost, including loan receivables and held-to-maturity debt securities. It also
applies to off-balance sheet credit exposures not accounted for as insurance (loan commitments, standby letters of credits, financial
guarantees, and other similar instruments) and net investments in leases recognized by a lessor in accordance with Topic 842 on leases.
ASC 326 requires enhanced disclosures related to the significant estimates and judgments used in estimating credit losses as well as
the credit quality and underwriting standards of a company&#8217;s portfolio. In addition, ASC 326 made changes to the accounting for
available-for-sale debt securities. One such change is to require credit losses to be presented as an allowance rather than as a write-down
on available-for-sale debt securities the Company does not intend to sell or believes that it is more likely than not they will be required
to sell. The ASU can be adopted no later than January 1, 2020 for SEC filers and January 1, 2023 for private companies and smaller reporting
companies. The Company has not yet adopted this ASU as it qualifies as a smaller reporting company. The Company does not expect this
ASU will have a material impact on its consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2021, the FASB issued ASU 2021-08, &#8220;Business Combinations - Accounting for Contract Assets and Contract Liabilities (Topic
805)&#8221;. The amendments in this Update address diversity and inconsistency related to the recognition and measurement of contract
assets and contract liabilities acquired in a business combination. The amendments in this Update require that an acquirer recognize
and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606, Revenue from Contracts
with Customers. ASU 2021-08 is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal
years. The Company does not expect the adoption of this ASU to have a material impact on the Company&#8217;s financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
FASB has issued ASU 2021-04, Earnings Per Share (Topic 260), Debt&#8212;Modifications and Extinguishments (Subtopic 470-50), Compensation&#8212;Stock
Compensation (Topic 718), and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40). ASU 2021-04 provides
guidance that an entity should treat a modification of the terms or conditions or an exchange of a freestanding equity-classified written
call option that remains equity classified after modification or exchange as an exchange of the original instrument for a new instrument.
The standard also provides guidance on how an entity should measure and recognize the effect of a modification or an exchange of a freestanding
equity-classified written call option that remains equity classified. The amendments in this ASU are effective for the Company for fiscal
years beginning after December 15, 2021. Early adoption is permitted for all entities, including adoption in an interim period. The adoption
of the new standard did not have a material effect on the Company&#8217;s consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
recently issued accounting pronouncements did not, or are not believed by management to, have a material effect on the Company&#8217;s
present or future consolidated financial statements.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_InterimFinancialStatementsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interim Financial Statements Policy [Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_InterimFinancialStatementsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_PrepaidInventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid Inventory Policy [Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_PrepaidInventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_WarrantsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants Policy [Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_WarrantsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (a)-(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479515/805-10-05-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480981/942-825-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 60<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482053/820-10-60-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 825<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//830/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//350-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480091/360-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482338/360-10-05-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-25<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-19<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsFiniteLivedPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 920<br> -SubTopic 350<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483256/920-350-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 920<br> -SubTopic 350<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483256/920-350-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 920<br> -SubTopic 350<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483256/920-350-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsFiniteLivedPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483489/210-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 330<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482105/912-330-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//330/tableOfContent<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483080/330-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483080/330-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 270<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482989/270-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 205<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483504/205-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-18<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org//606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.C.Q3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.1.Q5)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.3.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//718/tableOfContent<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481569/310-20-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 310<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-11B<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 10<br> -Topic 310<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-6<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 310<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007869344912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2023</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems', window );"><strong>Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">SCHEDULE OF INVENTORY</a></td>
<td class="text"><p id="xdx_890_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zf97HVif52hc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B6_zoqiVAt0juPa" style="display: none">SCHEDULE OF INVENTORY</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_491_20230731_zE6h5LaOen1g" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">July 31, 2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_492_20230430_ziGSNULllzaa" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">April 30, 2023</td><td style="font-weight: bold">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--InventoryFinishedGoods_iI_maINzzOV_zXcYG5jS1aEb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Finished Goods</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">400,598</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">1,509,985</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--InventoryRawMaterialsAndSupplies_iI_maINzzOV_z45YZrOaZ1fb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Component/Replacement Parts</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,064,041</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,712,553</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--CapitalizedDutyAndFreight_iI_maINzzOV_zqWK1brM4sCc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Capitalized Duty/Freight</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">47,279</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">517,228</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--InventoryAdjustments_iNI_di_msINzzOV_ztNimEQags14" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Inventory Reserve</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(175,000</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(550,000</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--InventoryNet_iTI_mtINzzOV_zZKqAyFQU6p8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Total</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,336,918</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,189,766</td><td style="text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
<td class="text"><p id="xdx_896_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zrmeoIreLo6e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_zOGEgcyNOtTi" style="display: none">SCHEDULE OF INVENTORY</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_492_20230430_zCNs6Kvremrg" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">April 30, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20220430_zUbYmp0KTAV2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">April 30, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--InventoryFinishedGoods_iI_maINzzOV_zgpMKI5OqRDg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left">Finished Goods</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">1,509,985</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">4,073,791</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--InventoryRawMaterialsAndSupplies_iI_maINzzOV_zA8Ecmzavp07" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Component/Replacement Parts</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,712,553</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2,559,848</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--CapitalizedDutyAndFreight_iI_maINzzOV_zJz4ApKsSv12" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Capitalized Duty/Freight</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">517,228</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,328,198</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--InventoryAdjustments_iNI_di_msINzzOV_zMRWSmi26TMa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Inventory Reserve</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(550,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(100,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--InventoryNet_iTI_mtINzzOV_zaS27xIt7Avl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Total</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">3,189,766</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">7,861,837</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock', window );">SCHEDULE OF DERIVATIVE LIABILITIES</a></td>
<td class="text"><p id="xdx_89F_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_zv0dvk3LFGO3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BB_zkFsh03XdvSa" style="display: none">SCHEDULE OF DERIVATIVE LIABILITIES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Note derivative is related to</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">July 31, 2023</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">ending balance</p></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">(Gain) loss for the</p>
                                                                                                    <p style="margin-top: 0; margin-bottom: 0">three months ended</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">July 31, 2023</p></td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">4/11/21 profit guaranty</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--ProfitGuarantyMember_zDJadryzbuC2" style="width: 14%; text-align: right" title="Note derivative balance">1,456,854</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20230501__20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--ProfitGuarantyMember_zHh9mPuqcsS7" style="width: 14%; text-align: right" title="Note derivative (gain) loss"><span style="-sec-ix-hidden: xdx2ixbrl0787">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">8/6/21 convertible notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--ConvertibleNotesMember_zcQdpsaz83l1" style="text-align: right" title="Note derivative balance">74,958</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20230501__20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--ConvertibleNotesMember_zJ1AURkaGhUa" style="text-align: right" title="Note derivative (gain) loss">(26,966</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">6/17/22 underwriter warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--UnderwriterWarrantsMember_z67ge1gtPjuh" style="text-align: right" title="Underwriter warrants">4,966</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20230501__20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--UnderwriterWarrantsMember_zPpqveywdCy" style="text-align: right" title="Note derivative (gain) loss">(1,565</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">9/30/22 warrants issued with common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsIssuedWithCommonStockMember_zxe6iTEE7M98" style="text-align: right" title="Other derivative liabilities eliminated in uplist">4,668,608</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20230501__20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsIssuedWithCommonStockMember_zzgik92kwAIf" style="text-align: right" title="Note derivative (gain) loss">(1,440,951</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">1/6/2023 warrants issued with note payable</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsIssuedWithNotesPayableMember_zCWepP1a6mqg" style="border-bottom: Black 1.5pt solid; text-align: right" title="Other derivative liabilities eliminated in uplist">2,139,666</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20230501__20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsIssuedWithNotesPayableMember_zunZlzLuQT98" style="border-bottom: Black 1.5pt solid; text-align: right" title="Note derivative (gain) loss">(675,072</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">Total</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230731_zLRaRIC2AP9a" style="border-bottom: Black 2.5pt double; text-align: right" title="Note derivative balance">8,345,052</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20230501__20230731_zyUgb91QhYpb" style="border-bottom: Black 2.5pt double; text-align: right" title="Note derivative (gain) loss">(2,144,554</td><td style="text-align: left">)</td></tr>
  </table>

<span></span>
</td>
<td class="text"><p id="xdx_895_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_zKdxFAaIrev6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BC_zth2ZPbd4ldg" style="display: none">SCHEDULE OF DERIVATIVE LIABILITIES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">April 30, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">(Gain) loss for the year</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Note derivative is related to</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">ending balance</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">ended April 30, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 58%; text-align: left">4/11/21 profit guaranty</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--ProfitGuarantyMember_zLoVdfg4BcMg" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Note derivative balance">1,456,854</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20220501__20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--ProfitGuarantyMember_ztU1z71Fcr69" style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right" title="Note derivative (gain) loss">395,304</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">8/6/21 convertible notes</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--ConvertibleNotesMember_za5ouNOASKYj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Note derivative balance">101,924</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20220501__20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--ConvertibleNotesMember_zbyjmW8ypLJi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Note derivative (gain) loss">(2,611,410</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">6/17/22 underwriter warrants</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--UnderwriterWarrantsMember_zk2QYBRehJBf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Underwriter warrants">6,531</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20220501__20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--UnderwriterWarrantsMember_z2kIb4szkMl9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Note derivative (gain) loss">(57,951</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Other derivative liabilities eliminated in uplist</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--OtherDerivativeLiabilitiesMember_zJoLszxw8Ko5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other derivative liabilities eliminated in uplist"><span style="-sec-ix-hidden: xdx2ixbrl2020">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20220501__20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--OtherDerivativeLiabilitiesMember_zZaELMDW4F8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Note derivative (gain) loss">(1,604,413</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">9/30/22 warrants issued with common stock</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsIssuedWithCommonStockMember_zSHGxJ6QgJva" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other derivative liabilities eliminated in uplist">6,109,559</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20220501__20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsIssuedWithCommonStockMember_zDUauxaNsYN3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Note derivative (gain) loss">(6,170,728</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">1/6/2023 warrants issued with note payable</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsIssuedWithNotesPayableMember_zDflVje0ufDd" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other derivative liabilities eliminated in uplist">2,814,738</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20220501__20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsIssuedWithNotesPayableMember_zWeXeUvmeepj" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Note derivative (gain) loss">(900,819</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Total</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230430_zQU5Cl2xeNz7" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Note derivative balance">10,489,606</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_980_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20220501__20230430_zRROsfnxGTP5" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Note derivative (gain) loss">(10,950,017</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">SCHEDULE OF WARRANTS GRANTED VALUATION USING BLACK-SCHOLES PRICING METHOD</a></td>
<td class="text"><p id="xdx_894_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zxJveoNkqJJ3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B1_zmeSKHeg1jZ8" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE
OF DERIVATIVE AND WARRANTS GRANTED VALUATION USING BLACK-SCHOLES PRICING METHOD</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Period Ended</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">July 31, 2023</p></td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Period Ended</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">July 31, 2022</p></td><td style="font-weight: bold">&#160;</td>
    </tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected life in years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecustom--DerivativeLiabilitiesMeasurementInputTerm_dtY_c20230501__20230731__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zOM7Nc73Uq2c" title="Derivative liabilities Measurement input, term">0.7</span>-<span id="xdx_906_ecustom--DerivativeLiabilitiesMeasurementInputTerm_dtY_c20230501__20230731__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zRXshLS2zzR2" title="Derivative liabilities Measurement input, term">10</span> years</span></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_ecustom--DerivativeLiabilitiesMeasurementInputTerm_dtY_c20220501__20220731__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_z0nVauo9IEb6" title="Derivative liabilities measurement input">4</span>-<span id="xdx_90D_ecustom--DerivativeLiabilitiesMeasurementInputTerm_dtY_c20220501__20220731__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zqEOo8AIaq2c" title="Derivative liabilities measurement input">4.3</span> years</span></td><td style="text-align: left">&#160;</td>
    </tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 64%">Stock price volatility</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><span id="xdx_904_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230731__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zeMg7ysdKVnf" title="Derivative liability measurement input">150</span></td><td style="width: 1%; text-align: left">%</td>
    <td style="width: 2%; text-align: left">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220731__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__srt--RangeAxis__srt--MinimumMember_zUAxzfGuc3k8" title="Derivative liability measurement input">50</span>-<span id="xdx_903_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220731__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__srt--RangeAxis__srt--MaximumMember_z9VBkbRCPujc" title="Derivative liability measurement input">148</span></span></td><td style="width: 1%; text-align: left">%</td>
    </tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Risk free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230731__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zYWf0ns4haFi" title="Derivative liability measurement input">4.08</span>%-<span id="xdx_90F_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230731__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zJhudoQoifl" title="Derivative liability measurement input">5.37</span></span></td><td style="text-align: left">%</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220731__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_za4ttfqB5Tdj" title="Derivative liability measurement input">2.90</span>%-<span id="xdx_90A_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220731__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zGntoDYd2FDl" title="Derivative liability measurement input">3.27</span></span></td><td style="text-align: left">%</td>
    </tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Expected dividends</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_902_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230731__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zD8ftCahm3Xa" title="Derivative liability measurement input">0</span></td><td style="text-align: left">%</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220731__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_z2f9hunjDTE8" title="Derivative liability measurement input">0</span></td><td style="text-align: left">%</td>
    </tr>
  </table>

<span></span>
</td>
<td class="text"><p id="xdx_892_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_z4Bz6LcfV8Y7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B1_zSBUudjmpz4c" style="display: none">SCHEDULE
OF DERIVATIVE AND WARRANTS GRANTED VALUATION USING BLACK-SCHOLES PRICING METHOD</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Year Ended April 30, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Year Ended April 30, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Expected life in years</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--DerivativeLiabilitiesMeasurementInputTerm_dtY_c20220501__20230430__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zExvjDnpbI51" title="Derivative liabilities Measurement input, term">3.25</span>-<span id="xdx_902_ecustom--DerivativeLiabilitiesMeasurementInputTerm_dtY_c20220501__20230430__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zp2qcuPMSE22" title="Derivative liabilities Measurement input, term">10</span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecustom--DerivativeLiabilitiesMeasurementInputTerm_dtY_c20210501__20220430__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_z6yeJH9ymBcl" title="Derivative liabilities measurement input">1.95</span>-<span id="xdx_90E_ecustom--DerivativeLiabilitiesMeasurementInputTerm_dtY_c20210501__20220430__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zWD6oIs7ALNd" title="Derivative liabilities measurement input">4.3</span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 68%">Stock price volatility</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230430__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__srt--RangeAxis__srt--MinimumMember_zDuwBbVQde9c" title="Derivative liability measurement input">50</span> - <span id="xdx_90D_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230430__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__srt--RangeAxis__srt--MaximumMember_ziEpBdVqYX01" title="Derivative liability measurement input">150</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span id="xdx_90A_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220430__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zLjQhYmj1Zt6" title="Derivative liability measurement input">50</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Risk free interest rate</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230430__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zJAEIQfPKexl" title="Derivative liability measurement input">2.90%</span>-<span id="xdx_908_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230430__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zhWQyeeXjsV1" title="Derivative liability measurement input">4.34</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220430__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zMfFROROnH6l" title="Derivative liability measurement input">2.67%</span>-<span id="xdx_908_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220430__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zawH3Uq2Hv7e" title="Derivative liability measurement input">2.90</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Expected dividends</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230430__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_z7qeqaaslk7j" title="Derivative liability measurement input">0</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220430__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zakTy1zyVZ3h" title="Derivative liability measurement input">0</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems', window );"><strong>Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">SCHEDULE OF WARRANTS GRANTED VALUATION USING BLACK-SCHOLES PRICING METHOD</a></td>
<td class="text"><p id="xdx_89A_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_hus-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_zwUBj2Ktlrbc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B7_zevv4dX2q55a" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE
OF WARRANTS GRANTED VALUATION USING BLACK-SCHOLES PRICING METHOD</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Period Ended</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">July 31, 2023</p></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Period Ended</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">July 31, 2022</p></td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected life in years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;&#160;<span id="xdx_90A_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dxL_c20230731__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_z3Rj0J3GgEx8" title="Warrants measurement input, term::XDX::P0Y"><span style="-sec-ix-hidden: xdx2ixbrl0857">-</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220731__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MinimumMember_z6lktadzpOMc" title="Warrants measurement input, term">5</span> &#8211; <span id="xdx_90F_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220731__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MaximumMember_zv1e5yHUtgVg" title="Warrants measurement input, term">10</span> years</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Stock price volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230731__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_zrSfyLGPFr61" title="Warrants measurement input, rate"><span style="-sec-ix-hidden: xdx2ixbrl0863">-</span></span></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220731__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_z5u1bPOjwnR7" title="Warrants measurement input, rate">50</span>% - <span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220731__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_z96TgwhrYCQl" title="Warrants measurement input, rate">148</span></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Risk free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230731__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zRAoz5ytefj6" title="Warrants measurement input, rate"><span style="-sec-ix-hidden: xdx2ixbrl0869">-</span></span></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220731__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember_zNyzrC9VnPcf" title="Warrants measurement input, rate">2.50</span>% - <span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220731__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember_zJu0UEQstGkg" title="Warrants measurement input, rate">3.50</span></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 64%; text-align: left">Expected dividends</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230731__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zIeSl2LJtWth" title="Warrants measurement input, rate"><span style="-sec-ix-hidden: xdx2ixbrl0875">-</span></span></span></td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><span id="xdx_909_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220731__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zrjwzYtj2Wk1" title="Warrants measurement input, rate">0</span></td><td style="width: 1%; text-align: left">%</td></tr>
  </table>

<span></span>
</td>
<td class="text"><p id="xdx_899_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_hus-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_zzz3XHpZ7AW7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B9_zSnX45WTkLQ7" style="display: none">SCHEDULE OF WARRANTS GRANTED VALUATION USING BLACK-SCHOLES PRICING
METHOD</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">Year Ended</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">April 30, 2023</p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">Year Ended</p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">April 30, 2022</p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Expected life in years</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20230430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MinimumMember_z39j4GVFPZU2" title="Warrants measurement input, term">5</span> &#8211; <span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20230430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MaximumMember_zxLRWNDFvyMe" title="Warrants measurement input, term">10</span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MinimumMember_zQGYyHPQeRa2" title="Warrants measurement input, term">5</span> &#8211; <span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MaximumMember_zuhSHLVH1bph" title="Warrants measurement input, term">10</span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">Stock price volatility</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230430__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_zVgcGSscX8Rd" title="Warrants measurement input, rate">50</span>% - <span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230430__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_zTqr0kjgX1B3" title="Warrants measurement input, rate">150</span>%</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220430__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_zB8DinQqZMWj" title="Warrants measurement input, rate">50</span>% - <span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220430__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_zyePRTOpLbxf" title="Warrants measurement input, rate">148</span></span>%</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Risk free interest rate</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember_zFCjvCwWOVDe" title="Warrants measurement input, rate">2.50</span>% - <span id="xdx_909_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember_zVHayA4Yshze" title="Warrants measurement input, rate">4.68</span>%</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember_zcX2q7oqNHhb" title="Warrants measurement input, rate">0.77</span>% - <span id="xdx_90F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember_zriimxW75qde" title="Warrants measurement input, rate">1.63</span></span>%</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left">Expected dividends</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: center"><span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zpCT0ha2u6w" title="Warrants measurement input, rate">0</span>%</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: center"><span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zselrYextILl" title="Warrants measurement input, rate">0</span>%</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"></td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset) using recurring unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483489/210-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007866700608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INTANGIBLE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2023</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock', window );">SCHEDULE OF INTANGIBLE ASSETS</a></td>
<td class="text"><p id="xdx_89E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_zdEzhIregm3k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets reflect only those intangible assets of our continuing operations, and consist of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BB_zvVdOUPUW9F9" style="display: none">SCHEDULE
OF INTANGIBLE ASSETS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(in years)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_485_eus-gaap--FiniteLivedIntangibleAssetsGross_iE_zAMiHKf66H3b" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_486_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iE_zn4EwGG06JF" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amortization</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_48B_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_zeA61Y01H2y4" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Loss</b></span></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_485_eus-gaap--FiniteLivedIntangibleAssetsNet_iE_z7YLFPhaw6S5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="14" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Average Period</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">July 31, 2023</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Amortization</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">(in years)</p></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Carrying</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Value</p></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Accumulated</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Amortization</p></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Impairment</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Loss</p></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Net Carrying</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Value</p></td><td style="font-weight: bold">&#160;</td></tr>
  <tr id="xdx_410_20230501__20230731__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TradeNamesAndPatentsMember_zaNuV3NGaLb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 34%; text-align: left">Tradenames and patents</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: center"><span id="xdx_901_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20230731__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TradeNamesAndPatentsMember_z15UgE7F6uN3" title="Weighted average amortization">15.26</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">385,582</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">24,031</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">360,551</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">1,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_418_20230501__20230731__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zmmmos5dRDHh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Customer relationships</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span id="xdx_90F_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20230731__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zqRBMbGreqdd" title="Weighted average amortization">9.92</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,930,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50,038</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,879,962</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0905">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_41C_20230501__20230731__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zsfso3WFD4Rf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Internally developed software</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span id="xdx_90E_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20230731__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zDZ7wlhv6lS3" title="Weighted average amortization">4.91</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">580,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">79,608</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">500,392</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0911">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_418_20230501__20230731__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangiableAssetMember_z8yKTM7fUQr2" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Total intangible assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,895,582</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">153,677</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,740,905</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,000</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(in years)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_486_eus-gaap--FiniteLivedIntangibleAssetsGross_iE_zrmAEid9knCg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_482_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iE_zCIJrg6DzlS4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amortization</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_481_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_zywsPGGp4Jp7" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Loss</b></span></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_480_eus-gaap--FiniteLivedIntangibleAssetsNet_iE_zbstifZDGLHa" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="14" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Average Period</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">April 30, 2023</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Amortization</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">(in years)</p></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Carrying</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Value</p></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Accumulated</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Amortization</p></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Impairment</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Loss</p></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Net Carrying</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Value</p></td><td style="font-weight: bold">&#160;</td></tr>
  <tr id="xdx_418_20220501__20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TradeNamesAndPatentsMember_zUXbS0TrERQi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 34%; text-align: left">Tradenames and patents</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 9%; text-align: center"><span id="xdx_908_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TradeNamesAndPatentsMember_zxdUY4D2xPT6" title="Weighted average amortization">15.26</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">385,582</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">24,031</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">260,270</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">101,281</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_41A_20220501__20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zMmZ6D87bZDl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Customer relationships</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_z4ku75IpaXC7" title="Weighted average amortization">9.92</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,930,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50,038</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,879,962</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0927">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_416_20220501__20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_za6FJOcFioy8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Internally developed software</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zrhiKnlnaysi" title="Weighted average amortization">4.91</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">580,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">79,608</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">500,392</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0933">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_411_20220501__20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangiableAssetMember_z1lHJnMQjOM3" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Total intangible assets</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,895,582</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">153,677</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,640,624</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">101,281</td><td style="text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
<td class="text"><p id="xdx_898_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_zdr9hxZMF1qc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets reflect only those intangible assets of our continuing operations, and consist of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BC_zLJRfJD0K8e9" style="display: none">SCHEDULE
OF INTANGIBLE ASSETS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Amortization (in years)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_484_eus-gaap--FiniteLivedIntangibleAssetsGross_iE_zrSxTrqNDeLh" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Carrying Value</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_486_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iE_z2DiURFhwMZg" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Accumulated Amortization</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_480_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_zGoK4o3VPHci" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Impairment Loss</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_489_eus-gaap--FiniteLivedIntangibleAssetsNet_iE_zOmVLXhWvedh" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Net Carrying Value</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="14" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center">Average Period</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">April 30, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Amortization (in years)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Carrying Value</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Accumulated Amortization</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Impairment Loss</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Net Carrying Value</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_414_20220501__20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zFDBZ3AM1HT6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: left">Tradenames and patents</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: center"><span id="xdx_90E_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zx6h3gqzWEL5" title="Weighted average amortization">15.26</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">385,582</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">24,031</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">260,270</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">101,281</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_417_20220501__20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zAsmufx8AcW1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Customer relationships</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zwD9Z1VsmnG3" title="Weighted average amortization">9.92</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3,930,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">50,038</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3,879,962</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2160">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_414_20220501__20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zikGWA91n2t9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Internally developed software</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_z7pg1tb3zqug" title="Weighted average amortization">4.91</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">580,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">79,608</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">500,392</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2166">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_417_20220501__20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangiableAssetMember_zXx2lvZtMOkf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Total intangible assets</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">4,895,582</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">153,677</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">4,640,624</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">101,281</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Amortization (in years)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_48B_eus-gaap--FiniteLivedIntangibleAssetsGross_iE_zUNr6toUcijk" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Carrying Value</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_486_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iE_zOV8G52KINe9" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Accumulated Amortization</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_485_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_zUmOVotCGov3" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Impairment Loss</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_487_eus-gaap--FiniteLivedIntangibleAssetsNet_iE_zGiQqowKXHbe" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Net Carrying Value</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="14" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center">Average Period</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">April 30, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Amortization (in years)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Carrying Value</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Accumulated Amortization</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Impairment Loss</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Net Carrying Value</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_419_20210501__20220430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zAgrvwPJvN0b" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%">Tradenames</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: center"><span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20220430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zbXyobP3JYwi" title="Weighted average amortization">15.26</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">385,582</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">9,478</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl2175">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">376,104</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_419_20210501__20220430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zDeHVQJJ5QD1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Customer relationships</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_901_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20220430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zP4mPbnhLrR4" title="Weighted average amortization">9.92</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3,930,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">33,749</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2181">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3,896,251</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_418_20210501__20220430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zrzQlmK69ly3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Internally developed software</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span id="xdx_90C_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20220430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zcIkXcNe90Of" title="Weighted average period amortization (in years)">4.91</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">580,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">9,499</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2187">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">570,501</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_417_20210501__20220430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangiableAssetMember_zxTxREyI4cf2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Total intangible assets</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">4,895,582</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">52,726</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2193">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">4,842,856</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">SCHEDULE OF ESTIMATED FUTURE AMORTIZATION</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_89A_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zH05izqLdxi5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of April 30, 2023, the estimated future amortization expense associated with the Company&#8217;s intangible assets for each of the five
succeeding fiscal years is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B6_zB85NosWLREd" style="display: none">SCHEDULE
OF ESTIMATED FUTURE AMORTIZATION</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">For the Periods Ended April 30,</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20230430_zSqYeLWsNuG" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Amortization Expense</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_maFLIANz0wb_zvOaBo4f6dU9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 83%; text-align: left">2024</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">5,780</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_maFLIANz0wb_ze3pjAkRb9Gd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">2025</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">5,780</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_maFLIANz0wb_z3V7ftmG7Me9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">2026</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">5,780</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_maFLIANz0wb_zXxqRIFFMZb9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">2027</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">5,780</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_maFLIANz0wb_zQReO9dlgiN1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">2028</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">5,780</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_maFLIANz0wb_z7NR33BokaSh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thereafter</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">72,381</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_mtFLIANz0wb_z9mqaNM9uZv6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">101,281</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007859275872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCRUED EXPENSES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2023</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">SCHEDULE OF ACCRUED EXPENSES</a></td>
<td class="text"><p id="xdx_89B_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_z16P7oj1WSEf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
composition of accrued expenses is summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_z0Lf5A9wMVac" style="display: none">SCHEDULE
OF ACCRUED EXPENSES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_490_20230731_zA4I6a2iRVk7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">July 31, 2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_493_20230430_zgHAdCwGXbea" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">April 30, 2023</td><td style="font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--AccruedPayrollTaxesCurrent_iI_maALCzIie_zgsakoVu0Rhl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Accrued payroll</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">1,754,936</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">1,535,186</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AccruedBonusesCurrent_iI_maALCzIie_zVAUtZkGQhRi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accrued bonus</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,829,604</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,720,606</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--AccruedProfessionalFeesCurrent_iI_maALCzIie_zOd59yZFR5qh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accrued professional fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">35,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">490,424</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AccountsPayableOtherCurrent_iI_maALCzIie_zlN7830IRz81" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Other accrued expenses</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,577,920</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,165,623</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AccruedLiabilitiesCurrent_iTI_mtALCzIie_zQqIU9SIRQHi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Total</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,197,460</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,911,839</td><td style="text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
<td class="text"><p id="xdx_89E_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_zI2oQEiZV7X6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
composition of accrued expenses is summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B8_zZslrlmApOp" style="display: none">SCHEDULE
OF ACCRUED EXPENSES</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_492_20230430_zqbAUjkkGpMk" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">April 30, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20220430_zZfgJFMt77n8" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">April 30, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--AccruedPayrollTaxesCurrent_iI_maALCzIie_zJwwlQCiGI93" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left">Accrued payroll</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">1,535,186</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">921,759</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AccruedBonusesCurrent_iI_maALCzIie_znHv2XcDokc9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accrued bonus</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,720,606</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,014,833</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--AccruedProfessionalFeesCurrent_iI_maALCzIie_z5moAxsGpls1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accrued professional fees</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">490,424</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,706,560</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AccountsPayableOtherCurrent_iI_maALCzIie_zVSMdWQ8Rqb1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Other accrued expenses</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,165,623</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">738,749</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AccruedLiabilitiesCurrent_iTI_mtALCzIie_zF0V6kHDPthf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Total</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">4,911,839</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">4,381,901</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007864829104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DISCONTINUED OPERATIONS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2023</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">SCHEDULE OF DISCONTINUED OPERATIONS</a></td>
<td class="text"><p id="xdx_897_eus-gaap--ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_zD9USQreYrA2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company reclassified the following operations to discontinued operations for the three months ended July 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;<span id="xdx_8BF_zlX69MpnFq96" style="display: none">SCHEDULE OF DISCONTINUED OPERATIONS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49B_20230501__20230731_z6vBlsAeZem6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--DisposalGroupIncludingDiscontinuedOperationRevenue_maDGIDOzOqT_zTX4Zsk8tpa8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 78%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,363,113</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOperatingExpense_msDGIDOzOqT_zN6SKIa4H6Ua" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,278,269</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_407_ecustom--DisposalGroupIncludingDiscontinuedOperationOtherIncomeLoss_msDGIDOzOqT_zt6ZTRD3r8wb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other (income) loss</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(155,442</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_401_ecustom--DisposalGroupIncludingDiscontinuedOperationNetIncomeLoss_iT_mtDGIDOzOqT_zYbWwszeHEt3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net loss from discontinued
    operations</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,759,714</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  </table>

<span></span>
</td>
<td class="text"><p id="xdx_897_eus-gaap--ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_zr6y7QmCcvs3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current
assets as of April 30, 2022 &#8211; Discontinued Operations:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BF_zS55T0AWOdM3" style="display: none">SCHEDULE OF DISCONTINUED OPERATIONS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20220430_zAXYTYYV3Pne" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">April 30, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_iI_maAODGIzvOg_zNbesnP5QK2k" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: left">Cash and restricted cash</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">916,082</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_iI_maAODGIzvOg_zdDC2skQzck8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accounts receivable</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">288,980</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_iI_maAODGIzvOg_zlLcREfZLJ4h" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">Inventory</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">323,307</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesCurrent_iI_maAODGIzvOg_zGlG9f4oYRSh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Right of use asset &#8211; operating leases</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">239,689</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_iI_maAODGIzvOg_zsJimypo1AG2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Prepaid expenses</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">490,260</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_iI_mtAODGIzvOg_z3FiX2D68ymj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Current Asset</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">2,258,318</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-current
assets as of April 30, 2022 &#8211; Discontinued Operations:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20220430_zGKs8tZid6s3" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">April 30, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent_iI_maDGIDOzWYq_zVWAQYz7uwB7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 80%">Goodwill</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">25,862,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent_iI_maDGIDOzWYq_zys3pYq034kc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Property and equipment, net</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">126,862</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent_iI_maDGIDOzWYq_zeQRqCFy3RE7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Intangible assets, net</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">19,473,646</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets_iI_maDGIDOzWYq_z4dQgbkQTPF6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Contract assets, net of current portion</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">209,363</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--DisposalGroupIncludingDiscontinuedOperationInventoryNoncurrent_iI_maDGIDOzWYq_zKzdc3EJ5mP2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Finished products used in operations, net</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">4,693,575</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent_iTI_mtDGIDOzWYq_zOlJYK0X4Esl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-current Asset</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">50,365,446</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current
liabilities as of April 30, 2022 &#8211; Discontinued Operations:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_490_20220430_z3C8XOSHfqid" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">April 30, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent_iI_maLODGIzSPI_zeW9FtDqNNx9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: left">Accounts payable and accrued expenses</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">2,432,818</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityOperatingLeasesCurrent_iI_maLODGIzSPI_z1fKG0C7uLzd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Lease liability &#8211; operating leases</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">237,204</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_iI_maLODGIzSPI_z5oXsB11HdIe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Contract liabilities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">2,545,200</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_iTI_mtLODGIzSPI_zyAFqNfeWXy5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Current Liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">5,215,222</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-current
liabilities as of April 30, 2022 &#8211; Discontinued Operations:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20220430_zhtEx84wNVr3" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">April 30, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities_iI_z16OtV0zyiT8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: left">Contract liabilities, net of current portion</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">1,370,492</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent_iTI_zqQDyCr2mKQf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Current Liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">1,370,492</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company reclassified the following operations to discontinued operations for the years ended April 30, 2023 and 2022, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_499_20220501__20230430_zDERT3DSewv8" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20210501__20220430_zJapoXaVfHd7" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--DisposalGroupIncludingDiscontinuedOperationRevenue_maDGIDOzOqT_zeWuCX7w9BJa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 64%">Revenue</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">3,954,149</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">728,805</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOperatingExpense_msDGIDOzOqT_zr3tWtPGQDgc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Operating expenses</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">8,416,117</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">5,948,508</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--DisposalGroupIncludingDiscontinuedOperationOtherIncomeLoss_msDGIDOzOqT_zYceM7Z9yMs5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Other (income) loss</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2750">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">27,974</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--DisposalGroupIncludingDiscontinuedOperationNetIncomeLoss_iT_mtDGIDOzOqT_zRg2zyDOURul" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Net loss from discontinued operations</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(4,461,968</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(5,247,677</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>


<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_ScheduleOfCalculationOfTheLossOnDisposalTableTextBlock', window );">SCHEDULE OF CALCULATION OF THE LOSS ON DISPOSAL</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_892_ecustom--ScheduleOfCalculationOfTheLossOnDisposalTableTextBlock_za4oTSQUDTGb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following represents the calculation of the loss on disposal of PlaySight and Foundation Sports:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BD_zTqKPL8EhYYa" style="display: none">SCHEDULE OF CALCULATION OF THE LOSS ON DISPOSAL</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_49C_20230430__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--PlaySightAndFoundationSportsMember_zK9sBTh5L6z7" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_iI_zn03MDRPyxcl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 84%; text-align: left">Note receivable</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">2,000,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_iNI_di_zkUH2AW88oId" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Cash and restricted cash</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(714,507</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_40B_ecustom--DisposalGroupIncludingDiscontinuedOperationAccountsReceivable_iI_zZFpJqoLXvxf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accounts receivable</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(411,249</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_iNI_di_zl12gf6FqCTi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Prepaid expenses</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(106,031</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--DisposalGroupIncludingDiscontinuedOperationInventory1_iNI_di_za1eheOaBBYk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">Inventory</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(296,920</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherAssets_iNI_di_zg0Yzds1vmu2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Finished products used in operations</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(4,117,986</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_40B_ecustom--DisposalGroupIncludingDiscontinuedOperationContractAssets_iI_zCLtxuXTSZak" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Contract assets</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(298,162</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_40C_ecustom--DisposalGroupIncludingDiscontinuedOperationRightOfUseAsset_iI_zGWJgZuu6w8b" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Right of use asset</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(103,228</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--DisposalGroupIncludingDiscontinuedOperationGoodwill1_iNI_di_zPLmUSwo4hPf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">Goodwill</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(25,862,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_407_eus-gaap--DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_iNI_di_zeJH3gAdTAt7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Property and equipment</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(116,505</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_40F_eus-gaap--DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_iNI_di_zkLVx0OIHIp6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Intangible assets</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(18,576,475</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_405_ecustom--DisposalGroupIncludingDiscontinuedOperationContractLiabilities_iI_zFHdNclfSDc5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Contract liabilities</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3,785,408</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_iI_z9Yd9DZxM7l1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Lease liabilities</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">78,016</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_iI_zb9hKD2ofYD2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Accounts payable and accrued expenses</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">3,325,747</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--DisposalGroupIncludingDiscontinuedOperationLossOnDisposalOfDiscontinuedOperations_iI_z9xd8SmzKwz1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Loss on disposal of discontinued operations</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(41,413,892</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_ScheduleOfCalculationOfTheLossOnDisposalTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of calculation of the loss on disposal (Table Text Block)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_ScheduleOfCalculationOfTheLossOnDisposalTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-3A<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-4A<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-4B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5A<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5C<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5D<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3A<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007864600320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS AND BUSINESS COMBINATIONS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock', window );">SCHEDULE OF PROFORMA FINANCIAL INFORMATION</a></td>
<td class="text"><p id="xdx_898_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_zyENlt8bYm4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B7_zFAhyN7MQ28c" style="display: none">SCHEDULE OF PROFORMA FINANCIAL INFORMATION</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_495_20220501__20230430__us-gaap--BusinessAcquisitionAxis__custom--PlaySightAndGameFaceMember_zVxQYrY8QOx8" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--BusinessAcquisitionsProFormaRevenue_zM2xjz0arDz" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 80%">Revenues</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">16,102,672</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_zN8TPAqShFb8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Net loss</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(53,069,215</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Basic and diluted earnings (loss) per share</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_903_eus-gaap--BusinessAcquisitionProFormaEarningsPerShareBasic_pid_c20220501__20230430__us-gaap--BusinessAcquisitionAxis__custom--PlaySightAndGameFaceMember_zDPrP6mamX03" title="Basic earnings (loss) per share"><span id="xdx_90D_eus-gaap--BusinessAcquisitionProFormaEarningsPerShareDiluted_pid_c20220501__20230430__us-gaap--BusinessAcquisitionAxis__custom--PlaySightAndGameFaceMember_zFKKqatP7QUb" title="Diluted earnings (loss) per share">(13.79</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -SubTopic 10<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -SubTopic 10<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007864567888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE PAYABLE - RELATED PARTY (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">SCHEDULE OF WARRANTS ISSUED, EXERCISED AND EXPIRED</a></td>
<td class="text"><p id="xdx_891_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zfYvdOdwoDS3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following represents a summary of the warrants:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B7_zHSt7Ikw6fI7" style="display: none">SCHEDULE OF WARRANTS ISSUED, EXERCISED AND EXPIRED</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Year Ended April 30, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Year Ended April 30, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Number</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted<br/> Average<br/> Exercise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Price</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Number</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted<br/> Average<br/> Exercise <br/> Price</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 44%; text-align: left; padding-left: 10pt">Beginning balance</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20220501__20230430_zQS3EBU3QrYf" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Warrants Shares, Beginning Balance">97,075</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_iS_c20220501__20230430_zy4gGvH51cl9" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Weighted Avg. Exercise Price Warrant, Beginning Balance">444.50</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20210501__20220430_zm8N1W04iELd" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Warrants Shares, Beginning Balance">47,633</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_iS_c20210501__20220430_zyqVXmwwiRL5" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Weighted Avg. Exercise Price Warrant, Beginning Balance">205.156</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">Granted</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20220501__20230430_zfcqRTePcdxf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Shares, Granted">1,714,127</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceIssued_c20220501__20230430_zkW5YL7VJ1T7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Avg. Exercise Price Warrant, Issued">11.696</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20210501__20220430_zmpBNxMzqr3a" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Shares, Granted">49,442</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceIssued_c20210501__20220430_ztppr5zG0k5b" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Avg. Exercise Price Warrant, Issued">139.344</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">Exercised</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20220501__20230430_zvkZc9JU4MBj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Shares, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl2497">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised_c20220501__20230430_zhXg1c5J2b3b" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Avg. Exercise Price Warrant, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl2499">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20210501__20220430_zwQRqeahawA9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Shares, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl2501">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised_c20210501__20220430_z7KnUWuTYoo4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Avg. Exercise Price Warrant, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl2503">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">Forfeited</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_c20220501__20230430_z3vgb86jfu07" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Shares, Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl2505">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceForfeited_c20220501__20230430_zG3sPPIIrK96" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Avg. Exercise Price Warrant, Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl2507">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_c20210501__20220430_zdGNprtYwxL1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Shares, Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl2509">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceForfeited_c20210501__20220430_ziZC4Fb2tKtj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Avg. Exercise Price Warrant, Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl2511">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 10pt">Expired</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_di_c20220501__20230430_zMGNuIwZQRea" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Shares, Expired">(18,750</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExpired_c20220501__20230430_z3sI9I6OFO24" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Avg. Exercise Price Warrant, Expired"><span style="-sec-ix-hidden: xdx2ixbrl2515">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_c20210501__20220430_z8nTdQWi32Lc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Shares, Expired"><span style="-sec-ix-hidden: xdx2ixbrl2517">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExpired_c20210501__20220430_zgoMBBv2B5V4" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Avg. Exercise Price Warrant, Expired"><span style="-sec-ix-hidden: xdx2ixbrl2519">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; padding-left: 10pt">Ending balance</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20220501__20230430_zBS45zMYqtQj" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Shares, Ending Balance">1,792,451</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_iE_c20220501__20230430_zXXTZbbs6uq3" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Avg. Exercise Price Warrant, Ending Balance">34.208</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20210501__20220430_zPV3Wt3KFUV4" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Shares, Ending Balance">97,075</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_iE_c20210501__20220430_zoNIGys6szG5" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Avg. Exercise Price Warrant, Ending Balance">444.50</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">Intrinsic value of warrants</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_eus-gaap--WarrantsAndRightsOutstanding_iI_c20230430_zHoXi7XU4vB2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intrinsic value of warrants">2,344,529</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_eus-gaap--WarrantsAndRightsOutstanding_iI_c20220430_zhyimSuk9F14" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intrinsic value of warrants">33,752,623</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Weighted Average Remaining Contractual Life (Years)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20220501__20230430_z2dE7b7khvp9" title="Weighted Average Remaining Contractual Life (Years)">6.45</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20210501__20220430_zrBNJ9rRDBJl" title="Weighted Average Remaining Contractual Life (Years)">6.50</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007866456080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">SCHEDULE OF NET DEFERRED TAX ASSETS</a></td>
<td class="text"><p id="xdx_89B_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_z2AE3kOtBPR6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BF_zRjK5fgziMnf" style="display: none">SCHEDULE OF NET DEFERRED TAX ASSETS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20230430_zUhHvHnWkzui" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20220430_zLOZcy4LIYvh" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Deferred tax assets:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_maDTANzBNt_zT5aGXx64QK6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left">Loss carryforwards</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">3,049,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">2,166,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--DeferredTaxAssetsStockOptions_iI_maDTANzBNt_zro8rrgGG2y6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Stock options</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">8,454,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">8,259,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--DeferredTaxAssetsAccruedPayroll_iI_maDTANzBNt_zkbAOTiKWbpf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Capital loss carryforward/Disposal</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">11,039,000</p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2570">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--DeferredTaxAssetsRelatedPartyAccruals_iI_maDTANzBNt_zju1Q1RMXwu5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Related party accruals</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,001,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">799,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--DeferredTaxAssetsInventory_iI_maDTANzBNt_z3d7L5uivjz4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Inventory reserve</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">133,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">100,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--DeferredTaxAssetsInterestDeferral_iI_maDTANzBNt_zzCDf3sfSZ56" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Interest deferral</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">221,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">191,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--DeferredTaxAssetsStartupCosts_iI_maDTANzBNt_zqK7gkOdlDXb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Start-up costs</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">81,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">84,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--DeferredTaxAssetsOther_iI_maDTANzBNt_ziLxY4zPKx7c" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">Other</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">131,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">57,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTANzBNt_zDi0uPryjKWh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Valuation allowance</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(24,109,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(11,656,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_406_eus-gaap--DeferredTaxAssetsNet_iTI_mtDTANzBNt_zrTfHcLACBXe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Net deferred tax assets</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2590">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2591">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">SCHEDULE OF INCOME TAX PROVISION</a></td>
<td class="text"><p id="xdx_89B_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zZdbK7C9StIe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B4_z277PxFE5MX9" style="display: none">SCHEDULE OF INCOME TAX PROVISION</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20220501__20230430_zSYkEArpVZ7c" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20210501__20220430_zDOpuxbJ3qYf" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_zqZyBjHRvqPj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left">Income tax benefit based on book loss at US statutory rate</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">(10,983,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">(10,259,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_403_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_zhri02ZJ9u3d" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Share-based compensation and shares for services</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2598">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2599">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--IncomeTaxReconciliationDebtDiscountAmortization_zXBZ5ejqgJbd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Debt discount amortization</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">860,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,841,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--IncomeTaxReconciliationRelatedPartyAccruals_z8zDNlxx4Auj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Related party accruals</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">226,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">150,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--IncomeTaxReconciliationStartUpCosts_ziAUtmiEoAR1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Stock options</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(145,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">6,815,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--IncomeTaxRecociliationInterestExpense_zbhxuvvHojKi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Interest expense</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">79,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">5,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseDepreciation_zyQtSeco2zoc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">Depreciation</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(18,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">21,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--IncomeTaxRecociliationInventoryReserve_zmD0Ipxqcx9l" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Inventory reserve</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">26,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">55,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--IncomeTaxRecociliationInterestDeferral_zhhT14nkNcra" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Interest deferral</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(5,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">13,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--IncomeTaxRecociliationAcquisitionCosts_zzwAJg20p5t5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Acquisition costs</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">260,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,268,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--IncomeTaxRecociliationAccruedLegal_zXbwDQZrYnSh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accrued legal</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(76,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">76,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--IncomeTaxRecociliationLossOnExtinguishmentOfDebt_zu0MXotoIhv" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Loss on sale of capital assets</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">8,713,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2629">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--IncomeTaxRecociliationAccruedPayroll_zENPJxtZd2E9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accrued payroll</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2631">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2632">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--IncomeTaxRecociliationGainOnChangeInFairValueOfDerivatives_zOI3YqG0zZTh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Change in fair value of derivatives</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">481,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(1,298,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_406_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseOther_z2SFeyKefiN8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">Other</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">40,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(29,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_zfdO8oJRg5Xj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Valuation allowance</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">542,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,342,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--IncomeTaxExpenseBenefit_iT_zBfcCPiEPHC4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Total income tax provision</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2643">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2644">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IL', window );">ISRAEL</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">SCHEDULE OF NET DEFERRED TAX ASSETS</a></td>
<td class="text"><p id="xdx_89F_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_hsrt--StatementGeographicalAxis__country--IL_zkQP64j9UtEl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BB_zaO9Oav9nn7i" style="display: none">SCHEDULE OF NET DEFERRED TAX ASSETS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20230430__srt--StatementGeographicalAxis__country--IL_zrQ3hHo4o6me" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_494_20220430__srt--StatementGeographicalAxis__country--IL_zolONJx3g3ic" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Deferred tax assets:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_iI_maDTANzt5N_zzRXV9umt465" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left">Loss carryforwards</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">241,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">234,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--DeferredTaxAssetsStartupCostsForeign_iI_maDTANzt5N_zlH8a3Ay7mCl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Start-up costs</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2657">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2658">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--DeferredTaxAssetsInProcessResearchAndDevelopmentCosts_iNI_di_maDTANzt5N_zLdCDmopdcA2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Research and development costs</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(113,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(113,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTANzt5N_z5PyGyR1v4hk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Valuation allowance</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(128,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(121,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsNet_iTI_mtDTANzt5N_zo2uxdV8AiT6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Net deferred tax assets</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2666">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2667">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">SCHEDULE OF INCOME TAX PROVISION</a></td>
<td class="text"><p id="xdx_893_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_hsrt--StatementGeographicalAxis__country--IL_zGiHqeY3bNT9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B6_zcbxKGXTalUh" style="display: none">SCHEDULE OF INCOME TAX PROVISION</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20220501__20230430__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--IsraelTaxAuthorityMember_zzbqXDH4Buuk" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_490_20210501__20220430__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--IsraelTaxAuthorityMember_zEPgXcUk1VY5" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_maCITEBzAlg_zMdAlHiNqyX8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left">Income tax provision (benefit) based on book income (loss) at Israeli statutory rate</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">(54,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">(56,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_maCITEBzAlg_zEliVMCQHBcf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">Valuation allowance</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">54,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">56,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--IncomeTaxExpenseBenefit_mtCITEBzAlg_zlY9ZPEkmuv5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Total income tax provision</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2679">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2680">&#8212;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 9<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007859134720">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ORGANIZATION AND NATURE OF BUSINESS (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 14, 2022</div></th>
<th class="th"><div>Sep. 16, 2019</div></th>
<th class="th"><div>Aug. 23, 2019</div></th>
<th class="th"><div>Jul. 31, 2023</div></th>
<th class="th"><div>Jul. 26, 2023</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Dec. 05, 2022</div></th>
<th class="th"><div>Jul. 31, 2022</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
<th class="th"><div>Jun. 21, 2021</div></th>
<th class="th"><div>Apr. 30, 2021</div></th>
<th class="th"><div>Feb. 10, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Stockholders' Equity, Reverse Stock Split</a></td>
<td class="text">1-for-10
reverse stock split<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (18,369,272)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (18,613,761)<span></span>
</td>
<td class="nump">$ 11,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 47,773,360<span></span>
</td>
<td class="nump">$ 32,511,932<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Impaired of intangible assets and goodwill amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,486,599<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (18,613,761)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32,511,932<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (18,450,744)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=CNXA_SlingerBagAmericasIncMember', window );">Slinger Bag Americas Inc [Member] | Stock Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Number of shares issued for acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned', window );">Number of value issued for acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 332,239<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=CNXA_SlingerBagAmericasIncMember', window );">Slinger Bag Americas Inc [Member] | Stock Purchase Agreement [Member] | Previously Reported [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Number of shares issued for acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=CNXA_SoleShareholderofSBLMember', window );">Sole Shareholder of SBL [Member] | Stock Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_NumberOfSharesOwned', window );">Number of shares owned</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=CNXA_SoleShareholderofSBLMember', window );">Sole Shareholder of SBL [Member] | Stock Purchase Agreement [Member] | Previously Reported [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_NumberOfSharesOwned', window );">Number of shares owned</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=CNXA_SlingerBagAmericasIncMember', window );">Slinger Bag Americas Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Percentage of ownership</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_NumberOfSharesExchanged', window );">Number of shares exchanged</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=CNXA_SlingerBagAmericasIncMember', window );">Slinger Bag Americas Inc [Member] | Previously Reported [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_NumberOfSharesExchanged', window );">Number of shares exchanged</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=CNXA_SoleShareholderofSBLMember', window );">Sole Shareholder of SBL [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Percentage of ownership</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=CNXA_FoundationSportsSystemsLLCMember', window );">Foundation Sports Systems LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Percentage of ownership</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=CNXA_FoundationSportsSystemsLLCMember', window );">Foundation Sports Systems LLC [Member] | Charles Ruddy [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Percentage of ownership</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_NumberOfSharesExchanged">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares exchanged.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_NumberOfSharesExchanged</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_NumberOfSharesOwned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares owned.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_NumberOfSharesOwned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479402/808-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairedAccumulatedImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityReverseStockSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityReverseStockSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=CNXA_SlingerBagAmericasIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=CNXA_SlingerBagAmericasIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=CNXA_StockPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=CNXA_StockPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=CNXA_SoleShareholderofSBLMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=CNXA_SoleShareholderofSBLMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=CNXA_SlingerBagAmericasIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=CNXA_SlingerBagAmericasIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=CNXA_SoleShareholderofSBLMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=CNXA_SoleShareholderofSBLMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=CNXA_FoundationSportsSystemsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=CNXA_FoundationSportsSystemsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=CNXA_CharlesRuddyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=CNXA_CharlesRuddyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007859291168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOING CONCERN (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2023</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Nov. 30, 2022</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MultiemployerPlansLineItems', window );"><strong>Multiemployer Plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="nump">$ 152,597,375<span></span>
</td>
<td class="nump">$ 151,750,610<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 80,596,925<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=CNXA_FoundationSportsSystemsLLCMember', window );">Foundation Sports Systems LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MultiemployerPlansLineItems', window );"><strong>Multiemployer Plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal', window );">Investment retained after disposal, ownership interest after disposal</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AlternativeInvestment', window );">Investment amount</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=CNXA_PlaySightMember', window );">Play Sight [Member] | Foundation Sports Systems LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MultiemployerPlansLineItems', window );"><strong>Multiemployer Plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_DisposalEquityInterestOwnershipInterestPercentage', window );">Discontinuing operations percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_DisposalEquityInterestOwnershipInterestPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal equity interest ownership interest percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_DisposalEquityInterestOwnershipInterestPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AlternativeInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment other than investment in equity security, investment in debt security and equity method investment. Includes, but is not limited to, investment in certain entities that calculate net asset value per share. Example includes, but is not limited to, investment in hedge fund, venture capital fund, private equity fund, and real estate partnership or fund.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 54B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482134/820-10-35-54B<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-6A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AlternativeInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percent, after disposal, of ownership interest of a discontinued operation in which an equity method investment is retained.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-4B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MultiemployerPlansLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480547/715-80-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480576/715-80-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480576/715-80-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480576/715-80-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480576/715-80-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480576/715-80-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480606/715-80-35-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480576/715-80-50-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480576/715-80-50-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480576/715-80-50-5<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480576/715-80-50-5<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480576/715-80-50-5<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480576/715-80-50-5<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480576/715-80-50-5<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480576/715-80-50-5<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480576/715-80-50-5<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480576/715-80-50-5<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480576/715-80-50-9<br><br>Reference 19: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480576/715-80-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MultiemployerPlansLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=CNXA_FoundationSportsSystemsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=CNXA_FoundationSportsSystemsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=CNXA_PlaySightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=CNXA_PlaySightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007860195616">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF INVENTORY (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jul. 31, 2023</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished Goods</a></td>
<td class="nump">$ 400,598<span></span>
</td>
<td class="nump">$ 1,509,985<span></span>
</td>
<td class="nump">$ 4,073,791<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsAndSupplies', window );">Component/Replacement Parts</a></td>
<td class="nump">2,064,041<span></span>
</td>
<td class="nump">1,712,553<span></span>
</td>
<td class="nump">2,559,848<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_CapitalizedDutyAndFreight', window );">Capitalized Duty/Freight</a></td>
<td class="nump">47,279<span></span>
</td>
<td class="nump">517,228<span></span>
</td>
<td class="nump">1,328,198<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryAdjustments', window );">Inventory Reserve</a></td>
<td class="num">(175,000)<span></span>
</td>
<td class="num">(550,000)<span></span>
</td>
<td class="num">(100,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total</a></td>
<td class="nump">$ 2,336,918<span></span>
</td>
<td class="nump">$ 3,189,766<span></span>
</td>
<td class="nump">$ 7,861,837<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_CapitalizedDutyAndFreight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capitalized duty and freight.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_CapitalizedDutyAndFreight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of inventory reserves for last-in first-out (LIFO) and other inventory valuation methods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483080/330-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsAndSupplies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsAndSupplies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007860403664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF DERIVATIVE LIABILITIES (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2023</div></th>
<th class="th"><div>Jul. 31, 2022</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgesLiabilities', window );">Note derivative balance</a></td>
<td class="nump">$ 8,345,052<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,489,606<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Note derivative (gain) loss</a></td>
<td class="num">(2,144,554)<span></span>
</td>
<td class="num">$ (3,687,495)<span></span>
</td>
<td class="num">(10,950,017)<span></span>
</td>
<td class="num">$ (18,557,184)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=CNXA_ProfitGuarantyMember', window );">Profit Guaranty [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgesLiabilities', window );">Note derivative balance</a></td>
<td class="nump">1,456,854<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,456,854<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Note derivative (gain) loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">395,304<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=CNXA_ConvertibleNotesMember', window );">Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgesLiabilities', window );">Note derivative balance</a></td>
<td class="nump">74,958<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101,924<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Note derivative (gain) loss</a></td>
<td class="num">(26,966)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,611,410)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=CNXA_UnderwriterWarrantsMember', window );">Underwriter Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgesLiabilities', window );">Note derivative balance</a></td>
<td class="nump">4,966<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,531<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Note derivative (gain) loss</a></td>
<td class="num">(1,565)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(57,951)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=CNXA_WarrantsIssuedWithCommonStockMember', window );">Warrants Issued With Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgesLiabilities', window );">Note derivative balance</a></td>
<td class="nump">4,668,608<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,109,559<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Note derivative (gain) loss</a></td>
<td class="num">(1,440,951)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,170,728)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=CNXA_WarrantsIssuedWithNotesPayableMember', window );">Warrants Issued With Notes Payable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgesLiabilities', window );">Note derivative balance</a></td>
<td class="nump">2,139,666<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,814,738<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Note derivative (gain) loss</a></td>
<td class="num">$ (675,072)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(900,819)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=CNXA_OtherDerivativeLiabilitiesMember', window );">Other Derivative Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgesLiabilities', window );">Note derivative balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Note derivative (gain) loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,604,413)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgesLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum as of the balance sheet date of the (a) fair values of all liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments, and (b) the carrying amounts of the liabilities arising from financial instruments or contracts used to mitigate a specified risk (hedge), and which are expected to be extinguished or otherwise disposed of within a year or the normal operating cycle, if longer, net of the effects of master netting arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgesLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OffsettingAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OffsettingAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=CNXA_ProfitGuarantyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=CNXA_ProfitGuarantyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=CNXA_ConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=CNXA_ConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=CNXA_UnderwriterWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=CNXA_UnderwriterWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=CNXA_WarrantsIssuedWithCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=CNXA_WarrantsIssuedWithCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=CNXA_WarrantsIssuedWithNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=CNXA_WarrantsIssuedWithNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=CNXA_OtherDerivativeLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=CNXA_OtherDerivativeLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007860396032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF DERIVATIVE AND WARRANTS GRANTED VALUATION USING BLACK-SCHOLES PRICING METHOD (Details) - Valuation Technique, Option Pricing Model [Member]<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2023</div></th>
<th class="th"><div>Jul. 31, 2022</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Measurement Input, Price Volatility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability measurement input</a></td>
<td class="nump">150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember', window );">Measurement Input, Expected Dividend Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability measurement input</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Measurement Input, Expected Term [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_DerivativeLiabilitiesMeasurementInputTerm', window );">Derivative liabilities measurement input</a></td>
<td class="text">8 months 12 days<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">3 years 3 months<span></span>
</td>
<td class="text">1 year 11 months 12 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Measurement Input, Price Volatility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Measurement Input, Risk Free Interest Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability measurement input</a></td>
<td class="nump">4.08<span></span>
</td>
<td class="nump">2.90<span></span>
</td>
<td class="nump">2.90<span></span>
</td>
<td class="nump">2.67<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Measurement Input, Expected Term [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_DerivativeLiabilitiesMeasurementInputTerm', window );">Derivative liabilities measurement input</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">4 years 3 months 18 days<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">4 years 3 months 18 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Measurement Input, Price Volatility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">148<span></span>
</td>
<td class="nump">150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Measurement Input, Risk Free Interest Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability measurement input</a></td>
<td class="nump">5.37<span></span>
</td>
<td class="nump">3.27<span></span>
</td>
<td class="nump">4.34<span></span>
</td>
<td class="nump">2.90<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_DerivativeLiabilitiesMeasurementInputTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative liabilities measurement inpu term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_DerivativeLiabilitiesMeasurementInputTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure derivative liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueOptionPricingModelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueOptionPricingModelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007867578816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF WARRANTS GRANTED VALUATION USING BLACK-SCHOLES PRICING METHOD (Details) - Warrant [Member] - Valuation Technique, Option Pricing Model [Member]<br></strong></div></th>
<th class="th"><div>Jul. 31, 2023</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Jul. 31, 2022</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember', window );">Measurement Input, Expected Term [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants measurement input, term</a></td>
<td class="text">0 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember', window );">Measurement Input, Expected Term [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants measurement input, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember', window );">Measurement Input, Expected Term [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants measurement input, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember', window );">Measurement Input, Price Volatility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input, rate</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember', window );">Measurement Input, Price Volatility [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input, rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember', window );">Measurement Input, Price Volatility [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input, rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150<span></span>
</td>
<td class="nump">148<span></span>
</td>
<td class="nump">148<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember', window );">Measurement Input, Risk Free Interest Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input, rate</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember', window );">Measurement Input, Risk Free Interest Rate [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input, rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.50<span></span>
</td>
<td class="nump">2.50<span></span>
</td>
<td class="nump">0.77<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember', window );">Measurement Input, Risk Free Interest Rate [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input, rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.68<span></span>
</td>
<td class="nump">3.50<span></span>
</td>
<td class="nump">1.63<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember', window );">Measurement Input, Expected Dividend Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input, rate</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueOptionPricingModelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueOptionPricingModelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007863517008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 06, 2023</div></th>
<th class="th"><div>Jul. 31, 2023</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_PlatformOperatorCryptoAssetLineItems', window );"><strong>Platform Operator, Crypto-Asset [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for doubtful accounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="nump">$ 209,690<span></span>
</td>
<td class="nump">$ 175,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property plant and equipment, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Impaired intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 101,281<span></span>
</td>
<td class="nump">4,842,856<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,281<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment of fixed assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,791<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,781,193<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_PlatformOperatorCryptoAssetLineItems', window );"><strong>Platform Operator, Crypto-Asset [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_RecognizedDerivativeExpense', window );">Recognized derivative expense</a></td>
<td class="nump">$ 1,715,557<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,280,405<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_PlatformOperatorCryptoAssetLineItems', window );"><strong>Platform Operator, Crypto-Asset [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Fair value of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 418,455<span></span>
</td>
<td class="nump">$ 418,455<span></span>
</td>
<td class="nump">$ 1,334,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_RecognizedDerivativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Recognized derivative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_RecognizedDerivativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_PlatformOperatorCryptoAssetLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_PlatformOperatorCryptoAssetLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479344/326-20-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007854975632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONCENTRATION OF CREDIT RISK AND OTHER RISKS AND UNCERTAINTIES (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2023</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable [Member] | Credit Concentration Risk [Member] | Customer Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">47.00%<span></span>
</td>
<td class="nump">43.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable [Member] | Credit Concentration Risk [Member] | Customer One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsPayableMember', window );">Accounts Payable [Member] | Lender Concentration Risk [Member] | Customer Four [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">60.00%<span></span>
</td>
<td class="nump">59.00%<span></span>
</td>
<td class="nump">59.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481027/954-310-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-21<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-20<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-18<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CreditConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CreditConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=CNXA_CustomerTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=CNXA_CustomerTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=CNXA_CustomerOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=CNXA_CustomerOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_LenderConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_LenderConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=CNXA_CustomerFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=CNXA_CustomerFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007859137360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF INTANGIBLE ASSETS (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2023</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment of Intangible Assets, Finite-Lived</a></td>
<td class="nump">$ 100,281<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net, Ending Balance</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">$ 101,281<span></span>
</td>
<td class="nump">$ 4,842,856<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=CNXA_TradeNamesAndPatentsMember', window );">Trade Names And Patents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">385,582<span></span>
</td>
<td class="nump">385,582<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="nump">24,031<span></span>
</td>
<td class="nump">24,031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment of Intangible Assets, Finite-Lived</a></td>
<td class="nump">360,551<span></span>
</td>
<td class="nump">260,270<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net, Ending Balance</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 101,281<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted average period amortization (in years)</a></td>
<td class="text">15 years 3 months 3 days<span></span>
</td>
<td class="text">15 years 3 months 3 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">$ 3,930,000<span></span>
</td>
<td class="nump">$ 3,930,000<span></span>
</td>
<td class="nump">3,930,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="nump">50,038<span></span>
</td>
<td class="nump">50,038<span></span>
</td>
<td class="nump">33,749<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment of Intangible Assets, Finite-Lived</a></td>
<td class="nump">3,879,962<span></span>
</td>
<td class="nump">3,879,962<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net, Ending Balance</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 3,896,251<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted average period amortization (in years)</a></td>
<td class="text">9 years 11 months 1 day<span></span>
</td>
<td class="text">9 years 11 months 1 day<span></span>
</td>
<td class="text">9 years 11 months 1 day<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Impairment of Intangible Assets (Excluding Goodwill)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,879,962<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember', window );">Computer Software, Intangible Asset [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">$ 580,000<span></span>
</td>
<td class="nump">580,000<span></span>
</td>
<td class="nump">580,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="nump">79,608<span></span>
</td>
<td class="nump">79,608<span></span>
</td>
<td class="nump">9,499<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment of Intangible Assets, Finite-Lived</a></td>
<td class="nump">500,392<span></span>
</td>
<td class="nump">500,392<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net, Ending Balance</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 570,501<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted average period amortization (in years)</a></td>
<td class="text">4 years 10 months 28 days<span></span>
</td>
<td class="text">4 years 10 months 28 days<span></span>
</td>
<td class="text">4 years 10 months 28 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Impairment of Intangible Assets (Excluding Goodwill)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,392<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=CNXA_IntangiableAssetMember', window );">Intangiable Asset [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">$ 4,895,582<span></span>
</td>
<td class="nump">4,895,582<span></span>
</td>
<td class="nump">4,895,582<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="nump">153,677<span></span>
</td>
<td class="nump">153,677<span></span>
</td>
<td class="nump">52,726<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment of Intangible Assets, Finite-Lived</a></td>
<td class="nump">4,740,905<span></span>
</td>
<td class="nump">4,640,624<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net, Ending Balance</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">101,281<span></span>
</td>
<td class="nump">4,842,856<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Impairment of Intangible Assets (Excluding Goodwill)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,640,624<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade Names [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">385,582<span></span>
</td>
<td class="nump">385,582<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,031<span></span>
</td>
<td class="nump">9,478<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net, Ending Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 101,281<span></span>
</td>
<td class="nump">$ 376,104<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted average period amortization (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years 3 months 3 days<span></span>
</td>
<td class="text">15 years 3 months 3 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Impairment of Intangible Assets (Excluding Goodwill)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 260,270<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 928<br> -SubTopic 340<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483147/928-340-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=CNXA_TradeNamesAndPatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=CNXA_TradeNamesAndPatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=CNXA_IntangiableAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=CNXA_IntangiableAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007860545328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INTANGIBLE ASSETS (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2023</div></th>
<th class="th"><div>Jul. 31, 2022</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,445<span></span>
</td>
<td class="nump">$ 100,951<span></span>
</td>
<td class="nump">$ 49,983<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment loss</a></td>
<td class="num">(100,281)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIntangibleAssetsNet', window );">Other intangible assets</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=CNXA_FoundationSportsSystemsLLCMember', window );">Foundation Sports Systems LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment loss</a></td>
<td class="nump">$ 100,281<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated amortization of finite-lived and indefinite-lived intangible assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=CNXA_FoundationSportsSystemsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=CNXA_FoundationSportsSystemsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007951946240">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF ACCRUED EXPENSES (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jul. 31, 2023</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedPayrollTaxesCurrent', window );">Accrued payroll</a></td>
<td class="nump">$ 1,754,936<span></span>
</td>
<td class="nump">$ 1,535,186<span></span>
</td>
<td class="nump">$ 921,759<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedBonusesCurrent', window );">Accrued bonus</a></td>
<td class="nump">1,829,604<span></span>
</td>
<td class="nump">1,720,606<span></span>
</td>
<td class="nump">1,014,833<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Accrued professional fees</a></td>
<td class="nump">35,000<span></span>
</td>
<td class="nump">490,424<span></span>
</td>
<td class="nump">1,706,560<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableOtherCurrent', window );">Other accrued expenses</a></td>
<td class="nump">1,577,920<span></span>
</td>
<td class="nump">1,165,623<span></span>
</td>
<td class="nump">738,749<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total</a></td>
<td class="nump">$ 5,197,460<span></span>
</td>
<td class="nump">$ 4,911,839<span></span>
</td>
<td class="nump">$ 4,381,901<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableOtherCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligations incurred classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableOtherCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedBonusesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for incentive compensation awarded to employees and directors or earned by them based on the terms of one or more relevant arrangements. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedBonusesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedPayrollTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory payroll taxes incurred through that date and withheld from employees pertaining to services received from them, including entity's matching share of the employees FICA taxes and contributions to the state and federal unemployment insurance programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedPayrollTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007860710992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE PAYABLE &#8211; RELATED PARTY (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 06, 2023</div></th>
<th class="th"><div>Jan. 14, 2022</div></th>
<th class="th"><div>Jul. 31, 2023</div></th>
<th class="th"><div>Jul. 31, 2022</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
<th class="th"><div>Jun. 17, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Proceeds from related party debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrumental</a></td>
<td class="nump">$ 2,092,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">13,200,000<span></span>
</td>
<td class="nump">$ 13,200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Outstanding borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,655,966<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,953,842<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 61,121<span></span>
</td>
<td class="nump">293,090<span></span>
</td>
<td class="nump">165,558<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 917,957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 917,957<span></span>
</td>
<td class="nump">$ 908,756<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_PaymentForExchangeOfNotesPayable', window );">Payment of exchange</a></td>
<td class="nump">$ 103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=CNXA_LoanAgreementsMember', window );">Loan Agreements [Member] | Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansPayable', window );">Loans payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Proceeds from related party debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_PaymentForExchangeOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_PaymentForExchangeOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479402/808-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=CNXA_LoanAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=CNXA_LoanAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007853167328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONVERTIBLE NOTES PAYABLE (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 17, 2022</div></th>
<th class="th"><div>Jun. 17, 2022</div></th>
<th class="th"><div>Jun. 15, 2022</div></th>
<th class="th"><div>Apr. 01, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Aug. 06, 2021</div></th>
<th class="th"><div>Jul. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
<th class="th"><div>Jan. 06, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt conversion</a></td>
<td class="nump">109,737<span></span>
</td>
<td class="nump">109,737<span></span>
</td>
<td class="nump">109,737<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1', window );">Debt conversion shares issued</a></td>
<td class="nump">13,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Interest payable</a></td>
<td class="nump">$ 846,301<span></span>
</td>
<td class="nump">$ 846,301<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortizated discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 122,222<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Gross proceeds from issuance of senior convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 11,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Convertible notes maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jul.  01,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,344,529<span></span>
</td>
<td class="nump">33,752,623<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_RemainingDerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,862,450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Debt issuance cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800,251<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits', window );">Stock issued during period value conversion of units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,046,300<span></span>
</td>
<td class="nump">14,689,369<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_LossOnIssuanceOfConvertibleNotes', window );">Loss on issuance of convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,689,369<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_SecuritiesOutstandingRateConvertibleNotesDescripition', window );">Convertible note description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">On
December 31, 2021, the Company entered into an Omnibus Amendment Agreement (the &#8220;Omnibus Agreement&#8221;) with certain Purchasers
who are collectively holders of 67% or more of the Securities outstanding related to the August 6, 2021 Convertible Notes, amending each
of (i) the Purchase Agreement and (ii) the Registration Rights Agreement. Simultaneously with the execution of the Omnibus Agreement,
the Company issued to each Purchaser a Replacement Note (as defined below) in replacement of the Convertible Note held prior to December
31, 2021 by such Purchaser (each, an &#8220;Existing Note&#8221;).<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertiable notes</a></td>
<td class="nump">13,200,000<span></span>
</td>
<td class="nump">13,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 13,200,000<span></span>
</td>
<td class="nump">$ 2,092,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentIncreaseAccruedInterest', window );">Debt Instrument, Increase, Accrued Interest</a></td>
<td class="nump">846,301<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=CNXA_ConvertibleNotesMember', window );">Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortizated discount</a></td>
<td class="nump">$ 122,222<span></span>
</td>
<td class="nump">$ 122,222<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAxis=CNXA_MonteCarloSimulationMember', window );">Monte Carlo Simulation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,026,668<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=CNXA_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Senior convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_WarrantsIssuedToPurchaseOfCommonStockShares', window );">Warrants issued to purchase of common stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">733,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Gross proceeds from issuance of senior convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Convertible notes maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug.  06,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable', window );">Warrants rights date from which warrants exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug.  06,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_WarrantsExercisePrice', window );">Warrants exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=CNXA_OmnibusAgreementMember', window );">Omnibus Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_LossOnIssuanceOfConvertibleNotes', window );">Loss on issuance of convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_LossOnIssuanceOfConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss on issuance of convertible notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_LossOnIssuanceOfConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_RemainingDerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remaining derivative liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_RemainingDerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_SecuritiesOutstandingRateConvertibleNotesDescripition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities outstanding rate convertible notes descripition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_SecuritiesOutstandingRateConvertibleNotesDescripition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_WarrantsExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants exercise price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_WarrantsExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_WarrantsIssuedToPurchaseOfCommonStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants issued to purchase of common stock shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_WarrantsIssuedToPurchaseOfCommonStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date the warrants or rights are exercisable, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of warrants issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentIncreaseAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase for accrued, but unpaid interest on the debt instrument for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentIncreaseAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-1A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest payable on debt, including, but not limited to, trade payables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=CNXA_ConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=CNXA_ConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=CNXA_MonteCarloSimulationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=CNXA_MonteCarloSimulationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=CNXA_SecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=CNXA_SecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=CNXA_OmnibusAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=CNXA_OmnibusAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007848277712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTES PAYABLE (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1">15 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Aug. 07, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 08, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 06, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 06, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 01, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 29, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 01, 2022 </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 01, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 15, 2022 </div>
<div>USD ($) </div>
<div>Integer</div>
</th>
<th class="th">
<div>Apr. 11, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 30, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Jul. 06, 2023</div></th>
<th class="th">
<div>Jun. 17, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 24, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">151,579<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">151,579<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,501,914<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">$ (7,096,730)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Debt conversion, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,250,004<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredOther1', window );">Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_NumberOfConsignedGoods', window );">Consignment units | Integer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_PaymentsOfRelatedPartyDebt', window );">Repayments of notes - related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,559,109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jul.  01,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Note payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2,092,700<span></span>
</td>
<td class="nump">$ 2,092,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">13,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds from notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 925,000<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="nump">5,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_DerivativeExpense', window );">Derivative expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,995,962<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_IncreaseDecreaseInDerivativeFairValueLiability', window );">Derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">675,072<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 777,192<span></span>
</td>
<td class="nump">$ 2,872,222<span></span>
</td>
<td class="nump">4,095,030<span></span>
</td>
<td class="nump">8,150,284<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateIncreaseDecrease', window );">Interest rate, increase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.43%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=CNXA_UFSAgreementMember', window );">UFS Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction', window );">Sale of consideration received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,124,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireReceivables', window );">Payment for exchange received amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_CashLessFees', window );">Cash less fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=CNXA_UFSAgreementMember', window );">UFS Agreement [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction', window );">Sale of consideration received</a></td>
<td class="nump">$ 797,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireReceivables', window );">Payment for exchange received amount</a></td>
<td class="nump">550,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_CashLessFees', window );">Cash less fees</a></td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=CNXA_UFSAgreementMember', window );">UFS Agreement [Member] | Each Week for Next Three Weeks [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireReceivables', window );">Payment for exchange received amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,491<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=CNXA_UFSAgreementMember', window );">UFS Agreement [Member] | Each Week for Next Three Weeks [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireReceivables', window );">Payment for exchange received amount</a></td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=CNXA_UFSAgreementMember', window );">UFS Agreement [Member] | Thereafter Per Week [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireReceivables', window );">Payment for exchange received amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,970<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=CNXA_CedarAgreementMember', window );">Cedar Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction', window );">Sale of consideration received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,124,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireReceivables', window );">Payment for exchange received amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_CashLessFees', window );">Cash less fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=CNXA_CedarAgreementMember', window );">Cedar Agreement [Member] | Each Week for Next Three Weeks [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireReceivables', window );">Payment for exchange received amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,491<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=CNXA_CedarAgreementMember', window );">Cedar Agreement [Member] | Thereafter Per Week [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireReceivables', window );">Payment for exchange received amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44,970<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=CNXA_LoanAndSecurityAgreementMember', window );">Loan and Security Agreement [Member] | Armistice Capital Master Fund Ltd [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds from notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares issued price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.84<span></span>
</td>
<td class="nump">$ 8.84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_DerivativeExpense', window );">Derivative expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,715,557<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,715,557<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityFairValueOfCollateral', window );">Fair value derivate liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,139,666<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,814,738<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,139,666<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,814,738<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 777,192<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,222,808<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_SharesIssuedPricePerShares', window );">[custom:SharesIssuedPricePerShares-0] | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.221<span></span>
</td>
<td class="nump">0.221<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDerivativeLiabilities', window );">Increase (Decrease) in Derivative Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,814,738<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=CNXA_LoanAndSecurityAgreementMember', window );">Loan and Security Agreement [Member] | Armistice Capital Master Fund Ltd [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.43%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=CNXA_LoanAndSecurityAgreementMember', window );">Loan and Security Agreement [Member] | Armistice Capital Master Fund Ltd [Member] | Previously Reported [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares issued price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.221<span></span>
</td>
<td class="nump">0.221<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityFairValueOfCollateral', window );">Fair value derivate liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,819<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,819<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteStockSplit', window );">Stockholders' Equity Note, Stock Split</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8.84
per share after adjusting for the one-for-forty (1-for-40) reverse stock split<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_SharesIssuedPricePerShares', window );">[custom:SharesIssuedPricePerShares-0] | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.84<span></span>
</td>
<td class="nump">$ 8.84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=CNXA_LoanAndSecurityAgreementMember', window );">Loan and Security Agreement [Member] | Armistice Capital Master Fund Ltd [Member] | Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Note payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentOfWarrantsGrantedForServices', window );">Warrants granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,715,557<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=CNXA_LoanAndSecurityAgreementMember', window );">Loan and Security Agreement [Member] | Armistice Capital Master Fund Ltd [Member] | Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds from notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=CNXA_LoanAndSecurityAgreementMember', window );">Loan and Security Agreement [Member] | Armistice Capital Master Fund Ltd [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Note payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Common stock exercisable, shares | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">452,489<span></span>
</td>
<td class="nump">452,489<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=CNXA_LoanAndSecurityAgreementMember', window );">Loan and Security Agreement [Member] | Armistice Capital Master Fund Ltd [Member] | Maximum [Member] | Previously Reported [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Common stock exercisable, shares | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">452,489<span></span>
</td>
<td class="nump">452,489<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=CNXA_MegedAgreementMember', window );">Meged Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction', window );">Sale of consideration received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 315,689<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodValue', window );">Stock redeemed value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">210,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LegalFees', window );">Legal fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,580<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfOtherDebt', window );">Debt repayment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,538<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=CNXA_MegedAgreementMember', window );">Meged Agreement [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction', window );">Sale of consideration received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">315,689<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireReceivables', window );">Payment for exchange received amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">210,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_CashLessFees', window );">Cash less fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,580<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=CNXA_MegedAgreementMember', window );">Meged Agreement [Member] | Each Week for Next Three Weeks [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireReceivables', window );">Payment for exchange received amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,538<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=CNXA_LoanAgreementMember', window );">Loan Agreement [Member] | Montsaic Investments, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Note payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 120,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.60%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueOptionPricingModelMember', window );">Valuation Technique, Option Pricing Model [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,251,910<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,251,910<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=CNXA_PromissoryNotePayableMember', window );">Promissory Note Payable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">681<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionOriginalDebtInterestRateOfDebt', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Payables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair value of derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,456,854<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,456,854<span></span>
</td>
<td class="nump">1,456,854<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=CNXA_PromissoryNotePayableMember', window );">Promissory Note Payable [Member] | Previously Reported [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,233<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair value of derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,061,550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=CNXA_PromissoryNotePayableMember', window );">Promissory Note Payable [Member] | Third Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Note payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=CNXA_NotesPayableMember', window );">Notes Payable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Note payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_CashLessFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash less fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_CashLessFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_DerivativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_DerivativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_IncreaseDecreaseInDerivativeFairValueLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_IncreaseDecreaseInDerivativeFairValueLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_NumberOfConsignedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of consigned goods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_NumberOfConsignedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_PaymentsOfRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_PaymentsOfRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_SharesIssuedPricePerShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_SharesIssuedPricePerShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentOfWarrantsGrantedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustment for noncash service expenses paid for by granting of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentOfWarrantsGrantedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-1A<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredOther1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tangible or intangible assets, including a business or subsidiary of the acquirer transferred by the entity to the former owners of the acquiree. Excludes cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredOther1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionOriginalDebtInterestRateOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate of interest that was being paid on the original debt issue that is being converted in the noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionOriginalDebtInterestRateOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Incremental percentage increase (decrease) in the stated rate on a debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair values as of the balance sheet date of the net amount of all assets and liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -SubTopic 10<br> -Topic 815<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480463/815-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of the assets less the liabilities of a derivative or group of derivatives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column G)(Footnote 8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column G))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5A<br> -Subparagraph (SX 210.12-13A(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-10<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityFairValueOfCollateral">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of securities pledged as collateral against derivative liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityFairValueOfCollateral</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481303/470-50-40-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481303/470-50-40-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the carrying value of derivative instruments reported as liabilities that are due to be disposed of within one year (or the normal operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchase of all receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfOtherDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for the payment of debt classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfOtherDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received by subsidiary or equity investee in exchange for shares of stock issued or sold. Includes amount of cash received, fair value of noncash assets received, and fair value of liabilities assumed by the investor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedPerTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRedeemedOrCalledDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock bought back by the entity at the exercise price or redemption price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRedeemedOrCalledDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteStockSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the stock split arrangement. Also provide the retroactive effect given by a stock split that occurs after the balance date but before the release of financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteStockSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=CNXA_UFSAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=CNXA_UFSAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=CNXA_EachWeekForNextThreeWeeksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=CNXA_EachWeekForNextThreeWeeksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=CNXA_ThereafterPerWeekMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=CNXA_ThereafterPerWeekMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=CNXA_CedarAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=CNXA_CedarAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=CNXA_LoanAndSecurityAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=CNXA_LoanAndSecurityAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=CNXA_ArmisticeCapitalMasterFundLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=CNXA_ArmisticeCapitalMasterFundLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=CNXA_NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=CNXA_NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=CNXA_MegedAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=CNXA_MegedAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=CNXA_LoanAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=CNXA_LoanAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=CNXA_MontsaicInvestmentsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=CNXA_MontsaicInvestmentsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueOptionPricingModelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueOptionPricingModelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=CNXA_PromissoryNotePayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=CNXA_PromissoryNotePayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=CNXA_ThirdPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=CNXA_ThirdPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=CNXA_NotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=CNXA_NotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007854902432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2023</div></th>
<th class="th"><div>Jul. 31, 2022</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
<th class="th"><div>Jun. 17, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued interest - related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 846,301<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Outstanding notes payable</a></td>
<td class="nump">$ 1,655,966<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,953,842<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued interest - related party</a></td>
<td class="nump">917,957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">917,957<span></span>
</td>
<td class="nump">908,756<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue from related parties</a></td>
<td class="nump">50,900<span></span>
</td>
<td class="nump">$ 91,200<span></span>
</td>
<td class="nump">164,661<span></span>
</td>
<td class="nump">368,164<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Outstanding accounts receivable</a></td>
<td class="nump">$ 28,800<span></span>
</td>
<td class="nump">$ 28,800<span></span>
</td>
<td class="nump">$ 28,800<span></span>
</td>
<td class="nump">$ 93,535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480833/946-310-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(5)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481058/954-310-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest payable on debt, including, but not limited to, trade payables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007832082576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS&#8217; EQUITY (DEFICIT) (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 26, 2023</div></th>
<th class="th"><div>Jan. 06, 2023</div></th>
<th class="th"><div>Nov. 21, 2022</div></th>
<th class="th"><div>Oct. 12, 2022</div></th>
<th class="th"><div>Sep. 28, 2022</div></th>
<th class="th"><div>Aug. 25, 2022</div></th>
<th class="th"><div>Jun. 27, 2022</div></th>
<th class="th"><div>Jun. 17, 2022</div></th>
<th class="th"><div>Jun. 17, 2022</div></th>
<th class="th"><div>Jun. 15, 2022</div></th>
<th class="th"><div>May 01, 2022</div></th>
<th class="th"><div>Feb. 02, 2022</div></th>
<th class="th"><div>Jan. 11, 2022</div></th>
<th class="th"><div>Oct. 11, 2021</div></th>
<th class="th"><div>Sep. 03, 2021</div></th>
<th class="th"><div>Aug. 06, 2021</div></th>
<th class="th"><div>Jul. 11, 2021</div></th>
<th class="th"><div>Jul. 06, 2021</div></th>
<th class="th"><div>Jun. 23, 2021</div></th>
<th class="th"><div>May 26, 2021</div></th>
<th class="th"><div>Oct. 28, 2020</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
<th class="th"><div>Jul. 31, 2023</div></th>
<th class="th"><div>Jul. 31, 2022</div></th>
<th class="th"><div>Jul. 31, 2021</div></th>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
<th class="th"><div>Oct. 31, 2023</div></th>
<th class="th"><div>Oct. 03, 2022</div></th>
<th class="th"><div>Oct. 29, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,194,836<span></span>
</td>
<td class="nump">528,297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">338,579<span></span>
</td>
<td class="nump">4,194,836<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,194,836<span></span>
</td>
<td class="nump">528,297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">338,579<span></span>
</td>
<td class="nump">4,194,836<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Shares, issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">189,718<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Number of shares issued during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 188<span></span>
</td>
<td class="nump">$ 4,195,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_StockIssuedDuringPeriodSharesIssuedSettlementOfAccountsPayable', window );">Stock issued during period, shares, issued for settlement of accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_StockIssuedDuringPeriodSharesIssuedSettlementWithFormerOwners', window );">Stock issued during period, shares, issued for settlement with former owners</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised', window );">Exercise of warrants, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_StockIssuedDuringPeriodSharesIssuedProfitGuaranteeOnNote', window );">Profit guarantee on note, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,680<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">151,579<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">151,579<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt conversion of convertible notes, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">109,737<span></span>
</td>
<td class="nump">109,737<span></span>
</td>
<td class="nump">109,737<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Shares issued for services</a></td>
<td class="nump">150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants and Rights Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,752,623<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,344,529<span></span>
</td>
<td class="nump">$ 33,752,623<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.221<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from Issuance of Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">4,195,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,744,882<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Shares issued for acquisition</a></td>
<td class="nump">6,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">675<span></span>
</td>
<td class="nump">48,098<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrumental</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,092,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,200,000<span></span>
</td>
<td class="nump">$ 13,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">13,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds from Notes Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">925,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="nump">$ 5,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Stock Issued During Period, Value, Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">915,545<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,714,127<span></span>
</td>
<td class="nump">49,442<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Operating Expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,747,413<span></span>
</td>
<td class="nump">4,090,858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,737,239<span></span>
</td>
<td class="nump">$ 50,932,697<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Warrants vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71,698,014<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Number of shares issued during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Shares issued for services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">188<span></span>
</td>
<td class="nump">625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Shares issued for acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,350<span></span>
</td>
<td class="nump">14,960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Stock Issued During Period, Value, Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants and Rights Outstanding, Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=CNXA_RelatedPartyLenderMember', window );">Related Party Lender [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,304<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Class of Warrant or Right, Number of Securities Called by Each Warrant or Right</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">688<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Conversion of Stock, Shares Converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,992<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=CNXA_NotePayableHolderMember', window );">Note Payable Holder [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Class of Warrant or Right, Number of Securities Called by Each Warrant or Right</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Conversion of Stock, Shares Converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=CNXA_AsCompensationMember', window );">As Compensation [Member] | Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,525<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=CNXA_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_WarrantsIssuedToPurchaseOfCommonStockShares', window );">[custom:WarrantsIssuedToPurchaseOfCommonStockShares-0]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=CNXA_FoundationSportsSystemsLLCMember', window );">Foundation Sports Systems LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Shares issued for acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Stock Issued During Period, Value, Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,550,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=CNXA_GamefaceMember', window );">Gameface [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Shares issued for acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Number of shares issued during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,195,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt conversion of convertible notes, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">109,740<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Shares issued for services</a></td>
<td class="nump">150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Shares issued for acquisition</a></td>
<td class="nump">6,994<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">675<span></span>
</td>
<td class="nump">48,098<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">598,396<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Stock Issued During Period, Value, Conversion of Convertible Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,046,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Stock Issued During Period, Value, Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">915,545<span></span>
</td>
<td class="nump">$ 3,550,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Number of shares issued during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,068<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,682<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Shares issued for services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">775<span></span>
</td>
<td class="nump">518<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Shares issued for acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70,727<span></span>
</td>
<td class="nump">1,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Stock Issued During Period, Shares, Conversion of Convertible Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">109,737<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Stock Issued During Period, Value, Conversion of Convertible Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,389<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Stock Issued During Period, Value, Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,829<span></span>
</td>
<td class="nump">$ 54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=CNXA_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0004<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants and Rights Outstanding, Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_WarrantsIssuedToPurchaseOfCommonStockShares', window );">[custom:WarrantsIssuedToPurchaseOfCommonStockShares-0]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">733,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=CNXA_GamefaceAIMember', window );">Gameface AI [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=CNXA_GamefaceAIMember', window );">Gameface AI [Member] | Previously Reported [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=CNXA_MidcityCapitalLtdMember', window );">Midcity Capital Ltd [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=CNXA_MidcityCapitalLtdMember', window );">Midcity Capital Ltd [Member] | Previously Reported [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=CNXA_ArmisticeCapitalMasterFundLtdMember', window );">Armistice Capital Master Fund Ltd [Member] | Loan and Security Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds from Notes Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_SharesIssuedPricePerShares', window );">[custom:SharesIssuedPricePerShares-0]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.221<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares Issued, Price Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=CNXA_ArmisticeCapitalMasterFundLtdMember', window );">Armistice Capital Master Fund Ltd [Member] | Loan and Security Agreement [Member] | Previously Reported [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_SharesIssuedPricePerShares', window );">[custom:SharesIssuedPricePerShares-0]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares Issued, Price Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.221<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=CNXA_ArmisticeCapitalMasterFundLtdMember', window );">Armistice Capital Master Fund Ltd [Member] | Loan and Security Agreement [Member] | Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds from Notes Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=CNXA_ArmisticeCapitalMasterFundLtdMember', window );">Armistice Capital Master Fund Ltd [Member] | Loan and Security Agreement [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrumental</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Debt Instrument, Interest Rate, Effective Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.33%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">452,489<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=CNXA_ArmisticeCapitalMasterFundLtdMember', window );">Armistice Capital Master Fund Ltd [Member] | Loan and Security Agreement [Member] | Maximum [Member] | Previously Reported [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">452,489<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=us-gaap_InvestorMember', window );">Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=us-gaap_InvestorMember', window );">Investor [Member] | Previously Reported [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=us-gaap_InvestorMember', window );">Investor [Member] | Securities Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,463<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">295,050<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_WarrantPerShare', window );">[custom:WarrantPerShare-0]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15.596<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants and Rights Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0004<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from Issuance of Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,549,882<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=us-gaap_InvestorMember', window );">Investor [Member] | Securities Purchase Agreement [Member] | Previously Reported [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,463<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,463<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">295,050<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_WarrantPerShare', window );">[custom:WarrantPerShare-0]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15.596<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=us-gaap_InvestorMember', window );">Investor [Member] | Securities Purchase Agreement [Member] | 5-Year Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">320,513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=us-gaap_InvestorMember', window );">Investor [Member] | Securities Purchase Agreement [Member] | 5-Year Warrants [Member] | Previously Reported [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">320,513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=us-gaap_InvestorMember', window );">Investor [Member] | Securities Purchase Agreement [Member] | 7-Year Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">641,026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">641,026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=us-gaap_InvestorMember', window );">Investor [Member] | Securities Purchase Agreement [Member] | 7-Year Warrants [Member] | Previously Reported [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">641,026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=us-gaap_InvestorMember', window );">Investor [Member] | Securities Purchase Agreement [Member] | 7.5 -Year Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">641,026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">641,026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=us-gaap_InvestorMember', window );">Investor [Member] | Securities Purchase Agreement [Member] | 7.5 -Year Warrants [Member] | Previously Reported [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">641,026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=CNXA_GabrielGoldmanMember', window );">Gabriel Goldman [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Shares issued for services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=CNXA_GabrielGoldmanMember', window );">Gabriel Goldman [Member] | Previously Reported [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Shares issued for services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=CNXA_RelatedPartyLenderMember', window );">Related Party Lender [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Stock Issued During Period, Shares, Conversion of Convertible Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,093<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Stock Issued During Period, Value, Conversion of Convertible Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,220,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=CNXA_TwoEmployeesMember', window );">Two Employees [Member] | Services rendered in lieu of cash [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross', window );">Shares Issued, Shares, Share-Based Payment Arrangement, before Forfeiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">126<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross', window );">Shares Issued, Value, Share-Based Payment Arrangement, before Forfeiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">187,803<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=CNXA_VendorMember', window );">Vendor [Member] | Marketing And Advisory Services [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross', window );">Shares Issued, Shares, Share-Based Payment Arrangement, before Forfeiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47<span></span>
</td>
<td class="nump">47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross', window );">Shares Issued, Value, Share-Based Payment Arrangement, before Forfeiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=CNXA_SixNewBrandAmbassadorsMember', window );">Six New Brand Ambassadors [Member] | As Compensation [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">228<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=CNXA_SixNewBrandAmbassadorsMember', window );">Six New Brand Ambassadors [Member] | Maximum [Member] | As Compensation [Member] | Share-Based Payment Arrangement, Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=CNXA_BrandAmbassadorsMember', window );">Brand Ambassadors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-Based Payment Arrangement, Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">907,042<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=CNXA_VendorOneMember', window );">Vendor One [Member] | Marketing And Advisory Services [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross', window );">Shares Issued, Value, Share-Based Payment Arrangement, before Forfeiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,874<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=CNXA_KeyEmployeesAndOfficersMember', window );">Key Employees and Officers [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-Based Payment Arrangement, Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">255,124<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=CNXA_KeyEmployeesAndOfficersMember', window );">Key Employees and Officers [Member] | Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-Based Payment Arrangement, Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,381,309<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants and Rights Outstanding, Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=CNXA_KeyEmployeesAndOfficersMember', window );">Key Employees and Officers [Member] | Exercise Price One [Member] | Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=CNXA_KeyEmployeesAndOfficersMember', window );">Key Employees and Officers [Member] | Exercise Price Two [Member] | Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,368<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=CNXA_ServiceProviderMember', window );">Service Provider [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants and Rights Outstanding, Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=CNXA_ServiceProviderMember', window );">Service Provider [Member] | Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=CNXA_ThreeMembersMember', window );">Three Members [Member] | Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-Based Payment Arrangement, Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 214,552<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=CNXA_ThreeMembersMember', window );">Three Members [Member] | As Compensation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-Based Payment Arrangement, Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 67,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">87,656<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,152<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=CNXA_LeadPlacementAgentMember', window );">Lead Placement Agent [Member] | Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Operating Expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 376,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=CNXA_LeadPlacementAgentMember', window );">Lead Placement Agent [Member] | Exercise Price One [Member] | Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_SharesIssuedPricePerShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_SharesIssuedPricePerShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_StockIssuedDuringPeriodSharesIssuedProfitGuaranteeOnNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares issued profit guarantee on note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_StockIssuedDuringPeriodSharesIssuedProfitGuaranteeOnNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_StockIssuedDuringPeriodSharesIssuedSettlementOfAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares issued settlement of accounts payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_StockIssuedDuringPeriodSharesIssuedSettlementOfAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_StockIssuedDuringPeriodSharesIssuedSettlementWithFormerOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares issued settlement with former owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_StockIssuedDuringPeriodSharesIssuedSettlementWithFormerOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_WarrantPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrant per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_WarrantPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_WarrantsIssuedToPurchaseOfCommonStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants issued to purchase of common stock shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_WarrantsIssuedToPurchaseOfCommonStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of non-option equity instruments exercised by participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of non-option equity instruments granted to participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Intrinsic value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options vested.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=CNXA_RelatedPartyLenderMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=CNXA_RelatedPartyLenderMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=CNXA_NotePayableHolderMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=CNXA_NotePayableHolderMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=CNXA_AsCompensationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=CNXA_AsCompensationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=CNXA_SecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=CNXA_SecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=CNXA_FoundationSportsSystemsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=CNXA_FoundationSportsSystemsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=CNXA_GamefaceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=CNXA_GamefaceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=CNXA_SecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=CNXA_SecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=CNXA_GamefaceAIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=CNXA_GamefaceAIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=CNXA_MidcityCapitalLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=CNXA_MidcityCapitalLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=CNXA_ArmisticeCapitalMasterFundLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=CNXA_ArmisticeCapitalMasterFundLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=CNXA_LoanAndSecurityAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=CNXA_LoanAndSecurityAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=CNXA_NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=CNXA_NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=us-gaap_InvestorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=us-gaap_InvestorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=CNXA_FiveYearWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=CNXA_FiveYearWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=CNXA_SevenYearWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=CNXA_SevenYearWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=CNXA_SevenPointFiveYearWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=CNXA_SevenPointFiveYearWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=CNXA_GabrielGoldmanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=CNXA_GabrielGoldmanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=CNXA_RelatedPartyLenderMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=CNXA_RelatedPartyLenderMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=CNXA_TwoEmployeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=CNXA_TwoEmployeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=CNXA_ServicesRenderedInLieuOfCashMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=CNXA_ServicesRenderedInLieuOfCashMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=CNXA_VendorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=CNXA_VendorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=CNXA_MarketingAndAdvisoryServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=CNXA_MarketingAndAdvisoryServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=CNXA_SixNewBrandAmbassadorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=CNXA_SixNewBrandAmbassadorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=CNXA_BrandAmbassadorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=CNXA_BrandAmbassadorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=CNXA_VendorOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=CNXA_VendorOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=CNXA_KeyEmployeesAndOfficersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=CNXA_KeyEmployeesAndOfficersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=CNXA_ExercisePriceOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=CNXA_ExercisePriceOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=CNXA_ExercisePriceTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=CNXA_ExercisePriceTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=CNXA_ServiceProviderMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=CNXA_ServiceProviderMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=CNXA_ThreeMembersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=CNXA_ThreeMembersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=CNXA_LeadPlacementAgentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=CNXA_LeadPlacementAgentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007869149376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 26, 2023</div></th>
<th class="th"><div>Nov. 21, 2022</div></th>
<th class="th"><div>Oct. 12, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jul. 31, 2023</div></th>
<th class="th"><div>Jul. 31, 2022</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
<th class="th"><div>Jul. 26, 2023</div></th>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Apr. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRent', window );">Rent expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,969<span></span>
</td>
<td class="nump">$ 700<span></span>
</td>
<td class="nump">$ 4,900<span></span>
</td>
<td class="nump">$ 22,176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_FairValueOfCommonStock', window );">Fair value of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,334,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,334,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Number of stock issued</a></td>
<td class="nump">6,993<span></span>
</td>
<td class="nump">675<span></span>
</td>
<td class="nump">48,098<span></span>
</td>
<td class="nump">14,960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Balance of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">418,455<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">418,455<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (18,369,272)<span></span>
</td>
<td class="nump">$ 47,773,360<span></span>
</td>
<td class="num">(18,613,761)<span></span>
</td>
<td class="nump">32,511,932<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Number of stock issued</a></td>
<td class="nump">6,994<span></span>
</td>
<td class="nump">675<span></span>
</td>
<td class="nump">48,098<span></span>
</td>
<td class="nump">598,396<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (18,613,761)<span></span>
</td>
<td class="nump">$ 32,511,932<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (18,450,744)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500,000<span></span>
</td>
<td class="nump">$ 2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_FairValueOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_FairValueOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479668/805-30-25-6<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479613/805-30-35-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482425/460-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-4<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash payments to lessor's for use of assets under operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007831804928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF DISCONTINUED OPERATIONS (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2023</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue', window );">Revenue</a></td>
<td class="nump">$ 1,363,113<span></span>
</td>
<td class="nump">$ 3,954,149<span></span>
</td>
<td class="nump">$ 728,805<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense', window );">Operating expenses</a></td>
<td class="nump">3,278,269<span></span>
</td>
<td class="nump">8,416,117<span></span>
</td>
<td class="nump">5,948,508<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_DisposalGroupIncludingDiscontinuedOperationOtherIncomeLoss', window );">Other (income) loss</a></td>
<td class="num">(155,442)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">27,974<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_DisposalGroupIncludingDiscontinuedOperationNetIncomeLoss', window );">Net loss from discontinued operations</a></td>
<td class="num">$ (1,759,714)<span></span>
</td>
<td class="num">(4,461,968)<span></span>
</td>
<td class="num">(5,247,677)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents', window );">Cash and restricted cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">916,082<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">288,980<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent', window );">Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">323,307<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesCurrent', window );">Right of use asset &#8211; operating leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">239,689<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent', window );">Prepaid expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">490,260<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Current Asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,258,318<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,862,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent', window );">Property and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">126,862<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent', window );">Intangible assets, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,473,646<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets', window );">Contract assets, net of current portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">209,363<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryNoncurrent', window );">Finished products used in operations, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,693,575<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent', window );">Non-current Asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">50,365,446<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,432,818<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityOperatingLeasesCurrent', window );">Lease liability &#8211; operating leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">237,204<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities', window );">Contract liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,545,200<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Current Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">5,215,222<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities', window );">Contract liabilities, net of current portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,370,492<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent', window );">Non-Current Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1,370,492<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityOperatingLeasesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease liability &#8211; operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityOperatingLeasesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_DisposalGroupIncludingDiscontinuedOperationNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net income loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_DisposalGroupIncludingDiscontinuedOperationNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_DisposalGroupIncludingDiscontinuedOperationOtherIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other income loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_DisposalGroupIncludingDiscontinuedOperationOtherIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Right of use asset &#8211; operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5C<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-9<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts payable and accrued liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-9<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as goodwill attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-11<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-11<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as inventory attributable to disposal group, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-9<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as inventory attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-11<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating expense attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-9<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other assets attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-11<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-11<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as prepaid and other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-9<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-11<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5C<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-9<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007860379296">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DISCONTINUED OPERATIONS (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th"><div>Nov. 27, 2022</div></th>
<th class="th"><div>Dec. 05, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Investments', window );">Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=CNXA_FoundationSportsToCharlesRuddyMember', window );">Foundation Sports To Charles Ruddy [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Ownership percentage by parrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Ownership percentage by non-controlling owners</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=CNXA_SharePurchaseAgreementMember', window );">Share Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_SharesIssuedAndOutstandingPercentage', window );">Shares issued and outstanding percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationDescriptionAndTimingOfDisposal', window );">Discontinued operation description</a></td>
<td class="text">(1) releasing the Company from all of PlaySight&#8217;s obligations towards its vendors, employees,
tax authorities and any other (past, current and future) creditors of PlaySight; (2) waiver by the Buyer of 100% of the personal consideration
owed to them under their employment agreements in the total amount of $600,000; and (3) cash consideration of $2,000,000 to be paid to
the Company in the form of a promissory note that matures on December 31, 2023.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Cash consideration</a></td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=CNXA_EmployeeAgreementMember', window );">Employee Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Cash consideration</a></td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_SharesIssuedAndOutstandingPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares issued and outstanding percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_SharesIssuedAndOutstandingPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480555/946-210-45-21<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 210<br> -Topic 946<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480555/946-210-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479402/808-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationDescriptionAndTimingOfDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the facts and circumstances leading to the completed or expected disposal, and the manner and timing of that disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.Z.5.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480781/205-20-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationDescriptionAndTimingOfDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(h))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The parent entity's interest in net assets of the subsidiary, expressed as a percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=CNXA_FoundationSportsToCharlesRuddyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=CNXA_FoundationSportsToCharlesRuddyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=CNXA_SharePurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=CNXA_SharePurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=CNXA_EmployeeAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=CNXA_EmployeeAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007821216912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 19, 2023</div></th>
<th class="th"><div>Sep. 18, 2023</div></th>
<th class="th"><div>Sep. 13, 2023</div></th>
<th class="th"><div>Aug. 31, 2023</div></th>
<th class="th"><div>Aug. 21, 2023</div></th>
<th class="th"><div>Aug. 17, 2023</div></th>
<th class="th"><div>Aug. 07, 2023</div></th>
<th class="th"><div>Aug. 01, 2023</div></th>
<th class="th"><div>Jun. 08, 2023</div></th>
<th class="th"><div>May 01, 2023</div></th>
<th class="th"><div>Oct. 03, 2022</div></th>
<th class="th"><div>Jul. 29, 2022</div></th>
<th class="th"><div>May 01, 2022</div></th>
<th class="th"><div>Jul. 31, 2023</div></th>
<th class="th"><div>Jul. 31, 2022</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">151,579<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">151,579<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Shares, Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">189,718<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock Issued During Period, Value, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 188<span></span>
</td>
<td class="nump">$ 4,195,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_StockIssuedDuringPeriodSharesIssuedSettlementOfAccountsPayable', window );">[custom:StockIssuedDuringPeriodSharesIssuedSettlementOfAccountsPayable]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_StockIssuedDuringPeriodSharesIssuedSettlementWithFormerOwners', window );">[custom:StockIssuedDuringPeriodSharesIssuedSettlementWithFormerOwners]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_StockIssuedDuringPeriodSharesIssuedProfitGuaranteeOnNote', window );">[custom:StockIssuedDuringPeriodSharesIssuedProfitGuaranteeOnNote]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,680<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.221<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=CNXA_PreFundedWarrantMember', window );">Pre Funded Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,802,002<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=CNXA_UFSAgreementMember', window );">UFS Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction', window );">Sale of consideration received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,124,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireReceivables', window );">Payment for exchange received amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_CashLessFees', window );">Cash less fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=CNXA_UFSAgreementMember', window );">UFS Agreement [Member] | Each Week for Next Three Weeks [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireReceivables', window );">Payment for exchange received amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,491<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=CNXA_MegedAgreementMember', window );">Meged Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction', window );">Sale of consideration received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 315,689<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Shares, Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">220,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock Issued During Period, Value, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 188<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_StockIssuedDuringPeriodSharesIssuedSettlementOfAccountsPayable', window );">[custom:StockIssuedDuringPeriodSharesIssuedSettlementOfAccountsPayable]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_StockIssuedDuringPeriodSharesIssuedSettlementWithFormerOwners', window );">[custom:StockIssuedDuringPeriodSharesIssuedSettlementWithFormerOwners]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.3500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,042<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_StockIssuedDuringPeriodSharesIssuedProfitGuaranteeOnNote', window );">[custom:StockIssuedDuringPeriodSharesIssuedProfitGuaranteeOnNote]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,681<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | UFS Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction', window );">Sale of consideration received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 797,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireReceivables', window );">Payment for exchange received amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">550,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_CashLessFees', window );">Cash less fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | UFS Agreement [Member] | Each Week for Next Three Weeks [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireReceivables', window );">Payment for exchange received amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Amended U F S Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Second Meged Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction', window );">Sale of consideration received</a></td>
<td class="nump">$ 423,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireReceivables', window );">Payment for exchange received amount</a></td>
<td class="nump">70,153.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Second Meged Agreement [Member] | Each Week for Next Three Weeks [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireReceivables', window );">Payment for exchange received amount</a></td>
<td class="nump">$ 15,107.14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Meged Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction', window );">Sale of consideration received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">315,689<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireReceivables', window );">Payment for exchange received amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">210,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_CashLessFees', window );">Cash less fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,580<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Meged Agreement [Member] | Each Week for Next Three Weeks [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireReceivables', window );">Payment for exchange received amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,538<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock Issued During Period, Value, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,820,512<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants and Rights Outstanding, Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued</a></td>
<td class="nump">9,444<span></span>
</td>
<td class="nump">125,134<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,042<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of convertible securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Stock Repurchased During Period, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,018,510<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | Subsequent Event [Member] | Rodney Rapson [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,876<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=CNXA_WarrantOneMember', window );">Warrant One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,641,024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants and Rights Outstanding, Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=CNXA_WarrantTwoMember', window );">Warrant Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,099,548<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants and Rights Outstanding, Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_CashLessFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash less fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_CashLessFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_StockIssuedDuringPeriodSharesIssuedProfitGuaranteeOnNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares issued profit guarantee on note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_StockIssuedDuringPeriodSharesIssuedProfitGuaranteeOnNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_StockIssuedDuringPeriodSharesIssuedSettlementOfAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares issued settlement of accounts payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_StockIssuedDuringPeriodSharesIssuedSettlementOfAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_StockIssuedDuringPeriodSharesIssuedSettlementWithFormerOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares issued settlement with former owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_StockIssuedDuringPeriodSharesIssuedSettlementWithFormerOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchase of all receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received by subsidiary or equity investee in exchange for shares of stock issued or sold. Includes amount of cash received, fair value of noncash assets received, and fair value of liabilities assumed by the investor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedPerTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of non-option equity instruments exercised by participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=CNXA_PreFundedWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=CNXA_PreFundedWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=CNXA_UFSAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=CNXA_UFSAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=CNXA_EachWeekForNextThreeWeeksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=CNXA_EachWeekForNextThreeWeeksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=CNXA_MegedAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=CNXA_MegedAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=CNXA_AmendedUFSAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=CNXA_AmendedUFSAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=CNXA_SecondMegedAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=CNXA_SecondMegedAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=CNXA_RodneyRapsonMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=CNXA_RodneyRapsonMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=CNXA_WarrantOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=CNXA_WarrantOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=CNXA_WarrantTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=CNXA_WarrantTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007863503136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF PROFORMA FINANCIAL INFORMATION (Details) - Play Sight And Game Face [Member]<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Apr. 30, 2023 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Revenues | $</a></td>
<td class="nump">$ 16,102,672<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Net loss | $</a></td>
<td class="num">$ (53,069,215)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic', window );">Basic earnings (loss) per share | $ / shares</a></td>
<td class="num">$ (13.79)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted', window );">Diluted earnings (loss) per share | $ / shares</a></td>
<td class="num">$ (13.79)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma basic net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -SubTopic 10<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -SubTopic 10<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -SubTopic 10<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -SubTopic 10<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=CNXA_PlaySightAndGameFaceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=CNXA_PlaySightAndGameFaceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007866738992">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF ESTIMATED FUTURE AMORTIZATION (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jul. 31, 2023</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,780<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,780<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,780<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,780<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,780<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72,381<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 101,281<span></span>
</td>
<td class="nump">$ 4,842,856<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007865257552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS AND BUSINESS COMBINATIONS (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2023</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Nov. 30, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=CNXA_FoundationSportsMember', window );">Foundation Sports [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_DisposalEquityInterestOwnershipInterestPercentage', window );">Disposal equity interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=CNXA_FoundationSportsSystemsLLCMember', window );">Foundation Sports Systems LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal', window );">Discontinuing operations percentage</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AlternativeInvestment', window );">Investments</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=CNXA_PlaySightMember', window );">Play Sight [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_DisposalEquityInterestOwnershipInterestPercentage', window );">Disposal equity interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_DisposalEquityInterestOwnershipInterestPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal equity interest ownership interest percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_DisposalEquityInterestOwnershipInterestPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AlternativeInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment other than investment in equity security, investment in debt security and equity method investment. Includes, but is not limited to, investment in certain entities that calculate net asset value per share. Example includes, but is not limited to, investment in hedge fund, venture capital fund, private equity fund, and real estate partnership or fund.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 54B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482134/820-10-35-54B<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-6A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AlternativeInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percent, after disposal, of ownership interest of a discontinued operation in which an equity method investment is retained.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-4B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=CNXA_FoundationSportsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=CNXA_FoundationSportsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=CNXA_FoundationSportsSystemsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=CNXA_FoundationSportsSystemsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=CNXA_PlaySightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=CNXA_PlaySightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007866659728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF WARRANTS ISSUED, EXERCISED AND EXPIRED (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2023</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Warrants Shares, Beginning Balance</a></td>
<td class="nump">1,792,451<span></span>
</td>
<td class="nump">97,075<span></span>
</td>
<td class="nump">47,633<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding', window );">Weighted Avg. Exercise Price Warrant, Beginning Balance</a></td>
<td class="nump">$ 34.208<span></span>
</td>
<td class="nump">$ 444.50<span></span>
</td>
<td class="nump">$ 205.156<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted', window );">Warrants Shares, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,714,127<span></span>
</td>
<td class="nump">49,442<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceIssued', window );">Weighted Avg. Exercise Price Warrant, Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.696<span></span>
</td>
<td class="nump">$ 139.344<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised', window );">Warrants Shares, Exercised</a></td>
<td class="nump">27,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised', window );">Weighted Avg. Exercise Price Warrant, Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures', window );">Warrants Shares, Forfeited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceForfeited', window );">Weighted Avg. Exercise Price Warrant, Forfeited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations', window );">Warrants Shares, Expired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18,750)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExpired', window );">Weighted Avg. Exercise Price Warrant, Expired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations', window );">Warrants Shares, Expired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,750<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Warrants Shares, Ending Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,792,451<span></span>
</td>
<td class="nump">97,075<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding', window );">Weighted Avg. Exercise Price Warrant, Ending Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34.208<span></span>
</td>
<td class="nump">$ 444.50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Intrinsic value of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,344,529<span></span>
</td>
<td class="nump">$ 33,752,623<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Weighted Average Remaining Contractual Life (Years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years 5 months 12 days<span></span>
</td>
<td class="text">6 years 6 months<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted Avg. Exercise Price Warrant, Exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted Avg. Exercise Price Warrant, Expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award non option equity instruments weighted average exercise price forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted Avg. Exercise Price Warrant, Issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted Avg. Exercise Price Warrant, Balance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of non-option equity instruments exercised by participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares under non-option equity instrument agreements for which rights to exercise lapsed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(4)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of non-option equity instruments granted to participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of equity instruments other than options outstanding, including both vested and non-vested instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007832069632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE PAYABLE - RELATED PARTY (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 14, 2022</div></th>
<th class="th"><div>Jul. 31, 2023</div></th>
<th class="th"><div>Jul. 31, 2022</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Proceeds from related party debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Outstanding borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,655,966<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,953,842<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 61,121<span></span>
</td>
<td class="nump">293,090<span></span>
</td>
<td class="nump">165,558<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 917,957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 917,957<span></span>
</td>
<td class="nump">$ 908,756<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=CNXA_LoanAgreementsMember', window );">Loan Agreements [Member] | Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansPayable', window );">Loans payable</a></td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Proceeds from related party debt</a></td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479402/808-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=CNXA_LoanAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=CNXA_LoanAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007853081760">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF NET DEFERRED TAX ASSETS (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Loss carryforwards</a></td>
<td class="nump">$ 3,049,000<span></span>
</td>
<td class="nump">$ 2,166,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_DeferredTaxAssetsStockOptions', window );">Stock options</a></td>
<td class="nump">8,454,000<span></span>
</td>
<td class="nump">8,259,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_DeferredTaxAssetsAccruedPayroll', window );">Capital loss carryforward/Disposal</a></td>
<td class="nump">11,039,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_DeferredTaxAssetsRelatedPartyAccruals', window );">Related party accruals</a></td>
<td class="nump">1,001,000<span></span>
</td>
<td class="nump">799,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInventory', window );">Inventory reserve</a></td>
<td class="nump">133,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_DeferredTaxAssetsInterestDeferral', window );">Interest deferral</a></td>
<td class="nump">221,000<span></span>
</td>
<td class="nump">191,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_DeferredTaxAssetsStartupCosts', window );">Start-up costs</a></td>
<td class="nump">81,000<span></span>
</td>
<td class="nump">84,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">131,000<span></span>
</td>
<td class="nump">57,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(24,109,000)<span></span>
</td>
<td class="num">(11,656,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Net deferred tax assets</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IL', window );">ISRAEL</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(128,000)<span></span>
</td>
<td class="num">(121,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Net deferred tax assets</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign', window );">Loss carryforwards</a></td>
<td class="nump">241,000<span></span>
</td>
<td class="nump">234,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_DeferredTaxAssetsStartupCostsForeign', window );">Start-up costs</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_DeferredTaxAssetsInProcessResearchAndDevelopmentCosts', window );">Research and development costs</a></td>
<td class="num">$ (113,000)<span></span>
</td>
<td class="num">$ (113,000)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_DeferredTaxAssetsAccruedPayroll">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets accrued payroll.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_DeferredTaxAssetsAccruedPayroll</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_DeferredTaxAssetsInProcessResearchAndDevelopmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets in process research and development costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_DeferredTaxAssetsInProcessResearchAndDevelopmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_DeferredTaxAssetsInterestDeferral">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets interest deferral.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_DeferredTaxAssetsInterestDeferral</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_DeferredTaxAssetsRelatedPartyAccruals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets related party accruals.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_DeferredTaxAssetsRelatedPartyAccruals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_DeferredTaxAssetsStartupCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets start up costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_DeferredTaxAssetsStartupCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_DeferredTaxAssetsStartupCostsForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets startup costs foreign.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_DeferredTaxAssetsStartupCostsForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_DeferredTaxAssetsStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_DeferredTaxAssetsStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007859059056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF INCOME TAX PROVISION (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2023</div></th>
<th class="th"><div>Jul. 31, 2022</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Income tax provision (benefit) based on book income (loss) at Israeli statutory rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (10,983,000)<span></span>
</td>
<td class="num">$ (10,259,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount', window );">Share-based compensation and shares for services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_IncomeTaxReconciliationDebtDiscountAmortization', window );">Debt discount amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">860,000<span></span>
</td>
<td class="nump">1,841,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_IncomeTaxReconciliationRelatedPartyAccruals', window );">Related party accruals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">226,000<span></span>
</td>
<td class="nump">150,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_IncomeTaxReconciliationStartUpCosts', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(145,000)<span></span>
</td>
<td class="nump">6,815,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_IncomeTaxRecociliationInterestExpense', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79,000<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseDepreciation', window );">Depreciation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18,000)<span></span>
</td>
<td class="nump">21,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_IncomeTaxRecociliationInventoryReserve', window );">Inventory reserve</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,000<span></span>
</td>
<td class="nump">55,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_IncomeTaxRecociliationInterestDeferral', window );">Interest deferral</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,000)<span></span>
</td>
<td class="nump">13,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_IncomeTaxRecociliationAcquisitionCosts', window );">Acquisition costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">260,000<span></span>
</td>
<td class="nump">1,268,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_IncomeTaxRecociliationAccruedLegal', window );">Accrued legal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(76,000)<span></span>
</td>
<td class="nump">76,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_IncomeTaxRecociliationLossOnExtinguishmentOfDebt', window );">Loss on sale of capital assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,713,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_IncomeTaxRecociliationAccruedPayroll', window );">Accrued payroll</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_IncomeTaxRecociliationGainOnChangeInFairValueOfDerivatives', window );">Change in fair value of derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">481,000<span></span>
</td>
<td class="num">(1,298,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
<td class="num">(29,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">542,000<span></span>
</td>
<td class="nump">1,342,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total income tax provision</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total income tax provision</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_IsraelTaxAuthorityMember', window );">Israel Tax Authority [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Income tax provision (benefit) based on book income (loss) at Israeli statutory rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(54,000)<span></span>
</td>
<td class="num">(56,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54,000<span></span>
</td>
<td class="nump">56,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total income tax provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total income tax provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_IncomeTaxRecociliationAccruedLegal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income tax recociliation accrued legal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_IncomeTaxRecociliationAccruedLegal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_IncomeTaxRecociliationAccruedPayroll">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income tax recociliation accrued payroll.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_IncomeTaxRecociliationAccruedPayroll</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_IncomeTaxRecociliationAcquisitionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income tax recociliation acquisition costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_IncomeTaxRecociliationAcquisitionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_IncomeTaxRecociliationGainOnChangeInFairValueOfDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income tax recociliation gain on change in fair value of derivatives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_IncomeTaxRecociliationGainOnChangeInFairValueOfDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_IncomeTaxRecociliationInterestDeferral">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income tax recociliation interest deferral.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_IncomeTaxRecociliationInterestDeferral</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_IncomeTaxRecociliationInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income tax reconciliation, Interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_IncomeTaxRecociliationInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_IncomeTaxRecociliationInventoryReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income tax recociliation inventory reserve.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_IncomeTaxRecociliationInventoryReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_IncomeTaxRecociliationLossOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income tax recociliation loss on extinguishment of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_IncomeTaxRecociliationLossOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_IncomeTaxReconciliationDebtDiscountAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income tax reconciliation debt discount amortization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_IncomeTaxReconciliationDebtDiscountAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_IncomeTaxReconciliationRelatedPartyAccruals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income tax reconciliation, related party accruals.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_IncomeTaxReconciliationRelatedPartyAccruals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_IncomeTaxReconciliationStartUpCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income tax reconciliation, start up costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_IncomeTaxReconciliationStartUpCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -SubTopic 740<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480887/718-740-35-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_IsraelTaxAuthorityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_IsraelTaxAuthorityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007863854048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF NET DEFERRED TAX ASSETS (Details) (Parenthetical)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IL', window );">ISRAEL</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Effective tax rate</a></td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007866459648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF INCOME TAX PROVISION (Details) (Parenthetical)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IL', window );">ISRAEL</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Effective tax rate</a></td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007865954112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">$ 1,049,000<span></span>
</td>
<td class="nump">$ 1,020,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Effective tax rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">$ 17,038,000<span></span>
</td>
<td class="nump">$ 12,366,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140007860517216">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF CALCULATION OF THE LOSS ON DISPOSAL (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MultiemployerPlansLineItems', window );"><strong>Multiemployer Plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet', window );">Note receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 288,980<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents', window );">Cash and restricted cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (916,082)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=CNXA_PlaySightAndFoundationSportsMember', window );">Play Sight And Foundation Sports [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MultiemployerPlansLineItems', window );"><strong>Multiemployer Plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet', window );">Note receivable</a></td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents', window );">Cash and restricted cash</a></td>
<td class="num">(714,507)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_DisposalGroupIncludingDiscontinuedOperationAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(411,249)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets', window );">Prepaid expenses</a></td>
<td class="num">(106,031)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1', window );">Inventory</a></td>
<td class="num">(296,920)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets', window );">Finished products used in operations</a></td>
<td class="num">(4,117,986)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_DisposalGroupIncludingDiscontinuedOperationContractAssets', window );">Contract assets</a></td>
<td class="num">(298,162)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_DisposalGroupIncludingDiscontinuedOperationRightOfUseAsset', window );">Right of use asset</a></td>
<td class="num">(103,228)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1', window );">Goodwill</a></td>
<td class="num">(25,862,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="num">(116,505)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets', window );">Intangible assets</a></td>
<td class="num">(18,576,475)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_DisposalGroupIncludingDiscontinuedOperationContractLiabilities', window );">Contract liabilities</a></td>
<td class="nump">3,785,408<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities', window );">Lease liabilities</a></td>
<td class="nump">78,016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">3,325,747<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_CNXA_DisposalGroupIncludingDiscontinuedOperationLossOnDisposalOfDiscontinuedOperations', window );">Loss on disposal of discontinued operations</a></td>
<td class="num">$ (41,413,892)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_DisposalGroupIncludingDiscontinuedOperationAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_DisposalGroupIncludingDiscontinuedOperationAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_DisposalGroupIncludingDiscontinuedOperationContractAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_DisposalGroupIncludingDiscontinuedOperationContractAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_DisposalGroupIncludingDiscontinuedOperationContractLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_DisposalGroupIncludingDiscontinuedOperationContractLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_DisposalGroupIncludingDiscontinuedOperationLossOnDisposalOfDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss on disposal of discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_DisposalGroupIncludingDiscontinuedOperationLossOnDisposalOfDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CNXA_DisposalGroupIncludingDiscontinuedOperationRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Right of use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">CNXA_DisposalGroupIncludingDiscontinuedOperationRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>CNXA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts payable and accrued liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as goodwill attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as inventory attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as prepaid and other assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MultiemployerPlansLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480547/715-80-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480576/715-80-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480576/715-80-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480576/715-80-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480576/715-80-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480576/715-80-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480606/715-80-35-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480576/715-80-50-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480576/715-80-50-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480576/715-80-50-5<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480576/715-80-50-5<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480576/715-80-50-5<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480576/715-80-50-5<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480576/715-80-50-5<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480576/715-80-50-5<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480576/715-80-50-5<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480576/715-80-50-5<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480576/715-80-50-9<br><br>Reference 19: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480576/715-80-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MultiemployerPlansLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=CNXA_PlaySightAndFoundationSportsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=CNXA_PlaySightAndFoundationSportsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>froms-1_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:CNXA="http://connexasports.com/20230731"
  xmlns:country="http://xbrl.sec.gov/country/2023"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2023"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="cnxa-20230731.xsd" xlink:type="simple"/>
    <context id="From2023-05-01to2023-07-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-07-31</endDate>
        </period>
    </context>
    <context id="From2023-05-012023-07-31_dei_BusinessContactMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-07-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-07-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
        </entity>
        <period>
            <instant>2023-07-31</instant>
        </period>
    </context>
    <context id="AsOf2023-04-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="AsOf2023-07-31_us-gaap_NonrelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-31</instant>
        </period>
    </context>
    <context id="AsOf2023-04-30_us-gaap_NonrelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="AsOf2023-07-31_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-31</instant>
        </period>
    </context>
    <context id="AsOf2023-04-30_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="AsOf2022-04-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="AsOf2022-04-30_us-gaap_NonrelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="AsOf2022-04-30_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="AsOf2023-04-30_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="AsOf2022-04-30_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="From2022-05-012022-07-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="From2023-05-012023-07-31_us-gaap_NonrelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-07-31</endDate>
        </period>
    </context>
    <context id="From2022-05-012022-07-31_us-gaap_NonrelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="From2023-05-012023-07-31_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-07-31</endDate>
        </period>
    </context>
    <context id="From2022-05-012022-07-31_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="From2022-05-012023-04-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="From2021-05-012022-04-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="From2022-05-012023-04-30_us-gaap_NonrelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="From2021-05-012022-04-30_us-gaap_NonrelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="From2022-05-012023-04-30_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="From2021-05-012022-04-30_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-04-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="AsOf2022-04-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="AsOf2022-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="AsOf2022-04-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="AsOf2023-04-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="AsOf2023-04-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="AsOf2023-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="AsOf2023-04-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="AsOf2021-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="AsOf2021-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="AsOf2021-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="AsOf2021-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="AsOf2021-04-30_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="AsOf2022-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="AsOf2022-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="AsOf2022-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="AsOf2022-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="From2022-05-012022-07-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="From2022-05-012022-07-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="From2022-05-012022-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="From2022-05-012022-07-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="From2023-05-012023-07-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-07-31</endDate>
        </period>
    </context>
    <context id="From2023-05-012023-07-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-07-31</endDate>
        </period>
    </context>
    <context id="From2023-05-012023-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-07-31</endDate>
        </period>
    </context>
    <context id="From2023-05-012023-07-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-07-31</endDate>
        </period>
    </context>
    <context id="From2021-05-012022-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="From2021-05-012022-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="From2021-05-012022-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="From2021-05-012022-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="From2021-05-012022-04-30_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="From2021-05-012022-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember_custom_GamefaceLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CNXA:GamefaceLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="From2021-05-012022-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember_custom_GamefaceLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CNXA:GamefaceLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="From2021-05-012022-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember_custom_GamefaceLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CNXA:GamefaceLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="From2021-05-012022-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember_custom_GamefaceLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CNXA:GamefaceLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="From2021-05-012022-04-30_srt_ScenarioPreviouslyReportedMember_custom_GamefaceLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CNXA:GamefaceLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="From2021-05-012022-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember_custom_PlaySightInteractiveLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CNXA:PlaySightInteractiveLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="From2021-05-012022-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember_custom_PlaySightInteractiveLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CNXA:PlaySightInteractiveLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="From2021-05-012022-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember_custom_PlaySightInteractiveLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CNXA:PlaySightInteractiveLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="From2021-05-012022-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember_custom_PlaySightInteractiveLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CNXA:PlaySightInteractiveLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="From2021-05-012022-04-30_srt_ScenarioPreviouslyReportedMember_custom_PlaySightInteractiveLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CNXA:PlaySightInteractiveLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="From2022-05-012023-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="From2022-05-012023-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="From2022-05-012023-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="From2022-05-012023-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="From2022-05-012023-04-30_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-07-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-31</instant>
        </period>
    </context>
    <context id="AsOf2022-07-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-31</instant>
        </period>
    </context>
    <context id="AsOf2022-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-31</instant>
        </period>
    </context>
    <context id="AsOf2022-07-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-31</instant>
        </period>
    </context>
    <context id="AsOf2022-07-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
        </entity>
        <period>
            <instant>2022-07-31</instant>
        </period>
    </context>
    <context id="AsOf2023-07-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-31</instant>
        </period>
    </context>
    <context id="AsOf2023-07-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-31</instant>
        </period>
    </context>
    <context id="AsOf2023-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-31</instant>
        </period>
    </context>
    <context id="AsOf2023-07-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-31</instant>
        </period>
    </context>
    <context id="AsOf2023-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="AsOf2023-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="AsOf2023-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="AsOf2023-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="AsOf2021-04-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="AsOf2019-08-23_custom_SlingerBagAmericasIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">CNXA:SlingerBagAmericasIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-23</instant>
        </period>
    </context>
    <context id="From2019-08-232019-08-23_custom_SlingerBagAmericasIncMember_custom_StockPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CNXA:SlingerBagAmericasIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:StockPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-23</startDate>
            <endDate>2019-08-23</endDate>
        </period>
    </context>
    <context id="AsOf2019-08-23_custom_StockPurchaseAgreementMember_custom_SlingerBagAmericasIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CNXA:SlingerBagAmericasIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:StockPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-23</instant>
        </period>
    </context>
    <context id="From2019-09-162019-09-16_custom_SlingerBagAmericasIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">CNXA:SlingerBagAmericasIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-16</startDate>
            <endDate>2019-09-16</endDate>
        </period>
    </context>
    <context id="AsOf2019-09-16_custom_SlingerBagAmericasIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">CNXA:SlingerBagAmericasIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-16</instant>
        </period>
    </context>
    <context id="From2019-09-162019-09-16_custom_SoleShareholderofSBLMember_custom_StockPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CNXA:SoleShareholderofSBLMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:StockPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-16</startDate>
            <endDate>2019-09-16</endDate>
        </period>
    </context>
    <context id="AsOf2019-09-16_custom_SoleShareholderofSBLMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">CNXA:SoleShareholderofSBLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-16</instant>
        </period>
    </context>
    <context id="AsOf2020-02-10_custom_SlingerBagAmericasIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">CNXA:SlingerBagAmericasIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-10</instant>
        </period>
    </context>
    <context id="AsOf2021-06-21_custom_FoundationSportsSystemsLLCMember_custom_CharlesRuddyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">CNXA:FoundationSportsSystemsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:CharlesRuddyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-21</instant>
        </period>
    </context>
    <context id="AsOf2022-12-05_custom_FoundationSportsSystemsLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">CNXA:FoundationSportsSystemsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-05</instant>
        </period>
    </context>
    <context id="From2022-06-142022-06-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
        </entity>
        <period>
            <startDate>2022-06-14</startDate>
            <endDate>2022-06-14</endDate>
        </period>
    </context>
    <context id="AsOf2023-07-26_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-26</instant>
        </period>
    </context>
    <context id="From2019-08-232019-08-23_custom_SlingerBagAmericasIncMember_custom_StockPurchaseAgreementMember_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CNXA:SlingerBagAmericasIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:StockPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-23</startDate>
            <endDate>2019-08-23</endDate>
        </period>
    </context>
    <context id="From2019-09-162019-09-16_custom_SlingerBagAmericasIncMember_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">CNXA:SlingerBagAmericasIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-16</startDate>
            <endDate>2019-09-16</endDate>
        </period>
    </context>
    <context id="From2019-09-162019-09-16_custom_SoleShareholderofSBLMember_custom_StockPurchaseAgreementMember_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CNXA:SoleShareholderofSBLMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:StockPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-16</startDate>
            <endDate>2019-09-16</endDate>
        </period>
    </context>
    <context id="AsOf2022-11-30_custom_PlaySightMember_custom_FoundationSportsSystemsLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CNXA:FoundationSportsSystemsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">CNXA:PlaySightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-30</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_PlaySightMember_custom_FoundationSportsSystemsLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CNXA:FoundationSportsSystemsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">CNXA:PlaySightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-05-012023-07-31_custom_FoundationSportsSystemsLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CNXA:FoundationSportsSystemsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-07-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-07-31_custom_FoundationSportsSystemsLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CNXA:FoundationSportsSystemsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-31</instant>
        </period>
    </context>
    <context id="From2022-05-012023-04-30_custom_FoundationSportsSystemsLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CNXA:FoundationSportsSystemsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-30_custom_FoundationSportsSystemsLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CNXA:FoundationSportsSystemsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="From2023-05-012023-07-31_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-07-31</endDate>
        </period>
    </context>
    <context id="From2022-05-012023-04-30_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="From2021-05-012022-04-30_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="From2022-05-012023-04-30_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="From2023-01-062023-01-06_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-06</startDate>
            <endDate>2023-01-06</endDate>
        </period>
    </context>
    <context id="From2023-05-012023-07-31_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-07-31</endDate>
        </period>
    </context>
    <context id="From2022-05-012023-04-30_us-gaap_WarrantMember30671140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-07-31_custom_ProfitGuarantyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">CNXA:ProfitGuarantyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-31</instant>
        </period>
    </context>
    <context id="From2023-05-012023-07-31_custom_ProfitGuarantyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">CNXA:ProfitGuarantyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-07-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-07-31_custom_ConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">CNXA:ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-31</instant>
        </period>
    </context>
    <context id="From2023-05-012023-07-31_custom_ConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">CNXA:ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-07-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-07-31_custom_UnderwriterWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">CNXA:UnderwriterWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-31</instant>
        </period>
    </context>
    <context id="From2023-05-012023-07-31_custom_UnderwriterWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">CNXA:UnderwriterWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-07-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-07-31_custom_WarrantsIssuedWithCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">CNXA:WarrantsIssuedWithCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-31</instant>
        </period>
    </context>
    <context id="From2023-05-012023-07-31_custom_WarrantsIssuedWithCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">CNXA:WarrantsIssuedWithCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-07-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-07-31_custom_WarrantsIssuedWithNotesPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">CNXA:WarrantsIssuedWithNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-31</instant>
        </period>
    </context>
    <context id="From2023-05-012023-07-31_custom_WarrantsIssuedWithNotesPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">CNXA:WarrantsIssuedWithNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-07-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-30_custom_ProfitGuarantyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">CNXA:ProfitGuarantyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="From2022-05-012023-04-30_custom_ProfitGuarantyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">CNXA:ProfitGuarantyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-30_custom_ConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">CNXA:ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="From2022-05-012023-04-30_custom_ConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">CNXA:ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-30_custom_UnderwriterWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">CNXA:UnderwriterWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="From2022-05-012023-04-30_custom_UnderwriterWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">CNXA:UnderwriterWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-30_custom_OtherDerivativeLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">CNXA:OtherDerivativeLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="From2022-05-012023-04-30_custom_OtherDerivativeLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">CNXA:OtherDerivativeLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-30_custom_WarrantsIssuedWithCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">CNXA:WarrantsIssuedWithCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="From2022-05-012023-04-30_custom_WarrantsIssuedWithCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">CNXA:WarrantsIssuedWithCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-30_custom_WarrantsIssuedWithNotesPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">CNXA:WarrantsIssuedWithNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="From2022-05-012023-04-30_custom_WarrantsIssuedWithNotesPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">CNXA:WarrantsIssuedWithNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="From2023-05-012023-07-31_srt_MinimumMember_us-gaap_MeasurementInputExpectedTermMember_us-gaap_ValuationTechniqueOptionPricingModelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-07-31</endDate>
        </period>
    </context>
    <context id="From2023-05-012023-07-31_srt_MaximumMember_us-gaap_MeasurementInputExpectedTermMember_us-gaap_ValuationTechniqueOptionPricingModelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-07-31</endDate>
        </period>
    </context>
    <context id="From2022-05-012022-07-31_srt_MinimumMember_us-gaap_MeasurementInputExpectedTermMember_us-gaap_ValuationTechniqueOptionPricingModelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="From2022-05-012022-07-31_srt_MaximumMember_us-gaap_MeasurementInputExpectedTermMember_us-gaap_ValuationTechniqueOptionPricingModelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-07-31_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ValuationTechniqueOptionPricingModelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-31</instant>
        </period>
    </context>
    <context id="AsOf2022-07-31_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ValuationTechniqueOptionPricingModelMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-31</instant>
        </period>
    </context>
    <context id="AsOf2022-07-31_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ValuationTechniqueOptionPricingModelMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-31</instant>
        </period>
    </context>
    <context id="AsOf2023-07-31_srt_MinimumMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_us-gaap_ValuationTechniqueOptionPricingModelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-31</instant>
        </period>
    </context>
    <context id="AsOf2023-07-31_srt_MaximumMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_us-gaap_ValuationTechniqueOptionPricingModelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-31</instant>
        </period>
    </context>
    <context id="AsOf2022-07-31_srt_MinimumMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_us-gaap_ValuationTechniqueOptionPricingModelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-31</instant>
        </period>
    </context>
    <context id="AsOf2022-07-31_srt_MaximumMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_us-gaap_ValuationTechniqueOptionPricingModelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-31</instant>
        </period>
    </context>
    <context id="AsOf2023-07-31_us-gaap_MeasurementInputExpectedDividendRateMember_us-gaap_ValuationTechniqueOptionPricingModelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-31</instant>
        </period>
    </context>
    <context id="AsOf2022-07-31_us-gaap_MeasurementInputExpectedDividendRateMember_us-gaap_ValuationTechniqueOptionPricingModelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-31</instant>
        </period>
    </context>
    <context id="From2022-05-012023-04-30_srt_MinimumMember_us-gaap_MeasurementInputExpectedTermMember_us-gaap_ValuationTechniqueOptionPricingModelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="From2022-05-012023-04-30_srt_MaximumMember_us-gaap_MeasurementInputExpectedTermMember_us-gaap_ValuationTechniqueOptionPricingModelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="From2021-05-012022-04-30_srt_MinimumMember_us-gaap_MeasurementInputExpectedTermMember_us-gaap_ValuationTechniqueOptionPricingModelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="From2021-05-012022-04-30_srt_MaximumMember_us-gaap_MeasurementInputExpectedTermMember_us-gaap_ValuationTechniqueOptionPricingModelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-30_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ValuationTechniqueOptionPricingModelMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="AsOf2023-04-30_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ValuationTechniqueOptionPricingModelMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="AsOf2022-04-30_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ValuationTechniqueOptionPricingModelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="AsOf2023-04-30_srt_MinimumMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_us-gaap_ValuationTechniqueOptionPricingModelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="AsOf2023-04-30_srt_MaximumMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_us-gaap_ValuationTechniqueOptionPricingModelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="AsOf2022-04-30_srt_MinimumMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_us-gaap_ValuationTechniqueOptionPricingModelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="AsOf2022-04-30_srt_MaximumMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_us-gaap_ValuationTechniqueOptionPricingModelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="AsOf2023-04-30_us-gaap_MeasurementInputExpectedDividendRateMember_us-gaap_ValuationTechniqueOptionPricingModelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="AsOf2022-04-30_us-gaap_MeasurementInputExpectedDividendRateMember_us-gaap_ValuationTechniqueOptionPricingModelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="AsOf2023-07-31_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputExpectedTermMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-31</instant>
        </period>
    </context>
    <context id="AsOf2022-07-31_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputExpectedTermMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-31</instant>
        </period>
    </context>
    <context id="AsOf2022-07-31_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputExpectedTermMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-31</instant>
        </period>
    </context>
    <context id="AsOf2023-07-31_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-31</instant>
        </period>
    </context>
    <context id="AsOf2022-07-31_srt_MinimumMember_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-31</instant>
        </period>
    </context>
    <context id="AsOf2022-07-31_srt_MaximumMember_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-31</instant>
        </period>
    </context>
    <context id="AsOf2023-07-31_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputRiskFreeInterestRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-31</instant>
        </period>
    </context>
    <context id="AsOf2022-07-31_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-31</instant>
        </period>
    </context>
    <context id="AsOf2022-07-31_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-31</instant>
        </period>
    </context>
    <context id="AsOf2023-07-31_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputExpectedDividendRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-31</instant>
        </period>
    </context>
    <context id="AsOf2022-07-31_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputExpectedDividendRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-31</instant>
        </period>
    </context>
    <context id="AsOf2023-04-30_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputExpectedTermMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="AsOf2023-04-30_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputExpectedTermMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="AsOf2022-04-30_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputExpectedTermMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="AsOf2022-04-30_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputExpectedTermMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="AsOf2023-04-30_srt_MinimumMember_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="AsOf2023-04-30_srt_MaximumMember_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="AsOf2022-04-30_srt_MinimumMember_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="AsOf2022-04-30_srt_MaximumMember_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="AsOf2023-04-30_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="AsOf2023-04-30_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="AsOf2022-04-30_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="AsOf2022-04-30_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="AsOf2023-04-30_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputExpectedDividendRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="AsOf2022-04-30_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputExpectedDividendRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="From2023-05-012023-07-31_us-gaap_AccountsReceivableMember_us-gaap_CreditConcentrationRiskMember_custom_CustomerTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">CNXA:CustomerTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-07-31</endDate>
        </period>
    </context>
    <context id="From2022-05-012023-04-30_us-gaap_AccountsReceivableMember_us-gaap_CreditConcentrationRiskMember_custom_CustomerTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">CNXA:CustomerTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="From2023-05-012023-07-31_us-gaap_LenderConcentrationRiskMember_custom_CustomerFourMember_us-gaap_AccountsPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">CNXA:CustomerFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:LenderConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-07-31</endDate>
        </period>
    </context>
    <context id="From2022-05-012023-04-30_us-gaap_LenderConcentrationRiskMember_custom_CustomerFourMember_us-gaap_AccountsPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">CNXA:CustomerFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:LenderConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="From2022-05-012023-04-30_us-gaap_AccountsReceivableMember_us-gaap_CreditConcentrationRiskMember_custom_CustomerOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">CNXA:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="From2021-05-012022-04-30_us-gaap_AccountsReceivableMember_us-gaap_CreditConcentrationRiskMember_custom_CustomerTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">CNXA:CustomerTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="From2021-05-012022-04-30_us-gaap_LenderConcentrationRiskMember_custom_CustomerFourMember_us-gaap_AccountsPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">CNXA:CustomerFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:LenderConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-07-31_custom_TradeNamesAndPatentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">CNXA:TradeNamesAndPatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-31</instant>
        </period>
    </context>
    <context id="From2023-05-012023-07-31_custom_TradeNamesAndPatentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">CNXA:TradeNamesAndPatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-07-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-07-31_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-31</instant>
        </period>
    </context>
    <context id="From2023-05-012023-07-31_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-07-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-07-31_us-gaap_ComputerSoftwareIntangibleAssetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-31</instant>
        </period>
    </context>
    <context id="From2023-05-012023-07-31_us-gaap_ComputerSoftwareIntangibleAssetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-07-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-07-31_custom_IntangiableAssetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">CNXA:IntangiableAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-31</instant>
        </period>
    </context>
    <context id="From2023-05-012023-07-31_custom_IntangiableAssetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">CNXA:IntangiableAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-07-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-30_custom_TradeNamesAndPatentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">CNXA:TradeNamesAndPatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="From2022-05-012023-04-30_custom_TradeNamesAndPatentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">CNXA:TradeNamesAndPatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-30_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="From2022-05-012023-04-30_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-30_us-gaap_ComputerSoftwareIntangibleAssetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="From2022-05-012023-04-30_us-gaap_ComputerSoftwareIntangibleAssetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-30_custom_IntangiableAssetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">CNXA:IntangiableAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="From2022-05-012023-04-30_custom_IntangiableAssetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">CNXA:IntangiableAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-30_us-gaap_TradeNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="From2022-05-012023-04-30_us-gaap_TradeNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-04-30_us-gaap_TradeNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="From2021-05-012022-04-30_us-gaap_TradeNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-04-30_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="From2021-05-012022-04-30_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-04-30_us-gaap_ComputerSoftwareIntangibleAssetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="From2021-05-012022-04-30_us-gaap_ComputerSoftwareIntangibleAssetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-04-30_custom_IntangiableAssetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">CNXA:IntangiableAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="From2021-05-012022-04-30_custom_IntangiableAssetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">CNXA:IntangiableAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="From2023-05-012023-07-31_custom_FoundationSportsSystemsLLCMember30673109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">CNXA:FoundationSportsSystemsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-07-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-07-31_us-gaap_PatentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-31</instant>
        </period>
    </context>
    <context id="AsOf2022-01-14_custom_LoanAgreementsMember_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:LoanAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-14</instant>
        </period>
    </context>
    <context id="From2022-01-132022-01-14_custom_LoanAgreementsMember_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:LoanAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-13</startDate>
            <endDate>2022-01-14</endDate>
        </period>
    </context>
    <context id="From2023-01-062023-01-06_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-06</startDate>
            <endDate>2023-01-06</endDate>
        </period>
    </context>
    <context id="AsOf2023-01-06">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
        </entity>
        <period>
            <instant>2023-01-06</instant>
        </period>
    </context>
    <context id="From2022-06-172022-06-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
        </entity>
        <period>
            <startDate>2022-06-17</startDate>
            <endDate>2022-06-17</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
        </entity>
        <period>
            <instant>2022-06-17</instant>
        </period>
    </context>
    <context id="AsOf2021-08-06_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-06</instant>
        </period>
    </context>
    <context id="From2021-08-052021-08-06_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-05</startDate>
            <endDate>2021-08-06</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-30_custom_MonteCarloSimulationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">CNXA:MonteCarloSimulationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="AsOf2021-10-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="From2021-08-012021-10-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
        </entity>
        <period>
            <startDate>2021-08-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="From2021-12-302021-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
        </entity>
        <period>
            <startDate>2021-12-30</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-04-30_custom_OmnibusAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:OmnibusAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="From2021-05-012022-04-30_custom_OmnibusAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:OmnibusAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="From2022-06-162022-06-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
        </entity>
        <period>
            <startDate>2022-06-16</startDate>
            <endDate>2022-06-17</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-17_custom_ConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CNXA:ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-17</instant>
        </period>
    </context>
    <context id="From2021-04-102021-04-11_custom_PromissoryNotePayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CNXA:PromissoryNotePayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-10</startDate>
            <endDate>2021-04-11</endDate>
        </period>
    </context>
    <context id="AsOf2021-04-11_custom_PromissoryNotePayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CNXA:PromissoryNotePayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-11</instant>
        </period>
    </context>
    <context id="From2021-04-102021-04-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
        </entity>
        <period>
            <startDate>2021-04-10</startDate>
            <endDate>2021-04-11</endDate>
        </period>
    </context>
    <context id="AsOf2021-04-11_us-gaap_ValuationTechniqueOptionPricingModelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-11</instant>
        </period>
    </context>
    <context id="AsOf2023-04-30_custom_PromissoryNotePayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CNXA:PromissoryNotePayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="AsOf2022-04-30_custom_PromissoryNotePayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CNXA:PromissoryNotePayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="From2022-02-142022-02-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
        </entity>
        <period>
            <startDate>2022-02-14</startDate>
            <endDate>2022-02-15</endDate>
        </period>
    </context>
    <context id="From2021-05-012022-07-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-04-01_custom_NotesPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CNXA:NotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-01</instant>
        </period>
    </context>
    <context id="From2022-04-012022-04-01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-01</endDate>
        </period>
    </context>
    <context id="From2022-08-012022-08-01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
        </entity>
        <period>
            <startDate>2022-08-01</startDate>
            <endDate>2022-08-01</endDate>
        </period>
    </context>
    <context id="From2022-07-292022-07-29_custom_UFSAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:UFSAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-29</startDate>
            <endDate>2022-07-29</endDate>
        </period>
    </context>
    <context id="From2022-07-292022-07-29_custom_UFSAgreementMember_custom_EachWeekForNextThreeWeeksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">CNXA:EachWeekForNextThreeWeeksMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:UFSAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-29</startDate>
            <endDate>2022-07-29</endDate>
        </period>
    </context>
    <context id="From2022-07-292022-07-29_custom_UFSAgreementMember_custom_ThereafterPerWeekMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">CNXA:ThereafterPerWeekMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:UFSAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-29</startDate>
            <endDate>2022-07-29</endDate>
        </period>
    </context>
    <context id="From2022-07-292022-07-29_custom_CedarAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:CedarAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-29</startDate>
            <endDate>2022-07-29</endDate>
        </period>
    </context>
    <context id="From2022-07-292022-07-29_custom_CedarAgreementMember_custom_EachWeekForNextThreeWeeksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">CNXA:EachWeekForNextThreeWeeksMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:CedarAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-29</startDate>
            <endDate>2022-07-29</endDate>
        </period>
    </context>
    <context id="From2022-07-292022-07-29_custom_CedarAgreementMember_custom_ThereafterPerWeekMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">CNXA:ThereafterPerWeekMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:CedarAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-29</startDate>
            <endDate>2022-07-29</endDate>
        </period>
    </context>
    <context id="AsOf2023-01-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">CNXA:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-06</instant>
        </period>
    </context>
    <context id="From2023-01-042023-01-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember_custom_NotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">CNXA:NotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">CNXA:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-04</startDate>
            <endDate>2023-01-06</endDate>
        </period>
    </context>
    <context id="AsOf2023-01-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">CNXA:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-06</instant>
        </period>
    </context>
    <context id="From2023-01-042023-01-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">CNXA:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-04</startDate>
            <endDate>2023-01-06</endDate>
        </period>
    </context>
    <context id="From2023-01-062023-01-06_us-gaap_WarrantMember_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">CNXA:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-06</startDate>
            <endDate>2023-01-06</endDate>
        </period>
    </context>
    <context id="AsOf2023-01-06_us-gaap_WarrantMember_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">CNXA:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-06</instant>
        </period>
    </context>
    <context id="From2023-07-312023-07-31_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">CNXA:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-31</startDate>
            <endDate>2023-07-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-07-31_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">CNXA:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-31</instant>
        </period>
    </context>
    <context id="AsOf2023-04-30_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">CNXA:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="From2023-05-012023-07-31_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">CNXA:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-07-31</endDate>
        </period>
    </context>
    <context id="From2023-06-082023-06-08_custom_MegedAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:MegedAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-08</startDate>
            <endDate>2023-06-08</endDate>
        </period>
    </context>
    <context id="AsOf2020-06-30_custom_LoanAgreementMember_custom_MontsaicInvestmentsLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">CNXA:MontsaicInvestmentsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:LoanAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-12-24_custom_PromissoryNotePayableMember_custom_ThirdPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:ThirdPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CNXA:PromissoryNotePayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-24</instant>
        </period>
    </context>
    <context id="From2021-04-102021-04-11_custom_PromissoryNotePayableMember_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CNXA:PromissoryNotePayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-10</startDate>
            <endDate>2021-04-11</endDate>
        </period>
    </context>
    <context id="AsOf2022-04-30_custom_PromissoryNotePayableMember_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CNXA:PromissoryNotePayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="From2023-04-302023-04-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-01-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">CNXA:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-06</instant>
        </period>
    </context>
    <context id="From2023-01-062023-01-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">CNXA:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-06</startDate>
            <endDate>2023-01-06</endDate>
        </period>
    </context>
    <context id="AsOf2023-01-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember_srt_MaximumMember_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">CNXA:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-06</instant>
        </period>
    </context>
    <context id="From2023-04-302023-04-30_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">CNXA:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-30_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">CNXA:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="From2022-05-012023-04-30_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">CNXA:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-07-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">CNXA:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-06</instant>
        </period>
    </context>
    <context id="AsOf2022-07-31_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-31</instant>
        </period>
    </context>
    <context id="From2022-06-152022-06-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
        </entity>
        <period>
            <startDate>2022-06-15</startDate>
            <endDate>2022-06-15</endDate>
        </period>
    </context>
    <context id="From2022-06-152022-06-15_us-gaap_InvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-15</startDate>
            <endDate>2022-06-15</endDate>
        </period>
    </context>
    <context id="From2022-06-272022-06-27_custom_GabrielGoldmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:GabrielGoldmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-27</startDate>
            <endDate>2022-06-27</endDate>
        </period>
    </context>
    <context id="From2022-06-272022-06-27_custom_GamefaceAIMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">CNXA:GamefaceAIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-27</startDate>
            <endDate>2022-06-27</endDate>
        </period>
    </context>
    <context id="From2022-08-252022-08-25_custom_MidcityCapitalLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">CNXA:MidcityCapitalLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-25</startDate>
            <endDate>2022-08-25</endDate>
        </period>
    </context>
    <context id="From2022-09-282022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-28</startDate>
            <endDate>2022-09-28</endDate>
        </period>
    </context>
    <context id="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-28</instant>
        </period>
    </context>
    <context id="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_custom_FiveYearWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">CNXA:FiveYearWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-28</instant>
        </period>
    </context>
    <context id="From2022-09-282022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_custom_SevenYearWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">CNXA:SevenYearWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-28</startDate>
            <endDate>2022-09-28</endDate>
        </period>
    </context>
    <context id="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_custom_SevenPointFiveYearWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">CNXA:SevenPointFiveYearWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-28</instant>
        </period>
    </context>
    <context id="From2022-10-122022-10-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
        </entity>
        <period>
            <startDate>2022-10-12</startDate>
            <endDate>2022-10-12</endDate>
        </period>
    </context>
    <context id="From2022-11-212022-11-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
        </entity>
        <period>
            <startDate>2022-11-21</startDate>
            <endDate>2022-11-21</endDate>
        </period>
    </context>
    <context id="From2023-01-262023-01-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
        </entity>
        <period>
            <startDate>2023-01-26</startDate>
            <endDate>2023-01-26</endDate>
        </period>
    </context>
    <context id="From2022-09-282022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_custom_SevenPointFiveYearWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">CNXA:SevenPointFiveYearWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-28</startDate>
            <endDate>2022-09-28</endDate>
        </period>
    </context>
    <context id="AsOf2023-01-31_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="AsOf2023-10-31_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="From2022-05-012022-05-01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-05-01</endDate>
        </period>
    </context>
    <context id="From2022-06-152022-06-15_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-15</startDate>
            <endDate>2022-06-15</endDate>
        </period>
    </context>
    <context id="From2022-06-152022-06-15_us-gaap_InvestorMember_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-15</startDate>
            <endDate>2022-06-15</endDate>
        </period>
    </context>
    <context id="From2022-06-272022-06-27_custom_GabrielGoldmanMember_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:GabrielGoldmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-27</startDate>
            <endDate>2022-06-27</endDate>
        </period>
    </context>
    <context id="From2022-06-272022-06-27_custom_GamefaceAIMember_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">CNXA:GamefaceAIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-27</startDate>
            <endDate>2022-06-27</endDate>
        </period>
    </context>
    <context id="From2022-08-252022-08-25_custom_MidcityCapitalLtdMember_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">CNXA:MidcityCapitalLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-25</startDate>
            <endDate>2022-08-25</endDate>
        </period>
    </context>
    <context id="From2022-09-282022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-28</startDate>
            <endDate>2022-09-28</endDate>
        </period>
    </context>
    <context id="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-28</instant>
        </period>
    </context>
    <context id="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-28</instant>
        </period>
    </context>
    <context id="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_custom_FiveYearWarrantsMember_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">CNXA:FiveYearWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-28</instant>
        </period>
    </context>
    <context id="From2022-09-282022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_custom_SevenYearWarrantsMember_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">CNXA:SevenYearWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-28</startDate>
            <endDate>2022-09-28</endDate>
        </period>
    </context>
    <context id="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_custom_SevenPointFiveYearWarrantsMember_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">CNXA:SevenPointFiveYearWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-28</instant>
        </period>
    </context>
    <context id="AsOf2023-10-31_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="From2022-10-122022-10-12_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-12</startDate>
            <endDate>2022-10-12</endDate>
        </period>
    </context>
    <context id="From2022-11-212022-11-21_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-21</startDate>
            <endDate>2022-11-21</endDate>
        </period>
    </context>
    <context id="From2023-01-262023-01-26_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-26</startDate>
            <endDate>2023-01-26</endDate>
        </period>
    </context>
    <context id="From2021-05-252021-05-26_custom_RelatedPartyLenderMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:RelatedPartyLenderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-25</startDate>
            <endDate>2021-05-26</endDate>
        </period>
    </context>
    <context id="From2021-06-222021-06-23_custom_FoundationSportsSystemsLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CNXA:FoundationSportsSystemsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-22</startDate>
            <endDate>2021-06-23</endDate>
        </period>
    </context>
    <context id="From2021-07-052021-07-06_custom_ServicesRenderedInLieuOfCashMember_custom_TwoEmployeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">CNXA:ServicesRenderedInLieuOfCashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:TwoEmployeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-05</startDate>
            <endDate>2021-07-06</endDate>
        </period>
    </context>
    <context id="From2021-05-012022-04-30_custom_ServicesRenderedInLieuOfCashMember_custom_TwoEmployeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">CNXA:ServicesRenderedInLieuOfCashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:TwoEmployeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="From2021-07-092021-07-11_custom_MarketingAndAdvisoryServicesMember_custom_VendorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">CNXA:MarketingAndAdvisoryServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:VendorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-09</startDate>
            <endDate>2021-07-11</endDate>
        </period>
    </context>
    <context id="From2021-05-012022-04-30_custom_MarketingAndAdvisoryServicesMember_custom_VendorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">CNXA:MarketingAndAdvisoryServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:VendorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="From2021-05-012021-07-31_custom_AsCompensationMember_custom_SixNewBrandAmbassadorsMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">CNXA:AsCompensationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:SixNewBrandAmbassadorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-07-31</endDate>
        </period>
    </context>
    <context id="From2021-05-012021-07-31_srt_MaximumMember_custom_AsCompensationMember_custom_SixNewBrandAmbassadorsMember_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">CNXA:AsCompensationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:SixNewBrandAmbassadorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-07-31</endDate>
        </period>
    </context>
    <context id="From2021-05-012022-04-30_custom_BrandAmbassadorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:BrandAmbassadorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-08-06_custom_NotePayableHolderMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CNXA:NotePayableHolderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-06</instant>
        </period>
    </context>
    <context id="From2021-08-052021-08-06_custom_NotePayableHolderMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">CNXA:NotePayableHolderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-05</startDate>
            <endDate>2021-08-06</endDate>
        </period>
    </context>
    <context id="AsOf2021-08-06_custom_RelatedPartyLenderMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">CNXA:RelatedPartyLenderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-06</instant>
        </period>
    </context>
    <context id="From2021-08-052021-08-06_custom_RelatedPartyLenderMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">CNXA:RelatedPartyLenderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-05</startDate>
            <endDate>2021-08-06</endDate>
        </period>
    </context>
    <context id="From2021-10-102021-10-11_custom_MarketingAndAdvisoryServicesMember_custom_VendorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">CNXA:MarketingAndAdvisoryServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:VendorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-10</startDate>
            <endDate>2021-10-11</endDate>
        </period>
    </context>
    <context id="From2022-01-102022-01-11_custom_MarketingAndAdvisoryServicesMember_custom_VendorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">CNXA:MarketingAndAdvisoryServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:VendorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-10</startDate>
            <endDate>2022-01-11</endDate>
        </period>
    </context>
    <context id="From2021-05-012022-04-30_custom_MarketingAndAdvisoryServicesMember_custom_VendorOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">CNXA:MarketingAndAdvisoryServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:VendorOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-04-30_us-gaap_CommonStockMember_custom_KeyEmployeesAndOfficersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:KeyEmployeesAndOfficersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="From2021-05-012022-04-30_us-gaap_CommonStockMember_custom_KeyEmployeesAndOfficersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:KeyEmployeesAndOfficersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="From2020-10-272020-10-28_us-gaap_WarrantMember_custom_ServiceProviderMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:ServiceProviderMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-27</startDate>
            <endDate>2020-10-28</endDate>
        </period>
    </context>
    <context id="AsOf2020-10-28_custom_ServiceProviderMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:ServiceProviderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-28</instant>
        </period>
    </context>
    <context id="From2021-05-012022-01-31_us-gaap_WarrantMember_custom_ThreeMembersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:ThreeMembersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-10-29_custom_AsCompensationMember_custom_ThreeMembersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">CNXA:AsCompensationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:ThreeMembersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-29</instant>
        </period>
    </context>
    <context id="From2022-05-012023-01-31_custom_AsCompensationMember_custom_ThreeMembersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">CNXA:AsCompensationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:ThreeMembersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="From2021-05-012022-04-30_custom_AsCompensationMember_custom_ThreeMembersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">CNXA:AsCompensationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:ThreeMembersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-08-06_custom_SecuritiesPurchaseAgreementMember30681312">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">CNXA:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-06</instant>
        </period>
    </context>
    <context id="AsOf2021-08-06_us-gaap_WarrantMember_custom_LeadPlacementAgentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:LeadPlacementAgentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-06</instant>
        </period>
    </context>
    <context id="From2021-05-012022-04-30_us-gaap_WarrantMember_custom_LeadPlacementAgentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:LeadPlacementAgentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="From2021-09-032021-09-03_custom_AsCompensationMember_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">CNXA:AsCompensationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-03</startDate>
            <endDate>2021-09-03</endDate>
        </period>
    </context>
    <context id="AsOf2021-09-03_us-gaap_WarrantMember_custom_KeyEmployeesAndOfficersMember_custom_ExercisePriceOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">CNXA:ExercisePriceOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:KeyEmployeesAndOfficersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-03</instant>
        </period>
    </context>
    <context id="From2021-09-032021-09-03_us-gaap_WarrantMember_custom_LeadPlacementAgentMember_custom_ExercisePriceOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">CNXA:ExercisePriceOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:LeadPlacementAgentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-03</startDate>
            <endDate>2021-09-03</endDate>
        </period>
    </context>
    <context id="AsOf2021-09-03_us-gaap_WarrantMember_custom_KeyEmployeesAndOfficersMember_custom_ExercisePriceTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">CNXA:ExercisePriceTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:KeyEmployeesAndOfficersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-03</instant>
        </period>
    </context>
    <context id="From2021-09-032021-09-03_us-gaap_WarrantMember_custom_KeyEmployeesAndOfficersMember_custom_ExercisePriceTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">CNXA:ExercisePriceTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:KeyEmployeesAndOfficersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-03</startDate>
            <endDate>2021-09-03</endDate>
        </period>
    </context>
    <context id="AsOf2021-09-03_us-gaap_WarrantMember_custom_KeyEmployeesAndOfficersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:KeyEmployeesAndOfficersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-03</instant>
        </period>
    </context>
    <context id="From2021-05-012022-04-30_us-gaap_WarrantMember_custom_KeyEmployeesAndOfficersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">CNXA:KeyEmployeesAndOfficersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="From2022-02-022022-02-02_custom_GamefaceMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CNXA:GamefaceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-02</startDate>
            <endDate>2022-02-02</endDate>
        </period>
    </context>
    <context id="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_custom_SevenYearWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">CNXA:SevenYearWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-28</instant>
        </period>
    </context>
    <context id="AsOf2023-01-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="From2022-06-012022-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-01-31_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="From2022-06-012022-06-30_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-11-252022-11-27_custom_SharePurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:SharePurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-25</startDate>
            <endDate>2022-11-27</endDate>
        </period>
    </context>
    <context id="AsOf2022-11-27_custom_EmployeeAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:EmployeeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-27</instant>
        </period>
    </context>
    <context id="AsOf2022-11-27_custom_SharePurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:SharePurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-27</instant>
        </period>
    </context>
    <context id="AsOf2022-12-05_custom_FoundationSportsToCharlesRuddyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">CNXA:FoundationSportsToCharlesRuddyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-05</instant>
        </period>
    </context>
    <context id="AsOf2022-12-05">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
        </entity>
        <period>
            <instant>2022-12-05</instant>
        </period>
    </context>
    <context id="From2023-08-012023-08-01_us-gaap_CommonStockMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-01</startDate>
            <endDate>2023-08-01</endDate>
        </period>
    </context>
    <context id="From2023-08-172023-08-17_us-gaap_CommonStockMember_us-gaap_SubsequentEventMember_custom_RodneyRapsonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">CNXA:RodneyRapsonMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-17</startDate>
            <endDate>2023-08-17</endDate>
        </period>
    </context>
    <context id="From2023-08-312023-08-31_us-gaap_CommonStockMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-31</startDate>
            <endDate>2023-08-31</endDate>
        </period>
    </context>
    <context id="From2023-09-182023-09-18_us-gaap_CommonStockMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-18</startDate>
            <endDate>2023-09-18</endDate>
        </period>
    </context>
    <context id="From2023-09-192023-09-19_us-gaap_CommonStockMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-19</startDate>
            <endDate>2023-09-19</endDate>
        </period>
    </context>
    <context id="From2023-08-072023-08-07_us-gaap_SubsequentEventMember_custom_UFSAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:UFSAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-07</startDate>
            <endDate>2023-08-07</endDate>
        </period>
    </context>
    <context id="From2023-08-072023-08-07_us-gaap_SubsequentEventMember_custom_UFSAgreementMember_custom_EachWeekForNextThreeWeeksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">CNXA:EachWeekForNextThreeWeeksMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:UFSAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-07</startDate>
            <endDate>2023-08-07</endDate>
        </period>
    </context>
    <context id="From2023-08-212023-08-21_custom_AmendedUFSAgreementMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:AmendedUFSAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-21</startDate>
            <endDate>2023-08-21</endDate>
        </period>
    </context>
    <context id="From2023-09-192023-09-19_us-gaap_SubsequentEventMember_custom_SecondMegedAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:SecondMegedAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-19</startDate>
            <endDate>2023-09-19</endDate>
        </period>
    </context>
    <context id="From2023-09-192023-09-19_us-gaap_SubsequentEventMember_custom_SecondMegedAgreementMember_custom_EachWeekForNextThreeWeeksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">CNXA:EachWeekForNextThreeWeeksMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:SecondMegedAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-19</startDate>
            <endDate>2023-09-19</endDate>
        </period>
    </context>
    <context id="AsOf2023-05-01_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-01</instant>
        </period>
    </context>
    <context id="From2023-05-012023-05-01_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-05-01</endDate>
        </period>
    </context>
    <context id="From2023-06-082023-06-08_us-gaap_SubsequentEventMember_custom_MegedAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:MegedAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-08</startDate>
            <endDate>2023-06-08</endDate>
        </period>
    </context>
    <context id="From2023-06-082023-06-08_us-gaap_SubsequentEventMember_custom_MegedAgreementMember_custom_EachWeekForNextThreeWeeksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">CNXA:EachWeekForNextThreeWeeksMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">CNXA:MegedAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-08</startDate>
            <endDate>2023-06-08</endDate>
        </period>
    </context>
    <context id="From2023-09-122023-09-13_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-12</startDate>
            <endDate>2023-09-13</endDate>
        </period>
    </context>
    <context id="AsOf2023-09-13_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-13</instant>
        </period>
    </context>
    <context id="From2022-10-022022-10-03_custom_PreFundedWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">CNXA:PreFundedWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-02</startDate>
            <endDate>2022-10-03</endDate>
        </period>
    </context>
    <context id="AsOf2022-10-03_custom_PreFundedWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">CNXA:PreFundedWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-03</instant>
        </period>
    </context>
    <context id="From2022-10-022022-10-03_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-02</startDate>
            <endDate>2022-10-03</endDate>
        </period>
    </context>
    <context id="AsOf2022-10-03_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-03</instant>
        </period>
    </context>
    <context id="From2022-10-022022-10-03_custom_WarrantOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">CNXA:WarrantOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-02</startDate>
            <endDate>2022-10-03</endDate>
        </period>
    </context>
    <context id="AsOf2022-10-03_custom_WarrantOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">CNXA:WarrantOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-03</instant>
        </period>
    </context>
    <context id="AsOf2022-10-03_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-03</instant>
        </period>
    </context>
    <context id="From2022-10-022022-10-03_custom_WarrantTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">CNXA:WarrantTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-02</startDate>
            <endDate>2022-10-03</endDate>
        </period>
    </context>
    <context id="AsOf2022-10-03_custom_WarrantTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">CNXA:WarrantTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-03</instant>
        </period>
    </context>
    <context id="AsOf2022-10-03">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
        </entity>
        <period>
            <instant>2022-10-03</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_FoundationSportsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CNXA:FoundationSportsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-11-30_custom_PlaySightMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CNXA:PlaySightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-30</instant>
        </period>
    </context>
    <context id="From2022-05-012023-04-30_custom_PlaySightAndGameFaceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">CNXA:PlaySightAndGameFaceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="From2022-05-012023-04-30_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-30_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="AsOf2022-04-30_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="From2022-05-012023-04-30_country_IL">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-30_country_IL">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="AsOf2022-04-30_country_IL">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="From2022-05-012023-04-30_us-gaap_IsraelTaxAuthorityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:IsraelTaxAuthorityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="From2021-05-012022-04-30_us-gaap_IsraelTaxAuthorityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:IsraelTaxAuthorityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="From2021-05-012022-04-30_country_IL">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-30_custom_PlaySightAndFoundationSportsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001674440</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">CNXA:PlaySightAndFoundationSportsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Integer">
        <measure>CNXA:Integer</measure>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2023-05-01to2023-07-31">0001674440</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2023-05-01to2023-07-31">false</dei:AmendmentFlag>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2023-07-31"
      id="xdx2ixbrl0070"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2023-07-31"
      id="xdx2ixbrl0154"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2023-04-30"
      id="xdx2ixbrl0155"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2023-05-01to2023-07-31"
      id="xdx2ixbrl0212"
      unitRef="USD"
      xsi:nil="true"/>
    <CNXA:LossOnConversionOfAccountsPayableToCommonStock
      contextRef="From2022-05-012022-07-31"
      id="xdx2ixbrl0237"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestExpense
      contextRef="From2023-05-012023-07-31_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl0248"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestExpense
      contextRef="From2023-05-012023-07-31_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl0251"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax
      contextRef="From2023-05-01to2023-07-31"
      id="xdx2ixbrl0260"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
      contextRef="From2023-05-01to2023-07-31"
      id="xdx2ixbrl0263"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
      contextRef="From2023-05-01to2023-07-31"
      id="xdx2ixbrl0266"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2023-05-01to2023-07-31"
      id="xdx2ixbrl0272"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2022-05-012022-07-31"
      id="xdx2ixbrl0273"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="From2023-05-01to2023-07-31"
      id="xdx2ixbrl0298"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="From2023-05-01to2023-07-31"
      id="xdx2ixbrl0300"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="From2022-05-012022-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0338"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="From2022-05-012022-07-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0339"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2022-05-012022-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0346"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2022-05-012022-07-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0347"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-05-012022-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0354"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-05-012022-07-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0355"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-05-012022-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0362"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-05-012022-07-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0363"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2022-05-012022-07-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0368"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2022-05-012022-07-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0369"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2022-05-012022-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0370"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2022-05-012022-07-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0371"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2022-05-012022-07-31"
      id="xdx2ixbrl0372"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2022-05-012022-07-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0376"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2022-05-012022-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0378"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2022-05-012022-07-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0379"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2022-05-012022-07-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0382"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2022-05-012022-07-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0383"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2022-05-012022-07-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0385"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2022-05-012022-07-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0388"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2022-05-012022-07-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0389"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2022-05-012022-07-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0391"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-05-012022-07-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0394"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-05-012022-07-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0395"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-05-012022-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0396"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-05-012023-07-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0430"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-05-012023-07-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0431"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-05-012023-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0432"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-05-012023-07-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0433"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-05-01to2023-07-31"
      id="xdx2ixbrl0434"
      unitRef="USD"
      xsi:nil="true"/>
    <CNXA:StockIssuedDuringPeriodValueAccountsPayable
      contextRef="From2023-05-012023-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0440"
      unitRef="USD"
      xsi:nil="true"/>
    <CNXA:StockIssuedDuringPeriodValueAccountsPayable
      contextRef="From2023-05-012023-07-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0441"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2023-05-012023-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0448"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2023-05-012023-07-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0449"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2023-05-01to2023-07-31"
      id="xdx2ixbrl0450"
      unitRef="USD"
      xsi:nil="true"/>
    <CNXA:StockIssuedDuringPeriodValueCashlessExerciseOfWarrants
      contextRef="From2023-05-012023-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0456"
      unitRef="USD"
      xsi:nil="true"/>
    <CNXA:StockIssuedDuringPeriodValueCashlessExerciseOfWarrants
      contextRef="From2023-05-012023-07-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0457"
      unitRef="USD"
      xsi:nil="true"/>
    <CNXA:StockIssuedDuringPeriodValueCashlessExerciseOfWarrants
      contextRef="From2023-05-01to2023-07-31"
      id="xdx2ixbrl0458"
      unitRef="USD"
      xsi:nil="true"/>
    <CNXA:StockIssuedDuringPeriodValueSatisfactionOfProfitGuaranteeOnNotePayable
      contextRef="From2023-05-012023-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0464"
      unitRef="USD"
      xsi:nil="true"/>
    <CNXA:StockIssuedDuringPeriodValueSatisfactionOfProfitGuaranteeOnNotePayable
      contextRef="From2023-05-012023-07-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0465"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2023-05-012023-07-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0470"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2023-05-012023-07-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0471"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2023-05-012023-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0472"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2023-05-012023-07-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0473"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2023-05-01to2023-07-31"
      id="xdx2ixbrl0474"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2023-05-012023-07-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0476"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2023-05-012023-07-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0477"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2023-05-012023-07-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0479"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2023-05-012023-07-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0482"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2023-05-012023-07-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0483"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2023-05-012023-07-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0485"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-05-012023-07-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0488"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-05-012023-07-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0489"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-05-012023-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0490"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2022-05-012022-07-31"
      id="xdx2ixbrl0520"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims
      contextRef="From2023-05-01to2023-07-31"
      id="xdx2ixbrl0525"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensation
      contextRef="From2023-05-01to2023-07-31"
      id="xdx2ixbrl0528"
      unitRef="USD"
      xsi:nil="true"/>
    <CNXA:SettlementExpense
      contextRef="From2022-05-012022-07-31"
      id="xdx2ixbrl0550"
      unitRef="USD"
      xsi:nil="true"/>
    <CNXA:LossOnSettlementOfAccountsPayable
      contextRef="From2022-05-012022-07-31"
      id="xdx2ixbrl0553"
      unitRef="USD"
      xsi:nil="true"/>
    <CNXA:GainLossOnIssuanceOfConvertibleNotes
      contextRef="From2023-05-01to2023-07-31"
      id="xdx2ixbrl0555"
      unitRef="USD"
      xsi:nil="true"/>
    <CNXA:GainLossOnIssuanceOfConvertibleNotes
      contextRef="From2022-05-012022-07-31"
      id="xdx2ixbrl0556"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2022-05-012022-07-31"
      id="xdx2ixbrl0562"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2022-05-012022-07-31"
      id="xdx2ixbrl0565"
      unitRef="USD"
      xsi:nil="true"/>
    <CNXA:IncreaseDecreaseInPrepaidInventory
      contextRef="From2022-05-012022-07-31"
      id="xdx2ixbrl0568"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="From2022-05-012022-07-31"
      id="xdx2ixbrl0571"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
      contextRef="From2022-05-012022-07-31"
      id="xdx2ixbrl0574"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="From2022-05-012022-07-31"
      id="xdx2ixbrl0580"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInInterestPayableNet
      contextRef="From2022-05-012022-07-31"
      id="xdx2ixbrl0583"
      unitRef="USD"
      xsi:nil="true"/>
    <CNXA:IncreaseDecreaseInInterestPayableRelatedParty
      contextRef="From2023-05-01to2023-07-31"
      id="xdx2ixbrl0585"
      unitRef="USD"
      xsi:nil="true"/>
    <CNXA:IncreaseDecreaseInInterestPayableRelatedParty
      contextRef="From2022-05-012022-07-31"
      id="xdx2ixbrl0586"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
      contextRef="From2023-05-01to2023-07-31"
      id="xdx2ixbrl0594"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
      contextRef="From2022-05-012022-07-31"
      id="xdx2ixbrl0595"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2023-05-01to2023-07-31"
      id="xdx2ixbrl0621"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="From2023-05-01to2023-07-31"
      id="xdx2ixbrl0627"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestPaidNet
      contextRef="From2023-05-01to2023-07-31"
      id="xdx2ixbrl0660"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestPaidNet
      contextRef="From2022-05-012022-07-31"
      id="xdx2ixbrl0661"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2023-05-01to2023-07-31"
      id="xdx2ixbrl0663"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2022-05-012022-07-31"
      id="xdx2ixbrl0664"
      unitRef="USD"
      xsi:nil="true"/>
    <CNXA:ConversionOfConvertibleNotesPayableAndAccruedInterestToCommonStock
      contextRef="From2023-05-01to2023-07-31"
      id="xdx2ixbrl0672"
      unitRef="USD"
      xsi:nil="true"/>
    <CNXA:SharesIssuedForContingentConsideration
      contextRef="From2023-05-01to2023-07-31"
      id="xdx2ixbrl0675"
      unitRef="USD"
      xsi:nil="true"/>
    <CNXA:SharesIssuedForSettlementOfAccountsPayable
      contextRef="From2022-05-012022-07-31"
      id="xdx2ixbrl0688"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="From2023-05-012023-07-31_custom_ProfitGuarantyMember"
      id="xdx2ixbrl0787"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="AsOf2023-07-31_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputExpectedTermMember"
      id="xdx2ixbrl0857">P0Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2023-07-31_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_WarrantMember"
      id="xdx2ixbrl0863"
      unitRef="Pure"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2023-07-31_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputRiskFreeInterestRateMember"
      id="xdx2ixbrl0869"
      unitRef="Pure"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2023-07-31_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputExpectedDividendRateMember"
      id="xdx2ixbrl0875"
      unitRef="Pure"
      xsi:nil="true"/>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2023-07-31_us-gaap_CustomerRelationshipsMember"
      id="xdx2ixbrl0905"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2023-07-31_us-gaap_ComputerSoftwareIntangibleAssetMember"
      id="xdx2ixbrl0911"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2023-04-30_us-gaap_CustomerRelationshipsMember"
      id="xdx2ixbrl0927"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2023-04-30_us-gaap_ComputerSoftwareIntangibleAssetMember"
      id="xdx2ixbrl0933"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestExpense
      contextRef="From2023-05-012023-07-31_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl0980"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommodityContractAssetCurrent
      contextRef="AsOf2023-04-30"
      id="xdx2ixbrl1286"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="AsOf2023-04-30"
      id="xdx2ixbrl1292"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherReceivables
      contextRef="AsOf2022-04-30"
      id="xdx2ixbrl1302"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Goodwill
      contextRef="AsOf2023-04-30"
      id="xdx2ixbrl1310"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
      contextRef="AsOf2023-04-30"
      id="xdx2ixbrl1313"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PurchaseObligation
      contextRef="AsOf2023-04-30"
      id="xdx2ixbrl1337"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="AsOf2023-04-30"
      id="xdx2ixbrl1340"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ConvertibleNotesPayableCurrent
      contextRef="AsOf2023-04-30"
      id="xdx2ixbrl1355"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="AsOf2023-04-30"
      id="xdx2ixbrl1367"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
      contextRef="AsOf2023-04-30"
      id="xdx2ixbrl1379"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2023-04-30"
      id="xdx2ixbrl1388"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2022-04-30"
      id="xdx2ixbrl1389"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2022-05-012023-04-30"
      id="xdx2ixbrl1458"
      unitRef="USD"
      xsi:nil="true"/>
    <CNXA:GainLossOnIssuanceOfConvertibleNotes
      contextRef="From2022-05-012023-04-30"
      id="xdx2ixbrl1461"
      unitRef="USD"
      xsi:nil="true"/>
    <CNXA:GainLossOnChangeInFairValueOfContingentConsideration
      contextRef="From2022-05-012023-04-30"
      id="xdx2ixbrl1464"
      unitRef="USD"
      xsi:nil="true"/>
    <CNXA:DerivativeExpense
      contextRef="From2021-05-012022-04-30"
      id="xdx2ixbrl1471"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
      contextRef="From2021-05-012022-04-30"
      id="xdx2ixbrl1492"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2022-05-012023-04-30"
      id="xdx2ixbrl1500"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2021-05-012022-04-30"
      id="xdx2ixbrl1501"
      unitRef="USD"
      xsi:nil="true"/>
    <CNXA:StockIssuedDuringPeriodValueConversionofNotesPayableRelatedParties
      contextRef="From2021-05-012022-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl1566"
      unitRef="USD"
      xsi:nil="true"/>
    <CNXA:StockIssuedDuringPeriodValueConversionofNotesPayableRelatedParties
      contextRef="From2021-05-012022-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl1567"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2021-05-012022-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl1574"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2021-05-012022-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl1575"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="From2021-05-012022-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl1582"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="From2021-05-012022-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl1583"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2021-05-012022-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl1590"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2021-05-012022-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl1591"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2021-05-012022-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl1598"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2021-05-012022-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl1599"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2021-05-012022-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl1606"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2021-05-012022-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl1607"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="From2021-05-012022-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl1612"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="From2021-05-012022-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl1614"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="From2021-05-012022-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl1615"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2021-05-012022-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember_custom_GamefaceLtdMember"
      id="xdx2ixbrl1618"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2021-05-012022-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember_custom_GamefaceLtdMember"
      id="xdx2ixbrl1620"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2021-05-012022-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember_custom_GamefaceLtdMember"
      id="xdx2ixbrl1621"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2021-05-012022-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember_custom_PlaySightInteractiveLtdMember"
      id="xdx2ixbrl1624"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2021-05-012022-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember_custom_PlaySightInteractiveLtdMember"
      id="xdx2ixbrl1626"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2021-05-012022-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember_custom_PlaySightInteractiveLtdMember"
      id="xdx2ixbrl1627"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2021-05-012022-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl1630"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2021-05-012022-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl1631"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2021-05-012022-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl1633"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-05-012022-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl1636"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-05-012022-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl1637"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-05-012022-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl1638"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2022-05-012023-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl1666"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2022-05-012023-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl1667"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2022-05-012023-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl1674"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2022-05-012023-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl1675"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-05-012023-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl1682"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-05-012023-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl1683"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-05-012023-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl1690"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-05-012023-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl1691"
      unitRef="USD"
      xsi:nil="true"/>
    <CNXA:StockIssuedDuringPeriodValueCashlessExerciseOfWarrants
      contextRef="From2022-05-012023-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl1698"
      unitRef="USD"
      xsi:nil="true"/>
    <CNXA:StockIssuedDuringPeriodValueCashlessExerciseOfWarrants
      contextRef="From2022-05-012023-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl1699"
      unitRef="USD"
      xsi:nil="true"/>
    <CNXA:StockIssuedDuringPeriodValueCashlessExerciseOfWarrants
      contextRef="From2022-05-012023-04-30_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl1700"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2022-05-012023-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl1706"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2022-05-012023-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl1707"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2022-05-012023-04-30_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl1708"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2022-05-012023-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl1712"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2022-05-012023-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl1714"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2022-05-012023-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl1715"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2022-05-012023-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl1718"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2022-05-012023-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl1719"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2022-05-012023-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl1721"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2022-05-012023-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl1724"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2022-05-012023-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl1725"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2022-05-012023-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl1727"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-05-012023-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl1730"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-05-012023-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl1731"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-05-012023-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl1732"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GainLossOnSaleOfOtherAssets
      contextRef="From2021-05-012022-04-30"
      id="xdx2ixbrl1766"
      unitRef="USD"
      xsi:nil="true"/>
    <CNXA:GainLossOnChangeInFairValueOfContingentConsideration
      contextRef="From2022-05-012023-04-30"
      id="xdx2ixbrl1768"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2022-05-012023-04-30"
      id="xdx2ixbrl1771"
      unitRef="USD"
      xsi:nil="true"/>
    <CNXA:DerivativeExpense
      contextRef="From2021-05-012022-04-30"
      id="xdx2ixbrl1778"
      unitRef="USD"
      xsi:nil="true"/>
    <CNXA:GainLossOnIssuanceOfConvertibleNotes
      contextRef="From2022-05-012023-04-30"
      id="xdx2ixbrl1783"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="From2022-05-012023-04-30"
      id="xdx2ixbrl1831"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsToAcquireNotesReceivable
      contextRef="From2022-05-012023-04-30"
      id="xdx2ixbrl1834"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
      contextRef="From2022-05-012023-04-30"
      id="xdx2ixbrl1837"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
      contextRef="From2022-05-012023-04-30"
      id="xdx2ixbrl1840"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2022-05-012023-04-30"
      id="xdx2ixbrl1843"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2021-05-012022-04-30"
      id="xdx2ixbrl1850"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="From2022-05-012023-04-30"
      id="xdx2ixbrl1852"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="From2022-05-012023-04-30"
      id="xdx2ixbrl1858"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2022-05-012023-04-30"
      id="xdx2ixbrl1861"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="From2021-05-012022-04-30"
      id="xdx2ixbrl1865"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2022-05-012023-04-30"
      id="xdx2ixbrl1891"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssued1
      contextRef="From2022-05-012023-04-30"
      id="xdx2ixbrl1897"
      unitRef="USD"
      xsi:nil="true"/>
    <CNXA:SharesIssuedForContingentConsideration
      contextRef="From2021-05-012022-04-30"
      id="xdx2ixbrl1904"
      unitRef="USD"
      xsi:nil="true"/>
    <CNXA:EliminationOfRelatedPartyDerivativeLiabilities
      contextRef="From2022-05-012023-04-30"
      id="xdx2ixbrl1906"
      unitRef="USD"
      xsi:nil="true"/>
    <CNXA:DerivativeLiabilitiesRecordedAsDebtDiscountsOfConvertibleNotes
      contextRef="From2022-05-012023-04-30"
      id="xdx2ixbrl1909"
      unitRef="USD"
      xsi:nil="true"/>
    <CNXA:DerivativeLiabilityRecordedForSharesAndWarrantsIssuedInPrivatePlacement
      contextRef="From2021-05-012022-04-30"
      id="xdx2ixbrl1913"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NotesIssued1
      contextRef="From2021-05-012022-04-30"
      id="xdx2ixbrl1916"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DerivativeInstrumentsAndHedgesLiabilities
      contextRef="AsOf2023-04-30_custom_OtherDerivativeLiabilitiesMember"
      id="xdx2ixbrl2020"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2023-04-30_us-gaap_CustomerRelationshipsMember"
      id="xdx2ixbrl2160"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2023-04-30_us-gaap_ComputerSoftwareIntangibleAssetMember"
      id="xdx2ixbrl2166"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="From2021-05-012022-04-30_us-gaap_TradeNamesMember"
      id="xdx2ixbrl2175"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="From2021-05-012022-04-30_us-gaap_CustomerRelationshipsMember"
      id="xdx2ixbrl2181"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="From2021-05-012022-04-30_us-gaap_ComputerSoftwareIntangibleAssetMember"
      id="xdx2ixbrl2187"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="From2021-05-012022-04-30_custom_IntangiableAssetMember"
      id="xdx2ixbrl2193"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="AsOf2023-04-30_custom_MonteCarloSimulationMember"
      id="xdx2ixbrl2279">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2022-04-30"
      decimals="INF"
      id="xdx2ixbrl2401"
      unitRef="Shares">4194836</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
      contextRef="From2022-05-012023-04-30"
      id="xdx2ixbrl2497"
      unitRef="Shares"
      xsi:nil="true"/>
    <CNXA:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised
      contextRef="From2022-05-012023-04-30"
      id="xdx2ixbrl2499"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
      contextRef="From2021-05-012022-04-30"
      id="xdx2ixbrl2501"
      unitRef="Shares"
      xsi:nil="true"/>
    <CNXA:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised
      contextRef="From2021-05-012022-04-30"
      id="xdx2ixbrl2503"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
      contextRef="From2022-05-012023-04-30"
      id="xdx2ixbrl2505"
      unitRef="Shares"
      xsi:nil="true"/>
    <CNXA:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceForfeited
      contextRef="From2022-05-012023-04-30"
      id="xdx2ixbrl2507"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
      contextRef="From2021-05-012022-04-30"
      id="xdx2ixbrl2509"
      unitRef="Shares"
      xsi:nil="true"/>
    <CNXA:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceForfeited
      contextRef="From2021-05-012022-04-30"
      id="xdx2ixbrl2511"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <CNXA:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExpired
      contextRef="From2022-05-012023-04-30"
      id="xdx2ixbrl2515"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations
      contextRef="From2021-05-012022-04-30"
      id="xdx2ixbrl2517"
      unitRef="Shares"
      xsi:nil="true"/>
    <CNXA:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExpired
      contextRef="From2021-05-012022-04-30"
      id="xdx2ixbrl2519"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <CNXA:DeferredTaxAssetsAccruedPayroll
      contextRef="AsOf2022-04-30"
      id="xdx2ixbrl2570"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="AsOf2023-04-30"
      id="xdx2ixbrl2590"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="AsOf2022-04-30"
      id="xdx2ixbrl2591"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="From2022-05-012023-04-30"
      id="xdx2ixbrl2598"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="From2021-05-012022-04-30"
      id="xdx2ixbrl2599"
      unitRef="USD"
      xsi:nil="true"/>
    <CNXA:IncomeTaxRecociliationLossOnExtinguishmentOfDebt
      contextRef="From2021-05-012022-04-30"
      id="xdx2ixbrl2629"
      unitRef="USD"
      xsi:nil="true"/>
    <CNXA:IncomeTaxRecociliationAccruedPayroll
      contextRef="From2022-05-012023-04-30"
      id="xdx2ixbrl2631"
      unitRef="USD"
      xsi:nil="true"/>
    <CNXA:IncomeTaxRecociliationAccruedPayroll
      contextRef="From2021-05-012022-04-30"
      id="xdx2ixbrl2632"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2022-05-012023-04-30"
      id="xdx2ixbrl2643"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2021-05-012022-04-30"
      id="xdx2ixbrl2644"
      unitRef="USD"
      xsi:nil="true"/>
    <CNXA:DeferredTaxAssetsStartupCostsForeign
      contextRef="AsOf2023-04-30_country_IL"
      id="xdx2ixbrl2657"
      unitRef="USD"
      xsi:nil="true"/>
    <CNXA:DeferredTaxAssetsStartupCostsForeign
      contextRef="AsOf2022-04-30_country_IL"
      id="xdx2ixbrl2658"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="AsOf2023-04-30_country_IL"
      id="xdx2ixbrl2666"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="AsOf2022-04-30_country_IL"
      id="xdx2ixbrl2667"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2022-05-012023-04-30_us-gaap_IsraelTaxAuthorityMember"
      id="xdx2ixbrl2679"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2021-05-012022-04-30_us-gaap_IsraelTaxAuthorityMember"
      id="xdx2ixbrl2680"
      unitRef="USD"
      xsi:nil="true"/>
    <CNXA:DisposalGroupIncludingDiscontinuedOperationOtherIncomeLoss
      contextRef="From2022-05-012023-04-30"
      id="xdx2ixbrl2750"
      unitRef="USD"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="From2023-05-01to2023-07-31">S-1</dei:DocumentType>
    <dei:EntityRegistrantName contextRef="From2023-05-01to2023-07-31">CONNEXA SPORTS TECHNOLOGIES, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2023-05-01to2023-07-31">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2023-05-01to2023-07-31">61-1789640</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2023-05-01to2023-07-31">2709 N. Rolling Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2023-05-01to2023-07-31">Suite 138</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2023-05-01to2023-07-31">Windsor Mill</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2023-05-01to2023-07-31">MD</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2023-05-01to2023-07-31">21244</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2023-05-01to2023-07-31">(443)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2023-05-01to2023-07-31">407-7564</dei:LocalPhoneNumber>
    <dei:ContactPersonnelName contextRef="From2023-05-012023-07-31_dei_BusinessContactMember">Vcorp Services LLC</dei:ContactPersonnelName>
    <dei:EntityAddressAddressLine1 contextRef="From2023-05-012023-07-31_dei_BusinessContactMember">1013 Centre Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2023-05-012023-07-31_dei_BusinessContactMember">Suite 403-B</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2023-05-012023-07-31_dei_BusinessContactMember">Wilmington</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2023-05-012023-07-31_dei_BusinessContactMember">DE</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2023-05-012023-07-31_dei_BusinessContactMember">19805</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2023-05-012023-07-31_dei_BusinessContactMember">(888)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2023-05-012023-07-31_dei_BusinessContactMember">528-2677</dei:LocalPhoneNumber>
    <dei:EntityFilerCategory contextRef="From2023-05-01to2023-07-31">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2023-05-01to2023-07-31">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2023-05-01to2023-07-31">false</dei:EntityEmergingGrowthCompany>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2023-07-31" decimals="0" unitRef="USD">386459</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">202095</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2023-07-31" decimals="0" unitRef="USD">444622</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">399680</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet contextRef="AsOf2023-07-31" decimals="0" unitRef="USD">2336918</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">3189766</us-gaap:InventoryNet>
    <CNXA:PrepaidInventoryCurrent contextRef="AsOf2023-07-31" decimals="0" unitRef="USD">1134368</CNXA:PrepaidInventoryCurrent>
    <CNXA:PrepaidInventoryCurrent contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">936939</CNXA:PrepaidInventoryCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2023-07-31" decimals="0" unitRef="USD">280820</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">263020</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2023-07-31" decimals="0" unitRef="USD">4583187</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">4991500</us-gaap:AssetsCurrent>
    <us-gaap:OtherReceivables contextRef="AsOf2023-07-31" decimals="0" unitRef="USD">2000000</us-gaap:OtherReceivables>
    <us-gaap:OtherReceivables contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">2000000</us-gaap:OtherReceivables>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">14791</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2023-07-31" decimals="0" unitRef="USD">1000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">101281</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AssetsNoncurrent contextRef="AsOf2023-07-31" decimals="0" unitRef="USD">2001000</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">2116072</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets contextRef="AsOf2023-07-31" decimals="0" unitRef="USD">6584187</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">7107572</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2023-07-31" decimals="0" unitRef="USD">6087311</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">5496629</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2023-07-31" decimals="0" unitRef="USD">5197460</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">4911839</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="AsOf2023-07-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      unitRef="USD">41522</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="AsOf2023-04-30_us-gaap_NonrelatedPartyMember"
      decimals="0"
      unitRef="USD">25387</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="AsOf2023-07-31_us-gaap_RelatedPartyMember"
      decimals="0"
      unitRef="USD">917957</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="AsOf2023-04-30_us-gaap_RelatedPartyMember"
      decimals="0"
      unitRef="USD">917957</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="AsOf2023-07-31_us-gaap_RelatedPartyMember"
      decimals="0"
      unitRef="USD">917957</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="AsOf2023-04-30_us-gaap_RelatedPartyMember"
      decimals="0"
      unitRef="USD">917957</us-gaap:InterestPayableCurrent>
    <us-gaap:OtherNotesPayableCurrent contextRef="AsOf2023-07-31" decimals="0" unitRef="USD">1959671</us-gaap:OtherNotesPayableCurrent>
    <us-gaap:OtherNotesPayableCurrent contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">1484647</us-gaap:OtherNotesPayableCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent contextRef="AsOf2023-07-31" decimals="0" unitRef="USD">8345052</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">10489606</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent contextRef="AsOf2023-07-31" decimals="0" unitRef="USD">418455</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">418455</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="AsOf2023-07-31" decimals="0" unitRef="USD">330065</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">22971</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2023-07-31" decimals="0" unitRef="USD">23297493</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">23767491</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermNotesPayable
      contextRef="AsOf2023-07-31_us-gaap_RelatedPartyMember"
      decimals="0"
      unitRef="USD">1655966</us-gaap:LongTermNotesPayable>
    <us-gaap:LongTermNotesPayable
      contextRef="AsOf2023-04-30_us-gaap_RelatedPartyMember"
      decimals="0"
      unitRef="USD">1953842</us-gaap:LongTermNotesPayable>
    <us-gaap:LiabilitiesNoncurrent contextRef="AsOf2023-07-31" decimals="0" unitRef="USD">1655966</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">1953842</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="AsOf2023-07-31" decimals="0" unitRef="USD">24953459</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">25721333</us-gaap:Liabilities>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-07-31"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-04-30"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2023-07-31" decimals="INF" unitRef="Shares">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2023-04-30" decimals="INF" unitRef="Shares">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2023-07-31" decimals="INF" unitRef="Shares">528297</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2023-07-31" decimals="INF" unitRef="Shares">528297</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2023-04-30" decimals="INF" unitRef="Shares">338579</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2023-04-30" decimals="INF" unitRef="Shares">338579</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="AsOf2023-07-31" decimals="0" unitRef="USD">528</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">339</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="AsOf2023-07-31" decimals="0" unitRef="USD">134112083</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">132993998</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2023-07-31" decimals="0" unitRef="USD">-152597375</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">-151750610</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2023-07-31" decimals="0" unitRef="USD">115492</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">142512</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity contextRef="AsOf2023-07-31" decimals="0" unitRef="USD">-18369272</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">-18613761</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2023-07-31" decimals="0" unitRef="USD">6584187</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">7107572</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-05-01to2023-07-31"
      decimals="0"
      unitRef="USD">3120231</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-05-012022-07-31"
      decimals="0"
      unitRef="USD">3583336</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="From2023-05-01to2023-07-31"
      decimals="0"
      unitRef="USD">2227482</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="From2022-05-012022-07-31"
      decimals="0"
      unitRef="USD">2562044</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="From2023-05-01to2023-07-31"
      decimals="0"
      unitRef="USD">892749</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2022-05-012022-07-31"
      decimals="0"
      unitRef="USD">1021292</us-gaap:GrossProfit>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2023-05-01to2023-07-31"
      decimals="0"
      unitRef="USD">242353</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2022-05-012022-07-31"
      decimals="0"
      unitRef="USD">756823</us-gaap:SellingAndMarketingExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2023-05-01to2023-07-31"
      decimals="0"
      unitRef="USD">2505060</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2022-05-012022-07-31"
      decimals="0"
      unitRef="USD">3314610</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2022-05-012022-07-31"
      decimals="0"
      unitRef="USD">19425</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:OperatingExpenses
      contextRef="From2023-05-01to2023-07-31"
      decimals="0"
      unitRef="USD">2747413</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2022-05-012022-07-31"
      decimals="0"
      unitRef="USD">4090858</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2023-05-01to2023-07-31"
      decimals="0"
      unitRef="USD">-1854664</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2022-05-012022-07-31"
      decimals="0"
      unitRef="USD">-3069566</us-gaap:OperatingIncomeLoss>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="From2023-05-01to2023-07-31"
      decimals="0"
      unitRef="USD">777192</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="From2022-05-012022-07-31"
      decimals="0"
      unitRef="USD">2872222</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <CNXA:LossOnConversionOfAccountsPayableToCommonStock
      contextRef="From2023-05-01to2023-07-31"
      decimals="0"
      unitRef="USD">-289980</CNXA:LossOnConversionOfAccountsPayableToCommonStock>
    <CNXA:GainLossOnChangeInFairValueOfDerivativesLiability
      contextRef="From2023-05-01to2023-07-31"
      decimals="0"
      unitRef="USD">2144554</CNXA:GainLossOnChangeInFairValueOfDerivativesLiability>
    <CNXA:GainLossOnChangeInFairValueOfDerivativesLiability
      contextRef="From2022-05-012022-07-31"
      decimals="0"
      unitRef="USD">3687495</CNXA:GainLossOnChangeInFairValueOfDerivativesLiability>
    <us-gaap:InterestExpense
      contextRef="From2023-05-012023-07-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      unitRef="USD">69483</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2022-05-012022-07-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      unitRef="USD">191303</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2022-05-012022-07-31_us-gaap_RelatedPartyMember"
      decimals="0"
      unitRef="USD">61121</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2022-05-012022-07-31_us-gaap_RelatedPartyMember"
      decimals="0"
      unitRef="USD">61121</us-gaap:InterestExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2023-05-01to2023-07-31"
      decimals="0"
      unitRef="USD">1007899</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2022-05-012022-07-31"
      decimals="0"
      unitRef="USD">562849</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2023-05-01to2023-07-31"
      decimals="0"
      unitRef="USD">-846765</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2022-05-012022-07-31"
      decimals="0"
      unitRef="USD">-2506717</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax
      contextRef="From2022-05-012022-07-31"
      decimals="0"
      unitRef="USD">-1759714</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
      contextRef="From2022-05-012022-07-31"
      decimals="0"
      unitRef="USD">-1759714</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
    <CNXA:IncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2023-05-01to2023-07-31"
      decimals="0"
      unitRef="USD">-846765</CNXA:IncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <CNXA:IncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2022-05-012022-07-31"
      decimals="0"
      unitRef="USD">-4266431</CNXA:IncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-05-01to2023-07-31"
      decimals="0"
      unitRef="USD">-846765</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-05-012022-07-31"
      decimals="0"
      unitRef="USD">-4266431</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2023-05-01to2023-07-31"
      decimals="0"
      unitRef="USD">-27020</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2022-05-012022-07-31"
      decimals="0"
      unitRef="USD">58139</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2023-05-01to2023-07-31"
      decimals="0"
      unitRef="USD">-873785</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2022-05-012022-07-31"
      decimals="0"
      unitRef="USD">-4208292</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2023-05-01to2023-07-31"
      decimals="INF"
      unitRef="USDPShares">-1.93</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="From2023-05-01to2023-07-31"
      decimals="INF"
      unitRef="USDPShares">-1.93</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2022-05-012022-07-31"
      decimals="INF"
      unitRef="USDPShares">-14.27</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="From2022-05-012022-07-31"
      decimals="INF"
      unitRef="USDPShares">-14.27</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="From2022-05-012022-07-31"
      decimals="INF"
      unitRef="USDPShares">-10.02</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="From2022-05-012022-07-31"
      decimals="INF"
      unitRef="USDPShares">-10.02</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-05-01to2023-07-31"
      decimals="INF"
      unitRef="USDPShares">-1.93</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-05-01to2023-07-31"
      decimals="INF"
      unitRef="USDPShares">-1.93</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2022-05-012022-07-31"
      decimals="INF"
      unitRef="USDPShares">-24.29</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2022-05-012022-07-31"
      decimals="INF"
      unitRef="USDPShares">-24.29</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-05-01to2023-07-31"
      decimals="INF"
      unitRef="Shares">438354</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-05-01to2023-07-31"
      decimals="INF"
      unitRef="Shares">438354</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-05-012022-07-31"
      decimals="INF"
      unitRef="Shares">175653</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2022-05-012022-07-31"
      decimals="INF"
      unitRef="Shares">175653</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-04-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">104871</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-04-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">105</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-04-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">113053790</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      unitRef="USD">54962</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-04-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-80596925</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">32511932</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits
      contextRef="From2022-05-012022-07-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">109737</us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="From2022-05-012022-07-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">110</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="From2022-05-012022-07-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">14046190</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="From2022-05-012022-07-31"
      decimals="0"
      unitRef="USD">14046300</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2022-05-012022-07-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">14960</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2022-05-012022-07-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">15</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2022-05-012022-07-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">915530</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2022-05-012022-07-31"
      decimals="0"
      unitRef="USD">915545</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2022-05-012022-07-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">625</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-05-012022-07-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">1</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-05-012022-07-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">35249</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-05-012022-07-31"
      decimals="0"
      unitRef="USD">35250</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-05-012022-07-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">26219</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-05-012022-07-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">26</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-05-012022-07-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">4194974</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-05-012022-07-31"
      decimals="0"
      unitRef="USD">4195000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="From2022-05-012022-07-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">38</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2022-05-012022-07-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">277625</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2022-05-012022-07-31"
      decimals="0"
      unitRef="USD">277625</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2022-05-012022-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      unitRef="USD">58139</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2022-05-012022-07-31"
      decimals="0"
      unitRef="USD">58139</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2022-05-012022-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      unitRef="USD">58139</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2022-05-012022-07-31"
      decimals="0"
      unitRef="USD">58139</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-05-012022-07-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-4266431</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-05-012022-07-31"
      decimals="0"
      unitRef="USD">-4266431</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-07-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">256450</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-07-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">257</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-07-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">132523358</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      unitRef="USD">113101</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-07-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-84863356</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2022-07-31" decimals="0" unitRef="USD">47773360</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-04-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">338579</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-04-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">339</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-04-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">132993998</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      unitRef="USD">142512</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-04-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-151750610</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">-18613761</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-04-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">338579</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-04-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">339</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-04-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">132993998</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      unitRef="USD">142512</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-04-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-151750610</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">-18613761</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2023-05-012023-07-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">188</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <CNXA:StockIssuedDuringPeriodSharesAccountsPayable
      contextRef="From2023-05-012023-07-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">67500</CNXA:StockIssuedDuringPeriodSharesAccountsPayable>
    <CNXA:StockIssuedDuringPeriodValueAccountsPayable
      contextRef="From2023-05-012023-07-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">67</CNXA:StockIssuedDuringPeriodValueAccountsPayable>
    <CNXA:StockIssuedDuringPeriodValueAccountsPayable
      contextRef="From2023-05-012023-07-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">559913</CNXA:StockIssuedDuringPeriodValueAccountsPayable>
    <CNXA:StockIssuedDuringPeriodValueAccountsPayable
      contextRef="From2023-05-01to2023-07-31"
      decimals="0"
      unitRef="USD">559980</CNXA:StockIssuedDuringPeriodValueAccountsPayable>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2023-05-012023-07-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">1350</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2023-05-012023-07-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">1</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2023-05-012023-07-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">-1</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <CNXA:StockIssuedDuringPeriodCashlessExerciseOfWarrantsShares
      contextRef="From2023-05-012023-07-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">27000</CNXA:StockIssuedDuringPeriodCashlessExerciseOfWarrantsShares>
    <CNXA:StockIssuedDuringPeriodValueCashlessExerciseOfWarrants
      contextRef="From2023-05-012023-07-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">27</CNXA:StockIssuedDuringPeriodValueCashlessExerciseOfWarrants>
    <CNXA:StockIssuedDuringPeriodValueCashlessExerciseOfWarrants
      contextRef="From2023-05-012023-07-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">-27</CNXA:StockIssuedDuringPeriodValueCashlessExerciseOfWarrants>
    <CNXA:StockIssuedDuringPeriodSharesSatisfactionOfProfitGuaranteeOnNotePayable
      contextRef="From2023-05-012023-07-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">93680</CNXA:StockIssuedDuringPeriodSharesSatisfactionOfProfitGuaranteeOnNotePayable>
    <CNXA:StockIssuedDuringPeriodValueSatisfactionOfProfitGuaranteeOnNotePayable
      contextRef="From2023-05-012023-07-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">94</CNXA:StockIssuedDuringPeriodValueSatisfactionOfProfitGuaranteeOnNotePayable>
    <CNXA:StockIssuedDuringPeriodValueSatisfactionOfProfitGuaranteeOnNotePayable
      contextRef="From2023-05-012023-07-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">558200</CNXA:StockIssuedDuringPeriodValueSatisfactionOfProfitGuaranteeOnNotePayable>
    <CNXA:StockIssuedDuringPeriodValueSatisfactionOfProfitGuaranteeOnNotePayable
      contextRef="From2023-05-01to2023-07-31"
      decimals="0"
      unitRef="USD">558294</CNXA:StockIssuedDuringPeriodValueSatisfactionOfProfitGuaranteeOnNotePayable>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2023-05-012023-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      unitRef="USD">-27020</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2023-05-01to2023-07-31"
      decimals="0"
      unitRef="USD">-27020</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2023-05-012023-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      unitRef="USD">-27020</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2023-05-01to2023-07-31"
      decimals="0"
      unitRef="USD">-27020</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-05-012023-07-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-846765</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-05-01to2023-07-31"
      decimals="0"
      unitRef="USD">-846765</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-07-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">528297</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-07-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">528</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-07-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">134112083</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      unitRef="USD">115492</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-07-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-152597375</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2023-07-31" decimals="0" unitRef="USD">-18369272</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-07-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">528297</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-07-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">528</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-07-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">134112083</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-07-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      unitRef="USD">115492</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-07-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-152597375</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2023-07-31" decimals="0" unitRef="USD">-18369272</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-05-01to2023-07-31"
      decimals="0"
      unitRef="USD">-846765</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-05-012022-07-31"
      decimals="0"
      unitRef="USD">-4266431</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2023-05-01to2023-07-31"
      decimals="0"
      unitRef="USD">115072</us-gaap:DepreciationAndAmortization>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="From2023-05-01to2023-07-31"
      decimals="0"
      unitRef="USD">2144554</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="From2022-05-012022-07-31"
      decimals="0"
      unitRef="USD">3687495</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims
      contextRef="From2022-05-012022-07-31"
      decimals="0"
      unitRef="USD">35250</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:ShareBasedCompensation
      contextRef="From2022-05-012022-07-31"
      decimals="0"
      unitRef="USD">277625</us-gaap:ShareBasedCompensation>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2023-05-01to2023-07-31"
      decimals="0"
      unitRef="USD">777192</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2022-05-012022-07-31"
      decimals="0"
      unitRef="USD">2872222</us-gaap:AmortizationOfDebtDiscountPremium>
    <CNXA:SettlementExpense
      contextRef="From2023-05-01to2023-07-31"
      decimals="0"
      unitRef="USD">558294</CNXA:SettlementExpense>
    <CNXA:LossOnSettlementOfAccountsPayable
      contextRef="From2023-05-01to2023-07-31"
      decimals="0"
      unitRef="USD">289980</CNXA:LossOnSettlementOfAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2023-05-01to2023-07-31"
      decimals="0"
      unitRef="USD">-265992</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2023-05-01to2023-07-31"
      decimals="0"
      unitRef="USD">-852848</us-gaap:IncreaseDecreaseInInventories>
    <CNXA:IncreaseDecreaseInPrepaidInventory
      contextRef="From2023-05-01to2023-07-31"
      decimals="0"
      unitRef="USD">197429</CNXA:IncreaseDecreaseInPrepaidInventory>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="From2023-05-01to2023-07-31"
      decimals="0"
      unitRef="USD">1316</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
      contextRef="From2023-05-01to2023-07-31"
      decimals="0"
      unitRef="USD">255199</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="From2023-05-01to2023-07-31"
      decimals="0"
      unitRef="USD">326550</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInInterestPayableNet
      contextRef="From2023-05-01to2023-07-31"
      decimals="0"
      unitRef="USD">16135</us-gaap:IncreaseDecreaseInInterestPayableNet>
    <us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
      contextRef="From2023-05-01to2023-07-31"
      decimals="0"
      unitRef="USD">1113963</us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities>
    <us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
      contextRef="From2022-05-012022-07-31"
      decimals="0"
      unitRef="USD">-502398</us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
      contextRef="From2023-05-01to2023-07-31"
      decimals="0"
      unitRef="USD">267198</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
      contextRef="From2022-05-012022-07-31"
      decimals="0"
      unitRef="USD">-4768829</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2023-05-01to2023-07-31"
      decimals="0"
      unitRef="USD">267198</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2022-05-012022-07-31"
      decimals="0"
      unitRef="USD">-4768829</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2022-05-012022-07-31"
      decimals="0"
      unitRef="USD">4195000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="From2022-05-012022-07-31"
      decimals="0"
      unitRef="USD">925000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="From2023-05-01to2023-07-31"
      decimals="0"
      unitRef="USD">298834</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="From2022-05-012022-07-31"
      decimals="0"
      unitRef="USD">15386</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="From2023-05-01to2023-07-31"
      decimals="0"
      unitRef="USD">302168</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="From2022-05-012022-07-31"
      decimals="0"
      unitRef="USD">1698485</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2023-05-01to2023-07-31"
      decimals="0"
      unitRef="USD">-601002</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2022-05-012022-07-31"
      decimals="0"
      unitRef="USD">3406129</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="From2023-05-01to2023-07-31"
      decimals="0"
      unitRef="USD">-17996</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="From2022-05-012022-07-31"
      decimals="0"
      unitRef="USD">67357</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2023-05-01to2023-07-31"
      decimals="0"
      unitRef="USD">-351800</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2022-05-012022-07-31"
      decimals="0"
      unitRef="USD">-1295343</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">202095</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">665002</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2023-07-31" decimals="0" unitRef="USD">149705</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2022-07-31" decimals="0" unitRef="USD">630341</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <CNXA:ConversionOfConvertibleNotesPayableAndAccruedInterestToCommonStock
      contextRef="From2022-05-012022-07-31"
      decimals="0"
      unitRef="USD">14046300</CNXA:ConversionOfConvertibleNotesPayableAndAccruedInterestToCommonStock>
    <CNXA:SharesIssuedForContingentConsideration
      contextRef="From2022-05-012022-07-31"
      decimals="0"
      unitRef="USD">915545</CNXA:SharesIssuedForContingentConsideration>
    <CNXA:SharesIssuedForSettlementOfAccountsPayable
      contextRef="From2023-05-01to2023-07-31"
      decimals="0"
      unitRef="USD">270000</CNXA:SharesIssuedForSettlementOfAccountsPayable>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="From2023-05-01to2023-07-31">&lt;p id="xdx_80C_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zIECnxm6DOkj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
1: &lt;span id="xdx_82C_z9SjvE1EOv06"&gt;ORGANIZATION AND NATURE OF BUSINESS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Organization&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Lazex
Inc. (&#x201c;Lazex&#x201d;) was incorporated under the laws of the State of Nevada on July 12, 2015. On August 23, 2019, the majority
owner of Lazex entered into a Stock Purchase Agreement with Slinger Bag Americas Inc., a Delaware corporation (&#x201c;Slinger Bag Americas&#x201d;),
which was &lt;span id="xdx_908_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20190823__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SlingerBagAmericasIncMember_zb0Kp5zOX4h1" title="Percentage of ownership"&gt;100&lt;/span&gt;% owned by Slinger Bag Ltd. (&#x201c;SBL&#x201d;), an Israeli company. In connection with the Stock Purchase Agreement, Slinger
Bag Americas acquired &lt;span id="xdx_900_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_pid_c20190823__20190823__us-gaap--BusinessAcquisitionAxis__custom--SlingerBagAmericasIncMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember_zWW7shUyWnLf" title="Number of shares issued for acquisition"&gt;50,000&lt;/span&gt; shares of common stock of Lazex for $&lt;span id="xdx_90B_eus-gaap--BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_iI_c20190823__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--SlingerBagAmericasIncMember_z5FRoT0zmPo6" title="Number of value issued for acquisition"&gt;332,239&lt;/span&gt;. On September 16, 2019, SBL transferred its ownership of Slinger
Bag Americas to Lazex in exchange for the &lt;span id="xdx_90D_ecustom--NumberOfSharesExchanged_pid_c20190916__20190916__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SlingerBagAmericasIncMember_z14jzn0f0qY7" title="Number of shares exchanged"&gt;50,000&lt;/span&gt; shares of Lazex acquired on August 23, 2019. As a result of these transactions, Lazex
owned &lt;span id="xdx_904_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20190916__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SlingerBagAmericasIncMember_zQHBxu41BHwi" title="Percentage of ownership"&gt;100&lt;/span&gt;% of Slinger Bag Americas and the sole shareholder of SBL owned &lt;span id="xdx_907_ecustom--NumberOfSharesOwned_pid_c20190916__20190916__us-gaap--BusinessAcquisitionAxis__custom--SoleShareholderofSBLMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember_zLZixwULw6f4" title="Number of shares owned"&gt;50,000&lt;/span&gt; shares of common stock (approximately &lt;span id="xdx_905_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20190916__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SoleShareholderofSBLMember_zwL9qIftaEje" title="Percentage of ownership"&gt;82&lt;/span&gt;%) of Lazex.
Effective September 13, 2019, Lazex changed its name to Slinger Bag Inc.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
October 31, 2019, Slinger Bag Americas acquired control of Slinger Bag Canada, Inc., (&#x201c;Slinger Bag Canada&#x201d;) a Canadian company
incorporated on November 3, 2017. There were no assets, liabilities or historical operational activity of Slinger Bag Canada.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 10, 2020, Slinger Bag Americas became the &lt;span id="xdx_90F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20200210__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SlingerBagAmericasIncMember_zZjqFjug4zXk" title="Percentage of ownership"&gt;100&lt;/span&gt;% owner of SBL, along with SBL&#x2019;s wholly owned subsidiary Slinger Bag International
(UK) Limited (&#x201c;Slinger Bag UK&#x201d;), which was formed on April 3, 2019. On February 10, 2020, the owner of SBL, contributed Slinger
Bag UK to Slinger Bag Americas for no consideration.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
June 21, 2021, Slinger Bag Americas entered into a membership interest purchase agreement with Charles Ruddy to acquire a &lt;span id="xdx_90E_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20210621__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FoundationSportsSystemsLLCMember__srt--TitleOfIndividualAxis__custom--CharlesRuddyMember_z48w02DFsOwd" title="Percentage of ownership"&gt;100&lt;/span&gt;% ownership
stake in Foundation Sports Systems, LLC (&#x201c;Foundation Sports&#x201d;). On December 5, 2022, the Company sold &lt;span id="xdx_90C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20221205__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FoundationSportsSystemsLLCMember_zBYj7LVgJNwa" title="Percentage of ownership"&gt;75&lt;/span&gt;% of Foundation Sports
back to the original sellers. As a result, at that time, the Company recorded a loss on the sale and deconsolidated Foundation Sports.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 2, 2022, the Company entered into a share purchase agreement with Flixsense Pty, Ltd. (&#x201c;Gameface&#x201d;). As a result
of the share purchase agreement, Gameface would become a wholly owned subsidiary of the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 22, 2022, the Company entered into a merger agreement with PlaySight Interactive Ltd. (&#x201c;PlaySight&#x201d;) and Rohit Krishnan
(the &#x201c;Shareholders&#x2019; Representative&#x201d;). As a result of the merger agreement, PlaySight would become a wholly owned subsidiary
of the Company. In November 2022, the Company sold PlaySight and recorded a loss on the sale.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
May 16, 2022, the Company changed its domicile from Nevada to Delaware. On April 7, 2022, the Company effected a name change to Connexa
Sports Technologies Inc. We also changed our ticker symbol, &#x201c;CNXA.&#x201d;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
June 14, 2022, the Company effected a &lt;span id="xdx_90F_eus-gaap--StockholdersEquityReverseStockSplit_c20220614__20220614_zWD2L7dicP9i"&gt;1-for-10
reverse stock split&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;, where the Company&#x2019;s
common stock began to trade on a reverse split adjusted basis. No fractional shares were issued in connection with the reverse stock
split and all such fractional interests were rounded up to the nearest whole number of shares of common stock. All references to the
outstanding stock have been retrospectively adjusted to reflect this reverse stock split. The Company also consummated a public offering
of shares of its common stock and the listing of its common stock on the Nasdaq.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
July 26, 2023, the Company received a letter from the Listing Qualifications Department of Nasdaq indicating that the Company&#x2019;s
stockholders&#x2019; equity as reported in its Quarterly Report on Form 10-Q for the quarterly period ended January 31, 2023 did not satisfy
the continued listing requirement under Nasdaq Listing Rule 5550(b)(1), which requires that a listed company&#x2019;s stockholders&#x2019;
equity be at least $&lt;span id="xdx_909_eus-gaap--StockholdersEquity_iI_pn5n6_c20230726__srt--RangeAxis__srt--MinimumMember_z8jBgES4xAuh" title="Stockholders equity"&gt;2.5&lt;/span&gt; million (the &#x201c;Minimum Stockholders&#x2019; Equity Requirement&#x201d;). In addition, the Company did not
meet the alternatives of listed securities or net income from continuing operations as of the date of the letter. The Company timely
submitted a compliance plan to the Panel and on August 23, 2023 received notice from Nasdaq that it has until January 22, 2024 to demonstrate
compliance with the Minimum Stockholders&#x2019; Equity Requirement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;There
can be no assurance that the Company will be able to satisfy the Nasdaq&#x2019;s continued listing requirements, regain compliance
with the Rule, the Minimum Stockholders&#x2019; Equity Requirement and maintain compliance
with other Nasdaq listing requirements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
further details on PlaySight and Foundation Sports, we refer you to our Annual Report on Form 10-K for the year ended April 30,
2023, filed with the Securities and Exchange Commission on September 14, 2023. This Form 10-K and the consolidated financial statements
will concentrate on our existing business as reflected in the following paragraph.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company operates in the sport equipment and technology business. The Company is the owner of the Slinger Launcher, which is a portable
tennis ball launcher as well as other associated tennis accessories and Gameface AI an Australian artificial intelligence sports software
company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
operations of Slinger Bag Inc., Slinger Bag Americas, Slinger Bag Canada, Slinger Bag UK, SBL, and Gameface are collectively referred
to as the &#x201c;Company.&#x201d;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Basis
of Presentation&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying condensed consolidated financial statements of the Company are presented in accordance with accounting principles generally
accepted in the United States of America (&#x201c;GAAP&#x201d;). As a result of the transactions described above, the accompanying consolidated
financial statements include the combined results of Slinger Bag Inc., Slinger Bag Americas, Slinger Bag Canada, Slinger Bag UK, SBL,
and Gameface for the periods ended July 31, 2023 and 2022. The operations of Foundation Sports and PlaySight are included as discontinued
operations in our statements of operations as these entities were sold in November 2022 and December 2022 for the period ended July 31,
2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Impact
of COVID-19 Pandemic&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company continues to carefully monitor the global COVID-19 pandemic status and its impact on its business. In that regard, while the
Company has continued to sell its products it has previously experienced certain minor disruptions in its supply chains. The Company
expects the significance of the COVID-19 pandemic, including the extent of its effect on the Company&#x2019;s financial and operational
results, to be dictated by, among other things, the on-going global efforts to contain it. While the Company has not experienced any
material disruptions to its business and operations as a result of the COVID-19 pandemic, it is possible such disruptions may occur in
the future which may impact its financial and operational results, and which could be material.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Impact
of Russian and Ukrainian Conflict&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. We are closely monitoring
the unfolding events due to the Russia-Ukraine conflict and its regional and global ramifications. We have one distributor in Russia,
which is not material to our overall financial results. We do not currently have operations in Ukraine or Belarus. We are monitoring
any broader economic impact from the current crisis. The specific impact on the Company&#x2019;s financial condition, results of operations,
and cash flows is also not determinable as of the date of these financial statements. However, to the extent that such military action
spreads to other countries, intensifies, or otherwise remains active, such action could have a material adverse effect on our financial
condition, results of operations, and cash flows.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2019-08-23_custom_SlingerBagAmericasIncMember"
      decimals="INF"
      unitRef="Pure">1</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="From2019-08-232019-08-23_custom_SlingerBagAmericasIncMember_custom_StockPurchaseAgreementMember"
      decimals="INF"
      unitRef="Shares">50000</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
      contextRef="AsOf2019-08-23_custom_StockPurchaseAgreementMember_custom_SlingerBagAmericasIncMember"
      decimals="0"
      unitRef="USD">332239</us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned>
    <CNXA:NumberOfSharesExchanged
      contextRef="From2019-09-162019-09-16_custom_SlingerBagAmericasIncMember"
      decimals="INF"
      unitRef="Shares">50000</CNXA:NumberOfSharesExchanged>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2019-09-16_custom_SlingerBagAmericasIncMember"
      decimals="INF"
      unitRef="Pure">1</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <CNXA:NumberOfSharesOwned
      contextRef="From2019-09-162019-09-16_custom_SoleShareholderofSBLMember_custom_StockPurchaseAgreementMember"
      decimals="INF"
      unitRef="Shares">50000</CNXA:NumberOfSharesOwned>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2019-09-16_custom_SoleShareholderofSBLMember"
      decimals="INF"
      unitRef="Pure">0.82</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2020-02-10_custom_SlingerBagAmericasIncMember"
      decimals="INF"
      unitRef="Pure">1</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2021-06-21_custom_FoundationSportsSystemsLLCMember_custom_CharlesRuddyMember"
      decimals="INF"
      unitRef="Pure">1</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2022-12-05_custom_FoundationSportsSystemsLLCMember"
      decimals="INF"
      unitRef="Pure">0.75</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:StockholdersEquityReverseStockSplit contextRef="From2022-06-142022-06-14">1-for-10
reverse stock split</us-gaap:StockholdersEquityReverseStockSplit>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-07-26_srt_MinimumMember"
      decimals="-5"
      unitRef="USD">2500000</us-gaap:StockholdersEquity>
    <us-gaap:SubstantialDoubtAboutGoingConcernTextBlock contextRef="From2023-05-01to2023-07-31">&lt;p id="xdx_804_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zo5YW9xYk8ce" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
2: &lt;span id="xdx_82B_zfEFiCkxTaI"&gt;GOING CONCERN&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
financial statements have been prepared on a going concern basis, which assumes the Company will be able to realize its assets and discharge
its liabilities in the normal course of business for the foreseeable future. The Company has an accumulated deficit of $&lt;span id="xdx_909_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_di_c20230731_zvrO36LP53Sc" title="Accumulated deficit"&gt;152,597,375&lt;/span&gt; as
of July 31, 2023, and more losses are anticipated in the development of the business. Accordingly, there is substantial doubt about the
Company&#x2019;s ability to continue as a going concern. These financial statements do not include any adjustments related to the recoverability
and classification of assets or the amounts and classification of liabilities that might be necessary should the Company be unable to
continue as a going concern.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/or being able
to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they
become due. Management intends to finance operating costs over the next twelve months with existing cash on hand, loans from related
parties, and/or private placement of debt and/or common stock. In the event that the Company is unable to successfully raise capital
and/or generate revenues, the Company will likely reduce general and administrative expenses, and cease or delay its development plan
until it is able to obtain sufficient financing. The Company has begun reducing operating expenses and cash outflows by selling PlaySight,
as well as selling &lt;span id="xdx_909_ecustom--DisposalEquityInterestOwnershipInterestPercentage_iI_pid_dp_uPure_c20221130__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--PlaySightMember__us-gaap--BusinessAcquisitionAxis__custom--FoundationSportsSystemsLLCMember_z3siq21eHoRb" title="Discontinuing operations percentage"&gt;&lt;span id="xdx_90B_ecustom--DisposalEquityInterestOwnershipInterestPercentage_iI_pid_dp_uPure_c20221231__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--PlaySightMember__us-gaap--BusinessAcquisitionAxis__custom--FoundationSportsSystemsLLCMember_zQKpHzjcrJr1" title="Discontinuing operations percentage"&gt;75&lt;/span&gt;&lt;/span&gt;% of Foundation Sports in November and December 2022, respectively to the former shareholders of those companies.
There can be no assurance that additional funds will be available on terms acceptable to the Company, or at all. We have recorded the
&lt;span id="xdx_900_eus-gaap--DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal_pid_dp_uPure_c20230501__20230731__us-gaap--BusinessAcquisitionAxis__custom--FoundationSportsSystemsLLCMember_zRIWUx4TSfs2" title="Investment retained after disposal, ownership interest after disposal"&gt;25&lt;/span&gt;% investment in Foundation Sprots at $&lt;span id="xdx_90B_eus-gaap--AlternativeInvestment_iI_dp_c20230731__us-gaap--BusinessAcquisitionAxis__custom--FoundationSportsSystemsLLCMember_zP3AoFqVMwt8" title="Investment amount"&gt;0&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubstantialDoubtAboutGoingConcernTextBlock>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2023-07-31" decimals="0" unitRef="USD">-152597375</us-gaap:RetainedEarningsAccumulatedDeficit>
    <CNXA:DisposalEquityInterestOwnershipInterestPercentage
      contextRef="AsOf2022-11-30_custom_PlaySightMember_custom_FoundationSportsSystemsLLCMember"
      decimals="INF"
      unitRef="Pure">0.75</CNXA:DisposalEquityInterestOwnershipInterestPercentage>
    <CNXA:DisposalEquityInterestOwnershipInterestPercentage
      contextRef="AsOf2022-12-31_custom_PlaySightMember_custom_FoundationSportsSystemsLLCMember"
      decimals="INF"
      unitRef="Pure">0.75</CNXA:DisposalEquityInterestOwnershipInterestPercentage>
    <us-gaap:DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal
      contextRef="From2023-05-012023-07-31_custom_FoundationSportsSystemsLLCMember"
      decimals="INF"
      unitRef="Pure">0.25</us-gaap:DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal>
    <us-gaap:AlternativeInvestment
      contextRef="AsOf2023-07-31_custom_FoundationSportsSystemsLLCMember"
      decimals="0"
      unitRef="USD">0</us-gaap:AlternativeInvestment>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2023-05-01to2023-07-31">&lt;p id="xdx_80D_eus-gaap--SignificantAccountingPoliciesTextBlock_zcgpH5YnIzIh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
3: &lt;span id="xdx_827_zryQOHZAwtc6"&gt;SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_ecustom--InterimFinancialStatementsPolicyTextBlock_z3ReT6v36Rv2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_863_zq2qmsTvlyJ8"&gt;Interim
Financial Statements&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying condensed financial statements of the Company have been prepared without audit, pursuant to the rules and regulations of
the Securities and Exchange Commission. Certain information and disclosures required by accounting principles generally accepted in the
United States have been condensed or omitted pursuant to such rules and regulations. These condensed financial statements reflect all
adjustments that, in the opinion of management, are necessary to present fairly the results of operations of the Company for the period
presented. The results of operations for the three months ended July 31, 2023, are not necessarily indicative of the results that may
be expected for any future period or the fiscal year ending April 30, 2024 and should be read in conjunction with the Company&#x2019;s
Annual Report on Form 10-K for the year ended April 30, 2023, filed with the Securities and Exchange Commission on September 14, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_843_eus-gaap--UseOfEstimates_zIkrIaVahK7d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86C_zzrlLoow2ZNe"&gt;Use
of Estimates&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect
the amounts reported in the financial statements and accompanying notes. Accordingly, actual results could differ from those estimates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84A_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zr5w94rNkM43" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86F_zbnq689LntWg"&gt;Financial
Statement Reclassification&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Certain
prior year amounts within accounts payable, accrued expenses, and certain operating expenses have been reclassified for consistency with
the current year presentation and had no effect on the Company&#x2019;s balance sheet, net loss, shareholders&#x2019; deficit or cash flows.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zhD2tR7itqmd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_861_zSHAEa0JHxjh"&gt;Cash
and Cash Equivalents&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents.
The majority of payments due from banks for credit card transactions process within 24 to 48 hours and are accordingly classified as
cash and cash equivalents.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_841_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zPN1BOFN4m35" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_863_zPz2KWLalQB8"&gt;Accounts
Receivable&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s accounts receivable are non-interest bearing trade receivables resulting from the sale of products and payable over terms
ranging from 15 to 60 days. The Company provides an allowance for doubtful accounts at the point when collection is considered doubtful.
Once all collection efforts have been exhausted, the Company charges-off the receivable with the allowance for doubtful accounts. The
Company recorded $&lt;span id="xdx_907_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pdp0_do_c20230731_zhmumFZM17wi" title="Allowance for doubtful accounts"&gt;200,000&lt;/span&gt; and $&lt;span id="xdx_90D_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pdp0_do_c20230430_zHacZLXt7vVi" title="Allowance for doubtful accounts"&gt;209,690&lt;/span&gt; in allowance for doubtful accounts as of July 31, 2023 and April 30, 2023, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_840_eus-gaap--InventoryPolicyTextBlock_zRZiyRgkdyL" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_861_zAr5yrHEeHy7"&gt;Inventory&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Inventory
is valued at the lower of the cost (determined principally on a first-in, first-out basis) or net realizable value. The Company&#x2019;s
valuation of inventory includes inventory reserves for inventory that will be sold below cost and the impact of inventory shrink. Inventory
reserves are based on historical information and assumptions about future demand and inventory shrink trends. The Company&#x2019;s inventory
as of July 31, 2023 and April 30, 2023 consisted of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_890_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zf97HVif52hc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B6_zoqiVAt0juPa" style="display: none"&gt;SCHEDULE OF INVENTORY&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20230731_zE6h5LaOen1g" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;July 31, 2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20230430_ziGSNULllzaa" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;April 30, 2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--InventoryFinishedGoods_iI_maINzzOV_zXcYG5jS1aEb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Finished Goods&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;400,598&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;1,509,985&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--InventoryRawMaterialsAndSupplies_iI_maINzzOV_z45YZrOaZ1fb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Component/Replacement Parts&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,064,041&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,712,553&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--CapitalizedDutyAndFreight_iI_maINzzOV_zqWK1brM4sCc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Capitalized Duty/Freight&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;47,279&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;517,228&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--InventoryAdjustments_iNI_di_msINzzOV_ztNimEQags14" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Inventory Reserve&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(175,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(550,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--InventoryNet_iTI_mtINzzOV_zZKqAyFQU6p8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Total&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,336,918&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;3,189,766&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A2_zHURQhQOcA4b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_ecustom--PrepaidInventoryPolicyTextBlock_zmMnuOG8vY0f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_864_zDDc8lVOgI7j"&gt;Prepaid
Inventory&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Prepaid
inventory represents inventory that is in-transit that has been paid for but not received from the Company&#x2019;s third-party vendors.
The Company typically prepays for the purchase of materials and receives the products within three months after making payments. The
Company continuously monitors delivery from, and payments to, the vendors. If the Company has difficulty receiving products from a vendor,
the Company would cease purchasing products from such vendors in future periods. The Company has not had difficulty receiving products
during the reporting periods.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zRJYPi8gDXoi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86A_zm2FNh7RXyGh"&gt;Property
and equipment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Property
and equipment acquired through business combinations are stated at the estimated fair value at the date of the acquisition. Purchases
of property and equipment are stated at cost, net of accumulated depreciation and impairment losses. Expenditures that materially increase
the useful life of the assets are capitalized. Ordinary repairs and maintenance are expensed as incurred. Depreciation and amortization
are computed using the straight-line method over the estimated useful lives of the related assets, which is an average of &lt;span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230731_zi4ZPPFFOzyh" title="Property plant and equipment, useful life"&gt;5&lt;/span&gt; years.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_840_eus-gaap--ConcentrationRiskCreditRisk_zcbmzjBRP1f3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_866_zuHXeODpB3a4"&gt;Concentration
of Credit Risk&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company maintains its cash in bank deposit accounts, the balances of which at times may exceed insured limits. The Company continually
monitors its banking relationships and consequently has not experienced any losses in such accounts. While we may be exposed to credit
risk, we consider the risk remote and do not expect that any such risk would result in a significant effect on our results of operations
or financial condition. See Note 4 for further details on the Company&#x2019;s concentration of credit risk as well as other risks and
uncertainties.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zy1IUkRinSj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_867_zw8cnRxFDc0e"&gt;Revenue
Recognition&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes revenue for their continuing operations in accordance with Accounting Standards Codification (&#x201c;ASC&#x201d;) 606,
the core principle of which is that an entity should recognize revenue to depict the transfer of promised goods or services to customers
in an amount that reflects the consideration to which the entity expects to be entitled to receive in exchange for those goods or services.
The Company recognizes revenue for its performance obligation associated with its contracts with customers at a point in time once products
are shipped. Amounts collected from customers in advance of shipping products ordered are reflected as contract liabilities on the accompanying
consolidated balance sheets. The Company&#x2019;s standard terms are non-cancelable and do not provide for the right-of-return, other
than for defective merchandise covered under the Company&#x2019;s standard warranty. The Company has not historically experienced any
significant returns or warranty issues.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes revenue under ASC 606, &#x201c;Revenue from Contracts with Customers&#x201d;. The core principle of this revenue standard
is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects
the consideration to which the company expects to be entitled in exchange for those goods or services. The following five steps are applied
to achieve that core principle:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Step
1: Identify the contract with the customer&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company determines that it has a contract with a customer when each party&#x2019;s rights regarding the products or services to be transferred
can be identified, the payment terms for the services can be identified, the Company has determined the customer has the ability and
intent to pay, and the contract has commercial substance. At contract inception, the Company evaluates whether two or more contracts
should be combined and accounted for as a single contract and whether the combined or single contract includes more than one performance
obligation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Step
2: Identify the performance obligations in the contract&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s customers are buying an integrated system. In evaluating whether the equipment is a separate performance obligation,
the Company&#x2019;s management considered the customer&#x2019;s ability to benefit from the equipment on its own or together with other
readily available resources and if so, whether the service and equipment are separately identifiable (i.e., is the service highly dependent
on, or highly interrelated with the equipment). Because the Products and Services included in the customer&#x2019;s contract are integrated
and highly interdependent, and because they must work together to deliver the Solution, the Company has concluded that Products installed
on customer&#x2019;s premise and Services contracted for by the customer are generally not distinct within the context of the contract
and, therefore, constitute a single, combined performance obligation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Step
3: Determine the transaction price&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
transaction price is the amount of consideration to which an entity expects to be entitled in exchange for transferring promised goods
or services to a customer. The consideration promised in a contract with a customer includes predetermined fixed amounts, variable amounts,
or both. The Company&#x2019;s contracts do not include any rights of returns or refunds.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company collects each year&#x2019;s service fees in advance and should therefore consider the existence of a significant financing component.
However, due to the fact that the payments are provided for the service of a one-year term, the Company elected to apply the practical
expedient under ASC 606 which exempts the adjustment of the consideration for the existence of a significant financing component when
the period between the transfer of the services and the payment for such services is one year or less.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Step
4: Allocate the transaction price to the performance obligations in the contract&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Contracts
that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on
each performance obligation&#x2019;s relative standalone selling price (&#x201c;SSP&#x201d;). The Company has identified a single performance
obligation in the contract, and therefore, the allocation provisions under ASC 606 do not apply to the Company&#x2019;s contracts.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Step
5: Recognize revenue when the Company satisfies a performance obligation&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Revenues
for the Company&#x2019;s single, combined performance obligation are recognized on a straight-line basis over the customer&#x2019;s contract
term, which is the period in which the parties to the contract have enforceable rights and obligations (Typically 3-4 years).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--BusinessCombinationsPolicy_zMxLHHnW5pb1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_868_zraUzDeO6OYj"&gt;Business
Combinations&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Upon
acquisition of a company, we determine if the transaction is a business combination, which is accounted for using the acquisition method
of accounting. Under the acquisition method, once control is obtained of a business, the assets acquired, and liabilities assumed, are
recorded at fair value. We use our best estimates and assumptions to assign fair value to the tangible and intangible assets acquired
and liabilities assumed at the acquisition date. One of the most significant estimates relates to the determination of the fair value
of these assets and liabilities. The determination of the fair values is based on estimates and judgments made by management. Our estimates
of fair value are based upon assumptions we believe to be reasonable, but which are inherently uncertain and unpredictable. Measurement
period adjustments are reflected at the time identified, up through the conclusion of the measurement period, which is the time at which
all information for determination of the values of assets acquired and liabilities assumed is received and is not to exceed one year
from the acquisition date. We may record adjustments to the fair value of these tangible and intangible assets acquired and liabilities
assumed, with the corresponding offset to goodwill. The Company elected to apply pushdown accounting to all entities acquired.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Additionally,
uncertain tax positions and tax-related valuation allowances are initially recorded in connection with a business combination as of the
acquisition date. We continue to collect information and reevaluate these estimates and assumptions periodically and record any adjustments
to preliminary estimates to goodwill, provided we are within the measurement period. If outside of the measurement period, any subsequent
adjustments are recorded to the consolidated statement of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zWhCbAGBHus2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86E_zaoTLTt5EeV3"&gt;Fair
Value of Financial Instruments&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
value of financial and non-financial assets and liabilities is defined as an exit price, representing the amount that would be received
to sell an asset or paid to transfer a liability in an orderly transaction between market participants. The three-tier hierarchy for
inputs used in measuring fair value, which prioritizes the inputs used in the methodologies of measuring fair value for assets and liabilities,
is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
1 &#x2014; Quoted prices in active markets for identical assets or liabilities&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
2 &#x2014; Observable inputs other than quoted prices in active markets for identical assets and liabilities&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
3 &#x2014; Unobservable pricing inputs in the market&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
assets and financial liabilities are classified in their entirety based on the lowest level of input that is significant to the fair
value measurements. Our assessment of the significance of a particular input to the fair value measurements requires judgment and may
affect the valuation of the assets and liabilities being measured and their categorization within the fair value hierarchy.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s financial instruments consist of cash and cash equivalents, accounts receivable, and accounts payable. The carrying amount
of these financial instruments approximates fair value due to their short-term maturity.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s contingent consideration in connection with the acquisition of Gameface was calculated using Level 3 inputs. The fair
value of contingent consideration as of July 31, 2023 and April 30, 2023 was $&lt;span id="xdx_90D_eus-gaap--BusinessCombinationConsiderationTransferred1_c20230501__20230731__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zAYKla0QEGTb" title="Fair value of contingent consideration"&gt;418,455&lt;/span&gt; and $&lt;span id="xdx_908_eus-gaap--BusinessCombinationConsiderationTransferred1_c20220501__20230430__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z2qpHLFJ4zb1" title="Fair value of contingent consideration"&gt;418,455&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company estimates the fair value of its intangible assets using Level 3 assumptions, primarily based on the income approach utilizing
the discounted cash flow method.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s derivative liabilities were calculated using Level 2 assumptions on the issuance and balance sheet dates via a Black-Scholes
option pricing model and consisted of the following ending balances and gain amounts as of and for the three months ended July 31, 2023:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89F_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_zv0dvk3LFGO3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8BB_zkFsh03XdvSa" style="display: none"&gt;SCHEDULE OF DERIVATIVE LIABILITIES&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Note derivative is related to&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;July 31, 2023&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;ending balance&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;(Gain) loss for the&lt;/p&gt;
                                                                                                    &lt;p style="margin-top: 0; margin-bottom: 0"&gt;three months ended&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;July 31, 2023&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;4/11/21 profit guaranty&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--ProfitGuarantyMember_zDJadryzbuC2" style="width: 14%; text-align: right" title="Note derivative balance"&gt;1,456,854&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20230501__20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--ProfitGuarantyMember_zHh9mPuqcsS7" style="width: 14%; text-align: right" title="Note derivative (gain) loss"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0787"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;8/6/21 convertible notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--ConvertibleNotesMember_zcQdpsaz83l1" style="text-align: right" title="Note derivative balance"&gt;74,958&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20230501__20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--ConvertibleNotesMember_zJ1AURkaGhUa" style="text-align: right" title="Note derivative (gain) loss"&gt;(26,966&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;6/17/22 underwriter warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--UnderwriterWarrantsMember_z67ge1gtPjuh" style="text-align: right" title="Underwriter warrants"&gt;4,966&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20230501__20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--UnderwriterWarrantsMember_zPpqveywdCy" style="text-align: right" title="Note derivative (gain) loss"&gt;(1,565&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;9/30/22 warrants issued with common stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsIssuedWithCommonStockMember_zxe6iTEE7M98" style="text-align: right" title="Other derivative liabilities eliminated in uplist"&gt;4,668,608&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20230501__20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsIssuedWithCommonStockMember_zzgik92kwAIf" style="text-align: right" title="Note derivative (gain) loss"&gt;(1,440,951&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;1/6/2023 warrants issued with note payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsIssuedWithNotesPayableMember_zCWepP1a6mqg" style="border-bottom: Black 1.5pt solid; text-align: right" title="Other derivative liabilities eliminated in uplist"&gt;2,139,666&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20230501__20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsIssuedWithNotesPayableMember_zunZlzLuQT98" style="border-bottom: Black 1.5pt solid; text-align: right" title="Note derivative (gain) loss"&gt;(675,072&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold"&gt;Total&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230731_zLRaRIC2AP9a" style="border-bottom: Black 2.5pt double; text-align: right" title="Note derivative balance"&gt;8,345,052&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20230501__20230731_zyUgb91QhYpb" style="border-bottom: Black 2.5pt double; text-align: right" title="Note derivative (gain) loss"&gt;(2,144,554&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A0_zeamAmoTTs8i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Black-Scholes option pricing model assumptions for the derivative liabilities during the periods ended July 31, 2023 and 2022 consisted
of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_894_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zxJveoNkqJJ3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B1_zmeSKHeg1jZ8" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SCHEDULE
OF DERIVATIVE AND WARRANTS GRANTED VALUATION USING BLACK-SCHOLES PRICING METHOD&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Period Ended&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;July 31, 2023&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Period Ended&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;July 31, 2022&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Expected life in years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_ecustom--DerivativeLiabilitiesMeasurementInputTerm_dtY_c20230501__20230731__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zOM7Nc73Uq2c" title="Derivative liabilities Measurement input, term"&gt;0.7&lt;/span&gt;-&lt;span id="xdx_906_ecustom--DerivativeLiabilitiesMeasurementInputTerm_dtY_c20230501__20230731__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zRXshLS2zzR2" title="Derivative liabilities Measurement input, term"&gt;10&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_904_ecustom--DerivativeLiabilitiesMeasurementInputTerm_dtY_c20220501__20220731__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_z0nVauo9IEb6" title="Derivative liabilities measurement input"&gt;4&lt;/span&gt;-&lt;span id="xdx_90D_ecustom--DerivativeLiabilitiesMeasurementInputTerm_dtY_c20220501__20220731__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zqEOo8AIaq2c" title="Derivative liabilities measurement input"&gt;4.3&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 64%"&gt;Stock price volatility&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230731__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zeMg7ysdKVnf" title="Derivative liability measurement input"&gt;150&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;
    &lt;td style="width: 2%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220731__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__srt--RangeAxis__srt--MinimumMember_zUAxzfGuc3k8" title="Derivative liability measurement input"&gt;50&lt;/span&gt;-&lt;span id="xdx_903_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220731__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__srt--RangeAxis__srt--MaximumMember_z9VBkbRCPujc" title="Derivative liability measurement input"&gt;148&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Risk free interest rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230731__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zYWf0ns4haFi" title="Derivative liability measurement input"&gt;4.08&lt;/span&gt;%-&lt;span id="xdx_90F_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230731__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zJhudoQoifl" title="Derivative liability measurement input"&gt;5.37&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220731__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_za4ttfqB5Tdj" title="Derivative liability measurement input"&gt;2.90&lt;/span&gt;%-&lt;span id="xdx_90A_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220731__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zGntoDYd2FDl" title="Derivative liability measurement input"&gt;3.27&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Expected dividends&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230731__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zD8ftCahm3Xa" title="Derivative liability measurement input"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220731__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_z2f9hunjDTE8" title="Derivative liability measurement input"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;
    &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AC_zQYg66YFzXs6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_eus-gaap--IncomeTaxPolicyTextBlock_zppSzQX0t9Vg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_863_zaywpz6ou28f"&gt;Income
Taxes&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Income
taxes are accounted for in accordance with the provisions of ASC 740, Accounting for Income Taxes. Deferred tax assets and liabilities
are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing
assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected
to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred
tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Valuation
allowances are established, when necessary, to reduce deferred tax assets to the amounts that are more likely than not to be realized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zesjwOfLxi9d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86A_zD5DR2xEc4E2"&gt;Intangible
Assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intangible
assets relate to the &#x201c;Slinger&#x201d; technology trademark, which the Company purchased on November 10, 2020. The Company also acquired
intangible assets as a part of the Gameface acquisition. These intangible assets include tradenames, internally developed software, and
customer relationships. The acquired intangible assets are amortized based on the estimated present value of cash flows of each class
of intangible assets in order to determine their economic useful life. During the three months ended July 31, 2023, the Company impaired
their intangible assets down to a nominal value of $&lt;span id="xdx_900_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20230731_zzrz3YtscFX9" title="Impaired intangible assets"&gt;1,000&lt;/span&gt; as the technology has changed and Management determined the value to be greater
than the fair value of those assets. Refer to Note 5 for more information.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_847_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zxm3S6rGta88" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_866_z6N84RRVYQK1"&gt;Impairment
of Long-Lived Assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
accordance with ASC 360-10, the Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate
that their net book value may not be recoverable. Factors which could trigger impairment review include significant underperformance
relative to historical or projected future operating results, significant changes in the manner of use of the assets or the strategy
for the overall business, a significant decrease in the market value of the assets or significant negative industry or economic trends.
When such factors and circumstances exist, the Company compares the projected undiscounted future cash flows associated with the related
asset or group of assets over their estimated useful lives against their respective carrying amount. If those net undiscounted cash flows
do not exceed the carrying amount, impairment, if any, is based on the excess of the carrying amount over the fair value based on the
market value or discounted expected cash flows of those assets and is recorded in the period in which the determination is made. The
Company impaired $&lt;span id="xdx_905_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_c20230501__20230731_zfr6CP7eOfEf" title="Impairment of intangible assets"&gt;100,281&lt;/span&gt; in intangible assets and $&lt;span id="xdx_901_eus-gaap--AssetImpairmentCharges_c20230501__20230731_z5FvrWnHNQ4i" title="Impairment of fixed assets"&gt;14,791&lt;/span&gt; in fixed assets during the three months ended July 31, 2023. Refer to Note
5 for more information.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_843_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_zeF6mMKwyE08" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_863_zUOK4TBL5uS5"&gt;Goodwill&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for goodwill in accordance with ASC 350, Intangibles &#x2013; Goodwill and Other (&#x201c;ASC 350&#x201d;). ASC 350 requires
that goodwill not be amortized, but reviewed for impairment if impairment indicators arise and, at a minimum, annually. The Company records
goodwill as the excess purchase price over assets acquired and includes any work force acquired as goodwill. Goodwill is evaluated for
impairment on an annual basis.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;With
the adoption of the ASU 2017-04, which eliminates the second step of the goodwill impairment test, the Company tests impairment of goodwill
in one step. In this step, the Company compares the fair value of each reporting unit with goodwill to its carrying value. The Company
determines the fair value of its reporting units with goodwill using a combination of a discounted cash flow and a market value approach.
If the carrying value of the net assets assigned to the reporting unit exceeds the fair value of the reporting unit, the Company will
record an impairment charge based on the excess of a reporting unit&#x2019;s carrying amount over its fair value. If the fair value of
the reporting unit exceeds the carrying value of the net assets assigned to that reporting unit, goodwill is not impaired and the Company
will not record an impairment charge.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company impaired all goodwill as of April 30, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_843_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zrn4WeDCwaa8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86A_zXggy9lV9VBf"&gt;Share-Based
Payment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for share-based compensation in accordance with ASC 718, Compensation-Stock Compensation (ASC 718). Under the fair value
recognition provisions of this topic, stock-based compensation cost is measured at the grant date based on the fair value of the award
and is recognized as an expense on a straight-line basis over the requisite service period, which is the vesting period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_846_ecustom--WarrantsPolicyTextBlock_zQgLZsdCZl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_861_zAmNMHbm5Z9f"&gt;Warrants&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company grants warrants to key employees and executives as compensation on a discretionary basis. The Company also grants warrants in
connection with certain note payable agreements and other key arrangements. The Company is required to estimate the fair value of share-based
awards on the measurement date and recognize as expense that value of the portion of the award that is ultimately expected to vest over
the requisite service period. Warrants granted in connection with ongoing arrangements are more fully described in Note 11.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
warrants granted during the periods ended July 31, 2023 and 2022 were valued using a Black-Scholes option pricing model on the date of
grant using the following assumptions:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_hus-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_zwUBj2Ktlrbc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B7_zevv4dX2q55a" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SCHEDULE
OF WARRANTS GRANTED VALUATION USING BLACK-SCHOLES PRICING METHOD&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Period Ended&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;July 31, 2023&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Period Ended&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;July 31, 2022&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Expected life in years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&#160;&lt;span id="xdx_90A_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dxL_c20230731__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_z3Rj0J3GgEx8" title="Warrants measurement input, term::XDX::P0Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0857"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220731__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MinimumMember_z6lktadzpOMc" title="Warrants measurement input, term"&gt;5&lt;/span&gt; &#x2013; &lt;span id="xdx_90F_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220731__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MaximumMember_zv1e5yHUtgVg" title="Warrants measurement input, term"&gt;10&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Stock price volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230731__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_zrSfyLGPFr61" title="Warrants measurement input, rate"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0863"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220731__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_z5u1bPOjwnR7" title="Warrants measurement input, rate"&gt;50&lt;/span&gt;% - &lt;span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220731__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_z96TgwhrYCQl" title="Warrants measurement input, rate"&gt;148&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Risk free interest rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230731__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zRAoz5ytefj6" title="Warrants measurement input, rate"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0869"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220731__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember_zNyzrC9VnPcf" title="Warrants measurement input, rate"&gt;2.50&lt;/span&gt;% - &lt;span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220731__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember_zJu0UEQstGkg" title="Warrants measurement input, rate"&gt;3.50&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Expected dividends&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230731__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zIeSl2LJtWth" title="Warrants measurement input, rate"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0875"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220731__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zrjwzYtj2Wk1" title="Warrants measurement input, rate"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AA_z1yeXYmEtQW8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_842_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zdQ42ttIlWX2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Foreign
Currency Translation&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Our
functional currency is the U.S. dollar. The functional currency of our foreign operations, generally, is the respective local currency
for each foreign subsidiary. Assets and liabilities of foreign operations denominated in local currencies are translated at the spot
rate in effect at the applicable reporting date. Our consolidated statements of comprehensive loss are translated at the weighted average
rate of exchange during the applicable period. The resulting unrealized cumulative translation adjustment is recorded as a component
of accumulated other comprehensive loss in shareholders&#x2019; equity. Realized and unrealized transaction gains and losses generated
by transactions denominated in a currency different from the functional currency of the applicable entity are recorded in other income
(loss) in the period in which they occur.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--EarningsPerSharePolicyTextBlock_za4e88dFSBw" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_867_z8WUWUMhtAEk"&gt;Earnings
Per Share&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic
earnings per share are calculated by dividing the income available to shareholders by the weighted-average number of common shares
outstanding during each period. Diluted earnings per share are computed using the weighted average number of common and dilutive common
share equivalents outstanding during the period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;All
common stock equivalents such as shares to be issued for the conversion of notes payable and warrants were excluded from the calculation
of diluted earnings per share as the effect is antidilutive. As a result, the basic and diluted earnings per share are the same for each
of the periods presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_842_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zJ7cZEIBYy9i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_868_z6X96o6xT916"&gt;Recent
Accounting Pronouncements&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Recently
Adopted&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
January 2017, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued ASU No. 2017-04, Intangibles &#x2013; Goodwill and
Other (Topic 350): Simplifying the Test for Goodwill Impairment (&#x201c;ASU 2017-04&#x201d;), which simplifies how an entity is required
to test goodwill for impairment by eliminating Step 2 from the goodwill impairment test. Under ASU 2017-04, goodwill impairment will
be tested by comparing the fair value of a reporting unit with its carrying amount, and recognizing an impairment charge for the amount
by which the carrying amount exceeds the reporting unit&#x2019;s fair value. The new guidance must be applied on a prospective basis and
is effective for periods beginning after December 15, 2022, with early adoption permitted. The Company adopted ASU 2017-04 effective
May 1, 2021. The adoption of the new standard did not have a material effect on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
December 2019, the FASB issued Accounting Standards Update (&#x201c;ASU&#x201d;), 2019-12, &lt;i&gt;Simplifying the Accounting for Income Taxes&lt;/i&gt;,
which amends ASC 740, &lt;i&gt;Income Taxes&lt;/i&gt; (ASC 740). This update is intended to simplify accounting for income taxes by removing certain
exceptions to the general principles in ASC 740 and amending existing guidance to improve consistent application of ASC 740. This update
is effective for fiscal years beginning after December 15, 2021. The guidance in this update has various elements, some of which are
applied on a prospective basis and others on a retrospective basis with earlier application permitted. The adoption of the new standard
did not have a material effect on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
August 2020, the FASB issued ASU No. 2020-06, Debt &#x2013; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives
and Hedging Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s
Own Equity. ASU 2020-06 will simplify the accounting for convertible instruments by reducing the number of accounting models for convertible
debt instruments and convertible preferred stock. Limiting the accounting models results in fewer embedded conversion features being
separately recognized from the host contract as compared with current GAAP. Convertible instruments that continue to be subject to separation
models are (1) those with embedded conversion features that are not clearly and closely related to the host contract, that meet the definition
of a derivative, and that do not qualify for a scope exception from derivative accounting and (2) convertible debt instruments issued
with substantial premiums for which the premiums are recorded as paid-in capital. ASU 2020-06 also amends the guidance for the derivatives
scope exception for contracts in an entity&#x2019;s own equity to reduce form-over-substance-based accounting conclusions. ASU 2020-06
will be effective for public companies for fiscal years beginning after December 15, 2023, including interim periods within those fiscal
years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within
those fiscal years. The Company is currently evaluating the impact that the adoption of ASU 2020-06 will have on the Company&#x2019;s
consolidated financial statement presentation or disclosures.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
June 2016, the FASB issued ASU 2016-13, Financial Instruments &#x2013; Credit Losses (Topic 326): Measurement of Credit Losses on Financial
Instruments (&#x201c;ASC 326&#x201d;). The guidance replaces the incurred loss methodology with an expected loss methodology that is referred
to as the current expected credit loss (&#x201c;CECL&#x201d;) methodology. The measurement of expected credit losses under the CECL methodology
is applicable to financial assets measured at amortized cost, including loan receivables and held-to-maturity debt securities. It also
applies to off-balance sheet credit exposures not accounted for as insurance (loan commitments, standby letters of credits, financial
guarantees, and other similar instruments) and net investments in leases recognized by a lessor in accordance with Topic 842 on leases.
ASC 326 requires enhanced disclosures related to the significant estimates and judgments used in estimating credit losses as well as
the credit quality and underwriting standards of a company&#x2019;s portfolio. In addition, ASC 326 made changes to the accounting for
available-for-sale debt securities. One such change is to require credit losses to be presented as an allowance rather than as a write-down
on available-for-sale debt securities the Company does not intend to sell or believes that it is more likely than not they will be required
to sell. The ASU can be adopted no later than January 1, 2020 for SEC filers and January 1, 2023 for private companies and smaller reporting
companies. The adoption of the new standard did not have a material effect on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
October 2021, the FASB issued ASU 2021-08, &#x201c;Business Combinations &#x2013; Accounting for Contract Assets and Contract Liabilities
(Topic 805)&#x201d;. The amendments in this Update address diversity and inconsistency related to the recognition and measurement of contract
assets and contract liabilities acquired in a business combination. The amendments in this Update require that an acquirer recognize
and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606, Revenue from Contracts
with Customers. ASU 2021-08 is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal
years. The adoption of the new standard did not have a material effect on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
FASB has issued ASU 2021-04, Earnings Per Share (Topic 260), Debt&#x2014;Modifications and Extinguishments (Subtopic 470-50), Compensation&#x2014;Stock
Compensation (Topic 718), and Derivatives and Hedging&#x2014;Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40). ASU 2021-04 provides
guidance that an entity should treat a modification of the terms or conditions or an exchange of a freestanding equity-classified written
call option that remains equity classified after modification or exchange as an exchange of the original instrument for a new instrument.
The standard also provides guidance on how an entity should measure and recognize the effect of a modification or an exchange of a freestanding
equity-classified written call option that remains equity classified. The amendments in this ASU are effective for the Company for fiscal
years beginning after December 15, 2021. Early adoption is permitted for all entities, including adoption in an interim period. The adoption
of the new standard did not have a material effect on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
recently issued accounting pronouncements did not, or are not believed by management to, have a material effect on the Company&#x2019;s
present or future consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_855_zTHea6aTALfi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SignificantAccountingPoliciesTextBlock>
    <CNXA:InterimFinancialStatementsPolicyTextBlock contextRef="From2023-05-01to2023-07-31">&lt;p id="xdx_84B_ecustom--InterimFinancialStatementsPolicyTextBlock_z3ReT6v36Rv2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_863_zq2qmsTvlyJ8"&gt;Interim
Financial Statements&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying condensed financial statements of the Company have been prepared without audit, pursuant to the rules and regulations of
the Securities and Exchange Commission. Certain information and disclosures required by accounting principles generally accepted in the
United States have been condensed or omitted pursuant to such rules and regulations. These condensed financial statements reflect all
adjustments that, in the opinion of management, are necessary to present fairly the results of operations of the Company for the period
presented. The results of operations for the three months ended July 31, 2023, are not necessarily indicative of the results that may
be expected for any future period or the fiscal year ending April 30, 2024 and should be read in conjunction with the Company&#x2019;s
Annual Report on Form 10-K for the year ended April 30, 2023, filed with the Securities and Exchange Commission on September 14, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</CNXA:InterimFinancialStatementsPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2023-05-01to2023-07-31">&lt;p id="xdx_843_eus-gaap--UseOfEstimates_zIkrIaVahK7d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86C_zzrlLoow2ZNe"&gt;Use
of Estimates&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect
the amounts reported in the financial statements and accompanying notes. Accordingly, actual results could differ from those estimates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:UseOfEstimates>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription contextRef="From2023-05-01to2023-07-31">&lt;p id="xdx_84A_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zr5w94rNkM43" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86F_zbnq689LntWg"&gt;Financial
Statement Reclassification&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Certain
prior year amounts within accounts payable, accrued expenses, and certain operating expenses have been reclassified for consistency with
the current year presentation and had no effect on the Company&#x2019;s balance sheet, net loss, shareholders&#x2019; deficit or cash flows.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2023-05-01to2023-07-31">&lt;p id="xdx_84B_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zhD2tR7itqmd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_861_zSHAEa0JHxjh"&gt;Cash
and Cash Equivalents&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents.
The majority of payments due from banks for credit card transactions process within 24 to 48 hours and are accordingly classified as
cash and cash equivalents.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy contextRef="From2023-05-01to2023-07-31">&lt;p id="xdx_841_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zPN1BOFN4m35" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_863_zPz2KWLalQB8"&gt;Accounts
Receivable&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s accounts receivable are non-interest bearing trade receivables resulting from the sale of products and payable over terms
ranging from 15 to 60 days. The Company provides an allowance for doubtful accounts at the point when collection is considered doubtful.
Once all collection efforts have been exhausted, the Company charges-off the receivable with the allowance for doubtful accounts. The
Company recorded $&lt;span id="xdx_907_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pdp0_do_c20230731_zhmumFZM17wi" title="Allowance for doubtful accounts"&gt;200,000&lt;/span&gt; and $&lt;span id="xdx_90D_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pdp0_do_c20230430_zHacZLXt7vVi" title="Allowance for doubtful accounts"&gt;209,690&lt;/span&gt; in allowance for doubtful accounts as of July 31, 2023 and April 30, 2023, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="AsOf2023-07-31" decimals="0" unitRef="USD">200000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">209690</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:InventoryPolicyTextBlock contextRef="From2023-05-01to2023-07-31">&lt;p id="xdx_840_eus-gaap--InventoryPolicyTextBlock_zRZiyRgkdyL" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_861_zAr5yrHEeHy7"&gt;Inventory&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Inventory
is valued at the lower of the cost (determined principally on a first-in, first-out basis) or net realizable value. The Company&#x2019;s
valuation of inventory includes inventory reserves for inventory that will be sold below cost and the impact of inventory shrink. Inventory
reserves are based on historical information and assumptions about future demand and inventory shrink trends. The Company&#x2019;s inventory
as of July 31, 2023 and April 30, 2023 consisted of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_890_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zf97HVif52hc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B6_zoqiVAt0juPa" style="display: none"&gt;SCHEDULE OF INVENTORY&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20230731_zE6h5LaOen1g" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;July 31, 2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20230430_ziGSNULllzaa" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;April 30, 2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--InventoryFinishedGoods_iI_maINzzOV_zXcYG5jS1aEb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Finished Goods&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;400,598&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;1,509,985&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--InventoryRawMaterialsAndSupplies_iI_maINzzOV_z45YZrOaZ1fb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Component/Replacement Parts&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,064,041&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,712,553&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--CapitalizedDutyAndFreight_iI_maINzzOV_zqWK1brM4sCc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Capitalized Duty/Freight&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;47,279&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;517,228&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--InventoryAdjustments_iNI_di_msINzzOV_ztNimEQags14" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Inventory Reserve&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(175,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(550,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--InventoryNet_iTI_mtINzzOV_zZKqAyFQU6p8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Total&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,336,918&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;3,189,766&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A2_zHURQhQOcA4b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="From2023-05-01to2023-07-31">&lt;p id="xdx_890_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zf97HVif52hc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B6_zoqiVAt0juPa" style="display: none"&gt;SCHEDULE OF INVENTORY&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20230731_zE6h5LaOen1g" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;July 31, 2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20230430_ziGSNULllzaa" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;April 30, 2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--InventoryFinishedGoods_iI_maINzzOV_zXcYG5jS1aEb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Finished Goods&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;400,598&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;1,509,985&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--InventoryRawMaterialsAndSupplies_iI_maINzzOV_z45YZrOaZ1fb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Component/Replacement Parts&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,064,041&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,712,553&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--CapitalizedDutyAndFreight_iI_maINzzOV_zqWK1brM4sCc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Capitalized Duty/Freight&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;47,279&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;517,228&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--InventoryAdjustments_iNI_di_msINzzOV_ztNimEQags14" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Inventory Reserve&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(175,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(550,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--InventoryNet_iTI_mtINzzOV_zZKqAyFQU6p8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Total&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,336,918&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;3,189,766&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryFinishedGoods contextRef="AsOf2023-07-31" decimals="0" unitRef="USD">400598</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">1509985</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryRawMaterialsAndSupplies contextRef="AsOf2023-07-31" decimals="0" unitRef="USD">2064041</us-gaap:InventoryRawMaterialsAndSupplies>
    <us-gaap:InventoryRawMaterialsAndSupplies contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">1712553</us-gaap:InventoryRawMaterialsAndSupplies>
    <CNXA:CapitalizedDutyAndFreight contextRef="AsOf2023-07-31" decimals="0" unitRef="USD">47279</CNXA:CapitalizedDutyAndFreight>
    <CNXA:CapitalizedDutyAndFreight contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">517228</CNXA:CapitalizedDutyAndFreight>
    <us-gaap:InventoryAdjustments contextRef="AsOf2023-07-31" decimals="0" unitRef="USD">175000</us-gaap:InventoryAdjustments>
    <us-gaap:InventoryAdjustments contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">550000</us-gaap:InventoryAdjustments>
    <us-gaap:InventoryNet contextRef="AsOf2023-07-31" decimals="0" unitRef="USD">2336918</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">3189766</us-gaap:InventoryNet>
    <CNXA:PrepaidInventoryPolicyTextBlock contextRef="From2023-05-01to2023-07-31">&lt;p id="xdx_84D_ecustom--PrepaidInventoryPolicyTextBlock_zmMnuOG8vY0f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_864_zDDc8lVOgI7j"&gt;Prepaid
Inventory&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Prepaid
inventory represents inventory that is in-transit that has been paid for but not received from the Company&#x2019;s third-party vendors.
The Company typically prepays for the purchase of materials and receives the products within three months after making payments. The
Company continuously monitors delivery from, and payments to, the vendors. If the Company has difficulty receiving products from a vendor,
the Company would cease purchasing products from such vendors in future periods. The Company has not had difficulty receiving products
during the reporting periods.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</CNXA:PrepaidInventoryPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="From2023-05-01to2023-07-31">&lt;p id="xdx_84B_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zRJYPi8gDXoi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86A_zm2FNh7RXyGh"&gt;Property
and equipment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Property
and equipment acquired through business combinations are stated at the estimated fair value at the date of the acquisition. Purchases
of property and equipment are stated at cost, net of accumulated depreciation and impairment losses. Expenditures that materially increase
the useful life of the assets are capitalized. Ordinary repairs and maintenance are expensed as incurred. Depreciation and amortization
are computed using the straight-line method over the estimated useful lives of the related assets, which is an average of &lt;span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230731_zi4ZPPFFOzyh" title="Property plant and equipment, useful life"&gt;5&lt;/span&gt; years.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="AsOf2023-07-31">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="From2023-05-01to2023-07-31">&lt;p id="xdx_840_eus-gaap--ConcentrationRiskCreditRisk_zcbmzjBRP1f3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_866_zuHXeODpB3a4"&gt;Concentration
of Credit Risk&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company maintains its cash in bank deposit accounts, the balances of which at times may exceed insured limits. The Company continually
monitors its banking relationships and consequently has not experienced any losses in such accounts. While we may be exposed to credit
risk, we consider the risk remote and do not expect that any such risk would result in a significant effect on our results of operations
or financial condition. See Note 4 for further details on the Company&#x2019;s concentration of credit risk as well as other risks and
uncertainties.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="From2023-05-01to2023-07-31">&lt;p id="xdx_84E_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zy1IUkRinSj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_867_zw8cnRxFDc0e"&gt;Revenue
Recognition&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes revenue for their continuing operations in accordance with Accounting Standards Codification (&#x201c;ASC&#x201d;) 606,
the core principle of which is that an entity should recognize revenue to depict the transfer of promised goods or services to customers
in an amount that reflects the consideration to which the entity expects to be entitled to receive in exchange for those goods or services.
The Company recognizes revenue for its performance obligation associated with its contracts with customers at a point in time once products
are shipped. Amounts collected from customers in advance of shipping products ordered are reflected as contract liabilities on the accompanying
consolidated balance sheets. The Company&#x2019;s standard terms are non-cancelable and do not provide for the right-of-return, other
than for defective merchandise covered under the Company&#x2019;s standard warranty. The Company has not historically experienced any
significant returns or warranty issues.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes revenue under ASC 606, &#x201c;Revenue from Contracts with Customers&#x201d;. The core principle of this revenue standard
is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects
the consideration to which the company expects to be entitled in exchange for those goods or services. The following five steps are applied
to achieve that core principle:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Step
1: Identify the contract with the customer&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company determines that it has a contract with a customer when each party&#x2019;s rights regarding the products or services to be transferred
can be identified, the payment terms for the services can be identified, the Company has determined the customer has the ability and
intent to pay, and the contract has commercial substance. At contract inception, the Company evaluates whether two or more contracts
should be combined and accounted for as a single contract and whether the combined or single contract includes more than one performance
obligation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Step
2: Identify the performance obligations in the contract&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s customers are buying an integrated system. In evaluating whether the equipment is a separate performance obligation,
the Company&#x2019;s management considered the customer&#x2019;s ability to benefit from the equipment on its own or together with other
readily available resources and if so, whether the service and equipment are separately identifiable (i.e., is the service highly dependent
on, or highly interrelated with the equipment). Because the Products and Services included in the customer&#x2019;s contract are integrated
and highly interdependent, and because they must work together to deliver the Solution, the Company has concluded that Products installed
on customer&#x2019;s premise and Services contracted for by the customer are generally not distinct within the context of the contract
and, therefore, constitute a single, combined performance obligation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Step
3: Determine the transaction price&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
transaction price is the amount of consideration to which an entity expects to be entitled in exchange for transferring promised goods
or services to a customer. The consideration promised in a contract with a customer includes predetermined fixed amounts, variable amounts,
or both. The Company&#x2019;s contracts do not include any rights of returns or refunds.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company collects each year&#x2019;s service fees in advance and should therefore consider the existence of a significant financing component.
However, due to the fact that the payments are provided for the service of a one-year term, the Company elected to apply the practical
expedient under ASC 606 which exempts the adjustment of the consideration for the existence of a significant financing component when
the period between the transfer of the services and the payment for such services is one year or less.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Step
4: Allocate the transaction price to the performance obligations in the contract&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Contracts
that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on
each performance obligation&#x2019;s relative standalone selling price (&#x201c;SSP&#x201d;). The Company has identified a single performance
obligation in the contract, and therefore, the allocation provisions under ASC 606 do not apply to the Company&#x2019;s contracts.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Step
5: Recognize revenue when the Company satisfies a performance obligation&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Revenues
for the Company&#x2019;s single, combined performance obligation are recognized on a straight-line basis over the customer&#x2019;s contract
term, which is the period in which the parties to the contract have enforceable rights and obligations (Typically 3-4 years).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:BusinessCombinationsPolicy contextRef="From2023-05-01to2023-07-31">&lt;p id="xdx_84E_eus-gaap--BusinessCombinationsPolicy_zMxLHHnW5pb1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_868_zraUzDeO6OYj"&gt;Business
Combinations&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Upon
acquisition of a company, we determine if the transaction is a business combination, which is accounted for using the acquisition method
of accounting. Under the acquisition method, once control is obtained of a business, the assets acquired, and liabilities assumed, are
recorded at fair value. We use our best estimates and assumptions to assign fair value to the tangible and intangible assets acquired
and liabilities assumed at the acquisition date. One of the most significant estimates relates to the determination of the fair value
of these assets and liabilities. The determination of the fair values is based on estimates and judgments made by management. Our estimates
of fair value are based upon assumptions we believe to be reasonable, but which are inherently uncertain and unpredictable. Measurement
period adjustments are reflected at the time identified, up through the conclusion of the measurement period, which is the time at which
all information for determination of the values of assets acquired and liabilities assumed is received and is not to exceed one year
from the acquisition date. We may record adjustments to the fair value of these tangible and intangible assets acquired and liabilities
assumed, with the corresponding offset to goodwill. The Company elected to apply pushdown accounting to all entities acquired.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Additionally,
uncertain tax positions and tax-related valuation allowances are initially recorded in connection with a business combination as of the
acquisition date. We continue to collect information and reevaluate these estimates and assumptions periodically and record any adjustments
to preliminary estimates to goodwill, provided we are within the measurement period. If outside of the measurement period, any subsequent
adjustments are recorded to the consolidated statement of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BusinessCombinationsPolicy>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2023-05-01to2023-07-31">&lt;p id="xdx_845_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zWhCbAGBHus2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86E_zaoTLTt5EeV3"&gt;Fair
Value of Financial Instruments&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
value of financial and non-financial assets and liabilities is defined as an exit price, representing the amount that would be received
to sell an asset or paid to transfer a liability in an orderly transaction between market participants. The three-tier hierarchy for
inputs used in measuring fair value, which prioritizes the inputs used in the methodologies of measuring fair value for assets and liabilities,
is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
1 &#x2014; Quoted prices in active markets for identical assets or liabilities&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
2 &#x2014; Observable inputs other than quoted prices in active markets for identical assets and liabilities&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
3 &#x2014; Unobservable pricing inputs in the market&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
assets and financial liabilities are classified in their entirety based on the lowest level of input that is significant to the fair
value measurements. Our assessment of the significance of a particular input to the fair value measurements requires judgment and may
affect the valuation of the assets and liabilities being measured and their categorization within the fair value hierarchy.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s financial instruments consist of cash and cash equivalents, accounts receivable, and accounts payable. The carrying amount
of these financial instruments approximates fair value due to their short-term maturity.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s contingent consideration in connection with the acquisition of Gameface was calculated using Level 3 inputs. The fair
value of contingent consideration as of July 31, 2023 and April 30, 2023 was $&lt;span id="xdx_90D_eus-gaap--BusinessCombinationConsiderationTransferred1_c20230501__20230731__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zAYKla0QEGTb" title="Fair value of contingent consideration"&gt;418,455&lt;/span&gt; and $&lt;span id="xdx_908_eus-gaap--BusinessCombinationConsiderationTransferred1_c20220501__20230430__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z2qpHLFJ4zb1" title="Fair value of contingent consideration"&gt;418,455&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company estimates the fair value of its intangible assets using Level 3 assumptions, primarily based on the income approach utilizing
the discounted cash flow method.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s derivative liabilities were calculated using Level 2 assumptions on the issuance and balance sheet dates via a Black-Scholes
option pricing model and consisted of the following ending balances and gain amounts as of and for the three months ended July 31, 2023:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89F_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_zv0dvk3LFGO3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8BB_zkFsh03XdvSa" style="display: none"&gt;SCHEDULE OF DERIVATIVE LIABILITIES&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Note derivative is related to&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;July 31, 2023&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;ending balance&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;(Gain) loss for the&lt;/p&gt;
                                                                                                    &lt;p style="margin-top: 0; margin-bottom: 0"&gt;three months ended&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;July 31, 2023&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;4/11/21 profit guaranty&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--ProfitGuarantyMember_zDJadryzbuC2" style="width: 14%; text-align: right" title="Note derivative balance"&gt;1,456,854&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20230501__20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--ProfitGuarantyMember_zHh9mPuqcsS7" style="width: 14%; text-align: right" title="Note derivative (gain) loss"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0787"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;8/6/21 convertible notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--ConvertibleNotesMember_zcQdpsaz83l1" style="text-align: right" title="Note derivative balance"&gt;74,958&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20230501__20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--ConvertibleNotesMember_zJ1AURkaGhUa" style="text-align: right" title="Note derivative (gain) loss"&gt;(26,966&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;6/17/22 underwriter warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--UnderwriterWarrantsMember_z67ge1gtPjuh" style="text-align: right" title="Underwriter warrants"&gt;4,966&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20230501__20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--UnderwriterWarrantsMember_zPpqveywdCy" style="text-align: right" title="Note derivative (gain) loss"&gt;(1,565&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;9/30/22 warrants issued with common stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsIssuedWithCommonStockMember_zxe6iTEE7M98" style="text-align: right" title="Other derivative liabilities eliminated in uplist"&gt;4,668,608&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20230501__20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsIssuedWithCommonStockMember_zzgik92kwAIf" style="text-align: right" title="Note derivative (gain) loss"&gt;(1,440,951&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;1/6/2023 warrants issued with note payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsIssuedWithNotesPayableMember_zCWepP1a6mqg" style="border-bottom: Black 1.5pt solid; text-align: right" title="Other derivative liabilities eliminated in uplist"&gt;2,139,666&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20230501__20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsIssuedWithNotesPayableMember_zunZlzLuQT98" style="border-bottom: Black 1.5pt solid; text-align: right" title="Note derivative (gain) loss"&gt;(675,072&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold"&gt;Total&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230731_zLRaRIC2AP9a" style="border-bottom: Black 2.5pt double; text-align: right" title="Note derivative balance"&gt;8,345,052&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20230501__20230731_zyUgb91QhYpb" style="border-bottom: Black 2.5pt double; text-align: right" title="Note derivative (gain) loss"&gt;(2,144,554&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A0_zeamAmoTTs8i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Black-Scholes option pricing model assumptions for the derivative liabilities during the periods ended July 31, 2023 and 2022 consisted
of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_894_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zxJveoNkqJJ3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B1_zmeSKHeg1jZ8" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SCHEDULE
OF DERIVATIVE AND WARRANTS GRANTED VALUATION USING BLACK-SCHOLES PRICING METHOD&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Period Ended&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;July 31, 2023&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Period Ended&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;July 31, 2022&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Expected life in years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_ecustom--DerivativeLiabilitiesMeasurementInputTerm_dtY_c20230501__20230731__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zOM7Nc73Uq2c" title="Derivative liabilities Measurement input, term"&gt;0.7&lt;/span&gt;-&lt;span id="xdx_906_ecustom--DerivativeLiabilitiesMeasurementInputTerm_dtY_c20230501__20230731__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zRXshLS2zzR2" title="Derivative liabilities Measurement input, term"&gt;10&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_904_ecustom--DerivativeLiabilitiesMeasurementInputTerm_dtY_c20220501__20220731__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_z0nVauo9IEb6" title="Derivative liabilities measurement input"&gt;4&lt;/span&gt;-&lt;span id="xdx_90D_ecustom--DerivativeLiabilitiesMeasurementInputTerm_dtY_c20220501__20220731__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zqEOo8AIaq2c" title="Derivative liabilities measurement input"&gt;4.3&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 64%"&gt;Stock price volatility&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230731__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zeMg7ysdKVnf" title="Derivative liability measurement input"&gt;150&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;
    &lt;td style="width: 2%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220731__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__srt--RangeAxis__srt--MinimumMember_zUAxzfGuc3k8" title="Derivative liability measurement input"&gt;50&lt;/span&gt;-&lt;span id="xdx_903_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220731__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__srt--RangeAxis__srt--MaximumMember_z9VBkbRCPujc" title="Derivative liability measurement input"&gt;148&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Risk free interest rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230731__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zYWf0ns4haFi" title="Derivative liability measurement input"&gt;4.08&lt;/span&gt;%-&lt;span id="xdx_90F_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230731__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zJhudoQoifl" title="Derivative liability measurement input"&gt;5.37&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220731__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_za4ttfqB5Tdj" title="Derivative liability measurement input"&gt;2.90&lt;/span&gt;%-&lt;span id="xdx_90A_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220731__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zGntoDYd2FDl" title="Derivative liability measurement input"&gt;3.27&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Expected dividends&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230731__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zD8ftCahm3Xa" title="Derivative liability measurement input"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220731__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_z2f9hunjDTE8" title="Derivative liability measurement input"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;
    &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AC_zQYg66YFzXs6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="From2023-05-012023-07-31_us-gaap_FairValueInputsLevel3Member"
      decimals="0"
      unitRef="USD">418455</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="From2022-05-012023-04-30_us-gaap_FairValueInputsLevel3Member"
      decimals="0"
      unitRef="USD">418455</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock contextRef="From2023-05-01to2023-07-31">&lt;p id="xdx_89F_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_zv0dvk3LFGO3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8BB_zkFsh03XdvSa" style="display: none"&gt;SCHEDULE OF DERIVATIVE LIABILITIES&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Note derivative is related to&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;July 31, 2023&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;ending balance&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;(Gain) loss for the&lt;/p&gt;
                                                                                                    &lt;p style="margin-top: 0; margin-bottom: 0"&gt;three months ended&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;July 31, 2023&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;4/11/21 profit guaranty&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--ProfitGuarantyMember_zDJadryzbuC2" style="width: 14%; text-align: right" title="Note derivative balance"&gt;1,456,854&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20230501__20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--ProfitGuarantyMember_zHh9mPuqcsS7" style="width: 14%; text-align: right" title="Note derivative (gain) loss"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0787"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;8/6/21 convertible notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--ConvertibleNotesMember_zcQdpsaz83l1" style="text-align: right" title="Note derivative balance"&gt;74,958&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20230501__20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--ConvertibleNotesMember_zJ1AURkaGhUa" style="text-align: right" title="Note derivative (gain) loss"&gt;(26,966&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;6/17/22 underwriter warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--UnderwriterWarrantsMember_z67ge1gtPjuh" style="text-align: right" title="Underwriter warrants"&gt;4,966&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20230501__20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--UnderwriterWarrantsMember_zPpqveywdCy" style="text-align: right" title="Note derivative (gain) loss"&gt;(1,565&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;9/30/22 warrants issued with common stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsIssuedWithCommonStockMember_zxe6iTEE7M98" style="text-align: right" title="Other derivative liabilities eliminated in uplist"&gt;4,668,608&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20230501__20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsIssuedWithCommonStockMember_zzgik92kwAIf" style="text-align: right" title="Note derivative (gain) loss"&gt;(1,440,951&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;1/6/2023 warrants issued with note payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsIssuedWithNotesPayableMember_zCWepP1a6mqg" style="border-bottom: Black 1.5pt solid; text-align: right" title="Other derivative liabilities eliminated in uplist"&gt;2,139,666&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20230501__20230731__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsIssuedWithNotesPayableMember_zunZlzLuQT98" style="border-bottom: Black 1.5pt solid; text-align: right" title="Note derivative (gain) loss"&gt;(675,072&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold"&gt;Total&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230731_zLRaRIC2AP9a" style="border-bottom: Black 2.5pt double; text-align: right" title="Note derivative balance"&gt;8,345,052&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20230501__20230731_zyUgb91QhYpb" style="border-bottom: Black 2.5pt double; text-align: right" title="Note derivative (gain) loss"&gt;(2,144,554&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock>
    <us-gaap:DerivativeInstrumentsAndHedgesLiabilities
      contextRef="AsOf2023-07-31_custom_ProfitGuarantyMember"
      decimals="0"
      unitRef="USD">1456854</us-gaap:DerivativeInstrumentsAndHedgesLiabilities>
    <us-gaap:DerivativeInstrumentsAndHedgesLiabilities
      contextRef="AsOf2023-07-31_custom_ConvertibleNotesMember"
      decimals="0"
      unitRef="USD">74958</us-gaap:DerivativeInstrumentsAndHedgesLiabilities>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="From2023-05-012023-07-31_custom_ConvertibleNotesMember"
      decimals="0"
      unitRef="USD">26966</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeInstrumentsAndHedgesLiabilities
      contextRef="AsOf2023-07-31_custom_UnderwriterWarrantsMember"
      decimals="0"
      unitRef="USD">4966</us-gaap:DerivativeInstrumentsAndHedgesLiabilities>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="From2023-05-012023-07-31_custom_UnderwriterWarrantsMember"
      decimals="0"
      unitRef="USD">1565</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeInstrumentsAndHedgesLiabilities
      contextRef="AsOf2023-07-31_custom_WarrantsIssuedWithCommonStockMember"
      decimals="0"
      unitRef="USD">4668608</us-gaap:DerivativeInstrumentsAndHedgesLiabilities>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="From2023-05-012023-07-31_custom_WarrantsIssuedWithCommonStockMember"
      decimals="0"
      unitRef="USD">1440951</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeInstrumentsAndHedgesLiabilities
      contextRef="AsOf2023-07-31_custom_WarrantsIssuedWithNotesPayableMember"
      decimals="0"
      unitRef="USD">2139666</us-gaap:DerivativeInstrumentsAndHedgesLiabilities>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="From2023-05-012023-07-31_custom_WarrantsIssuedWithNotesPayableMember"
      decimals="0"
      unitRef="USD">675072</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeInstrumentsAndHedgesLiabilities contextRef="AsOf2023-07-31" decimals="0" unitRef="USD">8345052</us-gaap:DerivativeInstrumentsAndHedgesLiabilities>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="From2023-05-01to2023-07-31"
      decimals="0"
      unitRef="USD">2144554</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock contextRef="From2023-05-01to2023-07-31">&lt;p id="xdx_894_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zxJveoNkqJJ3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B1_zmeSKHeg1jZ8" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SCHEDULE
OF DERIVATIVE AND WARRANTS GRANTED VALUATION USING BLACK-SCHOLES PRICING METHOD&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Period Ended&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;July 31, 2023&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Period Ended&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;July 31, 2022&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Expected life in years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_ecustom--DerivativeLiabilitiesMeasurementInputTerm_dtY_c20230501__20230731__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zOM7Nc73Uq2c" title="Derivative liabilities Measurement input, term"&gt;0.7&lt;/span&gt;-&lt;span id="xdx_906_ecustom--DerivativeLiabilitiesMeasurementInputTerm_dtY_c20230501__20230731__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zRXshLS2zzR2" title="Derivative liabilities Measurement input, term"&gt;10&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_904_ecustom--DerivativeLiabilitiesMeasurementInputTerm_dtY_c20220501__20220731__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_z0nVauo9IEb6" title="Derivative liabilities measurement input"&gt;4&lt;/span&gt;-&lt;span id="xdx_90D_ecustom--DerivativeLiabilitiesMeasurementInputTerm_dtY_c20220501__20220731__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zqEOo8AIaq2c" title="Derivative liabilities measurement input"&gt;4.3&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 64%"&gt;Stock price volatility&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230731__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zeMg7ysdKVnf" title="Derivative liability measurement input"&gt;150&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;
    &lt;td style="width: 2%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220731__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__srt--RangeAxis__srt--MinimumMember_zUAxzfGuc3k8" title="Derivative liability measurement input"&gt;50&lt;/span&gt;-&lt;span id="xdx_903_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220731__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__srt--RangeAxis__srt--MaximumMember_z9VBkbRCPujc" title="Derivative liability measurement input"&gt;148&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Risk free interest rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230731__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zYWf0ns4haFi" title="Derivative liability measurement input"&gt;4.08&lt;/span&gt;%-&lt;span id="xdx_90F_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230731__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zJhudoQoifl" title="Derivative liability measurement input"&gt;5.37&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220731__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_za4ttfqB5Tdj" title="Derivative liability measurement input"&gt;2.90&lt;/span&gt;%-&lt;span id="xdx_90A_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220731__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zGntoDYd2FDl" title="Derivative liability measurement input"&gt;3.27&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Expected dividends&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230731__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zD8ftCahm3Xa" title="Derivative liability measurement input"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220731__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_z2f9hunjDTE8" title="Derivative liability measurement input"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;
    &lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <CNXA:DerivativeLiabilitiesMeasurementInputTerm contextRef="From2023-05-012023-07-31_srt_MinimumMember_us-gaap_MeasurementInputExpectedTermMember_us-gaap_ValuationTechniqueOptionPricingModelMember">P0Y8M12D</CNXA:DerivativeLiabilitiesMeasurementInputTerm>
    <CNXA:DerivativeLiabilitiesMeasurementInputTerm contextRef="From2023-05-012023-07-31_srt_MaximumMember_us-gaap_MeasurementInputExpectedTermMember_us-gaap_ValuationTechniqueOptionPricingModelMember">P10Y</CNXA:DerivativeLiabilitiesMeasurementInputTerm>
    <CNXA:DerivativeLiabilitiesMeasurementInputTerm contextRef="From2022-05-012022-07-31_srt_MinimumMember_us-gaap_MeasurementInputExpectedTermMember_us-gaap_ValuationTechniqueOptionPricingModelMember">P4Y</CNXA:DerivativeLiabilitiesMeasurementInputTerm>
    <CNXA:DerivativeLiabilitiesMeasurementInputTerm contextRef="From2022-05-012022-07-31_srt_MaximumMember_us-gaap_MeasurementInputExpectedTermMember_us-gaap_ValuationTechniqueOptionPricingModelMember">P4Y3M18D</CNXA:DerivativeLiabilitiesMeasurementInputTerm>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="AsOf2023-07-31_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ValuationTechniqueOptionPricingModelMember"
      decimals="INF"
      unitRef="Pure">150</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="AsOf2022-07-31_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ValuationTechniqueOptionPricingModelMember_srt_MinimumMember"
      decimals="INF"
      unitRef="Pure">50</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="AsOf2022-07-31_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ValuationTechniqueOptionPricingModelMember_srt_MaximumMember"
      decimals="INF"
      unitRef="Pure">148</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="AsOf2023-07-31_srt_MinimumMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_us-gaap_ValuationTechniqueOptionPricingModelMember"
      decimals="INF"
      unitRef="Pure">4.08</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="AsOf2023-07-31_srt_MaximumMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_us-gaap_ValuationTechniqueOptionPricingModelMember"
      decimals="INF"
      unitRef="Pure">5.37</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="AsOf2022-07-31_srt_MinimumMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_us-gaap_ValuationTechniqueOptionPricingModelMember"
      decimals="INF"
      unitRef="Pure">2.90</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="AsOf2022-07-31_srt_MaximumMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_us-gaap_ValuationTechniqueOptionPricingModelMember"
      decimals="INF"
      unitRef="Pure">3.27</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="AsOf2023-07-31_us-gaap_MeasurementInputExpectedDividendRateMember_us-gaap_ValuationTechniqueOptionPricingModelMember"
      decimals="INF"
      unitRef="Pure">0</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="AsOf2022-07-31_us-gaap_MeasurementInputExpectedDividendRateMember_us-gaap_ValuationTechniqueOptionPricingModelMember"
      decimals="INF"
      unitRef="Pure">0</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2023-05-01to2023-07-31">&lt;p id="xdx_844_eus-gaap--IncomeTaxPolicyTextBlock_zppSzQX0t9Vg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_863_zaywpz6ou28f"&gt;Income
Taxes&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Income
taxes are accounted for in accordance with the provisions of ASC 740, Accounting for Income Taxes. Deferred tax assets and liabilities
are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing
assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected
to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred
tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Valuation
allowances are established, when necessary, to reduce deferred tax assets to the amounts that are more likely than not to be realized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:IntangibleAssetsFiniteLivedPolicy contextRef="From2023-05-01to2023-07-31">&lt;p id="xdx_84E_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zesjwOfLxi9d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86A_zD5DR2xEc4E2"&gt;Intangible
Assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intangible
assets relate to the &#x201c;Slinger&#x201d; technology trademark, which the Company purchased on November 10, 2020. The Company also acquired
intangible assets as a part of the Gameface acquisition. These intangible assets include tradenames, internally developed software, and
customer relationships. The acquired intangible assets are amortized based on the estimated present value of cash flows of each class
of intangible assets in order to determine their economic useful life. During the three months ended July 31, 2023, the Company impaired
their intangible assets down to a nominal value of $&lt;span id="xdx_900_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20230731_zzrz3YtscFX9" title="Impaired intangible assets"&gt;1,000&lt;/span&gt; as the technology has changed and Management determined the value to be greater
than the fair value of those assets. Refer to Note 5 for more information.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IntangibleAssetsFiniteLivedPolicy>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2023-07-31" decimals="0" unitRef="USD">1000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="From2023-05-01to2023-07-31">&lt;p id="xdx_847_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zxm3S6rGta88" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_866_z6N84RRVYQK1"&gt;Impairment
of Long-Lived Assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
accordance with ASC 360-10, the Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate
that their net book value may not be recoverable. Factors which could trigger impairment review include significant underperformance
relative to historical or projected future operating results, significant changes in the manner of use of the assets or the strategy
for the overall business, a significant decrease in the market value of the assets or significant negative industry or economic trends.
When such factors and circumstances exist, the Company compares the projected undiscounted future cash flows associated with the related
asset or group of assets over their estimated useful lives against their respective carrying amount. If those net undiscounted cash flows
do not exceed the carrying amount, impairment, if any, is based on the excess of the carrying amount over the fair value based on the
market value or discounted expected cash flows of those assets and is recorded in the period in which the determination is made. The
Company impaired $&lt;span id="xdx_905_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_c20230501__20230731_zfr6CP7eOfEf" title="Impairment of intangible assets"&gt;100,281&lt;/span&gt; in intangible assets and $&lt;span id="xdx_901_eus-gaap--AssetImpairmentCharges_c20230501__20230731_z5FvrWnHNQ4i" title="Impairment of fixed assets"&gt;14,791&lt;/span&gt; in fixed assets during the three months ended July 31, 2023. Refer to Note
5 for more information.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="From2023-05-01to2023-07-31"
      decimals="0"
      unitRef="USD">100281</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:AssetImpairmentCharges
      contextRef="From2023-05-01to2023-07-31"
      decimals="0"
      unitRef="USD">14791</us-gaap:AssetImpairmentCharges>
    <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy contextRef="From2023-05-01to2023-07-31">&lt;p id="xdx_843_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_zeF6mMKwyE08" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_863_zUOK4TBL5uS5"&gt;Goodwill&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for goodwill in accordance with ASC 350, Intangibles &#x2013; Goodwill and Other (&#x201c;ASC 350&#x201d;). ASC 350 requires
that goodwill not be amortized, but reviewed for impairment if impairment indicators arise and, at a minimum, annually. The Company records
goodwill as the excess purchase price over assets acquired and includes any work force acquired as goodwill. Goodwill is evaluated for
impairment on an annual basis.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;With
the adoption of the ASU 2017-04, which eliminates the second step of the goodwill impairment test, the Company tests impairment of goodwill
in one step. In this step, the Company compares the fair value of each reporting unit with goodwill to its carrying value. The Company
determines the fair value of its reporting units with goodwill using a combination of a discounted cash flow and a market value approach.
If the carrying value of the net assets assigned to the reporting unit exceeds the fair value of the reporting unit, the Company will
record an impairment charge based on the excess of a reporting unit&#x2019;s carrying amount over its fair value. If the fair value of
the reporting unit exceeds the carrying value of the net assets assigned to that reporting unit, goodwill is not impaired and the Company
will not record an impairment charge.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company impaired all goodwill as of April 30, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="From2023-05-01to2023-07-31">&lt;p id="xdx_843_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zrn4WeDCwaa8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86A_zXggy9lV9VBf"&gt;Share-Based
Payment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for share-based compensation in accordance with ASC 718, Compensation-Stock Compensation (ASC 718). Under the fair value
recognition provisions of this topic, stock-based compensation cost is measured at the grant date based on the fair value of the award
and is recognized as an expense on a straight-line basis over the requisite service period, which is the vesting period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <CNXA:WarrantsPolicyTextBlock contextRef="From2023-05-01to2023-07-31">&lt;p id="xdx_846_ecustom--WarrantsPolicyTextBlock_zQgLZsdCZl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_861_zAmNMHbm5Z9f"&gt;Warrants&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company grants warrants to key employees and executives as compensation on a discretionary basis. The Company also grants warrants in
connection with certain note payable agreements and other key arrangements. The Company is required to estimate the fair value of share-based
awards on the measurement date and recognize as expense that value of the portion of the award that is ultimately expected to vest over
the requisite service period. Warrants granted in connection with ongoing arrangements are more fully described in Note 11.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
warrants granted during the periods ended July 31, 2023 and 2022 were valued using a Black-Scholes option pricing model on the date of
grant using the following assumptions:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_hus-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_zwUBj2Ktlrbc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B7_zevv4dX2q55a" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SCHEDULE
OF WARRANTS GRANTED VALUATION USING BLACK-SCHOLES PRICING METHOD&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Period Ended&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;July 31, 2023&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Period Ended&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;July 31, 2022&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Expected life in years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&#160;&lt;span id="xdx_90A_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dxL_c20230731__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_z3Rj0J3GgEx8" title="Warrants measurement input, term::XDX::P0Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0857"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220731__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MinimumMember_z6lktadzpOMc" title="Warrants measurement input, term"&gt;5&lt;/span&gt; &#x2013; &lt;span id="xdx_90F_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220731__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MaximumMember_zv1e5yHUtgVg" title="Warrants measurement input, term"&gt;10&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Stock price volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230731__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_zrSfyLGPFr61" title="Warrants measurement input, rate"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0863"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220731__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_z5u1bPOjwnR7" title="Warrants measurement input, rate"&gt;50&lt;/span&gt;% - &lt;span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220731__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_z96TgwhrYCQl" title="Warrants measurement input, rate"&gt;148&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Risk free interest rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230731__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zRAoz5ytefj6" title="Warrants measurement input, rate"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0869"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220731__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember_zNyzrC9VnPcf" title="Warrants measurement input, rate"&gt;2.50&lt;/span&gt;% - &lt;span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220731__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember_zJu0UEQstGkg" title="Warrants measurement input, rate"&gt;3.50&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Expected dividends&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230731__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zIeSl2LJtWth" title="Warrants measurement input, rate"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0875"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220731__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zrjwzYtj2Wk1" title="Warrants measurement input, rate"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AA_z1yeXYmEtQW8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</CNXA:WarrantsPolicyTextBlock>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock contextRef="From2023-05-012023-07-31_us-gaap_WarrantMember">&lt;p id="xdx_89A_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_hus-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_zwUBj2Ktlrbc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B7_zevv4dX2q55a" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SCHEDULE
OF WARRANTS GRANTED VALUATION USING BLACK-SCHOLES PRICING METHOD&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Period Ended&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;July 31, 2023&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Period Ended&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;July 31, 2022&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Expected life in years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&#160;&lt;span id="xdx_90A_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dxL_c20230731__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_z3Rj0J3GgEx8" title="Warrants measurement input, term::XDX::P0Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0857"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220731__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MinimumMember_z6lktadzpOMc" title="Warrants measurement input, term"&gt;5&lt;/span&gt; &#x2013; &lt;span id="xdx_90F_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220731__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MaximumMember_zv1e5yHUtgVg" title="Warrants measurement input, term"&gt;10&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Stock price volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230731__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_zrSfyLGPFr61" title="Warrants measurement input, rate"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0863"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220731__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_z5u1bPOjwnR7" title="Warrants measurement input, rate"&gt;50&lt;/span&gt;% - &lt;span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220731__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_z96TgwhrYCQl" title="Warrants measurement input, rate"&gt;148&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Risk free interest rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230731__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zRAoz5ytefj6" title="Warrants measurement input, rate"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0869"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220731__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember_zNyzrC9VnPcf" title="Warrants measurement input, rate"&gt;2.50&lt;/span&gt;% - &lt;span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220731__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember_zJu0UEQstGkg" title="Warrants measurement input, rate"&gt;3.50&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Expected dividends&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230731__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zIeSl2LJtWth" title="Warrants measurement input, rate"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0875"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220731__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zrjwzYtj2Wk1" title="Warrants measurement input, rate"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="AsOf2022-07-31_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputExpectedTermMember_srt_MinimumMember">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="AsOf2022-07-31_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputExpectedTermMember_srt_MaximumMember">P10Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2022-07-31_srt_MinimumMember_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_WarrantMember"
      decimals="INF"
      unitRef="Pure">50</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2022-07-31_srt_MaximumMember_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_WarrantMember"
      decimals="INF"
      unitRef="Pure">148</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2022-07-31_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MinimumMember"
      decimals="INF"
      unitRef="Pure">2.50</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2022-07-31_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MaximumMember"
      decimals="INF"
      unitRef="Pure">3.50</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2022-07-31_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputExpectedDividendRateMember"
      decimals="INF"
      unitRef="Pure">0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="From2023-05-01to2023-07-31">&lt;p id="xdx_842_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zdQ42ttIlWX2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Foreign
Currency Translation&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Our
functional currency is the U.S. dollar. The functional currency of our foreign operations, generally, is the respective local currency
for each foreign subsidiary. Assets and liabilities of foreign operations denominated in local currencies are translated at the spot
rate in effect at the applicable reporting date. Our consolidated statements of comprehensive loss are translated at the weighted average
rate of exchange during the applicable period. The resulting unrealized cumulative translation adjustment is recorded as a component
of accumulated other comprehensive loss in shareholders&#x2019; equity. Realized and unrealized transaction gains and losses generated
by transactions denominated in a currency different from the functional currency of the applicable entity are recorded in other income
(loss) in the period in which they occur.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2023-05-01to2023-07-31">&lt;p id="xdx_84F_eus-gaap--EarningsPerSharePolicyTextBlock_za4e88dFSBw" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_867_z8WUWUMhtAEk"&gt;Earnings
Per Share&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic
earnings per share are calculated by dividing the income available to shareholders by the weighted-average number of common shares
outstanding during each period. Diluted earnings per share are computed using the weighted average number of common and dilutive common
share equivalents outstanding during the period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;All
common stock equivalents such as shares to be issued for the conversion of notes payable and warrants were excluded from the calculation
of diluted earnings per share as the effect is antidilutive. As a result, the basic and diluted earnings per share are the same for each
of the periods presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2023-05-01to2023-07-31">&lt;p id="xdx_842_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zJ7cZEIBYy9i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_868_z6X96o6xT916"&gt;Recent
Accounting Pronouncements&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Recently
Adopted&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
January 2017, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued ASU No. 2017-04, Intangibles &#x2013; Goodwill and
Other (Topic 350): Simplifying the Test for Goodwill Impairment (&#x201c;ASU 2017-04&#x201d;), which simplifies how an entity is required
to test goodwill for impairment by eliminating Step 2 from the goodwill impairment test. Under ASU 2017-04, goodwill impairment will
be tested by comparing the fair value of a reporting unit with its carrying amount, and recognizing an impairment charge for the amount
by which the carrying amount exceeds the reporting unit&#x2019;s fair value. The new guidance must be applied on a prospective basis and
is effective for periods beginning after December 15, 2022, with early adoption permitted. The Company adopted ASU 2017-04 effective
May 1, 2021. The adoption of the new standard did not have a material effect on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
December 2019, the FASB issued Accounting Standards Update (&#x201c;ASU&#x201d;), 2019-12, &lt;i&gt;Simplifying the Accounting for Income Taxes&lt;/i&gt;,
which amends ASC 740, &lt;i&gt;Income Taxes&lt;/i&gt; (ASC 740). This update is intended to simplify accounting for income taxes by removing certain
exceptions to the general principles in ASC 740 and amending existing guidance to improve consistent application of ASC 740. This update
is effective for fiscal years beginning after December 15, 2021. The guidance in this update has various elements, some of which are
applied on a prospective basis and others on a retrospective basis with earlier application permitted. The adoption of the new standard
did not have a material effect on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
August 2020, the FASB issued ASU No. 2020-06, Debt &#x2013; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives
and Hedging Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s
Own Equity. ASU 2020-06 will simplify the accounting for convertible instruments by reducing the number of accounting models for convertible
debt instruments and convertible preferred stock. Limiting the accounting models results in fewer embedded conversion features being
separately recognized from the host contract as compared with current GAAP. Convertible instruments that continue to be subject to separation
models are (1) those with embedded conversion features that are not clearly and closely related to the host contract, that meet the definition
of a derivative, and that do not qualify for a scope exception from derivative accounting and (2) convertible debt instruments issued
with substantial premiums for which the premiums are recorded as paid-in capital. ASU 2020-06 also amends the guidance for the derivatives
scope exception for contracts in an entity&#x2019;s own equity to reduce form-over-substance-based accounting conclusions. ASU 2020-06
will be effective for public companies for fiscal years beginning after December 15, 2023, including interim periods within those fiscal
years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within
those fiscal years. The Company is currently evaluating the impact that the adoption of ASU 2020-06 will have on the Company&#x2019;s
consolidated financial statement presentation or disclosures.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
June 2016, the FASB issued ASU 2016-13, Financial Instruments &#x2013; Credit Losses (Topic 326): Measurement of Credit Losses on Financial
Instruments (&#x201c;ASC 326&#x201d;). The guidance replaces the incurred loss methodology with an expected loss methodology that is referred
to as the current expected credit loss (&#x201c;CECL&#x201d;) methodology. The measurement of expected credit losses under the CECL methodology
is applicable to financial assets measured at amortized cost, including loan receivables and held-to-maturity debt securities. It also
applies to off-balance sheet credit exposures not accounted for as insurance (loan commitments, standby letters of credits, financial
guarantees, and other similar instruments) and net investments in leases recognized by a lessor in accordance with Topic 842 on leases.
ASC 326 requires enhanced disclosures related to the significant estimates and judgments used in estimating credit losses as well as
the credit quality and underwriting standards of a company&#x2019;s portfolio. In addition, ASC 326 made changes to the accounting for
available-for-sale debt securities. One such change is to require credit losses to be presented as an allowance rather than as a write-down
on available-for-sale debt securities the Company does not intend to sell or believes that it is more likely than not they will be required
to sell. The ASU can be adopted no later than January 1, 2020 for SEC filers and January 1, 2023 for private companies and smaller reporting
companies. The adoption of the new standard did not have a material effect on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
October 2021, the FASB issued ASU 2021-08, &#x201c;Business Combinations &#x2013; Accounting for Contract Assets and Contract Liabilities
(Topic 805)&#x201d;. The amendments in this Update address diversity and inconsistency related to the recognition and measurement of contract
assets and contract liabilities acquired in a business combination. The amendments in this Update require that an acquirer recognize
and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606, Revenue from Contracts
with Customers. ASU 2021-08 is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal
years. The adoption of the new standard did not have a material effect on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
FASB has issued ASU 2021-04, Earnings Per Share (Topic 260), Debt&#x2014;Modifications and Extinguishments (Subtopic 470-50), Compensation&#x2014;Stock
Compensation (Topic 718), and Derivatives and Hedging&#x2014;Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40). ASU 2021-04 provides
guidance that an entity should treat a modification of the terms or conditions or an exchange of a freestanding equity-classified written
call option that remains equity classified after modification or exchange as an exchange of the original instrument for a new instrument.
The standard also provides guidance on how an entity should measure and recognize the effect of a modification or an exchange of a freestanding
equity-classified written call option that remains equity classified. The amendments in this ASU are effective for the Company for fiscal
years beginning after December 15, 2021. Early adoption is permitted for all entities, including adoption in an interim period. The adoption
of the new standard did not have a material effect on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
recently issued accounting pronouncements did not, or are not believed by management to, have a material effect on the Company&#x2019;s
present or future consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:ConcentrationRiskDisclosureTextBlock contextRef="From2023-05-01to2023-07-31">&lt;p id="xdx_80F_eus-gaap--ConcentrationRiskDisclosureTextBlock_zHm4faf0TNh6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
4&lt;/b&gt;: &lt;b&gt;&lt;span id="xdx_827_zS0gHlITecGd"&gt;CONCENTRATION OF CREDIT RISK AND OTHER RISKS AND UNCERTAINTIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Accounts
Receivable Concentration&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of July 31, 2023 and April 30, 2023, the Company had two customers that accounted for &lt;span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230501__20230731__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CreditConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zWzcr1YPamI9"&gt;50&lt;/span&gt;% and &lt;span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220501__20230430__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CreditConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_ziGcEZALq1J8"&gt;47&lt;/span&gt;% of the Company&#x2019;s trade receivables
balance, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Accounts
Payable Concentration&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of July 31, 2023 and April 30, 2023, the Company had four significant suppliers that accounted for &lt;span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230501__20230731__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--LenderConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerFourMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember_z0yGgWWhmXfg" title="Accounts payable concentration percentage"&gt;60&lt;/span&gt;%, and &lt;span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220501__20230430__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--LenderConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerFourMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember_zlpWrIsMZOjl" title="Accounts payable concentration percentage"&gt;59&lt;/span&gt;% of the Company&#x2019;s
trade payables balances, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConcentrationRiskDisclosureTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-05-012023-07-31_us-gaap_AccountsReceivableMember_us-gaap_CreditConcentrationRiskMember_custom_CustomerTwoMember"
      decimals="INF"
      unitRef="Pure">0.50</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-05-012023-04-30_us-gaap_AccountsReceivableMember_us-gaap_CreditConcentrationRiskMember_custom_CustomerTwoMember"
      decimals="INF"
      unitRef="Pure">0.47</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-05-012023-07-31_us-gaap_LenderConcentrationRiskMember_custom_CustomerFourMember_us-gaap_AccountsPayableMember"
      decimals="INF"
      unitRef="Pure">0.60</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-05-012023-04-30_us-gaap_LenderConcentrationRiskMember_custom_CustomerFourMember_us-gaap_AccountsPayableMember"
      decimals="INF"
      unitRef="Pure">0.59</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="From2023-05-01to2023-07-31">&lt;p id="xdx_801_eus-gaap--IntangibleAssetsDisclosureTextBlock_zVU1pdktvOEh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
5: &lt;span id="xdx_82B_zvFeVTNqg97j"&gt;INTANGIBLE ASSETS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_zdEzhIregm3k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intangible
assets reflect only those intangible assets of our continuing operations, and consist of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BB_zvVdOUPUW9F9" style="display: none"&gt;SCHEDULE
OF INTANGIBLE ASSETS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;(in years)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_485_eus-gaap--FiniteLivedIntangibleAssetsGross_iE_zAMiHKf66H3b" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_486_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iE_zn4EwGG06JF" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Amortization&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_48B_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_zeA61Y01H2y4" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Loss&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_485_eus-gaap--FiniteLivedIntangibleAssetsNet_iE_z7YLFPhaw6S5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Weighted&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Average Period&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;July 31, 2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Amortization&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;(in years)&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Carrying&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Value&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Accumulated&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Amortization&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Impairment&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Loss&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Net Carrying&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Value&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_410_20230501__20230731__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TradeNamesAndPatentsMember_zaNuV3NGaLb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 34%; text-align: left"&gt;Tradenames and patents&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: center"&gt;&lt;span id="xdx_901_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20230731__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TradeNamesAndPatentsMember_z15UgE7F6uN3" title="Weighted average amortization"&gt;15.26&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;385,582&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;24,031&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;360,551&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;1,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_418_20230501__20230731__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zmmmos5dRDHh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Customer relationships&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span id="xdx_90F_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20230731__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zqRBMbGreqdd" title="Weighted average amortization"&gt;9.92&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,930,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;50,038&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,879,962&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0905"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_41C_20230501__20230731__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zsfso3WFD4Rf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Internally developed software&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span id="xdx_90E_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20230731__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zDZ7wlhv6lS3" title="Weighted average amortization"&gt;4.91&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;580,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;79,608&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;500,392&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0911"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_418_20230501__20230731__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangiableAssetMember_z8yKTM7fUQr2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Total intangible assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;4,895,582&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;153,677&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;4,740,905&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;(in years)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_486_eus-gaap--FiniteLivedIntangibleAssetsGross_iE_zrmAEid9knCg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_482_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iE_zCIJrg6DzlS4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Amortization&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_481_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_zywsPGGp4Jp7" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Loss&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_480_eus-gaap--FiniteLivedIntangibleAssetsNet_iE_zbstifZDGLHa" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Weighted&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Average Period&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;April 30, 2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Amortization&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;(in years)&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Carrying&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Value&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Accumulated&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Amortization&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Impairment&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Loss&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Net Carrying&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Value&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_418_20220501__20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TradeNamesAndPatentsMember_zUXbS0TrERQi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 34%; text-align: left"&gt;Tradenames and patents&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: center"&gt;&lt;span id="xdx_908_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TradeNamesAndPatentsMember_zxdUY4D2xPT6" title="Weighted average amortization"&gt;15.26&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;385,582&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;24,031&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;260,270&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;101,281&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_41A_20220501__20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zMmZ6D87bZDl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Customer relationships&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_z4ku75IpaXC7" title="Weighted average amortization"&gt;9.92&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,930,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;50,038&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,879,962&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0927"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_416_20220501__20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_za6FJOcFioy8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Internally developed software&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zrhiKnlnaysi" title="Weighted average amortization"&gt;4.91&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;580,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;79,608&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;500,392&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0933"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_411_20220501__20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangiableAssetMember_z1lHJnMQjOM3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Total intangible assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;4,895,582&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;153,677&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;4,640,624&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;101,281&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AF_zYT6wIoYj7ze" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amortization
expense for the three months ended July 31, 2023 and 2022 was approximately $&lt;span id="xdx_903_eus-gaap--AmortizationOfIntangibleAssets_c20230501__20230731_zjqve7B0YdP3" title="Amortization expense"&gt;0&lt;/span&gt; and $&lt;span id="xdx_903_eus-gaap--AmortizationOfIntangibleAssets_c20220501__20220731_zcIkcSC8Qh5k" title="Amortization expense"&gt;1,445&lt;/span&gt;, respectively. The Company impaired $&lt;span id="xdx_903_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_iN_di_c20230501__20230731__dei--LegalEntityAxis__custom--FoundationSportsSystemsLLCMember_zvekOeYPzmz" title="Impairment loss"&gt;100,281&lt;/span&gt;
in the three months ended July 31, 2023. The remaining $&lt;span id="xdx_902_eus-gaap--OtherIntangibleAssetsNet_iI_c20230731__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zHmwc2OGK7e3" title="Other intangible assets"&gt;1,000&lt;/span&gt; is a nominal value related to the Company&#x2019;s patents. This amount
is not expected to be amortized any further.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock contextRef="From2023-05-01to2023-07-31">&lt;p id="xdx_89E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_zdEzhIregm3k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intangible
assets reflect only those intangible assets of our continuing operations, and consist of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BB_zvVdOUPUW9F9" style="display: none"&gt;SCHEDULE
OF INTANGIBLE ASSETS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;(in years)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_485_eus-gaap--FiniteLivedIntangibleAssetsGross_iE_zAMiHKf66H3b" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_486_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iE_zn4EwGG06JF" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Amortization&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_48B_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_zeA61Y01H2y4" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Loss&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_485_eus-gaap--FiniteLivedIntangibleAssetsNet_iE_z7YLFPhaw6S5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Weighted&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Average Period&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;July 31, 2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Amortization&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;(in years)&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Carrying&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Value&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Accumulated&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Amortization&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Impairment&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Loss&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Net Carrying&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Value&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_410_20230501__20230731__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TradeNamesAndPatentsMember_zaNuV3NGaLb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 34%; text-align: left"&gt;Tradenames and patents&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: center"&gt;&lt;span id="xdx_901_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20230731__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TradeNamesAndPatentsMember_z15UgE7F6uN3" title="Weighted average amortization"&gt;15.26&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;385,582&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;24,031&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;360,551&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;1,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_418_20230501__20230731__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zmmmos5dRDHh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Customer relationships&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span id="xdx_90F_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20230731__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zqRBMbGreqdd" title="Weighted average amortization"&gt;9.92&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,930,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;50,038&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,879,962&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0905"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_41C_20230501__20230731__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zsfso3WFD4Rf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Internally developed software&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span id="xdx_90E_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20230731__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zDZ7wlhv6lS3" title="Weighted average amortization"&gt;4.91&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;580,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;79,608&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;500,392&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0911"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_418_20230501__20230731__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangiableAssetMember_z8yKTM7fUQr2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Total intangible assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;4,895,582&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;153,677&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;4,740,905&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;(in years)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_486_eus-gaap--FiniteLivedIntangibleAssetsGross_iE_zrmAEid9knCg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_482_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iE_zCIJrg6DzlS4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Amortization&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_481_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_zywsPGGp4Jp7" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Loss&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_480_eus-gaap--FiniteLivedIntangibleAssetsNet_iE_zbstifZDGLHa" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Weighted&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Average Period&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;April 30, 2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Amortization&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;(in years)&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Carrying&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Value&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Accumulated&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Amortization&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Impairment&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Loss&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Net Carrying&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Value&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_418_20220501__20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TradeNamesAndPatentsMember_zUXbS0TrERQi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 34%; text-align: left"&gt;Tradenames and patents&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: center"&gt;&lt;span id="xdx_908_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TradeNamesAndPatentsMember_zxdUY4D2xPT6" title="Weighted average amortization"&gt;15.26&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;385,582&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;24,031&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;260,270&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;101,281&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_41A_20220501__20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zMmZ6D87bZDl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Customer relationships&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_z4ku75IpaXC7" title="Weighted average amortization"&gt;9.92&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,930,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;50,038&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,879,962&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0927"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_416_20220501__20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_za6FJOcFioy8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Internally developed software&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zrhiKnlnaysi" title="Weighted average amortization"&gt;4.91&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;580,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;79,608&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;500,392&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0933"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_411_20220501__20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangiableAssetMember_z1lHJnMQjOM3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Total intangible assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;4,895,582&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;153,677&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;4,640,624&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;101,281&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1 contextRef="AsOf2023-07-31_custom_TradeNamesAndPatentsMember">P15Y3M3D</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2023-07-31_custom_TradeNamesAndPatentsMember"
      decimals="0"
      unitRef="USD">385582</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2023-07-31_custom_TradeNamesAndPatentsMember"
      decimals="0"
      unitRef="USD">24031</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="From2023-05-012023-07-31_custom_TradeNamesAndPatentsMember"
      decimals="0"
      unitRef="USD">360551</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2023-07-31_custom_TradeNamesAndPatentsMember"
      decimals="0"
      unitRef="USD">1000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1 contextRef="AsOf2023-07-31_us-gaap_CustomerRelationshipsMember">P9Y11M1D</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2023-07-31_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      unitRef="USD">3930000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2023-07-31_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      unitRef="USD">50038</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="From2023-05-012023-07-31_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      unitRef="USD">3879962</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1 contextRef="AsOf2023-07-31_us-gaap_ComputerSoftwareIntangibleAssetMember">P4Y10M28D</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2023-07-31_us-gaap_ComputerSoftwareIntangibleAssetMember"
      decimals="0"
      unitRef="USD">580000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2023-07-31_us-gaap_ComputerSoftwareIntangibleAssetMember"
      decimals="0"
      unitRef="USD">79608</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="From2023-05-012023-07-31_us-gaap_ComputerSoftwareIntangibleAssetMember"
      decimals="0"
      unitRef="USD">500392</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2023-07-31_custom_IntangiableAssetMember"
      decimals="0"
      unitRef="USD">4895582</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2023-07-31_custom_IntangiableAssetMember"
      decimals="0"
      unitRef="USD">153677</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="From2023-05-012023-07-31_custom_IntangiableAssetMember"
      decimals="0"
      unitRef="USD">4740905</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2023-07-31_custom_IntangiableAssetMember"
      decimals="0"
      unitRef="USD">1000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1 contextRef="AsOf2023-04-30_custom_TradeNamesAndPatentsMember">P15Y3M3D</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2023-04-30_custom_TradeNamesAndPatentsMember"
      decimals="0"
      unitRef="USD">385582</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2023-04-30_custom_TradeNamesAndPatentsMember"
      decimals="0"
      unitRef="USD">24031</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="From2022-05-012023-04-30_custom_TradeNamesAndPatentsMember"
      decimals="0"
      unitRef="USD">260270</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2023-04-30_custom_TradeNamesAndPatentsMember"
      decimals="0"
      unitRef="USD">101281</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1 contextRef="AsOf2023-04-30_us-gaap_CustomerRelationshipsMember">P9Y11M1D</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2023-04-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      unitRef="USD">3930000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2023-04-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      unitRef="USD">50038</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="From2022-05-012023-04-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      unitRef="USD">3879962</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1 contextRef="AsOf2023-04-30_us-gaap_ComputerSoftwareIntangibleAssetMember">P4Y10M28D</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2023-04-30_us-gaap_ComputerSoftwareIntangibleAssetMember"
      decimals="0"
      unitRef="USD">580000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2023-04-30_us-gaap_ComputerSoftwareIntangibleAssetMember"
      decimals="0"
      unitRef="USD">79608</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="From2022-05-012023-04-30_us-gaap_ComputerSoftwareIntangibleAssetMember"
      decimals="0"
      unitRef="USD">500392</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2023-04-30_custom_IntangiableAssetMember"
      decimals="0"
      unitRef="USD">4895582</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2023-04-30_custom_IntangiableAssetMember"
      decimals="0"
      unitRef="USD">153677</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="From2022-05-012023-04-30_custom_IntangiableAssetMember"
      decimals="0"
      unitRef="USD">4640624</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2023-04-30_custom_IntangiableAssetMember"
      decimals="0"
      unitRef="USD">101281</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2023-05-01to2023-07-31"
      decimals="0"
      unitRef="USD">0</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2022-05-012022-07-31"
      decimals="0"
      unitRef="USD">1445</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="From2023-05-012023-07-31_custom_FoundationSportsSystemsLLCMember30673109"
      decimals="0"
      unitRef="USD">-100281</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:OtherIntangibleAssetsNet
      contextRef="AsOf2023-07-31_us-gaap_PatentsMember"
      decimals="0"
      unitRef="USD">1000</us-gaap:OtherIntangibleAssetsNet>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="From2023-05-01to2023-07-31">&lt;p id="xdx_80E_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zWm9muZZGcYh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
6&lt;/b&gt;: &lt;b&gt;&lt;span id="xdx_827_zribUoJTNjt8"&gt;ACCRUED EXPENSES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89B_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_z16P7oj1WSEf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
composition of accrued expenses is summarized below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BA_z0Lf5A9wMVac" style="display: none"&gt;SCHEDULE
OF ACCRUED EXPENSES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20230731_zA4I6a2iRVk7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;July 31, 2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20230430_zgHAdCwGXbea" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;April 30, 2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--AccruedPayrollTaxesCurrent_iI_maALCzIie_zgsakoVu0Rhl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Accrued payroll&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;1,754,936&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;1,535,186&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--AccruedBonusesCurrent_iI_maALCzIie_zVAUtZkGQhRi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Accrued bonus&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,829,604&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,720,606&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--AccruedProfessionalFeesCurrent_iI_maALCzIie_zOd59yZFR5qh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Accrued professional fees&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;35,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;490,424&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--AccountsPayableOtherCurrent_iI_maALCzIie_zlN7830IRz81" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Other accrued expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,577,920&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,165,623&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--AccruedLiabilitiesCurrent_iTI_mtALCzIie_zQqIU9SIRQHi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Total&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;5,197,460&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;4,911,839&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A9_z2b3GRh7pzRa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock contextRef="From2023-05-01to2023-07-31">&lt;p id="xdx_89B_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_z16P7oj1WSEf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
composition of accrued expenses is summarized below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BA_z0Lf5A9wMVac" style="display: none"&gt;SCHEDULE
OF ACCRUED EXPENSES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20230731_zA4I6a2iRVk7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;July 31, 2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20230430_zgHAdCwGXbea" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;April 30, 2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--AccruedPayrollTaxesCurrent_iI_maALCzIie_zgsakoVu0Rhl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Accrued payroll&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;1,754,936&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;1,535,186&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--AccruedBonusesCurrent_iI_maALCzIie_zVAUtZkGQhRi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Accrued bonus&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,829,604&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,720,606&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--AccruedProfessionalFeesCurrent_iI_maALCzIie_zOd59yZFR5qh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Accrued professional fees&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;35,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;490,424&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--AccountsPayableOtherCurrent_iI_maALCzIie_zlN7830IRz81" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Other accrued expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,577,920&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,165,623&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--AccruedLiabilitiesCurrent_iTI_mtALCzIie_zQqIU9SIRQHi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Total&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;5,197,460&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;4,911,839&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccruedPayrollTaxesCurrent contextRef="AsOf2023-07-31" decimals="0" unitRef="USD">1754936</us-gaap:AccruedPayrollTaxesCurrent>
    <us-gaap:AccruedPayrollTaxesCurrent contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">1535186</us-gaap:AccruedPayrollTaxesCurrent>
    <us-gaap:AccruedBonusesCurrent contextRef="AsOf2023-07-31" decimals="0" unitRef="USD">1829604</us-gaap:AccruedBonusesCurrent>
    <us-gaap:AccruedBonusesCurrent contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">1720606</us-gaap:AccruedBonusesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="AsOf2023-07-31" decimals="0" unitRef="USD">35000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">490424</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccountsPayableOtherCurrent contextRef="AsOf2023-07-31" decimals="0" unitRef="USD">1577920</us-gaap:AccountsPayableOtherCurrent>
    <us-gaap:AccountsPayableOtherCurrent contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">1165623</us-gaap:AccountsPayableOtherCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2023-07-31" decimals="0" unitRef="USD">5197460</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">4911839</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:DebtDisclosureTextBlock contextRef="From2023-05-01to2023-07-31">&lt;p id="xdx_806_eus-gaap--DebtDisclosureTextBlock_zQvQCyP8YwC" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
7: &lt;span id="xdx_82C_zP6VnEk0igv6"&gt;NOTE PAYABLE &#x2013; RELATED PARTY&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
discussion of note payable &#x2013; related party only includes those that existed as of April 30, 2023. For a discussion of all prior
note payable &#x2013; related party we refer you to the Annual Report on Form 10-K filed September 14, 2023 for the fiscal year end April
30, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 14, 2022, the Company entered into two loan agreements with related party lenders, each for $&lt;span id="xdx_905_eus-gaap--LoansPayable_iI_c20220114__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zOuZbdwjQKyd" title="Loans payable"&gt;1,000,000&lt;/span&gt;, pursuant to which the
Company received a total amount of $&lt;span id="xdx_904_eus-gaap--ProceedsFromRelatedPartyDebt_c20220113__20220114__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zStnO0B0KIy" title="Proceeds from related party debt"&gt;2,000,000&lt;/span&gt;. The loans bear interest at a rate of &lt;span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20220114__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zIAMsQ4zg99e" title="Interest rate"&gt;8&lt;/span&gt;% per annum and are required to be repaid in full
by April 30, 2022 or such other date as may be accepted by the lenders. The Company is not permitted to make any distribution or pay
any dividends unless or until the loans are repaid in full. On June 28, 2022, the Company entered into amendments for the two related
party loan agreements with the lenders in which the repayment date was extended to July 31, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;There
was $&lt;span id="xdx_900_eus-gaap--NotesPayable_iI_c20230731__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zHiDvsuEX3E8" title="Outstanding borrowings"&gt;1,655,966&lt;/span&gt; and $&lt;span id="xdx_901_eus-gaap--NotesPayable_iI_c20230430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z8btvF5Q4S7f" title="Outstanding borrowings"&gt;1,953,842&lt;/span&gt; in outstanding borrowings from related parties as of July 31, 2023 and April 30, 2023. Interest expense
related to the related parties for the three months ended July 31, 2023 and 2022 amounted to $&lt;span id="xdx_90F_eus-gaap--InterestExpense_pp0p0_dxL_c20230501__20230731__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zo8hpH2syyhc" title="Interest expense::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0980"&gt;0&lt;/span&gt;&lt;/span&gt; and $&lt;span id="xdx_90F_eus-gaap--InterestExpense_pp0p0_c20220501__20220731__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zpHx78pL61v1" title="Interest expense"&gt;61,121&lt;/span&gt;, respectively. Accrued interest
due to related parties as of July 31, 2023 and April 30, 2023 amounted to $&lt;span id="xdx_909_eus-gaap--InterestPayableCurrent_iI_c20230731__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zrnaeNlv0Wy5" title="Accrued interest"&gt;917,957&lt;/span&gt; and $&lt;span id="xdx_90B_eus-gaap--InterestPayableCurrent_iI_c20230430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zk3QkPxIbLP" title="Accrued interest"&gt;917,957&lt;/span&gt;, respectively. The accrued interest includes
notes that were either repaid or converted but the interest remained.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 6, 2023, we sold certain of our inventory including all components, parts, additions and accessions thereto to Yonah Kalfa and
Naftali Kalfa who immediately consigned it back to us in exchange for a payment of $&lt;span id="xdx_902_ecustom--PaymentForExchangeOfNotesPayable_c20230106__20230106__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zVDx7hTo7wFc" title="Payment of exchange"&gt;103&lt;/span&gt; per ball launcher we sell until we have paid
them an aggregate total of $&lt;span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_c20230106_z5yDxH0EXo4j" title="Debt instrumental"&gt;2,092,700&lt;/span&gt;, which represents payment in full of the principal amounts of and accrued interest in respect of
the Loan Agreements (as defined above) and certain other expenses they incurred in connection with the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LoansPayable
      contextRef="AsOf2022-01-14_custom_LoanAgreementsMember_us-gaap_RelatedPartyMember"
      decimals="0"
      unitRef="USD">1000000</us-gaap:LoansPayable>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="From2022-01-132022-01-14_custom_LoanAgreementsMember_us-gaap_RelatedPartyMember"
      decimals="0"
      unitRef="USD">2000000</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2022-01-14_custom_LoanAgreementsMember_us-gaap_RelatedPartyMember"
      decimals="INF"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:NotesPayable
      contextRef="AsOf2023-07-31_us-gaap_RelatedPartyMember"
      decimals="0"
      unitRef="USD">1655966</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="AsOf2023-04-30_us-gaap_RelatedPartyMember"
      decimals="0"
      unitRef="USD">1953842</us-gaap:NotesPayable>
    <us-gaap:InterestExpense
      contextRef="From2022-05-012022-07-31_us-gaap_RelatedPartyMember"
      decimals="0"
      unitRef="USD">61121</us-gaap:InterestExpense>
    <us-gaap:InterestPayableCurrent
      contextRef="AsOf2023-07-31_us-gaap_RelatedPartyMember"
      decimals="0"
      unitRef="USD">917957</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="AsOf2023-04-30_us-gaap_RelatedPartyMember"
      decimals="0"
      unitRef="USD">917957</us-gaap:InterestPayableCurrent>
    <CNXA:PaymentForExchangeOfNotesPayable
      contextRef="From2023-01-062023-01-06_us-gaap_RelatedPartyMember"
      decimals="0"
      unitRef="USD">103</CNXA:PaymentForExchangeOfNotesPayable>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2023-01-06" decimals="0" unitRef="USD">2092700</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ShortTermDebtTextBlock contextRef="From2023-05-01to2023-07-31">&lt;p id="xdx_80F_eus-gaap--ShortTermDebtTextBlock_zCrPA7zh49d3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
8: &lt;span id="xdx_82D_zqG1bvJTPy9d"&gt;CONVERTIBLE NOTES PAYABLE&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
discussion of convertible notes payable only includes those that existed as of April 30, 2023. For a discussion of all prior convertible
notes payable we refer you to the Annual Report on Form 10-K filed September 14, 2023 for the fiscal year end April 30, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of April 30, 2023, all outstanding convertible notes payable had been fully converted into outstanding common shares. On June 17, 2022,
the Company issued &lt;span id="xdx_90D_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20220617__20220617_z2oJMUksGX4k" title="Debt conversion"&gt;109,737&lt;/span&gt; shares of common stock in conversion of the $&lt;span id="xdx_907_eus-gaap--DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1_c20220617__20220617_z1zUGkrQexg7" title="Debt conversion shares issued"&gt;13,200,000&lt;/span&gt; in convertible notes payable and $&lt;span id="xdx_90D_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20220617_zeC5KRWRMXS1" title="Interest payable"&gt;846,301&lt;/span&gt; in accrued
interest. In addition, the remaining $&lt;span id="xdx_901_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20220731_z56BNFizMO4h" title="Unamortizated discount"&gt;122,222&lt;/span&gt; of unamortized discount on the convertible notes payable was amortized and included in
our consolidated statements of operations for the three months ended July 31, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ShortTermDebtTextBlock>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="From2022-06-172022-06-17"
      decimals="INF"
      unitRef="Shares">109737</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1
      contextRef="From2022-06-172022-06-17"
      decimals="INF"
      unitRef="Shares">13200000</us-gaap:DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1>
    <us-gaap:InterestPayableCurrentAndNoncurrent contextRef="AsOf2022-06-17" decimals="0" unitRef="USD">846301</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="AsOf2022-07-31" decimals="0" unitRef="USD">122222</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:LongTermDebtTextBlock contextRef="From2023-05-01to2023-07-31">&lt;p id="xdx_804_eus-gaap--LongTermDebtTextBlock_zTHbqlGRBac5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
9: &lt;span id="xdx_823_zta9wt3wCcm8"&gt;NOTES PAYABLE&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
discussion of notes payable only includes those that existed as of April 30, 2023. For a discussion of all prior notes payable we refer
you to the Annual Report on Form 10-K filed September 14, 2023 for the fiscal year end April 30, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 11, 2021, the Company and the lender entered into an agreement whereby the lender converted the promissory note into &lt;span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210410__20210411__us-gaap--DebtInstrumentAxis__custom--PromissoryNotePayableMember_zqXwU2pav0Y8" title="Shares issued"&gt;681&lt;/span&gt; shares
of Company stock, which were issued to the lender at a &lt;span id="xdx_90F_eus-gaap--DebtConversionOriginalDebtInterestRateOfDebt_pid_dp_uPure_c20210410__20210411__us-gaap--DebtInstrumentAxis__custom--PromissoryNotePayableMember_zPgxUkLNBCee" title="Interest rate"&gt;20&lt;/span&gt;% discount from the closing price of the stock on the day prior to the conversion.
In addition to the discount, the agreement contains a guarantee that the aggregate gross sales of the shares by the lender will be no
less than $&lt;span id="xdx_904_eus-gaap--DebtInstrumentCarryingAmount_iI_c20210411__us-gaap--DebtInstrumentAxis__custom--PromissoryNotePayableMember_zN8QfdijfQGc" title="Payables"&gt;1,500,000&lt;/span&gt; over the next three years and if the aggregate gross sales are less than $&lt;span id="xdx_90D_eus-gaap--DebtInstrumentCarryingAmount_iI_c20210411__us-gaap--DebtInstrumentAxis__custom--PromissoryNotePayableMember_zH0mZoFFRUi" title="Payables"&gt;1,500,000&lt;/span&gt; the Company will issue additional
shares of common stock to the lender for the difference between the total gross proceeds and $&lt;span id="xdx_902_eus-gaap--DebtInstrumentCarryingAmount_iI_c20210411__us-gaap--DebtInstrumentAxis__custom--PromissoryNotePayableMember_zj3Clgvchjs9" title="Payables"&gt;1,500,000&lt;/span&gt;, which could result in an infinite
number of shares being required to be issued.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company evaluated the conversion option of the note payable to shares under the guidance in ASC 815-40, Derivatives and Hedging, and
determined the conversion option qualified for equity classification. The Company also evaluated the profit guarantee under ASC 815,
Derivatives and Hedging, and determined it to be a make-whole provision, which is an embedded derivative within the host instrument.
As the economic characteristics are dissimilar to the host instrument, the profit guarantee was bifurcated from the host instrument and
stated as a separate derivative liability, which is marked to market at the end of each reporting period with the non-cash gain or loss
recorded in the period as a gain or loss on derivative.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
the date of conversion, the Company recognized a $&lt;span id="xdx_903_eus-gaap--GainsLossesOnExtinguishmentOfDebt_c20210410__20210411_zA0krLbTwjYa" title="Extinguishment of debt"&gt;1,501,914&lt;/span&gt; loss on extinguishment of debt, which represented the difference between
the promissory note and the fair value of the shares issued of $&lt;span id="xdx_902_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20210410__20210411_zeP0eupTgEqc" title="Debt conversion, amount"&gt;1,250,004&lt;/span&gt;, which were recorded in shares issued in connection with conversion
of note payable within shareholders&#x2019; equity, as well as the derivative liability of $&lt;span id="xdx_906_eus-gaap--DerivativeLiabilities_iI_c20210411__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zvHEfMyShSb9" title="Derivative liability"&gt;1,251,910&lt;/span&gt;, which was valued using a Black-Scholes
option pricing model.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of the derivative liability was $&lt;span id="xdx_90A_eus-gaap--DerivativeFairValueOfDerivativeNet_iI_c20230430__us-gaap--DebtInstrumentAxis__custom--PromissoryNotePayableMember_z6m9qlpUXks2" title="Fair value of derivative liability"&gt;1,456,854&lt;/span&gt; and $&lt;span id="xdx_901_eus-gaap--DerivativeFairValueOfDerivativeNet_iI_c20220430__us-gaap--DebtInstrumentAxis__custom--PromissoryNotePayableMember_z1zs54G7Hadg" title="Fair value of derivative liability"&gt;1,456,854&lt;/span&gt; as of April 30, 2023 and 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 15, 2022, for and in consideration of $&lt;span id="xdx_908_eus-gaap--BusinessCombinationConsiderationTransferredOther1_c20220214__20220215_zaULfRNOH1rg" title="Consideration"&gt;4,000,000&lt;/span&gt; the Company conveyed, sold, transferred, set over, assigned and delivered to
Slinger Bag Consignment, LLC, a Virginia limited liability company (&#x201c;Consignor&#x201d;), all of the Company&#x2019;s right, title
and interest in and to &lt;span id="xdx_903_ecustom--NumberOfConsignedGoods_pid_uInteger_c20220214__20220215_z4pgX4UCYwWk" title="Consignment units"&gt;13,000&lt;/span&gt; units of certain surplus inventory, including all components, parts, additions and accessions thereto (collectively,
the &#x201c;Consigned Goods&#x201d;). The Company has repaid the $&lt;span id="xdx_903_ecustom--PaymentsOfRelatedPartyDebt_c20220501__20230430_zi7g2gY8Cxp8" title="Repayments of notes - related party"&gt;4,000,000&lt;/span&gt; as of April 30, 2023 ($&lt;span id="xdx_908_ecustom--PaymentsOfRelatedPartyDebt_c20210501__20220731_zv6Hf1DF2Omg" title="Repayments of notes - related party"&gt;1,559,109&lt;/span&gt; as of July 31, 2022).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 1, 2022, the Company entered into a $&lt;span id="xdx_90A_eus-gaap--NotesPayable_iI_c20220401__us-gaap--DebtInstrumentAxis__custom--NotesPayableMember_ziA7qzQb1Gz4" title="Note payable"&gt;500,000&lt;/span&gt; note payable. The note was to mature on &lt;span id="xdx_903_eus-gaap--DebtInstrumentMaturityDate_c20220401__20220401_zcAyOTLmHl2a" title="Debt maturity date"&gt;July 1, 2022&lt;/span&gt; and bears interest at eight percent
(&lt;span id="xdx_902_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20220401__us-gaap--DebtInstrumentAxis__custom--NotesPayableMember_zgkIjEQs4XKa" title="Interest rate"&gt;8&lt;/span&gt;%) per year. The Company pays interest monthly and will pay all accrued and unpaid interest on the maturity date in which the outstanding
principal is due. On August 1, 2022, the Company repaid the $&lt;span id="xdx_90B_ecustom--PaymentsOfRelatedPartyDebt_c20220801__20220801_zxkzaF0ou8T8" title="Repayments of notes - related party"&gt;500,000&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Cash
Advance Agreements&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
July 29, 2022, the Company entered into two merchant cash advance agreements. The details of the merchant cash advance agreements are
as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;UFS
Agreement&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company entered into an agreement (the &#x201c;UFS Agreement&#x201d;) with Unique Funding Solutions LLC (&#x201c;UFS&#x201d;) pursuant to
which the Company sold $&lt;span id="xdx_90B_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20220729__20220729__us-gaap--TypeOfArrangementAxis__custom--UFSAgreementMember_zYzhCY1HgIak" title="Sale of consideration received"&gt;1,124,250&lt;/span&gt; in future receivables (the &#x201c;UFS Receivables Purchased Amount&#x201d;) to UFS in exchange for payment
to the Company of $&lt;span id="xdx_90D_eus-gaap--PaymentsToAcquireReceivables_c20220729__20220729__us-gaap--TypeOfArrangementAxis__custom--UFSAgreementMember_z8hPL08hXBWk" title="Payment for exchange received amount"&gt;750,000&lt;/span&gt; in cash less fees of $&lt;span id="xdx_903_ecustom--CashLessFees_c20220729__20220729__us-gaap--TypeOfArrangementAxis__custom--UFSAgreementMember_zEFetVEIdivg" title="Cash less fees"&gt;60,000&lt;/span&gt;. The Company agreed to pay UFS $&lt;span id="xdx_902_eus-gaap--PaymentsToAcquireReceivables_c20220729__20220729__us-gaap--TypeOfArrangementAxis__custom--UFSAgreementMember__srt--StatementScenarioAxis__custom--EachWeekForNextThreeWeeksMember_zFMezKZhuWqg" title="Payment for exchange received amount"&gt;13,491&lt;/span&gt; each week for the first three weeks and
thereafter $&lt;span id="xdx_90C_eus-gaap--PaymentsToAcquireReceivables_c20220729__20220729__us-gaap--TypeOfArrangementAxis__custom--UFSAgreementMember__srt--StatementScenarioAxis__custom--ThereafterPerWeekMember_zdClw0NkQkf8" title="Payment for exchange received amount"&gt;44,970&lt;/span&gt; per week until the UFS Receivables Purchased Amount is paid in full.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
order to secure payment and performance of the Company&#x2019;s obligations to UFS under the UFS Agreement, the Company granted to UFS
a security interest in the following collateral: all accounts receivable and all proceeds as such term is defined by Article 9 of the
UCC. The Company also agreed not to create, incur, assume, or permit to exist, directly or indirectly, any lien on or with respect to
any of such collateral.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Cedar
Agreement&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company entered into an agreement (the &#x201c;Cedar Agreement&#x201d;) with Cedar Advance LLC (&#x201c;Cedar&#x201d;) pursuant to which
the Company sold $&lt;span id="xdx_906_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20220729__20220729__us-gaap--TypeOfArrangementAxis__custom--CedarAgreementMember_zarWIa63UrLb" title="Sale of consideration received"&gt;1,124,250&lt;/span&gt; in future receivables (the &#x201c;Cedar Receivables Purchased Amount&#x201d;) to Cedar in exchange for payment
to the Company of $&lt;span id="xdx_900_eus-gaap--PaymentsToAcquireReceivables_c20220729__20220729__us-gaap--TypeOfArrangementAxis__custom--CedarAgreementMember_zZARwyKrSCg1" title="Payment for exchange received amount"&gt;750,000&lt;/span&gt; in cash less fees of $&lt;span id="xdx_902_ecustom--CashLessFees_c20220729__20220729__us-gaap--TypeOfArrangementAxis__custom--CedarAgreementMember_zHoK88Cw3Lwj" title="Cash less fees"&gt;60,000&lt;/span&gt;. The Company agreed to pay Cedar $&lt;span id="xdx_907_eus-gaap--PaymentsToAcquireReceivables_c20220729__20220729__us-gaap--TypeOfArrangementAxis__custom--CedarAgreementMember__srt--StatementScenarioAxis__custom--EachWeekForNextThreeWeeksMember_z1CQEw0pw4u4" title="Payment for exchange received amount"&gt;13,491&lt;/span&gt; each week for the first three weeks
and thereafter $&lt;span id="xdx_90E_eus-gaap--PaymentsToAcquireReceivables_c20220729__20220729__us-gaap--TypeOfArrangementAxis__custom--CedarAgreementMember__srt--StatementScenarioAxis__custom--ThereafterPerWeekMember_zoy8lLUdqCfc" title="Payment for exchange received amount"&gt;44,970&lt;/span&gt; per week until the Cedar Receivables Purchased Amount is paid in full.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
order to secure payment and performance of the Company&#x2019;s obligations to Cedar under the Cedar Agreement, the Company granted to
Cedar a security interest in the following collateral: all accounts, including without limitation, all deposit accounts, accounts receivable
and other receivables, chattel paper, documents, equipment, instruments and inventory as those terms are defined by Article 9 of the
UCC. The Company also agreed not to create, incur, assume, or permit to exist, directly or indirectly, any lien on or with respect to
any of such collateral.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 6, 2023, the Company entered into a loan and security agreement (the &#x201c;Loan and Security Agreement&#x201d;) with one or more
institutional investors (the &#x201c;Lenders&#x201d;) and Armistice Capital Master Fund Ltd. as agent for the Lenders (the &#x201c;Agent&#x201d;)
for the issuance and sale of (i) a note in an aggregate principal amount of up to $&lt;span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_c20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember__srt--RangeAxis__srt--MaximumMember_zZRDGUDFGRR9" title="Aggregate principal amount"&gt;2,000,000&lt;/span&gt; (the &#x201c;Note&#x201d;) with the initial
advance under the Loan and Security Agreement being $&lt;span id="xdx_904_eus-gaap--ProceedsFromNotesPayable_c20230104__20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember__us-gaap--ShortTermDebtTypeAxis__custom--NotesMember_zf6uRhIQrfub" title="Borrowing from notes payable"&gt;1,400,000&lt;/span&gt; and (ii) warrants (the &#x201c;Warrants&#x201d;) to purchase a number of
shares of common stock of the Company equal to 200% of the face amount of the Note divided by the closing price of the common stock of
the Company on the date of the issuance of the Notes (collectively, the &#x201c;Initial Issuance&#x201d;). The closing price of the Company&#x2019;s
common stock on January 6, 2023, as reported by Nasdaq, was $&lt;span id="xdx_90A_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember_zWA1WpfI1wR1" title="Shares issued price per share"&gt;8.84&lt;/span&gt; per share, so the Warrants in respect of the initial advance under
the Note are exercisable for up to &lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember__srt--RangeAxis__srt--MaximumMember_zxtYxxbFu9tl" title="Common stock exercisable, shares"&gt;452,489&lt;/span&gt; shares of the Company&#x2019;s common stock. The Warrants have an exercise price per share
equal to the closing price of the common stock of the Company on the date of the issuance of the Note, or $&lt;span id="xdx_906_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember_zCdtAyhcOnB3" title="Shares issued price per share"&gt;8.84&lt;/span&gt; per share and a term
of five- and one-half (5&#xbd;) years following the initial exercise date. The initial exercise date of the Warrants will be the date
stockholder approval is received and effective allowing exercisability of the Warrants under Nasdaq rules. Pursuant to the terms of the
Loan and Security Agreement, an additional advance of $&lt;span id="xdx_903_eus-gaap--ProceedsFromNotesPayable_c20230104__20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember_zWGho3kkU7pj" title="Proceeds from notes payable"&gt;600,000&lt;/span&gt; may be made to the Company under the Note. The Company&#x2019;s obligations
under the terms of the Loan and Security Agreement are fully and unconditionally guaranteed by all of the Company&#x2019;s subsidiaries
(the &#x201c;Guarantors&#x201d;). The Company measured the warrants granted on January 6, 2023 at $&lt;span id="xdx_909_eus-gaap--AdjustmentOfWarrantsGrantedForServices_c20230106__20230106__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember_zVK9ReFSDJd5" title="Warrants granted"&gt;3,715,557&lt;/span&gt;, and discounted the note payable
to $&lt;span id="xdx_90B_eus-gaap--NotesPayable_iI_c20230106__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember_z2H7vrJjgBTd" title="Notes payable"&gt;0&lt;/span&gt; and recorded a derivative expense of $&lt;span id="xdx_907_ecustom--DerivativeExpense_c20230731__20230731__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember_z15ZE4xrE1r4" title="Derivative expense"&gt;1,715,557&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
derivative liability was valued at $&lt;span id="xdx_90C_eus-gaap--DerivativeLiabilityFairValueOfCollateral_iI_c20230731__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember_zrnSzUdYfaj7" title="Fair value derivate liability"&gt;2,139,666&lt;/span&gt; and $&lt;span id="xdx_90C_eus-gaap--DerivativeLiabilityFairValueOfCollateral_iI_c20230430__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember_zLGpciGq1FP2" title="Fair value derivate liability"&gt;2,814,738&lt;/span&gt; as of July 31, 2023 and April 30, 2023, respectively. The Company recognized
a gain on the change in fair value of the derivative liability when remeasured for the three months ended July 31, 2023 of $&lt;span id="xdx_904_ecustom--IncreaseDecreaseInDerivativeFairValueLiability_c20230501__20230731_zYMfT4btlKLa" title="Derivative liability"&gt;675,072&lt;/span&gt;.
In addition, the Company recognized $&lt;span id="xdx_90B_eus-gaap--AmortizationOfDebtDiscountPremium_c20230501__20230731__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember_zzLDniOtYGIi" title="Amortization of debt discount"&gt;777,192&lt;/span&gt; in amortization of debt discount for the three months ended July 31, 2023. On July 6, 2023,
the Company failed to repay the note and is currently in default. The interest rate has since increased to &lt;span id="xdx_900_eus-gaap--DebtInstrumentInterestRateIncreaseDecrease_dp_c20230501__20230731_z5iwB9SBnLJb" title="Interest rate, increase"&gt;6.43&lt;/span&gt;% per annum.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Meged
Agreement&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
June 8, 2023, the Company entered into a merchant cash advance agreement with Meged Funding Group (&#x201c;Meged&#x201d;) pursuant to which
the Company sold $&lt;span id="xdx_903_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20230608__20230608__us-gaap--TypeOfArrangementAxis__custom--MegedAgreementMember_zcNcGV8iRhV6" title="Sale of stock"&gt;315,689&lt;/span&gt; in future receivables to Meged (the &#x201c;Meged Receivables Purchased Amount&#x201d;) to in exchange for payment
to the Company of $&lt;span id="xdx_908_eus-gaap--StockRedeemedOrCalledDuringPeriodValue_c20230608__20230608__us-gaap--TypeOfArrangementAxis__custom--MegedAgreementMember_zlvtKtDWDJX1" title="Stock redeemed value"&gt;210,600&lt;/span&gt; in cash less fees of $&lt;span id="xdx_904_eus-gaap--LegalFees_c20230608__20230608__us-gaap--TypeOfArrangementAxis__custom--MegedAgreementMember_zkJCMoIB6TYf" title="Legal fees"&gt;10,580&lt;/span&gt;. The Company agreed to pay Meged $&lt;span id="xdx_902_eus-gaap--RepaymentsOfOtherDebt_c20230608__20230608__us-gaap--TypeOfArrangementAxis__custom--MegedAgreementMember_zmzFEul5yRE9" title="Debt repayment"&gt;17,538&lt;/span&gt; each week until the Meged Receivables
Purchased Amount is paid in full.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:LongTermDebtTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2021-04-102021-04-11_custom_PromissoryNotePayableMember"
      decimals="INF"
      unitRef="Shares">681</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:DebtConversionOriginalDebtInterestRateOfDebt
      contextRef="From2021-04-102021-04-11_custom_PromissoryNotePayableMember"
      decimals="INF"
      unitRef="Pure">0.20</us-gaap:DebtConversionOriginalDebtInterestRateOfDebt>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="AsOf2021-04-11_custom_PromissoryNotePayableMember"
      decimals="0"
      unitRef="USD">1500000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="AsOf2021-04-11_custom_PromissoryNotePayableMember"
      decimals="0"
      unitRef="USD">1500000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="AsOf2021-04-11_custom_PromissoryNotePayableMember"
      decimals="0"
      unitRef="USD">1500000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2021-04-102021-04-11"
      decimals="0"
      unitRef="USD">1501914</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2021-04-102021-04-11"
      decimals="0"
      unitRef="USD">1250004</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DerivativeLiabilities
      contextRef="AsOf2021-04-11_us-gaap_ValuationTechniqueOptionPricingModelMember"
      decimals="0"
      unitRef="USD">1251910</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="AsOf2023-04-30_custom_PromissoryNotePayableMember"
      decimals="0"
      unitRef="USD">1456854</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="AsOf2022-04-30_custom_PromissoryNotePayableMember"
      decimals="0"
      unitRef="USD">1456854</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:BusinessCombinationConsiderationTransferredOther1
      contextRef="From2022-02-142022-02-15"
      decimals="0"
      unitRef="USD">4000000</us-gaap:BusinessCombinationConsiderationTransferredOther1>
    <CNXA:NumberOfConsignedGoods
      contextRef="From2022-02-142022-02-15"
      decimals="INF"
      unitRef="Integer">13000</CNXA:NumberOfConsignedGoods>
    <CNXA:PaymentsOfRelatedPartyDebt
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">4000000</CNXA:PaymentsOfRelatedPartyDebt>
    <CNXA:PaymentsOfRelatedPartyDebt
      contextRef="From2021-05-012022-07-31"
      decimals="0"
      unitRef="USD">1559109</CNXA:PaymentsOfRelatedPartyDebt>
    <us-gaap:NotesPayable
      contextRef="AsOf2022-04-01_custom_NotesPayableMember"
      decimals="0"
      unitRef="USD">500000</us-gaap:NotesPayable>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2022-04-012022-04-01">2022-07-01</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2022-04-01_custom_NotesPayableMember"
      decimals="INF"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <CNXA:PaymentsOfRelatedPartyDebt
      contextRef="From2022-08-012022-08-01"
      decimals="0"
      unitRef="USD">500000</CNXA:PaymentsOfRelatedPartyDebt>
    <us-gaap:SaleOfStockConsiderationReceivedPerTransaction
      contextRef="From2022-07-292022-07-29_custom_UFSAgreementMember"
      decimals="0"
      unitRef="USD">1124250</us-gaap:SaleOfStockConsiderationReceivedPerTransaction>
    <us-gaap:PaymentsToAcquireReceivables
      contextRef="From2022-07-292022-07-29_custom_UFSAgreementMember"
      decimals="0"
      unitRef="USD">750000</us-gaap:PaymentsToAcquireReceivables>
    <CNXA:CashLessFees
      contextRef="From2022-07-292022-07-29_custom_UFSAgreementMember"
      decimals="0"
      unitRef="USD">60000</CNXA:CashLessFees>
    <us-gaap:PaymentsToAcquireReceivables
      contextRef="From2022-07-292022-07-29_custom_UFSAgreementMember_custom_EachWeekForNextThreeWeeksMember"
      decimals="0"
      unitRef="USD">13491</us-gaap:PaymentsToAcquireReceivables>
    <us-gaap:PaymentsToAcquireReceivables
      contextRef="From2022-07-292022-07-29_custom_UFSAgreementMember_custom_ThereafterPerWeekMember"
      decimals="0"
      unitRef="USD">44970</us-gaap:PaymentsToAcquireReceivables>
    <us-gaap:SaleOfStockConsiderationReceivedPerTransaction
      contextRef="From2022-07-292022-07-29_custom_CedarAgreementMember"
      decimals="0"
      unitRef="USD">1124250</us-gaap:SaleOfStockConsiderationReceivedPerTransaction>
    <us-gaap:PaymentsToAcquireReceivables
      contextRef="From2022-07-292022-07-29_custom_CedarAgreementMember"
      decimals="0"
      unitRef="USD">750000</us-gaap:PaymentsToAcquireReceivables>
    <CNXA:CashLessFees
      contextRef="From2022-07-292022-07-29_custom_CedarAgreementMember"
      decimals="0"
      unitRef="USD">60000</CNXA:CashLessFees>
    <us-gaap:PaymentsToAcquireReceivables
      contextRef="From2022-07-292022-07-29_custom_CedarAgreementMember_custom_EachWeekForNextThreeWeeksMember"
      decimals="0"
      unitRef="USD">13491</us-gaap:PaymentsToAcquireReceivables>
    <us-gaap:PaymentsToAcquireReceivables
      contextRef="From2022-07-292022-07-29_custom_CedarAgreementMember_custom_ThereafterPerWeekMember"
      decimals="0"
      unitRef="USD">44970</us-gaap:PaymentsToAcquireReceivables>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2023-01-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember_srt_MaximumMember"
      decimals="0"
      unitRef="USD">2000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="From2023-01-042023-01-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember_custom_NotesMember"
      decimals="0"
      unitRef="USD">1400000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2023-01-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember"
      decimals="INF"
      unitRef="USDPShares">8.84</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="AsOf2023-01-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember_srt_MaximumMember"
      decimals="INF"
      unitRef="Shares">452489</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2023-01-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember"
      decimals="INF"
      unitRef="USDPShares">8.84</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="From2023-01-042023-01-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember"
      decimals="0"
      unitRef="USD">600000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:AdjustmentOfWarrantsGrantedForServices
      contextRef="From2023-01-062023-01-06_us-gaap_WarrantMember_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember"
      decimals="0"
      unitRef="USD">3715557</us-gaap:AdjustmentOfWarrantsGrantedForServices>
    <us-gaap:NotesPayable
      contextRef="AsOf2023-01-06_us-gaap_WarrantMember_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember"
      decimals="0"
      unitRef="USD">0</us-gaap:NotesPayable>
    <CNXA:DerivativeExpense
      contextRef="From2023-07-312023-07-31_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember"
      decimals="0"
      unitRef="USD">1715557</CNXA:DerivativeExpense>
    <us-gaap:DerivativeLiabilityFairValueOfCollateral
      contextRef="AsOf2023-07-31_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember"
      decimals="0"
      unitRef="USD">2139666</us-gaap:DerivativeLiabilityFairValueOfCollateral>
    <us-gaap:DerivativeLiabilityFairValueOfCollateral
      contextRef="AsOf2023-04-30_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember"
      decimals="0"
      unitRef="USD">2814738</us-gaap:DerivativeLiabilityFairValueOfCollateral>
    <CNXA:IncreaseDecreaseInDerivativeFairValueLiability
      contextRef="From2023-05-01to2023-07-31"
      decimals="0"
      unitRef="USD">675072</CNXA:IncreaseDecreaseInDerivativeFairValueLiability>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2023-05-012023-07-31_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember"
      decimals="0"
      unitRef="USD">777192</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:DebtInstrumentInterestRateIncreaseDecrease
      contextRef="From2023-05-01to2023-07-31"
      decimals="INF"
      unitRef="Pure">0.0643</us-gaap:DebtInstrumentInterestRateIncreaseDecrease>
    <us-gaap:SaleOfStockConsiderationReceivedPerTransaction
      contextRef="From2023-06-082023-06-08_custom_MegedAgreementMember"
      decimals="0"
      unitRef="USD">315689</us-gaap:SaleOfStockConsiderationReceivedPerTransaction>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue
      contextRef="From2023-06-082023-06-08_custom_MegedAgreementMember"
      decimals="0"
      unitRef="USD">210600</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
    <us-gaap:LegalFees
      contextRef="From2023-06-082023-06-08_custom_MegedAgreementMember"
      decimals="0"
      unitRef="USD">10580</us-gaap:LegalFees>
    <us-gaap:RepaymentsOfOtherDebt
      contextRef="From2023-06-082023-06-08_custom_MegedAgreementMember"
      decimals="0"
      unitRef="USD">17538</us-gaap:RepaymentsOfOtherDebt>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2023-05-01to2023-07-31">&lt;p id="xdx_808_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_ztX1anZXdfRb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
10: &lt;span id="xdx_820_zXFBXyalPQY9"&gt;RELATED PARTY TRANSACTIONS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
support of the Company&#x2019;s efforts and cash requirements, it may rely on advances from related parties until such time that the Company
can support its operations or attain adequate financing through sales of its equity or traditional debt financing. There is no formal
written commitment for continued support by officers, directors, or shareholders. Amounts represent advances, amounts paid in satisfaction
of liabilities, or accrued compensation that has been deferred. The advances are considered temporary in nature and have not been formalized
by a promissory note.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has outstanding notes payable of &lt;span style="background-color: white"&gt;$&lt;span id="xdx_909_eus-gaap--NotesPayable_iI_pp0p0_c20230731__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zMDSztotECJ2" title="Outstanding notes payable"&gt;1,655,966&lt;/span&gt; and $&lt;span id="xdx_90C_eus-gaap--NotesPayable_iI_pp0p0_c20230430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zfieMaFOM2O7" title="Outstanding notes payable"&gt;1,953,842&lt;/span&gt;&lt;/span&gt; and accrued interest
of $&lt;span id="xdx_90F_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20230731__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zyXBQqWdPbz6" title="Accrued interest - related party"&gt;917,957&lt;/span&gt; and $&lt;span id="xdx_906_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20230430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zgplJo3AVHTe" title="Accrued interest - related party"&gt;917,957&lt;/span&gt; due to a related party as of July 31, 2023 and April 30, 2023, respectively (see Note 7).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognized net sales of $&lt;span id="xdx_904_eus-gaap--Revenues_pp0p0_c20230501__20230731__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zCWCen2MXLa9" title="Revenue from related parties"&gt;50,900&lt;/span&gt; and $&lt;span id="xdx_90F_eus-gaap--Revenues_pp0p0_c20220501__20220731__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zk3PxjAjZKHb" title="Revenue from related parties"&gt;91,200&lt;/span&gt; during the three months ended July 31, 2023 and 2022, respectively, to related parties.
As of July 31, 2023 and 2022, related parties had accounts receivable due to the Company of $&lt;span id="xdx_90F_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20230731__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zkS3JQ5C1Yx3" title="Outstanding accounts receivable"&gt;28,800&lt;/span&gt; and $&lt;span id="xdx_90E_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20220731__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zeaL1kmQS1m9" title="Outstanding accounts receivable"&gt;28,800&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:NotesPayable
      contextRef="AsOf2023-07-31_us-gaap_RelatedPartyMember"
      decimals="0"
      unitRef="USD">1655966</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="AsOf2023-04-30_us-gaap_RelatedPartyMember"
      decimals="0"
      unitRef="USD">1953842</us-gaap:NotesPayable>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2023-07-31_us-gaap_RelatedPartyMember"
      decimals="0"
      unitRef="USD">917957</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2023-04-30_us-gaap_RelatedPartyMember"
      decimals="0"
      unitRef="USD">917957</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:Revenues
      contextRef="From2023-05-012023-07-31_us-gaap_RelatedPartyMember"
      decimals="0"
      unitRef="USD">50900</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2022-05-012022-07-31_us-gaap_RelatedPartyMember"
      decimals="0"
      unitRef="USD">91200</us-gaap:Revenues>
    <us-gaap:AccountsReceivableNet
      contextRef="AsOf2023-07-31_us-gaap_RelatedPartyMember"
      decimals="0"
      unitRef="USD">28800</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableNet
      contextRef="AsOf2022-07-31_us-gaap_RelatedPartyMember"
      decimals="0"
      unitRef="USD">28800</us-gaap:AccountsReceivableNet>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2023-05-01to2023-07-31">&lt;p id="xdx_804_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zFiOa0dq6LO1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
11: &lt;span id="xdx_829_zBTlGZIYTUa"&gt;SHAREHOLDERS&#x2019; EQUITY (DEFICIT)&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Common
Stock&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has &lt;span id="xdx_905_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20230731_z6u19YQESDOj" title="Common stock, shares authorized"&gt;300,000,000&lt;/span&gt; shares of common stock authorized with a par value of $&lt;span id="xdx_907_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20230731_zqGmQen3E37i" title="Common stock, par value"&gt;0.001&lt;/span&gt; per share. As of July 31, 2023 and April 30, 2023,
the Company had &lt;span id="xdx_900_eus-gaap--CommonStockSharesIssued_iI_c20230731_zPMbFx0yGZze" title="Common stock, shares issued"&gt;&lt;span id="xdx_90F_eus-gaap--CommonStockSharesOutstanding_iI_c20230731_zFwg4tf7gOb4" title="Common stock, shares outstanding"&gt;528,297&lt;/span&gt;&lt;/span&gt; and &lt;span id="xdx_903_eus-gaap--CommonStockSharesIssued_iI_c20230430_z6cRESjqlU1l" title="Common stock, shares issued"&gt;&lt;span id="xdx_90C_eus-gaap--CommonStockSharesOutstanding_iI_c20230430_zA0238zczz3" title="Common stock, shares outstanding"&gt;338,579&lt;/span&gt;&lt;/span&gt; shares of common stock issued and outstanding, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
the period May 1, 2023 through July 31, 2023, the Company issued &lt;span id="xdx_90C_eus-gaap--SharesIssued_iI_c20230731_zGB3SCqNKyZh" title="Shares, issued"&gt;189,718&lt;/span&gt; shares of common stock to ambassadors under their agreements
(&lt;span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230501__20230731_zqFXHEaRPRK2" title="Number of shares issued during the period"&gt;188&lt;/span&gt;), to vendors in settlement of accounts payable (&lt;span id="xdx_90B_ecustom--StockIssuedDuringPeriodSharesIssuedSettlementOfAccountsPayable_c20230501__20230731_zWaxfldn73B4" title="Stock issued during period, shares, issued for settlement of accounts payable"&gt;67,500&lt;/span&gt;), for settlement with former owners of FSS (&lt;span id="xdx_90C_ecustom--StockIssuedDuringPeriodSharesIssuedSettlementWithFormerOwners_c20230501__20230731_zPQkhnUJULai" title="Stock issued during period, shares, issued for settlement with former owners"&gt;1,350&lt;/span&gt;), for the exercise of warrants
(&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20230501__20230731_zcW8tZjeITub" title="Exercise of warrants, shares"&gt;27,000&lt;/span&gt;) and to satisfy the profit guarantee on a note (&lt;span id="xdx_906_ecustom--StockIssuedDuringPeriodSharesIssuedProfitGuaranteeOnNote_c20230501__20230731_zxKbEevQ2QL9" title="Profit guarantee on note, shares"&gt;93,680&lt;/span&gt;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Equity
Transactions During the Year Ended April 30, 2023&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has issued an aggregate of &lt;span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220501__20230430_zLMHSjhBqfZ1" title="Number of common stock, shares issued"&gt;151,579&lt;/span&gt; shares of its common stock consisting of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
    June 15, 2022, the Company issued &lt;span id="xdx_901_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pid_c20220615__20220615_zVVN5WVq72t1" title="Debt conversion of convertible notes, shares"&gt;109,737&lt;/span&gt; shares of common stock to the Convertible Noteholders upon conversion of convertible notes.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
    June 15, 2022, the Company issued &lt;span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220615__20220615__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_z5EW015SOjxb" title="Number of common stock, shares issued"&gt;26,219&lt;/span&gt; shares to investors who participated in the Company&#x2019;s Nasdaq uplist round.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
    June 27, 2022, the Company issued &lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20220627__20220627__srt--TitleOfIndividualAxis__custom--GabrielGoldmanMember_zOyzqycg5le5" title="Number of common stock, shares for services"&gt;625&lt;/span&gt; shares of common stock to Gabriel Goldman for consulting services performed in the first quarter
    of calendar 2022. Gabriel Goldman became a director of the Company on June 15, 2022.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
    June 27, 2022, the Company issued &lt;span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220627__20220627__dei--LegalEntityAxis__custom--GamefaceAIMember_z8US1zG0EuV7" title="Number of common stock, shares issued"&gt;14,960&lt;/span&gt; shares of common stock to the former Gameface shareholders in connection with the purchase
    of Gameface. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            August 25, 2022, the Company issued &lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220825__20220825__dei--LegalEntityAxis__custom--MidcityCapitalLtdMember_zqAbEvmelHXb" title="Number of common stock, shares issued"&gt;750&lt;/span&gt; shares of common stock to Midcity Capital Ltd (&#x201c;Midcity&#x201d;)
                                            pursuant to a cashless conversion of warrants Midcity received from its warrant agreement
                                            with the Company dated March 2020.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
    September 28, 2022, the Company entered into a securities purchase agreement (the &#x201c;Securities Purchase Agreement&#x201d;) with
    a single institutional investor (the &#x201c;Investor&#x201d;) for the issuance and sale of (i) &lt;span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220928__20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zEAr7Dn7PT73"&gt;25,463
    &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock and (ii) pre-funded
    warrants (the &#x201c;Pre-Funded Warrants&#x201d;) to purchase an aggregate of &lt;span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zNRWXEzs1sBc"&gt;295,050
    &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of its common stock, together with
    accompanying common stock warrants, at a combined purchase price of $&lt;span id="xdx_904_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zNSKTWMy3mV"&gt;15.60
    &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share of the common stock and associated
    common stock warrant and $&lt;span id="xdx_904_ecustom--WarrantPerShare_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_ziC3L3Msqypi"&gt;15.596
    &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per Pre-Funded Warrant and associated common
    stock warrants for an aggregate amount of approximately $&lt;span id="xdx_904_eus-gaap--WarrantsAndRightsOutstanding_iI_pn5n6_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zZBbxXyALJQf"&gt;5.0
    &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;million (the &#x201c;Offering&#x201d;). The
    Pre-Funded Warrants have an exercise price of $&lt;span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zt1R1zNansKf"&gt;0.0004
    &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share of common stock and are exercisable
    until the Pre-Funded Warrants are exercised in full. The shares of common stock and Pre-Funded Warrants were sold in the offering
    together with common stock warrants to purchase &lt;span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--FiveYearWarrantsMember_zFl047dNUglc"&gt;320,513
    &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock at an exercise price
    of $&lt;span id="xdx_904_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--FiveYearWarrantsMember_zTy7fFHPKFs4"&gt;15.60
    &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share and a term of five years following
    the initial exercise date (the &#x201c;5-Year Warrants&#x201d;) and &lt;span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220928__20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--SevenYearWarrantsMember_z1W8xEemzbS"&gt;641,026
    &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;common stock warrants to purchase &lt;span id="xdx_904_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--SevenPointFiveYearWarrantsMember_zWrUgZEuscf6"&gt;641,026
    &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock at an exercise price
    of $&lt;span id="xdx_905_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--SevenPointFiveYearWarrantsMember_zRt6LcJKfH3j"&gt;17.20
    &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share and a term of seven and one half
    years (the &#x201c;7.5-Year Warrants&#x201d;) following the initial exercise date (collectively, the &#x201c;Warrants&#x201d;). The Warrants
    issued in the Offering contain variable pricing features. The Warrants and Pre-Funded Warrants will be exercisable beginning on the
    date stockholder approval is received and effective allowing exercisability of the Warrants and Pre-Funded Warrants under Nasdaq
    rules. Net proceeds to the Company were $&lt;span id="xdx_907_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20220928__20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zLxJbyF4qYA9"&gt;4,549,882&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
    October 12, 2022, the Company issued &lt;span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20221012__20221012_zqqGfJFPVi4j" title="Shares issued for acquisition"&gt;48,098&lt;/span&gt; shares of common stock, on November 21, 2022 issued &lt;span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20221121__20221121_zn5om8i945bi" title="Shares issued for acquisition"&gt;675&lt;/span&gt; shares of common stock and January
    26, 2023 issued &lt;span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20230126__20230126_zEJqt4NF9Ff9" title="Shares issued for acquisition"&gt;6,993&lt;/span&gt; shares of common stock in connection with the acquisition of PlaySight.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
    January 26, 2023, the Company issued &lt;span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20230126__20230126_zbzEyY8oED56" title="Shares issued for services"&gt;150&lt;/span&gt; shares of common stock for services rendered to their ambassadors.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has not granted any warrants for the three months ended July 31, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Warrants
Granted During the Year Ended April 30, 2023&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September 28, 2022, the Company entered into a securities purchase agreement (the &#x201c;Securities Purchase Agreement&#x201d;) with a
single institutional investor (the &#x201c;Investor&#x201d;) for the issuance and sale of (i) &lt;span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220928__20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zPBVO4Wkbcof"&gt;25,463
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock and (ii) pre-funded warrants
(the &#x201c;Pre-Funded Warrants&#x201d;) to purchase an aggregate of &lt;span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zj75Eba8GHT5"&gt;295,050
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of its common stock, together with accompanying
common stock warrants, at a combined purchase price of $&lt;span id="xdx_904_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_z5d0PNcEZor3"&gt;15.60
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share of the common stock and associated
common stock warrant and $&lt;span id="xdx_90C_ecustom--WarrantPerShare_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zYbOSycnhwCk"&gt;15.596
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per Pre-Funded Warrant and associated common
stock warrants for an aggregate amount of approximately $&lt;span id="xdx_903_eus-gaap--WarrantsAndRightsOutstanding_iI_pn5n6_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zhEGqkHNs4q2"&gt;5.0
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;million (the &#x201c;Offering&#x201d;). The Pre-Funded
Warrants have an exercise price of $&lt;span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zZVaxX3BNoJk"&gt;0.0004
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share of common stock and are exercisable
until the Pre-Funded Warrants are exercised in full. The shares of common stock and Pre-Funded Warrants were sold in the offering together
with common stock warrants to purchase &lt;span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--FiveYearWarrantsMember_z1zWWlUQIkN8"&gt;320,513
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock at an exercise price of
$&lt;span id="xdx_904_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--FiveYearWarrantsMember_zQNCYbEegTS8"&gt;15.60
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share and a term of five years following
the initial exercise date (the &#x201c;5-Year Warrants&#x201d;) and &lt;span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220928__20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--SevenPointFiveYearWarrantsMember_z0Az8mwMhSa"&gt;641,026
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;common stock warrants to purchase &lt;span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--SevenPointFiveYearWarrantsMember_zXB6PPbx2At4"&gt;641,026
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock at an exercise price of
$&lt;span id="xdx_905_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--SevenPointFiveYearWarrantsMember_zL0xkE54lbMg"&gt;17.20
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share and a term of seven and one half years
(the &#x201c;7.5-Year Warrants&#x201d;) following the initial exercise date (collectively, the &#x201c;Warrants&#x201d;). The Warrants issued
in the Offering contain variable pricing features. The Warrants and Pre-Funded Warrants became exercisable beginning on the date stockholder
approval was received and effective allowing exercisability of the Warrants and Pre-Funded Warrants under Nasdaq rules. The exercise
price of the Warrants was reset in January 2023 to $&lt;span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230131__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_z0dqSJawS6I1"&gt;8.84
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share and in October 2023 to $&lt;span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20231031__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zULTXh6WUJN1"&gt;3.55
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 6, 2023, the Company entered into a loan and security agreement (the &#x201c;Loan and Security Agreement&#x201d;) with one or more
institutional investors (the &#x201c;Lenders&#x201d;) and Armistice Capital Master Fund Ltd. as agent for the Lenders (the &#x201c;Agent&#x201d;)
for the issuance and sale of (i) a note in an aggregate principal amount of up to $&lt;span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_c20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember__srt--RangeAxis__srt--MaximumMember_zGvlCOUpRUx5"&gt;2,000,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(the &#x201c;Note&#x201d;) at &lt;span id="xdx_907_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember__srt--RangeAxis__srt--MaximumMember_z0n0MFoFxKzk"&gt;4.33&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%
interest per annum unless in default, with the initial advance under the Loan and Security Agreement being $&lt;span id="xdx_902_eus-gaap--ProceedsFromNotesPayable_c20230104__20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember__us-gaap--ShortTermDebtTypeAxis__custom--NotesMember_zESWNTzFj6bj"&gt;1,400,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;and (ii) warrants (the &#x201c;Warrants&#x201d;)
to purchase a number of shares of common stock of the Company equal to 200% of the face amount of the Note divided by the closing price
of the common stock of the Company on the date of the issuance of the Notes (collectively, the &#x201c;Initial Issuance&#x201d;). The closing
price of the Company&#x2019;s common stock on January 6, 2023, as reported by Nasdaq, was $&lt;span id="xdx_903_ecustom--SharesIssuedPricePerShares_iI_pid_c20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember_zCyflaimytJb"&gt;0.221
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share (or &lt;span id="xdx_903_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember_zkI6lBmBM1if"&gt;8.84
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share after adjusting for the one-for-forty
(1-for-40) reverse stock split), so the Warrants in respect of the initial advance under the Note are exercisable for up to &lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember__srt--RangeAxis__srt--MaximumMember_zkYf6spSb78g"&gt;452,489
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of the Company&#x2019;s common stock. The
Warrants have an exercise price per share equal to the closing price of the common stock of the Company on the date of the issuance of
the Note, or $&lt;span id="xdx_909_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember_zH3PN1RLgy08"&gt;8.84
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share and a term of five- and one-half (5&#xbd;)
years following the initial exercise date. The exercise price of the Warrants was reset in October 2023 to $&lt;span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember_zcg7OOrczYg4"&gt;3.55
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share The initial exercise date of the
Warrants was the date stockholder approval was received and effective allowing exercisability of the Warrants under Nasdaq rules. Pursuant
to the terms of the Loan and Security Agreement, an additional advance of $&lt;span id="xdx_90E_eus-gaap--ProceedsFromNotesPayable_c20230104__20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember_z1gwHaLonZWi"&gt;600,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;was made to the Company under the Note which
occurred on February 2, 2023. The Company&#x2019;s obligations under the terms of the Loan and Security Agreement are fully and unconditionally
guaranteed by all of the Company&#x2019;s subsidiaries (the &#x201c;Guarantors&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2023-07-31" decimals="INF" unitRef="Shares">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-07-31"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2023-07-31" decimals="INF" unitRef="Shares">528297</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2023-07-31" decimals="INF" unitRef="Shares">528297</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2023-04-30" decimals="INF" unitRef="Shares">338579</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2023-04-30" decimals="INF" unitRef="Shares">338579</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:SharesIssued contextRef="AsOf2023-07-31" decimals="INF" unitRef="Shares">189718</us-gaap:SharesIssued>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-05-01to2023-07-31"
      decimals="0"
      unitRef="USD">188</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <CNXA:StockIssuedDuringPeriodSharesIssuedSettlementOfAccountsPayable
      contextRef="From2023-05-01to2023-07-31"
      decimals="INF"
      unitRef="Shares">67500</CNXA:StockIssuedDuringPeriodSharesIssuedSettlementOfAccountsPayable>
    <CNXA:StockIssuedDuringPeriodSharesIssuedSettlementWithFormerOwners
      contextRef="From2023-05-01to2023-07-31"
      decimals="INF"
      unitRef="Shares">1350</CNXA:StockIssuedDuringPeriodSharesIssuedSettlementWithFormerOwners>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
      contextRef="From2023-05-01to2023-07-31"
      decimals="INF"
      unitRef="Shares">27000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised>
    <CNXA:StockIssuedDuringPeriodSharesIssuedProfitGuaranteeOnNote
      contextRef="From2023-05-01to2023-07-31"
      decimals="INF"
      unitRef="Shares">93680</CNXA:StockIssuedDuringPeriodSharesIssuedProfitGuaranteeOnNote>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-05-012023-04-30"
      decimals="INF"
      unitRef="Shares">151579</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="From2022-06-152022-06-15"
      decimals="INF"
      unitRef="Shares">109737</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-06-152022-06-15_us-gaap_InvestorMember"
      decimals="INF"
      unitRef="Shares">26219</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2022-06-272022-06-27_custom_GabrielGoldmanMember"
      decimals="INF"
      unitRef="Shares">625</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-06-272022-06-27_custom_GamefaceAIMember"
      decimals="INF"
      unitRef="Shares">14960</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-08-252022-08-25_custom_MidcityCapitalLtdMember"
      decimals="INF"
      unitRef="Shares">750</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-09-282022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember"
      decimals="INF"
      unitRef="Shares">25463</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember"
      decimals="INF"
      unitRef="Shares">295050</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember"
      decimals="INF"
      unitRef="USDPShares">15.60</us-gaap:CommonStockParOrStatedValuePerShare>
    <CNXA:WarrantPerShare
      contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember"
      decimals="INF"
      unitRef="USDPShares">15.596</CNXA:WarrantPerShare>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember"
      decimals="-5"
      unitRef="USD">5000000.0</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember"
      decimals="INF"
      unitRef="USDPShares">0.0004</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_custom_FiveYearWarrantsMember"
      decimals="INF"
      unitRef="Shares">320513</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_custom_FiveYearWarrantsMember"
      decimals="INF"
      unitRef="USDPShares">15.60</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-09-282022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_custom_SevenYearWarrantsMember"
      decimals="INF"
      unitRef="Shares">641026</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_custom_SevenPointFiveYearWarrantsMember"
      decimals="INF"
      unitRef="Shares">641026</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_custom_SevenPointFiveYearWarrantsMember"
      decimals="INF"
      unitRef="USDPShares">17.20</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2022-09-282022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember"
      decimals="0"
      unitRef="USD">4549882</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2022-10-122022-10-12"
      decimals="INF"
      unitRef="Shares">48098</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2022-11-212022-11-21"
      decimals="INF"
      unitRef="Shares">675</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2023-01-262023-01-26"
      decimals="INF"
      unitRef="Shares">6993</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2023-01-262023-01-26"
      decimals="INF"
      unitRef="Shares">150</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-09-282022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember"
      decimals="INF"
      unitRef="Shares">25463</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember"
      decimals="INF"
      unitRef="Shares">295050</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember"
      decimals="INF"
      unitRef="USDPShares">15.60</us-gaap:CommonStockParOrStatedValuePerShare>
    <CNXA:WarrantPerShare
      contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember"
      decimals="INF"
      unitRef="USDPShares">15.596</CNXA:WarrantPerShare>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember"
      decimals="-5"
      unitRef="USD">5000000.0</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember"
      decimals="INF"
      unitRef="USDPShares">0.0004</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_custom_FiveYearWarrantsMember"
      decimals="INF"
      unitRef="Shares">320513</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_custom_FiveYearWarrantsMember"
      decimals="INF"
      unitRef="USDPShares">15.60</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-09-282022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_custom_SevenPointFiveYearWarrantsMember"
      decimals="INF"
      unitRef="Shares">641026</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_custom_SevenPointFiveYearWarrantsMember"
      decimals="INF"
      unitRef="Shares">641026</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_custom_SevenPointFiveYearWarrantsMember"
      decimals="INF"
      unitRef="USDPShares">17.20</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2023-01-31_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember"
      decimals="INF"
      unitRef="USDPShares">8.84</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2023-10-31_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember"
      decimals="INF"
      unitRef="USDPShares">3.55</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2023-01-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember_srt_MaximumMember"
      decimals="0"
      unitRef="USD">2000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="AsOf2023-01-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember_srt_MaximumMember"
      decimals="INF"
      unitRef="Pure">0.0433</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="From2023-01-042023-01-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember_custom_NotesMember"
      decimals="0"
      unitRef="USD">1400000</us-gaap:ProceedsFromNotesPayable>
    <CNXA:SharesIssuedPricePerShares
      contextRef="AsOf2023-01-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember"
      decimals="INF"
      unitRef="USDPShares">0.221</CNXA:SharesIssuedPricePerShares>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2023-01-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember"
      decimals="INF"
      unitRef="USDPShares">8.84</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="AsOf2023-01-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember_srt_MaximumMember"
      decimals="INF"
      unitRef="Shares">452489</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2023-01-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember"
      decimals="INF"
      unitRef="USDPShares">8.84</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2023-01-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember"
      decimals="INF"
      unitRef="USDPShares">3.55</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="From2023-01-042023-01-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember"
      decimals="0"
      unitRef="USD">600000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2023-05-01to2023-07-31">&lt;p id="xdx_80F_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zolbRweiCHJ5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
12: &lt;span id="xdx_82E_zSVzlluGIHLg"&gt;COMMITMENTS AND CONTINGENCIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Leases&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company leases office space under short-term leases with terms under a year. Total rent expense for the three months ended July 31, 2023
and 2022 amounted to $&lt;span id="xdx_90A_eus-gaap--PaymentsForRent_pp0p0_c20230501__20230731_zIpgkLfFn7w4" title="Rent expense"&gt;1,969&lt;/span&gt; and $&lt;span id="xdx_900_eus-gaap--PaymentsForRent_pp0p0_c20220501__20220731_zkgi2HQTfDj5" title="Rent expense"&gt;700&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Contingencies&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the Gameface acquisition on February 2, 2022, the Company agreed to earn-out consideration of common shares of the Company&#x2019;s
common stock with a fair value of $&lt;span id="xdx_908_ecustom--FairValueOfCommonStock_iI_pp0p0_c20230131_z2y6ACVWCork" title="Fair value of common stock"&gt;1,334,000&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company issued &lt;span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20220601__20220630_zjiLZiKbQykd" title="Number of stock issued"&gt;14,960&lt;/span&gt; common shares to the former Gameface shareholders in June 2022. The balance of the contingent consideration as
of July 31, 2023 and April 30, 2023 is $&lt;span id="xdx_900_eus-gaap--BusinessCombinationContingentConsiderationLiability_iI_c20230731_ztO2Gf9dLNn6" title="Balance of contingent consideration"&gt;&lt;span id="xdx_90B_eus-gaap--BusinessCombinationContingentConsiderationLiability_iI_c20230430_zT4nkbrpaxj5" title="Balance of contingent consideration"&gt;418,455&lt;/span&gt;&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;From
time to time, the Company may become involved in legal proceedings arising in the ordinary course of business. The Company is not presently
a party to any legal proceedings that it currently believes would individually or taken together have a material adverse effect on the
Company&#x2019;s business or financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Nasdaq
Compliance&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
July 26, 2023, the Company received a letter from the Listing Qualifications Department of Nasdaq indicating that the Company&#x2019;s
stockholders&#x2019; equity as reported in its Quarterly Report on Form 10-Q for the quarterly period ended January 31, 2023 did not satisfy
the continued listing requirement under Nasdaq Listing Rule 5550(b)(1), which requires that a listed company&#x2019;s stockholders&#x2019;
equity be at least $&lt;span id="xdx_903_eus-gaap--StockholdersEquity_iI_pn5n6_c20230131__srt--RangeAxis__srt--MinimumMember_zAMGyi7Eedjf" title="Stockholders equity"&gt;2.5&lt;/span&gt; million (the &#x201c;Minimum Stockholders&#x2019; Equity Requirement&#x201d;). As reported in its Form 10-Q for
the period ended January 31, 2023, the Company&#x2019;s stockholders&#x2019; equity as of January 31, 2023 was approximately $(&lt;span id="xdx_902_eus-gaap--StockholdersEquity_iI_pn5n6_c20230131_zqYuvOsXPlHl" title="Stockholders equity"&gt;11.7&lt;/span&gt;) million.
In addition, the Company did not meet the alternatives of listed securities or net income from continuing operations as of the date of
the letter. The Nasdaq has given the Company until January 22, 2024 to regain compliance with the Minimum Stockholders&#x2019; Equity
Requirement and net income from continuing operations requirement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company offers no assurance that it will regain compliance with the Minimum Stockholders&#x2019; Equity Requirement
and/or any other delinquency in a timely manner.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:PaymentsForRent
      contextRef="From2023-05-01to2023-07-31"
      decimals="0"
      unitRef="USD">1969</us-gaap:PaymentsForRent>
    <us-gaap:PaymentsForRent
      contextRef="From2022-05-012022-07-31"
      decimals="0"
      unitRef="USD">700</us-gaap:PaymentsForRent>
    <CNXA:FairValueOfCommonStock contextRef="AsOf2023-01-31" decimals="0" unitRef="USD">1334000</CNXA:FairValueOfCommonStock>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2022-06-012022-06-30"
      decimals="INF"
      unitRef="Shares">14960</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="AsOf2023-07-31" decimals="0" unitRef="USD">418455</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">418455</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-01-31_srt_MinimumMember"
      decimals="-5"
      unitRef="USD">2500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2023-01-31" decimals="-5" unitRef="USD">11700000</us-gaap:StockholdersEquity>
    <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock contextRef="From2023-05-01to2023-07-31">&lt;p id="xdx_80A_eus-gaap--DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_zqsTLSMtcog6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
13&lt;/b&gt;: &lt;b&gt;&lt;span id="xdx_822_zOLqE3kwNLeh"&gt;DISCONTINUED OPERATIONS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
November 27, 2022, the Company entered into a share purchase agreement (the &#x201c;Agreement&#x201d;) with PlaySight, Chen Shachar and
Evgeni Khazanov (together, the &#x201c;Buyer&#x201d;) pursuant to which the Buyer purchased &lt;span id="xdx_90D_ecustom--SharesIssuedAndOutstandingPercentage_pid_dp_uPure_c20221125__20221127__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember_zJU0KbEi8TAb" title="Shares issued and outstanding percentage"&gt;100&lt;/span&gt;% of the issued and outstanding shares of
PlaySight from the Company in exchange for &lt;span id="xdx_905_eus-gaap--DisposalGroupIncludingDiscontinuedOperationDescriptionAndTimingOfDisposal_c20221125__20221127__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember_zG6yH5PSSKy8" title="Discontinued operation description"&gt;(1) releasing the Company from all of PlaySight&#x2019;s obligations towards its vendors, employees,
tax authorities and any other (past, current and future) creditors of PlaySight; (2) waiver by the Buyer of 100% of the personal consideration
owed to them under their employment agreements in the total amount of $&lt;span id="xdx_909_eus-gaap--DisposalGroupIncludingDiscontinuedOperationConsideration_iI_c20221127__us-gaap--TypeOfArrangementAxis__custom--EmployeeAgreementMember_zAV7iMwVqdic" title="Personal consideration"&gt;600,000&lt;/span&gt;; and (3) cash consideration of $&lt;span id="xdx_906_eus-gaap--DisposalGroupIncludingDiscontinuedOperationConsideration_iI_c20221127__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember_ztSWoFANk2h3" title="Cash consideration"&gt;2,000,000&lt;/span&gt; to be paid to
the Company in the form of a promissory note that matures on December 31, 2023.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 5, 2022, the Company assigned &lt;span id="xdx_90A_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20221205__srt--OwnershipAxis__custom--FoundationSportsToCharlesRuddyMember_ziH1sCbkdwfd" title="Ownership percentage by parrent"&gt;75&lt;/span&gt;% of its membership interest in Foundation Sports to Charles Ruddy, its founder and granted
him the right for a period of three years to purchase the remaining &lt;span id="xdx_901_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_iI_pid_dp_uPure_c20221205__srt--OwnershipAxis__custom--FoundationSportsToCharlesRuddyMember_zKu9bTBjuC3h" title="Ownership percentage by non-controlling owners"&gt;25&lt;/span&gt;% of its Foundation Sports membership interests for $&lt;span id="xdx_90F_eus-gaap--Cash_iI_c20221205_z77Df8HlJ1E4" title="Cash"&gt;500,000&lt;/span&gt; in
cash. As of December 5, 2022, the results of Foundation Sports will no longer be consolidated in the Company&#x2019;s financial statements,
and the investment was accounted for as an equity method investment. On December 5, 2022, the Company analyzed this investment and established
a reserve for the investment at the full amount of $&lt;span id="xdx_90A_eus-gaap--Investments_iI_c20221205_zKUuewtlAQVk" title="Investments"&gt;500,000&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounted for these sales as a disposal of a business under ASC 205-20-50-1(a). The Company had reclassified the operations of
PlaySight and Foundation Sports as discontinued operations as the disposal represents a strategic shift that will have a major effect
on the Company&#x2019;s operations and financial results.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_897_eus-gaap--ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_zD9USQreYrA2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company reclassified the following operations to discontinued operations for the three months ended July 31, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;span id="xdx_8BF_zlX69MpnFq96" style="display: none"&gt;SCHEDULE OF DISCONTINUED OPERATIONS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20230501__20230731_z6vBlsAeZem6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--DisposalGroupIncludingDiscontinuedOperationRevenue_maDGIDOzOqT_zTX4Zsk8tpa8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 78%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,363,113&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOperatingExpense_msDGIDOzOqT_zN6SKIa4H6Ua" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,278,269&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--DisposalGroupIncludingDiscontinuedOperationOtherIncomeLoss_msDGIDOzOqT_zt6ZTRD3r8wb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other (income) loss&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(155,442&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--DisposalGroupIncludingDiscontinuedOperationNetIncomeLoss_iT_mtDGIDOzOqT_zYbWwszeHEt3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net loss from discontinued
    operations&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,759,714&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AE_znieVEgpL9ag" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
    <CNXA:SharesIssuedAndOutstandingPercentage
      contextRef="From2022-11-252022-11-27_custom_SharePurchaseAgreementMember"
      decimals="INF"
      unitRef="Pure">1</CNXA:SharesIssuedAndOutstandingPercentage>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationDescriptionAndTimingOfDisposal contextRef="From2022-11-252022-11-27_custom_SharePurchaseAgreementMember">(1) releasing the Company from all of PlaySight&#x2019;s obligations towards its vendors, employees,
tax authorities and any other (past, current and future) creditors of PlaySight; (2) waiver by the Buyer of 100% of the personal consideration
owed to them under their employment agreements in the total amount of $600,000; and (3) cash consideration of $2,000,000 to be paid to
the Company in the form of a promissory note that matures on December 31, 2023.</us-gaap:DisposalGroupIncludingDiscontinuedOperationDescriptionAndTimingOfDisposal>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="AsOf2022-11-27_custom_EmployeeAgreementMember"
      decimals="0"
      unitRef="USD">600000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="AsOf2022-11-27_custom_SharePurchaseAgreementMember"
      decimals="0"
      unitRef="USD">2000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="AsOf2022-12-05_custom_FoundationSportsToCharlesRuddyMember"
      decimals="INF"
      unitRef="Pure">0.75</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="AsOf2022-12-05_custom_FoundationSportsToCharlesRuddyMember"
      decimals="INF"
      unitRef="Pure">0.25</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:Cash contextRef="AsOf2022-12-05" decimals="0" unitRef="USD">500000</us-gaap:Cash>
    <us-gaap:Investments contextRef="AsOf2022-12-05" decimals="0" unitRef="USD">500000</us-gaap:Investments>
    <us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock contextRef="From2023-05-01to2023-07-31">&lt;p id="xdx_897_eus-gaap--ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_zD9USQreYrA2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company reclassified the following operations to discontinued operations for the three months ended July 31, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;span id="xdx_8BF_zlX69MpnFq96" style="display: none"&gt;SCHEDULE OF DISCONTINUED OPERATIONS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20230501__20230731_z6vBlsAeZem6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--DisposalGroupIncludingDiscontinuedOperationRevenue_maDGIDOzOqT_zTX4Zsk8tpa8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 78%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,363,113&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOperatingExpense_msDGIDOzOqT_zN6SKIa4H6Ua" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,278,269&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--DisposalGroupIncludingDiscontinuedOperationOtherIncomeLoss_msDGIDOzOqT_zt6ZTRD3r8wb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other (income) loss&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(155,442&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--DisposalGroupIncludingDiscontinuedOperationNetIncomeLoss_iT_mtDGIDOzOqT_zYbWwszeHEt3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net loss from discontinued
    operations&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,759,714&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue
      contextRef="From2023-05-01to2023-07-31"
      decimals="0"
      unitRef="USD">1363113</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense
      contextRef="From2023-05-01to2023-07-31"
      decimals="0"
      unitRef="USD">3278269</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense>
    <CNXA:DisposalGroupIncludingDiscontinuedOperationOtherIncomeLoss
      contextRef="From2023-05-01to2023-07-31"
      decimals="0"
      unitRef="USD">-155442</CNXA:DisposalGroupIncludingDiscontinuedOperationOtherIncomeLoss>
    <CNXA:DisposalGroupIncludingDiscontinuedOperationNetIncomeLoss
      contextRef="From2023-05-01to2023-07-31"
      decimals="0"
      unitRef="USD">-1759714</CNXA:DisposalGroupIncludingDiscontinuedOperationNetIncomeLoss>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2023-05-01to2023-07-31">&lt;p id="xdx_805_eus-gaap--SubsequentEventsTextBlock_zwySO9EnbtKi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
14: &lt;span id="xdx_829_zEX5YMHawsth"&gt;SUBSEQUENT EVENTS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;From
August 1, 2023 through the date hereof, the Company issued the following shares of common stock:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 1, 2023, the Company issued &lt;span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230801__20230801__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zy8F1mTvx409" title="Shares issued"&gt;31,042&lt;/span&gt; shares of common stock to Armistice upon the exercise of its Pre-Funded Warrants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 17, 2023, the Company issued &lt;span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230817__20230817__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RodneyRapsonMember_zwKXAt1sXCP1" title="Shares issued"&gt;1,876&lt;/span&gt; shares of common stock to Rodney Rapson as compensation for Mr. Rapson&#x2019;s advisory services
under the advisory agreement between the Company and Mr. Rapson.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 31, 2023, the Company issued &lt;span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20230831__20230831__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zzcDYDKRgBqc" title="Conversion of convertible securities"&gt;42,500&lt;/span&gt; shares of common stock to the Lender (as defined below) in connection with the Conversion
(as defined below).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September 18, 2023, the Company issued &lt;span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230918__20230918__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zjELcZ0dh7qk" title="Shares issued"&gt;125,134&lt;/span&gt; shares of common stock to Armistice upon the exercise of its Pre-Funded Warrants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September 19, 2023, the Company issued &lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230919__20230919__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zfkU79xTYOBa" title="Shares issued"&gt;9,444&lt;/span&gt; shares of common stock to Armistice upon the exercise of its Pre-Funded Warrants.&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;UFS
Agreement&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 7, 2023, the Company entered into an agreement with UFS (the &#x201c;UFS Agreement&#x201d;) pursuant to which the Company sold $&lt;span id="xdx_90C_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20230807__20230807__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--UFSAgreementMember_zlzl3d4gVVS2" title="Sale of consideration received"&gt;797,500&lt;/span&gt;
in future receivables (the &#x201c;UFS Second Receivables Purchased Amount&#x201d;) to UFS in exchange for payment to the Company of $&lt;span id="xdx_900_eus-gaap--PaymentsToAcquireReceivables_c20230807__20230807__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--UFSAgreementMember_zsK9iEPe5qtf" title="Payment for exchange received amount"&gt;550,000&lt;/span&gt;
in cash less fees of $&lt;span id="xdx_90C_ecustom--CashLessFees_c20230807__20230807__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--UFSAgreementMember_zkiL1HtQX6Mj" title="Cash less fees"&gt;50,000&lt;/span&gt;. The Company agreed to pay UFS $&lt;span id="xdx_903_eus-gaap--PaymentsToAcquireReceivables_c20230807__20230807__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--UFSAgreementMember__srt--StatementScenarioAxis__custom--EachWeekForNextThreeWeeksMember_zE0DtvmpYZz6" title="Payment for exchange received amount"&gt;30,000&lt;/span&gt; each week until the UFS Second Receivables Purchased Amount is paid
in full.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
order to secure payment and performance of the Company&#x2019;s obligations to UFS under the UFS Agreement, the Company granted to UFS
a security interest in the following collateral: all accounts receivable and all proceeds as such term is defined by Article 9 of the
UCC. The Company also agreed not to create, incur, assume, or permit to exist, directly or indirectly, any lien on or with respect to
any of such collateral.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 21, 2023, the Company amended its arrangement with MidCity and agreed to issue &lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230821__20230821__us-gaap--TypeOfArrangementAxis__custom--AmendedUFSAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zqqJzfmOueFa" title="Shares issued"&gt;42,500&lt;/span&gt; shares of stock monthly for eight months
to settle the profit guarantee under its prior note arrangement from April 2020. The parties agreed to a one-time true-up at March 31,
2024 if any further amounts are due MidCity at that time.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September 19, 2023, the Company entered into an agreement with Meged (the &#x201c;Second Meged Agreement&#x201d;) pursuant to which the
Company sold $&lt;span id="xdx_90D_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20230919__20230919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecondMegedAgreementMember_zQXZfHWwcmr4" title="Sale of consideration received"&gt;423,000&lt;/span&gt; in future receivables to Meged (the &#x201c;Meged Second Receivable Amount&#x201d;) in exchange for paying the then
outstanding balance of $&lt;span id="xdx_90A_eus-gaap--PaymentsToAcquireReceivables_pp2d_c20230919__20230919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecondMegedAgreementMember_zr2zndDoqNxi" title="Outstanding balance receivable"&gt;70,153.20&lt;/span&gt; of the Meged Receivables Purchased Amount in full with the balance being retained by the Company in
cash for general purposes. The Company agreed to pay Meged $&lt;span id="xdx_90C_eus-gaap--PaymentsToAcquireReceivables_pp2d_c20230919__20230919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecondMegedAgreementMember__srt--StatementScenarioAxis__custom--EachWeekForNextThreeWeeksMember_zIuYNxo8FP7k" title="Payment for exchange received amount"&gt;15,107.14&lt;/span&gt; each week until the Meged Second Receivable Amount is paid in full.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
order to secure payment and performance of the Company&#x2019;s obligations to Meged under the Second Meged Agreement, the Company granted
to Meged a security interest in the following collateral: all accounts receivable and all proceeds as such term is defined by Article
9 of the UCC. The Company also agreed not to create, incur, assume, or permit to exist, directly or indirectly, any lien on or with respect
to any of such collateral.&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-08-012023-08-01_us-gaap_CommonStockMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      unitRef="Shares">31042</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-08-172023-08-17_us-gaap_CommonStockMember_us-gaap_SubsequentEventMember_custom_RodneyRapsonMember"
      decimals="INF"
      unitRef="Shares">1876</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2023-08-312023-08-31_us-gaap_CommonStockMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      unitRef="Shares">42500</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-09-182023-09-18_us-gaap_CommonStockMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      unitRef="Shares">125134</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-09-192023-09-19_us-gaap_CommonStockMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      unitRef="Shares">9444</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockConsiderationReceivedPerTransaction
      contextRef="From2023-08-072023-08-07_us-gaap_SubsequentEventMember_custom_UFSAgreementMember"
      decimals="0"
      unitRef="USD">797500</us-gaap:SaleOfStockConsiderationReceivedPerTransaction>
    <us-gaap:PaymentsToAcquireReceivables
      contextRef="From2023-08-072023-08-07_us-gaap_SubsequentEventMember_custom_UFSAgreementMember"
      decimals="0"
      unitRef="USD">550000</us-gaap:PaymentsToAcquireReceivables>
    <CNXA:CashLessFees
      contextRef="From2023-08-072023-08-07_us-gaap_SubsequentEventMember_custom_UFSAgreementMember"
      decimals="0"
      unitRef="USD">50000</CNXA:CashLessFees>
    <us-gaap:PaymentsToAcquireReceivables
      contextRef="From2023-08-072023-08-07_us-gaap_SubsequentEventMember_custom_UFSAgreementMember_custom_EachWeekForNextThreeWeeksMember"
      decimals="0"
      unitRef="USD">30000</us-gaap:PaymentsToAcquireReceivables>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-08-212023-08-21_custom_AmendedUFSAgreementMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      unitRef="Shares">42500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockConsiderationReceivedPerTransaction
      contextRef="From2023-09-192023-09-19_us-gaap_SubsequentEventMember_custom_SecondMegedAgreementMember"
      decimals="0"
      unitRef="USD">423000</us-gaap:SaleOfStockConsiderationReceivedPerTransaction>
    <us-gaap:PaymentsToAcquireReceivables
      contextRef="From2023-09-192023-09-19_us-gaap_SubsequentEventMember_custom_SecondMegedAgreementMember"
      decimals="2"
      unitRef="USD">70153.20</us-gaap:PaymentsToAcquireReceivables>
    <us-gaap:PaymentsToAcquireReceivables
      contextRef="From2023-09-192023-09-19_us-gaap_SubsequentEventMember_custom_SecondMegedAgreementMember_custom_EachWeekForNextThreeWeeksMember"
      decimals="2"
      unitRef="USD">15107.14</us-gaap:PaymentsToAcquireReceivables>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">202095</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">665002</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">399680</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">1033390</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">3189766</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">7861837</us-gaap:InventoryNet>
    <CNXA:PrepaidInventoryCurrent contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">936939</CNXA:PrepaidInventoryCurrent>
    <CNXA:PrepaidInventoryCurrent contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">499353</CNXA:PrepaidInventoryCurrent>
    <us-gaap:CommodityContractAssetCurrent contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">235526</us-gaap:CommodityContractAssetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">263020</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">272670</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">2258318</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">4991500</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">12826096</us-gaap:AssetsCurrent>
    <us-gaap:OtherReceivables contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">2000000</us-gaap:OtherReceivables>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">14791</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">47355</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">101281</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">4842856</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:Goodwill contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">6781193</us-gaap:Goodwill>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">50365446</us-gaap:DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent>
    <us-gaap:AssetsNoncurrent contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">2116072</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">62036850</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">7107572</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">74862946</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">5496629</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">5252665</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">4911839</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">4381901</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:PurchaseObligation contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">500000</us-gaap:PurchaseObligation>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">111506</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="AsOf2023-04-30_us-gaap_NonrelatedPartyMember"
      decimals="0"
      unitRef="USD">25387</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="AsOf2022-04-30_us-gaap_NonrelatedPartyMember"
      decimals="0"
      unitRef="USD">708677</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="AsOf2023-04-30_us-gaap_RelatedPartyMember"
      decimals="0"
      unitRef="USD">917957</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="AsOf2022-04-30_us-gaap_RelatedPartyMember"
      decimals="0"
      unitRef="USD">908756</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="AsOf2023-04-30_us-gaap_RelatedPartyMember"
      decimals="0"
      unitRef="USD">917957</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="AsOf2022-04-30_us-gaap_RelatedPartyMember"
      decimals="0"
      unitRef="USD">908756</us-gaap:InterestPayableCurrent>
    <us-gaap:OtherNotesPayableCurrent contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">1484647</us-gaap:OtherNotesPayableCurrent>
    <us-gaap:OtherNotesPayableCurrent contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">4639376</us-gaap:OtherNotesPayableCurrent>
    <us-gaap:ConvertibleNotesPayableCurrent contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">10327778</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">10489606</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">5443779</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">418455</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">1334000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">22971</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">156862</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">5215222</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">23767491</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">38980522</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermNotesPayable
      contextRef="AsOf2023-04-30_us-gaap_RelatedPartyMember"
      decimals="0"
      unitRef="USD">1953842</us-gaap:LongTermNotesPayable>
    <us-gaap:LongTermNotesPayable
      contextRef="AsOf2022-04-30_us-gaap_RelatedPartyMember"
      decimals="0"
      unitRef="USD">2000000</us-gaap:LongTermNotesPayable>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">1370492</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">1953842</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">3370492</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">25721333</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">42351014</us-gaap:Liabilities>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-04-30"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-04-30"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2023-04-30" decimals="INF" unitRef="Shares">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2022-04-30" decimals="INF" unitRef="Shares">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2022-04-30" decimals="INF" unitRef="Shares">4194836</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2022-04-30" decimals="INF" unitRef="Shares">4194836</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2023-04-30_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">13544</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">4195</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="AsOf2023-04-30_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">132980793</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="AsOf2022-04-30_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">113049700</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">-151750610</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">-80596925</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">142512</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">54962</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">-18613761</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">32511932</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">7107572</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">74862946</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">9922799</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">16102672</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">7144335</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">11878010</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">2778464</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">4224662</us-gaap:GrossProfit>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">1928198</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">3477570</us-gaap:SellingAndMarketingExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">22743877</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">46718986</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">65164</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">736141</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:OperatingExpenses
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">24737239</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">50932697</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">-21958775</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">-46708035</us-gaap:OperatingIncomeLoss>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">4095030</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">8150284</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">-7096730</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <CNXA:GainLossOnIssuanceOfConvertibleNotes
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">-5889369</CNXA:GainLossOnIssuanceOfConvertibleNotes>
    <CNXA:GainLossOnChangeInFairValueOfContingentConsideration
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">4847000</CNXA:GainLossOnChangeInFairValueOfContingentConsideration>
    <CNXA:GainLossOnChangeInFairValueOfDerivativesLiability
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">10950017</CNXA:GainLossOnChangeInFairValueOfDerivativesLiability>
    <CNXA:GainLossOnChangeInFairValueOfDerivativesLiability
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">18557184</CNXA:GainLossOnChangeInFairValueOfDerivativesLiability>
    <CNXA:DerivativeExpense
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">8995962</CNXA:DerivativeExpense>
    <us-gaap:InterestExpense
      contextRef="From2022-05-012023-04-30_us-gaap_NonrelatedPartyMember"
      decimals="0"
      unitRef="USD">884985</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2021-05-012022-04-30_us-gaap_NonrelatedPartyMember"
      decimals="0"
      unitRef="USD">1920183</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2022-05-012023-04-30_us-gaap_RelatedPartyMember"
      decimals="0"
      unitRef="USD">293090</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2021-05-012022-04-30_us-gaap_RelatedPartyMember"
      decimals="0"
      unitRef="USD">165558</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2022-05-012023-04-30_us-gaap_RelatedPartyMember"
      decimals="0"
      unitRef="USD">293090</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2021-05-012022-04-30_us-gaap_RelatedPartyMember"
      decimals="0"
      unitRef="USD">165558</us-gaap:InterestExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">-3319050</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">182060</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">-25277825</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">-46525975</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">-4461968</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">-5247677</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">-41413892</us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">-45875860</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">-5247677</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
    <CNXA:IncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">-71153685</CNXA:IncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <CNXA:IncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">-51773652</CNXA:IncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">-71153685</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">-51773652</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">87550</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">75132</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">-71066135</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">-51698520</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2022-05-012023-04-30"
      decimals="INF"
      unitRef="USDPShares">-2.26</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="From2022-05-012023-04-30"
      decimals="INF"
      unitRef="USDPShares">-2.26</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2021-05-012022-04-30"
      decimals="INF"
      unitRef="USDPShares">-12.09</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="From2021-05-012022-04-30"
      decimals="INF"
      unitRef="USDPShares">-12.09</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="From2022-05-012023-04-30"
      decimals="INF"
      unitRef="USDPShares">-4.10</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="From2022-05-012023-04-30"
      decimals="INF"
      unitRef="USDPShares">-4.10</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="From2021-05-012022-04-30"
      decimals="INF"
      unitRef="USDPShares">-1.36</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="From2021-05-012022-04-30"
      decimals="INF"
      unitRef="USDPShares">-1.36</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2022-05-012023-04-30"
      decimals="INF"
      unitRef="USDPShares">-6.36</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2022-05-012023-04-30"
      decimals="INF"
      unitRef="USDPShares">-6.36</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2021-05-012022-04-30"
      decimals="INF"
      unitRef="USDPShares">-13.46</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2021-05-012022-04-30"
      decimals="INF"
      unitRef="USDPShares">-13.46</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-05-012023-04-30"
      decimals="INF"
      unitRef="Shares">11195345</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2022-05-012023-04-30"
      decimals="INF"
      unitRef="Shares">11195345</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2021-05-012022-04-30"
      decimals="INF"
      unitRef="Shares">3847672</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2021-05-012022-04-30"
      decimals="INF"
      unitRef="Shares">3847672</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      unitRef="Shares">69108</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">2764</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">10389935</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">-20170</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">-28823273</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-04-30_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">-18450744</us-gaap:StockholdersEquity>
    <CNXA:StockIssuedDuringPeriodShareConversionofNotesPayableRelatedParties
      contextRef="From2021-05-012022-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      unitRef="Shares">4093</CNXA:StockIssuedDuringPeriodShareConversionofNotesPayableRelatedParties>
    <CNXA:StockIssuedDuringPeriodValueConversionofNotesPayableRelatedParties
      contextRef="From2021-05-012022-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">164</CNXA:StockIssuedDuringPeriodValueConversionofNotesPayableRelatedParties>
    <CNXA:StockIssuedDuringPeriodValueConversionofNotesPayableRelatedParties
      contextRef="From2021-05-012022-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">6219838</CNXA:StockIssuedDuringPeriodValueConversionofNotesPayableRelatedParties>
    <CNXA:StockIssuedDuringPeriodValueConversionofNotesPayableRelatedParties
      contextRef="From2021-05-012022-04-30_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">6220002</CNXA:StockIssuedDuringPeriodValueConversionofNotesPayableRelatedParties>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2021-05-012022-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      unitRef="Shares">1350</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2021-05-012022-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">54</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2021-05-012022-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">3549946</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2021-05-012022-04-30_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">3550000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits
      contextRef="From2021-05-012022-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      unitRef="Shares">17304</us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="From2021-05-012022-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">692</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="From2021-05-012022-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">6229</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="From2021-05-012022-04-30_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">6921</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="From2021-05-012022-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      unitRef="Shares">12375</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2021-05-012022-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">495</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2021-05-012022-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">2255</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2021-05-012022-04-30_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">2750</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2021-05-012022-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      unitRef="Shares">518</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2021-05-012022-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">21</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2021-05-012022-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">2003362</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2021-05-012022-04-30_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">2003383</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="From2021-05-012022-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      unitRef="Shares">126</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2021-05-012022-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">5</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2021-05-012022-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">32473597</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2021-05-012022-04-30_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">32473602</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="From2021-05-012022-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">8754538</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="From2021-05-012022-04-30_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">8754538</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2021-05-012022-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember_custom_GamefaceLtdMember"
      decimals="0"
      unitRef="USD">9700000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2021-05-012022-04-30_srt_ScenarioPreviouslyReportedMember_custom_GamefaceLtdMember"
      decimals="0"
      unitRef="USD">9700000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2021-05-012022-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember_custom_PlaySightInteractiveLtdMember"
      decimals="0"
      unitRef="USD">39950000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2021-05-012022-04-30_srt_ScenarioPreviouslyReportedMember_custom_PlaySightInteractiveLtdMember"
      decimals="0"
      unitRef="USD">39950000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2021-05-012022-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">75132</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2021-05-012022-04-30_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">75132</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-05-012022-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">-51773652</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-05-012022-04-30_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">-51773652</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      unitRef="Shares">104872</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">4195</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">113049700</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">54962</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">-80596925</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-04-30_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">32511932</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      unitRef="Shares">104872</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">4195</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">113049700</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">54962</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">-80596925</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-04-30_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">32511932</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2022-05-012023-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      unitRef="Shares">109737</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2022-05-012023-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">4389</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2022-05-012023-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">14041911</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2022-05-012023-04-30_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">14046300</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2022-05-012023-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      unitRef="Shares">70727</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2022-05-012023-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">2829</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2022-05-012023-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">912716</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2022-05-012023-04-30_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">915545</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2022-05-012023-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      unitRef="Shares">775</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-05-012023-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">31</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-05-012023-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">37055</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-05-012023-04-30_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">37086</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-05-012023-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      unitRef="Shares">51682</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-05-012023-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">2068</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-05-012023-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">4192932</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-05-012023-04-30_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">4195000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <CNXA:StockIssuedDuringPeriodCashlessExerciseOfWarrantsShares
      contextRef="From2022-05-012023-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      unitRef="Shares">750</CNXA:StockIssuedDuringPeriodCashlessExerciseOfWarrantsShares>
    <CNXA:StockIssuedDuringPeriodValueCashlessExerciseOfWarrants
      contextRef="From2022-05-012023-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">30</CNXA:StockIssuedDuringPeriodValueCashlessExerciseOfWarrants>
    <CNXA:StockIssuedDuringPeriodValueCashlessExerciseOfWarrants
      contextRef="From2022-05-012023-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">-30</CNXA:StockIssuedDuringPeriodValueCashlessExerciseOfWarrants>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="From2022-05-012023-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      unitRef="Shares">39</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2022-05-012023-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">2</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2022-05-012023-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">-2</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2022-05-012023-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">746511</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2022-05-012023-04-30_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">746511</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2022-05-012023-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">87550</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2022-05-012023-04-30_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">87550</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2022-05-012023-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">87550</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2022-05-012023-04-30_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">87550</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-05-012023-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">-71153685</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-05-012023-04-30_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">-71153685</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      unitRef="Shares">338579</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">13544</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-04-30_us-gaap_AdditionalPaidInCapitalMember_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">132980793</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-04-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">142512</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-04-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">-151750610</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-04-30_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">-18613761</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">-71153685</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">-51773652</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">11555332</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">43534</us-gaap:DepreciationAndAmortization>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">10950017</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">18557184</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">37086</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">2010304</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:ShareBasedCompensation
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">746511</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">32473602</us-gaap:ShareBasedCompensation>
    <us-gaap:GainLossOnSaleOfOtherAssets
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">-41413892</us-gaap:GainLossOnSaleOfOtherAssets>
    <CNXA:GainLossOnChangeInFairValueOfContingentConsideration
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">4847000</CNXA:GainLossOnChangeInFairValueOfContingentConsideration>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">-7096730</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">4095030</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">8150284</us-gaap:AmortizationOfDebtDiscountPremium>
    <CNXA:DerivativeExpense
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">8995962</CNXA:DerivativeExpense>
    <CNXA:NoncashTransactionCosts
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">454823</CNXA:NoncashTransactionCosts>
    <CNXA:NoncashTransactionCosts
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">2250000</CNXA:NoncashTransactionCosts>
    <CNXA:GainLossOnIssuanceOfConvertibleNotes
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">-5889369</CNXA:GainLossOnIssuanceOfConvertibleNotes>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">1368643</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">268930</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">-4413056</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">4186493</us-gaap:IncreaseDecreaseInInventories>
    <CNXA:IncreaseDecreaseInPrepaidInventory
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">138308</CNXA:IncreaseDecreaseInPrepaidInventory>
    <CNXA:IncreaseDecreaseInPrepaidInventory
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">520580</CNXA:IncreaseDecreaseInPrepaidInventory>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">-430193</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">320679</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">-598814</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">6087601</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">-53287</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">-41451</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">1126123</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">-2978265</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInInterestPayableNet
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">158187</us-gaap:IncreaseDecreaseInInterestPayableNet>
    <us-gaap:IncreaseDecreaseInInterestPayableNet
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">1813516</us-gaap:IncreaseDecreaseInInterestPayableNet>
    <CNXA:IncreaseDecreaseInInterestPayableRelatedParty
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">9201</CNXA:IncreaseDecreaseInInterestPayableRelatedParty>
    <CNXA:IncreaseDecreaseInInterestPayableRelatedParty
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">161120</CNXA:IncreaseDecreaseInInterestPayableRelatedParty>
    <us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">60326327</us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities>
    <us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">34255478</us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">-10827358</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">-17518174</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
    <us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">4461969</us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations>
    <us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">5151474</us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">-6365389</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">-12366700</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">125659</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:PaymentsToAcquireNotesReceivable
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">2250000</us-gaap:PaymentsToAcquireNotesReceivable>
    <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">-2124341</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
    <us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">506000</us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">-1618341</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">8744882</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">800251</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">2000000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">5500000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">2000000</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">11000000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">546158</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">4377537</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">3965463</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">5821187</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">13734286</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">81295</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">-193</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">-462907</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">-250948</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">665002</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2021-04-30" decimals="0" unitRef="USD">915950</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">202095</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">665002</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:InterestPaidNet
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">482687</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">222210</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">111105</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:StockIssued1
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">3550000</us-gaap:StockIssued1>
    <CNXA:ConversionOfConvertibleNotesPayableAndAccruedInterestToCommonStock
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">14046300</CNXA:ConversionOfConvertibleNotesPayableAndAccruedInterestToCommonStock>
    <CNXA:ConversionOfConvertibleNotesPayableAndAccruedInterestToCommonStock
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">6220003</CNXA:ConversionOfConvertibleNotesPayableAndAccruedInterestToCommonStock>
    <CNXA:SharesIssuedForContingentConsideration
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">915545</CNXA:SharesIssuedForContingentConsideration>
    <CNXA:EliminationOfRelatedPartyDerivativeLiabilities
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">8754538</CNXA:EliminationOfRelatedPartyDerivativeLiabilities>
    <CNXA:DerivativeLiabilitiesRecordedAsDebtDiscountsOfConvertibleNotes
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">10199749</CNXA:DerivativeLiabilitiesRecordedAsDebtDiscountsOfConvertibleNotes>
    <CNXA:DerivativeLiabilityRecordedForSharesAndWarrantsIssuedInPrivatePlacement
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">4999882</CNXA:DerivativeLiabilityRecordedForSharesAndWarrantsIssuedInPrivatePlacement>
    <us-gaap:NotesIssued1
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">2000000</us-gaap:NotesIssued1>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="From2022-05-012023-04-30">&lt;p id="xdx_80C_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zm2Szh295vD6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
1: &lt;span id="xdx_82A_zQEqeRaIBLnf"&gt;ORGANIZATION AND NATURE OF BUSINESS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Organization&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Lazex
Inc. (&#x201c;Lazex&#x201d;) was incorporated under the laws of the State of Nevada on July 12, 2015. On August 23, 2019, the majority
owner of Lazex entered into a Stock Purchase Agreement with Slinger Bag Americas Inc., a Delaware corporation (&#x201c;Slinger Bag Americas&#x201d;),
which was &lt;span id="xdx_908_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20190823__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SlingerBagAmericasIncMember_zuJJRIEOBcO6" title="Percentage of ownership"&gt;100%&lt;/span&gt; owned by Slinger Bag Ltd. (&#x201c;SBL&#x201d;), an Israeli company. In connection with the Stock Purchase Agreement, Slinger
Bag Americas acquired &lt;span id="xdx_90B_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_pid_c20190823__20190823__us-gaap--BusinessAcquisitionAxis__custom--SlingerBagAmericasIncMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z74SFsgzmyN6" title="Number of shares issued for acquisition"&gt;2,000,000&lt;/span&gt; shares of common stock of Lazex for $&lt;span id="xdx_90B_eus-gaap--BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_iI_c20190823__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--SlingerBagAmericasIncMember_zxFpsS5Rx3he" title="Number of value issued for acquisition"&gt;332,239&lt;/span&gt;. On September 16, 2019, SBL transferred its ownership of
Slinger Bag Americas to Lazex in exchange for the &lt;span id="xdx_90F_ecustom--NumberOfSharesExchanged_pid_c20190916__20190916__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SlingerBagAmericasIncMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zBIHrv8YkQN2" title="Number of shares exchanged"&gt;2,000,000&lt;/span&gt; shares of Lazex acquired on August 23, 2019. As a result of these transactions,
Lazex owned &lt;span id="xdx_904_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20190916__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SlingerBagAmericasIncMember_zjiGqxtJqpd2" title="Percentage of ownership"&gt;100%&lt;/span&gt; of Slinger Bag Americas and the sole shareholder of SBL owned &lt;span id="xdx_903_ecustom--NumberOfSharesOwned_pid_c20190916__20190916__us-gaap--BusinessAcquisitionAxis__custom--SoleShareholderofSBLMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zFqgF6v8K853" title="Number of shares owned"&gt;2,000,000&lt;/span&gt; shares of common stock (approximately &lt;span id="xdx_905_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20190916__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SoleShareholderofSBLMember_zakPiRUvDj14" title="Percentage of ownership"&gt;82%&lt;/span&gt;) of
Lazex. Effective September 13, 2019, Lazex changed its name to Slinger Bag Inc.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
October 31, 2019, Slinger Bag Americas acquired control of Slinger Bag Canada, Inc., (&#x201c;Slinger Bag Canada&#x201d;) a Canadian company
incorporated on November 3, 2017. There were no assets, liabilities or historical operational activity of Slinger Bag Canada.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 10, 2020, Slinger Bag Americas became the &lt;span id="xdx_90F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20200210__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SlingerBagAmericasIncMember_zWucosLaeuR" title="Percentage of ownership"&gt;100%&lt;/span&gt; owner of SBL, along with SBL&#x2019;s wholly owned subsidiary Slinger Bag International
(UK) Limited (&#x201c;Slinger Bag UK&#x201d;), which was formed on April 3, 2019. On February 10, 2020, the owner of SBL, contributed Slinger
Bag UK to Slinger Bag Americas for no consideration.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
June 21, 2021, Slinger Bag Americas entered into a membership interest purchase agreement with Charles Ruddy to acquire a &lt;span id="xdx_90E_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20210621__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FoundationSportsSystemsLLCMember__srt--TitleOfIndividualAxis__custom--CharlesRuddyMember_z3e8zpAeBDw3" title="Percentage of ownership"&gt;100%&lt;/span&gt; ownership
stake in Foundation Sports Systems, LLC (&#x201c;Foundation Sports&#x201d;). On December 5, 2022, the Company sold &lt;span id="xdx_90C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20221205__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FoundationSportsSystemsLLCMember_zJIsmcdKQusc" title="Percentage of ownership"&gt;75%&lt;/span&gt; of Foundation Sports
back to the original sellers. As a result, at that time, the Company recorded a loss on the sale and deconsolidated Foundation Sports.
(refer to Note 5 and Note 16). During the year ended April 30, 2022, the Company impaired certain intangible assets and goodwill in the
amount of $&lt;span id="xdx_90E_eus-gaap--GoodwillImpairedAccumulatedImpairmentLoss_iI_c20220430_zQajjfPuYy31" title="Impaired of intangible assets and goodwill amount"&gt;3,486,599&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 2, 2022, the Company entered into a share purchase agreement with Flixsense Pty, Ltd. (&#x201c;Gameface&#x201d;). As a result
of the share purchase agreement, Gameface would become a wholly owned subsidiary of the Company (refer to Note 5).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 22, 2022, the Company entered into a merger agreement with PlaySight Interactive Ltd. (&#x201c;PlaySight&#x201d;) and Rohit Krishnan
(the &#x201c;Shareholders&#x2019; Representative&#x201d;). As a result of the merger agreement, PlaySight would become a wholly owned subsidiary
of the Company (refer to Note 5). In November 2022, the Company sold PlaySight and recorded a loss on the sale. See Note 16 for further
details on the sale of PlaySight.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
May 16, 2022, the Company changed its domicile from Nevada to Delaware. On April 7, 2022, the Company effected a name change to Connexa
Sports Technologies Inc. We also changed our ticker symbol, &#x201c;CNXA.&#x201d;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
operations of Slinger Bag Inc., Slinger Bag Americas, Slinger Bag Canada, Slinger Bag UK, SBL, and Gameface are collectively referred
to as the &#x201c;Company.&#x201d;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
June 14, 2022, the Company effected a &lt;span id="xdx_90F_eus-gaap--StockholdersEquityReverseStockSplit_c20220614__20220614_z6QItGR6YtTg"&gt;1-for-10
reverse stock split&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;, where the Company&#x2019;s
common stock began to trade on a reverse split adjusted basis. No fractional shares were issued in connection with the reverse stock
split and all such fractional interests were rounded up to the nearest whole number of shares of common stock. All references herein
to the outstanding stock have been retrospectively adjusted to reflect this reverse stock split. The Company also consummated a public
offering of shares of its common stock and the listing of its common stock on the Nasdaq.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
further details on PlaySight and Foundation Sports we refer you to our Annual Report on Form 10-K for the year ended April 30, 2022,
filed with the Securities and Exchange Commission on May 17, 2023. This Form 10-K and the consolidated financial statements will concentrate
on our existing business as reflected in the following paragraph.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company operates in the sport equipment and technology business. The Company is the owner of the Slinger Launcher, which is a portable
tennis ball launcher as well as other associated tennis accessories and Gameface AI an Australian artificial intelligence sports software
company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Basis
of Presentation&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying consolidated financial statements of the Company are presented in accordance with accounting principles generally
accepted in the United States of America (&#x201c;GAAP&#x201d;). As a result of the transactions described above, the accompanying consolidated financial statements include the combined results of Slinger Bag Inc., Slinger Bag Americas, Slinger Bag Canada, Slinger
Bag UK, SBL, and Gameface for the years ended April 30, 2023 and 2022. The operations of Foundation Sports and PlaySight are included
as discontinued operations in our statements of operations as these entities were sold in November 2022 and December 2022 as disclosed
in Note 16.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company reports Gameface on a one-month calendar lag allowing for the timely preparation of financial statements. Gameface operates on
fiscal year end periods as of December 31. This one-month reporting lag is with the exception of significant transactions or events that
occur during the intervening period. The Company did not identify any significant transactions during the one month ended April 30, 2023
at Gameface that would need to be disclosed as not included within the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Impact
of COVID-19 Pandemic&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has been carefully monitoring the COVID-19 pandemic and its impact on its business. In that regard, while the Company has continued
to sell its products and grow its business it did experience certain disruptions in its supply chains. The Company expects the significance
of the COVID-19 pandemic, including the extent of its effect on the Company&#x2019;s financial and operational results, to be dictated
by, among other things, its duration, the success of efforts to contain it and the impact of actions taken in response. While the Company
has not experienced any material disruptions to its business and operations as a result of the COVID-19 pandemic, it is possible such
disruptions may occur in the future which may impact its financial and operational results, and which could be material.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Impact
of Russian and Ukrainian Conflict&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. We are closely monitoring
the unfolding events due to the Russia-Ukraine conflict and its regional and global ramifications. We have one distributor in Russia,
which is not material to our overall financial results. We do not have operations in Ukraine or Belarus. We are monitoring any broader
economic impact from the current crisis. The specific impact on the Company&#x2019;s financial condition, results of operations, and cash
flows is also not determinable as of the date of these financial statements. However, to the extent that such military action spreads
to other countries, intensifies, or otherwise remains active, such action could have a material adverse effect on our financial condition,
results of operations, and cash flows.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2019-08-23_custom_SlingerBagAmericasIncMember"
      decimals="INF"
      unitRef="Pure">1</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="From2019-08-232019-08-23_custom_SlingerBagAmericasIncMember_custom_StockPurchaseAgreementMember_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      unitRef="Shares">2000000</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
      contextRef="AsOf2019-08-23_custom_StockPurchaseAgreementMember_custom_SlingerBagAmericasIncMember"
      decimals="0"
      unitRef="USD">332239</us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned>
    <CNXA:NumberOfSharesExchanged
      contextRef="From2019-09-162019-09-16_custom_SlingerBagAmericasIncMember_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      unitRef="Shares">2000000</CNXA:NumberOfSharesExchanged>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2019-09-16_custom_SlingerBagAmericasIncMember"
      decimals="INF"
      unitRef="Pure">1</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <CNXA:NumberOfSharesOwned
      contextRef="From2019-09-162019-09-16_custom_SoleShareholderofSBLMember_custom_StockPurchaseAgreementMember_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      unitRef="Shares">2000000</CNXA:NumberOfSharesOwned>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2019-09-16_custom_SoleShareholderofSBLMember"
      decimals="INF"
      unitRef="Pure">0.82</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2020-02-10_custom_SlingerBagAmericasIncMember"
      decimals="INF"
      unitRef="Pure">1</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2021-06-21_custom_FoundationSportsSystemsLLCMember_custom_CharlesRuddyMember"
      decimals="INF"
      unitRef="Pure">1</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2022-12-05_custom_FoundationSportsSystemsLLCMember"
      decimals="INF"
      unitRef="Pure">0.75</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">3486599</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:StockholdersEquityReverseStockSplit contextRef="From2022-06-142022-06-14">1-for-10
reverse stock split</us-gaap:StockholdersEquityReverseStockSplit>
    <us-gaap:SubstantialDoubtAboutGoingConcernTextBlock contextRef="From2022-05-012023-04-30">&lt;p id="xdx_804_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_z5JGZe90xVX1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
2: &lt;span id="xdx_820_zpx4tnGNlCs8"&gt;GOING CONCERN&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
financial statements have been prepared on a going concern basis, which assumes the Company will be able to realize its assets and discharge
its liabilities in the normal course of business for the foreseeable future. The Company has an accumulated deficit of $&lt;span id="xdx_907_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_di_c20230430_zdxGomWt0Ou7" title="Accumulated deficit"&gt;151,750,610&lt;/span&gt; as
of April 30, 2023, and more losses are anticipated in the development of the business. Accordingly, there is substantial doubt about
the Company&#x2019;s ability to continue as a going concern. These financial statements do not include any adjustments related to the
recoverability and classification of assets or the amounts and classification of liabilities that might be necessary should the Company
be unable to continue as a going concern.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/or being able
to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they
become due. Management intends to finance operating costs over the next twelve months with existing cash on hand, loans from related
parties, and/or private placement of debt and/or common stock. In the event that the Company is unable to successfully raise capital
and/or generate revenues, the Company will likely reduce general and administrative expenses, and cease or delay its development plan
until it is able to obtain sufficient financing. The Company has begun reducing operating expenses and cash outflows by selling PlaySight,
as well as selling &lt;span id="xdx_903_ecustom--DisposalEquityInterestOwnershipInterestPercentage_iI_pid_dp_uPure_c20221130__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--PlaySightMember__us-gaap--BusinessAcquisitionAxis__custom--FoundationSportsSystemsLLCMember_z03WAVdg00xj" title="Discontinuing operations percentage"&gt;&lt;span id="xdx_907_ecustom--DisposalEquityInterestOwnershipInterestPercentage_iI_pid_dp_uPure_c20221231__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--PlaySightMember__us-gaap--BusinessAcquisitionAxis__custom--FoundationSportsSystemsLLCMember_z2ZaThKYhH2e" title="Discontinuing operations percentage"&gt;75%&lt;/span&gt;&lt;/span&gt; of Foundation Sports in November and December 2022, respectively to the former shareholders of those companies.
There can be no assurance that additional funds will be available on terms acceptable to the Company, or at all. We have recorded the
&lt;span id="xdx_903_eus-gaap--DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal_pid_dp_uPure_c20220501__20230430__us-gaap--BusinessAcquisitionAxis__custom--FoundationSportsSystemsLLCMember_zgm6FrBTUnee" title="Investment retained after disposal, ownership interest after disposal"&gt;25%&lt;/span&gt; investment in Foundation Sprots at $&lt;span id="xdx_906_eus-gaap--AlternativeInvestment_iI_dp_c20230430__us-gaap--BusinessAcquisitionAxis__custom--FoundationSportsSystemsLLCMember_zd8gDelqxUG" title="Investment amount"&gt;0&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubstantialDoubtAboutGoingConcernTextBlock>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">-151750610</us-gaap:RetainedEarningsAccumulatedDeficit>
    <CNXA:DisposalEquityInterestOwnershipInterestPercentage
      contextRef="AsOf2022-11-30_custom_PlaySightMember_custom_FoundationSportsSystemsLLCMember"
      decimals="INF"
      unitRef="Pure">0.75</CNXA:DisposalEquityInterestOwnershipInterestPercentage>
    <CNXA:DisposalEquityInterestOwnershipInterestPercentage
      contextRef="AsOf2022-12-31_custom_PlaySightMember_custom_FoundationSportsSystemsLLCMember"
      decimals="INF"
      unitRef="Pure">0.75</CNXA:DisposalEquityInterestOwnershipInterestPercentage>
    <us-gaap:DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal
      contextRef="From2022-05-012023-04-30_custom_FoundationSportsSystemsLLCMember"
      decimals="INF"
      unitRef="Pure">0.25</us-gaap:DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal>
    <us-gaap:AlternativeInvestment
      contextRef="AsOf2023-04-30_custom_FoundationSportsSystemsLLCMember"
      decimals="0"
      unitRef="USD">0</us-gaap:AlternativeInvestment>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2022-05-012023-04-30">&lt;p id="xdx_80D_eus-gaap--SignificantAccountingPoliciesTextBlock_zx7LYYX5i9v6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
3: &lt;span id="xdx_823_zCwfPw8bDz02"&gt;SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--UseOfEstimates_zbweqBbIOfHj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_869_zZphjCY6iJMd"&gt;Use
of Estimates&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect
the amounts reported in the financial statements and accompanying notes. Accordingly, actual results could differ from those estimates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84A_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zmBTVTVg1Vzh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86D_z4iek6XCOzT7"&gt;Financial
Statement Reclassification&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Certain
prior year amounts within accounts payable, accrued expenses, and certain operating expenses have been reclassified for consistency with
the current year presentation and had no effect on the Company&#x2019;s balance sheet, net loss, shareholders&#x2019; deficit or cash flows.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zBSpXuLMoEBl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_867_zQa3IPLkAvBk"&gt;Cash
and Cash Equivalents&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents.
The majority of payments due from banks for credit card transactions process within 24 to 48 hours and are accordingly classified as
cash and cash equivalents.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zHA0nqyIm9Y3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86E_zuXjhSOa7Vce"&gt;Accounts
Receivable&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s accounts receivable are non-interest bearing trade receivables resulting from the sale of products and payable over terms
ranging from 15 to 60 days. The Company provides an allowance for doubtful accounts at the point when collection is considered doubtful.
Once all collection efforts have been exhausted, the Company charges-off the receivable with the allowance for doubtful accounts. The
Company recorded $&lt;span id="xdx_909_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pdp0_do_c20230430_zVJAPCDSDaJ1" title="Allowance for doubtful accounts"&gt;209,690 &lt;/span&gt;and $&lt;span id="xdx_90F_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pdp0_do_c20220430_zQbRZFlenFp1" title="Allowance for doubtful accounts"&gt;175,000 &lt;/span&gt;in allowance for doubtful accounts for the years ended April 30, 2023 and 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_eus-gaap--InventoryPolicyTextBlock_z4GZIc49tAJc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_860_zJHbInc5rlCg"&gt;Inventory&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Inventory
is valued at the lower of the cost (determined principally on a first-in, first-out basis) or net realizable value. The Company&#x2019;s
valuation of inventory includes inventory reserves for inventory that will be sold below cost and the impact of inventory shrink. Inventory
reserves are based on historical information and assumptions about future demand and inventory shrink trends. The Company&#x2019;s inventory
as of April 30, 2023 and April 30, 2022 consisted of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_896_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zrmeoIreLo6e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B0_zOGEgcyNOtTi" style="display: none"&gt;SCHEDULE OF INVENTORY&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20230430_zCNs6Kvremrg" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;April 30, 2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20220430_zUbYmp0KTAV2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;April 30, 2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--InventoryFinishedGoods_iI_maINzzOV_zgpMKI5OqRDg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left"&gt;Finished Goods&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;1,509,985&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;4,073,791&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--InventoryRawMaterialsAndSupplies_iI_maINzzOV_zA8Ecmzavp07" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Component/Replacement Parts&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,712,553&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;2,559,848&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--CapitalizedDutyAndFreight_iI_maINzzOV_zJz4ApKsSv12" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Capitalized Duty/Freight&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;517,228&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,328,198&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--InventoryAdjustments_iNI_di_msINzzOV_zMRWSmi26TMa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;Inventory Reserve&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(550,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(100,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--InventoryNet_iTI_mtINzzOV_zaS27xIt7Avl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;3,189,766&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;7,861,837&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A4_zFzPuYXmiymi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_840_ecustom--PrepaidInventoryPolicyTextBlock_zd7vebe9uPi3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_867_zPvsYKuKBeq9"&gt;Prepaid
Inventory&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Prepaid
inventory represents inventory that is in-transit that has been paid for but not received from the Company&#x2019;s third-party vendors.
The Company typically prepays for the purchase of materials and receives the products within three months after making payments. The
Company continuously monitors delivery from, and payments to, the vendors. If the Company has difficulty receiving products from a vendor,
the Company would cease purchasing products from such vendors in future periods. The Company has not had difficulty receiving products
during the reporting periods.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_840_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zinPRBGbmrKh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_865_zvMa9q1QY8T1"&gt;Property
and equipment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Property
and equipment acquired through business combinations are stated at the estimated fair value at the date of the acquisition. Purchases
of property and equipment are stated at cost, net of accumulated depreciation and impairment losses. Expenditures that materially increase
the useful life of the assets are capitalized. Ordinary repairs and maintenance are expensed as incurred. Depreciation and amortization
are computed using the straight-line method over the estimated useful lives of the related assets, which is an average of &lt;span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230430_zLmLxV15L8H2" title="Property plant and equipment, useful life"&gt;5&lt;/span&gt; years.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_eus-gaap--ConcentrationRiskCreditRisk_zd7FSsePjhgi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86D_z14jdvKg80tl"&gt;Concentration
of Credit Risk&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company maintains its cash in bank deposit accounts, the balances of which at times may exceed insured limits. The Company continually
monitors its banking relationships and consequently has not experienced any losses in such accounts. While we may be exposed to credit
risk, we consider the risk remote and do not expect that any such risk would result in a significant effect on our results of operations
or financial condition. See Note 4 for further details on the Company&#x2019;s concentration of credit risk as well as other risks and
uncertainties.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84C_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_z413dCELoeZj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_862_z1ghWZ0Zkwn3"&gt;Revenue
Recognition&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes revenue for their continuing operations in accordance with Accounting Standards Codification (&#x201c;ASC&#x201d;) 606,
the core principle of which is that an entity should recognize revenue to depict the transfer of promised goods or services to customers
in an amount that reflects the consideration to which the entity expects to be entitled to receive in exchange for those goods or services.
The Company recognizes revenue for its performance obligation associated with its contracts with customers at a point in time once products
are shipped. Amounts collected from customers in advance of shipping products ordered are reflected as contract liabilities on the accompanying
consolidated balance sheets. The Company&#x2019;s standard terms are non-cancelable and do not provide for the right-of-return, other
than for defective merchandise covered under the Company&#x2019;s standard warranty. The Company has not historically experienced any
significant returns or warranty issues.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes revenue under ASC 606, &#x201c;Revenue from Contracts with Customers&#x201d;. The core principle of this revenue standard
is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects
the consideration to which the company expects to be entitled in exchange for those goods or services. The following five steps are applied
to achieve that core principle:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Step
1: Identify the contract with the customer&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company determines that it has a contract with a customer when each party&#x2019;s rights regarding the products or services to be transferred
can be identified, the payment terms for the services can be identified, the Company has determined the customer has the ability and
intent to pay, and the contract has commercial substance. At contract inception, the Company evaluates whether two or more contracts
should be combined and accounted for as a single contract and whether the combined or single contract includes more than one performance
obligation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Step
2: Identify the performance obligations in the contract&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s customers are buying an integrated system. In evaluating whether the equipment is a separate performance obligation,
the Company&#x2019;s management considered the customer&#x2019;s ability to benefit from the equipment on its own or together with other
readily available resources and if so, whether the service and equipment are separately identifiable (i.e., is the service highly dependent
on, or highly interrelated with the equipment). Because the Products and Services included in the customer&#x2019;s contract are integrated
and highly interdependent, and because they must work together to deliver the Solution, the Company has concluded that Products installed
on customer&#x2019;s premise and Services contracted for by the customer are generally not distinct within the context of the contract
and, therefore, constitute a single, combined performance obligation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Step
3: Determine the transaction price&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
transaction price is the amount of consideration to which an entity expects to be entitled in exchange for transferring promised goods
or services to a customer. The consideration promised in a contract with a customer includes predetermined fixed amounts, variable amounts,
or both. The Company&#x2019;s contracts do not include any rights of returns or refunds.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company collects each year&#x2019;s service fees in advance and should therefore consider the existence of a significant financing component.
However, due to the fact that the payments are provided for the service of a one-year term, the Company elected to apply the practical
expedient under ASC 606 which exempts the adjustment of the consideration for the existence of a significant financing component when
the period between the transfer of the services and the payment for such services is one year or less.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Step
4: Allocate the transaction price to the performance obligations in the contract&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Contracts
that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on
each performance obligation&#x2019;s relative standalone selling price (&#x201c;SSP&#x201d;). The Company has identified a single performance
obligation in the contract, and therefore, the allocation provisions under ASC 606 do not apply to the Company&#x2019;s contracts.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Step
5: Recognize revenue when the Company satisfies a performance obligation&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Revenues
for the Company&#x2019;s single, combined performance obligation are recognized on a straight-line basis over the customer&#x2019;s contract
term, which is the period in which the parties to the contract have enforceable rights and obligations (Typically 3-4 years).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--BusinessCombinationsPolicy_z0ZRa7SHCO76" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86A_zbCzDWV4khLc"&gt;Business
Combinations&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Upon
acquisition of a company, we determine if the transaction is a business combination, which is accounted for using the acquisition method
of accounting. Under the acquisition method, once control is obtained of a business, the assets acquired, and liabilities assumed, are
recorded at fair value. We use our best estimates and assumptions to assign fair value to the tangible and intangible assets acquired
and liabilities assumed at the acquisition date. One of the most significant estimates relates to the determination of the fair value
of these assets and liabilities. The determination of the fair values is based on estimates and judgments made by management. Our estimates
of fair value are based upon assumptions we believe to be reasonable, but which are inherently uncertain and unpredictable. Measurement
period adjustments are reflected at the time identified, up through the conclusion of the measurement period, which is the time at which
all information for determination of the values of assets acquired and liabilities assumed is received and is not to exceed one year
from the acquisition date. We may record adjustments to the fair value of these tangible and intangible assets acquired and liabilities
assumed, with the corresponding offset to goodwill. The Company elected to apply pushdown accounting to all entities acquired.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Additionally,
uncertain tax positions and tax-related valuation allowances are initially recorded in connection with a business combination as of the
acquisition date. We continue to collect information and reevaluate these estimates and assumptions periodically and record any adjustments
to preliminary estimates to goodwill, provided we are within the measurement period. If outside of the measurement period, any subsequent
adjustments are recorded to the consolidated statement of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_842_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zsR4gXGRnvj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_867_zSfb8dCDzeK1"&gt;Fair
Value of Financial Instruments&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
value of financial and non-financial assets and liabilities is defined as an exit price, representing the amount that would be received
to sell an asset or paid to transfer a liability in an orderly transaction between market participants. The three-tier hierarchy for
inputs used in measuring fair value, which prioritizes the inputs used in the methodologies of measuring fair value for assets and liabilities,
is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
1 &#x2014; Quoted prices in active markets for identical assets or liabilities&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
2 &#x2014; Observable inputs other than quoted prices in active markets for identical assets and liabilities&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
3 &#x2014; Unobservable pricing inputs in the market&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
assets and financial liabilities are classified in their entirety based on the lowest level of input that is significant to the fair
value measurements. Our assessment of the significance of a particular input to the fair value measurements requires judgment and may
affect the valuation of the assets and liabilities being measured and their categorization within the fair value hierarchy.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s financial instruments consist of cash and cash equivalents, accounts receivable, and accounts payable. The carrying amount
of these financial instruments approximates fair value due to their short-term maturity.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s contingent consideration in connection with the acquisition of Gameface was calculated using Level 3 inputs. The fair
value of contingent consideration as of April 30, 2023 and 2022 was $&lt;span id="xdx_908_eus-gaap--BusinessCombinationConsiderationTransferred1_c20220501__20230430__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zWAvbj1aT4ua" title="Fair value of contingent consideration"&gt;418,455&lt;/span&gt; and $&lt;span id="xdx_905_eus-gaap--BusinessCombinationConsiderationTransferred1_c20210501__20220430__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zMgFaUDRB6Ii" title="Fair value of contingent consideration"&gt;1,334,000&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company estimates the fair value of its intangible assets using Level 3 assumptions, primarily based on the income approach utilizing
the discounted cash flow method.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s derivative liabilities were calculated using Level 2 assumptions on the issuance and balance sheet dates via a Black-Scholes
option pricing model and consisted of the following ending balances and gain amounts as of and for the year ended April 30, 2023:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_895_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_zKdxFAaIrev6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BC_zth2ZPbd4ldg" style="display: none"&gt;SCHEDULE OF DERIVATIVE LIABILITIES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;April 30, 2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;(Gain) loss for the year&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Note derivative is related to&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;ending balance&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;ended April 30, 2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 58%; text-align: left"&gt;4/11/21 profit guaranty&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--ProfitGuarantyMember_zLoVdfg4BcMg" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Note derivative balance"&gt;1,456,854&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20220501__20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--ProfitGuarantyMember_ztU1z71Fcr69" style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right" title="Note derivative (gain) loss"&gt;395,304&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;8/6/21 convertible notes&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--ConvertibleNotesMember_za5ouNOASKYj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Note derivative balance"&gt;101,924&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20220501__20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--ConvertibleNotesMember_zbyjmW8ypLJi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Note derivative (gain) loss"&gt;(2,611,410&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;6/17/22 underwriter warrants&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--UnderwriterWarrantsMember_zk2QYBRehJBf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Underwriter warrants"&gt;6,531&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20220501__20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--UnderwriterWarrantsMember_z2kIb4szkMl9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Note derivative (gain) loss"&gt;(57,951&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Other derivative liabilities eliminated in uplist&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--OtherDerivativeLiabilitiesMember_zJoLszxw8Ko5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other derivative liabilities eliminated in uplist"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2020"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20220501__20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--OtherDerivativeLiabilitiesMember_zZaELMDW4F8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Note derivative (gain) loss"&gt;(1,604,413&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;9/30/22 warrants issued with common stock&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsIssuedWithCommonStockMember_zSHGxJ6QgJva" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other derivative liabilities eliminated in uplist"&gt;6,109,559&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20220501__20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsIssuedWithCommonStockMember_zDUauxaNsYN3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Note derivative (gain) loss"&gt;(6,170,728&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;1/6/2023 warrants issued with note payable&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsIssuedWithNotesPayableMember_zDflVje0ufDd" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other derivative liabilities eliminated in uplist"&gt;2,814,738&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20220501__20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsIssuedWithNotesPayableMember_zWeXeUvmeepj" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Note derivative (gain) loss"&gt;(900,819&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230430_zQU5Cl2xeNz7" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Note derivative balance"&gt;10,489,606&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20220501__20230430_zRROsfnxGTP5" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Note derivative (gain) loss"&gt;(10,950,017&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A1_zXI5Tz8hx0v2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company also recognized derivative expense of $&lt;span id="xdx_901_ecustom--RecognizedDerivativeExpense_c20220501__20230430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zeDeQ562lBAa" title="Recognized derivative expense"&gt;7,280,405&lt;/span&gt; at inception on the warrants issued in connection with a funding on September
30, 2022 and $&lt;span id="xdx_906_ecustom--RecognizedDerivativeExpense_c20230106__20230106__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zLga0pE9MI41" title="Recognized derivative expense"&gt;1,715,557&lt;/span&gt; at inception on the warrants issued in connection with a funding on January 6, 2023. The Black-Scholes option
pricing model assumptions for the derivative liabilities during the years ended April 30, 2023 and 2022 consisted of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_892_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_z4Bz6LcfV8Y7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B1_zSBUudjmpz4c" style="display: none"&gt;SCHEDULE
OF DERIVATIVE AND WARRANTS GRANTED VALUATION USING BLACK-SCHOLES PRICING METHOD&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Year Ended April 30, 2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Year Ended April 30, 2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Expected life in years&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_ecustom--DerivativeLiabilitiesMeasurementInputTerm_dtY_c20220501__20230430__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zExvjDnpbI51" title="Derivative liabilities Measurement input, term"&gt;3.25&lt;/span&gt;-&lt;span id="xdx_902_ecustom--DerivativeLiabilitiesMeasurementInputTerm_dtY_c20220501__20230430__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zp2qcuPMSE22" title="Derivative liabilities Measurement input, term"&gt;10&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_ecustom--DerivativeLiabilitiesMeasurementInputTerm_dtY_c20210501__20220430__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_z6yeJH9ymBcl" title="Derivative liabilities measurement input"&gt;1.95&lt;/span&gt;-&lt;span id="xdx_90E_ecustom--DerivativeLiabilitiesMeasurementInputTerm_dtY_c20210501__20220430__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zWD6oIs7ALNd" title="Derivative liabilities measurement input"&gt;4.3&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 68%"&gt;Stock price volatility&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230430__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__srt--RangeAxis__srt--MinimumMember_zDuwBbVQde9c" title="Derivative liability measurement input"&gt;50&lt;/span&gt; - &lt;span id="xdx_90D_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230430__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__srt--RangeAxis__srt--MaximumMember_ziEpBdVqYX01" title="Derivative liability measurement input"&gt;150&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220430__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zLjQhYmj1Zt6" title="Derivative liability measurement input"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Risk free interest rate&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230430__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zJAEIQfPKexl" title="Derivative liability measurement input"&gt;2.90%&lt;/span&gt;-&lt;span id="xdx_908_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230430__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zhWQyeeXjsV1" title="Derivative liability measurement input"&gt;4.34&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220430__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zMfFROROnH6l" title="Derivative liability measurement input"&gt;2.67%&lt;/span&gt;-&lt;span id="xdx_908_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220430__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zawH3Uq2Hv7e" title="Derivative liability measurement input"&gt;2.90&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Expected dividends&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230430__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_z7qeqaaslk7j" title="Derivative liability measurement input"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220430__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zakTy1zyVZ3h" title="Derivative liability measurement input"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A5_zgqcHLHfEXN5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Refer
to Note 10 and Note 11 for more information regarding the derivative instruments.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_843_eus-gaap--IncomeTaxPolicyTextBlock_z5WkW3YJHNGa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_863_zwElE196j3Sc"&gt;Income
Taxes&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Income
taxes are accounted for in accordance with the provisions of ASC 740, Accounting for Income Taxes. Deferred tax assets and liabilities
are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing
assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected
to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred
tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Valuation
allowances are established, when necessary, to reduce deferred tax assets to the amounts that are more likely than not to be realized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--IntangibleAssetsFiniteLivedPolicy_ztN5wHRUMbGb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_864_zxZ4eLNANbOd"&gt;Intangible
Assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intangible
assets relate to the &#x201c;Slinger&#x201d; technology trademark, which the Company purchased on November 10, 2020. The Company also acquired
intangible assets as a part of the Gameface acquisition. These intangible assets include tradenames, internally developed software, and
customer relationships. The acquired intangible assets are amortized based on the estimated present value of cash flows of each class
of intangible assets in order to determine their economic useful life. All intangible assets acquired with the PlaySight transaction
are included in discontinued operations. Refer to Note 6 for more information.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_842_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zaGl9aLjyzXj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86C_zcm7DRP8PEHj"&gt;Impairment
of Long-Lived Assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
accordance with ASC 360-10, the Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate
that their net book value may not be recoverable. Factors which could trigger impairment review include significant underperformance
relative to historical or projected future operating results, significant changes in the manner of use of the assets or the strategy
for the overall business, a significant decrease in the market value of the assets or significant negative industry or economic trends.
When such factors and circumstances exist, the Company compares the projected undiscounted future cash flows associated with the related
asset or group of assets over their estimated useful lives against their respective carrying amount. If those net undiscounted cash flows
do not exceed the carrying amount, impairment, if any, is based on the excess of the carrying amount over the fair value based on the
market value or discounted expected cash flows of those assets and is recorded in the period in which the determination is made. There
was impairment of long-lived assets identified during the year ended April 30, 2023 and 2022 in our continuing operations. Refer to Note
6 for more information.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_848_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_zdtNV2nGJ5md" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_864_z8EmZ71508Hl"&gt;Goodwill&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for goodwill in accordance with ASC 350, Intangibles - Goodwill and Other (&#x201c;ASC 350&#x201d;). ASC 350 requires
that goodwill not be amortized, but reviewed for impairment if impairment indicators arise and, at a minimum, annually. The Company records
goodwill as the excess purchase price over assets acquired and includes any work force acquired as goodwill. Goodwill is evaluated for
impairment on an annual basis.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;With
the adoption of the ASU 2017-04, which eliminates the second step of the goodwill impairment test, the Company tests impairment of goodwill
in one step. In this step, the Company compares the fair value of each reporting unit with goodwill to its carrying value. The Company
determines the fair value of its reporting units with goodwill using a combination of a discounted cash flow and a market value approach.
If the carrying value of the net assets assigned to the reporting unit exceeds the fair value of the reporting unit, the Company will
record an impairment charge based on the excess of a reporting unit&#x2019;s carrying amount over its fair value. If the fair value of
the reporting unit exceeds the carrying value of the net assets assigned to that reporting unit, goodwill is not impaired and the Company
will not record an impairment charge.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company impaired the remaining $&lt;span id="xdx_905_eus-gaap--GoodwillImpairmentLoss_c20220501__20230430_zRpSVtbWOkhh" title="Goodwill impairment charges"&gt;6,781,193&lt;/span&gt; of goodwill as of April 30, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zATxgYgULnF" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86F_zoExeEVYsUjb"&gt;Share-Based
Payment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for share-based compensation in accordance with ASC 718, Compensation-Stock Compensation (ASC 718). Under the fair value
recognition provisions of this topic, stock-based compensation cost is measured at the grant date based on the fair value of the award
and is recognized as an expense on a straight-line basis over the requisite service period, which is the vesting period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_841_ecustom--WarrantsPolicyTextBlock_z8UZfjEmf8Bh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86F_z4dLffk0HYub"&gt;Warrants&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company grants warrants to key employees and executives as compensation on a discretionary basis. The Company also grants warrants in
connection with certain note payable agreements and other key arrangements. The Company is required to estimate the fair value of share-based
awards on the measurement date and recognize as expense that value of the portion of the award that is ultimately expected to vest over
the requisite service period. Warrants granted in connection with ongoing arrangements are more fully described in Note 11 and Note 14.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
warrants granted during the years ended April 30, 2023 and 2022 were valued using a Black-Scholes option pricing model on the date of
grant using the following assumptions:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_899_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_hus-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_zzz3XHpZ7AW7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B9_zSnX45WTkLQ7" style="display: none"&gt;SCHEDULE OF WARRANTS GRANTED VALUATION USING BLACK-SCHOLES PRICING
METHOD&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"&gt;Year Ended&lt;/p&gt;
                                                                                &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"&gt;April 30, 2023&lt;/p&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"&gt;Year Ended&lt;/p&gt;
                                                                                &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"&gt;April 30, 2022&lt;/p&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Expected life in years&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20230430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MinimumMember_z39j4GVFPZU2" title="Warrants measurement input, term"&gt;5&lt;/span&gt; &#x2013; &lt;span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20230430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MaximumMember_zxLRWNDFvyMe" title="Warrants measurement input, term"&gt;10&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MinimumMember_zQGYyHPQeRa2" title="Warrants measurement input, term"&gt;5&lt;/span&gt; &#x2013; &lt;span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MaximumMember_zuhSHLVH1bph" title="Warrants measurement input, term"&gt;10&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Stock price volatility&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230430__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_zVgcGSscX8Rd" title="Warrants measurement input, rate"&gt;50&lt;/span&gt;% - &lt;span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230430__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_zTqr0kjgX1B3" title="Warrants measurement input, rate"&gt;150&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220430__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_zB8DinQqZMWj" title="Warrants measurement input, rate"&gt;50&lt;/span&gt;% - &lt;span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220430__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_zyePRTOpLbxf" title="Warrants measurement input, rate"&gt;148&lt;/span&gt;&lt;/span&gt;%&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Risk free interest rate&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember_zFCjvCwWOVDe" title="Warrants measurement input, rate"&gt;2.50&lt;/span&gt;% - &lt;span id="xdx_909_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember_zVHayA4Yshze" title="Warrants measurement input, rate"&gt;4.68&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember_zcX2q7oqNHhb" title="Warrants measurement input, rate"&gt;0.77&lt;/span&gt;% - &lt;span id="xdx_90F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember_zriimxW75qde" title="Warrants measurement input, rate"&gt;1.63&lt;/span&gt;&lt;/span&gt;%&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left"&gt;Expected dividends&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: center"&gt;&lt;span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zpCT0ha2u6w" title="Warrants measurement input, rate"&gt;0&lt;/span&gt;%&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: center"&gt;&lt;span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zselrYextILl" title="Warrants measurement input, rate"&gt;0&lt;/span&gt;%&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A0_zvMHtNt7z2Aj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zYoHJGrSLQRa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_860_zQ4xReBtLj69"&gt;Foreign
Currency Translation&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Our
functional currency is the U.S. dollar. The functional currency of our foreign operations, generally, is the respective local currency
for each foreign subsidiary. Assets and liabilities of foreign operations denominated in local currencies are translated at the spot
rate in effect at the applicable reporting date. Our consolidated statements of comprehensive loss are translated at the weighted average
rate of exchange during the applicable period. The resulting unrealized cumulative translation adjustment is recorded as a component
of accumulated other comprehensive loss in shareholders&#x2019; equity. Realized and unrealized transaction gains and losses generated
by transactions denominated in a currency different from the functional currency of the applicable entity are recorded in other income
(loss) in the period in which they occur.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84C_eus-gaap--EarningsPerSharePolicyTextBlock_z6hMfSfComha" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_862_zeDZCwcJ1dj3"&gt;Earnings
Per Share&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic
earnings per share are calculated by dividing the income available to shareholders by the weighted-average number of common shares
outstanding during each period. Diluted earnings per share are computed using the weighted average number of common and dilutive common
share equivalents outstanding during the period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;All
common stock equivalents such as shares to be issued for the conversion of notes payable and warrants were excluded from the calculation
of diluted earnings per share as the effect is antidilutive. As a result, the basic and diluted earnings per share are the same for each
of the periods presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zWCSSiuretbd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_862_z6AWpOXz8wfd"&gt;Recent
Accounting Pronouncements&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Recently
Adopted&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
January 2017, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued ASU No. 2017-04, Intangibles &#x2013; Goodwill and
Other (Topic 350): Simplifying the Test for Goodwill Impairment (&#x201c;ASU 2017-04&#x201d;), which simplifies how an entity is required
to test goodwill for impairment by eliminating Step 2 from the goodwill impairment test. Under ASU 2017-04, goodwill impairment will
be tested by comparing the fair value of a reporting unit with its carrying amount, and recognizing an impairment charge for the amount
by which the carrying amount exceeds the reporting unit&#x2019;s fair value. The new guidance must be applied on a prospective basis and
is effective for periods beginning after December 15, 2022, with early adoption permitted. The Company adopted ASU 2017-04 effective
May 1, 2021. The adoption of the new standard did not have a material effect on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
December 2019, the FASB issued Accounting Standards Update (&#x201c;ASU&#x201d;), 2019-12, &lt;i&gt;Simplifying the Accounting for Income Taxes&lt;/i&gt;,
which amends ASC 740, &lt;i&gt;Income Taxes&lt;/i&gt; (ASC 740). This update is intended to simplify accounting for income taxes by removing certain
exceptions to the general principles in ASC 740 and amending existing guidance to improve consistent application of ASC 740. This update
is effective for fiscal years beginning after December 15, 2021. The guidance in this update has various elements, some of which are
applied on a prospective basis and others on a retrospective basis with earlier application permitted. The adoption of the new standard
did not have a material effect on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
August 2020, the FASB issued ASU No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging
Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own
Equity. ASU 2020-06 will simplify the accounting for convertible instruments by reducing the number of accounting models for convertible
debt instruments and convertible preferred stock. Limiting the accounting models results in fewer embedded conversion features being
separately recognized from the host contract as compared with current GAAP. Convertible instruments that continue to be subject to separation
models are (1) those with embedded conversion features that are not clearly and closely related to the host contract, that meet the definition
of a derivative, and that do not qualify for a scope exception from derivative accounting and (2) convertible debt instruments issued
with substantial premiums for which the premiums are recorded as paid-in capital. ASU 2020-06 also amends the guidance for the derivatives
scope exception for contracts in an entity&#x2019;s own equity to reduce form-over-substance-based accounting conclusions. ASU 2020-06
will be effective for public companies for fiscal years beginning after December 15, 2023, including interim periods within those fiscal
years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within
those fiscal years. The Company is currently evaluating the impact that the adoption of ASU 2020-06 will have on the Company&#x2019;s
consolidated financial statement presentation or disclosures.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
June 2016, the FASB issued ASU 2016-13, Financial Instruments &#x2013; Credit Losses (Topic 326): Measurement of Credit Losses on Financial
Instruments (&#x201c;ASC 326&#x201d;). The guidance replaces the incurred loss methodology with an expected loss methodology that is referred
to as the current expected credit loss (&#x201c;CECL&#x201d;) methodology. The measurement of expected credit losses under the CECL methodology
is applicable to financial assets measured at amortized cost, including loan receivables and held-to-maturity debt securities. It also
applies to off-balance sheet credit exposures not accounted for as insurance (loan commitments, standby letters of credits, financial
guarantees, and other similar instruments) and net investments in leases recognized by a lessor in accordance with Topic 842 on leases.
ASC 326 requires enhanced disclosures related to the significant estimates and judgments used in estimating credit losses as well as
the credit quality and underwriting standards of a company&#x2019;s portfolio. In addition, ASC 326 made changes to the accounting for
available-for-sale debt securities. One such change is to require credit losses to be presented as an allowance rather than as a write-down
on available-for-sale debt securities the Company does not intend to sell or believes that it is more likely than not they will be required
to sell. The ASU can be adopted no later than January 1, 2020 for SEC filers and January 1, 2023 for private companies and smaller reporting
companies. The Company has not yet adopted this ASU as it qualifies as a smaller reporting company. The Company does not expect this
ASU will have a material impact on its consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
October 2021, the FASB issued ASU 2021-08, &#x201c;Business Combinations - Accounting for Contract Assets and Contract Liabilities (Topic
805)&#x201d;. The amendments in this Update address diversity and inconsistency related to the recognition and measurement of contract
assets and contract liabilities acquired in a business combination. The amendments in this Update require that an acquirer recognize
and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606, Revenue from Contracts
with Customers. ASU 2021-08 is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal
years. The Company does not expect the adoption of this ASU to have a material impact on the Company&#x2019;s financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
FASB has issued ASU 2021-04, Earnings Per Share (Topic 260), Debt&#x2014;Modifications and Extinguishments (Subtopic 470-50), Compensation&#x2014;Stock
Compensation (Topic 718), and Derivatives and Hedging&#x2014;Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40). ASU 2021-04 provides
guidance that an entity should treat a modification of the terms or conditions or an exchange of a freestanding equity-classified written
call option that remains equity classified after modification or exchange as an exchange of the original instrument for a new instrument.
The standard also provides guidance on how an entity should measure and recognize the effect of a modification or an exchange of a freestanding
equity-classified written call option that remains equity classified. The amendments in this ASU are effective for the Company for fiscal
years beginning after December 15, 2021. Early adoption is permitted for all entities, including adoption in an interim period. The adoption
of the new standard did not have a material effect on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
recently issued accounting pronouncements did not, or are not believed by management to, have a material effect on the Company&#x2019;s
present or future consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85A_zZcFC4aQkV58" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2022-05-012023-04-30">&lt;p id="xdx_845_eus-gaap--UseOfEstimates_zbweqBbIOfHj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_869_zZphjCY6iJMd"&gt;Use
of Estimates&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect
the amounts reported in the financial statements and accompanying notes. Accordingly, actual results could differ from those estimates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:UseOfEstimates>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription contextRef="From2022-05-012023-04-30">&lt;p id="xdx_84A_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zmBTVTVg1Vzh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86D_z4iek6XCOzT7"&gt;Financial
Statement Reclassification&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Certain
prior year amounts within accounts payable, accrued expenses, and certain operating expenses have been reclassified for consistency with
the current year presentation and had no effect on the Company&#x2019;s balance sheet, net loss, shareholders&#x2019; deficit or cash flows.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2022-05-012023-04-30">&lt;p id="xdx_84F_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zBSpXuLMoEBl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_867_zQa3IPLkAvBk"&gt;Cash
and Cash Equivalents&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents.
The majority of payments due from banks for credit card transactions process within 24 to 48 hours and are accordingly classified as
cash and cash equivalents.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy contextRef="From2022-05-012023-04-30">&lt;p id="xdx_845_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zHA0nqyIm9Y3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86E_zuXjhSOa7Vce"&gt;Accounts
Receivable&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s accounts receivable are non-interest bearing trade receivables resulting from the sale of products and payable over terms
ranging from 15 to 60 days. The Company provides an allowance for doubtful accounts at the point when collection is considered doubtful.
Once all collection efforts have been exhausted, the Company charges-off the receivable with the allowance for doubtful accounts. The
Company recorded $&lt;span id="xdx_909_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pdp0_do_c20230430_zVJAPCDSDaJ1" title="Allowance for doubtful accounts"&gt;209,690 &lt;/span&gt;and $&lt;span id="xdx_90F_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pdp0_do_c20220430_zQbRZFlenFp1" title="Allowance for doubtful accounts"&gt;175,000 &lt;/span&gt;in allowance for doubtful accounts for the years ended April 30, 2023 and 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">209690</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">175000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:InventoryPolicyTextBlock contextRef="From2022-05-012023-04-30">&lt;p id="xdx_844_eus-gaap--InventoryPolicyTextBlock_z4GZIc49tAJc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_860_zJHbInc5rlCg"&gt;Inventory&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Inventory
is valued at the lower of the cost (determined principally on a first-in, first-out basis) or net realizable value. The Company&#x2019;s
valuation of inventory includes inventory reserves for inventory that will be sold below cost and the impact of inventory shrink. Inventory
reserves are based on historical information and assumptions about future demand and inventory shrink trends. The Company&#x2019;s inventory
as of April 30, 2023 and April 30, 2022 consisted of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_896_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zrmeoIreLo6e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B0_zOGEgcyNOtTi" style="display: none"&gt;SCHEDULE OF INVENTORY&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20230430_zCNs6Kvremrg" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;April 30, 2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20220430_zUbYmp0KTAV2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;April 30, 2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--InventoryFinishedGoods_iI_maINzzOV_zgpMKI5OqRDg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left"&gt;Finished Goods&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;1,509,985&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;4,073,791&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--InventoryRawMaterialsAndSupplies_iI_maINzzOV_zA8Ecmzavp07" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Component/Replacement Parts&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,712,553&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;2,559,848&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--CapitalizedDutyAndFreight_iI_maINzzOV_zJz4ApKsSv12" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Capitalized Duty/Freight&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;517,228&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,328,198&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--InventoryAdjustments_iNI_di_msINzzOV_zMRWSmi26TMa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;Inventory Reserve&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(550,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(100,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--InventoryNet_iTI_mtINzzOV_zaS27xIt7Avl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;3,189,766&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;7,861,837&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A4_zFzPuYXmiymi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="From2022-05-012023-04-30">&lt;p id="xdx_896_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zrmeoIreLo6e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B0_zOGEgcyNOtTi" style="display: none"&gt;SCHEDULE OF INVENTORY&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20230430_zCNs6Kvremrg" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;April 30, 2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20220430_zUbYmp0KTAV2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;April 30, 2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--InventoryFinishedGoods_iI_maINzzOV_zgpMKI5OqRDg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left"&gt;Finished Goods&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;1,509,985&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;4,073,791&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--InventoryRawMaterialsAndSupplies_iI_maINzzOV_zA8Ecmzavp07" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Component/Replacement Parts&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,712,553&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;2,559,848&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--CapitalizedDutyAndFreight_iI_maINzzOV_zJz4ApKsSv12" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Capitalized Duty/Freight&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;517,228&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,328,198&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--InventoryAdjustments_iNI_di_msINzzOV_zMRWSmi26TMa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;Inventory Reserve&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(550,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(100,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--InventoryNet_iTI_mtINzzOV_zaS27xIt7Avl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;3,189,766&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;7,861,837&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryFinishedGoods contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">1509985</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">4073791</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryRawMaterialsAndSupplies contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">1712553</us-gaap:InventoryRawMaterialsAndSupplies>
    <us-gaap:InventoryRawMaterialsAndSupplies contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">2559848</us-gaap:InventoryRawMaterialsAndSupplies>
    <CNXA:CapitalizedDutyAndFreight contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">517228</CNXA:CapitalizedDutyAndFreight>
    <CNXA:CapitalizedDutyAndFreight contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">1328198</CNXA:CapitalizedDutyAndFreight>
    <us-gaap:InventoryAdjustments contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">550000</us-gaap:InventoryAdjustments>
    <us-gaap:InventoryAdjustments contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">100000</us-gaap:InventoryAdjustments>
    <us-gaap:InventoryNet contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">3189766</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">7861837</us-gaap:InventoryNet>
    <CNXA:PrepaidInventoryPolicyTextBlock contextRef="From2022-05-012023-04-30">&lt;p id="xdx_840_ecustom--PrepaidInventoryPolicyTextBlock_zd7vebe9uPi3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_867_zPvsYKuKBeq9"&gt;Prepaid
Inventory&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Prepaid
inventory represents inventory that is in-transit that has been paid for but not received from the Company&#x2019;s third-party vendors.
The Company typically prepays for the purchase of materials and receives the products within three months after making payments. The
Company continuously monitors delivery from, and payments to, the vendors. If the Company has difficulty receiving products from a vendor,
the Company would cease purchasing products from such vendors in future periods. The Company has not had difficulty receiving products
during the reporting periods.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</CNXA:PrepaidInventoryPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="From2022-05-012023-04-30">&lt;p id="xdx_840_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zinPRBGbmrKh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_865_zvMa9q1QY8T1"&gt;Property
and equipment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Property
and equipment acquired through business combinations are stated at the estimated fair value at the date of the acquisition. Purchases
of property and equipment are stated at cost, net of accumulated depreciation and impairment losses. Expenditures that materially increase
the useful life of the assets are capitalized. Ordinary repairs and maintenance are expensed as incurred. Depreciation and amortization
are computed using the straight-line method over the estimated useful lives of the related assets, which is an average of &lt;span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230430_zLmLxV15L8H2" title="Property plant and equipment, useful life"&gt;5&lt;/span&gt; years.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="AsOf2023-04-30">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="From2022-05-012023-04-30">&lt;p id="xdx_844_eus-gaap--ConcentrationRiskCreditRisk_zd7FSsePjhgi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86D_z14jdvKg80tl"&gt;Concentration
of Credit Risk&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company maintains its cash in bank deposit accounts, the balances of which at times may exceed insured limits. The Company continually
monitors its banking relationships and consequently has not experienced any losses in such accounts. While we may be exposed to credit
risk, we consider the risk remote and do not expect that any such risk would result in a significant effect on our results of operations
or financial condition. See Note 4 for further details on the Company&#x2019;s concentration of credit risk as well as other risks and
uncertainties.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="From2022-05-012023-04-30">&lt;p id="xdx_84C_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_z413dCELoeZj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_862_z1ghWZ0Zkwn3"&gt;Revenue
Recognition&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes revenue for their continuing operations in accordance with Accounting Standards Codification (&#x201c;ASC&#x201d;) 606,
the core principle of which is that an entity should recognize revenue to depict the transfer of promised goods or services to customers
in an amount that reflects the consideration to which the entity expects to be entitled to receive in exchange for those goods or services.
The Company recognizes revenue for its performance obligation associated with its contracts with customers at a point in time once products
are shipped. Amounts collected from customers in advance of shipping products ordered are reflected as contract liabilities on the accompanying
consolidated balance sheets. The Company&#x2019;s standard terms are non-cancelable and do not provide for the right-of-return, other
than for defective merchandise covered under the Company&#x2019;s standard warranty. The Company has not historically experienced any
significant returns or warranty issues.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes revenue under ASC 606, &#x201c;Revenue from Contracts with Customers&#x201d;. The core principle of this revenue standard
is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects
the consideration to which the company expects to be entitled in exchange for those goods or services. The following five steps are applied
to achieve that core principle:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Step
1: Identify the contract with the customer&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company determines that it has a contract with a customer when each party&#x2019;s rights regarding the products or services to be transferred
can be identified, the payment terms for the services can be identified, the Company has determined the customer has the ability and
intent to pay, and the contract has commercial substance. At contract inception, the Company evaluates whether two or more contracts
should be combined and accounted for as a single contract and whether the combined or single contract includes more than one performance
obligation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Step
2: Identify the performance obligations in the contract&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s customers are buying an integrated system. In evaluating whether the equipment is a separate performance obligation,
the Company&#x2019;s management considered the customer&#x2019;s ability to benefit from the equipment on its own or together with other
readily available resources and if so, whether the service and equipment are separately identifiable (i.e., is the service highly dependent
on, or highly interrelated with the equipment). Because the Products and Services included in the customer&#x2019;s contract are integrated
and highly interdependent, and because they must work together to deliver the Solution, the Company has concluded that Products installed
on customer&#x2019;s premise and Services contracted for by the customer are generally not distinct within the context of the contract
and, therefore, constitute a single, combined performance obligation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Step
3: Determine the transaction price&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
transaction price is the amount of consideration to which an entity expects to be entitled in exchange for transferring promised goods
or services to a customer. The consideration promised in a contract with a customer includes predetermined fixed amounts, variable amounts,
or both. The Company&#x2019;s contracts do not include any rights of returns or refunds.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company collects each year&#x2019;s service fees in advance and should therefore consider the existence of a significant financing component.
However, due to the fact that the payments are provided for the service of a one-year term, the Company elected to apply the practical
expedient under ASC 606 which exempts the adjustment of the consideration for the existence of a significant financing component when
the period between the transfer of the services and the payment for such services is one year or less.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Step
4: Allocate the transaction price to the performance obligations in the contract&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Contracts
that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on
each performance obligation&#x2019;s relative standalone selling price (&#x201c;SSP&#x201d;). The Company has identified a single performance
obligation in the contract, and therefore, the allocation provisions under ASC 606 do not apply to the Company&#x2019;s contracts.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Step
5: Recognize revenue when the Company satisfies a performance obligation&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Revenues
for the Company&#x2019;s single, combined performance obligation are recognized on a straight-line basis over the customer&#x2019;s contract
term, which is the period in which the parties to the contract have enforceable rights and obligations (Typically 3-4 years).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:BusinessCombinationsPolicy contextRef="From2022-05-012023-04-30">&lt;p id="xdx_84E_eus-gaap--BusinessCombinationsPolicy_z0ZRa7SHCO76" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86A_zbCzDWV4khLc"&gt;Business
Combinations&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Upon
acquisition of a company, we determine if the transaction is a business combination, which is accounted for using the acquisition method
of accounting. Under the acquisition method, once control is obtained of a business, the assets acquired, and liabilities assumed, are
recorded at fair value. We use our best estimates and assumptions to assign fair value to the tangible and intangible assets acquired
and liabilities assumed at the acquisition date. One of the most significant estimates relates to the determination of the fair value
of these assets and liabilities. The determination of the fair values is based on estimates and judgments made by management. Our estimates
of fair value are based upon assumptions we believe to be reasonable, but which are inherently uncertain and unpredictable. Measurement
period adjustments are reflected at the time identified, up through the conclusion of the measurement period, which is the time at which
all information for determination of the values of assets acquired and liabilities assumed is received and is not to exceed one year
from the acquisition date. We may record adjustments to the fair value of these tangible and intangible assets acquired and liabilities
assumed, with the corresponding offset to goodwill. The Company elected to apply pushdown accounting to all entities acquired.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Additionally,
uncertain tax positions and tax-related valuation allowances are initially recorded in connection with a business combination as of the
acquisition date. We continue to collect information and reevaluate these estimates and assumptions periodically and record any adjustments
to preliminary estimates to goodwill, provided we are within the measurement period. If outside of the measurement period, any subsequent
adjustments are recorded to the consolidated statement of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BusinessCombinationsPolicy>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2022-05-012023-04-30">&lt;p id="xdx_842_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zsR4gXGRnvj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_867_zSfb8dCDzeK1"&gt;Fair
Value of Financial Instruments&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
value of financial and non-financial assets and liabilities is defined as an exit price, representing the amount that would be received
to sell an asset or paid to transfer a liability in an orderly transaction between market participants. The three-tier hierarchy for
inputs used in measuring fair value, which prioritizes the inputs used in the methodologies of measuring fair value for assets and liabilities,
is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
1 &#x2014; Quoted prices in active markets for identical assets or liabilities&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
2 &#x2014; Observable inputs other than quoted prices in active markets for identical assets and liabilities&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
3 &#x2014; Unobservable pricing inputs in the market&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
assets and financial liabilities are classified in their entirety based on the lowest level of input that is significant to the fair
value measurements. Our assessment of the significance of a particular input to the fair value measurements requires judgment and may
affect the valuation of the assets and liabilities being measured and their categorization within the fair value hierarchy.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s financial instruments consist of cash and cash equivalents, accounts receivable, and accounts payable. The carrying amount
of these financial instruments approximates fair value due to their short-term maturity.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s contingent consideration in connection with the acquisition of Gameface was calculated using Level 3 inputs. The fair
value of contingent consideration as of April 30, 2023 and 2022 was $&lt;span id="xdx_908_eus-gaap--BusinessCombinationConsiderationTransferred1_c20220501__20230430__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zWAvbj1aT4ua" title="Fair value of contingent consideration"&gt;418,455&lt;/span&gt; and $&lt;span id="xdx_905_eus-gaap--BusinessCombinationConsiderationTransferred1_c20210501__20220430__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zMgFaUDRB6Ii" title="Fair value of contingent consideration"&gt;1,334,000&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company estimates the fair value of its intangible assets using Level 3 assumptions, primarily based on the income approach utilizing
the discounted cash flow method.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s derivative liabilities were calculated using Level 2 assumptions on the issuance and balance sheet dates via a Black-Scholes
option pricing model and consisted of the following ending balances and gain amounts as of and for the year ended April 30, 2023:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_895_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_zKdxFAaIrev6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BC_zth2ZPbd4ldg" style="display: none"&gt;SCHEDULE OF DERIVATIVE LIABILITIES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;April 30, 2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;(Gain) loss for the year&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Note derivative is related to&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;ending balance&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;ended April 30, 2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 58%; text-align: left"&gt;4/11/21 profit guaranty&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--ProfitGuarantyMember_zLoVdfg4BcMg" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Note derivative balance"&gt;1,456,854&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20220501__20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--ProfitGuarantyMember_ztU1z71Fcr69" style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right" title="Note derivative (gain) loss"&gt;395,304&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;8/6/21 convertible notes&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--ConvertibleNotesMember_za5ouNOASKYj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Note derivative balance"&gt;101,924&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20220501__20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--ConvertibleNotesMember_zbyjmW8ypLJi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Note derivative (gain) loss"&gt;(2,611,410&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;6/17/22 underwriter warrants&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--UnderwriterWarrantsMember_zk2QYBRehJBf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Underwriter warrants"&gt;6,531&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20220501__20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--UnderwriterWarrantsMember_z2kIb4szkMl9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Note derivative (gain) loss"&gt;(57,951&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Other derivative liabilities eliminated in uplist&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--OtherDerivativeLiabilitiesMember_zJoLszxw8Ko5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other derivative liabilities eliminated in uplist"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2020"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20220501__20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--OtherDerivativeLiabilitiesMember_zZaELMDW4F8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Note derivative (gain) loss"&gt;(1,604,413&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;9/30/22 warrants issued with common stock&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsIssuedWithCommonStockMember_zSHGxJ6QgJva" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other derivative liabilities eliminated in uplist"&gt;6,109,559&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20220501__20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsIssuedWithCommonStockMember_zDUauxaNsYN3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Note derivative (gain) loss"&gt;(6,170,728&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;1/6/2023 warrants issued with note payable&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsIssuedWithNotesPayableMember_zDflVje0ufDd" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other derivative liabilities eliminated in uplist"&gt;2,814,738&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20220501__20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsIssuedWithNotesPayableMember_zWeXeUvmeepj" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Note derivative (gain) loss"&gt;(900,819&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230430_zQU5Cl2xeNz7" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Note derivative balance"&gt;10,489,606&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20220501__20230430_zRROsfnxGTP5" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Note derivative (gain) loss"&gt;(10,950,017&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A1_zXI5Tz8hx0v2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company also recognized derivative expense of $&lt;span id="xdx_901_ecustom--RecognizedDerivativeExpense_c20220501__20230430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zeDeQ562lBAa" title="Recognized derivative expense"&gt;7,280,405&lt;/span&gt; at inception on the warrants issued in connection with a funding on September
30, 2022 and $&lt;span id="xdx_906_ecustom--RecognizedDerivativeExpense_c20230106__20230106__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zLga0pE9MI41" title="Recognized derivative expense"&gt;1,715,557&lt;/span&gt; at inception on the warrants issued in connection with a funding on January 6, 2023. The Black-Scholes option
pricing model assumptions for the derivative liabilities during the years ended April 30, 2023 and 2022 consisted of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_892_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_z4Bz6LcfV8Y7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B1_zSBUudjmpz4c" style="display: none"&gt;SCHEDULE
OF DERIVATIVE AND WARRANTS GRANTED VALUATION USING BLACK-SCHOLES PRICING METHOD&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Year Ended April 30, 2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Year Ended April 30, 2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Expected life in years&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_ecustom--DerivativeLiabilitiesMeasurementInputTerm_dtY_c20220501__20230430__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zExvjDnpbI51" title="Derivative liabilities Measurement input, term"&gt;3.25&lt;/span&gt;-&lt;span id="xdx_902_ecustom--DerivativeLiabilitiesMeasurementInputTerm_dtY_c20220501__20230430__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zp2qcuPMSE22" title="Derivative liabilities Measurement input, term"&gt;10&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_ecustom--DerivativeLiabilitiesMeasurementInputTerm_dtY_c20210501__20220430__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_z6yeJH9ymBcl" title="Derivative liabilities measurement input"&gt;1.95&lt;/span&gt;-&lt;span id="xdx_90E_ecustom--DerivativeLiabilitiesMeasurementInputTerm_dtY_c20210501__20220430__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zWD6oIs7ALNd" title="Derivative liabilities measurement input"&gt;4.3&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 68%"&gt;Stock price volatility&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230430__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__srt--RangeAxis__srt--MinimumMember_zDuwBbVQde9c" title="Derivative liability measurement input"&gt;50&lt;/span&gt; - &lt;span id="xdx_90D_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230430__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__srt--RangeAxis__srt--MaximumMember_ziEpBdVqYX01" title="Derivative liability measurement input"&gt;150&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220430__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zLjQhYmj1Zt6" title="Derivative liability measurement input"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Risk free interest rate&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230430__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zJAEIQfPKexl" title="Derivative liability measurement input"&gt;2.90%&lt;/span&gt;-&lt;span id="xdx_908_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230430__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zhWQyeeXjsV1" title="Derivative liability measurement input"&gt;4.34&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220430__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zMfFROROnH6l" title="Derivative liability measurement input"&gt;2.67%&lt;/span&gt;-&lt;span id="xdx_908_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220430__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zawH3Uq2Hv7e" title="Derivative liability measurement input"&gt;2.90&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Expected dividends&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230430__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_z7qeqaaslk7j" title="Derivative liability measurement input"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220430__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zakTy1zyVZ3h" title="Derivative liability measurement input"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A5_zgqcHLHfEXN5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Refer
to Note 10 and Note 11 for more information regarding the derivative instruments.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="From2022-05-012023-04-30_us-gaap_FairValueInputsLevel3Member"
      decimals="0"
      unitRef="USD">418455</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="From2021-05-012022-04-30_us-gaap_FairValueInputsLevel3Member"
      decimals="0"
      unitRef="USD">1334000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock contextRef="From2022-05-012023-04-30">&lt;p id="xdx_895_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_zKdxFAaIrev6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BC_zth2ZPbd4ldg" style="display: none"&gt;SCHEDULE OF DERIVATIVE LIABILITIES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;April 30, 2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;(Gain) loss for the year&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Note derivative is related to&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;ending balance&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;ended April 30, 2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 58%; text-align: left"&gt;4/11/21 profit guaranty&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--ProfitGuarantyMember_zLoVdfg4BcMg" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Note derivative balance"&gt;1,456,854&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20220501__20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--ProfitGuarantyMember_ztU1z71Fcr69" style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right" title="Note derivative (gain) loss"&gt;395,304&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;8/6/21 convertible notes&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--ConvertibleNotesMember_za5ouNOASKYj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Note derivative balance"&gt;101,924&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20220501__20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--ConvertibleNotesMember_zbyjmW8ypLJi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Note derivative (gain) loss"&gt;(2,611,410&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;6/17/22 underwriter warrants&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--UnderwriterWarrantsMember_zk2QYBRehJBf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Underwriter warrants"&gt;6,531&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20220501__20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--UnderwriterWarrantsMember_z2kIb4szkMl9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Note derivative (gain) loss"&gt;(57,951&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Other derivative liabilities eliminated in uplist&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--OtherDerivativeLiabilitiesMember_zJoLszxw8Ko5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other derivative liabilities eliminated in uplist"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2020"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20220501__20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--OtherDerivativeLiabilitiesMember_zZaELMDW4F8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Note derivative (gain) loss"&gt;(1,604,413&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;9/30/22 warrants issued with common stock&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsIssuedWithCommonStockMember_zSHGxJ6QgJva" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other derivative liabilities eliminated in uplist"&gt;6,109,559&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20220501__20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsIssuedWithCommonStockMember_zDUauxaNsYN3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Note derivative (gain) loss"&gt;(6,170,728&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;1/6/2023 warrants issued with note payable&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsIssuedWithNotesPayableMember_zDflVje0ufDd" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other derivative liabilities eliminated in uplist"&gt;2,814,738&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20220501__20230430__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsIssuedWithNotesPayableMember_zWeXeUvmeepj" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Note derivative (gain) loss"&gt;(900,819&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DerivativeInstrumentsAndHedgesLiabilities_iI_c20230430_zQU5Cl2xeNz7" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Note derivative balance"&gt;10,489,606&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_c20220501__20230430_zRROsfnxGTP5" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Note derivative (gain) loss"&gt;(10,950,017&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock>
    <us-gaap:DerivativeInstrumentsAndHedgesLiabilities
      contextRef="AsOf2023-04-30_custom_ProfitGuarantyMember"
      decimals="0"
      unitRef="USD">1456854</us-gaap:DerivativeInstrumentsAndHedgesLiabilities>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="From2022-05-012023-04-30_custom_ProfitGuarantyMember"
      decimals="0"
      unitRef="USD">-395304</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeInstrumentsAndHedgesLiabilities
      contextRef="AsOf2023-04-30_custom_ConvertibleNotesMember"
      decimals="0"
      unitRef="USD">101924</us-gaap:DerivativeInstrumentsAndHedgesLiabilities>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="From2022-05-012023-04-30_custom_ConvertibleNotesMember"
      decimals="0"
      unitRef="USD">2611410</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeInstrumentsAndHedgesLiabilities
      contextRef="AsOf2023-04-30_custom_UnderwriterWarrantsMember"
      decimals="0"
      unitRef="USD">6531</us-gaap:DerivativeInstrumentsAndHedgesLiabilities>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="From2022-05-012023-04-30_custom_UnderwriterWarrantsMember"
      decimals="0"
      unitRef="USD">57951</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="From2022-05-012023-04-30_custom_OtherDerivativeLiabilitiesMember"
      decimals="0"
      unitRef="USD">1604413</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeInstrumentsAndHedgesLiabilities
      contextRef="AsOf2023-04-30_custom_WarrantsIssuedWithCommonStockMember"
      decimals="0"
      unitRef="USD">6109559</us-gaap:DerivativeInstrumentsAndHedgesLiabilities>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="From2022-05-012023-04-30_custom_WarrantsIssuedWithCommonStockMember"
      decimals="0"
      unitRef="USD">6170728</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeInstrumentsAndHedgesLiabilities
      contextRef="AsOf2023-04-30_custom_WarrantsIssuedWithNotesPayableMember"
      decimals="0"
      unitRef="USD">2814738</us-gaap:DerivativeInstrumentsAndHedgesLiabilities>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="From2022-05-012023-04-30_custom_WarrantsIssuedWithNotesPayableMember"
      decimals="0"
      unitRef="USD">900819</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeInstrumentsAndHedgesLiabilities contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">10489606</us-gaap:DerivativeInstrumentsAndHedgesLiabilities>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">10950017</us-gaap:DerivativeGainLossOnDerivativeNet>
    <CNXA:RecognizedDerivativeExpense
      contextRef="From2022-05-012023-04-30_us-gaap_WarrantMember"
      decimals="0"
      unitRef="USD">7280405</CNXA:RecognizedDerivativeExpense>
    <CNXA:RecognizedDerivativeExpense
      contextRef="From2023-01-062023-01-06_us-gaap_WarrantMember"
      decimals="0"
      unitRef="USD">1715557</CNXA:RecognizedDerivativeExpense>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock contextRef="From2022-05-012023-04-30">&lt;p id="xdx_892_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_z4Bz6LcfV8Y7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B1_zSBUudjmpz4c" style="display: none"&gt;SCHEDULE
OF DERIVATIVE AND WARRANTS GRANTED VALUATION USING BLACK-SCHOLES PRICING METHOD&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Year Ended April 30, 2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Year Ended April 30, 2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Expected life in years&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_ecustom--DerivativeLiabilitiesMeasurementInputTerm_dtY_c20220501__20230430__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zExvjDnpbI51" title="Derivative liabilities Measurement input, term"&gt;3.25&lt;/span&gt;-&lt;span id="xdx_902_ecustom--DerivativeLiabilitiesMeasurementInputTerm_dtY_c20220501__20230430__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zp2qcuPMSE22" title="Derivative liabilities Measurement input, term"&gt;10&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_ecustom--DerivativeLiabilitiesMeasurementInputTerm_dtY_c20210501__20220430__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_z6yeJH9ymBcl" title="Derivative liabilities measurement input"&gt;1.95&lt;/span&gt;-&lt;span id="xdx_90E_ecustom--DerivativeLiabilitiesMeasurementInputTerm_dtY_c20210501__20220430__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zWD6oIs7ALNd" title="Derivative liabilities measurement input"&gt;4.3&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 68%"&gt;Stock price volatility&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230430__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__srt--RangeAxis__srt--MinimumMember_zDuwBbVQde9c" title="Derivative liability measurement input"&gt;50&lt;/span&gt; - &lt;span id="xdx_90D_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230430__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__srt--RangeAxis__srt--MaximumMember_ziEpBdVqYX01" title="Derivative liability measurement input"&gt;150&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220430__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zLjQhYmj1Zt6" title="Derivative liability measurement input"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Risk free interest rate&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230430__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zJAEIQfPKexl" title="Derivative liability measurement input"&gt;2.90%&lt;/span&gt;-&lt;span id="xdx_908_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230430__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zhWQyeeXjsV1" title="Derivative liability measurement input"&gt;4.34&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220430__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zMfFROROnH6l" title="Derivative liability measurement input"&gt;2.67%&lt;/span&gt;-&lt;span id="xdx_908_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220430__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zawH3Uq2Hv7e" title="Derivative liability measurement input"&gt;2.90&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Expected dividends&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20230430__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_z7qeqaaslk7j" title="Derivative liability measurement input"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220430__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zakTy1zyVZ3h" title="Derivative liability measurement input"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;%&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <CNXA:DerivativeLiabilitiesMeasurementInputTerm contextRef="From2022-05-012023-04-30_srt_MinimumMember_us-gaap_MeasurementInputExpectedTermMember_us-gaap_ValuationTechniqueOptionPricingModelMember">P3Y3M</CNXA:DerivativeLiabilitiesMeasurementInputTerm>
    <CNXA:DerivativeLiabilitiesMeasurementInputTerm contextRef="From2022-05-012023-04-30_srt_MaximumMember_us-gaap_MeasurementInputExpectedTermMember_us-gaap_ValuationTechniqueOptionPricingModelMember">P10Y</CNXA:DerivativeLiabilitiesMeasurementInputTerm>
    <CNXA:DerivativeLiabilitiesMeasurementInputTerm contextRef="From2021-05-012022-04-30_srt_MinimumMember_us-gaap_MeasurementInputExpectedTermMember_us-gaap_ValuationTechniqueOptionPricingModelMember">P1Y11M12D</CNXA:DerivativeLiabilitiesMeasurementInputTerm>
    <CNXA:DerivativeLiabilitiesMeasurementInputTerm contextRef="From2021-05-012022-04-30_srt_MaximumMember_us-gaap_MeasurementInputExpectedTermMember_us-gaap_ValuationTechniqueOptionPricingModelMember">P4Y3M18D</CNXA:DerivativeLiabilitiesMeasurementInputTerm>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="AsOf2023-04-30_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ValuationTechniqueOptionPricingModelMember_srt_MinimumMember"
      decimals="INF"
      unitRef="Pure">50</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="AsOf2023-04-30_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ValuationTechniqueOptionPricingModelMember_srt_MaximumMember"
      decimals="INF"
      unitRef="Pure">150</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="AsOf2022-04-30_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ValuationTechniqueOptionPricingModelMember"
      decimals="INF"
      unitRef="Pure">50</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="AsOf2023-04-30_srt_MinimumMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_us-gaap_ValuationTechniqueOptionPricingModelMember"
      decimals="INF"
      unitRef="Pure">2.90</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="AsOf2023-04-30_srt_MaximumMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_us-gaap_ValuationTechniqueOptionPricingModelMember"
      decimals="INF"
      unitRef="Pure">4.34</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="AsOf2022-04-30_srt_MinimumMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_us-gaap_ValuationTechniqueOptionPricingModelMember"
      decimals="INF"
      unitRef="Pure">2.67</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="AsOf2022-04-30_srt_MaximumMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_us-gaap_ValuationTechniqueOptionPricingModelMember"
      decimals="INF"
      unitRef="Pure">2.90</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="AsOf2023-04-30_us-gaap_MeasurementInputExpectedDividendRateMember_us-gaap_ValuationTechniqueOptionPricingModelMember"
      decimals="INF"
      unitRef="Pure">0</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="AsOf2022-04-30_us-gaap_MeasurementInputExpectedDividendRateMember_us-gaap_ValuationTechniqueOptionPricingModelMember"
      decimals="INF"
      unitRef="Pure">0</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2022-05-012023-04-30">&lt;p id="xdx_843_eus-gaap--IncomeTaxPolicyTextBlock_z5WkW3YJHNGa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_863_zwElE196j3Sc"&gt;Income
Taxes&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Income
taxes are accounted for in accordance with the provisions of ASC 740, Accounting for Income Taxes. Deferred tax assets and liabilities
are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing
assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected
to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred
tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Valuation
allowances are established, when necessary, to reduce deferred tax assets to the amounts that are more likely than not to be realized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:IntangibleAssetsFiniteLivedPolicy contextRef="From2022-05-012023-04-30">&lt;p id="xdx_84E_eus-gaap--IntangibleAssetsFiniteLivedPolicy_ztN5wHRUMbGb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_864_zxZ4eLNANbOd"&gt;Intangible
Assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intangible
assets relate to the &#x201c;Slinger&#x201d; technology trademark, which the Company purchased on November 10, 2020. The Company also acquired
intangible assets as a part of the Gameface acquisition. These intangible assets include tradenames, internally developed software, and
customer relationships. The acquired intangible assets are amortized based on the estimated present value of cash flows of each class
of intangible assets in order to determine their economic useful life. All intangible assets acquired with the PlaySight transaction
are included in discontinued operations. Refer to Note 6 for more information.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IntangibleAssetsFiniteLivedPolicy>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="From2022-05-012023-04-30">&lt;p id="xdx_842_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zaGl9aLjyzXj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86C_zcm7DRP8PEHj"&gt;Impairment
of Long-Lived Assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
accordance with ASC 360-10, the Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate
that their net book value may not be recoverable. Factors which could trigger impairment review include significant underperformance
relative to historical or projected future operating results, significant changes in the manner of use of the assets or the strategy
for the overall business, a significant decrease in the market value of the assets or significant negative industry or economic trends.
When such factors and circumstances exist, the Company compares the projected undiscounted future cash flows associated with the related
asset or group of assets over their estimated useful lives against their respective carrying amount. If those net undiscounted cash flows
do not exceed the carrying amount, impairment, if any, is based on the excess of the carrying amount over the fair value based on the
market value or discounted expected cash flows of those assets and is recorded in the period in which the determination is made. There
was impairment of long-lived assets identified during the year ended April 30, 2023 and 2022 in our continuing operations. Refer to Note
6 for more information.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy contextRef="From2022-05-012023-04-30">&lt;p id="xdx_848_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_zdtNV2nGJ5md" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_864_z8EmZ71508Hl"&gt;Goodwill&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for goodwill in accordance with ASC 350, Intangibles - Goodwill and Other (&#x201c;ASC 350&#x201d;). ASC 350 requires
that goodwill not be amortized, but reviewed for impairment if impairment indicators arise and, at a minimum, annually. The Company records
goodwill as the excess purchase price over assets acquired and includes any work force acquired as goodwill. Goodwill is evaluated for
impairment on an annual basis.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;With
the adoption of the ASU 2017-04, which eliminates the second step of the goodwill impairment test, the Company tests impairment of goodwill
in one step. In this step, the Company compares the fair value of each reporting unit with goodwill to its carrying value. The Company
determines the fair value of its reporting units with goodwill using a combination of a discounted cash flow and a market value approach.
If the carrying value of the net assets assigned to the reporting unit exceeds the fair value of the reporting unit, the Company will
record an impairment charge based on the excess of a reporting unit&#x2019;s carrying amount over its fair value. If the fair value of
the reporting unit exceeds the carrying value of the net assets assigned to that reporting unit, goodwill is not impaired and the Company
will not record an impairment charge.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company impaired the remaining $&lt;span id="xdx_905_eus-gaap--GoodwillImpairmentLoss_c20220501__20230430_zRpSVtbWOkhh" title="Goodwill impairment charges"&gt;6,781,193&lt;/span&gt; of goodwill as of April 30, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">6781193</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="From2022-05-012023-04-30">&lt;p id="xdx_84D_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zATxgYgULnF" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86F_zoExeEVYsUjb"&gt;Share-Based
Payment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for share-based compensation in accordance with ASC 718, Compensation-Stock Compensation (ASC 718). Under the fair value
recognition provisions of this topic, stock-based compensation cost is measured at the grant date based on the fair value of the award
and is recognized as an expense on a straight-line basis over the requisite service period, which is the vesting period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <CNXA:WarrantsPolicyTextBlock contextRef="From2022-05-012023-04-30">&lt;p id="xdx_841_ecustom--WarrantsPolicyTextBlock_z8UZfjEmf8Bh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_86F_z4dLffk0HYub"&gt;Warrants&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company grants warrants to key employees and executives as compensation on a discretionary basis. The Company also grants warrants in
connection with certain note payable agreements and other key arrangements. The Company is required to estimate the fair value of share-based
awards on the measurement date and recognize as expense that value of the portion of the award that is ultimately expected to vest over
the requisite service period. Warrants granted in connection with ongoing arrangements are more fully described in Note 11 and Note 14.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
warrants granted during the years ended April 30, 2023 and 2022 were valued using a Black-Scholes option pricing model on the date of
grant using the following assumptions:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_899_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_hus-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_zzz3XHpZ7AW7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B9_zSnX45WTkLQ7" style="display: none"&gt;SCHEDULE OF WARRANTS GRANTED VALUATION USING BLACK-SCHOLES PRICING
METHOD&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"&gt;Year Ended&lt;/p&gt;
                                                                                &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"&gt;April 30, 2023&lt;/p&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"&gt;Year Ended&lt;/p&gt;
                                                                                &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"&gt;April 30, 2022&lt;/p&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Expected life in years&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20230430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MinimumMember_z39j4GVFPZU2" title="Warrants measurement input, term"&gt;5&lt;/span&gt; &#x2013; &lt;span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20230430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MaximumMember_zxLRWNDFvyMe" title="Warrants measurement input, term"&gt;10&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MinimumMember_zQGYyHPQeRa2" title="Warrants measurement input, term"&gt;5&lt;/span&gt; &#x2013; &lt;span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MaximumMember_zuhSHLVH1bph" title="Warrants measurement input, term"&gt;10&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Stock price volatility&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230430__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_zVgcGSscX8Rd" title="Warrants measurement input, rate"&gt;50&lt;/span&gt;% - &lt;span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230430__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_zTqr0kjgX1B3" title="Warrants measurement input, rate"&gt;150&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220430__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_zB8DinQqZMWj" title="Warrants measurement input, rate"&gt;50&lt;/span&gt;% - &lt;span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220430__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_zyePRTOpLbxf" title="Warrants measurement input, rate"&gt;148&lt;/span&gt;&lt;/span&gt;%&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Risk free interest rate&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember_zFCjvCwWOVDe" title="Warrants measurement input, rate"&gt;2.50&lt;/span&gt;% - &lt;span id="xdx_909_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember_zVHayA4Yshze" title="Warrants measurement input, rate"&gt;4.68&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember_zcX2q7oqNHhb" title="Warrants measurement input, rate"&gt;0.77&lt;/span&gt;% - &lt;span id="xdx_90F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember_zriimxW75qde" title="Warrants measurement input, rate"&gt;1.63&lt;/span&gt;&lt;/span&gt;%&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left"&gt;Expected dividends&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: center"&gt;&lt;span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zpCT0ha2u6w" title="Warrants measurement input, rate"&gt;0&lt;/span&gt;%&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: center"&gt;&lt;span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zselrYextILl" title="Warrants measurement input, rate"&gt;0&lt;/span&gt;%&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A0_zvMHtNt7z2Aj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</CNXA:WarrantsPolicyTextBlock>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock contextRef="From2022-05-012023-04-30_us-gaap_WarrantMember30671140">&lt;p id="xdx_899_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_hus-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_zzz3XHpZ7AW7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B9_zSnX45WTkLQ7" style="display: none"&gt;SCHEDULE OF WARRANTS GRANTED VALUATION USING BLACK-SCHOLES PRICING
METHOD&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"&gt;Year Ended&lt;/p&gt;
                                                                                &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"&gt;April 30, 2023&lt;/p&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"&gt;Year Ended&lt;/p&gt;
                                                                                &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"&gt;April 30, 2022&lt;/p&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Expected life in years&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20230430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MinimumMember_z39j4GVFPZU2" title="Warrants measurement input, term"&gt;5&lt;/span&gt; &#x2013; &lt;span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20230430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MaximumMember_zxLRWNDFvyMe" title="Warrants measurement input, term"&gt;10&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MinimumMember_zQGYyHPQeRa2" title="Warrants measurement input, term"&gt;5&lt;/span&gt; &#x2013; &lt;span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MaximumMember_zuhSHLVH1bph" title="Warrants measurement input, term"&gt;10&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Stock price volatility&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230430__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_zVgcGSscX8Rd" title="Warrants measurement input, rate"&gt;50&lt;/span&gt;% - &lt;span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230430__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_zTqr0kjgX1B3" title="Warrants measurement input, rate"&gt;150&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220430__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_zB8DinQqZMWj" title="Warrants measurement input, rate"&gt;50&lt;/span&gt;% - &lt;span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220430__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_zyePRTOpLbxf" title="Warrants measurement input, rate"&gt;148&lt;/span&gt;&lt;/span&gt;%&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Risk free interest rate&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember_zFCjvCwWOVDe" title="Warrants measurement input, rate"&gt;2.50&lt;/span&gt;% - &lt;span id="xdx_909_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember_zVHayA4Yshze" title="Warrants measurement input, rate"&gt;4.68&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember_zcX2q7oqNHhb" title="Warrants measurement input, rate"&gt;0.77&lt;/span&gt;% - &lt;span id="xdx_90F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember_zriimxW75qde" title="Warrants measurement input, rate"&gt;1.63&lt;/span&gt;&lt;/span&gt;%&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left"&gt;Expected dividends&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: center"&gt;&lt;span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zpCT0ha2u6w" title="Warrants measurement input, rate"&gt;0&lt;/span&gt;%&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: center"&gt;&lt;span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220430__us-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zselrYextILl" title="Warrants measurement input, rate"&gt;0&lt;/span&gt;%&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="AsOf2023-04-30_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputExpectedTermMember_srt_MinimumMember">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="AsOf2023-04-30_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputExpectedTermMember_srt_MaximumMember">P10Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="AsOf2022-04-30_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputExpectedTermMember_srt_MinimumMember">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="AsOf2022-04-30_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputExpectedTermMember_srt_MaximumMember">P10Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2023-04-30_srt_MinimumMember_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_WarrantMember"
      decimals="INF"
      unitRef="Pure">50</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2023-04-30_srt_MaximumMember_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_WarrantMember"
      decimals="INF"
      unitRef="Pure">150</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2022-04-30_srt_MinimumMember_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_WarrantMember"
      decimals="INF"
      unitRef="Pure">50</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2022-04-30_srt_MaximumMember_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_WarrantMember"
      decimals="INF"
      unitRef="Pure">148</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2023-04-30_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MinimumMember"
      decimals="INF"
      unitRef="Pure">2.50</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2023-04-30_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MaximumMember"
      decimals="INF"
      unitRef="Pure">4.68</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2022-04-30_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MinimumMember"
      decimals="INF"
      unitRef="Pure">0.77</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2022-04-30_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MaximumMember"
      decimals="INF"
      unitRef="Pure">1.63</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2023-04-30_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputExpectedDividendRateMember"
      decimals="INF"
      unitRef="Pure">0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2022-04-30_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputExpectedDividendRateMember"
      decimals="INF"
      unitRef="Pure">0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="From2022-05-012023-04-30">&lt;p id="xdx_84F_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zYoHJGrSLQRa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_860_zQ4xReBtLj69"&gt;Foreign
Currency Translation&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Our
functional currency is the U.S. dollar. The functional currency of our foreign operations, generally, is the respective local currency
for each foreign subsidiary. Assets and liabilities of foreign operations denominated in local currencies are translated at the spot
rate in effect at the applicable reporting date. Our consolidated statements of comprehensive loss are translated at the weighted average
rate of exchange during the applicable period. The resulting unrealized cumulative translation adjustment is recorded as a component
of accumulated other comprehensive loss in shareholders&#x2019; equity. Realized and unrealized transaction gains and losses generated
by transactions denominated in a currency different from the functional currency of the applicable entity are recorded in other income
(loss) in the period in which they occur.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2022-05-012023-04-30">&lt;p id="xdx_84C_eus-gaap--EarningsPerSharePolicyTextBlock_z6hMfSfComha" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_862_zeDZCwcJ1dj3"&gt;Earnings
Per Share&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic
earnings per share are calculated by dividing the income available to shareholders by the weighted-average number of common shares
outstanding during each period. Diluted earnings per share are computed using the weighted average number of common and dilutive common
share equivalents outstanding during the period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;All
common stock equivalents such as shares to be issued for the conversion of notes payable and warrants were excluded from the calculation
of diluted earnings per share as the effect is antidilutive. As a result, the basic and diluted earnings per share are the same for each
of the periods presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2022-05-012023-04-30">&lt;p id="xdx_844_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zWCSSiuretbd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_862_z6AWpOXz8wfd"&gt;Recent
Accounting Pronouncements&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Recently
Adopted&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
January 2017, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued ASU No. 2017-04, Intangibles &#x2013; Goodwill and
Other (Topic 350): Simplifying the Test for Goodwill Impairment (&#x201c;ASU 2017-04&#x201d;), which simplifies how an entity is required
to test goodwill for impairment by eliminating Step 2 from the goodwill impairment test. Under ASU 2017-04, goodwill impairment will
be tested by comparing the fair value of a reporting unit with its carrying amount, and recognizing an impairment charge for the amount
by which the carrying amount exceeds the reporting unit&#x2019;s fair value. The new guidance must be applied on a prospective basis and
is effective for periods beginning after December 15, 2022, with early adoption permitted. The Company adopted ASU 2017-04 effective
May 1, 2021. The adoption of the new standard did not have a material effect on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
December 2019, the FASB issued Accounting Standards Update (&#x201c;ASU&#x201d;), 2019-12, &lt;i&gt;Simplifying the Accounting for Income Taxes&lt;/i&gt;,
which amends ASC 740, &lt;i&gt;Income Taxes&lt;/i&gt; (ASC 740). This update is intended to simplify accounting for income taxes by removing certain
exceptions to the general principles in ASC 740 and amending existing guidance to improve consistent application of ASC 740. This update
is effective for fiscal years beginning after December 15, 2021. The guidance in this update has various elements, some of which are
applied on a prospective basis and others on a retrospective basis with earlier application permitted. The adoption of the new standard
did not have a material effect on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
August 2020, the FASB issued ASU No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging
Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own
Equity. ASU 2020-06 will simplify the accounting for convertible instruments by reducing the number of accounting models for convertible
debt instruments and convertible preferred stock. Limiting the accounting models results in fewer embedded conversion features being
separately recognized from the host contract as compared with current GAAP. Convertible instruments that continue to be subject to separation
models are (1) those with embedded conversion features that are not clearly and closely related to the host contract, that meet the definition
of a derivative, and that do not qualify for a scope exception from derivative accounting and (2) convertible debt instruments issued
with substantial premiums for which the premiums are recorded as paid-in capital. ASU 2020-06 also amends the guidance for the derivatives
scope exception for contracts in an entity&#x2019;s own equity to reduce form-over-substance-based accounting conclusions. ASU 2020-06
will be effective for public companies for fiscal years beginning after December 15, 2023, including interim periods within those fiscal
years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within
those fiscal years. The Company is currently evaluating the impact that the adoption of ASU 2020-06 will have on the Company&#x2019;s
consolidated financial statement presentation or disclosures.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
June 2016, the FASB issued ASU 2016-13, Financial Instruments &#x2013; Credit Losses (Topic 326): Measurement of Credit Losses on Financial
Instruments (&#x201c;ASC 326&#x201d;). The guidance replaces the incurred loss methodology with an expected loss methodology that is referred
to as the current expected credit loss (&#x201c;CECL&#x201d;) methodology. The measurement of expected credit losses under the CECL methodology
is applicable to financial assets measured at amortized cost, including loan receivables and held-to-maturity debt securities. It also
applies to off-balance sheet credit exposures not accounted for as insurance (loan commitments, standby letters of credits, financial
guarantees, and other similar instruments) and net investments in leases recognized by a lessor in accordance with Topic 842 on leases.
ASC 326 requires enhanced disclosures related to the significant estimates and judgments used in estimating credit losses as well as
the credit quality and underwriting standards of a company&#x2019;s portfolio. In addition, ASC 326 made changes to the accounting for
available-for-sale debt securities. One such change is to require credit losses to be presented as an allowance rather than as a write-down
on available-for-sale debt securities the Company does not intend to sell or believes that it is more likely than not they will be required
to sell. The ASU can be adopted no later than January 1, 2020 for SEC filers and January 1, 2023 for private companies and smaller reporting
companies. The Company has not yet adopted this ASU as it qualifies as a smaller reporting company. The Company does not expect this
ASU will have a material impact on its consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
October 2021, the FASB issued ASU 2021-08, &#x201c;Business Combinations - Accounting for Contract Assets and Contract Liabilities (Topic
805)&#x201d;. The amendments in this Update address diversity and inconsistency related to the recognition and measurement of contract
assets and contract liabilities acquired in a business combination. The amendments in this Update require that an acquirer recognize
and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606, Revenue from Contracts
with Customers. ASU 2021-08 is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal
years. The Company does not expect the adoption of this ASU to have a material impact on the Company&#x2019;s financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
FASB has issued ASU 2021-04, Earnings Per Share (Topic 260), Debt&#x2014;Modifications and Extinguishments (Subtopic 470-50), Compensation&#x2014;Stock
Compensation (Topic 718), and Derivatives and Hedging&#x2014;Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40). ASU 2021-04 provides
guidance that an entity should treat a modification of the terms or conditions or an exchange of a freestanding equity-classified written
call option that remains equity classified after modification or exchange as an exchange of the original instrument for a new instrument.
The standard also provides guidance on how an entity should measure and recognize the effect of a modification or an exchange of a freestanding
equity-classified written call option that remains equity classified. The amendments in this ASU are effective for the Company for fiscal
years beginning after December 15, 2021. Early adoption is permitted for all entities, including adoption in an interim period. The adoption
of the new standard did not have a material effect on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
recently issued accounting pronouncements did not, or are not believed by management to, have a material effect on the Company&#x2019;s
present or future consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:ConcentrationRiskDisclosureTextBlock contextRef="From2022-05-012023-04-30">&lt;p id="xdx_80D_eus-gaap--ConcentrationRiskDisclosureTextBlock_zLeGex0IoJid" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
4&lt;/b&gt;: &lt;b&gt;&lt;span id="xdx_823_zPTOk1EbAPB2"&gt;CONCENTRATION OF CREDIT RISK AND OTHER RISKS AND UNCERTAINTIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Accounts
Receivable Concentration&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of April 30, 2023 and 2022, the Company had two customers that accounted for &lt;span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220501__20230430__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CreditConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_z6rKEuRzHNU4" title="Concentration risk, percentage"&gt;47%&lt;/span&gt;
and &lt;span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210501__20220430__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CreditConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zHcqTZpR9yM7" title="Concentration risk, percentage"&gt;43&lt;/span&gt;%
of the Company&#x2019;s trade receivables balance, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Accounts
Payable Concentration&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of April 30, 2023 and 2022, the Company had four significant suppliers that accounted for &lt;span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220501__20230430__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--LenderConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerFourMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember_zeclT50hbYDk" title="Concentration risk, percentage"&gt;59%&lt;/span&gt;
and &lt;span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210501__20220430__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--LenderConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerFourMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember_zrje7zCfKgHj" title="Concentration risk, percentage"&gt;59&lt;/span&gt;% of the Company&#x2019;s trade payables balances, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConcentrationRiskDisclosureTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-05-012023-04-30_us-gaap_AccountsReceivableMember_us-gaap_CreditConcentrationRiskMember_custom_CustomerOneMember"
      decimals="INF"
      unitRef="Pure">0.47</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-05-012022-04-30_us-gaap_AccountsReceivableMember_us-gaap_CreditConcentrationRiskMember_custom_CustomerTwoMember"
      decimals="INF"
      unitRef="Pure">0.43</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-05-012023-04-30_us-gaap_LenderConcentrationRiskMember_custom_CustomerFourMember_us-gaap_AccountsPayableMember"
      decimals="INF"
      unitRef="Pure">0.59</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-05-012022-04-30_us-gaap_LenderConcentrationRiskMember_custom_CustomerFourMember_us-gaap_AccountsPayableMember"
      decimals="INF"
      unitRef="Pure">0.59</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:BusinessCombinationDisclosureTextBlock contextRef="From2022-05-012023-04-30">&lt;p id="xdx_804_eus-gaap--BusinessCombinationDisclosureTextBlock_zIBVLAVytOQ9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
5: &lt;span id="xdx_824_z7eVkjqDa1v8"&gt;ACQUISITIONS AND BUSINESS COMBINATIONS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
the year ended April 30, 2022, the Company acquired three entities in accordance with ASC 805. A full description of those transactions
is reflected in the audited financial statements contained in our Annual Report on Form 10-K filed with the Securities and Exchange
Commission on May 17, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has elected to apply pushdown accounting to each of the entities acquired.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
Foundation Sports as referred to in Note 16, the Company disposed of &lt;span id="xdx_900_ecustom--DisposalEquityInterestOwnershipInterestPercentage_iI_pid_dp_uPure_c20221231__us-gaap--BusinessAcquisitionAxis__custom--FoundationSportsMember_zZqNxeNgxswg" title="Disposal equity interest percentage"&gt;75%&lt;/span&gt; of this entity in December 2022. The company has valued the
&lt;span id="xdx_904_eus-gaap--DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal_pid_dp_uPure_c20220501__20230430__us-gaap--BusinessAcquisitionAxis__custom--FoundationSportsSystemsLLCMember_z8mHPy8uk5J9" title="Discontinuing operations percentage"&gt;25%&lt;/span&gt; they continue to own in Foundation Sports at $&lt;span id="xdx_907_eus-gaap--AlternativeInvestment_iI_dp_c20230430__us-gaap--BusinessAcquisitionAxis__custom--FoundationSportsSystemsLLCMember_zPj3kCTGBYG8" title="Investments"&gt;0&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
PlaySight as referred to in Note 16, the Company sold back to the original shareholders &lt;span id="xdx_90C_ecustom--DisposalEquityInterestOwnershipInterestPercentage_iI_pid_dp_c20221130__us-gaap--BusinessAcquisitionAxis__custom--PlaySightMember_zbvbEbOGXx6b" title="Disposal equity interest percentage"&gt;100&lt;/span&gt;% of this entity in November 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Pro
Forma Results&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following pro forma financial information presents the results of operations of the Company as of the year ended April 30, 2022, respectively,
as if the acquisitions of Gameface had occurred as of the beginning of the first period presented instead of February 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_898_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_zyENlt8bYm4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B7_zFAhyN7MQ28c" style="display: none"&gt;SCHEDULE OF PROFORMA FINANCIAL INFORMATION&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_495_20220501__20230430__us-gaap--BusinessAcquisitionAxis__custom--PlaySightAndGameFaceMember_zVxQYrY8QOx8" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--BusinessAcquisitionsProFormaRevenue_zM2xjz0arDz" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 80%"&gt;Revenues&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;16,102,672&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_zN8TPAqShFb8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Net loss&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(53,069,215&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Basic and diluted earnings (loss) per share&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--BusinessAcquisitionProFormaEarningsPerShareBasic_pid_c20220501__20230430__us-gaap--BusinessAcquisitionAxis__custom--PlaySightAndGameFaceMember_zDPrP6mamX03" title="Basic earnings (loss) per share"&gt;&lt;span id="xdx_90D_eus-gaap--BusinessAcquisitionProFormaEarningsPerShareDiluted_pid_c20220501__20230430__us-gaap--BusinessAcquisitionAxis__custom--PlaySightAndGameFaceMember_zFKKqatP7QUb" title="Diluted earnings (loss) per share"&gt;(13.79&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A1_zLsYqKyzO9he" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BusinessCombinationDisclosureTextBlock>
    <CNXA:DisposalEquityInterestOwnershipInterestPercentage
      contextRef="AsOf2022-12-31_custom_FoundationSportsMember"
      decimals="INF"
      unitRef="Pure">0.75</CNXA:DisposalEquityInterestOwnershipInterestPercentage>
    <us-gaap:DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal
      contextRef="From2022-05-012023-04-30_custom_FoundationSportsSystemsLLCMember"
      decimals="INF"
      unitRef="Pure">0.25</us-gaap:DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal>
    <us-gaap:AlternativeInvestment
      contextRef="AsOf2023-04-30_custom_FoundationSportsSystemsLLCMember"
      decimals="0"
      unitRef="USD">0</us-gaap:AlternativeInvestment>
    <CNXA:DisposalEquityInterestOwnershipInterestPercentage
      contextRef="AsOf2022-11-30_custom_PlaySightMember"
      decimals="INF"
      unitRef="Pure">1</CNXA:DisposalEquityInterestOwnershipInterestPercentage>
    <us-gaap:BusinessAcquisitionProFormaInformationTextBlock contextRef="From2022-05-012023-04-30">&lt;p id="xdx_898_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_zyENlt8bYm4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B7_zFAhyN7MQ28c" style="display: none"&gt;SCHEDULE OF PROFORMA FINANCIAL INFORMATION&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_495_20220501__20230430__us-gaap--BusinessAcquisitionAxis__custom--PlaySightAndGameFaceMember_zVxQYrY8QOx8" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--BusinessAcquisitionsProFormaRevenue_zM2xjz0arDz" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 80%"&gt;Revenues&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;16,102,672&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_zN8TPAqShFb8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Net loss&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(53,069,215&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Basic and diluted earnings (loss) per share&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--BusinessAcquisitionProFormaEarningsPerShareBasic_pid_c20220501__20230430__us-gaap--BusinessAcquisitionAxis__custom--PlaySightAndGameFaceMember_zDPrP6mamX03" title="Basic earnings (loss) per share"&gt;&lt;span id="xdx_90D_eus-gaap--BusinessAcquisitionProFormaEarningsPerShareDiluted_pid_c20220501__20230430__us-gaap--BusinessAcquisitionAxis__custom--PlaySightAndGameFaceMember_zFKKqatP7QUb" title="Diluted earnings (loss) per share"&gt;(13.79&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:BusinessAcquisitionProFormaInformationTextBlock>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="From2022-05-012023-04-30_custom_PlaySightAndGameFaceMember"
      decimals="0"
      unitRef="USD">16102672</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="From2022-05-012023-04-30_custom_PlaySightAndGameFaceMember"
      decimals="0"
      unitRef="USD">-53069215</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic
      contextRef="From2022-05-012023-04-30_custom_PlaySightAndGameFaceMember"
      decimals="INF"
      unitRef="USDPShares">-13.79</us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted
      contextRef="From2022-05-012023-04-30_custom_PlaySightAndGameFaceMember"
      decimals="INF"
      unitRef="USDPShares">-13.79</us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted>
    <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="From2022-05-012023-04-30">&lt;p id="xdx_80C_eus-gaap--IntangibleAssetsDisclosureTextBlock_z2hMHofx60R5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
6: &lt;span id="xdx_822_zGpW20ub859g"&gt;INTANGIBLE ASSETS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_898_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_zdr9hxZMF1qc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intangible
assets reflect only those intangible assets of our continuing operations, and consist of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BC_zLJRfJD0K8e9" style="display: none"&gt;SCHEDULE
OF INTANGIBLE ASSETS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Amortization (in years)&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_484_eus-gaap--FiniteLivedIntangibleAssetsGross_iE_zrSxTrqNDeLh" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Carrying Value&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_486_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iE_z2DiURFhwMZg" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Accumulated Amortization&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_480_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_zGoK4o3VPHci" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Impairment Loss&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_489_eus-gaap--FiniteLivedIntangibleAssetsNet_iE_zOmVLXhWvedh" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Net Carrying Value&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Weighted&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"&gt;Average Period&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;April 30, 2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Amortization (in years)&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Carrying Value&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Accumulated Amortization&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Impairment Loss&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Net Carrying Value&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_414_20220501__20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zFDBZ3AM1HT6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: left"&gt;Tradenames and patents&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: center"&gt;&lt;span id="xdx_90E_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zx6h3gqzWEL5" title="Weighted average amortization"&gt;15.26&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;385,582&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;24,031&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;260,270&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;101,281&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_417_20220501__20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zAsmufx8AcW1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Customer relationships&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zwD9Z1VsmnG3" title="Weighted average amortization"&gt;9.92&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;3,930,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;50,038&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;3,879,962&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2160"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_414_20220501__20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zikGWA91n2t9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;Internally developed software&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"&gt;&lt;span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_z7pg1tb3zqug" title="Weighted average amortization"&gt;4.91&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;580,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;79,608&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;500,392&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2166"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_417_20220501__20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangiableAssetMember_zXx2lvZtMOkf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 10pt"&gt;Total intangible assets&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;4,895,582&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;153,677&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;4,640,624&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;101,281&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Amortization (in years)&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_48B_eus-gaap--FiniteLivedIntangibleAssetsGross_iE_zUNr6toUcijk" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Carrying Value&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_486_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iE_zOV8G52KINe9" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Accumulated Amortization&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_485_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_zUmOVotCGov3" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Impairment Loss&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_487_eus-gaap--FiniteLivedIntangibleAssetsNet_iE_zGiQqowKXHbe" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Net Carrying Value&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Weighted&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"&gt;Average Period&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;April 30, 2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Amortization (in years)&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Carrying Value&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Accumulated Amortization&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Impairment Loss&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Net Carrying Value&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_419_20210501__20220430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zAgrvwPJvN0b" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 32%"&gt;Tradenames&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: center"&gt;&lt;span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20220430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zbXyobP3JYwi" title="Weighted average amortization"&gt;15.26&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;385,582&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;9,478&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl2175"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;376,104&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_419_20210501__20220430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zDeHVQJJ5QD1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Customer relationships&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_901_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20220430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zP4mPbnhLrR4" title="Weighted average amortization"&gt;9.92&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;3,930,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;33,749&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2181"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;3,896,251&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_418_20210501__20220430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zrzQlmK69ly3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;Internally developed software&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"&gt;&lt;span id="xdx_90C_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20220430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zcIkXcNe90Of" title="Weighted average period amortization (in years)"&gt;4.91&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;580,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;9,499&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2187"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;570,501&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_417_20210501__20220430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangiableAssetMember_zxTxREyI4cf2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 10pt"&gt;Total intangible assets&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;4,895,582&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;52,726&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2193"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;4,842,856&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A1_zKvgv438iZql" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amortization
expense for the years ended April 30, 2023 and 2022 was approximately $&lt;span id="xdx_903_eus-gaap--AmortizationOfIntangibleAssets_c20220501__20230430_zNGo9DG5knV1" title="Amortization expense"&gt;100,951&lt;/span&gt; and $&lt;span id="xdx_908_eus-gaap--AmortizationOfIntangibleAssets_c20210501__20220430_zPjA4M57wJEl" title="Amortization expense"&gt;49,983&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zH05izqLdxi5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of April 30, 2023, the estimated future amortization expense associated with the Company&#x2019;s intangible assets for each of the five
succeeding fiscal years is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B6_zB85NosWLREd" style="display: none"&gt;SCHEDULE
OF ESTIMATED FUTURE AMORTIZATION&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;For the Periods Ended April 30,&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20230430_zSqYeLWsNuG" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Amortization Expense&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_maFLIANz0wb_zvOaBo4f6dU9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 83%; text-align: left"&gt;2024&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;5,780&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_maFLIANz0wb_ze3pjAkRb9Gd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;2025&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;5,780&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_maFLIANz0wb_z3V7ftmG7Me9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;2026&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;5,780&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_maFLIANz0wb_zXxqRIFFMZb9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;2027&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;5,780&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_maFLIANz0wb_zQReO9dlgiN1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;2028&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;5,780&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_maFLIANz0wb_z7NR33BokaSh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;72,381&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_mtFLIANz0wb_z9mqaNM9uZv6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;101,281&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A6_zp6xsGpTZQ53" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock contextRef="From2022-05-012023-04-30">&lt;p id="xdx_898_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_zdr9hxZMF1qc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intangible
assets reflect only those intangible assets of our continuing operations, and consist of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BC_zLJRfJD0K8e9" style="display: none"&gt;SCHEDULE
OF INTANGIBLE ASSETS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Amortization (in years)&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_484_eus-gaap--FiniteLivedIntangibleAssetsGross_iE_zrSxTrqNDeLh" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Carrying Value&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_486_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iE_z2DiURFhwMZg" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Accumulated Amortization&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_480_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_zGoK4o3VPHci" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Impairment Loss&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_489_eus-gaap--FiniteLivedIntangibleAssetsNet_iE_zOmVLXhWvedh" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Net Carrying Value&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Weighted&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"&gt;Average Period&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;April 30, 2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Amortization (in years)&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Carrying Value&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Accumulated Amortization&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Impairment Loss&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Net Carrying Value&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_414_20220501__20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zFDBZ3AM1HT6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: left"&gt;Tradenames and patents&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: center"&gt;&lt;span id="xdx_90E_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zx6h3gqzWEL5" title="Weighted average amortization"&gt;15.26&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;385,582&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;24,031&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;260,270&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;101,281&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_417_20220501__20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zAsmufx8AcW1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Customer relationships&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zwD9Z1VsmnG3" title="Weighted average amortization"&gt;9.92&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;3,930,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;50,038&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;3,879,962&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2160"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_414_20220501__20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zikGWA91n2t9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;Internally developed software&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"&gt;&lt;span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_z7pg1tb3zqug" title="Weighted average amortization"&gt;4.91&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;580,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;79,608&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;500,392&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2166"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_417_20220501__20230430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangiableAssetMember_zXx2lvZtMOkf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 10pt"&gt;Total intangible assets&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;4,895,582&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;153,677&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;4,640,624&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;101,281&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Amortization (in years)&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_48B_eus-gaap--FiniteLivedIntangibleAssetsGross_iE_zUNr6toUcijk" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Carrying Value&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_486_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iE_zOV8G52KINe9" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Accumulated Amortization&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_485_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_zUmOVotCGov3" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Impairment Loss&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_487_eus-gaap--FiniteLivedIntangibleAssetsNet_iE_zGiQqowKXHbe" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Net Carrying Value&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Weighted&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"&gt;Average Period&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;April 30, 2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Amortization (in years)&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Carrying Value&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Accumulated Amortization&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Impairment Loss&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Net Carrying Value&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_419_20210501__20220430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zAgrvwPJvN0b" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 32%"&gt;Tradenames&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: center"&gt;&lt;span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20220430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zbXyobP3JYwi" title="Weighted average amortization"&gt;15.26&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;385,582&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;9,478&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl2175"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;376,104&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_419_20210501__20220430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zDeHVQJJ5QD1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Customer relationships&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span id="xdx_901_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20220430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zP4mPbnhLrR4" title="Weighted average amortization"&gt;9.92&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;3,930,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;33,749&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2181"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;3,896,251&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_418_20210501__20220430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zrzQlmK69ly3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;Internally developed software&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"&gt;&lt;span id="xdx_90C_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20220430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zcIkXcNe90Of" title="Weighted average period amortization (in years)"&gt;4.91&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;580,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;9,499&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2187"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;570,501&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_417_20210501__20220430__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--IntangiableAssetMember_zxTxREyI4cf2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 10pt"&gt;Total intangible assets&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;4,895,582&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;52,726&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2193"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;4,842,856&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1 contextRef="AsOf2023-04-30_us-gaap_TradeNamesMember">P15Y3M3D</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2023-04-30_us-gaap_TradeNamesMember"
      decimals="0"
      unitRef="USD">385582</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2023-04-30_us-gaap_TradeNamesMember"
      decimals="0"
      unitRef="USD">24031</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="From2022-05-012023-04-30_us-gaap_TradeNamesMember"
      decimals="0"
      unitRef="USD">260270</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2023-04-30_us-gaap_TradeNamesMember"
      decimals="0"
      unitRef="USD">101281</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1 contextRef="AsOf2023-04-30_us-gaap_CustomerRelationshipsMember">P9Y11M1D</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2023-04-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      unitRef="USD">3930000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2023-04-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      unitRef="USD">50038</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="From2022-05-012023-04-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      unitRef="USD">3879962</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1 contextRef="AsOf2023-04-30_us-gaap_ComputerSoftwareIntangibleAssetMember">P4Y10M28D</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2023-04-30_us-gaap_ComputerSoftwareIntangibleAssetMember"
      decimals="0"
      unitRef="USD">580000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2023-04-30_us-gaap_ComputerSoftwareIntangibleAssetMember"
      decimals="0"
      unitRef="USD">79608</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="From2022-05-012023-04-30_us-gaap_ComputerSoftwareIntangibleAssetMember"
      decimals="0"
      unitRef="USD">500392</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2023-04-30_custom_IntangiableAssetMember"
      decimals="0"
      unitRef="USD">4895582</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2023-04-30_custom_IntangiableAssetMember"
      decimals="0"
      unitRef="USD">153677</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="From2022-05-012023-04-30_custom_IntangiableAssetMember"
      decimals="0"
      unitRef="USD">4640624</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2023-04-30_custom_IntangiableAssetMember"
      decimals="0"
      unitRef="USD">101281</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1 contextRef="AsOf2022-04-30_us-gaap_TradeNamesMember">P15Y3M3D</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2022-04-30_us-gaap_TradeNamesMember"
      decimals="0"
      unitRef="USD">385582</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2022-04-30_us-gaap_TradeNamesMember"
      decimals="0"
      unitRef="USD">9478</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2022-04-30_us-gaap_TradeNamesMember"
      decimals="0"
      unitRef="USD">376104</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1 contextRef="AsOf2022-04-30_us-gaap_CustomerRelationshipsMember">P9Y11M1D</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2022-04-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      unitRef="USD">3930000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2022-04-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      unitRef="USD">33749</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2022-04-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      unitRef="USD">3896251</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1 contextRef="AsOf2022-04-30_us-gaap_ComputerSoftwareIntangibleAssetMember">P4Y10M28D</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2022-04-30_us-gaap_ComputerSoftwareIntangibleAssetMember"
      decimals="0"
      unitRef="USD">580000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2022-04-30_us-gaap_ComputerSoftwareIntangibleAssetMember"
      decimals="0"
      unitRef="USD">9499</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2022-04-30_us-gaap_ComputerSoftwareIntangibleAssetMember"
      decimals="0"
      unitRef="USD">570501</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2022-04-30_custom_IntangiableAssetMember"
      decimals="0"
      unitRef="USD">4895582</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2022-04-30_custom_IntangiableAssetMember"
      decimals="0"
      unitRef="USD">52726</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2022-04-30_custom_IntangiableAssetMember"
      decimals="0"
      unitRef="USD">4842856</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">100951</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">49983</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock contextRef="From2022-05-012023-04-30">&lt;p id="xdx_89A_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zH05izqLdxi5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of April 30, 2023, the estimated future amortization expense associated with the Company&#x2019;s intangible assets for each of the five
succeeding fiscal years is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B6_zB85NosWLREd" style="display: none"&gt;SCHEDULE
OF ESTIMATED FUTURE AMORTIZATION&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;For the Periods Ended April 30,&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20230430_zSqYeLWsNuG" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Amortization Expense&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_maFLIANz0wb_zvOaBo4f6dU9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 83%; text-align: left"&gt;2024&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;5,780&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_maFLIANz0wb_ze3pjAkRb9Gd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;2025&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;5,780&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_maFLIANz0wb_z3V7ftmG7Me9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;2026&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;5,780&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_maFLIANz0wb_zXxqRIFFMZb9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;2027&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;5,780&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_maFLIANz0wb_zQReO9dlgiN1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;2028&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;5,780&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_maFLIANz0wb_z7NR33BokaSh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;72,381&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_mtFLIANz0wb_z9mqaNM9uZv6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;101,281&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">5780</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">5780</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">5780</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">5780</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">5780</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">72381</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">101281</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="From2022-05-012023-04-30">&lt;p id="xdx_808_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_z01754R0hRVb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
7&lt;/b&gt;: &lt;b&gt;&lt;span id="xdx_82C_z9nDJ29Hm4q2"&gt;ACCRUED EXPENSES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89E_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_zI2oQEiZV7X6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
composition of accrued expenses is summarized below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B8_zZslrlmApOp" style="display: none"&gt;SCHEDULE
OF ACCRUED EXPENSES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20230430_zqbAUjkkGpMk" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;April 30, 2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20220430_zZfgJFMt77n8" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;April 30, 2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--AccruedPayrollTaxesCurrent_iI_maALCzIie_zJwwlQCiGI93" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left"&gt;Accrued payroll&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;1,535,186&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;921,759&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--AccruedBonusesCurrent_iI_maALCzIie_znHv2XcDokc9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Accrued bonus&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,720,606&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,014,833&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--AccruedProfessionalFeesCurrent_iI_maALCzIie_z5moAxsGpls1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Accrued professional fees&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;490,424&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,706,560&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--AccountsPayableOtherCurrent_iI_maALCzIie_zVSMdWQ8Rqb1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;Other accrued expenses&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,165,623&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;738,749&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--AccruedLiabilitiesCurrent_iTI_mtALCzIie_zF0V6kHDPthf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;4,911,839&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;4,381,901&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AE_z0anScNuiLtl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock contextRef="From2022-05-012023-04-30">&lt;p id="xdx_89E_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_zI2oQEiZV7X6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
composition of accrued expenses is summarized below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B8_zZslrlmApOp" style="display: none"&gt;SCHEDULE
OF ACCRUED EXPENSES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20230430_zqbAUjkkGpMk" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;April 30, 2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20220430_zZfgJFMt77n8" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;April 30, 2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--AccruedPayrollTaxesCurrent_iI_maALCzIie_zJwwlQCiGI93" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left"&gt;Accrued payroll&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;1,535,186&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;921,759&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--AccruedBonusesCurrent_iI_maALCzIie_znHv2XcDokc9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Accrued bonus&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,720,606&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,014,833&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--AccruedProfessionalFeesCurrent_iI_maALCzIie_z5moAxsGpls1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Accrued professional fees&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;490,424&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,706,560&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--AccountsPayableOtherCurrent_iI_maALCzIie_zVSMdWQ8Rqb1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;Other accrued expenses&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,165,623&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;738,749&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--AccruedLiabilitiesCurrent_iTI_mtALCzIie_zF0V6kHDPthf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;4,911,839&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;4,381,901&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccruedPayrollTaxesCurrent contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">1535186</us-gaap:AccruedPayrollTaxesCurrent>
    <us-gaap:AccruedPayrollTaxesCurrent contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">921759</us-gaap:AccruedPayrollTaxesCurrent>
    <us-gaap:AccruedBonusesCurrent contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">1720606</us-gaap:AccruedBonusesCurrent>
    <us-gaap:AccruedBonusesCurrent contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">1014833</us-gaap:AccruedBonusesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">490424</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">1706560</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccountsPayableOtherCurrent contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">1165623</us-gaap:AccountsPayableOtherCurrent>
    <us-gaap:AccountsPayableOtherCurrent contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">738749</us-gaap:AccountsPayableOtherCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">4911839</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">4381901</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:DebtDisclosureTextBlock contextRef="From2022-05-012023-04-30">&lt;p id="xdx_808_eus-gaap--DebtDisclosureTextBlock_zE2tKhk8jNYg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
8: &lt;span id="xdx_82D_zPX7pZTZMBLd"&gt;NOTE PAYABLE - RELATED PARTY&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
discussion of note payable &#x2013; related party only includes those that existed as of April 30, 2022. For a discussion of all prior
note payable &#x2013; related party we refer you to the Annual Report on Form 10-K filed May 17, 2023 for the fiscal year end April 30,
2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 14, 2022, the Company entered into two loan agreements with related party lenders, each for $&lt;span id="xdx_905_eus-gaap--LoansPayable_iI_c20220114__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zknIW0cVSOA4" title="Loans payable"&gt;1,000,000&lt;/span&gt;, pursuant to which the
Company received a total amount of $&lt;span id="xdx_90E_eus-gaap--ProceedsFromRelatedPartyDebt_c20220113__20220114__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z1ZXDkC7dw0k" title="Proceeds from related party debt"&gt;2,000,000&lt;/span&gt;. The loans bear interest at a rate of &lt;span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20220114__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zXrfT5xWDzJk" title="Interest rate"&gt;8&lt;/span&gt;% per annum and are required to be repaid in full
by April 30, 2022 or such other date as may be accepted by the lenders. The Company is not permitted to make any distribution or pay
any dividends unless or until the loans are repaid in full. On June 28, 2022, the Company entered into amendments for the two related
party loan agreements with the lenders in which the repayment date was extended to July 31, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;There
was $&lt;span id="xdx_901_eus-gaap--NotesPayable_iI_c20230430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zUJQdH3WxUi6" title="Outstanding borrowings"&gt;1,953,842&lt;/span&gt; and $&lt;span id="xdx_90A_eus-gaap--NotesPayable_iI_c20220430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zRh3CbhqFaI1" title="Outstanding borrowings"&gt;2,000,000&lt;/span&gt; in outstanding borrowings from related parties as of April 30, 2023 and 2022. Interest expense related
to the related parties for the years ended April 30, 2023 and 2022 amounted to $&lt;span id="xdx_909_eus-gaap--InterestExpense_pp0p0_c20220501__20230430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zHcrAstEdSV5" title="Interest expense"&gt;293,090&lt;/span&gt; &#160;and $&lt;span id="xdx_906_eus-gaap--InterestExpense_pp0p0_c20210501__20220430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zeGFhLF6sECh" title="Interest expense"&gt;165,558&lt;/span&gt;, respectively. Accrued interest
due to related parties as of April 30, 2023 and 2022 amounted to $&lt;span id="xdx_90B_eus-gaap--InterestPayableCurrent_iI_c20230430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zHubxdAVsj6h" title="Accrued interest"&gt;917,957&lt;/span&gt; and $&lt;span id="xdx_909_eus-gaap--InterestPayableCurrent_iI_c20220430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zB7X8pl0mUFl" title="Accrued interest"&gt;908,756&lt;/span&gt;, respectively. The accrued interest includes notes
that were either repaid or converted but the interest remained.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LoansPayable
      contextRef="AsOf2022-01-14_custom_LoanAgreementsMember_us-gaap_RelatedPartyMember"
      decimals="0"
      unitRef="USD">1000000</us-gaap:LoansPayable>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="From2022-01-132022-01-14_custom_LoanAgreementsMember_us-gaap_RelatedPartyMember"
      decimals="0"
      unitRef="USD">2000000</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2022-01-14_custom_LoanAgreementsMember_us-gaap_RelatedPartyMember"
      decimals="INF"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:NotesPayable
      contextRef="AsOf2023-04-30_us-gaap_RelatedPartyMember"
      decimals="0"
      unitRef="USD">1953842</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="AsOf2022-04-30_us-gaap_RelatedPartyMember"
      decimals="0"
      unitRef="USD">2000000</us-gaap:NotesPayable>
    <us-gaap:InterestExpense
      contextRef="From2022-05-012023-04-30_us-gaap_RelatedPartyMember"
      decimals="0"
      unitRef="USD">293090</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2021-05-012022-04-30_us-gaap_RelatedPartyMember"
      decimals="0"
      unitRef="USD">165558</us-gaap:InterestExpense>
    <us-gaap:InterestPayableCurrent
      contextRef="AsOf2023-04-30_us-gaap_RelatedPartyMember"
      decimals="0"
      unitRef="USD">917957</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="AsOf2022-04-30_us-gaap_RelatedPartyMember"
      decimals="0"
      unitRef="USD">908756</us-gaap:InterestPayableCurrent>
    <us-gaap:ShortTermDebtTextBlock contextRef="From2022-05-012023-04-30">&lt;p id="xdx_805_eus-gaap--ShortTermDebtTextBlock_zZg2EFNe9WUe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
9: &lt;span id="xdx_825_z9za7CMUsoc7"&gt;CONVERTIBLE NOTES PAYABLE&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
discussion of convertible notes payable only includes those that existed as of April 30, 2022. For a discussion of all prior convertible
notes payable we refer you to the Annual Report on Form 10-K filed May 17, 2023 for the fiscal year end April 30, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 6, 2021, the Company consummated the closing (the &#x201c;Closing&#x201d;) of a private placement offering (the &#x201c;Offering&#x201d;)
pursuant to the terms and conditions of that certain Securities Purchase Agreement, dated as of August 6, 2021 (the &#x201c;Purchase Agreement&#x201d;),
between the Company and certain accredited investors (the &#x201c;Purchasers&#x201d;). At the Closing, the Company sold to the Purchasers
(i) &lt;span id="xdx_903_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20210806__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zBiTTA4ayfVb" title="Interest rate"&gt;8&lt;/span&gt;% Senior Convertible Notes (the &#x201c;Convertible Notes&#x201d;) in an aggregate principal amount of $&lt;span id="xdx_904_eus-gaap--ConvertibleNotesPayable_iI_c20210806__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zTbcFdEVILq8" title="Senior convertible notes"&gt;11,000,000&lt;/span&gt; and (ii) warrants
to purchase up to &lt;span id="xdx_909_ecustom--WarrantsIssuedToPurchaseOfCommonStockShares_iI_c20210806__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zttmeYU0NQJ" title="Warrants issued to purchase of common stock, shares"&gt;733,333&lt;/span&gt; shares of common stock of the Company (the &#x201c;Warrants&#x201d; and together with the Convertible Notes,
the &#x201c;Securities&#x201d;). The Company received an aggregate of $&lt;span id="xdx_902_eus-gaap--ProceedsFromConvertibleDebt_c20210805__20210806__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zbyM1DZwDJyl" title="Gross proceeds from issuance of senior convertible notes"&gt;11,000,000&lt;/span&gt; in gross proceeds from the Offering, before deducting
offering expenses and commissions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Convertible Notes were to mature on &lt;span id="xdx_90F_eus-gaap--DebtInstrumentMaturityDate_c20210805__20210806__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zuXH8J103QN9" title="Convertible notes maturity date"&gt;August 6, 2022&lt;/span&gt; (the &#x201c;Maturity Date&#x201d;) and bear interest at &lt;span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20210806__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zALpwTS2F6L4" title="Debt interest rate"&gt;8&lt;/span&gt;% per annum payable on each
conversion date (as to that principal amount then being converted), on each redemption date as well as mandatory redemption date (as
to that principal amount then being redeemed) and on the Maturity Date, in cash. The Convertible Notes are convertible into shares of
the Company&#x2019;s common stock at any time following the date of issuance and prior to Mandatory Conversion (as defined in the Convertible
Notes) at the conversion price equal to the lesser of: (i) $&lt;span id="xdx_904_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_uUSDPShares_c20210806__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zAurl4ys3mpl" title="Conversion price"&gt;3.00&lt;/span&gt;, subject to adjustment set forth in the Convertible Notes and (ii) in
the case of an uplist to the NASDAQ, the Uplist Conversion Price (as defined in the Convertible Notes) of the Company&#x2019;s common
stock during the two Trading Day (as defined in the Convertible Notes) period after each conversion date; provided, however, that at
any time from and after December 31, 2021 or an Event of Default (as defined in the Convertible Notes), the holder of the Convertible
Notes may, by delivery of written notice to the Company, elect to cause all, or any part, of the Convertible Notes to be converted, at
any time thereafter, each an &#x201c;Alternate Conversion&#x201d;, pursuant to the Section 4(f) of the Convertible Notes, all, or any part
of, the then outstanding aggregate principal amount of the Convertible Notes into shares of Common Stock at the Alternate Conversion
price. The Convertible Notes rank pari passu with all other notes now or thereafter issued under the terms set forth in the Convertible
Notes. The Convertible Notes contain certain price protection provisions providing for adjustment of the number of shares of common stock
issuable upon conversion of the Convertible Notes in case of certain future dilutive events or stock-splits and dividends.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Warrants are exercisable for &lt;span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_c20210806__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zfDV65DqD9wh" title="Warrants and rights outstanding, term"&gt;five years&lt;/span&gt; from &lt;span id="xdx_905_eus-gaap--ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable_c20210805__20210806__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zw4y00KGtM74" title="Warrants rights date from which warrants exercisable"&gt;August 6, 2021&lt;/span&gt;, at an exercise price equal to the lesser of $&lt;span id="xdx_903_ecustom--WarrantsExercisePrice_iI_pid_uUSDPShares_c20210806__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zvVuwaxlDfCi" title="Warrants exercise price"&gt;3.00&lt;/span&gt; or a 20% discount to the
public offering price that a share of the Company&#x2019;s common stock or unit (if units are offered) is offered to the public resulting
in the commencement of trading of the Company&#x2019;s common stock on the NASDAQ, New York Stock Exchange or NYSE American. The Warrants
contain certain price protection provisions providing for adjustment of the amount of securities issuable upon exercise of the Warrants
in case of certain future dilutive events or stock-splits and dividends.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company evaluated the Warrants and the conversion options under the guidance in ASC 815 and determined they represent derivative liabilities
given the variability in the exercise and conversion prices upon the event of an up list to the NASDAQ. The Company also evaluated the
other embedded features in the agreement and determined the interest make-whole provision and the subsequent financing redemption represent
put features that are also accounted for as derivative liabilities. The derivative liabilities are marked to market at the end of each
reporting period with the non-cash gain or loss recorded in the period as a gain or loss on derivative (see Note 3).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Warrants were valued at $&lt;span id="xdx_909_eus-gaap--WarrantsAndRightsOutstanding_iI_c20230430__us-gaap--ValuationTechniqueAxis__custom--MonteCarloSimulationMember_zCVDZn3Z7VXf" title="Warrants"&gt;12,026,668&lt;/span&gt; on the date of issuance using a Monte Carlo simulation that accounted for the variability in the
exercise price upon the event of an up list based on the Company&#x2019;s expected future stock prices over the &lt;span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dxL_c20230430__us-gaap--ValuationTechniqueAxis__custom--MonteCarloSimulationMember_zvPWagmPeYb8" title="Warrants term::XDX::P5Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2279"&gt;five&lt;/span&gt;&lt;/span&gt;-year term using inputs
in line with those listed in Note 3. The remaining derivatives were valued at $&lt;span id="xdx_908_ecustom--RemainingDerivativeLiabilities_iI_c20230430_zw2q7Jxutnh2" title="Derivative liabilities"&gt;1,862,450&lt;/span&gt; on the issuance date based on the present value
of their weighted average probability value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
part of the issuance of the Convertible Notes, the Company incurred and capitalized debt issuance costs of $&lt;span id="xdx_900_eus-gaap--DeferredFinanceCostsNet_iI_c20211031_zUkH6AyAiIR6" title="Debt issuance cost"&gt;800,251&lt;/span&gt; related to brokerage
and legal fees that met the debt issuance cost capitalization criteria of ASC 835. The total discount related to the Convertible Notes
on the date of issuance of $&lt;span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodValueConversionOfUnits_c20210801__20211031_zI7D8tKTnTmh" title="Stock issued during period value conversion of units"&gt;14,689,369&lt;/span&gt; exceeded their value, which resulted in the Company recognizing a $&lt;span id="xdx_909_ecustom--LossOnIssuanceOfConvertibleNotes_c20210801__20211031_zV9ejW3oug93" title="Loss on issuance of convertible notes"&gt;3,689,369&lt;/span&gt; loss on the issuance
of the Convertible Notes during the three months ended October 31, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_ecustom--SecuritiesOutstandingRateConvertibleNotesDescripition_c20211230__20211231_zmhLvShVygu3" title="Convertible note description"&gt;On
December 31, 2021, the Company entered into an Omnibus Amendment Agreement (the &#x201c;Omnibus Agreement&#x201d;) with certain Purchasers
who are collectively holders of 67% or more of the Securities outstanding related to the August 6, 2021 Convertible Notes, amending each
of (i) the Purchase Agreement and (ii) the Registration Rights Agreement. Simultaneously with the execution of the Omnibus Agreement,
the Company issued to each Purchaser a Replacement Note (as defined below) in replacement of the Convertible Note held prior to December
31, 2021 by such Purchaser (each, an &#x201c;Existing Note&#x201d;).&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Purchase Agreement was amended to, among other things, (i) delete Exhibit A and replace it in its entirety with the 8% Senior Convertible
Note (the &#x201c;Replacement Note&#x201d;) filed as Exhibit 10.2 to the Company&#x2019;s current report on Form 8-K dated January 5, 2021,
(ii) add a new definition of &#x201c;Inventory Financing&#x201d;, (iii) amend Section 4.18 to add at the end of Section 4.18 before the
final period &#x201c;, it being agreed that the provisions of this Section 4.18 shall not apply to the Qualified Subsequent Financing
expected to occur after the date hereof&#x201d;, (iv) delete Section 4.20 and replace it in its entirety with substantially the same text,
including the following after the period, replacing the period with a semicolon: &#x201c;; provided that the provisions of this Section
4.20 shall not apply to (i) in respect of any Holder to the extent that such Holder is an investor or a purchaser of the securities offered
pursuant such Subsequent Financing, and (ii) with respect to an Inventory Financing.&#x201d;, and (v) add a new Section 4.21. Most-Favored
Nation provision.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Registration Rights Agreement was amended to, among other things, (i) delete the definition &#x201c;Effectiveness Date&#x201d; in Section
1 and replace it in its entirety with substantially the same text but revise the definition of &#x201c;Effectiveness Date&#x201d; causing
the Initial Registration Statement required to be filed by January 31, 2022, and (ii) delete Section 2(d) and replace it in its entirety
with substantially the same text but revised to delete the following &#x201c;(2) no liquidated damages shall accrue or be payable hereunder
with respect to any day on which the high price of the Common Stock on the Trading Market on which the Common Stock is then listed or
traded is less than the then-applicable Conversion Price,&#x201d; resulting in renumbering the text that follows as (2) instead of (3).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
consideration for entering into the Omnibus Agreement, the outstanding principal balance of the Existing Note held by each Purchaser
was increased by twenty percent (&lt;span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20220430__us-gaap--TypeOfArrangementAxis__custom--OmnibusAgreementMember_zCJxZ8aLkdad" title="Debt interest rate"&gt;20&lt;/span&gt;%) and such increased principal balance is reflected on the Replacement Note issued to each Purchaser.
The Company recognized a $&lt;span id="xdx_900_ecustom--LossOnIssuanceOfConvertibleNotes_c20210501__20220430__us-gaap--TypeOfArrangementAxis__custom--OmnibusAgreementMember_zrdmHI8zpYc4" title="Loss on issuance of convertible notes"&gt;2,200,000&lt;/span&gt; loss on issuance of convertible notes during the year ended April 30, 2022 related to this amendment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
June 17, 2022, the Company issued &lt;span id="xdx_903_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pid_c20220616__20220617_zGJKBhq34c2"&gt;109,737 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares
of common stock in conversion of the $&lt;span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_c20220617_zzirrAZ9RC19"&gt;13,200,000&lt;/span&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;in
convertible notes payable and $&lt;span id="xdx_90B_eus-gaap--DebtInstrumentIncreaseAccruedInterest_c20220617__20220617_z8pbSFkQO4N3"&gt;846,301 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;in
accrued interest. In addition, the remaining $&lt;span id="xdx_904_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20220617__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_zZCYFzYl8xHc"&gt;122,222 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;of
unamortized discount on the convertible notes payable was amortized and included in our consolidated statements of operations for
the three months ended July 31, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
outstanding borrowings related to the Convertible Notes as of April 30, 2023 and 2022 were $&lt;span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_c20230430_zJLub0fi5g0i" title="Convertiable notes"&gt;0&lt;/span&gt; and $&lt;span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_c20220430_zuwuCuKqygQj" title="Convertiable notes"&gt;13,200,000&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ShortTermDebtTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2021-08-06_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ConvertibleNotesPayable
      contextRef="AsOf2021-08-06_custom_SecuritiesPurchaseAgreementMember"
      decimals="0"
      unitRef="USD">11000000</us-gaap:ConvertibleNotesPayable>
    <CNXA:WarrantsIssuedToPurchaseOfCommonStockShares
      contextRef="AsOf2021-08-06_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      unitRef="Shares">733333</CNXA:WarrantsIssuedToPurchaseOfCommonStockShares>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2021-08-052021-08-06_custom_SecuritiesPurchaseAgreementMember"
      decimals="0"
      unitRef="USD">11000000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2021-08-052021-08-06_custom_SecuritiesPurchaseAgreementMember">2022-08-06</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2021-08-06_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2021-08-06_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      unitRef="USDPShares">3.00</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="AsOf2021-08-06_custom_SecuritiesPurchaseAgreementMember">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="From2021-08-052021-08-06_custom_SecuritiesPurchaseAgreementMember">2021-08-06</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
    <CNXA:WarrantsExercisePrice
      contextRef="AsOf2021-08-06_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      unitRef="USDPShares">3.00</CNXA:WarrantsExercisePrice>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2023-04-30_custom_MonteCarloSimulationMember"
      decimals="0"
      unitRef="USD">12026668</us-gaap:WarrantsAndRightsOutstanding>
    <CNXA:RemainingDerivativeLiabilities contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">1862450</CNXA:RemainingDerivativeLiabilities>
    <us-gaap:DeferredFinanceCostsNet contextRef="AsOf2021-10-31" decimals="0" unitRef="USD">800251</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="From2021-08-012021-10-31"
      decimals="0"
      unitRef="USD">14689369</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
    <CNXA:LossOnIssuanceOfConvertibleNotes
      contextRef="From2021-08-012021-10-31"
      decimals="0"
      unitRef="USD">3689369</CNXA:LossOnIssuanceOfConvertibleNotes>
    <CNXA:SecuritiesOutstandingRateConvertibleNotesDescripition contextRef="From2021-12-302021-12-31">On
December 31, 2021, the Company entered into an Omnibus Amendment Agreement (the &#x201c;Omnibus Agreement&#x201d;) with certain Purchasers
who are collectively holders of 67% or more of the Securities outstanding related to the August 6, 2021 Convertible Notes, amending each
of (i) the Purchase Agreement and (ii) the Registration Rights Agreement. Simultaneously with the execution of the Omnibus Agreement,
the Company issued to each Purchaser a Replacement Note (as defined below) in replacement of the Convertible Note held prior to December
31, 2021 by such Purchaser (each, an &#x201c;Existing Note&#x201d;).</CNXA:SecuritiesOutstandingRateConvertibleNotesDescripition>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2022-04-30_custom_OmnibusAgreementMember"
      decimals="INF"
      unitRef="Pure">0.20</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <CNXA:LossOnIssuanceOfConvertibleNotes
      contextRef="From2021-05-012022-04-30_custom_OmnibusAgreementMember"
      decimals="0"
      unitRef="USD">2200000</CNXA:LossOnIssuanceOfConvertibleNotes>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="From2022-06-162022-06-17"
      decimals="INF"
      unitRef="Shares">109737</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2022-06-17" decimals="0" unitRef="USD">13200000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentIncreaseAccruedInterest
      contextRef="From2022-06-172022-06-17"
      decimals="0"
      unitRef="USD">846301</us-gaap:DebtInstrumentIncreaseAccruedInterest>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="AsOf2022-06-17_custom_ConvertibleNotesMember"
      decimals="0"
      unitRef="USD">122222</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">13200000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LongTermDebtTextBlock contextRef="From2022-05-012023-04-30">&lt;p id="xdx_80A_eus-gaap--LongTermDebtTextBlock_zBTxIeLApvnf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
10: &lt;span id="xdx_829_zE2AOCxhpB7i"&gt;NOTES PAYABLE&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
discussion of notes payable only includes those that existed as of April 30, 2022. For a discussion of all prior notes payable we refer
you to the Annual Report on Form 10-K filed May 17, 2023 for the fiscal year end April 30, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
June 30, 2020, the Company entered into a loan agreement with Mont-Saic to borrow $&lt;span id="xdx_905_eus-gaap--NotesPayable_iI_c20200630__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MontsaicInvestmentsLLCMember_zoteNowX5UJ9" title="Note payable"&gt;120,000&lt;/span&gt;. This loan bears interest at an annual rate
of &lt;span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20200630__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MontsaicInvestmentsLLCMember_zo9D2Si9ZPD9" title="Interest rate"&gt;12.6&lt;/span&gt;% and was required to be repaid in full, together with all accrued, but unpaid, interest by June 30, 2021. On December 3, 2020,
Mont-Saic entered into an Assignment and Conveyance Agreement with the Company&#x2019;s exiting related party lender wherein Mont-Saic
sold its full right, title and interest in this note to the Company&#x2019;s related party lender (see Note 8).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 24, 2020, the Company entered into a promissory note with a third-party to borrow $&lt;span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_c20201224__us-gaap--DebtInstrumentAxis__custom--PromissoryNotePayableMember__srt--TitleOfIndividualAxis__custom--ThirdPartyMember_zanRRvdMUk8d" title="Note payable"&gt;1,000,000&lt;/span&gt;. The promissory note bore interest
at &lt;span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20201224__us-gaap--DebtInstrumentAxis__custom--PromissoryNotePayableMember__srt--TitleOfIndividualAxis__custom--ThirdPartyMember_zmvIth3CiWf1" title="Interest rate"&gt;2.25&lt;/span&gt;% and was due February 8, 2021. On February 2, 2021, the Company and the third-party entered into an amendment to extend the promissory
note to April 30, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 11, 2021, the Company and the lender entered into an agreement whereby the lender converted the promissory note into &lt;span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210410__20210411__us-gaap--DebtInstrumentAxis__custom--PromissoryNotePayableMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zEsgCNZLEoZf" title="Shares issued"&gt;27,233&lt;/span&gt; shares
of Company stock, which were issued to the lender at a &lt;span id="xdx_90F_eus-gaap--DebtConversionOriginalDebtInterestRateOfDebt_pid_dp_uPure_c20210410__20210411__us-gaap--DebtInstrumentAxis__custom--PromissoryNotePayableMember_zbF7x755FSCh" title="Interest rate"&gt;20&lt;/span&gt;% discount from the closing price of the stock on the day prior to the conversion.
In addition to the discount, the agreement contains a guarantee that the aggregate gross sales of the shares by the lender will be no
less than $&lt;span id="xdx_904_eus-gaap--DebtInstrumentCarryingAmount_iI_c20210411__us-gaap--DebtInstrumentAxis__custom--PromissoryNotePayableMember_zcx25JH5PYN8" title="Payables"&gt;1,500,000&lt;/span&gt; over the next three years and if the aggregate gross sales are less than $&lt;span id="xdx_90D_eus-gaap--DebtInstrumentCarryingAmount_iI_c20210411__us-gaap--DebtInstrumentAxis__custom--PromissoryNotePayableMember_zNW4l3Zl8nvg" title="Payables"&gt;1,500,000&lt;/span&gt; the Company will issue additional
shares of common stock to the lender for the difference between the total gross proceeds and $&lt;span id="xdx_902_eus-gaap--DebtInstrumentCarryingAmount_iI_c20210411__us-gaap--DebtInstrumentAxis__custom--PromissoryNotePayableMember_z6BtwefdLto8" title="Payables"&gt;1,500,000&lt;/span&gt;, which could result in an infinite
number of shares being required to be issued.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company evaluated the conversion option of the note payable to shares under the guidance in ASC 815-40, Derivatives and Hedging, and
determined the conversion option qualified for equity classification. The Company also evaluated the profit guarantee under ASC 815,
Derivatives and Hedging, and determined it to be a make-whole provision, which is an embedded derivative within the host instrument.
As the economic characteristics are dissimilar to the host instrument, the profit guarantee was bifurcated from the host instrument and
stated as a separate derivative liability, which is marked to market at the end of each reporting period with the non-cash gain or loss
recorded in the period as a gain or loss on derivative.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
the date of conversion, the Company recognized a $&lt;span id="xdx_90A_eus-gaap--GainsLossesOnExtinguishmentOfDebt_c20210410__20210411_z8Lc6fqHODRb" title="Extinguishment of debt"&gt;1,501,914&lt;/span&gt; loss on extinguishment of debt, which represented the difference between
the promissory note and the fair value of the shares issued of $&lt;span id="xdx_907_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20210410__20210411_zUozt4HNRf86" title="Debt conversion, amount"&gt;1,250,004&lt;/span&gt;, which were recorded in shares issued in connection with conversion
of note payable within shareholders&#x2019; equity, as well as the derivative liability of $&lt;span id="xdx_903_eus-gaap--DerivativeAssetsLiabilitiesAtFairValueNet_iNI_di_c20210411__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember_zczkEipKH3Ej" title="Derivative liability"&gt;1,251,910&lt;/span&gt;, which was valued using a Black-Scholes
option pricing model.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of the derivative liability was $&lt;span id="xdx_908_eus-gaap--DerivativeFairValueOfDerivativeNet_iI_c20230430__us-gaap--DebtInstrumentAxis__custom--PromissoryNotePayableMember_zFc9FtAfuw0k" title="Fair value of derivative liability"&gt;1,456,854&lt;/span&gt; and $&lt;span id="xdx_90C_eus-gaap--DerivativeFairValueOfDerivativeNet_iI_c20220430__us-gaap--DebtInstrumentAxis__custom--PromissoryNotePayableMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zZbh8GzQEV92" title="Fair value of derivative liability"&gt;1,061,550&lt;/span&gt; as of April 30, 2023 and 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 15, 2022, for and in consideration of $&lt;span id="xdx_908_eus-gaap--BusinessCombinationConsiderationTransferredOther1_c20220214__20220215_zEeuLSMBbypf" title="Consideration"&gt;4,000,000&lt;/span&gt; the Company conveyed, sold, transferred, set over, assigned and delivered to
Slinger Bag Consignment, LLC, a Virginia limited liability company (&#x201c;Consignor&#x201d;), all of the Company&#x2019;s right, title
and interest in and to &lt;span id="xdx_903_ecustom--NumberOfConsignedGoods_pid_uInteger_c20220214__20220215_zA8VM9RYlhA8" title="Consignment units"&gt;13,000&lt;/span&gt; units of certain surplus inventory, including all components, parts, additions and accessions thereto (collectively,
the &#x201c;Consigned Goods&#x201d;). The Company has repaid the $&lt;span id="xdx_90A_eus-gaap--RepaymentsOfDebt_c20230430__20230430_zLQH2mtVVX04" title="Repayment of debt"&gt;4,000,000&lt;/span&gt; as of April 30, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 1, 2022, the Company entered into a $&lt;span id="xdx_90E_eus-gaap--NotesPayable_iI_c20220401__us-gaap--DebtInstrumentAxis__custom--NotesPayableMember_z2NpV8Vsevbi" title="Note payable"&gt;500,000&lt;/span&gt; note payable. The note was to mature on July 1, 2022 and bears interest at eight percent
(&lt;span id="xdx_903_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20220401__us-gaap--DebtInstrumentAxis__custom--NotesPayableMember_zU4cLmz9kGU6" title="Interest rate"&gt;8&lt;/span&gt;%) per year. The Company pays interest monthly and will pay all accrued and unpaid interest on the maturity date in which the outstanding
principal is due. On August 1, 2022, the Company repaid the $&lt;span id="xdx_909_eus-gaap--RepaymentsOfDebt_c20220801__20220801_z7VEEvywDAd1" title="Repayment of debt"&gt;500,000&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Cash
Advance Agreements&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
July 29, 2022, the Company entered into two merchant cash advance agreements. The details of the merchant cash advance agreements are
as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;UFS
Agreement&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company entered into an agreement (the &#x201c;UFS Agreement&#x201d;) with Unique Funding Solutions LLC (&#x201c;UFS&#x201d;) pursuant to
which the Company sold $&lt;span id="xdx_904_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20220729__20220729__us-gaap--TypeOfArrangementAxis__custom--UFSAgreementMember_zLVFM1X7PA78" title="Sale of consideration received"&gt;1,124,250&lt;/span&gt; in future receivables (the &#x201c;UFS Receivables Purchased Amount&#x201d;) to UFS in exchange for payment
to the Company of $&lt;span id="xdx_90D_eus-gaap--PaymentsToAcquireReceivables_c20220729__20220729__us-gaap--TypeOfArrangementAxis__custom--UFSAgreementMember_zT1QyV4J1BZb" title="Payment for exchange received amount"&gt;750,000 &lt;/span&gt;in cash less fees of $&lt;span id="xdx_903_ecustom--CashLessFees_c20220729__20220729__us-gaap--TypeOfArrangementAxis__custom--UFSAgreementMember_z7FqlReXkhRc" title="Cash less fees"&gt;60,000&lt;/span&gt;. The Company has agreed to pay UFS $&lt;span id="xdx_902_eus-gaap--PaymentsToAcquireReceivables_c20220729__20220729__us-gaap--TypeOfArrangementAxis__custom--UFSAgreementMember__srt--StatementScenarioAxis__custom--EachWeekForNextThreeWeeksMember_zGxFz9L8ZRQ3" title="Payment for exchange received amount"&gt;13,491&lt;/span&gt; each week for the next three weeks
and thereafter $&lt;span id="xdx_90C_eus-gaap--PaymentsToAcquireReceivables_c20220729__20220729__us-gaap--TypeOfArrangementAxis__custom--UFSAgreementMember__srt--StatementScenarioAxis__custom--ThereafterPerWeekMember_zed8zPDVpG8k" title="Payment for exchange received amount"&gt;44,970&lt;/span&gt; per week until the UFS Receivables Purchased Amount is paid in full.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
order to secure payment and performance of the Company&#x2019;s obligations to UFS under the UFS Agreement, the Company granted to UFS
a security interest in the following collateral: all accounts receivable and all proceeds as such term is defined by Article 9 of the
UCC. The Company also agreed not to create, incur, assume, or permit to exist, directly or indirectly, any lien on or with respect to
any of such collateral.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Cedar
Agreement&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company entered into an agreement (the &#x201c;Cedar Agreement&#x201d;) with Cedar Advance LLC (&#x201c;Cedar&#x201d;) pursuant to which
the Company sold $&lt;span id="xdx_906_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20220729__20220729__us-gaap--TypeOfArrangementAxis__custom--CedarAgreementMember_zQlFW56NWmH2" title="Sale of consideration received"&gt;1,124,250&lt;/span&gt; in future receivables (the &#x201c;Cedar Receivables Purchased Amount&#x201d;) to Cedar in exchange for payment
to the Company of $&lt;span id="xdx_900_eus-gaap--PaymentsToAcquireReceivables_c20220729__20220729__us-gaap--TypeOfArrangementAxis__custom--CedarAgreementMember_z8QFhAdToDba" title="Payment for exchange received amount"&gt;750,000&lt;/span&gt; in cash less fees of $&lt;span id="xdx_902_ecustom--CashLessFees_c20220729__20220729__us-gaap--TypeOfArrangementAxis__custom--CedarAgreementMember_zBojFB1XDxx7" title="Cash less fees"&gt;60,000&lt;/span&gt;. The Company has agreed to pay Cedar $&lt;span id="xdx_907_eus-gaap--PaymentsToAcquireReceivables_c20220729__20220729__us-gaap--TypeOfArrangementAxis__custom--CedarAgreementMember__srt--StatementScenarioAxis__custom--EachWeekForNextThreeWeeksMember_z9iGNFWnnEH2" title="Payment for exchange received amount"&gt;13,491&lt;/span&gt; each week for the next three weeks
and thereafter $&lt;span id="xdx_90E_eus-gaap--PaymentsToAcquireReceivables_c20220729__20220729__us-gaap--TypeOfArrangementAxis__custom--CedarAgreementMember__srt--StatementScenarioAxis__custom--ThereafterPerWeekMember_z2iL2d5r30dk" title="Payment for exchange received amount"&gt;44,970&lt;/span&gt; per week until the Cedar Receivables Purchased Amount is paid in full.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
order to secure payment and performance of the Company&#x2019;s obligations to Cedar under the Cedar Agreement, the Company granted to
Cedar a security interest in the following collateral: all accounts, including without limitation, all deposit accounts, accounts receivable
and other receivables, chattel paper, documents, equipment, instruments and inventory as those terms are defined by Article 9 of the
UCC. The Company also agreed not to create, incur, assume, or permit to exist, directly or indirectly, any lien on or with respect to
any of such collateral.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 6, 2023, the Company entered into a loan and security agreement (the &#x201c;Loan and Security Agreement&#x201d;) with one or more
institutional investors (the &#x201c;Lenders&#x201d;) and Armistice Capital Master Fund Ltd. as agent for the Lenders (the &#x201c;Agent&#x201d;)
for the issuance and sale of (i) a note in an aggregate principal amount of up to $&lt;span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_c20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember__srt--RangeAxis__srt--MaximumMember_z6Ynvbr25hwj"&gt;2,000,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(the &#x201c;Note&#x201d;) with the initial advance
under the Loan and Security Agreement being $&lt;span id="xdx_904_eus-gaap--ProceedsFromNotesPayable_c20230104__20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember__us-gaap--ShortTermDebtTypeAxis__custom--NotesMember_zZKkzHHFgqSa"&gt;1,400,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;and (ii) warrants (the &#x201c;Warrants&#x201d;)
to purchase a number of shares of common stock of the Company equal to 200% of the face amount of the Note divided by the closing price
of the common stock of the Company on the date of the issuance of the Notes (collectively, the &#x201c;Initial Issuance&#x201d;). The closing
price of the Company&#x2019;s common stock on January 6, 2023, as reported by Nasdaq, was $&lt;span id="xdx_90E_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z34WMk8rSla5"&gt;0.221
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share (or &lt;span id="xdx_90E_eus-gaap--StockholdersEquityNoteStockSplit_c20230106__20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zl3dmHBzyy0a"&gt;8.84
per share after adjusting for the one-for-forty (1-for-40) reverse stock split&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;),
so the Warrants in respect of the initial advance under the Note are exercisable for up to &lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember__srt--RangeAxis__srt--MaximumMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z9hn0lal8S43"&gt;452,489
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of the Company&#x2019;s common stock. The
Warrants have an exercise price per share equal to the closing price of the common stock of the Company on the date of the issuance of
the Note, or $&lt;span id="xdx_904_ecustom--SharesIssuedPricePerShares_iI_pid_c20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z9WpX9SA0ZEf"&gt;8.84
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share (which has subsequently been
reset to $3.55 per share) and a term of five- and one-half (5&#xbd;) years following the initial exercise date. The initial exercise
date of the Warrants will be the date stockholder approval is received and effective allowing exercisability of the Warrants under Nasdaq
rules. Pursuant to the terms of the Loan and Security Agreement, an additional advance of $&lt;span id="xdx_903_eus-gaap--ProceedsFromNotesPayable_c20230104__20230106__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember_zKFvDA9Bi5Ae"&gt;600,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;may be made to the Company under the Note. The
Company&#x2019;s obligations under the terms of the Loan and Security Agreement are fully and unconditionally guaranteed by all of the
Company&#x2019;s subsidiaries (the &#x201c;Guarantors&#x201d;). The Company measured the warrants granted on January 6, 2023 at $&lt;span id="xdx_909_eus-gaap--AdjustmentOfWarrantsGrantedForServices_c20230106__20230106__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember_zlO5YFV5hht3"&gt;3,715,557&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;,
and discounted the note payable to $&lt;span id="xdx_90B_eus-gaap--NotesPayable_iI_c20230106__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember_zWYPV1vDOvMe"&gt;0
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;and recorded a derivative expense of $&lt;span id="xdx_90E_ecustom--DerivativeExpense_c20230430__20230430__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember_zRDsIHRUejDb"&gt;1,715,557&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.
The Company recognized a gain on the change in fair value of the derivative liability when remeasured through April 30, 2023 of $&lt;span id="xdx_908_eus-gaap--DerivativeLiabilityFairValueOfCollateral_iI_c20230430__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zlQmSX59yxTb"&gt;900,819
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;to bring the derivative liability to $&lt;span id="xdx_901_eus-gaap--IncreaseDecreaseInDerivativeLiabilities_c20230430__20230430__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember_z6WmcFMEXmyl"&gt;2,814,738
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;at April 30, 2023. In addition, the Company recognized
$&lt;span id="xdx_900_eus-gaap--AmortizationOfDebtDiscountPremium_c20220501__20230430__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember_zQbAkVwTsTc8"&gt;1,222,808
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;in amortization of debt discount for the year
ended April 30, 2023. On July 6, 2023, the Company failed to repay the note and is currently in default. The interest rate has since
increased to &lt;span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20230706__us-gaap--TypeOfArrangementAxis__custom--LoanAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ArmisticeCapitalMasterFundLtdMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zRJ4AKv90xZc"&gt;6.43&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%
per annum.&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:LongTermDebtTextBlock>
    <us-gaap:NotesPayable
      contextRef="AsOf2020-06-30_custom_LoanAgreementMember_custom_MontsaicInvestmentsLLCMember"
      decimals="0"
      unitRef="USD">120000</us-gaap:NotesPayable>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2020-06-30_custom_LoanAgreementMember_custom_MontsaicInvestmentsLLCMember"
      decimals="INF"
      unitRef="Pure">0.126</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2020-12-24_custom_PromissoryNotePayableMember_custom_ThirdPartyMember"
      decimals="0"
      unitRef="USD">1000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2020-12-24_custom_PromissoryNotePayableMember_custom_ThirdPartyMember"
      decimals="INF"
      unitRef="Pure">0.0225</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2021-04-102021-04-11_custom_PromissoryNotePayableMember_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      unitRef="Shares">27233</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:DebtConversionOriginalDebtInterestRateOfDebt
      contextRef="From2021-04-102021-04-11_custom_PromissoryNotePayableMember"
      decimals="INF"
      unitRef="Pure">0.20</us-gaap:DebtConversionOriginalDebtInterestRateOfDebt>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="AsOf2021-04-11_custom_PromissoryNotePayableMember"
      decimals="0"
      unitRef="USD">1500000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="AsOf2021-04-11_custom_PromissoryNotePayableMember"
      decimals="0"
      unitRef="USD">1500000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="AsOf2021-04-11_custom_PromissoryNotePayableMember"
      decimals="0"
      unitRef="USD">1500000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2021-04-102021-04-11"
      decimals="0"
      unitRef="USD">1501914</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2021-04-102021-04-11"
      decimals="0"
      unitRef="USD">1250004</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="AsOf2021-04-11_us-gaap_ValuationTechniqueOptionPricingModelMember"
      decimals="0"
      unitRef="USD">-1251910</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="AsOf2023-04-30_custom_PromissoryNotePayableMember"
      decimals="0"
      unitRef="USD">1456854</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="AsOf2022-04-30_custom_PromissoryNotePayableMember_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">1061550</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:BusinessCombinationConsiderationTransferredOther1
      contextRef="From2022-02-142022-02-15"
      decimals="0"
      unitRef="USD">4000000</us-gaap:BusinessCombinationConsiderationTransferredOther1>
    <CNXA:NumberOfConsignedGoods
      contextRef="From2022-02-142022-02-15"
      decimals="INF"
      unitRef="Integer">13000</CNXA:NumberOfConsignedGoods>
    <us-gaap:RepaymentsOfDebt
      contextRef="From2023-04-302023-04-30"
      decimals="0"
      unitRef="USD">4000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:NotesPayable
      contextRef="AsOf2022-04-01_custom_NotesPayableMember"
      decimals="0"
      unitRef="USD">500000</us-gaap:NotesPayable>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2022-04-01_custom_NotesPayableMember"
      decimals="INF"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:RepaymentsOfDebt
      contextRef="From2022-08-012022-08-01"
      decimals="0"
      unitRef="USD">500000</us-gaap:RepaymentsOfDebt>
    <us-gaap:SaleOfStockConsiderationReceivedPerTransaction
      contextRef="From2022-07-292022-07-29_custom_UFSAgreementMember"
      decimals="0"
      unitRef="USD">1124250</us-gaap:SaleOfStockConsiderationReceivedPerTransaction>
    <us-gaap:PaymentsToAcquireReceivables
      contextRef="From2022-07-292022-07-29_custom_UFSAgreementMember"
      decimals="0"
      unitRef="USD">750000</us-gaap:PaymentsToAcquireReceivables>
    <CNXA:CashLessFees
      contextRef="From2022-07-292022-07-29_custom_UFSAgreementMember"
      decimals="0"
      unitRef="USD">60000</CNXA:CashLessFees>
    <us-gaap:PaymentsToAcquireReceivables
      contextRef="From2022-07-292022-07-29_custom_UFSAgreementMember_custom_EachWeekForNextThreeWeeksMember"
      decimals="0"
      unitRef="USD">13491</us-gaap:PaymentsToAcquireReceivables>
    <us-gaap:PaymentsToAcquireReceivables
      contextRef="From2022-07-292022-07-29_custom_UFSAgreementMember_custom_ThereafterPerWeekMember"
      decimals="0"
      unitRef="USD">44970</us-gaap:PaymentsToAcquireReceivables>
    <us-gaap:SaleOfStockConsiderationReceivedPerTransaction
      contextRef="From2022-07-292022-07-29_custom_CedarAgreementMember"
      decimals="0"
      unitRef="USD">1124250</us-gaap:SaleOfStockConsiderationReceivedPerTransaction>
    <us-gaap:PaymentsToAcquireReceivables
      contextRef="From2022-07-292022-07-29_custom_CedarAgreementMember"
      decimals="0"
      unitRef="USD">750000</us-gaap:PaymentsToAcquireReceivables>
    <CNXA:CashLessFees
      contextRef="From2022-07-292022-07-29_custom_CedarAgreementMember"
      decimals="0"
      unitRef="USD">60000</CNXA:CashLessFees>
    <us-gaap:PaymentsToAcquireReceivables
      contextRef="From2022-07-292022-07-29_custom_CedarAgreementMember_custom_EachWeekForNextThreeWeeksMember"
      decimals="0"
      unitRef="USD">13491</us-gaap:PaymentsToAcquireReceivables>
    <us-gaap:PaymentsToAcquireReceivables
      contextRef="From2022-07-292022-07-29_custom_CedarAgreementMember_custom_ThereafterPerWeekMember"
      decimals="0"
      unitRef="USD">44970</us-gaap:PaymentsToAcquireReceivables>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2023-01-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember_srt_MaximumMember"
      decimals="0"
      unitRef="USD">2000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="From2023-01-042023-01-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember_custom_NotesMember"
      decimals="0"
      unitRef="USD">1400000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2023-01-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      unitRef="USDPShares">0.221</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:StockholdersEquityNoteStockSplit contextRef="From2023-01-062023-01-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember_srt_ScenarioPreviouslyReportedMember">8.84
per share after adjusting for the one-for-forty (1-for-40) reverse stock split</us-gaap:StockholdersEquityNoteStockSplit>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="AsOf2023-01-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember_srt_MaximumMember_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      unitRef="Shares">452489</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <CNXA:SharesIssuedPricePerShares
      contextRef="AsOf2023-01-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      unitRef="USDPShares">8.84</CNXA:SharesIssuedPricePerShares>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="From2023-01-042023-01-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember"
      decimals="0"
      unitRef="USD">600000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:AdjustmentOfWarrantsGrantedForServices
      contextRef="From2023-01-062023-01-06_us-gaap_WarrantMember_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember"
      decimals="0"
      unitRef="USD">3715557</us-gaap:AdjustmentOfWarrantsGrantedForServices>
    <us-gaap:NotesPayable
      contextRef="AsOf2023-01-06_us-gaap_WarrantMember_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember"
      decimals="0"
      unitRef="USD">0</us-gaap:NotesPayable>
    <CNXA:DerivativeExpense
      contextRef="From2023-04-302023-04-30_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember"
      decimals="0"
      unitRef="USD">1715557</CNXA:DerivativeExpense>
    <us-gaap:DerivativeLiabilityFairValueOfCollateral
      contextRef="AsOf2023-04-30_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">900819</us-gaap:DerivativeLiabilityFairValueOfCollateral>
    <us-gaap:IncreaseDecreaseInDerivativeLiabilities
      contextRef="From2023-04-302023-04-30_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember"
      decimals="0"
      unitRef="USD">2814738</us-gaap:IncreaseDecreaseInDerivativeLiabilities>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2022-05-012023-04-30_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember"
      decimals="0"
      unitRef="USD">1222808</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2023-07-06_custom_LoanAndSecurityAgreementMember_custom_ArmisticeCapitalMasterFundLtdMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      unitRef="Pure">0.0643</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2022-05-012023-04-30">&lt;p id="xdx_808_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zofGkOILqKg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
11: &lt;span&gt;&lt;span id="xdx_824_z9LZWLKdBDYh"&gt;RELATED PARTY TRANSACTIONS&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
support of the Company&#x2019;s efforts and cash requirements, it may rely on advances from related parties until such time that the Company
can support its operations or attain adequate financing through sales of its equity or traditional debt financing. There is no formal
written commitment for continued support by officers, directors, or shareholders. Amounts represent advances, amounts paid in satisfaction
of liabilities, or accrued compensation that has been deferred. The advances are considered temporary in nature and have not been formalized
by a promissory note.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has outstanding notes payable of &lt;span style="background-color: white"&gt;&lt;span style="background-color: white"&gt;$&lt;span id="xdx_90C_eus-gaap--NotesPayable_iI_pp0p0_c20230430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zbKrLVDiBMgk" title="Outstanding notes payable"&gt;1,953,842&lt;/span&gt; &lt;/span&gt; and $&lt;span id="xdx_908_eus-gaap--NotesPayable_iI_pp0p0_c20220430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zH14YqEaxkol" title="Outstanding notes payable"&gt;2,000,000&lt;/span&gt;&lt;/span&gt; and accrued interest
of $&lt;span id="xdx_906_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20230430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zSzgnnFlxtOi" title="Accrued interest - related party"&gt;917,957&lt;/span&gt; and $&lt;span id="xdx_909_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20220430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zRX25uk8IQnf" title="Accrued interest - related party"&gt;908,756&lt;/span&gt; due to a related party as of April 30, 2023 and 2022, respectively (see Note 8).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognized net sales of $&lt;span id="xdx_90C_eus-gaap--Revenues_pp0p0_c20220501__20230430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zNLFQJGsyzS3" title="Revenue from related parties"&gt;164,661&lt;/span&gt; and $&lt;span id="xdx_90C_eus-gaap--Revenues_pp0p0_c20210501__20220430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z1L1W8td9grd" title="Revenue from related parties"&gt;368,164&lt;/span&gt; during the years ended April 30, 2023 and 2022, respectively, to related parties.
As of April 30, 2023 and 2022, related parties had accounts receivable due to the Company of $&lt;span id="xdx_901_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20230430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zQlsAFDzmKy4" title="Outstanding accounts receivable"&gt;28,800&lt;/span&gt; and $&lt;span id="xdx_900_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20220430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zH7NQHkKmOIa" title="Outstanding accounts receivable"&gt;93,535&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:NotesPayable
      contextRef="AsOf2023-04-30_us-gaap_RelatedPartyMember"
      decimals="0"
      unitRef="USD">1953842</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="AsOf2022-04-30_us-gaap_RelatedPartyMember"
      decimals="0"
      unitRef="USD">2000000</us-gaap:NotesPayable>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2023-04-30_us-gaap_RelatedPartyMember"
      decimals="0"
      unitRef="USD">917957</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2022-04-30_us-gaap_RelatedPartyMember"
      decimals="0"
      unitRef="USD">908756</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:Revenues
      contextRef="From2022-05-012023-04-30_us-gaap_RelatedPartyMember"
      decimals="0"
      unitRef="USD">164661</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-05-012022-04-30_us-gaap_RelatedPartyMember"
      decimals="0"
      unitRef="USD">368164</us-gaap:Revenues>
    <us-gaap:AccountsReceivableNet
      contextRef="AsOf2023-04-30_us-gaap_RelatedPartyMember"
      decimals="0"
      unitRef="USD">28800</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableNet
      contextRef="AsOf2022-04-30_us-gaap_RelatedPartyMember"
      decimals="0"
      unitRef="USD">93535</us-gaap:AccountsReceivableNet>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2022-05-012023-04-30">&lt;p id="xdx_804_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_z7wvekueFLv1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
12: &lt;span id="xdx_829_zan7toDLg2li"&gt;SHAREHOLDERS&#x2019; EQUITY (DEFICIT)&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Common
Stock&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has &lt;span id="xdx_90D_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20230430_zNgnpQRUOS5i"&gt;300,000,000&lt;/span&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares
of common stock authorized with a par value of $&lt;span id="xdx_907_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20220430_zWttYdquPUy3"&gt;0.001 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per
share. As of April 30, 2023 and 2022, the Company had &lt;span&gt;&lt;span id="xdx_908_eus-gaap--CommonStockSharesOutstanding_iI_c20230430_zimqsfw9jli1"&gt;338,579&lt;/span&gt; &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;and &lt;span&gt;&lt;span id="xdx_903_eus-gaap--CommonStockSharesOutstanding_iI_dxL_c20220430_zBaH6DRfJUN1" title="::XDX::4194836"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2401"&gt;104,871&lt;/span&gt;&lt;/span&gt; &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares
of common stock issued and outstanding, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Equity
Transactions During the Year Ended April 30, 2023&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Since
May 1, 2022, the Company has issued an aggregate of &lt;span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220501__20220501_zZR0ZBJOEit9"&gt;151,579 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares
of its common stock consisting of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
    June 15, 2022, the Company issued &lt;span id="xdx_906_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pid_c20220615__20220615__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zTGeJZaJvHA5"&gt;109,740 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares
    of common stock to the Convertible Noteholders upon conversion of convertible notes.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
    June 15, 2022, the Company issued &lt;span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220615__20220615__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zP6WKji4yMQc"&gt;26,219 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares
    to investors who participated in the Company&#x2019;s Nasdaq uplist round.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
    June 27, 2022, the Company issued &lt;span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20220627__20220627__srt--TitleOfIndividualAxis__custom--GabrielGoldmanMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zWy6fWc9WSg9"&gt;625 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock to Gabriel Goldman
    for consulting services performed in the first quarter of calendar 2022. Gabriel Goldman became a director of the Company on June
    15, 2022.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
    June 27, 2022, the Company issued &lt;span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220627__20220627__dei--LegalEntityAxis__custom--GamefaceAIMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zTfHCLfsOAr5"&gt;14,960 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares
    of common stock to the former Gameface shareholders in connection with the purchase of Gameface. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                                         August 25, 2022, the Company issued &lt;span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220825__20220825__dei--LegalEntityAxis__custom--MidcityCapitalLtdMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z4JuHQWxP8A4"&gt;750 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares
                                                         of common stock to Midcity Capital Ltd (&#x201c;Midcity&#x201d;) pursuant to a cashless conversion of warrants Midcity received from
                                                         its warrant agreement with the Company dated March 2020.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
    September 28, 2022, the Company entered into a securities purchase agreement (the &#x201c;Securities Purchase Agreement&#x201d;) with
    a single institutional investor (the &#x201c;Investor&#x201d;) for the issuance and sale of (i) &lt;span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220928__20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_ztJedXL1arxd"&gt;25,463
    &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock and (ii) pre-funded
    warrants (the &#x201c;Pre-Funded Warrants&#x201d;) to purchase an aggregate of &lt;span id="xdx_909_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zbytUP6eKPKg"&gt;295,050
    &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of its common stock, together with
    accompanying common stock warrants, at a combined purchase price of $&lt;span id="xdx_90B_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zit6bfviuTTc"&gt;15.60
    &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share of the common stock and associated
    common stock warrant and $&lt;span id="xdx_90C_ecustom--WarrantPerShare_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zIETuCcBezL3"&gt;15.596
    &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per Pre-Funded Warrant and associated common
    stock warrants for an aggregate amount of approximately $&lt;span id="xdx_904_eus-gaap--WarrantsAndRightsOutstanding_iI_pn5n6_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_ztyF8X0dbXG7"&gt;5.0
    &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;million (the &#x201c;Offering&#x201d;). The
    Pre-Funded Warrants have an exercise price of $&lt;span id="xdx_900_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zThepsd0uimb"&gt;0.0004
    &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share of common stock and are exercisable
    until the Pre-Funded Warrants are exercised in full. The shares of common stock and Pre-Funded Warrants were sold in the offering
    together with common stock warrants to purchase &lt;span id="xdx_908_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--FiveYearWarrantsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z1WPdsDCFjMb"&gt;320,513
    &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock at an exercise price
    of $&lt;span id="xdx_908_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--FiveYearWarrantsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zuOOWVGCsS74"&gt;15.60
    &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share and a term of five years following
    the initial exercise date (the &#x201c;5-Year Warrants&#x201d;) and &lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220928__20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--SevenYearWarrantsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zabgtiPUHrl4"&gt;641,026
    &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;common stock warrants to purchase &lt;span id="xdx_903_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--SevenPointFiveYearWarrantsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zfP624qt3dXk"&gt;641,026
    &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock at an exercise price
    of $&lt;span id="xdx_901_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--SevenPointFiveYearWarrantsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zHHQ0i3eZvca"&gt;17.20
    &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share and a term of seven and one half
    years (the &#x201c;7.5-Year Warrants&#x201d;) following the initial exercise date (collectively, the &#x201c;Warrants&#x201d;). The Warrants
    issued in the Offering contain variable pricing features. The Warrants and Pre-Funded Warrants became exercisable beginning on the
    date stockholder approval was received and effective allowing exercisability of the Warrants and Pre-Funded Warrants under Nasdaq
    rules. The exercise price of the Warrants was reset in October 2023 to $&lt;span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20231031__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zg4tqKHduW6f"&gt;3.55
    &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share. Net proceeds to the Company
    were $&lt;span id="xdx_907_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20220928__20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_z2orhv5fqdp5"&gt;4,549,882&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
    October 12, 2022, the Company issued &lt;span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20221012__20221012__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zXa09UsKfjob"&gt;48,098 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares
    of common stock, on November 21, 2022 issued &lt;span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20221121__20221121__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zDgtZ5o0OnFh"&gt;675 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares
    of common stock and January 26, 2023 issued &lt;span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20230126__20230126__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zDQcinvmexk3"&gt;6,994 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares
    of common stock in connection with the acquisition of PlaySight.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
    January 26, 2023, the Company issued &lt;span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20230126__20230126__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zdiNGy78zM54"&gt;150 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares
    of common stock for services rendered to their ambassadors.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Equity
Transactions During the Year Ended April 30, 2022&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
May 26, 2021, the Company issued &lt;span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_pid_c20210525__20210526__srt--TitleOfIndividualAxis__custom--RelatedPartyLenderMember_zU1NFjCdfgpb"&gt;4,093 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares
of its common stock for the conversion of related party notes payable (see Note 8). The fair value of the common stock was $&lt;span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_pp0p0_c20210525__20210526__srt--TitleOfIndividualAxis__custom--RelatedPartyLenderMember_ziTL6cMDO1Q7"&gt;6,220,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
June 23, 2021, the Company issued &lt;span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20210622__20210623__us-gaap--BusinessAcquisitionAxis__custom--FoundationSportsSystemsLLCMember_zr4DltCaxwWl"&gt;1,350 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares
of its common stock as partial consideration for the acquisition of Foundation Sports (see Note 5). The fair value of the total
shares of common stock to be issued related to the acquisition was $&lt;span id="xdx_900_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_pp0p0_c20210622__20210623__us-gaap--BusinessAcquisitionAxis__custom--FoundationSportsSystemsLLCMember_zAW4RBNwVWDl"&gt;3,550,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
July 6, 2021, the Company issued &lt;span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationGross_pid_c20210705__20210706__srt--ProductOrServiceAxis__custom--ServicesRenderedInLieuOfCashMember__srt--TitleOfIndividualAxis__custom--TwoEmployeesMember_zMwNANWjBFQe"&gt;126 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares
of its common stock to two employees as compensation for services rendered in lieu of cash, which resulted in $&lt;span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensationGross_pp0p0_c20210501__20220430__srt--ProductOrServiceAxis__custom--ServicesRenderedInLieuOfCashMember__srt--TitleOfIndividualAxis__custom--TwoEmployeesMember_zongsT59d4Nh"&gt;187,803 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;in
share-based compensation expense for the year ended April 30, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
July 11, 2021, the Company issued &lt;span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationGross_pid_c20210709__20210711__srt--ProductOrServiceAxis__custom--MarketingAndAdvisoryServicesMember__srt--TitleOfIndividualAxis__custom--VendorMember_zGDxXFOPz7T7"&gt;47 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares
of its common stock to a vendor as compensation for marketing and other services rendered, which resulted in $&lt;span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensationGross_pp0p0_c20210501__20220430__srt--ProductOrServiceAxis__custom--MarketingAndAdvisoryServicesMember__srt--TitleOfIndividualAxis__custom--VendorMember_zX7EB2hprSja"&gt;16,875 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;of
operating expenses for the year ended April 30, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the three months ended July 31, 2021, the Company granted an aggregate total of &lt;span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20210501__20210731__srt--StatementScenarioAxis__custom--AsCompensationMember__srt--TitleOfIndividualAxis__custom--SixNewBrandAmbassadorsMember__us-gaap--AwardTypeAxis__us-gaap--CommonStockMember_z25MJlpQ5jWb"&gt;228 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares
of its common stock and equity options to purchase up to &lt;span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20210501__20210731__srt--RangeAxis__srt--MaximumMember__srt--StatementScenarioAxis__custom--AsCompensationMember__srt--TitleOfIndividualAxis__custom--SixNewBrandAmbassadorsMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zZl9X5Zj71jl"&gt;150 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares
(which are now expired) to six new brand ambassadors as compensation for services. The expense related to the issuance of the shares
and equity options is being recognized over the service agreements, similar to the warrants and equity options issued to the four
other brand ambassadors in the prior year. During the year ended April 30, 2022, the Company recognized $&lt;span id="xdx_90E_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210501__20220430__srt--TitleOfIndividualAxis__custom--BrandAmbassadorsMember_zK0XkliXXZee"&gt;907,042 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;of
operating expenses related to the shares, warrants and equity options granted to brand ambassadors.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 6, 2021, the Note payable holder exercised its right to convert its &lt;span id="xdx_902_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_pid_c20210806__us-gaap--DebtInstrumentAxis__custom--NotePayableHolderMember_ze7Nk0K78s27"&gt;5,500 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;outstanding
warrants into &lt;span id="xdx_90B_eus-gaap--ConversionOfStockSharesConverted1_pid_c20210805__20210806__us-gaap--DebtInstrumentAxis__custom--NotePayableHolderMember_zOSIJ5Y2M6Q7"&gt;12,375 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares
of common stock of the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 6, 2021, the Company&#x2019;s related party lender exercised its right to convert its &lt;span id="xdx_900_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_pid_c20210806__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RelatedPartyLenderMember_zewAwfI4XsG1"&gt;688 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;outstanding
warrants and &lt;span id="xdx_901_eus-gaap--CommonStockSharesIssued_iI_pid_c20210806__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RelatedPartyLenderMember_zeMhRNxuuKRe"&gt;17,304 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;common
shares issuable into &lt;span id="xdx_908_eus-gaap--ConversionOfStockSharesConverted1_pid_c20210805__20210806__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RelatedPartyLenderMember_z64oRc5JCQk4"&gt;17,992 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares
of common stock of the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
October 11, 2021, the Company issued &lt;span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationGross_pid_c20211010__20211011__srt--ProductOrServiceAxis__custom--MarketingAndAdvisoryServicesMember__srt--TitleOfIndividualAxis__custom--VendorMember_zBMcv9cEsP3a"&gt;47 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares
of its common stock to a vendor as compensation for marketing and other services rendered, which resulted in $&lt;span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensationGross_pp0p0_c20210501__20220430__srt--ProductOrServiceAxis__custom--MarketingAndAdvisoryServicesMember__srt--TitleOfIndividualAxis__custom--VendorMember_zp5dRQCQ1YLb"&gt;16,875 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;of
operating expenses during the year ended April 30, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 11, 2022, the Company issued &lt;span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationGross_pid_c20220110__20220111__srt--ProductOrServiceAxis__custom--MarketingAndAdvisoryServicesMember__srt--TitleOfIndividualAxis__custom--VendorMember_zHaEy3mvPpmg"&gt;47 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares
of its common stock to a vendor as compensation for marketing and other services rendered, which resulted in $&lt;span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensationGross_pp0p0_c20210501__20220430__srt--ProductOrServiceAxis__custom--MarketingAndAdvisoryServicesMember__srt--TitleOfIndividualAxis__custom--VendorOneMember_zQ8DczK3bz3e"&gt;16,874 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;of
operating expenses during the year ended April 30, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
April 2022, the Company granted an aggregate total of &lt;span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20220401__20220430__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--KeyEmployeesAndOfficersMember_zEedkoPR0xe4"&gt;150 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares
of its common stock to 6 new brand ambassadors as compensation for services. During the year ended April 30, 2022, the Company
recognized $&lt;span id="xdx_906_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210501__20220430__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--KeyEmployeesAndOfficersMember_zXAK6CpkWXB3"&gt;255,124 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;of
operating expenses related to the shares granted to brand ambassadors.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Warrants
Issued and Expensed During the Years Ended April 30, 2023 and 2022&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
October 28, 2020, the Company granted &lt;span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20201027__20201028__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--ServiceProviderMember_ze6p6EUMyXVe"&gt;1,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;warrants to a service provider for advertising
services over the next year. The warrants have an exercise price of $&lt;span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20201028__srt--TitleOfIndividualAxis__custom--ServiceProviderMember_z3wiMCubfNJc"&gt;30
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share, a contractual life of &lt;span id="xdx_909_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20201028__srt--TitleOfIndividualAxis__custom--ServiceProviderMember_zhH2RHAAvdu7"&gt;10
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;years from the date of issuance, and vest quarterly
over a year from the grant date. The warrants were valued using a Black-Scholes option pricing model and the expense related to the issuance
of the warrants is being recognized over the service agreement. The Company recognized $&lt;span id="xdx_908_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210501__20220131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--ThreeMembersMember_z5sTUPP27Xf4"&gt;214,552
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;of operating expenses related to this agreement
during the nine months ended January 31, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
accordance with the October 29, 2020 agreement with three members of the advisory board mentioned above, &lt;span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_iI_pp0p0_c20201029__srt--StatementScenarioAxis__custom--AsCompensationMember__srt--TitleOfIndividualAxis__custom--ThreeMembersMember_zJ6xz2vSDvUj"&gt;1,152 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;warrants
were issued during the year ended April 30, 2022. The warrants were valued using a Black-Scholes option pricing model on the grant
date, which resulted in operating expenses of $&lt;span id="xdx_905_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20220501__20230131__srt--StatementScenarioAxis__custom--AsCompensationMember__srt--TitleOfIndividualAxis__custom--ThreeMembersMember_zbVYIYQ1cF84"&gt;67,500 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;and
$&lt;span id="xdx_904_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210501__20220430__srt--StatementScenarioAxis__custom--AsCompensationMember__srt--TitleOfIndividualAxis__custom--ThreeMembersMember_zUK5Z22devCc"&gt;87,656 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;during
the nine months ended January 31, 2023 and year ended April 30, 2022, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 6, 2021, in connection with the Convertible Notes issuance the Company issued warrants to purchase up to &lt;span id="xdx_90A_ecustom--WarrantsIssuedToPurchaseOfCommonStockShares_iI_c20210806__srt--StatementScenarioAxis__custom--SecuritiesPurchaseAgreementMember_z07ekRxcuFZ"&gt;18.334 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares
of common stock of the Company to the Purchasers.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 6, 2021, in connection with the Convertible Notes issuance the Company also granted the lead placement agent for the Offering &lt;span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20210806__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--LeadPlacementAgentMember_z3c6J0dGTXZk"&gt;667 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;warrants
that are exercisable for five years from August 6, 2021, at an exercise price of $&lt;span id="xdx_900_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20210806__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--LeadPlacementAgentMember_zWwRLcrjX1of"&gt;1.90 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(subject
to adjustment as set forth in the Convertible Notes per the terms of the agreement) and are vested immediately. The warrants were
valued using a Black-Scholes option pricing model on the grant date and the Company recognized $&lt;span id="xdx_907_eus-gaap--OperatingExpenses_pp0p0_c20210501__20220430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--LeadPlacementAgentMember_z61oUlLOS4D6"&gt;376,000 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;of
operating expenses related to them during the year ended April 30, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September 3, 2021, the Company granted an aggregate total of &lt;span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210903__20210903__srt--StatementScenarioAxis__custom--AsCompensationMember__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z8shZD5eGAxh"&gt;2,525 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;warrants
to key employees and officers of the Company as compensation. The warrants have an exercise price of $&lt;span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20210903__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--KeyEmployeesAndOfficersMember__srt--StatementScenarioAxis__custom--ExercisePriceOneMember_zI7sj2bVHmph"&gt;0.4 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per
share for &lt;span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20210903__20210903__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--LeadPlacementAgentMember__srt--StatementScenarioAxis__custom--ExercisePriceOneMember_ziei92n21Ktk"&gt;1,000,000 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;of
the warrants and $&lt;span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20210903__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--KeyEmployeesAndOfficersMember__srt--StatementScenarioAxis__custom--ExercisePriceTwoMember_z7PWwbPIvgrb"&gt;1,368 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;for &lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20210903__20210903__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--KeyEmployeesAndOfficersMember__srt--StatementScenarioAxis__custom--ExercisePriceTwoMember_zA1bojVCtdRe"&gt;10,000 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;of
the warrants, a contractual life of &lt;span id="xdx_902_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20210903__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--KeyEmployeesAndOfficersMember_zCUyfXy34qQi"&gt;10 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;years
from the date of issuance and are vested immediately upon grant. The warrants were valued using a Black-Scholes option pricing model
on the grant date and the Company recognized $&lt;span id="xdx_906_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210501__20220430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--KeyEmployeesAndOfficersMember_z7AGpZpAHoJk"&gt;32,381,309 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;of
share-based compensation expense related to them during the year ended April 30, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 2, 2022, in connection with the Gameface acquisition the Company issued warrants to purchase up to &lt;span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20220202__20220202__us-gaap--BusinessAcquisitionAxis__custom--GamefaceMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zu7Cf2m94XIi"&gt;1,196 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares
of common stock of the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September 28, 2022, the Company entered into a securities purchase agreement (the &#x201c;Securities Purchase Agreement&#x201d;) with a
single institutional investor (the &#x201c;Investor&#x201d;) for the issuance and sale of (i) &lt;span id="xdx_909_eus-gaap--CommonStockSharesIssued_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zhceaBX3I4eh"&gt;25,463
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock and (ii) pre-funded warrants
(the &#x201c;Pre-Funded Warrants&#x201d;) to purchase an aggregate of &lt;span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zHc0Gah5qQH"&gt;295,050
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of its common stock, together with accompanying
common stock warrants, at a combined purchase price of $&lt;span id="xdx_905_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zAu4uF3JObG2"&gt;15.60
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share of the common stock and associated
common stock warrant and $&lt;span id="xdx_90C_ecustom--WarrantPerShare_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z8N6sFZfVCej"&gt;15.596
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per Pre-Funded Warrant and associated common
stock warrants for an aggregate amount of approximately $&lt;span id="xdx_904_eus-gaap--WarrantsAndRightsOutstanding_iI_pn5n6_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zuJN6iVZXW67"&gt;5.0
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;million (the &#x201c;Offering&#x201d;). The Pre-Funded
Warrants have an exercise price of $&lt;span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z2y1DsgmO2Ql"&gt;0.0004
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share of common stock and are exercisable
until the Pre-Funded Warrants are exercised in full. The shares of common stock and Pre-Funded Warrants were sold in the offering together
with common stock warrants to purchase &lt;span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--FiveYearWarrantsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zgHWEcULfNed"&gt;320,513
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock at an exercise price of
$&lt;span id="xdx_905_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--FiveYearWarrantsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zmMDkHHCGfT8"&gt;15.60
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share and a term of five years following
the initial exercise date (the &#x201c;5-Year Warrants&#x201d;) and &lt;span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220928__20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--SevenYearWarrantsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zkWnLw8e1tAb"&gt;641,026
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;common stock warrants to purchase &lt;span id="xdx_903_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--SevenYearWarrantsMember_zDSMdE3r6Ese"&gt;641,026
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock at an exercise price of
$&lt;span id="xdx_90B_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20220928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--SevenYearWarrantsMember_zZE0ovrtL4bg"&gt;17.20
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share and a term of seven and one half years
(the &#x201c;7.5-Year Warrants&#x201d;) following the initial exercise date (collectively, the &#x201c;Warrants&#x201d;). The Warrants issued
in the Offering contain variable pricing features. The exercise price of the Warrants was reset in October 2023 to $&lt;span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20231031__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z9i3Baalyxol"&gt;3.55
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_891_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zfYvdOdwoDS3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following represents a summary of the warrants:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B7_zHSt7Ikw6fI7" style="display: none"&gt;SCHEDULE OF WARRANTS ISSUED, EXERCISED AND EXPIRED&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Year Ended April 30, 2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Year Ended April 30, 2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Number&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;br/&gt; Average&lt;br/&gt; Exercise&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Price&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Number&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Weighted&lt;br/&gt; Average&lt;br/&gt; Exercise &lt;br/&gt; Price&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 44%; text-align: left; padding-left: 10pt"&gt;Beginning balance&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20220501__20230430_zQS3EBU3QrYf" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Warrants Shares, Beginning Balance"&gt;97,075&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_iS_c20220501__20230430_zy4gGvH51cl9" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Weighted Avg. Exercise Price Warrant, Beginning Balance"&gt;444.50&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20210501__20220430_zm8N1W04iELd" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Warrants Shares, Beginning Balance"&gt;47,633&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_iS_c20210501__20220430_zyqVXmwwiRL5" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Weighted Avg. Exercise Price Warrant, Beginning Balance"&gt;205.156&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"&gt;Granted&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20220501__20230430_zfcqRTePcdxf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Shares, Granted"&gt;1,714,127&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceIssued_c20220501__20230430_zkW5YL7VJ1T7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Avg. Exercise Price Warrant, Issued"&gt;11.696&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20210501__20220430_zmpBNxMzqr3a" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Shares, Granted"&gt;49,442&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceIssued_c20210501__20220430_ztppr5zG0k5b" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Avg. Exercise Price Warrant, Issued"&gt;139.344&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"&gt;Exercised&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20220501__20230430_zvkZc9JU4MBj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Shares, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2497"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised_c20220501__20230430_zhXg1c5J2b3b" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Avg. Exercise Price Warrant, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2499"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20210501__20220430_zwQRqeahawA9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Shares, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2501"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised_c20210501__20220430_z7KnUWuTYoo4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Avg. Exercise Price Warrant, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2503"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"&gt;Forfeited&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_c20220501__20230430_z3vgb86jfu07" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Shares, Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2505"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceForfeited_c20220501__20230430_zG3sPPIIrK96" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Avg. Exercise Price Warrant, Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2507"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_c20210501__20220430_zdGNprtYwxL1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Shares, Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2509"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceForfeited_c20210501__20220430_ziZC4Fb2tKtj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Avg. Exercise Price Warrant, Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2511"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 10pt"&gt;Expired&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_di_c20220501__20230430_zMGNuIwZQRea" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Shares, Expired"&gt;(18,750&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExpired_c20220501__20230430_z3sI9I6OFO24" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Avg. Exercise Price Warrant, Expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2515"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_c20210501__20220430_z8nTdQWi32Lc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Shares, Expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2517"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExpired_c20210501__20220430_zgoMBBv2B5V4" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Avg. Exercise Price Warrant, Expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2519"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; padding-left: 10pt"&gt;Ending balance&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20220501__20230430_zBS45zMYqtQj" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Shares, Ending Balance"&gt;1,792,451&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_iE_c20220501__20230430_zXXTZbbs6uq3" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Avg. Exercise Price Warrant, Ending Balance"&gt;34.208&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20210501__20220430_zPV3Wt3KFUV4" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Shares, Ending Balance"&gt;97,075&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_iE_c20210501__20220430_zoNIGys6szG5" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Avg. Exercise Price Warrant, Ending Balance"&gt;444.50&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"&gt;Intrinsic value of warrants&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--WarrantsAndRightsOutstanding_iI_c20230430_zHoXi7XU4vB2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intrinsic value of warrants"&gt;2,344,529&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--WarrantsAndRightsOutstanding_iI_c20220430_zhyimSuk9F14" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intrinsic value of warrants"&gt;33,752,623&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Weighted Average Remaining Contractual Life (Years)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20220501__20230430_z2dE7b7khvp9" title="Weighted Average Remaining Contractual Life (Years)"&gt;6.45&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20210501__20220430_zrBNJ9rRDBJl" title="Weighted Average Remaining Contractual Life (Years)"&gt;6.50&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;&lt;p id="xdx_8A8_zV1NM4fwcgGf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of April 30, 2023, &lt;span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20220501__20230430_zjYi84YwUvyj" title="Warrants vested"&gt;71,698,014&lt;/span&gt; warrants are vested.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&#160;&lt;/p&gt;

</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2023-04-30" decimals="INF" unitRef="Shares">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-04-30"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2023-04-30" decimals="INF" unitRef="Shares">338579</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-05-012022-05-01"
      decimals="INF"
      unitRef="Shares">151579</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="From2022-06-152022-06-15_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      unitRef="Shares">109740</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-06-152022-06-15_us-gaap_InvestorMember_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      unitRef="Shares">26219</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2022-06-272022-06-27_custom_GabrielGoldmanMember_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      unitRef="Shares">625</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-06-272022-06-27_custom_GamefaceAIMember_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      unitRef="Shares">14960</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-08-252022-08-25_custom_MidcityCapitalLtdMember_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      unitRef="Shares">750</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-09-282022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      unitRef="Shares">25463</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      unitRef="Shares">295050</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      unitRef="USDPShares">15.60</us-gaap:CommonStockParOrStatedValuePerShare>
    <CNXA:WarrantPerShare
      contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      unitRef="USDPShares">15.596</CNXA:WarrantPerShare>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember"
      decimals="-5"
      unitRef="USD">5000000.0</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      unitRef="USDPShares">0.0004</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_custom_FiveYearWarrantsMember_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      unitRef="Shares">320513</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_custom_FiveYearWarrantsMember_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      unitRef="USDPShares">15.60</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-09-282022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_custom_SevenYearWarrantsMember_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      unitRef="Shares">641026</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_custom_SevenPointFiveYearWarrantsMember_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      unitRef="Shares">641026</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_custom_SevenPointFiveYearWarrantsMember_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      unitRef="USDPShares">17.20</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2023-10-31_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      unitRef="USDPShares">3.55</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2022-09-282022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember"
      decimals="0"
      unitRef="USD">4549882</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2022-10-122022-10-12_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      unitRef="Shares">48098</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2022-11-212022-11-21_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      unitRef="Shares">675</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2023-01-262023-01-26_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      unitRef="Shares">6994</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2023-01-262023-01-26_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      unitRef="Shares">150</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2021-05-252021-05-26_custom_RelatedPartyLenderMember"
      decimals="INF"
      unitRef="Shares">4093</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2021-05-252021-05-26_custom_RelatedPartyLenderMember"
      decimals="0"
      unitRef="USD">6220000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2021-06-222021-06-23_custom_FoundationSportsSystemsLLCMember"
      decimals="INF"
      unitRef="Shares">1350</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2021-06-222021-06-23_custom_FoundationSportsSystemsLLCMember"
      decimals="0"
      unitRef="USD">3550000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross
      contextRef="From2021-07-052021-07-06_custom_ServicesRenderedInLieuOfCashMember_custom_TwoEmployeesMember"
      decimals="INF"
      unitRef="Shares">126</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross
      contextRef="From2021-05-012022-04-30_custom_ServicesRenderedInLieuOfCashMember_custom_TwoEmployeesMember"
      decimals="0"
      unitRef="USD">187803</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross
      contextRef="From2021-07-092021-07-11_custom_MarketingAndAdvisoryServicesMember_custom_VendorMember"
      decimals="INF"
      unitRef="Shares">47</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross
      contextRef="From2021-05-012022-04-30_custom_MarketingAndAdvisoryServicesMember_custom_VendorMember"
      decimals="0"
      unitRef="USD">16875</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2021-05-012021-07-31_custom_AsCompensationMember_custom_SixNewBrandAmbassadorsMember_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">228</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2021-05-012021-07-31_srt_MaximumMember_custom_AsCompensationMember_custom_SixNewBrandAmbassadorsMember_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      unitRef="Shares">150</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2021-05-012022-04-30_custom_BrandAmbassadorsMember"
      decimals="0"
      unitRef="USD">907042</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="AsOf2021-08-06_custom_NotePayableHolderMember"
      decimals="INF"
      unitRef="Shares">5500</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2021-08-052021-08-06_custom_NotePayableHolderMember"
      decimals="INF"
      unitRef="Shares">12375</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="AsOf2021-08-06_custom_RelatedPartyLenderMember"
      decimals="INF"
      unitRef="Shares">688</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2021-08-06_custom_RelatedPartyLenderMember"
      decimals="INF"
      unitRef="Shares">17304</us-gaap:CommonStockSharesIssued>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2021-08-052021-08-06_custom_RelatedPartyLenderMember"
      decimals="INF"
      unitRef="Shares">17992</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross
      contextRef="From2021-10-102021-10-11_custom_MarketingAndAdvisoryServicesMember_custom_VendorMember"
      decimals="INF"
      unitRef="Shares">47</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross
      contextRef="From2021-05-012022-04-30_custom_MarketingAndAdvisoryServicesMember_custom_VendorMember"
      decimals="0"
      unitRef="USD">16875</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross
      contextRef="From2022-01-102022-01-11_custom_MarketingAndAdvisoryServicesMember_custom_VendorMember"
      decimals="INF"
      unitRef="Shares">47</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross
      contextRef="From2021-05-012022-04-30_custom_MarketingAndAdvisoryServicesMember_custom_VendorOneMember"
      decimals="0"
      unitRef="USD">16874</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="From2022-04-012022-04-30_us-gaap_CommonStockMember_custom_KeyEmployeesAndOfficersMember"
      decimals="INF"
      unitRef="Shares">150</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2021-05-012022-04-30_us-gaap_CommonStockMember_custom_KeyEmployeesAndOfficersMember"
      decimals="0"
      unitRef="USD">255124</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="From2020-10-272020-10-28_us-gaap_WarrantMember_custom_ServiceProviderMember"
      decimals="INF"
      unitRef="Shares">1000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2020-10-28_custom_ServiceProviderMember"
      decimals="INF"
      unitRef="USDPShares">30</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="AsOf2020-10-28_custom_ServiceProviderMember">P10Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2021-05-012022-01-31_us-gaap_WarrantMember_custom_ThreeMembersMember"
      decimals="0"
      unitRef="USD">214552</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested
      contextRef="AsOf2020-10-29_custom_AsCompensationMember_custom_ThreeMembersMember"
      decimals="0"
      unitRef="USD">1152</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2022-05-012023-01-31_custom_AsCompensationMember_custom_ThreeMembersMember"
      decimals="0"
      unitRef="USD">67500</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2021-05-012022-04-30_custom_AsCompensationMember_custom_ThreeMembersMember"
      decimals="0"
      unitRef="USD">87656</us-gaap:AllocatedShareBasedCompensationExpense>
    <CNXA:WarrantsIssuedToPurchaseOfCommonStockShares
      contextRef="AsOf2021-08-06_custom_SecuritiesPurchaseAgreementMember30681312"
      decimals="INF"
      unitRef="Shares">18.334</CNXA:WarrantsIssuedToPurchaseOfCommonStockShares>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2021-08-06_us-gaap_WarrantMember_custom_LeadPlacementAgentMember"
      decimals="INF"
      unitRef="Shares">667</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2021-08-06_us-gaap_WarrantMember_custom_LeadPlacementAgentMember"
      decimals="INF"
      unitRef="USDPShares">1.90</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:OperatingExpenses
      contextRef="From2021-05-012022-04-30_us-gaap_WarrantMember_custom_LeadPlacementAgentMember"
      decimals="0"
      unitRef="USD">376000</us-gaap:OperatingExpenses>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2021-09-032021-09-03_custom_AsCompensationMember_us-gaap_WarrantMember"
      decimals="INF"
      unitRef="Shares">2525</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2021-09-03_us-gaap_WarrantMember_custom_KeyEmployeesAndOfficersMember_custom_ExercisePriceOneMember"
      decimals="INF"
      unitRef="USDPShares">0.4</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="From2021-09-032021-09-03_us-gaap_WarrantMember_custom_LeadPlacementAgentMember_custom_ExercisePriceOneMember"
      decimals="INF"
      unitRef="Shares">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2021-09-03_us-gaap_WarrantMember_custom_KeyEmployeesAndOfficersMember_custom_ExercisePriceTwoMember"
      decimals="INF"
      unitRef="USDPShares">1368</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="From2021-09-032021-09-03_us-gaap_WarrantMember_custom_KeyEmployeesAndOfficersMember_custom_ExercisePriceTwoMember"
      decimals="INF"
      unitRef="Shares">10000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="AsOf2021-09-03_us-gaap_WarrantMember_custom_KeyEmployeesAndOfficersMember">P10Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2021-05-012022-04-30_us-gaap_WarrantMember_custom_KeyEmployeesAndOfficersMember"
      decimals="0"
      unitRef="USD">32381309</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2022-02-022022-02-02_custom_GamefaceMember_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">1196</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      unitRef="Shares">25463</us-gaap:CommonStockSharesIssued>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      unitRef="Shares">295050</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      unitRef="USDPShares">15.60</us-gaap:CommonStockParOrStatedValuePerShare>
    <CNXA:WarrantPerShare
      contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      unitRef="USDPShares">15.596</CNXA:WarrantPerShare>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember"
      decimals="-5"
      unitRef="USD">5000000.0</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      unitRef="USDPShares">0.0004</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_custom_FiveYearWarrantsMember_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      unitRef="Shares">320513</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_custom_FiveYearWarrantsMember_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      unitRef="USDPShares">15.60</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-09-282022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_custom_SevenYearWarrantsMember_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      unitRef="Shares">641026</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_custom_SevenYearWarrantsMember"
      decimals="INF"
      unitRef="Shares">641026</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-09-28_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_custom_SevenYearWarrantsMember"
      decimals="INF"
      unitRef="USDPShares">17.20</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2023-10-31_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      unitRef="USDPShares">3.55</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="From2022-05-012023-04-30">&lt;p id="xdx_891_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zfYvdOdwoDS3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following represents a summary of the warrants:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B7_zHSt7Ikw6fI7" style="display: none"&gt;SCHEDULE OF WARRANTS ISSUED, EXERCISED AND EXPIRED&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Year Ended April 30, 2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Year Ended April 30, 2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Number&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;br/&gt; Average&lt;br/&gt; Exercise&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Price&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Number&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Weighted&lt;br/&gt; Average&lt;br/&gt; Exercise &lt;br/&gt; Price&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 44%; text-align: left; padding-left: 10pt"&gt;Beginning balance&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20220501__20230430_zQS3EBU3QrYf" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Warrants Shares, Beginning Balance"&gt;97,075&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_iS_c20220501__20230430_zy4gGvH51cl9" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Weighted Avg. Exercise Price Warrant, Beginning Balance"&gt;444.50&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20210501__20220430_zm8N1W04iELd" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Warrants Shares, Beginning Balance"&gt;47,633&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_iS_c20210501__20220430_zyqVXmwwiRL5" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Weighted Avg. Exercise Price Warrant, Beginning Balance"&gt;205.156&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"&gt;Granted&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20220501__20230430_zfcqRTePcdxf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Shares, Granted"&gt;1,714,127&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceIssued_c20220501__20230430_zkW5YL7VJ1T7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Avg. Exercise Price Warrant, Issued"&gt;11.696&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20210501__20220430_zmpBNxMzqr3a" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Shares, Granted"&gt;49,442&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceIssued_c20210501__20220430_ztppr5zG0k5b" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Avg. Exercise Price Warrant, Issued"&gt;139.344&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"&gt;Exercised&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20220501__20230430_zvkZc9JU4MBj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Shares, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2497"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised_c20220501__20230430_zhXg1c5J2b3b" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Avg. Exercise Price Warrant, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2499"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20210501__20220430_zwQRqeahawA9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Shares, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2501"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised_c20210501__20220430_z7KnUWuTYoo4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Avg. Exercise Price Warrant, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2503"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"&gt;Forfeited&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_c20220501__20230430_z3vgb86jfu07" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Shares, Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2505"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceForfeited_c20220501__20230430_zG3sPPIIrK96" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Avg. Exercise Price Warrant, Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2507"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_c20210501__20220430_zdGNprtYwxL1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Shares, Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2509"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceForfeited_c20210501__20220430_ziZC4Fb2tKtj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Avg. Exercise Price Warrant, Forfeited"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2511"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 10pt"&gt;Expired&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_di_c20220501__20230430_zMGNuIwZQRea" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Shares, Expired"&gt;(18,750&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExpired_c20220501__20230430_z3sI9I6OFO24" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Avg. Exercise Price Warrant, Expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2515"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_c20210501__20220430_z8nTdQWi32Lc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Shares, Expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2517"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExpired_c20210501__20220430_zgoMBBv2B5V4" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Avg. Exercise Price Warrant, Expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2519"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; padding-left: 10pt"&gt;Ending balance&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20220501__20230430_zBS45zMYqtQj" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Shares, Ending Balance"&gt;1,792,451&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_iE_c20220501__20230430_zXXTZbbs6uq3" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Avg. Exercise Price Warrant, Ending Balance"&gt;34.208&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20210501__20220430_zPV3Wt3KFUV4" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Shares, Ending Balance"&gt;97,075&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding_iE_c20210501__20220430_zoNIGys6szG5" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Avg. Exercise Price Warrant, Ending Balance"&gt;444.50&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"&gt;Intrinsic value of warrants&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--WarrantsAndRightsOutstanding_iI_c20230430_zHoXi7XU4vB2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intrinsic value of warrants"&gt;2,344,529&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--WarrantsAndRightsOutstanding_iI_c20220430_zhyimSuk9F14" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intrinsic value of warrants"&gt;33,752,623&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Weighted Average Remaining Contractual Life (Years)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20220501__20230430_z2dE7b7khvp9" title="Weighted Average Remaining Contractual Life (Years)"&gt;6.45&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20210501__20220430_zrBNJ9rRDBJl" title="Weighted Average Remaining Contractual Life (Years)"&gt;6.50&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber contextRef="AsOf2022-04-30" decimals="INF" unitRef="Shares">97075</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <CNXA:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding
      contextRef="AsOf2022-04-30"
      decimals="INF"
      unitRef="USDPShares">444.50</CNXA:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber contextRef="AsOf2021-04-30" decimals="INF" unitRef="Shares">47633</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <CNXA:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding
      contextRef="AsOf2021-04-30"
      decimals="INF"
      unitRef="USDPShares">205.156</CNXA:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="From2022-05-012023-04-30"
      decimals="INF"
      unitRef="Shares">1714127</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <CNXA:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceIssued
      contextRef="From2022-05-012023-04-30"
      decimals="INF"
      unitRef="USDPShares">11.696</CNXA:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceIssued>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="From2021-05-012022-04-30"
      decimals="INF"
      unitRef="Shares">49442</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <CNXA:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceIssued
      contextRef="From2021-05-012022-04-30"
      decimals="INF"
      unitRef="USDPShares">139.344</CNXA:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceIssued>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations
      contextRef="From2022-05-012023-04-30"
      decimals="INF"
      unitRef="Shares">18750</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber contextRef="AsOf2023-04-30" decimals="INF" unitRef="Shares">1792451</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <CNXA:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding
      contextRef="AsOf2023-04-30"
      decimals="INF"
      unitRef="USDPShares">34.208</CNXA:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber contextRef="AsOf2022-04-30" decimals="INF" unitRef="Shares">97075</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <CNXA:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding
      contextRef="AsOf2022-04-30"
      decimals="INF"
      unitRef="USDPShares">444.50</CNXA:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">2344529</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">33752623</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms contextRef="From2022-05-012023-04-30">P6Y5M12D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms contextRef="From2021-05-012022-04-30">P6Y6M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="From2022-05-012023-04-30"
      decimals="INF"
      unitRef="Shares">71698014</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2022-05-012023-04-30">&lt;p id="xdx_80F_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zjWPmYMu9nQi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
13: &lt;span id="xdx_82B_zjiePuo1q2af"&gt;COMMITMENTS AND CONTINGENCIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Leases&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company leases office space under short-term leases with terms under a year. Total rent expense for the years ended April 30, 2023 and
2022 amounted to $&lt;span id="xdx_905_eus-gaap--PaymentsForRent_pp0p0_c20220501__20230430_zNEXEyQmS4fk" title="Rent expense"&gt;4,900&lt;/span&gt; and $&lt;span id="xdx_908_eus-gaap--PaymentsForRent_pp0p0_c20210501__20220430_zSXcB4bFqmj9" title="Rent expense"&gt;22,176&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Contingencies&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the Gameface acquisition on February 2, 2022, the Company agreed to earn-out consideration of common shares of the Company&#x2019;s
common stock with a fair value of $&lt;span id="xdx_909_ecustom--FairValueOfCommonStock_iI_pp0p0_c20230131_z9QURvQkW99e" title="Fair value of common stock"&gt;&lt;span id="xdx_901_ecustom--FairValueOfCommonStock_iI_pp0p0_c20220430_zpRgqrLPkkeb" title="Fair value of common stock"&gt;1,334,000&lt;/span&gt;&lt;/span&gt; which is included as a current liability on the Company&#x2019;s consolidated balance sheet
as of January 31, 2023 and April 30, 2022. The Company issued &lt;span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20220601__20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zM5bJm1NXWqd" title="Number of stock issued"&gt;598,396&lt;/span&gt; common shares to the former Gameface shareholders in June 2022.
The balance of the contingent consideration as of April 30, 2023 is $&lt;span id="xdx_90F_eus-gaap--BusinessCombinationContingentConsiderationLiability_iI_c20230430_zI3he9HkvW3l" title="Balance of contingent consideration"&gt;418,455&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;From
time to time, the Company may become involved in legal proceedings arising in the ordinary course of business. The Company is not presently
a party to any legal proceedings that it currently believes would individually or taken together have a material adverse effect on the
Company&#x2019;s business or financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Nasdaq
Compliance&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
July 26, 2023, the Company received a letter from the Listing Qualifications Department of Nasdaq indicating that the Company&#x2019;s
stockholders&#x2019; equity as reported in its Quarterly Report on Form 10-Q for the quarterly period ended January 31, 2023 did not satisfy
the continued listing requirement under Nasdaq Listing Rule 5550(b)(1), which requires that a listed company&#x2019;s stockholders&#x2019;
equity be at least $&lt;span id="xdx_903_eus-gaap--StockholdersEquity_iI_pn5n6_c20230131__srt--RangeAxis__srt--MinimumMember_zY8omWpaUswe" title="Stockholders equity"&gt;2.5&lt;/span&gt; million (the &#x201c;Minimum Stockholders&#x2019; Equity Requirement&#x201d;). As reported in its Form 10-Q for
the period ended January 31, 2023, the Company&#x2019;s stockholders&#x2019; equity as of January 31, 2023 was approximately $(&lt;span id="xdx_902_eus-gaap--StockholdersEquity_iI_pn5n6_c20230131_zd3uUfSphxl8" title="Stockholders equity"&gt;11.7&lt;/span&gt;) million.
In addition, the Company did not meet the alternatives of listed securities or net income from continuing operations as of the date of
the letter. The Nasdaq has given the Company until January 22, 2024 to regain compliance with the Minimum Stockholders&#x2019;
Equity Requirement and net income from continuing operations requirement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company offers no assurance that it will regain compliance with the Minimum Stockholders&#x2019; Equity Requirement and/or any other delinquency in a timely manner.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:PaymentsForRent
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">4900</us-gaap:PaymentsForRent>
    <us-gaap:PaymentsForRent
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">22176</us-gaap:PaymentsForRent>
    <CNXA:FairValueOfCommonStock contextRef="AsOf2023-01-31" decimals="0" unitRef="USD">1334000</CNXA:FairValueOfCommonStock>
    <CNXA:FairValueOfCommonStock contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">1334000</CNXA:FairValueOfCommonStock>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2022-06-012022-06-30_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      unitRef="Shares">598396</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">418455</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-01-31_srt_MinimumMember"
      decimals="-5"
      unitRef="USD">2500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2023-01-31" decimals="-5" unitRef="USD">11700000</us-gaap:StockholdersEquity>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2022-05-012023-04-30">&lt;p id="xdx_809_eus-gaap--IncomeTaxDisclosureTextBlock_zQr52uY46vGb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
14: &lt;span id="xdx_820_zu7xp3b83Ga8"&gt;INCOME TAXES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company does business in the US through its subsidiaries Slinger Bag Inc. and Slinger Bag Americas. It also does business in Israel through
SBL whose operations are reflected in the Company&#x2019;s consolidated financial statements. The Company&#x2019;s operations in Canada,
Israel, and the UK were immaterial for the years ended April 30, 2023 and 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net
deferred tax assets from operations in the US, using an effective tax rate of &lt;span id="xdx_900_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_uPure_c20220501__20230430__srt--StatementGeographicalAxis__country--US_zr0xM8rJmrf5" title="Effective tax rate"&gt;21&lt;/span&gt;%, consisted of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89B_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_z2AE3kOtBPR6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BF_zRjK5fgziMnf" style="display: none"&gt;SCHEDULE OF NET DEFERRED TAX ASSETS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20230430_zUhHvHnWkzui" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20220430_zLOZcy4LIYvh" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;Deferred tax assets:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_maDTANzBNt_zT5aGXx64QK6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left"&gt;Loss carryforwards&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;3,049,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;2,166,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--DeferredTaxAssetsStockOptions_iI_maDTANzBNt_zro8rrgGG2y6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Stock options&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;8,454,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;8,259,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--DeferredTaxAssetsAccruedPayroll_iI_maDTANzBNt_zkbAOTiKWbpf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Capital loss carryforward/Disposal&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;11,039,000&lt;/p&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2570"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--DeferredTaxAssetsRelatedPartyAccruals_iI_maDTANzBNt_zju1Q1RMXwu5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Related party accruals&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,001,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;799,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--DeferredTaxAssetsInventory_iI_maDTANzBNt_z3d7L5uivjz4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Inventory reserve&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;133,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;100,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--DeferredTaxAssetsInterestDeferral_iI_maDTANzBNt_zzCDf3sfSZ56" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Interest deferral&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;221,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;191,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--DeferredTaxAssetsStartupCosts_iI_maDTANzBNt_zqK7gkOdlDXb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Start-up costs&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;81,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;84,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--DeferredTaxAssetsOther_iI_maDTANzBNt_ziLxY4zPKx7c" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Other&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;131,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;57,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTANzBNt_zDi0uPryjKWh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;Valuation allowance&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(24,109,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(11,656,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--DeferredTaxAssetsNet_iTI_mtDTANzBNt_zrTfHcLACBXe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Net deferred tax assets&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2590"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2591"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AF_z6Mqu2TwSjfb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
income tax provision differs from the amount of income tax determined by applying the applicable statutory income tax rate to pretax
loss due to the following for the years ended April 30, 2023 and 2022:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89B_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zZdbK7C9StIe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B4_z277PxFE5MX9" style="display: none"&gt;SCHEDULE OF INCOME TAX PROVISION&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20220501__20230430_zSYkEArpVZ7c" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20210501__20220430_zDOpuxbJ3qYf" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_zqZyBjHRvqPj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left"&gt;Income tax benefit based on book loss at US statutory rate&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;(10,983,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;(10,259,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_zhri02ZJ9u3d" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Share-based compensation and shares for services&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2598"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2599"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--IncomeTaxReconciliationDebtDiscountAmortization_zXBZ5ejqgJbd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Debt discount amortization&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;860,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,841,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--IncomeTaxReconciliationRelatedPartyAccruals_z8zDNlxx4Auj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Related party accruals&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;226,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;150,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--IncomeTaxReconciliationStartUpCosts_ziAUtmiEoAR1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Stock options&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(145,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;6,815,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--IncomeTaxRecociliationInterestExpense_zbhxuvvHojKi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Interest expense&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;79,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;5,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseDepreciation_zyQtSeco2zoc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Depreciation&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(18,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;21,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--IncomeTaxRecociliationInventoryReserve_zmD0Ipxqcx9l" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Inventory reserve&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;26,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;55,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--IncomeTaxRecociliationInterestDeferral_zhhT14nkNcra" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Interest deferral&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(5,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;13,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--IncomeTaxRecociliationAcquisitionCosts_zzwAJg20p5t5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Acquisition costs&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;260,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,268,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--IncomeTaxRecociliationAccruedLegal_zXbwDQZrYnSh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Accrued legal&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(76,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;76,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--IncomeTaxRecociliationLossOnExtinguishmentOfDebt_zu0MXotoIhv" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Loss on sale of capital assets&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;8,713,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2629"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--IncomeTaxRecociliationAccruedPayroll_zENPJxtZd2E9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Accrued payroll&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2631"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2632"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--IncomeTaxRecociliationGainOnChangeInFairValueOfDerivatives_zOI3YqG0zZTh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Change in fair value of derivatives&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;481,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(1,298,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseOther_z2SFeyKefiN8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Other&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;40,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(29,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_zfdO8oJRg5Xj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;Valuation allowance&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;542,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,342,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--IncomeTaxExpenseBenefit_iT_zBfcCPiEPHC4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Total income tax provision&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2643"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2644"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AA_zIXoZIxQmxba" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company had net operating loss carryforwards of $&lt;span id="xdx_90C_eus-gaap--OperatingLossCarryforwards_iI_c20230430__srt--StatementGeographicalAxis__country--US_z6ZgIGiLu6z7" title="Operating loss carryforwards"&gt;17,038,000&lt;/span&gt; and $&lt;span id="xdx_906_eus-gaap--OperatingLossCarryforwards_iI_c20220430__srt--StatementGeographicalAxis__country--US_zpxAZTuJeEY7" title="Operating loss carryforwards"&gt;12,366,000&lt;/span&gt; as of April 30, 2023 and 2022, respectively, which may be
available to be used to offset future taxable income in the US for the years ended 2024 through 2042. The utilization of the Company&#x2019;s
net operating losses may be subject to a U.S. federal limitation due to the &#x201c;change in ownership provisions&#x201d; under Section
382 of the Internal Revenue Code and other similar limitations in various state jurisdictions. Such limitations may result in a reduction
of the amount of net operating loss carryforwards in future years and possibly the expiration of certain net operating loss carryforwards
before their utilization. The Company has not completed a full study to assess whether an &#x201c;ownership change&#x201d; as defined in
Section 382 has occurred or whether there have been multiple ownership changes since inception. Future changes in the Company&#x2019;s
stock ownership, which may be outside of the Company&#x2019;s control, may trigger an &#x201c;ownership change.&#x201d; In addition, future
equity offerings or acquisitions that have equity as a component of the purchase price could result in an &#x201c;ownership change.&#x201d;
Tax years that remain subject to examination are 2018 and forward.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net
deferred tax assets from operations in Israel, using an effective tax rate of &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBERUZFUlJFRCBUQVggQVNTRVRTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90C_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_uPure_c20210501__20220430__srt--StatementGeographicalAxis__country--IL_z3D5aGPRhYrh" title="Effective tax rate"&gt;23&lt;/span&gt;%, consisted of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89F_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_hsrt--StatementGeographicalAxis__country--IL_zkQP64j9UtEl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BB_zaO9Oav9nn7i" style="display: none"&gt;SCHEDULE OF NET DEFERRED TAX ASSETS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20230430__srt--StatementGeographicalAxis__country--IL_zrQ3hHo4o6me" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20220430__srt--StatementGeographicalAxis__country--IL_zolONJx3g3ic" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;Deferred tax assets:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_iI_maDTANzt5N_zzRXV9umt465" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left"&gt;Loss carryforwards&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;241,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;234,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--DeferredTaxAssetsStartupCostsForeign_iI_maDTANzt5N_zlH8a3Ay7mCl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Start-up costs&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2657"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2658"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--DeferredTaxAssetsInProcessResearchAndDevelopmentCosts_iNI_di_maDTANzt5N_zLdCDmopdcA2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Research and development costs&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(113,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(113,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTANzt5N_z5PyGyR1v4hk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;Valuation allowance&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(128,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(121,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--DeferredTaxAssetsNet_iTI_mtDTANzt5N_zo2uxdV8AiT6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Net deferred tax assets&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2666"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2667"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AF_zaEtbFcxJ7h2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
income tax provision differs from the amount of income tax determined by applying the applicable Israeli statutory income tax rate of
&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIElOQ09NRSBUQVggUFJPVklTSU9OIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_905_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_uPure_c20220501__20230430__srt--StatementGeographicalAxis__country--IL_zQ6OZxXo7yr8" title="Effective tax rate"&gt;23&lt;/span&gt;% due to the following for the years ended April 30, 2023 and 2022:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_893_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_hsrt--StatementGeographicalAxis__country--IL_zGiHqeY3bNT9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B6_zcbxKGXTalUh" style="display: none"&gt;SCHEDULE OF INCOME TAX PROVISION&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20220501__20230430__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--IsraelTaxAuthorityMember_zzbqXDH4Buuk" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20210501__20220430__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--IsraelTaxAuthorityMember_zEPgXcUk1VY5" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_maCITEBzAlg_zMdAlHiNqyX8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left"&gt;Income tax provision (benefit) based on book income (loss) at Israeli statutory rate&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;(54,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;(56,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_maCITEBzAlg_zEliVMCQHBcf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;Valuation allowance&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;54,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;56,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--IncomeTaxExpenseBenefit_mtCITEBzAlg_zlY9ZPEkmuv5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Total income tax provision&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2679"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2680"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AF_zbThvKQwT2yh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company had net operating loss carryforwards of approximately $&lt;span id="xdx_904_eus-gaap--OperatingLossCarryforwards_iI_c20230430_zPaHsgNRFA3c" title="Operating loss carryforwards"&gt;1,049,000&lt;/span&gt; and $&lt;span id="xdx_90C_eus-gaap--OperatingLossCarryforwards_iI_c20220430_zxITfjTmQRc9" title="Operating loss carryforwards"&gt;1,020,000&lt;/span&gt; as of April 30, 2023 and 2022, respectively,
which may be available to be used to offset future taxable income in Israel. All of the Company&#x2019;s tax years since inception are
open for examination.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s policy is to record interest and penalties on uncertain tax positions as income tax expense. There were no interest or
penalties recognized in the accompanying consolidated statements of comprehensive loss for the years ended April 30, 2023 and 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2022-05-012023-04-30_country_US"
      decimals="INF"
      unitRef="Pure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="From2022-05-012023-04-30">&lt;p id="xdx_89B_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_z2AE3kOtBPR6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BF_zRjK5fgziMnf" style="display: none"&gt;SCHEDULE OF NET DEFERRED TAX ASSETS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20230430_zUhHvHnWkzui" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20220430_zLOZcy4LIYvh" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;Deferred tax assets:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_maDTANzBNt_zT5aGXx64QK6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left"&gt;Loss carryforwards&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;3,049,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;2,166,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--DeferredTaxAssetsStockOptions_iI_maDTANzBNt_zro8rrgGG2y6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Stock options&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;8,454,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;8,259,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--DeferredTaxAssetsAccruedPayroll_iI_maDTANzBNt_zkbAOTiKWbpf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Capital loss carryforward/Disposal&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;11,039,000&lt;/p&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2570"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--DeferredTaxAssetsRelatedPartyAccruals_iI_maDTANzBNt_zju1Q1RMXwu5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Related party accruals&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,001,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;799,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--DeferredTaxAssetsInventory_iI_maDTANzBNt_z3d7L5uivjz4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Inventory reserve&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;133,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;100,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--DeferredTaxAssetsInterestDeferral_iI_maDTANzBNt_zzCDf3sfSZ56" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Interest deferral&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;221,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;191,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--DeferredTaxAssetsStartupCosts_iI_maDTANzBNt_zqK7gkOdlDXb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Start-up costs&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;81,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;84,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--DeferredTaxAssetsOther_iI_maDTANzBNt_ziLxY4zPKx7c" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Other&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;131,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;57,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTANzBNt_zDi0uPryjKWh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;Valuation allowance&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(24,109,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(11,656,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--DeferredTaxAssetsNet_iTI_mtDTANzBNt_zrTfHcLACBXe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Net deferred tax assets&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2590"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2591"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">3049000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">2166000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <CNXA:DeferredTaxAssetsStockOptions contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">8454000</CNXA:DeferredTaxAssetsStockOptions>
    <CNXA:DeferredTaxAssetsStockOptions contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">8259000</CNXA:DeferredTaxAssetsStockOptions>
    <CNXA:DeferredTaxAssetsAccruedPayroll contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">11039000</CNXA:DeferredTaxAssetsAccruedPayroll>
    <CNXA:DeferredTaxAssetsRelatedPartyAccruals contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">1001000</CNXA:DeferredTaxAssetsRelatedPartyAccruals>
    <CNXA:DeferredTaxAssetsRelatedPartyAccruals contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">799000</CNXA:DeferredTaxAssetsRelatedPartyAccruals>
    <us-gaap:DeferredTaxAssetsInventory contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">133000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsInventory contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">100000</us-gaap:DeferredTaxAssetsInventory>
    <CNXA:DeferredTaxAssetsInterestDeferral contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">221000</CNXA:DeferredTaxAssetsInterestDeferral>
    <CNXA:DeferredTaxAssetsInterestDeferral contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">191000</CNXA:DeferredTaxAssetsInterestDeferral>
    <CNXA:DeferredTaxAssetsStartupCosts contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">81000</CNXA:DeferredTaxAssetsStartupCosts>
    <CNXA:DeferredTaxAssetsStartupCosts contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">84000</CNXA:DeferredTaxAssetsStartupCosts>
    <us-gaap:DeferredTaxAssetsOther contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">131000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">57000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">24109000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">11656000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="From2022-05-012023-04-30">&lt;p id="xdx_89B_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zZdbK7C9StIe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B4_z277PxFE5MX9" style="display: none"&gt;SCHEDULE OF INCOME TAX PROVISION&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20220501__20230430_zSYkEArpVZ7c" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20210501__20220430_zDOpuxbJ3qYf" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_zqZyBjHRvqPj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left"&gt;Income tax benefit based on book loss at US statutory rate&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;(10,983,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;(10,259,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_zhri02ZJ9u3d" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Share-based compensation and shares for services&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2598"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2599"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--IncomeTaxReconciliationDebtDiscountAmortization_zXBZ5ejqgJbd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Debt discount amortization&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;860,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,841,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--IncomeTaxReconciliationRelatedPartyAccruals_z8zDNlxx4Auj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Related party accruals&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;226,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;150,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--IncomeTaxReconciliationStartUpCosts_ziAUtmiEoAR1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Stock options&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(145,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;6,815,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--IncomeTaxRecociliationInterestExpense_zbhxuvvHojKi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Interest expense&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;79,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;5,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseDepreciation_zyQtSeco2zoc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Depreciation&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(18,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;21,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--IncomeTaxRecociliationInventoryReserve_zmD0Ipxqcx9l" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Inventory reserve&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;26,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;55,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--IncomeTaxRecociliationInterestDeferral_zhhT14nkNcra" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Interest deferral&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(5,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;13,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--IncomeTaxRecociliationAcquisitionCosts_zzwAJg20p5t5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Acquisition costs&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;260,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,268,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--IncomeTaxRecociliationAccruedLegal_zXbwDQZrYnSh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Accrued legal&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(76,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;76,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--IncomeTaxRecociliationLossOnExtinguishmentOfDebt_zu0MXotoIhv" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Loss on sale of capital assets&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;8,713,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2629"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--IncomeTaxRecociliationAccruedPayroll_zENPJxtZd2E9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Accrued payroll&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2631"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2632"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--IncomeTaxRecociliationGainOnChangeInFairValueOfDerivatives_zOI3YqG0zZTh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Change in fair value of derivatives&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;481,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(1,298,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseOther_z2SFeyKefiN8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Other&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;40,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(29,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_zfdO8oJRg5Xj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;Valuation allowance&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;542,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,342,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--IncomeTaxExpenseBenefit_iT_zBfcCPiEPHC4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Total income tax provision&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2643"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2644"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">-10983000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">-10259000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <CNXA:IncomeTaxReconciliationDebtDiscountAmortization
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">860000</CNXA:IncomeTaxReconciliationDebtDiscountAmortization>
    <CNXA:IncomeTaxReconciliationDebtDiscountAmortization
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">1841000</CNXA:IncomeTaxReconciliationDebtDiscountAmortization>
    <CNXA:IncomeTaxReconciliationRelatedPartyAccruals
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">226000</CNXA:IncomeTaxReconciliationRelatedPartyAccruals>
    <CNXA:IncomeTaxReconciliationRelatedPartyAccruals
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">150000</CNXA:IncomeTaxReconciliationRelatedPartyAccruals>
    <CNXA:IncomeTaxReconciliationStartUpCosts
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">-145000</CNXA:IncomeTaxReconciliationStartUpCosts>
    <CNXA:IncomeTaxReconciliationStartUpCosts
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">6815000</CNXA:IncomeTaxReconciliationStartUpCosts>
    <CNXA:IncomeTaxRecociliationInterestExpense
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">79000</CNXA:IncomeTaxRecociliationInterestExpense>
    <CNXA:IncomeTaxRecociliationInterestExpense
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">5000</CNXA:IncomeTaxRecociliationInterestExpense>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseDepreciation
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">-18000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseDepreciation>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseDepreciation
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">21000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseDepreciation>
    <CNXA:IncomeTaxRecociliationInventoryReserve
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">26000</CNXA:IncomeTaxRecociliationInventoryReserve>
    <CNXA:IncomeTaxRecociliationInventoryReserve
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">55000</CNXA:IncomeTaxRecociliationInventoryReserve>
    <CNXA:IncomeTaxRecociliationInterestDeferral
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">-5000</CNXA:IncomeTaxRecociliationInterestDeferral>
    <CNXA:IncomeTaxRecociliationInterestDeferral
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">13000</CNXA:IncomeTaxRecociliationInterestDeferral>
    <CNXA:IncomeTaxRecociliationAcquisitionCosts
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">260000</CNXA:IncomeTaxRecociliationAcquisitionCosts>
    <CNXA:IncomeTaxRecociliationAcquisitionCosts
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">1268000</CNXA:IncomeTaxRecociliationAcquisitionCosts>
    <CNXA:IncomeTaxRecociliationAccruedLegal
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">-76000</CNXA:IncomeTaxRecociliationAccruedLegal>
    <CNXA:IncomeTaxRecociliationAccruedLegal
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">76000</CNXA:IncomeTaxRecociliationAccruedLegal>
    <CNXA:IncomeTaxRecociliationLossOnExtinguishmentOfDebt
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">8713000</CNXA:IncomeTaxRecociliationLossOnExtinguishmentOfDebt>
    <CNXA:IncomeTaxRecociliationGainOnChangeInFairValueOfDerivatives
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">481000</CNXA:IncomeTaxRecociliationGainOnChangeInFairValueOfDerivatives>
    <CNXA:IncomeTaxRecociliationGainOnChangeInFairValueOfDerivatives
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">-1298000</CNXA:IncomeTaxRecociliationGainOnChangeInFairValueOfDerivatives>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">40000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">-29000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">542000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">1342000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2023-04-30_country_US"
      decimals="0"
      unitRef="USD">17038000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2022-04-30_country_US"
      decimals="0"
      unitRef="USD">12366000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2021-05-012022-04-30_country_IL"
      decimals="INF"
      unitRef="Pure">0.23</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="From2022-05-012023-04-30_country_IL">&lt;p id="xdx_89F_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_hsrt--StatementGeographicalAxis__country--IL_zkQP64j9UtEl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BB_zaO9Oav9nn7i" style="display: none"&gt;SCHEDULE OF NET DEFERRED TAX ASSETS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20230430__srt--StatementGeographicalAxis__country--IL_zrQ3hHo4o6me" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20220430__srt--StatementGeographicalAxis__country--IL_zolONJx3g3ic" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;Deferred tax assets:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_iI_maDTANzt5N_zzRXV9umt465" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left"&gt;Loss carryforwards&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;241,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;234,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--DeferredTaxAssetsStartupCostsForeign_iI_maDTANzt5N_zlH8a3Ay7mCl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Start-up costs&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2657"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2658"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--DeferredTaxAssetsInProcessResearchAndDevelopmentCosts_iNI_di_maDTANzt5N_zLdCDmopdcA2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Research and development costs&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(113,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(113,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTANzt5N_z5PyGyR1v4hk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;Valuation allowance&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(128,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(121,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--DeferredTaxAssetsNet_iTI_mtDTANzt5N_zo2uxdV8AiT6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Net deferred tax assets&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2666"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2667"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign
      contextRef="AsOf2023-04-30_country_IL"
      decimals="0"
      unitRef="USD">241000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign
      contextRef="AsOf2022-04-30_country_IL"
      decimals="0"
      unitRef="USD">234000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign>
    <CNXA:DeferredTaxAssetsInProcessResearchAndDevelopmentCosts
      contextRef="AsOf2023-04-30_country_IL"
      decimals="0"
      unitRef="USD">113000</CNXA:DeferredTaxAssetsInProcessResearchAndDevelopmentCosts>
    <CNXA:DeferredTaxAssetsInProcessResearchAndDevelopmentCosts
      contextRef="AsOf2022-04-30_country_IL"
      decimals="0"
      unitRef="USD">113000</CNXA:DeferredTaxAssetsInProcessResearchAndDevelopmentCosts>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="AsOf2023-04-30_country_IL"
      decimals="0"
      unitRef="USD">128000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="AsOf2022-04-30_country_IL"
      decimals="0"
      unitRef="USD">121000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2022-05-012023-04-30_country_IL"
      decimals="INF"
      unitRef="Pure">0.23</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="From2022-05-012023-04-30_country_IL">&lt;p id="xdx_893_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_hsrt--StatementGeographicalAxis__country--IL_zGiHqeY3bNT9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B6_zcbxKGXTalUh" style="display: none"&gt;SCHEDULE OF INCOME TAX PROVISION&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20220501__20230430__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--IsraelTaxAuthorityMember_zzbqXDH4Buuk" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20210501__20220430__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--IsraelTaxAuthorityMember_zEPgXcUk1VY5" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_maCITEBzAlg_zMdAlHiNqyX8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left"&gt;Income tax provision (benefit) based on book income (loss) at Israeli statutory rate&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;(54,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;(56,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_maCITEBzAlg_zEliVMCQHBcf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;Valuation allowance&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;54,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;56,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--IncomeTaxExpenseBenefit_mtCITEBzAlg_zlY9ZPEkmuv5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Total income tax provision&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2679"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2680"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="From2022-05-012023-04-30_us-gaap_IsraelTaxAuthorityMember"
      decimals="0"
      unitRef="USD">-54000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="From2021-05-012022-04-30_us-gaap_IsraelTaxAuthorityMember"
      decimals="0"
      unitRef="USD">-56000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2022-05-012023-04-30_us-gaap_IsraelTaxAuthorityMember"
      decimals="0"
      unitRef="USD">54000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2021-05-012022-04-30_us-gaap_IsraelTaxAuthorityMember"
      decimals="0"
      unitRef="USD">56000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:OperatingLossCarryforwards contextRef="AsOf2023-04-30" decimals="0" unitRef="USD">1049000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">1020000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="From2022-05-012023-04-30">&lt;p id="xdx_808_eus-gaap--SegmentReportingDisclosureTextBlock_zoL5sEzZ72a4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
15&lt;/b&gt;: &lt;b&gt;&lt;span id="xdx_828_zCOawe9I3Zf9"&gt;SEGMENTS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;With
the disposal of Foundation Sports and PlaySight in November 2022 and December 2022, the Company has ceased reporting two segments. The
Company now only operates in the equipment segment. For previous segment reporting we refer you to our previously filed Annual Report
on Form 10-K filed May 17, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock contextRef="From2022-05-012023-04-30">&lt;p id="xdx_80A_eus-gaap--DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_zwsZSvFZtAk4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
16&lt;/b&gt;: &lt;b&gt;&lt;span id="xdx_828_z23vD9hsucn1"&gt;DISCONTINUED OPERATIONS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
November 27, 2022, the Company entered into a share purchase agreement (the &#x201c;Agreement&#x201d;) with PlaySight, Chen Shachar and
Evgeni Khazanov (together, the &#x201c;Buyer&#x201d;) pursuant to which the Buyer purchased &lt;span id="xdx_90C_ecustom--SharesIssuedAndOutstandingPercentage_pid_dp_uPure_c20221125__20221127__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember_zjOgkC4qRdQ3" title="Shares issued and outstanding percentage"&gt;100&lt;/span&gt;% of the issued and outstanding shares of
PlaySight from the Company in exchange for &lt;span id="xdx_905_eus-gaap--DisposalGroupIncludingDiscontinuedOperationDescriptionAndTimingOfDisposal_c20221125__20221127__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember_zZuZe1JBGEa2" title="Discontinued operation description"&gt;(1) releasing the Company from all of PlaySight&#x2019;s obligations towards its vendors, employees,
tax authorities and any other (past, current and future) creditors of PlaySight; (2) waiver by the Buyer of 100% of the personal consideration
owed to them under their employment agreements in the total amount of $&lt;span id="xdx_90C_eus-gaap--DisposalGroupIncludingDiscontinuedOperationConsideration_iI_c20221127__us-gaap--TypeOfArrangementAxis__custom--EmployeeAgreementMember_z5TZaBZUjYu8" title="Personal consideration"&gt;600,000&lt;/span&gt;; and (3) cash consideration of $&lt;span id="xdx_906_eus-gaap--DisposalGroupIncludingDiscontinuedOperationConsideration_iI_c20221127__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember_zHoboyNdfP0b" title="Cash consideration"&gt;2,000,000&lt;/span&gt; to be paid to
the Company in the form of a promissory note that matures on December 31, 2023.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 5, 2022, the Company assigned &lt;span id="xdx_90A_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20221205__srt--OwnershipAxis__custom--FoundationSportsToCharlesRuddyMember_z6yOhx9vHuv7" title="Ownership percentage by parrent"&gt;75&lt;/span&gt;% of its membership interest in Foundation Sports to Charles Ruddy, its founder and granted
him the right for a period of three years to purchase the remaining &lt;span id="xdx_901_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_iI_pid_dp_uPure_c20221205__srt--OwnershipAxis__custom--FoundationSportsToCharlesRuddyMember_zcGeYGz2HuQ3" title="Ownership percentage by non-controlling owners"&gt;25&lt;/span&gt;% of its Foundation Sports membership interests for $&lt;span id="xdx_90F_eus-gaap--Cash_iI_c20221205_zgZgBFBsMjhc" title="Cash"&gt;500,000&lt;/span&gt; in
cash. As of December 5, 2022, the results of Foundation Sports will no longer be consolidated in the Company&#x2019;s financial statements,
and the investment was accounted for as an equity method investment. On December 5, 2022, the Company analyzed this investment and established
a reserve for the investment at the full amount of $&lt;span id="xdx_90A_eus-gaap--Investments_iI_c20221205_zei3nOBfOUDg" title="Investments"&gt;500,000&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounted for these sales as a disposal of a business under ASC 205-20-50-1(a). The Company had reclassified the operations of
PlaySight and Foundation Sports as discontinued operations as the disposal represents a strategic shift that will have a major effect
on the Company&#x2019;s operations and financial results. Under ASC 855-10-55, the Company has reflected the reclassification of assets
and liabilities of these entities as held for sale and the operations as discontinued operations as of and for the year ended April 30,
2022 as well as for the period May 1, 2022 through the date of disposal for each company. As a result of this reclassification, the Company
identified the following assets and liabilities that were reclassified from continuing operations to discontinued operations as they
are discontinued.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_897_eus-gaap--ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_zr6y7QmCcvs3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Current
assets as of April 30, 2022 &#x2013; Discontinued Operations:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BF_zS55T0AWOdM3" style="display: none"&gt;SCHEDULE OF DISCONTINUED OPERATIONS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20220430_zAXYTYYV3Pne" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;April 30, 2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_iI_maAODGIzvOg_zNbesnP5QK2k" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: left"&gt;Cash and restricted cash&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;916,082&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_iI_maAODGIzvOg_zdDC2skQzck8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Accounts receivable&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;288,980&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_iI_maAODGIzvOg_zlLcREfZLJ4h" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Inventory&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;323,307&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesCurrent_iI_maAODGIzvOg_zGlG9f4oYRSh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Right of use asset &#x2013; operating leases&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;239,689&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_iI_maAODGIzvOg_zsJimypo1AG2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;Prepaid expenses&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;490,260&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_iI_mtAODGIzvOg_z3FiX2D68ymj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Current Asset&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;2,258,318&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Non-current
assets as of April 30, 2022 &#x2013; Discontinued Operations:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20220430_zGKs8tZid6s3" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;April 30, 2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent_iI_maDGIDOzWYq_zVWAQYz7uwB7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 80%"&gt;Goodwill&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;25,862,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent_iI_maDGIDOzWYq_zys3pYq034kc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Property and equipment, net&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;126,862&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent_iI_maDGIDOzWYq_zeQRqCFy3RE7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Intangible assets, net&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;19,473,646&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets_iI_maDGIDOzWYq_z4dQgbkQTPF6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Contract assets, net of current portion&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;209,363&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--DisposalGroupIncludingDiscontinuedOperationInventoryNoncurrent_iI_maDGIDOzWYq_zKzdc3EJ5mP2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;Finished products used in operations, net&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;4,693,575&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent_iTI_mtDGIDOzWYq_zOlJYK0X4Esl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Non-current Asset&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;50,365,446&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Current
liabilities as of April 30, 2022 &#x2013; Discontinued Operations:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20220430_z3C8XOSHfqid" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;April 30, 2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent_iI_maLODGIzSPI_zeW9FtDqNNx9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: left"&gt;Accounts payable and accrued expenses&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;2,432,818&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityOperatingLeasesCurrent_iI_maLODGIzSPI_z1fKG0C7uLzd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Lease liability &#x2013; operating leases&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;237,204&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_iI_maLODGIzSPI_z5oXsB11HdIe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;Contract liabilities&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;2,545,200&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_iTI_mtLODGIzSPI_zyAFqNfeWXy5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Current Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;5,215,222&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Non-current
liabilities as of April 30, 2022 &#x2013; Discontinued Operations:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20220430_zhtEx84wNVr3" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;April 30, 2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities_iI_z16OtV0zyiT8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: left"&gt;Contract liabilities, net of current portion&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;1,370,492&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent_iTI_zqQDyCr2mKQf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Non-Current Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,370,492&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company reclassified the following operations to discontinued operations for the years ended April 30, 2023 and 2022, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20220501__20230430_zDERT3DSewv8" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20210501__20220430_zJapoXaVfHd7" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--DisposalGroupIncludingDiscontinuedOperationRevenue_maDGIDOzOqT_zeWuCX7w9BJa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 64%"&gt;Revenue&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;3,954,149&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;728,805&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOperatingExpense_msDGIDOzOqT_zr3tWtPGQDgc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Operating expenses&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;8,416,117&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;5,948,508&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--DisposalGroupIncludingDiscontinuedOperationOtherIncomeLoss_msDGIDOzOqT_zYceM7Z9yMs5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;Other (income) loss&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2750"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;27,974&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--DisposalGroupIncludingDiscontinuedOperationNetIncomeLoss_iT_mtDGIDOzOqT_zRg2zyDOURul" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Net loss from discontinued operations&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(4,461,968&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(5,247,677&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8A6_zoBsu1uVpcY2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_892_ecustom--ScheduleOfCalculationOfTheLossOnDisposalTableTextBlock_za4oTSQUDTGb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following represents the calculation of the loss on disposal of PlaySight and Foundation Sports:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BD_zTqKPL8EhYYa" style="display: none"&gt;SCHEDULE OF CALCULATION OF THE LOSS ON DISPOSAL&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49C_20230430__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--PlaySightAndFoundationSportsMember_zK9sBTh5L6z7" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_iI_zn03MDRPyxcl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 84%; text-align: left"&gt;Note receivable&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;2,000,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_iNI_di_zkUH2AW88oId" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Cash and restricted cash&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(714,507&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--DisposalGroupIncludingDiscontinuedOperationAccountsReceivable_iI_zZFpJqoLXvxf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Accounts receivable&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(411,249&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_iNI_di_zl12gf6FqCTi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Prepaid expenses&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(106,031&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--DisposalGroupIncludingDiscontinuedOperationInventory1_iNI_di_za1eheOaBBYk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Inventory&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(296,920&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherAssets_iNI_di_zg0Yzds1vmu2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Finished products used in operations&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(4,117,986&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--DisposalGroupIncludingDiscontinuedOperationContractAssets_iI_zCLtxuXTSZak" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Contract assets&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(298,162&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--DisposalGroupIncludingDiscontinuedOperationRightOfUseAsset_iI_zGWJgZuu6w8b" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Right of use asset&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(103,228&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--DisposalGroupIncludingDiscontinuedOperationGoodwill1_iNI_di_zPLmUSwo4hPf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Goodwill&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(25,862,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_iNI_di_zeJH3gAdTAt7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Property and equipment&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(116,505&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_iNI_di_zkLVx0OIHIp6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Intangible assets&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(18,576,475&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--DisposalGroupIncludingDiscontinuedOperationContractLiabilities_iI_zFHdNclfSDc5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Contract liabilities&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;3,785,408&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_iI_z9Yd9DZxM7l1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Lease liabilities&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;78,016&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_iI_zb9hKD2ofYD2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;Accounts payable and accrued expenses&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;3,325,747&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--DisposalGroupIncludingDiscontinuedOperationLossOnDisposalOfDiscontinuedOperations_iI_z9xd8SmzKwz1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Loss on disposal of discontinued operations&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(41,413,892&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AC_zPuTFFglNmvf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
    <CNXA:SharesIssuedAndOutstandingPercentage
      contextRef="From2022-11-252022-11-27_custom_SharePurchaseAgreementMember"
      decimals="INF"
      unitRef="Pure">1</CNXA:SharesIssuedAndOutstandingPercentage>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationDescriptionAndTimingOfDisposal contextRef="From2022-11-252022-11-27_custom_SharePurchaseAgreementMember">(1) releasing the Company from all of PlaySight&#x2019;s obligations towards its vendors, employees,
tax authorities and any other (past, current and future) creditors of PlaySight; (2) waiver by the Buyer of 100% of the personal consideration
owed to them under their employment agreements in the total amount of $600,000; and (3) cash consideration of $2,000,000 to be paid to
the Company in the form of a promissory note that matures on December 31, 2023.</us-gaap:DisposalGroupIncludingDiscontinuedOperationDescriptionAndTimingOfDisposal>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="AsOf2022-11-27_custom_EmployeeAgreementMember"
      decimals="0"
      unitRef="USD">600000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="AsOf2022-11-27_custom_SharePurchaseAgreementMember"
      decimals="0"
      unitRef="USD">2000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="AsOf2022-12-05_custom_FoundationSportsToCharlesRuddyMember"
      decimals="INF"
      unitRef="Pure">0.75</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="AsOf2022-12-05_custom_FoundationSportsToCharlesRuddyMember"
      decimals="INF"
      unitRef="Pure">0.25</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:Cash contextRef="AsOf2022-12-05" decimals="0" unitRef="USD">500000</us-gaap:Cash>
    <us-gaap:Investments contextRef="AsOf2022-12-05" decimals="0" unitRef="USD">500000</us-gaap:Investments>
    <us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock contextRef="From2022-05-012023-04-30">&lt;p id="xdx_897_eus-gaap--ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_zr6y7QmCcvs3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Current
assets as of April 30, 2022 &#x2013; Discontinued Operations:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BF_zS55T0AWOdM3" style="display: none"&gt;SCHEDULE OF DISCONTINUED OPERATIONS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20220430_zAXYTYYV3Pne" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;April 30, 2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_iI_maAODGIzvOg_zNbesnP5QK2k" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: left"&gt;Cash and restricted cash&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;916,082&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_iI_maAODGIzvOg_zdDC2skQzck8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Accounts receivable&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;288,980&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_iI_maAODGIzvOg_zlLcREfZLJ4h" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Inventory&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;323,307&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesCurrent_iI_maAODGIzvOg_zGlG9f4oYRSh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Right of use asset &#x2013; operating leases&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;239,689&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_iI_maAODGIzvOg_zsJimypo1AG2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;Prepaid expenses&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;490,260&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_iI_mtAODGIzvOg_z3FiX2D68ymj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Current Asset&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;2,258,318&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Non-current
assets as of April 30, 2022 &#x2013; Discontinued Operations:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20220430_zGKs8tZid6s3" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;April 30, 2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent_iI_maDGIDOzWYq_zVWAQYz7uwB7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 80%"&gt;Goodwill&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;25,862,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent_iI_maDGIDOzWYq_zys3pYq034kc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Property and equipment, net&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;126,862&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent_iI_maDGIDOzWYq_zeQRqCFy3RE7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Intangible assets, net&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;19,473,646&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets_iI_maDGIDOzWYq_z4dQgbkQTPF6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Contract assets, net of current portion&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;209,363&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--DisposalGroupIncludingDiscontinuedOperationInventoryNoncurrent_iI_maDGIDOzWYq_zKzdc3EJ5mP2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;Finished products used in operations, net&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;4,693,575&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent_iTI_mtDGIDOzWYq_zOlJYK0X4Esl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Non-current Asset&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;50,365,446&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Current
liabilities as of April 30, 2022 &#x2013; Discontinued Operations:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20220430_z3C8XOSHfqid" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;April 30, 2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent_iI_maLODGIzSPI_zeW9FtDqNNx9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: left"&gt;Accounts payable and accrued expenses&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;2,432,818&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityOperatingLeasesCurrent_iI_maLODGIzSPI_z1fKG0C7uLzd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Lease liability &#x2013; operating leases&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;237,204&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_iI_maLODGIzSPI_z5oXsB11HdIe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;Contract liabilities&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;2,545,200&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_iTI_mtLODGIzSPI_zyAFqNfeWXy5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Current Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;5,215,222&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Non-current
liabilities as of April 30, 2022 &#x2013; Discontinued Operations:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20220430_zhtEx84wNVr3" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;April 30, 2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities_iI_z16OtV0zyiT8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: left"&gt;Contract liabilities, net of current portion&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;1,370,492&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent_iTI_zqQDyCr2mKQf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Non-Current Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,370,492&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company reclassified the following operations to discontinued operations for the years ended April 30, 2023 and 2022, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20220501__20230430_zDERT3DSewv8" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20210501__20220430_zJapoXaVfHd7" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--DisposalGroupIncludingDiscontinuedOperationRevenue_maDGIDOzOqT_zeWuCX7w9BJa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 64%"&gt;Revenue&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;3,954,149&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;728,805&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOperatingExpense_msDGIDOzOqT_zr3tWtPGQDgc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Operating expenses&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;8,416,117&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;5,948,508&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--DisposalGroupIncludingDiscontinuedOperationOtherIncomeLoss_msDGIDOzOqT_zYceM7Z9yMs5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;Other (income) loss&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2750"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;27,974&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--DisposalGroupIncludingDiscontinuedOperationNetIncomeLoss_iT_mtDGIDOzOqT_zRg2zyDOURul" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Net loss from discontinued operations&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(4,461,968&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(5,247,677&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


</us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">916082</us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">288980</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">323307</us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent>
    <CNXA:DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesCurrent contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">239689</CNXA:DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">490260</us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">2258318</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">25862000</us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">126862</us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">19473646</us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">209363</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryNoncurrent contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">4693575</us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryNoncurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">50365446</us-gaap:DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">2432818</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent>
    <CNXA:DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityOperatingLeasesCurrent contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">237204</CNXA:DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityOperatingLeasesCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">2545200</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">5215222</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">1370492</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent contextRef="AsOf2022-04-30" decimals="0" unitRef="USD">1370492</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">3954149</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">728805</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">8416117</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">5948508</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense>
    <CNXA:DisposalGroupIncludingDiscontinuedOperationOtherIncomeLoss
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">27974</CNXA:DisposalGroupIncludingDiscontinuedOperationOtherIncomeLoss>
    <CNXA:DisposalGroupIncludingDiscontinuedOperationNetIncomeLoss
      contextRef="From2022-05-012023-04-30"
      decimals="0"
      unitRef="USD">-4461968</CNXA:DisposalGroupIncludingDiscontinuedOperationNetIncomeLoss>
    <CNXA:DisposalGroupIncludingDiscontinuedOperationNetIncomeLoss
      contextRef="From2021-05-012022-04-30"
      decimals="0"
      unitRef="USD">-5247677</CNXA:DisposalGroupIncludingDiscontinuedOperationNetIncomeLoss>
    <CNXA:ScheduleOfCalculationOfTheLossOnDisposalTableTextBlock contextRef="From2022-05-012023-04-30">&lt;p id="xdx_892_ecustom--ScheduleOfCalculationOfTheLossOnDisposalTableTextBlock_za4oTSQUDTGb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following represents the calculation of the loss on disposal of PlaySight and Foundation Sports:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BD_zTqKPL8EhYYa" style="display: none"&gt;SCHEDULE OF CALCULATION OF THE LOSS ON DISPOSAL&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49C_20230430__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--PlaySightAndFoundationSportsMember_zK9sBTh5L6z7" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_iI_zn03MDRPyxcl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 84%; text-align: left"&gt;Note receivable&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;2,000,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_iNI_di_zkUH2AW88oId" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Cash and restricted cash&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(714,507&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--DisposalGroupIncludingDiscontinuedOperationAccountsReceivable_iI_zZFpJqoLXvxf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Accounts receivable&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(411,249&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_iNI_di_zl12gf6FqCTi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Prepaid expenses&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(106,031&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--DisposalGroupIncludingDiscontinuedOperationInventory1_iNI_di_za1eheOaBBYk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Inventory&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(296,920&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherAssets_iNI_di_zg0Yzds1vmu2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Finished products used in operations&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(4,117,986&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--DisposalGroupIncludingDiscontinuedOperationContractAssets_iI_zCLtxuXTSZak" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Contract assets&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(298,162&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--DisposalGroupIncludingDiscontinuedOperationRightOfUseAsset_iI_zGWJgZuu6w8b" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Right of use asset&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(103,228&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--DisposalGroupIncludingDiscontinuedOperationGoodwill1_iNI_di_zPLmUSwo4hPf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Goodwill&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(25,862,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_iNI_di_zeJH3gAdTAt7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Property and equipment&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(116,505&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_iNI_di_zkLVx0OIHIp6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Intangible assets&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(18,576,475&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--DisposalGroupIncludingDiscontinuedOperationContractLiabilities_iI_zFHdNclfSDc5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Contract liabilities&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;3,785,408&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_iI_z9Yd9DZxM7l1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Lease liabilities&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;78,016&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_iI_zb9hKD2ofYD2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;Accounts payable and accrued expenses&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;3,325,747&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--DisposalGroupIncludingDiscontinuedOperationLossOnDisposalOfDiscontinuedOperations_iI_z9xd8SmzKwz1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Loss on disposal of discontinued operations&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(41,413,892&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</CNXA:ScheduleOfCalculationOfTheLossOnDisposalTableTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet
      contextRef="AsOf2023-04-30_custom_PlaySightAndFoundationSportsMember"
      decimals="0"
      unitRef="USD">2000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
      contextRef="AsOf2023-04-30_custom_PlaySightAndFoundationSportsMember"
      decimals="0"
      unitRef="USD">714507</us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents>
    <CNXA:DisposalGroupIncludingDiscontinuedOperationAccountsReceivable
      contextRef="AsOf2023-04-30_custom_PlaySightAndFoundationSportsMember"
      decimals="0"
      unitRef="USD">-411249</CNXA:DisposalGroupIncludingDiscontinuedOperationAccountsReceivable>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets
      contextRef="AsOf2023-04-30_custom_PlaySightAndFoundationSportsMember"
      decimals="0"
      unitRef="USD">106031</us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1
      contextRef="AsOf2023-04-30_custom_PlaySightAndFoundationSportsMember"
      decimals="0"
      unitRef="USD">296920</us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets
      contextRef="AsOf2023-04-30_custom_PlaySightAndFoundationSportsMember"
      decimals="0"
      unitRef="USD">4117986</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets>
    <CNXA:DisposalGroupIncludingDiscontinuedOperationContractAssets
      contextRef="AsOf2023-04-30_custom_PlaySightAndFoundationSportsMember"
      decimals="0"
      unitRef="USD">-298162</CNXA:DisposalGroupIncludingDiscontinuedOperationContractAssets>
    <CNXA:DisposalGroupIncludingDiscontinuedOperationRightOfUseAsset
      contextRef="AsOf2023-04-30_custom_PlaySightAndFoundationSportsMember"
      decimals="0"
      unitRef="USD">-103228</CNXA:DisposalGroupIncludingDiscontinuedOperationRightOfUseAsset>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1
      contextRef="AsOf2023-04-30_custom_PlaySightAndFoundationSportsMember"
      decimals="0"
      unitRef="USD">25862000</us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment
      contextRef="AsOf2023-04-30_custom_PlaySightAndFoundationSportsMember"
      decimals="0"
      unitRef="USD">116505</us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets
      contextRef="AsOf2023-04-30_custom_PlaySightAndFoundationSportsMember"
      decimals="0"
      unitRef="USD">18576475</us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets>
    <CNXA:DisposalGroupIncludingDiscontinuedOperationContractLiabilities
      contextRef="AsOf2023-04-30_custom_PlaySightAndFoundationSportsMember"
      decimals="0"
      unitRef="USD">3785408</CNXA:DisposalGroupIncludingDiscontinuedOperationContractLiabilities>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities
      contextRef="AsOf2023-04-30_custom_PlaySightAndFoundationSportsMember"
      decimals="0"
      unitRef="USD">78016</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities
      contextRef="AsOf2023-04-30_custom_PlaySightAndFoundationSportsMember"
      decimals="0"
      unitRef="USD">3325747</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities>
    <CNXA:DisposalGroupIncludingDiscontinuedOperationLossOnDisposalOfDiscontinuedOperations
      contextRef="AsOf2023-04-30_custom_PlaySightAndFoundationSportsMember"
      decimals="0"
      unitRef="USD">-41413892</CNXA:DisposalGroupIncludingDiscontinuedOperationLossOnDisposalOfDiscontinuedOperations>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2022-05-012023-04-30">&lt;p id="xdx_805_eus-gaap--SubsequentEventsTextBlock_z9wH6lRDqGE7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
17: &lt;span id="xdx_82F_zMPsKc3EwkGh"&gt;SUBSEQUENT EVENTS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;From
May 1, 2023 through the date hereof, the Company issued &lt;span id="xdx_909_eus-gaap--SharesIssued_iI_c20230501__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zJhRcohjUOX8"&gt;220,760
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock to ambassadors under
their agreements (&lt;span id="xdx_903_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230501__20230501__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zMy6hNdawBng"&gt;188&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;),
&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;to vendors in settlement of accounts payable (&lt;span id="xdx_907_ecustom--StockIssuedDuringPeriodSharesIssuedSettlementOfAccountsPayable_c20230501__20230501__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zWoqslG9CPc5"&gt;67,500&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;),
&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;for settlement with former owners of FSS (&lt;span id="xdx_900_ecustom--StockIssuedDuringPeriodSharesIssuedSettlementWithFormerOwners_c20230501__20230501__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zTri4ZwSMI6"&gt;1,3500&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;),
&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;for the exercise of warrants (&lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20230501__20230501__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zg0K9SOpZya4"&gt;58,042&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)
&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;and to satisfy the profit guarantee on a note (&lt;span id="xdx_908_ecustom--StockIssuedDuringPeriodSharesIssuedProfitGuaranteeOnNote_c20230501__20230501__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zjnsMR0ms818"&gt;93,681&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Meged
Agreement &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
June 8, 2023, the Company entered into a merchant cash advance agreement with Meged Funding Group (&#x201c;Meged&#x201d;) pursuant to which
the Company sold $&lt;span id="xdx_901_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_pp2d_c20230608__20230608__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--MegedAgreementMember_z2iV8onaWnQ8" title="Sale of consideration received"&gt;315,689&lt;/span&gt; in future receivables to Meged (the &#x201c;Meged Receivables Purchased Amount&#x201d;) to in exchange for
payment to the Company of $&lt;span id="xdx_909_eus-gaap--PaymentsToAcquireReceivables_c20230608__20230608__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--MegedAgreementMember_zQKlZyehrFNe" title="Payment for exchange received amount"&gt;210,600&lt;/span&gt; in cash less fees of $&lt;span id="xdx_904_ecustom--CashLessFees_c20230608__20230608__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--MegedAgreementMember_zqSryT44Kf4i" title="Cash less fees"&gt;10,580&lt;/span&gt;. The Company has agreed to pay Meged $&lt;span id="xdx_908_eus-gaap--PaymentsToAcquireReceivables_pp2d_c20230608__20230608__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--MegedAgreementMember__srt--StatementScenarioAxis__custom--EachWeekForNextThreeWeeksMember_zusOWbSpxus5" title="Payment for exchange received amount"&gt;17,538&lt;/span&gt; each week until the Meged
Receivables Purchased Amount is paid in full.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;UFS
Agreement&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 7, 2023, the Company entered into an agreement with UFS (the &#x201c;UFS Agreement&#x201d;) pursuant to which the Company sold $&lt;span id="xdx_906_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20230807__20230807__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--UFSAgreementMember_zaAOwptmUE7i" title="Sale of consideration received"&gt;797,500&lt;/span&gt;
in future receivables (the &#x201c;UFS Second Receivables Purchased Amount&#x201d;) to UFS in exchange for payment to the Company of $&lt;span id="xdx_90F_eus-gaap--PaymentsToAcquireReceivables_c20230807__20230807__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--UFSAgreementMember_zBeAXivopmge" title="Payment for exchange received amount"&gt;550,000&lt;/span&gt;
in cash less fees of $&lt;span id="xdx_90C_ecustom--CashLessFees_c20230807__20230807__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--UFSAgreementMember_zzVSmgVgr7n6" title="Cash less fees"&gt;50,000&lt;/span&gt;. The Company has agreed to pay UFS $&lt;span id="xdx_903_eus-gaap--PaymentsToAcquireReceivables_c20230807__20230807__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--UFSAgreementMember__srt--StatementScenarioAxis__custom--EachWeekForNextThreeWeeksMember_zsSFQkWW9IXf" title="Payment for exchange received amount"&gt;30,000&lt;/span&gt; each week until the UFS Second Receivables Purchased Amount is
paid in full.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
order to secure payment and performance of the Company&#x2019;s obligations to UFS under the UFS Agreement, the Company granted to UFS
a security interest in the following collateral: all accounts receivable and all proceeds as such term is defined by Article 9 of the
UCC. The Company also agreed not to create, incur, assume, or permit to exist, directly or indirectly, any lien on or with respect to
any of such collateral.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On September 13, the Company held a special meeting
of stockholders in which the following items were approved: (i) the issuance of (i) &lt;span id="xdx_909_eus-gaap--StockRepurchasedDuringPeriodShares_c20230912__20230913__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zLV1jyoeypKk"&gt;1,018,510 &lt;/span&gt;shares of the our common stock, par value
$&lt;span id="xdx_900_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20230913__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zKjOVtyCWTb8"&gt;0.001&lt;/span&gt; per share, that were issued on October 3, 2022, and, (ii) &lt;span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20221002__20221003__us-gaap--AwardTypeAxis__custom--PreFundedWarrantMember_zlTLu0CsA2lk"&gt;11,802,002&lt;/span&gt; shares of our common stock issuable upon exercise of Pre-Funded
Warrants at an exercise price of $&lt;span id="xdx_902_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20221003__us-gaap--AwardTypeAxis__custom--PreFundedWarrantMember_zcFRp7Ya7Fp4"&gt;0.00001&lt;/span&gt; per share, (iii) &lt;span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20221002__20221003__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zluBkmRJAQz8"&gt;12,820,512&lt;/span&gt; shares of common stock issuable upon the exercise of &lt;span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20221003__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zzzhDKH1IaR4"&gt;5&lt;/span&gt;-Year Warrants
at an exercise price of $&lt;span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20221003__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zqB7XjdJPAM6"&gt;0.39&lt;/span&gt; per share, (iv) &lt;span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20221002__20221003__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember_zbnfyzkndwwd"&gt;25,641,024&lt;/span&gt; shares of common stock issuable upon the exercise of &lt;span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20221003__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember_zHx51HB4Kmre"&gt;7.5&lt;/span&gt; Year Warrants at an
exercise price of $&lt;span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20221003__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zNPVLHhdh6xi"&gt;0.43&lt;/span&gt; per share and (v) &lt;span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20221002__20221003__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember_z30auCts6hli"&gt;18,099,548&lt;/span&gt; shares of our common stock issuable upon the exercise of &lt;span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20221003__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember_zflm2AWE4bik"&gt;5.5&lt;/span&gt; Year Warrants at an exercise price per share equal to $&lt;span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20221003_zqC1WoDZDr1k"&gt;0.221&lt;/span&gt; per share to Armistice Capital Master Fund Ltd and (ii) a reverse stock split of our common
stock within a range of one (1)-for-ten (10) to one (1)-for-forty (40) (&#x201c;Reverse Stock Split&#x201d;), with the Board of Directors
of the Company to set the specific ratio and determine the date for the reverse split to be effective and any other action deemed necessary
to effectuate the Reverse Stock Split, without further approval or authorization of stockholders, at any time within 12 months of the
special meeting date.&lt;/p&gt;

</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:SharesIssued
      contextRef="AsOf2023-05-01_us-gaap_SubsequentEventMember"
      decimals="INF"
      unitRef="Shares">220760</us-gaap:SharesIssued>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-05-012023-05-01_us-gaap_SubsequentEventMember"
      decimals="0"
      unitRef="USD">188</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <CNXA:StockIssuedDuringPeriodSharesIssuedSettlementOfAccountsPayable
      contextRef="From2023-05-012023-05-01_us-gaap_SubsequentEventMember"
      decimals="INF"
      unitRef="Shares">67500</CNXA:StockIssuedDuringPeriodSharesIssuedSettlementOfAccountsPayable>
    <CNXA:StockIssuedDuringPeriodSharesIssuedSettlementWithFormerOwners
      contextRef="From2023-05-012023-05-01_us-gaap_SubsequentEventMember"
      decimals="INF"
      unitRef="Shares">1.3500</CNXA:StockIssuedDuringPeriodSharesIssuedSettlementWithFormerOwners>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
      contextRef="From2023-05-012023-05-01_us-gaap_SubsequentEventMember"
      decimals="INF"
      unitRef="Shares">58042</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised>
    <CNXA:StockIssuedDuringPeriodSharesIssuedProfitGuaranteeOnNote
      contextRef="From2023-05-012023-05-01_us-gaap_SubsequentEventMember"
      decimals="INF"
      unitRef="Shares">93681</CNXA:StockIssuedDuringPeriodSharesIssuedProfitGuaranteeOnNote>
    <us-gaap:SaleOfStockConsiderationReceivedPerTransaction
      contextRef="From2023-06-082023-06-08_us-gaap_SubsequentEventMember_custom_MegedAgreementMember"
      decimals="2"
      unitRef="USD">315689</us-gaap:SaleOfStockConsiderationReceivedPerTransaction>
    <us-gaap:PaymentsToAcquireReceivables
      contextRef="From2023-06-082023-06-08_us-gaap_SubsequentEventMember_custom_MegedAgreementMember"
      decimals="0"
      unitRef="USD">210600</us-gaap:PaymentsToAcquireReceivables>
    <CNXA:CashLessFees
      contextRef="From2023-06-082023-06-08_us-gaap_SubsequentEventMember_custom_MegedAgreementMember"
      decimals="0"
      unitRef="USD">10580</CNXA:CashLessFees>
    <us-gaap:PaymentsToAcquireReceivables
      contextRef="From2023-06-082023-06-08_us-gaap_SubsequentEventMember_custom_MegedAgreementMember_custom_EachWeekForNextThreeWeeksMember"
      decimals="2"
      unitRef="USD">17538</us-gaap:PaymentsToAcquireReceivables>
    <us-gaap:SaleOfStockConsiderationReceivedPerTransaction
      contextRef="From2023-08-072023-08-07_us-gaap_SubsequentEventMember_custom_UFSAgreementMember"
      decimals="0"
      unitRef="USD">797500</us-gaap:SaleOfStockConsiderationReceivedPerTransaction>
    <us-gaap:PaymentsToAcquireReceivables
      contextRef="From2023-08-072023-08-07_us-gaap_SubsequentEventMember_custom_UFSAgreementMember"
      decimals="0"
      unitRef="USD">550000</us-gaap:PaymentsToAcquireReceivables>
    <CNXA:CashLessFees
      contextRef="From2023-08-072023-08-07_us-gaap_SubsequentEventMember_custom_UFSAgreementMember"
      decimals="0"
      unitRef="USD">50000</CNXA:CashLessFees>
    <us-gaap:PaymentsToAcquireReceivables
      contextRef="From2023-08-072023-08-07_us-gaap_SubsequentEventMember_custom_UFSAgreementMember_custom_EachWeekForNextThreeWeeksMember"
      decimals="0"
      unitRef="USD">30000</us-gaap:PaymentsToAcquireReceivables>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="From2023-09-122023-09-13_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">1018510</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-09-13_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2022-10-022022-10-03_custom_PreFundedWarrantMember"
      decimals="INF"
      unitRef="Shares">11802002</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2022-10-03_custom_PreFundedWarrantMember"
      decimals="INF"
      unitRef="USDPShares">0.00001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2022-10-022022-10-03_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">12820512</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="AsOf2022-10-03_us-gaap_CommonStockMember">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2022-10-03_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="USDPShares">0.39</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2022-10-022022-10-03_custom_WarrantOneMember"
      decimals="INF"
      unitRef="Shares">25641024</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="AsOf2022-10-03_custom_WarrantOneMember">P7Y6M</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2022-10-03_us-gaap_WarrantMember"
      decimals="INF"
      unitRef="USDPShares">0.43</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2022-10-022022-10-03_custom_WarrantTwoMember"
      decimals="INF"
      unitRef="Shares">18099548</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="AsOf2022-10-03_custom_WarrantTwoMember">P5Y6M</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2022-10-03"
      decimals="INF"
      unitRef="USDPShares">0.221</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>82
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( !&(:%<'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    "  1B&A7YO?JK.T    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M2L0P$(9?17)O)VE!)'1[6?&D(+B@> O)[&ZP24,RTN[;F\;=+J(/X#$S?[[Y
M!J;30>HQXG,< T:RF&YF-_@D==BP(U&0 $D?T:E4YX3/S?T8G:+\C <(2G^H
M T+#^2TX)&44*5B 55B)K.^,ECJBHC&>\4:O^/ 9AP(S&G! AYX2B%H ZY>)
MX30/'5P!"XPPNO1=0+,22_5/;.D .R?G9-?4-$WUU)9<WD' V]/C2UFWLCZ1
M\AKSKV0EG0)NV&7R:[N]WSVPON%-6PE1\;M=TTC.I>#OB^L/OZNP&XW=VW]L
M?!'L._AU%_T74$L#!!0    ( !&(:%>97)PC$ 8  )PG   3    >&PO=&AE
M;64O=&AE;64Q+GAM;.U:6W/:.!1^[Z_0>&?V;0O&-H&VM!-S:7;;M)F$[4X?
MA1%8C6QY9)&$?[]'-A#+E@WMDDVZFSP$+.G[SD5'Y^@X>?/N+F+HAHB4\GA@
MV2_;UKNW+][@5S(D$4$P&:>O\, *I4Q>M5II ,,X?<D3$L/<@HL(2W@4R]9<
MX%L:+R/6ZK3;W5:$:6RA&$=D8'U>+&A T%116F]?(+3E'S/X%<M4C66C 1-7
M02:YB+3R^6S%_-K>/F7/Z3H=,H%N,!M8('_.;Z?D3EJ(X53"Q,!J9S]6:\?1
MTDB @LE]E 6Z2?:CTQ4(,@T[.IU8SG9\]L3MGXS*VG0T;1K@X_%X.+;+THMP
M' 3@4;N>PIWT;+^D00FTHVG09-CVVJZ1IJJ-4T_3]WW?ZYMHG J-6T_3:W?=
MTXZ)QJW0> V^\4^'PZZ)QJO0=.MI)B?]KFNDZ19H0D;CZWH2%;7E0-,@ %AP
M=M;,T@.67BGZ=90:V1V[W4%<\%CN.8D1_L;%!-9ITAF6-$9RG9 %#@ WQ-%,
M4'RO0;:*X,*2TER0UL\IM5 :")K(@?5'@B'%W*_]]9>[R:0S>IU].LYKE']I
MJP&G[;N;SY/\<^CDGZ>3UTU"SG"\+ GQ^R-;88<G;CL3<CH<9T)\S_;VD:4E
M,L_O^0KK3CQG'U:6L%W/S^2>C'(CN]WV6'WV3T=N(]>IP+,BUY1&)$6?R"VZ
MY!$XM4D-,A,_")V&F&I0' *D"3&6H8;XM,:L$> 3?;>^",C?C8CWJV^:/5>A
M6$G:A/@01AKBG'/F<]%L^P>E1M'V5;S<HY=8%0&7&-\TJC4LQ=9XE<#QK9P\
M'1,2S90+!D&&ER0F$JDY?DU($_XKI=K^G-- \)0O)/I*D8]ILR.G=";-Z#,:
MP4:O&W6':-(\>OX%^9PU"AR1&QT"9QNS1B&$:;OP'J\DCIJMPA$K0CYB&38:
M<K46@;9QJ81@6A+&T7A.TK01_%FL-9,^8,CLS9%USM:1#A&27C="/F+.BY 1
MOQZ&.$J:[:)Q6 3]GE[#2<'H@LMF_;A^AM4S;"R.]T?4%TKD#R:G/^DR- >C
MFED)O816:I^JAS0^J!XR"@7QN1X^Y7IX"C>6QKQ0KH)[ ?_1VC?"J_B"P#E_
M+GW/I>^Y]#VATK<W(WUGP=.+6]Y&;EO$^ZXQVM<T+BAC5W+-R,=4KY,IV#F?
MP.S]:#Z>\>WZV22$KYI9+2,6D$N!LT$DN/R+RO JQ GH9%LE"<M4TV4WBA*>
M0AMNZ5/U2I77Y:^Y*+@\6^3IKZ%T/BS/^3Q?Y[3-"S-#MW)+ZK:4OK4F.$KT
ML<QP3A[+##MG/)(=MG>@'37[]EUVY".E,%.70[@:0KX#;;J=W#HXGIB1N0K3
M4I!OP_GIQ7@:XCG9!+E]F%=MY]C1T?OGP5&PH^\\EAW'B/*B(>ZAAIC/PT.'
M>7M?F&>5QE T%&ULK"0L1K=@N-?Q+!3@9& MH >#KU$"\E)58#%;Q@,KD*)\
M3(Q%Z'#GEUQ?X]&2X]NF9;5NKREW&6TB4CG":9@39ZO*WF6QP54=SU5;\K"^
M:CVT%4[/_EFMR)\,$4X6"Q)(8Y07IDJB\QE3ON<K2<15.+]%,[82EQB\X^;'
M<4Y3N!)VM@\",KF[.:EZ93%GIO+?+0P)+%N(61+B35WMU>>;G*YZ(G;ZEW?!
M8/+]<,E'#^4[YU_T74.N?O;=X_INDSM(3)QYQ1$!=$4"(Y4<!A87,N10[I*0
M!A,!S93)1/ "@F2F'("8^@N]\@RY*17.K3XY?T4L@X9.7M(E$A2*L P%(1=R
MX^_ODVIWC-?Z+(%MA%0R9-47RD.)P3TS<D/85"7SKMHF"X7;XE3-NQJ^)F!+
MPWING2TG_]M>U#VT%SU&\Z.9X!ZSAW.;>KC"1:S_6-8>^3+?.7#;.MX#7N83
M+$.D?L%]BHJ $:MBOKJO3_DEG#NT>_&!()O\UMND]MW@#'S4JUJE9"L1/TL'
M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M:U647JX%#X1.*L#SI5+V4$A>D)_D#?X&4$L#!!0    ( !&(:%?\RS2V%PH
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M<8N@F=D0=8. $27S^@#,L7$O8P$P3AW,\("'#JIEK/70?5K(2&DJ8SE) DV
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MA@+<.IN9=%!;Z_#DG]/=8) FA$>WWL//Z"80_<W1,++J+<P,U7"J=P7RCQC
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MM6@!OI\;P+#P0 <T/SM[_#M02P,$%     @ $8AH5YO?VTB4!   ]PX  !@
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ME7>P=\L4X$Y61'& *Y$F@+\$MI"VS\"..$DR(S]*M8OVT2+5",JRJ&%-2)+
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MYKTD="?_[X+7M,I2=(UU)2KG2ROH:FCWSVD+U[>1JOHV4GT;J;Z-5-]&JEG
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M4%D%.E]**G$C6 /M[\SP.U!+ P04    "  1B&A7B[O''.L$  "C$   &0
M 'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6SM6%MOVS84?M>O(-2BV  UEJA[
MFAAP'*?UT*1![+3 ACTP$FT1DT2-I.)DOWZ'E.(+ZAK9!5T+["4F*7[?N1^2
M.5EQ\9LL*%7HH2IK>6H72C7'@X',"EH1><0;6L.7!1<543 5RX%L!"6Y 57E
M +MN-*@(J^WAB5F[%L,3WJJ2U?1:(-E6%1&/9[3DJU/;LY\6;MBR4'IA,#QI
MR)+.J+IMK@7,!FN6G%6TEHS72-#%J3WRCL>!WF\V?&1T);?&2%MRQ_EO>C+-
M3VU7*T1+FBG-0.#GGHYI66HB4./WGM->B]3 [?$3^X6Q'6RY(Y*.>?F)Y:HX
MM1,;Y71!VE+=\-4[VML3:KZ,E]+\1:MN;^C;*&NEXE4/!@TJ5G>_Y*'WPQ8@
M<;\ P#T /Q?@]P#?&-II9LPZ)XH,3P1?(:%W YL>&-\8-%C#:AW%F1+PE0%.
M#:=7\]'5V^G9^PD:S6:3^>QDH(!6?QQD/<591X&_0.&C2UZK0J))G=-\#WY\
M&._A P0#L&=M%'XRZ@P?9/RI+8^0[SD(N]C?I]!A^*@1 '?WP7?4\=<^]@V?
M_P6^MYSG*U:6B-0YFM:*U$MV5U(TDI(JB<Z9S$HN6T'1+Z,[J02D]J_[PM!)
M"?9+T>5^+!N2T5,;ZEE2<4_MX:L77N2^V>>"?XELQR'!VB'!(?;G)=U!BOT*
M7G%%K? 8?<:_Y76+=%Z';J%;">)U^8A4P25%;!.:?A-?(-X*E$%ZLKIE]1)!
M^Q1$-R#IF'#")\FDTCM50=&"E] 78>,QFHW?3<YOWT^L#Q>?*V3]P&KT2(F0
M/Z*/I&PA&2HN%/O#<*/W7,INW?ID&A'-K=$]2%Y2=$T%XSF"'']<Y[BU@][B
M'A,A'K7>O9 L:ZNV),"W*W!:-80)Z,ZJDWT%Y\<NUIH+DM.:5%0:PQL@J<%%
M7GB$(_02^4GHA F&$0X<U_?T4N0Z8:A'GN.ZKC4V[8P*\'W9^;!@C43I48J1
M[Z10<; +A?#C)["0Q*F31AB]MB!Z5-2D!(MS>@\G3P/Z2[Y0*P)%$QRE'@J3
M#@V8R$V Q'7\5&/G7)%R3VA?HL!)TB>=O=!WHC@VJW'@.JD;KM7^QZ&"?L+*
M=4/Y%F.%(5(X=K7)KN?@Q/M>8A5!K"(<;!3?<95%'^"V(W59"E.>JA"4HJH[
M;:@^;7;KR'@+!ABM"+BN:01_8'!7H+#G)7(A(8(@!%&N$672 ^UKKG^W=T7?
M1>_Z"@G\?RG]]Z7TS<09?^4X?Q[;U GB!+W6:W'D>&[PS*#Z/IPF*0 AK&GD
MX-#[*T$%J:D&AS&<HZ[WS)B&V(F-^J^[#P%VDC ZW!>-._N&N%MBASNB[H0I
MG/ !I&SBPX76@EZR2^ 8 50J@\K1HE7ZIDNVP_.D#MC#,V:VK9@J#'+,(7;U
MXZL7"?;B-W*/^=H(2K)BW<?@76C)-LLHS75\%W"_!K]U-C(P0O:M3NXVNLEL
M/KT<S2?GZ.)V?GL#[>[RP\U\^O-H/OUP95WTKNH2M'^K;-FZDV^3SB +'* +
M*G3BQ-63<#.,-L-X,TSZX;R@\"9?0*J@&#M^\A3\S3FW[QH^V'H'0FXNS?-8
M0I]O:]4]"=>KZQ?XR#P\!YOMW?/]DH@EJR4JZ0*@[E$<VDAT3^)NHGAC7I5W
M7$$AF&%!H82$W@#?%QP.M'ZB!:S_+S'\$U!+ P04    "  1B&A7@5QS$B@#
M  !V"   &0   'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6R]5M]/VS 0?N]?
M8673GB+B_&C:L+92*47;-*"BL$V:]N FUR;"B3/;I;"_?N<D!!BA0M.TE^1L
MW_?YSI]SE]%.R&N5 FARF_-"C:U4Z_+0<52<0L[4@2BAP)6UD#G3.)0;1Y42
M6%*!<NYXE(9.SK+"FHRJN86<C,16\ZR A21JF^=,WAT!%[NQY5KW$Q?9)M5F
MPIF,2K:!)>BK<B%QY+0L299#H3)1$ GKL35U#V>!\:\<OF2P4X]L8C)9"7%M
M!A^3L45-0, AUH:!X>L&9L"Y(<(P?C:<5KNE 3ZV[]E/JMPQEQ53,!/\:Y;H
M=&P-+9+ FFVYOA"[#]#DTS=\L>"J>I)=[>O[%HFW2HN\ 6,$>5;4;W;;G,,C
MP)"^ / :@/=:@-\ _"K1.K(JK6.FV60DQ8Y(XXULQJC.ID)C-EEA5%QJB:L9
MXO1D.IM=7,V/R?S;8GZVG"]'CD96L^;$#<-1S>"]P."34U'H5)%YD4#2@9_M
MQ[O>'@('TVES\NYS.O+V,G[:\@/BNS;QJ.=W!;0?/BTEPFD7_$DX?GO$?L7G
MO\"W8'=LQ4$15B1D&L=RR[@BWZ<KI27>XA]=1UXS!MV,YLL^5"6+86SAIZM
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M1\]1ZZ*XZ0P&2.X"^S2[8@:E SG(J (&S>@\Z7G-%8\\G4KX=7O40K!0SSF
M-I=)>X[M3 )^M "\NN-+0*4)>:ND\_##X3A#G8!+(QXH@4$1-C<\F%:[-T/=
MT;A[,^2ODP*^C?'W2SXG6>>XZ(W=:]\CZ2QX_OZ& +_77#5AJ8==W!RM!J@\
MXC*N6F^@5?0C"<5BK[F<,HN@S,!$V(2G=^WXN%1#['D#/)O5<F1.=9O$IQE3
M\FT0#OU5C;BZXKG#F+Q*N*.,!QYYR"V&:KY.]R3YL4RV! "&-3AC!.VDSXVU
M7)ON\:C]]+I@UR4HF\UW!7QNVA.C=OQW720/6[];I,HN^><<C%P4,_\31O.V
M^<5HQC^4#+?+_<]-J-HEZ@$%N(#H:'!RU!/6_X3C'PJ3\Z\@<U,4)N6/*Q2/
MLK0 WR\,'*L>:(/F=[3S?P)02P,$%     @ $8AH5[E[F&TQ"P  CRL  !D
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M:6=\$Q8P]PW/@6V&JF>OBV $@1P812:KS*KHM&B?7C?8,^[,P1PQ#KI%.P/
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M)C(< )^O4JALU!M<0/^&TXO_ E!+ P04    "  1B&A7C?*O:CP%   @$0
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M!0MDZ06PGVL\&]H;[V#SH\C9GU!+ P04    "  1B&A7.W@77!P(  #'&
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M4"1D3CZQ#6E(W4?6E_6BJ7N('$?]7410C@/#0&%8-([)!&/3H-=X)_0W@.P
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M&YJX-!S[-E[[+>_F_&_::R1J_9RI;6-M0]?T $ **VX/]\K-L>VE&W>W#75
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M<VS>/!BYLB?/#](8N;2W!6?0;>($&)]+2,SV 1?H_G=Q_B=02P,$%     @
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M,*#1N-\-1[T48A@D89(F,$Z&M#ALG\]T#QI?0A<[HT0.&6I+'S07>U5K4OY
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M!36AJ)T!O5\J.NSMQ&W0MK6SOP%02P,$%     @ $8AH5]E+" -K!@  A!
M !D   !X;"]W;W)K<VAE971S+W-H965T,C,N>&ULS5A;3QLY%'Z?7V&E595*
M4S*7) 0*2"&D:K0M($*[*ZWVP9EQ,E8GXZGM$-)?OY\ON0"!;A]VM2_$]IQS
M_)W;9YN3I9#?5,&8)O?SLE*GC4+K^KC54EG!YE0=B)I5^#(5<DXUIG+64K5D
M-+=*\[*51%&W-:>\:IR=V+5K>78B%KKD%;N61"WF<RI7YZP4R]-&W%@OW/!9
MH<U"Z^RDIC,V9OI+?2TQ:VVLY'S.*L5%122;GC;Z\?%YV\A;@:^<+=7.F!A/
M)D)\,Y-1?MJ(#"!6LDP;"Q0_=VS RM(8 HSOWF9CLZ51W!VOK7^POL.7"55L
M(,K?>:Z+TT:O07(VI8M2WXCE1^;]Z1A[F2B5_4N63C9-&R1;*"WF7AD(YKQR
MO_3>QV%'H1<]HY!XA<3B=AM9E!=4T[,3*99$&FE8,P/KJM4&.%Z9I(RUQ%<.
M/7TVNAQ<?1Z2V_X?P_%)2\.B66]E7OO<:2?/:,<)^2PJ72@RK'*6/S30 I0-
MGF2-YSQYT6*_E@<DC4*21$GZ@KUTXU]J[:7/^5=E8L[(+;TG%UQEI5 +R<B?
M_8G2$A7QUSZ?G<7V?HNF2XY533-VVD ;*";O6./LS:NX&[U_ 6][@[?]DO6?
MYN-%[?W8+H5F0=P^)KNVR6W!@H&8U[1:D5PP128+!6M*$5X173#R98P?*1:S
M@G"MT+43Q7-.)8?L&!O/F"3G=$80X0-"J_S!8G_.),_ 'F2D"2V5>+K'2$G*
MRO4>P?C\$UD60C$"PI'4M*PB%+E"EYH69OD:F$?]YE4OB0_?*Y)!4I0\IT9F
MRBM:99R61&DL@#[ 6<;9)VH[V\#P@%8TIV'@4(76(1N%W\B2 04'9VGX!,-@
M0OMIQ:A4A)G")RA;7F[JUFICD!R02Z8#D 23$E(:54B58@CG5(KY(P@NZ"$Q
M,9K!!&'3*;.D914AB=A,21*3\>#C\.++IR&Y^D NA[?D8OAA>',SO#"I)?WQ
M>'@[#BP.@R&X>+K]<?!)( L9E7(%=Y94YHJ\)FD8M8_"*(HP3L*XVS7C8*Q%
M]@U8'=!>V.ZTK4PO3#I6.AC0FFM$IGQLM(6>JX7"IS@.H]39MAE(W@<WK+0I
MJZG4*]!S)A>H% +!*+:"AT?._*BZ0QJ%7!%?TR1.4RL11Y&70&Z8TL2%&OLE
MB;,1'\7>">SR;E&C6A3"WW-?>]:3X JAES#J%CN'=O$K+1?4G1PECBY4%2/-
MI!W&D7/C+6G"J6ZGZV8!,DWV9?KUVN&=D6D^[IC)2-92W'%[S.4<.9>^/$Q!
MT+E85-KD?4<^9W 7AP$VFB!R=5VN3,E8>4S0>).2V098V+#MJ-HJT@);,DP#
MF[%\89>,^E087XVQ7ZCRXP<%N649<GUS]74T'EU=[E3C:(MEPBHVY=J>JCF!
M]^;P=D5$M>&?K0<6]FM$/ J/>JF/OYO[(D0&Q@7XXIVSADUP;U$^@0"JS$=E
MW3(UQ#-,UNE85^0%FR"'."9LS!%ZJ?D/9Z+7C5P]A;VVJZAGRC=)7$'$G6A/
M]S3C=L>C[X:]N/.P>MF]P<Q0^*X0[=<+AER!T2R,9MSSZJZ^]_2&W[_3>:8S
MFFL L8UCT,^^+U!\UKQKCF3C:]+M>1EX!U]+-C,6#GW-$S=P9 )U-+JEJ,SS
M@>^ 7GCH]MH$>FVOIBN)BGN2B$%!<9084IQ2+LD=6M$:SL' =]10HB)MW\--
MP#SR4?&=W';XF\G1LYW<:2?>Q]2-@EMA(._MRN=:>'U^%C0G%=K?\SFZYPD3
M*@/_-8G!+:D#&R=AZACV5PZ)]?GTLT,B_=<.B<35OQFE[7W<^CB9-RA,*K/"
MMF'.[O 0J,VY[,7!HNN&W@[WLV^<]#:2GM__A[SK4L1?X%\Q#1XEZ)^3YA9S
MT_/GVT<$ZG=KFAI\:YCT*: UG?J3W%+IYB#;WRZ.5+K_5:L@GE+<<W/I*E>F
M<397$XP2U]\[=C>WNAHWP0P15^9$ V\*:>Z-G@-- 8)A::G-)19H%_!-:FHN
M7\8+X6@0QX_:]<[3LKU&XBIH[X.5V)H5,MA:-7O.*OYC>U_%T>! &F\?7%:W
M5U3+FI"2K# /7G2S#<LO737WO3Y:.R]#7,EG]OUKKLPH;O=(W*QNGMA]][+<
MBKOW^6<J9QRQ*=D4JM'!8:=!I'OSNHD6M7UG3H3&J]4."T9!V48 WZ<"#Q$_
M,1ML_O%P]C=02P,$%     @ $8AH5_ .9MZL @  U 4  !D   !X;"]W;W)K
M<VAE971S+W-H965T,C0N>&UL?53;;MLP#'W/5Q >L*<NOB2]K$L")&UWP9 B
M:+KU8=B#8C.Q4%ER)3EN_GZ4[+@9D.;%EBB>PT-1Y*A6^MGDB!9>"R'-.,BM
M+:_#T*0Y%LST58F23M9*%\S25F]"4VIDF0<5(DRBZ"(L&)?!9.1M"ST9J<H*
M+G&AP51%P?1NAD+5XR .]H8'OLFM,X234<DVN$3[JUQHVH4=2\8+E(8K"1K7
MXV :7\^&SM\[_.98FX,UN$Q62CV[S8]L'$1.$ I,K6-@]-OB#0KAB$C&2\L9
M="$=\'"]9__J<Z=<5LS@C1)//+/Y.+@*(,,UJX1]4/5W;/,Y=WRI$L9_H6Y\
MD\\!I)6QJFC!I*#@LOFSU_8>#@!7T3N I 4D7G<3R*N\999-1EK5H)TWL;F%
M3]6C21R7KBA+J^F4$\Y.EG??YG?WC\M1:(G-V<*T1<X:9/(.,DY@KJ3-#=S)
M#+/_"4*2T6E)]EIFR4G&::G[,(C.((F2P0F^09?;P/,-WLL--_1\+#Q@J;3E
M<@-_IBMC-;V$O\?R;=B&Q]E<=UR;DJ4X#NCY&]1;#"8?/\07T9<36H>=UN$I
M]I-U.(D\KNM>6>S%Y["GA2=N\Y[-$3)N2F68 +6&KZJ2&?/=L7179(#)#!:"
M[9;N,0.7<*^V6*Q0NYHD_O@6TS?+&3C.&U643.X@9P92I![)J%_W=VYK!::I
MA.G#8XZ]O;ND*U)2[(!&C&86C0OH^/"EXJ4O70OLDU0-E-Z6J\KLK0=!:G03
M@D3M5 56@:K>W"G F@O2-)6RHL2;Y]"CI%U?0QQ]^MDZS-D.XLOF_?7A6%7#
M@TXK4&_\/*&DZ2)MTW2=M1M9TZ93W]R;>3=G>L.E 8%K@D;]R_, =#-#FHU5
MI>_;E;(T!?PRI[&+VCG0^5I1D=N-"] -\LD_4$L#!!0    ( !&(:%<VEU.M
M:"P  *7P   9    >&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;.U]:W/;1K+H
M=_R**9_=4W852)$4J8>3N$J6E41['-O7LI/:NG4_@,"01 P"7#PD<W_][=<\
M0(*TXKN[R=W%A\0B"<ST]/2[>WJ^?2C*3]5*ZUI]7F=Y]=V355UOGI^<5/%*
MKZ-J6&QT#K\LBG(=U?"Q7)Y4FU)'";VTSDXFH]'9R3I*\R<OOJ7OWI4OOBV:
M.DMS_:Y45;->1^7VI<Z*A^^>C)^8+]ZGRU6-7YR\^'83+?6=KC]NWI7PZ<2.
MDJ1KG5=ID:M2+[Y[<C5^?CV9X@OTQ,^I?JB\OQ4N95X4G_##;?+=DQ%"I#,=
MUSA$!/_<ZVN=93@2P/$W&?2)G1-?]/\VHW]/BX?%S*-*7Q?9+VE2K[Y[<O%$
M)7H1-5G]OGCX4<N"9CA>7&05_5\]\+.SZ1,5-U5=K.5E@&"=YOQO]%D0X;UP
M,3KPPD1>F#SVA5-YX906RI#1LEY%=?3BV[)X4"4^#:/A'X0;>AM6D^:XC7=U
M";^F\%[]XN[C3S]=O?^K>ON]NKO]X<WM][?75V\^J*OKZ[<?WWRX??.#>O?V
M]>WU[<V=>OJNR-(XU=6S;T]JF!H'.(EEFI<\S>3 -*?JIR*O5Y6ZR1.==+Q_
M??S]\>3( ">P9KOPB5GXR\G1$?_29$-U.@[59#0Y[0+H^.M7FQ)>'W6]W@+G
MU.[#*8UW>FB\."Z:O$[SI3)H5O_[:E[5)1#Z_^E".(\W[1X/N?]YM8EB_=T3
M8.]*E_?ZR8O__J_QV>B;KL7^@P9K+7UJESX]-OJ+V[S69;I6WZ=YE,=IE*F[
M.JHUR(JZZEKXT=&Z894I@JXIU(>5#B) _WH3Y5O<@+@ &LLKG:B%?;YRSQ<+
M5:^TNN87U"JZUVJN=:Y@ODU4PFL/:;T"D:FB)DGK4&V:LFJBO%9U06^630:[
M&^4)R,%EDT4HSW#8 '^\TW%3IG4J3]Q\CE=1OJ3IUFF%TG.HKG59@X16:<YR
MG.0A/)RD59P550/KAJ'_UJ0(S'RK(D=<FS*%!6T0@*7.=1EE&?VN-S4\"V,"
M#,''/,5/A*/*6Z!#3%&J8IW6^)2_NJJ)5]W+&R*:*_TEW((,1P&O *P@2GX%
M^<??UZL($,G@J6*3YKADV(AUE(.RP6="!:A7N8YU58$^0FAH_P&P1926L$I"
MO:Y OM,>@B8L+>I;.PI(I<_P0%HD@0RC$UK#@2',._6JU%JM659IE%4*),W6
M2AH!LZ@MJ"G\FN9)&D>HT PL9A9<.*QR&\RUTI\W@!M$'4Q&@#8U[+7 J02"
M!1 !('6KHQ(!P$T'895F1EI-:6LJ(- ,B -GBFCC86=^;7)6KDC /DK^^[\N
M)N/S;ZK@*L\;&/R]WA1EK>!)U*5J/!K\C\6 F1C@;,T+2U^DF7"'>ARIXPQW
M2)KKN2[5>,H##567"/L*L?!%$3:S(FQV5(1]K&CC;JHZ72//=(FMHR-TPP?#
M!OZP)*I8RC#3PX^P;14HC"2J#_$4[RU*BK3>,O9_N+IZ9R1$Y3$1<LTZ^@2D
M9J?$G8DJL/(V3.A$D-%B 91(\BI:HVA!SD62L#*D&Q0:S!>UP @:9 -JOQ))
M-=N&:-DAC1D.B(E0DQ2F+-6B+-8P?%%Y(':30X_N?Q&Z6PQS9AGF["C#="AB
M$"IQ!DM/%R0*B[R+B8Z.VKVK=JK@\%1&H\)NIR#&2(093.,.IKG1H97:1-MH
MGFE$7%PVL ,HED&C52'A.Q;=++H!D&Y^]Q1I:><7:8YDE5:USF,F&=IKD(XE
M0DO@B!9RRGX%8CLOE";:0$'9(:_!P\E@\5J1@Q""SJD5& @ :K4"/;0JLD27
ME3R-W@\8GC4JDCBJ5FH!/MX![NKWX??>AQ;;G5NV.S_*=M<X' )-?]R 0+J/
MLD-V]M&ANO<8APVZQB=1:NPK0C(N&,T\M0)'&TR@+(6G49S=:V/TD>R,8 O+
M= G$DX&LK-%@V+*1Y!E:@"FP.>&-%9KA30F&!)J8(%[!P"$<:@?+,$ S;AW]
M6IBQ@)1XQJ31+//F4?Z)C;H8;&C8BS@J8;PRRJLH9LF\*8N8YF2Z!+L*IIM>
M*#"L2A&]8)M%3M0JC]:B*HC-7NS!U\EQ_6[\,7:CQ7<7EN\NCO+=E1%:(/ T
MC QRJXOCC@[2O<=FY,"-[.^N%4!6;);N.?9$\D&*WC'L,VP/N",@*0&SB?:>
MK,0ZP-_$) !1!OBA[2J+I(G%VA"AK(I[L!Y@U'45P"XM[8OC&>[+V4@ET99]
M0NMUP3CW0(<X#E)B\4 "$S<]*9IYO6@RMPBPB<A!*P!T)K.XR$QD,*TL3</>
MFI>'P5L<#VG<>Q:D-IA1ODK0GU<1N)TZ"5L^(=!PN=35H%@8_\RBT?HS7X!Z
MV&([& !($0#\$_@THW T&L&_E^'9Y:B3_7O2^ \E#2:)\?F,2.2(++JTLNCR
M"^&V>Y!K1;GMDD!'7ST46Y/QE/TK #R#^$2C3+8#5@^[+K&-N "">IIH) *8
M(3%!*8I%H54%WDQ9U4!\H?R%P;1Y!);9,U0N:#V5.LK2OQ.2::86P=AP!?YD
M7;?4 @JS90W2D_M*EL-:QGU-[M=#"I0!J@L</XR8P%IX"4C5N)X4)D73SY^B
M6L&:/@T]G-@9D+?FI!$!KA58FZ#Y,&*S&\WSW<!HCBB0>$^BU_1[GNQ-"/RI
M\Z3JQ(9[.(@H?-4*3-%P[8"-M883LW.+ ND86/:YNKO^\>;5Q]<WF#FX??/S
MS9L/;]__-6@/V1X.HZ\I&,")^J$HD@JH>PJ";W9Y 7^-PQE0^N7%C)B@R '.
MD_=ZDP&MD:/P+D)6G(2CLVDXFH[A^?/Q))S-3H/K:)/62 LP[JNFWIY\7U+J
M1DW/P\GYI9J-X=_)1>#(]#UOA'IJF.J9>CJ;L0A^%GPH8#3DO/#T]"R\'"-T
MI^'XXC(\/SOK%,T]S_P'\<P.A^PQS>0KF&9GS/9X^UQC>04Y*!R=GX;GE^.C
M?&.Y1>'_+\.+Z<5AOA&&@9=.)Q?A^+*3=2R_ !>-=EG'L<N?U'EX<38.+T[/
MCZFN\<AE*T='E=<[C,:!8W)4B1T?HYLC96!OK>8;G][%^:]VJ3W%;P;DD*0U
M?P4^CV2%$%[DD#E0(P;^V3[ @(.QEW:)#ER8,AEL8.^V"N9)BE+<)&,AU-L-
MDG^VY9S3UN4?C+O%R1',>D692<;0M!4_9BPS\9=:_ENT@/<P,$D)(_'&AKM.
M(YA\3=%4  .\E@(NP&'3&<P 2,&5A<;JDPQ.P5:368^ZW4VC511U3&.P)K<"
M+6>L!%1"5R0#A('_\@,%+6.-"Q<,[+]*R2F9'L.FK>S)CL6)T.!>87#G*%1!
MTK!=3(8?QF3I5S-F9Z:[)\^>//^(Y-F6R5X%R?@+,AECK# ](A0C)QM$::=@
M/CK0(<KGT8/6Z.K UU$L66^@F*)9KH"J =48&(J+]3S-)5N+Y@3E2:RQ9=(;
M"66+V3XROV&RQRASF@"XB/+P[X2:JX"=W0XT[$R%-A"'?^$-\/Z:-2;(T1=%
MYHU39\F@@926- 1&BC'O<H,!["2M*;\OB6%F(4HAQR42&!%>4VET+[-TX0"'
M,6I>>>Q4_U"]Q7A8Q.(#)F1FQ/JO6N?DL.(;$CI'^PHGPG@XO/IJ%^9HC03V
M=_HBH)F 7AM<7E,9*L2*%K0S!KC[:JWK%::N*2;0V@:[!)0)-BG.R.*UA.#>
MI\ S*<<%8(AH2<N==8O=GOAZXOO7$U];J$Z<4)T<S]04L/R\=HGG:XY\OT^K
M3YVB]>AP!_(#_AQ!>XZ6.J4=@?\ _Y@AQ@@Y*"B,RB/I%&A4F$@6:U%)=Q'N
M&$](S>F:LM];V-%84^H:2Y420/,ZK7<TG&API*[ *G"<'6?%[:3M0'Y:I1NF
M&W2\@/1A19G3D$@\9:H!F(1*9IB<$7S2MRX ]\LJQ8"=)@"YV*:0K 4G'8(2
MT!+B$R:$R&2!R"KUN@ VI1JLPLX;BZV%\W)E%#[+Q@!'31&.2%7I,J<4*+";
M2R,63=E=:Q2 +>72_5A0)1+A#FRD-PC'E.RM15,"@"5L$>P=6%D'4I/Q+J5)
MCH6 !2P^:/#DT?FEP?!;0G?0Y))BQ0*> Y9N3Y0]4?YQB+(MBEUE[OAH]>N+
M]QJL<E#([W5< $X.E:8<'Z6;V&7HP!MZ+Q, W_^=TBP,A7A2:6FH$>G.*T24
M$HDR(?U)"0BOMOBN!BQ%95(!QA-7=O$4$3\9?7-U=TU_C;]YILY&9^S%P&#:
MU8TZ[DE-=5*N8*LP>2M%A19J"S30*_!D&K-)0X[H@F.;8+BL4R3I)46W8'&(
MFA39%(F<"N!U606XK%QJ07A:*16M)#S*U,_+@3<91-+J#!O3?B59:/HR8TX2
MSQ,QITT)(F,9ZY[VX&J[N@=V"(4"[ D%)W$?BGF6+L56J:H"[193"4G2J\BI
MT%NR[';9**$BR66A&PS"2B%G./^.+#R0-ANTB:ZD5$:R6,:'=\,A%I-[AFC!
M[[4<44P[H?##406_;'<9 $$L1O,TXZ)-X5V_PBQHU<>UJEX.!%@KH4A."=K$
M8XPO9IR+= ),$H$VG%"2,5<L!J4&PS0/61X U0*M4*)-H^#"S87EX]8F*=4@
MW],JF]S(RX- /40E$&N]/>!^VT!TMMT5ZH$O0!D\(B,S(K!/U>B.S-\.-3&0
MP)C$D$H8U<@DVM_K-O5<F^T65F;8][FX!O#M-&;%@>5J);OZ3^1J=9BK@R]P
MM0'N %L_EI<)-39 #QKL'E&A-TR(T6:3I3H)8/ H7J6P; :RC<OG(%7U)A@_
M5[<) K#8&I'$+&.3P&;=K2VW*1W!>\JQN6CG_<B]34EM#0 I"L%9HB5FP!U=
M1E3CTHZD[>S!W&T8L$( 5(I?I;R U*2X)3PFO&FXSHYSX*U6S,QEK%HHP-](
M>) T(;\U(+>/BF)AWM"FBBPB5B2(ULC*5.C:S)%J8PV"KW9/P:YHR@"U@=&<
MU])4ED160_U0(%;61>GFJ )7&,].NTYL&6V3V^+[BBRD?)EYX.%C=NR5]SZB
M?N=9FTVCV4E>%;GV54;@5,:0"6RR0V#=^J4R%<%VKJZ:#T_#8&:MH>K@"$^4
MU'I9DO"NML (:\S&&=SA,_X"79PA)7QPH?0AP%HA40N(5PSM56;XI.+J5(14
MB'ISO0!.L2%J!PI6>2"Y/^1T(*)8,KS$1*P=\, #'KJ([L$")0T#]A@8MK&4
M7Z>@&8NPM5*A^*[HBBP:@R#"!C3DTW2HAR';2.Y]J:X#J8D')/(Z0"H%,.5[
MJK8Q<08K-NR$SX;JI8ZCIM+T_3N_NN;.\*10EBT,WT.CH]=2>_M-L2P?#@LD
M<^+<S0R^%PQ*YS,=@DD94'R=SW846;//A,S!!D*2=W85X'C5H$@!$MC"/:C!
M9D:-TEZK68IPY7S;EC&X0'?("14VJ'^@8I&I'I_HS[5+M/.8B \"'C02\&A(
MY G:I4&72O@Y=#S>3?/"N:?/U2LC!YVNY-)%U",Q%V;M?ROD(PI2CA]T:$1G
M@C]6'QK9+^:?IZV#'4WA-(\Q)'P0[+OD-![465;>P3YZ*F&1?M:)J? .U7U4
M,O>8;Q"6.7!MM^GHK&8Q#V46\FU%&P+./.,+]K(QJ7XO692Q(T$Z%8N\G1TH
M?+O0NF4\>R>H+(6T/7#]F<O(R=)J>]/B)M-!0\G9#X,?BP<P+\J0BE[EG. B
M,LZZIXM98HLAG.SJ9)X-QAQ0L3HB>D<-BDV/&PO6C6@2Q"*:L0&23Y*B<&O9
MG4)F^K->;\3C<J?S/,[Q",, ]ML00<9-(-H-#[7-=?V :<I="[-EAQA+P9@K
M.#?%-NP3:47ZE9 BY<G"F]/GZ@K,OQ@55S=KRFX\5MU::SP06Y&B5" RLYHL
M[T/CR/D@4^,8V]#'0:C8!NSV,DVQ3'#D(6<Y4MCJWG@!&:*JTEDF!T;A)1,@
MN+M[9P($^RZ1LP.===1MT>PBS1I[1MC64C,96RESGU:$IC9="N,+*1>'8DF\
M(;+CL^<FE./Y,F14^XQ2P<S5@LXF'L*Q.&%58&A]SXU\G)80=UM 2KB<JYVJ
MH$(NEZDXJ-0#YG@O0&,Y"5#NW"?T'%*6[SLF]CUJ#0 RUFP:L1C%[?&)]>D'
MF^(_'4R)KZIG!X+ ?5RLCXOU<;$^+M;'Q?JX6!\7Z^-B?5RLCXOU<;$^+M;'
MQ?JX6!\7Z^-B?5RLCXO]1\7%VG5HKDWB^'B?Q)>FFOS:JR;OK$3[BE9H9O#
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M#=8QU+4Y;FMCH<(3WB:Y>8.?HJWBZ/-83G7ME(?@ZNPMQTF:\'W&>/L3%C(
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MC.P2'X#?%T51FP\X ?;Z)/!>_%]02P,$%     @ $8AH5_ 0*0%D!@  *14
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M)I?&:'BBLCB6 M]RE)/M\=W556?T&:[/8=R_&/;/^]W.\!8ZW>[UW?"V/[R
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M<VAE970R-RYX;6SM6%MOVS84?M>O(-RB: '5UL6ZI8X!QW%:#\T%L=,"&_;
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M&VCU# U?*KBRO^30Y(:A0]*]TJ)LP5A!653-E3VV/IP QO050- "@O\*"%M
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MYCC]09H$O+\50A\7Y@'=_XG9/U!+ P04    "  1B&A74N>+T;P%  #K#P
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MR?TAJV1.*"PY$E518/X[A)SM1Y9K'1TKLLND=MC^L,0[B$&NRR57EMVPI*0
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M_C_CU0K>@%8@T&?D#MJNX[4'-][57%UNSH3V7O>[;6=PU_;</FI=A5B0Q+Q
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MP]B]EI_,W3?'%R97'(M#"4M<&KP?HORE>\>[CA:-?3O?"XTO<=M<XZ</2&.
M\TLA]+YC-F@_ID9_ U!+ P04    "  1B&A7*ZYE/DT+   =L0  &0   'AL
M+W=O<FMS:&5E=',O<VAE970S,RYX;6S%W6U/VU@:QO'W^RF.LJO=&6E*8CL/
MT*61*'Y^:M5,=Z4=[0N3'(C5),[83FFE^?!KAQ!C,":9_E?T14L@]^\X..?&
MQ[YPSV^3]$LVES(7WY:+5?:N,\_S]=MN-YO.Y3+*3I*U7!5?N4[29907#].;
M;K9.933;%BT77;77&W:74;SJC,^WG_N8CL^33;Z(5_)C*K+-<AFEW]_+17+[
MKJ-T[C_Q*;Z9Y^4GNN/S=70C)S+_O/Z8%H^Z>V46+^4JBY.52.7UN\Z%\C;L
M]\J"[3/^%<O;[,''HGPI5TGRI7S@S-YU>N46R86<YB41%?]\E9=RL2BE8CM^
MWZ&=_9AEX<./[W5S^^*+%W,59?(R6?P[GN7S=YW3CIC)ZVBSR#\EM[;<O:!!
MZ4V31;;]6]SNGMOKB.DFRY/EKKC8@F6\NOLW^K;[1CPH4,^>*5!W!>JC J7_
M3(&V*] .+>CO"OJ'%@QV!8-#"X:[@N&A!:-=P>C0@M-=P>FA!6>[@K-#"Y3>
M_9[K'5RRW]F/]_;S)?>[6SEX?ROW.UPY>(\K][M<V>[S[MW;=_O>UZ,\&I^G
MR:U(R^<77OG!=@)MZXNW?+PJY_HD3XNOQD5=/O[PR;H(G?]<_.I\",5%J(OP
MXM?/GPSQP13O/T^<T)A,Q$^ZS*-XD8DP2M.HG)L_BS?B\T07/_WMY_-N7FQ&
MB76GNR'?WPVI/C.DNUF="*7_BU![JMI0?ME>/I'KHGQ8EBMG#>5Z>_G%YN9$
MJ-JSY<9+&[\X$9JRW7BMH=P\H%P=/EMNO;#QZ[08O?=LN?W"Z-&J=>.=]G)=
M3D]$;_#LCG,/_]8UE7N'O_:F<O^ =YUZ-[K24!X</GI3>=A>;LJKXDU[5]ZK
MEW>+&;N?MNI^VJI;3WO&*WZT+:*KY&XVBHMB6JYN9/$C.!?1:E9[_"&?RU3D
M\V@EZD6_^84IG%PNL_\V3>*[#>@W;T!Y"/(V6T=3^:Y3'&-D,OTJ.^.__U49
M]O[9-*5)3"<Q@\1,$K-(S"8QA\1<$O-(S">Q@,1""*NU'FW?>K0V?3S)D^F7
M>;*8R33[AS!^W\3Y]U_$)_FU>"S%]JMBLE[$>5-3::>5-\7BY8W2^TNZT[*M
MECVC7;9JQW85$C-(S"0QB\1L$G-(S"4QC\1\$@M(+(2P6E?I[[M*_^"N(N2V
MJ33UCU;DV(,2$M-)S+C#!ENL/%OS=?Q&.=6&9^JH./+]^K WD,-:C<,.%6TT
M5.K#VD^?J2BC7OFG_D2'W#[WZ:C]T6BD:<-'HWI/GZBI T4YTQY]^WQR\P(2
M"R&L-AD'^\DX:)V,SG(=Q:F<B>1:Q*N\6$O$5PLIHBR3>;9=8=PDR>PV7BQ$
MM$PVJ\8?]:U#'#M524PG,8/$3!*S2,PF,8?$7!+S[K#AP\;1/QT.SLX>]0UR
MT(#$0@BK]8WAOF\,6_O&Q^*X/4XVV>)[L1Y8)VE>M)#? KF\DFGC*896[=@6
M06(ZB1DD9I*816(VB3DDYI*81V(^B04D%D)8K8^,]GUD]-IG-T=DZR$QG<0,
M$C-)S"(QF\0<$G-)S",QG\0"$@LAK-9Z3O>MYY0X#]&*'-L^2$PG,8/$3!*S
M3@\^54$.ZY"82V+>TV_(,Z<\R%&#QMW0'_1&_7Y]V! :MC:IS_:3^JQU4@?Q
M*EYNEJUKD5;AV!E-8CJ)&21FDIA%8C:).23FDIA'8CZ)!2060EBM=RB]??,H
M\V&ONQK9;0'4?5!-1S4#U4Q4LU#-1C4'U5Q4\U#-1[4 U4)*JW>B!UE-A5B<
MM"M'=Q-2TU'-0#5SIST\FE4'#1<U+718^]!A'718%]4\5/-1+4"UD-+J/4"M
M>D!KN&L\*3YQ4QQEO(]NQ,52IO$TRH2SFNX7-^*/70CKXR:=SJ.L.&2Y2>7=
M 4K; JA]W*.[!IKX1#4#U4Q4LU#-1C4'U5Q4\U#-1[4 U4)*J_>?*OVI:*^^
M&B)3;9>HIJ.:@6HFJEFH9J.:@VHNJGFHYJ-:@&HAI=4[494855HS<.-P4Q[+
ME!FU;!X5 X@XRS9R)JZ35$338G64Q>6ODS9V&#*J=XEJ^DY[F$$:/%T,&.B@
M)JI9J&:CFH-J+JIYJ.:C6H!J(:756T>5;U7: ZY5Z_@:+3;RF,Z!QEI13=]I
MM6N FJIJ9X];!YI9134+U6Q4<U#-134/U7Q4"U MI+1ZZZ@BKDI[QA4Y_U(\
MY]BL;/MF'=UXT+0LJAFH9J*:A6HVJCFHYJ*:AVH^J@6H%E):O3U5R5GEU:.S
M"IJ=134=U0Q4,U'-0C4;U1Q4<U'-0S4?U0)4"RFMWHFJ(*W2GJ3]D=,S:+P6
MU?2=]O#TC-IKN%IKH,.:J&:AFHUJ#JJYJ.:AFH]J :J%E%9O'E5@5VE/[$Z2
MA123LF_<Q5W*-C)Y[__X16XTYHMJ.JH9J&:BFH5J-JHYJ.:BFH=J/JH%J!92
M6OWF:E7D5WWUR*^*1GY134<U ]5,5+-0S48U!]5<5/-0S4>U -5"2JMWHBKR
MJ[9'?I^LHI+;E9PU-A0T];O37K@*K:.#&JAFHIJ%:C:J.:CFHIJ':CZJ!:@6
M4EJ]4ZA5IW@A& PLF?[$=:GVK3JZ[; WBF7O%,O>*I:]5RQ[LUCV;K'L[6+9
M^\6R-XQE[QC+WC+V_Q$;5JO8L/KJL6$5C0VCFHYJ!JJ9J&:AFHUJ#JJYJ.:A
MFH]J :J%E%;O1%5L6&W-%AZSHB(CCY<[[<4+1SHZK(%J)JI9J&:CFH-J+JIY
MJ.:C6H!J(:75>T65$U;;<\(OAOT:VP8:$48U'=4,5#-1S4(U&]4<5'-1S4,U
M']4"5 LIK=Y;JB"Q.GSU%1&:&48U'=4,5#-1S4(U&]4<5'-1S4,U']4"5 LI
MK=Z)JLRPVIH$''^4Z;3H,]&-+%=%Y7(HS>;QNK&CH-G?G5;>56>_)E(>KX9>
M?HZ!;I6):A:JV:CFH)J+:AZJ^:@6H%K8_@ZOS^DJ?:L>F;Z5WZ;S\HBB^4P'
M&KA5GT9D&Z\=H[>J1343U2Q4LU'-0347U3Q4\U$M0+60TNK=HHK;JB_$;5\Z
MS_%G+@RC45M4TU'-0#43U2Q4LU'-0347U3Q4\U$M0+60TNK_F6@5M=5>/6JK
MH5%;5--1S4 U$]4L5+-1S4$U%]4\5/-1+4"UD-+JG:B*VFI'1FU;ETSMV-%-
MY6G<MOGB,#JL@6HFJEFH9J.:@VHNJGFHYJ-:@&HAI=7[A5KUBQ\+W#9V#30M
MBVHZJAFH9J*:A6HVJCFHYJ*:AVH^J@6H%E):O;54:5GMU=.R&IJ6134=U0Q4
M,U'-0C4;U1Q4<U'-0S4?U0)4"RFMWHFJM*S6FK [YMIPNW1T1^D_O2K6.SE5
M'Z^'R$$-5#-1S4(U&]4<5'-1S4,U']4"5 LIK=XJJK"LUAZ6-9/-:A:5]W02
MD_+Z4"8FW[/R^$/X_F7[J@A-S**:CFH&JIFH9J&:C6H.JKFHYJ&:CVH!JH64
M5F\P56)6>_7$K(8F9E%-1S4#U4Q4LU#-1C4'U5Q4\U#-1[4 U4)*JW>B*C&K
M88G9=NGHCH+>+1?5#%0S4<U"-1O5'*TA_]D[&0WJ*UT7'=1#-1_5 E0+*:W>
M*JH@KM8>Q#UL523^$)?S*%W(3'S:S&;?VY=+:%H7U714,U#-1#4+U6Q4<U#-
M134/U7Q4"U MI+1ZYZE"O=K9JR^7T(POJNFH9J":B6H6JMFHYJ":BVH>JOFH
M%J!:2&FU3M2O,K[]UN3>,<NE=NG8CH)J.JH9J&:BFH5J-JHYJ.:BFH=J_DYK
M^]77 !TQI+2[/M'-YE+F>I1'X_-U,?F#*+V)5YE8R.N"+Y>X'9'&-_/]@SQ9
M%R^W(ZZ2/$^6VP_G,IK)M'Q"\?7K),GO'W0+_S9)OVS'&/\/4$L#!!0    (
M !&(:%>FH5O;\@,  %<5   9    >&PO=V]R:W-H965T<R]S:&5E=#,T+GAM
M;*V878^C-A2&_XI%JVI7V@X?"229)D@S(6RGFLF.)MKV8M4+#YPDU@)F;9/L
M2/WQM8%A0I;0I/)-PL=Y']OGQ<?@Z9ZRKWP+(-#W-,GXS-@*D5^;)H^VD&)^
M17/(Y)TU92D6\I1M3)XSP'$I2A/3L2S/3#')#']:7GMD_I06(B$9/#+$BS3%
M[.46$KJ?&;;Q>N&);+9"73#]:8XWL +Q.7]D\LQL*#%)(>.$9HC!>F;<V->A
M70K*B#\)[/G!,5)#>:;TJSJYBV>&I7H$"41"(;#\V\$<DD219#^^U5"C:5,)
M#X]?Z6$Y>#F89\QA3I._2"RV,V-LH!C6N$C$$]W_#O6 7,6+:,++7[2O8D>6
M@:*""YK68MF#E&35/_Y>)^) (#G= J<6.,<"[X1@4 L&QX+A"<&P%@S/%;BU
MP#U7X-4"K\Q]E:PRTP$6V)\RND=,14N:.BCM*M4RP2133]9*,'F72)WP/WZZ
M6WY$\T_+^>)IB=X%(#!).%IBQK#R_#WZ%7U>!>C=S^^GII -*ID9U?#;"NZ<
M@ _0 \W$EJ-%%D/<H9_WZVVG!V#*D3;#=5Z'>^OT$O\HDBLTL#\@QW(&71WJ
ME]_D3,JMD_*@7QY U+3N=,@7_?(EW36M=\G#\SOO].1RT#PZ@Y(W.,%[D).7
M0)HG] 48>DQPAK[<RQAT)R#E?W<]+A5PV U41?2:YSB"F2&K) >V \/_Y2?;
MLW[KLDHG+- )6^B$A9I@+8N'C<7#/KI_$T5%6B180*S*-8F(Z+*U@K@E1"UE
M.]]V'7<R&HS<J;D[]*PKTAZYEF=;[<B@MV.7&J(3%OXXAK'E3KR)\S;85K+=
M)MEN;[)#6F0Q+M?;54Z9X&CUPM540O?W<_3E =)G8)W3JI=[Z;32"0MTPA8Z
M8:$F6,MIKW':TUTY/9T6ZX0%.F$+G;!0$ZQE\:BQ>-0[F>^R'7 A7\&%?/^6
M[U29K*!X+:3=,>$YY3CY@.@^ \:W)$<DDW=D_%%(UX-0-6M;!^7'NG*.Z^Q9
M44'O$"ZU3B<LU 1K63=NK!N?:QU.94WN7/+&/RP"1PO8_#\C@MYN7)I^G;!0
M$ZR5_DF3_DEO^F4Y?$$K]4'8K'GH'_3_%\?>UBZMG#IA@4[80B<LU 1K^6];
M;Y^DEN[EL29J<EDK+=!*6VBEA;IH;:</-A_LWKD>$![)#WR2%23;()H#*Z<X
M1_(HD@48;Z#3[5[JQ6[KI 4U[6CI/?X06IP7%NKJ6^6/>;!/E +;E#MZ'$5J
MD:NVC)JKS:[A3;E79KZ%5UN.#YAMB#0J@;64JIX;B%6[>-6)H'FYZ_1,A:!I
M>;@%' -3 ?+^FE+Q>J(::/92_7\!4$L#!!0    ( !&(:%=3K9_Q"@,   @)
M   9    >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;*U66V^;,!C]*Q:;IE9:
M"S;7= E2&YJUT]9&2=MIFO;@$B>Q"IC93M+NU\\&BA(@41_Z KZ<<_C.L<'T
M-XP_B24A$CRG228&QE+*_,PT1;PD*1:G+">9FIDSGF*INGQABIP3/"M(:6(B
MR_+,%-/,"/O%V)B'?;:2"<W(F .Q2E/,7RY(PC8# QJO Q.Z6$H]8(;]'"_(
ME,C[?,Q5SZQ59C0EF: L YS,!\8Y/(M\C2\ #Y1LQ%8;:">/C#WISO5L8%BZ
M()*06&H%K&YK,B1)HH54&7\K3:-^I"9NMU_51X5WY>41"S)DR4\ZD\N!$1A@
M1N9XE<@)VUR1RH^K]6*6B.(*-B7600:(5T*RM"*K"E*:E7?\7.6P18#.'@*J
M".BM!+LBV&\E.!7!*9(IK10Y1%CBL,_9!G"-5FJZ4819L)5]FNEEGTJN9JGB
MR7 ZO+J,[K]?@ML1N+YYN+RYNYW\ D<1D9@FXAB<@/MI!(X^'O=-J1ZG269<
M25^4TFB/]+=5<@IL^!D@"]D=].%A^GG.%=W:2X_>3D>[=%-E5 >%ZJ!0H6?O
MTXMCMLHDS19@S!(:4R+ [_-'(;G:NG^ZTBGUG&X]_3J?B1S'9&"H]U40OB9&
M^.D#]*PO75F]IUCT3F([.=IUCO8A]7!$,ZJVZPQ\96PFNG(K^6[!UU^M=>A8
MEML+^N9Z.Y$V#+I6KQ>XN[BH2\ZW_1ZL<3L^G-J'<]#'D*4YRT@FS0G)$Y66
M^A9*,,9<=IHJQ;RM*I#E.98#&Z[:..A#Y+IVPU6'GJLR<H)N5V[MRCWL"N=4
MXH3^4PL4K>2+.>+%E[/+DMLJP?&1WVL8:J-<Z"/46,VH#8,V"F!OCQ^O]N,=
M]'.=K=6R,/X")N5.[C+BM9Y] GW7LJR&E0Z<JV$-7-2E9^W@=KSXM1?_H)<[
MIE:FJWZ_M<.1;7L]V'QCVC@;!CW?\QKUMW%^X,' ]AOUFUO'COY'^('Y@F8"
M)&2NF-:IKR1X>>Z6'<GRXB1Z9%*=:T5SJ7Y5"-< -3]G3+YV].%6__R$_P%0
M2P,$%     @ $8AH5^ &02#<!0  <"P  !D   !X;"]W;W)K<VAE971S+W-H
M965T,S8N>&ULM9I=<YLX%(;_BL:[L]/.;&LDOK.)9Q)#M]Y)MYFF:2\Z>T%L
MV68*R)7DN/GW*S %@V4U=$YN$L"<YZ!S[!=>I/,=XU_%FE*)ON=9(2Y&:RDW
M9^.QF*]IGHC7;$,+]<F2\3R1:I>OQF+#:;*H@O)L3"S+&^=)6HPFY]6Q&SXY
M9UN9I06]X4AL\SSACU<T8[N+$1[]./ A7:UE>6 \.=\D*WI+Y=WFAJN]<4-9
MI#DM1,H*Q.GR8G2)SV(2E@'5&9]2NA,'VZ@<RCUC7\N=V>)B9)571#,ZER4B
M4?\>Z)1F64E2U_&MAHZ:G&7@X?8/^IMJ\&HP]XF@4Y9]3A=R?3$*1FA!E\DV
MDQ_8[BVM!^26O#G+1/47[?;GNNX(S;="LKP.5E>0I\7^?_*]+L1! #X50.H
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MR?)J<TT3U>_R!/7YDJG^USME@F:1\>1_4$L#!!0    ( !&(:%=O#&&<G 4
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M9LM81D$>K$80>&'VRU[S1*P$6+TM 3@/P&L!N+,EP,X#['U[</( 9]\>.GE
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M(- HG]$VG</Z:D%;&C7:GSU(WTA=&2PBM:W/CEM,:.+&S^B<,_D+#F2J9K%
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MWZI?E>W2G?8[W%%K$-#%^RQJ!)YK4?MH6M*BH]D'.OL,-<$J?G=*OSMG^+W
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MU27%8QC% 8W7^8,)CS&E<9B_7!$&,DD6P#Y?QC'='60)JH=AQO\#4$L#!!0
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M4X[T#0J35/"U&N9(I#.1I;F1GMG9OY'KVE#G^@,2YD+"O!QF[SR.O0?A'[;
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M.W5,7/\V35ZSQ0B;RZ__=*D6)UH?X,-1UFCMO?C4ASH[O9 T%Y3F@=)\4%H
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MHT'_,"W00@!4BU M1K4$U5)4RU MI[1V.#7% +*X&>!Y58RH]DQLG!U+:#\
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MH%J*:AFJY936SJBFN$ 1%Q>$NU-35\M**K]<W!2+Z_(YH@3?I"!FSTXJM-
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M#-5R2FM'5M/[,!3W/N#K:=</3NX_U^5O]QM">]B'.B,/+9! -175-%334<U
M-1/5+%2S4<U!-1?5/%3S42U M1#5(E2+42U!M135,E3+*:V=BTW/Q/!Q+2^U
MUG:(5D:@FHIJ&JKIJ&:@FHEJ%JK9J.:@FHMJ'JKYJ!:@6HAJ$:K%J):@6HIJ
M&:KEE-:.L:8R8BA<R_O!6JP_I)7U2JJ*5?<5Y&A'!*JIJ*:AFHYJ!JJ9J&:A
MFHUJ#JJYJ.:AFH]J :J%J!:A6HQJR4Z3Y=:Y[-YHT&^?M4C183-4RRFM%4FC
MIOYA)*Y_^#-F',.J?)@M[^OY5RDN[]:?W$IQP9]X%\]-/51344U#-1W5#%0S
M4<U"-1O5'%1S4<U#-1_5 E0+42U"M1C5$E1+42U#M9S2VM'8-$^,9'32<81V
M3:":BFH:JNFH9J":B6H6JMFHYJ":BVH>JOFH%J!:B&H1JL6HEJ!:BFH9JN64
MUHXQI8DQ<7?%'RM0$N-GAQJIJ:BFH9J^T\:MJ8F7E^/O'G;T<GQTYRQ4LU'-
M0347U3Q4\U$M0+40U2)4BU$M0;44U3)4RRFMG4--H<4(+K00>V='#ZFIJ*:-
M7J[RG_9Z$WEZ</4].JJ!:B:J6:AFHYJ#:BZJ>:CFHUJ :N&)KYD('35&M035
M4E3+4"VGM';V-,48ZYO"ST"KY<6O-\OY.GCJ_Y:TW^XW)[K\Y:K\0=K^E93<
MK5.H,X2$\-DA1&HJJFFHIA\Y()N:V/]H/H465YMSB<7E_]W7J]GB>ON]EZN;
M4EHNRA_7MS?_K _87^7M'P:]OTE5^; ^E*54;X]>_<K1,]#G9**:A6HVJCFH
MYJ*:AVH^J@6H%J):A&HQJB6HEJ):AFHYI;6#L"GI&/T[2CK$@YP=BFA)!ZII
MJ*;OM".MZB<]RD3WS$(U&]4<5'-1S4,U']4"5 M1+4*U&-425$M1+4.UG-+:
M8=04=(S$!1U_QK6'?R^JJCBRR%F\6V?'%]KK@6H:JNFH9J":B6H6JMFHYJ":
MBVH>JOFH%J!:B&H1JL6HEJ!:BFH9JN64UH[#IOQC]+B(&KO>$.WJ0#45U314
MTU'-0#43U2Q4LU'-0347U3Q4\U$M0+40U2)4BU$M0;44U3)4RRFM'6--5\=(
MN(CZP^:TFN@;A,6;GQU;:#<'JFFHIN^T_0[PWN',X=&'F.@^6:AFHYJ#:BZJ
M>:CFHUJ :B&J1:@6HUJ":BFJ9:B64UH[8)H6C9&X16,WQ5=+UYM_E9>=(8,6
M::":BFH:JND[;?^JJG[7MS\:Z+ FJEFH9J.:@VHNJGFHYJ-:@&HAJD6H%J-:
M@FHIJF6HEE-:*Y7&39'&^-]?I+'Y*%4+3V6)=^K<G$,U%=4T5--1S4 U$]4L
M5+-1S4$U%]4\5/-1+4"U$-4B5(M1+4&U%-4R5,LIK1V&377&F*W.&*/5&:BF
MHIJ&:CJJ&:AFHIJ%:C:J.:CFHIJ':CZJ!:@6HEJ$:C&J):B6HEJ&:CFEM6-,
M:6),7)T15LN+LKRLI:MJ>2LMMI_&!&>VQ-K9*89V9:":AFHZJAD[K?6MM8/>
MYG\'I\+082U4LU'-0347U3Q4\U$M0+40U2)4BU$M0;44U3)4RRFM'5!-I\98
MW*GQ9TPZ>L67V>W]K7C:$:WF0#45U314TU'-0#43U2Q4LU'-0347U3Q4\U$M
M0+40U2)4BU$M0;44U3)4RRFM'8=-S<?Z)CKM.$!CC-145--034<U ]5,5+-0
MS48U!]5<5/-0S4>U -5"5(M0+4:U!-525,M0+:>T=HPU)1UC<4G'L2OHQ9N?
M'5MH_0:J::BF[[3]R^.57L?,H''J TUT_RQ4LU'-0347U3Q4\U$M0+40U2)4
MBU$M0;44U3)4RRFM'39-"<=87,+Q:7E[NUSLBO3*+V5U,:LWP?/#KO])^B8H
M@A+;9R<1VJ2!:AJJZ3MM_QS58*@,)M/#(#KM<2:Z=Q:JV:CFH)J+:AZJ^:@6
MH%J(:A&JQ:B6H%J*:AFJY936SJ&F_6(L7);\;SF5]1W?32G>Z[,3#BW90#4-
MU714,U#-1#4+U6Q4<U#-134/U7Q4"U M1+4(U6)42U M1;4,U7)*:Z=E4[(Q
MGK!GNM#2#51344U#-1W5#%0S4<U"-1O5'%1S4<U#-1_5 E0+42U"M1C5$E1+
M42U#M9S2VC'65'F,Q54>?VSR$>WX0#45U314T\<O.SZZ)Q]/>YR)[IV%:C:J
M.:CFHIJ':CZJ!:@6HEJ$:C&J):B6HEJ&:CFEM7)HTI1W3,3E'5YY75YV3#AV
MQ8Z8.C=V4$U%-0W5=%0S4,U$-0O5;%1S4,U%-0_5?%0+4"U$M0C58E1+4"U%
MM0S5<DIK1UA3N3%A*S<F:.4&JJFHIJ&:CFH&JIFH9J&:C6H.JKFHYJ&:CVH!
MJH6H%J%:C&H)JJ6HEJ%:3FGM&%.:&!-7;B3%O)265]+%<E'/+LNJ6,V6"ZDJ
M+\K90W?5KQ@\.\C0UHV=MG\A>5\>C@ZGT#1T5!W5#%0S4<U"-1O5'%1S4<U#
M-1_5 E0+42U"M1C5$E1+42U#M9S2VA'5E&Y,Q*4;R?9L555>;B8++Z6'8G[?
MN4Q+S)P=3&A)QD[;/[>CR+W1X0(G#1U51S4#U4Q4LU#-1C4'U5Q4\U#-1[4
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M!LN9+&>QG,UR#LNY+.<]<<,3 @MMSV"YD.4BEHM9+F&YE.4RELLQ[B"PE+W
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M0K48U1)42U$M0[4<U0I4*U%-6M*\>ZUD!X18CHUQ87-<V" 7C>6PS*_7RNV
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MT8;;O<+>W]_8B-F#)BR7LES&<CG+%2Q7LIRT=8$SVBD\ L5Z<, +G/ "1[S
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M<@'+A2P7L5S,<@G+I2R7L5S.<@7+E2PG;07BC*X*3TFQ'MP$!*X" G<!@<N
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MRWDLY[-<P'(ART4L%[-<PG(IRV4LE[-<P7(ERTE;"3BCEL(35*P'-P&!JX#
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MU._5XGN?B&K^%71OKR0W9CF%Y526TUA.9SF#Y4R6LUC.9CF'Y5R6\UC.9[F
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M)8<%,H<=1K?Y(H4GRAB-\LT-\;G!LP#^^S.E[&TG2U N4YK^#U!+ P04
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MG-!"7M_T:OTD--JIV6+#N9I?8%[FD5:548WB2]"T:W -=) IR ULV&,Y8.L
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M2$Q/P.L+CCM4,="?8,I/;L-_ 5!+ P04    "  1B&A7OD14*ID9  !:Y0$
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M:A&JQ:B6H%I*:6)DM]4Z#7ZTFH:6ZU!-1S4#U4Q4LU#-1C4'U5Q4\U#-1[4
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M:A&JQ:B6H%I*:6),MRV\(=S"&Z(M/%334<U -1/5+%2S4<U!-1?5/%3S42U
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MXN94^24O[@[F+5JP0S4=U0Q4,U'-0C4;U1Q4<U'-0S7_E>_84/F99\6AHY8
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M<VAE970U-"YX;6RMEVMOVC 4AO^*E4U3*VW-/80.(J4$5*9UK;ALTJ9],&#
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MJH.\OJ%4/)^H =H-P-E_4$L#!!0    ( !&(:%?VJGK<H 0  ,$6   9
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M.;YGVY75'C&W(N;JB>75D$Q!;SUO@.$S86'$"7A@44A R?I"MD4@?V=_MM-
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M&KX\:E;,2XN%H,M\@OA$A:!)?KD@>$I89B"?SR@5KXLL0#6U[OX/4$L#!!0
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MOMYQ)KAE**?_2!IT756@*Z^ &(.OZ!K&:&3P098B\HR,\2\_V;[UN\Q:G;!
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M82WU W<\+/ #B8F\*VZXNG,;E&6:D5RD+ ><K$;.!%U,44\GE!$_4K(3!]=
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MW7&=M)&H/SZ.K!2A?RA"WUB$NPWA]"S76BFL=FI!\KTN]H%(/Q1 ?6E .I?
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M[S 2S0AH#,4KVT4;KG1/VFVNIR8($Z#/,\[5T3 )NCD<_ 902P,$%     @
M$8AH5Z+B:WE, @  D 4  !D   !X;"]W;W)K<VAE971S+W-H965T-C$N>&UL
MK51K;]HP%/TKEB=-K321!X]M+$3B516I% 1KMZ\FN2%6G3BS#:'_?K83,EH!
MVX=]27SM>\X]Q\F]0<G%BTP!%#ID+)<#G"I5]!U'1BED1+9X ;D^2;C(B-*A
MV#JR$$!B"\J8X[MNS\D(S7$8V+VE" .^4XSFL!1([K*,B-<1,%X.L(>/&RNZ
M3979<,*@(%M8@WHJED)'3L,2TPQR27F.!"0#//3ZXX[)MPG/%$IYLD;&R8;S
M%Q/,X@%VC2!@$"G#0/1K#V-@S!!I&;]J3MR4-,#3]9']SGK77C9$PIBS'S16
MZ0!_P2B&A.R86O'R'FH_7<,7<2;M$Y55;O<K1M%.*I[58*T@HWGU)H?Z'DX
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MI1A@,0>X2!6)D)PFDJ0@4?=,.%:EU^+X#9P/;54W1F:>H.8)K#QJ#J[!1*]
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MEW\</SSSUM3=(9\-_W::O0%02P$"% ,4    "  1B&A7!T%-8H$   "Q
M$               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    (
M !&(:%?F]^JL[0   "L"   1              "  :\   !D;V-0<F]P<R]C
M;W)E+GAM;%!+ 0(4 Q0    ( !&(:%>97)PC$ 8  )PG   3
M  "  <L!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ $8AH5SEI
M?(.K!   U1,  !@              ("!# @  'AL+W=O<FMS:&5E=',O<VAE
M970Q+GAM;%!+ 0(4 Q0    ( !&(:%?\RS2V%PH  /(Z   8
M  " @>T,  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4    "  1
MB&A7W<MS?[,"  """   &               @($Z%P  >&PO=V]R:W-H965T
M<R]S:&5E=#,N>&UL4$L! A0#%     @ $8AH5Z8RN6.<"@  :3L  !@
M         ("!(QH  'AL+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0
M   ( !&(:%?#NS.\)AL  #G, 0 8              " @?4D  !X;"]W;W)K
M<VAE971S+W-H965T-2YX;6Q02P$"% ,4    "  1B&A7FPRV<>T-  "A5P
M&               @(%10   >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L!
M A0#%     @ $8AH5^<9]0#=#0  @C8  !@              ("!=$X  'AL
M+W=O<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    ( !&(:%>;W]M(E 0
M /<.   8              " @8=<  !X;"]W;W)K<VAE971S+W-H965T."YX
M;6Q02P$"% ,4    "  1B&A72/$NW/PI  #_W@  &               @(%1
M80  >&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @ $8AH5]6<
M^^3E @  V@@  !D              ("!@XL  'AL+W=O<FMS:&5E=',O<VAE
M970Q,"YX;6Q02P$"% ,4    "  1B&A7B[O''.L$  "C$   &0
M    @(&?C@  >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    (
M !&(:%>!7',2* ,  '8(   9              " @<&3  !X;"]W;W)K<VAE
M971S+W-H965T,3(N>&UL4$L! A0#%     @ $8AH5Q8$&XCU P  [@H  !D
M             ("!()<  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"
M% ,4    "  1B&A7/IFO/20*  !3&P  &0              @(%,FP  >&PO
M=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    ( !&(:%>Y>YAM,0L
M (\K   9              " @:>E  !X;"]W;W)K<VAE971S+W-H965T,34N
M>&UL4$L! A0#%     @ $8AH5_Q1M+8/!   ^PL  !D              ("!
M#[$  'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"% ,4    "  1B&A7
M.X0@I$@0  #/20  &0              @(%5M0  >&PO=V]R:W-H965T<R]S
M:&5E=#$W+GAM;%!+ 0(4 Q0    ( !&(:%>-\J]J/ 4  " 1   9
M      " @=3%  !X;"]W;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#%
M  @ $8AH5SMX%UP<"   QQ@  !D              ("!1\L  'AL+W=O<FMS
M:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4    "  1B&A7(&<A@:T%  #A$0
M&0              @(&:TP  >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+
M 0(4 Q0    ( !&(:%<1F0;1/00  /L(   9              " @7[9  !X
M;"]W;W)K<VAE971S+W-H965T,C$N>&UL4$L! A0#%     @ $8AH5Y?;H]?Y
M P  X@H  !D              ("!\MT  'AL+W=O<FMS:&5E=',O<VAE970R
M,BYX;6Q02P$"% ,4    "  1B&A7V4L( VL&  "$$   &0
M@($BX@  >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( !&(
M:%?P#F;>K (  -0%   9              " @<3H  !X;"]W;W)K<VAE971S
M+W-H965T,C0N>&UL4$L! A0#%     @ $8AH5S:74ZUH+   I?   !D
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M=#(Y+GAM;%!+ 0(4 Q0    ( !&(:%>F2];XFP(  (,%   9
M  " @2DM 0!X;"]W;W)K<VAE971S+W-H965T,S N>&UL4$L! A0#%     @
M$8AH5_?]G!5# P  T@8  !D              ("!^R\! 'AL+W=O<FMS:&5E
M=',O<VAE970S,2YX;6Q02P$"% ,4    "  1B&A7!DN/$+X$  !8#0  &0
M            @(%U,P$ >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4
M Q0    ( !&(:%<KKF4^30L  !VQ   9              " @6HX 0!X;"]W
M;W)K<VAE971S+W-H965T,S,N>&UL4$L! A0#%     @ $8AH5Z:A6]OR P
M5Q4  !D              ("![D,! 'AL+W=O<FMS:&5E=',O<VAE970S-"YX
M;6Q02P$"% ,4    "  1B&A74ZV?\0H#   ("0  &0              @($7
M2 $ >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4 Q0    ( !&(:%?@
M!D$@W 4  ' L   9              " @5A+ 0!X;"]W;W)K<VAE971S+W-H
M965T,S8N>&UL4$L! A0#%     @ $8AH5V\,89R<!0  4RH  !D
M     ("!:U$! 'AL+W=O<FMS:&5E=',O<VAE970S-RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( !&(:%=!=8@SH0,  &(2   9              "
M@;EL 0!X;"]W;W)K<VAE971S+W-H965T-#(N>&UL4$L! A0#%     @ $8AH
M5T+J@?7Z @  "0D  !D              ("!D7 ! 'AL+W=O<FMS:&5E=',O
M<VAE970T,RYX;6Q02P$"% ,4    "  1B&A7$H9SO%L%   Q)P  &0
M        @('"<P$ >&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0
M   ( !&(:%>FK64T2@P  &&/   9              " @51Y 0!X;"]W;W)K
M<VAE971S+W-H965T-#4N>&UL4$L! A0#%     @ $8AH5Q8)+EF,)@  KQP#
M !D              ("!U84! 'AL+W=O<FMS:&5E=',O<VAE970T-BYX;6Q0
M2P$"% ,4    "  1B&A7&S%/RN #  "3$@  &0              @(&8K $
M>&PO=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+ 0(4 Q0    ( !&(:%<'^'"R
M %0  $99!P 9              " @:^P 0!X;"]W;W)K<VAE971S+W-H965T
M-#@N>&UL4$L! A0#%     @ $8AH5S B.)C[!0  LC0  !D
M ("!Y@0" 'AL+W=O<FMS:&5E=',O<VAE970T.2YX;6Q02P$"% ,4    "  1
MB&A7V=^1T]0%  #5'0  &0              @($8"P( >&PO=V]R:W-H965T
M<R]S:&5E=#4P+GAM;%!+ 0(4 Q0    ( !&(:%?"Q]MTOP0  'X3   9
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M970U-2YX;6Q02P$"% ,4    "  1B&A7]JIZW* $  #!%@  &0
M    @('Q.0( >&PO=V]R:W-H965T<R]S:&5E=#4V+GAM;%!+ 0(4 Q0    (
M !&(:%? EUWS?00  -@:   9              " @<@^ @!X;"]W;W)K<VAE
M971S+W-H965T-3<N>&UL4$L! A0#%     @ $8AH5Z'_$<[! P  ^@X  !D
M             ("!?$," 'AL+W=O<FMS:&5E=',O<VAE970U."YX;6Q02P$"
M% ,4    "  1B&A7F90'2"D&   @*   &0              @(%T1P( >&PO
M=V]R:W-H965T<R]S:&5E=#4Y+GAM;%!+ 0(4 Q0    ( !&(:%<X4T 030(
M ),%   9              " @=1- @!X;"]W;W)K<VAE971S+W-H965T-C N
M>&UL4$L! A0#%     @ $8AH5Z+B:WE, @  D 4  !D              ("!
M6% " 'AL+W=O<FMS:&5E=',O<VAE970V,2YX;6Q02P$"% ,4    "  1B&A7
MRS?#/HH"  #V!@  &0              @(';4@( >&PO=V]R:W-H965T<R]S
M:&5E=#8R+GAM;%!+ 0(4 Q0    ( !&(:%?6P=NY@@0  #X4   9
M      " @9Q5 @!X;"]W;W)K<VAE971S+W-H965T-C,N>&UL4$L! A0#%
M  @ $8AH5_\UC7YL P  O1<   T              ( !55H" 'AL+W-T>6QE
M<RYX;6Q02P$"% ,4    "  1B&A7EXJ[',     3 @  "P
M@ 'L70( 7W)E;',O+G)E;'-02P$"% ,4    "  1B&A7>NK:(U@%  #6*0
M#P              @ '57@( >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @
M$8AH5R=EU:4, @  A"4  !H              ( !6F0" 'AL+U]R96QS+W=O
M<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ $8AH5^[5[1CF 0  ]20  !,
M             ( !GF8" %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     $<
,1P!H$P  M6@"

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>392</ContextCount>
  <ElementCount>410</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>113</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://connexasports.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://connexasports.com/role/BalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://connexasports.com/role/BalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - Consolidated Statements of Operations (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://connexasports.com/role/StatementsOfOperations</Role>
      <ShortName>Consolidated Statements of Operations (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - Consolidated Statement of Changes in Shareholders' Equity (Deficit) (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://connexasports.com/role/StatementOfChangesInShareholdersEquityDeficit</Role>
      <ShortName>Consolidated Statement of Changes in Shareholders' Equity (Deficit) (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - Consolidated Statements of Cash Flows (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://connexasports.com/role/StatementsOfCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Disclosure - ORGANIZATION AND NATURE OF BUSINESS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://connexasports.com/role/OrganizationAndNatureOfBusiness</Role>
      <ShortName>ORGANIZATION AND NATURE OF BUSINESS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - GOING CONCERN</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://connexasports.com/role/GoingConcern</Role>
      <ShortName>GOING CONCERN</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://connexasports.com/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - CONCENTRATION OF CREDIT RISK AND OTHER RISKS AND UNCERTAINTIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://connexasports.com/role/ConcentrationOfCreditRiskAndOtherRisksAndUncertainties</Role>
      <ShortName>CONCENTRATION OF CREDIT RISK AND OTHER RISKS AND UNCERTAINTIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - INTANGIBLE ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://connexasports.com/role/IntangibleAssets</Role>
      <ShortName>INTANGIBLE ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - ACCRUED EXPENSES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://connexasports.com/role/AccruedExpenses</Role>
      <ShortName>ACCRUED EXPENSES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - NOTE PAYABLE ??? RELATED PARTY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://connexasports.com/role/NotePayableRelatedParty</Role>
      <ShortName>NOTE PAYABLE ??? RELATED PARTY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - CONVERTIBLE NOTES PAYABLE</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://connexasports.com/role/ConvertibleNotesPayable</Role>
      <ShortName>CONVERTIBLE NOTES PAYABLE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - NOTES PAYABLE</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://connexasports.com/role/NotesPayable</Role>
      <ShortName>NOTES PAYABLE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - RELATED PARTY TRANSACTIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://connexasports.com/role/RelatedPartyTransactions</Role>
      <ShortName>RELATED PARTY TRANSACTIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - SHAREHOLDERS??? EQUITY (DEFICIT)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://connexasports.com/role/ShareholdersEquityDeficit</Role>
      <ShortName>SHAREHOLDERS??? EQUITY (DEFICIT)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://connexasports.com/role/CommitmentsAndContingencies</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - DISCONTINUED OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://connexasports.com/role/DiscontinuedOperations</Role>
      <ShortName>DISCONTINUED OPERATIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://connexasports.com/role/SubsequentEvents</Role>
      <ShortName>SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - ACQUISITIONS AND BUSINESS COMBINATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://connexasports.com/role/AcquisitionsAndBusinessCombinations</Role>
      <ShortName>ACQUISITIONS AND BUSINESS COMBINATIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - NOTE PAYABLE - RELATED PARTY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://connexasports.com/role/NotePayable-RelatedParty</Role>
      <ShortName>NOTE PAYABLE - RELATED PARTY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://connexasports.com/role/IncomeTaxes</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - SEGMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://connexasports.com/role/Segments</Role>
      <ShortName>SEGMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://connexasports.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://connexasports.com/role/IntangibleAssetsTables</Role>
      <ShortName>INTANGIBLE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://connexasports.com/role/IntangibleAssets</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - ACCRUED EXPENSES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://connexasports.com/role/AccruedExpensesTables</Role>
      <ShortName>ACCRUED EXPENSES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://connexasports.com/role/AccruedExpenses</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - DISCONTINUED OPERATIONS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://connexasports.com/role/DiscontinuedOperationsTables</Role>
      <ShortName>DISCONTINUED OPERATIONS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://connexasports.com/role/DiscontinuedOperations</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - ACQUISITIONS AND BUSINESS COMBINATIONS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://connexasports.com/role/AcquisitionsAndBusinessCombinationsTables</Role>
      <ShortName>ACQUISITIONS AND BUSINESS COMBINATIONS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://connexasports.com/role/AcquisitionsAndBusinessCombinations</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - NOTE PAYABLE - RELATED PARTY (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://connexasports.com/role/NotePayable-RelatedPartyTables</Role>
      <ShortName>NOTE PAYABLE - RELATED PARTY (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://connexasports.com/role/NotePayable-RelatedParty</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - INCOME TAXES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://connexasports.com/role/IncomeTaxesTables</Role>
      <ShortName>INCOME TAXES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://connexasports.com/role/IncomeTaxes</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - ORGANIZATION AND NATURE OF BUSINESS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://connexasports.com/role/OrganizationAndNatureOfBusinessDetailsNarrative</Role>
      <ShortName>ORGANIZATION AND NATURE OF BUSINESS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://connexasports.com/role/OrganizationAndNatureOfBusiness</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - GOING CONCERN (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://connexasports.com/role/GoingConcernDetailsNarrative</Role>
      <ShortName>GOING CONCERN (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://connexasports.com/role/GoingConcern</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - SCHEDULE OF INVENTORY (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://connexasports.com/role/ScheduleOfInventoryDetails</Role>
      <ShortName>SCHEDULE OF INVENTORY (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000036 - Disclosure - SCHEDULE OF DERIVATIVE LIABILITIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://connexasports.com/role/ScheduleOfDerivativeLiabilitiesDetails</Role>
      <ShortName>SCHEDULE OF DERIVATIVE LIABILITIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - SCHEDULE OF DERIVATIVE AND WARRANTS GRANTED VALUATION USING BLACK-SCHOLES PRICING METHOD (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://connexasports.com/role/ScheduleOfDerivativeAndWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails</Role>
      <ShortName>SCHEDULE OF DERIVATIVE AND WARRANTS GRANTED VALUATION USING BLACK-SCHOLES PRICING METHOD (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>00000038 - Disclosure - SCHEDULE OF WARRANTS GRANTED VALUATION USING BLACK-SCHOLES PRICING METHOD (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://connexasports.com/role/ScheduleOfWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails</Role>
      <ShortName>SCHEDULE OF WARRANTS GRANTED VALUATION USING BLACK-SCHOLES PRICING METHOD (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>00000039 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>00000040 - Disclosure - CONCENTRATION OF CREDIT RISK AND OTHER RISKS AND UNCERTAINTIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://connexasports.com/role/ConcentrationOfCreditRiskAndOtherRisksAndUncertaintiesDetailsNarrative</Role>
      <ShortName>CONCENTRATION OF CREDIT RISK AND OTHER RISKS AND UNCERTAINTIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://connexasports.com/role/ConcentrationOfCreditRiskAndOtherRisksAndUncertainties</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>00000041 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://connexasports.com/role/ScheduleOfIntangibleAssetsDetails</Role>
      <ShortName>SCHEDULE OF INTANGIBLE ASSETS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>00000042 - Disclosure - INTANGIBLE ASSETS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://connexasports.com/role/IntangibleAssetsDetailsNarrative</Role>
      <ShortName>INTANGIBLE ASSETS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://connexasports.com/role/IntangibleAssetsTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>00000043 - Disclosure - SCHEDULE OF ACCRUED EXPENSES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://connexasports.com/role/ScheduleOfAccruedExpensesDetails</Role>
      <ShortName>SCHEDULE OF ACCRUED EXPENSES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>00000044 - Disclosure - NOTE PAYABLE ??? RELATED PARTY (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://connexasports.com/role/NotePayableRelatedPartyDetailsNarrative</Role>
      <ShortName>NOTE PAYABLE ??? RELATED PARTY (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://connexasports.com/role/NotePayableRelatedParty</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>00000045 - Disclosure - CONVERTIBLE NOTES PAYABLE (Details Narrative)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://connexasports.com/role/ConvertibleNotesPayableDetailsNarrative</Role>
      <ShortName>CONVERTIBLE NOTES PAYABLE (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://connexasports.com/role/ConvertibleNotesPayable</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>00000046 - Disclosure - NOTES PAYABLE (Details Narrative)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://connexasports.com/role/NotesPayableDetailsNarrative</Role>
      <ShortName>NOTES PAYABLE (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://connexasports.com/role/NotesPayable</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>00000047 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://connexasports.com/role/RelatedPartyTransactionsDetailsNarrative</Role>
      <ShortName>RELATED PARTY TRANSACTIONS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://connexasports.com/role/RelatedPartyTransactions</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>00000048 - Disclosure - SHAREHOLDERS??? EQUITY (DEFICIT) (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative</Role>
      <ShortName>SHAREHOLDERS??? EQUITY (DEFICIT) (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://connexasports.com/role/ShareholdersEquityDeficit</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>00000049 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://connexasports.com/role/CommitmentsAndContingenciesDetailsNarrative</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://connexasports.com/role/CommitmentsAndContingencies</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>00000050 - Disclosure - SCHEDULE OF DISCONTINUED OPERATIONS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://connexasports.com/role/ScheduleOfDiscontinuedOperationsDetails</Role>
      <ShortName>SCHEDULE OF DISCONTINUED OPERATIONS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>00000051 - Disclosure - DISCONTINUED OPERATIONS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://connexasports.com/role/DiscontinuedOperationsDetailsNarrative</Role>
      <ShortName>DISCONTINUED OPERATIONS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://connexasports.com/role/DiscontinuedOperationsTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>00000052 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://connexasports.com/role/SubsequentEventsDetailsNarrative</Role>
      <ShortName>SUBSEQUENT EVENTS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://connexasports.com/role/SubsequentEvents</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>00000053 - Disclosure - SCHEDULE OF PROFORMA FINANCIAL INFORMATION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://connexasports.com/role/ScheduleOfProformaFinancialInformationDetails</Role>
      <ShortName>SCHEDULE OF PROFORMA FINANCIAL INFORMATION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>00000054 - Disclosure - SCHEDULE OF ESTIMATED FUTURE AMORTIZATION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://connexasports.com/role/ScheduleOfEstimatedFutureAmortizationDetails</Role>
      <ShortName>SCHEDULE OF ESTIMATED FUTURE AMORTIZATION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>00000055 - Disclosure - ACQUISITIONS AND BUSINESS COMBINATIONS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://connexasports.com/role/AcquisitionsAndBusinessCombinationsDetailsNarrative</Role>
      <ShortName>ACQUISITIONS AND BUSINESS COMBINATIONS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://connexasports.com/role/AcquisitionsAndBusinessCombinationsTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>00000056 - Disclosure - SCHEDULE OF WARRANTS ISSUED, EXERCISED AND EXPIRED (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://connexasports.com/role/ScheduleOfWarrantsIssuedExercisedAndExpiredDetails</Role>
      <ShortName>SCHEDULE OF WARRANTS ISSUED, EXERCISED AND EXPIRED (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>00000057 - Disclosure - NOTE PAYABLE - RELATED PARTY (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://connexasports.com/role/NotePayable-RelatedPartyDetailsNarrative</Role>
      <ShortName>NOTE PAYABLE - RELATED PARTY (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://connexasports.com/role/NotePayable-RelatedPartyTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>00000058 - Disclosure - SCHEDULE OF NET DEFERRED TAX ASSETS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://connexasports.com/role/ScheduleOfNetDeferredTaxAssetsDetails</Role>
      <ShortName>SCHEDULE OF NET DEFERRED TAX ASSETS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>00000059 - Disclosure - SCHEDULE OF INCOME TAX PROVISION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://connexasports.com/role/ScheduleOfIncomeTaxProvisionDetails</Role>
      <ShortName>SCHEDULE OF INCOME TAX PROVISION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>00000060 - Disclosure - SCHEDULE OF NET DEFERRED TAX ASSETS (Details) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://connexasports.com/role/ScheduleOfNetDeferredTaxAssetsDetailsParenthetical</Role>
      <ShortName>SCHEDULE OF NET DEFERRED TAX ASSETS (Details) (Parenthetical)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>00000061 - Disclosure - SCHEDULE OF INCOME TAX PROVISION (Details) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://connexasports.com/role/ScheduleOfIncomeTaxProvisionDetailsParenthetical</Role>
      <ShortName>SCHEDULE OF INCOME TAX PROVISION (Details) (Parenthetical)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>00000062 - Disclosure - INCOME TAXES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://connexasports.com/role/IncomeTaxesDetailsNarrative</Role>
      <ShortName>INCOME TAXES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://connexasports.com/role/IncomeTaxesTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="froms-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>00000063 - Disclosure - SCHEDULE OF CALCULATION OF THE LOSS ON DISPOSAL (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://connexasports.com/role/ScheduleOfCalculationOfLossOnDisposalDetails</Role>
      <ShortName>SCHEDULE OF CALCULATION OF THE LOSS ON DISPOSAL (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>cnxa-20230731.xsd</File>
    <File>cnxa-20230731_cal.xml</File>
    <File>cnxa-20230731_def.xml</File>
    <File>cnxa-20230731_lab.xml</File>
    <File>cnxa-20230731_pre.xml</File>
    <File doctype="S-1" isDefinitelyFs="true" isUsgaap="true" original="froms-1.htm">froms-1.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>forms-1_001.jpg</File>
    <File>forms-1_002.jpg</File>
    <File>forms-1_003.jpg</File>
    <File>forms-1_004.jpg</File>
    <File>forms-1_005.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1399">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>88
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "froms-1.htm": {
   "nsprefix": "CNXA",
   "nsuri": "http://connexasports.com/20230731",
   "dts": {
    "schema": {
     "local": [
      "cnxa-20230731.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "cnxa-20230731_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "cnxa-20230731_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "cnxa-20230731_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cnxa-20230731_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "froms-1.htm"
     ]
    }
   },
   "keyStandard": 325,
   "keyCustom": 85,
   "axisStandard": 30,
   "axisCustom": 0,
   "memberStandard": 31,
   "memberCustom": 71,
   "hidden": {
    "total": 238,
    "http://connexasports.com/20230731": 46,
    "http://fasb.org/us-gaap/2023": 190,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 392,
   "entityCount": 1,
   "segmentCount": 113,
   "elementCount": 687,
   "unitCount": 5,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2023": 1399,
    "http://xbrl.sec.gov/dei/2023": 24
   },
   "report": {
    "R1": {
     "role": "http://connexasports.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2023-07-31",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2023-07-31",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://connexasports.com/role/BalanceSheets",
     "longName": "00000002 - Statement - Consolidated Balance Sheets",
     "shortName": "Consolidated Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "AsOf2023-07-31",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-07-31",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://connexasports.com/role/BalanceSheetsParenthetical",
     "longName": "00000003 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "AsOf2023-07-31",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R4": {
     "role": "http://connexasports.com/role/StatementsOfOperations",
     "longName": "00000004 - Statement - Consolidated Statements of Operations (Unaudited)",
     "shortName": "Consolidated Statements of Operations (Unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2023-07-31",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2023-07-31",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R5": {
     "role": "http://connexasports.com/role/StatementOfChangesInShareholdersEquityDeficit",
     "longName": "00000005 - Statement - Consolidated Statement of Changes in Shareholders' Equity (Deficit) (Unaudited)",
     "shortName": "Consolidated Statement of Changes in Shareholders' Equity (Deficit) (Unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "AsOf2021-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2021-04-30_us-gaap_CommonStockMember_srt_ScenarioPreviouslyReportedMember",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R6": {
     "role": "http://connexasports.com/role/StatementsOfCashFlows",
     "longName": "00000006 - Statement - Consolidated Statements of Cash Flows (Unaudited)",
     "shortName": "Consolidated Statements of Cash Flows (Unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2023-07-31",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2023-07-31",
      "name": "us-gaap:DepreciationAndAmortization",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://connexasports.com/role/OrganizationAndNatureOfBusiness",
     "longName": "00000007 - Disclosure - ORGANIZATION AND NATURE OF BUSINESS",
     "shortName": "ORGANIZATION AND NATURE OF BUSINESS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "7",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2023-07-31",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2023-07-31",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://connexasports.com/role/GoingConcern",
     "longName": "00000008 - Disclosure - GOING CONCERN",
     "shortName": "GOING CONCERN",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2023-07-31",
      "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2023-07-31",
      "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://connexasports.com/role/SummaryOfSignificantAccountingPolicies",
     "longName": "00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2023-07-31",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2023-07-31",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://connexasports.com/role/ConcentrationOfCreditRiskAndOtherRisksAndUncertainties",
     "longName": "00000010 - Disclosure - CONCENTRATION OF CREDIT RISK AND OTHER RISKS AND UNCERTAINTIES",
     "shortName": "CONCENTRATION OF CREDIT RISK AND OTHER RISKS AND UNCERTAINTIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2023-07-31",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2023-07-31",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://connexasports.com/role/IntangibleAssets",
     "longName": "00000011 - Disclosure - INTANGIBLE ASSETS",
     "shortName": "INTANGIBLE ASSETS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2023-07-31",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2023-07-31",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://connexasports.com/role/AccruedExpenses",
     "longName": "00000012 - Disclosure - ACCRUED EXPENSES",
     "shortName": "ACCRUED EXPENSES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2023-07-31",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2023-07-31",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://connexasports.com/role/NotePayableRelatedParty",
     "longName": "00000013 - Disclosure - NOTE PAYABLE \u2013 RELATED PARTY",
     "shortName": "NOTE PAYABLE \u2013 RELATED PARTY",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2023-07-31",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R14": {
     "role": "http://connexasports.com/role/ConvertibleNotesPayable",
     "longName": "00000014 - Disclosure - CONVERTIBLE NOTES PAYABLE",
     "shortName": "CONVERTIBLE NOTES PAYABLE",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2023-07-31",
      "name": "us-gaap:ShortTermDebtTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2023-07-31",
      "name": "us-gaap:ShortTermDebtTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://connexasports.com/role/NotesPayable",
     "longName": "00000015 - Disclosure - NOTES PAYABLE",
     "shortName": "NOTES PAYABLE",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2023-07-31",
      "name": "us-gaap:LongTermDebtTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2023-07-31",
      "name": "us-gaap:LongTermDebtTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://connexasports.com/role/RelatedPartyTransactions",
     "longName": "00000016 - Disclosure - RELATED PARTY TRANSACTIONS",
     "shortName": "RELATED PARTY TRANSACTIONS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2023-07-31",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2023-07-31",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://connexasports.com/role/ShareholdersEquityDeficit",
     "longName": "00000017 - Disclosure - SHAREHOLDERS\u2019 EQUITY (DEFICIT)",
     "shortName": "SHAREHOLDERS\u2019 EQUITY (DEFICIT)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2023-07-31",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2023-07-31",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://connexasports.com/role/CommitmentsAndContingencies",
     "longName": "00000018 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2023-07-31",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2023-07-31",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://connexasports.com/role/DiscontinuedOperations",
     "longName": "00000019 - Disclosure - DISCONTINUED OPERATIONS",
     "shortName": "DISCONTINUED OPERATIONS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2023-07-31",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2023-07-31",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://connexasports.com/role/SubsequentEvents",
     "longName": "00000020 - Disclosure - SUBSEQUENT EVENTS",
     "shortName": "SUBSEQUENT EVENTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2023-07-31",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2023-07-31",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://connexasports.com/role/AcquisitionsAndBusinessCombinations",
     "longName": "00000021 - Disclosure - ACQUISITIONS AND BUSINESS COMBINATIONS",
     "shortName": "ACQUISITIONS AND BUSINESS COMBINATIONS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "From2022-05-012023-04-30",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-05-012023-04-30",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://connexasports.com/role/NotePayable-RelatedParty",
     "longName": "00000022 - Disclosure - NOTE PAYABLE - RELATED PARTY",
     "shortName": "NOTE PAYABLE - RELATED PARTY",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2023-07-31",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R23": {
     "role": "http://connexasports.com/role/IncomeTaxes",
     "longName": "00000023 - Disclosure - INCOME TAXES",
     "shortName": "INCOME TAXES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "From2022-05-012023-04-30",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-05-012023-04-30",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://connexasports.com/role/Segments",
     "longName": "00000024 - Disclosure - SEGMENTS",
     "shortName": "SEGMENTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "From2022-05-012023-04-30",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-05-012023-04-30",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
     "longName": "00000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "25",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2023-07-31",
      "name": "CNXA:InterimFinancialStatementsPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2023-07-31",
      "name": "CNXA:InterimFinancialStatementsPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesTables",
     "longName": "00000026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "26",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2023-07-31",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:InventoryPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2023-07-31",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:InventoryPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://connexasports.com/role/IntangibleAssetsTables",
     "longName": "00000027 - Disclosure - INTANGIBLE ASSETS (Tables)",
     "shortName": "INTANGIBLE ASSETS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "27",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2023-07-31",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2023-07-31",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://connexasports.com/role/AccruedExpensesTables",
     "longName": "00000028 - Disclosure - ACCRUED EXPENSES (Tables)",
     "shortName": "ACCRUED EXPENSES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "28",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2023-07-31",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2023-07-31",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://connexasports.com/role/DiscontinuedOperationsTables",
     "longName": "00000029 - Disclosure - DISCONTINUED OPERATIONS (Tables)",
     "shortName": "DISCONTINUED OPERATIONS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2023-07-31",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2023-07-31",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://connexasports.com/role/AcquisitionsAndBusinessCombinationsTables",
     "longName": "00000030 - Disclosure - ACQUISITIONS AND BUSINESS COMBINATIONS (Tables)",
     "shortName": "ACQUISITIONS AND BUSINESS COMBINATIONS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "From2022-05-012023-04-30",
      "name": "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-05-012023-04-30",
      "name": "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://connexasports.com/role/NotePayable-RelatedPartyTables",
     "longName": "00000031 - Disclosure - NOTE PAYABLE - RELATED PARTY (Tables)",
     "shortName": "NOTE PAYABLE - RELATED PARTY (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "From2022-05-012023-04-30",
      "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-05-012023-04-30",
      "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://connexasports.com/role/IncomeTaxesTables",
     "longName": "00000032 - Disclosure - INCOME TAXES (Tables)",
     "shortName": "INCOME TAXES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "From2022-05-012023-04-30",
      "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-05-012023-04-30",
      "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://connexasports.com/role/OrganizationAndNatureOfBusinessDetailsNarrative",
     "longName": "00000033 - Disclosure - ORGANIZATION AND NATURE OF BUSINESS (Details Narrative)",
     "shortName": "ORGANIZATION AND NATURE OF BUSINESS (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "33",
     "firstAnchor": {
      "contextRef": "From2022-06-142022-06-14",
      "name": "us-gaap:StockholdersEquityReverseStockSplit",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-06-142022-06-14",
      "name": "us-gaap:StockholdersEquityReverseStockSplit",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://connexasports.com/role/GoingConcernDetailsNarrative",
     "longName": "00000034 - Disclosure - GOING CONCERN (Details Narrative)",
     "shortName": "GOING CONCERN (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "34",
     "firstAnchor": {
      "contextRef": "AsOf2023-07-31",
      "name": "us-gaap:RetainedEarningsAccumulatedDeficit",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-12-31_custom_PlaySightMember_custom_FoundationSportsSystemsLLCMember",
      "name": "CNXA:DisposalEquityInterestOwnershipInterestPercentage",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "CNXA:DisposalEquityInterestOwnershipInterestPercentage",
       "span",
       "span",
       "span",
       "p",
       "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "unique": true
     }
    },
    "R35": {
     "role": "http://connexasports.com/role/ScheduleOfInventoryDetails",
     "longName": "00000035 - Disclosure - SCHEDULE OF INVENTORY (Details)",
     "shortName": "SCHEDULE OF INVENTORY (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "35",
     "firstAnchor": {
      "contextRef": "AsOf2023-07-31",
      "name": "us-gaap:InventoryFinishedGoods",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-07-31",
      "name": "us-gaap:InventoryFinishedGoods",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://connexasports.com/role/ScheduleOfDerivativeLiabilitiesDetails",
     "longName": "00000036 - Disclosure - SCHEDULE OF DERIVATIVE LIABILITIES (Details)",
     "shortName": "SCHEDULE OF DERIVATIVE LIABILITIES (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "36",
     "firstAnchor": {
      "contextRef": "AsOf2023-07-31",
      "name": "us-gaap:DerivativeInstrumentsAndHedgesLiabilities",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock",
       "us-gaap:FairValueOfFinancialInstrumentsPolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-07-31",
      "name": "us-gaap:DerivativeInstrumentsAndHedgesLiabilities",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock",
       "us-gaap:FairValueOfFinancialInstrumentsPolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://connexasports.com/role/ScheduleOfDerivativeAndWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails",
     "longName": "00000037 - Disclosure - SCHEDULE OF DERIVATIVE AND WARRANTS GRANTED VALUATION USING BLACK-SCHOLES PRICING METHOD (Details)",
     "shortName": "SCHEDULE OF DERIVATIVE AND WARRANTS GRANTED VALUATION USING BLACK-SCHOLES PRICING METHOD (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "AsOf2023-07-31_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ValuationTechniqueOptionPricingModelMember",
      "name": "us-gaap:DerivativeLiabilityMeasurementInput",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "us-gaap:FairValueOfFinancialInstrumentsPolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-07-31_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_ValuationTechniqueOptionPricingModelMember",
      "name": "us-gaap:DerivativeLiabilityMeasurementInput",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "us-gaap:FairValueOfFinancialInstrumentsPolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://connexasports.com/role/ScheduleOfWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails",
     "longName": "00000038 - Disclosure - SCHEDULE OF WARRANTS GRANTED VALUATION USING BLACK-SCHOLES PRICING METHOD (Details)",
     "shortName": "SCHEDULE OF WARRANTS GRANTED VALUATION USING BLACK-SCHOLES PRICING METHOD (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "AsOf2023-04-30_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputExpectedTermMember_srt_MinimumMember",
      "name": "us-gaap:WarrantsAndRightsOutstandingTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "CNXA:WarrantsPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-04-30_us-gaap_WarrantMember_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputExpectedTermMember_srt_MinimumMember",
      "name": "us-gaap:WarrantsAndRightsOutstandingTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "CNXA:WarrantsPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
     "longName": "00000039 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "AsOf2023-07-31",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:TradeAndOtherAccountsReceivablePolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-07-31",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:TradeAndOtherAccountsReceivablePolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://connexasports.com/role/ConcentrationOfCreditRiskAndOtherRisksAndUncertaintiesDetailsNarrative",
     "longName": "00000040 - Disclosure - CONCENTRATION OF CREDIT RISK AND OTHER RISKS AND UNCERTAINTIES (Details Narrative)",
     "shortName": "CONCENTRATION OF CREDIT RISK AND OTHER RISKS AND UNCERTAINTIES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "From2023-05-012023-07-31_us-gaap_AccountsReceivableMember_us-gaap_CreditConcentrationRiskMember_custom_CustomerTwoMember",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:ConcentrationRiskDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-012023-07-31_us-gaap_AccountsReceivableMember_us-gaap_CreditConcentrationRiskMember_custom_CustomerTwoMember",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:ConcentrationRiskDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://connexasports.com/role/ScheduleOfIntangibleAssetsDetails",
     "longName": "00000041 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS (Details)",
     "shortName": "SCHEDULE OF INTANGIBLE ASSETS (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2023-07-31",
      "name": "us-gaap:ImpairmentOfIntangibleAssetsFinitelived",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-07-31_custom_TradeNamesAndPatentsMember",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "unique": true
     }
    },
    "R42": {
     "role": "http://connexasports.com/role/IntangibleAssetsDetailsNarrative",
     "longName": "00000042 - Disclosure - INTANGIBLE ASSETS (Details Narrative)",
     "shortName": "INTANGIBLE ASSETS (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2023-07-31",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2023-07-31",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://connexasports.com/role/ScheduleOfAccruedExpensesDetails",
     "longName": "00000043 - Disclosure - SCHEDULE OF ACCRUED EXPENSES (Details)",
     "shortName": "SCHEDULE OF ACCRUED EXPENSES (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "AsOf2023-07-31",
      "name": "us-gaap:AccruedPayrollTaxesCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-07-31",
      "name": "us-gaap:AccruedPayrollTaxesCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://connexasports.com/role/NotePayableRelatedPartyDetailsNarrative",
     "longName": "00000044 - Disclosure - NOTE PAYABLE \u2013 RELATED PARTY (Details Narrative)",
     "shortName": "NOTE PAYABLE \u2013 RELATED PARTY (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "From2021-05-012022-04-30",
      "name": "us-gaap:ProceedsFromRelatedPartyDebt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-062023-01-06_us-gaap_RelatedPartyMember",
      "name": "CNXA:PaymentForExchangeOfNotesPayable",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "unique": true
     }
    },
    "R45": {
     "role": "http://connexasports.com/role/ConvertibleNotesPayableDetailsNarrative",
     "longName": "00000045 - Disclosure - CONVERTIBLE NOTES PAYABLE (Details Narrative)",
     "shortName": "CONVERTIBLE NOTES PAYABLE (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "From2022-06-172022-06-17",
      "name": "us-gaap:DebtConversionConvertedInstrumentSharesIssued1",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:ShortTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-06-172022-06-17",
      "name": "us-gaap:DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:ShortTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "unique": true
     }
    },
    "R46": {
     "role": "http://connexasports.com/role/NotesPayableDetailsNarrative",
     "longName": "00000046 - Disclosure - NOTES PAYABLE (Details Narrative)",
     "shortName": "NOTES PAYABLE (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "From2022-05-012022-05-01",
      "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2021-04-102021-04-11",
      "name": "us-gaap:GainsLossesOnExtinguishmentOfDebt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "unique": true
     }
    },
    "R47": {
     "role": "http://connexasports.com/role/RelatedPartyTransactionsDetailsNarrative",
     "longName": "00000047 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)",
     "shortName": "RELATED PARTY TRANSACTIONS (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "AsOf2022-06-17",
      "name": "us-gaap:InterestPayableCurrentAndNoncurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:ShortTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-07-31_us-gaap_RelatedPartyMember",
      "name": "us-gaap:InterestPayableCurrentAndNoncurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "unique": true
     }
    },
    "R48": {
     "role": "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative",
     "longName": "00000048 - Disclosure - SHAREHOLDERS\u2019 EQUITY (DEFICIT) (Details Narrative)",
     "shortName": "SHAREHOLDERS\u2019 EQUITY (DEFICIT) (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "AsOf2022-04-30",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "us-gaap:CommonStockSharesAuthorized",
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-262023-01-26",
      "name": "us-gaap:StockIssuedDuringPeriodSharesIssuedForServices",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "unique": true
     }
    },
    "R49": {
     "role": "http://connexasports.com/role/CommitmentsAndContingenciesDetailsNarrative",
     "longName": "00000049 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2023-07-31",
      "name": "us-gaap:PaymentsForRent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2023-07-31",
      "name": "us-gaap:PaymentsForRent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://connexasports.com/role/ScheduleOfDiscontinuedOperationsDetails",
     "longName": "00000050 - Disclosure - SCHEDULE OF DISCONTINUED OPERATIONS (Details)",
     "shortName": "SCHEDULE OF DISCONTINUED OPERATIONS (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "From2023-05-01to2023-07-31",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-05-01to2023-07-31",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://connexasports.com/role/DiscontinuedOperationsDetailsNarrative",
     "longName": "00000051 - Disclosure - DISCONTINUED OPERATIONS (Details Narrative)",
     "shortName": "DISCONTINUED OPERATIONS (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "AsOf2022-12-05",
      "name": "us-gaap:Cash",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-12-05",
      "name": "us-gaap:Cash",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://connexasports.com/role/SubsequentEventsDetailsNarrative",
     "longName": "00000052 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)",
     "shortName": "SUBSEQUENT EVENTS (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "From2022-05-012022-05-01",
      "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-10-022022-10-03_custom_PreFundedWarrantMember",
      "name": "us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "unique": true
     }
    },
    "R53": {
     "role": "http://connexasports.com/role/ScheduleOfProformaFinancialInformationDetails",
     "longName": "00000053 - Disclosure - SCHEDULE OF PROFORMA FINANCIAL INFORMATION (Details)",
     "shortName": "SCHEDULE OF PROFORMA FINANCIAL INFORMATION (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "From2022-05-012023-04-30_custom_PlaySightAndGameFaceMember",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-05-012023-04-30_custom_PlaySightAndGameFaceMember",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://connexasports.com/role/ScheduleOfEstimatedFutureAmortizationDetails",
     "longName": "00000054 - Disclosure - SCHEDULE OF ESTIMATED FUTURE AMORTIZATION (Details)",
     "shortName": "SCHEDULE OF ESTIMATED FUTURE AMORTIZATION (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "AsOf2023-04-30",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-04-30",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://connexasports.com/role/AcquisitionsAndBusinessCombinationsDetailsNarrative",
     "longName": "00000055 - Disclosure - ACQUISITIONS AND BUSINESS COMBINATIONS (Details Narrative)",
     "shortName": "ACQUISITIONS AND BUSINESS COMBINATIONS (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "AsOf2022-12-31_custom_FoundationSportsMember",
      "name": "CNXA:DisposalEquityInterestOwnershipInterestPercentage",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-12-31_custom_FoundationSportsMember",
      "name": "CNXA:DisposalEquityInterestOwnershipInterestPercentage",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R56": {
     "role": "http://connexasports.com/role/ScheduleOfWarrantsIssuedExercisedAndExpiredDetails",
     "longName": "00000056 - Disclosure - SCHEDULE OF WARRANTS ISSUED, EXERCISED AND EXPIRED (Details)",
     "shortName": "SCHEDULE OF WARRANTS ISSUED, EXERCISED AND EXPIRED (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "AsOf2023-04-30",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2021-04-30",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "unique": true
     }
    },
    "R57": {
     "role": "http://connexasports.com/role/NotePayable-RelatedPartyDetailsNarrative",
     "longName": "00000057 - Disclosure - NOTE PAYABLE - RELATED PARTY (Details Narrative)",
     "shortName": "NOTE PAYABLE - RELATED PARTY (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "From2021-05-012022-04-30",
      "name": "us-gaap:ProceedsFromRelatedPartyDebt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R58": {
     "role": "http://connexasports.com/role/ScheduleOfNetDeferredTaxAssetsDetails",
     "longName": "00000058 - Disclosure - SCHEDULE OF NET DEFERRED TAX ASSETS (Details)",
     "shortName": "SCHEDULE OF NET DEFERRED TAX ASSETS (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "AsOf2023-04-30",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-04-30",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R59": {
     "role": "http://connexasports.com/role/ScheduleOfIncomeTaxProvisionDetails",
     "longName": "00000059 - Disclosure - SCHEDULE OF INCOME TAX PROVISION (Details)",
     "shortName": "SCHEDULE OF INCOME TAX PROVISION (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "From2022-05-012023-04-30",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-05-012023-04-30",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R60": {
     "role": "http://connexasports.com/role/ScheduleOfNetDeferredTaxAssetsDetailsParenthetical",
     "longName": "00000060 - Disclosure - SCHEDULE OF NET DEFERRED TAX ASSETS (Details) (Parenthetical)",
     "shortName": "SCHEDULE OF NET DEFERRED TAX ASSETS (Details) (Parenthetical)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "parenthetical",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "From2022-05-012023-04-30_country_IL",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R61": {
     "role": "http://connexasports.com/role/ScheduleOfIncomeTaxProvisionDetailsParenthetical",
     "longName": "00000061 - Disclosure - SCHEDULE OF INCOME TAX PROVISION (Details) (Parenthetical)",
     "shortName": "SCHEDULE OF INCOME TAX PROVISION (Details) (Parenthetical)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "parenthetical",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "From2022-05-012023-04-30_country_IL",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R62": {
     "role": "http://connexasports.com/role/IncomeTaxesDetailsNarrative",
     "longName": "00000062 - Disclosure - INCOME TAXES (Details Narrative)",
     "shortName": "INCOME TAXES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "AsOf2023-04-30",
      "name": "us-gaap:OperatingLossCarryforwards",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-04-30",
      "name": "us-gaap:OperatingLossCarryforwards",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R63": {
     "role": "http://connexasports.com/role/ScheduleOfCalculationOfLossOnDisposalDetails",
     "longName": "00000063 - Disclosure - SCHEDULE OF CALCULATION OF THE LOSS ON DISPOSAL (Details)",
     "shortName": "SCHEDULE OF CALCULATION OF THE LOSS ON DISPOSAL (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "AsOf2022-04-30",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-04-30_custom_PlaySightAndFoundationSportsMember",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "CNXA:ScheduleOfCalculationOfTheLossOnDisposalTableTextBlock",
       "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "froms-1.htm",
      "unique": true
     }
    }
   },
   "tag": {
    "us-gaap_MeasurementInputTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputTypeAxis",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfDerivativeAndWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails",
      "http://connexasports.com/role/ScheduleOfWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input Type [Axis]",
        "documentation": "Information by type of measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r570"
     ]
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeContractTypeDomain",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfDerivativeLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset."
       }
      }
     },
     "auth_ref": [
      "r712",
      "r714",
      "r728",
      "r729",
      "r730",
      "r734",
      "r735",
      "r736",
      "r737",
      "r739",
      "r740",
      "r741",
      "r742",
      "r757",
      "r758",
      "r759",
      "r760",
      "r763",
      "r764",
      "r765",
      "r766",
      "r784",
      "r785",
      "r788",
      "r790",
      "r849",
      "r851"
     ]
    },
    "us-gaap_PaymentsToAcquireNotesReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireNotesReceivable",
     "crdr": "credit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Note receivable issuance",
        "label": "Payments to Acquire Notes Receivable",
        "documentation": "The cash outflow to acquire an agreement for an unconditional promise by the maker to pay the entity (holder) a definite sum of money at a future date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics."
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://connexasports.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile net loss to net cash used in operating activities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total adjustments",
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities",
        "documentation": "The sum of adjustments which are added to or deducted from net income or loss, including the portion attributable to noncontrolling interest, to reflect cash provided by or used in operating activities, in accordance with the indirect cash flow method."
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "calculation": {
      "http://connexasports.com/role/ScheduleOfNetDeferredTaxAssetsDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/ScheduleOfNetDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Valuation allowance",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r534"
     ]
    },
    "us-gaap_ProceedsFromConvertibleDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromConvertibleDebt",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/ConvertibleNotesPayableDetailsNarrative",
      "http://connexasports.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from convertible notes payable",
        "verboseLabel": "Gross proceeds from issuance of senior convertible notes",
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "presentation": [
      "http://connexasports.com/role/IntangibleAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "INTANGIBLE ASSETS",
        "documentation": "The entire disclosure for all or part of the information related to intangible assets."
       }
      }
     },
     "auth_ref": [
      "r387"
     ]
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfDerivativeAndWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails",
      "http://connexasports.com/role/ScheduleOfWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "us-gaap_DepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DepreciationAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation, amortization and impairment expense",
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r82"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average period amortization (in years)",
        "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r637"
     ]
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://connexasports.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Current Liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r232",
      "r267",
      "r363",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r553",
      "r554",
      "r555",
      "r574",
      "r846",
      "r940",
      "r961",
      "r962"
     ]
    },
    "us-gaap_PaymentsToAcquireReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireReceivables",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/NotesPayableDetailsNarrative",
      "http://connexasports.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payment for exchange received amount",
        "documentation": "The cash outflow for the purchase of all receivables."
       }
      }
     },
     "auth_ref": [
      "r169"
     ]
    },
    "srt_PlatformOperatorCryptoAssetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "PlatformOperatorCryptoAssetLineItems",
     "presentation": [
      "http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Platform Operator, Crypto-Asset [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementTable",
     "presentation": [
      "http://connexasports.com/role/BalanceSheets",
      "http://connexasports.com/role/IncomeTaxesDetailsNarrative",
      "http://connexasports.com/role/IncomeTaxesTables",
      "http://connexasports.com/role/ScheduleOfIncomeTaxProvisionDetailsParenthetical",
      "http://connexasports.com/role/ScheduleOfNetDeferredTaxAssetsDetails",
      "http://connexasports.com/role/ScheduleOfNetDeferredTaxAssetsDetailsParenthetical",
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative",
      "http://connexasports.com/role/StatementOfChangesInShareholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]",
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed."
       }
      }
     },
     "auth_ref": [
      "r272",
      "r273",
      "r274",
      "r297",
      "r636",
      "r693",
      "r704",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r723",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r734",
      "r735",
      "r736",
      "r737",
      "r739",
      "r740",
      "r741",
      "r742",
      "r743",
      "r745",
      "r747",
      "r748",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764",
      "r765",
      "r766",
      "r769",
      "r852"
     ]
    },
    "srt_PlatformOperatorCryptoAssetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "PlatformOperatorCryptoAssetTable",
     "presentation": [
      "http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Platform Operator, Crypto-Asset [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://connexasports.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://connexasports.com/role/ScheduleOfDiscontinuedOperationsDetails": {
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/ScheduleOfDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts payable and accrued expenses",
        "label": "Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities, Current",
        "documentation": "Amount classified as accounts payable and accrued liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r119",
      "r134",
      "r179",
      "r182"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative",
      "http://connexasports.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from issuance of common stock for cash",
        "verboseLabel": "Proceeds from Issuance of Common Stock",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfCalculationOfLossOnDisposalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts payable and accrued expenses",
        "label": "Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities",
        "documentation": "Amount classified as accounts payable and accrued liabilities attributable to disposal group held for sale or disposed of."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r119",
      "r134",
      "r182"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://connexasports.com/role/BalanceSheetsParenthetical",
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative",
      "http://connexasports.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, par value",
        "verboseLabel": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/ScheduleOfDiscontinuedOperationsDetails": {
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/ScheduleOfDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid expenses",
        "documentation": "Amount classified as prepaid and other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r119",
      "r134",
      "r179",
      "r182"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets",
     "crdr": "debit",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfCalculationOfLossOnDisposalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid expenses",
        "label": "Disposal Group, Including Discontinued Operation, Prepaid and Other Assets",
        "documentation": "Amount classified as prepaid and other assets attributable to disposal group held for sale or disposed of."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r119",
      "r134",
      "r182"
     ]
    },
    "us-gaap_SaleOfStockConsiderationReceivedPerTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SaleOfStockConsiderationReceivedPerTransaction",
     "crdr": "debit",
     "presentation": [
      "http://connexasports.com/role/NotesPayableDetailsNarrative",
      "http://connexasports.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of consideration received",
        "documentation": "Amount of consideration received by subsidiary or equity investee in exchange for shares of stock issued or sold. Includes amount of cash received, fair value of noncash assets received, and fair value of liabilities assumed by the investor."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and development costs",
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use."
       }
      }
     },
     "auth_ref": [
      "r116",
      "r525",
      "r969"
     ]
    },
    "us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable",
     "presentation": [
      "http://connexasports.com/role/ConvertibleNotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants rights date from which warrants exercisable",
        "documentation": "Date the warrants or rights are exercisable, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r451"
     ]
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentFaceAmount",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/ConvertibleNotesPayableDetailsNarrative",
      "http://connexasports.com/role/NotePayableRelatedPartyDetailsNarrative",
      "http://connexasports.com/role/NotesPayableDetailsNarrative",
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt instrumental",
        "verboseLabel": "Convertiable notes",
        "terseLabel": "Note payable",
        "documentation": "Face (par) amount of debt instrument at time of issuance."
       }
      }
     },
     "auth_ref": [
      "r108",
      "r110",
      "r410",
      "r585",
      "r828",
      "r829"
     ]
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeLiabilityMeasurementInput": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeLiabilityMeasurementInput",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfDerivativeAndWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative liability measurement input",
        "documentation": "Value of input used to measure derivative liability."
       }
      }
     },
     "auth_ref": [
      "r571"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsForeign",
     "crdr": "debit",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfNetDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Loss carryforwards",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Foreign",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r94",
      "r947"
     ]
    },
    "us-gaap_LenderConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LenderConcentrationRiskMember",
     "presentation": [
      "http://connexasports.com/role/ConcentrationOfCreditRiskAndOtherRisksAndUncertaintiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lender Concentration Risk [Member]",
        "documentation": "Reflects the percentage that borrowings or credit lines from one or more lenders is to a specified benchmark, such as total debt, segment debt. Risk is the materially adverse effects from loss of financing arrangements with a particular lender."
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "us-gaap_IncreaseDecreaseInDerivativeLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInDerivativeLiabilities",
     "crdr": "debit",
     "presentation": [
      "http://connexasports.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Derivative Liabilities",
        "documentation": "The increase (decrease) during the period in the carrying value of derivative instruments reported as liabilities that are due to be disposed of within one year (or the normal operating cycle, if longer)."
       }
      }
     },
     "auth_ref": [
      "r909"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock",
     "presentation": [
      "http://connexasports.com/role/IntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF INTANGIBLE ASSETS",
        "documentation": "Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherReceivables",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note receivable - former subsidiary",
        "documentation": "Amount due from parties in nontrade transactions, classified as other."
       }
      }
     },
     "auth_ref": [
      "r238",
      "r732"
     ]
    },
    "us-gaap_InventoryFinishedGoods": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryFinishedGoods",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/ScheduleOfInventoryDetails": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/ScheduleOfInventoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finished Goods",
        "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r900"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/ScheduleOfNetDeferredTaxAssetsDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/ScheduleOfNetDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss carryforwards",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r94",
      "r947"
     ]
    },
    "CNXA_NotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "NotesMember",
     "presentation": [
      "http://connexasports.com/role/NotesPayableDetailsNarrative",
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes [Member]",
        "documentation": "Notes [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight",
     "presentation": [
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right",
        "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares."
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_ArmisticeCapitalMasterFundLtdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "ArmisticeCapitalMasterFundLtdMember",
     "presentation": [
      "http://connexasports.com/role/NotesPayableDetailsNarrative",
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Armistice Capital Master Fund Ltd [Member]",
        "documentation": "Armistice Capital Master Fund Ltd [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/ScheduleOfNetDeferredTaxAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://connexasports.com/role/ScheduleOfNetDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net deferred tax assets",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r946"
     ]
    },
    "CNXA_MegedAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "MegedAgreementMember",
     "presentation": [
      "http://connexasports.com/role/NotesPayableDetailsNarrative",
      "http://connexasports.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Meged Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://connexasports.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/BalanceSheets",
      "http://connexasports.com/role/GoingConcernDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated deficit",
        "negatedLabel": "Accumulated deficit",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r149",
      "r189",
      "r662",
      "r683",
      "r688",
      "r697",
      "r724",
      "r846"
     ]
    },
    "us-gaap_AssetImpairmentCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetImpairmentCharges",
     "crdr": "debit",
     "presentation": [
      "http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment of fixed assets",
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r81"
     ]
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsOther",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/ScheduleOfNetDeferredTaxAssetsDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/ScheduleOfNetDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other."
       }
      }
     },
     "auth_ref": [
      "r94",
      "r947"
     ]
    },
    "CNXA_LoanAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "LoanAgreementMember",
     "presentation": [
      "http://connexasports.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loan Agreement [Member]",
        "documentation": "Loan Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantsAndRightsOutstandingMeasurementInput": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WarrantsAndRightsOutstandingMeasurementInput",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants measurement input, rate",
        "documentation": "Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur."
       }
      }
     },
     "auth_ref": [
      "r571"
     ]
    },
    "CNXA_MontsaicInvestmentsLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "MontsaicInvestmentsLLCMember",
     "presentation": [
      "http://connexasports.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Montsaic Investments, LLC [Member]",
        "documentation": "Montsaic Investments, LLC [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WarrantMember",
     "presentation": [
      "http://connexasports.com/role/NotesPayableDetailsNarrative",
      "http://connexasports.com/role/ScheduleOfWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails",
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative",
      "http://connexasports.com/role/SubsequentEventsDetailsNarrative",
      "http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant [Member]",
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount."
       }
      }
     },
     "auth_ref": [
      "r849",
      "r850",
      "r853",
      "r854",
      "r855",
      "r856"
     ]
    },
    "CNXA_ThirdPartyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "ThirdPartyMember",
     "presentation": [
      "http://connexasports.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Third Party [Member]",
        "documentation": "Third Party [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentIncreaseAccruedInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentIncreaseAccruedInterest",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/ConvertibleNotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Increase, Accrued Interest",
        "documentation": "Increase for accrued, but unpaid interest on the debt instrument for the period."
       }
      }
     },
     "auth_ref": [
      "r911"
     ]
    },
    "CNXA_GabrielGoldmanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "GabrielGoldmanMember",
     "presentation": [
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gabriel Goldman [Member]",
        "documentation": "Gabriel Goldman [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "presentation": [
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r108",
      "r437",
      "r585"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "presentation": [
      "http://connexasports.com/role/ConvertibleNotesPayableDetailsNarrative",
      "http://connexasports.com/role/NotePayable-RelatedPartyDetailsNarrative",
      "http://connexasports.com/role/NotePayableRelatedPartyDetailsNarrative",
      "http://connexasports.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest rate",
        "verboseLabel": "Debt interest rate",
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r411"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "presentation": [
      "http://connexasports.com/role/IntangibleAssetsDetailsNarrative",
      "http://connexasports.com/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r637"
     ]
    },
    "CNXA_GamefaceAIMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "GamefaceAIMember",
     "presentation": [
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gameface AI [Member]",
        "documentation": "Gameface AI [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantsAndRightsOutstanding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WarrantsAndRightsOutstanding",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/ConvertibleNotesPayableDetailsNarrative",
      "http://connexasports.com/role/ScheduleOfWarrantsIssuedExercisedAndExpiredDetails",
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Warrants",
        "label": "Warrants and Rights Outstanding",
        "terseLabel": "Intrinsic value of warrants",
        "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://connexasports.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Liabilities",
        "label": "Liabilities",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r267",
      "r363",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r553",
      "r554",
      "r555",
      "r574",
      "r721",
      "r822",
      "r859",
      "r940",
      "r961",
      "r962"
     ]
    },
    "us-gaap_DebtInstrumentMaturityDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentMaturityDate",
     "presentation": [
      "http://connexasports.com/role/ConvertibleNotesPayableDetailsNarrative",
      "http://connexasports.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible notes maturity date",
        "verboseLabel": "Debt maturity date",
        "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r223",
      "r827",
      "r952"
     ]
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "crdr": "credit",
     "calculation": {
      "http://connexasports.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 11.0
      },
      "http://connexasports.com/role/ScheduleOfDiscontinuedOperationsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://connexasports.com/role/BalanceSheets",
      "http://connexasports.com/role/ScheduleOfDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current liabilities of discontinued operations",
        "totalLabel": "Current Liabilities",
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r119",
      "r134",
      "r179",
      "r182",
      "r229",
      "r230"
     ]
    },
    "CNXA_MidcityCapitalLtdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "MidcityCapitalLtdMember",
     "presentation": [
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Midcity Capital Ltd [Member]",
        "documentation": "Midcity Capital Ltd [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharesIssuedPricePerShare",
     "presentation": [
      "http://connexasports.com/role/NotesPayableDetailsNarrative",
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares issued price per share",
        "verboseLabel": "Shares Issued, Price Per Share",
        "documentation": "Per share or per unit amount of equity securities issued."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://connexasports.com/role/IntangibleAssetsDetailsNarrative",
      "http://connexasports.com/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "documentation": "Information by major type or class of finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r388",
      "r389",
      "r390",
      "r391",
      "r637",
      "r638"
     ]
    },
    "us-gaap_InventoryNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryNet",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      },
      "http://connexasports.com/role/ScheduleOfInventoryDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://connexasports.com/role/BalanceSheets",
      "http://connexasports.com/role/ScheduleOfInventoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventories, net",
        "totalLabel": "Total",
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r242",
      "r817",
      "r846"
     ]
    },
    "CNXA_FiveYearWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "FiveYearWarrantsMember",
     "presentation": [
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "5-Year Warrants [Member]",
        "documentation": "5-Year Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAbstract",
     "presentation": [
      "http://connexasports.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "LIABILITIES"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "presentation": [
      "http://connexasports.com/role/IntangibleAssetsDetailsNarrative",
      "http://connexasports.com/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r79"
     ]
    },
    "us-gaap_AlternativeInvestment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AlternativeInvestment",
     "crdr": "debit",
     "presentation": [
      "http://connexasports.com/role/AcquisitionsAndBusinessCombinationsDetailsNarrative",
      "http://connexasports.com/role/GoingConcernDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment amount",
        "verboseLabel": "Investments",
        "documentation": "Fair value of investment other than investment in equity security, investment in debt security and equity method investment. Includes, but is not limited to, investment in certain entities that calculate net asset value per share. Example includes, but is not limited to, investment in hedge fund, venture capital fund, private equity fund, and real estate partnership or fund."
       }
      }
     },
     "auth_ref": [
      "r568",
      "r572"
     ]
    },
    "CNXA_SevenYearWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "SevenYearWarrantsMember",
     "presentation": [
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "7-Year Warrants [Member]",
        "documentation": "7-Year Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://connexasports.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/BalanceSheets",
      "http://connexasports.com/role/ScheduleOfDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current liabilities of discontinued operations",
        "totalLabel": "Non-Current Liabilities",
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r10",
      "r119",
      "r134",
      "r182",
      "r229",
      "r230"
     ]
    },
    "country_IL": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "IL",
     "presentation": [
      "http://connexasports.com/role/IncomeTaxesTables",
      "http://connexasports.com/role/ScheduleOfIncomeTaxProvisionDetailsParenthetical",
      "http://connexasports.com/role/ScheduleOfNetDeferredTaxAssetsDetails",
      "http://connexasports.com/role/ScheduleOfNetDeferredTaxAssetsDetailsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ISRAEL"
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_MarketingAndAdvisoryServicesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "MarketingAndAdvisoryServicesMember",
     "presentation": [
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Marketing And Advisory Services [Member]",
        "documentation": "Marketing And Advisory Services [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_TwoEmployeesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "TwoEmployeesMember",
     "presentation": [
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Two Employees [Member]",
        "documentation": "Two Employees [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://connexasports.com/role/ConvertibleNotesPayableDetailsNarrative",
      "http://connexasports.com/role/NotesPayableDetailsNarrative",
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r271",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r416",
      "r421",
      "r422",
      "r423",
      "r424",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r585",
      "r827",
      "r828",
      "r829",
      "r830",
      "r831",
      "r911"
     ]
    },
    "CNXA_RelatedPartyLenderMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "RelatedPartyLenderMember",
     "presentation": [
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Lender [Member]",
        "documentation": "Related Party Lender [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://connexasports.com/role/BalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://connexasports.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS\u2019 EQUITY (DEFICIT)",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r152",
      "r203",
      "r663",
      "r846",
      "r912",
      "r925",
      "r953"
     ]
    },
    "CNXA_SevenPointFiveYearWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "SevenPointFiveYearWarrantsMember",
     "presentation": [
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "7.5 -Year Warrants [Member]",
        "documentation": "7.5 -Year Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_ServicesRenderedInLieuOfCashMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "ServicesRenderedInLieuOfCashMember",
     "presentation": [
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Services rendered in lieu of cash [Member]",
        "documentation": "Services rendered in lieu of cash [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://connexasports.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "LIABILITIES AND SHAREHOLDERS\u2019 EQUITY (DEFICIT)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "presentation": [
      "http://connexasports.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r86",
      "r87",
      "r88",
      "r89"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfWarrantsIssuedExercisedAndExpiredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Warrants Shares, Beginning Balance",
        "periodEndLabel": "Warrants Shares, Ending Balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number",
        "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r28"
     ]
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://connexasports.com/role/BalanceSheets",
      "http://connexasports.com/role/NotePayable-RelatedPartyDetailsNarrative",
      "http://connexasports.com/role/NotePayableRelatedPartyDetailsNarrative",
      "http://connexasports.com/role/NotesPayableDetailsNarrative",
      "http://connexasports.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative",
      "http://connexasports.com/role/StatementsOfOperations",
      "http://connexasports.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "auth_ref": [
      "r473",
      "r592",
      "r593",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r743",
      "r745",
      "r776"
     ]
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "presentation": [
      "http://connexasports.com/role/AccruedExpenses"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ACCRUED EXPENSES",
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period."
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateIncreaseDecrease": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentInterestRateIncreaseDecrease",
     "presentation": [
      "http://connexasports.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest rate, increase",
        "documentation": "Incremental percentage increase (decrease) in the stated rate on a debt instrument."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://connexasports.com/role/SummaryOfSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r173",
      "r264"
     ]
    },
    "us-gaap_AccountsReceivableNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsReceivableNet",
     "crdr": "debit",
     "presentation": [
      "http://connexasports.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding accounts receivable",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business."
       }
      }
     },
     "auth_ref": [
      "r733",
      "r798",
      "r852",
      "r973"
     ]
    },
    "us-gaap_RepaymentsOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RepaymentsOfDebt",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Repayment of debt",
        "documentation": "Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation."
       }
      }
     },
     "auth_ref": [
      "r907"
     ]
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsReceivableNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts receivable, net",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current."
       }
      }
     },
     "auth_ref": [
      "r324",
      "r325"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/ScheduleOfEstimatedFutureAmortizationDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/ScheduleOfEstimatedFutureAmortizationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2024",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/ScheduleOfEstimatedFutureAmortizationDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/ScheduleOfEstimatedFutureAmortizationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2025",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/ScheduleOfEstimatedFutureAmortizationDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/ScheduleOfEstimatedFutureAmortizationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2026",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "us-gaap_LossContingenciesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LossContingenciesTable",
     "presentation": [
      "http://connexasports.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss Contingencies [Table]",
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations."
       }
      }
     },
     "auth_ref": [
      "r394",
      "r395",
      "r396",
      "r399",
      "r936",
      "r937"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "presentation": [
      "http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF WARRANTS GRANTED VALUATION USING BLACK-SCHOLES PRICING METHOD",
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/ScheduleOfEstimatedFutureAmortizationDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/ScheduleOfEstimatedFutureAmortizationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2027",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/ScheduleOfEstimatedFutureAmortizationDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/ScheduleOfEstimatedFutureAmortizationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2028",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/ScheduleOfEstimatedFutureAmortizationDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/ScheduleOfEstimatedFutureAmortizationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Thereafter",
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableMember",
     "presentation": [
      "http://connexasports.com/role/ConcentrationOfCreditRiskAndOtherRisksAndUncertaintiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Payable [Member]",
        "documentation": "Obligations incurred and payable to vendors for goods and services received."
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r423",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r569",
      "r603",
      "r604",
      "r605",
      "r828",
      "r829",
      "r836",
      "r837",
      "r838"
     ]
    },
    "us-gaap_LossContingenciesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LossContingenciesLineItems",
     "presentation": [
      "http://connexasports.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss Contingencies [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r394",
      "r395",
      "r396",
      "r399",
      "r936",
      "r937"
     ]
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "presentation": [
      "http://connexasports.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Related Party Transactions, by Related Party [Table]",
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r111",
      "r112",
      "r749",
      "r750",
      "r753"
     ]
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "presentation": [
      "http://connexasports.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF INCOME TAX PROVISION",
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years."
       }
      }
     },
     "auth_ref": [
      "r193"
     ]
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "presentation": [
      "http://connexasports.com/role/IntangibleAssetsDetailsNarrative",
      "http://connexasports.com/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r79",
      "r637"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Allowance for doubtful accounts",
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r240",
      "r328",
      "r368"
     ]
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://connexasports.com/role/RelatedPartyTransactions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "RELATED PARTY TRANSACTIONS",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r589",
      "r590",
      "r591",
      "r593",
      "r596",
      "r699",
      "r700",
      "r701",
      "r751",
      "r752",
      "r753",
      "r773",
      "r775"
     ]
    },
    "CNXA_RodneyRapsonMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "RodneyRapsonMember",
     "presentation": [
      "http://connexasports.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rodney Rapson [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionLineItems",
     "presentation": [
      "http://connexasports.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r749",
      "r750",
      "r753"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToAdditionalPaidInCapitalOther",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/StatementOfChangesInShareholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elimination of related party derivative liability",
        "documentation": "Amount of other increase (decrease) in additional paid in capital (APIC)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfWarrantsIssuedExercisedAndExpiredDetails",
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted",
        "verboseLabel": "Warrants Shares, Granted",
        "documentation": "Net number of non-option equity instruments granted to participants."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "presentation": [
      "http://connexasports.com/role/IntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF ESTIMATED FUTURE AMORTIZATION",
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://connexasports.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF NET DEFERRED TAX ASSETS",
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r192"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfWarrantsIssuedExercisedAndExpiredDetails",
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative",
      "http://connexasports.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise of warrants, shares",
        "verboseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised",
        "terseLabel": "Warrants Shares, Exercised",
        "documentation": "Number of non-option equity instruments exercised by participants."
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationDisclosureTextBlock",
     "presentation": [
      "http://connexasports.com/role/AcquisitionsAndBusinessCombinations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ACQUISITIONS AND BUSINESS COMBINATIONS",
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable)."
       }
      }
     },
     "auth_ref": [
      "r194",
      "r549"
     ]
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r873"
     ]
    },
    "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners",
     "presentation": [
      "http://connexasports.com/role/DiscontinuedOperationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership percentage by non-controlling owners",
        "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_ServiceProviderMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "ServiceProviderMember",
     "presentation": [
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Service Provider [Member]",
        "documentation": "Service Provider [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r874"
     ]
    },
    "us-gaap_MinorityInterestOwnershipPercentageByParent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MinorityInterestOwnershipPercentageByParent",
     "presentation": [
      "http://connexasports.com/role/DiscontinuedOperationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership percentage by parrent",
        "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "presentation": [
      "http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property plant and equipment, useful life",
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IsraelTaxAuthorityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IsraelTaxAuthorityMember",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Israel Tax Authority [Member]",
        "documentation": "Designated tax department of the government of Israel."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Current Assets",
        "label": "Assets, Current",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r231",
      "r243",
      "r267",
      "r363",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r552",
      "r554",
      "r574",
      "r846",
      "r940",
      "r941",
      "r961"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationDescriptionAndTimingOfDisposal": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationDescriptionAndTimingOfDisposal",
     "presentation": [
      "http://connexasports.com/role/DiscontinuedOperationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued operation description",
        "documentation": "Description of the facts and circumstances leading to the completed or expected disposal, and the manner and timing of that disposal."
       }
      }
     },
     "auth_ref": [
      "r138",
      "r180",
      "r181",
      "r227",
      "r228"
     ]
    },
    "srt_StatementScenarioAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "StatementScenarioAxis",
     "presentation": [
      "http://connexasports.com/role/NotesPayableDetailsNarrative",
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative",
      "http://connexasports.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]"
       }
      }
     },
     "auth_ref": [
      "r287",
      "r484",
      "r880",
      "r881",
      "r919"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r874"
     ]
    },
    "us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax",
     "crdr": "credit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss on disposal of subsidiaries",
        "documentation": "Amount before tax of gain (loss) not previously recognized resulting from the disposal of a discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r120",
      "r122",
      "r124"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://connexasports.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Assets:"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "presentation": [
      "http://connexasports.com/role/GoingConcernDetailsNarrative",
      "http://connexasports.com/role/ScheduleOfCalculationOfLossOnDisposalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group."
       }
      }
     },
     "auth_ref": [
      "r839",
      "r842"
     ]
    },
    "srt_ScenarioUnspecifiedDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ScenarioUnspecifiedDomain",
     "presentation": [
      "http://connexasports.com/role/NotesPayableDetailsNarrative",
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative",
      "http://connexasports.com/role/SubsequentEventsDetailsNarrative"
     ],
     "auth_ref": [
      "r287",
      "r484",
      "r880",
      "r919"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingExpense",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/ScheduleOfDiscontinuedOperationsDetails": {
       "parentTag": "CNXA_DisposalGroupIncludingDiscontinuedOperationNetIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/ScheduleOfDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating expenses",
        "documentation": "Amount of operating expense attributable to disposal group, including, but not limited to, discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "us-gaap_TradeNamesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TradeNamesMember",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade Names [Member]",
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof."
       }
      }
     },
     "auth_ref": [
      "r98"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationRevenue",
     "crdr": "credit",
     "calculation": {
      "http://connexasports.com/role/ScheduleOfDiscontinuedOperationsDetails": {
       "parentTag": "CNXA_DisposalGroupIncludingDiscontinuedOperationNetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/ScheduleOfDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue",
        "documentation": "Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r132",
      "r230"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Extension",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://connexasports.com/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "INCOME TAXES",
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information."
       }
      }
     },
     "auth_ref": [
      "r268",
      "r526",
      "r531",
      "r532",
      "r536",
      "r540",
      "r543",
      "r544",
      "r545",
      "r698"
     ]
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "presentation": [
      "http://connexasports.com/role/GoingConcernDetailsNarrative",
      "http://connexasports.com/role/ScheduleOfCalculationOfLossOnDisposalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disposal Group Name [Axis]",
        "documentation": "Information by name of disposal group."
       }
      }
     },
     "auth_ref": [
      "r839",
      "r842"
     ]
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "presentation": [
      "http://connexasports.com/role/OrganizationAndNatureOfBusinessDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]"
       }
      }
     },
     "auth_ref": [
      "r360",
      "r361",
      "r362"
     ]
    },
    "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillImpairedAccumulatedImpairmentLoss",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/OrganizationAndNatureOfBusinessDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impaired of intangible assets and goodwill amount",
        "documentation": "Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r383",
      "r385",
      "r826"
     ]
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Balance of contingent consideration",
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r100",
      "r550"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r862"
     ]
    },
    "us-gaap_SubsequentEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventLineItems",
     "presentation": [
      "http://connexasports.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Line Items]",
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event."
       }
      }
     },
     "auth_ref": [
      "r582",
      "r598"
     ]
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r251",
      "r527",
      "r528",
      "r532",
      "r533",
      "r535",
      "r537",
      "r694"
     ]
    },
    "CNXA_KeyEmployeesAndOfficersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "KeyEmployeesAndOfficersMember",
     "presentation": [
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Key Employees and Officers [Member]",
        "documentation": "Key Employees and Officers [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://connexasports.com/role/IntangibleAssetsDetailsNarrative",
      "http://connexasports.com/role/NotesPayableDetailsNarrative",
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r868"
     ]
    },
    "CNXA_ThreeMembersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "ThreeMembersMember",
     "presentation": [
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Three Members [Member]",
        "documentation": "Three Members [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "presentation": [
      "http://connexasports.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityDomain",
     "presentation": [
      "http://connexasports.com/role/IntangibleAssetsDetailsNarrative",
      "http://connexasports.com/role/NotesPayableDetailsNarrative",
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r861"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://connexasports.com/role/NotesPayableDetailsNarrative",
      "http://connexasports.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r582",
      "r598"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfOperations": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://connexasports.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Comprehensive income (loss)",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r248",
      "r250",
      "r257",
      "r652",
      "r669"
     ]
    },
    "us-gaap_SubsequentEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTable",
     "presentation": [
      "http://connexasports.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Table]",
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued."
       }
      }
     },
     "auth_ref": [
      "r582",
      "r598"
     ]
    },
    "CNXA_LeadPlacementAgentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "LeadPlacementAgentMember",
     "presentation": [
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lead Placement Agent [Member]",
        "documentation": "Lead Placement Agent [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r862"
     ]
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskTypeDomain",
     "presentation": [
      "http://connexasports.com/role/ConcentrationOfCreditRiskAndOtherRisksAndUncertaintiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r71",
      "r105",
      "r106",
      "r323",
      "r799"
     ]
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "presentation": [
      "http://connexasports.com/role/ConvertibleNotesPayableDetailsNarrative",
      "http://connexasports.com/role/DiscontinuedOperationsDetailsNarrative",
      "http://connexasports.com/role/NotePayable-RelatedPartyDetailsNarrative",
      "http://connexasports.com/role/NotePayableRelatedPartyDetailsNarrative",
      "http://connexasports.com/role/NotesPayableDetailsNarrative",
      "http://connexasports.com/role/OrganizationAndNatureOfBusinessDetailsNarrative",
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative",
      "http://connexasports.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r551"
     ]
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "presentation": [
      "http://connexasports.com/role/DiscontinuedOperationsDetailsNarrative",
      "http://connexasports.com/role/NotePayable-RelatedPartyDetailsNarrative",
      "http://connexasports.com/role/NotePayableRelatedPartyDetailsNarrative",
      "http://connexasports.com/role/OrganizationAndNatureOfBusinessDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r551"
     ]
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "presentation": [
      "http://connexasports.com/role/DiscontinuedOperationsDetailsNarrative",
      "http://connexasports.com/role/NotePayable-RelatedPartyDetailsNarrative",
      "http://connexasports.com/role/NotePayableRelatedPartyDetailsNarrative",
      "http://connexasports.com/role/OrganizationAndNatureOfBusinessDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r551"
     ]
    },
    "CNXA_DeferredTaxAssetsAccruedPayroll": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "DeferredTaxAssetsAccruedPayroll",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/ScheduleOfNetDeferredTaxAssetsDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/ScheduleOfNetDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital loss carryforward/Disposal",
        "documentation": "Deferred tax assets accrued payroll."
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_DeferredTaxAssetsInterestDeferral": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "DeferredTaxAssetsInterestDeferral",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/ScheduleOfNetDeferredTaxAssetsDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/ScheduleOfNetDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest deferral",
        "documentation": "Deferred tax assets interest deferral."
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_DeferredTaxAssetsRelatedPartyAccruals": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "DeferredTaxAssetsRelatedPartyAccruals",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/ScheduleOfNetDeferredTaxAssetsDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/ScheduleOfNetDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related party accruals",
        "documentation": "Deferred tax assets related party accruals."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RepaymentsOfRelatedPartyDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RepaymentsOfRelatedPartyDebt",
     "crdr": "credit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payments of notes payable - related parties",
        "label": "Repayments of Related Party Debt",
        "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates."
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesContinuingOperations",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in investing activities of continuing operations",
        "label": "Net Cash Provided by (Used in) Investing Activities, Continuing Operations",
        "documentation": "Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r908"
     ]
    },
    "CNXA_DeferredTaxAssetsStartupCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "DeferredTaxAssetsStartupCosts",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/ScheduleOfNetDeferredTaxAssetsDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/ScheduleOfNetDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Start-up costs",
        "documentation": "Deferred tax assets start up costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://connexasports.com/role/NotesPayableDetailsNarrative",
      "http://connexasports.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r582",
      "r598"
     ]
    },
    "CNXA_DeferredTaxAssetsInProcessResearchAndDevelopmentCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "DeferredTaxAssetsInProcessResearchAndDevelopmentCosts",
     "crdr": "debit",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfNetDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Research and development costs",
        "documentation": "Deferred tax assets in process research and development costs.",
        "label": "DeferredTaxAssetsInProcessResearchAndDevelopmentCosts"
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_DeferredTaxAssetsStartupCostsForeign": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "DeferredTaxAssetsStartupCostsForeign",
     "crdr": "debit",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfNetDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Start-up costs",
        "documentation": "Deferred tax assets startup costs foreign.",
        "label": "DeferredTaxAssetsStartupCostsForeign"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative",
      "http://connexasports.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Operating Expenses",
        "label": "Operating Expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_IncomeTaxReconciliationDebtDiscountAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "IncomeTaxReconciliationDebtDiscountAmortization",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt discount amortization",
        "documentation": "Income tax reconciliation debt discount amortization."
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_IncomeTaxReconciliationRelatedPartyAccruals": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "IncomeTaxReconciliationRelatedPartyAccruals",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Related party accruals",
        "documentation": "Income tax reconciliation, related party accruals.",
        "label": "Related party accruals [Default Label]"
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_IncomeTaxReconciliationStartUpCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "IncomeTaxReconciliationStartUpCosts",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stock options",
        "documentation": "Income tax reconciliation, start up costs.",
        "label": "Start up costs"
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_IncomeTaxRecociliationInterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "IncomeTaxRecociliationInterestExpense",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Interest expense",
        "documentation": "Income tax reconciliation, Interest expense.",
        "label": "IncomeTaxRecociliationInterestExpense"
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_IncomeTaxRecociliationInventoryReserve": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "IncomeTaxRecociliationInventoryReserve",
     "crdr": "debit",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Inventory reserve",
        "documentation": "Income tax recociliation inventory reserve.",
        "label": "IncomeTaxRecociliationInventoryReserve"
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_IncomeTaxRecociliationInterestDeferral": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "IncomeTaxRecociliationInterestDeferral",
     "crdr": "debit",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Interest deferral",
        "documentation": "Income tax recociliation interest deferral.",
        "label": "IncomeTaxRecociliationInterestDeferral"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CreditConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CreditConcentrationRiskMember",
     "presentation": [
      "http://connexasports.com/role/ConcentrationOfCreditRiskAndOtherRisksAndUncertaintiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Credit Concentration Risk [Member]",
        "documentation": "Reflects the percentage that a specified receivable or amount at risk from a counterparty under a contractual arrangement is to a specified benchmark, such as total receivables, net revenues, pretax results. Risk is the materially adverse effects of loss attributable to (a) the failure to collect a significant receivable from a major customer or group of homogeneous accounts, or (b) a failure by a counterparty to perform under terms of a contractual arrangement."
       }
      }
     },
     "auth_ref": [
      "r199"
     ]
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://connexasports.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "OPERATING EXPENSES"
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_IncomeTaxRecociliationAcquisitionCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "IncomeTaxRecociliationAcquisitionCosts",
     "crdr": "debit",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquisition costs",
        "documentation": "Income tax recociliation acquisition costs."
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_IncomeTaxRecociliationAccruedLegal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "IncomeTaxRecociliationAccruedLegal",
     "crdr": "debit",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued legal",
        "documentation": "Income tax recociliation accrued legal."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeInstrumentsAndHedgesLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeInstrumentsAndHedgesLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfDerivativeLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note derivative balance",
        "documentation": "Sum as of the balance sheet date of the (a) fair values of all liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments, and (b) the carrying amounts of the liabilities arising from financial instruments or contracts used to mitigate a specified risk (hedge), and which are expected to be extinguished or otherwise disposed of within a year or the normal operating cycle, if longer, net of the effects of master netting arrangements."
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "CNXA_IncomeTaxRecociliationLossOnExtinguishmentOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "IncomeTaxRecociliationLossOnExtinguishmentOfDebt",
     "crdr": "debit",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss on sale of capital assets",
        "documentation": "Income tax recociliation loss on extinguishment of debt."
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_IncomeTaxRecociliationAccruedPayroll": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "IncomeTaxRecociliationAccruedPayroll",
     "crdr": "debit",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accrued payroll",
        "documentation": "Income tax recociliation accrued payroll.",
        "label": "IncomeTaxRecociliationAccruedPayroll"
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_IncomeTaxRecociliationGainOnChangeInFairValueOfDerivatives": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "IncomeTaxRecociliationGainOnChangeInFairValueOfDerivatives",
     "crdr": "debit",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in fair value of derivatives",
        "documentation": "Income tax recociliation gain on change in fair value of derivatives."
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_DisposalGroupIncludingDiscontinuedOperationAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsReceivable",
     "crdr": "debit",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfCalculationOfLossOnDisposalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts receivable",
        "documentation": "Accounts receivable.",
        "label": "DisposalGroupIncludingDiscontinuedOperationAccountsReceivable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://connexasports.com/role/Segments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEGMENTS",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r307",
      "r311",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r323"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensationGross",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, before Forfeiture",
        "documentation": "Value, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConversionOfStockSharesConverted1": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConversionOfStockSharesConverted1",
     "presentation": [
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of Stock, Shares Converted",
        "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r64",
      "r65"
     ]
    },
    "CNXA_DisposalGroupIncludingDiscontinuedOperationContractAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "DisposalGroupIncludingDiscontinuedOperationContractAssets",
     "crdr": "debit",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfCalculationOfLossOnDisposalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Contract assets",
        "documentation": "Contract assets.",
        "label": "DisposalGroupIncludingDiscontinuedOperationContractAssets"
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_DisposalGroupIncludingDiscontinuedOperationRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "DisposalGroupIncludingDiscontinuedOperationRightOfUseAsset",
     "crdr": "debit",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfCalculationOfLossOnDisposalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right of use asset",
        "documentation": "Right of use asset."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionProFormaEarningsPerShareBasic",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfProformaFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic earnings (loss) per share",
        "documentation": "The pro forma basic net income per share for a period as if the business combination or combinations had been completed at the beginning of a period."
       }
      }
     },
     "auth_ref": [
      "r884",
      "r885"
     ]
    },
    "CNXA_DisposalGroupIncludingDiscontinuedOperationContractLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "DisposalGroupIncludingDiscontinuedOperationContractLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfCalculationOfLossOnDisposalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Contract liabilities",
        "documentation": "Contract liabilities.",
        "label": "DisposalGroupIncludingDiscontinuedOperationContractLiabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract",
     "presentation": [
      "http://connexasports.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other comprehensive income (loss)"
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_DisposalGroupIncludingDiscontinuedOperationLossOnDisposalOfDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "DisposalGroupIncludingDiscontinuedOperationLossOnDisposalOfDiscontinuedOperations",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfCalculationOfLossOnDisposalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss on disposal of discontinued operations",
        "documentation": "Loss on disposal of discontinued operations."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationGross",
     "presentation": [
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, before Forfeiture",
        "documentation": "Number, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/OrganizationAndNatureOfBusinessDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of value issued for acquisition",
        "documentation": "Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity."
       }
      }
     },
     "auth_ref": [
      "r196"
     ]
    },
    "us-gaap_DebtConversionConvertedInstrumentAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtConversionConvertedInstrumentAmount1",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt conversion, amount",
        "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r65"
     ]
    },
    "us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net cash provided by operating activities of discontinued operations",
        "documentation": "Amount of cash inflow (outflow) of operating activities of discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r170"
     ]
    },
    "us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net cash provided by operating activities of discontinued operations",
        "label": "Cash Provided by (Used in) Investing Activities, Discontinued Operations",
        "documentation": "Amount of cash inflow (outflow) of investing activities of discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r170"
     ]
    },
    "us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1",
     "presentation": [
      "http://connexasports.com/role/ConvertibleNotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt conversion shares issued",
        "documentation": "The number of warrants issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r65"
     ]
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionAxis",
     "presentation": [
      "http://connexasports.com/role/AcquisitionsAndBusinessCombinationsDetailsNarrative",
      "http://connexasports.com/role/GoingConcernDetailsNarrative",
      "http://connexasports.com/role/OrganizationAndNatureOfBusinessDetailsNarrative",
      "http://connexasports.com/role/ScheduleOfProformaFinancialInformationDetails",
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative",
      "http://connexasports.com/role/StatementOfChangesInShareholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition [Axis]",
        "documentation": "Information by business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r97",
      "r548",
      "r839",
      "r842"
     ]
    },
    "us-gaap_DeferredTaxAssetsInventory": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsInventory",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/ScheduleOfNetDeferredTaxAssetsDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/ScheduleOfNetDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory reserve",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory."
       }
      }
     },
     "auth_ref": [
      "r94",
      "r947"
     ]
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionAcquireeDomain",
     "presentation": [
      "http://connexasports.com/role/AcquisitionsAndBusinessCombinationsDetailsNarrative",
      "http://connexasports.com/role/GoingConcernDetailsNarrative",
      "http://connexasports.com/role/OrganizationAndNatureOfBusinessDetailsNarrative",
      "http://connexasports.com/role/ScheduleOfProformaFinancialInformationDetails",
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative",
      "http://connexasports.com/role/StatementOfChangesInShareholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "auth_ref": [
      "r548",
      "r839",
      "r842"
     ]
    },
    "us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionProFormaEarningsPerShareDiluted",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfProformaFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Diluted earnings (loss) per share",
        "documentation": "The pro forma diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a period."
       }
      }
     },
     "auth_ref": [
      "r884",
      "r885"
     ]
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionLineItems",
     "presentation": [
      "http://connexasports.com/role/AcquisitionsAndBusinessCombinationsDetailsNarrative",
      "http://connexasports.com/role/ScheduleOfProformaFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r548"
     ]
    },
    "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtConversionConvertedInstrumentSharesIssued1",
     "presentation": [
      "http://connexasports.com/role/ConvertibleNotesPayableDetailsNarrative",
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt conversion",
        "verboseLabel": "Debt conversion of convertible notes, shares",
        "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r65"
     ]
    },
    "us-gaap_InterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestExpense",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/NotePayable-RelatedPartyDetailsNarrative",
      "http://connexasports.com/role/NotePayableRelatedPartyDetailsNarrative",
      "http://connexasports.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Interest expense",
        "verboseLabel": "Interest expense",
        "label": "Interest Expense",
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense."
       }
      }
     },
     "auth_ref": [
      "r109",
      "r208",
      "r255",
      "r305",
      "r583",
      "r754",
      "r857",
      "r980"
     ]
    },
    "CNXA_EmployeeAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "EmployeeAgreementMember",
     "presentation": [
      "http://connexasports.com/role/DiscontinuedOperationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Agreement [Member]",
        "documentation": "Employee Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_IncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "IncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "NET LOSS FROM OPERATIONS BEFORE PROVISION FOR INCOME TAXES",
        "documentation": "Income loss from operations before income taxes extraordinary items noncontrolling interest.",
        "label": "IncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_DerivativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "DerivativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 7.0
      },
      "http://connexasports.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/NotesPayableDetailsNarrative",
      "http://connexasports.com/role/StatementsOfCashFlows",
      "http://connexasports.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Derivative expense",
        "label": "Derivative expense",
        "documentation": "Derivative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedProfessionalFeesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://connexasports.com/role/ScheduleOfAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/ScheduleOfAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued professional fees",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "us-gaap_AccruedPayrollTaxesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedPayrollTaxesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://connexasports.com/role/ScheduleOfAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/ScheduleOfAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued payroll",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory payroll taxes incurred through that date and withheld from employees pertaining to services received from them, including entity's matching share of the employees FICA taxes and contributions to the state and federal unemployment insurance programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "CNXA_VendorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "VendorMember",
     "presentation": [
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vendor [Member]",
        "documentation": "Vendor [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_SecondMegedAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "SecondMegedAgreementMember",
     "presentation": [
      "http://connexasports.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Second Meged Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_AsCompensationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "AsCompensationMember",
     "presentation": [
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "As Compensation [Member]",
        "documentation": "As Compensation [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "presentation": [
      "http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and equipment",
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r218",
      "r221",
      "r664"
     ]
    },
    "us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IssuanceOfStockAndWarrantsForServicesOrClaims",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares and warrants issued for services",
        "documentation": "Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "CNXA_SixNewBrandAmbassadorsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "SixNewBrandAmbassadorsMember",
     "presentation": [
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Six New Brand Ambassadors [Member]",
        "documentation": "Six New Brand Ambassadors [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_BrandAmbassadorsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "BrandAmbassadorsMember",
     "presentation": [
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Brand Ambassadors [Member]",
        "documentation": "Brand Ambassadors [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://connexasports.com/role/NotesPayableDetailsNarrative",
      "http://connexasports.com/role/OrganizationAndNatureOfBusinessDetailsNarrative",
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r920",
      "r959"
     ]
    },
    "CNXA_NotePayableHolderMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "NotePayableHolderMember",
     "presentation": [
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note Payable Holder [Member]",
        "documentation": "Note Payable Holder [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfMultiemployerPlansTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfMultiemployerPlansTable",
     "presentation": [
      "http://connexasports.com/role/GoingConcernDetailsNarrative",
      "http://connexasports.com/role/ScheduleOfCalculationOfLossOnDisposalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Multiemployer Plan [Table]",
        "documentation": "Disclosure of information about multiemployer plan."
       }
      }
     },
     "auth_ref": [
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r839",
      "r840",
      "r841",
      "r842",
      "r843",
      "r844",
      "r845"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/StatementOfChangesInShareholdersEquityDeficit",
      "http://connexasports.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign currency translations adjustment",
        "verboseLabel": "Change in comprehensive income (loss)",
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "us-gaap_MeasurementInputExpectedDividendRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputExpectedDividendRateMember",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfDerivativeAndWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails",
      "http://connexasports.com/role/ScheduleOfWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Expected Dividend Rate [Member]",
        "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year."
       }
      }
     },
     "auth_ref": [
      "r951"
     ]
    },
    "us-gaap_MeasurementInputExpectedTermMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputExpectedTermMember",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfDerivativeAndWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails",
      "http://connexasports.com/role/ScheduleOfWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Expected Term [Member]",
        "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date."
       }
      }
     },
     "auth_ref": [
      "r951"
     ]
    },
    "CNXA_PreFundedWarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "PreFundedWarrantMember",
     "presentation": [
      "http://connexasports.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Funded Warrant [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MultiemployerPlansLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MultiemployerPlansLineItems",
     "presentation": [
      "http://connexasports.com/role/GoingConcernDetailsNarrative",
      "http://connexasports.com/role/ScheduleOfCalculationOfLossOnDisposalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Multiemployer Plan [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r839",
      "r840",
      "r841",
      "r842",
      "r843",
      "r844",
      "r845"
     ]
    },
    "CNXA_WarrantOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "WarrantOneMember",
     "presentation": [
      "http://connexasports.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant One [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 19.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Contract liabilities",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r631",
      "r909"
     ]
    },
    "us-gaap_MeasurementInputPriceVolatilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputPriceVolatilityMember",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfDerivativeAndWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails",
      "http://connexasports.com/role/ScheduleOfWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Price Volatility [Member]",
        "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns."
       }
      }
     },
     "auth_ref": [
      "r951"
     ]
    },
    "CNXA_WarrantTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "WarrantTwoMember",
     "presentation": [
      "http://connexasports.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant Two [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_FoundationSportsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "FoundationSportsMember",
     "presentation": [
      "http://connexasports.com/role/AcquisitionsAndBusinessCombinationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foundation Sports [Member]",
        "documentation": "Foundation Sports [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MeasurementInputRiskFreeInterestRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputRiskFreeInterestRateMember",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfDerivativeAndWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails",
      "http://connexasports.com/role/ScheduleOfWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Risk Free Interest Rate [Member]",
        "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss."
       }
      }
     },
     "auth_ref": [
      "r951"
     ]
    },
    "CNXA_PlaySightAndGameFaceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "PlaySightAndGameFaceMember",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfProformaFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Play Sight And Game Face [Member]",
        "documentation": "Play Sight And Game Face [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputTypeDomain",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfDerivativeAndWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails",
      "http://connexasports.com/role/ScheduleOfWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ValuationTechniqueOptionPricingModelMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ValuationTechniqueOptionPricingModelMember",
     "presentation": [
      "http://connexasports.com/role/NotesPayableDetailsNarrative",
      "http://connexasports.com/role/ScheduleOfDerivativeAndWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails",
      "http://connexasports.com/role/ScheduleOfWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Valuation Technique, Option Pricing Model [Member]",
        "documentation": "Valuation technique calculating price of option."
       }
      }
     },
     "auth_ref": [
      "r951"
     ]
    },
    "CNXA_PrepaidInventoryCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "PrepaidInventoryCurrent",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid inventory",
        "documentation": "Prepaid inventory current."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "presentation": [
      "http://connexasports.com/role/ConvertibleNotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion price",
        "documentation": "The price per share of the conversion feature embedded in the debt instrument."
       }
      }
     },
     "auth_ref": [
      "r187",
      "r412"
     ]
    },
    "CNXA_PlaySightAndFoundationSportsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "PlaySightAndFoundationSportsMember",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfCalculationOfLossOnDisposalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Play Sight And Foundation Sports [Member]",
        "documentation": "Play Sight And Foundation Sports [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accounts receivable",
        "label": "Increase (Decrease) in Accounts Receivable",
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "us-gaap_ValuationTechniqueAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ValuationTechniqueAxis",
     "presentation": [
      "http://connexasports.com/role/ConvertibleNotesPayableDetailsNarrative",
      "http://connexasports.com/role/NotesPayableDetailsNarrative",
      "http://connexasports.com/role/ScheduleOfDerivativeAndWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails",
      "http://connexasports.com/role/ScheduleOfWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Valuation Approach and Technique [Axis]",
        "documentation": "Information by valuation approach and technique."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "CNXA_GainLossOnChangeInFairValueOfDerivativesLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "GainLossOnChangeInFairValueOfDerivativesLiability",
     "crdr": "credit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in fair value of derivative liability",
        "documentation": "Gain (Loss) on change in fair value of derivatives liability."
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_GainLossOnChangeInFairValueOfContingentConsideration": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "GainLossOnChangeInFairValueOfContingentConsideration",
     "crdr": "credit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 4.0
      },
      "http://connexasports.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/StatementsOfCashFlows",
      "http://connexasports.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gain on change in fair value of contingent consideration",
        "negatedLabel": "Change in fair value of contingent consideration",
        "documentation": "Gain (Loss) on change in fair value of contingent consideration."
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_GainLossOnIssuanceOfConvertibleNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "GainLossOnIssuanceOfConvertibleNotes",
     "crdr": "credit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 3.0
      },
      "http://connexasports.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/StatementsOfCashFlows",
      "http://connexasports.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss on issuance of convertible notes",
        "negatedLabel": "Loss on conversion of convertible notes",
        "documentation": "Gain (Loss) on issuance of convertible notes."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ValuationTechniqueDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ValuationTechniqueDomain",
     "presentation": [
      "http://connexasports.com/role/ConvertibleNotesPayableDetailsNarrative",
      "http://connexasports.com/role/NotesPayableDetailsNarrative",
      "http://connexasports.com/role/ScheduleOfDerivativeAndWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails",
      "http://connexasports.com/role/ScheduleOfWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation approach and technique."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "CNXA_LossOnConversionOfAccountsPayableToCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "LossOnConversionOfAccountsPayableToCommonStock",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss on conversion of accounts payable to common stock"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r234",
      "r816"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAcquiredFromAcquisition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAcquiredFromAcquisition",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash acquired as part of Gameface acquisition",
        "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business)."
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NonoperatingIncomeExpenseAbstract",
     "presentation": [
      "http://connexasports.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NON-OPERATING INCOME (EXPENSE)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SellingAndMarketingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SellingAndMarketingExpense",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Selling and marketing expenses",
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "presentation": [
      "http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value of Financial Instruments",
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r36"
     ]
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r874"
     ]
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Non-Operating Income (Expenses)",
        "label": "Nonoperating Income (Expense)",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r167"
     ]
    },
    "us-gaap_AssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Non-Current Assets",
        "label": "Assets, Noncurrent",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r267",
      "r363",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r552",
      "r554",
      "r574",
      "r940",
      "r941",
      "r961"
     ]
    },
    "us-gaap_Investments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Investments",
     "crdr": "debit",
     "presentation": [
      "http://connexasports.com/role/DiscontinuedOperationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments."
       }
      }
     },
     "auth_ref": [
      "r656"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://connexasports.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in assets and liabilities, net of acquired amounts"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r862"
     ]
    },
    "us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable",
     "presentation": [
      "http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Table]",
        "documentation": "Disclosure of information about allowance for credit loss on investment in debt security measured at amortized cost (held-to-maturity)."
       }
      }
     },
     "auth_ref": [
      "r928"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesNoncurrentAbstract",
     "presentation": [
      "http://connexasports.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IntangibleAssetsFiniteLivedPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IntangibleAssetsFiniteLivedPolicy",
     "presentation": [
      "http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets",
        "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r633",
      "r634",
      "r635",
      "r637",
      "r819"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://connexasports.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net loss per share - diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r258",
      "r277",
      "r278",
      "r280",
      "r281",
      "r283",
      "r290",
      "r293",
      "r294",
      "r295",
      "r296",
      "r566",
      "r567",
      "r653",
      "r670",
      "r821"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy",
     "presentation": [
      "http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Goodwill",
        "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined."
       }
      }
     },
     "auth_ref": [
      "r380",
      "r386",
      "r826"
     ]
    },
    "us-gaap_AssetsNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsNoncurrentAbstract",
     "presentation": [
      "http://connexasports.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Current Assets:"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r877"
     ]
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
     "presentation": [
      "http://connexasports.com/role/DiscontinuedOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "DISCONTINUED OPERATIONS",
        "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component."
       }
      }
     },
     "auth_ref": [
      "r118",
      "r178"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://connexasports.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Long-Term Liabilities",
        "label": "Liabilities, Noncurrent",
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r140",
      "r141",
      "r142",
      "r145",
      "r267",
      "r363",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r553",
      "r554",
      "r555",
      "r574",
      "r940",
      "r961",
      "r962"
     ]
    },
    "us-gaap_LegalFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LegalFees",
     "crdr": "debit",
     "presentation": [
      "http://connexasports.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal fees",
        "documentation": "The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings."
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "us-gaap_DerivativeLiabilityFairValueOfCollateral": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeLiabilityFairValueOfCollateral",
     "crdr": "debit",
     "presentation": [
      "http://connexasports.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value derivate liability",
        "documentation": "Fair value of securities pledged as collateral against derivative liabilities."
       }
      }
     },
     "auth_ref": [
      "r246"
     ]
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CostOfGoodsAndServicesSold",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "COST OF SALES",
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities."
       }
      }
     },
     "auth_ref": [
      "r164",
      "r636"
     ]
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r862"
     ]
    },
    "us-gaap_GainLossOnSaleOfOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GainLossOnSaleOfOtherAssets",
     "crdr": "credit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Loss on disposal",
        "label": "Gain (Loss) on Disposition of Other Assets",
        "documentation": "Amount of gain (loss) on sale or disposal of other assets."
       }
      }
     },
     "auth_ref": [
      "r910"
     ]
    },
    "us-gaap_GrossProfit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GrossProfit",
     "crdr": "credit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "GROSS PROFIT",
        "label": "Gross Profit",
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity."
       }
      }
     },
     "auth_ref": [
      "r163",
      "r267",
      "r302",
      "r309",
      "r314",
      "r317",
      "r363",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r574",
      "r823",
      "r940"
     ]
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r862"
     ]
    },
    "us-gaap_AccountsReceivableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsReceivableMember",
     "presentation": [
      "http://connexasports.com/role/ConcentrationOfCreditRiskAndOtherRisksAndUncertaintiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable [Member]",
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold."
       }
      }
     },
     "auth_ref": [
      "r799"
     ]
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]"
       }
      }
     },
     "auth_ref": [
      "r319",
      "r636",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r813",
      "r833",
      "r847",
      "r887",
      "r938",
      "r939",
      "r944",
      "r976"
     ]
    },
    "CNXA_VendorOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "VendorOneMember",
     "presentation": [
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vendor One [Member]",
        "documentation": "Vendor One [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationContingentConsiderationLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://connexasports.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contingent consideration",
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r100"
     ]
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://connexasports.com/role/NotesPayableDetailsNarrative",
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative",
      "http://connexasports.com/role/StatementOfChangesInShareholdersEquityDeficit",
      "http://connexasports.com/role/SubsequentEventsDetailsNarrative",
      "http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r225",
      "r252",
      "r253",
      "r254",
      "r272",
      "r273",
      "r274",
      "r276",
      "r284",
      "r286",
      "r297",
      "r364",
      "r367",
      "r452",
      "r517",
      "r518",
      "r519",
      "r538",
      "r539",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r565",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r588",
      "r679",
      "r680",
      "r681",
      "r702",
      "r769"
     ]
    },
    "CNXA_GamefaceLtdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "GamefaceLtdMember",
     "presentation": [
      "http://connexasports.com/role/StatementOfChangesInShareholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gameface Ltd [Member]",
        "documentation": "Gameface Ltd [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "auth_ref": [
      "r319",
      "r636",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r813",
      "r833",
      "r847",
      "r887",
      "r938",
      "r939",
      "r944",
      "r976"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementAbstract",
     "auth_ref": []
    },
    "us-gaap_DerivativeLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative liability",
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset."
       }
      }
     },
     "auth_ref": [
      "r244",
      "r245",
      "r573",
      "r705",
      "r706",
      "r707",
      "r708",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r739",
      "r741",
      "r742",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791",
      "r818",
      "r979"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsPerBasicShare",
     "presentation": [
      "http://connexasports.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Continuing operations basic",
        "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r159",
      "r204",
      "r206",
      "r258",
      "r275",
      "r277",
      "r278",
      "r280",
      "r281",
      "r290",
      "r293",
      "r294",
      "r567",
      "r653",
      "r975"
     ]
    },
    "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock",
     "presentation": [
      "http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF DERIVATIVE LIABILITIES",
        "documentation": "Tabular disclosure of financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset) using recurring unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r34"
     ]
    },
    "srt_RestatementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RestatementAxis",
     "presentation": [
      "http://connexasports.com/role/BalanceSheets",
      "http://connexasports.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://connexasports.com/role/NotesPayableDetailsNarrative",
      "http://connexasports.com/role/OrganizationAndNatureOfBusinessDetailsNarrative",
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative",
      "http://connexasports.com/role/StatementOfChangesInShareholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Axis]"
       }
      }
     },
     "auth_ref": [
      "r226",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r296",
      "r365",
      "r366",
      "r539",
      "r564",
      "r565",
      "r566",
      "r567",
      "r586",
      "r587",
      "r588",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r692"
     ]
    },
    "CNXA_PlaySightInteractiveLtdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "PlaySightInteractiveLtdMember",
     "presentation": [
      "http://connexasports.com/role/StatementOfChangesInShareholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Play Sight Interactive Ltd [Member]",
        "documentation": "Play Sight Interactive Ltd [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsPerDilutedShare",
     "presentation": [
      "http://connexasports.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Continuing operations diluted",
        "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r159",
      "r258",
      "r275",
      "r277",
      "r278",
      "r280",
      "r281",
      "r290",
      "r293",
      "r294",
      "r295",
      "r567",
      "r653",
      "r975"
     ]
    },
    "srt_RestatementDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RestatementDomain",
     "presentation": [
      "http://connexasports.com/role/BalanceSheets",
      "http://connexasports.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://connexasports.com/role/NotesPayableDetailsNarrative",
      "http://connexasports.com/role/OrganizationAndNatureOfBusinessDetailsNarrative",
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative",
      "http://connexasports.com/role/StatementOfChangesInShareholdersEquityDeficit"
     ],
     "auth_ref": [
      "r226",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r296",
      "r365",
      "r366",
      "r539",
      "r564",
      "r565",
      "r566",
      "r567",
      "r586",
      "r587",
      "r588",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r692"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r867"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 18.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts payable and accrued expenses",
        "documentation": "The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare",
     "presentation": [
      "http://connexasports.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued operations diluted",
        "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r198",
      "r291",
      "r293",
      "r294"
     ]
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://connexasports.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net loss per share - basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r258",
      "r277",
      "r278",
      "r280",
      "r281",
      "r283",
      "r288",
      "r290",
      "r293",
      "r294",
      "r295",
      "r296",
      "r566",
      "r567",
      "r653",
      "r670",
      "r821"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_SlingerBagAmericasIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "SlingerBagAmericasIncMember",
     "presentation": [
      "http://connexasports.com/role/OrganizationAndNatureOfBusinessDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Slinger Bag Americas Inc [Member]",
        "documentation": "Slinger Bag Americas Inc [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MajorCustomersAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MajorCustomersAxis",
     "presentation": [
      "http://connexasports.com/role/ConcentrationOfCreditRiskAndOtherRisksAndUncertaintiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]"
       }
      }
     },
     "auth_ref": [
      "r323",
      "r835",
      "r944",
      "r976",
      "r977"
     ]
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare",
     "presentation": [
      "http://connexasports.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued operations basic",
        "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r161",
      "r258",
      "r291",
      "r293",
      "r294",
      "r970",
      "r975"
     ]
    },
    "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax",
     "crdr": "credit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfOperations": {
       "parentTag": "CNXA_IncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "LOSS FROM DISCONTINUED OPERATIONS",
        "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax",
        "documentation": "Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal."
       }
      }
     },
     "auth_ref": [
      "r120",
      "r121",
      "r122",
      "r123",
      "r124",
      "r131",
      "r161",
      "r974"
     ]
    },
    "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax",
     "crdr": "credit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss from discontinued operations",
        "documentation": "Amount before tax of income (loss) from operations classified as a discontinued operation. Excludes gain (loss) on disposal and provision for gain (loss) until its disposal."
       }
      }
     },
     "auth_ref": [
      "r120",
      "r121",
      "r131"
     ]
    },
    "CNXA_StockPurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "StockPurchaseAgreementMember",
     "presentation": [
      "http://connexasports.com/role/OrganizationAndNatureOfBusinessDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Purchase Agreement [Member]",
        "documentation": "Stock Purchase Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_SoleShareholderofSBLMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "SoleShareholderofSBLMember",
     "presentation": [
      "http://connexasports.com/role/OrganizationAndNatureOfBusinessDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sole Shareholder of SBL [Member]",
        "documentation": "Sole Shareholder of SBL [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_CharlesRuddyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "CharlesRuddyMember",
     "presentation": [
      "http://connexasports.com/role/OrganizationAndNatureOfBusinessDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Charles Ruddy [Member]",
        "documentation": "Charles Ruddy [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_FoundationSportsSystemsLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "FoundationSportsSystemsLLCMember",
     "presentation": [
      "http://connexasports.com/role/AcquisitionsAndBusinessCombinationsDetailsNarrative",
      "http://connexasports.com/role/GoingConcernDetailsNarrative",
      "http://connexasports.com/role/IntangibleAssetsDetailsNarrative",
      "http://connexasports.com/role/OrganizationAndNatureOfBusinessDetailsNarrative",
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foundation Sports Systems LLC [Member]",
        "documentation": "Foundation Sports Systems LLC [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_ProfitGuarantyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "ProfitGuarantyMember",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfDerivativeLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Profit Guaranty [Member]",
        "documentation": "Profit Guaranty [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "crdr": "credit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid expenses and other current assets",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://connexasports.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "NET DECREASE IN CASH AND RESTRICTED CASH",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r170"
     ]
    },
    "CNXA_PlaySightMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "PlaySightMember",
     "presentation": [
      "http://connexasports.com/role/AcquisitionsAndBusinessCombinationsDetailsNarrative",
      "http://connexasports.com/role/GoingConcernDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Play Sight [Member]",
        "documentation": "Play Sight [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r876"
     ]
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effect of exchange rate fluctuations on cash and cash equivalents",
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r954"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "crdr": "debit",
     "presentation": [
      "http://connexasports.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "CASH AND RESTRICTED CASH - BEGINNING OF PERIOD",
        "negatedPeriodEndLabel": "CASH AND RESTRICTED CASH - END OF PERIOD",
        "periodEndLabel": "CASH AND RESTRICTED CASH - END OF PERIOD",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r170",
      "r263"
     ]
    },
    "us-gaap_AmortizationOfDebtDiscountPremium": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AmortizationOfDebtDiscountPremium",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/NotesPayableDetailsNarrative",
      "http://connexasports.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization of debt discounts",
        "verboseLabel": "Amortization of debt discount",
        "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r107",
      "r168",
      "r431"
     ]
    },
    "us-gaap_IncomeTaxAuthorityNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxAuthorityNameAxis",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Authority, Name [Axis]",
        "documentation": "Information by name of taxing authority."
       }
      }
     },
     "auth_ref": [
      "r22"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r860"
     ]
    },
    "CNXA_ConvertibleNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "ConvertibleNotesMember",
     "presentation": [
      "http://connexasports.com/role/ConvertibleNotesPayableDetailsNarrative",
      "http://connexasports.com/role/ScheduleOfDerivativeLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Notes [Member]",
        "documentation": "Convertible Notes [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r866"
     ]
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "presentation": [
      "http://connexasports.com/role/OrganizationAndNatureOfBusinessDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage of ownership",
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting."
       }
      }
     },
     "auth_ref": [
      "r360"
     ]
    },
    "CNXA_UnderwriterWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "UnderwriterWarrantsMember",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfDerivativeLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underwriter Warrants [Member]",
        "documentation": "Underwriter Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_CustomerFourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "CustomerFourMember",
     "presentation": [
      "http://connexasports.com/role/ConcentrationOfCreditRiskAndOtherRisksAndUncertaintiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer Four [Member]",
        "documentation": "Customer Four [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_CustomerTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "CustomerTwoMember",
     "presentation": [
      "http://connexasports.com/role/ConcentrationOfCreditRiskAndOtherRisksAndUncertaintiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer Two [Member]",
        "documentation": "Customer Two [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_WarrantsIssuedWithNotesPayableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "WarrantsIssuedWithNotesPayableMember",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfDerivativeLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Issued With Notes Payable [Member]",
        "documentation": "Warrants Issued With Notes Payable [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_WarrantsIssuedWithCommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "WarrantsIssuedWithCommonStockMember",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfDerivativeLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Issued With Common Stock [Member]",
        "documentation": "Warrants Issued With Common Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RisksAndUncertaintiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RisksAndUncertaintiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Risks and Uncertainties [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxAuthorityNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxAuthorityNameDomain",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r873"
     ]
    },
    "CNXA_OtherDerivativeLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "OtherDerivativeLiabilitiesMember",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfDerivativeLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Derivative Liabilities [Member]",
        "documentation": "Other Derivative Liabilities [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtDisclosureTextBlock",
     "presentation": [
      "http://connexasports.com/role/NotePayable-RelatedParty",
      "http://connexasports.com/role/NotePayableRelatedParty"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NOTE PAYABLE \u2013 RELATED PARTY",
        "verboseLabel": "NOTE PAYABLE - RELATED PARTY",
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants."
       }
      }
     },
     "auth_ref": [
      "r186",
      "r265",
      "r409",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r425",
      "r432",
      "r433",
      "r435"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://connexasports.com/role/NotesPayableDetailsNarrative",
      "http://connexasports.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r582",
      "r598"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://connexasports.com/role/StatementOfChangesInShareholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r517",
      "r518",
      "r519",
      "r702",
      "r915",
      "r916",
      "r917",
      "r949",
      "r981"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r864"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r865"
     ]
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentUnamortizedDiscount",
     "crdr": "debit",
     "presentation": [
      "http://connexasports.com/role/ConvertibleNotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unamortizated discount",
        "documentation": "Amount, after accumulated amortization, of debt discount."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r110",
      "r943"
     ]
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Use of Estimates",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r73",
      "r74",
      "r75",
      "r215",
      "r216",
      "r219",
      "r220"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r869"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://connexasports.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average common shares outstanding - diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r289",
      "r295"
     ]
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://connexasports.com/role/ConvertibleNotesPayableDetailsNarrative",
      "http://connexasports.com/role/NotesPayableDetailsNarrative",
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r143",
      "r144",
      "r201",
      "r202",
      "r271",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r416",
      "r421",
      "r422",
      "r423",
      "r424",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r585",
      "r827",
      "r828",
      "r829",
      "r830",
      "r831",
      "r911"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://connexasports.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average common shares outstanding - basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r288",
      "r295"
     ]
    },
    "country_US": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "US",
     "presentation": [
      "http://connexasports.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentCarryingAmount",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables",
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r202",
      "r436"
     ]
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsOfDebtIssuanceCosts",
     "crdr": "credit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Debt issuance costs on convertible notes payable and other financing activities",
        "label": "Payments of Debt Issuance Costs",
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt."
       }
      }
     },
     "auth_ref": [
      "r59"
     ]
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskPercentage1",
     "presentation": [
      "http://connexasports.com/role/ConcentrationOfCreditRiskAndOtherRisksAndUncertaintiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration risk, percentage",
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r71",
      "r105",
      "r106",
      "r323"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfDerivativeAndWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails",
      "http://connexasports.com/role/ScheduleOfWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://connexasports.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CASH PAID DURING THE PERIOD FOR:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryAdjustments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryAdjustments",
     "crdr": "credit",
     "calculation": {
      "http://connexasports.com/role/ScheduleOfInventoryDetails": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/ScheduleOfInventoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Inventory Reserve",
        "label": "Inventory Adjustments",
        "documentation": "Amount of inventory reserves for last-in first-out (LIFO) and other inventory valuation methods."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r901"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherAssets",
     "crdr": "debit",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfCalculationOfLossOnDisposalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Finished products used in operations",
        "label": "Disposal Group, Including Discontinued Operation, Other Assets",
        "documentation": "Amount classified as other assets attributable to disposal group held for sale or disposed of."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r119",
      "r134",
      "r182"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfCalculationOfLossOnDisposalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease liabilities",
        "documentation": "Amount classified as other liabilities attributable to disposal group held for sale or disposed of."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r119",
      "r134",
      "r182"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract liabilities, net of current portion",
        "documentation": "Amount classified as other liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r10",
      "r119",
      "r134",
      "r182"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration",
     "crdr": "debit",
     "presentation": [
      "http://connexasports.com/role/DiscontinuedOperationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash consideration",
        "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://connexasports.com/role/NotesPayableDetailsNarrative",
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative",
      "http://connexasports.com/role/StatementOfChangesInShareholdersEquityDeficit",
      "http://connexasports.com/role/SubsequentEventsDetailsNarrative",
      "http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r51",
      "r225",
      "r252",
      "r253",
      "r254",
      "r272",
      "r273",
      "r274",
      "r276",
      "r284",
      "r286",
      "r297",
      "r364",
      "r367",
      "r452",
      "r517",
      "r518",
      "r519",
      "r538",
      "r539",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r565",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r588",
      "r679",
      "r680",
      "r681",
      "r702",
      "r769"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://connexasports.com/role/StatementOfChangesInShareholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r225",
      "r272",
      "r273",
      "r274",
      "r276",
      "r284",
      "r286",
      "r364",
      "r367",
      "r517",
      "r518",
      "r519",
      "r538",
      "r539",
      "r556",
      "r558",
      "r559",
      "r561",
      "r565",
      "r679",
      "r681",
      "r702",
      "r981"
     ]
    },
    "us-gaap_TradeAndOtherAccountsReceivablePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TradeAndOtherAccountsReceivablePolicy",
     "presentation": [
      "http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable",
        "documentation": "Disclosure of accounting policy for accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r209",
      "r210",
      "r211",
      "r326",
      "r327",
      "r329"
     ]
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r863"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://connexasports.com/role/StatementOfChangesInShareholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "AOCI Attributable to Parent [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r23",
      "r53",
      "r557",
      "r560",
      "r588",
      "r679",
      "r680",
      "r904",
      "r905",
      "r906",
      "r915",
      "r916",
      "r917"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      },
      "http://connexasports.com/role/ScheduleOfIncomeTaxProvisionDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://connexasports.com/role/ScheduleOfIncomeTaxProvisionDetails",
      "http://connexasports.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Provision for income taxes",
        "totalLabel": "Total income tax provision",
        "verboseLabel": "Total income tax provision",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r212",
      "r222",
      "r285",
      "r286",
      "r306",
      "r529",
      "r541",
      "r671"
     ]
    },
    "CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExpired": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExpired",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfWarrantsIssuedExercisedAndExpiredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Avg. Exercise Price Warrant, Expired",
        "documentation": "Weighted Avg. Exercise Price Warrant, Expired."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TypeOfArrangementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TypeOfArrangementAxis",
     "presentation": [
      "http://connexasports.com/role/ConvertibleNotesPayableDetailsNarrative",
      "http://connexasports.com/role/DiscontinuedOperationsDetailsNarrative",
      "http://connexasports.com/role/NotePayable-RelatedPartyDetailsNarrative",
      "http://connexasports.com/role/NotePayableRelatedPartyDetailsNarrative",
      "http://connexasports.com/role/NotesPayableDetailsNarrative",
      "http://connexasports.com/role/OrganizationAndNatureOfBusinessDetailsNarrative",
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative",
      "http://connexasports.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r551"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeAxis",
     "presentation": [
      "http://connexasports.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://connexasports.com/role/NotesPayableDetailsNarrative",
      "http://connexasports.com/role/OrganizationAndNatureOfBusinessDetailsNarrative",
      "http://connexasports.com/role/ScheduleOfDerivativeAndWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails",
      "http://connexasports.com/role/ScheduleOfWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails",
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r395",
      "r396",
      "r397",
      "r398",
      "r466",
      "r479",
      "r512",
      "r513",
      "r514",
      "r606",
      "r630",
      "r678",
      "r713",
      "r714",
      "r777",
      "r779",
      "r781",
      "r782",
      "r792",
      "r810",
      "r811",
      "r824",
      "r832",
      "r845",
      "r848",
      "r851",
      "r934",
      "r942",
      "r964",
      "r965",
      "r966",
      "r967",
      "r968"
     ]
    },
    "us-gaap_IncreaseDecreaseInInterestPayableNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInInterestPayableNet",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 21.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accrued interest",
        "label": "Increase (Decrease) in Interest Payable, Net",
        "documentation": "The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MaximumMember",
     "presentation": [
      "http://connexasports.com/role/NotesPayableDetailsNarrative",
      "http://connexasports.com/role/ScheduleOfDerivativeAndWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails",
      "http://connexasports.com/role/ScheduleOfWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails",
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]"
       }
      }
     },
     "auth_ref": [
      "r395",
      "r396",
      "r397",
      "r398",
      "r479",
      "r630",
      "r678",
      "r713",
      "r714",
      "r777",
      "r779",
      "r781",
      "r782",
      "r792",
      "r810",
      "r811",
      "r824",
      "r832",
      "r845",
      "r848",
      "r942",
      "r963",
      "r964",
      "r965",
      "r966",
      "r967",
      "r968"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeMember",
     "presentation": [
      "http://connexasports.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://connexasports.com/role/NotesPayableDetailsNarrative",
      "http://connexasports.com/role/OrganizationAndNatureOfBusinessDetailsNarrative",
      "http://connexasports.com/role/ScheduleOfDerivativeAndWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails",
      "http://connexasports.com/role/ScheduleOfWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails",
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "auth_ref": [
      "r395",
      "r396",
      "r397",
      "r398",
      "r466",
      "r479",
      "r512",
      "r513",
      "r514",
      "r606",
      "r630",
      "r678",
      "r713",
      "r714",
      "r777",
      "r779",
      "r781",
      "r782",
      "r792",
      "r810",
      "r811",
      "r824",
      "r832",
      "r845",
      "r848",
      "r851",
      "r934",
      "r942",
      "r964",
      "r965",
      "r966",
      "r967",
      "r968"
     ]
    },
    "us-gaap_DerivativeFairValueOfDerivativeNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeFairValueOfDerivativeNet",
     "crdr": "debit",
     "presentation": [
      "http://connexasports.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value of derivative liability",
        "documentation": "Fair value of the assets less the liabilities of a derivative or group of derivatives."
       }
      }
     },
     "auth_ref": [
      "r573"
     ]
    },
    "CNXA_WarrantsIssuedToPurchaseOfCommonStockShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "WarrantsIssuedToPurchaseOfCommonStockShares",
     "presentation": [
      "http://connexasports.com/role/ConvertibleNotesPayableDetailsNarrative",
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants issued to purchase of common stock, shares",
        "verboseLabel": "[custom:WarrantsIssuedToPurchaseOfCommonStockShares-0]",
        "documentation": "Warrants issued to purchase of common stock shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherNotesPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherNotesPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://connexasports.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current portion of notes payable, net of discount",
        "documentation": "Amount of long-term notes classified as other, payable within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "CNXA_PaymentForExchangeOfNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "PaymentForExchangeOfNotesPayable",
     "crdr": "debit",
     "presentation": [
      "http://connexasports.com/role/NotePayableRelatedPartyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payment of exchange"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherIntangibleAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherIntangibleAssetsNet",
     "crdr": "debit",
     "presentation": [
      "http://connexasports.com/role/IntangibleAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other intangible assets",
        "documentation": "Amount after accumulated amortization of finite-lived and indefinite-lived intangible assets classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MinimumMember",
     "presentation": [
      "http://connexasports.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://connexasports.com/role/OrganizationAndNatureOfBusinessDetailsNarrative",
      "http://connexasports.com/role/ScheduleOfDerivativeAndWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails",
      "http://connexasports.com/role/ScheduleOfWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]"
       }
      }
     },
     "auth_ref": [
      "r395",
      "r396",
      "r397",
      "r398",
      "r479",
      "r630",
      "r678",
      "r713",
      "r714",
      "r777",
      "r779",
      "r781",
      "r782",
      "r792",
      "r810",
      "r811",
      "r824",
      "r832",
      "r845",
      "r848",
      "r942",
      "r963",
      "r964",
      "r965",
      "r966",
      "r967",
      "r968"
     ]
    },
    "CNXA_WarrantsExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "WarrantsExercisePrice",
     "presentation": [
      "http://connexasports.com/role/ConvertibleNotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants exercise price",
        "documentation": "Warrants exercise price."
       }
      }
     },
     "auth_ref": []
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "EquityMethodInvesteeNameDomain",
     "presentation": [
      "http://connexasports.com/role/OrganizationAndNatureOfBusinessDetailsNarrative"
     ],
     "auth_ref": [
      "r360",
      "r361",
      "r362"
     ]
    },
    "us-gaap_InterestPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://connexasports.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/BalanceSheets",
      "http://connexasports.com/role/NotePayable-RelatedPartyDetailsNarrative",
      "http://connexasports.com/role/NotePayableRelatedPartyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued interest",
        "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "CNXA_RemainingDerivativeLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "RemainingDerivativeLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/ConvertibleNotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Derivative liabilities",
        "documentation": "Remaining derivative liabilities.",
        "label": "RemainingDerivativeLiabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillImpairmentLoss",
     "crdr": "debit",
     "presentation": [
      "http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill impairment charges",
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r382",
      "r384",
      "r386",
      "r826"
     ]
    },
    "CNXA_SecuritiesOutstandingRateConvertibleNotesDescripition": {
     "xbrltype": "stringItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "SecuritiesOutstandingRateConvertibleNotesDescripition",
     "presentation": [
      "http://connexasports.com/role/ConvertibleNotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible note description",
        "documentation": "Securities outstanding rate convertible notes descripition."
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_LossOnIssuanceOfConvertibleNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "LossOnIssuanceOfConvertibleNotes",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/ConvertibleNotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Loss on issuance of convertible notes",
        "documentation": "Loss on issuance of convertible notes.",
        "label": "LossOnIssuanceOfConvertibleNotes"
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_NumberOfConsignedGoods": {
     "xbrltype": "integerItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "NumberOfConsignedGoods",
     "presentation": [
      "http://connexasports.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consignment units",
        "documentation": "Number of consigned goods."
       }
      }
     },
     "auth_ref": []
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://connexasports.com/role/NotesPayableDetailsNarrative",
      "http://connexasports.com/role/OrganizationAndNatureOfBusinessDetailsNarrative",
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r423",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r603",
      "r604",
      "r605",
      "r828",
      "r829",
      "r836",
      "r837",
      "r838"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "presentation": [
      "http://connexasports.com/role/IncomeTaxesDetailsNarrative",
      "http://connexasports.com/role/ScheduleOfIncomeTaxProvisionDetailsParenthetical",
      "http://connexasports.com/role/ScheduleOfNetDeferredTaxAssetsDetailsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective tax rate",
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)."
       }
      }
     },
     "auth_ref": [
      "r268",
      "r530",
      "r542"
     ]
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeGainLossOnDerivativeNet",
     "crdr": "credit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/ScheduleOfDerivativeLiabilitiesDetails",
      "http://connexasports.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Change in fair value of derivative liability",
        "negatedTerseLabel": "Note derivative (gain) loss",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement."
       }
      }
     },
     "auth_ref": [
      "r948"
     ]
    },
    "CNXA_PaymentsOfRelatedPartyDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "PaymentsOfRelatedPartyDebt",
     "crdr": "debit",
     "presentation": [
      "http://connexasports.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Repayments of notes - related party"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "crdr": "credit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 2.0
      },
      "http://connexasports.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/NotesPayableDetailsNarrative",
      "http://connexasports.com/role/StatementsOfCashFlows",
      "http://connexasports.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss on extinguishment of debt",
        "negatedLabel": "Loss on extinguishment of debt",
        "verboseLabel": "Extinguishment of debt",
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r83",
      "r84"
     ]
    },
    "CNXA_IncreaseDecreaseInDerivativeFairValueLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "IncreaseDecreaseInDerivativeFairValueLiability",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Derivative liability",
        "label": "IncreaseDecreaseInDerivativeFairValueLiability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment of Intangible Assets (Excluding Goodwill)",
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r35"
     ]
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "presentation": [
      "http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment of Long-Lived Assets",
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r184"
     ]
    },
    "CNXA_CashLessFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "CashLessFees",
     "crdr": "debit",
     "presentation": [
      "http://connexasports.com/role/NotesPayableDetailsNarrative",
      "http://connexasports.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash less fees",
        "documentation": "Cash less fees."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "presentation": [
      "http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign Currency Translation",
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy."
       }
      }
     },
     "auth_ref": [
      "r575"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and administrative expenses",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r166",
      "r748"
     ]
    },
    "CNXA_DeferredTaxAssetsStockOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "DeferredTaxAssetsStockOptions",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/ScheduleOfNetDeferredTaxAssetsDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/ScheduleOfNetDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock options",
        "documentation": "Deferred tax assets stock options."
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceForfeited": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceForfeited",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfWarrantsIssuedExercisedAndExpiredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Avg. Exercise Price Warrant, Forfeited",
        "documentation": "Share based compensation arrangement by share based payment award non option equity instruments weighted average exercise price forfeited."
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_SharesIssuedPricePerShares": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "SharesIssuedPricePerShares",
     "presentation": [
      "http://connexasports.com/role/NotesPayableDetailsNarrative",
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:SharesIssuedPricePerShares-0]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r516",
      "r524"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/BalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://connexasports.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL ASSETS",
        "label": "Assets",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r200",
      "r237",
      "r267",
      "r302",
      "r310",
      "r315",
      "r363",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r552",
      "r554",
      "r574",
      "r657",
      "r738",
      "r846",
      "r859",
      "r940",
      "r941",
      "r961"
     ]
    },
    "CNXA_StockIssuedDuringPeriodSharesIssuedSettlementWithFormerOwners": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "StockIssuedDuringPeriodSharesIssuedSettlementWithFormerOwners",
     "presentation": [
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative",
      "http://connexasports.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock issued during period, shares, issued for settlement with former owners",
        "verboseLabel": "[custom:StockIssuedDuringPeriodSharesIssuedSettlementWithFormerOwners]",
        "documentation": "Stock issued during period shares issued settlement with former owners."
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_StockIssuedDuringPeriodSharesIssuedSettlementOfAccountsPayable": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "StockIssuedDuringPeriodSharesIssuedSettlementOfAccountsPayable",
     "presentation": [
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative",
      "http://connexasports.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock issued during period, shares, issued for settlement of accounts payable",
        "verboseLabel": "[custom:StockIssuedDuringPeriodSharesIssuedSettlementOfAccountsPayable]",
        "documentation": "Stock issued during period shares issued settlement of accounts payable."
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_FairValueOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "FairValueOfCommonStock",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value of common stock",
        "documentation": "Fair value of common stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestorMember",
     "presentation": [
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investor [Member]",
        "documentation": "Business entity or individual that puts money, by purchase or expenditure, in something offering potential profitable returns, such as interest income or appreciation in value."
       }
      }
     },
     "auth_ref": [
      "r957",
      "r958"
     ]
    },
    "srt_NameOfMajorCustomerDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "NameOfMajorCustomerDomain",
     "presentation": [
      "http://connexasports.com/role/ConcentrationOfCreditRiskAndOtherRisksAndUncertaintiesDetailsNarrative"
     ],
     "auth_ref": [
      "r323",
      "r835",
      "r944",
      "r976",
      "r977"
     ]
    },
    "CNXA_StockIssuedDuringPeriodSharesIssuedProfitGuaranteeOnNote": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "StockIssuedDuringPeriodSharesIssuedProfitGuaranteeOnNote",
     "presentation": [
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative",
      "http://connexasports.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Profit guarantee on note, shares",
        "verboseLabel": "[custom:StockIssuedDuringPeriodSharesIssuedProfitGuaranteeOnNote]",
        "documentation": "Stock issued during period shares issued profit guarantee on note."
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_WarrantPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "WarrantPerShare",
     "presentation": [
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:WarrantPerShare-0]",
        "documentation": "Warrant per share."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Share-based compensation",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfWarrantsIssuedExercisedAndExpiredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Avg. Exercise Price Warrant, Exercised",
        "documentation": "Weighted Avg. Exercise Price Warrant, Exercised."
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_DisposalGroupIncludingDiscontinuedOperationNetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "DisposalGroupIncludingDiscontinuedOperationNetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://connexasports.com/role/ScheduleOfDiscontinuedOperationsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://connexasports.com/role/ScheduleOfDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net loss from discontinued operations",
        "documentation": "Net income loss.",
        "label": "DisposalGroupIncludingDiscontinuedOperationNetIncomeLoss"
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_DisposalGroupIncludingDiscontinuedOperationOtherIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherIncomeLoss",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/ScheduleOfDiscontinuedOperationsDetails": {
       "parentTag": "CNXA_DisposalGroupIncludingDiscontinuedOperationNetIncomeLoss",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/ScheduleOfDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other (income) loss",
        "documentation": "Other income loss."
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceIssued": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceIssued",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfWarrantsIssuedExercisedAndExpiredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Avg. Exercise Price Warrant, Issued",
        "documentation": "Weighted Avg. Exercise Price Warrant, Issued."
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetOperatingLeasesCurrent",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/ScheduleOfDiscontinuedOperationsDetails": {
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/ScheduleOfDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right of use asset \u2013 operating leases",
        "documentation": "Right of use asset \u2013 operating leases."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesIssuedForServices",
     "presentation": [
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative",
      "http://connexasports.com/role/StatementOfChangesInShareholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Services, shares",
        "verboseLabel": "Shares issued for services",
        "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders."
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityOperatingLeasesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "DisposalGroupIncludingDiscontinuedOperationLeaseLiabilityOperatingLeasesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://connexasports.com/role/ScheduleOfDiscontinuedOperationsDetails": {
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/ScheduleOfDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease liability \u2013 operating leases",
        "documentation": "Lease liability \u2013 operating leases."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueIssuedForServices",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/StatementOfChangesInShareholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Services",
        "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders."
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_SharesIssuedAndOutstandingPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "SharesIssuedAndOutstandingPercentage",
     "presentation": [
      "http://connexasports.com/role/DiscontinuedOperationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares issued and outstanding percentage",
        "documentation": "Shares issued and outstanding percentage."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockMember",
     "presentation": [
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative",
      "http://connexasports.com/role/StatementOfChangesInShareholdersEquityDeficit",
      "http://connexasports.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r849",
      "r850",
      "r851",
      "r853",
      "r854",
      "r855",
      "r856",
      "r915",
      "r916",
      "r949",
      "r978",
      "r981"
     ]
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInInventories",
     "crdr": "credit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Inventories",
        "label": "Increase (Decrease) in Inventories",
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "CNXA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOutstanding",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfWarrantsIssuedExercisedAndExpiredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Weighted Avg. Exercise Price Warrant, Beginning Balance",
        "periodEndLabel": "Weighted Avg. Exercise Price Warrant, Ending Balance",
        "documentation": "Weighted Avg. Exercise Price Warrant, Balance.",
        "label": "Weighted Avg. Exercise Price Warrant, Balance"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r862"
     ]
    },
    "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionsProFormaNetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfProformaFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net loss",
        "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period."
       }
      }
     },
     "auth_ref": [
      "r546",
      "r547"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "presentation": [
      "http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue Recognition",
        "documentation": "Disclosure of accounting policy for revenue from contract with customer."
       }
      }
     },
     "auth_ref": [
      "r224",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r812"
     ]
    },
    "CNXA_GamefaceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "GamefaceMember",
     "presentation": [
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gameface [Member]",
        "documentation": "Gameface [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r862"
     ]
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "presentation": [
      "http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment",
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost."
       }
      }
     },
     "auth_ref": [
      "r486",
      "r490",
      "r509",
      "r510",
      "r511",
      "r512",
      "r515",
      "r520",
      "r521",
      "r522",
      "r523"
     ]
    },
    "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
     "presentation": [
      "http://connexasports.com/role/DiscontinuedOperationsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF DISCONTINUED OPERATIONS",
        "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r33",
      "r39",
      "r119",
      "r125",
      "r126",
      "r127",
      "r129",
      "r130",
      "r135",
      "r136",
      "r137",
      "r183"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r879"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 3.0
      },
      "http://connexasports.com/role/ScheduleOfEstimatedFutureAmortizationDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://connexasports.com/role/BalanceSheets",
      "http://connexasports.com/role/ScheduleOfEstimatedFutureAmortizationDetails",
      "http://connexasports.com/role/ScheduleOfIntangibleAssetsDetails",
      "http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible assets, net of amortization",
        "verboseLabel": "Impaired intangible assets",
        "periodEndLabel": "Finite-Lived Intangible Assets, Net, Ending Balance",
        "totalLabel": "Total",
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r176",
      "r637"
     ]
    },
    "us-gaap_Goodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Goodwill",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill",
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r235",
      "r381",
      "r651",
      "r826",
      "r846",
      "r929",
      "r930"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsGross",
     "crdr": "debit",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Finite-Lived Intangible Assets, Gross",
        "label": "Finite-Lived Intangible Assets, Gross",
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r176",
      "r638"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "presentation": [
      "http://connexasports.com/role/NotesPayableDetailsNarrative",
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock exercisable, shares",
        "verboseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan."
       }
      }
     },
     "auth_ref": [
      "r493"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://connexasports.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SHAREHOLDERS\u2019 EQUITY (DEFICIT)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "presentation": [
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares."
       }
      }
     },
     "auth_ref": [
      "r451"
     ]
    },
    "us-gaap_NotesIssued1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NotesIssued1",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note receivable issued in sale of PlaySight",
        "documentation": "The fair value of notes issued in noncash investing and financing activities."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r64",
      "r65"
     ]
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://connexasports.com/role/ShareholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "SHAREHOLDERS\u2019 EQUITY (DEFICIT)",
        "label": "Equity [Text Block]",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r188",
      "r266",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r450",
      "r452",
      "r563",
      "r772",
      "r774",
      "r796"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative",
      "http://connexasports.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r487",
      "r488",
      "r489",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515"
     ]
    },
    "us-gaap_StockIssued1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssued1",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares issued in connection with acquisition",
        "documentation": "The fair value of stock issued in noncash financing activities."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r64",
      "r65"
     ]
    },
    "us-gaap_StockholdersEquityNoteStockSplit": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityNoteStockSplit",
     "presentation": [
      "http://connexasports.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note, Stock Split",
        "documentation": "Description of the stock split arrangement. Also provide the retroactive effect given by a stock split that occurs after the balance date but before the release of financial statements."
       }
      }
     },
     "auth_ref": [
      "r190"
     ]
    },
    "us-gaap_StockholdersEquityReverseStockSplit": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityReverseStockSplit",
     "presentation": [
      "http://connexasports.com/role/OrganizationAndNatureOfBusinessDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Reverse Stock Split",
        "documentation": "Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements."
       }
      }
     },
     "auth_ref": [
      "r190"
     ]
    },
    "us-gaap_PurchaseObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PurchaseObligation",
     "crdr": "credit",
     "calculation": {
      "http://connexasports.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related party purchase obligation",
        "documentation": "Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressesTable",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Table]",
        "documentation": "Container of address information for the entity"
       }
      }
     },
     "auth_ref": [
      "r862"
     ]
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/ScheduleOfIncomeTaxProvisionDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/ScheduleOfIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Valuation allowance",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r945"
     ]
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredFinanceCostsNet",
     "crdr": "debit",
     "presentation": [
      "http://connexasports.com/role/ConvertibleNotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt issuance cost",
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs."
       }
      }
     },
     "auth_ref": [
      "r109",
      "r943"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeInstrumentRiskAxis",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfDerivativeLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instrument [Axis]",
        "documentation": "Information by type of derivative contract."
       }
      }
     },
     "auth_ref": [
      "r101",
      "r102",
      "r103",
      "r104",
      "r712",
      "r714",
      "r728",
      "r729",
      "r730",
      "r734",
      "r735",
      "r736",
      "r737",
      "r739",
      "r740",
      "r741",
      "r742",
      "r757",
      "r758",
      "r759",
      "r760",
      "r763",
      "r764",
      "r765",
      "r766",
      "r784",
      "r785",
      "r788",
      "r790",
      "r818",
      "r849",
      "r851"
     ]
    },
    "CNXA_SharePurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "SharePurchaseAgreementMember",
     "presentation": [
      "http://connexasports.com/role/DiscontinuedOperationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Purchase Agreement [Member]",
        "documentation": "Share Purchase Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "presentation": [
      "http://connexasports.com/role/ConcentrationOfCreditRiskAndOtherRisksAndUncertaintiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Benchmark [Axis]",
        "documentation": "Information by benchmark of concentration risk."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r71",
      "r105",
      "r106",
      "r323",
      "r689",
      "r799"
     ]
    },
    "us-gaap_ComputerSoftwareIntangibleAssetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComputerSoftwareIntangibleAssetMember",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Computer Software, Intangible Asset [Member]",
        "documentation": "Collection of computer programs and related data that provide instructions to a computer, for example, but not limited to, application program, control module or operating system, that perform one or more particular functions or tasks."
       }
      }
     },
     "auth_ref": [
      "r815",
      "r931",
      "r932"
     ]
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://connexasports.com/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUBSEQUENT EVENTS",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r597",
      "r599"
     ]
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskByTypeAxis",
     "presentation": [
      "http://connexasports.com/role/ConcentrationOfCreditRiskAndOtherRisksAndUncertaintiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Type [Axis]",
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r71",
      "r105",
      "r106",
      "r323",
      "r799",
      "r883"
     ]
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskBenchmarkDomain",
     "presentation": [
      "http://connexasports.com/role/ConcentrationOfCreditRiskAndOtherRisksAndUncertaintiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r71",
      "r105",
      "r106",
      "r323",
      "r799"
     ]
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskLineItems",
     "presentation": [
      "http://connexasports.com/role/ConcentrationOfCreditRiskAndOtherRisksAndUncertaintiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r799"
     ]
    },
    "us-gaap_InterestPayableCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestPayableCurrentAndNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/ConvertibleNotesPayableDetailsNarrative",
      "http://connexasports.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest payable",
        "verboseLabel": "Accrued interest - related party",
        "documentation": "Amount of interest payable on debt, including, but not limited to, trade payables."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r971"
     ]
    },
    "us-gaap_ConcentrationRiskTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskTable",
     "presentation": [
      "http://connexasports.com/role/ConcentrationOfCreditRiskAndOtherRisksAndUncertaintiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk [Table]",
        "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r69",
      "r71",
      "r72",
      "r105",
      "r199",
      "r799"
     ]
    },
    "us-gaap_ConcentrationRiskDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskDisclosureTextBlock",
     "presentation": [
      "http://connexasports.com/role/ConcentrationOfCreditRiskAndOtherRisksAndUncertainties"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CONCENTRATION OF CREDIT RISK AND OTHER RISKS AND UNCERTAINTIES",
        "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r174"
     ]
    },
    "us-gaap_PaymentsForRent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsForRent",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rent expense",
        "documentation": "Cash payments to lessor's for use of assets under operating leases."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/StatementOfChangesInShareholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based compensation",
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r91",
      "r146",
      "r147",
      "r189"
     ]
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "presentation": [
      "http://connexasports.com/role/OrganizationAndNatureOfBusiness"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ORGANIZATION AND NATURE OF BUSINESS",
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure."
       }
      }
     },
     "auth_ref": [
      "r117",
      "r197",
      "r690",
      "r691"
     ]
    },
    "us-gaap_InventoryRawMaterialsAndSupplies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryRawMaterialsAndSupplies",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/ScheduleOfInventoryDetails": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/ScheduleOfInventoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Component/Replacement Parts",
        "documentation": "Gross amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed."
       }
      }
     },
     "auth_ref": [
      "r901"
     ]
    },
    "us-gaap_LongTermNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermNotesPayable",
     "crdr": "credit",
     "calculation": {
      "http://connexasports.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes payable related parties, net of current portion",
        "documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion."
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative",
      "http://connexasports.com/role/StatementOfChangesInShareholdersEquityDeficit",
      "http://connexasports.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash",
        "verboseLabel": "Number of shares issued during the period",
        "terseLabel": "Stock Issued During Period, Value, New Issues",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r146",
      "r147",
      "r189",
      "r702",
      "r769",
      "r794",
      "r858"
     ]
    },
    "us-gaap_SharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharesIssued",
     "presentation": [
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative",
      "http://connexasports.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares, issued",
        "verboseLabel": "Shares, Issued",
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://connexasports.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts payable",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r41",
      "r846"
     ]
    },
    "us-gaap_FinancialInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinancialInstrumentAxis",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails",
      "http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instrument [Axis]",
        "documentation": "Information by type of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r434",
      "r449",
      "r562",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r668",
      "r825",
      "r891",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r921",
      "r922",
      "r923",
      "r924"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueAcquisitions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueAcquisitions",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative",
      "http://connexasports.com/role/StatementOfChangesInShareholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquisition",
        "verboseLabel": "Stock Issued During Period, Value, Acquisitions",
        "documentation": "Value of stock issued pursuant to acquisitions during the period."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r51",
      "r189"
     ]
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 1.0
      },
      "http://connexasports.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/StatementOfChangesInShareholdersEquityDeficit",
      "http://connexasports.com/role/StatementsOfCashFlows",
      "http://connexasports.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "NET LOSS",
        "label": "Net loss for the period",
        "verboseLabel": "Net loss",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r162",
      "r172",
      "r207",
      "r230",
      "r247",
      "r249",
      "r254",
      "r267",
      "r275",
      "r277",
      "r278",
      "r280",
      "r281",
      "r285",
      "r286",
      "r292",
      "r302",
      "r309",
      "r314",
      "r317",
      "r363",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r567",
      "r574",
      "r667",
      "r746",
      "r767",
      "r768",
      "r823",
      "r857",
      "r940"
     ]
    },
    "us-gaap_AccountsPayableOtherCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableOtherCurrent",
     "crdr": "credit",
     "calculation": {
      "http://connexasports.com/role/ScheduleOfAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/ScheduleOfAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other accrued expenses",
        "documentation": "Amount of obligations incurred classified as other, payable within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative",
      "http://connexasports.com/role/StatementOfChangesInShareholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of notes payable",
        "verboseLabel": "Stock Issued During Period, Value, Conversion of Convertible Securities",
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r51",
      "r189"
     ]
    },
    "us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems",
     "presentation": [
      "http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r928"
     ]
    },
    "us-gaap_AccruedBonusesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedBonusesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://connexasports.com/role/ScheduleOfAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/ScheduleOfAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued bonus",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for incentive compensation awarded to employees and directors or earned by them based on the terms of one or more relevant arrangements. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://connexasports.com/role/NotesPayableDetailsNarrative",
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative",
      "http://connexasports.com/role/StatementOfChangesInShareholdersEquityDeficit",
      "http://connexasports.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, shares",
        "verboseLabel": "Shares issued",
        "terseLabel": "Number of common stock, shares issued",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r146",
      "r147",
      "r189",
      "r695",
      "r769",
      "r794"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentOfWarrantsGrantedForServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentOfWarrantsGrantedForServices",
     "crdr": "debit",
     "presentation": [
      "http://connexasports.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants granted",
        "documentation": "Adjustment for noncash service expenses paid for by granting of warrants."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLossCarryforwardsTable",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Loss Carryforwards [Table]",
        "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization."
       }
      }
     },
     "auth_ref": [
      "r92"
     ]
    },
    "us-gaap_NotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NotesPayable",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/NotePayable-RelatedPartyDetailsNarrative",
      "http://connexasports.com/role/NotePayableRelatedPartyDetailsNarrative",
      "http://connexasports.com/role/NotesPayableDetailsNarrative",
      "http://connexasports.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding borrowings",
        "verboseLabel": "Note payable",
        "terseLabel": "Outstanding notes payable",
        "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r202",
      "r972"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "presentation": [
      "http://connexasports.com/role/StatementOfChangesInShareholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based compensation, shares",
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r146",
      "r147",
      "r189"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherCurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOtherCurrentLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other current liabilities",
        "label": "Increase (Decrease) in Other Current Liabilities",
        "documentation": "Amount of increase (decrease) in current liabilities classified as other."
       }
      }
     },
     "auth_ref": [
      "r909"
     ]
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLossCarryforwardsLineItems",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Loss Carryforwards [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RepaymentsOfNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RepaymentsOfNotesPayable",
     "crdr": "credit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payments of notes payable",
        "label": "Repayments of Notes Payable",
        "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation."
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://connexasports.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r146",
      "r147",
      "r189",
      "r496"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r423",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r569",
      "r605",
      "r828",
      "r829",
      "r836",
      "r837",
      "r838"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "presentation": [
      "http://connexasports.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative",
      "http://connexasports.com/role/StatementOfChangesInShareholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquisitions, shares",
        "verboseLabel": "Shares issued for acquisition",
        "terseLabel": "Number of stock issued",
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions."
       }
      }
     },
     "auth_ref": [
      "r146",
      "r147",
      "r189"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfOperations": {
       "parentTag": "CNXA_IncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "NET LOSS FROM CONTINUING OPERATIONS BEFORE PROVISION FOR INCOME TAXES",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r160",
      "r205",
      "r302",
      "r309",
      "r314",
      "r317",
      "r654",
      "r666",
      "r823"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "presentation": [
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative",
      "http://connexasports.com/role/StatementOfChangesInShareholdersEquityDeficit",
      "http://connexasports.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of notes payable, shares",
        "verboseLabel": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "terseLabel": "Conversion of convertible securities",
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r50",
      "r85",
      "r189",
      "r426"
     ]
    },
    "us-gaap_RepaymentsOfOtherDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RepaymentsOfOtherDebt",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt repayment",
        "documentation": "Amount of cash outflow for the payment of debt classified as other."
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
     "presentation": [
      "http://connexasports.com/role/OrganizationAndNatureOfBusinessDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of shares issued for acquisition",
        "documentation": "Number of shares of equity interests issued or issuable to acquire entity."
       }
      }
     },
     "auth_ref": [
      "r196"
     ]
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://connexasports.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://connexasports.com/role/ScheduleOfAccruedExpensesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://connexasports.com/role/BalanceSheets",
      "http://connexasports.com/role/ScheduleOfAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued expenses",
        "totalLabel": "Total",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fixed assets, net of depreciation",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r655",
      "r665",
      "r846"
     ]
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid expenses and other current assets",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r903"
     ]
    },
    "us-gaap_BusinessAcquisitionsProFormaRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionsProFormaRevenue",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfProformaFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues",
        "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period."
       }
      }
     },
     "auth_ref": [
      "r546",
      "r547"
     ]
    },
    "CNXA_LoanAndSecurityAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "LoanAndSecurityAgreementMember",
     "presentation": [
      "http://connexasports.com/role/NotesPayableDetailsNarrative",
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loan and Security Agreement [Member]",
        "documentation": "Loan and Security Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal",
     "presentation": [
      "http://connexasports.com/role/AcquisitionsAndBusinessCombinationsDetailsNarrative",
      "http://connexasports.com/role/GoingConcernDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment retained after disposal, ownership interest after disposal",
        "verboseLabel": "Discontinuing operations percentage",
        "documentation": "Percent, after disposal, of ownership interest of a discontinued operation in which an equity method investment is retained."
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationInventoryCurrent",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/ScheduleOfDiscontinuedOperationsDetails": {
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/ScheduleOfDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Inventory",
        "label": "Disposal Group, Including Discontinued Operation, Inventory, Current",
        "documentation": "Amount classified as inventory attributable to disposal group, expected to be disposed of within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r119",
      "r134",
      "r179",
      "r182"
     ]
    },
    "us-gaap_CustomerRelationshipsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CustomerRelationshipsMember",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer Relationships [Member]",
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships."
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "CNXA_CustomerOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "CustomerOneMember",
     "presentation": [
      "http://connexasports.com/role/ConcentrationOfCreditRiskAndOtherRisksAndUncertaintiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer One [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Cash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Cash",
     "crdr": "debit",
     "presentation": [
      "http://connexasports.com/role/DiscontinuedOperationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cash",
        "label": "Cash [Default Label]",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r213",
      "r659",
      "r703",
      "r731",
      "r846",
      "r859",
      "r899"
     ]
    },
    "CNXA_TradeNamesAndPatentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "TradeNamesAndPatentsMember",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade Names And Patents [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://connexasports.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ASSETS"
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_IntangiableAssetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "IntangiableAssetMember",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangiable Asset [Member]",
        "documentation": "Intangiable Asset [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/ScheduleOfDiscontinuedOperationsDetails": {
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/ScheduleOfCalculationOfLossOnDisposalDetails",
      "http://connexasports.com/role/ScheduleOfDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and restricted cash",
        "negatedLabel": "Cash and restricted cash",
        "documentation": "Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r119",
      "r134",
      "r182"
     ]
    },
    "CNXA_LoanAgreementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "LoanAgreementsMember",
     "presentation": [
      "http://connexasports.com/role/NotePayable-RelatedPartyDetailsNarrative",
      "http://connexasports.com/role/NotePayableRelatedPartyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loan Agreements [Member]",
        "documentation": "Loan Agreements [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/ScheduleOfDiscontinuedOperationsDetails": {
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/ScheduleOfCalculationOfLossOnDisposalDetails",
      "http://connexasports.com/role/ScheduleOfDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts receivable",
        "verboseLabel": "Note receivable",
        "documentation": "Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r119",
      "r134",
      "r182"
     ]
    },
    "CNXA_MonteCarloSimulationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "MonteCarloSimulationMember",
     "presentation": [
      "http://connexasports.com/role/ConvertibleNotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Monte Carlo Simulation [Member]",
        "documentation": "Monte Carlo Simulation [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementLineItems",
     "presentation": [
      "http://connexasports.com/role/BalanceSheets",
      "http://connexasports.com/role/IncomeTaxesDetailsNarrative",
      "http://connexasports.com/role/IncomeTaxesTables",
      "http://connexasports.com/role/ScheduleOfIncomeTaxProvisionDetailsParenthetical",
      "http://connexasports.com/role/ScheduleOfNetDeferredTaxAssetsDetails",
      "http://connexasports.com/role/ScheduleOfNetDeferredTaxAssetsDetailsParenthetical",
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative",
      "http://connexasports.com/role/StatementOfChangesInShareholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r272",
      "r273",
      "r274",
      "r297",
      "r636",
      "r693",
      "r704",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r723",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r734",
      "r735",
      "r736",
      "r737",
      "r739",
      "r740",
      "r741",
      "r742",
      "r743",
      "r745",
      "r747",
      "r748",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764",
      "r765",
      "r766",
      "r769",
      "r852"
     ]
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PayablesAndAccrualsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_SecuritiesPurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "SecuritiesPurchaseAgreementMember",
     "presentation": [
      "http://connexasports.com/role/ConvertibleNotesPayableDetailsNarrative",
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities Purchase Agreement [Member]",
        "documentation": "Securities Purchase Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Amortization of debt discounts",
        "label": "Amortization of Debt Issuance Costs and Discounts",
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r431",
      "r584",
      "r830",
      "r831",
      "r910"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://connexasports.com/role/ScheduleOfDiscontinuedOperationsDetails": {
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/ScheduleOfDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Contract liabilities",
        "label": "Disposal Group, Including Discontinued Operation, Other Liabilities, Current",
        "documentation": "Amount classified as other liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r119",
      "r134",
      "r179",
      "r182"
     ]
    },
    "CNXA_OmnibusAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "OmnibusAgreementMember",
     "presentation": [
      "http://connexasports.com/role/ConvertibleNotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Omnibus Agreement [Member]",
        "documentation": "Omnibus Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_PromissoryNotePayableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "PromissoryNotePayableMember",
     "presentation": [
      "http://connexasports.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Promissory Note Payable [Member]",
        "documentation": "Promissory Note Payable [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_NotesPayableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "NotesPayableMember",
     "presentation": [
      "http://connexasports.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes Payable [Member]",
        "documentation": "Notes Payable [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharesOutstanding",
     "presentation": [
      "http://connexasports.com/role/StatementOfChangesInShareholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance, shares",
        "periodEndLabel": "Balance, shares",
        "label": "Shares, Outstanding",
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury."
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_UFSAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "UFSAgreementMember",
     "presentation": [
      "http://connexasports.com/role/NotesPayableDetailsNarrative",
      "http://connexasports.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "UFS Agreement [Member]",
        "documentation": "UFS Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative",
      "http://connexasports.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r487",
      "r488",
      "r489",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515"
     ]
    },
    "us-gaap_PatentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PatentsMember",
     "presentation": [
      "http://connexasports.com/role/IntangibleAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Patents [Member]",
        "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law."
       }
      }
     },
     "auth_ref": [
      "r195"
     ]
    },
    "CNXA_EachWeekForNextThreeWeeksMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "EachWeekForNextThreeWeeksMember",
     "presentation": [
      "http://connexasports.com/role/NotesPayableDetailsNarrative",
      "http://connexasports.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Each Week for Next Three Weeks [Member]",
        "documentation": "Each Week for Next Three Weeks [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_ThereafterPerWeekMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "ThereafterPerWeekMember",
     "presentation": [
      "http://connexasports.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Thereafter Per Week [Member]",
        "documentation": "Thereafter Per Week [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtConversionOriginalDebtInterestRateOfDebt": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtConversionOriginalDebtInterestRateOfDebt",
     "presentation": [
      "http://connexasports.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Interest rate",
        "label": "Debt Conversion, Original Debt, Interest Rate of Debt",
        "documentation": "The rate of interest that was being paid on the original debt issue that is being converted in the noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r65"
     ]
    },
    "CNXA_CedarAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "CedarAgreementMember",
     "presentation": [
      "http://connexasports.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cedar Agreement [Member]",
        "documentation": "Cedar Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "presentation": [
      "http://connexasports.com/role/AcquisitionsAndBusinessCombinationsDetailsNarrative",
      "http://connexasports.com/role/ScheduleOfProformaFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r97",
      "r548"
     ]
    },
    "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionProFormaInformationTextBlock",
     "presentation": [
      "http://connexasports.com/role/AcquisitionsAndBusinessCombinationsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF PROFORMA FINANCIAL INFORMATION",
        "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate."
       }
      }
     },
     "auth_ref": [
      "r884",
      "r885"
     ]
    },
    "CNXA_FoundationSportsToCharlesRuddyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "FoundationSportsToCharlesRuddyMember",
     "presentation": [
      "http://connexasports.com/role/DiscontinuedOperationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foundation Sports To Charles Ruddy [Member]",
        "documentation": "Foundation Sports To Charles Ruddy [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfWarrantsIssuedExercisedAndExpiredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Shares, Forfeited",
        "documentation": "Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event."
       }
      }
     },
     "auth_ref": [
      "r31"
     ]
    },
    "us-gaap_OffsettingAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OffsettingAssetsTable",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfDerivativeLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offsetting Assets [Table]",
        "documentation": "Disclosure of information about derivative and financial assets that are subject to offsetting, including enforceable master netting arrangements."
       }
      }
     },
     "auth_ref": [
      "r156",
      "r157"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://connexasports.com/role/CommitmentsAndContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "COMMITMENTS AND CONTINGENCIES",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r185",
      "r392",
      "r393",
      "r800",
      "r935"
     ]
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://connexasports.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and contingency",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r114",
      "r658",
      "r722"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfWarrantsIssuedExercisedAndExpiredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Warrants Shares, Expired",
        "label": "Warrants Shares, Expired",
        "documentation": "Number of shares under non-option equity instrument agreements for which rights to exercise lapsed."
       }
      }
     },
     "auth_ref": [
      "r32"
     ]
    },
    "us-gaap_CommodityContractAssetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommodityContractAssetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract assets",
        "documentation": "Carrying amount as of the balance sheet date of the asset arising from commodity contracts such as futures contracts tied to the movement of a particular commodity, which are expected to be converted into cash or otherwise disposed of within a year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r902"
     ]
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShortTermDebtTypeDomain",
     "presentation": [
      "http://connexasports.com/role/NotesPayableDetailsNarrative",
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing."
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r878"
     ]
    },
    "us-gaap_BusinessCombinationsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationsPolicy",
     "presentation": [
      "http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations",
        "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy."
       }
      }
     },
     "auth_ref": [
      "r95"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/ScheduleOfDiscontinuedOperationsDetails": {
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/ScheduleOfDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract assets, net of current portion",
        "documentation": "Amount classified as other assets attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r10",
      "r119",
      "r134",
      "r182"
     ]
    },
    "us-gaap_ScheduleOfShortTermDebtTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShortTermDebtTable",
     "presentation": [
      "http://connexasports.com/role/ConvertibleNotesPayableDetailsNarrative",
      "http://connexasports.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Short-Term Debt [Table]",
        "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation."
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://connexasports.com/role/BalanceSheets",
      "http://connexasports.com/role/NotePayable-RelatedPartyDetailsNarrative",
      "http://connexasports.com/role/NotePayableRelatedPartyDetailsNarrative",
      "http://connexasports.com/role/NotesPayableDetailsNarrative",
      "http://connexasports.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative",
      "http://connexasports.com/role/StatementsOfOperations",
      "http://connexasports.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party, Type [Axis]",
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "auth_ref": [
      "r473",
      "r592",
      "r593",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r743",
      "r745",
      "r776",
      "r960"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
     "calculation": {
      "http://connexasports.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in operating activities of continuing operations",
        "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations",
        "documentation": "Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r170",
      "r171",
      "r172"
     ]
    },
    "us-gaap_ProceedsFromNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromNotesPayable",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/NotesPayableDetailsNarrative",
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative",
      "http://connexasports.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from notes payable",
        "verboseLabel": "Proceeds from Notes Payable",
        "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation."
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://connexasports.com/role/BalanceSheetsParenthetical",
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, shares issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r260"
     ]
    },
    "us-gaap_ShortTermDebtLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShortTermDebtLineItems",
     "presentation": [
      "http://connexasports.com/role/ConvertibleNotesPayableDetailsNarrative",
      "http://connexasports.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-Term Debt [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails",
      "http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms."
       }
      }
     },
     "auth_ref": [
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r434",
      "r449",
      "r562",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r668",
      "r891",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r921",
      "r922",
      "r923",
      "r924"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://connexasports.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CASH FLOWS FROM FINANCING ACTIVITES"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r260"
     ]
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShortTermDebtTypeAxis",
     "presentation": [
      "http://connexasports.com/role/NotesPayableDetailsNarrative",
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-Term Debt, Type [Axis]",
        "documentation": "Information by type of short-term debt arrangement."
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://connexasports.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CASH FLOWS FROM INVESTING ACTIVITIES"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r871",
      "r873",
      "r874"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://connexasports.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r170",
      "r171",
      "r172"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://connexasports.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock value",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r147",
      "r660",
      "r846"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://connexasports.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract liabilities",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r453",
      "r454",
      "r465"
     ]
    },
    "us-gaap_OperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://connexasports.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating loss carryforwards",
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r93"
     ]
    },
    "us-gaap_RelatedPartyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyMember",
     "presentation": [
      "http://connexasports.com/role/BalanceSheets",
      "http://connexasports.com/role/NotePayable-RelatedPartyDetailsNarrative",
      "http://connexasports.com/role/NotePayableRelatedPartyDetailsNarrative",
      "http://connexasports.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://connexasports.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party [Member]",
        "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family."
       }
      }
     },
     "auth_ref": [
      "r269",
      "r270",
      "r592",
      "r593",
      "r594",
      "r595",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r743",
      "r745",
      "r776"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://connexasports.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CASH FLOW FROM OPERTING ACTIVIITES"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r872"
     ]
    },
    "us-gaap_Revenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Revenues",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from related parties",
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r256",
      "r267",
      "r303",
      "r304",
      "r308",
      "r312",
      "r313",
      "r319",
      "r321",
      "r323",
      "r363",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r574",
      "r654",
      "r940"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://connexasports.com/role/BalanceSheetsParenthetical",
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, shares authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r147",
      "r723"
     ]
    },
    "us-gaap_NonrelatedPartyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NonrelatedPartyMember",
     "presentation": [
      "http://connexasports.com/role/BalanceSheets",
      "http://connexasports.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonrelated Party [Member]",
        "documentation": "Party not related to reporting entity."
       }
      }
     },
     "auth_ref": [
      "r913",
      "r914"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://connexasports.com/role/BalanceSheetsParenthetical",
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, shares outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r147",
      "r723",
      "r744",
      "r981",
      "r982"
     ]
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "OPERATING LOSS",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r302",
      "r309",
      "r314",
      "r317",
      "r823"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r870"
     ]
    },
    "us-gaap_WarrantsAndRightsOutstandingTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WarrantsAndRightsOutstandingTerm",
     "presentation": [
      "http://connexasports.com/role/ConvertibleNotesPayableDetailsNarrative",
      "http://connexasports.com/role/ScheduleOfWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails",
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative",
      "http://connexasports.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants measurement input, term",
        "verboseLabel": "Warrants term",
        "terseLabel": "Warrants and Rights Outstanding, Term",
        "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r952"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r875"
     ]
    },
    "us-gaap_ProceedsFromRelatedPartyDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromRelatedPartyDebt",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/NotePayable-RelatedPartyDetailsNarrative",
      "http://connexasports.com/role/NotePayableRelatedPartyDetailsNarrative",
      "http://connexasports.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from related party notes payable",
        "verboseLabel": "Proceeds from related party debt",
        "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates."
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "us-gaap_OffsettingAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OffsettingAssetsLineItems",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfDerivativeLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offsetting Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfStockholdersEquityAbstract",
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r873"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightAxis",
     "presentation": [
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Axis]",
        "documentation": "Information by type of warrant or right issued."
       }
      }
     },
     "auth_ref": [
      "r90"
     ]
    },
    "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued Operations and Disposal Groups [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ImpairmentOfIntangibleAssetsFinitelived",
     "crdr": "debit",
     "presentation": [
      "http://connexasports.com/role/IntangibleAssetsDetailsNarrative",
      "http://connexasports.com/role/ScheduleOfIntangibleAssetsDetails",
      "http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment of intangible assets",
        "verboseLabel": "Impairment of Intangible Assets, Finite-Lived",
        "negatedLabel": "Impairment loss",
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value."
       }
      }
     },
     "auth_ref": [
      "r910",
      "r933"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesConversionOfUnits",
     "presentation": [
      "http://connexasports.com/role/StatementOfChangesInShareholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of shares issuable (liability), shares",
        "documentation": "The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit)."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r85",
      "r146",
      "r147",
      "r189"
     ]
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r873",
      "r874"
     ]
    },
    "us-gaap_NetIncomeLossPerOutstandingLimitedPartnershipAndGeneralPartnershipUnitBasicAndDilutedAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLossPerOutstandingLimitedPartnershipAndGeneralPartnershipUnitBasicAndDilutedAbstract",
     "presentation": [
      "http://connexasports.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net income (loss) per share - basic and diluted"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfUnits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueConversionOfUnits",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/ConvertibleNotesPayableDetailsNarrative",
      "http://connexasports.com/role/StatementOfChangesInShareholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of shares issuable (liability)",
        "verboseLabel": "Stock issued during period value conversion of units",
        "documentation": "Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit)."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r51",
      "r189"
     ]
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "presentation": [
      "http://connexasports.com/role/AccruedExpensesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF ACCRUED EXPENSES",
        "documentation": "Tabular disclosure of the components of accrued liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRepurchasedDuringPeriodShares",
     "presentation": [
      "http://connexasports.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Repurchased During Period, Shares",
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r146",
      "r147",
      "r189",
      "r696",
      "r769",
      "r795"
     ]
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AmortizationOfIntangibleAssets",
     "crdr": "debit",
     "presentation": [
      "http://connexasports.com/role/IntangibleAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization expense",
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r77",
      "r80"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/ScheduleOfIncomeTaxProvisionDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/ScheduleOfIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income tax provision (benefit) based on book income (loss) at Israeli statutory rate",
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r530"
     ]
    },
    "CNXA_AmendedUFSAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "AmendedUFSAgreementMember",
     "presentation": [
      "http://connexasports.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amended U F S Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 5.0
      },
      "http://connexasports.com/role/ScheduleOfDiscontinuedOperationsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://connexasports.com/role/BalanceSheets",
      "http://connexasports.com/role/ScheduleOfDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current assets of discontinued operations",
        "totalLabel": "Non-current Asset",
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r10",
      "r119",
      "r134",
      "r182",
      "r229",
      "r230"
     ]
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "presentation": [
      "http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF INVENTORY",
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process."
       }
      }
     },
     "auth_ref": [
      "r40",
      "r153",
      "r154",
      "r155"
     ]
    },
    "srt_ScenarioPreviouslyReportedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ScenarioPreviouslyReportedMember",
     "presentation": [
      "http://connexasports.com/role/BalanceSheets",
      "http://connexasports.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://connexasports.com/role/NotesPayableDetailsNarrative",
      "http://connexasports.com/role/OrganizationAndNatureOfBusinessDetailsNarrative",
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative",
      "http://connexasports.com/role/StatementOfChangesInShareholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Previously Reported [Member]"
       }
      }
     },
     "auth_ref": [
      "r226",
      "r272",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r286",
      "r296",
      "r539",
      "r564",
      "r565",
      "r566",
      "r586",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r692",
      "r886",
      "r888",
      "r889",
      "r890",
      "r918",
      "r926",
      "r927",
      "r950",
      "r955",
      "r956"
     ]
    },
    "us-gaap_LoansPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LoansPayable",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/NotePayable-RelatedPartyDetailsNarrative",
      "http://connexasports.com/role/NotePayableRelatedPartyDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loans payable",
        "documentation": "Including the current and noncurrent portions, aggregate carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r202",
      "r972"
     ]
    },
    "dei_EntityAddressesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressesLineItems",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseDepreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationNondeductibleExpenseDepreciation",
     "crdr": "debit",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible depreciation."
       }
      }
     },
     "auth_ref": [
      "r945"
     ]
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://connexasports.com/role/IncomeTaxesDetailsNarrative",
      "http://connexasports.com/role/IncomeTaxesTables",
      "http://connexasports.com/role/ScheduleOfIncomeTaxProvisionDetailsParenthetical",
      "http://connexasports.com/role/ScheduleOfNetDeferredTaxAssetsDetails",
      "http://connexasports.com/role/ScheduleOfNetDeferredTaxAssetsDetailsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]"
       }
      }
     },
     "auth_ref": [
      "r321",
      "r322",
      "r707",
      "r709",
      "r711",
      "r778",
      "r780",
      "r783",
      "r793",
      "r797",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r814",
      "r834",
      "r851",
      "r944",
      "r976"
     ]
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "presentation": [
      "http://connexasports.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUPPLEMENTAL INFORMATION - NON-CASH INVESTING AND FINANCING ACTIVITIES:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConvertibleNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConvertibleNotesPayable",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/ConvertibleNotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior convertible notes",
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r202",
      "r972"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "presentation": [
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative",
      "http://connexasports.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": [
      "r451"
     ]
    },
    "us-gaap_StockRedeemedOrCalledDuringPeriodValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRedeemedOrCalledDuringPeriodValue",
     "crdr": "debit",
     "presentation": [
      "http://connexasports.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock redeemed value",
        "documentation": "Equity impact of the value of stock bought back by the entity at the exercise price or redemption price."
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationNondeductibleExpenseOther",
     "crdr": "debit",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses."
       }
      }
     },
     "auth_ref": [
      "r945"
     ]
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConvertibleNotesPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConvertibleNotesPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://connexasports.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current portion of convertible notes payable, net of discount",
        "documentation": "Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder."
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested",
     "crdr": "debit",
     "presentation": [
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested",
        "documentation": "Intrinsic value of nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/ScheduleOfDiscontinuedOperationsDetails": {
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/ScheduleOfDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Goodwill",
        "label": "Disposal Group, Including Discontinued Operation, Goodwill, Noncurrent",
        "documentation": "Amount classified as goodwill attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r10",
      "r119",
      "r134",
      "r182"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationGoodwill1",
     "crdr": "debit",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfCalculationOfLossOnDisposalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Goodwill",
        "label": "Disposal Group, Including Discontinued Operation, Goodwill",
        "documentation": "Amount classified as goodwill attributable to disposal group held for sale or disposed of."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r119",
      "r134",
      "r182"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/ScheduleOfDiscontinuedOperationsDetails": {
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/ScheduleOfDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and equipment, net",
        "documentation": "Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r10",
      "r119",
      "r134",
      "r182"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment",
     "crdr": "debit",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfCalculationOfLossOnDisposalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Property and equipment",
        "label": "Disposal Group, Including Discontinued Operation, Property, Plant and Equipment",
        "documentation": "Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r119",
      "r134",
      "r182"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/ScheduleOfDiscontinuedOperationsDetails": {
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/ScheduleOfDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible assets, net",
        "documentation": "Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r10",
      "r119",
      "r134",
      "r182"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://connexasports.com/role/IncomeTaxesDetailsNarrative",
      "http://connexasports.com/role/IncomeTaxesTables",
      "http://connexasports.com/role/ScheduleOfIncomeTaxProvisionDetailsParenthetical",
      "http://connexasports.com/role/ScheduleOfNetDeferredTaxAssetsDetails",
      "http://connexasports.com/role/ScheduleOfNetDeferredTaxAssetsDetailsParenthetical"
     ],
     "auth_ref": [
      "r321",
      "r322",
      "r707",
      "r709",
      "r711",
      "r778",
      "r780",
      "r783",
      "r793",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r814",
      "r834",
      "r851",
      "r944",
      "r976"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationIntangibleAssets",
     "crdr": "debit",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfCalculationOfLossOnDisposalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Intangible assets",
        "label": "Disposal Group, Including Discontinued Operation, Intangible Assets",
        "documentation": "Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r119",
      "r134",
      "r182"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationInventoryNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/ScheduleOfDiscontinuedOperationsDetails": {
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/ScheduleOfDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finished products used in operations, net",
        "documentation": "Amount classified as inventory attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r10",
      "r119",
      "r134",
      "r182"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueOther",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/StatementOfChangesInShareholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fractional share issuance",
        "documentation": "Value of shares of stock issued attributable to transactions classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
     "presentation": [
      "http://connexasports.com/role/NotePayable-RelatedPartyTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF WARRANTS ISSUED, EXERCISED AND EXPIRED",
        "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable."
       }
      }
     },
     "auth_ref": [
      "r90"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesOther": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesOther",
     "presentation": [
      "http://connexasports.com/role/StatementOfChangesInShareholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fractional share issuance, shares",
        "documentation": "Number of shares of stock issued attributable to transactions classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationInventory1",
     "crdr": "debit",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfCalculationOfLossOnDisposalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Inventory",
        "label": "Disposal Group, Including Discontinued Operation, Inventory",
        "documentation": "Amount classified as inventory attributable to disposal group held for sale or disposed of."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r119",
      "r134",
      "r182"
     ]
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightDomain",
     "presentation": [
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_RecognizedDerivativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "RecognizedDerivativeExpense",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recognized derivative expense",
        "documentation": "Recognized derivative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxesPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income taxes",
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes."
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount",
     "crdr": "debit",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based compensation and shares for services",
        "documentation": "Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r882",
      "r945"
     ]
    },
    "CNXA_ExercisePriceOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "ExercisePriceOneMember",
     "presentation": [
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price One [Member]",
        "documentation": "Exercise Price One [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubstantialDoubtAboutGoingConcernTextBlock",
     "presentation": [
      "http://connexasports.com/role/GoingConcern"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "GOING CONCERN",
        "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern."
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "CNXA_StockIssuedDuringPeriodForAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "StockIssuedDuringPeriodForAbstract",
     "presentation": [
      "http://connexasports.com/role/StatementOfChangesInShareholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock issued for:",
        "documentation": "Stock issued during period for abstract"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermDebtTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShortTermDebtTextBlock",
     "presentation": [
      "http://connexasports.com/role/ConvertibleNotesPayable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CONVERTIBLE NOTES PAYABLE",
        "documentation": "The entire disclosure for short-term debt."
       }
      }
     },
     "auth_ref": [
      "r186"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r236",
      "r390"
     ]
    },
    "us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeAssetsLiabilitiesAtFairValueNet",
     "crdr": "debit",
     "presentation": [
      "http://connexasports.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Derivative liability",
        "label": "Derivative Assets (Liabilities), at Fair Value, Net",
        "documentation": "Fair values as of the balance sheet date of the net amount of all assets and liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "CNXA_StockIssuedDuringPeriodValueAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "StockIssuedDuringPeriodValueAccountsPayable",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/StatementOfChangesInShareholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts payable",
        "label": "StockIssuedDuringPeriodValueAccountsPayable"
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_StockIssuedDuringPeriodSharesAccountsPayable": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "StockIssuedDuringPeriodSharesAccountsPayable",
     "presentation": [
      "http://connexasports.com/role/StatementOfChangesInShareholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts payable, shares"
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_StockIssuedDuringPeriodValueCashlessExerciseOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "StockIssuedDuringPeriodValueCashlessExerciseOfWarrants",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/StatementOfChangesInShareholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cashless exercise of warrants",
        "documentation": "Stock issued during period value cashless exercise of warrants."
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_StockIssuedDuringPeriodCashlessExerciseOfWarrantsShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "StockIssuedDuringPeriodCashlessExerciseOfWarrantsShares",
     "presentation": [
      "http://connexasports.com/role/StatementOfChangesInShareholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cashless exercise of warrants, shares",
        "documentation": "Stock issued during period cashless exercise of warrants shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryPolicyTextBlock",
     "presentation": [
      "http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory",
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost."
       }
      }
     },
     "auth_ref": [
      "r214",
      "r233",
      "r241",
      "r377",
      "r378",
      "r379",
      "r632",
      "r820"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://connexasports.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated other comprehensive income (loss)",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r53",
      "r158",
      "r239",
      "r661",
      "r684",
      "r688"
     ]
    },
    "CNXA_StockIssuedDuringPeriodValueSatisfactionOfProfitGuaranteeOnNotePayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "StockIssuedDuringPeriodValueSatisfactionOfProfitGuaranteeOnNotePayable",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/StatementOfChangesInShareholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Satisfaction of profit guarantee on note payable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r67"
     ]
    },
    "CNXA_StockIssuedDuringPeriodSharesSatisfactionOfProfitGuaranteeOnNotePayable": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "StockIssuedDuringPeriodSharesSatisfactionOfProfitGuaranteeOnNotePayable",
     "presentation": [
      "http://connexasports.com/role/StatementOfChangesInShareholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Satisfaction of profit guarantee on note payable, shares"
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_StockIssuedDuringPeriodValueConversionofNotesPayableRelatedParties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "StockIssuedDuringPeriodValueConversionofNotesPayableRelatedParties",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/StatementOfChangesInShareholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of notes payable - related parties",
        "documentation": "Stock issued during period value conversion of notes payable related parties"
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_StockIssuedDuringPeriodShareConversionofNotesPayableRelatedParties": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "StockIssuedDuringPeriodShareConversionofNotesPayableRelatedParties",
     "presentation": [
      "http://connexasports.com/role/StatementOfChangesInShareholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of notes payable - related parties, shares",
        "documentation": "Stock issued during period share conversion of notes payable related parties"
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_NoncashTransactionCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "NoncashTransactionCosts",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-cash transaction costs",
        "documentation": "Noncash transaction costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 7.0
      },
      "http://connexasports.com/role/ScheduleOfDiscontinuedOperationsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://connexasports.com/role/BalanceSheets",
      "http://connexasports.com/role/ScheduleOfDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current assets of discontinued operations",
        "verboseLabel": "Current Asset",
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r119",
      "r134",
      "r179",
      "r182",
      "r229",
      "r230"
     ]
    },
    "us-gaap_LongTermDebtTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtTextBlock",
     "presentation": [
      "http://connexasports.com/role/NotesPayable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NOTES PAYABLE",
        "documentation": "The entire disclosure for long-term debt."
       }
      }
     },
     "auth_ref": [
      "r186"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares",
     "presentation": [
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants vested",
        "documentation": "Number of options vested."
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_SettlementExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "SettlementExpense",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Settlement expense"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_IncreaseDecreaseInPrepaidInventory": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "IncreaseDecreaseInPrepaidInventory",
     "crdr": "credit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid inventory",
        "documentation": "Increase decrease in prepaid inventory.",
        "label": "IncreaseDecreaseInPrepaidInventory"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recent Accounting Pronouncements",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_LossOnSettlementOfAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "LossOnSettlementOfAccountsPayable",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss on settlement of accounts payable"
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_IncreaseDecreaseInInterestPayableRelatedParty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "IncreaseDecreaseInInterestPayableRelatedParty",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 22.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued interest - related parties",
        "documentation": "Increase decrease in interest payable related party."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_ConversionOfConvertibleNotesPayableAndAccruedInterestToCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "ConversionOfConvertibleNotesPayableAndAccruedInterestToCommonStock",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of convertible notes payable and accrued interest to common stock",
        "documentation": "Conversion of convertible notes payable and accrued interest to common stock."
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_SharesIssuedForContingentConsideration": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "SharesIssuedForContingentConsideration",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares issued for contingent consideration",
        "documentation": "Shares issued for contingent consideration"
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_EliminationOfRelatedPartyDerivativeLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "EliminationOfRelatedPartyDerivativeLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elimination of related party derivative liabilities",
        "documentation": "Elimination of related party derivative liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_DerivativeLiabilitiesRecordedAsDebtDiscountsOfConvertibleNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "DerivativeLiabilitiesRecordedAsDebtDiscountsOfConvertibleNotes",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative liabilities recorded as debt discounts of convertible notes",
        "documentation": "Derivative liabilities recorded as debt discounts of convertible notes."
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_DerivativeLiabilityRecordedForSharesAndWarrantsIssuedInPrivatePlacement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "DerivativeLiabilityRecordedForSharesAndWarrantsIssuedInPrivatePlacement",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative liability recorded for shares and warrants issued in private placement",
        "documentation": "Derivative liability recorded for shares and warrants issued in private placement."
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_SharesIssuedForSettlementOfAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "SharesIssuedForSettlementOfAccountsPayable",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares issued for settlement of accounts payable"
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_InterimFinancialStatementsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "InterimFinancialStatementsPolicyTextBlock",
     "presentation": [
      "http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interim Financial Statements",
        "documentation": "Interim Financial Statements Policy [Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_PrepaidInventoryPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "PrepaidInventoryPolicyTextBlock",
     "presentation": [
      "http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Inventory",
        "documentation": "Prepaid Inventory Policy [Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfWarrantsIssuedExercisedAndExpiredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Remaining Contractual Life (Years)",
        "documentation": "Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r191"
     ]
    },
    "CNXA_ExercisePriceTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "ExercisePriceTwoMember",
     "presentation": [
      "http://connexasports.com/role/ShareholdersEquityDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Two [Member]",
        "documentation": "Exercise Price Two [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://connexasports.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other current liabilities",
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r846"
     ]
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationConsiderationTransferred1",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value of contingent consideration",
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r3",
      "r20"
     ]
    },
    "CNXA_WarrantsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "WarrantsPolicyTextBlock",
     "presentation": [
      "http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants",
        "documentation": "Warrants Policy [Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "crdr": "credit",
     "calculation": {
      "http://connexasports.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NET SALES",
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise."
       }
      }
     },
     "auth_ref": [
      "r303",
      "r304",
      "r308",
      "r312",
      "r313",
      "r319",
      "r321",
      "r323",
      "r463",
      "r464",
      "r636"
     ]
    },
    "srt_OwnershipAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "OwnershipAxis",
     "presentation": [
      "http://connexasports.com/role/DiscontinuedOperationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_NumberOfSharesExchanged": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "NumberOfSharesExchanged",
     "presentation": [
      "http://connexasports.com/role/OrganizationAndNatureOfBusinessDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of shares exchanged",
        "documentation": "Number of shares exchanged."
       }
      }
     },
     "auth_ref": []
    },
    "CNXA_ScheduleOfCalculationOfTheLossOnDisposalTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "ScheduleOfCalculationOfTheLossOnDisposalTableTextBlock",
     "presentation": [
      "http://connexasports.com/role/DiscontinuedOperationsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF CALCULATION OF THE LOSS ON DISPOSAL",
        "documentation": "Schedule of calculation of the loss on disposal (Table Text Block)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest expense",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r259",
      "r261",
      "r262"
     ]
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://connexasports.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r873"
     ]
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "presentation": [
      "http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Statement Reclassification",
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error."
       }
      }
     },
     "auth_ref": [
      "r898"
     ]
    },
    "us-gaap_DerivativeLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://connexasports.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative liabilities",
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset."
       }
      }
     },
     "auth_ref": [
      "r244"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapitalCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://connexasports.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional paid in capital",
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital."
       }
      }
     },
     "auth_ref": [
      "r148"
     ]
    },
    "CNXA_NumberOfSharesOwned": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "NumberOfSharesOwned",
     "presentation": [
      "http://connexasports.com/role/OrganizationAndNatureOfBusinessDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of shares owned",
        "documentation": "Number of shares owned."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://connexasports.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration of Credit Risk",
        "documentation": "Disclosure of accounting policy for credit risk."
       }
      }
     },
     "auth_ref": [
      "r115",
      "r217"
     ]
    },
    "CNXA_DerivativeLiabilitiesMeasurementInputTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "DerivativeLiabilitiesMeasurementInputTerm",
     "presentation": [
      "http://connexasports.com/role/ScheduleOfDerivativeAndWarrantsGrantedValuationUsingBlack-scholesPricingMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative liabilities measurement input",
        "documentation": "Derivative liabilities measurement inpu term."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationConsiderationTransferredOther1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationConsiderationTransferredOther1",
     "crdr": "credit",
     "presentation": [
      "http://connexasports.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consideration",
        "documentation": "Amount of tangible or intangible assets, including a business or subsidiary of the acquirer transferred by the entity to the former owners of the acquiree. Excludes cash."
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://connexasports.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/BalanceSheets",
      "http://connexasports.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://connexasports.com/role/OrganizationAndNatureOfBusinessDetailsNarrative",
      "http://connexasports.com/role/StatementOfChangesInShareholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Stockholders\u2019 Equity (Deficit)",
        "periodStartLabel": "Balance - May 1, 2022",
        "periodEndLabel": "Balance - April 30, 2023",
        "label": "Stockholders equity",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r147",
      "r150",
      "r151",
      "r175",
      "r725",
      "r744",
      "r770",
      "r771",
      "r846",
      "r859",
      "r912",
      "r925",
      "r953",
      "r981"
     ]
    },
    "CNXA_CapitalizedDutyAndFreight": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "CapitalizedDutyAndFreight",
     "crdr": "debit",
     "calculation": {
      "http://connexasports.com/role/ScheduleOfInventoryDetails": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://connexasports.com/role/ScheduleOfInventoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capitalized Duty/Freight",
        "documentation": "Capitalized duty and freight."
       }
      }
     },
     "auth_ref": []
    },
    "srt_OwnershipDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "OwnershipDomain",
     "presentation": [
      "http://connexasports.com/role/DiscontinuedOperationsDetailsNarrative"
     ],
     "auth_ref": []
    },
    "CNXA_DisposalEquityInterestOwnershipInterestPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://connexasports.com/20230731",
     "localname": "DisposalEquityInterestOwnershipInterestPercentage",
     "presentation": [
      "http://connexasports.com/role/AcquisitionsAndBusinessCombinationsDetailsNarrative",
      "http://connexasports.com/role/GoingConcernDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinuing operations percentage",
        "verboseLabel": "Disposal equity interest percentage",
        "documentation": "Disposal equity interest ownership interest percentage."
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482338/360-10-05-4"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "940",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "7",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-7"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "8",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-8"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479613/805-30-35-1"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1",
   "Subparagraph": "b",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479613/805-30-35-1"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "SubTopic": "20",
   "Topic": "205",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-10"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-11"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(g)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480463/815-10-45-5"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-1"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "205",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "715",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c),(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(1)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(2)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(3)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(4)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "SubTopic": "30",
   "Topic": "350",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-3"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "60",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482053/820-10-60-1"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(19)",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "205",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-3"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(a),20,24)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.20)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.21)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.25)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29-30)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-16"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-21"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "330",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-1"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-4"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "50",
   "Section": "40",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481303/470-50-40-2"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "50",
   "Section": "40",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481303/470-50-40-4"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-2"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-4"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-8"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "05",
   "Paragraph": "4",
   "Subparagraph": "(a)-(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479515/805-10-05-4"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-14"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-20"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "30",
   "Section": "25",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479668/805-30-25-6"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.17)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r115": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "825",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480981/942-825-50-1"
  },
  "r116": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "985",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1"
  },
  "r117": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//205/tableOfContent"
  },
  "r118": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//205-20/tableOfContent"
  },
  "r119": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-11"
  },
  "r120": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-3"
  },
  "r121": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-3A"
  },
  "r122": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-3B"
  },
  "r123": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-4"
  },
  "r124": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1"
  },
  "r125": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-3A"
  },
  "r126": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-4A"
  },
  "r127": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-4B"
  },
  "r128": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-4B"
  },
  "r129": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5A"
  },
  "r130": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B"
  },
  "r131": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B"
  },
  "r132": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B"
  },
  "r133": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B"
  },
  "r134": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B"
  },
  "r135": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5C"
  },
  "r136": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5D"
  },
  "r137": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7"
  },
  "r138": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.Z.5.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480781/205-20-S99-2"
  },
  "r139": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//205-40/tableOfContent"
  },
  "r140": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 201.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r141": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 201.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r142": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 201.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r143": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r144": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r145": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r146": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r147": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r148": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r149": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r150": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r151": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r152": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r153": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r154": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r155": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r156": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3"
  },
  "r157": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-4"
  },
  "r158": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11"
  },
  "r159": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-1"
  },
  "r160": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r161": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r162": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r163": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r164": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r165": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r166": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r167": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r168": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.8)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r169": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r170": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r171": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r172": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r173": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//235/tableOfContent"
  },
  "r174": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "275",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//275/tableOfContent"
  },
  "r175": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2"
  },
  "r176": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r177": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r178": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//360/tableOfContent"
  },
  "r179": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-9"
  },
  "r180": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3"
  },
  "r181": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3"
  },
  "r182": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3"
  },
  "r183": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3A"
  },
  "r184": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480091/360-10-S99-2"
  },
  "r185": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//440/tableOfContent"
  },
  "r186": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//470/tableOfContent"
  },
  "r187": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-5"
  },
  "r188": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//505/tableOfContent"
  },
  "r189": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r190": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SAB Topic 4.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-4"
  },
  "r191": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r192": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r193": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r194": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//805/tableOfContent"
  },
  "r195": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-38"
  },
  "r196": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1"
  },
  "r197": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//810/tableOfContent"
  },
  "r198": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 5.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479836/810-10-S99-5"
  },
  "r199": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21"
  },
  "r200": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r201": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r202": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r203": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r204": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r205": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r206": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r207": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r208": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04.9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r209": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11B",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "310",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-11B"
  },
  "r210": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "310",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-15"
  },
  "r211": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "10",
   "Topic": "310",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-6"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "210",
   "Topic": "946",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-20"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "270",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482989/270-10-45-6"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22(a)(2))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//606/tableOfContent"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5C",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5C"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-10"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-12"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(210.5-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-12"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//280/tableOfContent"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-1"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-2"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-4"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-1"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-11"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-14"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-16"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-7"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//330/tableOfContent"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-1"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-4"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//350-20/tableOfContent"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-2"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//350-30/tableOfContent"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-3"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-6"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-1"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-2"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-17"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-19"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480606/715-80-35-1"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-9"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//718/tableOfContent"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.C.Q3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.1.Q5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.3.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//740/tableOfContent"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482134/820-10-35-54B"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//830/tableOfContent"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//850/tableOfContent"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//855/tableOfContent"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481444/860-30-45-1"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-7"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(4)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482312/912-310-45-11"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "330",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482105/912-330-50-1"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "920",
   "SubTopic": "350",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483256/920-350-50-1"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "920",
   "SubTopic": "350",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483256/920-350-50-1"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "920",
   "SubTopic": "350",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483256/920-350-50-4"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "928",
   "SubTopic": "340",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "33",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "33",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "35A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "35A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(h))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "825",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-1"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-2"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-3"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-21"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(5)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(5)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5A",
   "Subparagraph": "(SX 210.12-13A(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481058/954-310-45-1"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Subparagraph": "(b)",
   "SubTopic": "20",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-38"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479081/326-30-55-8"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r863": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r864": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r865": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r866": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r867": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r868": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r869": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r870": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r871": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r872": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r873": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r874": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r875": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r876": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r877": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r878": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r879": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r880": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-10"
  },
  "r881": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-3"
  },
  "r882": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "SubTopic": "740",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480887/718-740-35-2"
  },
  "r883": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "SubTopic": "825",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B"
  },
  "r884": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "SubTopic": "10",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r885": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(3)",
   "SubTopic": "10",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r886": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3"
  },
  "r887": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4H",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H"
  },
  "r888": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r889": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r890": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8"
  },
  "r891": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(a)",
   "Publisher": "SEC"
  },
  "r892": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r893": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r894": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(3)",
   "Publisher": "SEC"
  },
  "r895": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(i)",
   "Publisher": "SEC"
  },
  "r896": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(ii)",
   "Publisher": "SEC"
  },
  "r897": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(iii)",
   "Publisher": "SEC"
  },
  "r898": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "205",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483504/205-10-50-1"
  },
  "r899": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r900": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r901": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r902": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r903": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r904": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r905": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r906": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r907": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r908": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r909": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r910": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r911": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r912": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r913": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r914": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r915": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r916": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r917": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r918": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-12"
  },
  "r919": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4"
  },
  "r920": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13"
  },
  "r921": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9"
  },
  "r922": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3"
  },
  "r923": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3"
  },
  "r924": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3"
  },
  "r925": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r926": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r927": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r928": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r929": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r930": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r931": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r932": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r933": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-3"
  },
  "r934": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10"
  },
  "r935": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//450/tableOfContent"
  },
  "r936": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4"
  },
  "r937": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r938": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r939": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r940": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r941": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r942": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r943": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r944": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r945": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r946": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r947": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-6"
  },
  "r948": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A"
  },
  "r949": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r950": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r951": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r952": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r953": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r954": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "230",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
  },
  "r955": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r956": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r957": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r958": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r959": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2"
  },
  "r960": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3"
  },
  "r961": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r962": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r963": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r964": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r965": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r966": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r967": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r968": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r969": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1"
  },
  "r970": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r971": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r972": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r973": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r974": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r975": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r976": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B"
  },
  "r977": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
  },
  "r978": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r979": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r980": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r981": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r982": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>89
<FILENAME>0001493152-23-039934-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-23-039934-xbrl.zip
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M/B])OO H1<@E/\FT8NE?X-57.L1[J0[6B3\DF6=_ M<Y)V_M/H<V7(6LEQT
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MF&;W:B]"%...V:EU?R/&HTC?;B=Z4=U*$NI@TA?C7*QW.PY =%11.G27WQ@
MM (-DK$;8XM\XH;P-<FUE/^0Y5ZD;Y-NPUL!?Q,@_=@ACNBB^#7[*M=)<'NV
MPN8 Q/"):&,$W7L80)R:D&99A$K+["/3_!T#BZ*;6_PG\/%^";':!;+4AYO
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MYJB_&.V?=IE_L8R1,YL9Z,>!/9LX,W-4W-3*1BO^X]Y- /K-_P!02P,$%
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M^N*L=S[,D;5AEW1EQ^UQ>Q/@R>^WY?$ (J0O<,BV"=4SLYP*0>)W:1Q.(C9
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M5HINU2JA!.>/W13 2V(4G![:##O<C2;GWMH\$)5QT6;(21&KA(81&)SO_Y;
MH<TZP]Y=N6&<=I,]Z=U=5&TA/().389+RA8(GS9#39'8( .C@4H KVAD4#E5
M'PN_]TSR$LO2!YRTU!BU57!99:F'\"BG]&.AR 7'B:5G>:/XT7#'6KNAY:7(
M%X0P2/LV"S-5?D 4-2:-"ZE0D-.UB,\RLK=M.UI%<::U6RILVQ7LC/*^S4)1
ME1\019UI.G:4QG985G:"H"7+G?6,6'[P%>KC@#T>&<ZGUHLPMBC/0,W"MQ!S
M(-C:S"M9WO,H+\V"#*(?1,4$^PI7)U.ZO7%[-EG-5.,-1#-E#M&;)G]D,2/!
M$H6N;>T?N!WGS'^OGC._]</1>'])<5D%)X>2R</YWB0%9/[_(.+B,% +SUN'
MH5H_//I64JWY+WKJ ;#SF9[<-\BG/X3LM2NSPWDXB CJRTL$*';7M-_;2^1$
M'AK.LV0&!SH#65&!?,,84W,@%[2GQT<1T5VJ%!A3I: 0?)<B!I<B!N:#8V2R
MY.H O!0QN!0QN!0QT%S$(!<.S\B/T!WEE/>BI/NR=7>SE^'T_X[0JE1@L-E5
MW27?2E W"_,)X:]M7^S@(!S.6>Z3^-Z.R+-KHV!"K^XBMPO4IY%@RM@Q3EF\
M)S@(1@3/13;[5*-&HI*A'SS"M(5_)V81?['-[ZF0QP#LTDB()-R 2J V^PKR
M/+8I^\Z#1;ZA%.4"8PK81QMD:F+'N=@ ]1)M>QR=D,3R*,%M9T4ERCAD;X6D
M@$DZ-@HU)5X@Z+1%&(Y1@"@AK!3"+=63/!SG(90")^S6*-@4.(% TQ9^F.$S
MQR'6*'  ZB% M 4@[ND\^*L5(#DT;K9&<<H'!(^V ,,!]O$QL;LL[U(E4-JU
MD= I<@4!J2_!]@J3T/UW[-\<SN]<W_)MR@*[%++K8!SES[(,"4)I%$?0!FL^
M:/ 9S(G\:IKT2"J?@.TC*!CZW1<F@L@-ENQ 9LZF)]$-6M:UD8 J<@4B6=3J
M 53=8>0P:H9^+P@B%CHQG)_F<^! Q/JJ=&T61/FX B$J:A&10M196OX"]?P[
MRR5QR'),&N\)OQ0R]:&:#&%>+D%(B]I, $BWU,73*HAW]I-D>E,L#N]FH^0;
MI'DP%N$/!+#D8F7"*7;(K!+L4VD469"\<9H'8T$6022+VE4 ) \4P!82UC#3
MKGE( "R DM9F#-FE:I/:K$X:-@L2$0\@)MKL(2"+!2[:C<1)P@V(F#83R<&&
ML_.3NWY$B3^$$]^@.2;;!QE3ZP4%]#Y"+$HXO6:236QM8 ^WF8<=Q_Z+W5P5
MK<C*OK219IG*Y0'..VT6'6YBAF,Y<)O<1H1R-XJSX4;AB!Y6V#D1#CSO*OS2
M1LZ[RN4!A@-H,S5Q^=EIGUN&XSPB<4:1;-/SYEKQ+WH]\^M<&8!S2ENH3]%E
M5/F^]6KG4%'>P;E3LC7NF+YJ="GV1:5_3[.F2(4B &>*ML"H/2O;&\565#(M
M.].A61"K\ )BI2TP:H!"E8B HV:-Q(7# 8B&WC3YDO0"(^9!I4(.0^(^16%B
M.4[>!2M$C);S!8V< :7R#LX=?2%7 O;NZ 'C+K;I<^WTVZRV[\2_>4FU2N=_
MHB#<UOF5I/RHYOM>W<PZ5Q3@1-.9R^Z44?EL$71J).12?D#<],68I4_ $2+#
M* Q"RV</B_KNRMT^+_,1"9;NFD[.;;APZH^/%) ;*W#M.%3'BV@7A?BT*K^V
MD7.G!HF LT^;&55N.::2B'F:+.EY>XY)_FB@1LZ00CQ"F.M[):W$QG;^EH%Z
M>JC7BWN62Q!Y;89&!;/70><NLNYS#/D*9D)N;L$9H>UY8TZ&BNP*N0;],\R*
M'#N%-F/A+FDF)3>F,Y[),.+<YHW$4L )B)(V,^$IL=N9I8[3ML.K0.J(%Q K
M;4;$WY"[6+(;P3/=$A9H$#'!#.<QZ4'JKB%9:;F&:22N!3@$T=9F]@.82&_]
M:5YRXPT-])H0%_,(8IZRP-6>972?4G,X3^*0@YX?TW^4)O4D%?=QRLZ/2BD[
M6<;.[3>T7+^5_H[_M-8X^%LK^:K6#]LO^XO^K)Y[XC/S@9?I.-M65W[F+26R
MA)PG[8S)N F+/9.=F<>I\?DS]V0G,YZ9@+$?ES$1ILR4=-.7)9./ @"5B&>#
MDAF=D"G+KP@TUY/_4DW66(4!T/ZKS198!C FY[XL#3Q#,UZFWJ;)\BMFFL[T
M:(KBM0%6SSG0;-SN!M2+D0$B[%;!HBH='3D#(%3ZL))7#9'BICJ$KE2RN3#,
MQ0QX@!E3\4B>99;7?J;IUIP'*0'E-7F: A*F(*&_'>"@O["48+O3%E"]::M,
M(T,5;1ZIX.S7)&506SLF7I/Z+) @5\8U*\D5B=E(9;@8%'6JO!(T)C;R+>+B
M$4'/+HX";S-&S/2&''"_I]UDO68?:][UA1,>YZ,; N:C-E_R3130\RD(VC8]
MU8)$A$(3#-C!T#-!1C:X5DQ"A/U($)+=]!6ZZC''R*0OQXHK 9.,,E7"9N3Y
M5 VTU9Q?8*Z>%>7>1OT0/I*21#4G[2B5>NX>ZDL#2\F'704EY[0:>=9FPKR%
M\6L[%K'_+!6YL,_LJFXEX!SQ*[ "0O&QJ25.KS69PG(XSO@T&V>HS!%WD/6Z
MFP\#G^2R;^W SA1/ I;-$3G;]!9Q6HL[3 2/,5A/>4>#19^' >/48X#P.&M<
M.B,@>]<A]"3G&,9@+(NS R&K+3 2X"'9(<Z'%ABGL=@*^0$-#8:!&T_0E#95
M<,6F1V@LH  G$)3:PB2%\_$L++-#-!9,B!4(36U/D$63,?DSU0EVI=>*K<[,
M,(U%5<0.A*RV1\K"F7D^M, XC<56R \$KK8WP*().D#?XT\*+M=]]\9"R6,#
MMG89!F$R#XMC>-*_L2!R^0!1U&>>$4S!.#BGV"*,NS86NU,60-BT^3V%DZX8
M;JF^C04NPP.(G)$&H-WK3^2P\"SD!U#)$X7IRQ^KL<A*>0*1UF80>B5IN(R?
M,57R#7NVC,C=!$^&XR2'QF/((1<4?5'+43XGRM:<=527)Y\WA3>"P4@4X@0$
MJ:A!*!](.S/5&2AQAV@F3 )60)R*FG<*+*:.%2P]% 3=%T1L-T##^6\6H5LP
MUQDBFXWP8,W$3HDI$,6B=IQ\*,+D)3,O'XRRT9J)HQI78'Q R1%B0F6:*C[!
M/%&&AO,1P7,WO(\L1BM"0Y_5@RQ^[*D/WDR8"S$)HEYRZ5/A\5 5['E';R;N
MQ;@$@:\G'N@DC +/XUJO6PK'*'Z(QU**NGFW\!P#-Q/NW R"2)<<DRJ:GE4@
MG6/@9B*=FT$0:3,#D$HR+8H&,QCX<YD"P=9F!CH8K((I!A[%2_P RD.8#VQ.
M5D X30M*R@1 I@JV3Y!-6P);><ZX2NZPYL-> GO@5# MHBD;+UG.7% <M[&3
M(1=_X&Q(F<GT)?@+*.U6L+SS\/>#$(X2^7U22N07Q)G\Z$BM>*BC+'T'-JM@
M94@6EN_^V]HZ8 96&!$TG._>)?&9^DP9.21VI+\,Q_?M0>^_V]/><-!J#VY;
M@_;T<=QM#>]:-X^3WJ [F53,QSVF\XL*UT;$YQ/]Y93H^V%O<-_J# >=[GA0
M,7F3:+6RR&8XG[@+WYV[-KV8;LW";%W0&6&GMHICPK^>$CYY?'AHCW]GTIWT
M[@>]NUZG/9BVVIW.\'$P94R-AOU>I]>M6NBQO/TP26Y-EP)!=,Z.W> ;G4GQ
MX<Y^#N@OCPP7EK@DA+B\^NF4RQB8P72<3"K*:V?<O>U-6^/>Y!_Q'!M.?^F.
MXU\G\>^/#,AINT=%4#GG/3^T_ 7;L-I!@$* IZM3GBAM[<%][Z;?;;4GD^ZT
M:C+I%"-T]]V6NP.HO#ZEDDZD\6/WMM7]UZ@[F%0NRY1Q)G6MV_")?7]*[& X
M[;9&[=_;3*C_^1]?KJ^N_M8:=_OM*>5@U!Y/?Z]^$>P.K_0-E4_^!\XL_Y7.
MVGA*,%8F.UYJ$+J8U(\\2==%7GHBI$($@!G\Z934(_Q;= \93-H=MH]4/9?S
MI?F]RARDDU_:X^XOP_YM=SR))_/GO[6Z_WSL42Y^N.W2C;XWK5HC8-GVW.3F
M1G?NI,[) OG@^725.5@[PX>'WO2!;M[)QDSG.#N5NH,:CB1^W04^X9F#];8W
M26AEN]]PU$W.GLKG3/04H#\BEI[R&?G 67*=.1\GCS<3.C6HE%O=7YFL*S]+
M#D]/Z,38:8ATNCRYOD#,UYE3L-VA,WK2BV4;3Y"=CLAFSDUO4(O44Z?.6^FQ
M<YTY(X^.G;>U'CBI:L1\8C-G9&] !=MM3=O_JGS]39+L'@!EF>-OTKU_J&'N
MJJG?0C7\.G,>JJOAK1]V0U>]>:LQ&N<U MC,G*5YV$P&UI19_A8]A0?SP2_(
M<T*\8O=9>@JW/7JOMN@MY Z3Y)K"PMHR!HRLC>:L0?68J[(D3_&#D&1)4OO"
M QJ3_;Z$J7%BVSI3R,;GT[^C9SK5^2ROYP>4#D$ZSVT/L(.V-&[G0H35^ ,!
MU05=?%^:TPL(U=*21X>L2N&<PT PI60$_(]D.<;*_18]6>1DF.(*.08-V]J>
M#S9OWIB<QD[?W#*T2,$VZE*6FONHF:[\]Y4L=2SA$SQ(]#U%M9?(B3PTG/=\
M9IK 9).\VTDRHT[I>KBAW_Q-X.)4'*'V)+R5*8:Y.(8@U[9([RR7;!^[A[>(
MN,\62RX8^SCZKO7D>E0N#\AB5T-GZ(^9Y,BV"E_PZ..G@"X6QF;/7T<A_1C3
M->&YL75(=<K41L+KF7/UBLPXA7?/?N*+HWOVCFLJ7P[?S,^-?7(D!M8_81C9
M2]_](]I:2?),V"J__A5.ULK%!:K8&D-'3AW'(E-<QCN4<1\?+&ZU^I%%1&>\
M0:?>Y+IHYGN"1*2K^H/JD[K4XR)@YWW&8Z3F=ZF+.\@!(V(IXTH2N6'J8B3E
MCQ'1GG$AI;TRFDWGEZ*LEZ*L915IV9%ZC_""6.NE:UL>7 E*T-S0^A]BHNM1
MCF48)/,N39VH?)&@>?W5HN2RQ2J$UV1>K0D((PV=98%5@[TR0/:/"_S\+G:$
MDTT"V?:7 V+;/\QZ?0X\VP][_=KK.2I-=,RC$EP$!E@4;]$<$7K3HWH3[R*8
MW\"8:\#9!]/?3IS!EW%6Q0,SA]++S#ZZU9NWU\H;Y%, "IB6<P_:(/2+\::@
MA=1N^9"\-+EEA4V]8,#<(LQZR;]$94+;%%Z>M'[8CMW:#Z[IFM7!'IW'.*&A
MS?P_"[0+M!U@BB[_XW0 M,(%K=QOT;]CG,V-['I8P7<9<\6L8LH)-JMRL3+S
M@KMG-PGP?T#A$CO,V9>\=\[^%:&!M4*"._!9(^J[)E>'.RY)-D;<QB$213=!
M61\-]_(R@,#*#)IQ?R\?.F-O\G7"6VM-SHG'WB^1&VO17B%"K\X!U:.%I2(%
M/6;UW_T55PI6IK_L31&2.V4O]1P.SR<W?;'8P0ZS3XT0NYA^2.R?2I;['8Y\
M)[YE3>(;V&03,.6MW^\(I2_K-OO2! R4N("0^*+-+/8:BJ97K@W*6 =5!I-0
MO11>OQ1>-TW]JP;:!BMYFJ+."Q4#E_$!:GL&JWM-*L8N80,2_T=]S\/HV,-Y
MZN 5:QI \]>O9PCEQ-G1M.6=S'!N\9F5O;S)/9 >#42,"SZ/)?.T$5WPFJRI
M5#@%ZM5:6(+$443LI16@]H*>,XPH\:DIZ*)+;RFZRDYS0(O8 M68<F]W$GOP
ME#FCF2/><9]=)Q(%-@)-7_&Y"3,-@5=N8NZ\V/WFALLX\)QQM'374]SU0Y:Q
M2V#<SSU(_8X:,08"K-3DH=LEHP-&(\_"ZJ"N]0SLT+N3AX)QY#@;X<F7;:C#
M)%UTU6 I(Z!5NM83;LRV>_A42WW\ND^RC!PX5_C:<0'7QXY@33<SKKPPGS0S
M3I$\XC1U]U<4>9WI0"12?Z B6T4KD=R/FLRNZK[1 +,5B^B#+:RUAAF-4; +
M+Q;LWZ>-7ODNSI<)QPFO"2F1DLIIIF%?!R3(E;%9-X6B8C9VO\\/A4%[_\1&
MOD5</"+HV<51X&W&B(5H($=T',AZS:XTO,:"9SS.23ALU=+F3N"'_PV_^XBP
MZ\V(;O#T=VLA"*A7'F)V]5F/Q;*&J/B<0H!F@DE1$ E+/;IC$<I.D%3V&1+V
M+SM_!Q&3^7">U/=)/LT5*E%@_-<\@\J4$+C1&#N]3GG;I0QR%_Y9TTHX[I]Z
M.BE(!E3LRK4)'L_C[HN]9 SS4&?-@=:O$DLIOZ"R5R5"[%130R=N^2=!)L5K
M/0ZP7*ESL/WMJ$[-&+%R?"C^8++V#A5K@+J%XLZO$N*\[-=C.#X+]3P@_[DP
M%4.HK2SM/<;.=]?S>JNUY1+DM&T[6D5Q]K3D3W%Z 1P((OJ4AWC-@.<4 C0/
M4C5I:T^HD"YYJ98](5-^YZ@$ICEY$AXB+W31:NWA#2(CSU)*>R#LI#N+098X
MY:0$8%=C<@PHP 6F#) (QO@Z*4E.EGUBEQO+8PEQ)TN$0KI9'0J?'Y9=<+.A
MOZQQ8'GW!$=K%J_O10Y=R_R,I>+P[+J^WP _D6RJ8"V",<ZRDHL'X6/V[8B%
M!]03'UXS\+@<6=7D,FO@/#+2'=?@N59K=!_=IC<3=[$4![6?M-(5QW[NXL5B
MCN X$8.,\,U]=IY//;B\(K^\(F\L;"8?B4U^15Y5ZI0FO2=78@:.6]&UW,;,
M=.4CIVL1GY[90<J>=TLE;8O\&?*^LZ]Z$,QO65'DI>QP$V!![32J8T?S/@AF
M]P=A4!$;*/<X#0"L.%\FFARR&C(_ &HW/]MSRMJ._0S#1Y\*;Y05?F\#YE!]
M<C!.+6Y[E$0_]E(<N(.G"K=Y<Q"&R5<(^*C=,\6I@;EU+?']4A]/_5*3SB_=
MV\=^G,:[-_BU.Y@.Q[_O_5-5%W1*Y][?%5-,9=P7LO))Q,IM=]S[M3WM_=IM
M]7OMFUZ_-^UU)RF^M*RDX7P>H#!DI?;B^@*9N9A=38(N>G:#4X(DWC6@N3$>
M-2DD)]N#D'WC?6B'578HGCQV@V]B6Y2XES:#E!@*G(,%\]2\/;D=.I^)98<L
M$8O4["_LI<?^I"1X""N8>9/L3^6#9;+5J61 Z_61$#QWP_O((I8?BG,@\)K6
MG9(ZSWK <M++WN6@-!.8:J(D9(5W6>%1.%M6G*&!V[CVPE\%)2V@'MRF2I;V
M(U6YR7?BTDO+;W$NJ% L<+"]KDI->64N9@ 2^X>2Q;[[ZN0E!\M,TL&K%?;C
MZ%8A  H]:T_"7A *558@4,K.QYZE)UZ5V]+'.5')=JT]"4YIL "\0+@4SLX.
MX#(,EXAP+_A"3&3=9E<- 42-$?!XUI<LGZ?KL<CP7Y"S0$&*CWQW1^X0LVM-
M(?!Y+0 Y.2K;_U,BJ/=4.BSP?N@?_C9  M.NM&L#011RHJ R:S3Y'@BFTV^W
MZ]^S_R*'/2F-G1./ 17*C6?9W]X&]I(.$(R(:]._)?X*H8GULZ*)E56#_*T]
M'K<'TTGKGOW3O6W]VNX_)L4B677(^]9-O]WYQULZPK#?G;1&XUZ'_?6A._UE
M>*O;,$NO3&NJR&^8AX#%$S*/SCI^ER*WT*KTU?TH J11^6V$; 1C#+KJ4((O
M)=2DI<?8^YJ2"BK*.5>JP'H3@5U2!>H2IY$FTC]'JD"S$P76%K4C$ZOU(A5K
MNDGMH8MRN6;( P6K[8;Z@"RFFK+EV//747P1%SLSX1Z-.Q&E'(';NDEPR1QE
MHCYZ?)I2@<OQ,=>;62Y$1A[39<-8YV%^!I+=ES6R0^1,$8&/)8#9;%]-SE"%
MQ22&C<^)\3LE,]J@7S'+?N^Y M\UP#6WNRZ7W]D8PMR4[O\K'4@6*W%'$-H%
M (^M$+[S /S#8\PTV5_/AE3"$H3K9V,6Z&Y?N675*I#O%,$5'J/^_.QE[[<0
M3_"=0MN2W=O.I\A>^NX?D>1* ;5OZH5"S']Y&0\K $JFJ<(]]%PE)**6X6+N
M-:(\:$R^0I0"GZ'7ARRYPS7[=><^Q [R9 ><^AB:KA/2)26#4,1/V?LE]/23
M'UER<F[3ZPX09Z/<7YMW/[]/KP!?$%H&!&KLZ-^<4J\2J@%V;A"<>9E2\ !H
MC-NH(E3CBRA4XQ*;<8G-*&N)7V(SRH#_SO4MWW8M[Q!#*+YC@AV:>LF42,"@
MQWAQLN,Y(BS(<X+(<[PE#^<<!@)F'0GX'\FN/^5^BY[;K Q37"''YEV!FS=O
M3+YJZYM;AM[/MUJD[ I^U$S3+;N2E8[%;!IWC%RLROFLRMH\.Q>KLK%'ZL6J
M?+$J7ZS*ANV7EQC,(C&8VIRFEQC,2PRF,4?=)0;S$H-9E;NT&3&8O+G9! QA
M;D <_RPQF)K2MU09@RE,XV+, JTX!E-7#ML*0S!%>6V_EHOKY>6R^$)0;H7B
MR\ME4\5II#K^YWBY;-X3VPQYH-NBUNTA]^/ENA,VYGR\+,S(J*TT_"X.C!X@
M8U;!+!A&81!:/BN%!L1K'GN[P)ZS:TTZ:.$('S6.( QU.V&Y9*L':^89Y75!
MR^=.P7=;?_AFM%I99#.<3]R%[\Y=FTG!MG'$JH$L1MAS[4/% DEU\*^98,W'
MAX?V^'<6JSGIW0]Z=[U.>S!MM3N=X>-@RF(Q1\-^KY,N85!-Z7#)N4"Q#^>8
MK)+2)YATR&8=XCCE6F86'!\7:CWK.^$$]$!QEV(NC(FU5!9VYLQ4E8GYT966
M2YA3#=UL]C_^XE*FB+W<]-$S\B3!EHK]Z[^)YD$)%^))8>_5!&;JK BR+,C\
M(SF'T11 F0\D .$\@C+)[:4#:2-OX[7/!D.]9WMR8]TPB%E^+S/H"CKIJBM0
M;&4"> )L@<M9V\:]+]:>U,?KX-4:^XQS\>$KZ=:D,U=) @9%\IR0*=MH@>9Z
MCDXU66,5!LP[&<L QN23KC3P##W("L7J:WJ=*UX4HJA[8:(>;<=0V_/P=\NW
MT1TFMSAZ"N>1MS7<!&-D(_>9[>"=B! D+FN:8YCZT_44O/479\XX4RQHGWP,
M$&6G[\X%CVD5.C<-4V66C+OQWT0!Y2T(Z![TY/IQ9'0'TX/&V=9;WCTG(LBY
M@B'-,TK3L,W/FW&ZYAT3+>J[S\CI^:'E+U@5M:1XA[ &B;A?TX!4X0949W1!
MUUNMZ664;26L[/0QU0E#'F,(QE!Q@*:!F8LM"%5MWNB8S@,+G:5%%J+*3OSV
M3<-,Q 4$T<=R\S=1!0LO?/??R#GDMV$A>W[ 4UA8%T&/QLA?B0\(@4^Z%LD]
MQLYWU_,.,X;5CH(7";]]8T!2X *\\&GTU5-=R$:L,A\;<3CO4#7(38H4^TY<
MC(_]S.(1'FD[$E+!A:J^^P\_G?KN.\-!ISN8CI-\2L.[5F?<O>U-6^/>Y!]Q
M9:SA])?N./YU$O_^2-N/I^W>8%J]/S_'U#X2&A-09E9DI[>HCYX%FJ%(DD4)
M:J_?CZ\@8NYB%4O >-]]AOR;S0WR[>7*(M_$C@-Y3VV1XQ),)  "$C#HQIXE
M>4>PS%0M[ZG'G: ,@@P[OB!,<BY4!Y[)+H>* #;4 9$UYLI\$5 /36].E1<6
M5N;"N%UT1ZRL8/D);\>%O36%.)R)3Y8'<)_49O;B[!CR5!?"3HW51^3I+;39
ME;.L*21/$'8R1@&1)$=0X-QHM>-,H!JF;!0'TU 5([&R9.B6G6+";J8H&](G
MUU(NC-LG^\RJ1G+#)>QFC/(AQ4O.!@A8S55D_P>33A2$>,729X+/XWGM#-<N
M *KK\79*Q#ZP5F@X/R(//)EH>T'S^I_."X2*52BN25.H"0$CM8*S4:I&!0#\
MD[NOGG['X.G &F;:::@4+I_76$)PV?N/1*AW.")*4CTTU/'8OI!<3T@&-Y:B
M.I!$M$,?-J&DR=RWJ[T>:E'!'E,,R?6#.9:2$=4=Z!^L!1($[(EZS;X8HEGV
M\WK?3IF T$KQI[$TT6G8DJCFT(<K4<VAWF#:'MSW;NAO[<FD.YWHKB,D"+7+
M@)HK[+"OV^=]@$] I7(U(?D8QOC&\T *5A12E9GQGG,!(S>;Y(3QK$#R^B[7
M( 9D8E-&3SGN%I*508XB ?4'VIEF(7TJG7<@;76%<J.EC+=(8B;9RW6!;N0-
M6M?$J/7B/266@]AWLU#%D16R!Y'"&PW<09,AO>BRPZH\&;<U[ZYH8^3%5X!@
MZ:YAT':7!KB3MI0%YR&GR%A-1O9<5]?5.@H1F>!Y^-TBZ(1Y*9(JW6NW,Y2+
MJ3*+H&&B*+K /KFEP)*"Q%KS&^O*V5W"!BE@" +@D\Y:FMO=7+:23EO.KIH)
MD9 =\/C2AY" W7LB?.LBZZFMWO@99@(UGA1L>L: V+;M:!71XQ@Y[14FH?OO
M^&0N!"LPUBL#6LBE<0IH;8]S&PAR+M9 W=3 17W.B_D&XJC"4=E^W"KA&R,F
M,-=?I/>7$2(N%B6X*#C@*P-<SBIX#3%QB^Z^V%[$,F/OWMP6VZ@SPS01]0(,
M0EA_U.A=!7RJDG?&UZ?.5=BAJOWI\,6U>G&M-L:U&B#[QP5^?N<@-YD!](<#
M\/2761\M+*_KT_6X 9REM%6F40.=H3PV*KW0R&6?D *ZL&B3XQ8U.R0%$L,
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M:#@_/+7M6)Z'G)O-KNC(MF'>$FKJ YN/?RD,@A.BY*>SVV\76-Q9LY-6!F,
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MGATA0]%4''4$M2]U15J>]Z9HOCDY+"?K52P!_LN^'6UTSB+GYS=4I>*(X P
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MV8:SCXU]& 8P PG]8]%;%R#T]BH.$E&6/=A^]KFQ$(AY@I#X7/9K#$07OO.
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M17J F14XHJ?UDX>V#-RB-4&V"YUO8IU1-F"#$"^!46@:%(WKR+E.M^%5S-M
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M6!0,9=3XN+ZEDD:-.)1QZQZGX2L[)FZPK<+L5P69U"HV&64"ODTKE3P8;AF
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M@VWBB\1R,%BB!L<=DM72Z(DFEJ8\N72X+ Z\U&"2(9:S%S2K@-G$S0J$8-!
M@8P+M:"B]C8WV2Y^')0;K.\&3-!IV#T_T4+OGJ1(Q6'PQ BC\'2%YA2LU.RQ
M9Y+N62%B//4.8>Y%'[V,=%X/QSA8Y(&<0D9JUG@TP(F:3 8Z,!AE#I2[N%%I
MHE(5%;J(*B.B#6<;=;U+TIQF9Z6;=YH,"1)9FYNI2KCM_52AH'->F:#C5DE4
M]I8ET*72-^?,@Z#:,-/LE+G9(E/MC4'J._05<JQ4Q?F(7W!@,#$1R]D[<U7
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MG+59B IF/1,1"3G_ZCID_0]?BJ)2]O+??X^WGH\G<]6W[\M8_.YB>*UOWA6
M\KV%J/AO78BAR?SBZ](P\,/\O=P75QYU2$7MK4;58)N%J%@.!@?4X+CE9R%=
M'UR .JQ@"666V[(>ZS)=A2\[5>BW0MYJE@0=[$YF!)FP<S:9(N2.Y5D:H&1;
M5?M&9#;!="Y[B/$0ON*_8,^@'+Q,TEH_HX9:=S-B,>>\T&/K,^*?;ZFHM>KO
M:TR6-&94D(I:O,"H!-NZMBB4@\$&-;@^'7[O@ Y/21CGYEV$7L<N00S@=YFB
M4 !$&3U*CCM?_3.R2Q^660H7>[I%:E\Y;>2RUNBB@UO31"8(@QX:='U:E.+E
MCGJ9@=GI]8.G- F./IDNK7'Z&OJBG72YF*W+!RJ0U=T#D8QSCFB "2ZB4=$R
M](])7W8R6CXD6S$FTLR;BQ ?E]NIE^U4HXY>R^*X8^I":^31J3@GSC"<?'*%
M0A&EI28*8Q017;K<\8GVQ0]M/R>S_2%*WK$J8$LD9>_@5@JQ.;KE1&#P0HJ+
M.[[]G*!:\N);:%[Z*\[#^&42!Y/@-:3W:2LB*G;3#+3L;:P9N]#LL6E58'#&
M&"=?*;I49)EQ*U54=S$79M5/I >3G+()?K?&%!&LFA/M'V%\?0$BKD0\$[GX
M]8*,)A[%<:;)N2.6LW>!0 &SN3$@$(+QN17(N#L!&6K+7GR3(WQ[Q)_OR(HX
MF.R?O2SS".E4&QQ*>7N33 /8S?12(0R#'P8(N2EE^(:(#F)*J*4%YQAF\ME+
M TTT6$_&:J48$;Q.A9BV@'.BJ%!QG0B5 17:5<UZUWGB_[H\2 <; WF;'-'"
M;O-%*@R&.SJ$_)TB+\6W=U[&MLC>64#ZA&Z?OK#@]!M4V+CT(&4^/#D?F R'
M),B#T:!AZ'+#C^+.69D;Z,<D4NZJ2T6MWD53@.W<2Q/(P>"#&ISHOEJ=O*F0
MM[,D558CXT0L+TSEE<AZO\/XY&)0DA7J.6N02;[PG_![O6TVB8/E=AOZ6#4.
M:!2L?7TCX#47E-(PF&$"L<\3HM/:]:3C1:5V^2-\MBGVE":OH7*HD C:/C01
M ^V?DW2E8/!"!4UR&H(JX<O?6$MQV9.I#C\$4A9OK<D@MNZM]45@?'DI+O[N
M&LW"54I>_$8S]H*GR//9.F7RHK[6+)6U=[=9 [>YX"P1A,$%#3J^=(E'UI65
M/&(*ER;&[ VG?IB1GHIT0<HYHTS27E(_)=0FEY]0# 8AE-BXS'VE,&+2-N:5
M'7B;SXDA&5J2;LC 0163H18#2(8^-@T9Z,FYI:M%<A+T):Q?*Y)\].[/,#ZV
M$)/T0M&EUP%T'W-(I1JEO+U5@0'L9G&@$(9!"0.$P@UH!P5IJN6J 5>DHO:&
M!C789FP0R\$@AQH<-SJ4TE"2AB\_QV11LPL/DG#=WN^VXG2%L*H W<Z/SDD@
M0\25FJED+GPK+#G& 8O 6!^2-,\VR91T11'.5L<@4&2^,=.S=V-L@!O-_3$#
M)>=\&8JTSZ-&%16Z:).@4ALQ]8M?$$F"&+^OO$.F"KP22=F[%"*%V%P'X41@
M4$.*B[L"P@11(7GQ<+L]#0 /S*J.*(3M!=[I #?1=S))&'S0P>-": IY] D]
MH$O4)I$7UDSBP#0?ITK:9BE-#>1V#4V)* R2:/$)JF82!60Y7>=3BFF&:!R4
M=QGE!)%)6JQDIH+:*F(F$H-!"B4V_L881H5TG<;@PF2H\BNHMK)Y&6L$D,&K
M/WU? ,9'EZ#J?^[J&UO8JRX?I=REYF5L?V?YSG1? -1WUNU&5]_9PC9T?TUC
MOM9TOKHT7$]"^OY*;/HUXZ4'^LA[7[.T.7% ]\H?E,<3*FE[ [X6<C/H2T5A
M<$.+CQO\B0)B&NQN'M5!#^<\WCBMH.$'G+RDWF$7^EZD*VK(RUHO;"B#RQ4W
M[ LZ9X\).NXHK"5VB4L;&?:_>DE>R=L_QGGZ7A"F_(^&+^4??B&(NBZU?[#!
M!!X(_>S-7YU_8PX*5]+T<;Z9W:/U9K*9K1U^ROE"@IS^8/-3-D#:GW*^ /,I
M:RA<<MOU:C);.+]#-8_]9(\WWMODF.\26H;LD8PPBLMU*@6[J8]UP+MID&72
MSIEB#)%/CTP5$-% M<H-HDI0+NC-L]3#4=LEX413+VZ56!K0'5I)9.&02@V0
MHQ03[U+*YGK$?)UJHN5D?6*X?M6K..?0,)R:=<OEEKG":4R PZ*#(O]H^B7R
M'[_,XIR6Z P"\IHRG&WHG;*>XW(Q&XS2@:04DLDXYXP&&!=RPT11+8O^RJ0=
M<V(1QGA.%EK]*9!:U!$W.+ 2?M1R$#G2!Z?G"=5 3,4V6>X3_[@OB^((/.O^
M;(L4(E 5$=J_@?CX D#]#UZ)L'P3EC\P.Z6G#W^(O!<!_-[OMCZQ$%;UC3L_
M@OC((D3"> CVF:F0J\]\CS,_#5G2"94?'3'K'UT DOOV+1E8%."!R9G0DG74
ML:_P2YCE:3'1K79<%=V81-YVUZ^$W1\+A,(@2&."4#I:M)50K>6(1Y,X/GK1
M"M/ECL+1KIAMUHA ]LG2E@'%$0$P*34*650(.V+$OQ^]-,=I]*XE!2=IFQ<2
MJ'UJ],1 L4.,34J06MPM1S:I%V<A[<"T).%%K2\W)&"YI4=/#A1/).#D2Y):
MWBU3UCL<132OIQ?K.Q21L&VVR 'W^<)+@F*,%)Z4,TP#E2IP:,/JK=Z3:9*A
MLRUYE^3A8*OX4PN#I5 ?H2&+BF*Y5,\1DYYP&B8!F6:G.@YQDK;9(X':YTU/
M#!1CQ-BD7"G$$9-W3Y)9'!A1I)9S0Y >3#$]2B& Y.@BTU&#2+LDQD.8^5Y4
M8'D@?Q.=MBAD;1-$"K=/$DX0%%%DZ*1D*10JSC 5IX2A]=;,Z-*2=$,6#JJ8
M*K480*+TL>EHPJKAN2#)])BF'=3R$4<N:HLF.K 53V1R((BB <=5XBW$.T1Q
M- (5I\D/880?CX+X(K&(W>-]'ESW6+_Y'007)* DQ_A4#A6"3KY\=4H0YS18
M4NI.7\PN \0@NRSHR@!B@A"8A V-+(M==<*(*>F94B^:QP%^^Q-^E_K%R=GE
MA 1FEQ0](4"L$".3T*(41DP:$7$GQ'A*P[V7OJ]#7S-4\()VJ2$#VN5&7PH0
M.230).PHI=%Z/G4YDFR\MWE B!IN0Y\=.FM8(I6W2Q8-["YG),* J*-&*&$0
MC7'O:KDD$KW+D1Z25KC#M+A -$T"^0Q%HV675$8N=*FE5 %$,!.<$IIU5&^*
MF!24I*@T@*@%E]'.Y?\LPAA_*_5?*.LDWED$5QCPW!8$Q"0Y.G7(\TWU#T1U
M:&H0(*3Y;H"KW[DGS7>FI/D.-&F^&T.:S><$"&F^'^#J]^Y)\[TI:;X'39KO
M1Y&&%MAP29LI^><RW22?1<'94DDGE.&A"@G3B,&C"X=-1Q:J0.<S5,4E3=C$
M:IFR\C^Q+Y\RR\2=$$8"6LB:GBP\ZH@!ZOA33X@K/:=]33$IUS:22LQ-+],%
M*>YBRNP3X$C2!:;M7 IIEY1X2K+<B_XC/"@7XF)A)_00 A:2I",)CRHB>#K"
M%#J(*+E86)=TI0<:PJMDO=^MG3:+8-5'S.T?09! A(@[3"YW3PHAVY^9<C3%
MGJ1'Z/YL[2,+0-7?N/4;C$_, ^*^,&O71,9%0UXD-$9JE\3R  %>Q-:7EH&K
MOG;_=Q!?7 ***]Z7L%@S*N=H-_XMQW$F[KY;OUD;V?MPZH&\^@'$U^VCX>NN
ME;];_IH_IV%.GCQ-]OMC7)[RB.(&)7*VOK(29O7%A4(@OKX*&9?SN)!%76'+
MM%@G4>B'>1B_?"2+SS3T1%Z)A&P10@ZP8@,O 8(*4EA<C8-:$%62EDGPE&)*
M0AP7A6(WM#)'NMQNA:.]2M@6*?2 *W+()4&01 M/4/_@UF]IH$(%,1VWM)EG
MV1&G@\@C4'%$(2EX"9$X>8ATDH'4DJI0=,FM-?:/-./BM]\];\)<F):.%[$V
M)DG U2-2[W<0W)" XJK(T]]0LD7??O?E\^]0I67Y\S\FF]0+R)"X?M\_)Y$D
M^Y10RA8)%! K'@A$0%!!CJO/AL<$E:*HD'61G:H#5N!.[W=;!!#"JCY]YT<0
M'UV$B&O\G6_MJ,N?O?D[ @I++B2(Q6QW_2*0_>Z_+0." @I@@L)K3!15LBXN
M)#1#UHM^$O#B;!+PHID$O$"<!+R83@)>G$T"JL<6*4)(O[1\CL(73Y*<4"EM
MFQ0*R'U^"$1!446.3]IGU"JHT;&=T9*E.)O'VR3=L^<_D'\(O)3(6<MIJ8)9
M)[44"8'@B H9E]:R2#K7$D94VC8OCD&8XZ  \Q#&7NR'7E2G1Q3MB.M5K+'%
M$'Q-'(T\# Z9@>3H5*A5N0QKQ2;5I>VM]"( XV<<17^*D\_Q&GM9$N.@V$L1
MG12IY>U&S&A@=X-F),(@Z&2"4!(Z0Y5N?Z5:J%(K=\*<,.FG)#K&N9>RN^2I
M/ $_)V>7.1*87<;TA  Q18Q,PI!:&!72;BYH%]DCZDD6[?"$*6#4XI:O:RM!
M]VYM"V4!<48)4':'N\SYT<R-"RU'5RQSG'I^'K[B>R_W2FQ2?V7BMB]5JD#W
M;U.*9 %12 E0>G^RUJ&I8KR*4\Y2QJ13,M5Z2111XCTI^XEC.(A\[IA:!! ]
M1+@4&6125,DZX<)Z[T71W3$+8YS)!Z*>E%TN""%VN= 1 <0%$2X)%Y@HJF2=
M<&&VQ^D+&=X^I,GG?%?F9Y7Z)I&VRPTEY"Y'A** N*+")^%,I8(*G2JEKAOR
MO#4)Q8LLBW)/!:*6:2,%V^,,)P>),#)P'%LB[-/]EL<D1YL$?<HPRG<8L7#6
M@/R]E0F^L..JTHC/R@T7L_(X\%(1A53"UJN.2 %SM4<X21!$TL*3UR&I-5"E
M8IDU2\+AM+V.8R!H+3WI;0>]BBT&F8*O>*23!\$F0Y!]3C&U[N*:*;*ZB"ZS
M&;63V\NG>!TARS-C <#>Q+@E 8(C4EBR:7&[5H";W'G'YRCT'Z+$D^^R=&0L
M9\SCX?62Y34"@!C HY*ER&."B$DZ^?YW7OQK>CSD_OM3FO@8TRBKK.ZM=/MO
MAMIV.3/(I2Z;C%0!\6P(7@D#&Q.H9>.F-6*YW,RC0>,TFUOB_[K>>>0%+H]Y
M1D=0 DR^"ZY4LGR\8.! [Y!!H0&(>@8P90<.3!,QU1M4**.6MJ/U6=9D <3!
MW?L*;W%*[QUL\%M^1Q[TJV*%8:!K>_5F[$Y_,:=5!$'"H6AE2[T,M0V@9QHC
M5II ?Z5&$+-BNW[Y-(ESSZ<58[(DCG$D"3D6B]G+62$'V:2NX&5 $$@!C$]D
MP411+7O^D..MESTSX,?L]L7S#@4M<)1GU5\:?I1_^*6.)]IXSUP(LDS(!C?4
M "DSQ!+.>:&$Q0655D*DGZ!BY^TB3B+$(HPQW5[H'WFI!)T0@P,J)$<M!8\@
M?6@*DE!1MNF3N6?*),MPGDV>:4D'O[^\DPG99(@88)L=70DPS!#"XD)$U^O9
M9@V$!>7RSH@,G*Q]3DC@\M3H"0)CB!B=K!Y3H?.#<\9,O6PWB0/Z/[._'<-7
M+Z)3Z$D^]=+TG2S=?O*BHVPF8JAKDU&#W&DSS$@1#..&H.482)0069<CG_X#
M-^K.N5B>T64K[&,"BLS 'G$NWK T4[':EQF [W1I"GDP/#, R8V$I0I*:YT;
M%./S;C:.8=<\IH6;D_2=N"!QMRMBDSTB<&VVM'\'PPX!J#X;*I$09V=A@1^_
M>>S3?O/[[[]EGW?Z^.<)349R\,*@!B3N--2B-CZW"5CZV55RSC^_ 3A!UA<J
MC<)*W'EOP+:L [;K';/Y&IN0J0<;C8[5>8X)_,[\1J7@G%)#4(KV\J@H\MB4
MVCFS2J[/W@XXSC"9I;%XD<X:0>*]D:9-E@UPI<TU S4PC#/'*NO3<*&:L3EU
MPF*#_'*1!X21A3?+[7V8'9+,BSZDR?$PC_WH2 _GR%\)%?(P/N)@><!%R2S-
MK/L$@_;W%TYQG-^$&&,-#-M/=D&VG5$PG:;Q"%I&4%)9@=((3'CMD*I:]KD@
M5)[D7K0PW?^2I7FA1NJ;B1-('>,C^3H#=DQ%XO:9(@?-DX:7!=8A20'R.>+B
M6V@[J&44<;79(3NAX\5LDD8&LDV6O@P8DDB \>3(<6O7"=TBFOZ%3,>RXW,6
M!J$'8-GYE-(A,7]_(LAS,MNDN[<'>IHHWY12J]A=#NC!=]<!<GDPY#( V2?:
M0_A&YC;%E(?M:K%Y#SX0[H7G3T UAF8/81SF>!&^XF >YP1[2!I$V==*B:93
MLDDU,P?:9%-K@*&;$4Q^%[62[+/.V].0WK_#8-V') D^AY',]>9GFTSJ@VIS
MIOH-##MZ@/H\J'YV_J4'K!_[,SR)YR=9M,FG,[C>IN )YL"P]G0?1/-\_\JV
M%K04=\M;$S(Z99CA-H.6.\5. []2!$(3I7,N*"$G L3/+_OHR\UD@8!$X2U"
M[SF,PCS$&5E0L%LQNR0*<)K1Q47^KMEF,E>W29:A3K7I9*H+9D0;")BKIS>?
MW,T7\\U\MD:3QWNT_G&RFOVX7-S/5NM__(=_^>[;W_\1S?[]TWSS%_3E_>QA
M/IUO?@>*M>8$=<Y%0]I!9I@QF2!QQ"S(6*7@B#$&X<9R:8C\&19XW%)TOW=>
M!0L^>>]TR]8LUK,O["+*4PQ8%-_9E03#'R4\:4SGH9"&P)N4+ +Y1B#W5B9O
MF3UJV#T"B84A<4B)4$ C*E]'S#BGT1-Y&SLOP])B'RI!JR<O4J"=\Q9."@Q5
MI-#Z'%GAB%W;/GAI_HX.I1I*+E/<8USD:!%O^'.8[Z;'+$_V.*V:@"3P>)BJ
MW3A2<V>ZX:1Z/3#D&P!6&EP:-9V<<P:RY,PXRXUF33)AN[<;5("[]QQ$DF"8
MI(0G&^["4LDY;U@<!8V2,)MOR\6M1ZXH0',1+ )9,/S1 )2MV5C>IB2F9R Q
M5:[FX4WP 3T9.9XYH]/(P?$5$[#TII@QT71*E@=$ P=Z0Z%" PSUC& :$-!O
M[$ GXSU.PU>/UC P7BBJ5:R>,QN [QPD*^3!D-  ))?6J58!-0>K$M]/D_US
M&!>1\NQL^H6X0OZ5A4%Y/FVX-CC%H$U>GNYXF[7CK8'A],DNB-8<A3;M;!MU
MYYQGLQ?CKE0J;7WV:-:!2D3!\$R-3YRDNHJA@=1SMEPXXY6TDZTZ.HTZU^6T
M$TV"8?EY_)#-8UOM ') F7$?Z[I[->M9'7>JVL@BXTZU>XEM ;-3-;[.IM%Q
MQ".SBVU*!8B=F?$5MT42O]QN<+J'=5)/85%4[;T#F=="4:MT4H#ML$@@!X<\
M<G"BFV_U/@Q*6T=H5=X=MG/3W<QQ3ZF10[TVT/H<AJ]A.J@.YC[=*IRF<"Y7
M5/<,KF]N.*0A ."V,5VA7D!0011/%86#.20*Z3UU1A<-2<!20TT(0#2@R;;"
MG)5,H+E$JUU'7TX+I8;M]&<:Z/WD9Q)Q,&.<'B._3UQK%/E<:QWW>0X&7WJ!
M<LUEV,66*[C*,OCRRE5<5FG5*E)FJ.;$K"=I%(#D\C*V9,#P1@),U DE,<JH
M''JE@LZY,0D"5AS8BYY8AM*I=PC)V-MR2.*RB:+5<'%C1SIQXUHM,!PSALJ%
MUM6*J,PKB_Q"USG[5CCWPA@',R^-:=V]B>\?]T>V(W./MZ$?RD9 $T6;[#-W
MI,T^O188]AE#%01V5H(H*"2=TZZ%B1W]T@JT*=[A. M?,2V(ML>+)*,Y9I;;
MC?<F:Y!#K5B^/3/&Q=Z=FB$FP%!U'&X5;\M$M6T[I!>EAM"7$3'E?HK'3UR-
M9[BNEPQF2P58.QA2?.*-C+9XO4I@:F254/2)[BFDN\:OW\R1J$%*O*#9)Q/J
MP**>(5IQS@\NU\)F.?T3].5K741NN7T(8R_V0S(%3C(VI]5NE)BH.JG]9^",
ML!J@0@_,"#P K+QB8+)%M3*JM-%?*WWW501;*Z\G+UVF#'K UO]/.&6%G?7;
M!7)-1YLO.E<D^S$R-3"<-,>JVK6YH8$"0+9NN!+DDV.^2]+P[SC0OP->PQ'?
M9- E/.N+0^27!*.:5UE1"-ZKM>#Q:YYE1W-N5=).>=6%K.14(0J73QU\1EP*
MF08\'BV/>99[,8U$,76^H^*440+P2EJUY.%RBP=I1+"D47/.LK6_P\$QPLLM
M75''.+C#,?E'3E.59S3@*4JR(P&MK!8_S(;5=<,8]SH+B"$&P#!U#&IN25':
MH"N*T@HJS2!F![4,@:EFS_O;H%QH"MP;ZMJ]H3O G>Y570-%,'P=@I:_O,MS
MLT5-]%=J #$+[NFYPJ\X/N('\I%%&6-F;V6H*4U$2_Z_0'Z,,LJ2W;.]T:YV
M#_L&FP%#Z_'8N2#BV0:M)PL Z3FG298OM[1* -M(Q>EKZ.-LG43R%8Y<P>Z4
M5 >\.R&528-AEQ8B-QE=KC=H^0"$2!_2),N>TF0KC5;H2%BMY\%#ZY3T:'Z&
M=<C! ^.J>ZR6ZS5Z6BT?YAOG#"CO4,0O965474YHA;S5^_XZV)T;_S)A,-V(
M#B%WZ_]IMIILYH\?T.S/3[/'-8"N9(VCB ZC<?#12W_%+6=DZR.%@M7EJ19X
M9RTJE09#)BU$;I59*+#@\GVE B=[ZP>RJ$B]B/@S"?9A'-*60?,$J>FEU;(Z
MF)FYT!G@U"I@V&:&DQL#"RU&.:^C!X=W*YQA\E)WQ+5[LHB($E8N4,TZC8[=
MM9\!_.XJ3Z$ AF\F*/EDPX4.HUO0:"&?3-_=$XT;_4UG"8[G7$9S+5BS<QD\
M<?!;+8UF4#JE&E(3#:ISM2WIA"\\5"%C&C&@G.$ RJ?E"[+$<\Z5QR1.NMA+
M&FO6> 9Z-GED[$:;55HE, .:*5)N.W+Y>-L0;OXX77Z<H2_+]:#[T,=)JV)M
M'4L7O] -,[I5=E\FCY76R3-6MWHU8:!3G3L)AKIVB/F'@I@Q?J&Q9*KN;R!N
M[C)"2[VHG_V<UZF#W8^G'[PPSFB7CK-E/'NCC? 89KLB O2>8)4M>_1Z5A>8
MIFYTEI@Z)3!]I"E2/LE6EB'".]Q1J6AX*OG\^,UCC/KF]]]_RU@U??SSA(&E
M#U[&-.Z)M!:\W/:S<O?\'*!G@U6#W:"L,E9RSJJA2&6L"DM%8;KTBY-KNB.8
M\#Q^\,*4Q0(S_*)\Q&KWA]AQ0+[A;@K(:&X$&CD'(^=VVH@I2E:?&:(WJ+?$
M5!$'7A+W(EFH)?PMO6*M)6,SBEZ%NDTBO\ _RH(USHYSK6;K,'48/!V%6=:=
M^K49RDNO5XL0Y0F]QEI'<KKH7YL:!5F=XWUP\Q4;@=&SJAPTZU9%%F!P=2QL
M+H)#TI$&? &+D_,S24C:H!6?1LB$K)%,"K F$2<!9=FK1*<H6E(>6SE?T%:E
MR]3G5)R4BS)QBK.HG@@4<JCA]=E128'AAG2K<>C6)) -X$$;O[ .%70PQ0=2
M-(]M<R@U+_-X5(=3[C=]FQ.2*MXVC(\$:IVI-[O#VR0M4YELO#><S=[RU$O2
M((R]])U%B-.<JS12-V%1*54CDK;$"S[1;J=X\5?7[6 O]CA8#>WRCHKBQ.GY
M'WI8+3^BZ?)Q,W_\1,]HRM.:Y>,:W<T>EJL9#0+]:;XF?T'D/ZLSG,WDSP#B
M^82)MKLO4RAR?TS)*WIB1:"/^1.9("5![PU+OM1%GVCUPM#E7UWGFM'E'N=\
MY6;/1^&N!/VN8#/$"QVN5KGE&V$9]%DN?5[TA%9YRE.<M\337Y&V]8U_!.P6
M=[)?LKV_H#1&-U*RXW,6!J&70DB>/K;CN>R0!Z]1C7\EYQC*7#8B[0STO$YQ
M+:B>:=[/U^5D<W;?FFM>: ^RZ\#Y%WB7>HBU/="+O:!Z#_7L3X#1;B[JFWJQ
M=E4KM/HEE/L_Y>5[Y3I8(&U_DT,*F=^@X$3!S(_4^/HT>TJ3UY =;1+Z5@EX
M<\I?YS1ZQ+DVEKPG8W7S5P2OL^';%H#1@ZF@R3H@YSPP23C]5)04G.1Y&CX?
M\^*$_\DS*$)Z-NO6JXJ?[Y5P5<A/-PVF.SRO/Y(JYX"SF*O\?R SEO"E+%WM
MOV]2+\Z(K_15Q '[KXA-;B;!?QTS5NA)D[[_4@^#TK9.?V&F36W\DZZBY9WL
M7K\AE@;+&K/^.\H;(QGR:C/.VZ/@A6@:E5+#<MY&'?1>VD:9.*S9D!ZH(',C
MV Z_,[=[PFDK#^4BW(<Y#LC(EL<XS7;A@;2V\L9[ZX^?XC"_\[+09[=HHB-1
MT5W,N^PSG4WK+_7ZI,N$<S\0S&!@PTMN!8/S;MM$!S)98WE6T2UZIK:*B_>%
M-><M5Q\10%X<>P6J1/B#K< *)A&Z."Q I&,"3 L8AYL?>2J]UHEOP>7KX&_9
M=$]F<-<.. Z+W!S,XK:1Z^*Q +D9DV'VQ<)CL&;[8'"O/,B>.VZ/<%O.\0'&
M@')]N =<6+XX8@=D_ZWU=G!//M B8-X/Z]T'F;M6[AOT^#+V0^GSJSJL5>TB
MUIPE;T<B:Y.S2KAM-@H%P?!,A4ZTHJ,K.7XA!XX\97LP=+J6=DF@'F05A4I1
ML"3JXC.B$91>Z&<<ONSHYL8KZ2!?\.-Q_XS3Y98K*J/JG0;:L$FZ4>ZUJ3C(
M !B"CD'=IVUE WF%D?K:.5<Y"$RO*'&[/5DP*%TUV H 0NM<-*"TS 1T4FMP
MGT1K@U[Z@M]Z=*7M[ZQ^LP.[3K+.O317G7LI</:_T9T7L81"M^BC]XZ^O4&D
MI7_GO'<Q[3\<]Q!&?8#;5F[*&,,F7=*E*FIWH4AOQM^BA&-YG8IY\9"DDN-*
M8RUKL=CF+M3!U7H5Y^/#,)Q\N6JB6!;:I%&I/[CO9\2NL!0M[1Q#](A2%JDZ
MT(;=^NDCW.,&/%,#SMEY"FK!(48K-52K1BS+#/5EG6_'?5B(Q-NB1S^1Q%(C
M %BL<=" QA(+T'FLACV:R.<:TR_:*4]\,IW-0K:]/*+U=]4!D%CJE&DOW-:%
M3EP98"Z!<R,"E8QEU?K1;!3I Z"CW"WC[O2:""E%K&!D=A7]9/%G,B6O"D2.
M:*D"&P HJG;/M-OD#$"GJA(U7UZM^!DJ18MV=R)'I48 D%3CH'%G>G4T5<.6
M\?0JNM1'_)G],J8K;>D"8*?8'=.NLU:$SD4A6FYYY&4[J+0K&M-(WG'* (@G
M<<BX.[P:ZHGABKAW%5T?N_ WHO&5>@"8Q[MAVMTQ)>A\XY!RMRC3XA*F%Y5A
M,54E$:B\*P^DAA.OHPB >0)'C/N[J^ >#]68?%?1^56QBSB@ET-QG(DJW)QB
M" !)#1PU[2_%5J"36 ^=6[M0X=MG*LW21%3BC@)8KCZY@=U FE></B<95H5$
M7-A/>9&/D4E'+DBN@1F1['Y*56L7XY)&#=-,6>2KHR)HQFYP2WDXTJEE-"#Z
M0JSN.MQ%Y90N[D6D"Z6/&(F;/U;H5IRRR[CJ]&,LY23ZKCFG=$M'.J&R\^YL
M+&(=W]R$\15Q.%ZVBW"6S=YPZH<97FY_]E(R<'(1*B=9<LU%0U>-ND*Y&=#\
M-,,NVAJC"@B7&C1XY7.I8Y>N<NQ%TQOP+O2F7!/6U%D=8W5V0%/6$/P@SCKL
M:M=D*9)MB^7)<ON4)MLP_W#T*"R,ES&M.SQROCG$LFMFCWP51EVSN5G0O!_G
M"[<QTC) 6\"!F4 OE0U:?('6JW8YZ;U(DQANVG6;&/LRS&;1OY%6,=*94YN%
MR[EY'3*<;%E5^M*S%8Z\,I];.&C>,\BJZT8QXA68S=^-3()N"L/]4$>C4[XW
MY;9O45J8(']A-AR,#&>G_B"KKJD_XA48#06_ >H/]^,DZD,_&2T'Q3,<C:HM
M 3@;-7'5^$3_.D]'#;";'H^"(79S-)=MDDD0A$6$PI,7!O-XZAW"W(M4X2<#
M]&V2>+!;;>H:*X,A[%#$?9K.HG ?QEXU*6_WPN\H(.1_);^]8E1?DW/.6]/+
MK<6_\Y ,+VOL$TG!Q.5,-@%TTL/<'W/%66@03#LXAQ<#)BQ06P%_-?8,S<#8
M*(!V,/ %C+HD?94M89@; YJ"R83FTCP8D[CH>P=I:&9QH(JX4J"4IRV:'-(P
M0M]_PS(7?>_J*XQ+!.0B>93N&TA!7C@5T!F&!#)UHS-!TK2];/<0)9\S3743
MM8K=[EP/OMN@Y?* NF(M2#Y%4*E"^UFJA)@6^FNE]Y_.>?:(<PJ,U=<,<'#W
M_HFL<>=QF3LY?IGX9,7 !A-];9W!ABP7S!GI:"\T=* 5,/P=#9V;/DS6/Z*'
MQ?+GIN;O9O[X 4VFF_E/\_E&7=H73F"OW3F#08RV&)XLOM=YU]'9K5AA^H'"
M"'><V"3GZ5PN\RAG.UEG?EG23:\S/0=,%W9!Y[C@TN91*$]06CT,Q55X/?DK
M_;=/A_4CW1@.XZI:0/R"O/I!SMOI/3X0^*%77NB8[&D9V;^K#C>4&C9;C0'T
M-OD5XF XK,?(U:-H:=P@KZ7 RL*%^X,7IFR6B8M2Z@ 85VTU?_#"F#;+9=S\
MC;17Z;O1ZMEEGZ$;70YJE.PP\0\%$V/\0H\ 5+,.4\#R*UY;PC_T2C=GZ3H'
MY#G#O+RCN]RR;1G2\*H@V%9>EV4ZC;QP+]M0'6C#:EV@,>YU*@$-,0"F+QV#
M6GBTF[&>M(IN;B7U11F8Y%.#HA,@!""8QQBX#R,P6)U=_#ZU%1HU??S:BTC#
M8<?)DRS#TF2Z2@V;A#* WF:50AS:$*R'VN<7E:8QMD&8'9+,BRSON+#8L@9U
M,168QP]D(E D;]D693-?R*R4_"LC:[&4:_ZCC=@Z:=!_P--=,)U5^;4=^L_&
MD*.M-NIS1ITFXVL\>Z/0CF&V*[;'[_&S<&JL58+S88=#EK50W%$J)LC/N?-Q
MH+WN+#QA90^/<?Z4XGUXW,NV8/1Z5K?53-WH[)'IE,!,<$V1<KM7[4V"DG)T
MK"@N3+L8+)H5Y:S8I.!& DX"0.8-#3!^IZ9>^IYI*T82]/](WK:7[5J96J9)
M)KYL+A6U%IZO 5L30"('@P1J<-P931+?LHWAO)$GXW9VN=O>.,\C=M3<:UYM
M'P1"]NYHR  V5R[Z$C ^O P6G_VWDKMPVR\7"O7CEEN#I"<&2M:H8.Q 30VM
M!@RJF,*4316SAD)DS/8&I-.Y_!*OV6IK11JR6T.*)9U<"<Y,?SADV>?S.V&5
M?J->A%@ZG_+/8S_%7H;O<?&_K6/1\FZ!YA1^B &KN]^#'>ML?1MK.^]E1D,6
M[S)D=)O!8]M,;/^[.JYA-_;HV3;KA?YV#%-:]72O73LX8G'5R:ZPC\GTFQ\!
MAZFZ9:[<&35G>3TH'>P(S-),7VDM"9"'<]+AQ^1!\BL9&AVWS!/ 5U.NI0"?
M:SS8/LE:$A>:N?.HGE)\8)?[BD>_B^8F)EK6YN[F+M330;T*%/8,@]OG3RE&
MQM12#F 756*\QUN<DD&]7-%.XD!_##C6F-M.;8C#ZM[.Q!(4(I_%"QF_R]V-
M8LJ84#7DL\S1>3F7!,C[PKON8IP&W_E^>B2OL)GWFD^XS2TZ7@H-=5VS-C(U
M!WFQ-- '7>)9UA*\0KMN'@!; 3V+IHO"G\-\-SUF>;+':>5M?^HQVHI;MANY
MJ&:XT@2TH*1Q\ 47@IE.>P< ('^+&@;%6#.ZSQ;I ^BAY6X9],>\,GR>JH'W
M&;KLS#-@TW0>YYB\QKP<6>3A[F:JKG<%9,[H-@?Z>O I*<4LF "PL3XL%:SM
M%_00MC*U&6X=* TXW$4P<$RQH:#0=CX-'0U91[KS9Y@$=2-4%A%UUD=<ZPU0
M853;&>U;;35YDGN1JJ>^@&?]QK6A&)#7/,AY6S*_KE^$&!_)W\H?DUC6>DXU
M"C-A@^H%C$O>(+((JTV<Q1=1:@'M?>8F&IW:K$2(4>=-QO"%L!!:AA\'VA9S
MHDV;#>8L[K?;RTD&G4^\SNF%M*$<2L/H^5W:6(*694C-Q;P+.;D/@CIRG#9*
M7.N(<$KO#Y6U]'0V.T?"*J4A "PV<-2 S0HK8#KNT="E":O61<:J^>-/LW4K
M9=5FKDY996WR,BF#[1X($=B_LU!QR5NI87OBH8'>GU9(Q,%P3X]15"^M%2V9
ML4T9.OQ_\/9XZ_FX^+&PX9QM3]Y[E6:\@,Q"G+41E'HUF[PS=:)-/IT.M! .
M0[S\!:0<MZ(E648+&M;NG'CFG?KIVQK&1F$.ZR=N:QA:O(I)[#!?M!/;L#)W
MM=L:@A=R\K;& )NNMS4&NZ_;UC V".T4\QS._'?:W1"\FY.[(J@#R&F#Q;4.
M#*<, E!9^Q#&9/9VAMT-I2$ +#9PU(#-"BM@5IBCH>MV-Q[FCY/':6MW \#F
M!O'2QSC(Z%*Z?<-VOT]BEKI/MOK1ZUE=<)JZT5EQZI3 4-(4*7\SH-!#]&W5
M2\UB0DUU44:563I%V@.[9V.YIBXRZE2>BC*H&&FXV/)00!?M=@C$H6YTR*'R
MV7:>\X9M++M*<PV_=?&^$Z9?7%C95KTLI+&_W?S:]5@-6FM7W%67* (MZPG;
MLB [0 % =;\'JZ1<VY5V<&$[-Y_">U[%%:EDX&7$ZLN#))<$I)I@W7*><.G6
M2IQBR#9.PQ79)-!E7.N)@Z2:&*.::=(AU#G/5OA0SQ,,NS6UBDVFF8!O4TTE
M#VWZ9H"5XURI8%! 'A3O#.9F<G%7?-/-S62RD'EF,D63<<PYH\SW?T[>0(*Z
MLW?:CMY5[$_+<1L=NH!<I\ZV6^SGR^WLS6=IQ%:DS2YCZCW]_VFIVU<OPBRO
M4Y:GH4]:- NGB8/N'UJ2\]B/CK0^ZWV9S_Y#FAP/1&/0H28$8#9;&@1_^1;L
M'A68>3B85]'O; I@=%#$)31$%##:1D<_/Q:J;"^-!;7%0?$/W,!PW@F=]!*+
M(NK\I<SRU;8_5_&F%(?O-D'8#KNP_X+[<1KV$,":3CCQG9N2S#;H?C9=S2;K
M&9H_(G;2.'F\1ZO9>K.:3S>S>_:WZ^X,SC/W^.W.,ES/)WZS,X<#:Z;KW$OS
MBW4%YYDNR!H^ND5WLP_SQT<:;;!\0$^SU7QY[Z@DT7\KGCI)GUZ,*[-8N4'C
MY#4,(.R,_-6(JG:J.AX/AR+EOQ?1=_$0)9_G\39)]T6!8'60E[&VU;J/PUSJ
M%((T4P6SOAN&5TC2I\G\'MU_6M$>=//CK.0E>EBN?G!.SB9'31BHLECUI.PF
MK!)"[.:FZHB (8\8%Y^5NLSV Z6V=Y%S9>.]T:UW-2]X0<NYS"1 >YG+>E*
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MTV2U^8MS.JUW29IO<+JGGFFWL"7"5K>LE8 [6]1"23!44L(3[+[\-%MMV$*
MLFI=T<HY@19)_&+*'XFL3?HHX;;9(Q0$0QX5.E$O!(<O[4M7F]2+,X]=JM8>
M4FC5[&8U-W.BF]U<K0.&6X9 N0.+\AH<TT-M14C3)YESYE.J018@D-)PZC5
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M\S69E]":+V35,E_-W&_?MJ9Q>(O3% <;[TVT(3YPI3W0FJ/%PQB7)0N (:8
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MMO.YTJ=^+>9^;<#"O)?;3QF>9!G.ZW7W GMDT2WF]H6> 7$M,>CUC%EC&#W
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MG[4V!'3KN^?HR!WPT@JTQ VC/8"T+=[,)\6D'* '8YXOH)RQ$A2&#05\V36
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MJW9FCTLRLOH<MCQ3'&WB\JA.,MRY5PXZ7'W?KZ11CTE25QE6H;.JE!N\83*
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M>*:O#I?KP;,(,"T*CP 1FQ>N5-,+@(\O< AAI@=[<2$&<$#E$1!J 81)":A
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MX<.$"Z(1&IM^+4[)#\#\(RSD8L4O2ZQ5$L0"+\RJOVZ;):/C0IQW/(@X\+2
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M.52@_,#D?S\/U)4:PX<(NU'J6A;^@HG\H-E_A)#OJGQ4+0(-B#K=R''AV\N
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M\A]???CF&Q0^4R$G@X1L8A"O"ZWQ^2V3&#';"R3L6/\1B?6[?\SI^-U7#P9
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ME?O'D]'JE JX<7R'B@0U0TCA*N2D9,#'SKO.X;HDJQD0Q*'ON4RJ.KO^G=T
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M&X;3%HJ),>^$-B9BBM'!V-^%_N(EZUX:)^&&1'OZ)'?VARM52&\H8,9\&=J
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M1V]-(5@FBWY5'FYD7=&?(K=_FE%S\J+-4<JWB#@QN27Y?PN<V@5;JN_A=,9
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M[/D^!:I,R'&ZZD6F.0Q:G)Q@9H U!^J,O.1J@5F-J8,RR985N(N/V%4"$BS
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MLPC$=>A3ML8LZ(A%BR^]A9?P%V$EL&;V<W?:_WD\O.U/9]DIYR]_Z_3_YW%
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ML&;%@-ZZ2=^\?:R$H<#?O'7^M!\:Z>[/BN=O@O0X6=8[;\-Y>IE]=RM;9&P
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M&:LV?H9TU'^6=WEO--_<JURCRJ&)E[EV* ()D5/"3"$O6!7UWR2;M>2*KO:
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M+HEF-N 96;"LW!Z))VFT6#LQZ:XBDDU"<3Q5]D///5]3'$^/JT#VF#I,A4Y
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MMG_7G[*$(_/NOSK=V:P_GV'G'LDKR%'Z="[\I)V0;OW8[IU)I.+&KM3.#B<
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MQV%WSOS]],?YS_W.<#R;=>B/MX/99#SK#K$S_NVT[I0PSE#(U&<;<0\DL_J
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M-_+7C2*TY%9D]#>CF*^[!G8>ML9OUL9R9J2LF+W>$VZ@,3;C^_LSZ(N:;AG
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M?V-OE1*MH1\E9WU/,G$ATT+%4_MMO'/5]8)*ZQM6'$FZY$IS\!L\ON@)#2V
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M,0V^AR=3RP2'OF!%_I'6N*57@E5?VQQ>*&9B==0>&QOPFA946U9M5:49L+/
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M?# I,E6$#"G@\"4X(V634,L91*=,6<M?H&1CFWB\U0M>](*7O>!5#SH'_MV
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MH5C#_0(%2[T:N<,_GYFYU:TG:9XGJ1 +["/VH-OY*#S$C',7R(I'& EYW7&
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M0VN6678&Y[46'*0Y]C@2SUNQ02?^HB>CEXA1JGD1"XT),#E9+!56FEWGJ=4
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M\>^:KJFUM!]+GVQAADU OK0PPQ9FV,(,6YAA"\%I88:_TNBTU6JKU?JX!1Z
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MBX:/<99AG"K2M;O']_L/D=RGY2ACXASJ*RK.2-+QY0-KUT%QSC#=6I,).1Z
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M0@IE(R>: S]CR:V"1?/<QDMP&Q_3K!B3A?Q3) 6,/.6L<]!-NY ^Z3CF.ME
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MV2&5CV7XQF-78H8TA)76U3GP7C*/V)'Q$IY,CQD60^49/!"3)S,T7T/E&3P
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M]/=/__[DR5WDAS6@G4N7FOG[UQ_-SFP3%QN39O(K)B[ZB8?!U7F'BS;"2Y0
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M"CZ)Q26C<U*$YJ1H?F,*C3(*KHRO[^3O$@DJP/0]0GQ][ !02P,$%     @
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MC3<DY-G0YKEXO+1T08G5%<9F508Y*D$@X1_%(KJ@Q'5.4 ^/R"ET\#TBD-1
MPU-T&R19Z0FZPJ% Q>*4!9W+_SZKF4=R',7[LFK0=-^YBR&U,$LUT!Y8GSH@
MZ;PHM5B$>ERDRB[Z;'7I417JZ1W\^3A;,GI^-99+ADF+&>-_Z7K)+8W'9)H2
MJ7D(^IJJ;D'AA['&4ZWFQ#4Y:+5%PV85DFU<B,/SV\[7V+T=?NY?7[7^#U!+
M P04    "  1B&A7%4'&$.@#  #=10  "@   &5X,C$M,2YH=&WM7%%OXC@0
M?E]I_\,<TIYVI5):]GHZ018)"KWE-EL0Y+K:1Y.88)UCL[:YEOOU:R>D[:94
MU^I":7K# Q#'8\]\,YXOADR\C\%GO_/ZE?=QT.W;3W O+Q@&_J#C-;)/>[:Q
M.>WU1OVO, V^^H,/M;D4I@7'1TL# 4NHAG-Z"1.9$'&0-1S E"HVKUE!*SK.
MY1*B8B;J1BY;8(7;\-"!VK 152Q>F(WPIFDFC9%)VE;K>&>C\^"VFO4Y21A?
MM_YM_+2O9O_03)U:YV<QT\NVUW #6D#&Y9EBZ)6I$\YBT8*0"D/5P\W;E1[I
MQ'M V>MU!E<+-F/F]:OF\>&QU^AU=H$YAD_I?O-Z$VN4S[0!.8?I:J99Q(AB
M=AQ[;!84)C2V9Q41!H@&8M+&B!B:=6#:]EA*97;E]&>!U/9 "+H]?P"G ]^?
MCKNGP_/?/]2.:NGQN-OOY\>/3+=MN&216;BN1V_:,),JHJH>2L[)4EN%\F^U
M--U[P>3Q$_Q-E6$AX3FL&6BU#7]X03\?<C-Y#NJ,D_ O.#X\L5-HR5GT&#]N
MK'K??+/-IR6']3E)Z \!&?3O6O=HW7>O>B'.MFE=69_\L5),1RPT3(K,*IM
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MQWP*]-SFX=LT]<^,W=\-_1/D#U!+ P04    "  1B&A7%IB9S@Y&  "S1@
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MGT0 3]IS]_LO$Z?*C^?-!W3X"00W"*!@RC:+E9M\$NS+N"RN:\Z$6L0IJQV
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MS0QWEA^EF>='UO LAWE21[36L]'E?H![]M)N=3BLP'_3[.* " E$G#6$IU?
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MEK-:&D]3.+?,[_H16\!8*AI9#(/D0"Z[%^HGO:+8A!BYOI7LO(-A'Z]![I-
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M^8&KLVJ@,N+TAX#;?(TP3*U5(47OXZ:!4,J>,VWB<$V.<^>,OL^IJ=7<@Z\
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MHJ_--KDIU5P-5CF"0Y/L4_\*+*!?+%U&<!!.2@CN!]8ENH &X:B1H+>U1[*
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M??5&L1.3YOH+Z70Z"Z=1,ARM4<<&9[13NGAXOBJ>2*Y2^B06WN&_,P6^+CK
M71+D:)>]>/(@8]!1QO#F>.A2>=BF"(;R^7,\'X8-B?TIN^GEEHZY2=B>!3FV
MLZ%.I&O8JI41URM ?:[LAJRIC*^ZBUC-#AKY+N-DK?D5@-/Q6YAS(P+O]*C[
M\E_(HY9[7(@IN0UQ<;X 65L5Y#)L==VV:14G^N<</;FIA9C[>5X(GR<C&%N
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MCOBSI$-J .+V?$9[=^TM_C3=@TFTP= JK=7?G,.NM?<$L>8*()+SOU.TS=0
M=#K++B%)"Q "R;A7"66P2&U]$=:MK8FA'"5ZW./H#CL_X+R]4_N^MI&" *>H
MD ZO'[9+UEZWC+X0RK"_$D;_O:O (W!^S'U&=(XN!3W+H85V35]B?"-W"9JH
MY&-?OA-),\D\N/O%S=.V\[+^;C4M<124DO:)<X)A9>TW8<$\W>HN8D^\K7^;
M G%_SGG=NM (+4;DS'#3+]Y+V7'_DKCKH@S)AG*XPMU*\.UB;AJGS,N[!?K&
M^-R3ID,6EHB"X>P^A>(O8Z<V]Z:9B1HOA',>Z%M"OV84+0<(^M$3Q_FM]F]4
MT%7@@8E<))HX-_9W'3CZ<_^L20Q\M)()[04Y)(ZB\SL4>K8X;@I?=H\]B[DU
M[B+_/C/FB043,DBP'P>->M)*/<+N.T)? 8(W1K.[HYF<_UYHGXXFNUWY'460
M;9>LQ NF_/.F)SF-@\>^"&CP,(>GN>07]HGRL&\P)PJ\4%H9R.8&7K#]$NPO
MOAS>8U3;S>\_%H+TO@)^J8MMM,7XI#@;U=V$?%QM/!61V=;"J@(\Z%CU3$%F
M*444?W@Y@;B#9ZY96E Q<V3+J2G<SGM6P)T)=^$! <9QA>)3!D/)B 0LQBZW
MHV31O>:M*T;$4[&[(N'8]*Z;GG;:92HX?Y/::>?8KM,%/\:>;H:*CP9T#@H\
M:'VBNQ9 F2AG@9XS'^!Z1)C-[<]\J),UBEX@PN?>SEH>XTR;_SAVU3RUW,O[
M%0?(F#<'5/JD%*:APEJY*M@\YLQBMHW>^0+?FJJ=4#![9LX'O]-ZR9F,Z9G)
M>5]U-M?FMM4]9D#!?M8MBA5,Y"Q<7WW(=0;9D2$9FQ6 K:V@.-5MC902AR#R
M>H[24</MM3%L+ .-Z6889%#51R+VZ_6L1_T%RB)(*;[(N#N;CY-S%/]9X#=$
MYJ?2)U&;N?V*^37U:/R=(5H8:]+]@,WI=IE].*5U_#E1^(-RNN->\VE*3 B9
M.YEU*0H%EHODIH#%!78_BCXHC[IE"F M*51EV2^0^W23=;4,1.J/4VM7XL^P
M[+><0$:"Z:OY>TT1FB@+:GRQ%3>,<_U@9R6+R+"3QO4)A/_/-[=-R;E@9?D+
MO9!9O7V+L!\75074?.%XJ"R6/__[[S)&.X\/4\!PYHD49KD/5$<4/D&D?DM0
MJ3UUW];9;SMWP&XE(L)%L]4F<ACN0U:^3S;:?5;8.9V6B<>17%WJZ>10X&[N
MQQ;7$(F7X\PMIJREN"BN'PRS<"]U7TV1Q@ZCL+TU*@UKU<DWC.C]EM291$?(
M3L<1'M$XM<C?,7.M[ZA]8R<3&(=#\&O>F)O[G2_8:T?WV[3&%NG?O55(1$'I
MH44*E^"'E[JIO)](8YH.2#^-W5.[Q[$H'C)"J'!N4VA@>#?)5'?(H)[CH_D1
M^QZ"XEP*QGZLGX&7?PY0*3GO/@S<."M?R1Z0F_YE7.*4U4$ +B>CFB>_ B@G
MCSG5:F1[4LC!GAN.B@+EGEI%*R :>L,['GU9V"O N"P.$C%/7[.7NF)37!US
MR;=A);#?$.S,DO-8)[I'F,@GF<:U#=X4VZ1H"=E\!7A<?F]DE:N0Q)!.E_(4
M>C<VMW2[^+(SN?,PYV^[_4]ELB2\IK)1^KXFRFNY(6#^S+RA2!J\8K77DTOX
M^/NR".BAC5:^\$$Z.MLTJJVK>!)E^6[!!^MKY6J[[8@*.O?]O+GF)KE4UB(A
M4?#QI)) 3GO_/H?_/*8+R\3(M.<[>#EDO7A'R*G_8 5OM+D%_T[5T4V%)-;,
M3B\I@G)-5$J=+DXMXQCH+] #-I24A+)2:E*3X+B4KXD56;>PO9J6]"ELV1+V
M()IBTWZ9&/W2JEEC=5>I)QSV(9QYWT;^G6]@<9X5X.:F:.:[ 64\A-2<KE<)
M47F;=0"')]4I58:XC*QAJ;@](=UQ:)^?YU!]BO'<NL,SN<&"8S R6VZ@'-_^
M[#=53+]U:SN938'O)I9#T[WX"_5::^O@8N[LD"\1;:_>^)#(?7G#YI4EIY'5
MA-7=:/ZXJ_FW^G8JCM"J^XN_LML7/(/^O3^;U!1"J-BM!_<MZLR\0FJVL9"I
M0C,(O5GNL7]G?ZXBR?XL8>,<<(_P;S[9(T3!1[(7DKZ:$U\'.92C(?/[52]%
MC]YPDZ=+ER@>VIIIC"RB4L?#RT* MZB O9;W"@AV\:6H]A[X.+UIV+:Z8L7E
MV,AHNGZD 7I@:U@RQBA9V([E>=[*Q6Z31KLMNIYOF.;1W>&ZC_G\V/_DY#?&
MH@T==E,TKS"=!896F3G?_9Q3%4G:I1JJA7?ND\CKO0#Q@E\!/_M)&D\]2[)E
M#V<7L6@BY8[H/ZNZ+G$?,T&)K[2_^"B@@]2TG&QT+FL&Q1(^17.>G&FC\ /0
M/_\6.P*(QI?#S,2_?>T.A^MG.H']G'86M^$(/DZ; CCVB\;?;F?EA4A%'C*1
M.!4?CHA(@T0"K(PSX H(&G#1*@R1G<-#KP94Q=K.5'.MJN)V99Q:FHNS 2_$
M?2"C'MP+NBG#%1@BLE22,R?21-1FB5??$VE0%T5["<&[?G?9KE2& UT!TLN5
M@=KI.*V$LG2E]-.I(?03.1&/8]^$3)\"PX/+>_=W@EZ4Q;XA;Q2S8=FJ>?:7
MF]G(MY4S7K'?=ISJATNKP7FV]EQE,^F;"+07/,RE\?5D!63DR"NW>5JJ*T4E
M>,W"X0>D_:5.N%[HH?AI%T:A^UY8G$'38.'LU:A-Y4]!2ER.BI)N 7W4RG[=
M2:.W^4G;<9+OIKAG9E2(/"C^E6'X\%[^M0>C,#U?\D:-S%P<S$V,4BW9;X/X
M,&7L^*Y.5UG09PE @TG$JZF\VMV,M%&/Q4B&EYU]7,*_1&K4@S*AO@IJWO*Q
M<:LUJY'@GA@NE I'"00'HT/B:\0K8XVM-C]5>XKQO*\>(=L]S2Z<0;:L:D1X
M:=BZ4?WYLSL*]B0>E'>/&H_29,D1>0W@%45ES8:J^P[Y!U)/D<WW3';AJPJ4
M6<50)V*.,2YLD/Q^Y,UN\]<P&V&&33;- ](?.]W#ZI?TX,L-HF&+O0V7>T?P
MY&^8_DE[&W9FR=_*+Y_*]+=&V7;8]W=9BWWD^EF84Z04ZK!"BFG;EP-.F8+E
M4**L+D6L#2_Z"H*IC%KG<J;7Y&[+(31:"3K\ V<J%Q]75T]SY@4SJD"VIFP0
MD5]?;6+I%;-$S6<T&O>%29-WV)6,K7IN887C0-ZA?E!N*./*FFEPY\U>S>V@
MCSO(YT<Q3A7CMTE8B%[;G4XZ+&_QR-E#^TZ_K:F#B^6S>*T#@Y9IX+XP7)I%
MF[NI2D?-S/&':<JY=<E FEB#X/L&YW#2_G+X1$)][KNZ]>]%]:#AF0LY"_06
MV8CE&&6_[[I+ITT,(;6#KEIUC_)]M0K$MAU,_&/6_3T:Z?+@=ZM)WBPU/SN#
M&@Z4+G5$6));_T7D&JS [,G?-RA_U]M]!!H\!?] V7NP@+2@1-2B75O6:7B9
MU,5*XGD62@IAMVB:08Z*DK9-S_@KM3Z,MMH2F@R?R?HFQ&$W08WTNMRQ<VV^
MI8-E:.5JN;%7[F[+V+@L3VD\OR<*T-C8>BP[\,PGJ)6HX#7-!JO+E6',O&G'
M1P7R+,'Y]('DA%? FMA8&['/IK&W$Z<KG]CE9$>Z%[&,VYBP;)_2Z,NH;CB
MO]!4C%=PYCWI:'#*,L_,]]^:*([/+&UIYCF1,]L?I.C",76X^2+8:+>(Z>(?
MTAB+P[8Q2EH:L\&H'[2_87"P2J$A77\ZQ#,WQYCFD=8>HKS^K1'X+Y9"?3M]
MLH$J-$\ -FJ<3@\1%IR(C>.NHW1YC!7]*QEGB/LXNWQXM@NJR=02VS3\?#'J
M<9]Z%RN25LZ;/^AMDO$G$*V?F</QAB#X"J9X4T%-[XTP0186G9O]EZ5H-7OI
M !]ZK/'<[,EI3>?X6U-KH\1Y)<9PMEC>0ELV^5(0>[&\1]R'"",ER;BJT7)7
M^MUJGKE*3=6IQK\2*665;.&+4[G-=:R#AY/TVZ+BO"X\XBG"B/J]SP[(WN<L
M*B^$,[3JZ[9.<W-68<%BK3_OCJ;JKQ<W$F$J4[6S3:D*53%YCU)#)USXQYX\
MS52TTP=&+@="5LXSD/:@;4I#V10ZYN#!(PGA<Z;L2B:,HALQ^;]5P3"[FT$H
MJY"CVKX($SK_(>IX&1%&K%UG?A+%0?)/GU.F/%+6]_"+)[+2VWT?K)!U+R F
MF%X0$.U4FMR97,8S8^4PBQ==O8)WXT@,[*6LJP=V<LJL!NU/W#H\W#Z>Y'NH
M''Z$/7RZ*794_B#4S:+P)'2/<1:E#]8S]L2,K9$]>5)TLA(0(G6F6;920L2Q
M-]V3(/.Y&S.+._3V0;+8GWAQ@08<C'(PF08C_3D6R,^)B;.-.AH#Y6G]O;:>
M-[K\$"AVIKPL\V\F\\?4">RLW*S)_E2\1><*>!\X,HS 0'%XK"]U?-0HL5OP
M=!U]\G4.*M@0S;N@+V$EUJKC_6)>I.3JZ+)< )$CFUV*T*UE>PY3\G\%Y*W5
MCHGMIE=?O )\2+&A6$U]P?&<5&>#C[!BQ LEMC[RMJ&]8SE''V<G/S_A6+]6
MCZ=B?K+WJOOY%T\'*>/ZUN3?(NL(OX\JJQ$8%Y@7"+L6(5P+;#C>%-<[>]Y6
M#8G]D;8RO/H:J=/&7!TF\E>H)"WS3]X%17\N6ZDO4>6<RY]WK,;._H<+._N%
MA:Q/M*[VFX^HWZ:!80:-["-[ HJQI2PP:8:SB^ORO@7F1&%&$H:E(MZZ@M ,
MK5:9+YPAEB_?^)[7Q]J\/,OI-6>8)$U\TNR+I%5PU@>6FLM+"&MURBM0&^JT
M/)2=%/#O_AS$:1AZ.,W=/LJT-65XVEW/]CJ%8.QY-U#M\SAKM!M]4H'<6BZI
M$8E*"=<; 'SKI(3%@[<C#2P:TKYB"$SI?%WEG5INP,8ASDG_V=V\'WJ"Z/E2
ML^&C_*C:$;+<0_J39DME==T'.M3?=$B0V?9/)T_7\G9NB2<X8L1AE4Q6F\>3
M%FN HF:J\JQ5IT@R_^!N;LDCV5!">%HZK?K7IIZ/C^QU&0:;]OFAHR2_3PUH
M4H'J5'F</ZB%H<&N;AZ<P57'6,1#YN9'+9/ [0)?#""F )!K.,,039>:E-CG
M=6)EN*#7ZG5I,4:I11)R%F(N_=R7 8><_2PR/1#BB=I)C*$I%4;MY TD3  5
MXTO;T5#O)M-TF%.1FV5F3/$^9&@>J-LJE3\*'17J(FADHW$E%BB3$;ZTYGH%
MZ$0I) <2[EPJE!I4CBVB9_OFS;-C:=[^F5I%C'S?)SBS1%]0J'?P\&O).>Q'
MT'"<LC8?OU$''5B0RBM5\3SBVA=OHOS#U%:J:@/V+N7F1J+(:+16 $RYOX5[
MRUKZ N66^_.H6[4,*26) FYBURO M&.NW,]6#P.U0F]%DC6$W__S.!-B5((,
M _^HCY0AC)!8BMGKQ9PYS<ZATH,Q^7K95D8N/58!UM*,N_J')GP;P5=:V:=D
M HCA6;ITN2!ACYV)3[,H@_.C:[7EHO@5L*QOVF4OMDRC>RKW[I2?5:*+2M6C
MS$C8K^P!K&OCZK40VE]JV[A"DQB\Q)C3#MZ3O-T,]CP9> 4H9+XT\UU52-)"
MKEHV-%2;5+WDU\=:SOWP^2^$:$A.(F9KH\\\>B*@T1O@??ISE[]YRZO2^X_E
MO)ECS5^<N-693(.,4SH=&DB1BVSX1'*K'V!7VFZ4#-O,1T=+;5)RA\I+8 -K
MA:21V\F!];4?!.CSPETAMTC+]!5+]"7^;+&[\Y6<B81_'1:7OMR#YQ#M58-X
MK+WA(F4.E$]L&!#OA"_O>EYH9EEO?6(9^YT6;:$=F',_D@+KOC9X<B^5@NCL
M"D][SMY64!V;\WQ8;KO]Z+T&C*!>K@?:Q3RSH,?/RGB2:2351.0X$&5BG9&!
M6EHB.2/=G WF?.$G3RI_< VM)[@JL>L$/UOQ./ZUC&"$F0EHVE18YX%NOUZ<
MV9)FJC?Q.";@D.E0;J6V;@N14>8G>5(FN-$YT +@.J^A8X(O\2R8+GE(W%>8
M4?***+8H_YQO@/[?KJ%K;8UY6..J(+UP8PR7/B:!LZDX@>L\)!7%O>B^_ PO
MB-K+>7Y<T)P_5J/P=.MTPQ0D>_=;3*#NS"M@,6FW_CGQLXK?2QL;H-A)A4+D
MP#]&_^NBJ.KH[@J'7[6H^5,PI5N2]4OYFD(B!:EI\%,P^_?+E /\L643Z9@V
M7&>=)*DT^L<D\*+808GSO;I2J3'7<? <XLLQ2WT-1,9\Y:3Q(2Y.8<VD&9@"
MM/;-]X91G2.^ D@CZOY$V]2&8.B^ @YB?ZZGE-[2W6VE1FEH#:X(_*&#R*7^
M++_D*^$%P1&?*8H(3MG=C0KA.^Z 05WY]MLQLLI>Z&YP.X5G:HDH8-11XFT(
M*P)G'V< Q<5-02SJ]8,&CN)-3J>M)9\8[3*W4P>7G_XBW7Z98XSBA&(L["Y^
MGW!V:4W*_5TLEY/H^<M!Q5AC&'L\\Z,'&\GAIM4:K]E.^W2=OXV#[,"H\UP&
M0>2X7.-TXHM1G'+#QU]6Z$.H=%$F,LJS$^[ B45^0)K.^.;A?'X:J&P,9I>G
M0Z1F##KYX7;F2 8@KUH:#4J[F$H&1@BP*B4M;'N;VQ['8CVFMN!Y02H-MQ/V
M(,1QG6SZ?2;:2=48O3&(CK_02)D+NX,-D2@SY36HC5$0IGEP940$?2Q1NWRM
M1KM.F+"/*B__=5%!.3J*\N-]Q_R8L6]>:.\UO?E=;=A[/ZFCYGPDV8[(,]9*
MD6"YOB[>\^F *8'^D&!RZQ=SRE_8(J?+089&=_7:QZD@+4/M'-*;(?MKQ7[?
M%_MLK;%*Y[5? 6;1K7@R3)](:*T!RAXPJV@Y!H&#FX(_R:XHEV6TPHJ^),C!
MM)MM?&/U,5L@O"6N*NEC612W+=CCB$J9"^GW%?,G9G^3IVWZB@,K+2BBETYV
MTE!K%:<K:D)9=G8]6)_EV"8<S= "ZGD7:I(XKMJ8DAV3Z[Z2 V3WHS:.?F>>
MV4+!7P[A=EF=#)9E*J%D>2X/8OB_ E<%J/KL&J,?:QD_PI_]M@ 8TO5B?063
MYKVCS&_O'\Z/,;^\?SKI^MOL<_U<\976WQQHFLM_VY-4G]M3L?D\.ZVQ]!:D
M5[%YA]31O/K^M'UMC^KGCXU>_!^3PGK?U,-*=4U5^/\ A$];)]X@*]>WF@M[
MT?6V'U<\A6\U]O\ 5^#M4(_VMHI3<>)OX?!FH'ZNO^->N9]Z,T?6V/ZNCR+S
M?%9.%\&7@'^U,HJ1/^$P/W?!\P^MRM>L9I0?>E];EV#ZNCRG;XS X\('_@5V
MM-$/CIFX\*P*/]J[%>L<45/UJ78?L$>6K9>/"/\ D7+!?K>BD_L[Q^6^70M,
M7ZWF:]3YZ9HI?69=AJ@CRX:1\06/_(.T5?K<-3AHOQ _Y]-#'_;=J]0%%/ZS
M,/8(\M_L+XA-T30U]_,8TX>&OB"_WKG0E/LKFO3Z6I^L2#V,3S$^%O'V/^/_
M $'_ +]O3AX2\=-]_5-$7Z0N:],Q[TE'MY#]C$X"'PKXVB!*ZOH8?^\;)F(_
M,TLWAOX@W"[7\6:>%_NI9%17?CB@U/M9,KV<4>;_ /"$>,CU\3:=^%D:</ _
MBUA\_B>R_"R_^O7HPI< T_;20G3B><GP'XG;KXL@'TL1_C33\/?$Q_YG!1]+
M%:](P*,"CV\Q>QB>;#X>^)L_\CE_Y(K1_P *\\1G[WC(_A8K7I.!28%'MY=Q
M^RB><CX<ZV?O^+Y3]+-*>/ASJO?Q?<_A:)7H>*.*/;S[B]E'L>=GX<:D?^9O
MO/PM8Z3_ (5KJ(/_ ".%]^%M'_C7HA&>* *?MY]Q^RCV//1\-[[_ *'#4/PA
MCIP^&UQ_'XMU/\(XQ_2O0"!28 -2Z\NX>RCV."/PT<_\S7J__?,?^%)_PK(X
M_P"1LUC\H_\ "N^XI2 *GV\NX_91. _X5D?^AKU?\H_\*?#\-Y89-\?BW65;
MID>7_A7>#%+C-95*LI*TBE!(XP> ;S_H<-:_*/\ PI6\ W;C_D<-:/X1_P"%
M=GFEKDY8K:*^XT2.+7X?W0_YF[6?_(?^%'_" W(/_(VZS_XY_A7:9Q1GU J'
M"+W2^X=CC/\ A 9R?^1LUD_C'_A2?\*_FS_R->M?]]I_\37:4F:7LX?RK[@L
M<:/ $O\ T-6M?]])_P#$TC?#YV'/BG6S_P #3_XFNRSBC=1R0_E7W!RG$#X<
M1C[WB/6C_P!M5_\ B:D'P[@4C'B'6N/^FR?_ !-=GNI,]J?)'^5#Y3D1X!B!
MS_;^M?\ ?Y?_ (FE_P"$"C_Z&#6_^_Z__$UUO%(:EPC_ "H5CD_^$!M]P9M=
MUQB/^GD ?^@UL:=HEMI<+)"\DCM]Z25LNWUK2[]:2M(I+9#(3'[BBI<45KS,
M"6D--HS702+1FDHQ0*PN?:D)S124#%S1244 +FC)IN<<8I: %S1FC%&*  &E
MS2 4N!0 N:,^])BC&* %S[T9]Z2B@!<TIXIM!.: %S2YIM%(5AV<=:,YII(S
M0*86'YI,TTG-'- 6';J6F<TN:06' T$BFYI#S0%A])29I,G- 6'44W.:/QH"
MP[--SS0>*3-*XQPZT$TVC-(!>].!IE J6 [/O1NI,TE2T-#MU&XTVC-0T XM
M3<^])[T46 4&ES3:*5@'49IN:7-( )HYHS1FBPQ*2BDYIV ,44N<T4[ .I31
M1742)1110 4E%% !1110 E.%%% "FDHHI **.]%%  :!113 **** "BBB@ I
M#110 M%%% !2BBB@!*4T44 )1112 *2BB@ %*:** $'6BBBI *2BB@!11114
MC$I:**0"&@444 .[?A3:**EC"BBBD 4444F 4444(!#1113 ****8C__V5!+
M P04    "  1B&A7^S&RA$M7  "C8P  #P   &9O<FUS+3%?,# R+FIP9Z2[
M!5A47=<W?A 05 1!4E(!06DD)89.8:21%E!*ND$80@'I$% 0ANZ0;A") 92.
MH9'N;AAFOD&][]OG?9_G_;__[QLXUW7.V6O67FOMWZIS]J!&43^ 6PHR\C(
M!@8&8(3^ U 3@"2 >_4JSE5L7!P<G&O7<*_C$=_$NW$#CX+H-@$Q]1U:&NH[
M5%1T#.Q,=/=8Z:FHF/D?L')R\?#PT#()B@AP"[,_XN&^9(*!>^T:W@T\\ILW
MR;GO4MWE_O_]07T!"'$Q2#".,#'N 5<(,3 ),5"M "T 8&!C_/P OS\85S"Q
ML*_BX%Z[?@--4'$+N(*!B7D%"Q,;&PL+/>J%'@>P"+&)[G*)7[VM\ASGGCTQ
MMV]4*BZ]1$DSB6K_#L,C8P>_:]=)R<@I[C#>9V)^\)"'EX]?0/"QI)2TC*R<
MO(*:NH:FEO8S'1/3%R_-S"TL'9V<75S=W#W\W[P-" QZ%QP=\SXV+O[#QX2T
M](S,K.R<W+S2LO**RJKJFMJO+:UM[;".SJZ!P:'A$?CHV/CLW/S"XM+RRNK:
M[M[^P>'1\<GIV:5>&  FQE^??ZL7(5JO*UA8F%@XEWIA7'&])"#$PK[+=95(
M7 7GN?WM>]R^N,024:DES=?H'ZGND!@[]%\G9>"99=R]5.VG9O\[Q?S^KS3[
M6[%_]!H'\# QT(N'20B @.,SYC2?ZP\>W "N,?E.^Y &?VG:S0[D@>UM57AJ
MQ)P'GP<A\OF1I%#_=["CKY"9*A1P/?.:2!15I[/0'9WE Q1 <>*J;AWGT9;?
M=*RX"2JTM<'"'!VP*.Q2GL_)Z&:[^Y9810S/Q$=^57NY[0X= [7R*"'LK&LX
M\4+MXJ9;0T4!V-K+X:C;J?\)L51&J&FR,DL^@02OFH,GS4LA"E:AX."&7G44
M\"9?$@6D9!9?(#+^NBA$7Q0+EN]LL$?).Y@][1H+Q?BT.<GU)*3%@BG:;^$T
MFLXXT9TN=!<%P(N*\YXB7]I!+(RM=SCJ#Z G"N6@L^LZ*&"F"S3[H \%K+!8
MH0 (2W=O8-K=2OU'F$ONUHN[;]I=DV')#TK-.1_4C;DIC$4SW1<FA&'AGPH_
M_>Q$.XZXYI[%Z/7V./G]:Y4T/#/UBN7L;6:T<-D_A:M""T<9O]6&W)36MV(.
M@7]8=+^0VNR*L/B+XE*7="11(=[AL#5D>]&]HNCC<]%XBZ7J\+6%.3ZL9:&2
MP4'BEE2)D3W%F]\#MXDY:*X2__#SI%58.(NE*34S/,JZUYE37'_0^TN9\?^F
M3,\60HAHS/M'AUG(=]8GKSO]<# 'D\O[9T>?-_A1OGMISY,EW%X/B(!--A77
MWK/M<KHG_]0F! 5<TPQ$ >*ZMN>G"L)JJ3$1FXJOT$94V,V-9!BXMVQN?'77
M_V3@OO 0"GBMI=-E/'P:+@O54)[,.;(]4>!1=LS368 ,*H!F'U[*\L#Z4I9.
MIPGS8F?SPL7>N.^.X=E4/[PL%SR>:/&53O'(?,$LEW%P;Q847*;.I_CQ0'RL
M,[%%H)#7K8TF"2V*\CNT*(IH410O+_Z2R\#VXMT+\F20J,7+ #EU1!-']X7(
MFKN3HDR0)'"#;^!)V.AIG9<5T]MTR+N+]F]<K;JSANXKM#NQYI #D@H4T/0>
M^L]Y[%*4^8-'>K-;I )5P)X4P"@#)C'6OS+Z,9KTO>QM_YKX)7J;.6+7K)WW
MH(_O7KK%-6(?)P?^)8R0X:61P&DT"9FY,,/D^JG7_+=I3\Z,3&'O\5ZC@/RI
M?0]-*GU&%.!0F1T_"&VAO_ZQS0-"3+CQ2P#BRDMA(%_54E% G^H$$JD5,A==
MA>R(V">'%)" 8FD&_UJ-RXED$8R/F2ZP-B';M;N6S)=4-RZ,<A$Y1Y> !I]=
MFX!<0N!A/VB%Z:?5VT[2@T&E](AFY&?P*=C\;\>I^HF\) *D7]S,\5Z]2; M
M,<14]C00^5D=J>YY.0OM!38;&I1":*H;:*HF--6X]9VKC8H"J2^D@Q1L.GL3
M^!9\)U:5_<5+SS5*E=Q98,)9O(3%:<L)<V>9M$MFKD=9]*=:TQ[\/YEA;39M
M+S(A&'70?*W1I^Z+C;%&=SE83<MD:?I^'%K@=BX7DQCH7R.=8X9]6E+J/J]N
M'WXJM^:Y*__<G+_@P[1)D,(:\T'3?T)Z+V26MM*W/FV;]1M#5VLH1U<-K8+/
MB0OC^3$W4%??LGC&OAT_]/1S.>VX:?TWHL:OY[T*?WOA+UL4HFWA<FF+=KAB
MI9*-+D49\[APFGBS,09E29^C:MA5"NP<0V&> +! "K;:S?";:LW]RCU/%'E:
MY2V(/<"_%4,;C';G_<K?L)K9"6N'N'" O'KQH>Q8B1Y#RRV?OS$6V+NO7:_Z
M2,^,(_3Y&DZ%XE=T9.+]. >)\EI.A7S52(7T:<*12%44\%7E)RC0%UJ)TBD2
M9E*>[[0+K%C?4;EWL/G@'.:=5<:2Y$1K4WUHW:10[M__DA=^/32S*Z.-%4Y(
MOB_ 47](\,M>NI"_S?4;%CES=:"2>02,]JP9M"B2C5;_]B_U(_[!T:XW\US$
MAAL*X&P:N88"'FQ>J@8]N(U6K7'ETGI2:.LE%5\<&[#),"-A$?LX9\UJIRJ;
MH)\6N/W3R0B(5TQ]>!5?0<\L#-B"'4RZ(RYF$6LOWDO?/PT)@*BJ5CT4.>%3
M)^SK5_*_0 ?C6N9B[$)P7FA1D:*X0 9)U)R^RTQ+ G5/MIVW=ORBX7;)"K/"
M5D?EAO0< :%T:O,=5F[]&667B6<MQXN@/ORE^FP]^%:%EZ6N/D2GHK*\\NG>
MQ(3<ZP\S2/=H40O=(7R6\+K=N!(O>U=GAB]Z4SL#69(R#;'@YP<%F#!ALR%X
MOBS62,%LKL$9_0 [0F-V\TI'T<=,%&"NKP=KA7/AIFJL[N4LD\ B""SA'H9'
MY7=$FLL9:F)QMG8GS->#U\H) 'U+T.A9>%S)I(1\G&N#*AF5D?7VS!F\R#Q!
M&J&F/VD9<97)E'!<XA&57#H T7/*37*6E;/L4I\\-,/>V?ZRTWF46&@BRRW)
M/NPS>9\[T;T+ZK&AV^(1']@<WZ(5:D25Q+TGT<]?_LH]%!D+)U5?$SM+D'$>
M6[L&HX)#5=,3E\R>&*45F)Q 6OG.%NLV9:OJ?39JRN,O3-E6O&13MW5CO[DE
M2E;'QNCTNT@7CA-$)F-_=7UW(;ZY8J4F/O(<7N[&,8OM&BI/Z?P.AA<X>2>@
M-FUPQ4I%FCA W,X>*\-%%:*P)_>:-Q<%%(6H5@9UQNS)TOW8#Z]8=P7MKO.?
MAR'R0]&%081YTR3)V-M/Z9Y4Y+6<N3:FCJ"=T#44P(102KV8F3QEF%_M5K).
MM=(L*B;--K?#'6-0)?2'A\(5I9UK!SP>A3UGSG8*-X806)%Q?V-(R*Q\(6A$
M'XEY\C+JM6 ^PZ-67I8GX B>#Q]B(MIK@YF/!BK\U][;>E(-0WUY163NFQ_>
M8"3DC__.T0LQ]"A!5REP331$8R,N3B&[11,MGR:F(/!FI$1EB5XQI;Z0(R5K
MV?61S\+?D"3M97N0UI$.Z_.FVIC%L]<'33M%SJD4$>?&@]^8&(5S.2&[9P>3
M*L$1A2-;EJ4;W.=,"6CG;()_"T!.5DT^IHXVA<P/S9QH)6SA(L<JFZU']Q;6
MUX]KX5G&H:IGPS;SR-X6M/\L;N[,:#DH6KI()<MS-H%.#GF1U)9]] K.+$3T
ME"4+33:0!H-,7XUMR'S[/+*&?R__[!"R1'_.<0.1G9#=DJ3_)=99B$YWB;;6
M&Z3SV9MV?4,OR68TCMQVJK,7OEPL54F[$HD"JINZLMH4VS6]%)[94%C?_A[8
M4FA')%-B?FU-2M41O3P#M($ZG3W.GNC(]RKC# 5X-_# DTX258=2AP\SK+Z=
M:P9\%XTEJ8TN:_RJ_0E?3N!'_V'M5,LY_TU$ANPLLMYU6;=2J/'() 9:W"N/
M-O"^?A=T,U^O6'*Q$X8$H3V8@*-":(KFQYJ:DNA88(SPQY;<IW)8/LKXLO?J
MGOQABR7#G:+#[L7P,JMH!W#\??G#\T,#"&"I:=&HI/J%)2DS^3[@>7%VJ*<)
M"BI\9<LS4V9I<7M,[L>3TD\/:):@<"OV-'<;BHN8[JR=D(DIKSAKB))B.'>R
MXFY4U,Q K/!=AJB6A^N5V$R0AQR3H!YD"ZC0^>QM4\#L$'M&\OHW>SR5)RF+
MFGR4Q)YF(I::I?W%MY_(-B68O7FD\][V0\Z/ VH!$D.#8D0KY,4L*'+N]M<P
M]KU:9()+0:ALY.F51P'S(GF*$)QOKBPMML46 W)1UY)4R7KC/&@JX%_&.=Z;
MAJB]/^649P@K-RT("W@Y'Q.EJK-RQNF^Y.<^KJCK_.86C"M[6I4+/J1RB/:+
M[[1C;N % >B)5.+&+AB=ZJ]^N/=^ENKKA=?I?+;'*V\R(E@CZ-9J0>(=93H'
M.P$FBF.2L4G=%=!8I;=W6GN7T95EROL=##;SN9W"QUFZLBDMQ.](T=&RUW+:
M LD;UJ@J#U-9G)\@]O(D1+0@OWV%W.W1>0UJ:J@(7IO0_!Q]36;!'G,/]#@1
M29)5C"XQ6&C/]U# O$&,911C!LM5X4@?IO/JN>PV6H-6".=/:^P;GFC5KJAC
MZE9BX#_%73CUAO+R((3@%/Y\)>9Z5(%[&3U>WA<>-LQMLB/KKASG( )$]D=H
MH,>LX..V5-!A%QC)'NM-L[X&Z-N, @Y<5$GH0N:@7B58M$*K&F(VBP+>[X/1
M?K0,VA6L:!8$U<7$H "O0=W9Z6J)@!%K.17?#PL_/ B2&_B)C2,*-;9HQTX@
MB\*=HM3K49U+]TO,P]VF[\6 SJ@?OA:%&[=WOQP36PU:H/9  =0>+YG;0&CW
M98Q_'C\FW(LDZ:GT6#N"'J^A)4(7F;@X0?QQ:&?N).\9<XPXWVI@(3:.'\D[
MICWRICT%<QL&>LS)USB'B(VV2SE@1IRO!9PX%W;XZFI7O, 1,%^@1P&2Q4IM
MY-F'75-M%TF!2+5O*&!6QW+FX#8Z"C6Q(7D@7\N'FU:83- .IXNP&MR5>=C8
M$(0T!I7N0#O<(0@6)5VDGR;H>!$%M$><:"9476 50+;13,(\ D3?FZR"UP]1
MP ?()52$F]!K5?C/6LG^RY<;)&D5N&3AZ^BD_7.YT!3_L(.$<8,#/2KJE;B&
M7LD%V<*B$?-0G<,G&I[;)SLUZ+"NA,@5=G8]\GWAIK[=Q=WNR)=D;:=U53NV
M,GR,(NUC.L%)M#8$7@XYPTVK[I5IFS>XO0O5BU[6K^PW,3GRE&LM93*YNWI*
ML&RP/M*HMUL?#9YGTW3M))JL_.J%,0%;U*\FS];<3NT-LI;Z4I0_BWQ?&_].
M8XLGU_F&'/W+.(:G6BX"/6Y%D">EC\,+S8PS_.VYI2.Y9< Z9X%B.TCH;+?@
MJ_(3B9SV4\IM.2_M8]X5$RZ:'N%\%X>^S.];[D79GG/%>!.GN2:D$;.CN,&4
MSG8N."+:H9_V)U+3:(..'H]\M,TRL"):?;/<TT@+67Q>[@3[+G2N5=2-Y=AJ
M_)%4;M0H'\__&<Y7&AHKMTVH3"EGNWP8GF3H83&C>HC!GI >HQ=%H&T:7_Z/
M$7TA_>2#>JCYX%86X.YPQ;[/X=&ZOG(L]9#'JRLG4NQ'!,)MQXK'].O/$GC7
MFG/TS6]+XW'KYG@Z![UZ1B>"2Y.>6N38YA%>]J/PJE4.;TZ6)/N$MDWJY(E(
ME=DGCS-UAH4-C0$M$3PXI1F#!W]K8B$?G>9-S8E-7Z%K[V>#SD(UF?P;&>4+
MS6NCUPB9FTHJ'MVFI;'#S*&NTZ*8A9+U0G+<+$7$A.,UM<Z)UD6,(V]I-%$9
M5VB[YT^]DLPK%_4C+O>+JPGKL(',C]@>$^P5L<\@1=)0@)V6!3HYT Q"JB&Q
M]BXSN^MDYWZUS,Z"5@>,:<$L.<O7F=-\^.KYT23'AH<[D,C"8IVVG1F$YZ]\
M6F[+&'U#Z-US,+>Z1$=R-M7U_>7=1XU"][HIBAB%G^5<^+7/EJ\>UT4Y-*KT
M"+F_=H1"%+RCYJ@=O&18K"45HWF83-_(:%DPQ!IYAAK1>D3W]/*\K&:Q);=L
M'VY-4"\6="&$,L:ZT2H/VPMKY>036]/(FX[K$>,1[W^AH+;O3,'ORI]& ;"P
MW@L'V\5GM?=+V(O@B9M/:$T_3#3.)_4\GI_(M##XFT",I#"SX9P5M!)RC(.H
M.,I]/3%S>F!X?JZF"X%E@+8(%M6>8H/XCI%>9$AD_Q*:<2_:/#/C-=* ZKXM
M9+D?LKW)D>B) D3133+$<I$8 ]S3@ *@TF@WKT@J$!N/K7=Q37CU:.(;,Y$T
M_55-FKDJ*[)6'2>=R@16IFCMN>2G17V-<,S1HQ2\N@:0_./0&4N_*;,$YOEH
MLAK W=););R%E[R?)Z=P@UXNFNL*>6$&V0<!K&2"DFY^U9W#-[5O=Z :[^XE
M4SK%/2!W#UFLZG  .ZY/)Y(%_JCP?X*IJVH]:^XJ'PJ.8\KR3"8H!)2//&S'
MODO/$GI%2LF.PZ]2+8L()1_R//:*']N6DL.UHT\0=WM$CDGM:?],Q4T3J\SG
MIO%0B+6OMA3?:1*G^X))VEF_R:P^!WC0K#1"!XN8M*3D/1XQX^<6$-<RU!(8
M@"J5U9&^XV:142/MOT@!W*A\P^N=<R;  ZWAA9_)4(#L"WX?F[OU7PEJF.[[
MIH]/RYI8UK:Z<G^=MIAA^J#M(XLIC.^A(2+[M7+\#5GTU-K(;K,=4J^TW=?N
M$Y"R#/@]/D\ 5HU'5)^E^_%56.C9:(\L$+6,9UB+]Y76BF5R55-\F4C^>#:"
M)4KSN53^7NVPA)QQC)">E,E4:.DQ%?"PO)&RA-]5*]+*?'#RU5O$TK/;"\V&
M7C_P,XY3\..LU;\,L,Y-WP_C_^S^95P$7,%QE-M!7MEI].%<[!P6V:2GJ9P^
M^ZR"I;><=Y*EDIY*LK/G*_B[QSYT]:GXCUPV38'9AI"NX#4*N!.(?VO05N]0
MM!RC3]Z+U0%WFEE3!BN/PH<!/WLGISV_5B#CRLPK&"%_,N?RQ,CG[=?X\<H?
MAFUQXC*?UMF^XF+T94IV' V/-5'9J1]_S]4L,G2%6_R]+#Z_T2VN7O(><TPI
M*_L/]5-'R08#YXU]C_&OG6EDUM1$83*6<D=%?C42)^E&5Z+4SI3UGRUOP80C
MO]V6L_9=+.DSRR++KBF"@LOU1;].#[N\#> BO\XI0 RX5S7MKS0='T4\_@7Q
MX2[F*]"_\6S^%\3UTGP>G/Y%RO?_30K_-UR3_B$M_N^D*0T)^QMD@N5Z[DHH
M@,TK7SG?$ 5TB*Y?%KXIN.6VIU=&?^>:,$JD6!SMX28MTH\YY49 H]MN>X3#
M"#@WS29@\&EM%93:Y+Y2%[B*]T#$O;U>36GH-3BKXG.<B!:8_W/JR@#S&-W9
M 6\C37KH5JAE^[I::[F^C!*M3LG0/$;"R//[!/8S!\69K^I-9M<G2.HB-,OE
M@G'NR4N0T/PX*(Z#"\D.A*4< O 2P^OYSS;L!@IF4P\/&UJU.#/ZY$JEYAUJ
M/_D]M-PM]CO;> A/8-V3/PJ\9^[*IYY#3H<_NF[0+)R/IT1OZ@LGF=/(W%B:
M\^!9_%YD:GE&UUA=.60=#,O5,9U0\' <UJ56A[]!R"><G*2,K]V);*P.H.LI
MR1I-93HA]N+J7&I0@QDP#R%89C5BG%0MM;@_I$7SGM)3._I/7C\]\WQGL\58
M71V;F:#)QA#NH'T.3_7)F%CVI*K^F%$C?[ ILZQ0?ZZ4CW%_D ++E#O*CZ"$
MI.S'</AZ*]]CE^XLJY47$DE^1')G6OP&_CL0>7XDE]62JG%)4*6GK0W.81%"
M*5VI+"&N5.X,5W7@NLYIR\A==)T08=$T">JJKK,].0RY:-;/[$5X*B%GD1IM
M$Q!8@>'6]974H<7BOKA@YJ+T3\QIP<#X[TSAB'AKK<D1@*Y9IM>1C01[)!73
M]:M;/2<;?J&J_7(ES)EI/O3: Z#:%--EW^ET=%2-H(2>+<QT%6AXSISL_BI0
M<C!&FG97"<[]3]4K2*H0'I+('T@-7L ](@AAD3<ZX18\-XT<&;$6G65+*8GF
M-(TD@C9TBAQ3N<P56B+I1]C(OH[T3;73JD2+.S[8*WM+\6/9=E&_==PZ]GO6
MLX+-!8>Z&\)BT2*/5I6LV9MGPTE+*LV-EP3&2<:AXN',F-]?GO@7,VB1MFS,
M6.GN[?+'PT8'P&Q-/]SG=XN^-9\-]U38,D[UI-KL"=H>$#^EF<"3(?">6D\Y
M)\DV+)/LI;7S6#X=:+.PQMM3(JE_P-KD-<!YPPOL 7QF83(<W#Q4$G$Z3T)*
M[6';L@5_\B0<J,BG;7WLU9B;%7(C_9ZXT%M'JK?D!,:/GUZ]GYZV4IRGW^::
M<X^WE6^5@7V&DQ : W54LJ95*!TL;V8O*J@T(52\B]-]6OO)M9=*=4V'/>)^
MOBOU2"&5HC#?.EMY.#\0L4>U7#,7Z\1"7N#T(4;G>UR>%'<C06) YWT?4GWZ
M)S$2Y]=&@*J2:LUGMWR,[=QPJ,&\V,N!3IXE/&I6A&^K:[BJL<79*AQJD,==
M^!X#O9DK^^96V7P-N,$4I&O7) &)93]E;QOYI8\< 3QU)QS'5HH,HA;1"^UD
MS-?#,YQ S$*-Y< F1\OXP[4 *^L7F=75]Q>C[V-\B'@?%2X&(\\U&>"I4R)=
MO]-I)6/+7%[\(7)Y\'SZP&*:<I!G4Y5R:5@JPF/I!15SG%)U5]0$=>[ Z&A%
MY@7TZ(!KTD#/VJ'9[E%H^VV1+^V0AX!WZG.C8X>*I6(L6V)1RP> NZ2+XKF_
M[]/*P/1-[0FU()G[00\D,&VN7YU$ >5<JJ(A%A!WVJC\"4@.Z&4XCUH5'G=+
MLBPY3_O.%A2O5/I^+J!M^C;X%B9L[PV%X-KHMACUA\R\1VNUS@6A\62?I=8:
MGQ/0D1M\S$(WUZLI/K:;I::$**" UBW4]Y10[ Z/JFH?AC3QT_]X:*![L 5:
M9Q2@EWBJD5 (00%TY\67+N!SK[]IX=IS%&#0CP)6[@7SH./C7[6X#_M1D6[[
M-$V\?I\IJ>RW(>MF3RTU_T]&15ZX'45YD8,A%E/7\J&TW,+<PJKM)M&/*B+#
MU<.'QH]I@YIN0BJ^)[0'^5A2O_2Q8SJF"4.LMVZQ99551X\O4=RMCMB&W?L1
M\;4QA"#HK<:2N\8#@4<%)\\=7UC-?^.K9U3,E\6@YD_^6)S>P]51'#F;H&LQ
M7UT5">-Y<H>?6CT\H.$Q)$QK,Z/@ED5>U?13S1IW@:EP;7:6"(JW20K!*ORI
MSZ2?)22#AC>=>V_KN'&5X-&:RQ<5+43>_&1V VJY-W.K$7J_RIXFEEP1UQX/
M"_)-K-Z&J>9^V7*";LU"PIQ,W#.J\G!$M!);14/;8JO+R.=.X3TJ5I4L>01+
M5AB)M.7WATI#1.0OJI,%C,(RXR1(Z,6C6X](#HI]A5F3278V-'LPZN*/JUB%
M:C8/2+H10B>V%P']ZW>Z\BVE(:X$*CCS4_F#/FWNH]_!Y:]+1C=2%>,UB<O?
M5WQQOH4&"JQ\9HMV44\?'7_:D#^*>I:1(B_1-30*>#C/UC0_PG&,[?1TS0&^
MHBA-K*720ZPB#1CV<\2-LV28FX&:A#/<J;&M(%;HBE'TV/!X9>1^+#)O'5E'
MN\ B44-UVTPGL<3V7(?V]+@675+*1&R:0Y;1X?+B3JXTN$QR^473WS= %:GH
MPM.S^/S ,I/8DX=JH^JBD !Q/@692=?8YM5.Z+(_\BPRMCTU]7H02P)#>* +
M!;V94Y6-/L?2J<;\6Y5OO)+7MPC0PP\-_^:9:HLN\7<A<"Y$GH)( KZ++A(>
M@G331[-4NCSS*D(!V_UY%=V6R?0-E74CJCWCPZG]FV_V$]]=+W^32\=,7;UF
M(9#!>[^GY=R XQ\5FGYQ7T0\*%8J'IV4=WY5">=4H'<+D,66Q/3OZ.!M $?=
M2(I# 7^K9,6B%_U-:[#M[6+AX$3/K*G^6WE:%<U\?IV*A+TONKK3W\QX2GVJ
MN "=1VN/9,O$>SILRO6YU]:6M/SVNZJ#R3,BNC8)3^T\ANS,XTC7L]]X*3J'
MOF1T 1_Z"YXVN(/")%U3+,GN9,#E<SC#Y32Y>N_ZQ;*%)[G/9<3(-)D?E%"5
MB+WJW98HN:<,3&VY"7L.++)\L#QQZ53%/9Y9PB-OLKM*;@_M<,KE:<!1&K!&
M)$H/V=W;,YFAL:O?D=WUFA])$:5MF"!6T#!18XX2/KI8,(W.(S"^1G5N' />
M069;Y4Y.Z\V\HT^^2Q'J)"* 66G?B<A9Q#?^,< JG9F9EB2668)E&V+/@(??
M(/J^L]Q3]UWR,YV3.KD[$G28=EC/O7UR5C64_7-%PRRR*6+Q"'W@5U3U").U
M#CJW@_W@7X]WJ91851]@,L=PMI-A86YY0PJI4K];A-WK3@\6-'QJ/A>N_26<
M+9"(*EF:MUP(PYZU/^0PV?0:?;EN%1U=CN !S-!1@YWGIL?:X,;@NE'KZU*Q
MD)=3*3NXAT*0AX,#K.ROE+;'K\=75^_[R+*%^B8WSO,XI#KBU0\6%A<)C]U<
M6@PM>,(&VRIUA\&;^C149KLY[\E6GAMW4N))!F"(D?>FCC_2OXJ[+@UZ^>XH
MM)SW+V@8_H%SFFZ"?\&".7(D$.FUU81&WON?\)TY*@?M;Z/#I'<8[7@?ND5K
M@%^<\:H&_T+L7\3I_WA1GLHE1KY!_B;F@5A)_O:_807F(W/!L?_@<S3=.$)L
M*.!OZOY_?(PY?2SE?^V/SMIA85_.1>!<_(A2T?== =M(X>R?!4W8Y0P\Y7_$
M\W@9%!#)%GCA*8L"4H)9Z(VW+!YU<VNR4'*N7;7J87UM.%?XY/LKG@F+$;Y1
MF$ S8EU;U5&I*%#DE90%#U1M(/^VX4YRV)RVWYJ+(@O'Y'N[]0->$^F:1JA"
M@+XJ<56=X#X]-0YO9K5'<*]VPTTU52UAM*U_>.4+\4$+P$0N\NE$)KMS)8'-
M;+:]X\ZZ!!P@3ZOEO6*'R>0TGR\']VHU'Y;J?JQ5'UL8H<7<)/&W?%R_SW3\
M7)P&0F/55TYP?05YQP>6]2Q#ZF*5@'U&36>V;P>WMX)]=XWE86P>>.Z%#&=X
MCEW:QWJ:-W=N^ [YL-P[C6(D[OMRP+-VG>ZRM'SVL[3\]KNT3.I%AZW+TK)=
M]]^7EA49*" ?O6A%L-/K?0473!?Z\ L74(?F6\>&[I%F:6+UT$NJAT(1)X>)
MR)JJO=Q_3O.NX'+<TFT[ST4!PQ&707+F%?ATWO$25(HX",\6=+2$[>4R7ZF:
MN(UT0P?]F;S>QD$G:^55=MOR&.%O%*%RNU2;!Z)-8:_Z5<FX#R:\A.3*S_F@
MS]G*!7M:@_:\.A>&FRJ9$)=U:Y-,0;\ZMFU%,6(7BKS0]*Y@B(^3H+0HVEBR
M ,+G!!Q,1%-H*LJ>G=7?GAPKX(,[/.MF2&%LM21O]Q(3OA.GRFE;'K)>:*PX
M.BT;EJ;=UTGYDH\PTA0SR[&;Q4*KR6P@&A?9\VII_WX8)G>7_7$-57(VS:$-
M"A ?LN4H6E12EDM/8'$.3?_1;B+X$M8@8%[[;O 5VW(]D5YK!/5W/PGA/GDF
MV]357LNHCP[F_&4R0<]?/(UN;_D>&2=C_.6*+$XR>#;8^V.&):E'TN'"Q@LR
MTJ\D03(3\N3SU('4LJN:NBWC!97[[;;J0K*5W-&?84\P(YXX;R<T\B3.L*@3
M>)ORIX<N/C&SX<05QH I/'?P&YUA#\L>+["Y7_E!0;:[5%39SCX&[F/Y28>]
MD#3JB P%R#O2B9HF&\$$63E!(QXTP_DY%G>2-OA*8$YW.7V>^*G5! '6*,!I
M/R&GD7)8%EJG@A>]=1TO[+R"P8C@6,;.:P632YC?FVF&];OX ?>5;$%N?-%]
M?(),O3LR&3QJ62&GI _N[B6 RHCHOQ$IT&2'8[M<3R4A='P+X T,?BYR'.?1
MJG2M<B7K+Z.8>^M(,Q^GXF?G839>*3H*W6]?1GMYF316;.-?%W_<?4KRQ]VF
M_:\0=!CH)L;0W7R' H1M(.APM(GNA869?J%!C.3?\0 TSXTAO910=,C[Z^2_
M\OCK+)_G*;9M)0=B!_H_L$ 'NVN7"3N?YZ4/BU<):#FL%QTG28;GO,+M%WJ1
MN4V+T)+\89(9A+L>"H#?1\ID^O$X_==(Q/AW)/JTQ@2]D()N)>R!K_$'^1F@
M@.=L)6"AXT;78LO#W(Y;\M' N/O]^A:YS[LOWU01CLJ:E%KP0[E?\$X$6$4K
M@C\NS&MM/V=S:FR;H6I,2;XUJ'2.U; ?F+A(A?=C$$DGE!W 4UK*';W>(8"\
M4Y*_.@X-$J:G<AW0*<J)ML6-!K(G0 IM0^7%Q.N/E0HK9D:_5'[1;FUQ/)H$
M5U@KR4[5Z? Y#+]O6&?*TV38#8VGU^C3'#$+-PMZ6&W2S("7D&@0L/ZUD;IR
M8-.6,=ISM=-]PK_/5*/;5::N<=B))01R-[U"X_9M3DH[&>^*W+F+>QRW+*(R
M&[X_<,:T#8JC.O=4WV]SN#<L*.I2M>)0>Q3(Y+_YREF);P\"<I.OZHQ<IEA=
M57,KM0KIO64N,STG1[-$,MX![M ^O+ X3K ->BU[)"2B/:XS+C$6K?Z!*V;G
M, =A6;U+\X[D?4[IO8>M8QVJ!!2%=PNB;;;5[H3ER!>20G?D#A6O"9/,B3Q>
MZMES#9@]DF-X'=/1X^4Q8'7V_0XT>+%\^&5UR)-*;"G-TV^@W#9]9.>(\X7'
MP+J>E:ZGU4LL!H> J7"WL^$P+9G&DET6*QU*G=YE]K&4.+$'#V36$SUOMF="
M.5J\@A"8D# '%*!<D>#NM)G\BL9.4-D^W*J_)'BI7L0U'^S(?Y19F%1JY"YQ
M33+:<ZGVJ<AZ0%E]KR%NH3*<_I]X_1\?!>11RQJFLA&KZ,L*J$@38UC)HP M
M=-[6C]@C27UV!CZK*S[;@$067E_V3"ST"V9.>7[9!:E,HK\\<]C=%"NOHO?K
M% 7$ FQ-"(_?4?FA$ 0](;(F8E%5W?>C9_%JPNLJ0GU]=UM;\NA7,MI2!$H+
M^(]&U6/6^?AJ+2W)B.1)RL/I57<^OS2V _3,$KJ&$ _X4IS+_9]J&XV8J"?=
M$6E[)L.=+2(B+:2Z4W64'';3MR;X$7&4_&):#,9>CWV5X')--TMI.3LHF$>[
M<9)QB/3^X-RSH@&INZEJ?5'!R;TZ@\5;C;T6CLOR/O)20C(R=F Q.W&8SC(O
M06#DFL<G^,#TJ8,RQ)/*WGLS_MMUXH4]3& X-\7-!4+ NB,.6=)1?CTB2<I
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M*X>&"&P4L-Y_D0=9(<M# 3\X4(!!7E,PS_MD :P!>9Y&PWAB>Z+N)?;%+RC
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M,C]Z)9+V.-&&[2[.Y<\#QFC2:G"=J.DF6I43KRK@PP;752%?09=+^FL>FNY
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MS+V9F3OSW-]]>#3DLD]%7N2ZH!(LJY*T)BF4O,8_ =P8@8 :" V]]8MLKMO
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M6D[P.]NX"B_,\>*V6W@K&! V+^.:FB/L&%+O^;/RX.3B#>Q17[ !$UG$F3Q
M3G6Z8:#(A>O?).]9=VF[WDSM2@0&HHV+;),?QM"<"ZAQZZ)4V78+BY;]CH&F
M;E.,_2-N2=%M1HK;U%(K3,";'KBM4U'%LM4\ZY37>[]5 (+EPZJ7'&[0?$L5
M#2EELX9Q/SLB(7A$KD2B'Z@]E/\[<'OQ3S.(T3Z!(A:BI9;(H_S?N\K;[HBX
M#<WZISC83M+1WHR?SH30.BFS\-?R+WP9BXN"(WCO8]C=^I*)OR0&L.1> (MA
M*")V 4HCBKP$*1\9SI[:= ?0\X0NL8<"[U5./YWG5&:LB5@^]_IW0&02R5W
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MRK7T-#RO^>":M,IQ#&S6Y?)MT0D9.4A^ZU(W2R[/.E,FEG%\=FC%64[2PCM
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M8J ZD2PL60E_E;Z=H</_X0NE'&9%B>926/D]JU.?!&NZ=^ O9L/!/Z!*M/?
M*S<JZH8S_14O:?!*JG!_=?8VW':+0(L",)U<@P]C^GC8WIQ^*N#6X:-VIUY1
MI2$+/@!_S/NEC4U<7=.6ZW$#Q5?P2N43P<.^'TUL^R<CO6;##'5,^)J5?[0P
MVN::?&F.N1\"6W$0?5P\7Y&0(3)1J[WW+Y7ONP^"_TTZ[F[1#MX4,C&X"SBM
M<,!]_/XO\I3WG-;^('W(40BXY^F#%7B\^7K& >?^USQ*$IE&E<=6M(5*)>6.
M_2C:CRAIQO&YHI&WNP#- /PM2+O!)K8'<UI&Z@^ C>(Z'ZD)LM]K@L#)9[ _
ML>___&%9+N$V9#5DX<FAH5<_#/QL:+YU(G6*F(?65N5)SQH425_5,)Q[#1QP
MAU+[^YM@43+\"U++U[(+(.O?$21\(K6JUKL OR4",?LU6/1L!LHY&)I+M.(_
M0@(OX^CWGF[$$@Z_W=)5Y:)=O4&2:[XOEW]/KMB^7(!BL104>\0$,GD)$@@<
M22#U?/7?.10_$O=H0B-)R=U])2]4^E@8+QG$T +7O^T92T.K#A##&,10XB^_
MW=(C->+$GK5D%]#P8!=P3##M\!\VX(-(QK?O&__&[[]JD'29/'=QLE#[G"RP
M<H\)P8A&_1I,;*NL?RJMIR(NP_4C?U@,L790_,U4HL*_VK.!L"/P5W,SR?ZP
M\ \YNDJ4!TW,^'-Q 0<7#7I@7L0E@ORAY.#$B-O(_T^%":.<X>WOE@R-+0-P
MST@KEWUDD4>=QSA#I[@YG>%$ ZD.W/W\'U!+ P04    "  1B&A7HF$'X/16
M  "D8   #P   &9O<FUS+3%?,# S+FIP9ZR[!524V]\_^A!2*DAW#PTBW:72
M(-VE@%+2G4-WIX2 A#0(4I+2#=(-TB7=,,S<P>,YO_.^Z_W?]]Z[[L/::_$,
M>[[[&Y]O[;V!S<!^ D_DI&2E  0$!. U_ > S0,O #04%%24!VBHJ*CHZ&@8
MC_ >/WKX\!$Q#BX6'CD))04Y"1D9%>@I Q4-*RT9&2,?$^LS#FYN;DH& 1%^
M3N&G7-R<]T00T-#1'SU\1/3X,1$G-1DUY__K!_8=P$9#($5\@(1  R!B(R!A
M(\ Z 4H 0'B \/L!_CP(B$C(#U!0T= Q'L(GU#P!$!&0D!"1D1X\0$:&_]4;
M_G< &?L!#C6'! JNRAM4&GL\3K^X3VBTSRO;\%5'CT!<Q@[^Z!@$A$3$)'3T
M#(Q,S-P\O'S\ H(O7DI*2<O(RJFI:VAJ:>OHFIB^?6=F;F'IZ.3LXNKF[A$0
M&!0<$AH6'I^0F)2<\B$U+2<W+_]S06%1<=77ZIK:NOIO#>T=G5W=/;U]_6/C
M$Y-3TS.S<RNK:^L;FUO;.[O')Z=GYQ>75]<W]W(A $@(?S__HUS8<+D0D9&1
MD%'OY4) =+V?@(W\@)H#!4="!?6-/2X-IQ\:WO.X3Y5MZ+1<JD?XQ@ZC& 0@
M[A6ZXWO1?DOV_TPP__]/DOTCV'_DF@,>(2' C8>$#8@!ES>,.;X83$SHV8C)
MWZ*T>@1Y4^TN(EA37,U%S=EP!UG.15#7],OSC]54OXY/*\>TGWJ'I3\4_OJ(
MLE<S+I_I?:ACN(A4 OX:MI=#/2O?-IKT'5?]UK664JZ7QI>)_4S/,D[H&.,P
M*%%ZLSMU6SLZ2;5C(KSQ>91,<^HV=XU<AVK5I#7!;OLF2[K+#D@Q3HM+.^VA
M))XRHAKQI'KR3\SJFS(GL5$&&& ' Y@)UOMF\6# "O4H#-BFLX(!X >41W'F
M,. ,IQ8&M/HW92E5!IV%E4-[;>EU7OHH@ZPIEU:KRR!LUE7HY:89K$U$@28"
M<S)='DKH4D)]F<B.@B=7QC$R," P0AH&9"?5W4'PP.TO<F' #ZEY*!3CE/U*
M4NUM)2&K:3JJ140V55S 7@]W0(?+ 8ACH=].!K5O14;_8\^7?:7=";'4N[:[
MW#"HY&5F*@Q )XB! 1*DMK=73,OS-U)(8'.]GT=8'U@&4CJF3I18L1<36#%B
M>*^^(\CTT4[C1Z_X=!&@4EB!J74[V OX#GK;/]OK8IR$B^1"<=@HH?Z\RY='
M*G"BF'%PH@_A1%DZG[7XQZ3\T%*Z> G^T''W.NLD<_&?58W@JX+A.FK=IK.^
M5Y%[CH6N>FV:%P.VP:)4H.!Z9@$H^L/WPIRCC>:N+VFD11Q4[Z+6(S  _NL8
M$WTQ]=S)UOH#Z'C%&!-D1 FNFI#?JJFXNV#\MY[PM_@HR(+>YT8C,*5Q,=&M
M=LC[HP!G9]Q=1T/5?+%=]MP'50HF@RIVP-J62!1=4#9TG'307JPW1NX?BG^4
MG0?^(3<-A88?6WTP"3XP3R*U_(8TJ$_9J:XG?2GITL,4F30136QV3O-K-<:&
M@GH,_?L$VU<88  W?.PVW/#8?QE>\P&*TVH-ZR\::R(#-K^F9%D%:>081I.
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M<=XS/5<L7[%C;Z!H19>7OD8E=B#US#[@)AS(6V*ICT9_&[^$SR2LXOXF3,A
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M9Z$\8DXQ _BKQ/L++F5*6'O32V23.1/OC3";A$TA53$O]@WJTPSG/N8XCJ6
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MG))A!=*ESXWPN/.=&RB4S%8U]2;\U/$H6]K"XG%M3N07>;QU_9?:PJ$8F==
MP+@P2>MJB?RBO&;FU.0F3DCUZSC7&,^$6+=N^S2;+,?5])(]QK?Q)T*N]3!
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M>#+B:L^?XE7 ZJ <F24A3JFM(HD'W \-<B.H^&76>1<,2#(L%FR%^!V*[47
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MJEZ5K2BRJR9WZ\U^CL<-RUQ"B>=O77K3!;CB:=*UAE='E+ES:S^M6VHN;-3
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MF^QG;#G_CSU/SH(V7E#_H4Y/3> ,VRWA*87*,Q[Y]BF'_ ?MTF28RG'\M"-
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M;I!HST\>=8A$T5S0&Y3_D#I$HTVW*'.F"&QSW(5L]:5NE0(_S2*E[UJF$M(
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MYO,5UH2U1Y,&T:1-LI4*W5.>:+1S4TF2\),E!^YM_95.OG6BA%OR;[K-RS#
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M&]2V;S@K(T6XV%,\\=,O6\XZJP)C=#T6:F5GVU1E](P1?FY%D.HIIKKZ)=)
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MQZNJK1U&+I>B<%)CA3!+G,\XDO+*KL@,,;CHV<]I]B=*4*?YQ\0FL.SA^'U
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MMH.X*1@P6)L% _PUP('WJWS3J5-A0-%SZ#C#.O3R9CLV:FN#% :@&T%NKK=
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M\/!KJ..DG%Z-F?0>&Z&ZO*D.]O*N\+.&P^<AKK8FHFO%-&_79CTE2?D+YL&
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MFL0-Q:Q3@51IK/:L.[HN3#(#39TUTA+4*%])F=2PR"E8QK2![O?Y;R1W,^S
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MTDM#-I54#?9D([D0H4@ZVL2:^$!/J #9('\\651F$^M'/#1UYTASFB64#+O
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M%#\BRO-F_ER#&@A.SP%NGH=N0[[&;"L:[]9>73CM96(G:()^WV5?J(]?;",
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MRT*^E_8P?J07X9G)!_4F-4]]\]%C8?QPH$;ECW<Y3B>\9WMBK,J"/&1]!GT
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M@-">UK1SCSX97T&JL8I6YC#K=W<H?7KN;-<QN!VOEK7F=EJBCE8E[[]VW"?
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M!N[5>="VQ80'MEV:K$>;,$LH/$" Q -TJOQ7S+5+)BJ]DC;+D1FB=S5P6]$
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MSBW[&IYV/X"K\.\-\<?GC:IYWHW=/WLN;"X^N*=2D\"61MX[8\DEM'."]OV
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MAH\,T;/90,I5M3W[<M&[O^O> UL1#/3J[/J^HARF'@B$T[.[BL_A_M<SV)!
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M(XR3573I!Y73&*VQ"G-QR#G6,*C/Y@M:)U*:B)?+Y700X2Q(:QH5E HB#48
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M.X"W7W]_IUR*+GMI$__Z>[B=(1A0"O%9,O?,[H[8P-0YPM[\AP[($U'NZ<A
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M[-@QC,>P>'URT%.;G?JQ<@UO'<!*&@;+_K2(!BOIZ7!7HW544[[!OCC QZ]
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MK%Q5M)NST.K9X,P&9S8X3]_@Q-2Y\+T+$[PZ2G=-19%4!>;"EG^G!/"*MZX
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MOB'/&PZ=?8!&W,I?-B'L%^4^0K&8;+OJ&B:>+=MSX^67\^" \8K=I.5Z=/(
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M1[6D[,K#$HRI I>P[^>.>L):K.D8Y MQ2D#H[!I. B"WG(1\RJX;1 \!4F>
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MC&-ZL;JY'B*.>S$3QSTJ<=SO9N*X^1SXY\^!24?)'PX7>PX\//+'KQU]1.?
M'V)O/D9(L7="A(Y8ULLZ(A9-SSVF)N[#PMQ9AG:/L?H2N<;/JH GUY "<A,U
ML!-GCIL+7?H?TV*?QSHOJXM_51^1T?QK#835FD-G]I\3YAE@F:67Q=,BM24_
MB[>2XI34'3X]K\^/X95_W&.=E]7%CO4C,GNODF(]AFC=Q=#@'FN\BUBD9#6K
MX[P6/X;7^W&/=5Y6%SO6C\C$O62Z @Z%3:AH3/RRS/L! %4H;KGO71L '/9:
MZ6R8M25&OPJ]-*SAE_C\O)(_@L7Q<8]U7E87.]:/R$!&O)!Z@)82!%374#*3
M\O ^#E;4K^(66*$1'!6EL3;6-!RZ(/,9-'5H85R-J2.11"P-=;24T6P&061S
MC+U<A/VJ:&\;_M'*6K&3)"/C8C/L6J2FJUTSZ/?24!0OZR/W,DI7MJ :/ :J
M/H-]FA3:\TC^M!8G\!1>N47Z#PU)> X\(>Q5D3P;(%(E<'?T+\HZ0U\JN3JW
M;DRQE*&"N,\F $8G"F<Y:=;]KJD"X"%MQ^PON%[Q)C DKC%V@SMN^@KHAP()
M+XI:1=V7-^Y.W.K5M+9O!;F6-XO)9$N:BQL3JN"4[+B7_RY^86FC>=<+,:3]
M\OP+6FB'U.EKFGN/+OZ9(MP@FN(]6>!]Y/AEA.=IEZNP/%2%-MPEE'-SKXSG
MD4!'V1[*EN&Q]"'NKG'H5[CGZS8HG/KZZ@!YYF$OJ8I$W'1>FN7A1A,&6EG_
M9J2>1+^O4*^VY5VA'352/*.A[<+F%@ _/4,GV3OFQ7U)8$1!93*ENAX,UM9I
M_5S2YAK9S6E9H6%M.U1DW,-Z,!=G JJ7=%V,0PJ4TF\/$Y!EM./BV[$A--PH
M!6OPI)TS\O/BUC^0GW 'MLV:"0Q Q)8$? I!\=Z*3L=W52%]!W\.1<NJ]3U3
M:P[U1EE@OV[J.KPMI*E8VDR^LT\)MZS0B#2W09D,Z-\]T\R2"</?A WBC\4^
M; UT^AK6DS[\57&KM\)"'O8KLL15D3@0LEO_#41H51GN@@+:>=G+(+@LUI+-
MA]NC&R2"]HTJCML\1#JI(+-.7@;;?'L:X<2UN>D,]<H^@H.KTP,4U;$K%7$0
MBO6.QX8SAA\PJA<(A9U<SQJU^[#>U4W5W&HO9IRD=#5Y7L;MLPS FCM1_)#C
M_EO0H4?[M]BSO,=@_1?,)>BF&$.[*VD!@4QBD6?0C2].VT]V#5 5.&%@&>I;
MH1!6Z&X:_'C<HFRB;UC[S[EGQK>$Q ^\? 4/T;I=^7B^OL(]XT$J,E-54I6:
M#ZG+?R;AZ58FV-')XP^M$=E4U&5,9Y%XZ-@+MZ&A[7/8:?<X(]F3&DT>#@D'
M)/;<]=7+KBR6BS\,+7GW2V,#I=.+KK.,6I]TIY?H-*-Y*H06Y63899?:I?O%
M<#@=?HG8GGRY44]5#V?S'FQ+TB3!EA,Z$VQ4"CND=^4MT_YKFF'Q/T/3%XXT
M-V8C3GMQN(WG>'8.'!8JA#=L_0Q M3[O;&;OA8Y[&#SD2LZC]GVK]<,QF,SM
M]=5)H+M,?8;*5;$*=*D2E"&>AZ[HK+_*.>K6M"ATPC!+TT2Q8I,2%SPT4;G;
M8<S#P6Q\#9A9.?S$?SG2[6GU)Q* I?.[Q-;Y+G!USMB6FOON+BP\<[68UNNK
M>YP\]\$Y]2E*EUC<*X"PCQ<F>BE.G+T 2@(AYKP7C7-IU, @CC2L*(,7-MPD
M>&Z'\A'->B:ZOF(?"=Z7;=!..SF#?U!K1-P@P3!W>EV2N7ZU99J.O!G5'"3.
MF+[;3V0>JF2S'8]D%DPLIX(1BT5\6Z"E92:E.IXZ??<[>A8^GWL6'K5GX=_G
MGH6+-7X?K=C]XV>")LVT< =M,CDPN&R>&9?/9_&.,B9P,$Z0EZ1J%,*RQ)_M
M=@4*#LEA43:NU,5MN?95F+;&<S;HXDYY3B1:KN2!3.(XJE'B+!$)#<=(C.0D
MQMW:DB20#W[T,T[%BYEG6<8+[JYP:!TS]1"W,(59:M4V!?F<4ECUJ?A/0BG,
M@R 4V\%YH-NSH$(VCH8_X;)?')+9H\0<QJ?,G7"R.2R< ,>T$G0)[[?^@8=\
M4F9;*MUFN>T%E<-Q0YGSD/-&Y=1J04[X+M!YJ*2>D<NZ;-?#OF,J[RY+?HE:
MG,N E5F"+[T$DY@JZ[K1RH"4,""/Y7349$Z5J8R\L:%>:T11A[#IC""-:3C
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M^EF?D"1?TSFT81Q(/)DB=ZB2@ 8S9R*0K-7LQ/\<6<,1!V9*Y28L&14 MA2
MKXKU&[*405")72^0'K] 93%_;3R.O15<W+R>D#$:)GY4CY[R $]#.'H]\R%Z
M"8<H["@HW+E*B^54D.]'[_JNW(@H4Z)O=-RE]&$PMYJ0"[A1O$ZG%/52E7FJ
M;@>O2OLM<EW0XD#+K/*2-);2B<:+QSJ?RQ=[+C/Q1!YG"4TQDUG#J)PNLR&*
M/D^NN(AZ)I\<AE+9>;:+JJ0U1,OGR)IX(*EEXN3,-WSG>F3],CJG-HF[&)E+
MC%JD6_J0D?H6>Z!"I+<23\(0-A<[1NA=3^=RQ*2Y$^U RYH^W@&@6"U-45%R
MO*%H ?-FKNZHW2?)4'Q-U*92D+DQANFSO*M(K6(8T()1.5F:K6_CW^41JN8>
M1R>#/(HW"QH%)!3@%G6+8RC:4_R+-(I*^C--#LB2!]!<5V.-0/)C(%L9$P7
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M89RR/ L6?>-.9?;UVP5VT&WZHF("PB+F6?.X]1\_]*ZOQ@L?AFNTZH4F\LX
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M9AS+Q1W;AF,I%K>\FF(]G?,_G)B_+S<ARX[\-SO!M%3.+3R%4J>5E+(!Z8-
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M YEZ2:5;T9<4XG#XTGS"FY(!)V@DMG9J!_DZ@9%0- D?UCI()?&/T]NT4LX
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MC/^B,W&_HHG&2TDO/;O@'B/_A&;STT6^P+X/=5UV\39"AS:ZSU(R5@4H3@5
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M\:**#W &S8?NHQZZ]PG/IY5"3QM]BO2)_;2RXJ4F5!_=AX[RK0AMU\O[RZ9
MF\F,[(!*R>JSUMLI%KW3U+6/8]1\_DQ.<\8Y3#DKL:HBG [0"DUZK-4Q=I')
MQR6[8X!+P:")?^!8P/705I&Z[$4PBU0N%B]?]Z,]2(M=,@7"DE8B3R5Y^MIQ
M8(W<'&.$B=V2\=%R8T)C<[ 0^839OE$VL@UD_^QO3H5%:>\NVO3,#O\_^\3?
M-X*T@OI@S6@PE640)!H /$K)R*@8K/3UP*5FYRG)F9M\;-GJJ47.U9A7<O0%
MKHQRO>#DRSDB;H6L<I#6>",_U+1FS(@K.;HYHS1;-'NHX/?([K8;>GZ[3,9O
MZ  4BDC89G@HWNP"B,K!87NR;Y$O24(ELU)W95.EW^V+RAK$Q1.-_V$4VGT!
M B REP(12WT^TD^KSHV\(89D27$M+")K'AF<!V?_!*:8//4,R\8&(&*=)K &
MC*^[OD)(<D=Q@9#\^;3JP\.@<2JY?$**KHXJ;2TJXA;B+?%AY4<J43%O5F*.
MM:)N#=";9:18D!O4%,D,!8 K(8$;DW1T!(/)-/ H1 ]<N9CX/W(S^;&--^,2
M;?;HEGOGQZ8W=';Q.Z1>?BS(VVVE'VMB_I=Q\OF2B74@QL(6;L68V?FPEV2W
MG[2)_D#ZT\YE8'GQ\SN3N_E7(VL] E;%' C'2!J2Q$JGB[_)/(#@@:EP;_0"
MNKJSKY[@!MXE$<%0X-AN?PZW\LA5_@M[NSFW^<4\XT]"&(MC3M"&D7$38*>N
M*[L^)0'%-!^JYA@C]:DUOQ1K+AXZ('7V:;D(&>KU&R%P99:.0]/U-W)9D8"6
M4JPE'!G[F'A FUJX7",:4LJD$\F+R(?GVK%.DI!&.\$]T0VY*HT<+C]RD]LQ
M=LHGNHS[V'GV[""E(<N\1.R:N& YO)MFA0'2CJW&P1B44R\%3M,6I0_%7@P2
MMZ>XE,EZ!]YG\J"Z4\;R$08/R"FV0ME;H-!$==)1^<VHK]%]4=1T]@.;:?E6
MA<O^H;YE1DK[P(A#Z8SY8Q:IR(WIC>'$0R<\9N,6X?C(3ZMFO6N:3IM1C+G&
MH3XU?SA]K(^ZZR_(BLR'_(\_Y".'VO2FES8O(2Q^$\*!XB\3@F^+0[D!4=E.
MLX\C %, /Y'@!<?!T),_9C^DBLA'<-JRY(CP%,%:2  25YJB;CH$3+1X@#0+
M@I):'655R7G2D:WJ^<Z6!(2J7DY.Y[IVD,@?+[GK*Q> ;UO&+0BL39<[3A7Y
M*4+EE(=):EX,F^>.J$YD45@WP!7F\OXD>A,[;K2Q,T<(*NZ%IU&MJY+5@S<0
M8]V%XJX4B5XA,^-I0PN!H?;YFYK>9\O.)TB-=RB-%)(L(Q\"[7E%=:08OO/;
MT4J@@LKC6=*D",V2V]<8 D K&3TYLS_& UF'9WJ9UM,DLE;]-&$8S0_V_G:;
M&JNT-.,(^]VA]H9.;P7@2^\!<^>U H.\3Y:*1VF++.*AI*]N&;T>FU!1\J@3
MD^Z90B]\+:-&3CQXM&IQT@ZUE%6L:>J,;WA25IF6FM.D;P+BRU F"=M_.=;C
M'T%\_69&?#TJXNO%9T\*\35CE6;O^!^133,;3@.\B?8\W"@Z-R37EEP9A&C5
M,891[*P\W#V,YF&7BGCR7O$O-?GDW>&MT_#*5I7Q2'SUXJM().%6&AU2@^9!
MNM/0RZH2-7L-;@F*-!FSRZ9?*Q&R?$'5L7)(7$ [J?F_<((\J7%2'(M,(&<6
M=^X%:I^'P7'0NZLZN\XY-D&X^ 3<$RH"&UM!U@_B.$TTBIUR[7*OR22U_N4N
MO\=FJ5K%;?=T38L76!K'(I%8MXW17A@%$HQ8.1LO8!&-DA\/1:$C,M4'5*8G
M6FK'"=+Y3+B,3?E!Q)X\*,>UW"F>V?.NJ]"=P*A.^_"T\M9%8J=3(D[;!7S9
MO2* '+0';6'Q=L5&"/.%UZ9C:.5$:?[,=N*UK;5BL>=Z$!C4-4NQ*&8Q1>/V
M+%"Y@:1W427@E<O;2[2O+"Q"/;RA, 6(ZI0H[T0LS8@A4D^F?6:I^_U&]CO3
M_)1K)I:IL*N5(("'49VQ#<)F]6SQAW'FZ-3(W$>>*G]NQGG<9)D,)O/J^IOH
M(\*+D.0&OFRL?+').RH)<:F$C8V^_ZQ-+8)N$ZJ+<2(R'%\L.GW<J _*'H1F
MGW+Q55VJ/C/DM!&]1^ 9S^.:3LCM6L#P*X.R&D(]9OEL^0.3/I*C?><RCH]N
MK\._*RNX\<"V6];I$!"N7%<8&B9V!6UI8/G :2T 7:W,U5K6HO>DRGVYX_+/
MGA$78S?G(/-'>2Q?FP$7&5'7;!IW[-$Z+0P$%//H2A:2(&0YR8*";97CCOF4
M!?XP^Q1/U*>PE2&+"=EH9KG[?^R]:W/;2+(M^IT1_ ^(#L\-.0+2%JGWS#X[
M0NU';\^XV[TM]^X[]\L-D 0EM$& @X=DSJ\_N3*S'@!!/=R234F,\Y@VA4=5
MH2HK*W/E6@TM":W&O@+@ $SDL:!SF 2<=:/=H=(4B?OG*BEI\<!EY!)_)D,X
M\0@$O5DH\6SE+O"MNY2*VZF,%*.H3V%#&Q5Y-.G8?":U+0)O )HMF,COD13G
M^]Z-AR?P3H@\5#7X\T0QVQ[(U0VQ9)FA 35-\S3-KS@A(V[)7[_+)!OL[@QX
MNC^PP74A<#_DW0Z)W[G#C8CXRLCY#QP3]N+CMW]!1R3]!Q-A=M'S.S?XH:M-
MJLF]-!*VY1OLT">'1R?WU?8';BR?N- XSW(X*:/FKCJ#JTSG"F<_FJ(Z/I4)
MW%(PU2Y\3Q A-7B4JE3%GITQE=H*STQJ1M@< AH#RIF6-5D$:SOMOZTG^LC:
MNIE!Z_!5'I&E/.4SNK1/ZL6,I8)Y(WLYDP@#[*4C>%Y%HN6'6,7,:?&$%XC0
MJ_X&@[J9NNLU&QYW6S<S:!V^RB,R?EUNHB<[YM73LX/G8UJ[9IU"9)Y.=.49
M1.7>DZ/.XIKCW%$^<N;E?X7<L$T-;8I6D\R=(QROL-T#16P.&R?*!=M<O^[.
M^=RD5SAJ)Y&+AQ,Z7*]/L';SZ\'#=J?.O^)RW[:#9>J#I)!?>#^=VF[4$A/@
M^GF("_OD"BRQ*!#>2B5F?*].Q'"2\W,N6XG[/:CM(9_CX;-+!A7SQ,=;W=U&
ME*31-,[!Q_%$VJ1B3]$DFH.2 ?3@5] Q;"R6+O^1QT-3,J.Z\FB%;G!*D]*P
M%Z>&)\%2D[KHH'\&YX"D)\$BF&J^ RG)+(E]FB%.KMZR,2TXL()^30$49+<Z
MWFFN0\VXCX_A4IRXQ*Z"FJ(H137ZV,_J-=C;G6B\2K-\CM/D(L\GK>ID342>
M<^GRQ.N:$NTL=U IF+B'.\';NH"M0^;+46'%L1\=<?C_HI%TL[.B45=D BB-
M,(FDBE'B[L(J_9Z-REP34C'92%/+XI."692Y:8BH6LYS">[\J59T =,;LT$U
MJB4 O496[WL#N@\W@.[[!70/-H#N#:#[\7A=]^S5?X321K_WT:GD8*MY15ME
ME"TL7=Y[%G2!,_)1^%Q Y/[1PY8\8;_[^<!$WTJQ-2.8#&2,MF=#5K]:DHP1
M274Q4I[15,24P$"((UU2!8!J7T#8T!-I_(,).['E%R((U"&7)B>\#3CC*9_R
M.*[$&FP -I0@QIPO1.0.*(I*H&N3&% Z7Y7H.G4\<7)G"$9%(B7%\TC!EJ9D
MLP&F-W6;_=[O#$7,E]![6J%I;&01GY-C6[B#HB<=9VA=;*_D ND,E\:6<X@D
MY0TH7>BO&49:"H@2S<"H)%IW3M\%A!00+6V""9L\2H;6P9QQZK(NYI%IGQ%:
MXN%J\^6%0E^EQ+:= DAZ&N&U>5<1),:3>/A!E?V\4?2PWX,(FR^3B"+16#G'
M /=D56:5],)(*GF82#68@;BD&3ZQ"C?R[I;HQ[72B_W>;]D\Q:'% 9'Y1".Z
M9],X]N>I:B*TM*S,9%%RE&LG<YNN @55 '<ZS(Z2GI9M"D5I$&8JUF1>5Z6)
ME_RV<[83>J1QZ4()/^CYIV42^8CB5Q?T=4,'A$VO<-+7'LAQ=V7;=;$P^?0D
M!E\O#K!X>Y!&5P(HY209M; 1KKGMG! M&.9A*^-6AS6B@$5072P4D@RM4&%D
M&0.]O'A6A\NGTCEQ6'Y71)]&@SP"02.^S!&+66VY /#O?!&EME8=+$?G6,BE
MU=8!5RNN=;:1;?0,'$5Q7';QQK'"84ME^%K9N(TW\T2]F=-^S_<:6EJUW8;L
M(D+D-\Z:_(NM2<>\"F*_@4FE2<=UB!H;'$-+,M9]/3$W"J,6KX%*)S5O/I J
M_RV;2% [>%<649PFP:_LG@3OHZLP.#@:'FT/3@Z/K('V_VK7" >3F6:+FPP5
M)FUQ,*D+L]^6Y+O$G#>Z$"EE;(NNA09Z.Y9#IP;NH4Z*@&L9:/WGT@(M=[0>
ME"MI3"]P=*6]T*W#CW:]TY]F257%L?"8ZD%7?Z(&C/+)0@"_255CIZ[M&/F]
MQ^<"B7F2UR6M[HLX%>%XPPD]ACL02AS9?D"S%Z'I52I;G&^9^KUI0^#+#C _
MAIJPL.%8-[*)NX-MF1U"\AG9O]3)\ 6!5SJ&747,H&6D0-G J7KK5 /48E!]
M 7OZKJX73I^^8595&U%>)Y2O?&QCR2YPE(C:\H;Y\C%VKKW7^ONL074Z%3]X
M=74BY6LR@YH;IJU.7G5D2!-R MD]3[H8=,B^^J52[/1/I(2UY/2(5E/S#)<&
M;#;;)[K9WGE.\LE0S!KL*BMH)Y?)I.;#)$\B276>GV,'JN(EF0Y7FD:O03:X
M<E5JO,7=7*9FR0'8RBZO%U-@9^$11@I<]5=H^Y&*.?!+>BS62@W.PI]RRD12
MF^M F;+3X"JP:V@:VYS'?R;KC\,0=L&5PV=;&.KVG&KEZHP^3V5&RI0^]GLF
MFJ=RU'S@'G&>O<&DW#0.M^&JY8!A>.VG: 8<))#2^2F8R[O5/]I48PX6S/),
M],:-N+CGVJ%,\PMX3ITX.&IA1:C3>&KJ]ID_R6R]92=]EJQGSM3P#+97I6@P
MD)9NTLG"96G*.0?/H"=O.&O;2(KVF;A1!<81&)Y:M/017Y1H##5XP69,5J6&
M%>DE<%FY+1Q[=!3MPN3C+6'S0I'G,>3]U^KKR"HTRT!8!<D2HWJY(1X@MHO1
M%7,H[UHJ?PW'FL34.$UF#*L1P(%66$N "/@&N+.15+1WD]05'K5AOU=%7X*B
M=O38+4$#OS5">)]/_2]U^_?* ':JAZ@I%ETMH8EL60F6=(/A\O1;F\B1KS&U
M*YPT(W:V80E?BSY^FQQ-"YKCA^&5!Y/1=&W+9'E.<2YN3EJ$G[-8B3_%<<#3
M/)L%J]1>=AQLP[3^@P["Y21QJAU61HEIKC%CZ[;ZCOAX)8/'DF)<STHNH<6J
MGVH$?/5C<X"1))6DBU8#"<R47<2^4 8O2&J%4DAI[SH[Y)"# JJFNSR"*]-T
MM-&HN,L;G9$!'#"YC,9RVJ;U6#+)JH=T# .8,<F,T$%I)O!;S5<9I&)GXR[A
M #'(%X)^_N ( ERR'+R5L)D!/\AY4J;B^WE/RZU^-YNZHJ)M9)R4QI+*<\[A
M*AGA<7.UU59B+BVE_@Q&"QIE<M'.G8YC=@YO,$^-YKNER J1 DJJ>F+20[)%
ME(WO9,=ME$@(AZ5Q]"C)"8JVT306.NN2EK>VTUI+RR?B2_DMKP;ELIEKI$56
M%=K@I@+'D5A?7A"B=>FSG#1:97?9?J]!R<MK8/5<Q]/,-J(+GGH1L^,[@E>@
M7S7FPS<GDB+1Y#8_6P$8N!C"_5'6)8K6$U;SUM10G%%C9RK=HIL_K<6NN;A.
M/N_&O_U*8-AUX,:C#;CQ?L&-P^<+;GQ^J_;ADUNL0.D$)ENZ*0H)N<7VKPB-
M.[@ '8$3\@,[-SJ[D1JUCD8HQ6W2H>Y0M,-;#3QY17;+C=U$FVAK_:G1Z)H<
MM$+(N63OO$R8O@Y>!KT"N[J(T=$VF>9C]0M#F[?QL#$B>L9.H7>>I?\5K$M>
MJ&PE-5_$L$5PC7M#WRHI/TL7Q\EE(A#.<9% 8ID3D!K *GVX!YW9,5;J$XQ8
M[++BC&01<*[G(DJGS-M0Y! -9>I^^  <YI,,5Z*N,>1Y9R-L[N2HY>29+9RR
M-GM#[+?R2=4$8NU!F/G?Z%'B3&A8O_-#ARQ69R$W<&28RG\BYW>D(!N'$DM/
MO!.<P:]R8CS>D%B@(C\*AQ(F L)57J9?D3?D=9(?DPIV:HK602(N^;>*DM.
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MO$HBLVD"'B'/\0]P?#:4U<95%*F,3R!940E<ZK.->FE+R-)2'!LP'Q^I@(3
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M+]3FTM.5;Q"13FC681ZZ.G[,?291AIBYFX@L]&BDCE14(#)N6G.YF!U:J=O
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MOZ##(?C!;)3.";AS@Q]Z/R$?80T;N96\O*<6/O <CJ1I<S*M9,7S8L%5,\;
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M=9[G$XZ(B/]+;3MGG2FAT3 \>HP-</T!P!(1H077,#,%2,1AF38?GKP)+4^
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M$(5+*A3T91/\YT5>SST )!IKHIUZ2L%6%T]KA$BY</(\0H!E>3,UVS(SP==
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MH^%!6\.7C2^^-"5DK2+13", &C8R]:"WP]R8)?5,II4[I=F?&]1L4<F42-N
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M+@L-J4WF\K*]W7CF7VQ#RXOE/*5N!VJA89JK)MF)X3D1RQFV-0Q\JQI7<DE
M2S%'BO2\;U3IAXWH;F0J/9P<DF08#Y<FP),RZDNVBHOHQFDRW:6;Y_RVD%X]
M(1,?>M)FPOA2KZ#:O@$#L^_%@_WBJ.@K"^P^ELFMK?5>8$<S6ADI"Q^MW*J_
M+9U<_9-Z;;M1:9(ML NT0!P,S,LDPL=1E2:B/]$49L&;6%V= ZC+4L*%!Y9
M$$O2]8"D-U>Y0$B2(0TI-O8&YK<3AQQ^<C@(3X[I_Q]=DT]KBO::SAV$?5*
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M.[7).3ZY*CQX/?9 5I0#\P<'_;!_<,H?Y!P1:H8N]([L-Z'Q!P5Y.?E$2Y0
M 0KN4SF+%AR'6+G6](WD)<WH"^;67QJ@7.OFD"YMCKW@+.?^[)9&DYY#R\(C
M4R-IRMGMR&/DH_0,E&+E\$P)*HPD+<,P:5S<0#.61RR/L[:0.YSS_1C-)?YT
MTO_V*2\(CV(O>.D2O]ZZNKTN0Y6%D55-R%C!NOD#QI9]'*+E,8E)Q$1?CXH4
M7U12(WQ25FXTNZ69-#6-FSORN4I(/H9&-JT20G)%!=V2/T0JL2($$#!/(*=>
MGU79;<><",M0?IUQ($.:XH6USF!T-&>LE6&F5_X6PI+"I':U>NCM]MRXN6![
M_JB'F61W)>&R?\W^'.H1BQV2A4ZA62E(^BI.DZG1J*+'.(ET2<(26&X6DEXC
MXKKD(G6=F#W4[>R\__EI\$LTC[!%5VWS]S]7:K)2LD#=&WT@Z2.K#4A;-:=(
M!_%_]4Q=J."=7L0FOUR?D'2FS*)AB6'47]\4O6Z)H+625-(+8W,LVEV_<7-Q
MZM;;_/V!W?Q^2MTR88L)X,":@2J+&<F_/[&I5VM\3JL>#YR%15OF0/Z3_WD1
M*9+/$_)H=HMT-TVX.U9&IN98X&QX'MM/7M)V]9O(W(EC@^,S!2CF7U'"E2AL
M+&(S*\[U<(5(9/&27@_<3)/6429W"E0L/H?%-4QBQN4! 4<K4Z$:/01>N]$W
M;BZ.8:'?LW)OI=Q:XEK /F>KW644*\QR@^R&MAHJU-Z6XS'C 8T90X^IM 0>
MU>W01O[ :.[E#NSG5[35YC03GRUGZ;*'Q>.U.^US#8G^K2@Q9434=;OJQSCZ
MF"/S'+PIKL*ZF_P362$ O%= <L_?XS@1"Z9KGA\&]O[@DOLSFZZUZEI3I0X@
M;??>QLVEOO?6V7PD]R #&YON3:RNSKF/-RO2M^F,]/#/693/$E13^1CA\RH.
MD!M;-WAK\1L**G3E[O3H56OO#[UWK[<KW3YOM^6FSN4%MW^QS6.6]^18 _/.
M-AGG/@4%/YHE:9Q.KX*R('_[3VNPZ15*TP4,N%/$E=DYK&2Q4<AL-)U@I/K+
M$)Z3FTZ;D0Q/Y%.QS_%K4$0241IFMENXRC[HPJ"+9IRAM<W)3:OSF4(A;D3+
MK 2-7T0 )Y')6-OS,NEIFHZE*@)/I&.HDBDSC$N P6^SL3Q1#D8(YA_6)\]Y
M5:.GT+R2.\QRT9A<SD?<--$!8?KAR5$X.#W=0_C:P<M"VZ^G^EZ-SS7B6BHN
M^T8A=8#!893TT*4QURNB;4]XOGL4TYQI WHW=3MFI@*LPK48297*#@V\[(4>
M2;AF8.CHN?MZ5 C&[GCP[<K!.(@;>[GFDQG+# !G _&E+=#MT+/&X!_@G+!\
M$G@+GCX4*OL14KUC+EG,<ULGAN*]%;7@_DZG?T7Y(LU=T4PE^<PV'IMS8[&F
M*Z&FS?6=DQM?&#>-2P@C+[8EX-&;AQWP"<3_H67X0M+T(83I+3""7@LCN%L8
MP5$+(_AZ5#[(0:Y3]W[^9IS.25>BRA-1(I/X)-%HTXV2\^0'':\T9SF Q7*,
M4T$F:0925^0'/RJG4-Y9@P*!>T[6_JY%*-OQ(*E.)^4#PD97\V$:AXY.]K?_
M.=LS=JQ],&H6D_221P/[5RA&_.H_42:US"-$K_.Z2$63'FWMU8V;RSN46%4F
M1S.'(VFG5>&C<&6:JAXRE^RPOQ'($N2\>E4VCC"C9([AI.5^$;GU<LQN?!P+
M_I@VCXLT7E,B6 DLJ>+N[:\JXD8^![;^JG*D6G1]J*<T<%BT&2J1@1>US^MV
M)(#NXM=#E4=DCY,^GF22_U>QC:6S9X%:]>N+&E8,TQ$F<0V?]U0;+94'=SO<
M+AK(EX6UOA.M.)P*M]Y/*-P4V^=C :LA=S:\GQ7@<37"^%41E%L'+M&K OF<
M 5B:V0KC';Y .9\K^7J+<AA'(^#;-3M+M:%#M=4^D\5.Q!$W8)2&4\V+C!$N
M1>RM7MBXN>!H.U>JY^R1G]0P(]LR^(FL@+DIUZ^'S%C5<Y65JS$<ILAPT2X0
M7B^0SS3B6.ZYU?/XD)J<A(M[J7(<V1ZS<Q0IV3S7?!X5A0810G.$R!+;Y,9U
MW&R_D66&5'0B5LMS"Y:@AUP@20W;_;E]QQXMC(ZX4,J^*TDS,VHUOHALXM"C
M$>100I0W0H\-SA7\#YTX$&-P8,3$9#@AZ,4$%N1PC:0Q:A8L6 R-[K)=6WN$
M[N,(]5>;]&NF1^I\2BLYGUQ$)0R>(SQT/E/TE$P*(U]>3'42!3_/U)\J22\:
M-?;VR<_**WU;HPJ^Q@VQ0M%9^A=#:K(R@]WM5&&?9@'R$@YPIP?&EUBKW!*T
MV"OY5D/RX1YX#<\B<NLY'Z$+G8Q)\H2!GB_B](ID!0KIU4>;U9=*9*AXG$8^
MWCL+!6Y"+G\T1(_"1_H4U(8DB8PD<X/X/MCI P)+.CBS=?RR8'25OU)TG'.V
M'6J@$4!:7=/A>86<C3(S:*%"J:HY39!XB>' \K;L&* ,AX@K8Z'"-] #7' 1
MNY/-!>X42;<__5Y8K@Z>"O-I;:Q2S1K0R8CQ+P21I?ZUR0YS'^WBOBQTNXIJ
M^5&L9I3KDZ=6BSHAEN/%M=9_RHH(V#<V,E1%O3YY5/<=IBS&=S)(B/![WQ4[
MT=,[&O<]#U3)T!8D+TDTH^S>,NNQ+>4QHKAS[(GPL8XAQ_32B?:5T9OJV3[?
MWIZ_0!SMW) -O;%;^&$EV9:-M=U!7_ZK@.QR.T;*(4T,CIPIX9$#[XQ/V=>0
M6@AO.S/(4!D=(/GY+T-+J)A15=*2X#[*650:_L,H)VO*FD25Q6>:E&$<S6<?
M;JQX;.70HQGK)FVKK_6KD,S<.J'9E(TC>@&[=IG!%;&3A[B8^)X1*/V'I6M"
MH"^8PZB0G&%1:QP&GWA)&'(((C%1][F*$HX98RC&0H7TWHGV])YOJ'(;#O8O
MY2*\!I4AH(H8(L.48 O;T$J:D5\&&$L5MJY"$;X]^T(OTCSBP#E&P(B_?*GP
MQ+QD;"^NPGD@PT\O77(48*6XR&=E3!.FA\W4/'B7H6Y1P*W>FU_*G36V; 1"
M9" <1M6)GD1%(XA)<PL# R33L<ECU"\)O60'_HP" 8Y*FE@\V)^B"1WW@FG#
M'5Z&+L^!1^1HB%6I (CM<FP'05VI-3#N_TS'CK[0G\[&JKNO52YM]UC;'?3E
MO\I.=+%MBJU*NT(^.4%O9#PT@Y7J#K>(MCG9V.1A.&Z;YL7NG)R!J^!"Q:7R
MA6VLF((/[14X3LMIX*8D-HHM<;)8#7-MZ+8YK]Q\0.A%>->=@:<F&[T EOBP
M,9IJ)B+&_07PX)%,K8T<<F:)9%'>KJ*<LPA\9R)Y-'G?,&VDN&Q>6/RC6DK#
M/LC%CV1D[ZZ]6]B@# 6OQ5%'8P,F-2OD'ELMS:]EEBD8(1<T/P8]RLS/.&^'
M](#YTNSG%4[Y1AGI]-SI7C-S@13$L:&T"F9D3[!=I.3CVELDG>"6RZ-?'4;3
MX-"V9\)&FT1@1!=SY^6_J_GB^W^:3?/SFU]_"H,WOS_GI7BAXQ3IR*=[ZZY2
M:F ,_L!JJW2-FC8PQ3N(U_/_[5T3H6VDXW8?!AB[I:G%=WYC>NXW!]"&I,O
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M3N;):Q?.?3"CY!%]C(=->4GH7;L*J%RB"CA-BRI'4-%J#<FU273>(&B*A&W
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MF-A_A8SDBR.=0##33WRF;1T,'_@K5W18S?DA!>0&R,=FX]TE&<DE[;1Q:-6
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M=Y.VI1[H@3OLH, 5MGOM10CD9XZ=ST IC9$0K'Z"F%A36]#&20QY3*/'@C=
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M8<;M[2RC'"*C G3;,[4<M>U;!6JZG5S%QKZR,1<6:*P')&CD%2_60N%<>)M
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M:ZV#3=M(/D.*Q:$SE?.2V.>*0E]R9R"H<HV8&2Q21!61B>3U)"_*N#PUK\+
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MR> $^=U8<0^5K#"@RGOIW23_%R"]UE?XQ*"!XF3LI?UZMKL-<S#LDA:(2V7
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M*[]XH/4T'\Y#^V^QT5H'<S/.5RT+#*.:9&5B2V\$V\\R7\HD=R$IK\B,!ST
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MVMUF0^#>C_!^AI9SQ:C@E\&F"@8ZCTEQCF9;O'V0H'VVQBY2[]Z28 ]9#!'
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M%!5NR3J@9JTI9-E_??1R\M\_#'[WX[M(FIFB6 E5I!P@-W5NR,2[EH(CG7S
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MBZOWXZ<RFXFF>T8NVQRJGX%=NIUGG]B_29+)5$Y+TFP#-ZBANCD,]T_LG8^
M**9"IP)^* *FJLIIX*4WSM:/B\(^6*7-:JA>[X.Q_^P3N\0UB,SE&%GW:7,2
M&JI7\"0\OXJX0I&.S&4CCL!B48J^J0/(8X==*!0=8U* $%/ ^U\+V=05%0$K
M2M9S\[UT=MG<]6O(^GIN4[U*%D?IJTU>NX:LAM.^ZRU=4;(:3OO>3=G-Y_$5
M)6L)QFMOD]>O(:L1]-_UEJXH60VG-60UG+9AQFNUA?M+KL+O@>X#<N5-B;HF
M\OK21Z^)O#9D-8)^-=>N(:OAM.]Z2U>4K(;3ODOC=?,9>T7):L*M#5D;(]TW
M?P$;LAIV:\A:4;(:=FM2!SB]WY_<^*I7YDF2C\?^= UV;=/(:F*Q#5D;(_O7
M(6[1D-5PVHJO74-6PVF-*=OP^,J3U81E&[(:0;\.:]>0U7#:=[VE*TI6PVG?
M92+!IW@8^5,AY9,W2>-H#39JT\AJ0J\-68VD7X>U:\AJ..V[WM(5):OAM._2
M>MU\QEY1LIIX:T-6(]W78>T:LAI.^ZZW=$7):CC-LEA5CZ'U[5.R\F3_K8\V
MA?^%SH3H_L,-:'3'N("L-VZ_@(:$ -AV $Q;8-)R5QG )2BD!*=[?R-U+ZWM
M6Q,D1;/#M&AQAT8XTM=F%*3D@7![F]KN-J[3SS/GAAZ.XHQ^ECG#./*=--Z!
M4Q+Z_)*Z27%3>,?W!E9GG?(<N$]@D*7EB:!M.QH'CFNGQ)-!XS=K,BZ]I);"
M13/,XGE#,[8PR)HRN(**OY".LG^Y//[D_,+]9/6\-J13WJ+(?KX65^?$^*O.
M]<OJ[;9X_QC<SB\+AG__P?O\/YW.W@]Z$B>GGZZ.S\[;K4^G[[G=V^6O9Q\O
MG>/SMPY_<OK6N?IT?'YY?,)?\A>Z3YQS=O[V].,I_<_YR>GB%V8M#\OC6\3=
MT]]K<5.\B-JMW[PHYT;W>[K3O:WZRBWO[V(GC&ELT\LTE;:O5@]A5O#GWBBC
M.:I/MO!"](SM=7Y^#T4J?6=[W9^W7=&DI +;K1^[4*+\_\[$ZD-,LZ:?V$2I
M1L#HVINABX'CC6F9N+GNCSW]$NED"W)3IP\S(."II*JW;X*.MO3 ZY]LU1P-
MVRW2X33"?_(@$8W?QY^Z><XH#T,T:OTM#Z?.;I>7; _===*<B.0FOLX0KR:]
MC1ZQ]+ W&*!Y\Q"/819J"<J==@-1\Q-TF\WHQ^T6C3SV/OO<>GT8I%D2D,42
MJ-[GWE1]COZ_T1!]WD,_3?&=M!/.S-QE.C;]"Q:E&WX0%SD3VO&$C.4[^E^'
MV/U@?]\].CC@(T-_'NWONJ_W>MBF.,^X?2]LPGZ<)-S;,75&23RV3X)NQ$P;
M''I@L8F79(&?:C-9-]P6Z]7FV5WI#2\'GD[%A&Q..E+A=,<Y'@R27(Z\G)<A
M&;S$C=4Q/+;62R\U/2/5B90#].-1]Y F=RCS5'^41VTX\H4XTM8 !]HUNH.;
M$0[)UD@R#]PXXN;N071+5,0)'*)!F#-SDE_'W@Q9:*0-7&8.^@\::K+9+,W5
M20*FW%P:3)GX4"5Q56FT6V6M<7=#SM9X[ \#Z=<^H,=I:<"8&>M&O"-/<5K\
M+X,;+[KV'=5E7O5PASKH=G99OO=!:.CET0 2&A/TZ0.1E?37C7?K<X,TDKLW
M_I@[S%^3DKN&*!<=HY3+4<\]A(82K42"E=B8%:$>52L)U2R>O,YH$$R,DDKU
M%^^A2(\+16IW#>_[87RW+4?4; +K%O\+'$>?%Y+W(4]$/6-](APGTA"LDRTQ
MT0C\9S#X/\9A, C@[F.7/B;QP!_FB9*]GY2L_$B*GC;DBOS&U./-29?F$3^[
M[-BD+LH7.5F@_1@!*SJ?)@:C0C\IA[.&\026XUT""RTJ]*'L\03\,,4/4S]S
MI/<R"P#%)RP))V4VP?>)?QL0F2PG)_3]+;IRT7=DH :C8" Q(J*I,EQFL11,
M23(@%05W <OD6[9JI_8/22XG"02EB,=$WHDWW 03%Q_@@926B"-Q[58:T&J2
MZ6P/5GI)6GT+RV.1C21687N*!>V)V0!)&&7B8BBCG;1*',*8)RGN^[34)+,E
MG,9+HN?=;JF)WWC<S9)GR6+;4]N%3XE!Y-]C>B8)2.IJ*\:UE!9Y%Z0P4@DW
M7L?QD*>A HHI['3ZT]A:Y87GO:&9!VP#F<G._I!#=UX](4._3S^,2"FZSC7I
M7EH37ZBQO^,%\,>3,!;-0G3E_*.915E.)&I-!<J"Y?Y;)1O:K3-:B E,ZVC@
M-U)]%><R3ZKC:.;PPC/RL",^3RR$E6D66!N+STK1_AWG#8D.>F%$OR,A/A8)
M#<D=#,7++]\.D&%&-EQ$@J?=@IBFCV[8(M7A'=<^Y"ST1J,@##PE;F%ZSYG#
MT,\0,(#)F-UXF7VQ0HN2^62O:Q04,;$E15]EY[O.,.:H@Q*CMAR7]]W%>:@<
MP1%\5F-8^E_\9!"DOA99LEH9;>SP6EO! ](34XA;<F:5?$PG,.+[-+DL4!<E
M7K%0F#H/R^LG>T%#6,HXU6$D:TP52H([R@]C1?!+;4OS/HO"F4Q(0>)VT$GR
M4&EDLO%S-6VF!S^\/#U1Q/A.&!"KTB38'>>&L?2C<R\=>O_9<<XBQ&CPM2)5
M[<<#6\>NS)#C:AB";7BU]>0N0+2456JQ*%$<O1)F\8N%85;@K<%X.J+$C 0_
MA/V&$6EOF? @2 ;Y&-.!KIM#X1!>R9#I\&\]V4\].37=("F=DY6.S]?*-*+Q
M_WGURGD7^.'PK\Y'[]K_F5[PGQRS^:MSV/O9^9<7YGB'\^J5OO<>!K>:HDK;
MUS>S;5]E/N87!ZQ!^'J:O+HPG,!+CJ[__D/G!_Z;J!OHO\MC#.(PI"-+M.A_
M69UBT2IV5E$5B9O5=,PLGI2E<>B/^ ESI3][WU :CGYK+9Q>LI^=J^F$QC].
MO'XP^)G.R-B793V/L8 'A_93?]&/X:OB!E_?WO_M+[30=6N>^-[G5WV?Y"Z]
M?,)[IE:9IJ666.^V]0I[9) D.[IB7+IAMTC[YA:)Y.D_/YU=_;O=NOCC_/03
M[I"<BW>.NEQRWIR>G[X[.SD[?N_(]WR-].'X_/B7TP^GYU=KNAS+VLLE!J^1
M7Q&&'(QV1(Z1KYLJ9U<'JBRKR%5!X@O2*GW20CI.[(JZ4A%@=JY)8RF_:<N*
M+D;3=DNI?-A*$Z7LW1EMGZ<2!;M4(;#N[M9P>VMW6YMT]'F>B,]VJJ.%QP..
M$7:/=O?XA22P.$Z.^RHSK/UK?6NU+<')U/D<Q7>1BD.*GXNQ^GY$ML< 3A]]
M3=.F0<8Q7&%ZDS,*;CDN#YYSMO9_8A(Q_4'HI:F.M=[&&1N,J:';%8W. V4W
M,5D;1<H,GL"-50;OW4RTH".<,B6%<:J>*10^NYI?Z%G$X^EK>LZ7C]LM3Z*9
MCWL /B]OU8[S3W4G!0/D#L8B=CL8!;)36"GA(8YVNG*#5F(>,5VP:NV6;6M7
MF><QE+G8K[ZVW&V+GTRA3 4SR.RF[XV5:S$-+X3A!63V!!S1+EUNGIB/-:>4
M+C(5;Z;$G YQI\O_'6W+QN+?UX9=2SQJ3Y?O!3%?.[FH<?]7;BXL+*-\W)?C
M/R>[[9X3JH1A4'+R"E]&'!C%+07?&;?%.BYT=N1R.?)Q#>,E-"$.E"&VR"=D
M1F*Q!SA2\4 YA<3($Q(Z.-6@@0\K$^'6/RU"G$_.U"3&B?22B!F_P0J5D<WL
M<Q@.OQTJ >A,XCNLH%P^I1G[EO*9^#=I; U@Q>(P/_+'<R_DE_.2(2^6QB<R
M!GR[SP>+)%$:?"'!N770V7:&WI0H'M&"U^BL[(;DVO6L \P$\'[&$Q%<=QPB
MY8BDK!Z//2L1(=9X'_RA6]IVLR#6M#'ATJILZ=5*U6+RIRPMK#@#^=RD'+=G
MA"9FH?>EB%@KP5Q1\Y*KP%O*7(9+/+D7M!9??,8ZGA[&OG @'-\LR'+D1Q"O
M#C77EEB0W'##1<S@A:YK!-W*S:76*D30))UO_('#'I2-RN+0X0RV]G"?4"\S
MMX+M=LL^03I*/RV,M-+K'FFM[?^DA:R=DF$3^C.-'6QKLXJ-#;D2-.&9\DQ^
MYH-,S]!#8ED5MI9MQ5B&U)EE^TAD""L=UPM>LXYTK$7)3'GXXB*:%_PF#H=Z
M5-IG3UT*&2,IGU0"G*,\B8+T9E9%D4@@<I0)5$>2,H;:+8Z$3K)TGAXKVUN%
M$53H-ZU^)-RF](]74I8LA/2E4\WFTN9H(YG4X$@8RQ*[A5"UA:V^\#=J3:[V
M('!I+/HEZRYU^83OU,-J9GI MZS*VJU%OERD=+$6K!T?7A#QLLR2T =:C987
MQC,:U-$*M)8!E58]Z+ VM7;L$?O;;JD]+4X@DMX5%2JA[A%3XF4A?\Z9\9\>
M^RZEA5A 661;!LR-,E=\?E<11V=/=I!' 7)J+.+T!> .)N[C*IF5HD[WJ#<
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MR:=U/)]K/;I'[N%^9W5VYQ&,LMQC\UL^)''Y:QP%@\]D/RUC3UZOUI9T5_C
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MI9)JK81%^J^'I% N=R1NX"6F_YHF%".T&V:T@'+3I7O7Q%YY*4PY)O*(:0<
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M0%H9(F,&)DZ5RM>BT2GTP1H1FW"XD%Q]!: GPLHS/\%G(Z3)><ZMAW#3U!D
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MXOQ3I)JI-G1->TJ[47HQ/"-+*/%1'^]'71M[T$#STK$D]8+,]TW%EFI_.=9
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MF;@<MB8<21I=VLL12[ZM5413(QU,;IA-V$[D&)T@FT-,SF?XGF5%K%L$VY)
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M<\A*B ;=;)H*?A5>L^;MZ;17DEM+UF9O_/?LX\N-DKG,1 C:Y<:@%1#C080
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MX%P<P[HQ!+"-K7.$BM:=%>5KIO&[<#DMLX=FH?GP0;813$(B[J,R6F%-GB>
MRY;D>;SF#+-6N= RBE</C[^4@VNG?>5V3@RV\EXYO";S:RU@)U_FP] [I58A
M,\K_B'%R371:*XFGE2QHMK:"%;)(=&G()0KL;:N0$L9ZE)5H6\58E6J]4"^>
M8JRH.0.Q1%^21 /B*^^$#&?KO<\T2:5V=Y:Y>_\QJKW>S91M[B CV]IB0TX-
M$.B.STQ\'( >/0V!C^>>@XZ)_;(Q7&H\PVW=Q'*HB]*U+!+O]+\4S>;3-,/$
M,^J\'!!'DA&'-JKV_#=_"(DE8?"<8FKB[4O/<X>PO\FLRP0#@'?E <^!<P?(
M>$;&^#J$2!?=P#8()_L;:7#@%2&<G' ';LTIUX)<?YXQJ=3D1\RK]M8I5!^+
M)$9Y9H]9>7I//EZ=F>?BTYC,$K[V5GE;PZSG>/O78R9?8#B%ZT<PR#I*7O=6
M>D_WR_D?5?OEEW")9_9:,),\9EK]X4U%KZL1V-0HF62I_4SBH20+FO7]@BUI
M[#A?08IDT?=ZY2ZGF6NF_%LYZ.Y(VV>$N,/O56W70!)?2=XJ$L=>;)'/T3G^
M&!>>;4RUR&PXFZ;YW [S&M8/-?/B-N^5+@K<]5V^UV;NY1\WV\P V5$3+Y.R
M4-R1["J<9:<0>P,OP]%L9H=.A'\/U:.3:3J#-&$J%_G^PO16R5[_10%(N>^B
MX/J%592<H O5QV.H-]XZ>9%L3@U_G'N;+Y=A6!1>;C,Z\2A41ZSG$>$NU!23
MH=FMBB67.><[F_4$!R')@F:]=U8>#*2^V1B4W_MX]&\+^9X-%5@/_BN_3.17
M09'P[%3#U.4^\DQQP9PJ^G_A^615[2L3T+@E:U'@%3K,,?K&TNX3CS48#E]F
M3\\U[5J.QQB$4OR$*. &2A99* 2L1 V42=^<$+!QLAO7X*DB^4%R27 ,^F>-
M03@\8^S-T+!9.I^/;V9=HNU,0H\Y,ON5R=)\.GLR7A_&>,U7PVW-IDU)ES5Q
M<:R,Q;Q>@2!"0AJ]/+;JOJ[W9K_%^^+]-FMKHC)6]7*'*I6+K7*A7::J=0K7
MM!3J):I5;G=:U6*G7,*_.W"*:[]GM3?;P:=9.K?5'=BA<XX).)#H>[M8FLNG
M:3ZUS<"2*'J[3LH^MOZ+O<8D<KL[^_V;G_P0KG[7:\H!U?LR=4Y=4)?EJVJ]
M#M6*C0K5++>JC=+Q.Z2'<ST+1F- +$/J@F>VOH1B.)K)QSS*[W2"JTZ0V^T$
M,YGTEGG'4\QP:&ABCADV-B/U,MQPSM*_6[7?^2?^S=AFA-X>3$D9_38"(\)A
MQ2%JDYXB!4'PGU#J9_E3]N#91F1"=KJ_2^7I++/#[=WIZ':Q'3NEFW@&11_L
M*?KX"&:#\YB-]F0\)OMW!078KJ)H;U65, DZ8%]#4[J9U\V;N]1C)Z;6E?#:
MOEFHEJC270N"A,YUV5+P5*71^BN)YY L:,)LKK-'4,LBF;+.=F>Y'%\J9U*M
MJWQ\>UF6E3#9 &VTF_V0]B!L37YFZP'Z'P'Y2%821:F)$BRUR8(FU-)7;21U
MA'>H#O.HD4[[[;7V_GS#<P?0(@ 290),'T>(MMY-\!&03YTTR(?2(-Z41EU3
MH0#%G=&@BDZ=6-641OYV^]IO_>E[_7M1FF[3TK!3NWW[KMFLE6_+]4ZA1E7K
MR N]+72JC3IU0=4;]0OLL7K&G-5+@0WY)\_U)+3'= #![6JXIQVZOR61)0:?
MO>?3C>F]\B[%UY(6()-# 04,N).;3$?I:ZHJD=S,FVP.-QXCMY4YW.!R8JU-
MC(%[CA*GI4D->Z42Z9(TT,'"H 6G[]#;J."NQ[0CRXXV/[9C-LSW7V?3;/KQ
M;9LZF/"LZL)KS1A;,6E F-^T9&J^B1T?QK/+<A_1K5V^$7QWIHVY^29%,ZD,
MS<?4%\^ZXDLT-S$A%4TGDP4?)=5$/QFR:*6YB8A><8.[LI0?Y<O;+)0/D9)<
M9UCP@!P'0OC1!3'Y[!A6%O>Z\.SPLAB. V,>0L&FZ71JUWJ+I?UNMK"5%7F$
M8BH3ZQU_BZXNOZ+?OTK^?;-(Z"KF4[_#](WA>VXO@WL64?1 #2;3/X%"="#?
M>/'L4?I#'Q&GM6LS ]D3EI@A",6" 0WF^'9T@GM4YPTJX>/F=V-69?(_[]7A
M@?BX%,BJ,,T8XP'CKT681R7:J 0ZB!^7#3XB3DLGJ2UG[:G-V,@8$=N$7,%[
M0=<%J [ 9JJJ-O&WI":"'-_G$A[_??TP4CL];MB.8+![5#P^=3D<_">#>%00
MWKQ92'GB]C'!BQK;B'U<UOB(."V=7K/$W6]+IDD*$AH#%.U@K>>=]S9C)^G1
M4&D5L_4HQZJ&\?,-!S10PX(%W.[#-!+G\*XX@]AGW629"&:O)?D40L9<N5RT
M2\ 8W\6*:9^VE:/-M'\_<G??^^TAO\\D;=#N!J+U#4'!TVB1.9NV@7(?5T-^
M1)P<'OS3A(-%/Y^?_3WV7JJ16WJJ(X^0DJU+;U1+&PDJ37Y!4VWD-0R^42-!
M?Y31&^"CSG]^*/L2),/F! M?VPV$D:P@_EWS#OQ90YY)!"07$4OVQL<%?6<H
MG9^!<1JA)TYAH O)(B,-CUPLG#A^U 7%V:MC#B5#0EI8F(@R!-&0PH(."1Q1
M6U-AT,<-$_T"C_SY>JR4"3Q7!/__7%Q0%5E2Q+^HIO"(A* MO4PDM8^^F,M^
MHWX*R@2>05U<V-(IRJ\K9<K7:$)P=3Z1 5#^QF*!<%04JW0%VT+X-X*N;__;
M_PZD7A5A;"!8[)^^46^R: X!0>:/ (Q7W).:VCA(<2R1<'(8OM=]^J=RX26=
M3;1O5&<Z1A 4=.3L][]1=>1F$,+6-2!AVONE/^UOP5]<U6&KC;__1)0.(KHN
M"<\7/0GY&.C98WQH%ID17A:-[>/V/,+[9H"('.DN+$S>A^N-YLYYH09I?XK*
MMOI,JMSM@T_&I)&1[^*?LCPR]]D6*_UXF]VD)^XVN*/"_.^>]3! ];;=99@T
M^B4A1+%1KY=_%<[/VLU&J].F.N7B=;U1:UQ5RVVJ6B\B_=7[)S(==F@RU!N=
M<OO\K-.@$-[M1JU:*D#_BU5@4JA1[0[Z!=2FM"/%>\^Z&V%J<_LB$B16J$]&
MZ,O]T &*9/2%,>@Y?8+"&G^_1D-_%%1YAC/,1<<@0D&\*C91J 3U\B1G7K$M
M9-LQD)!X5#1CHDL=!,>E G=S_WC$,L<4/<YXU*_JSJKEHOH^RI0:ST];2_?*
MXWU"H;L\F$;-R<A-.3]C_Z)<R<;4XHK=6;[]]%IFRXU7)O/IGT;KJE"O_B8E
M5E!-52]T[EIE:/2ZO&M7Z^5VV^&0?7%\/"19SO+'@X7W2?A=(N3^,$O_A=Q.
MY-@HLHK"1:\<.-@>*=+[C"!B +\FS*3W\[.JVO]*??Z__\UQ'/,-_P[_S'[[
M0KT)!HHDT#F.X2A1H( /$F()2A'>#"NNH+"B@G_4I5=!%&"VV/>),J58CJ8X
MADU_I1HJ59@\(A0HCL>_R]/XFR/A2=-E<WI^IKVIZ,GH&1@""EL64@"C40*%
M*Q^HYD3O#P44QA0>=8EDZ'"-5UN!>UN=NA0>J0*V#@AN0(M&7RU)"%2(BFPT
M("EFHQOT31M[^OSL;2CWAY@*?F659W+>(70O$X3"K60.8:8(5+'BG!H@9 SE
M<5/2P5 B/[0K5[MC6>R*X^X$X2*!U\:B9W%\MVOHYL5%NS^4Q(DB-0;!SUS\
MK22!XUUXEXUNUTFU$J003C9*B!:WTJ@GZ=U9C[D9IV>-7ZDALHVF; (7N1#"
M 6@VX&N';X7%.ZA5D<U?,+D+A#F!NKL"Z)!)QFJ]@NP@BGT@X\9Y,HY ZD__
ML('I1BRZ?V"<\7Q4+T/43-$5C/9ES6$,"+"KABY(BDQ9 ?A7Q&\+M8=$-H(Y
ME[9?=7[F8UMG)^X\QWDS>Y<3 RE3P_ L^R6'85<,66F_AHX7],!]Z 0HV1AX
M4\"8%STLZ/ZTZD7A><U]#(2*C4$!+GT>,?9S#P$:V21R*&1S[/U]UAC>3>_5
MVL#A6((.<*NQD+_W5'RNX^!HZ!B4++?9>R-&=SZR@AZ;"(,C 03:3_^DEV7=
ML1C8M)S?#N8H9:#N?^;Y\G(3OIPG)TZZ% P8AX3X$:G'?@ 3[L(]$;'R+%UI
M:1UF-FIJF0 F? 4TXN+!E30+I5I7$2@R];LX>Y?G:(X/FKR+N0T[!6UI;.*7
M4&S&]@N0IJ5,=-;&0-*Q"P#U$+91 6H'*T[D)Q NE55W[BF<!6CA>:8MN1>3
M?HFV1W]YE6.>S5C*$?^T+TO-IIYF*C-@7AZRR_6>C:FX\N)O"8[+%%?^@LVX
M/T5LH;=72N1X'0.I+?B47ZD",J 4^OA$\22],3.1IR)OV/)ZB<6?YXM4A&[=
M7IGEQ_7E^R3%7EZ_R0=WZV)@FFW=ND%P;  U** 6#$V1"(,--44D@@7J)Y@Y
MLLN4!M!FA<+8P 0A>-HN.-H  1.M,U7[+;^_W=7>,H/4<J6"T=] H6#\-U0F
MRS%-IA/T61B/=>T=/=F44&@[SQOI)"N.Y;2>O=7R+]6!*92?I&3IC:4P1Z,V
M<D$#THC6^.+8FJ_G9V3\)U2U>5P5)X5!+))E3;&C B0!5\2K=B 3<;1)HB//
M<374\[-&W]3@W'C6<3$#C8+M6 !WZIHR;SV*@BJ( FTEEH(R2.033O9,(+^0
M!=7.$IR?^;)I2(3JVBMA*L)3V:]49XB\?NH-_I^J48)A2";"SULWC'S:H8RD
M!,!&4-H3H=#/UDZ7:3#H)R8\(!-6I)X^$?0I^A6<-,<LX<*>U,<J)"!HJ41E
M8SB&X5AF?\[I[Z>7RM/D,37[]7Q0(\,Q%PQW@3!/AG-J9[R1::,I0='41RN=
M35*-;/:;0;TA^X?<#>*0&I.>(2-]HD_G[(LIZ:JE \[//M_=?*%J\@B7^02I
MJ;L;-Y/I9K@!7RNJ&NNR0CDQ%0K3 Y@7&-2/ 5:;<F\"K_6%Z'<W\Q;1X7:(
MSU7-WT]W4E,'5%/?)ZI$<=A0PO\//+2YNYD1%AB<G'':E<=VOEOPW]04D4NG
M(*!:$U&< E=81A<]9E[;E2/3=BR3X=A(M5T%ZF QL[:1+3>-]M2 026U6M&.
MUO#+.J#J&H.J*B*K+$X$Q?\4BQB8%K:J3.7>&*Y402&5>%A5R5XPF0M$-DM5
MKL78^MPB3OO2I(#3^9EA"L\2I !=@"D",66!C+SV6M'1BPL?LU4CUGLEJ4^\
MLS06"(ZHO2)QYB![L)@D*$;&MAS+H;!RKVP[NWQXRM9^/GZOOPF'93]DIJ''
M-BS[1<-DV: ^7#>5M, KYV=0%0]J#%M#749*&VIH)45!2/JRD<C F^A3\/^0
M$O;SD=L'2"F:@5=SX>248 V#@$H*3['N A@G@YD$OYX+4A%SIA+GEI8:QXHB
MOQLP]I)JFE/:?_U\A61K(/0E5SUYF.O\S"K$6/9\FK*_3[UI$Z2U4)0!(_*$
MI?ZE]4 +CQ.')8+#PK 8<M+ 89MC+:>_A@0+ DEI^3C,^8B;OT"ZIZ4-99.Z
MT65CJ H(F,_P:CNF</-SAA6P4"UI[!0SO@9SJ\U;\Y#2'BC#<:G#]T5/$8:3
M45EBL-V7 'XK=.^)Z0_(]+?"U+H2GC]$;[95U$9R7T9F<J!K([OZ#(F!7?-%
M"L]P.)L-E!V<W<6GCQ.WUJTQ>D(12GG>A?,SRWGL2/VAJBG:(R3@<,7</6),
MQ= <>+2)CFQ[_QEQGC$=]32%MN4$;DR^6J)PM(?R 7@*Q[9L:@TCK,JZX3LI
M2^,1_[8EP3@G"?^A/59DD[CN3(9-X4X,\M/LOL35LJ+<;^9EQV]>4<C.0?#%
MIMR?Y@O70P""8J8+Y!1?L,SYF4[^:%UE&?!GV].UH/AGKA8W,L)#B@ERV1YJ
MV\FM\S/?#5M/>D3O!&=:%T0)-#%8# MP )D21. ,*-03#!GYUW4-"3YQU,'M
M)A=W.'.^?!X@P.$C!XH9R<-A[)J"'C/I#[V/M7,:UI-Q"RQ4PHYMOU^5!)SS
M ".%_K5PF>J_2$2F$+U$EP;H86I?,JRG(%,V,5'PJD*3F$60H8!L=$^25/1Q
M4]>,,;F)0H;0(03Z,GJ4 NM^S:%L4 $'C6\4'$8G*@N%$Y/12" ,/Y[T%,2&
M&A(!';T<&U47=E"SOF.R[\X5&4]K#?R,947K@B$*+Q_,CI)&%.D=EG5(_ZSL
M*LR=N@HC[BK,)*RK$&M1FQ<B9>Z3[9ZSW4CM<<0AY!?2)Q)2B]B%ETS$:<0;
MA(_4+!WU8X*@&R .)KO/2Q)T1=L3/HB60GI>Q!] 'R=YFB"#97CLKAWR2-C^
MPA G70)GD=@=T(GHM>B?.H*\A?\">K&BZ2.$U\4/IS;QQ?G4&*\E11$=&)CO
M@HJC/G)KS?&4*(O0XXUB$U,V!BCX@2\[BX$<?:Q+.*..L2/M&A:"-C%:$Z0\
MTNDT\[GWY3/KW %9WS,(]@)^'KX,]Y& "J# ^9E%@IX$62Y%$I U7*@37I@>
M['-?< 943:L9JY,UR]DU,"UPKTD>$__[5E;ET61D9RQS3Y>/Y7;JO3 9.AE+
M[^.MXUF7K5R$:/EJ+ 0:@J3K R1D O(B[>0?,PLS4;XN33]22' 4W+?B";^M
M]U/M )XD*""V<WC!#<51C Q6 Y[O%R2+P<[/1I)$^%]0K)O%5^(,6#QA2/V)
M[M0BJ.C#,EFY@ 7/8DGL&SC;JD \K&!=M)J%L!.!!=;OHD""5$'LC>+\D6P2
M'P6X4)$%T/5CQ?(2T5>:@BHIV".9+P9%\N+H!823W+=C1"(+F,>1TS=$8$T0
MN(HC;E:2)06O$"7DTL#L>>A8](#@.)*;'<$'<X2.!WQ<4H-.$#VN9U?53'1\
ME/.J'ITM<L]!D8&+A7C TK8>?]91A2MU+P)'1P&-K'IX]_S,X1Q0PO06/(29
M?80>:P8^6D-/=!1^$%0G'CP0^,CNGY\-)CH^(%%"QZ?@;*,_';EPMX.LLT2B
M16JJ38 A(<]44)&R4@*\BAO'JYBBJ-3R)*QZ#H8^/R/>TT!6T*_=%C57G0,,
M=GL B,0(!=)X^JJO58.D4'A0VRCF=-]MAX9K9\L MR(Q0Y^#V$#'!D'%F$GO
M%M/VK%IIXE?A$)<X5O"" 0IAM#?X&'+DA$==& ]/C'TXY7I^9FM/8O"A'\_*
MHV,&!?TS=K27::=2I\XA^QT V?!7%V$>M0I1:L)$[2,1LKU6&>X5X"6@KY%+
M+*DJ^E4/$CF*]5'@H#<4&V,7Q"2_,#3$D3B!0KX@]/L(#$VW9<"Y+BM4H=FS
M, $O #0MA7QUB"1D*S.$W+)''((:)$]L: ,3,L_$7SA=G1V8+ST.Z%Q)+*GB
M#:IOH@.K?OT%=+15M.=E%=)CKBA.E@ZK;5T2$5N"RT%Y?'?[PNIT*W <4RLN
M(>&,,Z/>62VG^16'EW#?"#SD4(A00!%BO-U<A0.67NOJFO@9\&!==.,]:Q L
M=CIT%._*8RAD1,H?:1@%XE6P(6./DW*GX@I</!P#O\Y2,&Y-1Z'07'E#[FU<
M1#ZCT=?E'H3#/>W5"A[FL7=P1KYF$-(RWC$M65[:J"?#A3IY:2P:$E'%JR)M
MYY0DN@P[TP6Y/2?-!5^ BR_B$_@5^&)1'WS:XT+#U0]!D4Q5]VS.]AD#F7B;
M?G;P9RM([RCZ&_&,\>4/+B"0YVH,, Q.I2#^C1_/.32Q%\Y]K/&*QZ,T0JO\
M*I*K/BFM*C9^5DL7;![R3:(TDOLGQ7]XQ>_4@U@"CF]2^T@##"90*S32D/JU
MQ/!1T5!$X![CV#I&+/\3HD0@7R_C(X=0%/[E!B=5E>2)(*&CBSCT4"1R:VM#
M 8E$-Q\$>2.(.. Q8UT3)WUX.DDW(B/S*FL3 \$(6ZY1R(%,##)8DHY3.B-9
M15 CQ:5/QHZN@N<8L,(=E[_(JC]@.C^#!\$K<,B%J([O.L!RV49N'G/:4I/D
MM@.IN7?3N@V!5Y%J"/L6=^X2Q&--<>+5;3^#.@-L26@@0$]"6/1-;(![4^0K
MCZ#!A01@YA"]V+":2-2+1PW@L$X)O1QK=KSQC*2YX!+[WJ8YY24YW(=XJ8BI
M 1?;.L#GI2)ZG/=0_;!CA3]O?8.(9D+ .=8, Z_EP*4"WI>,!!0"]_O(LL@J
MN9\93,P)M//A8!7^;/$8P+*4D)1#1[PL 7^W;U7$439VI\!R,_ ]4R1#7=[G
M3Y?W$5_>9_\UE_=+>-"&Z]@$=AN?J35!2A+R94B#W3WK2(W#OXJ:.E"053AV
M!^IC#.VL^JK+G:)(^^@JDMV2B4_Q4E($?4(JO2QK"_?2L@G?%N9*['"L3/H(
MR.E+I&(6<F2*9DBNAX9+SN K$W6 PBOP!*17')*)$\F^Z"4@75B/ L< LY'C
MN2'/S.J 1[^P' D=4<6I^<!OQP5UF@J.B4%:536PU-;3G7F/,O$K'#?"NG1!
M,1]$^AZS;9EI_&Q1PU]"ME]'P"M3ZV6^D-,&'[W5(J9#%"\QP+GIZ9H M1O0
M^@-%SK;?X)2V6"^B^KJ,:R$[.-LN]0%ECR.[VH&#?(E5".!) KA 6_$[K&>G
M!HKV9N!\.Y00 JZBA @$"_KPUMJ@^WT40 >N%J"NM3>H5*3M\[7\3^QE8Z]J
MCK&@2!-I?A'[<<2')!PF W]#(EXU$.;P#T1<_($WV8";,[@K-<A@!(DFS[9X
ME7A4^)@$][ %D510NCXPG+V#!>3UU]",\I/LH_EI\W7#T4_E;D]Z4 EK(G*7
MM$G/+/2TB7D%,4(1+@QU==F\;>_TKO /Z<ZT],-]_OWA.=>7CF^2-K<X2?NR
M.QN4*W+Q^;TC5#_]<]6HUJ]@;GRQW*J?1F8G!0N<Q0C,TKJ%WTCIC05KV)U
MD3BY3_B7%,';]Z!0T3*2C)6E+$B!*NC]V&"2N3*DO50V^D-$ 00-_,4[:<;*
M9*M0V@;68@*:$6D[)XJV$YW@CAN2A-]$0E[_E>X0#UV#=/5D-"%;7$4)KE%Q
MM+VR5K %M1*J))8%786L0<%]1HD\HBO7JUU1MBL'8?/%J][@,[5FFF_WG:K
MPN++UU4%KG_W\BK!39:C0<[FOY\N%I9QISDZG<_2_/+&9'20V-WVY=")"1JA
M,\%-;9*]%0B%@?)8\%Q1B,@(*]K8KH2%7[E9KP*^ $%H*U/L%^*V"MQ]9^E5
MO$W*A.N(B>G+ACF>AKT'TLKE0'*,9%I\G(Q998FK8/M5]L4%OJK!W0_DS_9.
M8,N/@'8^<-/(>RWO14',[GB">*<?87Z+=X416? 7_%FO.&#W9(1O&J".3(*:
M ?!1C"%V);RRU\.[EHC@89]A*?)'J[\^0A(Y'(,"WXO2&*YQH*AZ[/>KK3M
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M$85',JX@AGYKR%2KAF2'"!+TZ$.R'V%.SL^KCZ'.^?R,%">3O+,-ML4JQF0
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M)>C#'K/0>" ?::<+<%)&9T3>FYA8Z.H@9I/0VH1M(<^<&G%YO< P$&%A!$2
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M-IA,' :B_ID'Q?ES/"C^S[X8".Q8"@L[W)'TWLT=1R\LG !G2OB$XD[;MW/
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M WN[[!K7"8I#DE+HSMDZ_ALSVUDT8S+%,?PJP]S=@?-IZNSRBC6"U6U7-<Q
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M#A;.Z85=-!]!&%M#>$N/G<>$XB!Q8$)\.VSL@3M3IK'K!H?]PM;=B=]X8LM
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MNPRB7#U,+3&\7XGD&@[)RJNO\$)*1F7EJ3>89"0$=-O"3$3XX9?-Y?'@P3[
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M/IB26*"#>7';P=RO+UI.!_/\MH/YLI,<5I]S4^]:MGNCVWT4M'$I-[*/'OU
M8URQK\J%<3=;TC*;EW)3G$RY.6R,_QRGFH_?;JY&)>W3U\KEQ8]J[>84,VXP
M_:8N\F^VF3;KLHJ(3!ON*!%N!O.J1/;+*A)LY-<)+TZ\[TWR:I1M6LU[(V:!
M^S[!-@EB$3F2'<^7714+[G5F3HXD3Y^N_H)C]/O ,TY7!0/2OT!,%?@%(C,F
M_=M,!^W.679]A=Z'G%T1;_;-[SJ]ZI1&2O&X;#Y5X'%9_&N<MKZ=WSXXQS^S
M#T&CO^4-/(_)/_\TXF*L^;U4P?]KD1MKSRE@[T&/JY0H9.*#:VP'F+AA6^*"
M2N2F-U^&< PF'*O"(AMPIV+B@NM<VI<#<HVG[D5J?'O\8%_KSYU"W%Z(N3/N
M>/7.Q,WO+38IDTA/3T3Q-R3JW$5&2 ]G1DC+IG9A,6?+=X Y_?5*[GOMKG;^
MLQYQHS!GUM@<;XU+\%B I!.N<#&;3X ;/XV4W)-%]"TV1;Q7\\)4"7Z/%HNU
M%9_?<VMZZ$V8VRU'%CAL72Y_<'%DC,\OLUV/L-Y3=$^A\0<7"R]$O#F.N*\J
MU +AG$['WWJ"J!CZ,_'6@@8"$C6>APEF44*^TH2!@W^ 7AJ2A4+N*U')P50A
M%F/ @.1 MUDSFGGO.],?S<Q8O;]U9IF=6>Y6-I A&_'[QOCFI/FG=UP[4%NY
MS?.V2I/>5J8Q=M72DYMYJK3Z15;@L/6PUFX5,;4,*_:JHAVIW9VM)_61/2F\
M1V-;D6+:)A5,B43UYJ<SAC(DI<Q'Y0DOR *)GI)7Q8+U5A\,8+R&HP(9&F*:
MG5Y'^YZ9MH=#&\P;UD.)F:*P0OJ*0>ZFDME4DHQR_$M.8@B:'L$TY"MO1B@Q
MN>TG;K?^_'RZ30_4Q^2]GW!77\2,GV_ZD39["F_04TGO+P\,=LJ,7V76Y^-Q
M7[GO0OZV8 KRO,0U#=V=<[^7RPF^_Y1Y/BT3*>CI7-I&!W%*V9;YJ=:7;:I5
M&!A:,.E\!9M^U7F^?3B[.*CHKT@8GW=%[[+U\8GBD8@&/%/<,XXI(9#,XY[E
MH,<!HJ.E"[>;>>3<@-;4$=<LG"M\?WA_=T=R8L3WXB5, /F2!:D$_@TBV7:&
M*GJ^.E=W['?B6K6#+4@4!];G>!-B!S8HEIX,T'E-M.IW=RAW',8RIQ?1!!FJ
M O[WB/5WD[RFI3'A1?&ZK1F_V]?'@7MU_,G,/--I$XUTLI;.95& &3,B!A:P
M!6V0"9/CWA#:"2P)PVA/V6?,\9^RA_'WZ2O>PY-D_Y=U=%2[-?Z.+91-!CI?
MI!"\(Z[V=G=BXG=!E2&L1<UH@_%)-YM-W7W"2"UYRI0YP1A@(&K (F-*Z??:
M^=^92J_SV.K^=DI_Q=8+,P!$=T_#)(MAC](M<#?,-L&U[^[ ^] I@+T7$EE'
MY1$J-V)&Q-85>$^WTRN%0K!X5=CN<H1]X$J!]D"I.^PBW]XA'6;\06=H:"H>
M8V")<KVB%%.YO2PX?8<PB4<5,S79 3[1-5AR)\$RZC3=Q7HP,_;U?\ /-=H&
M?(\2 ]G('8%-HH)?VS9:%%\+EID!=UNA12%TG.%*-@6;-9]E8G=GVAP5:8J&
M*_#PJ7)M[ZEK]6CX1\.A("T[(0BG;RIX&C4,\6G>Z)0PQ+LK@"\OIVZ!I52F
M9"-%!R+ Z6XI+2 Q'$%X&CB@Q50@F$Z. ;NN>L96:)Q$](HQE-DTVD.[153Q
MK+O0TVQ3*(Y)L055<?2!2C6ETBIZ'&9F)"T8./E!U/3!7U2-2JL!"F*.H,KR
MO#"8BL8D>4A^_A2(F[V6ZG25#F5@V=2% \M(6IC20VE7M"SV&$U,_B5:HO[\
MMG+E'4,,S"%@-<C^:0Z&&G!;.R8+JD_O%G.,[L 9[+#N7)K59^2=H>%T6><5
MK[ ][!^.R\D'^ZQY\_3[7O54<_!IG-X\]>,S)S"?;_<:I9Q*E%)1,(;,'A/L
MKT<N;R+#DDO$2:N+[5PX="."0FW5L'E7D:##Q<,!,8G,\]_$,M,G%;V=^E52
M'PYN.M4_K;B+UP1/#'WUE2N?R*JW-9U#6RMV6P,A%UD*!LD>D8WJDX0".0&U
MS;4/C0&:"ZN6>3<8KE@3*%J?,+]99;HH2NA';G8014H\).&1Q9G?/TA1PW1O
M]%;7-/X,]5!"^N0/V%WXE6U@_N>YI>D]K[/32;5]/JIWZ\V2Q"B32YC-)1$K
MF&J7B[ST^6?[&MY!D3#33D>53T=64X84P5%9UBVVY "S!0-]S,0:L+DI?9S<
M5GF^IU$^*6<C3V!DQ7HY\@@>P8B4F8WJ2GP8Z+L5+$5[L3N<[Y?^] :W/Q^<
MM'?VC@++B5K*_"<Q;B'SM.Q<B;N<S>43Q5R\9IY9X3[_)J67M4FIL9/+'A=.
M5*WS_IN47H=-BK@_]:K.WT@6BJ8D6U$H^1%'>M-F8&HY >!"M7.FL'H<0^/Y
M-9$&25$Z: >H_W3' ?^C:9CT3$4>@(KCP!ZV=8T0CD7^7QJACOA?N<98O3UK
MURXN3U*V?W@"X\PZ)PO/(R[/+[V7RGI_Y5Z.XSH#:BK@M)%A.=*U!%5>@D/G
M3Q8^ H<?@_MH0/(:2!8ZP3Z8+.ZWNU/O@96AV\J!VE$JK%:212S.SBKPH/+#
M0&8S5! \?0,]%5_AM?@D/J.]FD[^RQ^W;/IWZM]_>$IP.[+3(4'H)MB6(:I0
ML%R,?)S)"^J,7X=Y04'-RW9%%'@>6Y;FT#WE$&_[8%'1'),=='YF;ROW3W</
M08YA*Z?]B(T54]ED]*N7RA?!BV*^'DH G<8:-'5R\GG9G#.T!SVJ=N4UN(DE
M%.%^Q@HN4>?-,["#+ !L0B01C! ,!G9!OO,R[\ALX<Q$L2VHIACP/!\YA/I3
M&85.NG-?K#P/_+2!FD!]<OQ4GKT@:MT\1;(1<YBO9_SJ)$&DGOP<)77GI&<J
MW#OY,7_23AT>I2_[G?>B9VIY/91SN5(BE8Q"R);I&4C^_&?K>KU_:M1LL+CI
MCE<4:A58[\EY;QSEYX71;I0+?\;7S=3Q..N=C LIKO-J2"HRQ)/>Y>+D'%Z,
MRS]#JLC1*2:XZ1-T;^DBP1W:F ,9I9MCJ'F.SX#%< BG72:^]]>X51Y=WISU
M3WII-1A,[/-'*7S]:8YD94XV_Z\@F7 82O76U!$F.>AF%$![]-1Y.T;.CA-Y
MU)*'V:3T"1D#E%I)X%4)^A6[.Y_GOS"?A00ZD9CU6L[N/)S^KEX[V9_?U?>"
M[5P*X[\8F?,?@IA [@C:+7 FI$TE+NJQ%$W*N8"OR:02Z ?XQ=#D )C\(9Z<
M%>#J($:E5/RVN^,C+!B.H@UU*H K#SM F6BI.,VL.EC K"IZQQ/_&C\_C-6C
MI#4LWKRG657TSG5QXEPO3?Q],'V_ %I$:8L6L6RTB,(6+>+O,UP#(]&[-+PK
MI&#2%Y;ETC.P^W9%=;I@XVJ/E*'C8^'$--[>& )L^/X1MAD:>NG27!TCP/Q#
M["Q7H5P9E6^G#TK-C A-=U6CYZ5&SWH(\XIV=U2L4NSUK"=G<SO3;S@W_&\3
MC)BOMT=U.*EB=T",;G:AWH;O23!5,K8FZK,4F(0-]"6L"$NRY(Q;R@A0CH8,
M<:)N]88L_'EV5O%BV_"\]Y34*F1WQ[?<O?(<Q$"<BD-:!Y_DLDT52H&KAAIO
M,@(.D@0-*(K"TR41F<._YFWV !/WUBT\O/MQMW*?.NF<JGX$'.?$T\.D2QS1
M]F1FM=5"*XHS\ M[Z9+_EW  )U?PBDZ6Z2QF^4PK^6\/*<#!5DYYXQ.,5).^
M V<2!+D##,B2E#PN 6[$WX9Q)KG3M+O#,T4%U\S"(Q3NTHU5;E':MC2)Y7-(
ML7MUEBQV?QY(=R0"7))2?L62_+XX<V5Z35O%>W%%(3<;40.5-!6Z8(_KR+V2
M+BW0KCN#'V,OY>5O3?5(=W]43\'2ERX\ _.;ZG;+DWLOBN?GZ*7C98[C*^DN
M$.,K>**FYC2^Z3%I.+:+A;(<8*(.KJ-J&U;PN:K:ZM[I^L.195\ J6^PO@K_
M+3K0C(_.]?'W7]WAW9_.QIPU\<V,Q;U84&<2V5)\32SEK3_!:Z3R=ML1M6OX
MA<-RYNG&4FV#@3#)-96UYIH;;^:@.I&B@ENT2N\I>?%P_= N;ARWQ"SJQ1>D
MV42I$"^W!X0,#$SB=R::I;PQS!KH6+2Q)O*&6_BGF"AM4Q63I3B@66W=0R'&
MN#KL+?&,Z5<_A_-+K";,3F66/+?%_+JH@#L0].\[5)RC\6? !V?OQVB]G*!"
M4H=\<P93U\,8MJWVOH@[ (:([)N1+)N"\#Y$Y:3#NG=A)1,%^#G\,?;YP@@F
M/%/BJ]O=N:U4(DJJN';$%EXPWQ:<+E=/,&!DROH9]N&?:'52?R_\#6&4)!0-
M3GC+[8WP2\,4_TI0VZ^>H9L*Z_C%NU\RZ&9T=[BI2O/V%[T])^\:G:CHFFIO
MXQ-K,_T7Q"=H"^,B%/Q+'B24PQ+T351@@MTH!M$QHP,3^7<*3-#4)[P;U;X[
M5?.96_NLN0&AB:@UO&=P@C'*O.$)]NO7!"B2;V)#1W/*KW+M:?3=KE<ZJ34U
MA)?)'<L)4J17$:2(WIX3ZWNQ6'G*G#W]?MLPQ3*I_O) !3M;4X%PW_C +"=8
MD:I<5Y^2@Z?L,+M!IV[MPQ4L 7Y:N**ZYIP3&["P1L7>V:WVI]*>[%.T_ASS
M[B&+V2I]&[18D^DO/VC!-M\/6X2\A+C !3@?],-7A2[D2A'T0JRARVJ 5 9]
MC;_5]('E&*[T3$3@@\DVBW?W\_@X@5 JKJMCXN0 BY0TJT4)H_ -%KX/V I]
M&!2.1^9UDU,][%7=[G,@EFT$97MH7Y#M$^YD.*70@'6<!T;TCE:T0W\F?E<7
MOXMQ[BU31S[I6YCP@]QNN$,&VD:\#EK(#CIY9ZRUO3<*M:0%YD0\(IBV.C 0
MI>U<==".P*P&Y<S5]@F?IR.4+G5@8^,$QBYWI/GM[HB?(K(%2U#"A7-W_+,!
M[Q9@LL$6>^'.<(3V/IC9('>^GGMS&S.X!653$QLP8=9HN@$_@AGWJJ!N1=-%
M\;1'4DY11E"D)Y S8!G5\/7L8?KWN?IL](=]SU&M'1[?'AX=UVH^_D4YEE2K
MZ!4HC)D9!.&_FF?AL,Y&8)FO:$<XHQQ%9D^L!0B>'M86UG -Q#@4:72^PIQR
M"CD(WE3@T2L>JD<+,K+'9S:RQ^?[\V5,)S.85T3]AV#4=GY8ZYY>V^VA'WL[
M$-WH&3I9 *5\IH4>0[TI746SJV1:N:#DU1 &LTHS@><^&R AGWBWF  ?BQ8R
M<C1NP,UZE*D"KS$6MC-H/J*]! ($!DDGD_\17[95%-B>_,6/J$!-,QX-C1E)
ML5#"H9<%X\@>PK#K_=Y3$-*+G%"AL"(1X)0=6>64/Q<L%(Z<4LA4WMT)SM%4
M)K0X*S.V6 OID7*A.IKZ)S$;IT5NO80003JX?O29*+=:2UTTOBNG[@;MT]13
M+14-F<[IB4XFL=7,R'D<'=Y4U[RH8!Y.Z95 5R_N%^.A1CQB((("\9DXF\&F
MM;*B40)ZAIT-.EGH@NC/NMTR'+KQ1?.)F3W3,OMHG@?HT".+ZZ9##I;$20<C
M_R<\ZE$&L:+Q]E-5_XT,F&"MV70ND^G9O7]^;AX-2VY/@FB0CKM$Y02'7YN+
MFY=)YLVPN*([#F1SZ42V&%\)[ZN=J"B%+'F9Q/8.#77>1IQ51BT]+'-V=SQ=
M-:_R45Z@>\AEGW[5N9E"OJ*YY5&W=6D>9+9"?F$ASW)P*&!$0(QML$SVZ$/P
MPO>Z:@^\VMS_^_]2Q1+89 P#WP^4R1K 8V]D1'8$(K\2/.F=#]']0# QXOH"
MFS/@1T4=(&PQ*_?UP^$P/;W=9G84AMW8=#P1Z.$_!E[$?"!F\RCVL(?=,Z^D
M_ #"<Z? F8B/3?&5$N3>>VCRG@*,283>>/]I?'?<M3(/#[>%@7][*1:S^9[0
MRZ]#ISL]?76$O-U7-5T)90_X+CFN/Q"'C0I^[^[X#\A<.M6AQP/.&LJRTGN@
MK>!8^,R#W29G8 HPE3-L.H9FJ+:!<)RRVW;,AK#L&&"COJXZ0YNC^7J.GXC+
M3[HH" PQ-2!6UC#BR7"-Q<D^9L,=679=MQ]AGQU9546<)N_BKDIPLA4/\2F$
MZ<I?,!%">/_3^.-[J:8?U0^_:3GO--Z%R#OK",Y'RBD',B\=2 $L&R39NAS3
M3**0RB5RN=AFOAQ"GS?\X?PJP[Y0\L_4$K8H2)V/QWCID\*C_>UWY^!&"X#\
MS"WX9Z+\; 9'38]S>5#8J@Q4JC^CDQ5M(Q3\/"0?D;3*'N"LA/!C#?^O-6**
M5.Y7-?ML5U-V-@K/FJ][:G;3Q*+CY [BG?E_K0T_I&9)F.UUYKLV+XV#I^;(
MXU%F1V4J5OQ(PA"N>)?6ON!?MS-JF_7QK7;?5G\7HB"5.8%>!3X?39(X(;]6
MQS>=2&5*B7P^OQA,]NM8) B6_?XL<G8\:!G'?U)'5Y'0Z&_/(C+L]AJP2#&5
M310RL2AI$6"9#*,["$>:$#%TN@,*NDM^QQFLLF*M@WCW=Y81B EM<V+O=W6,
MUGL.V)R]W3.1UDG6MTY.3<P(<O1#G?W_U(R 5?>VFW.ZCTE+&*KWY^V;;-/M
M?3]37]3_@BR&Q2829TY,MG%_82"@D$LD"^E8[1]H,!K;9FBJ@U'N8U>J,84#
M6%.?0^ZO7,$^&\-^)+'72<",SPY-X]*]/S[UNU#*JQ+M@#Q';*8+.XLDT[9]
M#=50H5!(I$JQ7$191=/H-?<I)]A$^D3<#0<OM$'(]%CJ/N(GCGQWF!(.'04(
M9 -AJ.L[YABJPYXK@KX2+B8!6SL&:[?'CFDDB'ER+JS/\(E'D,](^9(SG@Y*
M]0/S[%LS&J\SX4WGY<B=X=DL6<+,P.K,[V<S\>V1,;ROFC#V!_,ZYL=N3"63
M6_#&98,W%C\B>&,4L>0)P1 3G#"):KA.'O;4>4>RSC*KK\_U#IJO4NGU$LNN
M%UC:MEU-)(JCJ2O%.9*Z9Z QLE13VFH/)N[8MH8#KPZ;OGM='7;F=778F60^
M6>1F ?TUKR5,4Y\HWVQ=M(Y_%(U:]T=^H@Z;;JS?H.P:3(C\7K+H_R5LTJ@I
MO_BR))5+Y*=DPD077</&,G:0KP?9)_-67[^F[EKNHT0DKND:$D.[M"MJ#VS9
M0S#IS<X5=>8ENV 5/-)[=+^[AW>'WWY*"8>4M&/SZ3#/?2:KS+6"]V.1="J9
MR+^Z]EK.*R?'TJN\7O*V/'RKG%NG!_F;^[:W+?3"J5778C.\J;T?O8'<N>*+
MJJ[9"9P*$.?#UE^VJ9^7AWJ_Y&WHCX^JPUYN5*N6@BTM;#&#65L1.=5WW)9"
M(C<E'NA7.?O%JQ,2<7=GL>K5@.$^Z!GN7EWOX%*$O9Y,IIF_LSF62;1A%>XF
M,K/12:2SK8,//4"?R$:!&68GO\V"I'H=#"+U+(R;WL K#GI,N0^\\U,,J)L%
M1FF,W9\IU?SU4VO7FI\V97O J,=;^]V=5/)+*'0#!ZPQ_GET\'.D]JZN[TN?
MOM:J9^6;ZJ%R5:[=W"LWM?)%O5RY.;V\J'O[N\$P3$ *P:P;O HLRW:& RP$
MB4OYTML@$GF!,:ER6R=( 5Z.;+B4VF;K/4I YOX!3P24.YX8NL.E'P-V@XG!
M^U17?NGN3@L7QB=$_?H&W#9V,&M9=:ESGZIAHK2+6!$FO(TEH(+/T>E2 2;9
M&/@PZQ&.#[JVZB5H4IS4>Y)4IHV9THII,>G?V]UYL@W7U4U*MS9<#X\!18UA
MXC6QF&,3C="VT=)M1Y0]6_BG90>ZEN]SB>[XC>T]4HE.\+ZLQ_1[I\V$!^7B
M]ORFWC2T:*/3DK+U&3$QS-K4=0K%4JM+9A)XVX)Y@ (K"FT#O0_+P+0[ S4L
MV?*XT92JCG7?-!:C"KN,POQ A.GCG6\I%OS!8HN;,_T F!INO=0A*9B%BT<B
M\-ZFVGKHP)DQ-8Q)6O87],:Q?]74I,MP:MM@D!PD(_,<XG3AP4C^)I3M)G\E
M;,7SP_K8M=QJY9M_%WT9M\QEY)S1/9#(.9N<T?PF(H_91V0(Y7.Y1.DU*0;3
M]B&83+"T?6@;^KEZ='F>OBR\S3[0G?]J]Z&4RR2*V=A;-GD[A,@5MUHDER?V
MZ$C:(W%%Q)=981=E95.[L$Q^:_9&1VCT\^#ZSYUVU1S[ :MR:#WS]B<3.SC'
MZM[M@)7 '2O%)^!%'Z_\Z[9N1:>N,^A]LS+E'R<W^CILW<K/Y*RMTX94/J$&
M5_RBA!OELZ/SXM3"MI7M6I@P4@*,J;N^,3\U8%C3'W6PR9W <8Q+?5G:P:S<
M570S??[S3/5#6'PFD;[/[( 66\6<>2JK/(.Y9*(T [YAJN*+V)!TJ'GV"C;D
M(7/U_+O\^]?WD^;J-R0=;KR]8J&82$_9$(VN ^;+Z</-2U/?-ED4)EA^3X ^
M^[L[Y1BI*@8(.O==58O$=N<B>]:]C<Q!93Z,'QV]T-_*6'JH9[Y=YRJI^^=,
MI)T;L<29R6E1RWDWZRA=3!07/=[5Q39G98=<5\]2#_WK>JI?>OO->8NC/GUS
M0AG#&ZOTWRO,7_?KR1U6>(?FW^P@?S9\ISS/&(WQD7&I)K4_^;/+U :&^%.3
M(?Y28WQPTSO^=7I_<ZM^^EH_*=>J)Y=GA]5:G<>+E>KU[>G-O?+YL'IT6CF]
M^6<;ZU^;5<@C3>V]2Q@CNSO$Z=N&N^OC'F&$-ZR9<Y)H8AM'V\:P/\I#MVO9
MZ$\%D5LH-SH_3)7NKZOUP\O?D4!" CQ(4;U19NG2*1.89NZ\"JXGPX 7IH(O
MQ"#%^0MC66PJVK)^1<U4A'IIJ6  7-I4T,VR<:+1<HCF?X[[U[J9J68*1@S-
MO1DL0.NX"2R=YC*J3'(_F8S'=?=@9?:5."\B%)L)Y@&B,S&M-F""TQA*3[#J
M<GQUWCQZ3HZ.?XWUZ2S.\('$P8UV2B9>*1F>H?<>/76R;KO0N6QFI[]7NJ]9
M^&RQ%:_L7"TX&XD8*YM2#JSC="DJ.#@[?C\MI70F,V%P=YQOU:KUWW]ZMZEH
MX+69S%19F)GHO67XJSANC<>9]^(EC/JN&2^]>DJ93#&1*T3EMD[GI1A5P@'&
M""[+G_W']M<V9OI'%D>B'%#*K'*NCA2AB43B2$ _!1/B^=Y..\Y3=-#Q0:9>
M^7/Q??2K&T*E2_B28FX8NI7)UE2QE"BDXE,88_@>[V+Z3=5Q5 VQV#UD*L/V
M2P00*2I,O%38HV;+F\ALADVF;YSH^KX_1S]/JFKMJO;=3PZX$ C!07DLATD9
M'\R5>SUK7JLN)TX58_?D'PK;/NHFD1[SAG07*$#92K!Z+Q8F4D F-N' +^:.
M6:O,>G5O],NV")H%,>M"FW.G/K=[FEG('&1#.?#!'6&[(?28.!64<#5]15.K
MPE^WHE74<$Z<N7PAD8OW6F![0R0@)P7?A^S]9&*# J#*4;T^N;65%V[M';SB
MB-YP22^(WMFKZX>N>?OM]DPUEK"SD\M:WL:&U_,F^YI*9.);%?)M13'DP6'"
M+@I(O A9F5T&(/*%93*P7A:S]"N9!7BOKD7O=>NNZ/[ZK9_>2,CWU8B)KQQK
M>(X5O,GNI@O38@VLYP@V.:(D3E8P/["MMN'Z,(N4*<O*Z"=V.[_0R;VBD8_%
MP)<F!F^C-_+Y>[.J/UZGK\]*,F[GQ,1,P@B>OIGS'L3(Z;W)+I4RB7Q\H<PV
MWV/MH]#LE._NR/>%RJ%OP]WKJJU4Z8H[&$G:1JS7*V+MN<92$R0O&SG&G9HF
M67R70 17TY*HHY#)V?E)_7?WX$_[5RK"+6A-#=J\Q"4(36Q&RL@RPA>I7"HF
M?!%VU[ 0(N"R4?H_;#N<(]$-1>!X?]E8KHL^-#Y"AXS($4;L6'B) <".6&"/
M3P18(<%WS/^""*"/3P+^P@?W6'C"R?UTSC#?>B]<;6E37]M9O@%@ \Z-0!M2
MN03/P)HC2)4*X2E5+!.8RP%1P?YR=<TWI&7++25)UWPJQW/W\*_QCQ\7N;L?
M?PII-Q6LWFUY@_.6],3'> 2I.&!>#V&Q><8)V_Q>*N?_]3IAFRPE"IGXI.3X
MV!C;(9\.:/[RW!%E.+#,623;E_F34'761J9LDA#9SG7*7+=L];*YKNFT-D09
M+6SB!Y40:XUU@\KGLGUJ4M^^H=H+I9">\B:Q(GTT5[U+IG+UR]_/S77R"_Y_
M]KZT.7%D6?N[(_P?=/L]<Z([0O1( K%TSYD(S&+3MH$V>.LOA$ %R!82EH1M
M^/5O56D'L4L@V77C3AS:+*K*RGIRS_2+*B>_U+_Z_7Q669ICUUH+N/../5;W
M;:B:J=UH JN!RXT"Z\.M,3J3L2RAGHJHHI1(K23<XV2OE; 5D5H[2RTNMX74
MXC>56N;?O<.'/-*+R]G2"[U:);UL[_^YT-4D()]#<P%NT!9AC>GL9=H;\#+@
M-Q5A9KC-&N*SCR!;V.!R@<;EW%=VPZ6@#>T7/^7X'6PR:QF4M0Z[L8<^D;%/
MS*84"E[BH*0C^?J2!B7<RP0*133:%'$3^GE!!HHH:)BAOB_\>A?T(('1^!>K
M.4C U$:?)D6$9Q+@)-EK)6Q%A.=AA.?97B:?7VBNGCMP#F$6C74OUFQ1F;]M
ML;-SIC*YR\7+V@L6CO[E[^>PS-"%[-;E$):_TLK$L1?DZV.%^WFJB@),LN#,
M'9S@8'4N=*2B_>WO5##N6+W!$Q]BVJ8//4OZT(?=A[[P$?O0Q[;!.0FG)CZ<
M&K#69,=8]Q$?!].;-OV_XF0 %T%QVSC5-W9/!&E8><YVJN-7JS6L:TGLH5FU
MYK CSS2GEV*W\CH"\L5#K-SJ^13'NZ^<ML_!N]A+W\HM3_==H6Q9*Z&LI5!P
M+>[0!/,]NRG^=FSDG;$@X*:MN/VZ/];LS."VEZ%9TP?,;CDH;<CZB%O)L=TR
M'.W0YF 1QQ&N!:@K(OYF_$F8&!AB?9T#I&+\%VUC4 N,#<SI%)</@I>YL1^Z
M.?H,-?:QE7O/T _O:(>6^TF[@;D[>-Z9ZH"8P5R(@.: #60T" QNUIA8;7GM
MR)/OM^T0F/,S=NH\P@]S$(DBXCYAB*6_2M\6X+&Z#SP6N+P%C_C5IDWO78K8
M!%F8H;=3^+)2U')E)==LY]+1(F<AQ>7=5S9RKM]6%)%+GLYD%P><63?/G^H;
MVIU9UB\ \MI7"3+96 .I/LI5%LUU.%CJY=TF_% 5?XBR)I?KWADG[JU:DQCK
MJT&7!5UO]*W?:V@WTF!HF**VT7?/QQP3<C:UGVM]4/=V)(@)3]=O[A\J,YW5
MSWIKZX3WV_RRGD['9_$"3S,!&L2A>'P^0QB5%0X &JKA1>U>SQ04*$;BNQ5N
M 9!@('5#'74E!?6%LQE\K$F]X(8:F=T;:L2%?5N7[?OK:7IT%U6_CF-RJ+??
M!\M_#W I1LNC3A<1.VBV ,<0$=2>A"AIKB2(,X-;VGDF&5M($6,VDTKIJ_2U
M_C(=2RM+LN9V$G>&X@N+/="CYZA%P3S'2A87F2OQ@QQ60'T2VQS>@,N3QV--
M?8?[-E!WX95@9\NFHB*:PFFN_<=8X95LG!CPSUGW_6%:O/KUN[\.Z%;M+08,
MF>*=[HO9A<ZWWP^-</!;,B*A5W%L]/L J>RVMHA'>)C+"- IS5D=@N)6$R^7
MMVM52;N2MHE^PGG34:'8&$*CP=ZPL[J@Z)=K.7.G+<> 95<WX6(RQY3*BQ)9
M<PK;4;C 7(H[]BR(@SU? >ZP,SRX9H4E%O1+;VB4#YXA:N7LJ-9=,I?ATVN#
MM5B?:39_?\H?V13KK-Z:?PU5Z16@"EQ[6_9MK,I,)B?6;P=RDLTY^_O!N]RO
M[Q3'T#P;%X>&L2@XG!#^Q[/60N'P]C37KUXT+ZMZ)N8F7P1<'!^#$(L:R@#:
M"/%J'VZ1FL(]ZFXQLP7YR%D,ER\)LLOH*!#A4[GX%&XGL."G"^H<6/@X'N6M
M+D0+#40(NA'L??Z] D:S;BM)7FGW^X';VB\Q.</2#'=HVW9[?29#]!DO<S=5
M23&6X?Z]=COX4YGHO7[V V@VZ_:;0/8/1<=9TD[[@^HXZ[G^QLA>]7Y=]B_2
M3PG1=B+A;)_>D_O.Q47OT=%FS:ZS"J"&@MPWUV&J0EX-)_=]F8[C*$RK="64
MA>>9%N3^[OS/F6:[_5=S-5;FDF62V^XMS MHG.^KH$DXLQ#=3?1&'^!)M+K_
MMY8;_9(L4UV?UP'^<R I"NYQ@Y]J+@3O17<'>)@NVU>4?:"[^2_H.0 N$F^7
M$FSJ.#^/)O%.[8C$VM69+5'-*EES%=I$1GNK P,UANL!(.KS Y*P'V-E__FF
M]4VD'M6L9(A&WW,'8ZEPSJ[>?W6GU<S+8[&P#D_6[C!6V0L+C5LS-)\IT/G\
MNNFBX8$$2:<Z8#I5HV>H*)F*Y:*HABGV7B:2CB>6>ZQ'EF$Y\S+C5[.7E_/^
MKVKS3LH\S;66]G9:%=S?VLL^\ZYIR=5CF13+N:_V4B(S>9HI;-N/FD9P7U=?
MK40WLYTWM^PX<GL>!\M9,PWQJYG"JZ.\5,CP72DFQ\&F.-9]M6>OXJUK;9%$
M_"4H$T&;FG>&RUI-UR.Y'FEX)[)6%T#T:E;Y]6)DZM5"M5^(PWFD4PP\A:S[
M:K_SH N%12_RNBD%P=5;'A*@KS1E8=I"Q@(1* <4*-9-<2[)]C,(=NM-L'!M
MNK/*]#&O5LI\=L6U.6!#@7 O#KM]KKYWO]!,0 H]$"V5'0TZ< <@>&_,LHK'
M#U84%E;]YO)B*NN/$J0[>D(J_#JEA9ZUBFI0 ]RS&IF#4W_ZSR:#=B/K+WU,
M,B6\,_'&K:==[\6YQ0.D[W3LEX_D: QJ7"CA].20]2T+HVF3&XV<-<_N&IG[
MYVY/79O*%:=(8C3U+<>O;?'.)"%U+5OR\E..KW2%_/E%FT]PN#"BNI:CU[3X
MREE.3T@]B],A562:]5[ECZJM+3'\J 4M\2AFV;R0I92D0I;';J,U[2G#M]+S
MQR]DB4<12V@%+.DD%[ ,*^<OSQ=U/?/"?;H"EJ,7KWBX]?1DE\*5_ <L7/ES
M)[P_I,_JZJ^E4/@)"U=B4K1R]((51U\]/2'%*A&E\K.S^WOY]G?MN9Y/L(UV
ME&*5&"1QP@^=GGP\$RP4SOY=+SUV*V#0;JWG['BD;1ZX2"4>!2KA%Z<4/XX[
M..1,9J8XRX_>KH<M(4F^Y2/GZ\>G5.6,:#,;L_K#6;;9[+YS16-]B6+\]9H/
MQOI[:SBD1,7/[5?,^W.%S\C=ZT%"=)VCE:@<OSS%U('\ <7CE*98R6RG)U&5
MI5B37U95I2P4I)R>.!4I;\)!2E+L:A2T)9NPIR>.)\[W>^:2=& @9X63KX@2
M>J'DCK;93)IAT^S1D6O&B"^M7\);*UMC#^>SPUF/</?']MGEO^>/X[%#? PY
MSBZY6,IQN5 YCF7BP'&W5^V'8?;^]E?]H!S',G'@N/1W?K'JX  <%UGV)DGB
M6Y_$9PN6P#SXN0P^615,_<)*Y9LNR=^[LC_7LC^W)'L/Z2FJ1HU4#2#-("B!
MSU]7>X73P?U.F:(VDN WH02U6[M?"SI<-X4$,6KS_IV"DE08H%7:"7_6[_A^
MNSCPK._T9&UNH("'AB.H] 5XH3!7T!!7V1/JG8S7RFPTAMV=N5Y%LXGPUQ%(
M6B*9R6X.D.@(BHIH'\ ".JZ>/>"0U**H25!$3W<.@0FP-^CQYI?QOZ^%=VDT
M&=EX>OXJEQJWXYO;][5Y6<L(L%Q(0WI8D+EFM]:G-MD5W$3'MX=="U(YFF$8
M]-\!$=7+S77(F^XU,596X_E)7\.77C=N(#=7;"T8&FRHQ '>(EMJB^/.! HH
MD&#N9!3FNJI6WR]G:V/"6Y$H&2R+%0$KM2'%>?@7G>J7?S/?TTLKWD+GW+\0
M_)LT19- (:+"9<,5X4D:$&%%T!<FLD&[572V>2J(KQB=32L+8_MRZ0--0F3(
M+0 QMZ34'UTBO2E,D3GI\'G&+M^*&<>[D8BAJAEMH(T0TZ)U^7\,;\J^ I76
M?;T]JSYENVL[CBPCS/(J,B83)=];'_5L9U>L9NG,P;':R0 /G&8P[TPY/?'E
M>E.*,^]GB8-S;NPM>(&V#])!.(;YRWX3SQMTE13T)T1,"MM*4.OK3LW$25E%
M)19V+Y^@=,K%(;N.N\5ZR]&B/ _25WB3:M;UMEM1^+U*UI+F/"?6X]%'V=Q/
M?6Z)K@_%476Q@V4,+XNY6=-%0V/'2U ZGF-\>JHIL:%G>S/U.1]*O !B5IKV
M94$:38U?W979H,OW=U#!%D+6$V29H[A0OD+;854^YU(*QYN!GFM9^6QT=LU*
MZRN&ENTP62QT/"=<'UFP@HBM?N0-MZQ1:#&GX&OTGS$]/?G*XG]EF&\0R="X
M,<N_3>EC63*^T92N^IW*4)>"&QM#S'60>:DBA87!7*X>7HAISJX<C8<V<09E
ME8A &2@Z+OOT\.[9U/T(U",P.T-)*#;&N*5#Q7VB&1Z-]<78R-AX?NQG]7&K
MF\NO#9R%3KT$&22+G6EXCL[D"T>)&:_3*JQ9 >MRK-UK[>AA"XI58)G*5GJ5
MF>"$+BV-G&H+&DPA^0+H(MVLLS=7@RFS-M&."*"P$^I2=F@YA4/+7_G__C\V
M7T"VR5RFW?+PL3_P26T0]UP;A>)#CGO&C.-[@URCH?5FCX/=DHMV#X'&\38<
M*T*%V38X(<+D7H\,0.P;E&Q A9EK$)13T+3FT&)? >Z: B^O(\96>,5H', 0
M1<D*O=B:8%!I4.4#>,IF[.#M0KA2E3_W2^=[Q=3IM:N'*WMP_Q9B\I$@@OE>
MJW/FQ=M0Z@U/3]0>I R*-,(#J(*N9N:Z6,U]\.V;5\/4KBP-L%ZL>WYS4Y;'
M9@TJ(YKB#TP4>)HV_\O0KAK !:!>-*9C"/YMF3:H3[JZ)$J"AIJ5>#UXY^8O
MJ&ZP\H.%N>$&(#.!]YX\$<&___Q?*D55)2"+/ZBF,  _X8^]3 "$$?0CW$\*
MI_W!UU0J93>*$Z57>WE=58-'Z+37.I,%J/VRWWFX/5V5)7&A 5<6MQC"3;ZH
M'I#E,<(O98!9'_T;+K5G_]O_#.1R%,8Z7(O]ZB?U)HG&$"V4^2NHDY&AV;\!
M36QX0079)K:ACOW4ET$??T/T=3[R-0GS/>[+O]64EW8VU7Y2""9_4$4-BH#>
M3PCU(V!2MJXB$G*,]UM_VU]#;[F=T.PN:/_\#4D=1'4-",^I+H"8 G]\C(_-
MV_DLZSU\ST]XGXR69#[5PPW)8N]_NLXFNPL-I2S$A'8T_';/EA;6/Y<( 1ZB
MOZ&:KW.I-%2R@-X3QH@;M D4'8MILI*!4 G50)?@+T+&A8<)$:4LZ<A(G&B@
M#9]R)J,VS/]"PMKR..]/^]OJASHS5>[>O &I=/&+_Y*@LT)RX_2$Y7[,>:#R
M7*4S:]W-9'ER7KNX&GSYM]2XOJZUKROU=HLJULM4J5%OU^KGE7JI5FDY![UX
MYHGAW(3G'VW<(NX*"#K02<NWHR[?U[91QB>"ZJ>1"8^DK>TYUE'T.84=!]:'
MS)@]ULS,CP@X+QWJ=2K*UM*0/@;>D9\3;-SQ\?0$Z6VXW;09P31;A"[8*]X*
M/<M3JE=5[0;^;V<\9L:,9:SP#&L9*[DTVYG5QH/GJWY5R;UEG*ZL-YYUKC4;
M_(]:9BTL"HI-U7LK;R,@E%W(+OI*[8ZK@1UMF(U(Q#DDXDP2/0\D[N)WNU]^
MXB,C$6>2R'P5#H%R 5:011[:#HW@</0'4]>3L_R-I8)/PR'"X:C+KRFHB=9B
ML_-S>.?-/!-OU_,%(W^N<RA.*\: #N6$DE(G!D(':&@#DPV\Z2ZK@C7SC;UP
M+SJJ+T@:]8KLT67=;YR"?_A);+CZ9[T@C[%'=J!:F1DWS19+=_<E57MVX+#J
M>Y!W*2OS+X*?NJI8)0RYD4YG EU$%DL2.(R#VK5O8WK?* =3K&<=L9Y-,YW9
MDW3U1[KL_IX^BPX?U]UL,W.P ?[UJ.=I,%E']&=3:6:_-O09J!<M[T3OQQ++
M8XD>!W?M(!A^U_3EXSR*7Q,%8.PR'91=0?8FN/5LX30/78*.<^A\VJQ9Q^#K
M;XUF9*U4U<XF.I2"NE["'3/Q;SL"T2AY'WDE66$$MY8 :W!&@SOO%\2KNN*.
M'CAS=[%L!S9S!W<+V&M9&<2![8SRW-7&PKM'L=QL62O9<8>%+8/<[311/] >
M;)&9S>_,XC0M-D]G D)M:_+!B8PXTO(19IZ>&/!#&+S@__KUJ9$P1072Z@A%
M,5]5^=7LHR:C*)H]%0_R&&JU)N&4%+L]F@;_C+2TGCI!N67P^G4M#O5%91!8
MH2$.8Q2W5PP401&HL: 94[0>TU\P_RAC*!B4!"\Q"OR@[\ 5RA)X10X#=8);
MM-E%F_ ]Y!80GH'B-A8V<VTHU#Y3L_+7</Z;&4QU!A'.!VSL]:-?[,/-0>,!
M?EE'K0FP.4IX..YFGSW<$9VL+"&QD'3;SUJX?8"'6/Y/J*_TG@>:"@F+0F*J
M]@/%8@T0>GTITG."IRRY.1 0'@R4[]J'.&:&;B4S[?4WO/U27^I9@=XR0*""
M [@0BJST!X03Z ,X\0AB2J =Z$G$T*V_HF0\7,/JJ0* N(=ZF</'PG]J<.4W
M^!ULL4))"O>5^NWX*%^<3XVQ9FO[*:TR T>Y$R41HR-*X]3[4S-/SU1CD#(O
M6WO5T'HT,SSMR^^PB7$SD0'%\SSSM?OM*_N--H/G]O<L1!7P[YD-B?V1ZD4*
MG)Y8).@"5"*(W+7&ZD;$+<^/5/!W_>V'K<81P?FPDN+-ARU>GT^E7 6(3WUW
M\)7GYZWCV<C*\*UH95<'G)OJ74@(;8"Y[\N']04U[;6>3[4">-+< F0[AQ?<
MRI?B(J/ZF-)DK)6\2 <G,:R\',A8F6=IE-TQU[_ZZZJBNLWX9O;R.'EMZ ]-
M^4(^'$^$P $L^SVWC 6^V3SP_?2DYN99^:'0AH@1 ": "3)$%F0 O)K.+>M2
M>V;H0!!2<(XD5NLP<EJ8@CO>C"T[0;>.T),X;/*)";FF&F<!#9K%-9!0$R%_
MQ@YJSNLTH#$==AFDV*&*=SSDT!;$KM]O/8^?GGB8'!O FVW' Y.'U=4.(C*/
MH,0=9%\^+Q;NNHPL!M1 ?Z)ASK'- 3Q>?"_&\H(G#A/^C7OPP\=BNT&$5H:"
MLV6FN'<#-I=D9",I"KP/B54B@SDG^O25LJ2/55V0SR$#C?6:@C* X)5%&2>V
MBM-P;N_ZA!9OP';?GX8"16]?M:Z-GCK()C#%)8V24WY0\ _SF2Y<9]:X>JFD
MG]_J5V#XY=]RK64FM]Q6RE2C6;DIMFN-.LEQ.?[RD0WDCLC.;3(G#V><KQF1
MMZ2ACC-,F*9*0RC'6T,!_@J"/_'TI/(Z (I$70Z%F:"HK_#W+%^*K_+Z;#(%
M[H2\L954CL2]:6Z@C^+/.$M<C$>4@XNEBXKH&>[A:2FRT$\$S?CFG6G?N2T:
M@Z''+>N;-?MURUQV*U*^7>PN&;:+2US<-2)MVF[JL6G)]+)=KA@;SCNO<DX7
ML!4;":?!![L\V/>7M[PL@"I.T/7TQ.$XUWAWG(*H$ ZN'QX4MIE7E>[XH'XU
MTI>A--(D7.D(20VO'_Q@HV__0)3L<YZ=7O#-5NMRFG?8Q[M$5TV%I^ L\LL&
M4G='-E@AB?>AX9=_O[*HH!@Y!.QZ+OM0\2E;"?'.V0=FY1LJ*DG5L9T*;0HT
ML)FF -3HU"F B FM$.&=$B;&4+4L&EQRYNAI7\>"#F',<@_C-_L3U!'T&]6#
M:"GAWF#>1?RDOG*HG08T8#2[=X4)5/!3K*?O!22"C@M=?/&CTQ/US9DS/7)K
M"B3-6K1II]A'H-L^<@,GL;EM-%;676YQ1+YHCQTBVY*=*Q:U%SBY>)>3KM_N
M7D2IYW!R,Y L:QLC[;BC)9U_?<R_9/EA%\%8H/?3G,J9AOPEZ,/%A).%@\T>
M[V!7XY31NE>KQ?HS-TP[IUM:V-,Q3S8$Z;9%QS7;&0?O=A=>?T%"U]ST@GAD
ME1WSQ[/94*AJ!*6?JDW--G_8/AV9+8F1.[@,>J9.YYE!/F=K)3PJ\0$4;^>0
M^, L,UV'#P]07[TVZ+6D(/DTM5N^-=X4B)-#:>PJ=F?3IH!D5&!G/([EH*)C
M>L"=[\Z-E4&>%WQU6LB[J[?5$KP>,M!O)J(XM2^U=,'JI>ZS^-9W$W.<'_3H
MJ4CTC04L--?=\"WVMNQ2HPQ=9ZC,!OL(1W7-+76X_V6/HQWAQV':.)WE)!3%
ML==(F8M$H& MD\+KI/'7^ZJ5J@Y%PL <2W]Z,I1,!5<S]5WD5K+=[5BU0"GK
M9BV\MUL7_@88"1)N13[/:^RVO%974;&BH:FRC)0V_)%H.>]R4NBVSYXFI?1P
M+>?!(TEYED>I^'.A,&+0QN/%EMQZMESDOP!&-<>&KF[Q#L6YJSN@@Y[E<N5^
M_D+^Q58R/JF_MF\ ^LP*.NXJC_DUTEA"*</PV3BP!<D3#-:0'A/9P!]8I!UV
M%BLJ):M02]*0<$<:#BH8%:P@65"X*RCM@S8+2LS.%:CS,-;V<9BKU[/J2_"%
MUW%_%]/1/ +0>!$]7_A.-90E^W"$#M2PIS-D: PEW?LLW A 1P6;DCY$:"/@
M+AC:JUL4X_VT&29")<RK; ^O)*LYW];G..?R=@+>#+GX^\[-7?9\>AT#>3]Z
M>#[Z:![[Q"S?%]+QWQ+(FJ@3F8"$*KHQE&C9$J9N[>1@F3*VV"K!B\*G.";%
M,RGVJ_#-GUPV%$24*X+:FTA]"9BWU!,1]+NAT#U:1 JX"C'04X/?PL%1>XD:
ML-+8T,)U WX,#*0>!1&Z;YAF (8=)__L"6[83#H[/5&#$<?[-.3'< #(0K>/
MQL/A1YE:/8B)$S3+8:N@4 V'DULVS%MIQ*TA $91$8M.SQ,W>*0O"4P5O VS
MC[":SJQ<N&W]UL"C5N02$\OR8<3"'78[1GDN"%2=E]W438M#DWZ=K$OEC_F=
M53LS^2%;N!XKU9>"&\Y$N 7![P=2O:$.VBI=5,JW5Q6J4:76107]1-JJF<;F
MA%S?=J. VF"@UA*>1AN;__Y\2PZS0\@7NU>%VXEC\Y]<[-D1(62B9AWSB^RB
M$=7K5QKMJEP"PA-#?_[?%P@\-C]F"F>=H,KI[.N9K!?!'S#*SG=>6='=9:MM
M1WU :#/Q/Q[<X<6^-<ZI^++NMO#@WJ#9<1/0&0GE\UJY,6N\M#NS]D/FC_Z<
M-\9"?H>+'WPQ@[*-M$'W*\=D:"Z=ISF>_[;7Y;5 )9?_*TSZ6_19R19;K(X+
M=7&K[NZN*V3_"FQL%-J:_Q,6*=G\W$JQ=R[4A)RPPB06$X7?#6*AEC>;IMF
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MP9ZR\KZ>LJ5AS*A-%Y,:F!@+YNKOAS_]B_NWWDC+Q,ICMB2^N=(26;[/G<>
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MZ )/@#=N)SX/O"&>.$3=W-&;7^6/A[KR^*6NU])%J;1+590HZ6-9F/Z@(.U
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ME%>MW4]G*U>J?"''&W>S(>/N B5 M2(]/M0>!ESA4^-N3%3Z_7$W2N7^>_J
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MF"K%A'?4.T>LY4K^*UL.=9(2D1W]X6'Z]V_6N;V\6P]PL3AYA:L.Q%0;UZW
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M"%'$Q''*BJHA9V <M>KH8-#7+% .W!Q#.Y\'"M!-W?3N+3B/"#EV=\3@V#0
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M8N#OX*V2#2,NN;CJ!0IYG.!KZ.;$ZW[@=)/6Q!X%"[=$S!EJ<'&<N S!%W1
MWUL/^+6!:H.1I YZ[XRC>=XK>VP;GL:^S"Z.D-H61UAT<82#-2N.0 !!<L-"
MV7LKFZ.FBU3*W(3!="'AM2 A"XR@#\AU1+).VJI#7UQ%-;ON1&,!2,X*B^9,
M]<PV: $99Z"C%PA?@DP%"(29)GS40A1DB*^B+'Q@Z*L'G>'R#QP+9"O!#OZ
MV@8<XUBVE..^G52J8B);R<,VN0:&7:EPV#HZ26:$50;0E9C<X1K'L3HNFO8$
M#,EJVMB-W7"^G#O;^A"1.#G^PL4%MGG7;R]5(C6?GH9'8ZY;NLK@.\HQ$ YG
M:RJ>5M$%DTH'$R "<Z&M#S"0!(XSR###&-+[,4+7!U#7)D5 42HWO4YX88);
MEE+I8J:'.IR< D#6:=MZ"TV7EG4OKG"?N6:8-FHW 2#[+1W]V?R=B_(BR9"K
M.#=2&#$[<9 Y0]]'[,QE?-3'-8G8\=LA5(]V,%^A!MOA\ KKN&5H&H?&TCD.
MCC)#Z._<H07F)/R-HW6RA,E9KX_Y\VD.?IP&_X2_V; <G <]0![[%0GW5=6,
MV2SI$ 0[<-;QF9+<+I;)]L",AV..P1G 938 @BZZ1[@))#D7@R>,(0H*-(ID
M4Y;8XG&A-TB88YEH$6+\AV\T*O WW=*(YV DGY$R*6'Y!3/C,\?9X-1T)S K
M ;2"Y!&3P013Q!PJ *B( ($EL'OB=HP# 176!F-4T8+0#'+\P#=(Q-&THDA+
MTS6LI:?H&IZ+#LA,O,&:]KK0P+ &A:\A[LS#474#8E&,"K]^,QGW]+18<)Z0
M3C0'<<Z)"$+@CGG;GI:'6[2U[F@+XUW:/.*@7/]1/=I+'8 )"7_OZ^TMYEH?
MJ=JCQ %F@OBT6<?#RW(X\#JFB @9X&_?0&P?*4[TH.JTQRB'\;? R*N:7!C8
MK*O:&IEP1L2M3F_U%3PYE#'TC889V);FM67\E6T]1 :'7TB:L4>4<V21R3@S
MD#2V-_!Q C[E>(.!07>UNCEF?.( ;9=;H($D;+,@,F!\V0DANB1=8),8#UC#
M5_%K&>E''A=H@0S#587S;@2&2_CBLHU"#FC2&B8PZ@S]U63,HK#LPO?HPMGC
MSW,HZ7ADU>),8!:D(ZF#L,G#[US?\RCWJZ-(48\QKQBAA],8P =L'ZMY1S=K
M=Z<G1'= =(TT"/KC;5Q4F/3PZLB&119,VG(<+,=1VD4U.; <AR+R\*)C=R?\
MEKXZ5+@:E$Y/S_4P^8F\!?A7L5B<RQS4ISX/]&Q;!)#XJ]OJF@W2-9<>L RZ
M;V _K^]L. #X6]DR.P:<K*WB>=/I5R,Q:?[-MMRS8R83>6C[#IFAVAZ_IQ,R
M1^EC(B,^K8[=DY*%S^,1^;8S'AJ#X0\(/R-J#10./.*9'3 +49H+<*UY3%Z4
M\BGMB:%0EA+_^)H/-)M(FT0E95@ME"5 %50B)*#H[70=BA :)!=/<+)(7O'1
M_9IJ.I>NOC05%UA@JZ)_(B2]A+2BL36+'N*OB!C(<M+P+D%"GQ0AS8[RNV5;
MJH:&/X:)8PR3%)H4QT1D]6R;&@G;.EUC7Y&OE[5QH2'U/UOEP>":SM55R&,1
M3)I+W[;J@(SO@-GFD+<7KWUQA1H#LF"//QZ:+96&)LKLS2@"KIQ:#WB[G)"[
M*C0V81.Z.Q]G)P?,0U5S")!PK<OY2D>N1B/+=&#E^ L0E[[PH#MX]]A'@,%S
M:%F"CRV&Y.J$MDD-MEC5^*UW@!IPQ^-(AA$1,VFF$,G>FY(:#_E8=)G;AM?"
MV 47B'UD>2VWU+(\]\2"DU'&>U?;G%; -EQ+9OY!FJ/<UY/?["#Y^./G2_II
MO7%IVO1D:=ID<S1XS+KF2<TH.\5/7T[JU=H)EF$N5RYKVR*T;SY],O)B7<E!
MD YWAO'4757I6L(5C9S+XY;D[9OJ.!Z^/FS"49 "P&22RQ35 XL9,5*/H0P:
M]/_T@ (P&_Q+N!B!0.XF9KN@R/-0(H*4\TT'Z;O#.V*',7H3Q_E16ZY'Q7_0
MI2ZS;4!KX.5=?#I1(72$+S'(Q&1:1;71>^:$,G:.^!!-O59M:CH%RXGR\=KC
MB=6_<9-UK^#G$I4F7_Y4MM#3[XY-$WIV2QTT;__WT]Y$9\-<*E'()1/YU/2*
M-BJ_,(NZ_;CNZ<.F4)R[WZ'#A2D/U- ]B@;:U[#XC;!0VX&3H$2W-+!N8T@P
MD$+A*$1?B%3J0./BG8GG<L0V#C%DXSYA[:(S@=N7$58F7IF"$22,DM<K=)]$
MH6K\S[)I-P<0J(O;!,O$BTD'&\#M/O CXYISOV!>GCGF3/EN^#P0+NG3A4@+
M8_70J$=PXO0(0T1,\A;B5WGT9BU^8P78>Y"_\S$H\KW&!NAAAX/B#:* 6EQ4
MBNM+JZ/SP*,HY@]Y0(#/_@76:S%"^3Q: M!LBYQ!/ A4,I8X$>C/LI0^8]Q;
M8K6 *-);0VDM W2GC EO%2T"O%]!4T&(<%]PAR;WT&/T6N)92LH!,VM?.5=-
ME=<YX[A:(\<1GY"_."(1AK/BF1-S?P3\_L",>W$O(>Y2_, X0L1 P![,/ 'B
M284IT!3%2=[=P>Y!!.$%H29:>>*QI#;/X@O1D-@J)R*9C"(M-QK2$AQ+X9?C
M3E6PR4 & 2"%_3. ,_C88F]YG"]PAY.8U+&&?L<#]S4/2".NK7D,L 9V$9J6
M*B5EH7O.=)BT#1BF]ED81VF(_0O+8U@N6.-X+6X(;YN<MF 5Q^N@#L+O^GPR
MJ79;K.N9?&X46NMOG)Q,8*> &.?676M(WE[\EG\%G*!K7QF^(_\\HU;?D>X,
M+$<UHJ5;_21Q^<&3F?(I4.A!%;ZJB2SJ=YDX5 WDQT8/SD;)U$H:-\H [OO=
M)YS#H9S*B6UY RP$PYW$1Z$[[+I_(*)Y]?[ZGU\]]^F4_&3FIO1#ZR:3C[<^
M3 DF%=HN/*>#(*O^2PQ@6C39TYG4>R5[^K=ZU?OVJW>:9L\D^XPVN,\E^[32
M""E CK(TPC@55EHQ816+3>]E4FNQV)CR$%/K1<PJ&Q&)89D(7R'W6I!R(9Q>
M5)W)#M=#%3XTRV&BN!RHP_W='5X]K@TGOR7KQWDVJ6-2<ZI_"@%IH+[V#<![
M53<X)@'=R.P^#[,<N%*AA#0:.<YP,,,(/*1^WBQ![!B9[Y_.V+,=7RY$&E>E
M#DQ)<M0$#T7^&B.GQAJ'+51.=/OY8_OPZMID@9P(YH\9-+0 1<4YHAU-DTR$
M2G/[19.B7WG*[EPN%>=K"+O:\Y>>49Y%#T@^7OS'MM!N<R<]"/D03Y8,44/M
MG@5T0ZT'G-1>#N=HQ>X1,_X\7I_$,<Y\I4IBISW+W[#@'4O&[Q=Y)J;Z(]Z9
M-?N<-);T-HUEP6DLF>0VC>5EEP)R/9/>_:5?VP0QBR4_JOL"V!L,56?:E<U1
M^,IFK@&:H\?"V:]?/W/ZP?T&=A+,3%[79)JC\D/GXJ'8.AHETY^^-*[/STN7
MO[!S8*-Z4JL>5\NEVI52*I?KU[4KO,JYJ)]5R]7*.VXHN&CFO':PRAY,'J]Y
MG2@39L-5WJ-?;(Y:#^S/8:M:[YS>;@ZSS1N<,\:)^8/FZ/>@=UO^E=>_GFN?
MO@ QZ([!I\=XD,Z[XKF-F3[YK\>BY>=)4Z%8&0" Z/8FURSFRH Q0\5:,6[/
M]_NBSQE+;C*Y\=RGB5>-,I20[$X*D> 70/(NQ19='7S7=]Q<:+2);O)C%T^
M+[T@LD9$:V@Z%A:043!H)_MS?&<(=.D*^\+6+?N"4A(N6?3ZJ^3?LQU1@M1
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ME,M@(U 13=@<;#JJ&'HGF+IH'F/[Y?+QXFM?J6-FN\JA*+R1XSILO.4RWC4
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M.)S;!@XO.G XLPT<_GBRQS=\R!\GE4( J2/.1@S%,]!=3E$97!(!/$2M8C.
MNK[?&"44 $%TO1LHW!!3DOQ29'GLL,<[Y%R40#_DF7"X:QEGYSCAF+A@"!D
MQQ&T9ZBV?-N$VS(\L(R2<7S/MJB?B+4I>0DGZ8V-N&>GF!DMAF):O$"3(2A8
M[D1U61<P.*^M&';3A";F _SWYBS9F.G')L(%)T$/' ,\'-/A$=M82HU*E^$/
MR%"PGXRBG65A,F$]\AN-4':L@S&5_,:"XJY5V^9Y=F2!ANYSXB>A#@:V]2@<
M@R%."L)<X2.G9]GN'MXQ8,%1L.G<+8.M%8-Q%W,WG-^HRIBV<2_V^*T-,,@)
M:/&.BO62,&U.-=JB)BV_OR5DJ60$=A0E*Z+^E*GOY[[Q$L!/&"&94-!Y2=R+
M_DQZW?\=+]5:G!UG40Z/?Q5DU*>H6&LZF4NFFDV_;&MSTIUY./1_/)7BDI98
M>M2=N >JM&[Z2N:<]5O,;HYN2O>MVY1ZE?54OQKL<>1>:QI)GNJJ\YPE?YK+
M32R7U)RQHA?W*T\5$]E<7+MZ.EZTU1,[G'O-#J?\'4XO=8?/N\?J]='E8;ZJ
MK]L.I_P=3B]_AU.)3"8[I2$>[3%Z/YT!KS!E;/7".NB%\%W?Q(6[3O;_^ U[
M5-2'[AOQAA#&LC&5/0+-=;-M]1D'$!C0[;F 84=4 (T"371'A@(1J.D E!<^
MXBV/K &/^-@!Q [ 2O+SA0V1!T9UXF.Q0#IR(2WY 3[RLZ\B5>_H*MQ1[G45
MS"ORH>PUVCW+H B?@9]!0(:/I3'#+^*+B4F:'U[D5\EB/+3#+RZ,7^]2%(\H
M_L=1!]F@(BJ8THJPRH V!D8F;AF6=@U;8^Z13^H2GKHS>;TC0HVTNGG)L+0^
MK.X0@XW#+CR2Z!BK#AC>X!7WK_#S*;5A#W)Q5[G+GD-S]$U[/"ZI59O=;VCT
MZP+E0_3V^+#<'+F]].^+EI8UM*Y/'1"4 T.%EP';L4]?&N73RM'U646I'RM'
ME<OJC])5]4=%.:N6#JMGU:MJI3'E*OE93L?YMV0^]^0GOV'MLU\0WW)V86W
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M$-;'6]W__;0W?@8R![D$;,E;G( 5*;B;GNZRA=E.?!G%?_.HR&#W:!YH99K
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MBF'P*LD69:5%B.W'L=J^SIX_?<C)U5_Q.QB\3>>&S4,YB\X]G(N<=C!X7Y5
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M<?KHXN%;G#3-/G+/-<HDX@[0U"FX:>C$K.X*P1$N<7J3B>H<1&$"AZ:FF\+
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M6^9R4XO-I-#I.2AO%.N62L2@U45VSA\@LD)/7<'"C?-Y7#0>$ ;MY\_NC:U
M(J8/%[Z==^K$R)TV;KLE'WZCF\!(]XNE2Z'H0-+>5CX/ME;DMGIB+FXIZ%UV
M4KXTH#@!! /+U0F.IL\YJ6U$^^!G4 @L>I).%2OK;G1JA'<9&$?UWW%MMG53
M!?&-H;N0H"M&'5$2/I;&,)V-LQ=1#C7+H_"^8RZXPA8#E/ C3KA414FQ/>W)
M6TT>_C[-UO[$H5R/IU//C#.+M>'ITUYFG\'L= 9Y'/_[[2",X$".3#7NP4Z@
M,.,6!#W."SAH=L#6@?#@T+#Z=,#O?1CE3N.NTY(/"N=0MH6M#<.-#^%;FY1!
MQUE?NG!U_>#\"_O0]4ZY;E2ZYD?FS6;,NF<Z85.9G4VC)C)+/XA4?.Q<OL"6
M\M'J/#3$<;S0)ODK_-=S#//<[I5.)C>U^S*__AWF9][A)$]CPO()"LBRB^E=
M$%M-M<-Y79][8Q_0<WFK_!\W:QI8QI@+;R;,3G++VR/0L)*N([>H+0_P/<?N
M!^#T7((Y?@7YH!QE:Y[+T2IGGLN_3&J2>=&\/&J/AUUW^9?SG&G,-/<XHNJ@
M^0,N9W_*+\H=N6G9-AY?$MN[8\B-A;Q2%GKX68-E<7]B%3?/%G"&*RUAI;VJ
M<;AB?Z^I(#M&TI@CX97!\R:9L"QS<7&,;F3N92 V64#2J2^# ^6HU X=Q'<*
MG$5O5S4+6)(EO97#^PFZ4U\)>KL[]Q6[7L'3>1>X< /'6C$Z"IG<B:J*.FES
M":>0KY#L$D8QE=+]9?GV2>E52EZ*H3G L1#H&* E_-6)TH7W#)O.!Y<.QI$&
M:0CI:F*HF]I0,76,@XA!"5G& 7V$S8$]5 >0"\[B-&( [J6'&208*'0ZDDYP
M&X'Z)8!E=*,)4TQ=+PD@,L%+8D/5>F*4/9P$CK.^0P$GW"$0I'*$,<Y5=T4\
MJ 'FU,5>W)SR?>/^_C'CX/#8=\X:[/"_*G0_J96T?&'L=#X/TX([5V/]64IA
MP#>^%-@ 2=>F5$,A:S4SZ[&<^W[+SN0;P_O2O2Z-VG(ZY4K8=LS8)W#!,2S*
M!]-.7-TA'")&2%(QA&@@VHZ;L:'Y8!@%NC=8< 7KEG!?*PMW;G\O #SGARE:
M(A]UV?V\RW4N^I/RV\E=82T)I4EM]Y1DG,C.@/_Y ?N$TR.\N@-1@FM3,9"&
M0G($\7$\^ME=,H1_(!5#SDTT<0>3#I@Q.%XONZ$U72@0^WL.P)V,4U=QIBJ%
MOP^5!7&JK3Q-M?%VIQ#R:5*\K]5&XX]J1>125FV\W0B$?DJ)I7<Z;*V=.MQ%
M0B+$UK&7\Y.<"D.3QF^_C@6]A]2=./(6P>F[!@-KMT&PFN/+4VT0XP,I1PE
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M921]/P2@&<,KPA_HEXX4AX@$]1E 8/NA ?T D5[3%&PQQ"SH&7PF\Q_KQZX
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M1S88..+0) 4?O=,S,YVTO-4(5^!&'S)N7PSE;@3G!PT,NLL;[I?N[W5@8G1
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MC[<_9>WDX"EC7,[Q9;/K<'W#%(:@$[1Y02'=NI  PK.V-8DOT.6L"T,6QJ5
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MQAVHP->BM1$LMC>@SPKS;@J:@2P9Y QA.2 0W\F^%>L[_ "?4,!-<C"BD\@
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MJ#.ZA 4CDK<4/BDH<H?T=,"0M+X3JK,LAQ_8  =J)Q$>1N[W)5%&9(3L[6#
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MTYF,8[GR>CID[P"!-V_XWL,5BCW@@W["!WBXRH&6>%M938YH<(J5OL.=T$N
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MI(L2>[I^)C1,. 'O#;A%."53-O!> I^9VQ678BW#'0FTD*5A&)@?&S\57.L
M+I-:\I ]B[X,),TYB#:(; +W+'KN\1$7A/@(2?,>)S]?E^WJ@J(:K"6Q3+&K
M'H'UR#* PA2'[/CP6'5 1,H@"(S!.BOWA/BIV:<#3Q3!+,;11Q* Q#HF 4\)
MWZ:VVR:;; ?(:#\4_Z'PZQ,%W*&*T ?82@/,Y9MX!QR1A(H!_C/@N[GDT+-_
MM[!]"EEUWB7+?MXX90FJ:>B22&>@.F,9FBK'V.4&Z/7=N9 XLT%1 ?0 30X7
M&K..^?@(E!O)&"+-@EQ4NCH"@KA)^CJL@!@<&-:E #7"3H@-0+(7.3 U>)T.
M'T Q!P"H)AC\'KQ<N+SCHR88\1SMV#LUVD?<\M N?0'9KECN8H!R,I[(,Q2U
M\.SL8)6/ ]>=JM0X/O(9$LG'DEF<P>)N%5TC%)#7U)%7P *HW9G=G3<&.#5/
ML5JFE_NBJ1[BX,&\ PI@2L+D")[EU87*S<,H=9$A5W?UWB^MYZ@+Y:E-@:B7
M 2I\/X.>8CS4K^31K^3+4SOU??B[430JE]6+1OE[^?O]RV6E7+BJE#.7WTOG
MY?K][\M[^>MEO71^_^U[M_OM>[59_UYO5DJ]\N^?]1[Y\3*Z;A35^ZO+X>\?
MF3BY^AXG/ZJ]5NFQN$@U"0"4RSED'6VF<K.D-E.I7H)]"2!'1T72H]K@L;W[
MC*.A_'6:?V*X(EW248!8[,D94Q? Z+FQK2PWA6[*KUU4Q!L)S$\9N"S5YTZ@
MN_2=0+?2$Q]Z*R'TX[>[;/I/X=XHK]-P8Z<<=&)^W?G#B-0*-?)44)2<VUAN
MSORZ:KDI7)0OR_5Z^8)-L2LV&N5F(QIAMT)*P_K>_X!&V*UJ5R/2:]]2O2]J
M6LWVZ:1;*YIRM]&1I-<5K*I<JWY]2753TO8'#Q[F(+S=Q.BP"=R4[O?Q361'
M!?G(-Y=:%B[P9J;\.]K4E XUVU%WJ6H4WH->Q3ZY:!:K(R-3?1B-ZC^_%\R^
MD<[N>W^*^?, ;Z9<-NN?RFN9SS;?<%H==Y9RIR]M'4UWM@A\ LA<N&]*NQ&6
MK( E:]O0TUB22N\*2Q;684X!B_5--WG?]!D,6/Z2)ZGB,-<OA=L;,O2I";#3
M4W/PEAH%+9F(DLE%19G;!?C6QAO.S)J?R1$JRIVFXCA.;!U)M':OJ(@7](G*
MZ@#M2=XU3*I6'D1IC$W<B*6+OCH0V\75IU?OND+3WBJ+=(CN9M\0KYA7FK<6
MCH2LBR6VT%/B;?38V<[)!Z=?;?'D_;EG:9Y]ZU-49#-+W666F;OAU;">>$KW
M'@]7IXHJCK97\K&@1'#EHH[@^7$RZ-KHI6LZ-AAT'R%7B,@5(,L/?*["JLCE
M+PDNYDF"*L5"(;"E#9?OJTGS1?R>+TK-[ Z5Y. KA6"O@D]R2E1&L@5C,IN-
MRH1>]?D&Z)W93IG0Y<.(E(W69?OE:ZZWCC<@RA!<M[K"KUA3$"5,/;52!<?3
ME3W7B]2@6I^E\;:& AD,Y"&F#[+KX0\0/)B(PW,+)98YS1+5O(^P,@L!:A.I
MA9DP4PN33FKA.DDIW[*UWR\_U=Q0RP><6BC7OL4+U7J#IQ3>7WZ]^_XH-QOW
MA=H^IQ7.S\4+.:W06R'@Y!/ZEC',**?83>YAR4[5!L5W1LWXW/S#E&_^X<I/
M73$'\4KZ\I?^2K6JS77:;>Y3#F+V8=1NO5Q?_6P2^;ZW3 YBI5JJW999]N%=
MO?:]TJC4JE$"X@I>S5UFNQ4?_+C^=->&HFGT5$TRAEA^R@G O8C),>]%M[3?
MPC9IH];?GQ=?TN>F^1AE*09Z;O$'OT* H,ZM?-?]V;Y_3'S_E8E2&7?+"]:.
MD'CQ9I<K>H4[6IRK-Z-QT S58Y&*WB>E2K-\/BK*W8?1K5B4OTC5O\.?!]-Z
M<E$^7\7/TCII<>"\A[5AJ2Y\U5+51]M&.L&ZS?<",7S,*+0RHERO]5HAKH>B
M2YH_UKL?9DF>S0<$;C5?;(-H281D 2'9=.E>^$@6]+B:99#,7^84@^W9.29H
MRK+T_;;T[<MYN[/G64A+1Z"B:/KK:* 8IF0)6:!$_3U?/WJ&*9-"%D4;=_\\
M#(OD3:521U5_>PN\%3JQ3_3-[1L>54W^5?A]5W[LFT_[7M@7-<P]C$R)7( #
M[Z),F/T[WWS\ #-A6LW>T_6WYV9RN,[DLB@39EM]1LD F/4+Z*P&E8?3+3'3
M:W0='=V1+WJW6K\LIMH[;"2Z?J/^>'K6C)<YS4-7Z\_*@X"CETJS\Z?9_U9O
M%W;8#W0#2"5G341:O0?H\=%8J\)U>X!RL^U, +-O5IM#PVD'.-%E$7O_'1\!
MR2@L^<;3%3!J +@'3,TYP($J2^VA(.F($!IM@Z"&0S0HX)/!.XM2A<C8K0Q#
M4:9B=Q-ENJEJ]Y\DNE=GI5QG9VU# ;&>\1]%=1^K:L='[F/QI5T%UBG:G3A)
MN\U7B92+7>+0(T*P49QN)R8Q8L"K--J#=V&B'2/Q%1*]7AL>3FH1J^>M+4A6
MHUV$?)T.5 WYXH6DMP'FP#IF)*7%\]ZDM,5W/XS4FXQ>'OW.)<DZ$U%V<QC_
MMCY750,H*Y'Y]T/K\T<!OIC(+DOF'T:E&GFFA4KJ=P=,C$;YZK9<]32L:TWE
MC!TX,A[,\G](1N_X"%D&YOJI.F&B[A+-?QXR:2#"\B;+=S(9-M#@0$9559^8
M#Y/Q$O;S!6V[W\2\XI)U,6Y3%M#7; H0C&=5T#E9Z(Q7NBJGHCX#NP4MDNN<
MU&E2C.U]>6&Y=><9K%43@ T^\7;4_%O/6YXI_-&!50U5DPE]T[T<7M"19&21
MBF*R%MAX%XAM!9_:!Q"=7EM7W((JD<AQ%OK*..<*@SQ2\6B01]"#//+1((_U
MQ(Z]GVGA$;8J<&&QRBM--0=Z14%863(=GBTI)A5K3C_IQ7J"-YR_Z:,?1L_Z
M[\;3Y6^C^'B(2D1VGA*13#U=%'JZV582[SY?5!JE6K59J=Z7+X3:7;E>;%9J
MU4BGV/WR:\KQD:L><*$YH1 P_LDL'C;N0N]AJWRG/3_I:I29.<*)9])%T?[6
M:L;_'MBOT7.UDIA0 EM(:/0(/ 6'#8C'1^6G+E4DX;I'1D11G^!Y:I<-4(AY
M9VB<FT.J.4^%9>@F45@W?^Y'P$O9-<X21;_>[W9'H ;N1J_H.A!K41%KI@%V
MFX)D?$<U%!W :1\&DCA1A)5()#,\K1L^Y3P9VRA :IVBIF%\&@%@E:)X7W=G
M+<P!DIW4_:?6?2RE_];%;RG'+\07"$8OKI#/^G#7"!:OO<A9/B+6V6297<Y(
MXT@D3I,9YU/.VLG#O(T$4SB5F.U@^L=V\<R BLYAAK5YKA[LU /:> UJ*HA.
M/I(%;?%Y97QCK'X^I[\ ::1)S+$$H ;R@PMK'?L!8:+/;_,W37P]ORJ3I(,^
MWB6Z@Q/@%)Q%OEM*YJZ%!G,D\28P?/?Y)/$>+ 49K!2[:-,^5';*A#L!G;-W
M/$AJ"Q@IL>:0J-:(&K"8GJ@BJAJP2=H?R.J0 L<$0PLK^ZTD$'3^();A*_BL
MG9,!T8&-L6DO"G<_<>?D>Z$-W%(RX'ECB_@DG"2!#1()U%FL.749%5R%6JDS
M^81JNHI3?MC0 =$""5@ZS]P5"M?TK2%!?/P-7S3CP0XW=JPP@T5IW1K8N1[L
M%8ZHY%V<X]]>#9W+%K2G,#G3_$W.?]__^66Z9:IWOF!9V#!SS1W-<)R/(?^,
MY:_K5\_&YWK5/S$<.TD!?A&]-PX%WX/-[NY@Y_.I+VI+'5;%SEV\Y9QN:6I/
MNSS9 *3;=*=4/-RY81,>\1@0"<F<.WH\LHI7"6M]%K[#7(L^2#^LI5! &^<3
MCF!5IL:]WXZ#)Y5P'"$3EI9_ >C!:*ZO0/%V#BGCIW<3';/;?=17KPUZ*RDL
M2;%B!2QJ]C0L5[$[']X1E%%(RSZ:;!(4'=Y$P+EWG)A=!R/W+S;5$I"'3/6Z
M*8I.06)V6.N]%)Z^F$^>&8?NE#MG-2CZ!H0)S444OL+>9A$U.@MLHEYF'\&H
MKKG,7,T5-8X^>QV#C1-KDA0?9RXP!6N9 EMGC-W>4;D"@"*A"TS8H&! ]22N
MX&I<W\7!:PAX2;6F%@$;L^>AJ:X!Q^Y@H]%0EYK$M<2JN%95%6N>G(Q*&[LD
M7,QK7]%?5Z/D%]-C-<W"/#B24\_RK(EY@2"BW\;W"RV3B]%R&O]\$)6'+J?T
M#>]<*13GKNZ !SWJ_NZ>7Y[KMW]Z[3&IOPCX[)HY<%P[,7N!-,;ICJAIG0E%
MILC[,VL^D5#W#\0\2V"(**H@JPJ.5&S1\0BQ_S!'H2,I1&E+1/:$D,$<05)G
M-J_R!&? M/UG')W89FTNJ,@)7F<3\/A@Q3X%XT7TW' FU)09^W"$#FC80XQO
M&SU)][X+7P^?"5A0>@^Y#4X&U:GV1)U MO=J@^LK.&MSCNTQ7AQEWZU/8 Z5
M4DKMO%.[O^@ZF..Y>G$)@7OI]O'HE06@#F?Y8T'*<2H!U 3!![8#U?GT46\\
ME0@M'"6)4V&YC"TV2D HF=-D_#03/TV<D/>30V8Q4LHZ)DD=B7(J]<RH''=#
M(1WYA&QU7(./IX;]-!;RU>@ "0]-? * PI!K5VH+P*$[!C<#&-MA$U8)P/X/
MIC2Q]DDL6.K'<;QO0S^&PX L[G8FW#N0R&<RIPF 1&8Z:JS1C@ROL2#@@J3M
MV*B\42+G9;([7-#R?,"9P+8L9XLN]*C,CPL/2K#9WSADY@ -7Z>(8UDVDTDV
MQT<\( Z<FB*C<G-R++6)19(YFW2F2+/#L(:*.H?"\L9(NR=8V4!,:!![7BW;
MGJ1/@60,A,='8*+"5AP4<EM"6<-/)Z'&#QLSEL;0C[G +*@P'<<%"^A]\]$,
M5H'>?>]%KXV!!9YKY([07"4>R*M&G.Y5YT3&8K5&CU*CJ(A%:ZXRD=VXH3ZK
MH5;.?Z#GME;S,-*RP]RW?JG]I*<.)HQ9XHY;P'>+N*9S5I,LYI1(?!+&O.@N
MU*;ZKQT::4QT%KM\&#4RF6:\^*,FWJ:6Z2RV*+"[)\W%"OO56\R_L]*>]*TJ
MN]VJ1L6?OYJ_?GU/W2E;GF$Z3H?;[3?E5OFMZT$'JQ&X)OZO#);8$Z@OEE'3
M)\7:Q55E]%3K/HRJ+:HK=YEOU\D#&HM@$50^[ML)@WGQ44U!-P&(5]0%T89^
M0UU8LFN-==L4N<*H\R@DLK%X/KD_H]UFYE[-AUB1VWXZ9BVQJ>8J4?0Z;5,
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M#!'AL9JUW=;@BAN7'XRE_]VP'*'&7>5A1'\4+HV+O]7J2^%PK*GY%5I.=<B
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MZ%GCCG)/L0R+6 .]$]EYXO$1*^/V'F!FO(F40S_X!MX-)SL#>;S[LJ]<:E^
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M$<H,\V-<1HPK#O8487N(K;M%>!0FI?A2A HJ 1=:$;[O$[ZC[Q7+2- 0X.9
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M:#[TC+X,'_X_4$L! A0#%     @ $8AH5ZY!*_!5%@  8 @! !$
M     ( !     &-N>&$M,C R,S W,S$N>'-D4$L! A0#%     @ $8AH5U8$
MHZ5;&P  \WL! !4              ( !A!8  &-N>&$M,C R,S W,S%?8V%L
M+GAM;%!+ 0(4 Q0    ( !&(:%=_),3BR%X  %0N!@ 5              "
M 1(R  !C;GAA+3(P,C,P-S,Q7V1E9BYX;6Q02P$"% ,4    "  1B&A7]3Q>
M(M^4  "7E@@ %0              @ $-D0  8VYX82TR,#(S,#<S,5]L86(N
M>&UL4$L! A0#%     @ $8AH5V *2,!#;P  _$4' !4              ( !
M'R8! &-N>&$M,C R,S W,S%?<')E+GAM;%!+ 0(4 Q0    ( !&(:%?'O?7<
MB'(  - X!  +              "  965 0!E>#$P+3$T+FAT;5!+ 0(4 Q0
M   ( !&(:%<RNM/7Y@D  -6W   )              "  48( @!E>#$P-RYH
M=&U02P$"% ,4    "  1B&A7%4'&$.@#  #=10  "@              @ %3
M$@( 97@R,2TQ+FAT;5!+ 0(4 Q0    ( !&(:%=3QMHFQ@,   L9   *
M          "  6,6 @!E>#(S+3$N:'1M4$L! A0#%     @ $8AH5Q:8F<X.
M1@  LT8   \              ( !41H" &9O<FUS+3%?,# Q+FIP9U!+ 0(4
M Q0    ( !&(:%?[,;*$2U<  *-C   /              "  8Q@ @!F;W)M
M<RTQ7S P,BYJ<&=02P$"% ,4    "  1B&A7HF$'X/16  "D8   #P
M        @ $$N ( 9F]R;7,M,5\P,#,N:G!G4$L! A0#%     @ $8AH5\)O
M_J7&2P  _54   \              ( !)0\# &9O<FUS+3%?,# T+FIP9U!+
M 0(4 Q0    ( !&(:%<IC Z/$5<  (1@   /              "  1A; P!F
M;W)M<RTQ7S P-2YJ<&=02P$"% ,4    "  1B&A70L8^<1BH! #:]BP "P
M            @ %6L@, 9G)O;7,M,2YH=&U02P4&      \ #P"5 P  EUH(
#

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
